var graphJSON= { "nodes": [{ "data": { "annotation": "Created:  1989-07-01; Modified:  2016-01-20; Version:  221", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P10636", "conceptSize": "22px", "displayValue": "Microtubule-associated protei...", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1", "value": "Microtubule-associated protein tau", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20949042", "conceptSize": "18px", "displayValue": "PMID: 20949042", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "2", "value": "PMID: 20949042", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-214 BY SGK1,  INTERACTION WITH SGK1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16982696", "conceptSize": "18px", "displayValue": "PMID: 16982696", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "3", "value": "PMID: 16982696", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH VDAC1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "25168729", "conceptSize": "18px", "displayValue": "PMID: 25168729", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "4", "value": "PMID: 25168729", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK8 GLY-1441; CYS-1699; SER-2019 AND THR-2020,  VARIANT MET-1906]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17114044", "conceptSize": "18px", "displayValue": "PMID: 17114044", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "5", "value": "PMID: 17114044", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD SER-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10553987", "conceptSize": "26px", "displayValue": "PMID: 10553987", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "6", "value": "PMID: 10553987", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[GLYCOSYLATION,  PHOSPHORYLATION AT SER-516; SER-519; THR-522; THR-529; SER-531; THR-534; SER-579; SER-713; SER-721 AND SER-739,  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19451179", "conceptSize": "26px", "displayValue": "PMID: 19451179", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "7", "value": "PMID: 19451179", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 VAL-271]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12493737", "conceptSize": "18px", "displayValue": "PMID: 12493737", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "8", "value": "PMID: 12493737", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10899436", "conceptSize": "26px", "displayValue": "PMID: 10899436", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "9", "value": "PMID: 10899436", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PIDB THR-574 AND ARG-706,  CHARACTERIZATION OF VARIANTS PIDB THR-574 AND ARG-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11117542", "conceptSize": "18px", "displayValue": "PMID: 11117542", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "10", "value": "PMID: 11117542", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS MET-17; ALA-30 AND ILE-617]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20020531", "conceptSize": "18px", "displayValue": "PMID: 20020531", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "11", "value": "PMID: 20020531", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CAA-APP LYS-693]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20697050", "conceptSize": "18px", "displayValue": "PMID: 20697050", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "12", "value": "PMID: 20697050", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH LRRK2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16352719", "conceptSize": "18px", "displayValue": "PMID: 16352719", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "13", "value": "PMID: 16352719", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PIDB ILE-686,  CHARACTERIZATION OF VARIANT PIDB ILE-686]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11601501", "conceptSize": "26px", "displayValue": "PMID: 11601501", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "14", "value": "PMID: 11601501", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 170-175,  SUBUNIT,  DOMAIN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17468747", "conceptSize": "18px", "displayValue": "PMID: 17468747", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "15", "value": "PMID: 17468747", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH MAPT,  FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11943163", "conceptSize": "18px", "displayValue": "PMID: 11943163", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "16", "value": "PMID: 11943163", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PIDB THR-574]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11089577", "conceptSize": "26px", "displayValue": "PMID: 11089577", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "17", "value": "PMID: 11089577", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "navy", "conceptType": "Gene", "pid": "", "conceptSize": "26px", "displayValue": "MAPT", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "lightBlue", "conceptBorderStyle": "double", "conceptBorderWidth": "3px", "flagged": "true", "id": "18", "value": "MAPT", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Corticotropin", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "19", "value": "Corticotropin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "26px", "displayValue": "Heparin", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "20", "value": "<span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>", "conceptShape": "ellipse", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "[<span style=\"background-color: yellow\"><b>HEPARIN<\/b><\/span>-BINDING DOMAINS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9357988", "conceptSize": "18px", "displayValue": "PMID: 9357988", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "21", "value": "PMID: 9357988", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[N-TERMINAL <span style=\"background-color: yellow\"><b>HEPARIN<\/b><\/span>-BINDING DOMAIN,  MUTAGENESIS OF 99-LYS--ARG-102]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8158260", "conceptSize": "18px", "displayValue": "PMID: 8158260", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "22", "value": "PMID: 8158260", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[EXTRACELLULAR COPPER-BINDING DOMAIN,  MUTAGENESIS OF HIS-137; MET-141; CYS-144; HIS-147 AND HIS-151]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7913895", "conceptSize": "18px", "displayValue": "PMID: 7913895", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "23", "value": "PMID: 7913895", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 18-190,  PARTIAL PROTEIN SEQUENCE,  SUBUNIT,  DISULFIDE BONDS,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20212142", "conceptSize": "18px", "displayValue": "PMID: 20212142", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "24", "value": "PMID: 20212142", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-123]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10201399", "conceptSize": "18px", "displayValue": "PMID: 10201399", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "25", "value": "PMID: 10201399", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF CASEIN KINASE PHOSPHORYLATION,  MUTAGENESIS OF SER-198 AND SER-206]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10806211", "conceptSize": "18px", "displayValue": "PMID: 10806211", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "26", "value": "PMID: 10806211", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 523-555,  DOMAIN COLLAGEN-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8576160", "conceptSize": "18px", "displayValue": "PMID: 8576160", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "27", "value": "PMID: 8576160", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[EXTRACELLULAR ZINC-BINDING DOMAIN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8344894", "conceptSize": "18px", "displayValue": "PMID: 8344894", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "28", "value": "PMID: 8344894", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> ASSOCIATION];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19936054", "conceptSize": "18px", "displayValue": "PMID: 19936054", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "29", "value": "PMID: 19936054", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "260540", "conceptSize": "26px", "displayValue": "PARKINSON-DEMENTIA SYNDROME", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "30", "value": "<span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span>-DEMENTIA SYNDROME", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein,  small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. ( Reference:  GOC: go_curators Pfam: PF00018 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0017124", "conceptSize": "18px", "displayValue": "SH3 domain binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "31", "value": "SH3 domain binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The action of a molecule that contributes to the structural integrity of a cytoskeletal structure. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005200", "conceptSize": "18px", "displayValue": "structural constituent of cyt...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "32", "value": "structural constituent of cytoskeleton", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with microtubules,  filaments composed of tubulin monomers. ( Reference:  GOC: krc )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008017", "conceptSize": "18px", "displayValue": "microtubule binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "33", "value": "microtubule binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with any enzyme. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0019899", "conceptSize": "18px", "displayValue": "enzyme binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "34", "value": "enzyme binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an apolipoprotein,  the protein component of a lipoprotein complex. ( Reference:  GOC: BHF GOC: rl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0034185", "conceptSize": "18px", "displayValue": "apolipoprotein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "35", "value": "apolipoprotein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a lipoprotein particle. A lipoprotein particle,  also known as a lipoprotein,  is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids. ( Reference:  CHEBI: 6495 GOC: BHF GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0071813", "conceptSize": "18px", "displayValue": "lipoprotein particle binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "36", "value": "lipoprotein particle binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P27448", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "37", "value": "P27448", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "22px", "displayValue": "P63104", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "38", "value": "P63104", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "22px", "displayValue": "Q9UNE7", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "39", "value": "Q9UNE7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P07237", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "40", "value": "P07237", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  2006-01-24; Modified:  2016-01-20; Version:  130", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "Q5S007", "conceptSize": "22px", "displayValue": "Leucine-rich repeat serine\/th...", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "41", "value": "Leucine-rich repeat serine\/threonine-protein kinase 2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN RETROGRADE TRANSPORT,  INTERACTION WITH LRRK2,  CHARACTERIZATION OF VARIANT PARK17 ASN-620]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23395371", "conceptSize": "18px", "displayValue": "PMID: 23395371", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "42", "value": "PMID: 23395371", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH TPCN2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22012985", "conceptSize": "18px", "displayValue": "PMID: 22012985", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "43", "value": "PMID: 22012985", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8\/PD SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15852371", "conceptSize": "18px", "displayValue": "PMID: 15852371", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "44", "value": "PMID: 15852371", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 VAL-1371 AND SER-2019,  VARIANTS HIS-1398 AND THR-2397]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16157901", "conceptSize": "18px", "displayValue": "PMID: 16157901", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "45", "value": "PMID: 16157901", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16081470", "conceptSize": "18px", "displayValue": "PMID: 16081470", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "46", "value": "PMID: 16081470", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT ARG-2385,  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17019612", "conceptSize": "18px", "displayValue": "PMID: 17019612", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "47", "value": "PMID: 17019612", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 TRP-275]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22956510", "conceptSize": "18px", "displayValue": "PMID: 22956510", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "48", "value": "PMID: 22956510", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CYS-315]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21248752", "conceptSize": "18px", "displayValue": "PMID: 21248752", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "49", "value": "PMID: 21248752", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15680457", "conceptSize": "18px", "displayValue": "PMID: 15680457", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "50", "value": "PMID: 15680457", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 CYS-1441; GLY-1441; HIS-1441; GLN-1514; SER-1542; GLU-1598; CYS-1699; THR-1869; THR-2012; SER-2019; THR-2020 AND ARG-2385,  VARIANTS PRO-119; LYS-551; VAL-723; MET-793; VAL-1122; ALA-1262; HIS-1398; PRO-1628; THR-1646; THR-1647; ASP-2081; LEU-2119; ILE-2261 AND THR-2397]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16172858", "conceptSize": "18px", "displayValue": "PMID: 16172858", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "51", "value": "PMID: 16172858", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 CYS-1699; HIS-1941; SER-2019 AND ILE-2356]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16272164", "conceptSize": "18px", "displayValue": "PMID: 16272164", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "52", "value": "PMID: 16272164", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16532471", "conceptSize": "18px", "displayValue": "PMID: 16532471", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "53", "value": "PMID: 16532471", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O00499-1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "54", "value": "O00499-1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q7KZI7", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "55", "value": "Q7KZI7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1987-08-13; Modified:  2016-01-20; Version:  246", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P05067", "conceptSize": "26px", "displayValue": "C83", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "56", "value": "C83", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 GLY-692]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1303239", "conceptSize": "18px", "displayValue": "PMID: 1303239", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "57", "value": "PMID: 1303239", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH KIAA1191]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21153684", "conceptSize": "18px", "displayValue": "PMID: 21153684", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "58", "value": "PMID: 21153684", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH PLD3]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24336208", "conceptSize": "18px", "displayValue": "PMID: 24336208", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "59", "value": "PMID: 24336208", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10899933", "conceptSize": "18px", "displayValue": "PMID: 10899933", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "60", "value": "PMID: 10899933", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 THR-233 AND THR-278]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9172170", "conceptSize": "18px", "displayValue": "PMID: 9172170", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "61", "value": "PMID: 9172170", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-441 AND TYR-497]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "26091039", "conceptSize": "18px", "displayValue": "PMID: 26091039", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "62", "value": "PMID: 26091039", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION OF BETA-APP42 WITH CHRNA7]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10681545", "conceptSize": "18px", "displayValue": "PMID: 10681545", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "63", "value": "PMID: 10681545", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 ARG-134; ARG-163 AND VAL-262,  VARIANT TYR-214]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22503161", "conceptSize": "18px", "displayValue": "PMID: 22503161", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "64", "value": "PMID: 22503161", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH SORL1,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16174740", "conceptSize": "18px", "displayValue": "PMID: 16174740", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "65", "value": "PMID: 16174740", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9851443", "conceptSize": "18px", "displayValue": "PMID: 9851443", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "66", "value": "PMID: 9851443", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10593990", "conceptSize": "18px", "displayValue": "PMID: 10593990", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "67", "value": "PMID: 10593990", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 VAL-79; CYS-115 AND VAL-231,  VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9384602", "conceptSize": "18px", "displayValue": "PMID: 9384602", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "68", "value": "PMID: 9384602", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEASE-SPECIFICITY OF INHIBITOR DOMAIN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1969731", "conceptSize": "18px", "displayValue": "PMID: 1969731", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "69", "value": "PMID: 1969731", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8577393", "conceptSize": "18px", "displayValue": "PMID: 8577393", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "70", "value": "PMID: 8577393", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH GSAP]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20811458", "conceptSize": "18px", "displayValue": "PMID: 20811458", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "71", "value": "PMID: 20811458", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 LEU-82; HIS-115; ASP-120; THR-139; LEU-146; ILE-147; ARG-163; CYS-165; TRP-173; THR-231; THR-233; PRO-235; LEU-264; ILE-390; VAL-392 AND TYR-410,  VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10441572", "conceptSize": "18px", "displayValue": "PMID: 10441572", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "72", "value": "PMID: 10441572", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CLEAVAGE AT LEU-720]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11851430", "conceptSize": "18px", "displayValue": "PMID: 11851430", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "73", "value": "PMID: 11851430", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD1 ILE-717 AND PHE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8267572", "conceptSize": "18px", "displayValue": "PMID: 8267572", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "74", "value": "PMID: 8267572", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION OF BETA-AMYLOID WITH APOE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10816430", "conceptSize": "18px", "displayValue": "PMID: 10816430", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "75", "value": "PMID: 10816430", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 672-681]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3312495", "conceptSize": "18px", "displayValue": "PMID: 3312495", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "76", "value": "PMID: 3312495", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH FBLN1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11238726", "conceptSize": "18px", "displayValue": "PMID: 11238726", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "77", "value": "PMID: 11238726", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12679784", "conceptSize": "18px", "displayValue": "PMID: 12679784", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "78", "value": "PMID: 12679784", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 PRO-166]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12048239", "conceptSize": "18px", "displayValue": "PMID: 12048239", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "79", "value": "PMID: 12048239", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS EARLY-ONSET DEMENTIA LEU-102; ALA-183 AND LYS-188]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10631141", "conceptSize": "18px", "displayValue": "PMID: 10631141", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "80", "value": "PMID: 10631141", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 696-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8973180", "conceptSize": "18px", "displayValue": "PMID: 8973180", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "81", "value": "PMID: 8973180", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 36-42; 61-76; 109-129; 217-239; 270-278; 315-320; 345-352 AND 381-395 (ISOFORM 1),  IDENTIFICATION BY MASS SPECTROMETRY,  CHARACTERIZATION OF GAMMA-SECRETASE COMPLEX]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15274632", "conceptSize": "18px", "displayValue": "PMID: 15274632", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "82", "value": "PMID: 15274632", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  ACTIVE SITES ASP-263 AND ASP-366,  MUTAGENESIS OF ASP-263 AND ASP-366]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10652302", "conceptSize": "18px", "displayValue": "PMID: 10652302", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "83", "value": "PMID: 10652302", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 LEU-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10867787", "conceptSize": "18px", "displayValue": "PMID: 10867787", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "84", "value": "PMID: 10867787", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Intracellular mass of paired,  helically wound protein filaments (also called PHF) lying in the cytoplasm of neuronal cell bodies and neuritic cell processes. Neurofibrillary tangles contain an abnormally phosphorylated form of a microtubule-associated protein,  tau. The shape of these inclusions may resemble a flame or a star. ( Reference:  NIF_Subcellular: nlx_subcell_20090201 NIF_Subcellular: nlx_subcell_20090202 NIF_Subcellular: sao2409833926 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0097418", "conceptSize": "18px", "displayValue": "neurofibrillary tangle", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "85", "value": "neurofibrillary tangle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any multimeric complex connected to a microtubule. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005875", "conceptSize": "18px", "displayValue": "microtubule associated complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "86", "value": "microtubule associated complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A ribonucleoprotein granule located in the cytoplasm. ( Reference:  GOC: bf GOC: PARL PMID: 15121898 );", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0036464", "conceptSize": "18px", "displayValue": "cytoplasmic ribonucleoprotein...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "87", "value": "cytoplasmic ribonucleoprotein granule", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The part of the cytoplasm that does not contain organelles but which does contain other particulate matter,  such as protein complexes. ( Reference:  GOC: hjd GOC: jl )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005829", "conceptSize": "18px", "displayValue": "cytosol", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "88", "value": "cytosol", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any of the long,  generally straight,  hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin,  staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface,  and with the alpha beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation,  e.g. in the spindle. ( Reference:  ISBN: 0879693568 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005874", "conceptSize": "18px", "displayValue": "microtubuli", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "89", "value": "microtubuli", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements. ( Reference:  GOC: bf GOC: cilia ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005930", "conceptSize": "18px", "displayValue": "axoneme", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "90", "value": "axoneme", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. ( Reference:  ISBN: 0716731363 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005886", "conceptSize": "18px", "displayValue": "plasmalemma", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "91", "value": "plasmalemma", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The portion of a cell bearing surface projections such as axons,  dendrites,  cilia,  or flagella that includes the nucleus,  but excludes all cell projections. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0044297", "conceptSize": "18px", "displayValue": "cell soma", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "92", "value": "cell soma", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The postsynaptic density is a region that lies adjacent to the cytoplasmic face of the postsynaptic membrane at excitatory synapse. It forms a disc that consists of a range of proteins with different functions,  some of which contact the cytoplasmic domains of ion channels in the postsynaptic membrane. The proteins making up the disc include receptors,  and structural proteins linked to the actin cytoskeleton. They also include signalling machinery,  such as protein kinases and phosphatases. The postsynaptic density may be part of a neuron or a muscle cell or a glial cell. ( Reference:  GOC: BHF GOC: ef GOC: jid GOC: pr GOC: sjp http: \/\/molneuro.kaist.ac.kr\/psd PMID: 14532281 Wikipedia: Postsynaptic_density )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0014069", "conceptSize": "18px", "displayValue": "postsynaptic density", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "93", "value": "postsynaptic density", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A neuron projection that has a short,  tapering,  often branched,  morphology,  receives and integrates signals from other neurons or from sensory stimuli,  and conducts a nerve impulse towards the axon or the cell body. In most neurons,  the impulse is conveyed from dendrites to axon via the cell body,  but in some types of unipolar neuron,  the impulse does not travel via the cell body. ( Reference:  GOC: dos GOC: mah GOC: nln ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030425", "conceptSize": "18px", "displayValue": "dendrite", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "94", "value": "dendrite", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A heterodimer of tubulins alpha and beta that constitutes the protomer for microtubule assembly. ( Reference:  ISBN: 0716731363 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0045298", "conceptSize": "18px", "displayValue": "tubulin complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "95", "value": "tubulin complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The portion of the nuclear lumen proximal to the inner nuclear membrane. ( Reference:  GOC: krc GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0034399", "conceptSize": "18px", "displayValue": "nuclear periphery", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "96", "value": "nuclear periphery", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The long process of a neuron that conducts nerve impulses,  usually away from the cell body to the terminals and varicosities,  which are sites of storage and release of neurotransmitter. ( Reference:  GOC: nln ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030424", "conceptSize": "18px", "displayValue": "axon", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "97", "value": "axon", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The migrating motile tip of a growing nerve cell axon or dendrite. ( Reference:  ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030426", "conceptSize": "18px", "displayValue": "growth cone", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "98", "value": "growth cone", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Docetaxel", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "99", "value": "Docetaxel", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Paclitaxel", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "100", "value": "Paclitaxel", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons. ( Reference:  GOC: nln )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048699", "conceptSize": "18px", "displayValue": "neuron generation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "101", "value": "neuron generation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of axon extension. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045773", "conceptSize": "18px", "displayValue": "upregulation of axon extension", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "102", "value": "upregulation of axon extension", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a nutrient stimulus. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007584", "conceptSize": "18px", "displayValue": "response to nutrient", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "103", "value": "response to nutrient", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand),  and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process,  and is typically characterized by rounding-up of the cell,  retraction of pseudopodes,  reduction of cellular volume (pyknosis),  chromatin condensation,  nuclear fragmentation (karyorrhexis),  plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed,  the cell has died. ( Reference:  GOC: cjm GOC: dhl GOC: ecd GOC: go_curators GOC: mtg_apoptosis GOC: tb ISBN: 0198506732 PMID: 18846107 PMID: 21494263 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006915", "conceptSize": "18px", "displayValue": "apoptotic process", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "104", "value": "apoptotic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Long distance growth of a single axon process involved in cellular development. ( Reference:  GOC: BHF GOC: dgh GOC: dph GOC: jid GOC: lm GOC: rl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048675", "conceptSize": "18px", "displayValue": "axon extension", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "105", "value": "axon extension", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  and ends when the execution phase of apoptosis is triggered. ( Reference:  GOC: ai GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008631", "conceptSize": "18px", "displayValue": "oxidative stress-induced intr...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "106", "value": "oxidative stress-induced intrinsic apoptotic signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031113", "conceptSize": "18px", "displayValue": "regulation of microtubule pol...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "107", "value": "regulation of microtubule polymerization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an organic substance stimulus. ( Reference:  GOC: sm )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010033", "conceptSize": "18px", "displayValue": "response to organic substance", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "108", "value": "response to organic substance", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of substances within cells. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032387", "conceptSize": "18px", "displayValue": "downregulation of intracellul...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "109", "value": "downregulation of intracellular transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of cytoskeletal structures comprising microtubules and their associated proteins. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000226", "conceptSize": "18px", "displayValue": "microtubule dynamics", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "110", "value": "microtubule dynamics", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The behavior of an adult relating to the progression of that organism along the ground by the process of lifting and setting down each leg. ( Reference:  GOC: jid GOC: pr ISBN: 0198606907 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007628", "conceptSize": "18px", "displayValue": "adult walking behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "111", "value": "adult walking behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of organelles or molecules along microtubules in neuron projections. ( Reference:  ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008088", "conceptSize": "18px", "displayValue": "axo-dendritic transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "112", "value": "axo-dendritic transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031116", "conceptSize": "18px", "displayValue": "upregulation of microtubule p...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "113", "value": "upregulation of microtubule polymerization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. ( Reference:  ISBN: 0192800825 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007565", "conceptSize": "18px", "displayValue": "gestation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "114", "value": "gestation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of a mitochondrion along a microtubule,  mediated by motor proteins. ( Reference:  GOC: ecd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0047497", "conceptSize": "18px", "displayValue": "mitochondrial transport along...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "115", "value": "mitochondrial transport along microtubule", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010506", "conceptSize": "18px", "displayValue": "regulation of autophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "116", "value": "regulation of autophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the rate,  frequency,  or extent of microtubule-based movement,  the movement of organelles,  other microtubules and other particles along microtubules,  mediated by motor proteins. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060632", "conceptSize": "18px", "displayValue": "regulation of microtubule-bas...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "117", "value": "regulation of microtubule-based movement", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the brain over time,  from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight,  hearing,  smell,  etc.). ( Reference:  GOC: dph GOC: jid GOC: tb UBERON: 0000955 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007420", "conceptSize": "18px", "displayValue": "brain development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "118", "value": "brain development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The breakdown of structures such as organelles,  proteins,  or other macromolecular structures during apoptosis. ( Reference:  GOC: dph GOC: mah GOC: mtg_apoptosis GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006921", "conceptSize": "18px", "displayValue": "cellular component disassembl...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "119", "value": "cellular component disassembly involved in execution phase of apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature. ( Reference:  CL: 0000540 GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001764", "conceptSize": "18px", "displayValue": "neuron migration", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "120", "value": "neuron migration", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell. ( Reference:  GOC: lr GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0012501", "conceptSize": "18px", "displayValue": "PCD", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "121", "value": "PCD", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD HIS-5,  CHARACTERIZATION OF VARIANT FTD HIS-5]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11921059", "conceptSize": "18px", "displayValue": "PMID: 11921059", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "122", "value": "PMID: 11921059", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-554; SER-579; SER-602; SER-606 AND SER-669]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8999860", "conceptSize": "18px", "displayValue": "PMID: 8999860", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "123", "value": "PMID: 8999860", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD MET-654,  VARIANTS ASN-285; ALA-289; HIS-441 AND PRO-447]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9629852", "conceptSize": "18px", "displayValue": "PMID: 9629852", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "124", "value": "PMID: 9629852", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-519; THR-522; SER-713 AND SER-721 BY CSNK1D\/CK1,  INTERACTION WITH CSNK1D]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14761950", "conceptSize": "26px", "displayValue": "PMID: 14761950", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "125", "value": "PMID: 14761950", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1713721", "conceptSize": "18px", "displayValue": "PMID: 1713721", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "126", "value": "PMID: 1713721", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FETAL-TAU)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3131773", "conceptSize": "26px", "displayValue": "PMID: 3131773", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "127", "value": "PMID: 3131773", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS PNS-TAU; FETAL-TAU AND TAU-F),  ALTERNATIVE SPLICING,  VARIANT HIS-441]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1420178", "conceptSize": "18px", "displayValue": "PMID: 1420178", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "128", "value": "PMID: 1420178", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS FTD VAL-589; LYS-597 DEL; LEU-618 AND TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9973279", "conceptSize": "18px", "displayValue": "PMID: 9973279", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "129", "value": "PMID: 9973279", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  PHOSPHORYLATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10747907", "conceptSize": "26px", "displayValue": "PMID: 10747907", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "130", "value": "PMID: 10747907", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-B; TAU-C; TAU-E AND TAU-F),  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2484340", "conceptSize": "26px", "displayValue": "PMID: 2484340", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "131", "value": "PMID: 2484340", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD LEU-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9736786", "conceptSize": "26px", "displayValue": "PMID: 9736786", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "132", "value": "PMID: 9736786", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH SQSTM1,  UBIQUITINATION,  PROTEASOMAL DEGRADATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15953362", "conceptSize": "18px", "displayValue": "PMID: 15953362", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "133", "value": "PMID: 15953362", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 542-554 IN COMPLEX WITH PIN1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11313338", "conceptSize": "18px", "displayValue": "PMID: 11313338", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "134", "value": "PMID: 11313338", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PIDB ARG-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10604746", "conceptSize": "26px", "displayValue": "PMID: 10604746", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "135", "value": "PMID: 10604746", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11889249", "conceptSize": "18px", "displayValue": "PMID: 11889249", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "136", "value": "PMID: 11889249", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS FTD LEU-618; MET-654 AND TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10214944", "conceptSize": "26px", "displayValue": "PMID: 10214944", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "137", "value": "PMID: 10214944", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PSNP1 ASN-285 AND ALA-289]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10534245", "conceptSize": "18px", "displayValue": "PMID: 10534245", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "138", "value": "PMID: 10534245", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANTS FTD ASN-613 DEL AND HIS-613]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11906000", "conceptSize": "18px", "displayValue": "PMID: 11906000", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "139", "value": "PMID: 11906000", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PSNP1 ASN-613 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11220749", "conceptSize": "26px", "displayValue": "PMID: 11220749", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "140", "value": "PMID: 11220749", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD SER-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11071507", "conceptSize": "18px", "displayValue": "PMID: 11071507", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "141", "value": "PMID: 11071507", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD ASN-622]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10208578", "conceptSize": "18px", "displayValue": "PMID: 10208578", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "142", "value": "PMID: 10208578", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726,  DEPHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726 BY PPP5C]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15546861", "conceptSize": "26px", "displayValue": "PMID: 15546861", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "143", "value": "PMID: 15546861", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PPND LYS-596]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10412802", "conceptSize": "26px", "displayValue": "PMID: 10412802", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "144", "value": "PMID: 10412802", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[GLYCATION AT LYS-87; LYS-383; LYS-467; LYS-480; LYS-491; LYS-542; LYS-551; LYS-576; LYS-597; LYS-598; LYS-664; LYS-670 AND LYS-686,  LACK OF GLYCATION AT LYS-24; LYS-44; LYS-67; LYS-381; LYS-391; LYS-392; LYS-394; LYS-465; LYS-497; LYS-507; LYS-541; LYS-557; LYS-571; LYS-574; LYS-584; LYS-591; LYS-607; LYS-611; LYS-615; LYS-628; LYS-634; LYS-638; LYS-648; LYS-657; LYS-660; LYS-687; LYS-692; LYS-700; LYS-702; LYS-712 AND LYS-755]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9326300", "conceptSize": "18px", "displayValue": "PMID: 9326300", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "145", "value": "PMID: 9326300", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTDP17\/<span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14517953", "conceptSize": "26px", "displayValue": "PMID: 14517953", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "146", "value": "PMID: 14517953", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD LYS-596]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10489057", "conceptSize": "18px", "displayValue": "PMID: 10489057", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "147", "value": "PMID: 10489057", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD SER-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16240366", "conceptSize": "26px", "displayValue": "PMID: 16240366", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "148", "value": "PMID: 16240366", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PSNP1 LEU-5,  CHARACTERIZATION OF VARIANT PSNP1 LEU-5]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12325083", "conceptSize": "18px", "displayValue": "PMID: 12325083", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "149", "value": "PMID: 12325083", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  PHOSPHORYLATION AT THR-529 AND SER-579]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21985311", "conceptSize": "18px", "displayValue": "PMID: 21985311", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "150", "value": "PMID: 21985311", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS FTD LYS-596 AND LEU-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9789048", "conceptSize": "26px", "displayValue": "PMID: 9789048", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "151", "value": "PMID: 9789048", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD HIS-613]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11585254", "conceptSize": "26px", "displayValue": "PMID: 11585254", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "152", "value": "PMID: 11585254", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD MET-634]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15883319", "conceptSize": "18px", "displayValue": "PMID: 15883319", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "153", "value": "PMID: 15883319", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT THR-470; SER-516; SER-519; THR-529; SER-531; SER-552; SER-579; SER-713; SER-721 AND SER-739,  MUTAGENESIS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9614189", "conceptSize": "26px", "displayValue": "PMID: 9614189", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "154", "value": "PMID: 9614189", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 616-712]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1915258", "conceptSize": "18px", "displayValue": "PMID: 1915258", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "155", "value": "PMID: 1915258", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT FTD TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11278002", "conceptSize": "18px", "displayValue": "PMID: 11278002", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "156", "value": "PMID: 11278002", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD\/CBD SER-618]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10374757", "conceptSize": "18px", "displayValue": "PMID: 10374757", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "157", "value": "PMID: 10374757", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669,  CHARACTERIZATION OF VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14595660", "conceptSize": "18px", "displayValue": "PMID: 14595660", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "158", "value": "PMID: 14595660", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TAU-D)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2498079", "conceptSize": "18px", "displayValue": "PMID: 2498079", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "159", "value": "PMID: 2498079", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD LYS-596]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12473774", "conceptSize": "18px", "displayValue": "PMID: 12473774", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "160", "value": "PMID: 12473774", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT THR-529 BY DYRK2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18599021", "conceptSize": "18px", "displayValue": "PMID: 18599021", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "161", "value": "PMID: 18599021", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 577-584; 608-611; 616-628; 639-648 AND 671-686,  PHOSPHORYLATION AT SER-579; SER-610; SER-622; SER-641 AND SER-673,  MUTAGENESIS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7706316", "conceptSize": "18px", "displayValue": "PMID: 7706316", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "162", "value": "PMID: 7706316", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PIDB PHE-637,  CHARACTERIZATION OF VARIANT PIDB PHE-637]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11891833", "conceptSize": "18px", "displayValue": "PMID: 11891833", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "163", "value": "PMID: 11891833", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-A AND FETAL-TAU)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2516729", "conceptSize": "18px", "displayValue": "PMID: 2516729", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "164", "value": "PMID: 2516729", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT TYR-514; SER-515; SER-516; SER-519; SER-733; SER-739 AND THR-744]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16923168", "conceptSize": "18px", "displayValue": "PMID: 16923168", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "165", "value": "PMID: 16923168", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[GLYCOSYLATION AT SER-525; SER-555 AND SER-717,  PHOSPHORYLATION AT SER-519; SER-713 SER-717 AND SER-721,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21327254", "conceptSize": "18px", "displayValue": "PMID: 21327254", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "166", "value": "PMID: 21327254", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PSNP1\/ATYPICAL PSNP1 ASN-613 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14991828", "conceptSize": "18px", "displayValue": "PMID: 14991828", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "167", "value": "PMID: 14991828", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 2-73; 103-381; 468-497; 508-571; 577-583; 592-607; 616-634; 639-657; 661-664; 671-700 AND 703-758,  CLEAVAGE OF INITIATOR METHIONINE,  ACETYLATION AT ALA-2,  DEAMIDATION AT ASN-484]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1512244", "conceptSize": "18px", "displayValue": "PMID: 1512244", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "168", "value": "PMID: 1512244", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD VAL-659]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11117541", "conceptSize": "18px", "displayValue": "PMID: 11117541", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "169", "value": "PMID: 11117541", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS FTD VAL-589; LEU-618 AND TRP-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9641683", "conceptSize": "18px", "displayValue": "PMID: 9641683", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "170", "value": "PMID: 9641683", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD LYS-596]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10802785", "conceptSize": "18px", "displayValue": "PMID: 10802785", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "171", "value": "PMID: 10802785", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT THR-548 BY GSK3B]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14690523", "conceptSize": "18px", "displayValue": "PMID: 14690523", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "172", "value": "PMID: 14690523", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 251-264 AND 379-392,  PHOSPHORYLATION AT SER-396]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1899488", "conceptSize": "18px", "displayValue": "PMID: 1899488", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "173", "value": "PMID: 1899488", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION BY CSNK1D\/CK1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17562708", "conceptSize": "18px", "displayValue": "PMID: 17562708", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "174", "value": "PMID: 17562708", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 543-551; 560-574; 576-584 AND 623-634,  PHOSPHORYLATION AT SER-531; THR-534; THR-548; SER-552; SER-554; SER-579; SER-713 AND SER-739,  UBIQUITINATION AT LYS-571; LYS-628 AND LYS-670,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16443603", "conceptSize": "18px", "displayValue": "PMID: 16443603", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "175", "value": "PMID: 16443603", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT TYR-18 BY FYN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14999081", "conceptSize": "18px", "displayValue": "PMID: 14999081", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "176", "value": "PMID: 14999081", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[IDENTIFICATION (ISOFORM TAU-G),  VARIANT HIS-441]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15365985", "conceptSize": "18px", "displayValue": "PMID: 15365985", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "177", "value": "PMID: 15365985", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FTD VAL-583,  CHARACTERIZATION OF VARIANT FTD VAL-583]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12509859", "conceptSize": "18px", "displayValue": "PMID: 12509859", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "178", "value": "PMID: 12509859", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH EPM2A]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19542233", "conceptSize": "18px", "displayValue": "PMID: 19542233", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "179", "value": "PMID: 19542233", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT ATYPICAL PSNP1 ASN-613 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14991829", "conceptSize": "18px", "displayValue": "PMID: 14991829", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "180", "value": "PMID: 14991829", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PSNP1 VAL-620]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16157753", "conceptSize": "18px", "displayValue": "PMID: 16157753", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "181", "value": "PMID: 16157753", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 592-622 (ISOFORMS PNS-TAU\/TAU-D\/TAU-E\/TAU-F)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2495000", "conceptSize": "18px", "displayValue": "PMID: 2495000", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "182", "value": "PMID: 2495000", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION,  MUTAGENESIS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9735171", "conceptSize": "18px", "displayValue": "PMID: 9735171", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "183", "value": "PMID: 9735171", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "26px", "displayValue": "Parkinson's disease", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "184", "value": "Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "H1H2", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "185", "value": "H1H2", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "idiopathic pulmonary fibrosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "186", "value": "idiopathic pulmonary fibrosis", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs17690703", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "187", "value": "rs17690703", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "bone density", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "188", "value": "bone density", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs1864325", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "189", "value": "rs1864325", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs11012", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "190", "value": "rs11012", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs2942168", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "191", "value": "rs2942168", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs17577094", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "192", "value": "rs17577094", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "Interstitial lung disease", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "193", "value": "Interstitial lung disease", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs1981997", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "194", "value": "rs1981997", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs9303525", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "195", "value": "rs9303525", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "Intracranial volume", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "196", "value": "Intracranial volume", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs2732703", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "197", "value": "rs2732703", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "Alzheimers disease", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "198", "value": "Alzheimers disease", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs17649553", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "199", "value": "rs17649553", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs199498", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "200", "value": "rs199498", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "infant head circumference", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "201", "value": "infant head circumference", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs11655470", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "202", "value": "rs11655470", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs199533", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "203", "value": "rs199533", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs12185268", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "204", "value": "rs12185268", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "Corticobasal degeneration", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "205", "value": "Corticobasal degeneration", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs8072451", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "206", "value": "rs8072451", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs8070723", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "207", "value": "rs8070723", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Trait", "pid": "", "conceptSize": "18px", "displayValue": "Progressive supranuclear palsy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "greenYellow", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "208", "value": "Progressive supranuclear palsy", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "22px", "displayValue": "rs393152", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "209", "value": "rs393152", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "SNP", "pid": "", "conceptSize": "18px", "displayValue": "rs242557", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "210", "value": "rs242557", "conceptShape": "star", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P49841", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "211", "value": "P49841", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q12800", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "212", "value": "Q12800", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P08107", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "213", "value": "P08107", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P07900", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "214", "value": "P07900", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q86WG3", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "215", "value": "Q86WG3", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P11142", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "216", "value": "P11142", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q7Z7E8", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "217", "value": "Q7Z7E8", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q38SD2", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "218", "value": "Q38SD2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P10636-8", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "219", "value": "P10636-8", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P04179", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "220", "value": "P04179", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Ribostamycin", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "221", "value": "Ribostamycin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Adenosine monophosphate", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "222", "value": "Adenosine monophosphate", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Levodopa", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "223", "value": "Levodopa", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 ASN-161; ASN-211; CYS-256; TRP-275; ASN-280; GLY-289; GLU-328; CYS-334; ASN-415 AND ASP-430]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10824074", "conceptSize": "18px", "displayValue": "PMID: 10824074", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "224", "value": "PMID: 10824074", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 ASN-161; CYS-256; TRP-275 AND ASN-415,  VARIANTS ASN-167; LEU-380 AND ASN-394]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10072423", "conceptSize": "18px", "displayValue": "PMID: 10072423", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "225", "value": "PMID: 10072423", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Glycine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "226", "value": "Glycine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.75 ANGSTROMS) OF 61-65 IN COMPLEX WITH COPPER ION,  DOMAIN,  SUBUNIT];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11900542", "conceptSize": "18px", "displayValue": "PMID: 11900542", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "227", "value": "PMID: 11900542", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 SER-266]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11920851", "conceptSize": "18px", "displayValue": "PMID: 11920851", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "228", "value": "PMID: 11920851", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 58-85 AND 111-150]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1672107", "conceptSize": "18px", "displayValue": "PMID: 1672107", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "229", "value": "PMID: 1672107", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD VAL-131]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11709001", "conceptSize": "18px", "displayValue": "PMID: 11709001", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "230", "value": "PMID: 11709001", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 ALA-206]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11710891", "conceptSize": "18px", "displayValue": "PMID: 11710891", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "231", "value": "PMID: 11710891", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR IN COMPLEX WITH DETERGENT MICELLES]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15615727", "conceptSize": "18px", "displayValue": "PMID: 15615727", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "232", "value": "PMID: 15615727", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 GLU-378]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10200054", "conceptSize": "18px", "displayValue": "PMID: 10200054", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "233", "value": "PMID: 10200054", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Dopamine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "234", "value": "Dopamine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH FBXW7 AND CUL1,  UBIQUITINATION OF CYCLIN E]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12628165", "conceptSize": "18px", "displayValue": "PMID: 12628165", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "235", "value": "PMID: 12628165", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24896179", "conceptSize": "18px", "displayValue": "PMID: 24896179", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "236", "value": "PMID: 24896179", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH AIMP2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16135753", "conceptSize": "18px", "displayValue": "PMID: 16135753", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "237", "value": "PMID: 16135753", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  UBIQUITINATION,  S-NITROSYLATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15105460", "conceptSize": "18px", "displayValue": "PMID: 15105460", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "238", "value": "PMID: 15105460", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH ZNF746,  CHARACTERIZATION OF VARIANTS PARK2 TRP-275; ASP-430 AND PHE-431]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21376232", "conceptSize": "18px", "displayValue": "PMID: 21376232", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "239", "value": "PMID: 21376232", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 MET-15,  VARIANTS LEU-380 AND ASN-394]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12397156", "conceptSize": "18px", "displayValue": "PMID: 12397156", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "240", "value": "PMID: 12397156", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Adenosine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "241", "value": "Adenosine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Enzyme Classification", "pid": "2.7.11.1", "conceptSize": "18px", "displayValue": "2.7.11.1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "pink", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "242", "value": "2.7.11.1", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "607060", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE 8,  AUTOSOMA...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "243", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 8,  AUTOSOMAL DOMINANT; PARK8", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "168600", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE,  LATE-ONSET...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "244", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>,  LATE-ONSET; PD", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with ATP,  adenosine 5'-triphosphate,  a universally important coenzyme and enzyme regulator. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005524", "conceptSize": "18px", "displayValue": "ATP binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "245", "value": "ATP binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a beta-catenin destruction complex. ( Reference:  GO_REF: 000102 GOC: bf GOC: PARL GOC: TermGenie PMID: 22899650 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 1904713", "conceptSize": "18px", "displayValue": "BDC binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "246", "value": "BDC binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with any subunit of protein kinase A. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0051018", "conceptSize": "18px", "displayValue": "PKA binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "247", "value": "PKA binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with monomeric or multimeric forms of tubulin,  including microtubules. ( Reference:  GOC: clt )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0015631", "conceptSize": "18px", "displayValue": "tubulin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "248", "value": "tubulin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with the SNAP receptor syntaxin-1. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0017075", "conceptSize": "18px", "displayValue": "syntaxin-1 binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "249", "value": "syntaxin-1 binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the reaction:  GTP + H2O = GDP + phosphate. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0003924", "conceptSize": "18px", "displayValue": "GTPase activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "250", "value": "GTPase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a clathrin heavy or light chain,  the main components of the coat of coated vesicles and coated pits,  and which also occurs in synaptic vesicles. ( Reference:  GOC: jl GOC: mah ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0030276", "conceptSize": "18px", "displayValue": "clathrin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "251", "value": "clathrin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with monomeric or multimeric forms of actin,  including actin filaments. ( Reference:  GOC: clt )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0003779", "conceptSize": "18px", "displayValue": "actin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "252", "value": "actin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an identical protein to form a homodimer. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0042803", "conceptSize": "18px", "displayValue": "protein homodimerization acti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "253", "value": "protein homodimerization activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Functions to provide a physical support for the assembly of a multiprotein receptor signaling complex. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0030159", "conceptSize": "18px", "displayValue": "receptor signalling complex s...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "254", "value": "receptor signalling complex scaffold", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the reactions:  ATP + protein serine = ADP + protein serine phosphate,  and ATP + protein threonine = ADP + protein threonine phosphate. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004674", "conceptSize": "18px", "displayValue": "protein serine-threonine kina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "255", "value": "protein serine-threonine kinase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the concomitant phosphorylation of threonine (T) and tyrosine (Y) residues in a Thr-Glu-Tyr (TEY) thiolester sequence in a MAP kinase (MAPK) substrate. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004708", "conceptSize": "18px", "displayValue": "MAPK activator", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "256", "value": "MAPK activator", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with one or more specific sites on an ion channel,  a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. ( Reference:  GOC: BHF GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0044325", "conceptSize": "18px", "displayValue": "ion channel binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "257", "value": "ion channel binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a glycoprotein,  a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans. ( Reference:  GOC: hjd ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0001948", "conceptSize": "18px", "displayValue": "glycoprotein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "258", "value": "glycoprotein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an identical protein or proteins. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0042802", "conceptSize": "18px", "displayValue": "identical protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "259", "value": "identical protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the phosphorylation of an amino acid residue in a protein,  usually according to the reaction:  a protein + ATP = a phosphoprotein + ADP. ( Reference:  MetaCyc: PROTEIN-KINASE-RXN )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004672", "conceptSize": "18px", "displayValue": "protein kinase activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "260", "value": "protein kinase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with Rho protein,  any member of the Rho subfamily of the Ras superfamily of monomeric GTPases. Proteins in the Rho subfamily are involved in relaying signals from cell-surface receptors to the actin cytoskeleton. ( Reference:  ISBN: 0198547684 PMID: 12581856 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0017048", "conceptSize": "18px", "displayValue": "Rho GTPase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "261", "value": "Rho GTPase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Binds to and increases the activity of a GTPase,  an enzyme that catalyzes the hydrolysis of GTP. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005096", "conceptSize": "18px", "displayValue": "GAP", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "262", "value": "GAP", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein. ( Reference:  PMID: 12642621 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0000149", "conceptSize": "18px", "displayValue": "SNARE binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "263", "value": "SNARE binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the transfer of a phosphate group,  usually from ATP,  to a substrate molecule. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0016301", "conceptSize": "18px", "displayValue": "phosphokinase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "264", "value": "phosphokinase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the reaction:  ATP + a protein serine threonine = ADP + protein serine threonine phosphate,  dependent on the presence of GTP. ( Reference:  GOC: ecd PMID: 17200152 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0034211", "conceptSize": "18px", "displayValue": "GTP-dependent protein kinase ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "265", "value": "GTP-dependent protein kinase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with GTP,  guanosine triphosphate. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005525", "conceptSize": "18px", "displayValue": "GTP binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "266", "value": "GTP binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacts with,  and stops,  prevents or reduces the activity of a peroxidase. ( Reference:  GOC: bf GOC: PARL );", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0036479", "conceptSize": "18px", "displayValue": "peroxidase inhibitor activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "267", "value": "peroxidase inhibitor activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62258", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "268", "value": "P62258", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13467", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "269", "value": "Q13467", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P46778", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "270", "value": "P46778", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O00429", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "271", "value": "O00429", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9Y3D6", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "272", "value": "Q9Y3D6", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95456", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "273", "value": "O95456", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P07437", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "274", "value": "P07437", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q6NTE8", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "275", "value": "Q6NTE8", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q5TA50", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "276", "value": "Q5TA50", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q5VVH5", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "277", "value": "Q5VVH5", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8ND71", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "278", "value": "Q8ND71", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q86W54", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "279", "value": "Q86W54", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q99708", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "280", "value": "Q99708", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8NFW8", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "281", "value": "Q8NFW8", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9H496", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "282", "value": "Q9H496", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9BTP7", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "283", "value": "Q9BTP7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9BSD3", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "284", "value": "Q9BSD3", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P23497", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "285", "value": "P23497", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P30084", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "286", "value": "P30084", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95990", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "287", "value": "O95990", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P33981", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "288", "value": "P33981", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P31751", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "289", "value": "P31751", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P11308", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "290", "value": "P11308", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P42679", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "291", "value": "P42679", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q16670", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "292", "value": "Q16670", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q08E93", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "293", "value": "Q08E93", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q14195", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "294", "value": "Q14195", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62888", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "295", "value": "P62888", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62891", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "296", "value": "P62891", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62269", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "297", "value": "P62269", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62841", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "298", "value": "P62841", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P15880", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "299", "value": "P15880", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62249", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "300", "value": "P62249", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P46821-PRO_0000018605", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "301", "value": "P46821-PRO_0000018605", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9NWZ8", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "302", "value": "Q9NWZ8", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9H7L9", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "303", "value": "Q9H7L9", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9P209", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "304", "value": "Q9P209", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9ULZ0", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "305", "value": "Q9ULZ0", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9NQU5", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "306", "value": "Q9NQU5", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9Y6A4", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "307", "value": "Q9Y6A4", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62280", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "308", "value": "P62280", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P23396", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "309", "value": "P23396", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P05141", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "310", "value": "P05141", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q96PY6", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "311", "value": "Q96PY6", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P10636-7", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "312", "value": "P10636-7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O76075", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "313", "value": "O76075", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P12235", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "314", "value": "P12235", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O43247", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "315", "value": "O43247", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q16543", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "316", "value": "Q16543", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P41220", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "317", "value": "P41220", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95817", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "318", "value": "O95817", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95400", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "319", "value": "O95400", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61020", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "320", "value": "P61020", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O75581", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "321", "value": "O75581", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P60953", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "322", "value": "P60953", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P10415-1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "323", "value": "P10415-1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q14155-3", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "324", "value": "Q14155-3", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P39054", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "325", "value": "P39054", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P49674", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "326", "value": "P49674", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P48730-1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "327", "value": "P48730-1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9H4B7", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "328", "value": "Q9H4B7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9Y6M4", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "329", "value": "Q9Y6M4", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P10636-4", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "330", "value": "P10636-4", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q99962", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "331", "value": "Q99962", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P49207", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "332", "value": "P49207", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q99469", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "333", "value": "Q99469", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P31948", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "334", "value": "P31948", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8IU85", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "335", "value": "Q8IU85", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9UL15", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "336", "value": "Q9UL15", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q96MW1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "337", "value": "Q96MW1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8NA70", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "338", "value": "Q8NA70", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "A4UGR9", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "339", "value": "A4UGR9", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P24844", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "340", "value": "P24844", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q7L804", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "341", "value": "Q7L804", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1994-10-01; Modified:  2016-01-20; Version:  188", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P37840", "conceptSize": "22px", "displayValue": "Alpha-synuclein", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "342", "value": "Alpha-synuclein", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH SNCAIP]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15728840", "conceptSize": "18px", "displayValue": "PMID: 15728840", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "343", "value": "PMID: 15728840", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 GLU-56 AND TYR-212]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12056932", "conceptSize": "18px", "displayValue": "PMID: 12056932", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "344", "value": "PMID: 12056932", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  ISOPRENYLATION AT CYS-220]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19261853", "conceptSize": "18px", "displayValue": "PMID: 19261853", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "345", "value": "PMID: 19261853", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12408865", "conceptSize": "18px", "displayValue": "PMID: 12408865", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "346", "value": "PMID: 12408865", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11431533", "conceptSize": "18px", "displayValue": "PMID: 11431533", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "347", "value": "PMID: 11431533", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS ASN-167; TRP-366 AND LEU-380]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10965160", "conceptSize": "18px", "displayValue": "PMID: 10965160", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "348", "value": "PMID: 10965160", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 ARG-240; CYS-256; TRP-275 AND ASN-415,  MUTAGENESIS OF CYS-337; CYS-421 AND CYS-431]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11590439", "conceptSize": "18px", "displayValue": "PMID: 11590439", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "349", "value": "PMID: 11590439", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P53350", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "350", "value": "P53350", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8N2I9", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "351", "value": "Q8N2I9", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8TC29", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "352", "value": "Q8TC29", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q7L592", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "353", "value": "Q7L592", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q86V25", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "354", "value": "Q86V25", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q12972", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "355", "value": "Q12972", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O00214", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "356", "value": "O00214", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14625", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "357", "value": "O14625", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9H6T3", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "358", "value": "Q9H6T3", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P31946", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "359", "value": "P31946", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61983", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "360", "value": "P61983", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P27348", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "361", "value": "P27348", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "-", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "362", "value": "-", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P12369", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "363", "value": "P12369", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P31324", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "364", "value": "P31324", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14966", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "365", "value": "O14966", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95140", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "366", "value": "O95140", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P39053", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "367", "value": "P39053", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q811U4", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "368", "value": "Q811U4", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P04350", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "369", "value": "P04350", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O60313", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "370", "value": "O60313", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9BUF5", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "371", "value": "Q9BUF5", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9BVA1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "372", "value": "Q9BVA1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P63000", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "373", "value": "P63000", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P02687", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "374", "value": "P02687", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95295", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "375", "value": "O95295", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  2004-10-11; Modified:  2016-01-20; Version:  163", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "O60260", "conceptSize": "26px", "displayValue": "E3 ubiquitin-protein ligase p...", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "376", "value": "E3 ubiquitin-protein ligase parkin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION,  INTERACTION WITH PINK1,  CHARACTERIZATION OF VARIANTS PARK ASN-415 AND ASP-430]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19966284", "conceptSize": "18px", "displayValue": "PMID: 19966284", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "377", "value": "PMID: 19966284", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17846173", "conceptSize": "18px", "displayValue": "PMID: 17846173", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "378", "value": "PMID: 17846173", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ASN-211; ARG-240; ASN-280 AND GLU-328]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20404107", "conceptSize": "18px", "displayValue": "PMID: 20404107", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "379", "value": "PMID: 20404107", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24660806", "conceptSize": "18px", "displayValue": "PMID: 24660806", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "380", "value": "PMID: 24660806", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 307-384 IN COMPLEX WITH ZINC IONS,  CHARACTERIZATION OF VARIANT PARK2 PRO-351,  MUTAGENESIS OF CYS-332 AND CYS-365,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17360614", "conceptSize": "18px", "displayValue": "PMID: 17360614", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "381", "value": "PMID: 17360614", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  ENZYME REGULATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24751536", "conceptSize": "18px", "displayValue": "PMID: 24751536", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "382", "value": "PMID: 24751536", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  ENZYME REGULATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "25527291", "conceptSize": "18px", "displayValue": "PMID: 25527291", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "383", "value": "PMID: 25527291", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH PINK1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20798600", "conceptSize": "18px", "displayValue": "PMID: 20798600", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "384", "value": "PMID: 20798600", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65 AND TRP-403]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24784582", "conceptSize": "18px", "displayValue": "PMID: 24784582", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "385", "value": "PMID: 24784582", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH BAG4; BAG5; HSPA1L; HSPA1A AND HSPA8]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24270810", "conceptSize": "18px", "displayValue": "PMID: 24270810", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "386", "value": "PMID: 24270810", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-65,  FUNCTION,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23754282", "conceptSize": "18px", "displayValue": "PMID: 23754282", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "387", "value": "PMID: 23754282", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  COMPONENT OF A COMPLEX COMPOSED OF PARK2; PARK7 AND PINK1,  SUBCELLULAR LOCATION,  UBIQUITINATION,  CHARACTERIZATION OF VARIANT PARK2 PRO-42]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19229105", "conceptSize": "18px", "displayValue": "PMID: 19229105", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "388", "value": "PMID: 19229105", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN MITOPHAGY,  INTERACTION WITH MFN2,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23620051", "conceptSize": "18px", "displayValue": "PMID: 23620051", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "389", "value": "PMID: 23620051", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH FBXO7]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23933751", "conceptSize": "18px", "displayValue": "PMID: 23933751", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "390", "value": "PMID: 23933751", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13509", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "391", "value": "Q13509", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62136", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "392", "value": "P62136", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62140", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "393", "value": "P62140", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q53EL6", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "394", "value": "Q53EL6", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13637", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "395", "value": "Q13637", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O15027", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "396", "value": "O15027", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "A2AIX1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "397", "value": "A2AIX1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O00429-3", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "398", "value": "O00429-3", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P20108", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "399", "value": "P20108", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P30048", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "400", "value": "P30048", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P26038", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "401", "value": "P26038", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P00634", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "402", "value": "P00634", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13158", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "403", "value": "Q13158", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14640-2", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "404", "value": "O14640-2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P21796", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "405", "value": "P21796", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P52564", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "406", "value": "P52564", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14976", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "407", "value": "O14976", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14733", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "408", "value": "O14733", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P46734", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "409", "value": "P46734", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9WVI9", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "410", "value": "Q9WVI9", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O14641", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "411", "value": "O14641", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8IVP1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "412", "value": "Q8IVP1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q92997", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "413", "value": "Q92997", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q63481", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "414", "value": "Q63481", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q58A65", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "415", "value": "Q58A65", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q91YQ1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "416", "value": "Q91YQ1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q14155", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "417", "value": "Q14155", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q61081", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "418", "value": "Q61081", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P17046", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "419", "value": "P17046", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P13473", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "420", "value": "P13473", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q32KD4", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "421", "value": "Q32KD4", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "INTACT: EBI-6312987", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "422", "value": "INTACT: EBI-6312987", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61586", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "423", "value": "P61586", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P53355", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "424", "value": "P53355", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P42684", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "425", "value": "P42684", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13469", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "426", "value": "Q13469", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q8N6T3-2", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "427", "value": "Q8N6T3-2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q62848", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "428", "value": "Q62848", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. ( Reference:  GOC: mah NIF_Subcellular: sao1045389829 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031966", "conceptSize": "18px", "displayValue": "mitochondrial membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "429", "value": "mitochondrial membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A compound membranous cytoplasmic organelle of eukaryotic cells,  consisting of flattened,  ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes,  appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum,  secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle,  while in invertebrates and plants,  where they are known usually as dictyosomes,  there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins,  and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function:  cis,  in the vicinity of the cis face,  trans,  in the vicinity of the trans face,  and medial,  lying between the cis and trans regions. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005794", "conceptSize": "18px", "displayValue": "Golgi complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "430", "value": "Golgi complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "That part of a multicellular organism outside the cells proper,  usually taken to be outside the plasma membranes,  and occupied by fluid. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005615", "conceptSize": "18px", "displayValue": "extracellular space", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "431", "value": "extracellular space", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "All of the contents of a dendrite,  excluding the surrounding plasma membrane. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0032839", "conceptSize": "18px", "displayValue": "dendrite cytoplasm", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "432", "value": "dendrite cytoplasm", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The gel-like material,  with considerable fine structure,  that lies in the matrix space,  or lumen,  of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and,  in some organisms,  the enzymes concerned with fatty acid oxidation. ( Reference:  GOC: as ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005759", "conceptSize": "18px", "displayValue": "mitochondrial lumen", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "433", "value": "mitochondrial lumen", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The portion of the cell soma (cell body) that excludes the nucleus. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043204", "conceptSize": "18px", "displayValue": "perikaryon", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "434", "value": "perikaryon", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The outer,  i.e. cytoplasm-facing,  lipid bilayer of the mitochondrial envelope. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005741", "conceptSize": "18px", "displayValue": "mitochondrial outer membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "435", "value": "mitochondrial outer membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction,  anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix. ( Reference:  GOC: mah http: \/\/www.vivo.colostate.edu\/hbooks\/cmb\/cells\/pmemb\/junctions_a.html ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030054", "conceptSize": "18px", "displayValue": "cell junction", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "436", "value": "cell junction", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The external (cytoplasmic) face of the mitochondrial outer membrane. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0032473", "conceptSize": "18px", "displayValue": "external side of mitochondria...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "437", "value": "external side of mitochondrial outer membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A semiautonomous,  self replicating organelle that occurs in varying numbers,  shapes,  and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. ( Reference:  GOC: giardia ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005739", "conceptSize": "18px", "displayValue": "mitochondria", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "438", "value": "mitochondria", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases,  most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. ( Reference:  GOC: mah ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005764", "conceptSize": "18px", "displayValue": "lysosome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "439", "value": "lysosome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. ( Reference:  GOC: mah PMID: 11121744 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0016234", "conceptSize": "18px", "displayValue": "inclusion body", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "440", "value": "inclusion body", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding a synaptic vesicle. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030672", "conceptSize": "18px", "displayValue": "synaptic vesicle membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "441", "value": "synaptic vesicle membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes,  also simply called exosomes,  have a diameter of about 40-100 nm. ( Reference:  GOC: BHF GOC: mah PMID: 15908444 PMID: 17641064 PMID: 19442504 PMID: 19498381 PMID: 22418571 PMID: 24009894 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0070062", "conceptSize": "18px", "displayValue": "exosome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "442", "value": "exosome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any of the small (10-200 nm),  heterogeneous,  highly dynamic,  sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. ( Reference:  PMID: 16645198 PMID: 20044567 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0045121", "conceptSize": "18px", "displayValue": "lipid raft", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "443", "value": "lipid raft", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Terminal inflated portion of the axon,  containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. ( Reference:  GOC: dph GOC: mc GOC: nln PMID: 10218156 PMID: 8409967 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043195", "conceptSize": "18px", "displayValue": "bouton", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "444", "value": "bouton", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any vesicle associated with the Golgi complex and involved in mediating transport within the Golgi or between the Golgi and other parts of the cell. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005798", "conceptSize": "18px", "displayValue": "Golgi-associated vesicle", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "445", "value": "Golgi-associated vesicle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A prolongation or process extending from a nerve cell,  e.g. an axon or dendrite. ( Reference:  GOC: jl http: \/\/www.cogsci.princeton.edu\/~wn\/ )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043005", "conceptSize": "18px", "displayValue": "neuron process", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "446", "value": "neuron process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The portion of a neuron that includes the nucleus,  but excludes cell projections such as axons and dendrites. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043025", "conceptSize": "18px", "displayValue": "neuron cell body", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "447", "value": "neuron cell body", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "All of the contents of a cell excluding the plasma membrane and nucleus,  but including other subcellular structures. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005737", "conceptSize": "18px", "displayValue": "cytoplasm", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "448", "value": "cytoplasm", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A membrane-bounded organelle to which materials ingested by endocytosis are delivered. ( Reference:  ISBN: 0198506732 PMID: 19696797 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005768", "conceptSize": "18px", "displayValue": "endosome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "449", "value": "endosome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The inner,  i.e. lumen-facing,  lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005743", "conceptSize": "18px", "displayValue": "mitochondrial inner membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "450", "value": "mitochondrial inner membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An intracellular macromolecular complex containing both protein and RNA molecules. ( Reference:  GOC: krc GOC: vesicles )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030529", "conceptSize": "18px", "displayValue": "intracellular ribonucleoprote...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "451", "value": "intracellular ribonucleoprotein complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum,  from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. ( Reference:  GOC: vw ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005802", "conceptSize": "18px", "displayValue": "TGN", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "452", "value": "TGN", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The irregular network of unit membranes,  visible only by electron microscopy,  that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels,  which are often expanded into slitlike cavities called cisternae. The ER takes two forms,  rough (or granular),  with ribosomes adhering to the outer surface,  and smooth (with no ribosomes attached). ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005783", "conceptSize": "18px", "displayValue": "ER", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "453", "value": "ER", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A vesicle formed of membrane or protein,  found in the cytoplasm of a cell. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031410", "conceptSize": "18px", "displayValue": "cytoplasmic vesicle", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "454", "value": "cytoplasmic vesicle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein autoubiquitination. ( Reference:  GOC: rb GOC: TermGenie PMID: 24069405 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902499", "conceptSize": "18px", "displayValue": "upregulation of protein autou...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "455", "value": "upregulation of protein autoubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. ( Reference:  GOC: dph GOC: ef )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060079", "conceptSize": "18px", "displayValue": "excitatory postsynaptic poten...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "456", "value": "excitatory postsynaptic potential", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving GTP,  guanosine triphosphate. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046039", "conceptSize": "18px", "displayValue": "GTP metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "457", "value": "GTP metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of glutamatergic synaptic transmission,  the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051966", "conceptSize": "18px", "displayValue": "regulation of synaptic transm...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "458", "value": "regulation of synaptic transmission,  glutamatergic", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The control of viability and duration in the adult phase of the life-cycle. ( Reference:  GOC: ems )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008340", "conceptSize": "18px", "displayValue": "determination of adult lifesp...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "459", "value": "determination of adult lifespan", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution,  and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. ( Reference:  GOC: dph GOC: jl GOC: mah GOC: sgd_curators PMID: 9786946 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007005", "conceptSize": "18px", "displayValue": "mitochondria organization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "460", "value": "mitochondria organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of neuroblast proliferation. ( Reference:  GO_REF: 0000058 GOC: PARL GOC: rl GOC: TermGenie PMID: 21168496 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902692", "conceptSize": "18px", "displayValue": "regulation of neuroblast prol...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "461", "value": "regulation of neuroblast proliferation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. ( Reference:  GOC: signaling )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0019722", "conceptSize": "18px", "displayValue": "calcium signaling", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "462", "value": "calcium signaling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any series of molecular signals in which a small monomeric GTPase relays one or more of the signals. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007264", "conceptSize": "18px", "displayValue": "small GTPase mediated signal ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "463", "value": "small GTPase mediated signal transduction", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The specific behavior of an organism in response to a novel environment or stimulus. ( Reference:  GOC: BHF GOC: pr PMID: 11682103 PMID: 9767169 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035640", "conceptSize": "18px", "displayValue": "exploration behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "464", "value": "exploration behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of MAP kinase activity. ( Reference:  GOC: dph GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043406", "conceptSize": "18px", "displayValue": "upregulation of MAPK", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "465", "value": "upregulation of MAPK", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle exocytosis. ( Reference:  GOC: obol )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000300", "conceptSize": "18px", "displayValue": "regulation of synaptic vesicl...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "466", "value": "regulation of synaptic vesicle exocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which a signal is passed on to downstream components within the cell,  which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. ( Reference:  GOC: bf GOC: jl GOC: signaling ISBN: 3527303782 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035556", "conceptSize": "18px", "displayValue": "intracellular signaling chain", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "467", "value": "intracellular signaling chain", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of deprivation of nourishment. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0009267", "conceptSize": "18px", "displayValue": "cellular response to starvati...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "468", "value": "cellular response to starvation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that prevents the establishment or decreases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. ( Reference:  GOC: BHF )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090394", "conceptSize": "18px", "displayValue": "reduction of excitatory posts...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "469", "value": "reduction of excitatory postsynaptic membrane potential", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving a reactive oxygen species,  any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes,  regulation of signal transduction and gene expression,  and the oxidative damage to biopolymers. ( Reference:  CHEBI: 26523 GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0072593", "conceptSize": "18px", "displayValue": "ROS metabolic process", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "470", "value": "ROS metabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of the Golgi apparatus. ( Reference:  GOC: dph GOC: jl GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007030", "conceptSize": "18px", "displayValue": "Golgi organisation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "471", "value": "Golgi organisation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of hydrogen peroxide-induced cell death. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 14749723 PMID: 24252804 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903206", "conceptSize": "18px", "displayValue": "downregulation of cell death ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "472", "value": "downregulation of cell death in response to H2O2", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The migration of cells in the telencephalon from the subventricular zone to the olfactory bulb in which cells move orthogonally to the direction of radial migration and do not use radial glial cell processes as substrates for migration. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0022028", "conceptSize": "18px", "displayValue": "rostral migratory stream migr...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "473", "value": "rostral migratory stream migration", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The initiation of the activity of the inactive enzyme MAP kinase (MAPK). ( Reference:  PMID: 9561267 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000187", "conceptSize": "18px", "displayValue": "MAPK activation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "474", "value": "MAPK activation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 ISBN: 0878937420 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0021772", "conceptSize": "18px", "displayValue": "olfactory bulb development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "475", "value": "olfactory bulb development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle transport. ( Reference:  GO_REF: 0000058 GOC: kmv GOC: TermGenie PMID: 23527112 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902803", "conceptSize": "18px", "displayValue": "regulation of synaptic vesicl...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "476", "value": "regulation of synaptic vesicle transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a manganese ion stimulus. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0071287", "conceptSize": "18px", "displayValue": "cellular response to manganese", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "477", "value": "cellular response to manganese", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 21370995 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903215", "conceptSize": "18px", "displayValue": "downregulation of protein-mit...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "478", "value": "downregulation of protein-mitochondrial targeting", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the activity of a GTPase. ( Reference:  GOC: jl GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043547", "conceptSize": "18px", "displayValue": "upregulation of GTPase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "479", "value": "upregulation of GTPase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the dopamine receptor protein signaling pathway. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. ( Reference:  GOC: dph );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060161", "conceptSize": "18px", "displayValue": "positive regulation of dopami...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "480", "value": "positive regulation of dopamine receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the addition of ubiquitin groups to a protein. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031398", "conceptSize": "18px", "displayValue": "upregulation of protein ubiqu...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "481", "value": "upregulation of protein ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of protein processing involved in protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 21370995 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903217", "conceptSize": "18px", "displayValue": "downregulation of protein pro...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "482", "value": "downregulation of protein processing involved in protein targeting to mitochondrion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of late endosome to lysosome transport. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 23949442 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902823", "conceptSize": "18px", "displayValue": "downregulation of late endoso...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "483", "value": "downregulation of late endosome to lysosome transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the rate,  frequency,  or extent of protein kinase A signaling. PKA signaling is the series of reactions,  mediated by the intracellular serine threonine kinase protein kinase A,  which occurs as a result of a single trigger reaction or compound. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010738", "conceptSize": "18px", "displayValue": "regulation of protein kinase ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "484", "value": "regulation of protein kinase A signaling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops or reduces the rate of GTP hydrolysis by a GTPase. ( Reference:  GO_REF: 0000058 GOC: mah GOC: rb GOC: TermGenie PMID: 16143306 PMID: 24335649 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034260", "conceptSize": "18px", "displayValue": "downregulation of GTPase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "485", "value": "downregulation of GTPase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The specific movement from place to place of an organism in response to a novel environment. ( Reference:  GOC: sart PMID: 17151232 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035641", "conceptSize": "18px", "displayValue": "locomotory exploration behavi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "486", "value": "locomotory exploration behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates,  maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010508", "conceptSize": "18px", "displayValue": "positive regulation of autoph...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "487", "value": "positive regulation of autophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process in which a protein is transported to,  and or maintained in,  a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell,  from within the cell to the cell surface,  or from one location to another at the surface of a cell. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034613", "conceptSize": "18px", "displayValue": "cellular protein localisation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "488", "value": "cellular protein localisation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process in which a mitochondrion or mitochondria are transported to,  and or maintained in,  a specific location within the cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051646", "conceptSize": "18px", "displayValue": "mitochondria localization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "489", "value": "mitochondria localization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of branching morphogenesis of a nerve. ( Reference:  GOC: BHF )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000172", "conceptSize": "18px", "displayValue": "regulation of branching morph...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "490", "value": "regulation of branching morphogenesis of a nerve", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the change in the membrane potential of the mitochondria from negative to positive. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051900", "conceptSize": "18px", "displayValue": "regulation of mitochondrial d...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "491", "value": "regulation of mitochondrial depolarization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An intracellular protein kinase cascade containing at least a MAPK,  a MAPKK and a MAP3K. The cascade can also contain two additional tiers:  the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. ( Reference:  GOC: bf GOC: mtg_signaling_feb11 PMID: 20811974 PMID: 9561267 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000165", "conceptSize": "18px", "displayValue": "MAPK cascade", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "492", "value": "MAPK cascade", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of neuron death. ( Reference:  GOC: rph GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1901215", "conceptSize": "18px", "displayValue": "downregulation of neuron death", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "493", "value": "downregulation of neuron death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of programmed cell death,  cell death resulting from activation of endogenous cellular processes. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043068", "conceptSize": "18px", "displayValue": "upregulation of programmed ce...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "494", "value": "upregulation of programmed cell death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. ( Reference:  GOC: autophagy ISBN: 0198547684 PMID: 11099404 PMID: 9412464 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006914", "conceptSize": "18px", "displayValue": "autophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "495", "value": "autophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the size of a kidney. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035564", "conceptSize": "18px", "displayValue": "regulation of kidney size", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "496", "value": "regulation of kidney size", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a neuromuscular junction. ( Reference:  GOC: mtg_OBO2OWL_2013 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007528", "conceptSize": "18px", "displayValue": "neuromuscular junction develo...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "497", "value": "neuromuscular junction development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  e.g. superoxide anions,  hydrogen peroxide (H2O2),  and hydroxyl radicals. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034599", "conceptSize": "18px", "displayValue": "cellular response to oxidativ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "498", "value": "cellular response to oxidative stress", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a lysosome. A lysosome is a cytoplasmic,  membrane-bounded organelle that is found in most animal cells and that contains a variety of hydrolases. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007040", "conceptSize": "18px", "displayValue": "lysosome organization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "499", "value": "lysosome organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell,  such as axons or dendrites. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048812", "conceptSize": "18px", "displayValue": "neuron projection morphogenes...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "500", "value": "neuron projection morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein binding. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032092", "conceptSize": "18px", "displayValue": "upregulation of protein bindi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "501", "value": "upregulation of protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein binding. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032091", "conceptSize": "18px", "displayValue": "downregulation of protein bin...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "502", "value": "downregulation of protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds,  initiated by the covalent attachment of ubiquitin,  and mediated by the proteasome. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032436", "conceptSize": "18px", "displayValue": "upregulation of proteasomal u...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "503", "value": "upregulation of proteasomal ubiquitin-dependent protein catabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of locomotion of a cell or organism. ( Reference:  GOC: ems )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0040012", "conceptSize": "18px", "displayValue": "regulation of locomotion", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "504", "value": "regulation of locomotion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. ( Reference:  GOC: mah ISBN: 0198506732 ISBN: 0716731363 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006897", "conceptSize": "18px", "displayValue": "endocytosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "505", "value": "endocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a dopamine stimulus. ( Reference:  GO_REF: 0000071 GOC: mr GOC: TermGenie PMID: 11118945 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903351", "conceptSize": "18px", "displayValue": "cellular response to dopamine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "506", "value": "cellular response to dopamine", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. ( Reference:  RESID: AA0037 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0018105", "conceptSize": "18px", "displayValue": "peptidyl-serine phosphorylati...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "507", "value": "peptidyl-serine phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process in which a protein is transported to,  or maintained in,  a location within the mitochondrion. ( Reference:  GOC: ecd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070585", "conceptSize": "18px", "displayValue": "protein localization in mitoc...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "508", "value": "protein localization in mitochondrion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of a dopamine receptor signaling pathway activity. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060159", "conceptSize": "18px", "displayValue": "regulation of dopamine recept...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "509", "value": "regulation of dopamine receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the rate,  frequency or extent of protein maturation by peptide bond cleavage. ( Reference:  GOC: dph GOC: mah GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010955", "conceptSize": "18px", "displayValue": "negative regulation of protei...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "510", "value": "negative regulation of protein processing", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the rate,  frequency,  or extent of the Wnt signaling pathway through beta-catenin,  the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. ( Reference:  GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090263", "conceptSize": "18px", "displayValue": "positive regulation of canoni...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "511", "value": "positive regulation of canonical Wnt signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the rate of addition of phosphate groups to amino acids within a protein. ( Reference:  GOC: hjd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001933", "conceptSize": "18px", "displayValue": "negative regulation of protei...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "512", "value": "negative regulation of protein phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  e.g. superoxide anions,  hydrogen peroxide (H2O2),  and hydroxyl radicals. ( Reference:  GOC: jl PMID: 12115731 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006979", "conceptSize": "18px", "displayValue": "response to oxidative stress", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "513", "value": "response to oxidative stress", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. ( Reference:  RESID: AA0038 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0018107", "conceptSize": "18px", "displayValue": "peptidyl-threonine phosphoryl...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "514", "value": "peptidyl-threonine phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that establishes the spatial arrangement of mitochondria within the cell. ( Reference:  GOC: jid )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048312", "conceptSize": "18px", "displayValue": "mitochondria positioning with...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "515", "value": "mitochondria positioning within cell", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A peptidyl-threonine phosphorylation that results in negative regulation of thioredoxin peroxidase activity. ( Reference:  GO_REF: 0000063 GOC: bf GOC: PARL GOC: TermGenie PMID: 21850687 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903125", "conceptSize": "18px", "displayValue": "negative regulation of TPx ac...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "516", "value": "negative regulation of TPx activity by peptidyl-threonine phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation),  or residues on an identical protein (trans-autophosphorylation). ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046777", "conceptSize": "18px", "displayValue": "protein autophosphorylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "517", "value": "protein autophosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the rate,  frequency,  or extent of dendritic spine morphogenesis,  the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission. ( Reference:  GOC: dph );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0061001", "conceptSize": "18px", "displayValue": "regulation of dendritic spine...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "518", "value": "regulation of dendritic spine morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of addition of phosphate groups to amino acids within a protein. ( Reference:  GOC: hjd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001934", "conceptSize": "18px", "displayValue": "positive regulation of protei...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "519", "value": "positive regulation of protein phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. ( Reference:  GOC: BHF GOC: mtg_apoptosis GOC: rl GOC: TermGenie PMID: 20160352 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902236", "conceptSize": "18px", "displayValue": "downregulation of ER stress-i...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "520", "value": "downregulation of ER stress-induced apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process of introducing a phosphate group on to a protein. ( Reference:  GOC: hb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006468", "conceptSize": "18px", "displayValue": "protein phosphorylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "521", "value": "protein phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process of cell death in a neuron. ( Reference:  GOC: BHF GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070997", "conceptSize": "18px", "displayValue": "neuron death", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "522", "value": "neuron death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of neuron maturation,  the process leading to the attainment of the full functional capacity of a neuron. This process is independent of morphogenetic change. ( Reference:  GOC: ef )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0014041", "conceptSize": "18px", "displayValue": "regulation of neuron maturati...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "523", "value": "regulation of neuron maturation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of peroxidase activity. ( Reference:  GOC: obol )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000469", "conceptSize": "18px", "displayValue": "negative regulation of oxyper...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "524", "value": "negative regulation of oxyperoxidase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the establishment or extent of a membrane potential,  the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. ( Reference:  GOC: jl GOC: mtg_cardio GOC: tb ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042391", "conceptSize": "18px", "displayValue": "regulation of membrane potent...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "525", "value": "regulation of membrane potential", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the rate,  frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090140", "conceptSize": "18px", "displayValue": "regulation of mitochondrial f...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "526", "value": "regulation of mitochondrial fission", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of neuron death. ( Reference:  GOC: rph GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1901214", "conceptSize": "18px", "displayValue": "regulation of neuron death", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "527", "value": "regulation of neuron death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK). ( Reference:  PMID: 9561267 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000186", "conceptSize": "18px", "displayValue": "activation of MAP2K", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "528", "value": "activation of MAP2K", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 CYS-1441; HIS-1441 AND SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16157909", "conceptSize": "18px", "displayValue": "PMID: 16157909", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "529", "value": "PMID: 16157909", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 MET-793; THR-1869 AND SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16157908", "conceptSize": "18px", "displayValue": "PMID: 16157908", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "530", "value": "PMID: 16157908", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS LYS-551; VAL-723; HIS-1398; GLN-1514; SER-1542; PRO-1628; THR-1646; THR-1647; ASP-2081 AND THR-2397]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22415848", "conceptSize": "18px", "displayValue": "PMID: 22415848", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "531", "value": "PMID: 22415848", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 CYS-1441; GLY-1441 AND SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16533964", "conceptSize": "18px", "displayValue": "PMID: 16533964", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "532", "value": "PMID: 16533964", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15929036", "conceptSize": "18px", "displayValue": "PMID: 15929036", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "533", "value": "PMID: 15929036", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  TISSUE SPECIFICITY,  VARIANTS PARK8 VAL-1122; CYS-1441; CYS-1699 AND THR-2020]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15541309", "conceptSize": "18px", "displayValue": "PMID: 15541309", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "534", "value": "PMID: 15541309", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16102999", "conceptSize": "18px", "displayValue": "PMID: 16102999", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "535", "value": "PMID: 16102999", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16240353", "conceptSize": "18px", "displayValue": "PMID: 16240353", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "536", "value": "PMID: 16240353", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 GLN-1067]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16247070", "conceptSize": "18px", "displayValue": "PMID: 16247070", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "537", "value": "PMID: 16247070", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 VAL-1371; CYS-1441 AND SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16333314", "conceptSize": "18px", "displayValue": "PMID: 16333314", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "538", "value": "PMID: 16333314", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15732108", "conceptSize": "18px", "displayValue": "PMID: 15732108", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "539", "value": "PMID: 15732108", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16272257", "conceptSize": "18px", "displayValue": "PMID: 16272257", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "540", "value": "PMID: 16272257", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 GLY-1441];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15925109", "conceptSize": "18px", "displayValue": "PMID: 15925109", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "541", "value": "PMID: 15925109", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16001413", "conceptSize": "18px", "displayValue": "PMID: 16001413", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "542", "value": "PMID: 16001413", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 MET-793; ARG-930; CYS-1096 THR-1228; SER-2019 AND THR-2020,  VARIANT LYS-551]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16251215", "conceptSize": "18px", "displayValue": "PMID: 16251215", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "543", "value": "PMID: 16251215", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1333-1516 IN COMPLEX WITH GDP,  FUNCTION,  GTPASE ACTIVITY,  SUBUNIT,  DOMAIN ROC,  MUTAGENESIS OF THR-1343 AND ARG-1398];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18230735", "conceptSize": "18px", "displayValue": "PMID: 18230735", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "544", "value": "PMID: 18230735", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK8 CYS-1441 AND SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16269541", "conceptSize": "18px", "displayValue": "PMID: 16269541", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "545", "value": "PMID: 16269541", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[WD REPEATS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23776530", "conceptSize": "18px", "displayValue": "PMID: 23776530", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "546", "value": "PMID: 23776530", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBUNIT,  AUTOPHOSPHORYLATION];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22952686", "conceptSize": "18px", "displayValue": "PMID: 22952686", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "547", "value": "PMID: 22952686", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16250030", "conceptSize": "18px", "displayValue": "PMID: 16250030", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "548", "value": "PMID: 16250030", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ASSOCIATION OF VARIANTS PRO-1628 AND ARG-2385 WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21641266", "conceptSize": "18px", "displayValue": "PMID: 21641266", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "549", "value": "PMID: 21641266", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16298482", "conceptSize": "18px", "displayValue": "PMID: 16298482", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "550", "value": "PMID: 16298482", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANT PARK8 THR-2020]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16321986", "conceptSize": "18px", "displayValue": "PMID: 16321986", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "551", "value": "PMID: 16321986", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH PRDX3,  CHARACTERIZATION OF VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21850687", "conceptSize": "18px", "displayValue": "PMID: 21850687", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "552", "value": "PMID: 21850687", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17120249", "conceptSize": "18px", "displayValue": "PMID: 17120249", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "553", "value": "PMID: 17120249", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15811454", "conceptSize": "18px", "displayValue": "PMID: 15811454", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "554", "value": "PMID: 15811454", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15726496", "conceptSize": "18px", "displayValue": "PMID: 15726496", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "555", "value": "PMID: 15726496", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15680456", "conceptSize": "18px", "displayValue": "PMID: 15680456", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "556", "value": "PMID: 15680456", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 SER-2019]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15680455", "conceptSize": "18px", "displayValue": "PMID: 15680455", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "557", "value": "PMID: 15680455", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  ELECTRON MICROSCOPY,  WD REPEATS,  CHARACTERIZATION OF VARIANT ARG-2385]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24687852", "conceptSize": "18px", "displayValue": "PMID: 24687852", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "558", "value": "PMID: 24687852", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16087219", "conceptSize": "18px", "displayValue": "PMID: 16087219", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "559", "value": "PMID: 16087219", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 GLY-1441 AND CYS-1699,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15541308", "conceptSize": "18px", "displayValue": "PMID: 15541308", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "560", "value": "PMID: 15541308", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK8 VAL-712; LEU-1728; HIS-1728; SER-2019; MET-2141; HIS-2143 AND HIS-2466,  VARIANTS SER-228; VAL-716; GLU-871; PHE-1870 AND LYS-2395]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18213618", "conceptSize": "18px", "displayValue": "PMID: 18213618", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "561", "value": "PMID: 18213618", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK8 THR-2020]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15880653", "conceptSize": "18px", "displayValue": "PMID: 15880653", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "562", "value": "PMID: 15880653", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Glutathione", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "563", "value": "Glutathione", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Imatinib", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "564", "value": "Imatinib", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Sulindac", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "565", "value": "Sulindac", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "104300", "conceptSize": "26px", "displayValue": "ALZHEIMER DISEASE; AD", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "566", "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>; AD", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an acetylcholine receptor. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0033130", "conceptSize": "18px", "displayValue": "acetylcholine receptor binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "567", "value": "acetylcholine receptor binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). ( Reference:  GOC: dph GOC: jl GOC: tb GOC: vw )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0003677", "conceptSize": "18px", "displayValue": "DNA binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "568", "value": "DNA binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a transition metal ions; a transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons,  or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium,  manganese,  iron,  copper,  cobalt,  nickel,  molybdenum and silver. ( Reference:  ISBN: 0198506732 );", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0046914", "conceptSize": "18px", "displayValue": "transition metal ion binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "569", "value": "transition metal ion binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with one or more specific sites on a receptor molecule,  a macromolecule that undergoes combination with a hormone,  neurotransmitter,  drug or intracellular messenger to initiate a change in cell function. ( Reference:  GOC: bf GOC: ceb ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005102", "conceptSize": "18px", "displayValue": "receptor binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "570", "value": "receptor binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a phosphotyrosine-binding (PTB) domain of a protein. ( Reference:  Pfam: PF02174.5 PMID: 15924411 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0051425", "conceptSize": "18px", "displayValue": "PTB domain binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "571", "value": "PTB domain binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Binds to and increases the activity of a peptidase,  any enzyme that catalyzes the hydrolysis peptide bonds. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0016504", "conceptSize": "18px", "displayValue": "peptidase activator activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "572", "value": "peptidase activator activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Stops,  prevents or reduces the activity of serine-type endopeptidases,  enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004867", "conceptSize": "18px", "displayValue": "serine-type endopeptidase inh...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "573", "value": "serine-type endopeptidase inhibitor activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>,  any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. ( Reference:  GOC: jl ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008201", "conceptSize": "26px", "displayValue": "heparin binding", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "574", "value": "<span style=\"background-color: yellow\"><b>heparin<\/b><\/span> binding", "conceptShape": "pentagon", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P05412", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "575", "value": "P05412", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q13813", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "576", "value": "Q13813", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P01137", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "577", "value": "P01137", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P49840", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "578", "value": "P49840", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P01100", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "579", "value": "P01100", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1996-10-01; Modified:  2016-01-20; Version:  190", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P49768", "conceptSize": "22px", "displayValue": "Presenilin-1", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "580", "value": "Presenilin-1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 ASN-116]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10439444", "conceptSize": "18px", "displayValue": "PMID: 10439444", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "581", "value": "PMID: 10439444", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  MUTAGENESIS OF LEU-286]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10811883", "conceptSize": "18px", "displayValue": "PMID: 10811883", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "582", "value": "PMID: 10811883", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 ASP-120; ARG-163; VAL-209; VAL-260; LEU-264; TYR-410 AND PRO-426]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9521423", "conceptSize": "18px", "displayValue": "PMID: 9521423", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "583", "value": "PMID: 9521423", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH HERPUD1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11799129", "conceptSize": "18px", "displayValue": "PMID: 11799129", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "584", "value": "PMID: 11799129", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8875251", "conceptSize": "18px", "displayValue": "PMID: 8875251", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "585", "value": "PMID: 8875251", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8574969", "conceptSize": "18px", "displayValue": "PMID: 8574969", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "586", "value": "PMID: 8574969", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CMD1U GLY-333]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17186461", "conceptSize": "18px", "displayValue": "PMID: 17186461", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "587", "value": "PMID: 17186461", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD4 ILE-148]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10732806", "conceptSize": "18px", "displayValue": "PMID: 10732806", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "588", "value": "PMID: 10732806", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  MUTAGENESIS OF MET-292]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10545183", "conceptSize": "18px", "displayValue": "PMID: 10545183", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "589", "value": "PMID: 10545183", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9144240", "conceptSize": "18px", "displayValue": "PMID: 9144240", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "590", "value": "PMID: 9144240", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9521418", "conceptSize": "18px", "displayValue": "PMID: 9521418", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "591", "value": "PMID: 9521418", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 MET-174]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12484344", "conceptSize": "18px", "displayValue": "PMID: 12484344", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "592", "value": "PMID: 12484344", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH FLNA AND FLNB]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9437013", "conceptSize": "18px", "displayValue": "PMID: 9437013", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "593", "value": "PMID: 9437013", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 ALA-280]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9298817", "conceptSize": "18px", "displayValue": "PMID: 9298817", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "594", "value": "PMID: 9298817", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 VAL-139; VAL-146; TYR-163; THR-267; ALA-280 AND GLY-280]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7550356", "conceptSize": "18px", "displayValue": "PMID: 7550356", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "595", "value": "PMID: 7550356", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA]]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8618867", "conceptSize": "18px", "displayValue": "PMID: 8618867", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "596", "value": "PMID: 8618867", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH CTNND2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10037471", "conceptSize": "18px", "displayValue": "PMID: 10037471", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "597", "value": "PMID: 10037471", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 ASP-135]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9225696", "conceptSize": "18px", "displayValue": "PMID: 9225696", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "598", "value": "PMID: 9225696", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[TOPOLOGY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15385547", "conceptSize": "18px", "displayValue": "PMID: 15385547", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "599", "value": "PMID: 15385547", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  ACTIVE SITE ASP-366,  MUTAGENESIS OF ASP-366]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10497236", "conceptSize": "18px", "displayValue": "PMID: 10497236", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "600", "value": "PMID: 10497236", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[TISSUE SPECIFICITY,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11987239", "conceptSize": "18px", "displayValue": "PMID: 11987239", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "601", "value": "PMID: 11987239", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 VAL-260; VAL-285 AND VAL-392]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7651536", "conceptSize": "18px", "displayValue": "PMID: 7651536", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "602", "value": "PMID: 7651536", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9Y2H9", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "603", "value": "Q9Y2H9", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1986-11-01; Modified:  2016-01-20; Version:  208", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P04156", "conceptSize": "22px", "displayValue": "Major prion protein", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "604", "value": "Major prion protein", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD HIS-208]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8909447", "conceptSize": "18px", "displayValue": "PMID: 8909447", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "605", "value": "PMID: 8909447", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INVOLVEMENT IN HDL1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9792871", "conceptSize": "18px", "displayValue": "PMID: 9792871", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "606", "value": "PMID: 9792871", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING,  FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12732622", "conceptSize": "18px", "displayValue": "PMID: 12732622", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "607", "value": "PMID: 12732622", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P60709", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "608", "value": "P60709", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P04040", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "609", "value": "P04040", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P27797", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "610", "value": "P27797", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P13984", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "611", "value": "P13984", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P14136", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "612", "value": "P14136", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P62937", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "613", "value": "P62937", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O75955", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "614", "value": "O75955", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P35579", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "615", "value": "P35579", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9P2D7", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "616", "value": "Q9P2D7", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P18669", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "617", "value": "P18669", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P02647", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "618", "value": "P02647", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P46459", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "619", "value": "P46459", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q99683", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "620", "value": "Q99683", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61812", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "621", "value": "P61812", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P02511", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "622", "value": "P02511", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P56817", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "623", "value": "P56817", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P02686", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "624", "value": "P02686", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q16594", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "625", "value": "Q16594", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61764", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "626", "value": "P61764", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P36544", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "627", "value": "P36544", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P61457", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "628", "value": "P61457", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9UQF2", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "629", "value": "Q9UQF2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O35827", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "630", "value": "O35827", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q99714", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "631", "value": "Q99714", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O00213", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "632", "value": "O00213", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O95704", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "633", "value": "O95704", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1989-07-01; Modified:  2016-01-20; Version:  182", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P09936", "conceptSize": "22px", "displayValue": "Ubiquitin carboxyl-terminal h...", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "634", "value": "Ubiquitin carboxyl-terminal hydrolase isozyme L1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P15253", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "635", "value": "P15253", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Created:  1996-10-01; Modified:  2016-01-20; Version:  174", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "P49810", "conceptSize": "22px", "displayValue": "Presenilin-2", "conceptTextBGopacity": "0", "conceptDisplay": "element", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "636", "value": "Presenilin-2", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q9NP59", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "637", "value": "Q9NP59", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q05193", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "638", "value": "Q05193", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P07196", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "639", "value": "P07196", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "O75509", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "640", "value": "O75509", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P21359", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "641", "value": "P21359", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P56817-1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "642", "value": "P56817-1", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P30101", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "643", "value": "P30101", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "Q92876", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "644", "value": "Q92876", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Protein", "pid": "", "conceptSize": "18px", "displayValue": "P78536", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "red", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "645", "value": "P78536", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms,  and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane,  where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane,  in the trans-Golgi network,  and on some endosomes. ( Reference:  GOC: mah ISBN: 0198506732 NIF_Subcellular: sao1969557946 PMID: 10559856 PMID: 17284835 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005905", "conceptSize": "18px", "displayValue": "coated pit", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "646", "value": "coated pit", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A small,  membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse.  They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including   ( Reference:  GOC: nln )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043197", "conceptSize": "18px", "displayValue": "dendrite spine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "647", "value": "dendrite spine", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Cylindric portion of the dendrite,  directly stemming from the perikaryon,  and carrying the dendritic spines. ( Reference:  GOC: nln )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043198", "conceptSize": "18px", "displayValue": "dendritic shaft", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "648", "value": "dendritic shaft", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The volume enclosed by the membrane of an endosome. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031904", "conceptSize": "18px", "displayValue": "endosome lumen", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "649", "value": "endosome lumen", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. ( Reference:  GOC: dos GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0016021", "conceptSize": "18px", "displayValue": "integral component of membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "650", "value": "integral component of membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any protein complex that undergoes combination with a hormone,  neurotransmitter,  drug or intracellular messenger to initiate a change in cell function. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043235", "conceptSize": "18px", "displayValue": "receptor complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "651", "value": "receptor complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. ( Reference:  GOC: dos GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005887", "conceptSize": "18px", "displayValue": "integral component of plasma ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "652", "value": "integral component of plasma membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Cytoplasm situated near,  or occurring around,  the nucleus. ( Reference:  GOC: jid )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0048471", "conceptSize": "18px", "displayValue": "perinuclear region of cytopla...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "653", "value": "perinuclear region of cytoplasm", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0032588", "conceptSize": "18px", "displayValue": "trans-Golgi network membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "654", "value": "trans-Golgi network membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The external part of the cell wall and or plasma membrane. ( Reference:  GOC: jl GOC: mtg_sensu GOC: sm )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0009986", "conceptSize": "18px", "displayValue": "cell bound", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "655", "value": "cell bound", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Organized structure of distinctive morphology and function,  bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus,  mitochondria,  plastids,  vacuoles,  and vesicles. Excludes the plasma membrane. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043231", "conceptSize": "18px", "displayValue": "intracellular membrane-bounde...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "656", "value": "intracellular membrane-bounded organelle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005576", "conceptSize": "18px", "displayValue": "extracellular", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "657", "value": "extracellular", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005641", "conceptSize": "18px", "displayValue": "perinuclear space", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "658", "value": "perinuclear space", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The volume enclosed by the membrane of the platelet alpha granule. ( Reference:  GOC: mah PMID: 8467233 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031093", "conceptSize": "18px", "displayValue": "platelet alpha granule lumen", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "659", "value": "platelet alpha granule lumen", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell; the site of interneuronal communication. As the nerve fiber approaches the synapse it enlarges into a specialized structure,  the presynaptic nerve ending,  which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it,  and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell,  known as the postsynaptic membrane. In response to the arrival of nerve impulses,  the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0045202", "conceptSize": "18px", "displayValue": "synapse", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "660", "value": "synapse", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An immune response against a fungus mediated through a body fluid. An example of this process is the antifungal humoral response in Drosophila melanogaster. ( Reference:  GOC: go_curators GOC: mtg_sensu )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0019732", "conceptSize": "18px", "displayValue": "antifungal humoral response", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "661", "value": "antifungal humoral response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of substances from the Golgi to other parts of the cell,  including organelles and the plasma membrane,  mediated by small transport vesicles. ( Reference:  GOC: ai GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006892", "conceptSize": "18px", "displayValue": "post-Golgi transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "662", "value": "post-Golgi transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the dendrite over time,  from its formation to the mature structure. A dendrite is a freely branching protoplasmic process of a nerve cell. ( Reference:  GOC: jl ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016358", "conceptSize": "18px", "displayValue": "dendrite development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "663", "value": "dendrite development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process involved in the maintenance of an internal steady state of copper ions at the level of a cell. ( Reference:  GOC: ai GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006878", "conceptSize": "18px", "displayValue": "cellular copper ion homeostas...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "664", "value": "cellular copper ion homeostasis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006378", "conceptSize": "18px", "displayValue": "mRNA polyadenylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "665", "value": "mRNA polyadenylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. ( Reference:  GOC: go_curators GOC: mtg_sensu )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0019731", "conceptSize": "18px", "displayValue": "antibacterial humoral response", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "666", "value": "antibacterial humoral response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which outgrowths develop from the axons of intact undamaged neurons. ( Reference:  GOC: dgh GOC: dph GOC: jid GOC: lm )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048669", "conceptSize": "18px", "displayValue": "collateral sprouting in absen...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "667", "value": "collateral sprouting in absence of injury", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. ( Reference:  GOC: add )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0002576", "conceptSize": "18px", "displayValue": "platelet exocytosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "668", "value": "platelet exocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Locomotory behavior in a fully developed and mature organism. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008344", "conceptSize": "18px", "displayValue": "adult locomotory behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "669", "value": "adult locomotory behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The developmentally regulated remodeling of neuronal projections such as pruning to eliminate the extra dendrites and axons projections set up in early stages of nervous system development. ( Reference:  GOC: hb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016322", "conceptSize": "18px", "displayValue": "neuron remodeling", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "670", "value": "neuron remodeling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The attachment of a cell,  either to another cell or to an underlying substrate such as the extracellular matrix,  via cell adhesion molecules. ( Reference:  GOC: hb GOC: pf )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007155", "conceptSize": "18px", "displayValue": "cell adhesion", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "671", "value": "cell adhesion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell,  followed by the movement of ions through a channel in the receptor complex. Ends with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: signaling ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035235", "conceptSize": "18px", "displayValue": "ionotropic glutamate receptor...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "672", "value": "ionotropic glutamate receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The behavioral interactions between organisms for the purpose of mating,  or sexual reproduction resulting in the formation of zygotes. ( Reference:  GOC: ai GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007617", "conceptSize": "18px", "displayValue": "mating behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "673", "value": "mating behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of progressive,  overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change,  adhesiveness,  aggregation,  and release reactions. When carried through to completion,  these events lead to the formation of a stable hemostatic plug. ( Reference:  http: \/\/www.graylab.ac.uk\/omd\/ )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0030168", "conceptSize": "18px", "displayValue": "platelet activation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "674", "value": "platelet activation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA. ( Reference:  GOC: isa_complete )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006417", "conceptSize": "18px", "displayValue": "regulation of translation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "675", "value": "regulation of translation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050829", "conceptSize": "18px", "displayValue": "defense response to Gram-nega...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "676", "value": "defense response to Gram-negative bacteria", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The sequential process in which the multiple coagulation factors of the blood interact,  ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages:  stage 1,  the formation of intrinsic and extrinsic prothrombin converting principle; stage 2,  the formation of thrombin; stage 3,  the formation of stable fibrin polymers. ( Reference:  http: \/\/www.graylab.ac.uk\/omd\/ ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007596", "conceptSize": "18px", "displayValue": "blood clotting", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "677", "value": "blood clotting", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. ( Reference:  GO_REF: 0000022 GOC: add GOC: ebc GOC: mtg_15nov05 GOC: mtg_sensu )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045087", "conceptSize": "18px", "displayValue": "innate immunity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "678", "value": "innate immunity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any apoptotic process in a neuron,  the basic cellular unit of nervous tissue. Each neuron consists of a body,  an axon,  and dendrites. Their purpose is to receive,  conduct,  and transmit impulses in the nervous system. ( Reference:  CL: 0000540 GOC: mtg_apoptosis MeSH: A.08.663 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051402", "conceptSize": "18px", "displayValue": "apoptosis of neurons", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "679", "value": "apoptosis of neurons", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell,  and ending with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: go_curators GOC: signaling )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007219", "conceptSize": "18px", "displayValue": "N signaling pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "680", "value": "N signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The recognition of molecules at the central nervous system midline choice point by an axon growth cone; this choice point determines whether the growth cone will cross the midline. ( Reference:  PMID: 11376484 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016199", "conceptSize": "18px", "displayValue": "axon midline choice point rec...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "681", "value": "axon midline choice point recognition", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "De novo generation of a long process of a neuron,  that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon. ( Reference:  GOC: dph GOC: jid GOC: pg GOC: pr ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007409", "conceptSize": "18px", "displayValue": "axonogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "682", "value": "axonogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. ( Reference:  GOC: dph GOC: go_curators GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045931", "conceptSize": "18px", "displayValue": "positive regulation of mitoti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "683", "value": "positive regulation of mitotic cell cycle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of EGF-activated receptor activity. ( Reference:  GOC: dph GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007176", "conceptSize": "18px", "displayValue": "regulation of EGFR", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "684", "value": "regulation of EGFR", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the physical form or the activity of a synapse,  the junction between a neuron and a target (neuron,  muscle,  or secretory cell). ( Reference:  GOC: ai );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050803", "conceptSize": "18px", "displayValue": "regulation of synapse structu...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "685", "value": "regulation of synapse structure or activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of a neuron projection over time,  from its formation to the mature structure. A neuron projection is any process extending from a neural cell,  such as axons or dendrites (collectively called neurites). ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031175", "conceptSize": "18px", "displayValue": "neuron projection development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "686", "value": "neuron projection development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of an extracellular matrix. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0030198", "conceptSize": "18px", "displayValue": "extracellular matrix organiza...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "687", "value": "extracellular matrix organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals generated as a consequence of a nucleotide-binding domain,  leucine rich repeat containing receptor (NLR) binding to one of its physiological ligands. NLRs are cytoplasmic receptors defined by their tripartite domain architecture that contains:  a variable C-terminus,  a middle nucleotide-binding domain,  and a LRR domain that is variable in the repeats composition and number. The NLR signaling pathway begins with binding of a ligand to a NLR receptor and ends with regulation of a downstream cellular process. ( Reference:  GOC: sj PMID: 18280719 Reactome: 168643 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035872", "conceptSize": "18px", "displayValue": "NLR signaling pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "688", "value": "NLR signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process which results in the assembly,  arrangement of constituent parts,  or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells,  and,  in eukaryotes,  many organelles; may be a single or double lipid bilayer; also includes associated proteins. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0061024", "conceptSize": "18px", "displayValue": "membrane organization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "689", "value": "membrane organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of growth of the body of an organism so that it reaches its usual body size. ( Reference:  GOC: dph GOC: ems GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0040014", "conceptSize": "18px", "displayValue": "regulation of body size", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "690", "value": "regulation of body size", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stimulus from a yeast species. ( Reference:  PMID: 14707091 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001878", "conceptSize": "18px", "displayValue": "response to yeast", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "691", "value": "response to yeast", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050830", "conceptSize": "18px", "displayValue": "defence response to Gram-posi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "692", "value": "defence response to Gram-positive bacteria", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the frequency,  rate or extent of endopeptidase activity,  the endohydrolysis of peptide bonds within proteins. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010951", "conceptSize": "18px", "displayValue": "negative regulation of endope...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "693", "value": "negative regulation of endopeptidase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving a specific protein,  rather than of proteins in general,  occurring at the level of an individual cell. Includes cellular protein modification. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0044267", "conceptSize": "18px", "displayValue": "cellular protein metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "694", "value": "cellular protein metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007626", "conceptSize": "18px", "displayValue": "locomotory behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "695", "value": "locomotory behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue. ( Reference:  GOC: jid ISBN: 0582227089 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008542", "conceptSize": "18px", "displayValue": "visual learning", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "696", "value": "visual learning", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APPBP2,  MUTAGENESIS OF TYR-728]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9843960", "conceptSize": "18px", "displayValue": "PMID: 9843960", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "697", "value": "PMID: 9843960", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[MUTAGENESIS OF VAL-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8886002", "conceptSize": "18px", "displayValue": "PMID: 8886002", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "698", "value": "PMID: 8886002", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 656-737]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2675837", "conceptSize": "18px", "displayValue": "PMID: 2675837", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "699", "value": "PMID: 2675837", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION OF BETA-AMYLOID PEPTIDE AS LIPID PEROXIDATION INHIBITOR,  MUTAGENESIS OF MET-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9168929", "conceptSize": "18px", "displayValue": "PMID: 9168929", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "700", "value": "PMID: 9168929", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT THR-743]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8131745", "conceptSize": "18px", "displayValue": "PMID: 8131745", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "701", "value": "PMID: 8131745", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[IDENTIFICATION OF GAMMA-CTFS BY MASS SPECTROMETRY,  MUTAGENESIS OF ASP-739]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12214090", "conceptSize": "18px", "displayValue": "PMID: 12214090", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "702", "value": "PMID: 12214090", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[IDENTITY OF APP WITH NEXIN-II]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2506449", "conceptSize": "18px", "displayValue": "PMID: 2506449", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "703", "value": "PMID: 2506449", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP639),  TISSUE SPECIFICITY];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12859342", "conceptSize": "18px", "displayValue": "PMID: 12859342", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "704", "value": "PMID: 12859342", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 287-367]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2893291", "conceptSize": "18px", "displayValue": "PMID: 2893291", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "705", "value": "PMID: 2893291", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT VAL-713]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1307241", "conceptSize": "18px", "displayValue": "PMID: 1307241", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "706", "value": "PMID: 1307241", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1678058", "conceptSize": "18px", "displayValue": "PMID: 1678058", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "707", "value": "PMID: 1678058", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[IMPORTANCE OF CYS-144 IN COPPER REDUCTION,  MUTAGENESIS OF CYS-144 AND 147-HIS--HIS-149]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10461923", "conceptSize": "18px", "displayValue": "PMID: 10461923", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "708", "value": "PMID: 10461923", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-198 AND SER-206 BY CASEIN KINASES,  MUTAGENESIS OF SER-198 AND SER-206]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8999878", "conceptSize": "18px", "displayValue": "PMID: 8999878", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "709", "value": "PMID: 8999878", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 672-679 IN COMPLEX WITH IGG]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17895381", "conceptSize": "18px", "displayValue": "PMID: 17895381", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "710", "value": "PMID: 17895381", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 672-711]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7588758", "conceptSize": "18px", "displayValue": "PMID: 7588758", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "711", "value": "PMID: 7588758", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING,  DISULFIDE BOND FORMATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9585534", "conceptSize": "18px", "displayValue": "PMID: 9585534", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "712", "value": "PMID: 9585534", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 286-366];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2893290", "conceptSize": "18px", "displayValue": "PMID: 2893290", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "713", "value": "PMID: 2893290", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 609-713,  GLYCOSYLATION AT SER-614; SER-623; SER-628; SER-679 AND SER-697]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22576872", "conceptSize": "18px", "displayValue": "PMID: 22576872", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "714", "value": "PMID: 22576872", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[BETA-AMYLOID COPPER AND ZINC-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11274207", "conceptSize": "18px", "displayValue": "PMID: 11274207", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "715", "value": "PMID: 11274207", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION,  MUTAGENESIS OF THR-743]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10341243", "conceptSize": "18px", "displayValue": "PMID: 10341243", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "716", "value": "PMID: 10341243", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 672-699]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7516706", "conceptSize": "18px", "displayValue": "PMID: 7516706", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "717", "value": "PMID: 7516706", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 672-711 IN COMPLEX WITH IDE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17051221", "conceptSize": "18px", "displayValue": "PMID: 17051221", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "718", "value": "PMID: 17051221", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CAA-APP ASN-694]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12654973", "conceptSize": "18px", "displayValue": "PMID: 12654973", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "719", "value": "PMID: 12654973", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12142279", "conceptSize": "18px", "displayValue": "PMID: 12142279", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "720", "value": "PMID: 12142279", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APBB1,  FUNCTION,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11544248", "conceptSize": "18px", "displayValue": "PMID: 11544248", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "721", "value": "PMID: 11544248", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 681-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10940221", "conceptSize": "18px", "displayValue": "PMID: 10940221", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "722", "value": "PMID: 10940221", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 672-699]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10940222", "conceptSize": "18px", "displayValue": "PMID: 10940222", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "723", "value": "PMID: 10940222", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 THR-713]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1303275", "conceptSize": "18px", "displayValue": "PMID: 1303275", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "724", "value": "PMID: 1303275", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 GLY-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1944558", "conceptSize": "18px", "displayValue": "PMID: 1944558", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "725", "value": "PMID: 1944558", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 672-713]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8248178", "conceptSize": "18px", "displayValue": "PMID: 8248178", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "726", "value": "PMID: 8248178", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-703]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2949367", "conceptSize": "18px", "displayValue": "PMID: 2949367", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "727", "value": "PMID: 2949367", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 672-701]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8229004", "conceptSize": "18px", "displayValue": "PMID: 8229004", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "728", "value": "PMID: 8229004", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SIGNAL SEQUENCE CLEAVAGE SITE,  TOPOLOGY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2900137", "conceptSize": "18px", "displayValue": "PMID: 2900137", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "729", "value": "PMID: 2900137", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF KUNITZ DOMAIN IN COMPLEX WITH CHYMOTRYPSIN; TRYPSIN AND BASIC PANCREATIC TRYPSIN INHIBITOR]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9300481", "conceptSize": "18px", "displayValue": "PMID: 9300481", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "730", "value": "PMID: 9300481", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH FPRL1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11689470", "conceptSize": "18px", "displayValue": "PMID: 11689470", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "731", "value": "PMID: 11689470", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE OF CAA-APP VARIANTS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10821838", "conceptSize": "18px", "displayValue": "PMID: 10821838", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "732", "value": "PMID: 10821838", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON FUNCTION OF BETA-AMYLOID AS ANTIOXIDANT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11775062", "conceptSize": "18px", "displayValue": "PMID: 11775062", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "733", "value": "PMID: 11775062", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 672-678 IN COMPLEXES WITH ANTIBODY FAB FRAGMENTS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19923222", "conceptSize": "18px", "displayValue": "PMID: 19923222", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "734", "value": "PMID: 19923222", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 18-50]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3597385", "conceptSize": "18px", "displayValue": "PMID: 3597385", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "735", "value": "PMID: 3597385", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[IMPORTANCE OF MET-706 IN FREE RADICAL OXIDATIVE STRESS,  MUTAGENESIS OF MET-706]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10535332", "conceptSize": "18px", "displayValue": "PMID: 10535332", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "736", "value": "PMID: 10535332", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  ASSOCIATION OF AMYLOID FIBRILS WITH GCP1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15084524", "conceptSize": "18px", "displayValue": "PMID: 15084524", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "737", "value": "PMID: 15084524", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2569763", "conceptSize": "18px", "displayValue": "PMID: 2569763", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "738", "value": "PMID: 2569763", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 670-ASN-LEU-671]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1302033", "conceptSize": "18px", "displayValue": "PMID: 1302033", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "739", "value": "PMID: 1302033", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 GLY-693]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1415269", "conceptSize": "18px", "displayValue": "PMID: 1415269", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "740", "value": "PMID: 1415269", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ENDOCYTOSIS SIGNAL,  MUTAGENESIS OF TYR-728; GLY-756; TYR-757; ASN-759; PRO-760 AND TYR-762]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10383380", "conceptSize": "18px", "displayValue": "PMID: 10383380", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "741", "value": "PMID: 10383380", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2881207", "conceptSize": "18px", "displayValue": "PMID: 2881207", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "742", "value": "PMID: 2881207", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 289-344]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1718421", "conceptSize": "18px", "displayValue": "PMID: 1718421", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "743", "value": "PMID: 1718421", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ERRATUM]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1908403", "conceptSize": "18px", "displayValue": "PMID: 1908403", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "744", "value": "PMID: 1908403", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 133-189,  DISULFIDE BONDS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17909280", "conceptSize": "18px", "displayValue": "PMID: 17909280", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "745", "value": "PMID: 17909280", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-MEDIATED LIPID PEROXIDATION,  MUTAGENESIS OF HIS-147 AND HIS-151]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11784781", "conceptSize": "18px", "displayValue": "PMID: 11784781", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "746", "value": "PMID: 11784781", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON ZINC-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12032279", "conceptSize": "18px", "displayValue": "PMID: 12032279", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "747", "value": "PMID: 12032279", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH S100A9]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22457725", "conceptSize": "18px", "displayValue": "PMID: 22457725", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "748", "value": "PMID: 22457725", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION,  INTERACTION WITH APBB1,  MUTAGENESIS OF THR-743]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11517218", "conceptSize": "18px", "displayValue": "PMID: 11517218", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "749", "value": "PMID: 11517218", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT TYR-757,  INTERACTION WITH SHC1,  MUTAGENESIS OF THR-743 AND TYR-757]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11877420", "conceptSize": "18px", "displayValue": "PMID: 11877420", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "750", "value": "PMID: 11877420", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 672-704,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1406936", "conceptSize": "18px", "displayValue": "PMID: 1406936", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "751", "value": "PMID: 1406936", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 18-40]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12665801", "conceptSize": "18px", "displayValue": "PMID: 12665801", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "752", "value": "PMID: 12665801", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 691-698,  CLEAVAGE BY THETA-SECRETASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16816112", "conceptSize": "18px", "displayValue": "PMID: 16816112", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "753", "value": "PMID: 16816112", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APP-BP1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8626687", "conceptSize": "18px", "displayValue": "PMID: 8626687", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "754", "value": "PMID: 8626687", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT ASP-665]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8154870", "conceptSize": "18px", "displayValue": "PMID: 8154870", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "755", "value": "PMID: 8154870", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  CLEAVAGE,  INTERACTION WITH TNFRSF21]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19225519", "conceptSize": "18px", "displayValue": "PMID: 19225519", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "756", "value": "PMID: 19225519", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION OF BETA-AMYLOID PEPTIDE WITH HADH2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9338779", "conceptSize": "18px", "displayValue": "PMID: 9338779", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "757", "value": "PMID: 9338779", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 346-551,  PARTIAL PROTEIN SEQUENCE,  MUTAGENESIS OF ARG-499 AND LYS-503,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15304215", "conceptSize": "18px", "displayValue": "PMID: 15304215", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "758", "value": "PMID: 15304215", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT AD1 GLY-692]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11311152", "conceptSize": "18px", "displayValue": "PMID: 11311152", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "759", "value": "PMID: 11311152", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2538123", "conceptSize": "18px", "displayValue": "PMID: 2538123", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "760", "value": "PMID: 2538123", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2893289", "conceptSize": "18px", "displayValue": "PMID: 2893289", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "761", "value": "PMID: 2893289", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 672-711]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9693002", "conceptSize": "18px", "displayValue": "PMID: 9693002", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "762", "value": "PMID: 9693002", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CAA-APP ASN-694]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11409420", "conceptSize": "18px", "displayValue": "PMID: 11409420", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "763", "value": "PMID: 11409420", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 655-737,  VARIANTS AD1 GLY-717; ILE-717 AND PHE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8476439", "conceptSize": "18px", "displayValue": "PMID: 8476439", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "764", "value": "PMID: 8476439", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 133-189 IN COMPLEXES WITH COPPER IONS,  DISULFIDE BONDS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "17239395", "conceptSize": "18px", "displayValue": "PMID: 17239395", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "765", "value": "PMID: 17239395", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1908231", "conceptSize": "18px", "displayValue": "PMID: 1908231", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "766", "value": "PMID: 1908231", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10742146", "conceptSize": "18px", "displayValue": "PMID: 10742146", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "767", "value": "PMID: 10742146", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10319819", "conceptSize": "18px", "displayValue": "PMID: 10319819", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "768", "value": "PMID: 10319819", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 672-701 AND 707-713]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8109908", "conceptSize": "18px", "displayValue": "PMID: 8109908", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "769", "value": "PMID: 8109908", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 GLY-692,  CHARACTERIZATION OF PHENOTYPE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9754958", "conceptSize": "18px", "displayValue": "PMID: 9754958", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "770", "value": "PMID: 9754958", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9108164", "conceptSize": "18px", "displayValue": "PMID: 9108164", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "771", "value": "PMID: 9108164", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L-APP733)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1587857", "conceptSize": "18px", "displayValue": "PMID: 1587857", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "772", "value": "PMID: 1587857", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CAA-APP GLN-693]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2111584", "conceptSize": "18px", "displayValue": "PMID: 2111584", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "773", "value": "PMID: 2111584", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2110105", "conceptSize": "18px", "displayValue": "PMID: 2110105", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "774", "value": "PMID: 2110105", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH BBP]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11278849", "conceptSize": "18px", "displayValue": "PMID: 11278849", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "775", "value": "PMID: 11278849", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF L-APP733,  MUTAGENESIS OF SER-656]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7737970", "conceptSize": "18px", "displayValue": "PMID: 7737970", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "776", "value": "PMID: 7737970", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 PHE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1925564", "conceptSize": "18px", "displayValue": "PMID: 1925564", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "777", "value": "PMID: 1925564", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 MET-715,  CHARACTERIZATION OF VARIANT AD1 MET-715]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10097173", "conceptSize": "18px", "displayValue": "PMID: 10097173", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "778", "value": "PMID: 10097173", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-10]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3140222", "conceptSize": "18px", "displayValue": "PMID: 3140222", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "779", "value": "PMID: 3140222", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APBB2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8855266", "conceptSize": "18px", "displayValue": "PMID: 8855266", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "780", "value": "PMID: 8855266", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APBA2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9890987", "conceptSize": "18px", "displayValue": "PMID: 9890987", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "781", "value": "PMID: 9890987", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-714,  CHARACTERIZATION OF VARIANT AD1 ILE-714,  MUTAGENESIS OF VAL-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11063718", "conceptSize": "18px", "displayValue": "PMID: 11063718", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "782", "value": "PMID: 11063718", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ALA-714]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12034808", "conceptSize": "18px", "displayValue": "PMID: 12034808", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "783", "value": "PMID: 12034808", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 PRO-723]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10665499", "conceptSize": "18px", "displayValue": "PMID: 10665499", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "784", "value": "PMID: 10665499", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH AGER]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19901339", "conceptSize": "18px", "displayValue": "PMID: 19901339", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "785", "value": "PMID: 19901339", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CAA-APP VAL-705]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16178030", "conceptSize": "18px", "displayValue": "PMID: 16178030", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "786", "value": "PMID: 16178030", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APBB1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18468999", "conceptSize": "18px", "displayValue": "PMID: 18468999", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "787", "value": "PMID: 18468999", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 THR-713]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15365148", "conceptSize": "18px", "displayValue": "PMID: 15365148", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "788", "value": "PMID: 15365148", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3035574", "conceptSize": "18px", "displayValue": "PMID: 3035574", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "789", "value": "PMID: 3035574", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION BY MAPK10,  MUTAGENESIS OF THR-743]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11146006", "conceptSize": "18px", "displayValue": "PMID: 11146006", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "790", "value": "PMID: 11146006", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11438549", "conceptSize": "18px", "displayValue": "PMID: 11438549", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "791", "value": "PMID: 11438549", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH APBA1 AND APBB1,  MUTAGENESIS OF TYR-728; TYR-757; ASN-759 AND TYR-762]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8887653", "conceptSize": "18px", "displayValue": "PMID: 8887653", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "792", "value": "PMID: 8887653", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH ITM2C]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19366692", "conceptSize": "18px", "displayValue": "PMID: 19366692", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "793", "value": "PMID: 19366692", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1671712", "conceptSize": "18px", "displayValue": "PMID: 1671712", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "794", "value": "PMID: 1671712", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[BETA-AMYLOID ZINC-BINDING,  MUTAGENESIS OF ARG-676; TYR-681 AND HIS-684]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10413512", "conceptSize": "18px", "displayValue": "PMID: 10413512", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "795", "value": "PMID: 10413512", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH ANKS1B]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15347684", "conceptSize": "18px", "displayValue": "PMID: 15347684", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "796", "value": "PMID: 15347684", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 GLY-693]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11528419", "conceptSize": "18px", "displayValue": "PMID: 11528419", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "797", "value": "PMID: 11528419", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 ILE-714]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15668448", "conceptSize": "18px", "displayValue": "PMID: 15668448", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "798", "value": "PMID: 15668448", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 672-723,  VARIANT AD1 ASN-678]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15201367", "conceptSize": "18px", "displayValue": "PMID: 15201367", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "799", "value": "PMID: 15201367", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1363811", "conceptSize": "18px", "displayValue": "PMID: 1363811", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "800", "value": "PMID: 1363811", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP695)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2783775", "conceptSize": "18px", "displayValue": "PMID: 2783775", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "801", "value": "PMID: 2783775", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 287-344]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2125487", "conceptSize": "18px", "displayValue": "PMID: 2125487", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "802", "value": "PMID: 2125487", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH G(O)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8446172", "conceptSize": "18px", "displayValue": "PMID: 8446172", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "803", "value": "PMID: 8446172", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 VAL-716]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9328472", "conceptSize": "18px", "displayValue": "PMID: 9328472", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "804", "value": "PMID: 9328472", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-770]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3810169", "conceptSize": "18px", "displayValue": "PMID: 3810169", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "805", "value": "PMID: 3810169", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[GLYCOSYLATION AT THR-633; THR-651; THR-652; SER-656; THR-663 AND SER-667 PROTEOLYTIC PROCESSING,  STRUCTURE OF CARBOHYDRATES,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21712440", "conceptSize": "18px", "displayValue": "PMID: 21712440", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "806", "value": "PMID: 21712440", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD1 PHE-717]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8290042", "conceptSize": "18px", "displayValue": "PMID: 8290042", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "807", "value": "PMID: 8290042", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH MAPK8IP1,  MUTAGENESIS OF TYR-757]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11724784", "conceptSize": "18px", "displayValue": "PMID: 11724784", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "808", "value": "PMID: 11724784", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 507-770]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2893379", "conceptSize": "18px", "displayValue": "PMID: 2893379", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "809", "value": "PMID: 2893379", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Lithium", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "810", "value": "Lithium", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Rifabutin", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "811", "value": "Rifabutin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Nedocromil", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "812", "value": "Nedocromil", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Vincristine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "813", "value": "Vincristine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Colchicine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "814", "value": "Colchicine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Podofilox", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "815", "value": "Podofilox", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Vinblastine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "816", "value": "Vinblastine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Vinorelbine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "817", "value": "Vinorelbine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Clodronate", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "818", "value": "Clodronate", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Adenosine triphosphate", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "819", "value": "Adenosine triphosphate", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Vindesine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "820", "value": "Vindesine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Cabazitaxel", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "821", "value": "Cabazitaxel", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "605543", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE 4,  AUTOSOMA...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "822", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4,  AUTOSOMAL DOMINANT; PARK4", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "127750", "conceptSize": "18px", "displayValue": "DEMENTIA,  LEWY BODY; DLB", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "823", "value": "DEMENTIA,  LEWY BODY; DLB", "conceptShape": "triangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "168601", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE 1,  AUTOSOMA...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "824", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 1,  AUTOSOMAL DOMINANT; PARK1", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with magnesium (Mg) ions. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0000287", "conceptSize": "18px", "displayValue": "magnesium binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "825", "value": "magnesium binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with ferrous iron,  Fe(II). ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008198", "conceptSize": "18px", "displayValue": "ferrous iron binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "826", "value": "ferrous iron binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with Hsp70 proteins,  any of a group of heat shock proteins around 70kDa in size. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0030544", "conceptSize": "18px", "displayValue": "Hsp70 protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "827", "value": "Hsp70 protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA,  which may be a gene,  cistron,  or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. ( Reference:  GOC: jl GOC: txnOH SO: 0005836 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0044212", "conceptSize": "18px", "displayValue": "transcription regulatory regi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "828", "value": "transcription regulatory region DNA binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently and stoichiometrically with kinesin,  a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation. ( Reference:  GOC: curators PMID: 8606779 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0019894", "conceptSize": "18px", "displayValue": "kinesin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "829", "value": "kinesin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with phospholipids,  a class of lipids containing phosphoric acid as a mono- or diester. ( Reference:  ISBN: 0198506732 );", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005543", "conceptSize": "18px", "displayValue": "phospholipid binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "830", "value": "phospholipid binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with the microtubule constituent protein alpha-tubulin. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0043014", "conceptSize": "18px", "displayValue": "alpha tubulin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "831", "value": "alpha tubulin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with calcium ions (Ca2+). ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005509", "conceptSize": "18px", "displayValue": "calcium ion binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "832", "value": "calcium ion binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of an oxidation-reduction (redox) reaction,  a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized,  while the other acts as hydrogen or electron acceptor and becomes reduced. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0016491", "conceptSize": "18px", "displayValue": "redox", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "833", "value": "redox", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein,  implicated in Alzheimer's disease,  Down Syndrome and ALS. ( Reference:  GOC: jid )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0048156", "conceptSize": "18px", "displayValue": "tau protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "834", "value": "tau protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with dynein,  the multisubunit protein complex that is associated with microtubules. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0045502", "conceptSize": "18px", "displayValue": "dynein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "835", "value": "dynein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with copper (Cu) ions. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005507", "conceptSize": "18px", "displayValue": "copper binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "836", "value": "copper binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Stops,  prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis PMID: 14744432 Wikipedia: Caspase )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0043027", "conceptSize": "18px", "displayValue": "cysteine-type endopeptidase i...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "837", "value": "cysteine-type endopeptidase inhibitor activity involved in apoptotic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a phosphorylated protein. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0051219", "conceptSize": "18px", "displayValue": "phosphoprotein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "838", "value": "phosphoprotein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a histone,  any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0042393", "conceptSize": "18px", "displayValue": "histone binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "839", "value": "histone binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with zinc (Zn) ions. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008270", "conceptSize": "18px", "displayValue": "zinc binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "840", "value": "zinc binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An intracellular organelle,  about 200 A in diameter,  consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits,  one large and one small,  each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients,  expressed in Svedberg units (symbol:  S). Hence,  the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit,  while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation,  namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes,  eukaryotes,  mitochondria,  and chloroplasts have characteristically distinct ribosomal proteins. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005840", "conceptSize": "18px", "displayValue": "ribosome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "841", "value": "ribosome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. ( Reference:  GOC: jl ISBN: 0395825172 ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0015629", "conceptSize": "18px", "displayValue": "actin cytoskeleton", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "842", "value": "actin cytoskeleton", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Extracellular matrix material consisting of polysaccharides and protein. ( Reference:  PMID: 12704238 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043205", "conceptSize": "18px", "displayValue": "fibril", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "843", "value": "fibril", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A secretory organelle,  typically 50 nm in diameter,  of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. ( Reference:  PMID: 10099709 PMID: 12563290 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0008021", "conceptSize": "18px", "displayValue": "synaptic vesicle", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "844", "value": "synaptic vesicle", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding a cytoplasmic vesicle. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030659", "conceptSize": "18px", "displayValue": "cytoplasmic vesicle membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "845", "value": "cytoplasmic vesicle membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. ( Reference:  GOC: dos GOC: mah ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0016020", "conceptSize": "18px", "displayValue": "membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "846", "value": "membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The region of a cell that lies just beneath the plasma membrane and often,  but not always,  contains a network of actin filaments and associated proteins. ( Reference:  GOC: mah ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005938", "conceptSize": "18px", "displayValue": "cell cortex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "847", "value": "cell cortex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The outer,  i.e. cytoplasm-facing,  lipid bilayer of the nuclear envelope; continuous with the endoplasmic reticulum of the cell and sometimes studded with ribosomes. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005640", "conceptSize": "18px", "displayValue": "perinuclear membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "848", "value": "perinuclear membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins),  the proteins of the lysosomes,  or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005791", "conceptSize": "18px", "displayValue": "RER", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "849", "value": "RER", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells,  the nucleus contains all of the cell's chromosomes except the organellar chromosomes,  and is the site of RNA synthesis and processing. In some species,  or in specialized cell types,  RNA metabolism or DNA replication may be absent. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005634", "conceptSize": "18px", "displayValue": "nucleus", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "850", "value": "nucleus", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an iron(II) ion stimulus. ( Reference:  GOC: sm )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010040", "conceptSize": "18px", "displayValue": "response to iron(II)", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "851", "value": "response to iron(II)", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A metabolic process that results in the removal or addition of one or more electrons to or from a substance,  with or without the concomitant removal or addition of a proton or protons. ( Reference:  GOC: dhl GOC: ecd GOC: jh2 GOC: jid GOC: mlg GOC: rph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0055114", "conceptSize": "18px", "displayValue": "oxidation reduction", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "852", "value": "oxidation reduction", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops or reduces the activity of a monooxygenase. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032769", "conceptSize": "18px", "displayValue": "downregulation of monooxygena...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "853", "value": "downregulation of monooxygenase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of extracellular fibrils,  extracellular matrix material consisting of polysaccharides and or proteins. ( Reference:  GOC: mlg GOC: pr )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043206", "conceptSize": "18px", "displayValue": "extracellular fibril organiza...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "854", "value": "extracellular fibril organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of norepinephrine into a cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051622", "conceptSize": "18px", "displayValue": "downregulation of norepinephr...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "855", "value": "downregulation of norepinephrine uptake", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving fatty acids,  aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006631", "conceptSize": "18px", "displayValue": "fatty acid metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "856", "value": "fatty acid metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031115", "conceptSize": "18px", "displayValue": "downregulation of microtubule...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "857", "value": "downregulation of microtubule polymerization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle recycling. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 22745285 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903421", "conceptSize": "18px", "displayValue": "regulation of synaptic vesicl...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "858", "value": "regulation of synaptic vesicle recycling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of dopamine into a presynaptic neuron or glial cell. In this context,  dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051583", "conceptSize": "18px", "displayValue": "dopamine uptake involved in s...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "859", "value": "dopamine uptake involved in synaptic transmission", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine,  chemokine,  cellular ligand,  or soluble factor. ( Reference:  GOC: mgi_curators PMID: 10626665 PMID: 10695728 PMID: 12580336 PMID: 9893949 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001774", "conceptSize": "18px", "displayValue": "microglial cell activation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "860", "value": "microglial cell activation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone,  and released by certain neurons to act as a neurotransmitter active in the central nervous system. ( Reference:  CHEBI: 33568 GOC: BHF GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0071872", "conceptSize": "18px", "displayValue": "cellular response to adrenali...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "861", "value": "cellular response to adrenaline stimulus", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. ( Reference:  GOC: bf GOC: mah GOC: signaling PMID: 15006537 PMID: 19643732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031623", "conceptSize": "18px", "displayValue": "receptor internalization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "862", "value": "receptor internalization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. ( Reference:  GOC: add ISBN: 0721601464 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032496", "conceptSize": "18px", "displayValue": "response to LPS", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "863", "value": "response to LPS", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a magnesium ion stimulus. ( Reference:  GOC: mah );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032026", "conceptSize": "18px", "displayValue": "response to magnesium ion", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "864", "value": "response to magnesium ion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of cell death by apoptotic process in neurons. ( Reference:  GOC: go_curators GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043524", "conceptSize": "18px", "displayValue": "downregulation of neuron apop...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "865", "value": "downregulation of neuron apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of phospholipase activity,  the hydrolysis of a phospholipid. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010517", "conceptSize": "18px", "displayValue": "regulation of phospholipase a...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "866", "value": "regulation of phospholipase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of cell death by apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043066", "conceptSize": "18px", "displayValue": "anti-apoptosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "867", "value": "anti-apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways resulting in the formation of dopamine,  a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: jl ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042416", "conceptSize": "18px", "displayValue": "dopamine formation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "868", "value": "dopamine formation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The transfer of electrons through a series of electron donors and acceptors,  generating energy that is ultimately used for synthesis of ATP,  as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane. ( Reference:  GOC: mtg_sensu ISBN: 0716731363 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042775", "conceptSize": "18px", "displayValue": "mitochondrial ATP synthesis c...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "869", "value": "mitochondrial ATP synthesis coupled electron transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the rate,  frequency,  or extent of protein serine threonine kinase activity. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0071902", "conceptSize": "18px", "displayValue": "positive regulation of protei...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "870", "value": "positive regulation of protein serine\/threonine kinase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051281", "conceptSize": "18px", "displayValue": "upregulation of release of se...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "871", "value": "upregulation of release of sequestered calcium ion into cytosol", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an interleukin-1 stimulus. ( Reference:  GOC: BHF GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070555", "conceptSize": "18px", "displayValue": "response to IL-1", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "872", "value": "response to IL-1", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the platelet-derived growth factor receptor signaling pathway. ( Reference:  GOC: dph GOC: hjd GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010642", "conceptSize": "18px", "displayValue": "negative regulation of platel...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "873", "value": "negative regulation of platelet-derived growth factor receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of glutathione peroxidase activity. ( Reference:  GO_REF: 0000059 GOC: bf GOC: PARL GOC: TermGenie PMID: 23507046 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903284", "conceptSize": "18px", "displayValue": "enhancement of GPX", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "874", "value": "enhancement of GPX", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of thrombin receptor protein signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin receptor binding to one of its physiological ligands. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070495", "conceptSize": "18px", "displayValue": "negative regulation of thromb...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "875", "value": "negative regulation of thrombin receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of reactive oxygen species biosynthetic process. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 24252804 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903426", "conceptSize": "18px", "displayValue": "regulation of reactive oxygen...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "876", "value": "regulation of reactive oxygen species synthesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of endocytosis. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045807", "conceptSize": "18px", "displayValue": "upregulation of endocytosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "877", "value": "upregulation of endocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon. ( Reference:  GOC: add ISBN: 0126896631 PMID: 15546383 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034341", "conceptSize": "18px", "displayValue": "response to interferon-gamma", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "878", "value": "response to interferon-gamma", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of cell death by apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043065", "conceptSize": "18px", "displayValue": "upregulation of apoptosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "879", "value": "upregulation of apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a synapse,  the junction between a neuron and a target (neuron,  muscle,  or secretory cell). ( Reference:  GOC: ai GOC: pr )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050808", "conceptSize": "18px", "displayValue": "synapse development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "880", "value": "synapse development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Clathrin-mediated endocytosis of presynaptic membrane that recycles synaptic vesicle membrane and its components following synaptic vesicle exocytosis. This process starts with coating of the membrane with adaptor proteins and clathrin prior to invagination and ends when uncoating has finished. ( Reference:  GOC: jid GOC: lmg GOC: mah PMID: 20448150 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048488", "conceptSize": "18px", "displayValue": "synaptic vesicle endocytosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "881", "value": "synaptic vesicle endocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the regulated release of a neurotransmitter. ( Reference:  GOC: hjd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001956", "conceptSize": "18px", "displayValue": "upregulation of neurotransmit...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "882", "value": "upregulation of neurotransmitter secretion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving phospholipids,  any lipid containing phosphoric acid as a mono- or diester. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006644", "conceptSize": "18px", "displayValue": "phospholipid metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "883", "value": "phospholipid metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the stability of a protein,  making it more vulnerable to degradative processes or aggregation. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031648", "conceptSize": "18px", "displayValue": "protein destabilization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "884", "value": "protein destabilization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the addition of an acetyl group to a histone protein. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035067", "conceptSize": "18px", "displayValue": "downregulation of histone ace...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "885", "value": "downregulation of histone acetylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the phosphorylation of peptidyl-serine. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0033138", "conceptSize": "18px", "displayValue": "positive regulation of peptid...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "886", "value": "positive regulation of peptidyl-serine phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of mitochondrial electron transport,  NADH to ubiquinone. ( Reference:  GO_REF: 0000058 GOC: dph GOC: TermGenie PMID: 23530063 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902957", "conceptSize": "18px", "displayValue": "downregulation of oxidative p...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "887", "value": "downregulation of oxidative phosphorylation,  NADH to ubiquinone", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate,  or frequency of synaptic transmission at the synapse. ( Reference:  GOC: dgh GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060291", "conceptSize": "18px", "displayValue": "long-term synaptic potentiati...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "888", "value": "long-term synaptic potentiation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043154", "conceptSize": "18px", "displayValue": "downregulation of caspase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "889", "value": "downregulation of caspase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that modulates long-term neuronal synaptic plasticity,  the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers. ( Reference:  GOC: jid http: \/\/www.mercksource.com PMID: 11891290 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048169", "conceptSize": "18px", "displayValue": "regulation of long-term neuro...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "890", "value": "regulation of long-term neuronal synaptic plasticity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease,  homeostasis,  and fertility,  as well as wear and tear. Aging includes cellular senescence,  but is more inclusive. May precede death (GO: 0016265) and may succeed developmental maturation (GO: 0021700). ( Reference:  GOC: PO_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007568", "conceptSize": "18px", "displayValue": "aging", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "891", "value": "aging", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops or reduces the activity of a transporter. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032410", "conceptSize": "18px", "displayValue": "downregulation of transporter", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "892", "value": "downregulation of transporter", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of dopamine into a presynaptic neuron or glial cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051585", "conceptSize": "18px", "displayValue": "downregulation of dopamine up...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "893", "value": "downregulation of dopamine uptake involved in synaptic transmission", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency or rate of macrophage activation. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043030", "conceptSize": "18px", "displayValue": "regulation of macrophage acti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "894", "value": "regulation of macrophage activation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of exocytosis. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045920", "conceptSize": "18px", "displayValue": "downregulation of exocytosis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "895", "value": "downregulation of exocytosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the chemical reactions and pathways involving dopamine. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045963", "conceptSize": "18px", "displayValue": "negative regulation of dopami...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "896", "value": "negative regulation of dopamine metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. ( Reference:  GOC: al GOC: dph GOC: jl GOC: mtg_apoptosis GOC: tb PMID: 14744432 PMID: 18328827 Wikipedia: Caspase )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006919", "conceptSize": "18px", "displayValue": "caspase activation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "897", "value": "caspase activation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis,  treatment or prevention of a disease. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042493", "conceptSize": "18px", "displayValue": "response to drug", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "898", "value": "response to drug", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in the behavior of an organism as a result of a cocaine stimulus. ( Reference:  GOC: jid )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048148", "conceptSize": "18px", "displayValue": "behavioral response to cocaine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "899", "value": "behavioral response to cocaine", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a copper ion stimulus. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0071280", "conceptSize": "18px", "displayValue": "cellular response to copper", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "900", "value": "cellular response to copper", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of serotonin into a cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051612", "conceptSize": "18px", "displayValue": "negative regulation of 5HT up...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "901", "value": "negative regulation of 5HT uptake", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of transcription from an RNA polymerase II promoter. ( Reference:  GOC: go_curators GOC: txnOH )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000122", "conceptSize": "18px", "displayValue": "negative regulation of transc...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "902", "value": "negative regulation of transcription from Pol II promoter", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the rate,  frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate,  1, 2, 3, 4, 5, 6-cyclohexanehexol,  with one or more phosphate groups attached. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060732", "conceptSize": "18px", "displayValue": "positive regulation of inosit...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "903", "value": "positive regulation of inositol phosphate biosynthetic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an fibroblast growth factor stimulus. ( Reference:  GOC: jl GOC: yaf )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0044344", "conceptSize": "18px", "displayValue": "cellular response to FGF stim...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "904", "value": "cellular response to FGF stimulus", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving neutral lipids,  lipids only soluble in solvents of very low polarity. ( Reference:  ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006638", "conceptSize": "18px", "displayValue": "neutral lipid metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "905", "value": "neutral lipid metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the regulated release of dopamine. ( Reference:  GOC: ef )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0014059", "conceptSize": "18px", "displayValue": "regulation of dopamine secret...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "906", "value": "regulation of dopamine secretion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of hydrogen peroxide catabolic process. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23507046 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903285", "conceptSize": "18px", "displayValue": "upregulation of H2O2 cataboli...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "907", "value": "upregulation of H2O2 catabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a mitochondrial membrane,  either of the lipid bilayer surrounding a mitochondrion. ( Reference:  GOC: ai GOC: dph GOC: jl GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007006", "conceptSize": "18px", "displayValue": "mitochondrial membrane organi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "908", "value": "mitochondrial membrane organisation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways resulting in the formation of acyl-CoA. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050812", "conceptSize": "18px", "displayValue": "regulation of acyl-CoA synthe...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "909", "value": "regulation of acyl-CoA synthesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of receptor recycling. ( Reference:  GOC: add )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001921", "conceptSize": "18px", "displayValue": "upregulation of receptor recy...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "910", "value": "upregulation of receptor recycling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the controlled release of glutamate. ( Reference:  GOC: ef )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0014048", "conceptSize": "18px", "displayValue": "regulation of glutamate secre...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "911", "value": "regulation of glutamate secretion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK1 GLN-50]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23457019", "conceptSize": "18px", "displayValue": "PMID: 23457019", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "912", "value": "PMID: 23457019", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH PHOSPHOLIPASE D]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11821392", "conceptSize": "18px", "displayValue": "PMID: 11821392", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "913", "value": "PMID: 11821392", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15282274", "conceptSize": "18px", "displayValue": "PMID: 15282274", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "914", "value": "PMID: 15282274", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH HISTONES,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12859192", "conceptSize": "18px", "displayValue": "PMID: 12859192", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "915", "value": "PMID: 12859192", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12558071", "conceptSize": "18px", "displayValue": "PMID: 12558071", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "916", "value": "PMID: 12558071", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2-4 AND 2-5)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7601450", "conceptSize": "18px", "displayValue": "PMID: 7601450", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "917", "value": "PMID: 7601450", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ROLE OF THE C-TERMINUS IN FIBRILLOGENESIS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12859200", "conceptSize": "18px", "displayValue": "PMID: 12859200", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "918", "value": "PMID: 12859200", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT LYS-46]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15498564", "conceptSize": "18px", "displayValue": "PMID: 15498564", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "919", "value": "PMID: 15498564", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK1\/DLB LYS-46]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14755719", "conceptSize": "18px", "displayValue": "PMID: 14755719", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "920", "value": "PMID: 14755719", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING,  MUTAGENESIS OF ASP-2 AND HIS-50];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21319811", "conceptSize": "18px", "displayValue": "PMID: 21319811", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "921", "value": "PMID: 21319811", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT TYR-125 BY FYN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11162638", "conceptSize": "18px", "displayValue": "PMID: 11162638", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "922", "value": "PMID: 11162638", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANTS PARK1 PRO-30; LYS-46; GLN-50 AND THR-53,  MUTAGENESIS OF GLU-35 AND GLU-57,  SUBCELLULAR LOCATION,  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "25561023", "conceptSize": "18px", "displayValue": "PMID: 25561023", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "923", "value": "PMID: 25561023", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-129]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11813001", "conceptSize": "18px", "displayValue": "PMID: 11813001", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "924", "value": "PMID: 11813001", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK1 PRO-30]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9462735", "conceptSize": "18px", "displayValue": "PMID: 9462735", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "925", "value": "PMID: 9462735", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT PARK1 GLN-50,  SUBCELLULAR LOCATION,  SUBUNIT,  PHOSPHORYLATION AT SER-129]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "24936070", "conceptSize": "18px", "displayValue": "PMID: 24936070", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "926", "value": "PMID: 24936070", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2-4)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11156617", "conceptSize": "18px", "displayValue": "PMID: 11156617", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "927", "value": "PMID: 11156617", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK1 GLN-50,  CHARACTERIZATION OF VARIANT PARK1 GLN-50]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23427326", "conceptSize": "18px", "displayValue": "PMID: 23427326", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "928", "value": "PMID: 23427326", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1),  PROTEIN SEQUENCE OF 61-95]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8248242", "conceptSize": "18px", "displayValue": "PMID: 8248242", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "929", "value": "PMID: 8248242", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ACETYLATION AT MET-1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22407793", "conceptSize": "18px", "displayValue": "PMID: 22407793", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "930", "value": "PMID: 22407793", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION BY G-PROTEIN COUPLED RECEPTOR KINASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10852916", "conceptSize": "18px", "displayValue": "PMID: 10852916", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "931", "value": "PMID: 10852916", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-87 AND SER-129 BY CK1 AND CK2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10617630", "conceptSize": "18px", "displayValue": "PMID: 10617630", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "932", "value": "PMID: 10617630", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FIBRILS FORMATION,  DOMAIN NAC,  MUTAGENESIS OF 67-GLY--VAL-71; 71-VAL--VAL-82; 76-ALA-VAL-77; VAL-77; ALA-78 AND 85-ALA--PHE-94]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19722699", "conceptSize": "18px", "displayValue": "PMID: 19722699", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "933", "value": "PMID: 19722699", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2-4)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7802671", "conceptSize": "18px", "displayValue": "PMID: 7802671", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "934", "value": "PMID: 7802671", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[MUTAGENESIS OF TYR-39; TYR-125; TYR-133 AND TYR-136,  CHARACTERIZATION OF VARIANT THR-53,  PHOSPHORYLATION AT TYR-125]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12893833", "conceptSize": "18px", "displayValue": "PMID: 12893833", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "935", "value": "PMID: 12893833", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK1 THR-53]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9197268", "conceptSize": "18px", "displayValue": "PMID: 9197268", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "936", "value": "PMID: 9197268", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Dextromethorphan", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "937", "value": "Dextromethorphan", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Haloperidol", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "938", "value": "Haloperidol", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Enzyme Classification", "pid": "6.3.2.-", "conceptSize": "18px", "displayValue": "6.3.2.-", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "pink", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "939", "value": "6.3.2.-", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "600116", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE 2,  AUTOSOMA...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "940", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 2,  AUTOSOMAL RECESSIVE JUVENILE; PARK2", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with the beta subunit of the catenin complex. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008013", "conceptSize": "18px", "displayValue": "beta-catenin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "941", "value": "beta-catenin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a PDZ domain of a protein,  a domain found in diverse signaling proteins. ( Reference:  GOC: go_curators Pfam: PF00595 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0030165", "conceptSize": "18px", "displayValue": "PDZ domain binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "942", "value": "PDZ domain binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a heat shock protein,  any protein synthesized or activated in response to heat shock. ( Reference:  GOC: mah GOC: vw )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0031072", "conceptSize": "18px", "displayValue": "heat shock protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "943", "value": "heat shock protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X,  where both X-Ub and Y-Ub are covalent linkages. ( Reference:  GOC: BioGRID GOC: jh2 PMID: 9635407 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004842", "conceptSize": "18px", "displayValue": "ubiquitin-protein transferase...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "944", "value": "ubiquitin-protein transferase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the joining of two substances,  or two groups within a single molecule,  with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. ( Reference:  EC: 6 GOC: mah )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0016874", "conceptSize": "18px", "displayValue": "synthetase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "945", "value": "synthetase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a chaperone protein,  a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. ( Reference:  http: \/\/www.onelook.com )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0051087", "conceptSize": "18px", "displayValue": "chaperone binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "946", "value": "chaperone binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an F-box domain of a protein. ( Reference:  GOC: bf GOC: PARL InterPro: IPR001810 PMID: 12628165 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 1990444", "conceptSize": "18px", "displayValue": "F-box domain binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "947", "value": "F-box domain binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with any member of the cullin family,  hydrophobic proteins that act as scaffolds for ubiquitin ligases (E3). ( Reference:  GOC: ha InterPro: IPR016158 PMID: 18698375 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0097602", "conceptSize": "18px", "displayValue": "cullin family protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "948", "value": "cullin family protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with ubiquitin,  a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. ( Reference:  GOC: ecd )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0043130", "conceptSize": "18px", "displayValue": "ubiquitin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "949", "value": "ubiquitin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a ubiquitin conjugating enzyme,  any of the E2 proteins. ( Reference:  GOC: vp )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0031624", "conceptSize": "18px", "displayValue": "ubiquitin conjugating enzyme ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "950", "value": "ubiquitin conjugating enzyme binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme,  any of the E3 proteins. ( Reference:  GOC: vp )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0031625", "conceptSize": "18px", "displayValue": "ubiquitin ligase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "951", "value": "ubiquitin ligase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any ubiquitin protein ligase activity that is involved in the ERAD pathway (the targeting of endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome). ( Reference:  GO_REF: 0000061 GOC: bf GOC: PARL GOC: TermGenie PMID: 23990462 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 1904264", "conceptSize": "18px", "displayValue": "ubiquitin ligase activity inv...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "952", "value": "ubiquitin ligase activity involved in ERAD pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a protein kinase,  any enzyme that catalyzes the transfer of a phosphate group,  usually from ATP,  to a protein substrate. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0019901", "conceptSize": "18px", "displayValue": "protein kinase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "953", "value": "protein kinase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with any phospholipase,  enzymes that catalyze of the hydrolysis of a glycerophospholipid. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0043274", "conceptSize": "18px", "displayValue": "phospholipase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "954", "value": "phospholipase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with the enzyme histone deacetylase. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0042826", "conceptSize": "18px", "displayValue": "histone deacetylase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "955", "value": "histone deacetylase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a ubiquitin-specific protease. ( Reference:  GOC: bf GOC: PARL PMID: 24063750 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 1990381", "conceptSize": "18px", "displayValue": "deubiquitinase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "956", "value": "deubiquitinase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a kinase,  any enzyme that catalyzes the transfer of a phosphate group. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0019900", "conceptSize": "18px", "displayValue": "kinase binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "957", "value": "kinase binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with a G-protein coupled receptor. ( Reference:  GOC: ceb GOC: dph )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0001664", "conceptSize": "18px", "displayValue": "G-protein coupled receptor bi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "958", "value": "G-protein coupled receptor binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S --> X + S-ubiquitin,  where X is either an E2 or E3 enzyme,  the X-ubiquitin linkage is a thioester bond,  and the S-ubiquitin linkage is an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate. Note that this may include the extension of ubiquitin chains. ( Reference:  GOC: BioGRID GOC: dph );", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0061630", "conceptSize": "18px", "displayValue": "ubiquitin ligase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "959", "value": "ubiquitin ligase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Cytoplasmic,  spherical inclusion commonly found in damaged neurons,  and composed of abnormally phosphorylated,  neurofilament proteins aggregated with ubiquitin and alpha-synuclein. ( Reference:  NIF_Subcellular: sao4933778419 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0097413", "conceptSize": "18px", "displayValue": "Lewy body", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "960", "value": "Lewy body", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules. ( Reference:  PMID: 11121744 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0016235", "conceptSize": "18px", "displayValue": "aggresome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "961", "value": "aggresome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A ubiquitin ligase complex containing Parkin (PARK2),  the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein. ( Reference:  GOC: bf GOC: PARL PMID: 12628165 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 1990452", "conceptSize": "18px", "displayValue": "PARK2-FBXW7-Cul1 complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "962", "value": "PARK2-FBXW7-Cul1 complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex. ( Reference:  GOC: jh2 PMID: 9529603 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0000151", "conceptSize": "18px", "displayValue": "ubiquitin ligase complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "963", "value": "ubiquitin ligase complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the frequency,  rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010629", "conceptSize": "18px", "displayValue": "negative regulation of gene e...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "964", "value": "negative regulation of gene expression", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of a process involved in the formation,  arrangement of constituent parts,  or disassembly of a mitochondrion. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010821", "conceptSize": "18px", "displayValue": "regulation of mitochondrion o...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "965", "value": "regulation of mitochondrion organization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050821", "conceptSize": "18px", "displayValue": "protein stabilization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "966", "value": "protein stabilization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Addition of a single ubiquitin group to a protein. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006513", "conceptSize": "18px", "displayValue": "protein monoubiquitination", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "967", "value": "protein monoubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the rate,  frequency,  or extent of the Wnt signaling pathway through beta-catenin,  the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090090", "conceptSize": "18px", "displayValue": "negative regulation of canoni...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "968", "value": "negative regulation of canonical Wnt signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the establishment or extent of the mitochondrial membrane potential,  the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051881", "conceptSize": "18px", "displayValue": "regulation of mitochondrial m...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "969", "value": "regulation of mitochondrial membrane potential", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which ubiquitin monomers are attached to a protein,  and then ubiquitin polymers are formed by linkages between lysine residues at position 11 of the ubiquitin monomers. K11-linked polyubiquitination targets the substrate protein for degradation. The anaphase-promoting complex promotes the degradation of mitotic regulators by assembling K11-linked polyubiquitin chains. ( Reference:  GOC: jsg GOC: pr GOC: sp PMID: 18485873 PMID: 20655260 PMID: 21113135 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070979", "conceptSize": "18px", "displayValue": "protein K11-linked ubiquitina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "970", "value": "protein K11-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 6 of the ubiquitin monomers,  is added to a protein. K6-linked ubiquitination is involved in DNA repair. ( Reference:  GOC: sp )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0085020", "conceptSize": "18px", "displayValue": "protein K6-linked ubiquitinat...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "971", "value": "protein K6-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the frequency,  rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). ( Reference:  GOC: dph GOC: jl GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043388", "conceptSize": "18px", "displayValue": "upregulation of DNA binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "972", "value": "upregulation of DNA binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of primary amine oxidase activity. ( Reference:  GOC: TermGenie PMID: 23349812 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902283", "conceptSize": "18px", "displayValue": "downregulation of primary ami...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "973", "value": "downregulation of primary amine oxidase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process in which a host organism stops,  prevents or reduces the frequency,  rate or extent of viral genome replication. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0044828", "conceptSize": "18px", "displayValue": "negative regulation by host o...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "974", "value": "negative regulation by host of viral genome replication", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The aggregation,  arrangement and bonding together of a set of components to form an aggresome; requires the microtubule cytoskeleton and dynein. ( Reference:  GOC: BHF GOC: rl PMID: 14675537 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070842", "conceptSize": "18px", "displayValue": "aggresome assembly", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "975", "value": "aggresome assembly", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the frequency,  rate or extent of merging of two or more mitochondria within a cell to form a single compartment. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010636", "conceptSize": "18px", "displayValue": "positive regulation of mitoch...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "976", "value": "positive regulation of mitochondrial fusion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the assembly of actin filament bundles. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032232", "conceptSize": "18px", "displayValue": "downregulation of actin filam...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "977", "value": "downregulation of actin filament bundle formation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 15790595 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903377", "conceptSize": "18px", "displayValue": "negative regulation of oxidat...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "978", "value": "negative regulation of oxidative stress-induced neuron apoptosis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of proteasomal protein catabolic process. ( Reference:  GOC: BHF GOC: rl GOC: TermGenie PMID: 21669198 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1901800", "conceptSize": "18px", "displayValue": "activation of proteasome-medi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "979", "value": "activation of proteasome-mediated protein catabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of spontaneous neurotransmitter secretion. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 22314364 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1904049", "conceptSize": "18px", "displayValue": "downregulation of spontaneous...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "980", "value": "downregulation of spontaneous neurotransmitter secretion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 29 of the ubiquitin monomers,  is added to a protein. K29-linked ubiquitination targets the substrate protein for degradation. ( Reference:  PMID: 17028573 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035519", "conceptSize": "18px", "displayValue": "protein K29-linked ubiquitina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "981", "value": "protein K29-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of oxidative stress-induced cell death. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 24252804 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903202", "conceptSize": "18px", "displayValue": "negative regulation of oxidat...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "982", "value": "negative regulation of oxidative stress-induced cell death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 63 of the ubiquitin monomers,  is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation,  but is involved in several pathways,  notably as a signal to promote error-free DNA postreplication repair. ( Reference:  GOC: mah PMID: 15556404 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070534", "conceptSize": "18px", "displayValue": "protein K63-linked ubiquitina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "983", "value": "protein K63-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Addition of multiple ubiquitin groups to a protein,  forming a ubiquitin chain. ( Reference:  ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000209", "conceptSize": "18px", "displayValue": "protein polyubiquitylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "984", "value": "protein polyubiquitylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the rate,  frequency or extent of release of cytochrome c from mitochondria,  the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol,  which is an early step in apoptosis and leads to caspase activation. ( Reference:  GOC: BHF GOC: dph GOC: mtg_apoptosis GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090201", "conceptSize": "18px", "displayValue": "negative regulation of releas...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "985", "value": "negative regulation of release of cytochrome c from mitochondria", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the addition of ubiquitin groups to a protein. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031396", "conceptSize": "18px", "displayValue": "regulation of protein ubiquit...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "986", "value": "regulation of protein ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which one or more ubiquitin groups are added to a protein. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016567", "conceptSize": "18px", "displayValue": "protein ubiquitylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "987", "value": "protein ubiquitylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903378", "conceptSize": "18px", "displayValue": "upregulation of neuron intrin...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "988", "value": "upregulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 27 of the ubiquitin monomers,  is added to a protein. ( Reference:  PMID: 19345326 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0044314", "conceptSize": "18px", "displayValue": "protein K27-linked ubiquitina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "989", "value": "protein K27-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways involving dopamine. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042053", "conceptSize": "18px", "displayValue": "regulation of dopamine metabo...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "990", "value": "regulation of dopamine metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the frequency,  rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010628", "conceptSize": "18px", "displayValue": "positive regulation of gene e...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "991", "value": "positive regulation of gene expression", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of tumor necrosis factor-mediated signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23453807 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903265", "conceptSize": "18px", "displayValue": "upregulation of tumor necrosi...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "992", "value": "upregulation of tumor necrosis factor-mediated signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of the directed movement of lipids into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032368", "conceptSize": "18px", "displayValue": "regulation of lipid transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "993", "value": "regulation of lipid transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving norepinephrine,  a hormone secreted by the adrenal medulla,  and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system. It is also the demethylated biosynthetic precursor of epinephrine. ( Reference:  GOC: jl ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042415", "conceptSize": "18px", "displayValue": "levarterenol metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "994", "value": "levarterenol metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of cellular response to oxidative stress. ( Reference:  GOC: mah GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1900407", "conceptSize": "18px", "displayValue": "regulation of cellular respon...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "995", "value": "regulation of cellular response to oxidative stress", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of transcription from an RNA polymerase II promoter. ( Reference:  GOC: go_curators GOC: txnOH )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045944", "conceptSize": "18px", "displayValue": "positive regulation of transc...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "996", "value": "positive regulation of transcription from Pol II promoter", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The cellular synthesis of RNA on a template of DNA. ( Reference:  GOC: jl GOC: txnOH )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006351", "conceptSize": "18px", "displayValue": "DNA-dependent transcription", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "997", "value": "DNA-dependent transcription", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051582", "conceptSize": "18px", "displayValue": "upregulation of neurotransmit...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "998", "value": "upregulation of neurotransmitter uptake", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 48 of the ubiquitin monomers,  is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation. ( Reference:  GOC: cvs PMID: 15556404 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070936", "conceptSize": "18px", "displayValue": "protein K48-linked ubiquitina...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "999", "value": "protein K48-linked ubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein,  includes retrotranslocation (dislocation) of the protein from the ER to the cytosol,  protein modifications necessary for correct substrate transfer (e.g. ubiquitination),  transport of the protein to the proteasome,  and ends with degradation of the protein by the cytoplasmic proteasome. ( Reference:  GOC: bf GOC: PARL )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0036503", "conceptSize": "18px", "displayValue": "ERAD pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1000", "value": "ERAD pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. ( Reference:  GOC: kmv )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035249", "conceptSize": "18px", "displayValue": "synaptic transmission,  glutam...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1001", "value": "synaptic transmission,  glutamatergic", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease,  rather than simply deteriorating gradually over time,  which culminates in cell death. ( Reference:  GOC: BHF GOC: dph GOC: tb );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060548", "conceptSize": "18px", "displayValue": "negative regulation of cell d...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1002", "value": "negative regulation of cell death", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a toxic stimulus. ( Reference:  GOC: pr )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0097237", "conceptSize": "18px", "displayValue": "cellular response to toxic su...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1003", "value": "cellular response to toxic substance", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein by individual cells. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0044257", "conceptSize": "18px", "displayValue": "cellular protein breakdown", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1004", "value": "cellular protein breakdown", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds,  initiated by the covalent attachment of ubiquitin,  and mediated by the proteasome. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043161", "conceptSize": "18px", "displayValue": "proteasomal pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1005", "value": "proteasomal pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving dopamine,  a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: jl ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042417", "conceptSize": "18px", "displayValue": "dopamine metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1006", "value": "dopamine metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of glucokinase activity,  the catalysis of the transfer of a phosphate group,  usually from ATP,  to a glucose molecule. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0033132", "conceptSize": "18px", "displayValue": "downregulation of glucokinase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1007", "value": "downregulation of glucokinase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The ubiquitination by a protein of one or more of its own amino acid residues,  or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051865", "conceptSize": "18px", "displayValue": "protein autoubiquitination", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1008", "value": "protein autoubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome. ( Reference:  GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010498", "conceptSize": "18px", "displayValue": "proteasomal protein catabolic...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1009", "value": "proteasomal protein catabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein linear polyubiquitination. ( Reference:  GOC: TermGenie PMID: 21931591 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902530", "conceptSize": "18px", "displayValue": "upregulation of protein linea...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1010", "value": "upregulation of protein linear polyubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An action or movement due to the application of a sudden unexpected stimulus. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001964", "conceptSize": "18px", "displayValue": "startle response", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1011", "value": "startle response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The autophagic process in which mitochondria are delivered to the vacuole and degraded in response to changing cellular conditions. ( Reference:  GOC: autophagy PMID: 15798367 PMID: 19289147 PMID: 23065344 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000422", "conceptSize": "18px", "displayValue": "mitophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1012", "value": "mitophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the rate,  frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0090141", "conceptSize": "18px", "displayValue": "positive regulation of mitoch...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1013", "value": "positive regulation of mitochondrial fission", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience. ( Reference:  ISBN: 0582227089 ISBN: 0721662544 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007612", "conceptSize": "18px", "displayValue": "learning", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1014", "value": "learning", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of reactive oxygen species metabolic process. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000378", "conceptSize": "18px", "displayValue": "negative regulation of ROS me...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1015", "value": "negative regulation of ROS metabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of signal transduction mediated by the JNK cascade. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046329", "conceptSize": "18px", "displayValue": "downregulation of JNK cascade", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1016", "value": "downregulation of JNK cascade", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the central nervous system over time,  from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain,  cerebral ganglia and a nerve cord. ( Reference:  GOC: bf GOC: jid ISBN: 0582227089 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007417", "conceptSize": "18px", "displayValue": "CNS development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1017", "value": "CNS development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell. ( Reference:  GOC: ai GOC: jid GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0055069", "conceptSize": "18px", "displayValue": "zinc ion homeostasis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1018", "value": "zinc ion homeostasis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of mitochondrion degradation (mitophagy). ( Reference:  GO_REF: 0000058 GOC: autophagy GOC: bf GOC: PARL GOC: TermGenie PMID: 24600391 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903146", "conceptSize": "18px", "displayValue": "regulation of mitophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1019", "value": "regulation of mitophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the rate,  frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose,  the aldohexose gluco-hexose. ( Reference:  GOC: BHF GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010906", "conceptSize": "18px", "displayValue": "regulation of glucose metabol...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1020", "value": "regulation of glucose metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903214", "conceptSize": "18px", "displayValue": "regulation of protein-mitocho...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1021", "value": "regulation of protein-mitochondrial targeting", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Degradation of a mitochondrion by macroautophagy. ( Reference:  PMID: 15798367 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000423", "conceptSize": "18px", "displayValue": "macromitophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1022", "value": "macromitophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which a ubiquitin group,  or multiple groups,  are covalently attached to the target protein,  thereby initiating the degradation of that protein. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042787", "conceptSize": "18px", "displayValue": "protein ubiquitination during...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1023", "value": "protein ubiquitination during ubiquitin-dependent protein breakdown", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of reactive oxygen species metabolic process. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000377", "conceptSize": "18px", "displayValue": "regulation of ROS metabolic p...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1024", "value": "regulation of ROS metabolic process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The cellular homeostatic process that preserves a neuron in a stable,  differentiated functional and structural state. ( Reference:  GOC: BHF GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070050", "conceptSize": "18px", "displayValue": "neuron maintenance", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1025", "value": "neuron maintenance", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  PMID: 11038192 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000266", "conceptSize": "18px", "displayValue": "mitochondrial fission", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1026", "value": "mitochondrial fission", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of dendrite extension. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 24898855 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903861", "conceptSize": "18px", "displayValue": "upregulation of dendrite exte...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1027", "value": "upregulation of dendrite extension", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that decreases the frequency,  rate or extent of merging of two or more mitochondria within a cell to form a single compartment. ( Reference:  GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010637", "conceptSize": "18px", "displayValue": "negative regulation of mitoch...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1028", "value": "negative regulation of mitochondrial fusion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the regulated release of insulin. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046676", "conceptSize": "18px", "displayValue": "downregulation of insulin sec...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1029", "value": "downregulation of insulin secretion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The macromitophagy process that is triggered by a detection of the loss of mitochondrial membrane potential. ( Reference:  GOC: PARL PMID: 18200046 PMID: 23985961 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0098779", "conceptSize": "18px", "displayValue": "mitophagy in response to mito...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1030", "value": "mitophagy in response to mitochondrial depolarization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of I-kappaB kinase NF-kappaB signaling. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043123", "conceptSize": "18px", "displayValue": "positive regulation of I-kapp...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1031", "value": "positive regulation of I-kappaB kinase\/NF-kappaB signaling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells,  it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane-bounded autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane-bounded structure.  Autophagosomes then fuse with a lysosome (or vacuole) releasing single-membrane-bounded autophagic bodies that are then degraded within the lysosome (or vacuole). Though once thought to be a purely non-selective process,  it appears that some types of macroautophagy,  e.g. macropexophagy,  macromitophagy,  may involve selective targeting of the targets to be degraded. ( Reference:  PMID: 11099404 PMID: 12914914 PMID: 15798367 PMID: 16973210 PMID: 20159618 PMID: 9412464 );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016236", "conceptSize": "18px", "displayValue": "macroautophagy", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1032", "value": "macroautophagy", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. ( Reference:  GOC: cjm GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034976", "conceptSize": "18px", "displayValue": "ER stress response", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1033", "value": "ER stress response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process of creating free ubiquitin chains,  compounds composed of a large number of ubiquitin monomers. These chains are not conjugated to a protein. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0010994", "conceptSize": "18px", "displayValue": "free ubiquitin chain polymeri...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1034", "value": "free ubiquitin chain polymerization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of an endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23453807 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1903382", "conceptSize": "18px", "displayValue": "downregulation of ER stress-i...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1035", "value": "downregulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an unfolded protein stimulus. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034620", "conceptSize": "18px", "displayValue": "cellular response to unfolded...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1036", "value": "cellular response to unfolded protein", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH RNF41,  UBIQUITINATION,  MUTAGENESIS OF CYS-421,  FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18541373", "conceptSize": "18px", "displayValue": "PMID: 18541373", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1037", "value": "PMID: 18541373", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  SUBCELLULAR LOCATION,  TISSUE SPECIFICITY,  VARIANTS ARG-311 AND THR-371,  IDENTIFICATION BY MASS SPECTROMETRY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19501131", "conceptSize": "18px", "displayValue": "PMID: 19501131", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1038", "value": "PMID: 19501131", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10319893", "conceptSize": "18px", "displayValue": "PMID: 10319893", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1039", "value": "PMID: 10319893", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 GLU-82; CYS-256; TRP-275; GLU-328 AND ARG-441]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12116199", "conceptSize": "18px", "displayValue": "PMID: 12116199", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1040", "value": "PMID: 12116199", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH PSMA7]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15987638", "conceptSize": "18px", "displayValue": "PMID: 15987638", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1041", "value": "PMID: 15987638", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 ASN-211; TRP-275; ASP-430 AND LEU-437]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12114481", "conceptSize": "18px", "displayValue": "PMID: 12114481", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1042", "value": "PMID: 12114481", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  REACTION MECHANISM,  INTERACTION WITH UBE2L3]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21532592", "conceptSize": "18px", "displayValue": "PMID: 21532592", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1043", "value": "PMID: 21532592", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH BCL2,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ARG-240; PHE-431 AND LEU-437];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20889974", "conceptSize": "18px", "displayValue": "PMID: 20889974", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1044", "value": "PMID: 20889974", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2),  INVOLVEMENT IN PARK2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9560156", "conceptSize": "18px", "displayValue": "PMID: 9560156", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1045", "value": "PMID: 9560156", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH CHPF,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "22082830", "conceptSize": "18px", "displayValue": "PMID: 22082830", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1046", "value": "PMID: 22082830", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 1-76,  INTERACTION WITH PSMD4]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12634850", "conceptSize": "18px", "displayValue": "PMID: 12634850", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1047", "value": "PMID: 12634850", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 ARG-211; TRP-275 AND ASP-430]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11179010", "conceptSize": "18px", "displayValue": "PMID: 11179010", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1048", "value": "PMID: 11179010", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 ARG-240]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9731209", "conceptSize": "18px", "displayValue": "PMID: 9731209", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1049", "value": "PMID: 9731209", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 PRO-42; LEU-192; CYS-256; TRP-275; ASP-430 AND LEU-437]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11971093", "conceptSize": "18px", "displayValue": "PMID: 11971093", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1050", "value": "PMID: 11971093", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH RANBP2]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16332688", "conceptSize": "18px", "displayValue": "PMID: 16332688", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1051", "value": "PMID: 16332688", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS HIS-100; SER-271 AND SER-339]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12781599", "conceptSize": "18px", "displayValue": "PMID: 12781599", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1052", "value": "PMID: 12781599", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH SYT11,  CHARACTERIZATION OF VARIANTS PARK2 GLY-289 AND ARG-418]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12925569", "conceptSize": "18px", "displayValue": "PMID: 12925569", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1053", "value": "PMID: 12925569", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10888878", "conceptSize": "18px", "displayValue": "PMID: 10888878", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1054", "value": "PMID: 10888878", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 PRO-46]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12362318", "conceptSize": "18px", "displayValue": "PMID: 12362318", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1055", "value": "PMID: 12362318", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 GLN-33; GLU-82; ASP-430 AND LEU-437,  VARIANTS PARK TYR-253; CYS-256; TRP-275 AND ASN-280,  VARIANTS LEU-380 AND ASN-394]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12730996", "conceptSize": "18px", "displayValue": "PMID: 12730996", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1056", "value": "PMID: 12730996", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 137-465,  ACTIVE SITE,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23770887", "conceptSize": "18px", "displayValue": "PMID: 23770887", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1057", "value": "PMID: 23770887", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15229644", "conceptSize": "18px", "displayValue": "PMID: 15229644", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1058", "value": "PMID: 15229644", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PRESENCE OF ATYPICAL RING FINGER DOMAINS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12446796", "conceptSize": "18px", "displayValue": "PMID: 12446796", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1059", "value": "PMID: 12446796", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN PROTECTION OF APOPTOSIS,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; CYS-256; TRP-275; ARG-418 AND ARG-441,  DOMAIN];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19801972", "conceptSize": "18px", "displayValue": "PMID: 19801972", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1060", "value": "PMID: 19801972", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 137-465,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23727886", "conceptSize": "18px", "displayValue": "PMID: 23727886", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1061", "value": "PMID: 23727886", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19029340", "conceptSize": "18px", "displayValue": "PMID: 19029340", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1062", "value": "PMID: 19029340", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[UBIQUITINATION OF GPR37]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11439185", "conceptSize": "18px", "displayValue": "PMID: 11439185", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1063", "value": "PMID: 11439185", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 PHE-431]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10939576", "conceptSize": "18px", "displayValue": "PMID: 10939576", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1064", "value": "PMID: 10939576", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INVOLVEMENT IN CANCER]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14614460", "conceptSize": "18px", "displayValue": "PMID: 14614460", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1065", "value": "PMID: 14614460", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 LEU-37 AND PRO-351]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12112109", "conceptSize": "18px", "displayValue": "PMID: 12112109", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1066", "value": "PMID: 12112109", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 VAL-192; ASN-211; MET-240 AND LEU-437,  VARIANT ASN-167,  INVOLVEMENT IN LATE-ONSET PARK]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12629236", "conceptSize": "18px", "displayValue": "PMID: 12629236", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1067", "value": "PMID: 12629236", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH STUB1 AND HSP70,  UBIQUITINATION OF STUB1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12150907", "conceptSize": "18px", "displayValue": "PMID: 12150907", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1068", "value": "PMID: 12150907", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 GLU-82]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11487568", "conceptSize": "18px", "displayValue": "PMID: 11487568", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1069", "value": "PMID: 11487568", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH PACRG]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14532270", "conceptSize": "18px", "displayValue": "PMID: 14532270", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1070", "value": "PMID: 14532270", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT ASN-167]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10511432", "conceptSize": "18px", "displayValue": "PMID: 10511432", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1071", "value": "PMID: 10511432", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH UBE2L6 AND SEPT5,  UBIQUITINATION OF SEPT5]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11078524", "conceptSize": "18px", "displayValue": "PMID: 11078524", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1072", "value": "PMID: 11078524", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "25621951", "conceptSize": "18px", "displayValue": "PMID: 25621951", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1073", "value": "PMID: 25621951", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14976155", "conceptSize": "18px", "displayValue": "PMID: 14976155", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1074", "value": "PMID: 14976155", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT PARK2 TYR-212]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11163284", "conceptSize": "18px", "displayValue": "PMID: 11163284", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1075", "value": "PMID: 11163284", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION IN UBIQUITINATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10973942", "conceptSize": "18px", "displayValue": "PMID: 10973942", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1076", "value": "PMID: 10973942", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INVOLVEMENT IN CANCER]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12719539", "conceptSize": "18px", "displayValue": "PMID: 12719539", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1077", "value": "PMID: 12719539", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS PARK2 PRO-42; CYS-402; ASN-415 AND ARG-418]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15584030", "conceptSize": "18px", "displayValue": "PMID: 15584030", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1078", "value": "PMID: 15584030", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH SUMO1,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16955485", "conceptSize": "18px", "displayValue": "PMID: 16955485", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1079", "value": "PMID: 16955485", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Ixabepilone", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1080", "value": "Ixabepilone", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Dihydroxyaluminium", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1081", "value": "Dihydroxyaluminium", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Dasatinib", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1082", "value": "Dasatinib", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Pseudoephedrine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1083", "value": "Pseudoephedrine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Arsenic trioxide", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1084", "value": "Arsenic trioxide", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Irbesartan", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1085", "value": "Irbesartan", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Hyaluronidase (Human Recombin...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1086", "value": "Hyaluronidase (Human Recombinant)", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Hyaluronidase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1087", "value": "Hyaluronidase", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Nadroparin", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1088", "value": "Nadroparin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Enzyme Classification", "pid": "3.4.23.-", "conceptSize": "18px", "displayValue": "3.4.23.-", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "pink", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1089", "value": "3.4.23.-", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "607822", "conceptSize": "26px", "displayValue": "ALZHEIMER DISEASE 3", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1090", "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 3", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with cadherin,  a type I membrane protein involved in cell adhesion. ( Reference:  GOC: bf )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0045296", "conceptSize": "18px", "displayValue": "cadherin binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1091", "value": "cadherin binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004190", "conceptSize": "18px", "displayValue": "aspartic endopeptidase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1092", "value": "aspartic endopeptidase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. ( Reference:  GOC: mtg_transport GOC: pr ISBN: 0815340729 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0005262", "conceptSize": "18px", "displayValue": "calcium channel activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1093", "value": "calcium channel activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain. ( Reference:  http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#ENDOPEPTIDASE )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004175", "conceptSize": "18px", "displayValue": "endopeptidase activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1094", "value": "endopeptidase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding the endoplasmic reticulum. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005789", "conceptSize": "18px", "displayValue": "ER membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1095", "value": "ER membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein complex that has aspartic-type endopeptidase activity,  and contains a catalytic subunit,  presenilin (PS),  that is a prototypical member of the GxGD-type aspartyl peptidases. The complex also contains additional subunits,  including nicastrin,  APH-1,  PEN-2,  and a regulatory subunit,  CD147. Gamma-secretase cleaves several transmembrane proteins including the cell surface receptor Notch and the beta-amyloid precursor protein. ( Reference:  GOC: mah PMID: 15286082 PMID: 15890777 PMID: 17047368 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0070765", "conceptSize": "18px", "displayValue": "gamma-secretase complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1096", "value": "gamma-secretase complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules. ( Reference:  GOC: elh )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0000776", "conceptSize": "18px", "displayValue": "kinetochore", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1097", "value": "kinetochore", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A structure comprised of a core structure (in most organisms,  a pair of centrioles) and peripheral material from which a microtubule-based structure,  such as a spindle apparatus,  is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells,  though in animal cells it changes continually during the cell-division cycle. ( Reference:  GOC: mah ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005813", "conceptSize": "18px", "displayValue": "centrosome", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1098", "value": "centrosome", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The region of the plasma membrane located at the apical end of the cell. ( Reference:  GOC: curators )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0016324", "conceptSize": "18px", "displayValue": "apical plasma membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1099", "value": "apical plasma membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005765", "conceptSize": "18px", "displayValue": "lysosomal membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1100", "value": "lysosomal membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The smooth endoplasmic reticulum (smooth ER or SER) has no ribosomes attached to it. The smooth ER is the recipient of the proteins synthesized in the rough ER. Those proteins to be exported are passed to the Golgi complex,  the resident proteins are returned to the rough ER and the lysosomal proteins after phosphorylation of their mannose residues are passed to the lysosomes. Glycosylation of the glycoproteins also continues. The smooth ER is the site of synthesis of lipids,  including the phospholipids. The membranes of the smooth ER also contain enzymes that catalyze a series of reactions to detoxify both lipid-soluble drugs and harmful products of metabolism. Large quantities of certain compounds such as phenobarbital cause an increase in the amount of the smooth ER. ( Reference:  ISBN: 0198506732 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005790", "conceptSize": "18px", "displayValue": "SER", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1101", "value": "SER", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached. ( Reference:  GOC: mtg_muscle ISBN: 0815316194 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0030018", "conceptSize": "18px", "displayValue": "Z band", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1102", "value": "Z band", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The lipid bilayer surrounding any of the compartments of the Golgi apparatus. ( Reference:  GOC: mah );", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0000139", "conceptSize": "18px", "displayValue": "Golgi membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1103", "value": "Golgi membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials,  the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber,  leading to a change in post-synaptic potential. ( Reference:  GOC: nln )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031594", "conceptSize": "18px", "displayValue": "neuromuscular junction", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1104", "value": "neuromuscular junction", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A cytoskeleton-like structure,  originating from the basal body at the proximal end of a cilium,  and extending proximally toward the cell nucleus. Rootlets are typically 80-100 nm in diameter and contain cross striae distributed at regular intervals of approximately 55-70 nm. ( Reference:  GOC: cilia PMID: 12427867 );", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0035253", "conceptSize": "18px", "displayValue": "cilial rootlet", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1105", "value": "cilial rootlet", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. ( Reference:  GOC: mah GOC: pz )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031965", "conceptSize": "18px", "displayValue": "nuclear membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1106", "value": "nuclear membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. ( Reference:  GOC: add )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050852", "conceptSize": "18px", "displayValue": "TCR signaling pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1107", "value": "TCR signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell,  a class of cell types including myeloid progenitor cells and lymphoid progenitor cells. ( Reference:  GOC: add GOC: rl ISBN: 0781735149 PMID: 16551251 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0002244", "conceptSize": "18px", "displayValue": "hemopoietic progenitor cell d...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1108", "value": "hemopoietic progenitor cell differentiation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that results in the breakdown of the extracellular matrix. ( Reference:  GOC: jid )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0022617", "conceptSize": "18px", "displayValue": "extracellular matrix disassem...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1109", "value": "extracellular matrix disassembly", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process involved in the maintenance of an internal steady state of calcium ions within the smooth endoplasmic reticulum of a cell or between the smooth endoplasmic reticulum and its surroundings. ( Reference:  GOC: ai GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051563", "conceptSize": "18px", "displayValue": "smooth ER calcium ion homeost...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1110", "value": "smooth ER calcium ion homeostasis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that increases the rate,  frequency,  or extent of dendritic spine development,  the process whose specific outcome is the progression of the dendritic spine over time,  from its formation to the mature structure. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060999", "conceptSize": "18px", "displayValue": "positive regulation of dendri...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1111", "value": "positive regulation of dendritic spine development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which a monocyte acquires the specialized features of a dendritic cell,  an immunocompetent cell of the lymphoid and hemopoietic systems and skin. ( Reference:  CL: 0000782 GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043011", "conceptSize": "18px", "displayValue": "myeloid dendritic cell differ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1112", "value": "myeloid dendritic cell differentiation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of cellular DNA-templated transcription. ( Reference:  GOC: go_curators GOC: txnOH )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0045893", "conceptSize": "18px", "displayValue": "upregulation of transcription...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1113", "value": "upregulation of transcription,  DNA-dependent", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The series of successive proteolytic cleavages of the Notch protein,  which result in an active form of the receptor. ( Reference:  PMID: 12651094 PMID: 14986688 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007220", "conceptSize": "18px", "displayValue": "N receptor processing", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1114", "value": "N receptor processing", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process. ( Reference:  GOC: BHF )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2000059", "conceptSize": "18px", "displayValue": "negative regulation of protei...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1115", "value": "negative regulation of protein ubiquitination during ubiquitin-dependent protein breakdown", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of a neuron over time,  from initial commitment of the cell to a specific fate,  to the fully functional differentiated cell. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048666", "conceptSize": "18px", "displayValue": "neuron development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1116", "value": "neuron development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Transport of substances into,  out of or within a mitochondrion. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006839", "conceptSize": "18px", "displayValue": "mitochondrial transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1117", "value": "mitochondrial transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the thymus over time,  from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells,  with unique vascular,  nervous,  epithelial,  and lymphoid cell components. ( Reference:  GOC: add ISBN: 0781735149 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048538", "conceptSize": "18px", "displayValue": "thymus development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1118", "value": "thymus development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070588", "conceptSize": "18px", "displayValue": "calcium ion membrane transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1119", "value": "calcium ion membrane transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of a blood vessel over time,  from its formation to the mature structure. The blood vessel is the vasculature carrying blood. ( Reference:  GOC: hjd UBERON: 0001981 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001568", "conceptSize": "18px", "displayValue": "blood vessel development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1120", "value": "blood vessel development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways involving beta-amyloid,  a glycoprotein associated with Alzheimer's disease,  and its precursor,  amyloid precursor protein (APP). ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050435", "conceptSize": "18px", "displayValue": "beta-amyloid metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1121", "value": "beta-amyloid metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The activities involved in the mental information processing system that receives (registers),  modifies,  stores,  and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition),  storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). ( Reference:  GOC: curators http: \/\/www.onelook.com\/ ISBN: 0582227089 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007613", "conceptSize": "18px", "displayValue": "memory", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1122", "value": "memory", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of protein binding. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043393", "conceptSize": "18px", "displayValue": "regulation of protein binding", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1123", "value": "regulation of protein binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which the anatomical structures of the brain are generated and organized. The brain is one of the two components of the central nervous system and is the center of thought and emotion. It is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight,  hearing,  smell,  etc.). ( Reference:  GOC: dgh GOC: jid )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048854", "conceptSize": "18px", "displayValue": "brain morphogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1124", "value": "brain morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The orderly movement of cells from one site to another in the cerebral cortex. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0021795", "conceptSize": "18px", "displayValue": "cerebral cortex cell migration", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1125", "value": "cerebral cortex cell migration", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of ubiquitin transferase activity. ( Reference:  GOC: ai GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051444", "conceptSize": "18px", "displayValue": "downregulation of ubiquitin t...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1126", "value": "downregulation of ubiquitin transferase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process involved in the specification of cell identity. Once specification has taken place,  a cell will be committed to differentiate down a specific pathway if left in its normal environment. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001708", "conceptSize": "18px", "displayValue": "cell fate specification", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1127", "value": "cell fate specification", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0003407", "conceptSize": "18px", "displayValue": "neural retina development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1128", "value": "neural retina development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The generation of beta-amyloid by cleavage of the amyloid precursor protein (APP). ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0034205", "conceptSize": "18px", "displayValue": "beta-amyloid formation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1129", "value": "beta-amyloid formation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006974", "conceptSize": "18px", "displayValue": "DNA damage response", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1130", "value": "DNA damage response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which synaptic vesicles are directed to specific destination membranes,  mediated by molecules at the vesicle membrane and target membrane surfaces. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016080", "conceptSize": "18px", "displayValue": "synaptic vesicle targeting", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1131", "value": "synaptic vesicle targeting", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. ( Reference:  GOC: curators GOC: jl GOC: jsg )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016485", "conceptSize": "18px", "displayValue": "protein processing", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1132", "value": "protein processing", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen,  cytokine,  chemokine,  cellular ligand,  or an antigen for which it is specific,  leading to the initiation or perpetuation of an immune response. ( Reference:  GOC: add ISBN: 0781735149 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0002286", "conceptSize": "18px", "displayValue": "T cell activation involved in...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1133", "value": "T cell activation involved in immune response", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. In this pathway,  the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation,  thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. ( Reference:  GOC: bf GOC: dph PMID: 11532397 PMID: 19619488 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060070", "conceptSize": "18px", "displayValue": "canonical Wnt signaling pathw...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1134", "value": "canonical Wnt signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The attachment of one cell to another cell via adhesion molecules,  where both cells are part of the same organism. ( Reference:  GOC: hb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016337", "conceptSize": "18px", "displayValue": "single organismal cell-cell a...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1135", "value": "single organismal cell-cell adhesion", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which the anatomical structures of the skeleton are generated and organized. ( Reference:  GOC: dph GOC: dsf GOC: jid GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048705", "conceptSize": "18px", "displayValue": "skeletal morphogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1136", "value": "skeletal morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain). ( Reference:  GOC: jl http: \/\/www.copewithcytokines.de\/ )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006509", "conceptSize": "18px", "displayValue": "ectodomain cleavage", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1137", "value": "ectodomain cleavage", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP),  the precursor of beta-amyloid,  a glycoprotein associated with Alzheimer's disease. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042987", "conceptSize": "18px", "displayValue": "APP catabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1138", "value": "APP catabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation. ( Reference:  GOC: dph PMID: 12094232 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001947", "conceptSize": "18px", "displayValue": "heart looping", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1139", "value": "heart looping", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which the neural tube is regionalized in the dorsoventral axis. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 PMID: 11262869 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0021904", "conceptSize": "18px", "displayValue": "dorsoventral neural tube patt...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1140", "value": "dorsoventral neural tube patterning", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process,  occurring in the embryo,  by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. ( Reference:  GOC: bf GOC: jl ISBN: 0395825172 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0030326", "conceptSize": "18px", "displayValue": "embryonic limb morphogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1141", "value": "embryonic limb morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers,  an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper,  and being thrown off in the superficial layers,  as well as an inner,  sensitive and vascular dermis (cutis,  corium or true skin) composed mostly of connective tissue. ( Reference:  GOC: jl UBERON: 0002097 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043589", "conceptSize": "18px", "displayValue": "skin morphogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1142", "value": "skin morphogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of proteins into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0015031", "conceptSize": "18px", "displayValue": "protein transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1143", "value": "protein transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of L-glutamate,  the L enantiomer anion of 2-aminopentanedioic acid,  into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai GOC: dph GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0015813", "conceptSize": "18px", "displayValue": "L-glutamate transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1144", "value": "L-glutamate transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of apoptotic signaling pathway. ( Reference:  GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 2001234", "conceptSize": "18px", "displayValue": "negative regulation of apopto...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1145", "value": "negative regulation of apoptotic signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The formation of a double membrane-bounded structure,  the autophagosome,  that occurs when a specialized membrane sac,  called the isolation membrane,  starts to enclose a portion of the cytoplasm. ( Reference:  GOC: autophagy PMID: 9412464 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0000045", "conceptSize": "18px", "displayValue": "autophagosome assembly", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1146", "value": "autophagosome assembly", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid,  e.g. the addition of glycan chains to proteins. ( Reference:  GOC: curators GOC: pr )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006486", "conceptSize": "18px", "displayValue": "protein glycosylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1147", "value": "protein glycosylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of EGF-activated receptor activity. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007175", "conceptSize": "18px", "displayValue": "negative regulation of EGFR", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1148", "value": "negative regulation of EGFR", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the establishment or extent of a resting potential,  the electrical charge across the plasma membrane,  with the interior of the cell negative with respect to the exterior. The resting potential is the membrane potential of a cell that is not stimulated to be depolarized or hyperpolarized. ( Reference:  GOC: dph GOC: ef ISBN: 0195088433 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060075", "conceptSize": "18px", "displayValue": "regulation of resting potenti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1149", "value": "regulation of resting potential", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which a neuroblast acquires specialized structural and or functional features of a Cajal-Retzius cell,  one of a transient population of pioneering neurons in the cerebral cortex. These cells are slender bipolar cells of the developing marginal zone. One feature of these cells in mammals is that they express the Reelin gene. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0021870", "conceptSize": "18px", "displayValue": "Cajal-Retzius cell differenti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1150", "value": "Cajal-Retzius cell differentiation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of choline into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. Choline (2-hydroxyethyltrimethylammonium) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0015871", "conceptSize": "18px", "displayValue": "choline transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1151", "value": "choline transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the activity of an enzyme. ( Reference:  GOC: jl GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043085", "conceptSize": "18px", "displayValue": "upregulation of enzyme", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1152", "value": "upregulation of enzyme", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A process that modulates synaptic plasticity,  the ability of synapses to change as circumstances require. They may alter function,  such as increasing or decreasing their sensitivity,  or they may increase or decrease in actual numbers. ( Reference:  GOC: dph GOC: jid GOC: tb http: \/\/www.mercksource.com PMID: 11891290 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048167", "conceptSize": "18px", "displayValue": "regulation of synaptic plasti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1153", "value": "regulation of synaptic plasticity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the organism over time,  from the completion of embryonic development to the mature structure. See embryonic development. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0009791", "conceptSize": "18px", "displayValue": "post-embryonic development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1154", "value": "post-embryonic development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of axonogenesis. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050771", "conceptSize": "18px", "displayValue": "downregulation of axonogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1155", "value": "downregulation of axonogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that activates or increases the frequency,  rate or extent of coagulation. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050820", "conceptSize": "18px", "displayValue": "upregulation of coagulation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1156", "value": "upregulation of coagulation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process involved in the maintenance of an internal steady state of calcium ions within the endoplasmic reticulum of a cell or between the endoplasmic reticulum and its surroundings. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032469", "conceptSize": "18px", "displayValue": "ER calcium ion homeostasis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1157", "value": "ER calcium ion homeostasis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The multiplication or reproduction of epithelial cells,  resulting in the expansion of a cell population. Epithelial cells make up the epithelium,  the covering of internal and external surfaces of the body,  including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. ( Reference:  ISBN: 0721662544 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050673", "conceptSize": "18px", "displayValue": "epithelial cell proliferation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1158", "value": "epithelial cell proliferation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo. ( Reference:  ISBN: 0721662544 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001756", "conceptSize": "18px", "displayValue": "somitogenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1159", "value": "somitogenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of addition of phosphate groups into a molecule. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042325", "conceptSize": "18px", "displayValue": "regulation of phosphorylation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1160", "value": "regulation of phosphorylation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 SER-92]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11027672", "conceptSize": "18px", "displayValue": "PMID: 11027672", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1161", "value": "PMID: 11027672", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14759258", "conceptSize": "18px", "displayValue": "PMID: 14759258", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1162", "value": "PMID: 14759258", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 LYS-139]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9719376", "conceptSize": "18px", "displayValue": "PMID: 9719376", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1163", "value": "PMID: 9719376", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH CTNNB1,  SUBCELLULAR LOCATION]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9738936", "conceptSize": "18px", "displayValue": "PMID: 9738936", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1164", "value": "PMID: 9738936", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEOLYTIC PROCESSING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9173929", "conceptSize": "18px", "displayValue": "PMID: 9173929", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1165", "value": "PMID: 9173929", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 LEU-117]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9507958", "conceptSize": "18px", "displayValue": "PMID: 9507958", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1166", "value": "PMID: 9507958", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION OF PAL MOTIF,  MUTAGENESIS OF PRO-433; ALA-434 AND LEU-435]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16305624", "conceptSize": "18px", "displayValue": "PMID: 16305624", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1167", "value": "PMID: 16305624", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH CDH1 AND CTNNB1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16126725", "conceptSize": "18px", "displayValue": "PMID: 16126725", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1168", "value": "PMID: 16126725", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA \/ MRNA] (ISOFORMS 1 AND 2),  VARIANTS AD3 LEU-146; ARG-163; GLU-246 AND VAL-286]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7596406", "conceptSize": "18px", "displayValue": "PMID: 7596406", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1169", "value": "PMID: 7596406", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH GFAP,  MUTAGENESIS OF 66-ASP--ASP-72; 76-LYS-TYR-77; 82-VAL-ILE-83; VAL-82 AND 84-MET-LEU-85,  CHARACTERIZATION OF VARIANTS AD3 VAL-79 AND LEU-82]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12058025", "conceptSize": "18px", "displayValue": "PMID: 12058025", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1170", "value": "PMID: 12058025", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FRONTOTEMPORAL DEMENTIA PRO-113]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11094121", "conceptSize": "18px", "displayValue": "PMID: 11094121", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1171", "value": "PMID: 11094121", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1\/PSEN2 AND NCSTN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12740439", "conceptSize": "18px", "displayValue": "PMID: 12740439", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1172", "value": "PMID: 12740439", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH CDH2,  SUBCELLULAR LOCATION,  MUTAGENESIS OF ASP-385]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14515347", "conceptSize": "18px", "displayValue": "PMID: 14515347", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1173", "value": "PMID: 14515347", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8641442", "conceptSize": "18px", "displayValue": "PMID: 8641442", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1174", "value": "PMID: 8641442", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 PHE-96; ARG-163 AND THR-213]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8733303", "conceptSize": "18px", "displayValue": "PMID: 8733303", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1175", "value": "PMID: 8733303", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 LEU-169 AND GLN-436]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9831473", "conceptSize": "18px", "displayValue": "PMID: 9831473", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1176", "value": "PMID: 9831473", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 LEU-233; ARG-282 AND THR-409,  VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10533070", "conceptSize": "18px", "displayValue": "PMID: 10533070", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1177", "value": "PMID: 10533070", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-113]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9070286", "conceptSize": "18px", "displayValue": "PMID: 9070286", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1178", "value": "PMID: 9070286", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 ARG-209]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10447269", "conceptSize": "18px", "displayValue": "PMID: 10447269", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1179", "value": "PMID: 10447269", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10206644", "conceptSize": "18px", "displayValue": "PMID: 10206644", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1180", "value": "PMID: 10206644", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 24-32,  ALTERNATIVE SPLICING (ISOFORMS 6 AND 7)];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8804415", "conceptSize": "18px", "displayValue": "PMID: 8804415", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1181", "value": "PMID: 8804415", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 LEU-82; HIS-115; THR-139; ARG-163; THR-231; LEU-264; VAL-392 AND TYR-410]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8634712", "conceptSize": "18px", "displayValue": "PMID: 8634712", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1182", "value": "PMID: 8634712", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PHOSPHORYLATION AT SER-310 AND SER-346,  MUTAGENESIS OF SER-310 AND SER-346]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14576165", "conceptSize": "18px", "displayValue": "PMID: 14576165", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1183", "value": "PMID: 14576165", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 THR-143 AND ALA-384]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8634711", "conceptSize": "18px", "displayValue": "PMID: 8634711", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1184", "value": "PMID: 8634711", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBCELLULAR LOCATION,  INTERACTION WITH UBQLN1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21143716", "conceptSize": "18px", "displayValue": "PMID: 21143716", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1185", "value": "PMID: 21143716", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9851450", "conceptSize": "18px", "displayValue": "PMID: 9851450", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1186", "value": "PMID: 9851450", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH MTCH1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10551805", "conceptSize": "18px", "displayValue": "PMID: 10551805", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1187", "value": "PMID: 10551805", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INVOLVEMENT IN ACNINV3]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20929727", "conceptSize": "18px", "displayValue": "PMID: 20929727", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1188", "value": "PMID: 20929727", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 SER-405]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10644793", "conceptSize": "18px", "displayValue": "PMID: 10644793", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1189", "value": "PMID: 10644793", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS AD3 PHE-143 AND SER-436]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10090481", "conceptSize": "18px", "displayValue": "PMID: 10090481", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1190", "value": "PMID: 10090481", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  ACTIVE SITES ASP-257 AND ASP-385,  MUTAGENESIS OF TYR-256; ASP-257; ASP-385 AND TYR-389]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15341515", "conceptSize": "18px", "displayValue": "PMID: 15341515", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1191", "value": "PMID: 15341515", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18485326", "conceptSize": "18px", "displayValue": "PMID: 18485326", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1192", "value": "PMID: 18485326", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CASPASE CLEAVAGE SITE,  MUTAGENESIS OF ASP-345; ASP-373 AND ASP-385]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9485372", "conceptSize": "18px", "displayValue": "PMID: 9485372", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1193", "value": "PMID: 9485372", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 PRO-171]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9833068", "conceptSize": "18px", "displayValue": "PMID: 9833068", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1194", "value": "PMID: 9833068", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  INTERACTION WITH CDH1]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11226248", "conceptSize": "18px", "displayValue": "PMID: 11226248", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1195", "value": "PMID: 11226248", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GLY-318]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9915968", "conceptSize": "18px", "displayValue": "PMID: 9915968", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1196", "value": "PMID: 9915968", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 PRO-169]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10025789", "conceptSize": "18px", "displayValue": "PMID: 10025789", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1197", "value": "PMID: 10025789", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT AD3 PRO-219]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10208579", "conceptSize": "18px", "displayValue": "PMID: 10208579", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1198", "value": "PMID: 10208579", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "603218", "conceptSize": "26px", "displayValue": "HUNTINGTON DISEASE-LIKE 1; HD...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1199", "value": "HUNTINGTON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>-LIKE 1; HDL1", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces,  but not integrated into the hydrophobic region. ( Reference:  GOC: dos GOC: jl GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0019898", "conceptSize": "18px", "displayValue": "extrinsic to membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1200", "value": "extrinsic to membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The component of a membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor,  such as a lipid group that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping. ( Reference:  GOC: dos GOC: mah )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0031225", "conceptSize": "18px", "displayValue": "anchored to membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1201", "value": "anchored to membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Tetracycline", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1202", "value": "Tetracycline", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the calcineurin-NFAT signaling cascade. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0070885", "conceptSize": "18px", "displayValue": "downregulation of calcineurin...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1203", "value": "downregulation of calcineurin-NFAT signaling cascade", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. ( Reference:  ISBN: 0878932437 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007411", "conceptSize": "18px", "displayValue": "axon guidance", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1204", "value": "axon guidance", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The chemical reactions and pathways,  including anabolism and catabolism,  by which living organisms transform chemical substances. Metabolic processes typically transform small molecules,  but also include macromolecular processes such as DNA repair and replication,  and protein synthesis and degradation. ( Reference:  GOC: go_curators ISBN: 0198547684 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008152", "conceptSize": "18px", "displayValue": "metabolism", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1205", "value": "metabolism", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of interleukin-2 production. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032703", "conceptSize": "18px", "displayValue": "negative regulation of IL-2 p...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1206", "value": "negative regulation of IL-2 production", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the rate or extent of activated T cell proliferation. ( Reference:  GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046007", "conceptSize": "18px", "displayValue": "downregulation of activated T...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1207", "value": "downregulation of activated T cell proliferation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis,  treatment or prevention of a disease. ( Reference:  GOC: sl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0035690", "conceptSize": "18px", "displayValue": "cellular response to drug", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1208", "value": "cellular response to drug", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process of creating protein oligomers,  compounds composed of a small number,  usually between three and ten,  of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0051260", "conceptSize": "18px", "displayValue": "protein homooligomerization", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1209", "value": "protein homooligomerization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of potassium ion transmembrane transport. ( Reference:  GOC: BHF GOC: TermGenie )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1901379", "conceptSize": "18px", "displayValue": "regulation of potassium ion m...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1210", "value": "regulation of potassium ion membrane transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the activity of a transcription factor,  any factor involved in the initiation or regulation of transcription. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043433", "conceptSize": "18px", "displayValue": "downregulation of transcripti...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1211", "value": "downregulation of transcription factor", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050860", "conceptSize": "18px", "displayValue": "negative regulation of TCR si...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1212", "value": "negative regulation of TCR signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a cadmium (Cd) ion stimulus. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0046686", "conceptSize": "18px", "displayValue": "response to cadmium", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1213", "value": "response to cadmium", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. ( Reference:  GOC: add GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032689", "conceptSize": "18px", "displayValue": "downregulation of interferon-...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1214", "value": "downregulation of interferon-gamma production", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that modulates the frequency,  rate or extent of any process in which a protein is transported to,  or maintained in,  a specific location. ( Reference:  GOC: dph GOC: mah GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032880", "conceptSize": "18px", "displayValue": "regulation of protein localiz...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1215", "value": "regulation of protein localization", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A regulatory process that halts progression through the cell cycle during one of the normal phases (G1,  S,  G2,  M). ( Reference:  GOC: dph GOC: mah GOC: tb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007050", "conceptSize": "18px", "displayValue": "cell cycle arrest", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1216", "value": "cell cycle arrest", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of production of any member of the interleukin-17 family of cytokines. ( Reference:  GOC: add GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0032700", "conceptSize": "18px", "displayValue": "negative regulation of IL-17 ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1217", "value": "negative regulation of IL-17 production", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The acquisition and processing of information and or the storage and retrieval of this information over time. ( Reference:  GOC: jid PMID: 8938125 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007611", "conceptSize": "18px", "displayValue": "learning or memory", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1218", "value": "learning or memory", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8364585", "conceptSize": "18px", "displayValue": "PMID: 8364585", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1219", "value": "PMID: 8364585", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD LYS-200]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7913755", "conceptSize": "18px", "displayValue": "PMID: 7913755", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1220", "value": "PMID: 7913755", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19381258", "conceptSize": "18px", "displayValue": "PMID: 19381258", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1221", "value": "PMID: 19381258", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 119-226,  DOMAIN,  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11524679", "conceptSize": "18px", "displayValue": "PMID: 11524679", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1222", "value": "PMID: 11524679", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 119-231 IN COMPLEX WITH FAB FRAGMENT OF MONOCLONAL ANTIBODY ICSM 18,  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19204296", "conceptSize": "18px", "displayValue": "PMID: 19204296", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1223", "value": "PMID: 19204296", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING,  CIRCULAR DICHROISM,  DOMAIN,  FUNCTION,  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20564047", "conceptSize": "18px", "displayValue": "PMID: 20564047", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1224", "value": "PMID: 20564047", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ALTERNATIVE INITIATION (ISOFORM 2),  SUBCELLULAR LOCATION,  MUTAGENESIS OF MET-1 AND MET-8];", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19059915", "conceptSize": "18px", "displayValue": "PMID: 19059915", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1225", "value": "PMID: 19059915", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD ILE-210]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7902693", "conceptSize": "18px", "displayValue": "PMID: 7902693", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1226", "value": "PMID: 7902693", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS CJD LYS-196; ILE-203 AND GLN-211]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10790216", "conceptSize": "18px", "displayValue": "PMID: 10790216", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1227", "value": "PMID: 10790216", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD LEU-102]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2564168", "conceptSize": "18px", "displayValue": "PMID: 2564168", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1228", "value": "PMID: 2564168", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS LEU-102; VAL-117 AND VAL-129]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2783132", "conceptSize": "18px", "displayValue": "PMID: 2783132", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1229", "value": "PMID: 2783132", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA]]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3755672", "conceptSize": "18px", "displayValue": "PMID: 3755672", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1230", "value": "PMID: 3755672", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 23-230]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10618385", "conceptSize": "18px", "displayValue": "PMID: 10618385", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1231", "value": "PMID: 10618385", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT SENF ALA-183]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9266722", "conceptSize": "18px", "displayValue": "PMID: 9266722", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1232", "value": "PMID: 9266722", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING,  ZINC-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18034490", "conceptSize": "18px", "displayValue": "PMID: 18034490", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1233", "value": "PMID: 18034490", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 118-221]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10900000", "conceptSize": "18px", "displayValue": "PMID: 10900000", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1234", "value": "PMID: 10900000", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD LYS-200]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1975028", "conceptSize": "18px", "displayValue": "PMID: 1975028", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1235", "value": "PMID: 1975028", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 90-231 OF MUTANT LYS-200]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10954699", "conceptSize": "18px", "displayValue": "PMID: 10954699", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1236", "value": "PMID: 10954699", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[SUBUNIT,  DOMAIN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20375014", "conceptSize": "18px", "displayValue": "PMID: 20375014", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1237", "value": "PMID: 20375014", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT GSD ARG-187]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10581485", "conceptSize": "18px", "displayValue": "PMID: 10581485", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1238", "value": "PMID: 10581485", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 8-253]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "3014653", "conceptSize": "18px", "displayValue": "PMID: 3014653", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1239", "value": "PMID: 3014653", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9799790", "conceptSize": "18px", "displayValue": "PMID: 9799790", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1240", "value": "PMID: 9799790", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT FFI ASN-178]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1347910", "conceptSize": "18px", "displayValue": "PMID: 1347910", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1241", "value": "PMID: 1347910", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT LYS-219,  CHARACTERIZATION OF VARIANT LYS-219,  POLYMORPHISM]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9482303", "conceptSize": "18px", "displayValue": "PMID: 9482303", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1242", "value": "PMID: 9482303", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[STRUCTURE BY NMR OF 61-68,  DISULFIDE BOND,  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14623188", "conceptSize": "18px", "displayValue": "PMID: 14623188", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1243", "value": "PMID: 14623188", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT VAL-129,  CHARACTERIZATION OF VARIANT VAL-129]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12690204", "conceptSize": "18px", "displayValue": "PMID: 12690204", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1244", "value": "PMID: 12690204", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  CHARACTERIZATION OF VARIANT VAL-129,  CHARACTERIZATION OF VARIANT CJD ASN-178,  CHARACTERIZATION OF VARIANT FFI ASN-178,  POLYMORPHISM]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1439789", "conceptSize": "18px", "displayValue": "PMID: 1439789", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1245", "value": "PMID: 1439789", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[COPPER-BINDING]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16144413", "conceptSize": "18px", "displayValue": "PMID: 16144413", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1246", "value": "PMID: 16144413", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-85,  VARIANT 56-GLY--GLY-63 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7485229", "conceptSize": "18px", "displayValue": "PMID: 7485229", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1247", "value": "PMID: 7485229", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT 56-GLY--GLY-63 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1678248", "conceptSize": "18px", "displayValue": "PMID: 1678248", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1248", "value": "PMID: 1678248", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[REVIEW ON VARIANTS,  INVOLVEMENT IN DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8105771", "conceptSize": "18px", "displayValue": "PMID: 8105771", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1249", "value": "PMID: 8105771", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT VAL-127,  CHARACTERIZATION OF VARIANT VAL-127,  INVOLVEMENT IN KURU,  POLYMORPHISM]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "26061765", "conceptSize": "18px", "displayValue": "PMID: 26061765", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1250", "value": "PMID: 26061765", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[BICISTRONIC GENE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21478263", "conceptSize": "18px", "displayValue": "PMID: 21478263", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1251", "value": "PMID: 21478263", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-232,  VARIANT 56-GLY--GLY-63 DEL]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1363802", "conceptSize": "18px", "displayValue": "PMID: 1363802", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1252", "value": "PMID: 1363802", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[GLYCOSYLATION AT ASN-181,  VARIANT SENF ALA-183,  CHARACTERIZATION OF VARIANT SENF ALA-183]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12214108", "conceptSize": "18px", "displayValue": "PMID: 12214108", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1253", "value": "PMID: 12214108", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT VAL-127,  INVOLVEMENT IN KURU]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19923577", "conceptSize": "18px", "displayValue": "PMID: 19923577", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1254", "value": "PMID: 19923577", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 125-227 OF VARIANT VAL-129,  VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  VARIANT GSD SER-198,  SUBUNIT,  DOMAIN]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "19927125", "conceptSize": "18px", "displayValue": "PMID: 19927125", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1255", "value": "PMID: 19927125", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 84-91]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1683708", "conceptSize": "18px", "displayValue": "PMID: 1683708", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1256", "value": "PMID: 1683708", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD LYS-200]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7906019", "conceptSize": "18px", "displayValue": "PMID: 7906019", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1257", "value": "PMID: 7906019", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD LEU-105]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7699395", "conceptSize": "18px", "displayValue": "PMID: 7699395", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1258", "value": "PMID: 7699395", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD LEU-102,  VARIANT LYS-219]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8797472", "conceptSize": "18px", "displayValue": "PMID: 8797472", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1259", "value": "PMID: 8797472", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS ARG-188 AND SER-238]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10987652", "conceptSize": "18px", "displayValue": "PMID: 10987652", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1260", "value": "PMID: 10987652", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD LEU-105]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7902972", "conceptSize": "18px", "displayValue": "PMID: 7902972", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1261", "value": "PMID: 7902972", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT CJD ASN-178]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1671440", "conceptSize": "18px", "displayValue": "PMID: 1671440", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1262", "value": "PMID: 1671440", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-253,  VARIANT SCHIZOAFFECTIVE DISORDER SER-171]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9384372", "conceptSize": "18px", "displayValue": "PMID: 9384372", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1263", "value": "PMID: 9384372", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD LEU-102]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7783876", "conceptSize": "18px", "displayValue": "PMID: 7783876", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1264", "value": "PMID: 7783876", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS GSD ASN-202 AND PRO-212]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9786248", "conceptSize": "18px", "displayValue": "PMID: 9786248", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1265", "value": "PMID: 9786248", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANTS CJD ILE-180 AND ARG-232]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8461023", "conceptSize": "18px", "displayValue": "PMID: 8461023", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1266", "value": "PMID: 8461023", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT GSD ARG-217]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1363810", "conceptSize": "18px", "displayValue": "PMID: 1363810", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1267", "value": "PMID: 1363810", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Fomepizole", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1268", "value": "Fomepizole", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Antihemophilic Factor (Recomb...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1269", "value": "Antihemophilic Factor (Recombinant)", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Melatonin", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1270", "value": "Melatonin", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Tenecteplase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1271", "value": "Tenecteplase", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "L-Proline", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1272", "value": "L-Proline", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Cyclosporine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1273", "value": "Cyclosporine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Thiopental", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1274", "value": "Thiopental", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Methylphenobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1275", "value": "Methylphenobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Amobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1276", "value": "Amobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Secobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1277", "value": "Secobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Varenicline", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1278", "value": "Varenicline", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Talbutal", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1279", "value": "Talbutal", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Cytisine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1280", "value": "Cytisine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Aprobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1281", "value": "Aprobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Butalbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1282", "value": "Butalbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Ethanol", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1283", "value": "Ethanol", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Phenobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1284", "value": "Phenobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Nicotine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1285", "value": "Nicotine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Primidone", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1286", "value": "Primidone", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Pentobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1287", "value": "Pentobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Butabarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1288", "value": "Butabarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Hexobarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1289", "value": "Hexobarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Butethal", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1290", "value": "Butethal", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Galantamine", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1291", "value": "Galantamine", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Drug", "pid": "", "conceptSize": "18px", "displayValue": "Heptabarbital", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "slateBlue", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1292", "value": "Heptabarbital", "conceptShape": "ellipse", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Enzyme Classification", "pid": "6.-.-.-", "conceptSize": "18px", "displayValue": "6.-.-.-", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "pink", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1293", "value": "6.-.-.-", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Enzyme Classification", "pid": "3.4.19.12", "conceptSize": "18px", "displayValue": "3.4.19.12", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "pink", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1294", "value": "3.4.19.12", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "613643", "conceptSize": "26px", "displayValue": "PARKINSON DISEASE 5,  AUTOSOMA...", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1295", "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 5,  AUTOSOMAL DOMINANT,  SUSCEPTIBILITY TO; PARK5", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "Interacting selectively and non-covalently with an alpha-2A adrenergic receptor. ( Reference:  GOC: mah GOC: nln )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0031694", "conceptSize": "18px", "displayValue": "alpha-2A adrenergic receptor ...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1296", "value": "alpha-2A adrenergic receptor binding", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the removal of terminal peptide residues that are substituted,  cyclized or linked by isopeptide bonds (peptide linkages other than those of alpha-carboxyl to alpha-amino groups). ( Reference:  EC: 3.4.19.- )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0008242", "conceptSize": "18px", "displayValue": "omega peptidase activity", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1297", "value": "omega peptidase activity", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile. ( Reference:  GOC: mah http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#CATTYPE http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#ENDOPEPTIDASE )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004197", "conceptSize": "18px", "displayValue": "thiol endopeptidase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1298", "value": "thiol endopeptidase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Catalysis of the thiol-dependent hydrolysis of a peptide bond formed by the C-terminal glycine of ubiquitin and another protein. ( Reference:  GOC: jh2 ISBN: 0120793709 )", "conceptBorderColor": "black", "conceptType": "Molecular_Function", "pid": "GO: 0004843", "conceptSize": "18px", "displayValue": "deubiquitylase", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "purple", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1299", "value": "deubiquitylase", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells:  Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. ( Reference:  GOC: cjm GOC: jl NIF_Subcellular: sao-593830697 Wikipedia: Myelin )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043209", "conceptSize": "18px", "displayValue": "myelin sheath", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1300", "value": "myelin sheath", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "That part of the nuclear content other than the chromosomes or the nucleolus. ( Reference:  GOC: ma ISBN: 0124325653 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005654", "conceptSize": "18px", "displayValue": "nucleoplasm", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1301", "value": "nucleoplasm", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The specialized,  terminal region of a neuron projection such as an axon or a dendrite. ( Reference:  GOC: jl )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0044306", "conceptSize": "18px", "displayValue": "neuron projection terminal", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1302", "value": "neuron projection terminal", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process pertaining to the functions of the nervous and muscular systems of an organism. ( Reference:  GOC: ai );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0050905", "conceptSize": "18px", "displayValue": "neuromotor process", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1303", "value": "neuromotor process", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the muscle fiber over time,  from its formation to the mature structure. In skeletal muscle,  fibers are formed by the maturation of myotubes. They can be classed as slow,  intermediate fast or fast. ( Reference:  GOC: dph GOC: jid GOC: lm GOC: mtg_muscle )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048747", "conceptSize": "18px", "displayValue": "myofiber development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1304", "value": "myofiber development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The specific behavior of an organism relating to the intake of food,  any substance (usually solid) that can be metabolized by an organism to give energy and build tissue. ( Reference:  GOC: jl GOC: pr ISBN: 01928006X )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0042755", "conceptSize": "18px", "displayValue": "eating behavior", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1305", "value": "eating behavior", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of mitochondria along microtubules in nerve cell axons. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0019896", "conceptSize": "18px", "displayValue": "axon transport of mitochondria", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1306", "value": "axon transport of mitochondria", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of MAP kinase activity. ( Reference:  GOC: dph GOC: go_curators )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0043407", "conceptSize": "18px", "displayValue": "downregulation of MAPK", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1307", "value": "downregulation of MAPK", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The removal of one or more ubiquitin groups from a protein. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0016579", "conceptSize": "18px", "displayValue": "deubiquitination", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1308", "value": "deubiquitination", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that results in a change in state or activity of an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a inadequate blood supply. ( Reference:  GOC: hjd )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0002931", "conceptSize": "18px", "displayValue": "response to ischemia", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1309", "value": "response to ischemia", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which an axon recognizes and binds to a set of cells with which it may form stable connections. ( Reference:  ISBN: 0878932437 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0007412", "conceptSize": "18px", "displayValue": "axon target recognition", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1310", "value": "axon target recognition", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The series of events required for an organism to receive a painful stimulus,  convert it to a molecular signal,  and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness,  so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature,  mechanical damage,  electricity or from noxious chemical substances. This is a neurological process. ( Reference:  http: \/\/www.onelook.com\/ )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0019233", "conceptSize": "18px", "displayValue": "nociception", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1311", "value": "nociception", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The multiplication or reproduction of cells,  resulting in the expansion of a cell population. ( Reference:  GOC: mah GOC: mb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0008283", "conceptSize": "18px", "displayValue": "cell proliferation", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1312", "value": "cell proliferation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ACTIVE SITE,  MUTAGENESIS OF GLN-73; CYS-90; HIS-97; HIS-161 AND ASP-176,  BIOPHYSICOCHEMICAL PROPERTIES]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8639624", "conceptSize": "18px", "displayValue": "PMID: 8639624", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1313", "value": "PMID: 8639624", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS),  SUBUNIT]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16537382", "conceptSize": "18px", "displayValue": "PMID: 16537382", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1314", "value": "PMID: 16537382", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT TYR-18,  ANTIOXIDANT FUNCTION IN NEURONAL CELLS]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "18411255", "conceptSize": "18px", "displayValue": "PMID: 18411255", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1315", "value": "PMID: 18411255", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT TYR-18]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "15048890", "conceptSize": "18px", "displayValue": "PMID: 15048890", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1316", "value": "PMID: 15048890", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 20-25; 79-81; 106-121 AND 134-151]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1849484", "conceptSize": "18px", "displayValue": "PMID: 1849484", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1317", "value": "PMID: 1849484", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 20-25; 79-91; 106-123 AND 136-151]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "1286667", "conceptSize": "18px", "displayValue": "PMID: 1286667", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1318", "value": "PMID: 1286667", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT TYR-18]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "21268678", "conceptSize": "18px", "displayValue": "PMID: 21268678", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1319", "value": "PMID: 21268678", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-15]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2163617", "conceptSize": "18px", "displayValue": "PMID: 2163617", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1320", "value": "PMID: 2163617", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT TYR-18]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "11027850", "conceptSize": "18px", "displayValue": "PMID: 11027850", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1321", "value": "PMID: 11027850", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 16-223,  VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  BIOPHYSICOCHEMICAL PROPERTIES]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9774100", "conceptSize": "18px", "displayValue": "PMID: 9774100", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1322", "value": "PMID: 9774100", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 7-223,  PARTIAL PROTEIN SEQUENCE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "2947814", "conceptSize": "18px", "displayValue": "PMID: 2947814", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1323", "value": "PMID: 2947814", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT NDGOA ALA-7,  CHARACTERIZATION OF VARIANT NDGOA ALA-7]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "23359680", "conceptSize": "18px", "displayValue": "PMID: 23359680", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1324", "value": "PMID: 23359680", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF VARIANTS TYR-18 AND MET-93 IN COMPLEX WITH UBIQUITIN,  CATALYTIC ACTIVITY,  ACTIVE SITE,  MUTAGENESIS OF CYS-90 AND PHE-204]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "20439756", "conceptSize": "18px", "displayValue": "PMID: 20439756", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1325", "value": "PMID: 20439756", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT TYR-18,  LACK OF ASSOCIATION OF VARIANT TYR-18 WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16450370", "conceptSize": "18px", "displayValue": "PMID: 16450370", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1326", "value": "PMID: 16450370", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[PROTEIN SEQUENCE OF 1-15 AND 214-221,  SUSCEPTIBILITY TO OXIDATION,  IDENTIFICATION BY MASS SPECTROMETRY,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "14722078", "conceptSize": "18px", "displayValue": "PMID: 14722078", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1327", "value": "PMID: 14722078", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT TYR-18]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10203348", "conceptSize": "18px", "displayValue": "PMID: 10203348", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1328", "value": "PMID: 10203348", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[FUNCTION,  TISSUE SPECIFICITY]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "9790970", "conceptSize": "18px", "displayValue": "PMID: 9790970", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1329", "value": "PMID: 9790970", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[INTERACTION WITH COPS5]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12082530", "conceptSize": "18px", "displayValue": "PMID: 12082530", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1330", "value": "PMID: 12082530", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[VARIANT MET-93]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "10454131", "conceptSize": "18px", "displayValue": "PMID: 10454131", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1331", "value": "PMID: 10454131", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18,  MUTAGENESIS OF CYS-90,  BIOPHYSICOCHEMICAL PROPERTIES]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "12705903", "conceptSize": "18px", "displayValue": "PMID: 12705903", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1332", "value": "PMID: 12705903", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[ACTIVE SITE]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "16475834", "conceptSize": "18px", "displayValue": "PMID: 16475834", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1333", "value": "PMID: 16475834", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "", "conceptBorderColor": "black", "conceptType": "Disease", "pid": "606889", "conceptSize": "26px", "displayValue": "ALZHEIMER DISEASE 4", "conceptTextBGopacity": "1", "conceptDisplay": "element", "conceptColor": "lightGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1334", "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4", "conceptShape": "triangle", "conceptTextBGcolor": "gold"} , "group": "nodes"} , { "data": { "annotation": "A membrane-tethered,  short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum) that is similar in structure to a centriole and derives from it. The cilium basal body is the site of assembly and remodelling of the cilium and serves as a nucleation site for axoneme growth. As well as anchoring the cilium,  it is thought to provide a selective gateway regulating the entry of ciliary proteins and vesicles by intraflagellar transport. ( Reference:  GOC: cilia GOC: clt PMID: 21750193 )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0036064", "conceptSize": "18px", "displayValue": "cilium basal body", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1335", "value": "cilium basal body", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The inner,  i.e. lumen-facing,  lipid bilayer of the nuclear envelope. ( Reference:  GOC: ma )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0005637", "conceptSize": "18px", "displayValue": "inner nuclear membrane", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1336", "value": "inner nuclear membrane", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. ( Reference:  GOC: go_curators http: \/\/www.ebi.ac.uk\/intact\/complex\/documentation\/ )", "conceptBorderColor": "black", "conceptType": "Cellular_Component", "pid": "GO: 0043234", "conceptSize": "18px", "displayValue": "protein complex", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "springGreen", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1337", "value": "protein complex", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the hair follicle over time,  from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. ( Reference:  GOC: dph UBERON: 0002073 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0001942", "conceptSize": "18px", "displayValue": "hair follicle development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1338", "value": "hair follicle development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Muscle contraction of cardiac muscle tissue. ( Reference:  GOC: dph )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0060048", "conceptSize": "18px", "displayValue": "heart muscle contraction", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1339", "value": "heart muscle contraction", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal,  and ends when the execution phase of apoptosis is triggered. ( Reference:  GOC: mtg_apoptosis )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0097190", "conceptSize": "18px", "displayValue": "apoptotic signaling pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1340", "value": "apoptotic signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the alveolus over time,  from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways. ( Reference:  GOC: mtg_lung PMID: 9751757 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048286", "conceptSize": "18px", "displayValue": "alveologenesis", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1341", "value": "alveologenesis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage. ( Reference:  GOC: add PMID: 16551251 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0002573", "conceptSize": "18px", "displayValue": "myeloid leukocyte differentia...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1342", "value": "myeloid leukocyte differentiation", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. ( Reference:  GOC: TermGenie PMID: 17245429 );", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 1902042", "conceptSize": "18px", "displayValue": "downregulation of extrinsic a...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1343", "value": "downregulation of extrinsic apoptotic signaling pathway via death domain receptors", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein complex assembly. ( Reference:  GOC: mah )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031333", "conceptSize": "18px", "displayValue": "downregulation of protein com...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1344", "value": "downregulation of protein complex assembly", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The directed movement of calcium (Ca) ions into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0006816", "conceptSize": "18px", "displayValue": "calcium transport", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1345", "value": "calcium transport", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The process whose specific outcome is the progression of the forebrain over time,  from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates,  includes especially the cerebral hemispheres,  the thalamus,  and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing,  visceral functions,  and voluntary motor functions). ( Reference:  http: \/\/www2.merriam-webster.com\/cgi-bin\/mwmednlm?book=Medical&va=forebrain )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0030900", "conceptSize": "18px", "displayValue": "forebrain development", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1346", "value": "forebrain development", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin. ( Reference:  GOC: ceb )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048013", "conceptSize": "18px", "displayValue": "Eph receptor signaling pathway", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1347", "value": "Eph receptor signaling pathway", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain. ( Reference:  PMID: 12808018 )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0031293", "conceptSize": "18px", "displayValue": "membrane protein intracellula...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1348", "value": "membrane protein intracellular domain proteolysis", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity,  and ending with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: bf GOC: ceb GOC: jc GOC: signaling PMID: 12065629 Wikipedia: Trk_receptor )", "conceptBorderColor": "black", "conceptType": "Biological_Process", "pid": "GO: 0048011", "conceptSize": "18px", "displayValue": "tropomyosin-receptor-kinase s...", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "teal", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1349", "value": "tropomyosin-receptor-kinase signaling", "conceptShape": "pentagon", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  VARIANT AD4 ILE-141]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "7638622", "conceptSize": "18px", "displayValue": "PMID: 7638622", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1350", "value": "PMID: 7638622", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} , { "data": { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]", "conceptBorderColor": "black", "conceptType": "Publication", "pid": "8661049", "conceptSize": "18px", "displayValue": "PMID: 8661049", "conceptTextBGopacity": "0", "conceptDisplay": "none", "conceptColor": "orange", "conceptBorderStyle": "solid", "conceptBorderWidth": "1px", "flagged": "false", "id": "1351", "value": "PMID: 8661049", "conceptShape": "rectangle", "conceptTextBGcolor": "black"} , "group": "nodes"} ], "edges": [{ "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1", "source": "18", "label": "encodes", "relationColor": "grey", "target": "1"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e2", "source": "1", "label": "cooccurs_with", "relationColor": "blue", "target": "19"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e3", "source": "1", "label": "cooccurs_with", "relationColor": "blue", "target": "20"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e4", "source": "1", "label": "is_involved_in", "relationColor": "limeGreen", "target": "30"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e5", "source": "1", "label": "has_function", "relationColor": "purple", "target": "31"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e6", "source": "1", "label": "has_function", "relationColor": "purple", "target": "32"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e7", "source": "1", "label": "has_function", "relationColor": "purple", "target": "33"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e8", "source": "1", "label": "has_function", "relationColor": "purple", "target": "34"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e9", "source": "1", "label": "has_function", "relationColor": "purple", "target": "35"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e10", "source": "1", "label": "has_function", "relationColor": "purple", "target": "36"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e11", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "37"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e12", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "38"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e13", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "39"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e14", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "40"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e15", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "41"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e16", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "54"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e17", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "55"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e18", "source": "1", "label": "interacts_with", "relationColor": "steelBlue", "target": "56"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e19", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "85"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e20", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "86"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e21", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "87"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e22", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e23", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "89"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e24", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "90"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e25", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e26", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "92"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e27", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "93"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e28", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "94"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e29", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "95"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e30", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "96"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e31", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e32", "source": "1", "label": "located_in", "relationColor": "springGreen", "target": "98"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e33", "source": "99", "label": "has_target", "relationColor": "navy", "target": "1"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e34", "source": "100", "label": "has_target", "relationColor": "navy", "target": "1"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e35", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "101"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e36", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "102"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e37", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "103"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e38", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "104"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e39", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "105"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e40", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "106"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e41", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "107"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e42", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "108"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e43", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "109"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e44", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "110"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e45", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "111"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e46", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "112"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e47", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "113"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e48", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "114"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e49", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "115"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e50", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "116"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e51", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "117"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e52", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "118"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e53", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "119"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e54", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "120"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e55", "source": "1", "label": "participates_in", "relationColor": "teal", "target": "121"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e56", "source": "1", "label": "published_in", "relationColor": "orange", "target": "122"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e57", "source": "1", "label": "published_in", "relationColor": "orange", "target": "123"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e58", "source": "1", "label": "published_in", "relationColor": "orange", "target": "124"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e59", "source": "1", "label": "published_in", "relationColor": "orange", "target": "125"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e60", "source": "1", "label": "published_in", "relationColor": "orange", "target": "7"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e61", "source": "1", "label": "published_in", "relationColor": "orange", "target": "126"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e62", "source": "1", "label": "published_in", "relationColor": "orange", "target": "127"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e63", "source": "1", "label": "published_in", "relationColor": "orange", "target": "128"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e64", "source": "1", "label": "published_in", "relationColor": "orange", "target": "129"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e65", "source": "1", "label": "published_in", "relationColor": "orange", "target": "130"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e66", "source": "1", "label": "published_in", "relationColor": "orange", "target": "131"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e67", "source": "1", "label": "published_in", "relationColor": "orange", "target": "132"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e68", "source": "1", "label": "published_in", "relationColor": "orange", "target": "133"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e69", "source": "1", "label": "published_in", "relationColor": "orange", "target": "134"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e70", "source": "1", "label": "published_in", "relationColor": "orange", "target": "135"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e71", "source": "1", "label": "published_in", "relationColor": "orange", "target": "17"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e72", "source": "1", "label": "published_in", "relationColor": "orange", "target": "14"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e73", "source": "1", "label": "published_in", "relationColor": "orange", "target": "136"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e74", "source": "1", "label": "published_in", "relationColor": "orange", "target": "137"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e75", "source": "1", "label": "published_in", "relationColor": "orange", "target": "138"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e76", "source": "1", "label": "published_in", "relationColor": "orange", "target": "139"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e77", "source": "1", "label": "published_in", "relationColor": "orange", "target": "140"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e78", "source": "1", "label": "published_in", "relationColor": "orange", "target": "141"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e79", "source": "1", "label": "published_in", "relationColor": "orange", "target": "142"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e80", "source": "1", "label": "published_in", "relationColor": "orange", "target": "143"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e81", "source": "1", "label": "published_in", "relationColor": "orange", "target": "9"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e82", "source": "1", "label": "published_in", "relationColor": "orange", "target": "144"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e83", "source": "1", "label": "published_in", "relationColor": "orange", "target": "145"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e84", "source": "1", "label": "published_in", "relationColor": "orange", "target": "146"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e85", "source": "1", "label": "published_in", "relationColor": "orange", "target": "147"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e86", "source": "1", "label": "published_in", "relationColor": "orange", "target": "148"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e87", "source": "1", "label": "published_in", "relationColor": "orange", "target": "149"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e88", "source": "1", "label": "published_in", "relationColor": "orange", "target": "3"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e89", "source": "1", "label": "published_in", "relationColor": "orange", "target": "150"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e90", "source": "1", "label": "published_in", "relationColor": "orange", "target": "151"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e91", "source": "1", "label": "published_in", "relationColor": "orange", "target": "152"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e92", "source": "1", "label": "published_in", "relationColor": "orange", "target": "153"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e93", "source": "1", "label": "published_in", "relationColor": "orange", "target": "6"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e94", "source": "1", "label": "published_in", "relationColor": "orange", "target": "154"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e95", "source": "1", "label": "published_in", "relationColor": "orange", "target": "155"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e96", "source": "1", "label": "published_in", "relationColor": "orange", "target": "156"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e97", "source": "1", "label": "published_in", "relationColor": "orange", "target": "157"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e98", "source": "1", "label": "published_in", "relationColor": "orange", "target": "158"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e99", "source": "1", "label": "published_in", "relationColor": "orange", "target": "159"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e100", "source": "1", "label": "published_in", "relationColor": "orange", "target": "10"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e101", "source": "1", "label": "published_in", "relationColor": "orange", "target": "160"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e102", "source": "1", "label": "published_in", "relationColor": "orange", "target": "161"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e103", "source": "1", "label": "published_in", "relationColor": "orange", "target": "162"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e104", "source": "1", "label": "published_in", "relationColor": "orange", "target": "163"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e105", "source": "1", "label": "published_in", "relationColor": "orange", "target": "164"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e106", "source": "1", "label": "published_in", "relationColor": "orange", "target": "11"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e107", "source": "1", "label": "published_in", "relationColor": "orange", "target": "165"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e108", "source": "1", "label": "published_in", "relationColor": "orange", "target": "166"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e109", "source": "1", "label": "published_in", "relationColor": "orange", "target": "167"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e110", "source": "1", "label": "published_in", "relationColor": "orange", "target": "168"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e111", "source": "1", "label": "published_in", "relationColor": "orange", "target": "169"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e112", "source": "1", "label": "published_in", "relationColor": "orange", "target": "170"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e113", "source": "1", "label": "published_in", "relationColor": "orange", "target": "171"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e114", "source": "1", "label": "published_in", "relationColor": "orange", "target": "172"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e115", "source": "1", "label": "published_in", "relationColor": "orange", "target": "173"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e116", "source": "1", "label": "published_in", "relationColor": "orange", "target": "174"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e117", "source": "1", "label": "published_in", "relationColor": "orange", "target": "175"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e118", "source": "1", "label": "published_in", "relationColor": "orange", "target": "176"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e119", "source": "1", "label": "published_in", "relationColor": "orange", "target": "177"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e120", "source": "1", "label": "published_in", "relationColor": "orange", "target": "178"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e121", "source": "1", "label": "published_in", "relationColor": "orange", "target": "179"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e122", "source": "1", "label": "published_in", "relationColor": "orange", "target": "180"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e123", "source": "1", "label": "published_in", "relationColor": "orange", "target": "181"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e124", "source": "1", "label": "published_in", "relationColor": "orange", "target": "182"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e125", "source": "1", "label": "published_in", "relationColor": "orange", "target": "183"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e126", "source": "185", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e127", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "185"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e128", "source": "187", "label": "associated_with", "relationColor": "black", "target": "186"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e129", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "187"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e130", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "189"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e131", "source": "189", "label": "associated_with", "relationColor": "black", "target": "188"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e132", "source": "190", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e133", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "190"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e134", "source": "191", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e135", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "191"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e136", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "192"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e137", "source": "192", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e138", "source": "194", "label": "associated_with", "relationColor": "black", "target": "193"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e139", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "194"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e140", "source": "195", "label": "associated_with", "relationColor": "black", "target": "196"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e141", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "195"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e142", "source": "197", "label": "associated_with", "relationColor": "black", "target": "198"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e143", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "197"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e144", "source": "199", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e145", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "199"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e146", "source": "200", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e147", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "200"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e148", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "202"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e149", "source": "202", "label": "associated_with", "relationColor": "black", "target": "201"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e150", "source": "203", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e151", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "203"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e152", "source": "204", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e153", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "204"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e154", "source": "204", "label": "associated_with", "relationColor": "black", "target": "205"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e155", "source": "206", "label": "associated_with", "relationColor": "black", "target": "196"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e156", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "206"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e157", "source": "207", "label": "associated_with", "relationColor": "black", "target": "208"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e158", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "207"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e159", "source": "207", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e160", "source": "209", "label": "associated_with", "relationColor": "black", "target": "205"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e161", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "209"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e162", "source": "209", "label": "associated_with", "relationColor": "black", "target": "184"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e163", "source": "210", "label": "associated_with", "relationColor": "black", "target": "208"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e164", "source": "18", "label": "has_variation", "relationColor": "navy", "target": "210"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e165", "source": "38", "label": "interacts_with", "relationColor": "steelBlue", "target": "41"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e166", "source": "38", "label": "interacts_with", "relationColor": "steelBlue", "target": "211"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e167", "source": "38", "label": "interacts_with", "relationColor": "steelBlue", "target": "212"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e168", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "213"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e169", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "214"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e170", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "215"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e171", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "216"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e172", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "217"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e173", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "218"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e174", "source": "39", "label": "interacts_with", "relationColor": "steelBlue", "target": "41"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e175", "source": "40", "label": "interacts_with", "relationColor": "steelBlue", "target": "219"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e176", "source": "40", "label": "interacts_with", "relationColor": "steelBlue", "target": "220"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e177", "source": "221", "label": "has_target", "relationColor": "navy", "target": "40"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e178", "source": "41", "label": "cooccurs_with", "relationColor": "blue", "target": "222"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e179", "source": "223", "label": "cooccurs_with", "relationColor": "blue", "target": "41"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e180", "source": "41", "label": "cooccurs_with", "relationColor": "blue", "target": "226"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e181", "source": "41", "label": "cooccurs_with", "relationColor": "blue", "target": "234"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e182", "source": "41", "label": "cooccurs_with", "relationColor": "blue", "target": "241"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e183", "source": "41", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "242"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e184", "source": "41", "label": "is_involved_in", "relationColor": "limeGreen", "target": "243"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e185", "source": "41", "label": "is_involved_in", "relationColor": "limeGreen", "target": "244"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e186", "source": "41", "label": "has_function", "relationColor": "purple", "target": "245"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e187", "source": "41", "label": "has_function", "relationColor": "purple", "target": "246"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e188", "source": "41", "label": "has_function", "relationColor": "purple", "target": "247"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e189", "source": "41", "label": "has_function", "relationColor": "purple", "target": "248"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e190", "source": "41", "label": "has_function", "relationColor": "purple", "target": "249"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e191", "source": "41", "label": "has_function", "relationColor": "purple", "target": "250"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e192", "source": "41", "label": "has_function", "relationColor": "purple", "target": "251"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e193", "source": "41", "label": "has_function", "relationColor": "purple", "target": "252"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e194", "source": "41", "label": "has_function", "relationColor": "purple", "target": "253"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e195", "source": "41", "label": "has_function", "relationColor": "purple", "target": "254"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e196", "source": "41", "label": "has_function", "relationColor": "purple", "target": "255"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e197", "source": "41", "label": "has_function", "relationColor": "purple", "target": "256"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e198", "source": "41", "label": "has_function", "relationColor": "purple", "target": "257"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e199", "source": "41", "label": "has_function", "relationColor": "purple", "target": "258"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e200", "source": "41", "label": "has_function", "relationColor": "purple", "target": "259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e201", "source": "41", "label": "has_function", "relationColor": "purple", "target": "260"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e202", "source": "41", "label": "has_function", "relationColor": "purple", "target": "261"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e203", "source": "41", "label": "has_function", "relationColor": "purple", "target": "262"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e204", "source": "41", "label": "has_function", "relationColor": "purple", "target": "263"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e205", "source": "41", "label": "has_function", "relationColor": "purple", "target": "264"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e206", "source": "41", "label": "has_function", "relationColor": "purple", "target": "265"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e207", "source": "41", "label": "has_function", "relationColor": "purple", "target": "266"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e208", "source": "41", "label": "has_function", "relationColor": "purple", "target": "267"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e209", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "219"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e210", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "268"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e211", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "269"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e212", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "270"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e213", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "271"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e214", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "272"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e215", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "273"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e216", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e217", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "275"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e218", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "276"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e219", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "277"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e220", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "278"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e221", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "279"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e222", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "280"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e223", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "281"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e224", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "282"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e225", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "283"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e226", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "284"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e227", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "285"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e228", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "286"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e229", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "287"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e230", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "288"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e231", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "289"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e232", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "290"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e233", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "291"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e234", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "292"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e235", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "293"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e236", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "294"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e237", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "295"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e238", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "296"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e239", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "297"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e240", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "298"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e241", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "299"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e242", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "300"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e243", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "301"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e244", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "302"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e245", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "303"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e246", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "304"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e247", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "305"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e248", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "306"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e249", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "307"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e250", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "308"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e251", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "309"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e252", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "310"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e253", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "311"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e254", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "312"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e255", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "313"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e256", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "314"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e257", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "315"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e258", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "316"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e259", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "317"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e260", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "318"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e261", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "319"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e262", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "218"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e263", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "320"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e264", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "321"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e265", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "322"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e266", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "323"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e267", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "324"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e268", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "325"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e269", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "326"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e270", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "327"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e271", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e272", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "329"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e273", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "330"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e274", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "331"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e275", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "211"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e276", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "332"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e277", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "333"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e278", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "334"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e279", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "335"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e280", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "336"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e281", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "337"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e282", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "338"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e283", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "339"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e284", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "340"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e285", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "341"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e286", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "342"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e287", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "350"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e288", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "351"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e289", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "352"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e290", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "353"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e291", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "354"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e292", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "355"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e293", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "356"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e294", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "357"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e295", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "358"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e296", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "359"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e297", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "360"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e298", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "361"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e299", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "362"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e300", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "363"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e301", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "364"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e302", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "365"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e303", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "366"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e304", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "367"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e305", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "368"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e306", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "369"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e307", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "370"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e308", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "371"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e309", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "372"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e310", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "373"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e311", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "374"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e312", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "375"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e313", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "376"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e314", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "391"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e315", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "392"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e316", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "393"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e317", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "394"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e318", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "395"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e319", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "396"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e320", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "397"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e321", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "398"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e322", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "399"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e323", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "400"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e324", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "401"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e325", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "402"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e326", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "403"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e327", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "404"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e328", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "405"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e329", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "406"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e330", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "407"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e331", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "408"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e332", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "409"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e333", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "410"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e334", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "411"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e335", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "412"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e336", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "413"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e337", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "216"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e338", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "38"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e339", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "414"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e340", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "415"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e341", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "416"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e342", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "417"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e343", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "418"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e344", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "419"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e345", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "420"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e346", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "421"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e347", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "422"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e348", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "423"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e349", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "424"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e350", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "425"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e351", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "426"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e352", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "427"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e353", "source": "41", "label": "interacts_with", "relationColor": "steelBlue", "target": "428"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e354", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e355", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "429"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e356", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e357", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "431"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e358", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "98"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e359", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "432"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e360", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "433"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e361", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "434"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e362", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "435"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e363", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e364", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "436"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e365", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "437"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e366", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "438"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e367", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "439"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e368", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "440"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e369", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "441"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e370", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "442"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e371", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "443"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e372", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "444"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e373", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "445"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e374", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "446"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e375", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "447"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e376", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e377", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "449"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e378", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "450"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e379", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "451"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e380", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "452"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e381", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "94"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e382", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "453"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e383", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "454"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e384", "source": "41", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e385", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "455"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e386", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "456"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e387", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "457"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e388", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "458"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e389", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "459"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e390", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "460"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e391", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "461"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e392", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "462"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e393", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "463"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e394", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "464"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e395", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "465"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e396", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "466"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e397", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "467"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e398", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "468"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e399", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "469"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e400", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "470"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e401", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "471"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e402", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "472"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e403", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "473"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e404", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "474"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e405", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "475"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e406", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "476"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e407", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "477"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e408", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "478"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e409", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "479"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e410", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "480"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e411", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "481"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e412", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "482"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e413", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "483"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e414", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "484"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e415", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "485"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e416", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "486"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e417", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "487"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e418", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "488"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e419", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "489"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e420", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "490"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e421", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "491"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e422", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "492"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e423", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "493"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e424", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "494"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e425", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "495"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e426", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "496"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e427", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "497"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e428", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "498"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e429", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "499"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e430", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "500"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e431", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "501"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e432", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "502"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e433", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "503"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e434", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "504"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e435", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "505"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e436", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "116"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e437", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "506"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e438", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "507"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e439", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "508"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e440", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "509"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e441", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "510"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e442", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "511"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e443", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "512"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e444", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "513"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e445", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "514"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e446", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "515"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e447", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "516"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e448", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "517"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e449", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "518"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e450", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "519"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e451", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "520"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e452", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "521"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e453", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "522"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e454", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "523"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e455", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "524"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e456", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "525"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e457", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "526"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e458", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "527"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e459", "source": "41", "label": "participates_in", "relationColor": "teal", "target": "528"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e460", "source": "41", "label": "published_in", "relationColor": "orange", "target": "529"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e461", "source": "41", "label": "published_in", "relationColor": "orange", "target": "530"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e462", "source": "41", "label": "published_in", "relationColor": "orange", "target": "45"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e463", "source": "41", "label": "published_in", "relationColor": "orange", "target": "531"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e464", "source": "41", "label": "published_in", "relationColor": "orange", "target": "532"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e465", "source": "41", "label": "published_in", "relationColor": "orange", "target": "533"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e466", "source": "41", "label": "published_in", "relationColor": "orange", "target": "534"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e467", "source": "41", "label": "published_in", "relationColor": "orange", "target": "5"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e468", "source": "41", "label": "published_in", "relationColor": "orange", "target": "535"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e469", "source": "41", "label": "published_in", "relationColor": "orange", "target": "536"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e470", "source": "41", "label": "published_in", "relationColor": "orange", "target": "537"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e471", "source": "41", "label": "published_in", "relationColor": "orange", "target": "53"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e472", "source": "41", "label": "published_in", "relationColor": "orange", "target": "538"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e473", "source": "41", "label": "published_in", "relationColor": "orange", "target": "42"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e474", "source": "41", "label": "published_in", "relationColor": "orange", "target": "539"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e475", "source": "41", "label": "published_in", "relationColor": "orange", "target": "52"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e476", "source": "41", "label": "published_in", "relationColor": "orange", "target": "540"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e477", "source": "41", "label": "published_in", "relationColor": "orange", "target": "541"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e478", "source": "41", "label": "published_in", "relationColor": "orange", "target": "13"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e479", "source": "41", "label": "published_in", "relationColor": "orange", "target": "46"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e480", "source": "41", "label": "published_in", "relationColor": "orange", "target": "542"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e481", "source": "41", "label": "published_in", "relationColor": "orange", "target": "51"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e482", "source": "41", "label": "published_in", "relationColor": "orange", "target": "47"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e483", "source": "41", "label": "published_in", "relationColor": "orange", "target": "543"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e484", "source": "41", "label": "published_in", "relationColor": "orange", "target": "544"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e485", "source": "41", "label": "published_in", "relationColor": "orange", "target": "545"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e486", "source": "41", "label": "published_in", "relationColor": "orange", "target": "546"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e487", "source": "41", "label": "published_in", "relationColor": "orange", "target": "547"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e488", "source": "41", "label": "published_in", "relationColor": "orange", "target": "548"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e489", "source": "41", "label": "published_in", "relationColor": "orange", "target": "48"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e490", "source": "41", "label": "published_in", "relationColor": "orange", "target": "549"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e491", "source": "41", "label": "published_in", "relationColor": "orange", "target": "550"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e492", "source": "41", "label": "published_in", "relationColor": "orange", "target": "551"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e493", "source": "41", "label": "published_in", "relationColor": "orange", "target": "552"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e494", "source": "41", "label": "published_in", "relationColor": "orange", "target": "553"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e495", "source": "41", "label": "published_in", "relationColor": "orange", "target": "554"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e496", "source": "41", "label": "published_in", "relationColor": "orange", "target": "49"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e497", "source": "41", "label": "published_in", "relationColor": "orange", "target": "555"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e498", "source": "41", "label": "published_in", "relationColor": "orange", "target": "2"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e499", "source": "41", "label": "published_in", "relationColor": "orange", "target": "556"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e500", "source": "41", "label": "published_in", "relationColor": "orange", "target": "50"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e501", "source": "41", "label": "published_in", "relationColor": "orange", "target": "557"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e502", "source": "41", "label": "published_in", "relationColor": "orange", "target": "558"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e503", "source": "41", "label": "published_in", "relationColor": "orange", "target": "44"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e504", "source": "41", "label": "published_in", "relationColor": "orange", "target": "559"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e505", "source": "41", "label": "published_in", "relationColor": "orange", "target": "560"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e506", "source": "41", "label": "published_in", "relationColor": "orange", "target": "561"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e507", "source": "41", "label": "published_in", "relationColor": "orange", "target": "43"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e508", "source": "41", "label": "published_in", "relationColor": "orange", "target": "562"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e509", "source": "54", "label": "interacts_with", "relationColor": "steelBlue", "target": "312"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e510", "source": "56", "label": "cooccurs_with", "relationColor": "blue", "target": "563"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e511", "source": "56", "label": "cooccurs_with", "relationColor": "blue", "target": "564"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e512", "source": "56", "label": "cooccurs_with", "relationColor": "blue", "target": "565"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e513", "source": "20", "label": "cooccurs_with", "relationColor": "blue", "target": "56"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e514", "source": "56", "label": "is_involved_in", "relationColor": "limeGreen", "target": "566"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e515", "source": "56", "label": "has_function", "relationColor": "purple", "target": "34"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e516", "source": "56", "label": "has_function", "relationColor": "purple", "target": "567"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e517", "source": "56", "label": "has_function", "relationColor": "purple", "target": "568"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e518", "source": "56", "label": "has_function", "relationColor": "purple", "target": "569"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e519", "source": "56", "label": "has_function", "relationColor": "purple", "target": "570"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e520", "source": "56", "label": "has_function", "relationColor": "purple", "target": "571"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e521", "source": "56", "label": "has_function", "relationColor": "purple", "target": "572"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e522", "source": "56", "label": "has_function", "relationColor": "purple", "target": "259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e523", "source": "56", "label": "has_function", "relationColor": "purple", "target": "573"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e524", "source": "56", "label": "has_function", "relationColor": "purple", "target": "574"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e525", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "575"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e526", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "38"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e527", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "576"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e528", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "577"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e529", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "578"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e530", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "579"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e531", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "580"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e532", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "603"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e533", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "604"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e534", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "608"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e535", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "609"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e536", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "610"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e537", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "611"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e538", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "612"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e539", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "613"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e540", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "614"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e541", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e542", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "615"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e543", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "616"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e544", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "617"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e545", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "618"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e546", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "619"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e547", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "620"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e548", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "621"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e549", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "622"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e550", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "623"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e551", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "624"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e552", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "625"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e553", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "626"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e554", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e555", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "628"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e556", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "629"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e557", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "630"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e558", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "631"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e559", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "632"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e560", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "633"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e561", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "634"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e562", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "635"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e563", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "636"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e564", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "316"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e565", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "637"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e566", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "638"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e567", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "214"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e568", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "639"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e569", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "640"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e570", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "641"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e571", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "642"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e572", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "216"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e573", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "643"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e574", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "644"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e575", "source": "56", "label": "interacts_with", "relationColor": "steelBlue", "target": "645"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e576", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "646"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e577", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "431"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e578", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "647"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e579", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "648"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e580", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e581", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "449"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e582", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "649"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e583", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "650"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e584", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "651"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e585", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e586", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "652"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e587", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e588", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "653"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e589", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "654"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e590", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "655"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e591", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "656"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e592", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e593", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "443"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e594", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "657"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e595", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "658"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e596", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "442"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e597", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e598", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "444"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e599", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "659"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e600", "source": "56", "label": "located_in", "relationColor": "springGreen", "target": "660"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e601", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "661"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e602", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "662"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e603", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "663"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e604", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "664"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e605", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "665"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e606", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "666"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e607", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "667"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e608", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "668"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e609", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "669"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e610", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "670"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e611", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "671"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e612", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "672"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e613", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "673"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e614", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "674"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e615", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "675"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e616", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "676"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e617", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "677"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e618", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "678"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e619", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "679"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e620", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "680"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e621", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "521"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e622", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "681"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e623", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "682"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e624", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "683"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e625", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "684"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e626", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "685"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e627", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "686"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e628", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "687"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e629", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "688"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e630", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "689"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e631", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "690"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e632", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "691"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e633", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "692"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e634", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "693"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e635", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "112"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e636", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "694"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e637", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "695"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e638", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "505"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e639", "source": "56", "label": "participates_in", "relationColor": "teal", "target": "696"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e640", "source": "56", "label": "published_in", "relationColor": "orange", "target": "697"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e641", "source": "56", "label": "published_in", "relationColor": "orange", "target": "698"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e642", "source": "56", "label": "published_in", "relationColor": "orange", "target": "699"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e643", "source": "56", "label": "published_in", "relationColor": "orange", "target": "700"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e644", "source": "56", "label": "published_in", "relationColor": "orange", "target": "701"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e645", "source": "56", "label": "published_in", "relationColor": "orange", "target": "702"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e646", "source": "56", "label": "published_in", "relationColor": "orange", "target": "77"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e647", "source": "56", "label": "published_in", "relationColor": "orange", "target": "703"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e648", "source": "56", "label": "published_in", "relationColor": "orange", "target": "76"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e649", "source": "56", "label": "published_in", "relationColor": "orange", "target": "24"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e650", "source": "56", "label": "published_in", "relationColor": "orange", "target": "704"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e651", "source": "56", "label": "published_in", "relationColor": "orange", "target": "705"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e652", "source": "56", "label": "published_in", "relationColor": "orange", "target": "706"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e653", "source": "56", "label": "published_in", "relationColor": "orange", "target": "81"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e654", "source": "56", "label": "published_in", "relationColor": "orange", "target": "707"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e655", "source": "56", "label": "published_in", "relationColor": "orange", "target": "26"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e656", "source": "56", "label": "published_in", "relationColor": "orange", "target": "708"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e657", "source": "56", "label": "published_in", "relationColor": "orange", "target": "709"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e658", "source": "56", "label": "published_in", "relationColor": "orange", "target": "710"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e659", "source": "56", "label": "published_in", "relationColor": "orange", "target": "711"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e660", "source": "56", "label": "published_in", "relationColor": "orange", "target": "712"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e661", "source": "56", "label": "published_in", "relationColor": "orange", "target": "69"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e662", "source": "56", "label": "published_in", "relationColor": "orange", "target": "713"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e663", "source": "56", "label": "published_in", "relationColor": "orange", "target": "84"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e664", "source": "56", "label": "published_in", "relationColor": "orange", "target": "714"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e665", "source": "56", "label": "published_in", "relationColor": "orange", "target": "715"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e666", "source": "56", "label": "published_in", "relationColor": "orange", "target": "716"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e667", "source": "56", "label": "published_in", "relationColor": "orange", "target": "22"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e668", "source": "56", "label": "published_in", "relationColor": "orange", "target": "717"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e669", "source": "56", "label": "published_in", "relationColor": "orange", "target": "16"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e670", "source": "56", "label": "published_in", "relationColor": "orange", "target": "718"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e671", "source": "56", "label": "published_in", "relationColor": "orange", "target": "719"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e672", "source": "56", "label": "published_in", "relationColor": "orange", "target": "720"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e673", "source": "56", "label": "published_in", "relationColor": "orange", "target": "721"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e674", "source": "56", "label": "published_in", "relationColor": "orange", "target": "27"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e675", "source": "56", "label": "published_in", "relationColor": "orange", "target": "722"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e676", "source": "56", "label": "published_in", "relationColor": "orange", "target": "723"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e677", "source": "56", "label": "published_in", "relationColor": "orange", "target": "724"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e678", "source": "56", "label": "published_in", "relationColor": "orange", "target": "725"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e679", "source": "56", "label": "published_in", "relationColor": "orange", "target": "70"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e680", "source": "56", "label": "published_in", "relationColor": "orange", "target": "726"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e681", "source": "56", "label": "published_in", "relationColor": "orange", "target": "727"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e682", "source": "56", "label": "published_in", "relationColor": "orange", "target": "728"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e683", "source": "56", "label": "published_in", "relationColor": "orange", "target": "729"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e684", "source": "56", "label": "published_in", "relationColor": "orange", "target": "730"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e685", "source": "56", "label": "published_in", "relationColor": "orange", "target": "731"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e686", "source": "56", "label": "published_in", "relationColor": "orange", "target": "732"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e687", "source": "56", "label": "published_in", "relationColor": "orange", "target": "733"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e688", "source": "56", "label": "published_in", "relationColor": "orange", "target": "734"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e689", "source": "56", "label": "published_in", "relationColor": "orange", "target": "735"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e690", "source": "56", "label": "published_in", "relationColor": "orange", "target": "736"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e691", "source": "56", "label": "published_in", "relationColor": "orange", "target": "21"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e692", "source": "56", "label": "published_in", "relationColor": "orange", "target": "737"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e693", "source": "56", "label": "published_in", "relationColor": "orange", "target": "738"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e694", "source": "56", "label": "published_in", "relationColor": "orange", "target": "25"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e695", "source": "56", "label": "published_in", "relationColor": "orange", "target": "739"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e696", "source": "56", "label": "published_in", "relationColor": "orange", "target": "740"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e697", "source": "56", "label": "published_in", "relationColor": "orange", "target": "28"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e698", "source": "56", "label": "published_in", "relationColor": "orange", "target": "65"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e699", "source": "56", "label": "published_in", "relationColor": "orange", "target": "741"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e700", "source": "56", "label": "published_in", "relationColor": "orange", "target": "742"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e701", "source": "56", "label": "published_in", "relationColor": "orange", "target": "743"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e702", "source": "56", "label": "published_in", "relationColor": "orange", "target": "744"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e703", "source": "56", "label": "published_in", "relationColor": "orange", "target": "745"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e704", "source": "56", "label": "published_in", "relationColor": "orange", "target": "746"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e705", "source": "56", "label": "published_in", "relationColor": "orange", "target": "80"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e706", "source": "56", "label": "published_in", "relationColor": "orange", "target": "747"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e707", "source": "56", "label": "published_in", "relationColor": "orange", "target": "748"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e708", "source": "56", "label": "published_in", "relationColor": "orange", "target": "749"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e709", "source": "56", "label": "published_in", "relationColor": "orange", "target": "57"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e710", "source": "56", "label": "published_in", "relationColor": "orange", "target": "750"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e711", "source": "56", "label": "published_in", "relationColor": "orange", "target": "62"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e712", "source": "56", "label": "published_in", "relationColor": "orange", "target": "751"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e713", "source": "56", "label": "published_in", "relationColor": "orange", "target": "752"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e714", "source": "56", "label": "published_in", "relationColor": "orange", "target": "753"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e715", "source": "56", "label": "published_in", "relationColor": "orange", "target": "754"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e716", "source": "56", "label": "published_in", "relationColor": "orange", "target": "755"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e717", "source": "56", "label": "published_in", "relationColor": "orange", "target": "756"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e718", "source": "56", "label": "published_in", "relationColor": "orange", "target": "757"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e719", "source": "56", "label": "published_in", "relationColor": "orange", "target": "73"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e720", "source": "56", "label": "published_in", "relationColor": "orange", "target": "758"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e721", "source": "56", "label": "published_in", "relationColor": "orange", "target": "759"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e722", "source": "56", "label": "published_in", "relationColor": "orange", "target": "760"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e723", "source": "56", "label": "published_in", "relationColor": "orange", "target": "761"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e724", "source": "56", "label": "published_in", "relationColor": "orange", "target": "762"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e725", "source": "56", "label": "published_in", "relationColor": "orange", "target": "763"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e726", "source": "56", "label": "published_in", "relationColor": "orange", "target": "764"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e727", "source": "56", "label": "published_in", "relationColor": "orange", "target": "765"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e728", "source": "56", "label": "published_in", "relationColor": "orange", "target": "766"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e729", "source": "56", "label": "published_in", "relationColor": "orange", "target": "63"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e730", "source": "56", "label": "published_in", "relationColor": "orange", "target": "767"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e731", "source": "56", "label": "published_in", "relationColor": "orange", "target": "768"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e732", "source": "56", "label": "published_in", "relationColor": "orange", "target": "769"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e733", "source": "56", "label": "published_in", "relationColor": "orange", "target": "4"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e734", "source": "56", "label": "published_in", "relationColor": "orange", "target": "770"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e735", "source": "56", "label": "published_in", "relationColor": "orange", "target": "771"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e736", "source": "56", "label": "published_in", "relationColor": "orange", "target": "772"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e737", "source": "56", "label": "published_in", "relationColor": "orange", "target": "74"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e738", "source": "56", "label": "published_in", "relationColor": "orange", "target": "773"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e739", "source": "56", "label": "published_in", "relationColor": "orange", "target": "23"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e740", "source": "56", "label": "published_in", "relationColor": "orange", "target": "774"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e741", "source": "56", "label": "published_in", "relationColor": "orange", "target": "12"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e742", "source": "56", "label": "published_in", "relationColor": "orange", "target": "775"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e743", "source": "56", "label": "published_in", "relationColor": "orange", "target": "776"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e744", "source": "56", "label": "published_in", "relationColor": "orange", "target": "777"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e745", "source": "56", "label": "published_in", "relationColor": "orange", "target": "778"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e746", "source": "56", "label": "published_in", "relationColor": "orange", "target": "779"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e747", "source": "56", "label": "published_in", "relationColor": "orange", "target": "780"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e748", "source": "56", "label": "published_in", "relationColor": "orange", "target": "781"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e749", "source": "56", "label": "published_in", "relationColor": "orange", "target": "782"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e750", "source": "56", "label": "published_in", "relationColor": "orange", "target": "783"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e751", "source": "56", "label": "published_in", "relationColor": "orange", "target": "784"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e752", "source": "56", "label": "published_in", "relationColor": "orange", "target": "785"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e753", "source": "56", "label": "published_in", "relationColor": "orange", "target": "786"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e754", "source": "56", "label": "published_in", "relationColor": "orange", "target": "787"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e755", "source": "56", "label": "published_in", "relationColor": "orange", "target": "788"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e756", "source": "56", "label": "published_in", "relationColor": "orange", "target": "789"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e757", "source": "56", "label": "published_in", "relationColor": "orange", "target": "790"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e758", "source": "56", "label": "published_in", "relationColor": "orange", "target": "791"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e759", "source": "56", "label": "published_in", "relationColor": "orange", "target": "792"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e760", "source": "56", "label": "published_in", "relationColor": "orange", "target": "793"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e761", "source": "56", "label": "published_in", "relationColor": "orange", "target": "794"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e762", "source": "56", "label": "published_in", "relationColor": "orange", "target": "795"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e763", "source": "56", "label": "published_in", "relationColor": "orange", "target": "796"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e764", "source": "56", "label": "published_in", "relationColor": "orange", "target": "797"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e765", "source": "56", "label": "published_in", "relationColor": "orange", "target": "798"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e766", "source": "56", "label": "published_in", "relationColor": "orange", "target": "799"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e767", "source": "56", "label": "published_in", "relationColor": "orange", "target": "800"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e768", "source": "56", "label": "published_in", "relationColor": "orange", "target": "75"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e769", "source": "56", "label": "published_in", "relationColor": "orange", "target": "71"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e770", "source": "56", "label": "published_in", "relationColor": "orange", "target": "801"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e771", "source": "56", "label": "published_in", "relationColor": "orange", "target": "802"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e772", "source": "56", "label": "published_in", "relationColor": "orange", "target": "803"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e773", "source": "56", "label": "published_in", "relationColor": "orange", "target": "804"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e774", "source": "56", "label": "published_in", "relationColor": "orange", "target": "805"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e775", "source": "56", "label": "published_in", "relationColor": "orange", "target": "806"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e776", "source": "56", "label": "published_in", "relationColor": "orange", "target": "807"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e777", "source": "56", "label": "published_in", "relationColor": "orange", "target": "808"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e778", "source": "56", "label": "published_in", "relationColor": "orange", "target": "809"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e779", "source": "56", "label": "published_in", "relationColor": "orange", "target": "59"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e780", "source": "810", "label": "has_target", "relationColor": "navy", "target": "211"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e781", "source": "811", "label": "has_target", "relationColor": "navy", "target": "214"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e782", "source": "812", "label": "has_target", "relationColor": "navy", "target": "214"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e783", "source": "813", "label": "has_target", "relationColor": "navy", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e784", "source": "814", "label": "has_target", "relationColor": "navy", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e785", "source": "815", "label": "has_target", "relationColor": "navy", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e786", "source": "816", "label": "has_target", "relationColor": "navy", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e787", "source": "817", "label": "has_target", "relationColor": "navy", "target": "274"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e788", "source": "818", "label": "has_target", "relationColor": "navy", "target": "310"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e789", "source": "818", "label": "has_target", "relationColor": "navy", "target": "314"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e790", "source": "819", "label": "has_target", "relationColor": "navy", "target": "314"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e791", "source": "820", "label": "has_target", "relationColor": "navy", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e792", "source": "821", "label": "has_target", "relationColor": "navy", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e793", "source": "99", "label": "has_target", "relationColor": "navy", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e794", "source": "814", "label": "has_target", "relationColor": "navy", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e795", "source": "100", "label": "has_target", "relationColor": "navy", "target": "328"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e796", "source": "342", "label": "is_involved_in", "relationColor": "limeGreen", "target": "822"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e797", "source": "342", "label": "is_involved_in", "relationColor": "limeGreen", "target": "823"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e798", "source": "342", "label": "is_involved_in", "relationColor": "limeGreen", "target": "244"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e799", "source": "342", "label": "is_involved_in", "relationColor": "limeGreen", "target": "824"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e800", "source": "342", "label": "has_function", "relationColor": "purple", "target": "825"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e801", "source": "342", "label": "has_function", "relationColor": "purple", "target": "826"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e802", "source": "342", "label": "has_function", "relationColor": "purple", "target": "827"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e803", "source": "342", "label": "has_function", "relationColor": "purple", "target": "828"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e804", "source": "342", "label": "has_function", "relationColor": "purple", "target": "829"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e805", "source": "342", "label": "has_function", "relationColor": "purple", "target": "830"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e806", "source": "342", "label": "has_function", "relationColor": "purple", "target": "259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e807", "source": "342", "label": "has_function", "relationColor": "purple", "target": "831"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e808", "source": "342", "label": "has_function", "relationColor": "purple", "target": "832"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e809", "source": "342", "label": "has_function", "relationColor": "purple", "target": "833"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e810", "source": "342", "label": "has_function", "relationColor": "purple", "target": "834"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e811", "source": "342", "label": "has_function", "relationColor": "purple", "target": "835"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e812", "source": "342", "label": "has_function", "relationColor": "purple", "target": "836"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e813", "source": "342", "label": "has_function", "relationColor": "purple", "target": "837"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e814", "source": "342", "label": "has_function", "relationColor": "purple", "target": "838"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e815", "source": "342", "label": "has_function", "relationColor": "purple", "target": "839"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e816", "source": "342", "label": "has_function", "relationColor": "purple", "target": "840"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e817", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "657"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e818", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "841"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e819", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "842"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e820", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "843"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e821", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "439"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e822", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "440"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e823", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "844"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e824", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "845"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e825", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e826", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "846"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e827", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e828", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "653"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e829", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "431"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e830", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "436"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e831", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "438"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e832", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e833", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "847"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e834", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "444"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e835", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "848"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e836", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "849"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e837", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "850"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e838", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e839", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e840", "source": "342", "label": "located_in", "relationColor": "springGreen", "target": "98"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e841", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "851"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e842", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "852"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e843", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "853"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e844", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "854"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e845", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "855"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e846", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "856"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e847", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "857"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e848", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "858"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e849", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "859"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e850", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "860"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e851", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "861"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e852", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "862"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e853", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "863"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e854", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "864"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e855", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "865"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e856", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "866"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e857", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "512"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e858", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "867"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e859", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "868"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e860", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "498"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e861", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "869"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e862", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "504"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e863", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "870"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e864", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "871"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e865", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "872"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e866", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "873"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e867", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "874"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e868", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "875"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e869", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "876"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e870", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "877"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e871", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "456"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e872", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "878"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e873", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "879"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e874", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "880"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e875", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "881"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e876", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "882"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e877", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "883"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e878", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "884"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e879", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "885"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e880", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "886"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e881", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "887"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e882", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "888"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e883", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "889"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e884", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "890"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e885", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "891"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e886", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "892"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e887", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "893"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e888", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "694"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e889", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "894"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e890", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "895"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e891", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "896"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e892", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "897"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e893", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "669"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e894", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "898"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e895", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "899"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e896", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "900"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e897", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "901"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e898", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "902"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e899", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "903"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e900", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "904"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e901", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "905"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e902", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "906"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e903", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "907"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e904", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "908"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e905", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "909"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e906", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "910"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e907", "source": "342", "label": "participates_in", "relationColor": "teal", "target": "911"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e908", "source": "342", "label": "published_in", "relationColor": "orange", "target": "912"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e909", "source": "342", "label": "published_in", "relationColor": "orange", "target": "913"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e910", "source": "342", "label": "published_in", "relationColor": "orange", "target": "914"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e911", "source": "342", "label": "published_in", "relationColor": "orange", "target": "915"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e912", "source": "342", "label": "published_in", "relationColor": "orange", "target": "232"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e913", "source": "342", "label": "published_in", "relationColor": "orange", "target": "916"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e914", "source": "342", "label": "published_in", "relationColor": "orange", "target": "917"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e915", "source": "342", "label": "published_in", "relationColor": "orange", "target": "918"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e916", "source": "342", "label": "published_in", "relationColor": "orange", "target": "919"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e917", "source": "342", "label": "published_in", "relationColor": "orange", "target": "920"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e918", "source": "342", "label": "published_in", "relationColor": "orange", "target": "921"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e919", "source": "342", "label": "published_in", "relationColor": "orange", "target": "922"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e920", "source": "342", "label": "published_in", "relationColor": "orange", "target": "923"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e921", "source": "342", "label": "published_in", "relationColor": "orange", "target": "924"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e922", "source": "342", "label": "published_in", "relationColor": "orange", "target": "925"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e923", "source": "342", "label": "published_in", "relationColor": "orange", "target": "926"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e924", "source": "342", "label": "published_in", "relationColor": "orange", "target": "927"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e925", "source": "342", "label": "published_in", "relationColor": "orange", "target": "928"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e926", "source": "342", "label": "published_in", "relationColor": "orange", "target": "929"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e927", "source": "342", "label": "published_in", "relationColor": "orange", "target": "930"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e928", "source": "342", "label": "published_in", "relationColor": "orange", "target": "931"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e929", "source": "342", "label": "published_in", "relationColor": "orange", "target": "932"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e930", "source": "342", "label": "published_in", "relationColor": "orange", "target": "933"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e931", "source": "342", "label": "published_in", "relationColor": "orange", "target": "934"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e932", "source": "342", "label": "published_in", "relationColor": "orange", "target": "935"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e933", "source": "342", "label": "published_in", "relationColor": "orange", "target": "936"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e934", "source": "937", "label": "has_target", "relationColor": "navy", "target": "373"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e935", "source": "938", "label": "cooccurs_with", "relationColor": "blue", "target": "376"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e936", "source": "376", "label": "cooccurs_with", "relationColor": "blue", "target": "234"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e937", "source": "376", "label": "cooccurs_with", "relationColor": "blue", "target": "223"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e938", "source": "376", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "939"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e939", "source": "376", "label": "is_involved_in", "relationColor": "limeGreen", "target": "940"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e940", "source": "376", "label": "is_involved_in", "relationColor": "limeGreen", "target": "244"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e941", "source": "376", "label": "has_function", "relationColor": "purple", "target": "941"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e942", "source": "376", "label": "has_function", "relationColor": "purple", "target": "942"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e943", "source": "376", "label": "has_function", "relationColor": "purple", "target": "248"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e944", "source": "376", "label": "has_function", "relationColor": "purple", "target": "943"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e945", "source": "376", "label": "has_function", "relationColor": "purple", "target": "34"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e946", "source": "376", "label": "has_function", "relationColor": "purple", "target": "840"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e947", "source": "376", "label": "has_function", "relationColor": "purple", "target": "944"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e948", "source": "376", "label": "has_function", "relationColor": "purple", "target": "945"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e949", "source": "376", "label": "has_function", "relationColor": "purple", "target": "946"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e950", "source": "376", "label": "has_function", "relationColor": "purple", "target": "947"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e951", "source": "376", "label": "has_function", "relationColor": "purple", "target": "948"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e952", "source": "376", "label": "has_function", "relationColor": "purple", "target": "949"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e953", "source": "376", "label": "has_function", "relationColor": "purple", "target": "31"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e954", "source": "376", "label": "has_function", "relationColor": "purple", "target": "950"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e955", "source": "376", "label": "has_function", "relationColor": "purple", "target": "951"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e956", "source": "376", "label": "has_function", "relationColor": "purple", "target": "827"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e957", "source": "376", "label": "has_function", "relationColor": "purple", "target": "952"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e958", "source": "376", "label": "has_function", "relationColor": "purple", "target": "953"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e959", "source": "376", "label": "has_function", "relationColor": "purple", "target": "252"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e960", "source": "376", "label": "has_function", "relationColor": "purple", "target": "954"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e961", "source": "376", "label": "has_function", "relationColor": "purple", "target": "955"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e962", "source": "376", "label": "has_function", "relationColor": "purple", "target": "259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e963", "source": "376", "label": "has_function", "relationColor": "purple", "target": "956"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e964", "source": "376", "label": "has_function", "relationColor": "purple", "target": "957"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e965", "source": "376", "label": "has_function", "relationColor": "purple", "target": "958"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e966", "source": "376", "label": "has_function", "relationColor": "purple", "target": "959"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e967", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "453"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e968", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e969", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "960"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e970", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e971", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "961"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e972", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "446"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e973", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "962"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e974", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "850"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e975", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e976", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "963"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e977", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "653"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e978", "source": "376", "label": "located_in", "relationColor": "springGreen", "target": "438"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e979", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "964"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e980", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "965"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e981", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "966"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e982", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "967"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e983", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "968"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e984", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "969"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e985", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "970"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e986", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "971"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e987", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "972"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e988", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "973"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e989", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "460"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e990", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "974"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e991", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "975"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e992", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "976"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e993", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "977"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e994", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "978"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e995", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "979"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e996", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "980"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e997", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "981"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e998", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "982"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e999", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "983"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1000", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "984"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1001", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "985"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1002", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "986"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1003", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "503"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1004", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "987"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1005", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "988"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1006", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "989"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1007", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "990"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1008", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "991"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1009", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "992"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1010", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "506"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1011", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "993"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1012", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "994"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1013", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "508"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1014", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "995"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1015", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "884"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1016", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "996"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1017", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "997"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1018", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "998"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1019", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "999"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1020", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1000"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1021", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1001"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1022", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1002"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1023", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1003"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1024", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "865"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1025", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "477"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1026", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1004"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1027", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "512"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1028", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1005"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1029", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1006"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1030", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1007"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1031", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1008"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1032", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "669"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1033", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "513"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1034", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1009"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1035", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "116"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1036", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1010"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1037", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1011"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1038", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1012"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1039", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "520"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1040", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "476"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1041", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "859"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1042", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1013"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1043", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1014"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1044", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1015"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1045", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1016"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1046", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1017"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1047", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1018"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1048", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1019"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1049", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1020"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1050", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1021"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1051", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1022"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1052", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1023"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1053", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1024"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1054", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1025"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1055", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1026"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1056", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1027"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1057", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1028"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1058", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "493"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1059", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1029"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1060", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "906"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1061", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1030"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1062", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1031"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1063", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1032"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1064", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1033"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1065", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1034"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1066", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1035"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1067", "source": "376", "label": "participates_in", "relationColor": "teal", "target": "1036"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1068", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1037"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1069", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1038"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1070", "source": "376", "label": "published_in", "relationColor": "orange", "target": "384"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1071", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1039"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1072", "source": "376", "label": "published_in", "relationColor": "orange", "target": "382"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1073", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1040"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1074", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1041"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1075", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1042"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1076", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1043"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1077", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1044"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1078", "source": "376", "label": "published_in", "relationColor": "orange", "target": "377"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1079", "source": "376", "label": "published_in", "relationColor": "orange", "target": "344"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1080", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1045"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1081", "source": "376", "label": "published_in", "relationColor": "orange", "target": "347"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1082", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1046"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1083", "source": "376", "label": "published_in", "relationColor": "orange", "target": "239"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1084", "source": "376", "label": "published_in", "relationColor": "orange", "target": "388"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1085", "source": "376", "label": "published_in", "relationColor": "orange", "target": "236"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1086", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1047"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1087", "source": "376", "label": "published_in", "relationColor": "orange", "target": "379"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1088", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1048"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1089", "source": "376", "label": "published_in", "relationColor": "orange", "target": "240"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1090", "source": "376", "label": "published_in", "relationColor": "orange", "target": "48"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1091", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1049"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1092", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1050"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1093", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1051"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1094", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1052"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1095", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1053"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1096", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1054"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1097", "source": "376", "label": "published_in", "relationColor": "orange", "target": "349"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1098", "source": "376", "label": "published_in", "relationColor": "orange", "target": "390"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1099", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1055"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1100", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1056"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1101", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1057"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1102", "source": "376", "label": "published_in", "relationColor": "orange", "target": "381"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1103", "source": "376", "label": "published_in", "relationColor": "orange", "target": "380"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1104", "source": "376", "label": "published_in", "relationColor": "orange", "target": "383"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1105", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1058"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1106", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1059"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1107", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1060"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1108", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1061"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1109", "source": "376", "label": "published_in", "relationColor": "orange", "target": "237"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1110", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1062"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1111", "source": "376", "label": "published_in", "relationColor": "orange", "target": "378"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1112", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1063"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1113", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1064"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1114", "source": "376", "label": "published_in", "relationColor": "orange", "target": "385"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1115", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1065"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1116", "source": "376", "label": "published_in", "relationColor": "orange", "target": "343"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1117", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1066"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1118", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1067"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1119", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1068"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1120", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1069"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1121", "source": "376", "label": "published_in", "relationColor": "orange", "target": "238"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1122", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1070"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1123", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1071"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1124", "source": "376", "label": "published_in", "relationColor": "orange", "target": "386"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1125", "source": "376", "label": "published_in", "relationColor": "orange", "target": "13"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1126", "source": "376", "label": "published_in", "relationColor": "orange", "target": "389"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1127", "source": "376", "label": "published_in", "relationColor": "orange", "target": "225"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1128", "source": "376", "label": "published_in", "relationColor": "orange", "target": "387"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1129", "source": "376", "label": "published_in", "relationColor": "orange", "target": "235"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1130", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1072"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1131", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1073"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1132", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1074"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1133", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1075"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1134", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1076"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1135", "source": "376", "label": "published_in", "relationColor": "orange", "target": "348"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1136", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1077"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1137", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1078"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1138", "source": "376", "label": "published_in", "relationColor": "orange", "target": "224"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1139", "source": "376", "label": "published_in", "relationColor": "orange", "target": "1079"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1140", "source": "1080", "label": "has_target", "relationColor": "navy", "target": "391"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1141", "source": "1081", "label": "has_target", "relationColor": "navy", "target": "405"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1142", "source": "1082", "label": "has_target", "relationColor": "navy", "target": "425"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1143", "source": "819", "label": "has_target", "relationColor": "navy", "target": "425"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1144", "source": "1083", "label": "has_target", "relationColor": "navy", "target": "575"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1145", "source": "1084", "label": "has_target", "relationColor": "navy", "target": "575"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1146", "source": "1085", "label": "has_target", "relationColor": "navy", "target": "575"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1147", "source": "816", "label": "has_target", "relationColor": "navy", "target": "575"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1148", "source": "1086", "label": "has_target", "relationColor": "navy", "target": "577"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1149", "source": "1087", "label": "has_target", "relationColor": "navy", "target": "577"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1150", "source": "1088", "label": "has_target", "relationColor": "navy", "target": "579"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1151", "source": "1083", "label": "has_target", "relationColor": "navy", "target": "579"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1152", "source": "226", "label": "cooccurs_with", "relationColor": "blue", "target": "580"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1153", "source": "580", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "1089"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1154", "source": "580", "label": "is_involved_in", "relationColor": "limeGreen", "target": "1090"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1155", "source": "580", "label": "has_function", "relationColor": "purple", "target": "941"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1156", "source": "580", "label": "has_function", "relationColor": "purple", "target": "942"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1157", "source": "580", "label": "has_function", "relationColor": "purple", "target": "1091"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1158", "source": "580", "label": "has_function", "relationColor": "purple", "target": "1092"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1159", "source": "580", "label": "has_function", "relationColor": "purple", "target": "1093"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1160", "source": "580", "label": "has_function", "relationColor": "purple", "target": "1094"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1161", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "454"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1162", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1095"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1163", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "453"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1164", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "846"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1165", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1096"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1166", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "655"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1167", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1097"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1168", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "443"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1169", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1098"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1170", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "961"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1171", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1099"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1172", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "848"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1173", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1174", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "98"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1175", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "648"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1176", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1100"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1177", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1101"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1178", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1102"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1179", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "847"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1180", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "850"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1181", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "447"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1182", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "650"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1183", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "849"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1184", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "450"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1185", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1103"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1186", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "438"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1187", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1188", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "652"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1189", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1104"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1190", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1105"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1191", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "436"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1192", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "1106"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1193", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "653"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1194", "source": "580", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1195", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1107"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1196", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1108"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1197", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "867"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1198", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "528"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1199", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1109"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1200", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1110"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1201", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1111"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1202", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1112"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1203", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1113"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1204", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1114"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1205", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1115"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1206", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "679"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1207", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "458"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1208", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "879"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1209", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1116"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1210", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1117"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1211", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1118"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1212", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1119"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1213", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1120"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1214", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "687"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1215", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1121"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1216", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1122"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1217", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1123"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1218", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1124"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1219", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1125"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1220", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1126"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1221", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "465"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1222", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1127"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1223", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "467"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1224", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "503"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1225", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1128"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1226", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1129"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1227", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "910"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1228", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1130"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1229", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1131"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1230", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1132"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1231", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1133"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1232", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1134"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1233", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1135"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1234", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "865"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1235", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1136"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1236", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1137"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1237", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "513"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1238", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "902"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1239", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1138"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1240", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1139"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1241", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1140"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1242", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1141"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1243", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1142"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1244", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1143"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1245", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1144"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1246", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1145"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1247", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1146"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1248", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1147"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1249", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1148"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1250", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1149"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1251", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1150"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1252", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1151"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1253", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1152"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1254", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1153"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1255", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "680"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1256", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "120"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1257", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1154"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1258", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1155"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1259", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1156"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1260", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1157"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1261", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1158"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1262", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1159"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1263", "source": "580", "label": "participates_in", "relationColor": "teal", "target": "1160"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1264", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1161"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1265", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1162"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1266", "source": "580", "label": "published_in", "relationColor": "orange", "target": "231"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1267", "source": "580", "label": "published_in", "relationColor": "orange", "target": "60"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1268", "source": "580", "label": "published_in", "relationColor": "orange", "target": "587"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1269", "source": "580", "label": "published_in", "relationColor": "orange", "target": "581"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1270", "source": "580", "label": "published_in", "relationColor": "orange", "target": "590"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1271", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1163"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1272", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1164"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1273", "source": "580", "label": "published_in", "relationColor": "orange", "target": "594"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1274", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1165"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1275", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1166"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1276", "source": "580", "label": "published_in", "relationColor": "orange", "target": "72"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1277", "source": "580", "label": "published_in", "relationColor": "orange", "target": "79"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1278", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1167"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1279", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1168"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1280", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1169"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1281", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1170"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1282", "source": "580", "label": "published_in", "relationColor": "orange", "target": "601"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1283", "source": "580", "label": "published_in", "relationColor": "orange", "target": "585"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1284", "source": "580", "label": "published_in", "relationColor": "orange", "target": "593"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1285", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1171"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1286", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1172"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1287", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1173"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1288", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1174"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1289", "source": "580", "label": "published_in", "relationColor": "orange", "target": "592"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1290", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1175"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1291", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1176"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1292", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1177"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1293", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1178"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1294", "source": "580", "label": "published_in", "relationColor": "orange", "target": "49"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1295", "source": "580", "label": "published_in", "relationColor": "orange", "target": "595"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1296", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1179"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1297", "source": "580", "label": "published_in", "relationColor": "orange", "target": "78"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1298", "source": "580", "label": "published_in", "relationColor": "orange", "target": "82"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1299", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1180"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1300", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1181"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1301", "source": "580", "label": "published_in", "relationColor": "orange", "target": "61"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1302", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1182"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1303", "source": "580", "label": "published_in", "relationColor": "orange", "target": "591"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1304", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1183"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1305", "source": "580", "label": "published_in", "relationColor": "orange", "target": "597"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1306", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1184"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1307", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1185"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1308", "source": "580", "label": "published_in", "relationColor": "orange", "target": "68"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1309", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1186"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1310", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1187"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1311", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1188"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1312", "source": "580", "label": "published_in", "relationColor": "orange", "target": "602"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1313", "source": "580", "label": "published_in", "relationColor": "orange", "target": "233"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1314", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1189"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1315", "source": "580", "label": "published_in", "relationColor": "orange", "target": "586"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1316", "source": "580", "label": "published_in", "relationColor": "orange", "target": "228"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1317", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1190"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1318", "source": "580", "label": "published_in", "relationColor": "orange", "target": "66"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1319", "source": "580", "label": "published_in", "relationColor": "orange", "target": "589"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1320", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1191"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1321", "source": "580", "label": "published_in", "relationColor": "orange", "target": "599"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1322", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1192"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1323", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1193"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1324", "source": "580", "label": "published_in", "relationColor": "orange", "target": "583"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1325", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1194"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1326", "source": "580", "label": "published_in", "relationColor": "orange", "target": "67"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1327", "source": "580", "label": "published_in", "relationColor": "orange", "target": "8"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1328", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1195"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1329", "source": "580", "label": "published_in", "relationColor": "orange", "target": "598"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1330", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1196"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1331", "source": "580", "label": "published_in", "relationColor": "orange", "target": "80"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1332", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1197"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1333", "source": "580", "label": "published_in", "relationColor": "orange", "target": "584"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1334", "source": "580", "label": "published_in", "relationColor": "orange", "target": "582"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1335", "source": "580", "label": "published_in", "relationColor": "orange", "target": "64"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1336", "source": "580", "label": "published_in", "relationColor": "orange", "target": "1198"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1337", "source": "226", "label": "cooccurs_with", "relationColor": "blue", "target": "604"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1338", "source": "20", "label": "cooccurs_with", "relationColor": "blue", "target": "604"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1339", "source": "604", "label": "is_involved_in", "relationColor": "limeGreen", "target": "1199"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1340", "source": "604", "label": "has_function", "relationColor": "purple", "target": "836"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1341", "source": "604", "label": "has_function", "relationColor": "purple", "target": "33"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1342", "source": "604", "label": "has_function", "relationColor": "purple", "target": "248"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1343", "source": "604", "label": "has_function", "relationColor": "purple", "target": "259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1344", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1345", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1346", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "1200"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1347", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1348", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "453"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1349", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "850"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1350", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "655"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1351", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "1201"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1352", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "442"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1353", "source": "604", "label": "located_in", "relationColor": "springGreen", "target": "443"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1354", "source": "1202", "label": "has_target", "relationColor": "navy", "target": "604"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1355", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1203"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1356", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1204"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1357", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1205"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1358", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1206"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1359", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1207"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1360", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "664"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1361", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1208"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1362", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1209"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1363", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1210"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1364", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1211"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1365", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "512"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1366", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "867"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1367", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1212"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1368", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1213"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1369", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "513"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1370", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1214"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1371", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1215"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1372", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1216"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1373", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "900"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1374", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1217"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1375", "source": "604", "label": "participates_in", "relationColor": "teal", "target": "1218"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1376", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1219"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1377", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1220"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1378", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1221"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1379", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1222"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1380", "source": "604", "label": "published_in", "relationColor": "orange", "target": "227"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1381", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1223"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1382", "source": "604", "label": "published_in", "relationColor": "orange", "target": "29"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1383", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1224"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1384", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1225"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1385", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1226"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1386", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1227"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1387", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1228"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1388", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1229"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1389", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1230"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1390", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1231"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1391", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1232"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1392", "source": "604", "label": "published_in", "relationColor": "orange", "target": "80"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1393", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1233"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1394", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1234"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1395", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1235"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1396", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1236"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1397", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1237"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1398", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1238"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1399", "source": "604", "label": "published_in", "relationColor": "orange", "target": "15"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1400", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1239"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1401", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1240"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1402", "source": "604", "label": "published_in", "relationColor": "orange", "target": "58"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1403", "source": "604", "label": "published_in", "relationColor": "orange", "target": "229"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1404", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1241"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1405", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1242"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1406", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1243"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1407", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1244"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1408", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1245"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1409", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1246"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1410", "source": "604", "label": "published_in", "relationColor": "orange", "target": "605"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1411", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1247"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1412", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1248"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1413", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1249"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1414", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1250"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1415", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1251"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1416", "source": "604", "label": "published_in", "relationColor": "orange", "target": "606"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1417", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1252"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1418", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1253"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1419", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1254"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1420", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1255"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1421", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1256"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1422", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1257"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1423", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1258"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1424", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1259"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1425", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1260"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1426", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1261"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1427", "source": "604", "label": "published_in", "relationColor": "orange", "target": "230"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1428", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1262"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1429", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1263"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1430", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1264"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1431", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1265"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1432", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1266"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1433", "source": "604", "label": "published_in", "relationColor": "orange", "target": "1267"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1434", "source": "604", "label": "published_in", "relationColor": "orange", "target": "607"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1435", "source": "1268", "label": "has_target", "relationColor": "navy", "target": "609"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1436", "source": "1269", "label": "has_target", "relationColor": "navy", "target": "610"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1437", "source": "1270", "label": "has_target", "relationColor": "navy", "target": "610"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1438", "source": "1271", "label": "has_target", "relationColor": "navy", "target": "610"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1439", "source": "1272", "label": "has_target", "relationColor": "navy", "target": "613"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1440", "source": "1273", "label": "has_target", "relationColor": "navy", "target": "613"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1441", "source": "1274", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1442", "source": "1275", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1443", "source": "1276", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1444", "source": "1277", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1445", "source": "1278", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1446", "source": "1279", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1447", "source": "1280", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1448", "source": "1281", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1449", "source": "1282", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1450", "source": "1283", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1451", "source": "1284", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1452", "source": "1285", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1453", "source": "1286", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1454", "source": "1287", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1455", "source": "937", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1456", "source": "1288", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1457", "source": "1289", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1458", "source": "1290", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1459", "source": "1291", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1460", "source": "1292", "label": "has_target", "relationColor": "navy", "target": "627"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1461", "source": "634", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "1293"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1462", "source": "634", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "1294"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1463", "source": "634", "label": "is_involved_in", "relationColor": "limeGreen", "target": "1295"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1464", "source": "634", "label": "has_function", "relationColor": "purple", "target": "1296"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1465", "source": "634", "label": "has_function", "relationColor": "purple", "target": "1297"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1466", "source": "634", "label": "has_function", "relationColor": "purple", "target": "1298"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1467", "source": "634", "label": "has_function", "relationColor": "purple", "target": "1299"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1468", "source": "634", "label": "has_function", "relationColor": "purple", "target": "945"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1469", "source": "634", "label": "has_function", "relationColor": "purple", "target": "951"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1470", "source": "634", "label": "has_function", "relationColor": "purple", "target": "949"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1471", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1472", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1473", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "447"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1474", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "1095"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1475", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "1300"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1476", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "1301"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1477", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "442"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1478", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "448"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1479", "source": "634", "label": "located_in", "relationColor": "springGreen", "target": "1302"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1480", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1303"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1481", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1304"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1482", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1305"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1483", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1306"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1484", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1307"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1485", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "111"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1486", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1308"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1487", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1005"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1488", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1309"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1489", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1310"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1490", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1311"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1491", "source": "634", "label": "participates_in", "relationColor": "teal", "target": "1312"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1492", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1313"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1493", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1314"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1494", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1315"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1495", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1316"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1496", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1317"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1497", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1318"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1498", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1319"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1499", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1320"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1500", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1321"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1501", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1322"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1502", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1323"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1503", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1324"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1504", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1325"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1505", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1326"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1506", "source": "634", "label": "published_in", "relationColor": "orange", "target": "345"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1507", "source": "634", "label": "published_in", "relationColor": "orange", "target": "346"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1508", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1327"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1509", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1328"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1510", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1329"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1511", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1330"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1512", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1331"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1513", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1332"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1514", "source": "634", "label": "published_in", "relationColor": "orange", "target": "1333"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1515", "source": "636", "label": "part_of_catalyzing_class", "relationColor": "pink", "target": "1089"} , "group": "edges"} , { "data": { "relationDisplay": "element", "relationSize": "3px", "id": "e1516", "source": "636", "label": "is_involved_in", "relationColor": "limeGreen", "target": "1334"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1517", "source": "636", "label": "has_function", "relationColor": "purple", "target": "1092"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1518", "source": "636", "label": "has_function", "relationColor": "purple", "target": "1094"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1519", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "453"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1520", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1335"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1521", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "447"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1522", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "97"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1523", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "98"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1524", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1095"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1525", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1100"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1526", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "652"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1527", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1104"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1528", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1336"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1529", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "655"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1530", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1098"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1531", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "443"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1532", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1097"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1533", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1103"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1534", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1337"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1535", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "846"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1536", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "88"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1537", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "653"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1538", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1105"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1539", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1102"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1540", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "847"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1541", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "648"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1542", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "91"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1543", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "1099"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1544", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "450"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1545", "source": "636", "label": "located_in", "relationColor": "springGreen", "target": "430"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1546", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1114"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1547", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1137"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1548", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "684"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1549", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1153"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1550", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1338"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1551", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1339"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1552", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "680"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1553", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1156"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1554", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1340"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1555", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1122"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1556", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1121"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1557", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1341"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1558", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1124"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1559", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1342"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1560", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1107"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1561", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1108"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1562", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "867"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1563", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "512"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1564", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1343"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1565", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1152"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1566", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1138"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1567", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "879"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1568", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1344"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1569", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1141"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1570", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1118"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1571", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1143"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1572", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1140"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1573", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1345"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1574", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1157"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1575", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1346"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1576", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1347"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1577", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1132"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1578", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1159"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1579", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1133"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1580", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1127"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1581", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "502"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1582", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1348"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1583", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1349"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1584", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "1204"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1585", "source": "636", "label": "participates_in", "relationColor": "teal", "target": "467"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1586", "source": "636", "label": "published_in", "relationColor": "orange", "target": "584"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1587", "source": "636", "label": "published_in", "relationColor": "orange", "target": "64"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1588", "source": "636", "label": "published_in", "relationColor": "orange", "target": "588"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1589", "source": "636", "label": "published_in", "relationColor": "orange", "target": "591"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1590", "source": "636", "label": "published_in", "relationColor": "orange", "target": "1350"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1591", "source": "636", "label": "published_in", "relationColor": "orange", "target": "600"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1592", "source": "636", "label": "published_in", "relationColor": "orange", "target": "587"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1593", "source": "636", "label": "published_in", "relationColor": "orange", "target": "68"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1594", "source": "636", "label": "published_in", "relationColor": "orange", "target": "1351"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1595", "source": "636", "label": "published_in", "relationColor": "orange", "target": "602"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1596", "source": "636", "label": "published_in", "relationColor": "orange", "target": "586"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1597", "source": "636", "label": "published_in", "relationColor": "orange", "target": "593"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1598", "source": "636", "label": "published_in", "relationColor": "orange", "target": "596"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1599", "source": "636", "label": "published_in", "relationColor": "orange", "target": "599"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1600", "source": "636", "label": "published_in", "relationColor": "orange", "target": "83"} , "group": "edges"} , { "data": { "relationDisplay": "none", "relationSize": "1px", "id": "e1601", "source": "636", "label": "published_in", "relationColor": "orange", "target": "80"} , "group": "edges"} ]};

var allGraphData= { "ondexmetadata": { "graphName": "FilteredGraphUnconnected", "concepts": [{ "annotation": "Created:  1989-07-01; Modified:  2016-01-20; Version:  221", "conames": [{ "name": "Neurofibrillary tangle protein", "isPreferred": "false"} , { "name": "PHF-tau", "isPreferred": "false"} , { "name": "TAU", "isPreferred": "false"} , { "name": "MAPT", "isPreferred": "false"} , { "name": "MTBT1", "isPreferred": "false"} , { "name": "Microtubule-associated protein tau", "isPreferred": "true"} , { "name": "Paired helical filament-tau", "isPreferred": "false"} , { "name": "MAPTL", "isPreferred": "false"} ], "elementOf": "DrugBank: ENSEMBL: IntAct_AD: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "P10636", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "108"} ], "id": "1", "contexts": { "context": { "id": 17} } , "evidences": ["Imported from database"], "value": "Microtubule-associated protein tau", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENSP00000481769"} , { "elementOf": "ENSEMBL", "accession": "ENST00000334239"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000477703"} , { "elementOf": "ENSEMBL", "accession": "ENST00000622106"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000483784"} , { "elementOf": "ENSEMBL", "accession": "ENST00000613360"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000458742"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000334886"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000389250"} , { "elementOf": "ENSEMBL", "accession": "ENST00000340799"} , { "elementOf": "ENSEMBL", "accession": "ENST00000612872"} , { "elementOf": "ENSEMBL", "accession": "ENST00000431008"} , { "elementOf": "ENSEMBL", "accession": "ENST00000262410"} , { "elementOf": "ENSEMBL", "accession": "ENST00000574436"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000410838"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000478602"} , { "elementOf": "ENSEMBL", "accession": "ENST00000420682"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000484321"} , { "elementOf": "ENSEMBL", "accession": "ENST00000351559"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000479142"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000487837"} , { "elementOf": "ENSEMBL", "accession": "ENST00000621329"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000303214"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000488245"} , { "elementOf": "ENSEMBL", "accession": "ENST00000626571"} , { "elementOf": "ENSEMBL", "accession": "ENST00000631447"} , { "elementOf": "ENSEMBL", "accession": "ENST00000628393"} , { "elementOf": "ENSEMBL", "accession": "ENST00000620070"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000186868"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000460965"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000276155"} , { "elementOf": "ENSEMBL", "accession": "ENST00000620981"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000486039"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000413056"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000443028"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000340438"} , { "elementOf": "ENSEMBL", "accession": "ENST00000622728"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000262410"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000484491"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000488373"} , { "elementOf": "ENSEMBL", "accession": "ENST00000415613"} , { "elementOf": "ENSEMBL", "accession": "ENST00000634049"} , { "elementOf": "ENSEMBL", "accession": "ENST00000632500"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000340820"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000408975"} , { "elementOf": "ENSEMBL", "accession": "ENST00000344290"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000487819"} , { "elementOf": "UNIPROTKB", "accession": "P10636"} , { "elementOf": "ENSEMBL", "accession": "ENST00000571987"} , { "elementOf": "ENSEMBL", "accession": "ENST00000535772"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000277956"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000487570"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000482244"} , { "elementOf": "ENSEMBL", "accession": "ENST00000446361"} , { "elementOf": "ENSEMBL", "accession": "ENST00000633047"} , { "elementOf": "ENSEMBL", "accession": "ENST00000620818"} ]} , { "annotation": "[FUNCTION]", "conames": [{ "name": "PMID: 20949042", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20949042", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PloS one"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.1 protein kinase C zeta,  Nerve Tissue Proteins,  EC 2.7.1.- STK24 protein,  human,  EC 2.7.11.13 Protein Kinase C]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity."} , { "attrname": "Abstract", "value": "Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  however,  the underlying pathogenic mechanisms are poorly understood. Several in vitro studies have shown that the most frequent mutation,  LRRK2(G2019S),  increases kinase activity and impairs neuronal survival. LRRK2 has been linked to the mitogen-activated protein kinase kinase kinase family and the receptor-interacting protein kinases based on sequence similarity within the kinase domain and in vitro substrate phosphorylation. We used an unbiased proteomic approach to identify the kinase signaling pathways wherein LRRK2 may be active. By incubation of protein microarrays containing 260 signal transduction proteins we detected four arrayed Ste20 serine\/threonine kinase family members (TAOK3,  STK3,  STK24,  STK25) as novel LRRK2 substrates and LRRK2 interacting proteins,  respectively. Moreover,  we found that protein kinase C (PKC) zeta binds and phosphorylates LRRK2 both in vitro and in vivo. Ste20 kinases and PKC zeta contribute to neuronal Tau phosphorylation,  neurite outgrowth and synaptic plasticity under physiological conditions. Our data suggest that these kinases may also be involved in synaptic dysfunction and neurite fragmentation in transgenic mice and in human PD patients carrying toxic gain-of-function LRRK2 mutations. "} , { "attrname": "MeSH", "value": "[Phosphorylation,  Immunoprecipitation,  Signal Transduction,  Electrophoresis,  Polyacrylamide Gel,  Humans,  Mice,  Inbred C57BL,  Protein-Serine-Threonine Kinases,  Mice,  Transgenic,  Nerve Tissue Proteins,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Animals,  Proteomics,  Protein Array Analysis,  Mice,  Mutation,  Protein Kinase C]"} , { "attrname": "AUTHORS", "value": "[Susanne Zach,  Sandra Felk,  Frank Gillardon]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION]"} ], "id": "2", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20949042", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PONE.0013191"} , { "elementOf": "NLM", "accession": "20949042"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-214 BY SGK1,  INTERACTION WITH SGK1]", "conames": [{ "name": "PMID: 16982696", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16982696", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular and cellular biology"} , { "attrname": "Chemical", "value": "[Immediate-Early Proteins,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  452VLY9402 Serine,  EC 2.7.11.1 serum-glucocorticoid regulated kinase,  tau Proteins]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Serum- and glucocorticoid-inducible kinase 1 (SGK1) increases neurite formation through microtubule depolymerization by SGK1 and by SGK1 phosphorylation of tau."} , { "attrname": "Abstract", "value": "Serum- and glucocorticoid-inducible kinase 1 (SGK1) is a member of the Ser\/Thr protein kinase family that regulates a variety of cell functions. Recently,  SGK1 was shown to increase dendritic growth but the mechanism underlying the increase is unknown. Here we demonstrated that SGK1 increased the neurite formation of cultured hippocampal neurons through microtubule (MT) depolymerization via two distinct mechanisms. First,  SGK1 directly depolymerized MTs. In vitro MT depolymerization experiments revealed that SGK1,  especially N-truncated SGK1,  directly disassembled self-polymerized MTs and taxol-stabilized MTs in a dose-dependent and ATP-independent manner. The transfection of sgk1 to HeLa cells also inhibited MT assembly in vivo. Second,  SGK1 indirectly depolymerized MTs through the phosphorylation of tau at Ser214. An in vitro kinase assay revealed that active SGK1 phosphorylated tau Ser214 specifically. In vivo transfection of sgk1 also phosphorylated tau Ser214 in HEK293T cells and hippocampal neurons. Further,  sgk1 transfection significantly increased the number of primary neurites and shortened the length of the total process in cultured hippocampal neurons. These effects were antagonized by the cotransfection of the tauS214A mutant plasmid. Dexamethasone,  a synthetic glucocorticoid,  mimics the effect of sgk1 overexpression. Together,  these results suggest that SGK1 enhances neurite formation through MT depolymerization by a direct action of SGK1 and by the SGK1 phosphorylation of tau. "} , { "attrname": "MeSH", "value": "[Neurites,  Phosphorylation,  Neurons,  Protein-Serine-Threonine Kinases,  Serine,  Cells,  Cultured,  Rats,  Rats,  Sprague-Dawley,  tau Proteins,  Immediate-Early Proteins,  Animals,  Transfection,  Microtubules,  Female,  Hippocampus]"} , { "attrname": "AUTHORS", "value": "[Ying C Yang,  Cheng H Lin,  Eminy H Y Lee]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-214 BY SGK1,  INTERACTION WITH SGK1]"} ], "id": "3", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16982696", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16982696"} , { "elementOf": "DOI", "accession": "10.1128\/MCB.01017-06"} ]} , { "annotation": "[INTERACTION WITH VDAC1]", "conames": [{ "name": "PMID: 25168729", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "25168729", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience"} , { "attrname": "Chemical", "value": "[EC 1.6.- Voltage-Dependent Anion Channel 1,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  VDAC1 protein,  human]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "A? promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Voltage-dependent anion channel (VDAC) is a mitochondrial protein abundantly found in neuronal lipid rafts. In these membrane domains,  VDAC is associated with a complex of signaling proteins that trigger neuroprotective responses. Loss of lipid raft integrity may result in disruption of multicomplex association and alteration of signaling responses that may ultimately promote VDAC activation. Some data have demonstrated that VDAC at the neuronal membrane may be involved in the mechanisms of amyloid beta (A?)-induced neurotoxicity,  through yet unknown mechanisms. A? is generated from amyloid precursor protein (APP),  and is released to the extracellular space where it may undergo self-aggregation. A? aggregate deposition in the form of senile plaques may lead to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) neuropathology,  although other pathological hallmarks (such as hyper-phosphorylated Tau deposition) also participate in this neurodegenerative process. The present study demonstrates that VDAC1 associates with APP and A? in lipid rafts of neurons. Interaction of VDAC1 with APP was observed in lipid rafts from the frontal and entorhinal cortex of human brains affected by AD at early stages (I-IV\/0-B of Braak and Braak). Furthermore,  A? exposure enhanced the dephosphorylation of VDAC1 that correlated with cell death. Both effects were reverted in the presence of tyrosine phosphatase inhibitors. VDAC1 dephosphorylation was corroborated in lipid rafts of AD brains. These results demonstrate that A? is involved in alterations of the phosphorylation state of VDAC in neuronal lipid rafts. Modulation of this channel may contribute to the development and progression of AD pathology. "} , { "attrname": "MeSH", "value": "[Membrane Microdomains,  Brain,  Phosphorylation,  Neurons,  Humans,  Amyloid beta-Peptides,  Cells,  Cultured,  Cell Line,  Tumor,  Voltage-Dependent Anion Channel 1,  Neuroblastoma,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[C Fernandez-Echevarria,  M Daz,  I Ferrer,  A Canerina-Amaro,  R Marin]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH VDAC1]"} ], "id": "4", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 25168729", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "25168729"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEUROSCIENCE.2014.07.079"} ]} , { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK8 GLY-1441; CYS-1699; SER-2019 AND THR-2020,  VARIANT MET-1906]", "conames": [{ "name": "PMID: 17114044", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17114044", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Lrrk2 protein,  mouse,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  tau Proteins]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "The familial Parkinsonism gene LRRK2 regulates neurite process morphology."} , { "attrname": "Abstract", "value": "Mutations in LRRK2 underlie an autosomal-dominant,  inherited form of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) that mimics the clinical features of the common \"sporadic\" form of PD. The LRRK2 protein includes putative GTPase,  protein kinase,  WD40 repeat,  and leucine-rich repeat (LRR) domains of unknown function. Here we show that PD-associated LRRK2 mutations display disinhibited kinase activity and induce a progressive reduction in neurite length and branching both in primary neuronal cultures and in the intact rodent CNS. In contrast,  LRRK2 deficiency leads to increased neurite length and branching. Neurons that express PD-associated LRRK2 mutations additionally harbor prominent phospho-tau-positive inclusions with lysosomal characteristics and ultimately undergo apoptosis. "} , { "attrname": "MeSH", "value": "[Animals,  Newborn,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Brain,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Neurites,  Substantia Nigra,  Humans,  Protein-Serine-Threonine Kinases,  Cells,  Cultured,  Lysosomes,  Rats,  Rats,  Sprague-Dawley,  tau Proteins,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Animals,  Inclusion Bodies,  Cell Shape,  Mice,  Mutation,  Nerve Degeneration,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[David MacLeod,  Julia Dowman,  Rachel Hammond,  Thomas Leete,  Keiichi Inoue,  Asa Abeliovich]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK8 GLY-1441; CYS-1699; SER-2019 AND THR-2020,  VARIANT MET-1906]"} ], "id": "5", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17114044", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.NEURON.2006.10.008"} , { "elementOf": "NLM", "accession": "17114044"} ]} , { "annotation": "[VARIANT FTD SER-618]", "conames": [{ "name": "PMID: 10553987", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10553987", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Microtubule-Associated Proteins,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "FTDP-17:  an early-onset phenotype with <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism and epileptic seizures caused by a novel mutation."} , { "attrname": "Abstract", "value": "Recently,  mutations in the tau gene on chromosome 17 were found causative for autosomal dominantly inherited frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (FTDP-17). We describe a family carrying a missense mutation at nucleotide 1137 C --> T,  resulting in the amino acid substitution P301S. Methods of investigations include clinical,  electrophysiological,  and imaging techniques. This kindred presents with a novel phenotype characterized by an early onset of rapidly progressive frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism in combination with epileptic seizures. We define the dopaminergic deficits as being predominantly presynaptic by the use of single-photon emission computed tomography with a dopamine transporter ligand. The association of this early-onset phenotype with P301S mutation is not entirely consistent with current criteria for the diagnosis of frontotemporal dementias and may encourage the search for tau mutations in <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s similar but not identical to FTDP-17. Also,  the change from proline to serine suggests that this mutation might contribute to tau hyperphosphorylation. "} , { "attrname": "MeSH", "value": "[Brain,  Epilepsy,  Humans,  Middle Aged,  Tomography,  Emission-Computed,  Single-Photon,  Child,  Preschool,  Male,  Electroencephalography,  Mutation,  Missense,  tau Proteins,  Adult,  Female,  Child,  Infant,  Newborn,  Microtubule-Associated Proteins,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Progression,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Magnetic Resonance Imaging,  Phenotype,  Frontal Lobe,  Temporal Lobe,  Chromosomes,  Human,  Pair 17,  Pedigree,  Age of Onset,  Aged,  Amino Acid Substitution,  Dementia]"} , { "attrname": "AUTHORS", "value": "[A D Sperfeld,  M B Collatz,  H Baier,  M Palmbach,  A Storch,  J Schwarz,  K Tatsch,  S Reske,  M Joosse,  P Heutink,  A C Ludolph]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD SER-618]"} ], "id": "6", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10553987", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10553987"} , { "elementOf": "DOI", "accession": "10.1002\/1531-8249(199911)46: 5<708: : AID-ANA5>3.0.CO;2-K"} ]} , { "annotation": "[GLYCOSYLATION,  PHOSPHORYLATION AT SER-516; SER-519; THR-522; THR-529; SER-531; THR-534; SER-579; SER-713; SER-721 AND SER-739,  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE]", "conames": [{ "name": "PMID: 19451179", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19451179", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Brain :  a journal of neurology"} , { "attrname": "Chemical", "value": "[IY9XDZ35W2 Glucose,  EC 2.4.1.- N-Acetylglucosaminyltransferases,  Hexosamines,  EC 2.4.1.- UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase,  tau Proteins,  EC 3.1.3.16 Protein Phosphatase 2]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "It has been established for a long time that brain glucose metabolism is impaired in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Recent studies have demonstrated that impaired brain glucose metabolism precedes the appearance of clinical symptoms,  implying its active role in the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. However,  the molecular mechanism by which this impairment contributes to the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is not known. In this study,  we demonstrated that protein O-GlcNAcylation,  a common post-translational modification of nucleocytoplasmic proteins with beta-N-acetyl-glucosamine and a process regulated by glucose metabolism,  was markedly decreased in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cerebrum. More importantly,  the decrease in O-GlcNAc correlated negatively with phosphorylation at most phosphorylation sites of tau protein,  which is known to play a crucial role in the neurofibrillary degeneration of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We also found that hyperphosphorylated tau contained 4-fold less O-GlcNAc than non-hyperphosphorylated tau,  demonstrating for the first time an inverse relationship between O-GlcNAcylation and phosphorylation of tau in the human brain. Downregulation of O-GlcNAcylation by knockdown of O-GlcNAc transferase with small hairpin RNA led to increased phosphorylation of tau in HEK-293 cells. Inhibition of the hexosamine biosynthesis pathway in rat brain resulted in decreased O-GlcNAcylation and increased phosphorylation of tau,  which resembled changes of O-GlcNAcylation and phosphorylation of tau in rodent brains with decreased glucose metabolism induced by fasting,  but not those in rat brains when protein phosphatase 2A was inhibited. Comparison of tau phosphorylation patterns under various conditions suggests that abnormal tau hyperphosphorylation in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain may result from downregulation of both O-GlcNAcylation and protein phosphatase 2A. These findings suggest that impaired brain glucose metabolism leads to abnormal hyperphosphorylation of tau and neurofibrillary degeneration via downregulation of tau O-GlcNAcylation in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Thus,  restoration of brain tau O-GlcNAcylation and protein phosphatase 2A activity may offer promising therapeutic targets for treating <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Brain,  Phosphorylation,  Down-Regulation,  Humans,  Cells,  Cultured,  Male,  N-Acetylglucosaminyltransferases,  Glucose,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Aged,  80 and over,  Hexosamines,  Female,  Protein Phosphatase 2]"} , { "attrname": "AUTHORS", "value": "[Fei Liu,  Jianhua Shi,  Hitoshi Tanimukai,  Jinhua Gu,  Jianlan Gu,  Inge Grundke-Iqbal,  Khalid Iqbal,  Cheng-Xin Gong]"} , { "attrname": "PUB_TYPE", "value": "[GLYCOSYLATION,  PHOSPHORYLATION AT SER-516; SER-519; THR-522; THR-529; SER-531; THR-534; SER-579; SER-713; SER-721 AND SER-739,  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]"} ], "id": "7", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19451179", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19451179"} , { "elementOf": "DOI", "accession": "10.1093\/BRAIN\/AWP099"} ]} , { "annotation": "[VARIANT AD3 VAL-271]", "conames": [{ "name": "PMID: 12493737", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12493737", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 2.7.11.1 GSK3B protein,  human,  EC 2.7.11.1 Glycogen Synthase Kinase 3 beta,  Presenilin-1,  Protein Isoforms,  Amyloid beta-Peptides,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Presenilin-1 mutation L271V results in altered exon 8 splicing and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with non-cored plaques and no neuritic dystrophy."} , { "attrname": "Abstract", "value": "The mutation L271V in exon 8 of the presenilin-1 (PS-1) gene was detected in an <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pedigree. Neuropathological examination of affected individuals identified variant,  large,  non-cored plaques without neuritic dystrophy,  reminiscent of cotton wool plaques. Biochemical analysis of L271V mutation showed that it increased secretion of the 42-amino acid amyloid-beta peptide,  suggesting a pathogenic mutation. Analysis of PS-1 transcripts from the brains of two mutation carriers revealed a 17-50% increase in PS-1 transcripts with deletion of exon 8 (PS-1deltaexon8) compared with unrelated <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains. Exon trapping analysis confirmed that L271V mutation enhanced the deletion of exon 8. Western blots of brain lysates indicated that PS-1deltaexon8 was overexpressed in an affected individual. Biochemical analysis of PS-1deltaexon8 in COS and BD8 cells indicate the splice isoform is not intrinsically active but interacts with wild-type PS-1 to generate amyloid-beta. Western blots of cell lysates immunoprecipitated with anti-Tau or anti-GSK-3beta antibodies indicated that PS-1deltaexon8,  unlike wild-type PS-1,  does not interact directly with Tau or GSK-3beta,  potential modifiers of neuritic dystrophy. We postulate that variant plaques observed in this family are due in part to the effects of PS-1deltaexon8 and that interaction between PS-1 and various protein complexes are necessary for neuritic plaque formation. "} , { "attrname": "MeSH", "value": "[Brain,  Presenilin-1,  Exons,  Humans,  Middle Aged,  Glycogen Synthase Kinase 3,  Glycogen Synthase Kinase 3 beta,  Male,  RNA Splicing,  Transfection,  Genes,  Dominant,  Gene Deletion,  Mass Spectrometry,  Amyloid beta-Peptides,  Adult,  Female,  Neurons,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Reverse Transcriptase Polymerase Chain Reaction,  Blotting,  Western,  Precipitin Tests,  Membrane Proteins,  Animals,  Pedigree,  Plasmids,  Protein Isoforms,  Aged,  Mutation,  COS Cells,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[John B J Kwok,  Glenda M Halliday,  William S Brooks,  Georgia Dolios,  Hanna Laudon,  Ohoshi Murayama,  Marianne Hallupp,  Renee F Badenhop,  James Vickers,  Rong Wang,  Jan Naslund,  Akihiko Takashima,  Samuel E Gandy,  Peter R Schofield]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 VAL-271]"} ], "id": "8", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12493737", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M211827200"} , { "elementOf": "NLM", "accession": "12493737"} ]} , { "annotation": "[REVIEW ON VARIANTS];", "conames": [{ "name": "PMID: 10899436", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10899436", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochimica et biophysica acta"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Phosphoproteins,  Protein Isoforms,  Microtubule-Associated Proteins,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is characterised by the degeneration of selected populations of nerve cells that develop filamentous inclusions prior to degeneration. The neuronal inclusions of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> are made of the microtubule-associated protein tau,  in a hyperphosphorylated state. Abundant filamentous tau inclusions are not limited to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. They are the defining neuropathological characteristic of frontotemporal dementias,  such as Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and of progressive supranuclear palsy and corticobasal degeneration. The discovery of mutations in the tau gene in familial frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17 (FTDP-17) has provided a direct link between tau dysfunction and dementing <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Known mutations produce either a reduced ability of tau to interact with microtubules,  or an overproduction of tau isoforms with four microtubule-binding repeats. This leads in turn to the assembly of tau into filaments similar or identical to those found in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain. Several missense mutations also have a stimulatory effect on <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-induced tau filament formation. Assembly of tau into filaments may be the gain of toxic function that is believed to underlie the demise of affected brain cells. "} , { "attrname": "MeSH", "value": "[Brain,  Exons,  Introns,  Humans,  Microtubule-Associated Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Phosphoproteins,  Microtubules,  Protein Isoforms,  Age of Onset,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[M Goedert,  M G Spillantini]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "9", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10899436", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0925-4439(00)00037-5"} , { "elementOf": "NLM", "accession": "10899436"} ]} , { "annotation": "[VARIANTS PIDB THR-574 AND ARG-706,  CHARACTERIZATION OF VARIANTS PIDB THR-574 AND ARG-706]", "conames": [{ "name": "PMID: 11117542", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11117542", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Pick's disease is associated with mutations in the tau gene."} , { "attrname": "Abstract", "value": "Recently,  mutations within the tau gene have been associated with some familial forms of frontotemporal dementia. To investigate whether tau gene mutations are also associated with Pick's disease,  we analyzed the tau gene in 30 cases of pathologically confirmed Pick's disease. Two coding mutations were identified in separate cases of Pick's disease. A glycine-to-arginine mutation at codon 389 was detected in 1 case and a lysine-to-threonine mutation at codon 257 was identified in another. Analysis of dephosphorylated tau from the brain of the patient with the codon 389 mutation revealed a prominent band representing tau,  with four microtubule-binding domains and no amino terminal inserts. This is in contrast to Pick's disease without any tau gene mutations,  which consist of tau with mainly three microtubule-binding domains and only a trace of tau,  with four microtubule-binding domains. Functional analysis of tau with these two mutations demonstrated a reduced ability of tau to promote microtubule assembly. Surprisingly,  these mutations increased tau's susceptibility to calpain I digestion,  suggesting that this feature may be related to the formation of a Pick type of histology. Moreover,  these data suggest that Pick's disease is not a separate entity but part of the frontotemporal dementia disease spectrum. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Humans,  Pick Disease of the Brain,  Adult,  Female,  Mutation,  Missense,  tau Proteins,  Dementia]"} , { "attrname": "AUTHORS", "value": "[S Pickering-Brown,  M Baker,  S H Yen,  W K Liu,  M Hasegawa,  N Cairns,  P L Lantos,  M Rossor,  T Iwatsubo,  Y Davies,  D Allsop,  R Furlong,  F Owen,  J Hardy,  D Mann,  M Hutton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PIDB THR-574 AND ARG-706,  CHARACTERIZATION OF VARIANTS PIDB THR-574 AND ARG-706]"} ], "id": "10", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11117542", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/1531-8249(200012)48: 6<859: : AID-ANA6>3.3.CO;2-T"} , { "elementOf": "NLM", "accession": "11117542"} ]} , { "annotation": "[VARIANTS MET-17; ALA-30 AND ILE-617]", "conames": [{ "name": "PMID: 20020531", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20020531", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  GRN protein,  human,  Intercellular Signaling Peptides and Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "A thorough assessment of benign genetic variability in GRN and MAPT."} , { "attrname": "Abstract", "value": "Mutations in APP,  PSEN1,  MAPTand GRNare the most common genetic causes of dementia. The previous miss-assignment of pathogenicity to benign variants in these genes stresses the importance of discerning between disease causing mutations and benign variants with no pathogenic effect on the function of the respective protein. In this study we sequenced GRNand MAPTin 282 samples from the Centre d'Etude du Polymorphisme Humain - Human Genome Diversity Cell Line Panel,  in order to identify benign variants that could otherwise be mistaken for pathogenic mutations. We found sixteen different non-synonymous changes,  eleven of which are novel variants. "} , { "attrname": "MeSH", "value": "[Genetic Variation,  Protein Structure,  Tertiary,  Amino Acid Sequence,  Sequence Alignment,  Exons,  Humans,  Intercellular Signaling Peptides and Proteins,  Open Reading Frames,  Molecular Sequence Data,  tau Proteins,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Rita J Guerreiro,  Nicole Washecka,  John Hardy,  Andrew Singleton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS MET-17; ALA-30 AND ILE-617]"} ], "id": "11", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20020531", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20020531"} , { "elementOf": "DOI", "accession": "10.1002\/HUMU.21152"} ]} , { "annotation": "[VARIANT CAA-APP LYS-693]", "conames": [{ "name": "PMID: 20697050", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20697050", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[Apolipoprotein E4,  amyloid beta-protein (1-40),  Peptide Fragments,  amyloid beta-protein (1-42),  3KX376GY7L Glutamic Acid,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP."} , { "attrname": "Abstract", "value": "To report the clinical,  genetic,  neuroimaging,  and neuropathologic studies of patients with the hereditary cerebral hemorrhage with amyloidosis linked to the APP E693K mutation. Case series. Clinical details and laboratory results were collected by direct evaluation and previous medical records. DNA analysis was carried out in several affected subjects and healthy individuals. Neuropathologic examination was performed in 2 subjects. Southern Lombardy,  Italy. Patients Individuals with and without amyloidosis in 4 unrelated Italian families (N = 37). Main Outcome Measure Genotype-phenotype relationship. The affected individuals presented with recurrent headache and multiple strokes,  followed by epilepsy and cognitive decline in most of them. The disease was inherited with an autosomal dominant trait and segregated with the APP E693K mutation. Neuroimaging demonstrated small to large hematomas,  subarachnoid bleeding,  scars with hemosiderin deposits,  small infarcts,  and leukoaraiosis. Amyloid-beta immunoreactivity was detected in the wall of leptomeningeal and parenchymal vessels and in the neuropil,  whereas phosphorylated tau,  neurofibrillary changes,  and neuritic plaques were absent. These findings expand the number of APP mutations linked to hereditary cerebral hemorrhage with amyloidosis,  reinforcing the link between this phenotype and codon 693 of APP. "} , { "attrname": "MeSH", "value": "[Apolipoprotein E4,  Genetic Predisposition to Disease,  Genome-Wide Association Study,  Peptide Fragments,  Cerebral Hemorrhage,  Gene Frequency,  Humans,  Middle Aged,  Family Health,  Genotype,  Male,  Glutamic Acid,  Magnetic Resonance Imaging,  Amyloidosis,  Familial,  Lysine,  Amyloid beta-Peptides,  Female,  Italy,  Aged,  Mutation,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Orso Bugiani,  Giorgio Giaccone,  Giacomina Rossi,  Michela Mangieri,  Raffaella Capobianco,  Michela Morbin,  Giulia Mazzoleni,  Chiara Cupidi,  Gabriella Marcon,  Annarita Giovagnoli,  Alberto Bizzi,  Giuseppe Di Fede,  Gianfranco Puoti,  Francesco Carella,  Andrea Salmaggi,  Alessandro Romorini,  Giorgio M Patruno,  Mauro Magoni,  Alessandro Padovani,  Fabrizio Tagliavini]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CAA-APP LYS-693]"} ], "id": "12", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20697050", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20697050"} , { "elementOf": "DOI", "accession": "10.1001\/ARCHNEUROL.2010.178"} ]} , { "annotation": "[INTERACTION WITH LRRK2]", "conames": [{ "name": "PMID: 16352719", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16352719", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin,  and mutant LRRK2 induces neuronal degeneration."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a disorder of movement,  cognition,  and emotion,  and it is characterized pathologically by neuronal degeneration with Lewy bodies,  which are cytoplasmic inclusion bodies containing deposits of aggregated proteins. Most PD cases appear to be sporadic,  but genetic forms of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  caused by mutations in alpha-synuclein,  parkin,  and other genes,  have helped elucidate pathogenesis. Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism with clinical features of PD and with pleomorphic pathology including deposits of aggregated protein. To study expression and interactions of LRRK2,  we synthesized cDNAs and generated expression constructs coding for human WT and mutant LRRK2 proteins. Expression of full-length LRRK2 in cells in culture suggests that the protein is predominately cytoplasmic,  as is endogenous protein by subcellular fractionation. Using coimmunoprecipitation,  we find that LRRK2,  expressed in cells in culture,  interacts with parkin but not with alpha-synuclein,  DJ-1,  or tau. A small proportion of the cells overexpressing LRRK2 contain protein aggregates,  and this proportion is greatly increased by coexpression of parkin. In addition,  parkin increases ubiquitination of aggregated protein. Also,  mutant LRRK2 causes neuronal degeneration in both SH-SY5Y cells and primary neurons. This cell model may be useful for studies of PD cellular pathogenesis and therapeutics. These findings suggest a gain-of-function mechanism in the pathogenesis of LRRK2-linked PD and suggest that LRRK2 may be involved in a pathogenic pathway with other PD-related proteins such as parkin,  which may help illuminate both familial and sporadic PD. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Ubiquitin-Protein Ligases,  Cell Line,  Humans,  Protein-Serine-Threonine Kinases,  Protein Binding,  Mutation,  Nerve Degeneration,  Cytoplasm,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Wanli W Smith,  Zhong Pei,  Haibing Jiang,  Darren J Moore,  Yideng Liang,  Andrew B West,  Valina L Dawson,  Ted M Dawson,  Christopher A Ross]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH LRRK2]"} ], "id": "13", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16352719", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0508052102"} , { "elementOf": "NLM", "accession": "16352719"} ]} , { "annotation": "[VARIANT PIDB ILE-686,  CHARACTERIZATION OF VARIANT PIDB ILE-686]", "conames": [{ "name": "PMID: 11601501", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11601501", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Pick's disease associated with the novel Tau gene mutation K369I."} , { "attrname": "Abstract", "value": "Exonic and intronic mutations in Tau cause neurodegenerative syndromes characterized by frontotemporal dementia and filamentous tau protein deposits. We describe a K369I missense mutation in exon 12 of Tau in a patient with a pathology typical of sporadic Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The proband presented with severe personality changes,  followed by loss of cognitive function. Detailed postmortem examination of the brain showed atrophy,  which was most pronounced in the temporal lobes; and numerous tau-immunoreactive Pick bodies and Pick cells in the neocortex and the hippocampal formation,  as well as in subcortical brain regions. Their appearance and staining characteristics were indistinguishable from those of sporadic Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. However,  immunoblot analysis of sarkosyl-insoluble tau showed three major bands of 60,  64,  and 68 kDa,  consistent with the presence of 3- and 4-repeat tau isoforms,  as in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Isolated tau filaments were irregularly twisted ribbons,  with a small number of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>-type paired helical filaments. In the presence of <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>,  tau proteins with the K369I mutation formed short,  slender filaments. Biochemically,  recombinant tau proteins with the K369I mutation showed reduced ability to promote microtubule assembly,  suggesting that this may be the primary effect of the mutation by providing a pool of aberrant tau for filament assembly. Taken together,  results indicate that the K369I mutation in Tau can cause a dementing <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a neuropathology like that of Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Humans,  Middle Aged,  Pick <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> of the Brain,  Immunoblotting,  Lateral Ventricles,  Mutation,  Missense,  Microscopy,  Electron,  tau Proteins,  Frontal Lobe,  Temporal Lobe,  DNA Mutational Analysis,  Microtubules,  Female]"} , { "attrname": "AUTHORS", "value": "[M Neumann,  W Schulz-Schaeffer,  R A Crowther,  M J Smith,  M G Spillantini,  M Goedert,  H A Kretzschmar]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PIDB ILE-686,  CHARACTERIZATION OF VARIANT PIDB ILE-686]"} ], "id": "14", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11601501", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11601501"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.1223"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 170-175,  SUBUNIT,  DOMAIN]", "conames": [{ "name": "PMID: 17468747", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17468747", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Prions,  Amyloid]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Atomic structures of amyloid cross-beta spines reveal varied steric zippers."} , { "attrname": "Abstract", "value": "Amyloid fibrils formed from different proteins,  each associated with a particular disease,  contain a common cross-beta spine. The atomic architecture of a spine,  from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35,  was recently revealed by X-ray microcrystallography. It is a pair of beta-sheets,  with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'. Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils,  microcrystals,  or usually both. These include segments from the Alzheimer's amyloid-beta and tau proteins,  the PrP prion protein,  insulin,  islet amyloid polypeptide (IAPP),  lysozyme,  myoglobin,  alpha-synuclein and beta(2)-microglobulin,  suggesting that common structural features are shared by amyloid diseases at the molecular level. Structures of 13 of these microcrystals all reveal steric zippers,  but with variations that expand the range of atomic architectures for amyloid-like fibrils and offer an atomic-level hypothesis for the basis of prion strains. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Prions,  Crystallization,  Models,  Molecular,  Protein Conformation,  Amyloid]"} , { "attrname": "AUTHORS", "value": "[Michael R Sawaya,  Shilpa Sambashivan,  Rebecca Nelson,  Magdalena I Ivanova,  Stuart A Sievers,  Marcin I Apostol,  Michael J Thompson,  Melinda Balbirnie,  Jed J W Wiltzius,  Heather T McFarlane,  Anders  Madsen,  Christian Riekel,  David Eisenberg]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 170-175,  SUBUNIT,  DOMAIN]"} ], "id": "15", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17468747", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE05695"} , { "elementOf": "NLM", "accession": "17468747"} ]} , { "annotation": "[INTERACTION WITH MAPT,  FUNCTION]", "conames": [{ "name": "PMID: 11943163", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11943163", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Peptide Fragments,  amyloid beta-protein (1-42),  EC 2.7.11.1 Cyclin-Dependent Kinase 5,  EC 2.7.11.22 tau protein kinase II,  Amyloid beta-Peptides,  Epitopes,  Recombinant Proteins,  tau Proteins,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  Macromolecular Substances]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II."} , { "attrname": "Abstract", "value": "We report here that aggregated beta-amyloid (Abeta) 1-42 promotes tau aggregation in vitro in a dose-dependent manner. When Abeta-mediated aggregated tau was used as a substrate for tau protein kinase II (TPK II),  an 8-fold increase in the rate of TPK II-mediated tau phosphorylation was observed. The extent of TPK II-dependent tau phosphorylation increased as a function of time and Abeta 1-42 concentration,  and hyperphosphorylated tau was found to be decorated with an <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-related phosphoepitope (P-Thr-231). In HEK 293 cells co-expressing CT-100 amyloid precursor protein and tau,  the release of Abeta 1-42 from these cells was impaired. Taken together,  these in vitro results suggest that Abeta 1-42 promotes both tau aggregation and hyperphosphorylation. "} , { "attrname": "MeSH", "value": "[Cell Line,  Peptide Fragments,  Phosphorylation,  Humans,  Protein-Serine-Threonine Kinases,  Solubility,  Epitopes,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Kidney,  Recombinant Fusion Proteins,  Cyclin-Dependent Kinase 5,  Macromolecular Substances,  Dose-Response Relationship,  Drug,  Animals,  Cattle,  Amyloid beta-Peptides,  Protein Binding,  Amyloid beta-Protein Precursor,  Genes,  Reporter]"} , { "attrname": "AUTHORS", "value": "[Kenneth B Rank,  Adele M Pauley,  Keshab Bhattacharya,  Zhigang Wang,  David B Evans,  Timothy J Fleck,  Jennifer A Johnston,  Satish K Sharma]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH MAPT,  FUNCTION]"} ], "id": "16", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11943163", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11943163"} , { "elementOf": "DOI", "accession": "10.1016\/S0014-5793(02)02376-1"} ]} , { "annotation": "[VARIANT PIDB THR-574]", "conames": [{ "name": "PMID: 11089577", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11089577", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuropathology and experimental neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Tau gene mutation K257T causes a tauopathy similar to Pick's disease."} , { "attrname": "Abstract", "value": "Exonic and intronic mutations in Tau cause neurodegenerative syndromes characterized by frontotemporal dementia and filamentous tau protein deposits. Here we describe a K257T missense mutation in exon 9 of Tau. The proband,  a 47-yr-old male,  presented with severe personality changes followed by semantic memory loss. A diagnosis of Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was made. The symptoms progressed until death at age 51. The proband's brain showed a marked frontotemporal atrophy that was most pronounced in the temporal lobes. Numerous tau-immunoreactive Pick bodies were present in the neocortex and the hippocampal formation,  as well as in some subcortical brain regions. Their appearance and staining characteristics were indistinguishable from those of sporadic Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Diffuse staining for hyperphosphorylated tau was also observed in some nerve cell bodies. Immunoblot analysis of sarkosyl-insoluble tau showed 2 major bands of 60 and 64 kDa and 2 very minor bands of 68 and 72 kDa. Upon dephosphorylation,  these bands resolved into 6 bands consisting of 3-repeat and 4-repeat tau isoforms,  with an overall preponderance of 3-repeat tau. Isolated tau filaments were narrow,  irregularly twisted ribbons. Biochemically,  recombinant tau proteins with the K257T mutation showed a reduced ability to promote microtubule assembly,  suggesting that this may be the primary effect of the mutation. In addition,  the K257T mutation was found to stimulate <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-induced assembly of 3-repeat tau into filaments. Taken together,  the present findings indicate that the K257T mutation in Tau can cause a dementing condition similar to Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Memory Disorders,  Frontal Lobe,  Temporal Lobe,  Humans,  Microtubules,  Middle Aged,  Pick <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> of the Brain,  Male,  Mutation,  Missense,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[C Rizzini,  M Goedert,  J R Hodges,  M J Smith,  R Jakes,  R Hills,  J H Xuereb,  R A Crowther,  M G Spillantini]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PIDB THR-574]"} ], "id": "17", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11089577", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11089577"} ]} , { "annotation": "", "conames": [{ "name": "MAPT", "isPreferred": "true"} , { "name": "ENSG00000186868", "isPreferred": "false"} ], "elementOf": "ENSEMBL: NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} , { "attrname": "flagged", "value": "true"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46028334"} , { "attrname": "BEGIN", "value": "45894382"} ], "id": "18", "contexts": { } , "evidences": ["Imported from database"], "value": "MAPT", "ofType": "Gene", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENSG00000186868"} , { "elementOf": "ENSEMBL", "accession": "MAPT"} ]} , { "annotation": "", "conames": [{ "name": "Corticotropin", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "BiotechDrug"} , { "attrname": "CitNum", "value": "2"} ], "id": "19", "contexts": { } , "evidences": ["Imported from database"], "value": "Corticotropin", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01285"} ]} , { "annotation": "", "conames": [{ "name": "<span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} , { "attrname": "CitNum", "value": "17"} ], "id": "20", "contexts": { "context": { "id": 14} } , "evidences": ["Imported from database"], "value": "<span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01109"} ]} , { "annotation": "[<span style=\"background-color: yellow\"><b>HEPARIN<\/b><\/span>-BINDING DOMAINS]", "conames": [{ "name": "PMID: 9357988", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9357988", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Recombinant Proteins,  9005-49-6 Heparin,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Expression and analysis of <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding regions of the amyloid precursor protein of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Deletion mutagenesis studies have suggested that there are two domains within APP which bind heparan sulphate. These domains have been cloned and expressed in the yeast Pichia pastoris. Both recombinant proteins bound to <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>. One domain (APP316-447) was further characterised by binding studies with peptides encompassing this region. Peptides homologous to APP316-346 and APP416-447 were found to bind <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>. Circular dichroism studies show that APP416-447 shifted towards an alpha-helical conformation in the presence of <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>. This study suggests that <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding domains may lie within regions high in alpha-helical structure. "} , { "attrname": "MeSH", "value": "[Sequence Deletion,  Gene Expression,  Peptide Fragments,  Protein Structure,  Secondary,  Escherichia coli,  Humans,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Chromatography,  Affinity,  Mutagenesis,  Cloning,  Molecular,  Protein Binding,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Binding Sites,  Circular Dichroism,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S S Mok,  G Sberna,  D Heffernan,  R Cappai,  D Galatis,  H J Clarris,  W H Sawyer,  K Beyreuther,  C L Masters,  D H Small]"} , { "attrname": "PUB_TYPE", "value": "[<span style=\"background-color: yellow\"><b>HEPARIN<\/b><\/span>-BINDING DOMAINS]"} ], "id": "21", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9357988", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0014-5793(97)01146-0"} , { "elementOf": "NLM", "accession": "9357988"} ]} , { "annotation": "[N-TERMINAL <span style=\"background-color: yellow\"><b>HEPARIN<\/b><\/span>-BINDING DOMAIN,  MUTAGENESIS OF 99-LYS--ARG-102]", "conames": [{ "name": "PMID: 8158260", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8158260", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[Proteoglycans,  Heparan Sulfate Proteoglycans,  Recombinant Proteins,  9050-30-0 Heparitin Sulfate,  DNA Primers,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "A <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding domain in the amyloid protein precursor of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is involved in the regulation of neurite outgrowth."} , { "attrname": "Abstract", "value": "The amyloid protein precursor (APP) of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is synthesized as an integral transmembrane protein that is released from cells in culture following proteolytic cleavage. The function of released APP is not known,  although there is evidence that the protein may bind to components of the extracellular matrix (ECM). In the present study,  substratum-bound APP stimulated neurite outgrowth in cultures of chick sympathetic and mouse hippocampal neurons. This effect was dependent upon the presence of substratum-bound heparan sulfate proteoglycans (HSPG). The effect of APP on neurite outgrowth was comparable to that of laminin. A 14 K N-terminal fragment of APP was found to bind <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and a region close to the N-terminus of APP (residues 96-110) identified as a potential <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding domain based on secondary structure predictions and molecular modeling. Mutagenesis of three basic residues (lysine-99,  arginine-100,  and arginine-102) resulted in a recombinant protein (APPhep) with decreased <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding capacity. A peptide homologous to the <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding domain was synthesized and found to bind strongly to <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and to inhibit binding of 125I-labeled APP to <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> (IC50 approximately 10(-7) M). The peptide blocked the effect of APP on neurite outgrowth (IC50 approximately 10(-7) M),  whereas two other peptides homologous to other domains in APP had no effect. The results indicate that the binding of APP to HSPG in the ECM may stimulate the effects of APP on neurite outgrowth. "} , { "attrname": "MeSH", "value": "[Brain,  Neurites,  Embryo,  Mammalian,  Humans,  Molecular Sequence Data,  Recombinant Proteins,  Restriction Mapping,  Ganglia,  Sympathetic,  Cattle,  Base Sequence,  Polymerase Chain Reaction,  Binding Sites,  Animals,  Newborn,  Amino Acid Sequence,  Mutagenesis,  Site-Directed,  Proteoglycans,  Neurons,  Heparitin Sulfate,  DNA Primers,  Chick Embryo,  Animals,  Chromatography,  Affinity,  Heparan Sulfate Proteoglycans,  Mice,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Amyloid beta-Protein Precursor,  Hippocampus]"} , { "attrname": "AUTHORS", "value": "[D H Small,  V Nurcombe,  G Reed,  H Clarris,  R Moir,  K Beyreuther,  C L Masters]"} , { "attrname": "PUB_TYPE", "value": "[N-TERMINAL HEPARIN-BINDING DOMAIN,  MUTAGENESIS OF 99-LYS--ARG-102]"} ], "id": "22", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8158260", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8158260"} ]} , { "annotation": "[EXTRACELLULAR COPPER-BINDING DOMAIN,  MUTAGENESIS OF HIS-137; MET-141; CYS-144; HIS-147 AND HIS-151]", "conames": [{ "name": "PMID: 7913895", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7913895", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[789U1901C5 Copper,  9012-36-6 Sepharose,  Amyloid beta-Protein Precursor,  Chelating Agents,  Recombinant Fusion Proteins]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "The beta A4 amyloid precursor protein binding to copper."} , { "attrname": "Abstract", "value": "Previously it has been shown that the extracellular domain of transmembrane beta A4 amyloid precursor protein (APP) includes binding sites for zinc(II) and for molecules of the extracellular matrix such as collagen,  laminin and the <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> sulfate chains of proteoglycans (HSPGs). Here we report that APP also binds copper ions. A copper type II binding site was located within residues 135-155 of the cysteine-rich domain of APP695 which is present in all eight APP splice isoforms known so far. The two essential histidines in the type II copper binding site of APP are conserved in the related protein APLP2. Copper(II) binding is shown to inhibit homophilic APP binding. The identification of a copper(II) binding site in APP suggests that APP and APLP2 may be involved in electron transfer and radical reactions. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Sepharose,  Humans,  Molecular Sequence Data,  Rats,  Recombinant Fusion Proteins,  Sequence Homology,  Amino Acid,  Animals,  Base Sequence,  Protein Conformation,  Copper,  Binding Sites,  Amyloid beta-Protein Precursor,  Chelating Agents]"} , { "attrname": "AUTHORS", "value": "[L Hesse,  D Beher,  C L Masters,  G Multhaup]"} , { "attrname": "PUB_TYPE", "value": "[EXTRACELLULAR COPPER-BINDING DOMAIN,  MUTAGENESIS OF HIS-137; MET-141; CYS-144; HIS-147 AND HIS-151]"} ], "id": "23", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7913895", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0014-5793(94)00658-X"} , { "elementOf": "NLM", "accession": "7913895"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 18-190,  PARTIAL PROTEIN SEQUENCE,  SUBUNIT,  DISULFIDE BONDS,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 20212142", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20212142", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Recombinant Proteins,  9005-49-6 Heparin,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Structure and biochemical analysis of the <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-induced E1 dimer of the amyloid precursor protein."} , { "attrname": "Abstract", "value": "The amyloid precursor protein (APP) is the key player in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathology,  yet APP and its analogues are also essential for neuronal development and cell homeostasis in mammals. We have determined the crystal structure of the entire N-terminal APP-E1 domain consisting of the growth factor like and the copper binding domains at 2.7-A resolution and show that E1 functions as a rigid functional entity. The two subdomains interact tightly in a pH-dependent manner via an evolutionarily conserved interface area. Two E1 entities dimerize upon their interaction with <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>,  requiring 8-12 sugar rings to form the <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-bridged APP-E1 dimer in an endothermic and pH-dependent process that is characterized by a low micromolar dissociation constant. Limited proteolysis confirms that the <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-bridged E1 dimers obtained in solution correspond to a dimer contact in our crystal,  enabling us to model this <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-[APP-E1](2) complex. Correspondingly,  the APP-based signal transduction,  cell-cell- and\/or cell-ECM interaction should depend on dimerization induced by <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>,  as well as on pH,  arguing that APP could fulfill different functions depending on its (sub)cellular localization. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Biophysical Phenomena,  Humans,  Protein Multimerization,  Models,  Molecular,  Crystallography,  X-Ray,  Protein Interaction Domains and Motifs,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Recombinant Proteins,  In Vitro Techniques,  Amyloid beta-Protein Precursor,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[Sven O Dahms,  Sandra Hoefgen,  Dirk Roeser,  Bernhard Schlott,  Karl-Heinz Ghrs,  Manuel E Than]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 18-190,  PARTIAL PROTEIN SEQUENCE,  SUBUNIT,  DISULFIDE BONDS,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "24", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20212142", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0911326107"} , { "elementOf": "NLM", "accession": "20212142"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-123]", "conames": [{ "name": "PMID: 10201399", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10201399", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature structural biology"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Growth Substances,  67256-21-7 Hepatocyte Growth Factor,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Crystal structure of the N-terminal,  growth factor-like domain of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> amyloid precursor protein."} , { "attrname": "Abstract", "value": "Amyloid precursor protein (APP) plays a central role in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. A proteolytic-breakdown product of APP,  called beta-amyloid,  is a major component of the diffuse and fibrillar deposits found in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>d brains. The normal physiological role of APP remains largely unknown despite much work. A knowledge of its function will not only provide insights into the genesis of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> but may also prove vital in the development of an effective therapy. Here we describe the 1.8 A resolution crystal structure of the N-terminal,  <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>-binding domain of APP (residues 28-123),  which is responsible,  among other things,  for stimulation of neurite outgrowth. The structure reveals a highly charged basic surface that may interact with glycosaminoglycans in the brain and an abutting hydrophobic surface that is proposed to play an important functional role such as dimerization or ligand binding. Structural similarities with cysteine-rich growth factors,  taken together with its known growth-promoting properties,  suggests the APP N-terminal domain could function as a growth factor in vivo. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Models,  Molecular,  Molecular Sequence Data,  Crystallography,  X-Ray,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Hepatocyte Growth Factor,  Protein Conformation,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Growth Substances,  Binding Sites,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J Rossjohn,  R Cappai,  S C Feil,  A Henry,  W J McKinstry,  D Galatis,  L Hesse,  G Multhaup,  K Beyreuther,  C L Masters,  M W Parker]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 28-123]"} ], "id": "25", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10201399", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/7562"} , { "elementOf": "NLM", "accession": "10201399"} ]} , { "annotation": "[CHARACTERIZATION OF CASEIN KINASE PHOSPHORYLATION,  MUTAGENESIS OF SER-198 AND SER-206]", "conames": [{ "name": "PMID: 10806211", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10806211", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.1.- ectoprotein kinase,  EC 2.7.11.1 Casein Kinases,  EC 2.7.- Protein Kinases,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  EC 2.7.11.1 Casein Kinase II,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2."} , { "attrname": "Abstract", "value": "The beta-amyloid precursor protein (betaAPP) is one of the rare proteins known to be phosphorylated within its ectodomain. We have shown previously that betaAPP can be phosphorylated within secretory vesicles and at the cell surface (Walter,  J.,  Capell,  A.,  Hung,  A. Y. ,  Langen,  H.,  Schnlzer,  M.,  Thinakaran,  G.,  Sisodia,  S. S.,  Selkoe,  D. J.,  and Haass,  C. (1997) J. Biol. Chem. 272,  1896-1903). We have now specifically characterized the phosphorylation of cell surface-located betaAPP and identified two ectoprotein kinases that phosphorylate betaAPP at the outer face of the plasma membrane. By using selective protein kinase inhibitors and by investigating the usage of ATP and GTP as cosubstrates,  we demonstrate that membrane-bound betaAPP as well as secreted forms of betaAPP can be phosphorylated by casein kinase (CK) 1- and CK2-like ectoprotein kinases. The ectodomain of betaAPP was also phosphorylated by purified CK1 and CK2 in vitro,  but not by protein kinases A and C. Phosphorylation of betaAPP by ectoprotein kinases and by purified CK1 and CK2 occurred within an acidic domain in the N-terminal half of the protein. <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span> strongly inhibited the phosphorylation of cell-surface betaAPP by ecto-CK1 and ecto-CK2,  indicating a regulatory role of this extracellular matrix component in betaAPP phosphorylation. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Cell Membrane,  Phosphorylation,  Casein Kinase II,  Casein Kinases,  Protein Kinases,  Models,  Biological,  Humans,  Protein-Serine-Threonine Kinases,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J Walter,  A Schindzielorz,  B Hartung,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF CASEIN KINASE PHOSPHORYLATION,  MUTAGENESIS OF SER-198 AND SER-206]"} ], "id": "26", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10806211", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10806211"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M002850200"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 523-555,  DOMAIN COLLAGEN-BINDING]", "conames": [{ "name": "PMID: 8576160", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8576160", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  Peptide Fragments,  9007-34-5 Collagen,  J41CSQ7QDS Zinc,  Recombinant Proteins,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I."} , { "attrname": "Abstract", "value": "The specific binding of the amyloid precursor protein (APP) to extracellular matrix molecules suggests that APP regulates cell interactions and has a function as a cell adhesion molecule and\/or substrate adhesion molecule. On the molecular level APP has binding sites for collagen,  laminin,  and glycosaminoglycans which is a characteristic feature of cell adhesion molecules. We have examined the interactions between the APP and collagen types I and IV and identified the corresponding binding sites on APP and collagen type I. We show that APP bound most efficiently to collagen type I in a concentration-dependent and specific manner in the native and heat-denatured states,  suggesting an involvement of a contiguous binding site on collagen. This binding site was identified on the cyanogen bromide fragment alpha 1(I)CB6 of collagen type I,  which also binds <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>. APP did not bind to collagen type I-<span style=\"background-color: yellow\"><b>heparin<\/b><\/span> complexes,  which suggests that there are overlapping binding sites for <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and APP on collagen. We localized the site of APP that mediates collagen binding within residues 448-465 of APP695,  which are encoded by the ubiquitously expressed APP exon 12,  whereas the high affinity <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> binding site of APP is located in exon 9. Since a peptide encompassing this region binds to collagen type I and inhibits APP-collagen type I binding in nanomolar concentrations,  this region may comprise the major part of the collagen type I binding site of APP. Moreover,  our data also indicate that the collagen binding site is involved in APP-APP interaction that can be modulated by Zn(II) and <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>. Taken together,  the data suggest that the regulation of APP binding to collagen type I by <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> occurs through the competitive binding of <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and APP to collagen. "} , { "attrname": "MeSH", "value": "[Brain,  Peptide Fragments,  Exons,  Humans,  Molecular Sequence Data,  Recombinant Proteins,  Cattle,  Base Sequence,  Female,  Binding Sites,  Amino Acid Sequence,  Oligodeoxyribonucleotides,  Protein Structure,  Secondary,  Rats,  Zinc,  Pregnancy,  Sequence Homology,  Amino Acid,  Animals,  Placenta,  Plasmids,  Collagen,  Protein Binding,  Mice,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Kinetics,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[D Beher,  L Hesse,  C L Masters,  G Multhaup]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 523-555,  DOMAIN COLLAGEN-BINDING]"} ], "id": "27", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8576160", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8576160"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.271.3.1613"} ]} , { "annotation": "[EXTRACELLULAR ZINC-BINDING DOMAIN]", "conames": [{ "name": "PMID: 8344894", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8344894", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[J41CSQ7QDS Zinc,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Abnormalities of zinc metabolism occur in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD),  a condition where pathological catabolism of the amyloid protein precursor (APP) causes cerebral beta A4 amyloidosis. An association between zinc and APP metabolism was sought by studying the binding of 65Zn2+ to APP. 65Zn2+ bound in a rapid,  saturable,  and specific manner (KD = 764 nM). A novel zinc binding motif,  strongly conserved between members of the APP family,  was located between the cysteine-rich and negatively charged domains of the protein. Zinc increased binding of APP to <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and has been shown to potentiate the inhibition of coagulation factor XIa by an APP isoform containing a Kunitz-type inhibitory domain (Komiyama,  Y.,  Murakami,  T.,  Egawa,  H.,  Okubo,  S.,  Yasunaga,  K.,  and Murata,  K. (1992) Thromb. Res. 66,  397-408) situated near the zinc binding region. Zinc is a factor that modulates the functional properties of the substrate for beta A4 amyloidogenesis. "} , { "attrname": "MeSH", "value": "[Sequence Homology,  Amino Acid,  Amino Acid Sequence,  Humans,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Binding Sites,  Amyloid beta-Protein Precursor,  Zinc]"} , { "attrname": "AUTHORS", "value": "[A I Bush,  G Multhaup,  R D Moir,  T G Williamson,  D H Small,  B Rumble,  P Pollwein,  K Beyreuther,  C L Masters]"} , { "attrname": "PUB_TYPE", "value": "[EXTRACELLULAR ZINC-BINDING DOMAIN]"} ], "id": "28", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8344894", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8344894"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> ASSOCIATION];", "conames": [{ "name": "PMID: 19936054", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19936054", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PLoS pathogens"} , { "attrname": "Chemical", "value": "[Glypicans,  EC 3.4.- Amyloid Precursor Protein Secretases,  PrPSc Proteins,  Prions,  Protein Isoforms,  PrPC Proteins,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 Bace1 protein,  mouse,  Amyloid,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Glypican-1 mediates both prion protein lipid raft association and disease isoform formation."} , { "attrname": "Abstract", "value": "In prion <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  the cellular form of the prion protein,  PrP(C),  undergoes a conformational conversion to the infectious isoform,  PrP(Sc). PrP(C) associates with lipid rafts through its glycosyl-phosphatidylinositol (GPI) anchor and a region in its N-terminal domain which also binds to heparan sulfate proteoglycans (HSPGs). We show that <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> displaces PrP(C) from rafts and promotes its endocytosis,  suggesting that <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> competes with an endogenous raft-resident HSPG for binding to PrP(C). We then utilised a transmembrane-anchored form of PrP (PrP-TM),  which is targeted to rafts solely by its N-terminal domain,  to show that both <span style=\"background-color: yellow\"><b>heparin<\/b><\/span> and phosphatidylinositol-specific phospholipase C can inhibit its association with detergent-resistant rafts,  implying that a GPI-anchored HSPG targets PrP(C) to rafts. Depletion of the major neuronal GPI-anchored HSPG,  glypican-1,  significantly reduced the raft association of PrP-TM and displaced PrP(C) from rafts,  promoting its endocytosis. Glypican-1 and PrP(C) colocalised on the cell surface and both PrP(C) and PrP(Sc) co-immunoprecipitated with glypican-1. Critically,  treatment of scrapie-infected N2a cells with glypican-1 siRNA significantly reduced PrP(Sc) formation. In contrast,  depletion of glypican-1 did not alter the inhibitory effect of PrP(C) on the beta-secretase cleavage of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein. These data indicate that glypican-1 is a novel cellular cofactor for prion conversion and we propose that it acts as a scaffold facilitating the interaction of PrP(C) and PrP(Sc) in lipid rafts. "} , { "attrname": "MeSH", "value": "[Membrane Microdomains,  Cell Membrane,  Glypicans,  Prion <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Animals,  PrPSc Proteins,  Aspartic Acid Endopeptidases,  Prions,  Protein Isoforms,  Amyloid Precursor Protein Secretases,  PrPC Proteins,  Cell Line,  Tumor,  Amyloid,  Mice,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Models,  Animal]"} , { "attrname": "AUTHORS", "value": "[David R Taylor,  Isobel J Whitehouse,  Nigel M Hooper]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION,  DISEASE ASSOCIATION]"} ], "id": "29", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19936054", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19936054"} , { "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PPAT.1000666"} ]} , { "annotation": "", "conames": [{ "name": "<span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span>-DEMENTIA SYNDROME", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "260540", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "30", "contexts": { } , "evidences": ["Imported from database"], "value": "<span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span>-DEMENTIA SYNDROME", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "260540"} ]} , { "annotation": "Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein,  small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins. ( Reference:  GOC: go_curators Pfam: PF00018 )", "conames": [{ "name": "SH3 domain binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0017124", "attributes": [], "id": "31", "contexts": { } , "evidences": ["Imported from database"], "value": "SH3 domain binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0017124"} ]} , { "annotation": "The action of a molecule that contributes to the structural integrity of a cytoskeletal structure. ( Reference:  GOC: mah )", "conames": [{ "name": "structural constituent of cytoskeleton", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005200", "attributes": [], "id": "32", "contexts": { } , "evidences": ["Imported from database"], "value": "structural constituent of cytoskeleton", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005200"} ]} , { "annotation": "Interacting selectively and non-covalently with microtubules,  filaments composed of tubulin monomers. ( Reference:  GOC: krc )", "conames": [{ "name": "microtubule\/chromatin interaction", "isPreferred": "false"} , { "name": "microtubule binding", "isPreferred": "true"} , { "name": "microtubule severing", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008017", "attributes": [], "id": "33", "contexts": { } , "evidences": ["Imported from database"], "value": "microtubule binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008017"} ]} , { "annotation": "Interacting selectively and non-covalently with any enzyme. ( Reference:  GOC: jl )", "conames": [{ "name": "enzyme binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019899", "attributes": [], "id": "34", "contexts": { } , "evidences": ["Imported from database"], "value": "enzyme binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019899"} ]} , { "annotation": "Interacting selectively and non-covalently with an apolipoprotein,  the protein component of a lipoprotein complex. ( Reference:  GOC: BHF GOC: rl )", "conames": [{ "name": "apolipoprotein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034185", "attributes": [], "id": "35", "contexts": { } , "evidences": ["Imported from database"], "value": "apolipoprotein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034185"} ]} , { "annotation": "Interacting selectively and non-covalently with a lipoprotein particle. A lipoprotein particle,  also known as a lipoprotein,  is a clathrate complex consisting of a lipid enwrapped in a protein host without covalent binding in such a way that the complex has a hydrophilic outer surface consisting of all the protein and the polar ends of any phospholipids. ( Reference:  CHEBI: 6495 GOC: BHF GOC: mah )", "conames": [{ "name": "lipoprotein binding", "isPreferred": "false"} , { "name": "plasma lipoprotein particle binding", "isPreferred": "true"} , { "name": "lipoprotein particle binding", "isPreferred": "true"} , { "name": "plasma lipoprotein binding", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0071813", "attributes": [], "id": "36", "contexts": { } , "evidences": ["Imported from database"], "value": "lipoprotein particle binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0071813"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "37", "contexts": { } , "evidences": ["Imported from database"], "value": "P27448", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P27448"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} ], "id": "38", "contexts": { } , "evidences": ["Imported from database"], "value": "P63104", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P63104"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} ], "id": "39", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9UNE7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9UNE7"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "40", "contexts": { } , "evidences": ["Imported from database"], "value": "P07237", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P07237"} ]} , { "annotation": "Created:  2006-01-24; Modified:  2016-01-20; Version:  130", "conames": [{ "name": "Dardarin", "isPreferred": "false"} , { "name": "LRRK2", "isPreferred": "false"} , { "name": "Leucine-rich repeat serine\/threonine-protein kinase 2", "isPreferred": "true"} , { "name": "PARK8", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "Q5S007", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "66"} ], "id": "41", "contexts": { "context": { "id": 53} } , "evidences": ["Imported from database"], "value": "Leucine-rich repeat serine\/threonine-protein kinase 2", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENSG00000188906"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000298910"} , { "elementOf": "UNIPROTKB", "accession": "Q5S007"} , { "elementOf": "ENSEMBL", "accession": "ENST00000298910"} ]} , { "annotation": "[FUNCTION IN RETROGRADE TRANSPORT,  INTERACTION WITH LRRK2,  CHARACTERIZATION OF VARIANT PARK17 ASN-620]", "conames": [{ "name": "PMID: 23395371", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23395371", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Vesicle-Associated Membrane Protein 2,  Tubulin,  EC 3.6.5.2 rab GTP-Binding Proteins,  147336-22-9 Green Fluorescent Proteins,  EC 3.6.5.2 rab5 GTP-Binding Proteins,  Synaptosomal-Associated Protein 25,  EC 1.14.16.2 Tyrosine 3-Monooxygenase,  152989-05-4 rab7 protein]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk."} , { "attrname": "Abstract", "value": "Recent genome-wide association studies have linked common variants in the human genome to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) risk. Here we show that the consequences of variants at 2 such loci,  PARK16 and LRRK2,  are highly interrelated,  both in terms of their broad impacts on human brain transcriptomes of unaffected carriers,  and in terms of their associations with PD risk. Deficiency of the PARK16 locus gene RAB7L1 in primary rodent neurons,  or of a RAB7L1 ortholog in Drosophila dopamine neurons,  recapitulated degeneration observed with expression of a familial PD mutant form of LRRK2,  whereas RAB7L1 overexpression rescued the LRRK2 mutant phenotypes. PD-associated defects in RAB7L1 or LRRK2 led to endolysosomal and Golgi apparatus sorting defects and deficiency of the VPS35 component of the retromer complex. Expression of wild-type VPS35,  but not a familial PD-associated mutant form,  rescued these defects. Taken together,  these studies implicate retromer and lysosomal pathway alterations in PD risk. "} , { "attrname": "MeSH", "value": "[Green Fluorescent Proteins,  Immunoprecipitation,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Cerebral Cortex,  Male,  Statistics as Topic,  Tyrosine 3-Monooxygenase,  Transfection,  Tubulin,  Aged,  80 and over,  Female,  Synaptosomal-Associated Protein 25,  Animals,  Newborn,  rab5 GTP-Binding Proteins,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genome-Wide Association Study,  Vesicle-Associated Membrane Protein 2,  Animals,  Genetically Modified,  Neurons,  Drosophila,  Cells,  Cultured,  Rats,  Rats,  Sprague-Dawley,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Protein Transport,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  rab GTP-Binding Proteins,  Aged,  Mice,  Polymorphism,  Single Nucleotide,  Mutation]"} , { "attrname": "AUTHORS", "value": "[David A MacLeod,  Herve Rhinn,  Tomoki Kuwahara,  Ari Zolin,  Gilbert Di Paolo,  Brian D McCabe,  Brian D MacCabe,  Karen S Marder,  Lawrence S Honig,  Lorraine N Clark,  Scott A Small,  Asa Abeliovich]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN RETROGRADE TRANSPORT,  INTERACTION WITH LRRK2,  CHARACTERIZATION OF VARIANT PARK17 ASN-620]"} ], "id": "42", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23395371", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "23395371"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEURON.2012.11.033"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH TPCN2]", "conames": [{ "name": "PMID: 22012985", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22012985", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinase Kinase,  EC 2.7.11.1 AMP-Activated Protein Kinases,  5502-96-5 NAADP,  Proto-Oncogene Proteins c-bcl-2,  Proteasome Inhibitors,  53-59-8 NADP]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  but its physiological function has remained largely unknown. Here we report that LRRK2 activates a calcium-dependent protein kinase kinase-? (CaMKK-?)\/adenosine monophosphate (AMP)-activated protein kinase (AMPK) pathway which is followed by a persistent increase in autophagosome formation. Simultaneously,  LRKR2 overexpression increases the levels of the autophagy receptor p62 in a protein synthesis-dependent manner,  and decreases the number of acidic lysosomes. The LRRK2-mediated effects result in increased sensitivity of cells to stressors associated with abnormal protein degradation. These effects can be mimicked by the lysosomal Ca(2+)-mobilizing messenger nicotinic acid adenine dinucleotide phosphate (NAADP) and can be reverted by an NAADP receptor antagonist or expression of dominant-negative receptor constructs. Collectively,  our data indicate a molecular mechanism for LRRK2 deregulation of autophagy and reveal previously unidentified therapeutic targets. "} , { "attrname": "MeSH", "value": "[Humans,  Protein-Serine-Threonine Kinases,  Lysosomes,  Rats,  Endoplasmic Reticulum,  Autophagy,  PC12 Cells,  AMP-Activated Protein Kinases,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Calcium-Calmodulin-Dependent Protein Kinase Kinase,  Animals,  HEK293 Cells,  NADP,  Proto-Oncogene Proteins c-bcl-2,  Proteasome Inhibitors,  Calcium Signaling]"} , { "attrname": "AUTHORS", "value": "[Patricia Gmez-Suaga,  Berta Luzn-Toro,  Dev Churamani,  Ling Zhang,  Duncan Bloor-Young,  Sandip Patel,  Philip G Woodman,  Grant C Churchill,  Sabine Hilfiker]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH TPCN2]"} ], "id": "43", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22012985", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22012985"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/DDR481"} ]} , { "annotation": "[VARIANT PARK8\/PD SER-2019]", "conames": [{ "name": "PMID: 15852371", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15852371", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  46627O600J Levodopa]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Clinical features of LRRK2-associated Parkinson's disease in central Norway."} , { "attrname": "Abstract", "value": "Several pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2; PARK8) gene recently have been identified in familial and sporadic <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. We screened 435 Norwegian patients diagnosed with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and 519 control subjects for the presence of 7 LRRK2 mutations. Nine patients from seven families were found to be heterozygote carriers of the LRRK2 6055G>A (G2019S) mutation. Twelve of 28 first-degree relatives also carried the mutation,  but only 1 had <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The clinical features included asymmetric resting tremor,  bradykinesia,  and rigidity with a good response to levodopa and could not be distinguished from idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Muscle Rigidity,  Tremor,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Norway,  Pedigree,  Age of Onset,  Aged,  80 and over,  Adult,  Female,  Heterozygote,  Aged,  Levodopa,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Jan O Aasly,  Mathias Toft,  Ignacio Fernandez-Mata,  Jennifer Kachergus,  Mary Hulihan,  Linda R White,  Matthew Farrer]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8\/PD SER-2019]"} ], "id": "44", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15852371", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20456"} , { "elementOf": "NLM", "accession": "15852371"} ]} , { "annotation": "[VARIANTS PARK8 VAL-1371 AND SER-2019,  VARIANTS HIS-1398 AND THR-2397]", "conames": [{ "name": "PMID: 16157901", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16157901", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Apolipoproteins E]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "LRRK2 gene in Parkinson disease:  mutation analysis and case control association study."} , { "attrname": "Abstract", "value": "In addition to the four well-confirmed genes linked to early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) (SNCA,  PARKIN,  DJ-1,  and PINK1),  mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have recently been identified in families with autosomal dominant late-onset PD. To perform mutation analysis of LRRK2 in probands of families showing dominant inheritance of PD and to conduct a case control association study to test the hypothesis that common coding variations might be associated with increased susceptibility to PD. All 51 LRRK2 coding exons were sequenced in 23 probands and the mutation frequencies were evaluated in 180 neurologically normal control subjects. For the association study the authors genotyped four coding LRRK2 polymorphisms in 250 normal control subjects and 121 patients with PD (predominantly white patients of Canadian origin),  84% of whom had age at onset before 50 years and 42% had a positive family history. The authors identified three probands with heterozygous LRRK2 mutations:  two of them have the known G2019S substitution and one proband has a novel I1371V substitution. Mutation analysis of a large family demonstrated complete segregation of the G2019S with PD. However,  there was no association between PD and any of the four polymorphisms at the allelic or genotypic levels (p > 0.17). Furthermore,  the authors did not detect a modifying effect for any genotype or of APOE genotypes upon the age at onset in the PD group (p > 0.20). The results support the prior suggestion that LRRK2 mutations cause PD. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in the families reported here presents a phenotype indistinguishable from typical PD. All three families demonstrate a very variable age at onset that is not explained by APOE genotypes. The common coding variations in the LRRK2 gene neither constitute strong PD risk factors nor modify the age at onset; however,  the possibility of a modest risk effect remains to be assessed in large datasets. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Testing,  Exons,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Family Health,  Genotype,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Age of Onset,  Aged,  80 and over,  Adult,  Aged,  Apolipoproteins E,  Mutation]"} , { "attrname": "AUTHORS", "value": "[C Paisn-Ruz,  A E Lang,  T Kawarai,  C Sato,  S Salehi-Rad,  G K Fisman,  T Al-Khairallah,  P St George-Hyslop,  A Singleton,  E Rogaeva]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 VAL-1371 AND SER-2019,  VARIANTS HIS-1398 AND THR-2397]"} ], "id": "45", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16157901", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000167552.79769.B3"} , { "elementOf": "NLM", "accession": "16157901"} ]} , { "annotation": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]", "conames": [{ "name": "PMID: 16081470", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16081470", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Brain :  a journal of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Z9O08YRN8O Tetrabenazine,  207ZZ9QZ49 Methylphenidate,  3466-75-9 dihydrotetrabenazine,  EC 4.1.1.- Carboxy-Lyases,  Receptors,  Dopamine D2,  Fluorine Radioisotopes,  Radiopharmaceuticals,  Dopamine Plasma Membrane Transport Proteins,  Carbon Radioisotopes,  46627O600J Levodopa]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "PET in LRRK2 mutations:  comparison to sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and evidence for presymptomatic compensation."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> may arise from multiple aetiologies,  including genetic mutations that are for the most part uncommon. We describe here the positron emission tomography (PET) findings in clinically affected and asymptomatic,  high-risk members of two autosomal dominantly inherited <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> kindreds with recently described mutations at the PARK8 locus,  in a novel gene encoding a leucine-rich repeat kinase (LRRK2). Affected family members have L-dopa-responsive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism with loss of dopaminergic nigral neurons and pleomorphic subcellular pathology. Fifteen family members underwent PET using:  18F-6-fluoro-L-dopa (18F-dopa) to assess dopamine (DA) synthesis and storage,  11C-(+\/-)-dihydrotetrabenazine (11C-DTBZ) for the vesicular monoamine transporter,  and 11C-d-threo-methylphenidate (11C-MP) for the membrane dopamine transporter (DAT). Measurements were compared with normal (n = 33) and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (sPD) (n = 67) control groups. Four clinically affected members had findings similar to sPD,  with impaired presynaptic DA function affecting the putamen more than the caudate. In two affected members,  D2 dopamine receptor binding was intact. Two asymptomatic mutation carriers had abnormal DAT binding with another two developing such abnormalities over 4 years of follow-up. In these individuals,  18F-dopa uptake remained normal,  although two of them also displayed abnormal 11C-DTBZ binding. Our study demonstrates that the in vivo neurochemical phenotype of LRRK2 mutations is indistinguishable from that of sPD,  despite the pathological heterogeneity of the condition. Furthermore,  we suggest that compensatory changes including downregulation of the DAT and upregulation of decarboxylase activity may delay the onset of <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ian symptoms. "} , { "attrname": "MeSH", "value": "[Brain,  Age Factors,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Positron-Emission Tomography,  Carboxy-Lyases,  Tetrabenazine,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Regression Analysis,  Phenotype,  Image Processing,  Computer-Assisted,  Receptors,  Dopamine D2,  Adult,  Aged,  Fluorine Radioisotopes,  Levodopa,  Mutation,  Radiopharmaceuticals,  Dopamine Plasma Membrane Transport Proteins,  Methylphenidate,  Carbon Radioisotopes]"} , { "attrname": "AUTHORS", "value": "[John R Adams,  Hinke van Netten,  Michael Schulzer,  Edwin Mak,  Jessamyn Mckenzie,  Audrey Strongosky,  Vesna Sossi,  Thomas J Ruth,  Chong S Lee,  Matthew Farrer,  Thomas Gasser,  Ryan J Uitti,  Donald B Calne,  Zbigniew K Wszolek,  A Jon Stoessl]"} , { "attrname": "PUB_TYPE", "value": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]"} ], "id": "46", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16081470", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16081470"} , { "elementOf": "DOI", "accession": "10.1093\/BRAIN\/AWH607"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT ARG-2385,  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conames": [{ "name": "PMID: 17019612", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17019612", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human genetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "The LRRK2 Gly2385Arg variant is associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  genetic and functional evidence."} , { "attrname": "Abstract", "value": "Evidence of LRRK2 haplotypes associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) risk was recently found in the Chinese population from Singapore,  and a common LRRK2 missense variant,  Gly2385Arg,  was independently detected as a putative risk factor for PD in the Chinese population from Taiwan. To test the association between the Gly2385Arg variant in a large case-control sample of Chinese ethnicity from Singapore,  and to perform functional studies of the wild type and Gly2385Arg LRRK2 protein in human cell lines. In a case-control study involving 989 Chinese subjects,  the frequency of the heterozygous Gly2385Arg genotype was higher in PD compared to controls (7.3 vs. 3.6%,  odds ratio = 2.1,  95% CI:  1.1-3.9,  P = 0.014); these values yield an estimated population attributable risk (PAR) of approximately 4%. In a multivariate logistic regression analysis with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> group (PD vs. controls) as the dependent variable and the genotype as an independent factor with adjustments made for the effect of age and gender,  the heterozygous Gly2385Arg genotype remained associated with an increased risk of PD compared to wild type genotype (odds ratio = 2.67,  95% CI:  1.43-4.99,  P = 0.002). The glycine at position 2385 is a candidate site for N-myristoylation,  and the Gly2385Arg variant replaces the hydrophobic glycine with the hydrophilic arginine,  and increases the net positive charge of the LRRK2 WD40 domain. In transfection studies,  we demonstrated that both the wild type and Gly2385Arg variant LRRK2 protein localize to the cytoplasm and form aggregates. However,  under condition of oxidative stress,  the Gly2385Arg variant was more toxic and associated with a higher rate of apoptosis. Our study lends support to the contention that the Gly2385Arg is a common risk factor for PD in the Chinese population. Our bioinformatics and in-vitro studies also suggest that the Gly2385Arg variant is biologically relevant and it might act through pro-apoptotic mechanisms. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Protein Structure,  Tertiary,  Cell Line,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Singapore,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Models,  Molecular,  Male,  Recombinant Proteins,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Genetic Variation,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Asian Continental Ancestry Group,  Transfection,  Female,  Aged,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[E K Tan,  Y Zhao,  L Skipper,  M G Tan,  A Di Fonzo,  L Sun,  S Fook-Chong,  S Tang,  E Chua,  Y Yuen,  L Tan,  R Pavanni,  M C Wong,  P Kolatkar,  C S Lu,  V Bonifati,  J J Liu]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT ARG-2385,  ASSOCIATION WITH PARKINSON DISEASE]"} ], "id": "47", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17019612", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "17019612"} , { "elementOf": "DOI", "accession": "10.1007\/S00439-006-0268-0"} ]} , { "annotation": "[VARIANT PARK2 TRP-275]", "conames": [{ "name": "PMID: 22956510", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22956510", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Movement disorders :  official journal of the Movement Disorder Society"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  EC 3.1.2.- PARK7 protein,  human,  EC 2.7.- Protein Kinases,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.1.2.- Protein Deglycase DJ-1]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Systematic review and UK-based study of PARK2 (parkin),  PINK1,  PARK7 (DJ-1) and LRRK2 in early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Approximately 3.6% of patients with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> develop symptoms before age 45. Early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOPD) patients have a higher familial recurrence risk than late-onset patients,  and 3 main recessive EOPD genes have been described. We aimed to establish the prevalence of mutations in these genes in a UK cohort and in previous studies. We screened 136 EOPD probands from a high-ascertainment regional and community-based prevalence study for pathogenic mutations in PARK2 (parkin),  PINK1,  PARK7 (DJ-1),  and exon 41 of LRRK2. We also carried out a systematic review,  calculating the proportion of cases with pathogenic mutations in previously reported studies. We identified 5 patients with pathogenic PARK2,  1 patient with PINK1,  and 1 with LRRK2 mutations. The rate of mutations overall was 5.1%. Mutations were more common in patients with age at onset (AAO) < 40 (9.5%),  an affected first-degree relative (6.9%),  an affected sibling (28.6%),  or parental consanguinity (50%). In our study EOPD mutation carriers were more likely to present with rigidity and dystonia,  and 6 of 7 mutation carriers had lower limb symptoms at onset. Our systematic review included information from >5800 unique cases. Overall,  the weighted mean proportion of cases with PARK2 (parkin),  PINK1,  and PARK7 (DJ-1) mutations was 8.6%,  3.7%,  and 0.4%,  respectively. PINK1 mutations were more common in Asian subjects. The overall frequency of mutations in known EOPD genes was lower than previously estimated. Our study shows an increased likelihood of mutations in patients with lower AAO,  family history,  or parental consanguinity. "} , { "attrname": "MeSH", "value": "[Humans,  Protein-Serine-Threonine Kinases,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  Male,  United Kingdom,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Protein Deglycase DJ-1,  Protein Kinases,  DNA Mutational Analysis,  Female,  Mutation,  Cohort Studies]"} , { "attrname": "AUTHORS", "value": "[Laura L Kilarski,  Justin P Pearson,  Victoria Newsway,  Elisa Majounie,  M Duleeka W Knipe,  Anjum Misbahuddin,  Patrick F Chinnery,  David J Burn,  Carl E Clarke,  Marie-Helene Marion,  Alistair J Lewthwaite,  David J Nicholl,  Nicholas W Wood,  Karen E Morrison,  Caroline H Williams-Gray,  Jonathan R Evans,  Stephen J Sawcer,  Roger A Barker,  Mirdhu M Wickremaratchi,  Yoav Ben-Shlomo,  Nigel M Williams,  Huw R Morris]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 TRP-275]"} ], "id": "48", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22956510", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22956510"} , { "elementOf": "DOI", "accession": "10.1002\/MDS.25132"} ]} , { "annotation": "[VARIANT CYS-315]", "conames": [{ "name": "PMID: 21248752", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21248752", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Transcription Factors,  PBRM1 protein,  human,  Nuclear Proteins]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma."} , { "attrname": "Abstract", "value": "The genetics of renal cancer is dominated by inactivation of the VHL tumour suppressor gene in clear cell carcinoma (ccRCC),  the commonest histological subtype. A recent large-scale screen of ?3, 500 genes by PCR-based exon re-sequencing identified several new cancer genes in ccRCC including UTX (also known as KDM6A),  JARID1C (also known as KDM5C) and SETD2 (ref. 2). These genes encode enzymes that demethylate (UTX,  JARID1C) or methylate (SETD2) key lysine residues of histone H3. Modification of the methylation state of these lysine residues of histone H3 regulates chromatin structure and is implicated in transcriptional control. However,  together these mutations are present in fewer than 15% of ccRCC,  suggesting the existence of additional,  currently unidentified cancer genes. Here,  we have sequenced the protein coding exome in a series of primary ccRCC and report the identification of the SWI\/SNF chromatin remodelling complex gene PBRM1 (ref. 4) as a second major ccRCC cancer gene,  with truncating mutations in 41% (92\/227) of cases. These data further elucidate the somatic genetic architecture of ccRCC and emphasize the marked contribution of aberrant chromatin biology. "} , { "attrname": "MeSH", "value": "[Kidney Neoplasms,  Humans,  Gene Expression Regulation,  Gene Knockdown Techniques,  Nuclear Proteins,  Animals,  Cell Line,  Tumor,  Carcinoma,  Renal Cell,  Mice,  Transcription Factors,  Mutation,  Pancreatic Neoplasms,  Disease Models,  Animal]"} , { "attrname": "AUTHORS", "value": "[Ignacio Varela,  Patrick Tarpey,  Keiran Raine,  Dachuan Huang,  Choon Kiat Ong,  Philip Stephens,  Helen Davies,  David Jones,  Meng-Lay Lin,  Jon Teague,  Graham Bignell,  Adam Butler,  Juok Cho,  Gillian L Dalgliesh,  Danushka Galappaththige,  Chris Greenman,  Claire Hardy,  Mingming Jia,  Calli Latimer,  King Wai Lau,  John Marshall,  Stuart McLaren,  Andrew Menzies,  Laura Mudie,  Lucy Stebbings,  David A Largaespada,  L F A Wessels,  Stephane Richard,  Richard J Kahnoski,  John Anema,  David A Tuveson,  Pedro A Perez-Mancera,  Ville Mustonen,  Andrej Fischer,  David J Adams,  Alistair Rust,  Waraporn Chan-on,  Chutima Subimerb,  Karl Dykema,  Kyle Furge,  Peter J Campbell,  Bin Tean Teh,  Michael R Stratton,  P Andrew Futreal]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CYS-315]"} ], "id": "49", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21248752", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE09639"} , { "elementOf": "NLM", "accession": "21248752"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15680457", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15680457", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A common LRRK2 mutation in idiopathic Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been shown to cause autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Few mutations in this gene have been identified. We investigated the frequency of a common heterozygous mutation,  2877510 g-->A,  which produces a glycine to serine aminoacid substitution at codon 2019 (Gly2019 ser),  in idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We assessed 482 patients with the disorder,  of whom 263 had pathologically confirmed <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  by direct sequencing for mutations in exon 41 of LRRK2. The mutation was present in eight (1.6%) patients. We have shown that a common single Mendelian mutation is implicated in sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We suggest that testing for this mutation will be important in the management and genetic counselling of patients with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Brain,  Point Mutation,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Adult,  Heterozygote,  Aged,  Amino Acid Substitution,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[William P Gilks,  Patrick M Abou-Sleiman,  Sonia Gandhi,  Shushant Jain,  Andrew Singleton,  Andrew J Lees,  Karen Shaw,  Kailash P Bhatia,  Vincenzo Bonifati,  Niall P Quinn,  John Lynch,  Daniel G Healy,  Janice L Holton,  Tamas Revesz,  Nicholas W Wood]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "50", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15680457", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15680457"} , { "elementOf": "DOI", "accession": "10.1016\/S0140-6736(05)70237-3"} ]} , { "annotation": "[VARIANTS PARK8 CYS-1441; GLY-1441; HIS-1441; GLN-1514; SER-1542; GLU-1598; CYS-1699; THR-1869; THR-2012; SER-2019; THR-2020 AND ARG-2385,  VARIANTS PRO-119; LYS-551; VAL-723; MET-793; VAL-1122; ALA-1262; HIS-1398; PRO-1628; THR-1646; THR-1647; ASP-2081; LEU-2119; ILE-2261 AND THR-2397]", "conames": [{ "name": "PMID: 16172858", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16172858", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurogenetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Lrrk2 pathogenic substitutions in Parkinson's disease."} , { "attrname": "Abstract", "value": "Leucine-rich repeat kinase 2 (LRRK2) mutations have been implicated in autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  consistent with typical levodopa-responsive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The gene maps to chromosome 12q12 and encodes a large,  multifunctional protein. To identify novel LRRK2 mutations,  we have sequenced 100 affected probands with family history of <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. Semiquantitative analysis was also performed in all probands to identify LRRK2 genomic multiplication or deletion. In these kindreds,  referred from movement disorder clinics in many parts of Europe,  Asia,  and North America,  <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism segregates as an autosomal dominant trait. All 51 exons of the LRRK2 gene were analyzed and the frequency of all novel sequence variants was assessed within controls. The segregation of mutations with <span style=\"background-color: yellow\"><b>disease<\/b><\/span> has been examined in larger,  multiplex families. Our study identified 26 coding variants,  including 15 nonsynonymous amino acid substitutions of which three affect the same codon (R1441C,  R1441G,  and R1441H). Seven of these coding changes seem to be pathogenic,  as they segregate with <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and were not identified within controls. No multiplications or deletions were identified. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Polymorphism,  Genetic,  Genetic Variation,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Pedigree,  Gene Deletion,  Adult,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Ignacio F Mata,  Jennifer M Kachergus,  Julie P Taylor,  Sarah Lincoln,  Jan Aasly,  Timothy Lynch,  Mary M Hulihan,  Stephanie A Cobb,  Ruey-Meei Wu,  Chin-Song Lu,  Carlos Lahoz,  Zbigniew K Wszolek,  Matthew J Farrer]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 CYS-1441; GLY-1441; HIS-1441; GLN-1514; SER-1542; GLU-1598; CYS-1699; THR-1869; THR-2012; SER-2019; THR-2020 AND ARG-2385,  VARIANTS PRO-119; LYS-551; VAL-723; MET-793; VAL-1122; ALA-1262; HIS-1398; PRO-1628; THR-1646; THR-1647; ASP-2081; LEU-2119; ILE-2261 AND THR-2397]"} ], "id": "51", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16172858", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1007\/S10048-005-0005-1"} , { "elementOf": "NLM", "accession": "16172858"} ]} , { "annotation": "[VARIANTS PARK8 CYS-1699; HIS-1941; SER-2019 AND ILE-2356]", "conames": [{ "name": "PMID: 16272164", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16272164", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Brain :  a journal of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Radiopharmaceuticals]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  clinical,  pathological,  olfactory and functional imaging and genetic data."} , { "attrname": "Abstract", "value": "We have established that the frequency of LRRK2 mutations in a series of 118 cases of familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is 5.1%. In the largest family with autosomal dominant,  late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> where affected subjects share a Y1699C missense mutation we provide a detailed clinical,  pathological and imaging report. The phenotype in this large British kindred included asymmetrical,  levodopa-responsive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism where unilateral leg tremor at onset and foot dystonia were prominent features. There was no significant abnormality of cognition but there was prominent behavioural disorder. We observed a lower age of onset in successive generations. Histopathology in one patient showed substantia nigra cell loss and Lewy body formation,  with small numbers of cortical Lewy bodies. 18F-dopa positron emission tomography (PET) in another patient showed a pattern of nigrostriatal dysfunction typical of idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. 18F-dopa-PET scans in unaffected family members prior to identifying the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> locus did not detect subclinical nigrostriatal dysfunction. Olfaction was assessed in affected subjects and Lewy bodies were identified in the olfactory bulb as well as cortex and brainstem of one deceased patient. In order to assess the role of mutations in this gene in other familial cases we undertook a mutation screen of all 51 exons of LRRK2 in 117 other smaller British kindreds with familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The commonest mutation was G2019S and we also identified two novel mutations,  R1941H and T2356I,  in the coding sequence. These data suggest that <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism caused by mutations in LRRK2 is likely to represent the commonest locus for autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a phenotype,  pathology and in vivo imaging similar to idiopathic,  late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Brain,  Genetic Testing,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  England,  Male,  Olfactory Bulb,  Positron-Emission Tomography,  Mutation,  Missense,  Lod Score,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genes,  Dominant,  DNA Mutational Analysis,  Pedigree,  Age of Onset,  Adult,  Female,  Aged,  Radiopharmaceuticals,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[Naheed L Khan,  Shushant Jain,  John M Lynch,  Nicola Pavese,  Patrick Abou-Sleiman,  Janice L Holton,  Daniel G Healy,  William P Gilks,  Mary G Sweeney,  Milan Ganguly,  Vaneesha Gibbons,  Sonia Gandhi,  Jenny Vaughan,  Louise H Eunson,  Regina Katzenschlager,  Juliet Gayton,  Graham Lennox,  Tamas Revesz,  David Nicholl,  Kailash P Bhatia,  Niall Quinn,  David Brooks,  Andrew J Lees,  Mary B Davis,  Paola Piccini,  Andrew B Singleton,  Nicholas W Wood]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 CYS-1699; HIS-1941; SER-2019 AND ILE-2356]"} ], "id": "52", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16272164", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/BRAIN\/AWH667"} , { "elementOf": "NLM", "accession": "16272164"} ]} , { "annotation": "[TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 16532471", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16532471", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  VTD58H1Z2X Dopamine,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "LRRK2 expression linked to dopamine-innervated areas."} , { "attrname": "Abstract", "value": "Leucine-rich repeat kinase 2 (LRRK2) has been linked to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Our study explores the expression of LRRK2 in human and rodent brain tissue. We analyzed LRRK2 gene activity at the cellular level using in situ hybridization. We found a high and strikingly specific expression of LRRK2 mRNA in rodent striatum and parts of cortex and no signals in dopamine neurons. In human tissue,  LRRK2 mRNA was found in the corresponding brain areas caudatus and putamen at lower levels and dopamine neurons were also devoid of LRRK2 mRNA. Expression levels in striatal tissue did not differ between <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patients and control subjects. Unlike all other genes so far linked to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  our results demonstrate that LRRK2 expression is particularly high in brain dopaminoceptive areas. "} , { "attrname": "MeSH", "value": "[Brain,  Gene Expression,  Dopamine,  Humans,  Mice,  Inbred C57BL,  Middle Aged,  Protein-Serine-Threonine Kinases,  Rats,  Male,  Rats,  Sprague-Dawley,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  In Situ Hybridization,  Aged,  80 and over,  Female,  Aged,  Mice,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[Dagmar Galter,  Marie Westerlund,  Andrea Carmine,  Eva Lindqvist,  Olof Sydow,  Lars Olson]"} , { "attrname": "PUB_TYPE", "value": "[TISSUE SPECIFICITY]"} ], "id": "53", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16532471", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20808"} , { "elementOf": "NLM", "accession": "16532471"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "54", "contexts": { } , "evidences": ["Imported from database"], "value": "O00499-1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O00499-1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "55", "contexts": { } , "evidences": ["Imported from database"], "value": "Q7KZI7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q7KZI7"} ]} , { "annotation": "Created:  1987-08-13; Modified:  2016-01-20; Version:  246", "conames": [{ "name": "Cerebral vascular amyloid peptide", "isPreferred": "false"} , { "name": "Amyloid intracellular domain 57", "isPreferred": "false"} , { "name": "APP", "isPreferred": "false"} , { "name": "Amyloid intracellular domain 59", "isPreferred": "false"} , { "name": "P3(42)", "isPreferred": "true"} , { "name": "PN-II", "isPreferred": "false"} , { "name": "AICD-50", "isPreferred": "false"} , { "name": "PreA4", "isPreferred": "false"} , { "name": "S-APP-alpha", "isPreferred": "false"} , { "name": "P3(40)", "isPreferred": "true"} , { "name": "A4", "isPreferred": "false"} , { "name": "S-APP-beta", "isPreferred": "false"} , { "name": "Soluble APP-beta", "isPreferred": "true"} , { "name": "Gamma-CTF(59)", "isPreferred": "false"} , { "name": "Protease nexin-II", "isPreferred": "false"} , { "name": "Gamma-CTF(57)", "isPreferred": "false"} , { "name": "Amyloid intracellular domain 50", "isPreferred": "false"} , { "name": "C31", "isPreferred": "true"} , { "name": "AID(59)", "isPreferred": "false"} , { "name": "Gamma-CTF(50)", "isPreferred": "false"} , { "name": "N-APP", "isPreferred": "true"} , { "name": "C99", "isPreferred": "true"} , { "name": "Amyloid beta A4 protein", "isPreferred": "true"} , { "name": "AID(57)", "isPreferred": "false"} , { "name": "Gamma-secretase C-terminal fragment 50", "isPreferred": "true"} , { "name": "Beta-amyloid protein 42", "isPreferred": "true"} , { "name": "Gamma-secretase C-terminal fragment 57", "isPreferred": "true"} , { "name": "Alzheimer <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid protein", "isPreferred": "false"} , { "name": "Gamma-secretase C-terminal fragment 59", "isPreferred": "true"} , { "name": "AD1", "isPreferred": "false"} , { "name": "Soluble APP-alpha", "isPreferred": "true"} , { "name": "Beta-amyloid protein 40", "isPreferred": "true"} , { "name": "AICD-57", "isPreferred": "false"} , { "name": "Beta-APP42", "isPreferred": "false"} , { "name": "APPI", "isPreferred": "false"} , { "name": "Beta-APP40", "isPreferred": "false"} , { "name": "C80", "isPreferred": "true"} , { "name": "AID(50)", "isPreferred": "false"} , { "name": "CVAP", "isPreferred": "false"} , { "name": "AICD-59", "isPreferred": "false"} , { "name": "C83", "isPreferred": "true"} , { "name": "ABPP", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "P05067", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "166"} ], "id": "56", "contexts": { "context": { "id": 63} } , "evidences": ["Imported from database"], "value": "C83", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P05067"} , { "elementOf": "ENSEMBL", "accession": "ENST00000440126"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000284981"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000346129"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000387483"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000345463"} , { "elementOf": "ENSEMBL", "accession": "ENST00000357903"} , { "elementOf": "ENSEMBL", "accession": "ENST00000348990"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000142192"} , { "elementOf": "ENSEMBL", "accession": "ENST00000358918"} , { "elementOf": "ENSEMBL", "accession": "ENST00000346798"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000351796"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000350578"} , { "elementOf": "ENSEMBL", "accession": "ENST00000354192"} ]} , { "annotation": "[VARIANT AD1 GLY-692]", "conames": [{ "name": "PMID: 1303239", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1303239", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[Codon,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene."} , { "attrname": "Abstract", "value": "Several families with an early-onset form of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> have been found to harbour mutations at a specific codon (717) of the gene for the beta-amyloid precursor protein (APP) on chromosome 21. We now report,  a novel base mutation in the same exon of the APP gene which co-segregates in one family with presenile dementia and cerebral haemorrhage due to cerebral amyloid angiopathy. The mutation results in the substitution of alanine into glycine at codon 692. These results suggest that the clinically distinct entities,  presenile dementia and cerebral amyloid angiopathy,  can be caused by the same mutation in the APP gene. "} , { "attrname": "MeSH", "value": "[Cerebral Hemorrhage,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Codon,  DNA Mutational Analysis,  Pedigree,  Adult,  Cerebral Amyloid Angiopathy,  Female,  Amyloid beta-Protein Precursor,  Dementia,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[L Hendriks,  C M van Duijn,  P Cras,  M Cruts,  W Van Hul,  F van Harskamp,  A Warren,  M G McInnis,  S E Antonarakis,  J J Martin]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 GLY-692]"} ], "id": "57", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1303239", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1303239"} , { "elementOf": "DOI", "accession": "10.1038\/NG0692-218"} ]} , { "annotation": "[INTERACTION WITH KIAA1191]", "conames": [{ "name": "PMID: 21153684", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21153684", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular and cellular biochemistry"} , { "attrname": "Chemical", "value": "[EC 1.- p33MONOX protein,  human,  Nerve Tissue Proteins,  EC 1.- Mixed Function Oxygenases,  EC 1.- p33MONOX protein,  mouse,  EC 1.- p33MONOX protein,  rat]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Characterizing the novel protein p33MONOX."} , { "attrname": "Abstract", "value": "The novel protein p33MONOX (p33Monooxygenase) was over-expressed in neuroblastoma cells demonstrating its inhibitory effect on the phosphorylation of the App (amyloid precursor protein) and Bcl2 (B-cell lymphoma 2) proteins but mediating higher activation of Mapk1\/3 (mitogen-activated protein kinase 1\/3). We employed a variety of cell biology techniques to show the localization of p33MONOX to the cytoplasm of pyramidal neurons in the mouse brain hippocampus. We also carried out a yeast-two-hybrid screening plus co-immunoprecipitation and bio-informatics to determine COBRA1 (cofactor of BRCA1 (breast cancer type 1)),  NOL12 (nucleolar protein 12),  and PRNP (prion protein) as p33MONOX-interacting proteins. Bio-computational analyses revealed a flavine-containing monooxygenase (FMO)-1 motif,  thus linking p33MONOX to a group of previously characterized proteins,  the MICALs (molecule interacting with CasL). Concluding,  p33MONOX might regulate pre- and post-transcriptional control of dynamic processes related to growth cone guidance. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Mice,  Inbred C57BL,  Cells,  Cultured,  Molecular Sequence Data,  Rats,  Nerve Tissue Proteins,  PC12 Cells,  Mixed Function Oxygenases,  Axons,  Sequence Analysis,  Protein,  Animals,  Transfection,  Cloning,  Molecular,  Mice,  Pyramidal Cells]"} , { "attrname": "AUTHORS", "value": "[Manisha Mishra,  Noriko Inoue,  Klaus Heese]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH KIAA1191]"} ], "id": "58", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21153684", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1007\/S11010-010-0690-4"} , { "elementOf": "NLM", "accession": "21153684"} ]} , { "annotation": "[INTERACTION WITH PLD3]", "conames": [{ "name": "PMID: 24336208", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24336208", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[APP protein,  human,  amyloid beta-protein (1-40),  EC 3.1.4.4 Phospholipase D,  Peptide Fragments,  amyloid beta-protein (1-42),  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  EC 3.1.4.4 phospholipase D3,  human]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease."} , { "attrname": "Abstract", "value": "Genome-wide association studies (GWAS) have identified several risk variants for late-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (LOAD). These common variants have replicable but small effects on LOAD risk and generally do not have obvious functional effects. Low-frequency coding variants,  not detected by GWAS,  are predicted to include functional variants with larger effects on risk. To identify low-frequency coding variants with large effects on LOAD risk,  we carried out whole-exome sequencing (WES) in 14 large LOAD families and follow-up analyses of the candidate variants in several large LOAD case-control data sets. A rare variant in PLD3 (phospholipase D3; Val232Met) segregated with <span style=\"background-color: yellow\"><b>disease<\/b><\/span> status in two independent families and doubled risk for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in seven independent case-control series with a total of more than 11, 000 cases and controls of European descent. Gene-based burden analyses in 4, 387 cases and controls of European descent and 302 African American cases and controls,  with complete sequence data for PLD3,  reveal that several variants in this gene increase risk for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in both populations. PLD3 is highly expressed in brain regions that are vulnerable to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathology,  including hippocampus and cortex,  and is expressed at significantly lower levels in neurons from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains compared to control brains. Overexpression of PLD3 leads to a significant decrease in intracellular amyloid-? precursor protein (APP) and extracellular A?42 and A?40 (the 42- and 40-residue isoforms of the amyloid-? peptide),  and knockdown of PLD3 leads to a significant increase in extracellular A?42 and A?40. Together,  our genetic and functional data indicate that carriers of PLD3 coding variants have a twofold increased risk for LOAD and that PLD3 influences APP processing. This study provides an example of how densely affected families may help to identify rare variants with large effects on risk for <span style=\"background-color: yellow\"><b>disease<\/b><\/span> or other complex traits. "} , { "attrname": "MeSH", "value": "[Brain,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Peptide Fragments,  Europe,  Humans,  African Americans,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Case-Control Studies,  Phospholipase D,  Exome,  Genetic Variation,  Proteolysis,  Age of Onset,  Amyloid beta-Peptides,  Aged,  80 and over,  Female,  Aged,  Protein Processing,  Post-Translational,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Carlos Cruchaga,  Celeste M Karch,  Sheng Chih Jin,  Bruno A Benitez,  Yefei Cai,  Rita Guerreiro,  Oscar Harari,  Joanne Norton,  John Budde,  Sarah Bertelsen,  Amanda T Jeng,  Breanna Cooper,  Tara Skorupa,  David Carrell,  Denise Levitch,  Simon Hsu,  Jiyoon Choi,  Mina Ryten,   UK Brain Expression Consortium,  John Hardy,  Mina Ryten,  Daniah Trabzuni,  Michael E Weale,  Adaikalavan Ramasamy,  Colin Smith,  Celeste Sassi,  Jose Bras,  J Raphael Gibbs,  Dena G Hernandez,  Michelle K Lupton,  John Powell,  Paola Forabosco,  Perry G Ridge,  Christopher D Corcoran,  Joann T Tschanz,  Maria C Norton,  Ronald G Munger,  Cameron Schmutz,  Maegan Leary,  F Yesim Demirci,  Mikhil N Bamne,  Xingbin Wang,  Oscar L Lopez,  Mary Ganguli,  Christopher Medway,  James Turton,  Jenny Lord,  Anne Braae,  Imelda Barber,  Kristelle Brown,   <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>\u2019s Research UK Consortium,  Peter Passmore,  David Craig,  Janet Johnston,  Bernadette McGuinness,  Stephen Todd,  Reinhard Heun,  Heike Klsch,  Patrick G Kehoe,  Nigel M Hooper,  Emma R L C Vardy,  David M Mann,  Stuart Pickering-Brown,  Kristelle Brown,  Noor Kalsheker,  James Lowe,  Kevin Morgan,  A David Smith,  Gordon Wilcock,  Donald Warden,  Clive Holmes,  Pau Pastor,  Oswaldo Lorenzo-Betancor,  Zoran Brkanac,  Erick Scott,  Eric Topol,  Kevin Morgan,  Ekaterina Rogaeva,  Andrew B Singleton,  John Hardy,  M Ilyas Kamboh,  Peter St George-Hyslop,  Nigel Cairns,  John C Morris,  John S K Kauwe,  Alison M Goate]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH PLD3]"} ], "id": "59", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24336208", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE12825"} , { "elementOf": "NLM", "accession": "24336208"} ]} , { "annotation": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]", "conames": [{ "name": "PMID: 10899933", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10899933", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-2,  Presenilin-1,  RBPJ protein,  human,  Protease Inhibitors,  Repressor Proteins,  147336-22-9 Green Fluorescent Proteins,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  NOTCH1 protein,  human,  Receptors,  Cell Surface,  30KYC7MIAI Aspartic Acid,  EC 1.13.12.- Luciferases,  Recombinant Fusion Proteins,  Nuclear Proteins,  Membrane Proteins,  PSEN2 protein,  human,  EC 3.4.- Endopeptidases,  Immunoglobulin J Recombination Signal Sequence-Binding Protein,  Transcription Factors,  Receptor,  Notch1,  Luminescent Proteins,  PSEN1 protein,  human,  DNA-Binding Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling."} , { "attrname": "Abstract", "value": "It has been hypothesized that a presenilin 1 (PS1)-related enzymatic activity is responsible for proteolytic cleavage of the C-terminal intracellular protein of Notch1,  in addition to its role in beta-amyloid protein (Abeta) formation from the amyloid precursor protein (APP). We developed an assay to monitor ligand-induced Notch1 proteolysis and nuclear translocation in individual cells :  Treatment of full-length Notch1-enhanced green fluorescent protein-transfected Chinese hamster ovary (CHO) cells with a soluble preclustered form of the physiologic ligand Delta leads to rapid accumulation of the C terminus of Notch1 in the nucleus and to transcriptional activation of a C-promoter binding factor 1 (CBF1) reporter construct. Nuclear translocation was blocked by cotransfection with Notch's physiologic inhibitor Numb. Using this assay,  we now confirm and extend the observation that PS1 is involved in Notch1 nuclear translocation and signaling in mammalian cells. We demonstrate that the D257A and the D385A PS1 mutations,  which had been shown previously to block APP gamma-secretase activity,  also prevent Notch1 cleavage and translocation to the nucleus but do not alter Notch1 trafficking to the cell surface. We also show that two APP gamma-secretase inhibitors block Notch1 nuclear translocation with an IC(50) similar to that reported for APP gamma-secretase. Notch1 signaling,  assessed by measuring the activity of CBF1,  a downstream transcription factor,  was impaired but not abolished by the PS1 aspartate mutations or gamma-secretase inhibitors. Our results support the hypotheses that (a) PS1-dependent APP gamma-secretase-like enzymatic activity is critical for both APP and Notch processing and (b) the Notch1 signaling pathway remains partially activated even when Notch1 proteolytic processing and nuclear translocation are markedly inhibited. The latter is an important finding from the perspective of therapeutic treatment of Alzheimer's disease by targeting gamma-secretase processing of APP to reduce Abeta production. "} , { "attrname": "MeSH", "value": "[Green Fluorescent Proteins,  Presenilin-2,  Presenilin-1,  Humans,  Protease Inhibitors,  Repressor Proteins,  Transcriptional Activation,  Receptors,  Cell Surface,  Aspartic Acid,  Recombinant Fusion Proteins,  Transfection,  Luciferases,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Genes,  Reporter,  Luminescent Proteins,  CHO Cells,  DNA-Binding Proteins,  Cricetinae,  Nuclear Proteins,  Membrane Proteins,  Point Mutation,  Animals,  Immunoglobulin J Recombination Signal Sequence-Binding Protein,  Transcription Factors,  Receptor,  Notch1,  Endopeptidases,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[O Berezovska,  C Jack,  P McLean,  J C Aster,  C Hicks,  W Xia,  M S Wolfe,  W T Kimberly,  G Weinmaster,  D J Selkoe,  B T Hyman]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]"} ], "id": "60", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10899933", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10899933"} , { "elementOf": "DOI", "accession": "10.1046\/J.1471-4159.2000.0750583.X"} ]} , { "annotation": "[VARIANTS AD3 THR-233 AND THR-278]", "conames": [{ "name": "PMID: 9172170", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9172170", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Two novel (M233T and R278T) presenilin-1 mutations in early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype."} , { "attrname": "Abstract", "value": "Eleven early-onset dementia families,  all with affected individuals who have either presented clinical symptoms of early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOFAD) or have been confirmed to have EOFAD by autopsy,  and two early onset cases with biopsy-confirmed AD pathology,  were screened for missense mutations in the entire coding region of presenilin-1 (PS-1) and -2 (PS-2) genes. Missense mutations were detected by direct sequence analysis of PCR products amplified from genomic DNA templates of affected individuals. Three pedigrees were attributable to known mutations in the PS-1 gene:  P264L,  E280A and the splice acceptor site (G to T) mutation,  which results in the deletion of residues 290-319 of PS-1 (PS-1 delta 290-319). In a fourth pedigree,  a novel PS-1 mutation was identified in exon 7 (M233T),  which is homologous to a pathogenic PS-2 mutation (M239V),  and is characterized by a very early average age of onset (before the age of 35). In one early onset case,  another novel PS-1 mutation was identified in exon 8 (R278T). Of the five remaining families and the other early onset case,  none have missense mutations in the PS-1 or PS-2 genes,  or in exon 16 and 17 of the APP gene. Moreover,  two of the PS-1 mutations,  PS-1 delta 290-319 and R278T,  are associated with the co-presentation of familial spastic paraparesis (FSP) in some of the affected family members. Our data raise the possibility that the phenotypic spectrum associated with PS-1 mutations may extend beyond typical FAD to include FSP,  a <span style=\"background-color: yellow\"><b>disease<\/b><\/span> heretofore unsuspected to bear any relationship to FAD. In addition,  our data suggest that other novel EOFAD loci,  in addition to APP and the presenilin genes,  are involved in the aetiology of up to 50% of EOFAD cases. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Genetic Testing,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Point Mutation,  Phenotype,  Pedigree,  Age of Onset,  Adult,  Female]"} , { "attrname": "AUTHORS", "value": "[J B Kwok,  K Taddei,  M Hallupp,  C Fisher,  W S Brooks,  G A Broe,  J Hardy,  M J Fulham,  G A Nicholson,  R Stell,  P H St George Hyslop,  P E Fraser,  B Kakulas,  R Clarnette,  N Relkin,  S E Gandy,  P R Schofield,  R N Martins]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 THR-233 AND THR-278]"} ], "id": "61", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9172170", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9172170"} , { "elementOf": "DOI", "accession": "10.1097\/00001756-199704140-00043"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-441 AND TYR-497]", "conames": [{ "name": "PMID: 26091039", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "26091039", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cell"} , { "attrname": "Chemical", "value": "[Blood Proteins,  Extracellular Matrix Proteins,  Phosphoproteins,  EC 2.7.11.1 Casein Kinase I,  EC 2.7.11.1 FAM20C protein,  human,  Cerebrospinal Fluid Proteins]"} , { "attrname": "YEAR", "value": "2015"} , { "attrname": "AbstractHeader", "value": "A Single Kinase Generates the Majority of the Secreted Phosphoproteome."} , { "attrname": "Abstract", "value": "The existence of extracellular phosphoproteins has been acknowledged for over a century. However,  research in this area has been undeveloped largely because the kinases that phosphorylate secreted proteins have escaped identification. Fam20C is a kinase that phosphorylates S-x-E\/pS motifs on proteins in milk and in the extracellular matrix of bones and teeth. Here,  we show that Fam20C generates the majority of the extracellular phosphoproteome. Using CRISPR\/Cas9 genome editing,  mass spectrometry,  and biochemistry,  we identify more than 100 secreted phosphoproteins as genuine Fam20C substrates. Further,  we show that Fam20C exhibits broader substrate specificity than previously appreciated. Functional annotations of Fam20C substrates suggest roles for the kinase beyond biomineralization,  including lipid homeostasis,  wound healing,  and cell migration and adhesion. Our results establish Fam20C as the major secretory pathway protein kinase and serve as a foundation for new areas of investigation into the role of secreted protein phosphorylation in human biology and disease. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Secretory Pathway,  Molecular Sequence Data,  Substrate Specificity,  Gene Knockout Techniques,  Casein Kinase I,  Cell Adhesion,  Cerebrospinal Fluid Proteins,  Blood Proteins,  Extracellular Matrix Proteins,  Phosphoproteins,  Gene Ontology,  Cell Movement]"} , { "attrname": "AUTHORS", "value": "[Vincent S Tagliabracci,  Sandra E Wiley,  Xiao Guo,  Lisa N Kinch,  Eric Durrant,  Jianzhong Wen,  Junyu Xiao,  Jixin Cui,  Kim B Nguyen,  James L Engel,  Joshua J Coon,  Nick Grishin,  Lorenzo A Pinna,  David J Pagliarini,  Jack E Dixon]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-441 AND TYR-497]"} ], "id": "62", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 26091039", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.CELL.2015.05.028"} , { "elementOf": "NLM", "accession": "26091039"} ]} , { "annotation": "[INTERACTION OF BETA-APP42 WITH CHRNA7]", "conames": [{ "name": "PMID: 10681545", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10681545", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[SY7Q814VUP Calcium,  Peptide Fragments,  nicotinic acetylcholine receptor alpha4 subunit,  amyloid beta-protein (1-42),  Nicotinic Agonists,  Receptors,  Nicotinic,  N9YNS0M02X Acetylcholine,  Amyloid beta-Peptides,  88813-36-9 Galanin,  Culture Media,  Serum-Free]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathology."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathology is characterized by the presence of neuritic plaques and the loss of cholinergic neurons in the brain. The underlying mechanisms leading to these events are unclear,  but the 42-amino acid beta-amyloid peptide (Abeta(1-42)) is involved. Immunohistochemical studies on human sporadic <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains demonstrate that Abeta(1-42) and a neuronal pentameric cation channel,  the alpha7 nicotinic acetylcholine receptor (alpha7nAChR),  are both present in neuritic plaques and co-localize in individual cortical neurons. Using human brain tissues and cells that overexpress either alpha7nAChR or amyloid precursor protein as the starting material,  Abeta(1-42) and alpha7nAChR can be co-immunoprecipitated by the respective specific antibodies,  suggesting that they are tightly associated. The formation of the alpha7nAChR.Abeta(1-42) complex can be efficiently suppressed by Abeta(12-28),  implying that this Abeta sequence region contains the binding epitope. Receptor binding experiments show that Abeta(1-42) and alpha7nAChR bind with high affinity,  and this interaction can be inhibited by alpha7nAChR ligands. Human neuroblastoma cells overexpressing alpha7nAChR are readily killed by Abeta(1-42),  whereas alpha7nAChR agonists such as nicotine and epibatidine offered protection. Because Abeta(1-42) inhibits alpha7nAChR-dependent calcium activation and acetylcholine release,  two processes critically involved in memory and cognitive functions,  and the distribution of alpha7nAChR correlates with neuritic plaques in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains,  we propose that interaction of the alpha7nAChR and Abeta(1-42) is a pivotal mechanism involved in the pathophysiology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Peptide Fragments,  Calcium,  Galanin,  Receptors,  Nicotinic,  Neurons,  Humans,  Middle Aged,  Cerebral Cortex,  Culture Media,  Serum-Free,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Case-Control Studies,  Precipitin Tests,  Dose-Response Relationship,  Drug,  Plaque,  Amyloid,  Nicotinic Agonists,  Amyloid beta-Peptides,  Cell Death,  Aged,  80 and over,  Protein Binding,  Female,  Acetylcholine,  Aged,  Hippocampus]"} , { "attrname": "AUTHORS", "value": "[H Y Wang,  D H Lee,  M R D'Andrea,  P A Peterson,  R P Shank,  A B Reitz]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION OF BETA-APP42 WITH CHRNA7]"} ], "id": "63", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10681545", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.275.8.5626"} , { "elementOf": "NLM", "accession": "10681545"} ]} , { "annotation": "[VARIANTS AD3 ARG-134; ARG-163 AND VAL-262,  VARIANT TYR-214]", "conames": [{ "name": "PMID: 22503161", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22503161", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurobiology of aging"} , { "attrname": "Chemical", "value": "[Presenilin-1,  Genetic Markers,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients."} , { "attrname": "Abstract", "value": "In order to assess the frequency of mutations in the known <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> causative genes in Turkish dementia patients we screened amyloid precursor protein (APP),  PSEN1 and PSEN2 for mutations in a cohort of 98 Turkish dementia families. Six families were found to carry PSEN1 mutations (p.H163R,  p.P264L,  and p.H214Y) or variants suggested to cause the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (p.L134R,  p.L262V,  and p.A396T). In 4 other families,  previously reported PSEN2 variants were identified (p.R62H,  p.R71W,  p.M174V (n = 2),  and p.S130L). The phenotype of the carriers varied from rapid progressing <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> to frontotemporal dementia,  with spasticity and seizures also observed. Here we report a frequency of 11.2% of mutations and variants in the known <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> genes in the dementia cohort studied and 24% in the early onset subgroup of patients,  suggesting that mutations in these genes are not uncommon in Turkey and are associated with various phenotypes. We thus believe that genetic analysis should become a standardized diagnostic implement,  not only for the identification of the genetic <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  but also for appropriate genetic counseling. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Presenilin-1,  Prevalence,  Humans,  Middle Aged,  Risk Factors,  Male,  Genetic Markers,  Genetic Variation,  Turkey,  Female,  Aged,  Polymorphism,  Single Nucleotide,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Ebba Lohmann,  Rita J Guerreiro,  Nihan Erginel-Unaltuna,  Nicole Gurunlian,  Basar Bilgic,  Hakan Gurvit,  Hasmet A Hanagasi,  Nga Luu,  Murat Emre,  Andrew Singleton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 ARG-134; ARG-163 AND VAL-262,  VARIANT TYR-214]"} ], "id": "64", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22503161", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22503161"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEUROBIOLAGING.2012.02.020"} ]} , { "annotation": "[INTERACTION WITH SORL1,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 16174740", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16174740", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[LDL-Receptor Related Proteins,  Membrane Transport Proteins,  Receptors,  LDL,  SORL1 protein,  human,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Neuronal sorting protein-related receptor sorLA\/LR11 regulates processing of the amyloid precursor protein."} , { "attrname": "Abstract", "value": "sorLA (Sorting protein-related receptor) is a type-1 membrane protein of unknown function that is expressed in neurons. Its homology to sorting receptors that shuttle between the plasma membrane,  endosomes,  and the Golgi suggests a related function in neuronal trafficking processes. Because expression of sorLA is reduced in the brain of patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD),  we tested involvement of this receptor in intracellular transport and processing of the amyloid precursor protein (APP) to the amyloid beta-peptide (Abeta),  the principal component of senile plaques. We demonstrate that sorLA interacts with APP in vitro and in living cells and that both proteins colocalize in endosomal and Golgi compartments. Overexpression of sorLA in neurons causes redistribution of APP to the Golgi and decreased processing to Abeta,  whereas ablation of sorLA expression in knockout mice results in increased levels of Abeta in the brain similar to the situation in AD patients. Thus,  sorLA acts as a sorting receptor that protects APP from processing into Abeta and thereby reduces the burden of amyloidogenic peptide formation. Consequently,  reduced receptor expression in the human brain may increase Abeta production and plaque formation and promote spontaneous AD. "} , { "attrname": "MeSH", "value": "[Brain,  Cricetinae,  Cricetulus,  LDL-Receptor Related Proteins,  Humans,  Receptors,  LDL,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Mice,  Knockout,  Protein Transport,  Golgi Apparatus,  Plaque,  Amyloid,  Animals,  Membrane Transport Proteins,  Mice,  Protein Processing,  Post-Translational,  Amyloid beta-Protein Precursor,  CHO Cells,  Endosomes]"} , { "attrname": "AUTHORS", "value": "[Olav M Andersen,  Juliane Reiche,  Vanessa Schmidt,  Michael Gotthardt,  Robert Spoelgen,  Joachim Behlke,  Christine A F von Arnim,  Tilman Breiderhoff,  Pernille Jansen,  Xin Wu,  Kelly R Bales,  Roberto Cappai,  Colin L Masters,  Jrgen Gliemann,  Elliott J Mufson,  Bradley T Hyman,  Steven M Paul,  Anders Nykjaer,  Thomas E Willnow]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH SORL1,  SUBCELLULAR LOCATION]"} ], "id": "65", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16174740", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16174740"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0503689102"} ]} , { "annotation": "[VARIANT GLY-318]", "conames": [{ "name": "PMID: 9851443", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9851443", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Apolipoprotein E4,  Presenilin-1,  Apolipoproteins E,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease."} , { "attrname": "Abstract", "value": "In early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) pathogenic mutations have been found in the amyloid precursor protein (APP) gene and in the presenilin (PS)-1 and PS-2 genes. We screened for mutations in these genes in 20 patients with familial AD from the Finnish population. In addition,  we sampled 41 sporadic AD patients and 59 controls to test for mutations identified in our familial AD cases. We detected an A-to-G transition in the PS-1 gene,  resulting in a glutamic acid (Glu)-to-glycine (Gly) substitution at codon 318 in 2 familial and 2 sporadic AD patients. The Glu318Gly mutation has previously been reported to cause AD. We also found the Glu318Gly mutation in 4 healthy aged controls (range,  74-87 years). We thus conclude that the mutation is most likely a rare polymorphism not related to AD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Apolipoprotein E4,  Presenilin-1,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Base Sequence,  Aged,  80 and over,  Female,  Aged,  Apolipoproteins E,  Mutation,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[K M Mattila,  C Forsell,  T Pirttil,  J O Rinne,  T Lehtimki,  M Rytt,  L Lilius,  A Eerola,  P H St George-Hyslop,  H Frey,  L Lannfelt]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GLY-318]"} ], "id": "66", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9851443", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9851443"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.410440617"} ]} , { "annotation": "[FUNCTION]", "conames": [{ "name": "PMID: 10593990", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10593990", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-1,  Receptors,  Notch,  EC 3.4.- Endopeptidases,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  EC 3.4.23.46 Bace1 protein,  mouse,  Receptors,  Cell Surface,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Cell surface presenilin-1 participates in the gamma-secretase-like proteolysis of Notch."} , { "attrname": "Abstract", "value": "Presenilin-1 (PS1),  a polytopic membrane protein primarily localized to the endoplasmic reticulum,  is required for efficient proteolysis of both Notch and beta-amyloid precursor protein (APP) within their trans- membrane domains. The activity that cleaves APP (called gamma-secretase) has properties of an aspartyl protease,  and mutation of either of the two aspartate residues located in adjacent transmembrane domains of PS1 inhibits gamma-secretase processing of APP. We show here that these aspartates are required for Notch processing,  since mutation of these residues prevents PS1 from inducing the gamma-secretase-like proteolysis of a Notch1 derivative. Thus PS1 might function in Notch cleavage as an aspartyl protease or di-aspartyl protease cofactor. However,  the ER localization of PS1 is inconsistent with that hypothesis,  since Notch cleavage occurs near the cell surface. Using pulse-chase and biotinylation assays,  we provide evidence that PS1 binds Notch in the ER\/Golgi and is then co-transported to the plasma membrane as a complex. PS1 aspartate mutants were indistinguishable from wild-type PS1 in their ability to bind Notch or traffic with it to the cell surface,  and did not alter the secretion of Notch. Thus,  PS1 appears to function specifically in Notch proteolysis near the plasma membrane as an aspartyl protease or cofactor. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Signal Transduction,  Humans,  Receptors,  Cell Surface,  Membrane Proteins,  Receptors,  Notch,  Animals,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Mice,  Mutation,  Endopeptidases,  3T3 Cells]"} , { "attrname": "AUTHORS", "value": "[W J Ray,  M Yao,  J Mumm,  E H Schroeter,  P Saftig,  M Wolfe,  D J Selkoe,  R Kopan,  A M Goate]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION]"} ], "id": "67", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10593990", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.274.51.36801"} , { "elementOf": "NLM", "accession": "10593990"} ]} , { "annotation": "[VARIANTS AD3 VAL-79; CYS-115 AND VAL-231,  VARIANT GLY-318]", "conames": [{ "name": "PMID: 9384602", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9384602", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Two closely related genes,  the presenilins ( PS ),  located at chromosomes 14q24.3 and 1q42.1,  have been identified for autosomal dominant <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) with onset age below 65 years (presenile AD). We performed a systematic mutation analysis of all coding and 5'-non-coding exons of PS -1 and PS -2 in a population-based epidemiological series of 101 unrelated familial and sporadic presenile AD cases. The familial cases included 10 patients of autosomal dominant AD families sampled for linkage analysis studies. In all patients mutations in the amyloid precursor protein gene ( APP ) had previously been excluded. Four different PS -1 missense mutations were identified in six familial cases,  two of which where autosomal dominant cases. Three mutations resulted in onset ages above 55 years,  with one segregating in an autosomal dominant family with mean onset age 64 years (range 50-78 years). One PS -2 mutation was identified in a sporadic case with onset age 62 years. Our mutation data provided estimates for PS -1 and PS -2 mutation frequencies in presenile AD of 6 and 1% respectively. When family history was accounted for mutation frequencies for PS -1 were 9% in familial cases and 18% in autosomal dominant cases. Further,  polymorphisms were detected in the promoter and the 5'-non-coding region of PS -1 and in intronic and exonic sequences of PS -2 that will be useful in genetic association studies. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-2,  Presenilin-1,  Humans,  Middle Aged,  Female,  Male,  Aged,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[M Cruts,  C M van Duijn,  H Backhovens,  M Van den Broeck,  A Wehnert,  S Serneels,  R Sherrington,  M Hutton,  J Hardy,  P H St George-Hyslop,  A Hofman,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 VAL-79; CYS-115 AND VAL-231,  VARIANT GLY-318]"} ], "id": "68", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9384602", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9384602"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/7.1.43"} ]} , { "annotation": "[PROTEASE-SPECIFICITY OF INHIBITOR DOMAIN]", "conames": [{ "name": "PMID: 1969731", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1969731", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[9088-41-9 Trypsin Inhibitor,  Kunitz Soybean,  Protein Precursors,  EC 3.4.- Peptide Hydrolases,  Amyloid,  EC 3.4.21.7 Fibrinolysin,  EC 3.4.21.4 Trypsin,  EC 3.4.- tosylarginine methyl ester hydrolase,  Amyloid beta-Protein Precursor,  Trypsin Inhibitors]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursor."} , { "attrname": "Abstract", "value": "The putative inhibitor domain of Alzheimer's disease amyloid protein precursor was purified from E. coli containing a synthetic gene encoding the Kunitz domain. The purified protein (A4 inhibitor) inhibited the activity of trypsin,  forming a 1: 1 molar complex with the enzyme. It also strongly inhibited plasmin (Ki = 7.5 x 10(-11) M) from human serum and tryptase (Ki = 2.2 x 10(-10) M) from rat mast cells (tryptase M). In addition,  it inhibited rat pancreatic trypsin,  alpha-chymotrypsin and kallikrein and human serum kallikrein,  but did not inhibit rat chymase,  pancreatic elastase,  alpha-thrombin,  urokinase,  papain or cathepsin B. "} , { "attrname": "MeSH", "value": "[Fibrinolysin,  Amino Acid Sequence,  Escherichia coli,  Humans,  Trypsin Inhibitor,  Kunitz Soybean,  Genes,  Synthetic,  Molecular Sequence Data,  Rats,  Substrate Specificity,  Trypsin,  Animals,  Cloning,  Molecular,  Protein Precursors,  Amyloid,  Peptide Hydrolases,  Kinetics,  Amyloid beta-Protein Precursor,  Trypsin Inhibitors,  Mast Cells]"} , { "attrname": "AUTHORS", "value": "[H Kido,  A Fukutomi,  J Schilling,  Y Wang,  B Cordell,  N Katunuma]"} , { "attrname": "PUB_TYPE", "value": "[PROTEASE-SPECIFICITY OF INHIBITOR DOMAIN]"} ], "id": "69", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1969731", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0006-291X(90)92084-D"} , { "elementOf": "NLM", "accession": "1969731"} ]} , { "annotation": "[VARIANT AD1 ILE-717]", "conames": [{ "name": "PMID: 8577393", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8577393", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "DNA from the probands of seven Australian families with hereditary <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was screened for the presence of known mutations in the amyloid precursor protein (APP) gene on chromosome 21 using single stranded conformational polymorphism (SSCP) analysis [14]. One subject was found to have a mutation causing a Val-->Ile substitution at position 717. This was confirmed by restriction enzyme digestion and sequencing. The mutation has been found in both the other affected family members available for study and in two at-risk relatives. It was not present in the only living unaffected relative who has passed the usual age of onset in this family. There is so far no evidence that apolipoprotein E (APOE) genotype influences age of onset in this family,  though numbers are small. Two other families with autopsy confirmation and age of onset in the fifth decade had no APP mutation and are thought likely to have a mutation on chromosome 14 on the basis of their earlier onset age. "} , { "attrname": "MeSH", "value": "[Pedigree,  Base Sequence,  Humans,  Molecular Sequence Data,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Australia,  Chromosomes,  Human,  Pair 21,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[W S Brooks,  R N Martins,  J De Voecht,  G A Nicholson,  P R Schofield,  J B Kwok,  C Fisher,  L U Yeung,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-717]"} ], "id": "70", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8577393", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8577393"} , { "elementOf": "DOI", "accession": "10.1016\/0304-3940(95)12046-7"} ]} , { "annotation": "[INTERACTION WITH GSAP]", "conames": [{ "name": "PMID: 20811458", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20811458", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Proteins,  8A1O1M485B Imatinib Mesylate,  EC 3.4.- Amyloid Precursor Protein Secretases,  Notch1 protein,  mouse,  Peptide Fragments,  Pyrimidines,  Piperazines,  Amyloid beta-Peptides,  Benzamides,  Receptor,  Notch1,  Amyloid beta-Protein Precursor,  gamma-secretase activating protein,  mouse]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease."} , { "attrname": "Abstract", "value": "Accumulation of neurotoxic amyloid-beta is a major hallmark of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Formation of amyloid-beta is catalysed by gamma-secretase,  a protease with numerous substrates. Little is known about the molecular mechanisms that confer substrate specificity on this potentially promiscuous enzyme. Knowledge of the mechanisms underlying its selectivity is critical for the development of clinically effective gamma-secretase inhibitors that can reduce amyloid-beta formation without impairing cleavage of other gamma-secretase substrates,  especially Notch,  which is essential for normal biological functions. Here we report the discovery of a novel gamma-secretase activating protein (GSAP) that drastically and selectively increases amyloid-beta production through a mechanism involving its interactions with both gamma-secretase and its substrate,  the amyloid precursor protein carboxy-terminal fragment (APP-CTF). GSAP does not interact with Notch,  nor does it affect its cleavage. Recombinant GSAP stimulates amyloid-beta production in vitro. Reducing GSAP concentrations in cell lines decreases amyloid-beta concentrations. Knockdown of GSAP in a mouse model of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> reduces levels of amyloid-beta and plaque development. GSAP represents a type of gamma-secretase regulator that directs enzyme specificity by interacting with a specific substrate. We demonstrate that imatinib,  an anticancer drug previously found to inhibit amyloid-beta formation without affecting Notch cleavage,  achieves its amyloid-beta-lowering effect by preventing GSAP interaction with the gamma-secretase substrate,  APP-CTF. Thus,  GSAP can serve as an amyloid-beta-lowering therapeutic target without affecting other key functions of gamma-secretase. "} , { "attrname": "MeSH", "value": "[Cell Line,  Peptide Fragments,  Piperazines,  Humans,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Imatinib Mesylate,  Gene Knockdown Techniques,  Proteins,  Pyrimidines,  Animals,  RNA Interference,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Mice,  Benzamides,  Receptor,  Notch1,  Amyloid beta-Protein Precursor,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Models,  Animal]"} , { "attrname": "AUTHORS", "value": "[Gen He,  Wenjie Luo,  Peng Li,  Christine Remmers,  William J Netzer,  Joseph Hendrick,  Karima Bettayeb,  Marc Flajolet,  Fred Gorelick,  Lawrence P Wennogle,  Paul Greengard]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH GSAP]"} ], "id": "71", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20811458", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE09325"} , { "elementOf": "NLM", "accession": "20811458"} ]} , { "annotation": "[VARIANTS AD3 LEU-82; HIS-115; ASP-120; THR-139; LEU-146; ILE-147; ARG-163; CYS-165; TRP-173; THR-231; THR-233; PRO-235; LEU-264; ILE-390; VAL-392 AND TYR-410,  VARIANT GLY-318]", "conames": [{ "name": "PMID: 10441572", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10441572", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Codon,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Early-onset autosomal dominant <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  prevalence,  genetic heterogeneity,  and mutation spectrum."} , { "attrname": "Abstract", "value": "To determine the prevalence of early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOAD) and of autosomal dominant forms of EOAD (ADEOAD),  we performed a population-based study in the city of Rouen (426, 710 residents). EOAD was defined as onset of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> at age <61 years,  and ADEOAD was defined as the occurrence of at least three EOAD cases in three generations. Using these stringent criteria,  we calculated that the EOAD and ADEOAD prevalences per 100, 000 persons at risk were 41.2 and 5.3,  respectively. We then performed a mutational analysis of the genes for amyloid precursor protein (APP),  presenilin 1 (PSEN1),  and presenilin 2 (PSEN2) in 34 families with ADEOAD ascertained in France. In 19 (56%) of these families,  we identified 16 distinct PSEN1 missense mutations,  including 4 (Thr147Ile,  Trp165Cys,  Leu173Trp,  and Ser390Ile) not reported elsewhere. APP mutations,  including a novel mutation located at codon 715,  were identified in 5 (15%) of the families. In the 10 remaining ADEOAD families and in 9 additional autosomal dominant <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> families that did not fulfill the strict criteria for ADEOAD,  no PSEN1,  PSEN2,  or APP mutation was identified. These results show that (1) PSEN1 and APP mutations account for 71% of ADEOAD families and (2) nonpenetrance at age <61 years is probably infrequent for PSEN1 or APP mutations. "} , { "attrname": "MeSH", "value": "[Presenilin-2,  Presenilin-1,  Prevalence,  Exons,  Humans,  Middle Aged,  Male,  Codon,  Genes,  Dominant,  DNA Mutational Analysis,  Adult,  Female,  France,  Gene Frequency,  Genotype,  Penetrance,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Heterogeneity,  Membrane Proteins,  Pedigree,  Age of Onset,  Aged,  Mutation,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[D Campion,  C Dumanchin,  D Hannequin,  B Dubois,  S Belliard,  M Puel,  C Thomas-Anterion,  A Michon,  C Martin,  F Charbonnier,  G Raux,  A Camuzat,  C Penet,  V Mesnage,  M Martinez,  F Clerget-Darpoux,  A Brice,  T Frebourg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 LEU-82; HIS-115; ASP-120; THR-139; LEU-146; ILE-147; ARG-163; CYS-165; TRP-173; THR-231; THR-233; PRO-235; LEU-264; ILE-390; VAL-392 AND TYR-410,  VARIANT GLY-318]"} ], "id": "72", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10441572", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1086\/302553"} , { "elementOf": "NLM", "accession": "10441572"} ]} , { "annotation": "[CLEAVAGE AT LEU-720]", "conames": [{ "name": "PMID: 11851430", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11851430", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Protease Inhibitors,  DNA Primers,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "A novel epsilon-cleavage within the transmembrane domain of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> amyloid precursor protein demonstrates homology with Notch processing."} , { "attrname": "Abstract", "value": "Proteolytic processing of the transmembrane domain of the amyloid precursor protein (APP) is a key component of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis. Using C-terminally tagged APP derivatives,  we have identified by amino-terminal sequencing a novel cleavage site of APP,  at Leu-49,  distal to the gamma-secretase site. This was termed -cleavage. Brefeldin A treatment and pulse-chase experiments indicate that this cleavage occurs late in the secretory pathway. The level of -cleavage is decreased by expression of presenilin-1 mutants known to impair Abeta formation,  and it is sensitive to the gamma-secretase inhibitors MDL28170 and L-685, 458. Remarkably,  it shares similarities with site 3 cleavage of Notch-1:  membrane topology,  cleavage before a valine,  dependence on presenilins,  and inhibition profile. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Protease Inhibitors,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Blotting,  Western,  Hydrolysis,  Membrane Proteins,  Animals,  Base Sequence,  Tumor Cells,  Cultured,  COS Cells,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Andreas Weidemann,  Simone Eggert,  Friedrich B M Reinhard,  Markus Vogel,  Krzysztof Paliga,  Gottfried Baier,  Colin L Masters,  Konrad Beyreuther,  Genevive Evin]"} , { "attrname": "PUB_TYPE", "value": "[CLEAVAGE AT LEU-720]"} ], "id": "73", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11851430", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11851430"} , { "elementOf": "DOI", "accession": "10.1021\/BI015794O"} ]} , { "annotation": "[VARIANTS AD1 ILE-717 AND PHE-717]", "conames": [{ "name": "PMID: 8267572", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8267572", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Amyloid beta-Peptides,  OS382OHJ8P Cyanogen Bromide,  APP717,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Characterization of amyloid fibril beta-peptide in familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with APP717 mutations."} , { "attrname": "Abstract", "value": "Amyloid fibrils were isolated from the brain tissue of two individuals who died with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  one with the phenylalanine 717 mutation in amyloid precursor protein (APP) and one with the isoleucine 717 APP mutation. After solubilization in guanidine hydrochloride and fractionation by sieve chromatography,  low molecular weight fractions were treated with cyanogen bromide to generate the beta-peptide fragment starting after the methionine at position 35. Amino acid sequence analysis of all resultant peptides identified the peptide Val-Gly-Gly-Val-Val-Ile-Ala which represents residues 36-42 of the beta-amyloid peptide. No sequence beyond position 42 was found. These findings show that the amino acid substitution at position 717 is not incorporated into the amyloid deposits and suggests that the mutation may have metabolic affects which determine pathogenesis. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Point Mutation,  Peptide Fragments,  Humans,  Amyloid beta-Peptides,  Molecular Sequence Data,  Cerebral Cortex,  Brain Chemistry,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cyanogen Bromide,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J J Liepnieks,  B Ghetti,  M Farlow,  A D Roses,  M D Benson]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD1 ILE-717 AND PHE-717]"} ], "id": "74", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8267572", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8267572"} , { "elementOf": "DOI", "accession": "10.1006\/BBRC.1993.2491"} ]} , { "annotation": "[INTERACTION OF BETA-AMYLOID WITH APOE]", "conames": [{ "name": "PMID: 10816430", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10816430", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Biochemical journal"} , { "attrname": "Chemical", "value": "[Apolipoprotein E4,  Protein Isoforms,  Amyloid beta-Peptides,  Apolipoproteins E,  Apolipoprotein E3]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides."} , { "attrname": "Abstract", "value": "The inheritance of the apolipoprotein E (apoE) epsilon4 allele is a prevailing risk factor for sporadic and familial Alzheimer's disease (AD). ApoE isoforms bind directly to Alzheimer's amyloid beta (Abeta) peptides both in vitro and in vivo. Recent studies suggest that association of apoE with lipids may modulate its interaction with Abeta. We examined the binding of lipid-associated and delipidated apoE3 and apoE4 isoforms to Abeta utilizing a solid-phase binding assay and estimated the dissociation constants for the interaction of various apoE and Abeta species. Using native apoE isoforms from stably transfected RAW 264 and human embryonic kidney 293 cells,  apoE3 had greater affinity than apoE4 for both Abeta1-40 and Abeta1-42. Delipidation of apoE decreased its affinity for Abeta peptides by 5-10-fold and abolished the isoform-specificity. Conversely,  incorporation of apoE isoforms produced by baculovirus-infected Sf9 cells into reconstituted human high-density-lipoprotein lipoparticles restored the affinity values for Abeta peptides and resulted in preferential binding of apoE3. The data demonstrate that native lipid-associated apoE3 binds to Abeta peptides with 2-3-fold higher affinity than lipid-associated apoE4. Since the isoforms' binding efficiency correlate inversely with the risk of developing late-onset AD,  the results suggest a possible involvement of apoE3 in the clearance or routing out of Abeta from the central nervous system as one of the mechanisms underlying the pathology of the disease. "} , { "attrname": "MeSH", "value": "[Apolipoprotein E4,  Cell Line,  Humans,  Macrophages,  Apolipoprotein E3,  Kidney,  Spodoptera,  Animals,  Transfection,  Protein Isoforms,  Amyloid beta-Peptides,  Apolipoproteins E,  Mice,  Kinetics]"} , { "attrname": "AUTHORS", "value": "[T Tokuda,  M Calero,  E Matsubara,  R Vidal,  A Kumar,  B Permanne,  B Zlokovic,  J D Smith,  M J Ladu,  A Rostagno,  B Frangione,  J Ghiso]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION OF BETA-AMYLOID WITH APOE]"} ], "id": "75", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10816430", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10816430"} , { "elementOf": "DOI", "accession": "10.1042\/0264-6021: 3480359"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 672-681]", "conames": [{ "name": "PMID: 3312495", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3312495", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  Neuropeptides,  Amyloid,  Amino Acids]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Amyloid angiopathy of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  amino acid composition and partial sequence of a 4, 200-dalton peptide isolated from cortical microvessels."} , { "attrname": "Abstract", "value": "The cardinal lesions of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> are neurofibrillary tangles,  senile neuritic plaques,  and vascular amyloid,  the latter generally involving cortical arteries and small arterioles. All three lesions are composed of amyloid-like,  beta-pleated sheet fibrils. Recently,  a 4, 200-dalton peptide has been isolated from extraparenchymal meningeal vessels,  neuritic plaques,  and neurofibrillary tangles. The assumption of N-terminal homogeneity in vascular amyloid has been used as an argument for a neuronal (versus blood) origin of the peptide. However,  intracortical microvessels from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> have not been previously isolated. The present studies describe the isolation of a microvessel fraction from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and control fresh autopsy human brain. <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> isolated brain microvessels that were extensively laden with amyloid and control microvessels were solubilized in 90% formic acid and analyzed by urea sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The arteriole fraction from the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s subject with extensive amyloid angiopathy contained a unique 4, 200-dalton peptide,  whereas the arterioles or capillaries isolated from two controls and two <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> subjects without angiopathy did not. This peptide was purified by HPLC and amino acid composition analysis showed the peptide is nearly identical to the 4, 200-dalton peptide recently isolated from neuritic plaques or from neurofibrillary tangles. Sequence analysis revealed N-terminal heterogeneity. The N-terminal sequence was:  Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr,  which is identical to the N-terminal sequence of the 4, 200-dalton peptide isolated previously from extraparenchymal meningeal vessels and neuritic plaques.(ABSTRACT TRUNCATED AT 250 WORDS) "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Molecular Weight,  Arterioles,  Humans,  Middle Aged,  Male,  Neuropeptides,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acids,  Vascular <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Amyloid beta-Peptides,  Aged,  80 and over,  Female,  Aged,  Amyloid,  Capillaries]"} , { "attrname": "AUTHORS", "value": "[W M Pardridge,  H V Vinters,  J Yang,  J Eisenberg,  T B Choi,  W W Tourtellotte,  V Huebner,  J E Shively]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 672-681]"} ], "id": "76", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3312495", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.1987.TB01005.X"} , { "elementOf": "NLM", "accession": "3312495"} ]} , { "annotation": "[INTERACTION WITH FBLN1]", "conames": [{ "name": "PMID: 11238726", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11238726", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Calcium-Binding Proteins,  Extracellular Matrix Proteins,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  fibulin]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Fibulin-1 binds the amino-terminal head of beta-amyloid precursor protein and modulates its physiological function."} , { "attrname": "Abstract", "value": "Genetic studies have implicated amyloid precursor protein (APP) in the pathogenesis of Alzheimer's disease. While accumulating lines of evidence indicate that APP has various functions in cells,  little is known about the proteins that modulate its biological activity. Toward this end,  we employed a two-hybrid system to identify potential interacting factors. We now report that fibulin-1,  which contains repetitive Ca(2+)-binding EGF-like elements,  binds to APP at its amino-terminal growth factor-like domain,  the region that is responsible for its neurotrophic activities. Fibulin-1 expression in the brain is confined to neurons,  and is not expressed significantly by astrocytes or microglia. Direct binding of fibulin-1 to the secreted form of APP (sAPP) was demonstrated with a pull-down assay using fragments of both fibulin-1 fused with glutathione-S transferase and sAPP,  produced in bacteria and yeast,  respectively. The fibulin-1\/sAPP heteromer was shown to form in the conditioned medium of transfected COS-7 cells. Furthermore,  fibulin-1 blocks sAPP-mediated proliferation of primary cultured rat neural stem cells. These results suggest that fibulin-1 may play a significant role in modulating the neurotrophic activities of APP. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Peptide Fragments,  Calcium-Binding Proteins,  Neurons,  Humans,  Cercopithecus aethiops,  Molecular Sequence Data,  Reverse Transcriptase Polymerase Chain Reaction,  Recombinant Fusion Proteins,  Stem Cells,  Animals,  Transfection,  Extracellular Matrix Proteins,  Cell Division,  Mice,  COS Cells,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[I Ohsawa,  C Takamura,  S Kohsaka]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH FBLN1]"} ], "id": "77", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11238726", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11238726"} , { "elementOf": "DOI", "accession": "10.1046\/J.1471-4159.2001.00144.X"} ]} , { "annotation": "[ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX]", "conames": [{ "name": "PMID: 12679784", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12679784", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature cell biology"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-1,  EC 3.4.- Peptide Hydrolases,  EC 3.4.23.- Aspartic Acid Endopeptidases,  nicastrin protein,  EC 3.4.23.46 BACE1 protein,  human,  EC 3.4.- APH1A protein,  human,  Recombinant Fusion Proteins,  Macromolecular Substances,  Membrane Proteins,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  Membrane Glycoproteins,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human,  PSENEN protein,  human]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Reconstitution of gamma-secretase activity."} , { "attrname": "Abstract", "value": "gamma-Secretase is a membrane protein complex with an unusual aspartyl protease activity that catalyses the regulated intramembranous cleavage of the beta-amyloid precursor protein (APP) to release the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD)-associated amyloid beta-peptide (Abeta) and the APP intracellular domain (AICD). Here we show the reconstitution of gamma-secretase activity in the yeast Saccharomyces cerevisiae,  which lacks endogenous gamma-secretase activity. Reconstituted gamma-secretase activity depends on the presence of four complex components including presenilin (PS),  nicastrin (Nct),  APH-1 (refs 3-6) and PEN-2 (refs 4,  7),  is associated with endoproteolysis of PS,  and produces Abeta and AICD in vitro. Thus,  the biological activity of gamma-secretase is reconstituted by the co-expression of human PS,  Nct,  APH-1 and PEN-2 in yeast. "} , { "attrname": "MeSH", "value": "[Gene Expression Regulation,  Fungal,  Cell Membrane,  Presenilin-1,  Eukaryotic Cells,  Humans,  Cells,  Cultured,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Recombinant Fusion Proteins,  Macromolecular Substances,  Gene Expression Regulation,  Enzymologic,  Membrane Proteins,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Peptide Hydrolases,  Membrane Glycoproteins,  Endopeptidases,  Saccharomyces cerevisiae,  Amyloid beta-Protein Precursor,  Genes,  Reporter]"} , { "attrname": "AUTHORS", "value": "[Dieter Edbauer,  Edith Winkler,  Joerg T Regula,  Brigitte Pesold,  Harald Steiner,  Christian Haass]"} , { "attrname": "PUB_TYPE", "value": "[ENZYME ACTIVITY OF A GAMMA-SECRETASE COMPLEX]"} ], "id": "78", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12679784", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12679784"} , { "elementOf": "DOI", "accession": "10.1038\/NCB960"} ]} , { "annotation": "[VARIANT AD3 PRO-166]", "conames": [{ "name": "PMID: 12048239", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12048239", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Peptide Fragments,  Presenilin-1,  Receptors,  Notch,  GMW67QNF9C Leucine,  amyloid beta-protein (1-42),  Amyloid beta-Peptides,  Recombinant Proteins,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production."} , { "attrname": "Abstract", "value": "The <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD)-associated presenilin (PS) proteins are required for the gamma-secretase cleavages of the beta-amyloid precursor protein and the site 3 (S3) protease cleavage of Notch. These intramembrane cleavages release amyloid-beta peptide (Abeta),  including the pathogenic 42-aa variant (Abeta(42)),  as well as the beta-amyloid precursor protein and the Notch intracellular domains (AICD,  NICD). Whereas Abeta is generated by endoproteolysis in the middle of the transmembrane domain,  AICD and NICD are generated by cleavages at analogous positions close to the cytoplasmic border of the transmembrane domain. Numerous mutations causing familial AD (FAD) that all cause increased production of Abeta(42) have been found in the PS1 gene. Here we have investigated the previously uncharacterized,  very aggressive FAD mutation L166P that causes onset of AD in adolescence. Strikingly,  the PS1 L166P mutation not only induces an exceptionally high increase of Abeta(42) production but also impairs NICD production and Notch signaling,  as well as AICD generation. Thus,  FAD-associated PS mutants cannot only affect the generation of NICD,  but also that of AICD. Moreover,  further analysis with artificial L166 mutants revealed that the gamma-secretase cleavage at position 40\/42 and the S3-like gamma-secretase cleavage at position 49 of the Abeta domain are both differentially affected by PS1 L166 mutants. Finally,  we show that PS1 L166 mutants affect the generation of NICD and AICD in a similar manner,  supporting the concept that S3 protease and S3-like gamma-secretase cleavages are mediated by identical proteolytic activities. "} , { "attrname": "MeSH", "value": "[Cell Line,  Peptide Fragments,  Presenilin-1,  Humans,  Leucine,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Kidney,  Membrane Proteins,  Receptors,  Notch,  Transfection,  Amyloid beta-Peptides,  Fibroblasts,  Mutation,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Tobias Moehlmann,  Edith Winkler,  Xuefeng Xia,  Dieter Edbauer,  Jill Murrell,  Anja Capell,  Christoph Kaether,  Hui Zheng,  Bernardino Ghetti,  Christian Haass,  Harald Steiner]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 PRO-166]"} ], "id": "79", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12048239", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12048239"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.112686799"} ]} , { "annotation": "[VARIANTS EARLY-ONSET DEMENTIA LEU-102; ALA-183 AND LYS-188]", "conames": [{ "name": "PMID: 10631141", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10631141", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Prion Proteins,  PRNP protein,  human,  Presenilin-1,  Prions,  Protein Precursors,  Amyloid,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes."} , { "attrname": "Abstract", "value": "Clinical differential diagnosis of early-onset dementia (EOD) includes familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) and hereditary prion <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. In both <span style=\"background-color: yellow\"><b>disease<\/b><\/span> entities,  postmortem brain histopathological examination is essential for unambiguous diagnosis. Mutations in the genes encoding the presenilins (PS1 and PS2) and amyloid precursor protein (APP) are associated with FAD,  whereas mutations in the prion protein (PrP) gene are associated with prion <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. To investigate the proportion of EOD attributable to known genes,  we prospectively (i.e.,  antemortem) screened these four genes for mutations by sequencing genomic PCR products from patients with EOD before age 60 years. Family history for dementia was positive (PFH) in 16 patients,  negative (NFH) in 17 patients,  and unknown (UFH) in 3 patients. In 12 patients,  we found five novel mutations (in PS1,  F105L; in PS2,  T122P and M239I; and in PrP,  Q160X and T188K) and five previously reported mutations (in APP,  in three patients who were most likely unrelated,  V717I; in PS1,  A79V and M139V; and in PrP,  P102L and T183A) that are all considered to be <span style=\"background-color: yellow\"><b>disease<\/b><\/span> causing. Of these 12 patients,  9 had PFH. This indicates a detection rate of 56% (9\/16) in patients with PFH. We found two mutations (APP V717I) in two of the three UFH patients,  and only one mutation (PrP T188K) in 1 of the 17 patients with NFH. We conclude that because of the lack of specific antemortem diagnostic markers for FAD and hereditary prion <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  all four genes should be included in a molecular diagnostic program in patients with EOD who had PFH. "} , { "attrname": "MeSH", "value": "[Presenilin-2,  Prion Proteins,  Presenilin-1,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Prion <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  DNA Mutational Analysis,  Pedigree,  Prions,  Age of Onset,  Protein Precursors,  Aged,  80 and over,  Adult,  Female,  Aged,  Amyloid,  Continental Population Groups,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[U Finckh,  T Mller-Thomsen,  U Mann,  C Eggers,  J Marksteiner,  W Meins,  G Binetti,  A Alberici,  C Hock,  R M Nitsch,  A Gal]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS EARLY-ONSET DEMENTIA LEU-102; ALA-183 AND LYS-188]"} ], "id": "80", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10631141", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10631141"} , { "elementOf": "DOI", "accession": "10.1086\/302702"} ]} , { "annotation": "[STRUCTURE BY NMR OF 696-706]", "conames": [{ "name": "PMID: 8973180", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8973180", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  33507-63-0 Substance P,  Amyloid beta-Peptides,  amyloid beta-protein (25-35)]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment."} , { "attrname": "Abstract", "value": "The three-dimensional structure of amyloid beta peptide (25-35),  which has neurotoxic activity,  in lithium dodecyl sulfate micelles was determined by two-dimensional 1H NMR spectroscopy with simulated annealing calculations. A total of 20 converged amyloid beta peptide structures were obtained on the basis of 110 experimental constraints,  including 106 distance constraints reduced from the nuclear Overhauser effect (NOE) connectivities and four torsion angle (phi) constraints. The atomic root mean square difference about averaged coordinates is 1.04 +\/- 0.25 A for the backbone atoms (N,  C alpha,  C) and 1.39 +\/- 0.27 A for all heavy atoms of the entire peptide. The molecular structure of amyloid beta peptide in membrane-mimicking environment is composed of a short alpha helix in the C terminal position. The three residues from the N-terminus are disordered,  but the remaining eight C-terminal residues are well-ordered,  which is supported by the RMSD values of the C-terminal region,  Lys28-Leu34. In this region,  the RMS differences from averaged coordinates are 0.26 +\/- 0.11 A for the backbone atoms (N,  C alpha,  C) and 0.77 +\/- 0.21 A for all heavy atoms,  which is very low compared with those for the entire peptide. The four amino acid residues from the N-terminus are hydrophilic and the other seven amino acid residues in C-terminus are hydrophobic. So,  our results show that the C-terminal region of amyloid beta peptide (25-35) is buried in the membrane and assumes alpha-helical structure,  whereas the N-terminal region is exposed to the solvent with a flexible structure. This structure is very similar to membrane-mediated structure of substance P previously reported. The three-dimensional structure of a non-neurotoxic mutant of amyloid beta peptide (25-35),  where Asn27 is replaced by Ala,  in lithium dodecyl sulfate micelles was also determined. The structure is similar to that of the wild type amyloid beta peptide (25-35) in the C-terminal region,  but the N-terminal flexible region is different. The structural comparison of amyloid beta peptide (25-35),  its non-neurotoxic mutant and substance P gives a structural basis to understand the mechanism of neurotoxicity caused by amyloid beta peptide. "} , { "attrname": "MeSH", "value": "[Sequence Homology,  Amino Acid,  Amino Acid Sequence,  Cell Membrane,  Peptide Fragments,  Magnetic Resonance Spectroscopy,  Models,  Biological,  Substance P,  Amyloid beta-Peptides,  Models,  Molecular,  Protein Conformation]"} , { "attrname": "AUTHORS", "value": "[T Kohno,  K Kobayashi,  T Maeda,  K Sato,  A Takashima]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 696-706]"} ], "id": "81", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8973180", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8973180"} , { "elementOf": "DOI", "accession": "10.1021\/BI961598J"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 36-42; 61-76; 109-129; 217-239; 270-278; 315-320; 345-352 AND 381-395 (ISOFORM 1),  IDENTIFICATION BY MASS SPECTROMETRY,  CHARACTERIZATION OF GAMMA-SECRETASE COMPLEX]", "conames": [{ "name": "PMID: 15274632", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15274632", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  368GB5141J Sodium Dodecyl Sulfate,  Peptide Fragments,  Presenilin-1,  Oligopeptides,  Peptides,  93349-26-9 1, 2-dilinolenoyl-3-(4-aminobutyryl)propane-1, 2, 3-triol,  Protease Inhibitors,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 Bace1 protein,  mouse,  Lipids,  98849-88-8 FLAG peptide,  Receptors,  Notch,  Amyloid beta-Peptides,  Membrane Glycoproteins,  amyloid beta-protein (1-40),  amyloid beta-protein (1-42),  56-12-2 gamma-Aminobutyric Acid,  EC 3.4.- Peptide Hydrolases,  nicastrin protein,  EC 3.4.23.46 BACE1 protein,  human,  184SNS8VUH Sulindac,  EC 3.4.- APH1A protein,  human,  Triglycerides,  Macromolecular Substances,  Membrane Proteins,  EC 3.4.- Endopeptidases,  6UVA8S2DEY sulindac sulfide,  PSEN1 protein,  human,  PSENEN protein,  human]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Purification and characterization of the human gamma-secretase complex."} , { "attrname": "Abstract", "value": "Gamma-secretase is a member of an unusual class of proteases with intramembrane catalytic sites. This enzyme cleaves many type I membrane proteins,  including the amyloid beta-protein (Abeta) precursor (APP) and the Notch receptor. Biochemical and genetic studies have identified four membrane proteins as components of gamma-secretase:  heterodimeric presenilin (PS) composed of its N- and C-terminal fragments (PS-NTF\/CTF),  a mature glycosylated form of nicastrin (NCT),  Aph-1,  and Pen-2. Recent data from studies in Drosophila,  mammalian,  and yeast cells suggest that PS,  NCT,  Aph-1,  and Pen-2 are necessary and sufficient to reconstitute gamma-secretase activity. However,  many unresolved issues,  in particular the possibility of other structural or regulatory components,  would be resolved by actually purifying the enzyme. Here,  we report a detailed,  multistep purification procedure for active gamma-secretase and an initial characterization of the purified protease. Extensive mass spectrometry of the purified proteins strongly suggests that PS-NTF\/CTF,  mNCT,  Aph-1,  and Pen-2 are the components of active gamma-secretase. Using the purified gamma-secretase,  we describe factors that modulate the production of specific Abeta species:  (1) phosphatidylcholine and sphingomyelin dramatically improve activity without changing cleavage specificity within an APP substrate; (2) increasing CHAPSO concentrations from 0.1 to 0.25% yields a approximately 100% increase in Abeta42 production; (3) exposure of an APP-based recombinant substrate to 0.5% SDS modulates cleavage specificity from a disease-mimicking pattern (high Abeta42\/43) to a physiological pattern (high Abeta40); and (4) sulindac sulfide directly and preferentially decreases Abeta42 cleavage within the purified complex. Taken together,  our results define a procedure for purifying active gamma-secretase and suggest that the lipid-mediated conformation of both enzyme and substrate regulate the production of the potentially neurotoxic Abeta42 and Abeta43 peptides. "} , { "attrname": "MeSH", "value": "[Peptide Fragments,  Presenilin-1,  Oligopeptides,  Peptides,  Humans,  Protease Inhibitors,  Molecular Sequence Data,  Substrate Specificity,  Lipids,  Receptors,  Notch,  Aspartic Acid Endopeptidases,  Mass Spectrometry,  Sulindac,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Membrane Glycoproteins,  CHO Cells,  gamma-Aminobutyric Acid,  Amino Acid Sequence,  Cricetinae,  Triglycerides,  Sodium Dodecyl Sulfate,  Macromolecular Substances,  Hydrolysis,  Membrane Proteins,  Animals,  Mice,  Peptide Hydrolases,  Kinetics,  Endopeptidases]"} , { "attrname": "AUTHORS", "value": "[Patrick C Fraering,  Wenjuan Ye,  Jean-Marc Strub,  Georgia Dolios,  Matthew J LaVoie,  Beth L Ostaszewski,  Alain van Dorsselaer,  Rong Wang,  Dennis J Selkoe,  Michael S Wolfe]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 36-42; 61-76; 109-129; 217-239; 270-278; 315-320; 345-352 AND 381-395 (ISOFORM 1),  IDENTIFICATION BY MASS SPECTROMETRY,  CHARACTERIZATION OF GAMMA-SECRETASE COMPLEX]"} ], "id": "82", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15274632", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15274632"} , { "elementOf": "DOI", "accession": "10.1021\/BI0494976"} ]} , { "annotation": "[FUNCTION,  ACTIVE SITES ASP-263 AND ASP-366,  MUTAGENESIS OF ASP-263 AND ASP-366]", "conames": [{ "name": "PMID: 10652302", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10652302", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-2,  Presenilin-1,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  30KYC7MIAI Aspartic Acid]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation."} , { "attrname": "Abstract", "value": "The discovery that a deficiency of presenilin 1 (PS1) decreases the production of amyloid beta-protein (Abeta) identified the presenilins as important mediators of the gamma-secretase cleavage of beta-amyloid precursor protein (APP). Recently,  we found that two conserved transmembrane (TM) aspartates in PS1 are critical for Abeta production,  providing evidence that PS1 either functions as a required diaspartyl cofactor for gamma-secretase or is itself gamma-secretase. Presenilin 2 (PS2) shares substantial sequence and possibly functional homology with PS1. Here,  we show that the two TM aspartates in PS2 are also critical for gamma-secretase activity,  providing further evidence that PS2 is functionally homologous to PS1. Cells stably co-expressing TM Asp --> Ala mutations in both PS1 and PS2 show further accumulation of the APP-derived gamma-secretase substrates,  C83 and C99. The production of Abeta is reduced to undetectable levels in the conditioned media of these cells. Furthermore,  endoproteolysis of the exogenous Asp mutant PS2 is absent,  and endogenous PS1 C-terminal fragments are diminished to undetectable levels. Therefore,  the co-expression of PS1 and PS2 TM Asp --> Ala mutants suppresses the formation of any detectable PS1 or PS2 heterodimeric fragments and essentially abolishes the production of Abeta. These results explain the residual Abeta production seen in PS1-deficient cells and demonstrate the absolute requirement of functional presenilins for Abeta generation. We conclude that presenilins,  and their TM aspartates in particular,  are attractive targets for lowering Abeta therapeutically to prevent Alzheimer's disease. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-2,  Cricetinae,  Presenilin-1,  Animals,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Aspartic Acid,  Endopeptidases,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[W T Kimberly,  W Xia,  T Rahmati,  M S Wolfe,  D J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  ACTIVE SITES ASP-263 AND ASP-366,  MUTAGENESIS OF ASP-263 AND ASP-366]"} ], "id": "83", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10652302", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.275.5.3173"} , { "elementOf": "NLM", "accession": "10652302"} ]} , { "annotation": "[VARIANT AD1 LEU-717]", "conames": [{ "name": "PMID: 10867787", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10867787", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  DNA Primers,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> caused by a new mutation (V717L) in the amyloid precursor protein gene."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is the most common form of dementia. Mutations in the genes amyloid precursor protein (APP),  presenilin 1(PS1) and presenilin 2(PS2) have been found in early-onset familial forms of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> To determine the cause of dementia in a family with early-onset illness. A family with a history of dementia was referred to the Indiana <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Center,  Indianapolis. All the research in this study was done in a university or university hospital. The proband and her 4 siblings took part in the study. The proband,  who is still alive,  showed symptoms of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> at 38 years of age. Genomic DNA was obtained from blood samples of 5 family members. The APPandPS1genes of the proband were screened for mutations by amplification followed by direct sequencing. Sequence of exon 17 of the APPgene revealed a single nucleotide (guanine to cytosine) substitution in 1 allele,  resulting in an amino acid change at codon 717 (valine to leucine). Each of the proband's siblings were tested for this mutation by direct sequencing. Two of the 4 were found to have the mutation; one of whom was recently clinically diagnosed at the age of 36 years. A novel mutation in the APPgene (V717L) has been found in a family with a history of dementia,  beginning in the mid to late 30s. The age of onset in this family is earlier than most of the other families with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> who also have APPmutations. Arch Neurol. 2000. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  DNA,  Age of Onset,  Adult,  Family,  Female,  Mutation,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[J R Murrell,  A M Hake,  K A Quaid,  M R Farlow,  B Ghetti]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 LEU-717]"} ], "id": "84", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10867787", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.57.6.885"} , { "elementOf": "NLM", "accession": "10867787"} ]} , { "annotation": "Intracellular mass of paired,  helically wound protein filaments (also called PHF) lying in the cytoplasm of neuronal cell bodies and neuritic cell processes. Neurofibrillary tangles contain an abnormally phosphorylated form of a microtubule-associated protein,  tau. The shape of these inclusions may resemble a flame or a star. ( Reference:  NIF_Subcellular: nlx_subcell_20090201 NIF_Subcellular: nlx_subcell_20090202 NIF_Subcellular: sao2409833926 )", "conames": [{ "name": "neurofibrillary tangle", "isPreferred": "true"} , { "name": "star-shaped neurofibrillary tangle", "isPreferred": "false"} , { "name": "flame-shaped neurofibrillary tangle", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0097418", "attributes": [], "id": "85", "contexts": { } , "evidences": ["Imported from database"], "value": "neurofibrillary tangle", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0097418"} ]} , { "annotation": "Any multimeric complex connected to a microtubule. ( Reference:  GOC: jl )", "conames": [{ "name": "microtubule associated complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005875", "attributes": [], "id": "86", "contexts": { } , "evidences": ["Imported from database"], "value": "microtubule associated complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005875"} ]} , { "annotation": "A ribonucleoprotein granule located in the cytoplasm. ( Reference:  GOC: bf GOC: PARL PMID: 15121898 );", "conames": [{ "name": "Staufen granule", "isPreferred": "false"} , { "name": "cytoplasmic ribonucleoprotein granule", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0036464", "attributes": [], "id": "87", "contexts": { } , "evidences": ["Imported from database"], "value": "cytoplasmic ribonucleoprotein granule", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0036464"} ]} , { "annotation": "The part of the cytoplasm that does not contain organelles but which does contain other particulate matter,  such as protein complexes. ( Reference:  GOC: hjd GOC: jl )", "conames": [{ "name": "cytosol", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005829", "attributes": [], "id": "88", "contexts": { } , "evidences": ["Imported from database"], "value": "cytosol", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005829"} ]} , { "annotation": "Any of the long,  generally straight,  hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin,  staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface,  and with the alpha beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation,  e.g. in the spindle. ( Reference:  ISBN: 0879693568 )", "conames": [{ "name": "microtubule", "isPreferred": "true"} , { "name": "microtubuli", "isPreferred": "true"} , { "name": "neurotubule", "isPreferred": "false"} , { "name": "microtubulus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005874", "attributes": [], "id": "89", "contexts": { } , "evidences": ["Imported from database"], "value": "microtubuli", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005874"} ]} , { "annotation": "The bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements. ( Reference:  GOC: bf GOC: cilia ISBN: 0198547684 )", "conames": [{ "name": "axoneme", "isPreferred": "true"} , { "name": "flagellum axoneme", "isPreferred": "true"} , { "name": "flagellar axoneme", "isPreferred": "true"} , { "name": "ciliary axoneme", "isPreferred": "true"} , { "name": "cilium axoneme", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005930", "attributes": [], "id": "90", "contexts": { } , "evidences": ["Imported from database"], "value": "axoneme", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005930"} , { "elementOf": "GO", "accession": "GO: 0035085"} , { "elementOf": "GO", "accession": "GO: 0035086"} ]} , { "annotation": "The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. ( Reference:  ISBN: 0716731363 )", "conames": [{ "name": "plasma membrane lipid bilayer", "isPreferred": "false"} , { "name": "cellular membrane", "isPreferred": "true"} , { "name": "plasma membrane", "isPreferred": "true"} , { "name": "bacterial inner membrane", "isPreferred": "false"} , { "name": "juxtamembrane", "isPreferred": "false"} , { "name": "cell membrane", "isPreferred": "true"} , { "name": "cytoplasmic membrane", "isPreferred": "true"} , { "name": "plasmalemma", "isPreferred": "true"} , { "name": "inner endospore membrane", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005886", "attributes": [], "id": "91", "contexts": { } , "evidences": ["Imported from database"], "value": "plasmalemma", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005886"} , { "elementOf": "GO", "accession": "GO: 0005904"} ]} , { "annotation": "The portion of a cell bearing surface projections such as axons,  dendrites,  cilia,  or flagella that includes the nucleus,  but excludes all cell projections. ( Reference:  GOC: go_curators )", "conames": [{ "name": "cell body", "isPreferred": "true"} , { "name": "cell soma", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044297", "attributes": [], "id": "92", "contexts": { } , "evidences": ["Imported from database"], "value": "cell soma", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044297"} ]} , { "annotation": "The postsynaptic density is a region that lies adjacent to the cytoplasmic face of the postsynaptic membrane at excitatory synapse. It forms a disc that consists of a range of proteins with different functions,  some of which contact the cytoplasmic domains of ion channels in the postsynaptic membrane. The proteins making up the disc include receptors,  and structural proteins linked to the actin cytoskeleton. They also include signalling machinery,  such as protein kinases and phosphatases. The postsynaptic density may be part of a neuron or a muscle cell or a glial cell. ( Reference:  GOC: BHF GOC: ef GOC: jid GOC: pr GOC: sjp http: \/\/molneuro.kaist.ac.kr\/psd PMID: 14532281 Wikipedia: Postsynaptic_density )", "conames": [{ "name": "postsynaptic density", "isPreferred": "true"} , { "name": "post synaptic density", "isPreferred": "true"} , { "name": "post-synaptic density", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0014069", "attributes": [], "id": "93", "contexts": { } , "evidences": ["Imported from database"], "value": "postsynaptic density", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0014069"} ]} , { "annotation": "A neuron projection that has a short,  tapering,  often branched,  morphology,  receives and integrates signals from other neurons or from sensory stimuli,  and conducts a nerve impulse towards the axon or the cell body. In most neurons,  the impulse is conveyed from dendrites to axon via the cell body,  but in some types of unipolar neuron,  the impulse does not travel via the cell body. ( Reference:  GOC: dos GOC: mah GOC: nln ISBN: 0198506732 )", "conames": [{ "name": "dendrite", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030425", "attributes": [], "id": "94", "contexts": { } , "evidences": ["Imported from database"], "value": "dendrite", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030425"} ]} , { "annotation": "A heterodimer of tubulins alpha and beta that constitutes the protomer for microtubule assembly. ( Reference:  ISBN: 0716731363 )", "conames": [{ "name": "tubulin complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045298", "attributes": [], "id": "95", "contexts": { } , "evidences": ["Imported from database"], "value": "tubulin complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045298"} ]} , { "annotation": "The portion of the nuclear lumen proximal to the inner nuclear membrane. ( Reference:  GOC: krc GOC: mah )", "conames": [{ "name": "nuclear periphery", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034399", "attributes": [], "id": "96", "contexts": { } , "evidences": ["Imported from database"], "value": "nuclear periphery", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034399"} ]} , { "annotation": "The long process of a neuron that conducts nerve impulses,  usually away from the cell body to the terminals and varicosities,  which are sites of storage and release of neurotransmitter. ( Reference:  GOC: nln ISBN: 0198506732 )", "conames": [{ "name": "axon", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030424", "attributes": [], "id": "97", "contexts": { } , "evidences": ["Imported from database"], "value": "axon", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030424"} ]} , { "annotation": "The migrating motile tip of a growing nerve cell axon or dendrite. ( Reference:  ISBN: 0815316194 )", "conames": [{ "name": "growth cone", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030426", "attributes": [], "id": "98", "contexts": { } , "evidences": ["Imported from database"], "value": "growth cone", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030426"} ]} , { "annotation": "", "conames": [{ "name": "Docetaxel", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "2"} ], "id": "99", "contexts": { } , "evidences": ["Imported from database"], "value": "Docetaxel", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01248"} ]} , { "annotation": "", "conames": [{ "name": "Paclitaxel", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "6"} ], "id": "100", "contexts": { } , "evidences": ["Imported from database"], "value": "Paclitaxel", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01229"} ]} , { "annotation": "The process in which nerve cells are generated. This includes the production of neuroblasts and their differentiation into neurons. ( Reference:  GOC: nln )", "conames": [{ "name": "neuron generation", "isPreferred": "true"} , { "name": "generation of neurons", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048699", "attributes": [], "id": "101", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron generation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048699"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of axon extension. ( Reference:  GOC: go_curators )", "conames": [{ "name": "upregulation of axon extension", "isPreferred": "true"} , { "name": "positive regulation of axon extension", "isPreferred": "true"} , { "name": "up regulation of axon extension", "isPreferred": "true"} , { "name": "up-regulation of axon extension", "isPreferred": "true"} , { "name": "stimulation of axon extension", "isPreferred": "false"} , { "name": "activation of axon extension", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045773", "attributes": [], "id": "102", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of axon extension", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045773"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a nutrient stimulus. ( Reference:  GOC: go_curators )", "conames": [{ "name": "response to nutrient", "isPreferred": "true"} , { "name": "response to nutrients", "isPreferred": "true"} , { "name": "nutritional response pathway", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007584", "attributes": [], "id": "103", "contexts": { } , "evidences": ["Imported from database"], "value": "response to nutrient", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007584"} ]} , { "annotation": "A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand),  and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process,  and is typically characterized by rounding-up of the cell,  retraction of pseudopodes,  reduction of cellular volume (pyknosis),  chromatin condensation,  nuclear fragmentation (karyorrhexis),  plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed,  the cell has died. ( Reference:  GOC: cjm GOC: dhl GOC: ecd GOC: go_curators GOC: mtg_apoptosis GOC: tb ISBN: 0198506732 PMID: 18846107 PMID: 21494263 )", "conames": [{ "name": "apoptosis signaling", "isPreferred": "false"} , { "name": "cellular suicide", "isPreferred": "false"} , { "name": "apoptosis activator", "isPreferred": "false"} , { "name": "cell suicide", "isPreferred": "false"} , { "name": "induction of apoptosis", "isPreferred": "false"} , { "name": "induction of apoptosis by p53", "isPreferred": "false"} , { "name": "apoptosis", "isPreferred": "false"} , { "name": "apoptotic program", "isPreferred": "false"} , { "name": "apoptotic cell death", "isPreferred": "true"} , { "name": "commitment to apoptosis", "isPreferred": "false"} , { "name": "programmed cell death by apoptosis", "isPreferred": "true"} , { "name": "type I programmed cell death", "isPreferred": "false"} , { "name": "apoptotic programmed cell death", "isPreferred": "true"} , { "name": "apoptotic process", "isPreferred": "true"} , { "name": "signaling (initiator) caspase", "isPreferred": "false"} , { "name": "activation of apoptosis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006915", "attributes": [], "id": "104", "contexts": { } , "evidences": ["Imported from database"], "value": "apoptotic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008632"} , { "elementOf": "GO", "accession": "GO: 0006917"} , { "elementOf": "GO", "accession": "GO: 0006915"} ]} , { "annotation": "Long distance growth of a single axon process involved in cellular development. ( Reference:  GOC: BHF GOC: dgh GOC: dph GOC: jid GOC: lm GOC: rl )", "conames": [{ "name": "axon extension involved in development", "isPreferred": "true"} , { "name": "axon extension", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048675", "attributes": [], "id": "105", "contexts": { } , "evidences": ["Imported from database"], "value": "axon extension", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048676"} , { "elementOf": "GO", "accession": "GO: 0048675"} ]} , { "annotation": "A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  and ends when the execution phase of apoptosis is triggered. ( Reference:  GOC: ai GOC: mtg_apoptosis )", "conames": [{ "name": "intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "oxidative stress-induced intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "induction of apoptosis by oxidative stress", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008631", "attributes": [], "id": "106", "contexts": { } , "evidences": ["Imported from database"], "value": "oxidative stress-induced intrinsic apoptotic signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008631"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conames": [{ "name": "regulation of microtubule polymerization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031113", "attributes": [], "id": "107", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of microtubule polymerization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031113"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an organic substance stimulus. ( Reference:  GOC: sm )", "conames": [{ "name": "response to organic substance", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010033", "attributes": [], "id": "108", "contexts": { } , "evidences": ["Imported from database"], "value": "response to organic substance", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010033"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of substances within cells. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of intracellular transport", "isPreferred": "true"} , { "name": "downregulation of intracellular transport", "isPreferred": "true"} , { "name": "down regulation of intracellular transport", "isPreferred": "true"} , { "name": "inhibition of intracellular transport", "isPreferred": "false"} , { "name": "down-regulation of intracellular transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032387", "attributes": [], "id": "109", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of intracellular transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032387"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of cytoskeletal structures comprising microtubules and their associated proteins. ( Reference:  GOC: mah )", "conames": [{ "name": "microtubule cytoskeleton organization and biogenesis", "isPreferred": "false"} , { "name": "microtubule dynamics", "isPreferred": "true"} , { "name": "microtubule cytoskeleton organisation", "isPreferred": "true"} , { "name": "microtubule cytoskeleton organization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000226", "attributes": [], "id": "110", "contexts": { } , "evidences": ["Imported from database"], "value": "microtubule dynamics", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000226"} ]} , { "annotation": "The behavior of an adult relating to the progression of that organism along the ground by the process of lifting and setting down each leg. ( Reference:  GOC: jid GOC: pr ISBN: 0198606907 )", "conames": [{ "name": "adult walking behaviour", "isPreferred": "true"} , { "name": "adult walking behavior", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007628", "attributes": [], "id": "111", "contexts": { } , "evidences": ["Imported from database"], "value": "adult walking behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007628"} ]} , { "annotation": "The directed movement of organelles or molecules along microtubules in neuron projections. ( Reference:  ISBN: 0815316194 )", "conames": [{ "name": "axon cargo transport", "isPreferred": "false"} , { "name": "axonal transport", "isPreferred": "false"} , { "name": "axo-dendritic transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008088", "attributes": [], "id": "112", "contexts": { } , "evidences": ["Imported from database"], "value": "axo-dendritic transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008088"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conames": [{ "name": "activation of microtubule polymerization", "isPreferred": "false"} , { "name": "positive regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "up regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "up-regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "upregulation of microtubule polymerization", "isPreferred": "true"} , { "name": "stimulation of microtubule polymerization", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031116", "attributes": [], "id": "113", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of microtubule polymerization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031116"} ]} , { "annotation": "The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. ( Reference:  ISBN: 0192800825 )", "conames": [{ "name": "female pregnancy", "isPreferred": "true"} , { "name": "carrying of young", "isPreferred": "false"} , { "name": "gestation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007565", "attributes": [], "id": "114", "contexts": { } , "evidences": ["Imported from database"], "value": "gestation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007565"} ]} , { "annotation": "The directed movement of a mitochondrion along a microtubule,  mediated by motor proteins. ( Reference:  GOC: ecd )", "conames": [{ "name": "mitochondrion transport along microtubule", "isPreferred": "true"} , { "name": "mitochondrial migration along microtubule", "isPreferred": "true"} , { "name": "mitochondrial transport along microtubule", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0047497", "attributes": [], "id": "115", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial transport along microtubule", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0047497"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "regulation of autophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010506", "attributes": [], "id": "116", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of autophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010506"} ]} , { "annotation": "Any process that modulates the rate,  frequency,  or extent of microtubule-based movement,  the movement of organelles,  other microtubules and other particles along microtubules,  mediated by motor proteins. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "regulation of microtubule-based movement", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060632", "attributes": [], "id": "117", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of microtubule-based movement", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060632"} ]} , { "annotation": "The process whose specific outcome is the progression of the brain over time,  from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight,  hearing,  smell,  etc.). ( Reference:  GOC: dph GOC: jid GOC: tb UBERON: 0000955 )", "conames": [{ "name": "brain development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007420", "attributes": [], "id": "118", "contexts": { } , "evidences": ["Imported from database"], "value": "brain development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007420"} ]} , { "annotation": "The breakdown of structures such as organelles,  proteins,  or other macromolecular structures during apoptosis. ( Reference:  GOC: dph GOC: mah GOC: mtg_apoptosis GOC: tb )", "conames": [{ "name": "cellular component disassembly involved in apoptotic process", "isPreferred": "false"} , { "name": "disassembly of cell structures", "isPreferred": "false"} , { "name": "cellular component disassembly involved in apoptosis", "isPreferred": "false"} , { "name": "cellular component disassembly involved in execution phase of apoptosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006921", "attributes": [], "id": "119", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular component disassembly involved in execution phase of apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006921"} ]} , { "annotation": "The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature. ( Reference:  CL: 0000540 GOC: go_curators )", "conames": [{ "name": "neuron migration", "isPreferred": "true"} , { "name": "neuronal migration", "isPreferred": "true"} , { "name": "neuron guidance", "isPreferred": "false"} , { "name": "neuron chemotaxis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001764", "attributes": [], "id": "120", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron migration", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001764"} ]} , { "annotation": "A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell. ( Reference:  GOC: lr GOC: mtg_apoptosis )", "conames": [{ "name": "caspase-independent apoptosis", "isPreferred": "false"} , { "name": "regulated cell death", "isPreferred": "false"} , { "name": "PCD", "isPreferred": "true"} , { "name": "non-apoptotic programmed cell death", "isPreferred": "false"} , { "name": "programmed cell death", "isPreferred": "true"} , { "name": "nonapoptotic programmed cell death", "isPreferred": "false"} , { "name": "caspase-independent cell death", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0012501", "attributes": [], "id": "121", "contexts": { } , "evidences": ["Imported from database"], "value": "PCD", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016244"} , { "elementOf": "GO", "accession": "GO: 0012501"} ]} , { "annotation": "[VARIANT FTD HIS-5,  CHARACTERIZATION OF VARIANT FTD HIS-5]", "conames": [{ "name": "PMID: 11921059", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11921059", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Z711V88R5F Sarcosine,  632GS99618 sarkosyl,  Detergents,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation."} , { "attrname": "Abstract", "value": "We report a case of frontotemporal dementia and parkinsonism linked to chromosome 17 of 5 years' duration in an 81-year-old man whose brother had died at age 86 years with dementia. In this patient,  we found frontal and temporal neuronal loss,  glial-predominant tau deposits,  progressive supranuclear palsy-like straight tubules,  accumulation of 4-repeat-predominant Sarkosyl-insoluble tau,  and a novel exon 1 (Arg5His) tau gene mutation. This mutation decreased microtubule-promoting capacity and increased fibrillation of tau in vitro. Thus,  we consider that the Arg5His mutation is an authentic tau gene abnormality responsible for the patient's tau pathology and late-onset dementia. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Solubility,  Male,  Detergents,  Microscopy,  Electron,  tau Proteins,  Point Mutation,  Inclusion Bodies,  Microtubules,  Age of Onset,  Sarcosine,  Aged,  80 and over,  Oligodendroglia,  Aged,  RNA,  Messenger,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Shintaro Hayashi,  Yasuko Toyoshima,  Masato Hasegawa,  Yuri Umeda,  Koichi Wakabayashi,  Susumu Tokiguchi,  Takeshi Iwatsubo,  Hitoshi Takahashi]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD HIS-5,  CHARACTERIZATION OF VARIANT FTD HIS-5]"} ], "id": "122", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11921059", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.10163"} , { "elementOf": "NLM", "accession": "11921059"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-554; SER-579; SER-602; SER-606 AND SER-669]", "conames": [{ "name": "PMID: 8999860", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8999860", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.1.19 Phosphorylase Kinase,  Recombinant Proteins,  452VLY9402 Serine,  tau Proteins]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase."} , { "attrname": "Abstract", "value": "Abnormally phosphorylated tau is the major component of paired helical filaments found in the brains of patients suffering from Alzheimer's disease. Therefore,  the identification of kinases that phosphorylate tau is of considerable interest. A DEAE-Sepharose column resolved porcine brain extract into five tau kinase activity peaks. Among these peaks,  two were completely inhibited by EGTA,  indicating that these two activity peaks contained Ca2+-dependent tau kinases. One of the above two Ca2+-dependent tau kinase activity peaks also contained phosphorylase kinase activity. The tau kinase and phosphorylase kinase activities associated with this peak could not be separated from each other by Superose 12 gel filtration,  hydroxylapatite,  and calmodulin-agarose affinity chromatographies. Phosphorylase kinase,  purified from rabbit skeletal muscle,  phosphorylated tau to a stoichiometry of 2.1 mol of phosphate\/mol of tau and converted tau to a species with a retarded mobility on SDS-polyacrylamide gel electrophoresis. The apparent Km and kcat values for tau phosphorylation by muscle phosphorylase kinase were 6.9 microM and 47.4 min-1,  respectively. As a substrate of muscle phosphorylase kinase,  phosphorylase was eight times better than tau. Sequence analyses of tryptic and thermolytic phosphopeptides derived from tau phosphorylated by muscle phosphorylase kinase revealed five phosphorylation sites,  Ser237,  Ser262,  Ser285,  Ser305,  and Ser352. Among these sites,  Ser262 was previously shown to be phosphorylated in human tau from fetal,  adult,  and Alzheimer's diseased brains (Seubert,  P.,  Mawal-Dewan,  M.,  Barbour,  R.,  Jakes,  R.,  Goedert,  M.,  Johnson,  G. V. W.,  Litersky,  J. M.,  Schenk,  D.,  Lieberburg,  I.,  Trojanowski,  J. Q.,  and Lee,  V. M. Y. (1995) J. Biol. Chem. 270,  18917-18922); and its phosphorylation abolished tau's binding to microtubules (Drewes,  G.,  Trinczek,  B.,  Illenberger,  S.,  Biernat,  J.,  Schmitt-Ulms,  G.,  Meyer,  H. E.,  Mandelkow,  E.-M.,  and Mandelkow,  E. (1995) J. Biol. Chem. 270,  7679-7688). Slot-blot analysis using a monoclonal antibody against muscle phosphorylase kinase and an activity assay using phosphorylase revealed that phosphorylase kinase was present in microtubules extensively purified by repeated cycles of polymerization and depolymerization. Taken together,  these results suggest that in neurons,  phosphorylase kinase may be one of the kinases that participate in the phosphorylation of tau. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Chromatography,  Ion Exchange,  Phosphorylation,  Humans,  Serine,  Molecular Sequence Data,  Chromatography,  High Pressure Liquid,  Recombinant Proteins,  tau Proteins,  Phosphorylase Kinase,  Animals,  Swine,  Microtubules,  Protein Binding,  Kinetics]"} , { "attrname": "AUTHORS", "value": "[H K Paudel]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-554; SER-579; SER-602; SER-606 AND SER-669]"} ], "id": "123", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8999860", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8999860"} ]} , { "annotation": "[VARIANT FTD MET-654,  VARIANTS ASN-285; ALA-289; HIS-441 AND PRO-447]", "conames": [{ "name": "PMID: 9629852", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9629852", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[DNA Primers,  tau Proteins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Tau is a candidate gene for chromosome 17 frontotemporal dementia."} , { "attrname": "Abstract", "value": "Frontotemporal dementia with parkinsonism,  chromosome 17 type (FTDP-17),  a recently defined disease entity,  is clinically characterized by personality changes sometimes associated with psychosis,  hyperorality,  and diminished speech output,  disturbed executive function and nonfluent aphasia,  bradykinesia,  and rigidity. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia,  substantia nigra,  and amygdala. Neurofibrillary tangles (NFTs) are seen in some but not all families. Inheritance is autosomal dominant and the gene has been regionally localized to 17q21-22 in a 2- to 4-centimorgan (cM) region flanked by markers D17S800 and D17S791. The gene for tau,  the primary component of NFTs,  is located in the same region of chromosome 17. Tau was evaluated as a candidate gene. Physical mapping studies place tau within 2 megabases or less of D17S791,  but it is probably outside the D17S800-D17S791 FTDP-17 interval. DNA sequence analysis of tau coding regions in affected subjects from two FTDP-17 families revealed nine DNA sequence variants,  eight of which were also identified in controls and are thus polymorphisms. A ninth variant (Val279Met) was found in one FTDP-17 family but not in the second FTDP-17 family. Three lines of evidence indicate that the Val279Met change is an FTDP-17 causative mutation. First,  the mutation site is highly conserved,  and a normal valine is found at this position in all three tau interrepeat sequences and in other microtubule associated protein tau homologues. Second,  the mutation co-segregates with the disease in family A. Third,  the mutation is not found in normal controls. "} , { "attrname": "MeSH", "value": "[Humans,  Molecular Sequence Data,  Family Health,  Male,  Chromosome Mapping,  DNA Primers,  tau Proteins,  Polymorphism,  Genetic,  Sequence Homology,  Amino Acid,  Frontal Lobe,  Temporal Lobe,  Chromosomes,  Human,  Pair 17,  Pedigree,  Female,  Dementia,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[P Poorkaj,  T D Bird,  E Wijsman,  E Nemens,  R M Garruto,  L Anderson,  A Andreadis,  W C Wiederholt,  M Raskind,  G D Schellenberg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD MET-654,  VARIANTS ASN-285; ALA-289; HIS-441 AND PRO-447]"} ], "id": "124", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9629852", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9629852"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.410430617"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-519; THR-522; SER-713 AND SER-721 BY CSNK1D\/CK1,  INTERACTION WITH CSNK1D]", "conames": [{ "name": "PMID: 14761950", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14761950", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Protein Kinase Inhibitors,  DHD7FFG6YS Phloroglucinol,  IC 261,  EC 2.7.11.1 Casein Kinases,  EC 2.7.- Protein Kinases,  Indoles,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules."} , { "attrname": "Abstract", "value": "Tau hyperphosphorylation precedes neuritic lesion formation in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  suggesting it participates in the tau fibrillization reaction pathway. Candidate tau protein kinases include members of the casein kinase 1 (CK1) family of phosphotransferases,  which are highly overexpressed in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain and colocalize with neuritic and granulovacuolar lesions. Here we characterized the contribution of one CK1 isoform,  Ckidelta,  to the phosphorylation of tau at residues Ser202\/Thr205 and Ser396\/Ser404 in human embryonic kidney 293 cells using immunodetection and fluorescence microscopy. Treatment of cells with membrane permeable CK1 inhibitor 3-[(2, 3, 6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261) lowered occupancy of Ser396\/Ser404 phosphorylation sites by >70% at saturation,  suggesting that endogenous CK1 was the major source of basal phosphorylation activity at these sites. Overexpression of Ckidelta increased CK1 enzyme activity and further raised tau phosphorylation at residues Ser202\/Thr205 and Ser396\/Ser404 in situ. Inhibitor IC261 reversed tau hyperphosphorylation induced by Ckidelta overexpression. Co-immunoprecipitation assays showed direct association of tau and Ckidelta in situ,  consistent with tau being a Ckidelta substrate. Ckidelta overexpression also produced a decrease in the fraction of bulk tau bound to detergent-insoluble microtubules. These results suggest that Ckidelta phosphorylates tau at sites that modulate tau\/microtubule binding,  and that the expression pattern of Ckidelta in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is consistent with it playing an important role in tau aggregation. "} , { "attrname": "MeSH", "value": "[Cell Line,  Phosphorylation,  Casein Kinases,  Humans,  Phloroglucinol,  Substrate Specificity,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Protein Kinase Inhibitors,  Protein Kinases,  Microtubules,  Protein Binding,  Indoles]"} , { "attrname": "AUTHORS", "value": "[Guibin Li,  Haishan Yin,  Jeff Kuret]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-519; THR-522; SER-713 AND SER-721 BY CSNK1D\/CK1,  INTERACTION WITH CSNK1D]"} ], "id": "125", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14761950", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M314116200"} , { "elementOf": "NLM", "accession": "14761950"} ]} , { "annotation": "[REVIEW]", "conames": [{ "name": "PMID: 1713721", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1713721", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Trends in neurosciences"} , { "attrname": "Chemical", "value": "[Microtubule-Associated Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Molecular characterization of microtubule-associated proteins tau and MAP2."} , { "attrname": "Abstract", "value": "Tau and MAP2 are two of the major microtubule-associated proteins in the vertebrate nervous system. They promote microtubule assembly and stability,  and might be involved in the establishment and maintenance of neuronal polarity. In nerve cells immunohistochemistry shows complementary distributions,  with tau being concentrated in axons and high molecular mass MAP2 being confined to dendrites. Each protein consists of multiple isoforms that contain three or four homologous tandem repeats near the carboxy-terminus,  which constitute microtubule-binding domains. In humans,  tau consists of at least six isoforms of related amino acid sequences that are produced from a single gene by alternative mRNA splicing and that are expressed in a stage- and cell type-specific manner. Tau is also a component of the paired helical filaments associated with Alzheimer's disease and other disorders of the CNS. Rat MAP2 consists of at least three isoforms produced from a single gene:  high molecular mass MAP2a and MAP2b,  and low molecular mass MAP2c. MAP2c is expressed only during early development and has so far been seen only in axons; MAP2a appears to replace MAP2c,  whereas MAP2b is expressed throughout life. Messenger RNAs for MAP2 of high molecular mass are expressed both in cell bodies and in dendrites,  consistent with the dendritic localization of the corresponding protein isoforms. "} , { "attrname": "MeSH", "value": "[Consensus Sequence,  Amino Acid Sequence,  Animals,  Humans,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Repetitive Sequences,  Nucleic Acid,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[M Goedert,  R A Crowther,  C C Garner]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW]"} ], "id": "126", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1713721", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0166-2236(91)90105-4"} , { "elementOf": "NLM", "accession": "1713721"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FETAL-TAU)]", "conames": [{ "name": "PMID: 3131773", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3131773", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Microtubule-Associated Proteins,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  identification as the microtubule-associated protein tau."} , { "attrname": "Abstract", "value": "Screening of cDNA libraries prepared from the frontal cortex of an <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patient and from fetal human brain has led to isolation of the cDNA for a core protein of the paired helical filament of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The partial amino acid sequence of this core protein was used to design synthetic oligonucleotide probes. The cDNA encodes a protein of 352 amino acids that contains a characteristic amino acid repeat in its carboxyl-terminal half. This protein is highly homologous to the sequence of the mouse microtubule-associated protein tau and thus constitutes the human equivalent of mouse tau. RNA blot analysis indicates the presence of two major transcripts,  6 and 2 kilobases lon g,  with a wide distribution in normal human brain. Tau protein mRNAs were found in normal amounts in the frontal cortex from patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The proof that at least part of tau protein forms a component of the paired helical filament core opens the way to understanding the mode of formation of paired helical filaments and thus,  ultimately,  the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Tissue Distribution,  Amino Acid Sequence,  Brain,  Base Sequence,  DNA,  Humans,  Cloning,  Molecular,  Microtubule-Associated Proteins,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[M Goedert,  C M Wischik,  R A Crowther,  J E Walker,  A Klug]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM FETAL-TAU)]"} ], "id": "127", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3131773", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.85.11.4051"} , { "elementOf": "NLM", "accession": "3131773"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS PNS-TAU; FETAL-TAU AND TAU-F),  ALTERNATIVE SPLICING,  VARIANT HIS-441]", "conames": [{ "name": "PMID: 1420178", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1420178", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Dinucleoside Phosphates,  RNA,  Messenger,  tau Proteins,  2382-65-2 cytidylyl-3'-5'-guanosine]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Structure and novel exons of the human tau gene."} , { "attrname": "Abstract", "value": "The microtubule-binding protein tau is important in establishing and maintaining neuronal morphology and is a major component of the neurofibrillary tangles (NFTs) characteristic of Alzheimer's brain. The neuron-specific tau transcript undergoes complex alternative splicing. The human tau gene has been cloned and mapped. The restriction analysis and partial sequencing of the gene shows that it contains (1) four alternatively spliced exons previously described in rodent and bovine but not in human tau cDNAs and (2) two CpG islands,  one associated with the promoter region,  the other with exon 9. Examination of human tau mRNA indicates that the human cerebrocortical splicing pattern differs from that previously reported for the murine and bovine tau mRNAs,  despite conserved exon organization in all three genes. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Alternative Splicing,  Exons,  Humans,  Molecular Sequence Data,  Sequence Homology,  Nucleic Acid,  tau Proteins,  Sequence Homology,  Amino Acid,  Animals,  Base Sequence,  DNA,  Polymerase Chain Reaction,  Dinucleoside Phosphates,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[A Andreadis,  W M Brown,  K S Kosik]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS PNS-TAU; FETAL-TAU AND TAU-F),  ALTERNATIVE SPLICING,  VARIANT HIS-441]"} ], "id": "128", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1420178", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1420178"} , { "elementOf": "DOI", "accession": "10.1021\/BI00158A027"} ]} , { "annotation": "[VARIANTS FTD VAL-589; LYS-597 DEL; LEU-618 AND TRP-723]", "conames": [{ "name": "PMID: 9973279", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9973279", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands."} , { "attrname": "Abstract", "value": "Mutations in microtubule-associated protein tau recently have been identified in familial cases of frontotemporal dementia (FTD). We report the frequency of tau mutations in a large population-based study of FTD carried out in the Netherlands from January 1994 to June 1998. Thirty-seven patients had >\/=1 first-degree relative with dementia. A mutation in the tau gene was found in 17.8% of the group of patients with FTD and in 43% of patients with FTD who also had a positive family history of FTD. Three distinct missense mutations (G272V,  P301L,  R406W) accounted for 15.6% of the mutations. These three missense mutations,  and a single amino acid deletion (DeltaK280) that was detected in one patient,  strongly reduce the ability of tau to promote microtubule assembly. We also found an intronic mutation at position +33 after exon 9,  which is likely to affect the alternative splicing of tau. Tau mutations are responsible for a large proportion of familial FTD cases; however,  there are also families with FTD in which no mutations in tau have been found,  which indicates locus and\/or allelic heterogeneity. The different tau mutations may result in disturbances in the interactions of the protein tau with microtubules,  resulting in hyperphosphorylation of tau protein,  assembly into filaments,  and subsequent cell death. "} , { "attrname": "MeSH", "value": "[Prevalence,  Humans,  Middle Aged,  Male,  Mutation,  Missense,  tau Proteins,  Point Mutation,  Netherlands,  Frontal Lobe,  Temporal Lobe,  Gene Deletion,  Female,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[P Rizzu,  J C Van Swieten,  M Joosse,  M Hasegawa,  M Stevens,  A Tibben,  M F Niermeijer,  M Hillebrand,  R Ravid,  B A Oostra,  M Goedert,  C M van Duijn,  P Heutink]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS FTD VAL-589; LYS-597 DEL; LEU-618 AND TRP-723]"} ], "id": "129", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9973279", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9973279"} , { "elementOf": "DOI", "accession": "10.1086\/302256"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  PHOSPHORYLATION]", "conames": [{ "name": "PMID: 10747907", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10747907", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[1W21G5Q4N2 Okadaic Acid,  Actins,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments."} , { "attrname": "Abstract", "value": "The axonal microtubule-associated phosphoprotein tau interacts with neural plasma membrane (PM) components during neuronal development (Brandt,  R.,  Lger,  J.,  and Lee,  G. (1995) J. Cell Biol. 131,  1327-1340). To analyze the mechanism and potential regulation of tau's PM association,  a method was developed to isolate PM-associated tau using microsphere separation of surface-biotinylated cells. We show that tau's PM association requires an intact membrane cortex and that PM-associated tau and cytosolic tau are differentially phosphorylated at sites detected by several <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) diagnostic antibodies (Ser(199)\/Ser(202),  Thr(231),  and Ser(396)\/Ser(404)). In polar neurons,  the association of endogenous tau phosphoisoforms with the membrane cortex correlates with an enrichment in the axonal compartment. To test for a direct effect of AD-specific tau modifications in determining tau's interactions,  a phosphomutant that simulates an AD-like hyperphosphorylation of tau was produced by site-directed mutagenesis of Ser\/Thr residues to negatively charged amino acids (Glu). These mutations completely abolish tau's association with the membrane cortex; however,  the construct retains its capability to bind to microtubules. The data suggest that a loss of tau's association with the membrane cortex as a result of phosphorylation at sites that are modified during <span style=\"background-color: yellow\"><b>disease<\/b><\/span> contributes to somatodendritic tau accumulation,  axonal microtubule disintegration,  and neuronal death characteristic for AD. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Cell Membrane,  Phosphorylation,  Biotinylation,  Mutagenesis,  Site-Directed,  Neurons,  Actins,  Rats,  Okadaic Acid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microscopy,  Electron,  Cytosol,  PC12 Cells,  tau Proteins,  Microscopy,  Confocal,  Microspheres,  Animals,  Transfection,  Microtubules,  Protein Binding]"} , { "attrname": "AUTHORS", "value": "[T Maas,  J Eidenmller,  R Brandt]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  PHOSPHORYLATION]"} ], "id": "130", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10747907", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10747907"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M000389200"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-B; TAU-C; TAU-E AND TAU-F),  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE]", "conames": [{ "name": "PMID: 2484340", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2484340", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[Microtubule-Associated Proteins,  Nerve Tissue Proteins,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Multiple isoforms of human microtubule-associated protein tau:  sequences and localization in neurofibrillary tangles of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "We have determined the sequences of isoforms of human tau protein,  which differ from previously reported forms by insertions of 29 or 58 amino acids in the amino-terminal region. Complementary DNA cloning shows that the insertions occur in combination with both three and four tandem repeats. RNAase protection assays indicate that transcripts encoding isoforms with the insertions are expressed in an adult-specific manner. Transcripts encoding four tandem repeats are also expressed in an adult-specific manner,  whereas mRNAs encoding three tandem repeats are expressed throughout life,  including in fetal brain. The levels of transcripts encoding the 29 or 58 amino acid inserts were not significantly changed in cerebral cortex from patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Antisera raised against synthetic peptides corresponding to these different human tau isoforms demonstrate that multiple tau protein isoforms are incorporated into the neurofibrillary tangles of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Immunologic Techniques,  Humans,  Staining and Labeling,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Neurofibrils,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Isomerism,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[M Goedert,  M G Spillantini,  R Jakes,  D Rutherford,  R A Crowther]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-B; TAU-C; TAU-E AND TAU-F),  ASSOCIATION WITH <span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]"} ], "id": "131", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2484340", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2484340"} , { "elementOf": "DOI", "accession": "10.1016\/0896-6273(89)90210-9"} ]} , { "annotation": "[VARIANT FTD LEU-618]", "conames": [{ "name": "PMID: 9736786", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9736786", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism."} , { "attrname": "Abstract", "value": "Frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (FTDP) is the second most common cause of neurodegenerative dementia after <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Recently,  several kindreds with an autosomal dominant form of FTDP have been reported and in some families the pathological locus was mapped to a 2 cM interval on 17q21-22. The MAPT gene,  located on 17q21 and coding for the human microtubule-associated protein tau,  is a strong candidate gene,  since tau-positive neuronal inclusions have been observed in brains from some FTDP patients. Direct sequencing of the MAPT exonic sequences in 21 French FTDP families revealed in six index cases the same missense mutation in exon 10 resulting in a Pro-->Leu change at amino acid 301. Co-segregation of this mutation with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was demonstrated by restriction fragment analysis in two families for which several affected relatives were available. The Pro301Leu mutation was not observed in either 50 unrelated French controls or in 11 patients with sporadic frontotemporal dementia. This mutation,  which occurs in the second microtubule-binding domain of the MAPT protein,  is likely to have a drastic functional consequence. The observation of this mutation in several FTDP families might suggest that disruption of binding of MAPT protein to the microtubule is a key event in the pathogenesis of FTDP. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Male,  Mutation,  Missense,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Frontal Lobe,  Temporal Lobe,  Pedigree,  Age of Onset,  Adult,  Female,  Aged,  Dementia]"} , { "attrname": "AUTHORS", "value": "[C Dumanchin,  A Camuzat,  D Campion,  P Verpillat,  D Hannequin,  B Dubois,  P Saugier-Veber,  C Martin,  C Penet,  F Charbonnier,  Y Agid,  T Frebourg,  A Brice]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD LEU-618]"} ], "id": "132", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9736786", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9736786"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/7.11.1825"} ]} , { "annotation": "[INTERACTION WITH SQSTM1,  UBIQUITINATION,  PROTEASOMAL DEGRADATION]", "conames": [{ "name": "PMID: 15953362", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15953362", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Proteins,  120904-94-1 Polyubiquitin,  Adaptor Proteins,  Signal Transducing,  Sequestosome-1 Protein,  SQSTM1 protein,  human,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  tau Proteins]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Sequestosome 1\/p62 shuttles polyubiquitinated tau for proteasomal degradation."} , { "attrname": "Abstract", "value": "Inclusions isolated from several neurodegenerative diseases,  including Alzheimer's disease (AD),  are characterized by ubiquitin-positive proteinaceous aggregates. Employing confocal and immunoelectron microscopy,  we find that the ubiquitin-associating protein sequestosome1\/p62,  co-localizes to aggregates isolated from AD but not control brain,  along with the E3 ubiquitin ligase,  TRAF6. This interaction could be recapitulated by co-transfection in HEK293 cells. Employing both in vitro and in vivo approaches,  tau was found to be a substrate of the TRAF6,  possessing lysine 63 polyubiquitin chains. Moreover,  tau recovered from brain of TRAF6 knockout mice,  compared with wild type,  was not ubiquitinated. Tau degradation took place through the ubiquitin-proteasome pathway and was dependent upon either the K63-polyubiquitin chains or upon p62. In brain lysates of p62 knockout mice,  tau fails to co-interact with Rpt1,  a proteasomal subunit,  thereby indicating a requirement for p62 shuttling of tau to the proteasome. Our results demonstrate that p62 interacts with K63-polyubiquitinated tau through its UBA domain and serves a novel role in regulating tau proteasomal degradation. We propose a model whereby either a decline in p62 expression or a decrease in proteasome activity may contribute to accumulation of insoluble\/aggregated K63-polyubiquitinated tau. "} , { "attrname": "MeSH", "value": "[Cell Line,  Sequestosome-1 Protein,  Humans,  Rats,  Male,  Polyubiquitin,  Proteasome Endopeptidase Complex,  PC12 Cells,  tau Proteins,  Proteins,  Adaptor Proteins,  Signal Transducing,  Animals,  Female,  Aged,  Genetic Vectors]"} , { "attrname": "AUTHORS", "value": "[Jeganathan Ramesh Babu,  Thangiah Geetha,  Marie W Wooten]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH SQSTM1,  UBIQUITINATION,  PROTEASOMAL DEGRADATION]"} ], "id": "133", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15953362", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15953362"} , { "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.2005.03181.X"} ]} , { "annotation": "[STRUCTURE BY NMR OF 542-554 IN COMPLEX WITH PIN1]", "conames": [{ "name": "PMID: 11313338", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11313338", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[8DUH1N11BX Tryptophan,  EC 5.2.1.8 Peptidylprolyl Isomerase,  EC 5.2.1.8 PIN1 protein,  human,  1114-81-4 Phosphothreonine,  Ligands,  NIMA-Interacting Peptidylprolyl Isomerase]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides."} , { "attrname": "Abstract", "value": "The recent crystal structure of Pin1 protein bound to a doubly phosphorylated peptide from the C-terminal domain of RNA polymerase II revealed that binding interactions between Pin1 and its substrate take place through its Trp-Trp (WW) domain at the level of the loop Ser(11)-Arg(12) and the aromatic pair Tyr(18)-Trp(29),  and showed a trans conformation for both pSer-Pro peptide bonds. However,  the orientation of the ligand in the aromatic recognition groove still could be sequence-specific,  as previously observed in SH3 domains complexed by peptide ligands or for different class of WW domains (Zarrinpar,  A.,  and Lim,  W. A. (2000) Nat. Struct. Biol. 7,  611-613). Because the bound peptide conformation could also differ as observed for peptide ligands bound to the 14-3-3 domain,  ligand orientation and conformation for two other biologically relevant monophosphate substrates,  one derived from the Cdc25 phosphatase of Xenopus laevis (EQPLpTPVTDL) and another from the human tau protein (KVSVVRpTPPKSPS) in complex with the WW domain are here studied by solution NMR methods. First,  the proton resonance perturbations on the WW domain upon complexation with both peptide ligands were determined to be essentially located in the positively charged beta-hairpin Ser(11)-Gly(15) and around the aromatic Trp(29). Dissociation equilibrium constants of 117 and 230 microm for Cdc25 and tau peptides,  respectively,  were found. Several intermolecular nuclear Overhauser effects between WW domain and substrates were obtained from a ligand-saturated solution and were used to determine the structures of the complexes in solution. We found a similar N to C orientation as the one observed in the crystal complex structure of Pin1 and a trans conformation for the pThr-Pro peptidic bond in both peptide ligands,  thereby indicating a unique binding scheme for the Pin1 WW domain to its multiple substrates. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Magnetic Resonance Spectroscopy,  Xenopus laevis,  Models,  Molecular,  Molecular Sequence Data,  Tryptophan,  Crystallography,  X-Ray,  NIMA-Interacting Peptidylprolyl Isomerase,  Peptidylprolyl Isomerase,  Animals,  Ligands,  Protein Conformation,  Phosphothreonine]"} , { "attrname": "AUTHORS", "value": "[R Wintjens,  J M Wieruszeski,  H Drobecq,  P Rousselot-Pailley,  L Bue,  G Lippens,  I Landrieu]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 542-554 IN COMPLEX WITH PIN1]"} ], "id": "134", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11313338", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M010327200"} , { "elementOf": "NLM", "accession": "11313338"} ]} , { "annotation": "[VARIANT PIDB ARG-706]", "conames": [{ "name": "PMID: 10604746", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10604746", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuropathology and experimental neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits."} , { "attrname": "Abstract", "value": "Exonic and intronic mutations in Tau cause familial neurodegenerative syndromes characterized by frontotemporal dementia and dysfunction of multiple cortical and subcortical circuits. Here we describe a G389R mutation in exon 13 of Tau. When 38 years old,  the proband presented with progressive aphasia and memory disturbance,  followed by apathy,  indifference,  and hyperphagia. Repeated magnetic resonance imaging showed the dramatic progression of cerebral atrophy. Positron emission tomography revealed marked glucose hypometabolism that was most severe in left frontal,  temporal,  and parietal cortical regions. Rigidity,  pyramidal signs and profound dementia progressed until death at 43 years of age. A paternal uncle,  who had died at 43 years of age,  had presented with similar symptoms. The proband's brain showed numerous tau-immunoreactive Pick body-like inclusions in the neocortex and the fascia dentata of the hippocampus. In addition,  large numbers of tau-positive filamentous inclusions were present in axons in the frontal,  temporal,  and parietal lobes. Immunoblot analysis of sarkosyl-insoluble tau showed 2 major bands of 60 and 64 kDa. Upon dephosphorylation,  these bands resolved into 4 bands consisting of three- and four-repeat tau isoforms. Most isolated tau filaments were straight and resembled filaments found in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and some frontotemporal dementias with tau mutations. A smaller number of twisted filaments was also observed. Biochemically,  recombinant tau proteins with the G389R mutation showed a reduced ability to promote microtubule assembly,  suggesting that this may be the primary effect of the mutation. Taken together,  the present findings indicate that the G389R mutation in Tau can cause a dementing condition that closely resembles Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Neurodegenerative <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Humans,  Medical Records,  Male,  Microscopy,  Electron,  tau Proteins,  Axons,  Magnetic Resonance Imaging,  Inclusion Bodies,  Pedigree,  Microtubules,  Adult,  Mutation]"} , { "attrname": "AUTHORS", "value": "[J R Murrell,  M G Spillantini,  P Zolo,  M Guazzelli,  M J Smith,  M Hasegawa,  F Redi,  R A Crowther,  P Pietrini,  B Ghetti,  M Goedert]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PIDB ARG-706]"} ], "id": "135", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10604746", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10604746"} , { "elementOf": "DOI", "accession": "10.1097\/00005072-199912000-00002"} ]} , { "annotation": "[VARIANT FTD TRP-723]", "conames": [{ "name": "PMID: 11889249", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11889249", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Early-onset,  rapidly progressive familial tauopathy with R406W mutation."} , { "attrname": "Abstract", "value": "An early-onset and rapidly progressive familial tauopathy with R406W mutation is described. The patient was a 47-year-old man who first presented with psychiatric symptoms followed by overt dementia at age 52 and died 1 year later. Postmortem study revealed tangle-associated neuronal degeneration,  accentuated in the medial temporal lobe. R406W mutation was determined by sequence analysis and immunocytochemically with anti-mutant tau antibody. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Humans,  Middle Aged,  Male,  Neurofibrillary Tangles,  tau Proteins,  Disease Progression,  Tauopathies,  Temporal Lobe,  Age of Onset,  Mutation,  Hippocampus,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Y Saito,  A Geyer,  R Sasaki,  S Kuzuhara,  E Nanba,  T Miyasaka,  K Suzuki,  S Murayama]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD TRP-723]"} ], "id": "136", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11889249", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11889249"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.58.5.811"} ]} , { "annotation": "[VARIANTS FTD LEU-618; MET-654 AND TRP-723]", "conames": [{ "name": "PMID: 10214944", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10214944", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[Recombinant Proteins,  DNA Primers,  9005-49-6 <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  Biopolymers,  tau Proteins,  27YG812J1I Arachidonic Acid]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Accelerated filament formation from tau protein with specific FTDP-17 missense mutations."} , { "attrname": "Abstract", "value": "Tau is the major component of the neurofibrillar tangles that are a pathological hallmark of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>s' <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The identification of missense and splicing mutations in tau associated with the inherited frontotemporal dementia and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism linked to chromosome 17 demonstrated that tau dysfunction can cause neurodegeneration. However,  the mechanism by which tau dysfunction leads to neurodegeneration remains uncertain. Here,  we present evidence that frontotemporal dementia and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism linked to chromosome 17 missense mutations,  P301L,  V337M and R406W,  cause an accelerated aggregation of tau into filaments. These results suggest one mechanism by which these mutations can cause neurodegeneration and frontotemporal dementia and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism linked to chromosome 17. "} , { "attrname": "MeSH", "value": "[Humans,  Mutation,  Missense,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Microscopy,  Electron,  Biopolymers,  Neurofibrillary Tangles,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Chromosomes,  Human,  Pair 17,  Base Sequence,  <span style=\"background-color: yellow\"><b>Heparin<\/b><\/span>,  In Vitro Techniques,  Nerve Degeneration,  Arachidonic Acid,  Dementia,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[P Nacharaju,  J Lewis,  C Easson,  S Yen,  J Hackett,  M Hutton,  S H Yen]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS FTD LEU-618; MET-654 AND TRP-723]"} ], "id": "137", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10214944", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10214944"} , { "elementOf": "DOI", "accession": "10.1016\/S0014-5793(99)00294-X"} ]} , { "annotation": "[VARIANTS PSNP1 ASN-285 AND ALA-289]", "conames": [{ "name": "PMID: 10534245", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10534245", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Mutational analysis of the tau gene in progressive supranuclear palsy."} , { "attrname": "Abstract", "value": "To identify genetic mutations in the coding regions and the splice-donor sites of the tau gene on chromosome 17q in individuals with progressive supranuclear palsy (PSP). Several studies provide evidence for linkage disequilibrium between a PSP disease gene and allelic variants of the tau gene. However,  a causative mutation has not been identified. We designed a study to search for genetic mutations in 15 coding regions of the tau gene including the splice-donor sites in 22 patients with PSP by comparing the mobility shifts on single-strand conformation analysis with those of age-matched controls. Fragments with altered migration were sequenced directly and compared for differences in nucleotide composition. Restriction enzyme digests were used to confirm single base-pair substitutions. Significant differences in mobility shifts were found in exons 1,  4A,  and 8 between affected individuals and age-matched controls. All individuals with PSP had a common extended haplotype characterized by a homozygous polymorphism in the 5' splice site untranslated region of exon 1,  two missense mutations in exon 4A (Asp285Asn,  Ala289Val),  and a nonsense mutation in the 5' splice site of exon 8. This study demonstrates that 22 unrelated progressive supranuclear palsy (PSP) patients have four identical sequence variants within the tau gene that are not present in 24 age-matched controls. Although the functional significance of these results on tau protein expression is unknown,  the presence of this \"susceptibility\" haplotype in individuals may place them at risk for developing PSP. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Supranuclear Palsy,  Progressive,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  tau Proteins,  Genetic Variation,  Polymorphism,  Single-Stranded Conformational,  Phenotype,  DNA Mutational Analysis,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[J J Higgins,  R L Adler,  J M Loveless]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PSNP1 ASN-285 AND ALA-289]"} ], "id": "138", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10534245", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.53.7.1421"} , { "elementOf": "NLM", "accession": "10534245"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANTS FTD ASN-613 DEL AND HIS-613]", "conames": [{ "name": "PMID: 11906000", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11906000", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Functional effects of tau gene mutations deltaN296 and N296H."} , { "attrname": "Abstract", "value": "Mutations in the tau gene cause frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17). Functionally,  about half of the known mutations increase the alternative mRNA splicing of exon 10 of the tau gene,  resulting in the overproduction of tau isoforms with four microtubule-binding repeats. The other mutations reduce the ability of tau to interact with microtubules,  with some mutations also increasing the propensity of tau to assemble into filaments. Here we have examined the functional effects of the recently described tau gene mutations deltaN296 and N296H. Both mutations reduced the ability of tau to promote microtubule assembly,  without having a significant effect on tau filament formation. By exon trapping,  they increased the splicing of exon 10. DeltaN296 and N296H thus define a class of tau mutations with effects at both the RNA and the protein level. "} , { "attrname": "MeSH", "value": "[Mutagenesis,  Site-Directed,  Exons,  Humans,  Microtubules,  Microscopy,  Electron,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[Hirotaka Yoshida,  R Anthony Crowther,  Michel Goedert]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANTS FTD ASN-613 DEL AND HIS-613]"} ], "id": "139", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11906000", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1046\/J.0022-3042.2001.00729.X"} , { "elementOf": "NLM", "accession": "11906000"} ]} , { "annotation": "[VARIANT PSNP1 ASN-613 DEL]", "conames": [{ "name": "PMID: 11220749", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11220749", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene."} , { "attrname": "Abstract", "value": "Heterozygous missense and splice-site mutations in the tau gene have been previously identified in familial frontotemporal dementia with autosomal dominant inheritance. Here we report a Spanish kindred in which two brothers born from a third-degree consanguineous marriage were both affected with atypical progressive supranuclear palsy. A homozygous deletion at codon 296 (delN296) was identified in one of the affected siblings. Among the heterozygous carriers,  two members with probable <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> were identified,  but none of heterozygotes developed atypical <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. The delN296 mutation lies in the sequence corresponding to the second tubulin-binding repeat of tau protein and affects one asparagine residue absolutely conserved in other species. This finding indicates that homozygous mutations in the tau gene may also cause hereditary tauopathies. "} , { "attrname": "MeSH", "value": "[Supranuclear Palsy,  Progressive,  Humans,  Middle Aged,  Male,  tau Proteins,  Spain,  Polymorphism,  Single-Stranded Conformational,  Homozygote,  Amyotrophic Lateral Sclerosis,  Pedigree,  Polymerase Chain Reaction,  Adult,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[P Pastor,  E Pastor,  C Carnero,  R Vela,  T Garca,  G Amer,  E Tolosa,  R Oliva]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PSNP1 ASN-613 DEL]"} ], "id": "140", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11220749", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/1531-8249(20010201)49: 2<263: : AID-ANA50>3.0.CO;2-K"} , { "elementOf": "NLM", "accession": "11220749"} ]} , { "annotation": "[VARIANT FTD SER-618]", "conames": [{ "name": "PMID: 11071507", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11071507", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation."} , { "attrname": "Abstract", "value": "The authors report a patient carrying a missense mutation in exon 10 of tau that causes a substitution at codon 301 (P301S). Although the patient shares the rapidly progressive frontotemporal dementia of the other reported pedigrees with P301S,  the clinical phenotype is unique in that parkinsonism was a major symptom in the early stage and because behavioral symptoms with dementia became prominent 2 years after the onset of the disease. This study substantiates the notion that tau mutations at codon 301 can show various phenotypes. "} , { "attrname": "MeSH", "value": "[Brain,  Magnetic Resonance Imaging,  Humans,  Japan,  Adult,  Male,  Mutation,  tau Proteins,  Dementia]"} , { "attrname": "AUTHORS", "value": "[M Yasuda,  K Yokoyama,  T Nakayasu,  Y Nishimura,  M Matsui,  T Yokoyama,  K Miyoshi,  C Tanaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD SER-618]"} ], "id": "141", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11071507", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11071507"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.55.8.1224"} ]} , { "annotation": "[VARIANT FTD ASN-622]", "conames": [{ "name": "PMID: 10208578", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10208578", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A distinct familial presenile dementia with a novel missense mutation in the tau gene."} , { "attrname": "Abstract", "value": "We report a Japanese family with early onset hereditary frontotemporal dementia and a novel missense mutation (Ser305Asn) in the tau gene. The patients presented with personality changes followed by impaired cognition and memory as well as disorientation,  but minimal Parkinsonism. Imaging studies showed fronto-temporal atrophy with ventricular dilatation more on the left,  and postmortem examination of the brain revealed numerous neurofibrillary tangles (NFTs) with an unusual morphology and distribution. Silver-stained sections showed ring-shaped NFTs partially surrounding the nucleus that were most prominent in frontal,  temporal,  insular and postcentral cortices,  as well as in dentate gyrus. Cortical NFTs were restricted primarily to layer II,  and were composed of straight tubules. Numerous glial cells containing coiled bodies and abundant neuropil threads were detected in cerebral white matter,  hippocampus,  basal ganglia,  diencephalon and brain stem,  but no senile plaques or other diagnostic lesions were seen. Both the glial and neuronal tangles were stained by antibodies to phosphorylation-independent and phosphorylation-dependent epitopes in tau. Thus,  this novel mutation causes a distinct familial tauopathy. "} , { "attrname": "MeSH", "value": "[Atrophy,  Amino Acid Sequence,  Brain,  Pedigree,  Humans,  Adult,  Female,  Male,  Mutation,  Missense,  Neurofibrillary Tangles,  tau Proteins,  Dementia]"} , { "attrname": "AUTHORS", "value": "[M Iijima,  T Tabira,  P Poorkaj,  G D Schellenberg,  J Q Trojanowski,  V M Lee,  M L Schmidt,  K Takahashi,  T Nabika,  T Matsumoto,  Y Yamashita,  S Yoshioka,  H Ishino]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD ASN-622]"} ], "id": "142", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10208578", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10208578"} , { "elementOf": "DOI", "accession": "10.1097\/00001756-199902250-00010"} ]} , { "annotation": "[PHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726,  DEPHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726 BY PPP5C]", "conames": [{ "name": "PMID: 15546861", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15546861", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 3.1.3.16 Phosphoprotein Phosphatases,  EC 3.1.3.16 protein phosphatase 5,  Recombinant Proteins,  tau Proteins,  Nuclear Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Dephosphorylation of tau by protein phosphatase 5:  impairment in Alzheimer's disease."} , { "attrname": "Abstract", "value": "Protein phosphatase (PP) 5 is highly expressed in the mammalian brain,  but few physiological substrates have yet been identified. Here,  we investigated the kinetics of dephosphoryation of phospho-tau by PP5 and found that PP5 had a K(m) of 8-13 microm toward tau,  which is similar to that of PP2A,  the major known tau phosphatase. This K(m) value is within the range of intraneuronal tau concentration in human brain,  suggesting that tau could be a physiological substrate of both PP5 and PP2A. PP5 dephosphorylated tau at all 12 <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD)-associated abnormal phosphorylation sites studied,  with different efficiency toward each site. Thr(205),  Thr(212),  and Ser(409) of tau were the most favorable sites; Ser(199),  Ser(202),  Ser(214),  Ser(396),  and Ser(404) were less favorable sites; and Ser(262) was the poorest site for PP5. Overexpression of PP5 in PC12 cells resulted in dephosphorylation of tau at multiple phosphorylation sites. The activity but not the protein level of PP5 was found to be decreased by approximately 20% in AD neocortex. These results suggest that tau is probably a physiological substrate of PP5 and that the abnormal hyperphosphorylation of tau in AD might result in part from the decreased PP5 activity in the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>d brains. "} , { "attrname": "MeSH", "value": "[Phosphorylation,  Immunoprecipitation,  Humans,  Rats,  Male,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  PC12 Cells,  tau Proteins,  Nuclear Proteins,  Animals,  Transfection,  Aged,  80 and over,  Female,  Aged,  Catalysis,  Kinetics,  Phosphoprotein Phosphatases]"} , { "attrname": "AUTHORS", "value": "[Fei Liu,  Khalid Iqbal,  Inge Grundke-Iqbal,  Sandra Rossie,  Cheng-Xin Gong]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726,  DEPHOSPHORYLATION AT THR-498; SER-516; SER-519; THR-522; THR-529; SER-531; THR-548; SER-552; SER-579; SER-713; SER-721 AND SER-726 BY PPP5C]"} ], "id": "143", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15546861", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15546861"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M410775200"} ]} , { "annotation": "[VARIANT PPND LYS-596]", "conames": [{ "name": "PMID: 10412802", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10412802", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Acta neuropathologica"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy."} , { "attrname": "Abstract", "value": "Recently intronic and exonic mutations in the Tau gene have been found to be associated with familial neurodegenerative syndromes characterized not only by a predominantly frontotemporal dementia but also by the presence of neurological signs consistent with the dysfunction of multiple subcortical neuronal circuitries. Among families,  the symptomatology appears to vary in quality and severity in relation to the specific Tau gene mutation and often may include <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  supranuclear palsies,  and\/or myoclonus,  in addition to dementia. We carried out molecular genetic and neuropathological studies on two patients from a French family presenting,  early in their fifth decade,  a cognitive impairment and supranuclear palsy followed by an akinetic rigid syndrome and dementia. The proband died severely demented 7 years after the onset of the symptoms; currently,  his brother is still alive although his <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is progressing. In both patients,  we found a Tau gene mutation in exon 10 at codon 279,  resulting in an asparagine to lysine substitution (N279K). Neuropathologically,  widespread neuronal and glial tau accumulation in the cortex,  basal ganglia,  brain stem nuclei as well as in the white matter were the hallmark of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. These deposits were shown by immunohistochemistry and immunoelectron microscopy,  using a battery of antibodies to phosphorylation-dependent and phosphorylation-independent epitopes present in multiple tau regions. In the neocortex,  tau-immunopositive glial cells were more numerous than immunopositive neurons; the deeper cortical layers as well as the white matter adjacent to the cortex contained the largest amount of immunolabeled glial cells. In contrast,  some brain stem nuclei contained more neurons with tau deposits than immunolabeled glial cells. The correlation of clinical,  neuropathological and molecular genetic findings emphasize the phenotypic heterogeneity of <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s caused by Tau gene mutations. Furthermore,  to test the effect of the N279K mutation and compare it with the effect of the P301L exon 10 mutation on alternative splicing of Tau exon 10,  we used an exon amplification assay. Our results suggest that the N279K mutation affects splicing similar to the intronic mutations,  allowing exon 10 to be incorporated more frequently in the Tau transcript. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Supranuclear Palsy,  Progressive,  Brain,  Alternative Splicing,  Exons,  Neurons,  Humans,  Neuroglia,  Neurofibrils,  Male,  Neurofibrillary Tangles,  tau Proteins,  Microscopy,  Immunoelectron,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Pedigree,  Adult,  Mutation,  Amino Acid Substitution,  Dementia]"} , { "attrname": "AUTHORS", "value": "[M B Delisle,  J R Murrell,  R Richardson,  J A Trofatter,  O Rascol,  X Soulages,  M Mohr,  P Calvas,  B Ghetti]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PPND LYS-596]"} ], "id": "144", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10412802", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1007\/S004010051052"} , { "elementOf": "NLM", "accession": "10412802"} ]} , { "annotation": "[GLYCATION AT LYS-87; LYS-383; LYS-467; LYS-480; LYS-491; LYS-542; LYS-551; LYS-576; LYS-597; LYS-598; LYS-664; LYS-670 AND LYS-686,  LACK OF GLYCATION AT LYS-24; LYS-44; LYS-67; LYS-381; LYS-391; LYS-392; LYS-394; LYS-465; LYS-497; LYS-507; LYS-541; LYS-557; LYS-571; LYS-574; LYS-584; LYS-591; LYS-607; LYS-611; LYS-615; LYS-628; LYS-634; LYS-638; LYS-648; LYS-657; LYS-660; LYS-687; LYS-692; LYS-700; LYS-702; LYS-712 AND LYS-755]", "conames": [{ "name": "PMID: 9326300", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9326300", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  IY9XDZ35W2 Glucose,  Phosphoproteins,  tau protein (389-402),  synthetic,  Recombinant Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Characterization of in vitro glycation sites of tau."} , { "attrname": "Abstract", "value": "Tau is a microtubule-associated protein that loses microtubule binding activity and aggregates into paired helical filaments (PHFs) in Alzheimer's disease. Nonenzymic glycation is one of the posttranslational modifications detected in PHF-tau,  but not in normal tau. PHF-tau has reduced ability to bind to microtubules. To determine whether glycation of tau occurs in its microtubule binding domains,  we have characterized in vitro glycation sites of the longest isoform of tau,  which has four microtubule binding domains (Tau-4). The identified glycation sites are Lys-87,  132,  150,  163,  174,  225,  234,  259,  280,  281,  347,  353,  and 369. We have also studied glycation of another isoform of tau,  which has only three microtubule binding domains (Tau-3). This isoform is modified by glucose 15-20% more slowly than Tau-4. However,  the glycation sites appear to be the same in both isoforms,  except for Lys-280 and 281; these are located in the second microtubule binding domain,  which is missing in Tau-3. Lys-150,  163,  and 174 are located within or proximal to the sequence of tau that is involved in the microtubule nucleation activity,  and Lys-259,  280,  281,  347,  353,  and 369 are located in the microtubule binding domains. Glycation at these sites can affect the functional properties of tau,  and advanced glycation at these sites might lead to the formation of insoluble aggregates similar to the ones seen in Alzheimer's disease. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Phosphoproteins,  Humans,  Genes,  Synthetic,  Molecular Sequence Data,  Glycosylation,  Glucose,  Kinetics,  Recombinant Proteins,  Binding Sites,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[P Nacharaju,  L Ko,  S H Yen]"} , { "attrname": "PUB_TYPE", "value": "[GLYCATION AT LYS-87; LYS-383; LYS-467; LYS-480; LYS-491; LYS-542; LYS-551; LYS-576; LYS-597; LYS-598; LYS-664; LYS-670 AND LYS-686,  LACK OF GLYCATION AT LYS-24; LYS-44; LYS-67; LYS-381; LYS-391; LYS-392; LYS-394; LYS-465; LYS-497; LYS-507; LYS-541; LYS-557; LYS-571; LYS-574; LYS-584; LYS-591; LYS-607; LYS-611; LYS-615; LYS-628; LYS-634; LYS-638; LYS-648; LYS-657; LYS-660; LYS-687; LYS-692; LYS-700; LYS-702; LYS-712 AND LYS-755]"} ], "id": "145", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9326300", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9326300"} ]} , { "annotation": "[VARIANT FTDP17\/<span style=\"background-color: yellow\"><b>ALZHEIMER<\/b><\/span> DISEASE TRP-723]", "conames": [{ "name": "PMID: 14517953", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14517953", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[8DUH1N11BX Tryptophan,  tau Proteins,  94ZLA3W45F Arginine]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Tau (MAPT) mutation Arg406Trp presenting clinically with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> does not share a common founder in Western Europe."} , { "attrname": "MeSH", "value": "[Founder Effect,  Arginine,  Pedigree,  Europe,  Humans,  Middle Aged,  Tryptophan,  Aged,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Microsatellite Repeats]"} , { "attrname": "AUTHORS", "value": "[R Rademakers,  B Dermaut,  K Peeters,  M Cruts,  P Heutink,  A Goate,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTDP17\/ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> TRP-723]"} ], "id": "146", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14517953", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14517953"} , { "elementOf": "DOI", "accession": "10.1002\/HUMU.10269"} ]} , { "annotation": "[VARIANT FTD LYS-596]", "conames": [{ "name": "PMID: 10489057", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10489057", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration."} , { "attrname": "Abstract", "value": "We detected a missense mutation in exon 10 of tau that causes a substitution at codon 279 (N279K) in a Japanese patient with a familial background of parkinsonism and dementia originally described as pallido-nigro-luysian degeneration. This mutation is the same as one seen in a Caucasian family with pallido-ponto-nigral degeneration. The similarities between these two families suggest a common genetic mechanism that may account for the peculiar distribution of neuroglial degeneration with tauopathy. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Pons,  Globus Pallidus,  Pedigree,  Substantia Nigra,  Base Sequence,  Molecular Sequence Data,  Mutation,  Nerve Degeneration,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[M Yasuda,  T Kawamata,  O Komure,  S Kuno,  I D'Souza,  P Poorkaj,  J Kawai,  S Tanimukai,  Y Yamamoto,  H Hasegawa,  M Sasahara,  F Hazama,  G D Schellenberg,  C Tanaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD LYS-596]"} ], "id": "147", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10489057", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.53.4.864"} , { "elementOf": "NLM", "accession": "10489057"} ]} , { "annotation": "[VARIANT FTD SER-618]", "conames": [{ "name": "PMID: 16240366", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16240366", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Nerve Tissue Proteins,  tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Phenotypic heterogeneity within a new family with the MAPT p301s mutation."} , { "attrname": "Abstract", "value": "Mutations in the gene encoding the microtubule-associated protein tau (MAPT) cause frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17. Clinical variability is seen not only among families with different mutations,  but also among family members with the same mutation. We investigated a newly identified familial frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism family. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was of early onset and was inherited as an autosomal dominant trait. Clinically,  <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism was the prominent and often early feature,  and it preceded dementia. Three autopsied cases shared involvement predominantly in the frontal and temporal lobes and also in the subcortical nuclei,  including substantia nigra,  globus pallidus,  and subthalamic nucleus,  that microscopically consisted of neuronal loss,  microvacuolation,  and astrocytic fibrosis. Immunohistochemistry demonstrated neuropil threads,  ballooned cells,  and glial fibrillary tangles. Sequencing analysis of the MAPT gene showed an alteration in one allele,  resulting in a P301S substitution. These findings suggest that the MAPT P301S mutation can cause pathologically subcortical-predominant,  neuropil thread-rich,  tau-containing lesions,  which could result in consistent <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. Our study confirms the notion that the phenotype observed in affected individuals from P301S MAPT mutation families is heterogeneous and is broader than the phenotypes seen to date in affected family members carrying other MAPT mutations. "} , { "attrname": "MeSH", "value": "[Cerebellum,  Humans,  Family Health,  Male,  Nerve Tissue Proteins,  tau Proteins,  Genetic Heterogeneity,  Entorhinal Cortex,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Phenotype,  Pedigree,  Adult,  Female,  Basal Ganglia,  Hippocampus,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Minoru Yasuda,  Yoshitsugu Nakamura,  Toshio Kawamata,  Hiroshi Kaneyuki,  Kiyoshi Maeda,  Osamu Komure]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD SER-618]"} ], "id": "148", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16240366", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20668"} , { "elementOf": "NLM", "accession": "16240366"} ]} , { "annotation": "[VARIANT PSNP1 LEU-5,  CHARACTERIZATION OF VARIANT PSNP1 LEU-5]", "conames": [{ "name": "PMID: 12325083", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12325083", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype."} , { "attrname": "Abstract", "value": "MAPT,  the gene encoding tau,  was screened for mutations in 96 progressive supranuclear palsy subjects. A point mutation (R5L) was identified in a single progressive supranuclear palsy subject that was not in the other progressive supranuclear palsy subjects or in 96 controls. Functionally,  this mutation alters the ability of tau to promote microtubule assembly. Analysis of soluble tau from different brain regions indicates that the mutation does not affect the ratio of tau isoforms synthesized. Aggregated insoluble tau from subcortical regions was predominantly four-repeat tau with no or one amino terminal insert (0N4R and 1N4R). Insoluble tau from cortical regions also contained 1N3R tau. Thus,  the R5L mutation causes a progressive supranuclear palsy phenotype,  presumably by a gain-of-function mechanism. "} , { "attrname": "MeSH", "value": "[Supranuclear Palsy,  Progressive,  Tauopathies,  Amino Acid Sequence,  Phenotype,  Exons,  Humans,  Middle Aged,  Molecular Sequence Data,  Female,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[Parvoneh Poorkaj,  Nancy A Muma,  Victoria Zhukareva,  Elizabeth J Cochran,  Kathleen M Shannon,  Howard Hurtig,  William C Koller,  Thomas D Bird,  John Q Trojanowski,  Virginia M-Y Lee,  Gerard D Schellenberg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PSNP1 LEU-5,  CHARACTERIZATION OF VARIANT PSNP1 LEU-5]"} ], "id": "149", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12325083", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12325083"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10340"} ]} , { "annotation": "[FUNCTION,  PHOSPHORYLATION AT THR-529 AND SER-579]", "conames": [{ "name": "PMID: 21985311", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21985311", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Protein Kinase Inhibitors,  EC 2.7.11.11 Cyclic AMP-Dependent Protein Kinases,  Microtubule-Associated Proteins,  Antibodies,  Monoclonal,  Epitopes,  Recombinant Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of microtubule-associated protein tau by AMPK-related kinases."} , { "attrname": "Abstract", "value": "Microtubule-associated protein tau is abnormally hyperphosphorylated in the intracellular filamentous inclusions seen in neurodegenerative disorders with dementia,  such as Alzheimer's disease and other tauopathies. Microtubule-associated protein\/microtubule-affinity regulating kinases (MARKs) have previously been identified as kinases which phosphorylate KxGS motifs in the tandem repeats of tau. They are members of the 5'-AMP-activated protein kinase (AMPK)-related kinases in the Ca(2+)\/calmodulin-dependent protein kinase group. In this study,  we examined the ability of AMPK-related kinases,  brain-specific kinases 1 and 2,  maternal embryonic leucine-zipper kinase,  MARK1,  and salt-inducible kinase (SIK),  to phosphorylate tau. We found that they phosphorylated S262 and S356 in KxGS motifs in the repeats of tau,  thus resulting in immunoreactivity with antibody 12E8. MARK1 and SIK most effectively phosphorylated tau,  and their down-regulation resulted in a reduction of 12E8-labelling. BX 795,  an inhibitor of MARK1 and SIK,  reduced 12E8-immunolabelling of tau in rat cortical neurons. These findings reveal a significant contribution of AMPK-related kinases to the phosphorylation of tau at S262\/S356. "} , { "attrname": "MeSH", "value": "[Cell Line,  Phosphorylation,  Neurons,  Down-Regulation,  Humans,  Microtubule-Associated Proteins,  Rats,  Antibodies,  Monoclonal,  Epitopes,  Recombinant Proteins,  Rats,  Sprague-Dawley,  tau Proteins,  Blotting,  Western,  Protein Kinase Inhibitors,  Animals,  Plasmids,  Microtubules,  Polymerase Chain Reaction,  Cyclic AMP-Dependent Protein Kinases]"} , { "attrname": "AUTHORS", "value": "[Hirotaka Yoshida,  Michel Goedert]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  PHOSPHORYLATION AT THR-529 AND SER-579]"} ], "id": "150", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21985311", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21985311"} , { "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.2011.07523.X"} ]} , { "annotation": "[VARIANTS FTD LYS-596 AND LEU-618]", "conames": [{ "name": "PMID: 9789048", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9789048", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17."} , { "attrname": "Abstract", "value": "Pallido-ponto-nigral degeneration (PPND) is one of the most well characterized familial neurodegenerative disorders linked to chromosome 17q21-22. These hereditary disorders are known collectively as frontotemporal dementia (FTD) and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17 (FTDP-17). Although the clinical features and associated regional variations in the neuronal loss observed in different FTDP-17 kindreds are diverse,  the diagnostic lesions of FTDP-17 brains are tau-rich filaments in the cytoplasm of specific subpopulations of neurons and glial cells. The microtubule associated protein (tau) gene is located on chromosome 17q21-22. For these reasons,  we investigated the possibility that PPND and other FTDP-17 syndromes might be caused by mutations in the tau gene. Two missense mutations in exon 10 of the tau gene that segregate with <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  Asn279(Lys) in the PPND kindred and Pro301(Leu) in four other FTDP-17 kindreds,  were found. A third mutation was found in the intron adjacent to the 3' splice site of exon 10 in patients from another FTDP-17 family. Transcripts that contain exon 10 encode tau isoforms with four microtubule (MT)-binding repeats (4Rtau) as opposed to tau isoforms with three MT-binding repeats (3Rtau). The insoluble tau aggregates isolated from brains of patients with each mutation were analyzed by immunoblotting using tau-specific antibodies. For each of three mutations,  abnormal tau with an apparent Mr of 64 and 69 was observed. The dephosphorylated material comigrated with tau isoforms containing exon 10 having four MT-binding repeats but not with 3Rtau. Thus,  the brains of patients with both the missense mutations and the splice junction mutation contain aggregates of insoluble 4Rtau in filamentous inclusions,  which may lead to neurodegeneration. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Neurodegenerative <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Pons,  Globus Pallidus,  Alternative Splicing,  Introns,  Substantia Nigra,  Humans,  Middle Aged,  Molecular Sequence Data,  Chromosome Mapping,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Point Mutation,  Repetitive Sequences,  Amino Acid,  Sequence Alignment,  Chromosomes,  Human,  Pair 17,  Age of Onset,  Adult,  Aged,  Dementia,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[L N Clark,  P Poorkaj,  Z Wszolek,  D H Geschwind,  Z S Nasreddine,  B Miller,  D Li,  H Payami,  F Awert,  K Markopoulou,  A Andreadis,  I D'Souza,  V M Lee,  L Reed,  J Q Trojanowski,  V Zhukareva,  T Bird,  G Schellenberg,  K C Wilhelmsen]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS FTD LYS-596 AND LEU-618]"} ], "id": "151", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9789048", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.95.22.13103"} , { "elementOf": "NLM", "accession": "9789048"} ]} , { "annotation": "[VARIANT FTD HIS-613]", "conames": [{ "name": "PMID: 11585254", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11585254", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Acta neuropathologica"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "Familial frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells."} , { "attrname": "Abstract", "value": "We report a 62-year-old Japanese man with familial frontotemporal dementia and a novel missense mutation (N296H) in exon 10 of the tau gene. The patient presented with frontal signs followed by temporal signs and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. The brain showed localized frontotemporal lobe atrophy including the precentral gyrus and discoloration of the substantia nigra,  and revealed severe neuronal loss with proliferation of tau-positive protoplasmic astroglia in the affected cerebral cortex,  tau-positive coiled bodies and threads in the subcortical white matter,  and tau-positive pretangle neurons in the subcortical and brain stem nuclei. There were no tau-positive neurofibrillary tangles,  Pick bodies,  tuft-shaped astrocytes or astrocytic plaques in the cerebral cortex. Immunoelectron microscopically,  phosphorylated tau accumulated in both neurons and glial cells in different modalities,  such as glial filaments in protoplasmic astroglia,  straight tubules in coiled bodies,  and free ribosomes in pretangle neurons. These findings suggest that tau proteins are not always assembled in abnormal filaments such as twisted ribbons,  paired helical filaments and straight tubules in neurons and glial cells,  which have been shown in previous cases with frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17. Immunoblotting of sarkosyl-insoluble tau exhibited accumulation of four-repeat tau isoforms in the brain. The N296H mutation may interfere with the ability of mutated tau to bind with microtubules and lead to tau aggregation. Further study is necessary to determine whether this mutation can account for the characteristic tau pathology of this case. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Middle Aged,  Neuroglia,  Male,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Radiography,  Frontal Lobe,  Temporal Lobe,  Pedigree,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[E Iseki,  T Matsumura,  W Marui,  H Hino,  T Odawara,  N Sugiyama,  K Suzuki,  H Sawada,  T Arai,  K Kosaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD HIS-613]"} ], "id": "152", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11585254", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11585254"} ]} , { "annotation": "[VARIANT FTD MET-634]", "conames": [{ "name": "PMID: 15883319", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15883319", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Nerve Tissue Proteins,  Genetic Markers,  tau Proteins]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease."} , { "attrname": "Abstract", "value": "Frontotemporal dementia with parkinsonism is often linked to chromosome 17 and is related to mutations in the MAPT gene. In some families the genetic basis is still unknown. The authors report two pedigrees with FTDP-17 harboring a novel mutation (K317M) in exon 11 in the MAPT gene. The authors identified two apparently unrelated pedigrees with an autosomal dominant neurodegenerative condition. Thirteen patients were examined and eight autopsies were performed. Mean age at onset was 48 years. Mean disease duration was 6 years. Dysarthria often heralded the disease. All cases had parkinsonism and pyramidalism and half of them had amyotrophy. Behavioral or personality changes were not a prominent feature. Cognitive decline appeared late in the evolution. Neuropathologically,  a massive degeneration of the substantia nigra without Lewy bodies was a constant finding. A variable degree of frontotemporal atrophy was found. Corticospinal tract degeneration and anterior horn neuron loss were present in six of seven autopsies in which the spinal cord was examined. An extensive deposition of abnormal tau protein in a mixed pattern (neuronal,  glial) was observed. Pick's bodies were not seen. Biochemical analysis of tau revealed two bands of 64 and 68 kDa. Genetic analysis revealed the same novel mutation (K317M) in exon 11 of the MAPT gene in both pedigrees. A common haplotype between members of the two pedigrees suggests that they belong to the same family. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Brain,  Genetic Predisposition to Disease,  Genetic Testing,  Substantia Nigra,  Humans,  Middle Aged,  Motor Neuron Disease,  Genotype,  Male,  Nerve Tissue Proteins,  Genetic Markers,  tau Proteins,  Pyramidal Tracts,  Chromosomes,  Human,  Pair 17,  Genes,  Dominant,  Spinal Cord,  DNA Mutational Analysis,  Pedigree,  Motor Neurons,  Adult,  Female,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[J J Zarranz,  I Ferrer,  E Lezcano,  M I Forcadas,  B Eizaguirre,  B Atars,  B Puig,  J C Gmez-Esteban,  C Fernndez-Maiztegui,  I Rouco,  T Prez-Concha,  M Fernndez,  O Rodrguez,  A B Rodrguez-Martnez,  M Martnez de Pancorbo,  P Pastor,  J Prez-Tur]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD MET-634]"} ], "id": "153", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15883319", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15883319"} , { "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000160116.65034.12"} ]} , { "annotation": "[PHOSPHORYLATION AT THR-470; SER-516; SER-519; THR-529; SER-531; SER-552; SER-579; SER-713; SER-721 AND SER-739,  MUTAGENESIS]", "conames": [{ "name": "PMID: 9614189", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9614189", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular biology of the cell"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.22 Cyclin-Dependent Kinases,  EC 2.7.11.22 CDK5 protein,  human,  EC 2.7.11.1 Cyclin-Dependent Kinase 5,  EC 2.7.1.- MARK1 protein,  human,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  EC 2.7.11.22 CDC2 Protein Kinase,  452VLY9402 Serine,  tau Proteins,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinases]"} , { "attrname": "visible", "value": "true"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "size", "value": "70"} , { "attrname": "AbstractHeader", "value": "The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells:  implications for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "In <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> the neuronal microtubule-associated protein tau becomes highly phosphorylated,  loses its binding properties,  and aggregates into paired helical filaments. There is increasing evidence that the events leading to this hyperphosphorylation are related to mitotic mechanisms. Hence,  we have analyzed the physiological phosphorylation of endogenous tau protein in metabolically labeled human neuroblastoma cells and in Chinese hamster ovary cells stably transfected with tau. In nonsynchronized cultures the phosphorylation pattern was remarkably similar in both cell lines,  suggesting a similar balance of kinases and phosphatases with respect to tau. Using phosphopeptide mapping and sequencing we identified 17 phosphorylation sites comprising 80-90% of the total phosphate incorporated. Most of these are in SP or TP motifs,  except S214 and S262. Since phosphorylation of microtubule-associated proteins increases during mitosis,  concomitant with increased microtubule dynamics,  we analyzed cells mitotically arrested with nocodazole. This revealed that S214 is a prominent phosphorylation site in metaphase,  but not in interphase. Phosphorylation of this residue strongly decreases the tau-microtubule interaction in vitro,  suppresses microtubule assembly,  and may be a key factor in the observed detachment of tau from microtubules during mitosis. Since S214 is also phosphorylated in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> tau,  our results support the view that reactivation of the cell cycle machinery is involved in tau hyperphosphorylation. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  CDC2 Protein Kinase,  Cell Line,  Cricetinae,  Gene Expression,  Phosphorylation,  Interphase,  Mitosis,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Molecular Sequence Data,  Glycogen Synthase Kinase 3,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Calcium-Calmodulin-Dependent Protein Kinases,  tau Proteins,  Cyclin-Dependent Kinase 5,  Animals,  Cell Cycle,  Microtubules,  Cyclin-Dependent Kinases,  HeLa Cells,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[S Illenberger,  Q Zheng-Fischhfer,  U Preuss,  K Stamer,  K Baumann,  B Trinczek,  J Biernat,  R Godemann,  E M Mandelkow,  E Mandelkow]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT THR-470; SER-516; SER-519; THR-529; SER-531; SER-552; SER-579; SER-713; SER-721 AND SER-739,  MUTAGENESIS]"} ], "id": "154", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9614189", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9614189"} , { "elementOf": "DOI", "accession": "10.1091\/MBC.9.6.1495"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 616-712]", "conames": [{ "name": "PMID: 1915258", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1915258", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[EC 3.4.24.- Pronase,  tau Proteins]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease."} , { "attrname": "Abstract", "value": "The microtubule associated protein tau is incorporated into the pronase resistant core of the paired helical filament (PHF) in such a way that the repeat region is protected from proteases,  but can be released as a major 12 kDa species from the PHF core by formic acid treatment and by boiling in SDS. This fragment retains the ability to aggregate in the presence of SDS. Detailed sequence analysis of the 12 kDa species shows that it consists of a mixture of peptides derived from the repeat region of 3- and 4-repeat tau isoforms comigrating as a single electrophoretic band. However,  the 4-repeat isoforms released from the core lack either the first or the last repeat. The pronase-protected region of tau within the PHF core is therefore restricted to three repeats,  regardless of isoform. The alignment of cleavage sites at homologous positions within tandem repeats after protease treatment indicates that the tau-core association is precisely constrained by the tandem repeat structure of the tau molecule. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Intermediate Filaments,  Electrophoresis,  Polyacrylamide Gel,  Humans,  Molecular Sequence Data,  Pronase,  Repetitive Sequences,  Nucleic Acid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microscopy,  Electron,  tau Proteins,  Blotting,  Western]"} , { "attrname": "AUTHORS", "value": "[R Jakes,  M Novak,  M Davison,  C M Wischik]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 616-712]"} ], "id": "155", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1915258", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1915258"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT FTD TRP-723]", "conames": [{ "name": "PMID: 11278002", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11278002", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Protein Isoforms,  Microtubule-Associated Proteins,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  EC 2.7.11.- Glycogen Synthase Kinases,  Recombinant Proteins,  tau Proteins,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes."} , { "attrname": "Abstract", "value": "In vitro phosphorylation of recombinant wild-type 2N4R tau and FTDP-17 exonic mutant forms P301L,  V337M and R406W by glycogen synthase kinase 3beta (GSK3beta) was examined by two dimensional phosphopeptide mapping analysis on thin layer cellulose plates. Comparison of these peptide maps with those generated from wild-type 1N4R tau isoform from which the phosphopeptide constituents and sites of phosphorylation had been determined previously,  enabled us to monitor directly changes in phosphorylation of the individual tau proteins. No differences were found in the phosphorylation of wild-type,  P301L or V337M tau by GSK3beta but the R406W mutant showed at least two clear differences from the other three tau proteins. The peptides,  identified by mass spectrometry corresponding to phosphorylation at both threonine 231 and serine 235 (spot 3),  serines 396,  400 and 404 (spot 6a) and serines 195 and 199 (spot 6b) were absent from the R406W peptide map. The findings imply that the R406W mutation in tau exerts long-range conformational effects on the structure of tau. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Phosphorylation,  Exons,  Humans,  Microtubule-Associated Proteins,  Electrophoresis,  Gel,  Two-Dimensional,  Glycogen Synthase Kinase 3,  Mutation,  Missense,  Recombinant Proteins,  Calcium-Calmodulin-Dependent Protein Kinases,  tau Proteins,  Glycogen Synthase Kinases,  Spectrometry,  Mass,  Electrospray Ionization,  Peptide Mapping,  Mass Spectrometry,  Protein Isoforms,  Protein Conformation,  Mutation]"} , { "attrname": "AUTHORS", "value": "[J W Connell,  G M Gibb,  J C Betts,  W P Blackstock,  J Gallo,  S Lovestone,  M Hutton,  B H Anderton]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT FTD TRP-723]"} ], "id": "156", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11278002", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11278002"} , { "elementOf": "DOI", "accession": "10.1016\/S0014-5793(01)02267-0"} ]} , { "annotation": "[VARIANT FTD\/CBD SER-618]", "conames": [{ "name": "PMID: 10374757", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10374757", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuropathology and experimental neurology"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  tau Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau."} , { "attrname": "Abstract", "value": "The tau gene has been found to be the locus of dementia with rigidity linked to chromosome 17. Exonic and intronic mutations have been described in a number of families. Here we describe a P301S mutation in exon 10 of the tau gene in a new family. Two members of this family were affected. One individual presented with frontotemporal dementia,  whereas his son has corticobasal degeneration,  demonstrating that the same primary gene defect in tau can lead to 2 distinct clinical phenotypes. Both individuals developed rapidly progressive disease in the third decade. Neuropathologically,  the father presented with an extensive filamentous pathology made of hyperphosphorylated tau protein. Biochemically,  recombinant tau protein with the P301S mutation showed a greatly reduced ability to promote microtubule assembly. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Humans,  Middle Aged,  Basal Ganglia Diseases,  Cerebral Cortex,  Family Health,  tau Proteins,  Magnetic Resonance Imaging,  Frontal Lobe,  Temporal Lobe,  Pedigree,  DNA,  Microtubules,  Adult,  Mutation,  Nerve Degeneration,  Dementia]"} , { "attrname": "AUTHORS", "value": "[O Bugiani,  J R Murrell,  G Giaccone,  M Hasegawa,  G Ghigo,  M Tabaton,  M Morbin,  A Primavera,  F Carella,  C Solaro,  M Grisoli,  M Savoiardo,  M G Spillantini,  F Tagliavini,  M Goedert,  B Ghetti]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD\/CBD SER-618]"} ], "id": "157", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10374757", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1097\/00005072-199906000-00011"} , { "elementOf": "NLM", "accession": "10374757"} ]} , { "annotation": "[VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669,  CHARACTERIZATION OF VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669]", "conames": [{ "name": "PMID: 14595660", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14595660", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "An English kindred with a novel recessive tauopathy and respiratory failure."} , { "attrname": "Abstract", "value": "We present the clinicopathological features of two siblings from a consanguineous marriage who presented with respiratory hypoventilation and died 10 days and 4 years later,  respectively. This disorder showed extensive tau neuropathology,  and both had a novel homozygous S352L tau gene mutation. This is the first description of a pathologically proved young-onset tauopathy with apparent recessive inheritance. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Respiratory Insufficiency,  Brain,  Humans,  Molecular Sequence Data,  Male,  Genes,  Recessive,  tau Proteins,  Tauopathies,  Pedigree,  Base Sequence,  Microtubules,  Age of Onset,  Adult,  Female,  Mutation]"} , { "attrname": "AUTHORS", "value": "[David J Nicholl,  Michael A Greenstone,  Carl E Clarke,  Patrizia Rizzu,  Daniel Crooks,  Alex Crowe,  John Q Trojanowski,  Virginia M-Y Lee,  Peter Heutink]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669,  CHARACTERIZATION OF VARIANT FATAL RESPIRATORY HYPOVENTILATION LEU-669]"} ], "id": "158", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14595660", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14595660"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10747"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TAU-D)]", "conames": [{ "name": "PMID: 2498079", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2498079", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Microtubule-Associated Proteins,  Nerve Tissue Proteins,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats:  differential expression of tau protein mRNAs in human brain."} , { "attrname": "Abstract", "value": "We have isolated cDNA clones encoding a 383-amino acid isoform of the human microtubule-associated protein tau. It differs from previously determined tau sequences by the presence of an additional repeat of 31 amino acids,  giving four,  rather than three,  tandem repeats in its carboxy-terminal half. The extra repeat is encoded by a separate exon. Probes derived from cDNA clones encoding the three (type I) and four repeat (type II) tau protein isoforms detected mRNAs for both forms in all adult human brain areas examined. However,  in foetal brain only type I mRNA was found. Type I and type II mRNAs were present in pyramidal cells in cerebral cortex. In the hippocampal formation,  type I mRNA was found in pyramidal and granule cells; type II mRNA was detected in most,  though not all,  pyramidal cells but not in granule cells. These observations indicate that tau protein mRNAs are expressed in a stage- and cell-specific manner. Tau protein is found in the protease-resistant core of the paired helical filament,  the major constituent of the neurofibrillary tangle in Alzheimer's disease. Taken in conjunction with previous findings,  the present results indicate that both the three and four repeat-containing tau protein isoforms are present in the core of the paired helical filament. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Humans,  Gene Expression Regulation,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Nerve Tissue Proteins,  tau Proteins,  Tissue Distribution,  Base Sequence,  DNA,  Cloning,  Molecular,  Repetitive Sequences,  Nucleic Acid,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[M Goedert,  M G Spillantini,  M C Potier,  J Ulrich,  R A Crowther]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TAU-D)]"} ], "id": "159", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2498079", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2498079"} ]} , { "annotation": "[VARIANT FTD LYS-596]", "conames": [{ "name": "PMID: 12473774", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12473774", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Antiparkinson Agents,  tau Proteins,  46627O600J Levodopa]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)."} , { "attrname": "Abstract", "value": "The tau N279K mutation was identified in four separately ascertained families in the United States,  Japan,  and France and in another recently discovered affected individual in Japan. The authors analyzed genealogical and clinical records and DNA samples. Average age at onset was 43 years; survival time was 7 years. All families exhibited similar clinical features,  with <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  dementia,  and supranuclear palsy uniformly seen. A founder effect indicated by a shared <span style=\"background-color: yellow\"><b>disease<\/b><\/span> haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world. "} , { "attrname": "MeSH", "value": "[Molecular Biology,  United States,  Humans,  Japan,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  Male,  Penetrance,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Founder Effect,  Frontal Lobe,  Temporal Lobe,  Chromosomes,  Human,  Pair 17,  DNA,  Adult,  Levodopa,  Mutation,  France,  Nerve Degeneration,  Microsatellite Repeats,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Y Tsuboi,  M Baker,  M L Hutton,  R J Uitti,  O Rascol,  M-B Delisle,  X Soulages,  J R Murrell,  B Ghetti,  M Yasuda,  O Komure,  S Kuno,  K Arima,  N Sunohara,  T Kobayashi,  Y Mizuno,  Z K Wszolek]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD LYS-596]"} ], "id": "160", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12473774", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000038909.49164.4B"} , { "elementOf": "NLM", "accession": "12473774"} ]} , { "annotation": "[PHOSPHORYLATION AT THR-529 BY DYRK2]", "conames": [{ "name": "PMID: 18599021", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18599021", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical pharmacology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Tumor Suppressor Protein p53,  EC 2.7.10.1 Protein-Tyrosine Kinases,  EC 2.7.1.- Dyrk kinase]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Role for DYRK family kinases on regulation of apoptosis."} , { "attrname": "Abstract", "value": "The cellular response to a variety of stress including DNA damage is involved in cell cycle arrest,  activation of DNA repair,  and in the event of irreparable damage,  induction of apoptosis. However,  the signals that determine cell fate,  that is,  survival or apoptosis,  are largely unknown. Accumulating studies have revealed that dual-specificity tyrosine-regulated kinases (DYRKs) play key roles on cell proliferation and apoptosis induction. In particular,  DYRK2 translocates from the cytoplasm into the nucleus following genotoxic stress. DYRK2 is then activated by ATM and induce apoptosis by phosphorylating p53 at Ser46. Importantly,  whereas precise regulation of these kinases remain uncertain,  this mechanism has consequences for cell proliferation,  differentiation,  or apoptosis. This progress review highlights recent efforts demonstrating that DYRKs could be novel and essential regulatory molecules for the regulation of cell fate including apoptosis. "} , { "attrname": "MeSH", "value": "[Phosphorylation,  Animals,  Tumor Suppressor Protein p53,  Cell Cycle,  Humans,  Protein-Serine-Threonine Kinases,  DNA Damage,  Protein-Tyrosine Kinases,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[Kiyotsugu Yoshida]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT THR-529 BY DYRK2]"} ], "id": "161", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18599021", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "18599021"} , { "elementOf": "DOI", "accession": "10.1016\/J.BCP.2008.05.021"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 577-584; 608-611; 616-628; 639-648 AND 671-686,  PHOSPHORYLATION AT SER-579; SER-610; SER-622; SER-641 AND SER-673,  MUTAGENESIS]", "conames": [{ "name": "PMID: 7706316", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7706316", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Peptide Fragments,  Tubulin,  EC 2.7.1.- MARK1 protein,  human,  Phosphopeptides,  Recombinant Proteins,  452VLY9402 Serine,  EC 3.4.21.4 Trypsin,  tau Proteins,  17885-08-4 Phosphoserine]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Microtubule-associated protein\/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>-specific site serine 262."} , { "attrname": "Abstract", "value": "Aberrant phosphorylation of the microtubule-associated protein tau is one of the pathological features of neuronal degeneration in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The phosphorylation of Ser-262 within the microtubule binding region of tau is of particular interest because so far it is observed only in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (Hasegawa,  M.,  Morishima-Kawashima,  M.,  Takio,  K.,  Suzuki,  M.,  Titani,  K.,  and Ihara,  Y. (1992) J. Biol. Chem. 26,  17047-17054) and because phosphorylation of this site alone dramatically reduces the affinity for microtubules in vitro (Biernat,  J.,  Gustke,  N.,  Drewes,  G.,  Mandelkow,  E.-M.,  and Mandelkow,  E. (1993) Neuron 11,  153-163). Here we describe the purification and characterization of a protein-serine kinase from brain tissue with an apparent molecular mass of 110 kDa on SDS gels. This kinase specifically phosphorylates tau on its KIGS or KCGS motifs in the repeat domain,  whereas no significant phosphorylation outside this region was detected. Phosphorylation occurs mainly on Ser-262 located in the first repeat. This largely abolishes tau's binding to microtubules and makes them dynamically unstable,  in contrast to other protein kinases that phosphorylate tau at or near the repeat domain. The data suggest a role for this novel kinase in cellular events involving rearrangement of the microtuble-associated proteins\/microtubule arrays and their pathological degeneration in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Chromatography,  Ion Exchange,  Peptide Fragments,  Phosphorylation,  Escherichia coli,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Molecular Sequence Data,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Trypsin,  Animals,  Tubulin,  Peptide Mapping,  Swine,  Microtubules,  Cloning,  Molecular,  Phosphopeptides,  Kinetics,  Phosphoserine]"} , { "attrname": "AUTHORS", "value": "[G Drewes,  B Trinczek,  S Illenberger,  J Biernat,  G Schmitt-Ulms,  H E Meyer,  E M Mandelkow,  E Mandelkow]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 577-584; 608-611; 616-628; 639-648 AND 671-686,  PHOSPHORYLATION AT SER-579; SER-610; SER-622; SER-641 AND SER-673,  MUTAGENESIS]"} ], "id": "162", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7706316", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7706316"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.270.13.7679"} ]} , { "annotation": "[VARIANT PIDB PHE-637,  CHARACTERIZATION OF VARIANT PIDB PHE-637]", "conames": [{ "name": "PMID: 11891833", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11891833", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Recombinant Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "A novel tau mutation,  S320F,  causes a tauopathy with inclusions similar to those in Pick's disease."} , { "attrname": "Abstract", "value": "Mutations in the tau gene cause familial frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17. In this article,  we describe a novel missense mutation,  S320F,  in the tau gene in a family with presenile dementia. To our knowledge,  it is the first mutation to be described in exon 11 of tau. The proband died at age 53 years,  after a <span style=\"background-color: yellow\"><b>disease<\/b><\/span> duration of 15 years,  and autopsy revealed a neuropathological picture similar to Pick's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Recombinant tau protein with the S320F mutation showed a greatly reduced ability to promote microtubule assembly. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Pick <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> of the Brain,  Male,  Mutation,  Missense,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microscopy,  Electron,  tau Proteins,  Inclusion Bodies,  DNA,  Microtubules,  Ultrasonography,  Adult]"} , { "attrname": "AUTHORS", "value": "[Sonia M Rosso,  Esther van Herpen,  Wout Deelen,  Wouter Kamphorst,  Lies-Anne Severijnen,  Rob Willemsen,  Rivka Ravid,  Martinus F Niermeijer,  Dennis Dooijes,  Michael J Smith,  Michel Goedert,  Peter Heutink,  John C van Swieten]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PIDB PHE-637,  CHARACTERIZATION OF VARIANT PIDB PHE-637]"} ], "id": "163", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11891833", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11891833"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10140"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-A AND FETAL-TAU)]", "conames": [{ "name": "PMID: 2516729", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2516729", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[Tubulin,  9007-49-2 DNA,  Microtubule-Associated Proteins,  tau Proteins,  Recombinant Fusion Proteins]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "The microtubule binding domain of tau protein."} , { "attrname": "Abstract", "value": "Tau protein is a microtubule-associated protein implicated in the spatial and temporal specification of microtubules and has been found in the neurofibrillary tangles of Alzheimer's disease. Determination of tau protein structure has revealed three 18 amino acid repeated sequences hypothesized to be tubulin binding sites. Using tau cDNA clones from human fetal brain,  we employed E. coli expression systems to synthesize tau protein and fragments of tau protein in order to identify the microtubule binding site. A fragment containing the three repeated sequences binds microtubules,  while the amino-terminal half of the protein does not bind. Fragments containing two or one repeat are also capable of binding,  indicating that the basic tubulin interacting unit is one repeat. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Sequence Homology,  Nucleic Acid,  tau Proteins,  Recombinant Fusion Proteins,  Tubulin,  Base Sequence,  DNA,  Microtubules,  Protein Binding,  Repetitive Sequences,  Nucleic Acid,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[G Lee,  R L Neve,  K S Kosik]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS TAU-A AND FETAL-TAU)]"} ], "id": "164", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2516729", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2516729"} , { "elementOf": "DOI", "accession": "10.1016\/0896-6273(89)90050-0"} ]} , { "annotation": "[PHOSPHORYLATION AT TYR-514; SER-515; SER-516; SER-519; SER-733; SER-739 AND THR-744]", "conames": [{ "name": "PMID: 16923168", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16923168", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  2ZD004190S Threonine,  452VLY9402 Serine,  EC 2.7.1.11 tau-tubulin kinase,  tau Proteins]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Tau-tubulin kinase 1 (TTBK1),  a neuron-specific tau kinase candidate,  is involved in tau phosphorylation and aggregation."} , { "attrname": "Abstract", "value": "Neurofibrillary tangles,  which are major pathological hallmarks of Alzheimer's disease (AD),  are composed of paired helical filaments (PHFs) containing hyperphosphorylated tau. Specific kinases regulate tau phosphorylation and are closely linked to the pathogenesis of AD. We have characterized a human tau-tubulin kinase 1 (TTBK1) gene located on chromosome 6p21.1. TTBK1 is a serine\/threonine\/tyrosine kinase that is conserved among species and belongs to the casein kinase 1 superfamily. It is specifically expressed in the brain,  especially in the cytoplasm of cortical and hippocampal neurons. TTBK1 phosphorylates tau proteins in both a Mg2+- and a Mn2+-dependent manner. Phosphopeptide mapping and immunoblotting analysis confirmed a direct tau phosphorylation by TTBK1 at Ser198,  Ser199,  Ser202 and Ser422,  which are also phosphorylated in PHFs. TTBK1 also induces tau aggregation in human neuronal cells in a dose-dependent manner. We conclude that TTBK1 is a neuron-specific dual kinase involved in tau phosphorylation at AD-related sites and is also associated with tau aggregation. "} , { "attrname": "MeSH", "value": "[Cell Line,  Gene Expression,  Phosphorylation,  Immunoprecipitation,  Threonine,  Humans,  Mice,  Inbred C57BL,  Protein-Serine-Threonine Kinases,  Serine,  Computational Biology,  Cercopithecus aethiops,  Molecular Sequence Data,  Neuroblastoma,  tau Proteins,  Tissue Distribution,  Sequence Alignment,  Animals,  Transfection,  Fluorescent Antibody Technique,  Mice]"} , { "attrname": "AUTHORS", "value": "[Shinji Sato,  Ronald L Cerny,  James L Buescher,  Tsuneya Ikezu]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT TYR-514; SER-515; SER-516; SER-519; SER-733; SER-739 AND THR-744]"} ], "id": "165", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16923168", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16923168"} , { "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.2006.04059.X"} ]} , { "annotation": "[GLYCOSYLATION AT SER-525; SER-555 AND SER-717,  PHOSPHORYLATION AT SER-519; SER-713 SER-717 AND SER-721,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 21327254", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21327254", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular bioSystems"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 GSK3B protein,  human,  EC 2.7.11.1 Glycogen Synthase Kinase 3 beta,  Peptides,  Cyclin A,  EC 2.4.1.- N-Acetylglucosaminyltransferases,  EC 2.7.11.22 Cyclin-Dependent Kinase 2,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  V956696549 Acetylglucosamine,  Recombinant Proteins,  452VLY9402 Serine,  tau Proteins]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation."} , { "attrname": "Abstract", "value": "Phosphorylation of the microtubule-associated Tau protein plays a major role in the regulation of its activity of tubulin polymerization and\/or stabilization of microtubule assembly. A dysregulation of the phosphorylation\/dephosphorylation balance leading to the hyperphosphorylation of Tau proteins in neurons is thought to favor their aggregation into insoluble filaments. This in turn might underlie neuronal death as encountered in many neurodegenerative disorders,  including Alzheimer's disease. Another post-translational modification,  the O-linked ?-N-acetylglucosaminylation (O-GlcNAcylation),  controls the phosphorylation state of Tau,  although the precise mechanism is not known. Moreover,  analytical difficulties have hampered the precise localization of the O-GlcNAc sites on Tau,  except for the S400 site that was very recently identified on the basis of ETD-FT-MS. Here,  we identify three O-GlcNAc sites by screening a library of small peptides sampling the proline-rich,  the microtubule-associated repeats and the carboxy-terminal domains of Tau as potential substrates for the O-?-N-acetylglucosaminyltransferase (OGT). The in vitro activity of the nucleocytoplasmic OGT was assessed by tandem mass spectrometry and NMR spectroscopy. Using phosphorylated peptides,  we establish the relationship between phosphate and O-GlcNAc incorporation at these sites. Phosphorylation of neighboring residues S396 and S404 was found to decrease significantly S400 O-GlcNAcylation. Reciprocally,  S400 O-GlcNAcylation reduces S404 phosphorylation by the CDK2\/cyclinA3 kinase and interrupts the GSK3?-mediated sequential phosphorylation process. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Phosphorylation,  Magnetic Resonance Spectroscopy,  Peptides,  Humans,  Serine,  Molecular Sequence Data,  Substrate Specificity,  Acetylglucosamine,  Glycogen Synthase Kinase 3,  Glycogen Synthase Kinase 3 beta,  Glycosylation,  N-Acetylglucosaminyltransferases,  Recombinant Proteins,  tau Proteins,  Cyclin-Dependent Kinase 2,  Cyclin A,  Spectrometry,  Mass,  Matrix-Assisted Laser Desorption-Ionization,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[Caroline Smet-Nocca,  Malgorzata Broncel,  Jean-Michel Wieruszeski,  Caroline Tokarski,  Xavier Hanoulle,  Arnaud Leroy,  Isabelle Landrieu,  Christian Rolando,  Guy Lippens,  Christian P R Hackenberger]"} , { "attrname": "PUB_TYPE", "value": "[GLYCOSYLATION AT SER-525; SER-555 AND SER-717,  PHOSPHORYLATION AT SER-519; SER-713 SER-717 AND SER-721,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "166", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21327254", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21327254"} , { "elementOf": "DOI", "accession": "10.1039\/C0MB00337A"} ]} , { "annotation": "[VARIANT PSNP1\/ATYPICAL PSNP1 ASN-613 DEL]", "conames": [{ "name": "PMID: 14991828", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14991828", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[7006-34-0 Asparagine,  tau Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Tau gene delN296 mutation,  Parkinson's disease,  and atypical supranuclear palsy."} , { "attrname": "MeSH", "value": "[Supranuclear Palsy,  Progressive,  Exons,  Humans,  Middle Aged,  Family Health,  Genotype,  Male,  tau Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Gene Deletion,  Asparagine,  Adult,  Female,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Rafael Oliva,  Pau Pastor]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PSNP1\/ATYPICAL PSNP1 ASN-613 DEL]"} ], "id": "167", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14991828", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14991828"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20025"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 2-73; 103-381; 468-497; 508-571; 577-583; 592-607; 616-634; 639-657; 661-664; 671-700 AND 703-758,  CLEAVAGE OF INITIATOR METHIONINE,  ACETYLATION AT ALA-2,  DEAMIDATION AT ASN-484]", "conames": [{ "name": "PMID: 1512244", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1512244", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  tau Proteins]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain."} , { "attrname": "Abstract", "value": "Tau with unusually slow mobilities in sodium dodecyl sulfate-polyacrylamide gel electrophoresis was purified from the Sarkosyl-insoluble pellet of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain homogenates. Such species of tau (PHF-tau) are considered to construct the framework of the sodium dodecyl sulfate-soluble form of paired helical filaments (PHF). Detailed comparison of peptide maps of PHF-tau and normal tau before and after dephosphorylation pointed to three anomalously eluted peaks which contained abnormally phosphorylated peptides,  residues 191-225,  226-240,  260-267,  and 386-438,  according to the numbering of the longest tau isoform (Goedert,  M.,  Spillantini,  M. G.,  Jakes,  R.,  Rutherford,  D.,  and Crowther,  R. A. (1989) Neuron 3,  519-526). Protein sequence and mass spectrometric analyses localized Thr-231 and Ser-235 as the abnormal phosphorylation sites and further indicated that each tau 1 site (residues 191-225) and the most carboxyl-terminal portion of the protein (residues 386-438) carries more than two abnormal phosphates. Ser-262 was also phosphorylated in a fraction of PHF-tau. Modifications other than phosphorylation,  removal of the initiator methionine,  and N alpha-acetylation at the amino terminus and deamidation at 2 asparaginyl residues were found in PHF-tau,  but these modifications were also present in normal tau. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Peptide Fragments,  Peptide Mapping,  Electrophoresis,  Polyacrylamide Gel,  Humans,  Mass Spectrometry,  Molecular Sequence Data,  Brain Chemistry,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[M Hasegawa,  M Morishima-Kawashima,  K Takio,  M Suzuki,  K Titani,  Y Ihara]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 2-73; 103-381; 468-497; 508-571; 577-583; 592-607; 616-634; 639-657; 661-664; 671-700 AND 703-758,  CLEAVAGE OF INITIATOR METHIONINE,  ACETYLATION AT ALA-2,  DEAMIDATION AT ASN-484]"} ], "id": "168", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1512244", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1512244"} ]} , { "annotation": "[VARIANT FTD VAL-659]", "conames": [{ "name": "PMID: 11117541", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11117541", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation."} , { "attrname": "Abstract", "value": "It is unclear how tau gene mutations cause frontotemporal dementia (FTD) with parkinsonism linked to chromosome 17 (FTDP-17),  but those in exon 10 (E10) or the following intron may be pathogenic by altering E10 splicing,  perturbing the normal 1: 1 ratio of four versus three microtubule-binding repeat tau (4R: 3R tau ratio) and forming tau inclusions. We report on a 55-year old woman with frontotemporal dementia and a family history of FTDP-17 in whom we found a novel E12 (Glu342Val) tau gene mutation,  prominent frontotemporal neuron loss,  intracytoplasmic tau aggregates,  paired helical tau filaments,  increased 4R tau messenger RNA,  increased 4R tau without E2 or E3 inserts,  decreased 4R tau with these inserts,  and a 4R: 3R tau ratio greater than 1 in gray and white matter. Thus,  this novel Glu342Val mutation may cause FTDP-17 by unprecedented mechanisms that alter splicing of E2,  E3,  and E10 to preferentially increase 4R tau without amino terminal inserts and promote aggregation of tau filaments into cytopathic inclusions. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Humans,  Middle Aged,  tau Proteins,  Microscopy,  Immunoelectron,  Neuropsychological Tests,  Magnetic Resonance Imaging,  Frontal Lobe,  Temporal Lobe,  Pedigree,  Female,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[C F Lippa,  V Zhukareva,  T Kawarai,  K Uryu,  M Shafiq,  L E Nee,  J Grafman,  Y Liang,  P H St George-Hyslop,  J Q Trojanowski,  V M Lee]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD VAL-659]"} ], "id": "169", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11117541", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/1531-8249(200012)48: 6<850: : AID-ANA5>3.0.CO;2-V"} , { "elementOf": "NLM", "accession": "11117541"} ]} , { "annotation": "[VARIANTS FTD VAL-589; LEU-618 AND TRP-723]", "conames": [{ "name": "PMID: 9641683", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9641683", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17."} , { "attrname": "Abstract", "value": "Thirteen families have been described with an autosomal dominantly inherited dementia named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17),  historically termed Pick's disease. Most FTDP-17 cases show neuronal and\/or glial inclusions that stain positively with antibodies raised against the microtubule-associated protein Tau,  although the Tau pathology varies considerably in both its quantity (or severity) and characteristics. Previous studies have mapped the FTDP-17 locus to a 2-centimorgan region on chromosome 17q21.11; the tau gene also lies within this region. We have now sequenced tau in FTDP-17 families and identified three missense mutations (G272V,  P301L and R406W) and three mutations in the 5' splice site of exon 10. The splice-site mutations all destabilize a potential stem-loop structure which is probably involved in regulating the alternative splicing of exon10. This causes more frequent usage of the 5' splice site and an increased proportion of tau transcripts that include exon 10. The increase in exon 10+ messenger RNA will increase the proportion of Tau containing four microtubule-binding repeats,  which is consistent with the neuropathology described in several families with FTDP-17. "} , { "attrname": "MeSH", "value": "[Alternative Splicing,  Exons,  Humans,  Male,  tau Proteins,  RNA Splicing,  Chromosomes,  Human,  Pair 17,  DNA Mutational Analysis,  Pedigree,  Female,  Mutation,  Nerve Degeneration,  Dementia]"} , { "attrname": "AUTHORS", "value": "[M Hutton,  C L Lendon,  P Rizzu,  M Baker,  S Froelich,  H Houlden,  S Pickering-Brown,  S Chakraverty,  A Isaacs,  A Grover,  J Hackett,  J Adamson,  S Lincoln,  D Dickson,  P Davies,  R C Petersen,  M Stevens,  E de Graaff,  E Wauters,  J van Baren,  M Hillebrand,  M Joosse,  J M Kwon,  P Nowotny,  L K Che,  J Norton,  J C Morris,  L A Reed,  J Trojanowski,  H Basun,  L Lannfelt,  M Neystat,  S Fahn,  F Dark,  T Tannenberg,  P R Dodd,  N Hayward,  J B Kwok,  P R Schofield,  A Andreadis,  J Snowden,  D Craufurd,  D Neary,  F Owen,  B A Oostra,  J Hardy,  A Goate,  J van Swieten,  D Mann,  T Lynch,  P Heutink]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS FTD VAL-589; LEU-618 AND TRP-723]"} ], "id": "170", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9641683", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/31508"} , { "elementOf": "NLM", "accession": "9641683"} ]} , { "annotation": "[VARIANT FTD LYS-596]", "conames": [{ "name": "PMID: 10802785", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10802785", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Codon,  7006-34-0 Asparagine,  tau Proteins,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene."} , { "attrname": "Abstract", "value": "To characterize the clinical diagnostic features,  neuropathologic phenotype of tau deposition,  and subunit structure of tau filaments in patients who had an asparagine-to-lysine substitution at codon 279 (the N279K missense mutation) of the gene for microtubule-associated tau protein. The N279K mutation is a causative genetic defect for pallidopontonigral degeneration in an American kindred that presents with frontotemporal dementia (FTD) and parkinsonism. The authors analyzed retrospectively the clinical symptoms of two Japanese brothers who carry this mutation. Postmortem neuropathologic and electron microscopic studies,  and Western blot analysis of insoluble tau were performed to correlate tau-mediated lesions with neurologic deficits. Both patients exhibited impairment in recent memory,  parkinsonism,  and corticospinal disturbances in addition to FTD. Parkinsonism in one patient was responsive temporarily to l-dopa. There was intense tau deposition in the medial temporal cortices and upper and lower motor neurons with accompanying corticospinal tract degeneration. Two distinct tau isoforms with four microtubule-binding repeats,  in hyperphosphorylated forms,  were the primary constituents of insoluble tau,  which aggregated to the filamentous component,  termed \"paired tubules, \" in neurons,  oligodendrocytes,  and astrocytes. The elemental filaments were hollow tubules measuring 11 to 12 nm in diameter,  two of which adhered to each other along their longitudinal axes to form \"paired tubules.\" Early memory loss and pyramidal signs,  which are atypical of FTD,  can be presenting symptoms in this disorder. The authors demonstrated that the subunit structure of tau filaments is a pair of hollow tubules despite the prevailing twisted ribbon model. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Diagnosis,  Differential,  Humans,  Middle Aged,  Male,  Mutation,  Missense,  Microscopy,  Electron,  tau Proteins,  Neuropsychological Tests,  Pyramidal Tracts,  Codon,  Frontal Lobe,  Neurologic Examination,  Temporal Lobe,  Lysine,  Pedigree,  Asparagine,  Motor Neurons,  Retrospective Studies,  Amino Acid Substitution,  Dementia]"} , { "attrname": "AUTHORS", "value": "[K Arima,  A Kowalska,  M Hasegawa,  M Mukoyama,  R Watanabe,  M Kawai,  K Takahashi,  T Iwatsubo,  T Tabira,  N Sunohara]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD LYS-596]"} ], "id": "171", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10802785", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10802785"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.54.9.1787"} ]} , { "annotation": "[PHOSPHORYLATION AT THR-548 BY GSK3B]", "conames": [{ "name": "PMID: 14690523", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14690523", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Glycogen Synthase Kinase 3 beta,  2ZD004190S Threonine,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  tau Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules."} , { "attrname": "Abstract", "value": "Site-specific phosphorylation of tau negatively regulates its ability to bind and stabilize microtubule structure. Although tau is a substrate of glycogen synthase kinase 3beta (GSK3beta),  the exact sites on tau that are phosphorylated by this kinase in situ have not yet been established,  and the effect of these phosphorylation events on tau-microtubule interactions have not been fully elucidated. GSK3beta phosphorylates both primed and unprimed sites on tau,  but only primed phosphorylation events significantly decrease the ability of tau to bind microtubules. The focus of the present study is on determining the importance of the GSK3beta-mediated phosphorylation of a specific primed site,  Thr231,  in regulating tau's function. Pre-phosphorylation of Ser235 primes tau for phosphorylation by GSK3beta at Thr231. Phosphorylation by GSK3beta of wild-type tau or tau with Ser235 mutated to Ala decreases tau-microtubule interactions. However,  when Thr231 alone or Thr231 and Ser235 in tau were mutated to Ala,  phosphorylation by GSK3beta did not decrease the association of tau with the cytoskeleton. Further,  T231A tau was still able to efficiently bind microtubules after phosphorylation by GSK3beta. Expression of each tau construct alone increased tubulin acetylation,  a marker of microtubule stability. However,  when cells were cotransfected with wild-type tau and GSK3beta,  the level of tubulin acetylation was decreased to vector-transfected levels. In contrast,  coexpression of GSK3beta with mutated tau (T231A\/S235A) did not significantly decrease the levels of acetylated tubulin. These results strongly indicate that phosphorylation of Thr231 in tau by GSK3beta plays a critical role in regulating tau's ability to bind and stabilize microtubules. "} , { "attrname": "MeSH", "value": "[Cricetinae,  Phosphorylation,  Animals,  Threonine,  Microtubules,  Protein Binding,  Glycogen Synthase Kinase 3,  Glycogen Synthase Kinase 3 beta,  Mutation,  tau Proteins,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[Jae-Hyeon Cho,  Gail V W Johnson]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT THR-548 BY GSK3B]"} ], "id": "172", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14690523", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14690523"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 251-264 AND 379-392,  PHOSPHORYLATION AT SER-396]", "conames": [{ "name": "PMID: 1899488", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1899488", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Phosphoproteins,  Microtubule-Associated Proteins,  Antibodies,  Monoclonal,  tau Proteins]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "A68:  a major subunit of paired helical filaments and derivatized forms of normal Tau."} , { "attrname": "Abstract", "value": "Putative <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD)-specific proteins (A68) were purified to homogeneity and shown to be major subunits of one form of paired helical filaments (PHFs). The amino acid sequence and immunological data indicate that the backbone of A68 is indistinguishable from that of the protein tau (tau),  but A68 could be distinguished from normal human tau by the degree to which A68 was phosphorylated and by the specific residues in A68 that served as phosphate acceptors. The larger apparent relative molecular mass (Mr) of A68,  compared to normal human tau,  was attributed to abnormal phosphorylation of A68 because enzymatic dephosphorylation of A68 reduced its Mr to close to that of normal tau. Moreover,  the LysSerProVal motif in normal human tau appeared to be an abnormal phosphorylation site in A68 because the Ser in this motif was a phosphate acceptor site in A68,  but not in normal human tau. Thus,  the major subunits of a class of PHFs are A68 proteins and the excessive or inappropriate phosphorylation of normal tau may change its apparent Mr,  thus transforming tau into A68. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Molecular Weight,  Intermediate Filaments,  Phosphoproteins,  Humans,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Antibodies,  Monoclonal,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Blotting,  Western]"} , { "attrname": "AUTHORS", "value": "[V M Lee,  B J Balin,  L Otvos,  J Q Trojanowski]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 251-264 AND 379-392,  PHOSPHORYLATION AT SER-396]"} ], "id": "173", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1899488", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1899488"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1899488"} ]} , { "annotation": "[PHOSPHORYLATION BY CSNK1D\/CK1]", "conames": [{ "name": "PMID: 17562708", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17562708", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 GSK3B protein,  human,  EC 2.7.11.1 Glycogen Synthase Kinase 3 beta,  Protein Isoforms,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  EC 2.7.11.1 Casein Kinase Idelta,  EC 2.7.11.1 Gsk3b protein,  rat,  Recombinant Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Novel phosphorylation sites in tau from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brain support a role for casein kinase 1 in <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis."} , { "attrname": "Abstract", "value": "Tau in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain is highly phosphorylated and aggregated into paired helical filaments comprising characteristic neurofibrillary tangles. Here we have analyzed insoluble Tau (PHF-tau) extracted from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brain by mass spectrometry and identified 11 novel phosphorylation sites,  10 of which were assigned unambiguously to specific amino acid residues. This brings the number of directly identified sites in PHF-tau to 39,  with an additional six sites indicated by reactivity with phosphospecific antibodies to Tau. We also identified five new phosphorylation sites in soluble Tau from control adult human brain,  bringing the total number of reported sites to nine. To assess which kinases might be responsible for Tau phosphorylation,  we used mass spectrometry to determine which sites were phosphorylated in vitro by several kinases. Casein kinase 1delta and glycogen synthase kinase-3beta were each found to phosphorylate numerous sites,  and each kinase phosphorylated at least 15 sites that are also phosphorylated in PHF-tau from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brain. A combination of casein kinase 1delta and glycogen synthase kinase-3beta activities could account for over three-quarters of the serine\/threonine phosphorylation sites identified in PHF-tau,  indicating that casein kinase 1delta may have a role,  together with glycogen synthase kinase-3beta,  in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Casein Kinase Idelta,  Neurons,  Humans,  Molecular Sequence Data,  Rats,  Glycogen Synthase Kinase 3,  Glycogen Synthase Kinase 3 beta,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Animals,  Models,  Biological,  Protein Isoforms,  Protein Binding]"} , { "attrname": "AUTHORS", "value": "[Diane P Hanger,  Helen L Byers,  Selina Wray,  Kit-Yi Leung,  Malcolm J Saxton,  Anjan Seereeram,  C Hugh Reynolds,  Malcolm A Ward,  Brian H Anderton]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION BY CSNK1D\/CK1]"} ], "id": "174", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17562708", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "17562708"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M703269200"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 543-551; 560-574; 576-584 AND 623-634,  PHOSPHORYLATION AT SER-531; THR-534; THR-548; SER-552; SER-554; SER-579; SER-713 AND SER-739,  UBIQUITINATION AT LYS-571; LYS-628 AND LYS-670,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 16443603", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16443603", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Ubiquitin,  Solvents,  Peptides,  2ZD004190S Threonine,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  452VLY9402 Serine,  EC 3.4.21.4 Trypsin,  tau Proteins,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48,  Lys-11,  and Lys-6 ubiquitin conjugation."} , { "attrname": "Abstract", "value": "One of the key pathological hallmarks of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is the accumulation of paired helical filaments (PHFs) of hyperphosphorylated microtubule-associated protein Tau. Tandem mass spectrometry was employed to examine PHF-Tau post-translational modifications,  in particular protein phosphorylation and ubiquitination,  to shed light on their role in the early stages of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. PHF-Tau from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain was affinity-purified by MC1 monoclonal antibody to isolate a soluble fraction of PHF-Tau in a conformation unique to human AD brain. A large number of phosphorylation sites were identified by employing a data-dependent neutral loss algorithm to trigger MS3 scans of phosphopeptides. It was found that soluble PHF-Tau is ubiquitinated at its microtubule-binding domain at residues Lys-254,  Lys-311,  and Lys-353,  suggesting that ubiquitination of PHF-Tau may be an earlier pathological event than previously thought and that ubiquitination could play a regulatory role in modulating the integrity of microtubules during the course of AD. Tandem mass spectrometry data for ubiquitin itself indicate that PHF-Tau is modified by three polyubiquitin linkages,  at Lys-6,  Lys-11,  and Lys-48. Relative quantitative analysis indicates that Lys-48-linked polyubiquitination is the primary form of polyubiquitination with a minor portion of ubiquitin linked at Lys-6 and Lys-11. Because modification by Lys-48-linked polyubiquitin chains is known to serve as the essential means of targeting proteins for degradation by the ubiquitin-proteasome system,  and it has been reported that modification at Lys-6 inhibits ubiquitin-dependent protein degradation,  a failure of the ubiquitin-proteasome system could play a role in initiating the formation of degradation-resistant PHF tangles. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Amino Acid Sequence,  Solvents,  Phosphorylation,  Immunoprecipitation,  Peptides,  Threonine,  Humans,  Serine,  Molecular Sequence Data,  Immunoblotting,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteasome Endopeptidase Complex,  Neurofibrillary Tangles,  tau Proteins,  Sequence Homology,  Amino Acid,  Trypsin,  Algorithms,  Lysine,  Mass Spectrometry,  Chromatography,  Liquid,  Protein Conformation,  Nerve Degeneration]"} , { "attrname": "AUTHORS", "value": "[Diane Cripps,  Stefani N Thomas,  Young Jeng,  Frank Yang,  Peter Davies,  Austin J Yang]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 543-551; 560-574; 576-584 AND 623-634,  PHOSPHORYLATION AT SER-531; THR-534; THR-548; SER-552; SER-554; SER-579; SER-713 AND SER-739,  UBIQUITINATION AT LYS-571; LYS-628 AND LYS-670,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "175", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16443603", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16443603"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M512786200"} ]} , { "annotation": "[PHOSPHORYLATION AT TYR-18 BY FYN]", "conames": [{ "name": "PMID: 14999081", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14999081", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[EC 3.1.3.48 Protein Tyrosine Phosphatases,  42HK56048U Tyrosine,  EC 2.7.10.2 FYN protein,  human,  EC 2.7.10.2 Fyn protein,  mouse,  EC 2.7.10.2 Proto-Oncogene Proteins c-fyn,  Proto-Oncogene Proteins,  Antibodies,  Monoclonal,  tau Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of tau by fyn:  implications for Alzheimer's disease."} , { "attrname": "Abstract", "value": "The abnormal phosphorylation of tau protein on serines and threonines is a hallmark characteristic of the neurofibrillary tangles of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). The discovery that tau could be phosphorylated on tyrosine and evidence that Abeta signal transduction involved tyrosine phosphorylation led us to question whether tyrosine phosphorylation of tau occurred during the neurodegenerative process. In this study we determined that human tau tyr18 was phosphorylated by the src family tyrosine kinase fyn. By developing both polyclonal and monoclonal probes specific for phospho-tyr18,  we found that the phosphorylation of tau at tyr18 occurred at early developmental stages in mouse but was absent in the adult. Our phosphospecific probes also revealed that paired helical filament preparations exhibited phospho-tyr18 reactivity that was sensitive to phosphotyrosine-specific protein phosphatase treatment. Moreover,  immunocytochemical studies indicated that tyrosine phosphorylated tau was present in the neurofibrillary tangles in AD brain. However,  the staining pattern excluded neuropil threads and dystrophic neurites indicating that tyrosine phosphorylated tau was distributed in AD brain in a manner dissimilar from other abnormally phosphorylated tau. We also found evidence suggesting that differentially phosphorylated tau existed within degenerating neurons. Our data add new support for a role for fyn in the neurodegenerative process. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Tyrosine,  Antibody Specificity,  Brain,  Cell Line,  Phosphorylation,  Age Factors,  Humans,  Proto-Oncogene Proteins c-fyn,  Cercopithecus aethiops,  Antibody Affinity,  Antibodies,  Monoclonal,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Animals,  Microtubules,  Mice,  Proto-Oncogene Proteins,  Nerve Degeneration,  Protein Tyrosine Phosphatases]"} , { "attrname": "AUTHORS", "value": "[Gloria Lee,  Ramasamy Thangavel,  Vandana M Sharma,  Joel M Litersky,  Kiran Bhaskar,  Sandy M Fang,  Lana H Do,  Athena Andreadis,  Gary Van Hoesen,  Hanna Ksiezak-Reding]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT TYR-18 BY FYN]"} ], "id": "176", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14999081", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14999081"} , { "elementOf": "DOI", "accession": "10.1523\/JNEUROSCI.4162-03.2004"} ]} , { "annotation": "[IDENTIFICATION (ISOFORM TAU-G),  VARIANT HIS-441]", "conames": [{ "name": "PMID: 15365985", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15365985", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[MAPT protein,  human,  Protein Isoforms,  Nerve Tissue Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "The role of tau (MAPT) in frontotemporal dementia and related tauopathies."} , { "attrname": "Abstract", "value": "Tau is a multifunctional protein that was originally identified as a microtubule-associated protein. In patients diagnosed with frontotemporal dementia and <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism linked to chromosome 17,  mutations in the gene encoding tau (MAPT) have been identified that disrupt the normal binding of tau to tubulin resulting in pathological deposits of hyperphosphorylated tau. Abnormal filamentous tau deposits have been reported as a pathological characteristic in several other neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  including frontotemporal dementia,  Pick <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  argyrophilic grain <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  progressive supranuclear palsy,  and corticobasal degeneration. In the last five years,  extensive research has identified 34 different pathogenic MAPT mutations in 101 families worldwide. In vitro,  cell-free and transfected cell studies have provided valuable information on tau dysfunction and transgenic mice carrying human MAPT mutations are being generated to study the influence of MAPT mutations in vivo. This mutation update describes the considerable differences in clinical and pathological presentation of patients with MAPT mutations and summarizes the effect of the different mutations on tau functioning. In addition,  the role of tau as a genetic susceptibility factor is discussed,  together with the genetic evidence for additional causal genes for tau-positive as well as tau-negative dementia. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Molecular Sequence Data,  Genotype,  Male,  Mice,  Transgenic,  Nerve Tissue Proteins,  Structure-Activity Relationship,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Forecasting,  tau Proteins,  Genetic Heterogeneity,  Tauopathies,  Phenotype,  Animals,  Chromosomes,  Human,  Pair 17,  Protein Isoforms,  Female,  Mice,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[R Rademakers,  M Cruts,  C van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[IDENTIFICATION (ISOFORM TAU-G),  VARIANT HIS-441]"} ], "id": "177", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15365985", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/HUMU.20086"} , { "elementOf": "NLM", "accession": "15365985"} ]} , { "annotation": "[VARIANT FTD VAL-583,  CHARACTERIZATION OF VARIANT FTD VAL-583]", "conames": [{ "name": "PMID: 12509859", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12509859", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[tau Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology."} , { "attrname": "Abstract", "value": "We report a novel mutation of tau (L266V missense mutation in exon 9) which may cause a type of familial frontotemporal dementia. The brain of a patient showed Pick body-like inclusions and unique tau-positive,  argyrophilic astrocytes with stout filaments and naked,  round,  or irregular argyrophilic inclusions with deposits of both three-repeat and four-repeat tau. Recombinant tau with a L266V mutation showed a reduced ability to promote microtubule assembly,  which may be the primary effect of the mutation. "} , { "attrname": "MeSH", "value": "[Inclusion Bodies,  Astrocytes,  Neurons,  Humans,  Adult,  Male,  Mutation,  Missense,  tau Proteins,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Tomonori Kobayashi,  Satoru Ota,  Kuniaki Tanaka,  Yuji Ito,  Masato Hasegawa,  Yuri Umeda,  Yumiko Motoi,  Masashi Takanashi,  Masahiro Yasuhara,  Midori Anno,  Yoshikuni Mizuno,  Hideo Mori]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FTD VAL-583,  CHARACTERIZATION OF VARIANT FTD VAL-583]"} ], "id": "178", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12509859", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.10447"} , { "elementOf": "NLM", "accession": "12509859"} ]} , { "annotation": "[INTERACTION WITH EPM2A]", "conames": [{ "name": "PMID: 19542233", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19542233", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 3.1.3.48 Epm2a protein,  mouse,  EC 3.1.3.48 Dual-Specificity Phosphatases,  tau Proteins]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Hyperphosphorylation and aggregation of Tau in laforin-deficient mice,  an animal model for Lafora <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Lafora progressive myoclonous epilepsy (Lafora <span style=\"background-color: yellow\"><b>disease<\/b><\/span>; LD) is caused by mutations in the EPM2A gene encoding a dual specificity protein phosphatase named laforin. Our analyses on the Epm2a gene knock-out mice,  which developed most of the symptoms of LD,  reveal the presence of hyperphosphorylated Tau protein (Ser(396) and Ser(202)) as neurofibrillary tangles (NFTs) in the brain. Intriguingly,  NFTs were also observed in the skeletal muscle tissues of the knock-out mice. The hyperphosphorylation of Tau was associated with increased levels of the active form of GSK3 beta. The observations on Tau protein were replicated in cell lines using laforin overexpression and knockdown approaches. We also show here that laforin and Tau proteins physically interact and that the interaction was limited to the phosphatase domain of laforin. Finally,  our in vitro and in vivo assays demonstrate that laforin dephosphorylates Tau,  and therefore laforin is a novel Tau phosphatase. Taken together,  our study suggests that laforin is one of the critical regulators of Tau protein,  that the NFTs could underlie some of the symptoms seen in LD,  and that laforin can contribute to the NFT formation in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and other tauopathies. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Phosphorylation,  Immunoprecipitation,  Lafora <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cercopithecus aethiops,  Immunoblotting,  Microscopy,  Electron,  tau Proteins,  Mice,  Knockout,  Animals,  Cell Line,  Tumor,  Protein Binding,  Female,  Mice,  Dual-Specificity Phosphatases,  Muscle,  Skeletal,  In Vitro Techniques,  COS Cells,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Models,  Animal]"} , { "attrname": "AUTHORS", "value": "[Rajat Puri,  Toshimitsu Suzuki,  Kazuhiro Yamakawa,  Subramaniam Ganesh]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH EPM2A]"} ], "id": "179", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19542233", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19542233"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M109.009688"} ]} , { "annotation": "[VARIANT ATYPICAL PSNP1 ASN-613 DEL]", "conames": [{ "name": "PMID: 14991829", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14991829", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[7006-34-0 Asparagine,  tau Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Progressive supranuclear palsy and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in a family with a new mutation in the tau gene."} , { "attrname": "MeSH", "value": "[Parkinson Disease,  Supranuclear Palsy,  Progressive,  Humans,  Asparagine,  Mutation,  tau Proteins]"} , { "attrname": "AUTHORS", "value": "[Giacomina Rossi,  Elisabetta Gasparoli,  Claudio Pasquali,  Giuseppe Di Fede,  Daniela Testa,  Alberto Albanese,  Fulvio Bracco,  Fabrizio Tagliavini]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT ATYPICAL PSNP1 ASN-613 DEL]"} ], "id": "180", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14991829", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20006"} , { "elementOf": "NLM", "accession": "14991829"} ]} , { "annotation": "[VARIANT PSNP1 VAL-620]", "conames": [{ "name": "PMID: 16157753", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16157753", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[2C598205QX fluorodopa F 18,  Protein Isoforms,  430K3SOZ7G Raclopride,  63-84-3 Dihydroxyphenylalanine,  TE7660XO1C Glycine,  HG18B9YRS7 Valine,  RNA,  Messenger,  tau Proteins]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A new mutation of the tau gene,  G303V,  in early-onset familial progressive supranuclear palsy."} , { "attrname": "Abstract", "value": "Progressive supranuclear palsy (PSP) is a clinicopathological syndrome related to tau deposits and in linkage disequilibrium with tau polymorphisms. Some rare familial PSP cases have been related to tau gene mutations. To present the clinical,  pathological,  and molecular data of one family with early-onset autosomal dominant PSP. We performed clinical examinations,  quantitative neurological tests,  positron emission tomographic scans with fluorodopa F 18 and raclopride C 11,  analysis of tau mutations,  neuropathological examinations,  and protein analyses on brain specimens. Three family members had PSP confirmed by pathological features in the proband. A novel mutation of tau,  G303V,  was found in the proband and other family members. tau Isoforms with 4 microtubule-binding repeats were overexpressed in the proband brain. The G303V mutation of tau is associated with autosomal dominant PSP. Expression of 4 microtubule-binding repeat tau isoforms is increased in the proband. "} , { "attrname": "MeSH", "value": "[Dihydroxyphenylalanine,  Immunohistochemistry,  Supranuclear Palsy,  Progressive,  Brain,  Genetic Predisposition to Disease,  Raclopride,  Humans,  Middle Aged,  Family Health,  Positron-Emission Tomography,  Glycine,  Reverse Transcriptase Polymerase Chain Reaction,  tau Proteins,  Blotting,  Western,  Blotting,  Northern,  Neurologic Examination,  DNA Mutational Analysis,  Valine,  Protein Isoforms,  Female,  Mutation,  RNA,  Messenger,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Raquel Ros,  Stphane Thobois,  Nathalie Streichenberger,  Nicolas Kopp,  Marina P Snchez,  Mar Prez,  Janet Hoenicka,  Jess Avila,  Jerome Honnorat,  Justo G de Ybenes]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PSNP1 VAL-620]"} ], "id": "181", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16157753", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.62.9.1444"} , { "elementOf": "NLM", "accession": "16157753"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 592-622 (ISOFORMS PNS-TAU\/TAU-D\/TAU-E\/TAU-F)]", "conames": [{ "name": "PMID: 2495000", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2495000", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Microtubule-Associated Proteins,  Nerve Tissue Proteins,  tau Proteins]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments."} , { "attrname": "Abstract", "value": "Tau,  a microtubule-associated phosphoprotein,  was identified as a definite component of paired helical filaments which progressively accumulate in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain. To learn more about tau in the aged brain,  we have isolated and sequenced a cDNA clone encoding tau from a cDNA library of an aged human brain. The cloned cDNA sequence included a new insert of 93 nucleotides,  which added a fourth repeat to the three-repeat type of tau already reported. Perhaps,  this four-repeat type of tau is predominant in normal aged brain. In contrast,  the sequence analysis of paired helical filaments showed that the integrated tau is of three-repeat type. This indicates that a distinct form of tau is selectively incorporated into paired helical filaments. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Cerebral Cortex,  Reference Values,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  tau Proteins,  Base Sequence,  DNA,  Cloning,  Molecular,  Aged,  80 and over,  Aged]"} , { "attrname": "AUTHORS", "value": "[H Mori,  Y Hamada,  M Kawaguchi,  T Honda,  J Kondo,  Y Ihara]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 592-622 (ISOFORMS PNS-TAU\/TAU-D\/TAU-E\/TAU-F)]"} ], "id": "182", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2495000", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2495000"} , { "elementOf": "DOI", "accession": "10.1016\/0006-291X(89)92240-7"} ]} , { "annotation": "[PHOSPHORYLATION,  MUTAGENESIS]", "conames": [{ "name": "PMID: 9735171", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9735171", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of biochemistry and biophysics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinase Type 2,  EC 2.7.11.22 Cyclin-Dependent Kinases,  2ZD004190S Threonine,  EC 2.7.11.22 CDK5 protein,  human,  EC 2.7.11.1 Cyclin-Dependent Kinase 5,  Microtubule-Associated Proteins,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  452VLY9402 Serine,  tau Proteins,  EC 2.7.11.22 Cdk5 protein,  rat,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinases]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules."} , { "attrname": "Abstract", "value": "The paired helical filaments (PHFs) found in Alzheimer's disease (AD) brains are composed primarily of the microtubule-associated protein tau. PHF-tau is in a hyperphosphorylated state and is unable to promote microtubule assembly. We investigated whether the inhibition of tau binding to microtubules is increased when tau is phosphorylated by different kinases in combination with GSK-3. We found that when tau was first phosphorylated by A-kinase,  C-kinase,  cdk5,  or CaM kinase II and then by GSK-3,  its binding to microtubules was inhibited by 45,  61,  78,  and 79%,  respectively. Further,  the kinase combinations cdk5\/GSK-3 and CaM kinase II\/GSK-3 rapidly phosphorylated the sites Thr 231 and Ser 235. When these sites were individually replaced by Ala and the phosphorylation experiments repeated,  tau binding to microtubules was inhibited by 54 and 71%,  respectively. By comparison,  when Ser 262 was replaced by Ala,  tau binding to microtubules was inhibited by only 8% after phosphorylation by CaM kinase II. From these observations we estimate that the phosphorylation of Thr 231,  Ser 235,  and Ser 262 contributes approximately 26,  approximately 9,  and approximately 33%,  respectively,  of the overall inhibition of tau binding to microtubules. Together,  our results indicate that the binding of tau to microtubules is controlled by the phosphorylation of several sites,  among which are Thr 231,  Ser 235,  and Ser 262. "} , { "attrname": "MeSH", "value": "[Binding,  Competitive,  Amino Acid Sequence,  Phosphorylation,  Threonine,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Microtubule-Associated Proteins,  Molecular Sequence Data,  Rats,  Glycogen Synthase Kinase 3,  Calcium-Calmodulin-Dependent Protein Kinases,  Isomerism,  tau Proteins,  Cyclin-Dependent Kinase 5,  Animals,  Microtubules,  Protein Binding,  Cyclin-Dependent Kinases,  Calcium-Calmodulin-Dependent Protein Kinase Type 2]"} , { "attrname": "AUTHORS", "value": "[A Sengupta,  J Kabat,  M Novak,  Q Wu,  I Grundke-Iqbal,  K Iqbal]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION,  MUTAGENESIS]"} ], "id": "183", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9735171", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/ABBI.1998.0813"} , { "elementOf": "NLM", "accession": "9735171"} ]} , { "annotation": "", "conames": [{ "name": "Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (motor and cognition)", "isPreferred": "false"} , { "name": "Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (familial)", "isPreferred": "false"} , { "name": "Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Genome-wide genotyping in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and neurologically normal controls:  first stage analysis and public release of data."} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} , { "attrname": "CitNum", "value": "20"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0002508"} ], "id": "184", "contexts": { } , "evidences": ["Imported from database"], "value": "Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "PARKINSON'S DISEASE"} ]} , { "annotation": "", "conames": [{ "name": "H1H2", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} ], "id": "185", "contexts": { } , "evidences": ["Imported from database"], "value": "H1H2", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "H1H2"} ]} , { "annotation": "", "conames": [{ "name": "Idiopathic pulmonary fibrosis", "isPreferred": "true"} , { "name": "idiopathic pulmonary fibrosis", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis."} , { "attrname": "CitNum", "value": "2"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0000768"} ], "id": "186", "contexts": { } , "evidences": ["Imported from database"], "value": "idiopathic pulmonary fibrosis", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "IDIOPATHIC PULMONARY FIBROSIS"} ]} , { "annotation": "", "conames": [{ "name": "rs17690703", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45847931"} , { "attrname": "BEGIN", "value": "45847931"} ], "id": "187", "contexts": { } , "evidences": ["Imported from database"], "value": "rs17690703", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS17690703"} ]} , { "annotation": "", "conames": [{ "name": "Bone mineral density (hip)", "isPreferred": "true"} , { "name": "Bone mineral density (paediatric,  lower limb)", "isPreferred": "false"} , { "name": "Bone mineral density (spine)", "isPreferred": "false"} , { "name": "Bone mineral density (paediatric,  skull)", "isPreferred": "false"} , { "name": "bone density", "isPreferred": "true"} , { "name": "Bone mineral density (paediatric,  total body less head)", "isPreferred": "false"} , { "name": "Bone mineral density", "isPreferred": "false"} , { "name": "Obesity-related traits", "isPreferred": "false"} , { "name": "Bone properties (heel)", "isPreferred": "false"} , { "name": "Biomedical quantitative traits", "isPreferred": "false"} , { "name": "Bone mineral density (paediatric,  upper limb)", "isPreferred": "false"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies."} , { "attrname": "CitNum", "value": "21"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0003923"} ], "id": "188", "contexts": { } , "evidences": ["Imported from database"], "value": "bone density", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "BONE DENSITY"} ]} , { "annotation": "", "conames": [{ "name": "rs1864325", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45900461"} , { "attrname": "BEGIN", "value": "45900461"} ], "id": "189", "contexts": { } , "evidences": ["Imported from database"], "value": "rs1864325", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS1864325"} ]} , { "annotation": "", "conames": [{ "name": "rs11012", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45436075"} , { "attrname": "BEGIN", "value": "45436075"} ], "id": "190", "contexts": { } , "evidences": ["Imported from database"], "value": "rs11012", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS11012"} ]} , { "annotation": "", "conames": [{ "name": "rs2942168", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45637484"} , { "attrname": "BEGIN", "value": "45637484"} ], "id": "191", "contexts": { } , "evidences": ["Imported from database"], "value": "rs2942168", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS2942168"} ]} , { "annotation": "", "conames": [{ "name": "rs17577094", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46110126"} , { "attrname": "BEGIN", "value": "46110126"} ], "id": "192", "contexts": { } , "evidences": ["Imported from database"], "value": "rs17577094", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS17577094"} ]} , { "annotation": "", "conames": [{ "name": "interstitial lung disease", "isPreferred": "true"} , { "name": "Interstitial lung disease", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis."} , { "attrname": "CitNum", "value": "2"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0004244"} ], "id": "193", "contexts": { } , "evidences": ["Imported from database"], "value": "Interstitial lung disease", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "INTERSTITIAL LUNG DISEASE"} ]} , { "annotation": "", "conames": [{ "name": "rs1981997", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45979401"} , { "attrname": "BEGIN", "value": "45979401"} ], "id": "194", "contexts": { } , "evidences": ["Imported from database"], "value": "rs1981997", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS1981997"} ]} , { "annotation": "", "conames": [{ "name": "rs9303525", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46109891"} , { "attrname": "BEGIN", "value": "46109891"} ], "id": "195", "contexts": { } , "evidences": ["Imported from database"], "value": "rs9303525", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS9303525"} ]} , { "annotation": "", "conames": [{ "name": "Intracranial volume", "isPreferred": "true"} , { "name": "Subcortical brain region volumes", "isPreferred": "false"} , { "name": "intra cranial volume", "isPreferred": "true"} , { "name": "Brain structure", "isPreferred": "false"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Common variants at 6q22 and 17q21 are associated with intracranial volume."} , { "attrname": "CitNum", "value": "3"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0004886"} ], "id": "196", "contexts": { } , "evidences": ["Imported from database"], "value": "Intracranial volume", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "INTRA CRANIAL VOLUME"} ]} , { "annotation": "", "conames": [{ "name": "rs2732703", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46275856"} , { "attrname": "BEGIN", "value": "46275856"} ], "id": "197", "contexts": { } , "evidences": ["Imported from database"], "value": "rs2732703", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS2732703"} ]} , { "annotation": "", "conames": [{ "name": "Alzheimer's disease in APOE e4+ carriers", "isPreferred": "false"} , { "name": "Alzheimer's disease (late onset)", "isPreferred": "false"} , { "name": "Alzheimer's disease in APOE e4- carriers", "isPreferred": "false"} , { "name": "Brain structure (temporal lobe volume)", "isPreferred": "false"} , { "name": "Alzheimer's disease (APOE e4 interaction)", "isPreferred": "false"} , { "name": "Alzheimers disease", "isPreferred": "true"} , { "name": "Alzheimer's disease", "isPreferred": "true"} , { "name": "Alzheimer's disease (cognitive decline)", "isPreferred": "false"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "The membrane-spanning 4-domains,  subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease."} , { "attrname": "CitNum", "value": "36"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0000249"} ], "id": "198", "contexts": { } , "evidences": ["Imported from database"], "value": "Alzheimers disease", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "ALZHEIMERS DISEASE"} ]} , { "annotation": "", "conames": [{ "name": "rs17649553", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45917282"} , { "attrname": "BEGIN", "value": "45917282"} ], "id": "199", "contexts": { } , "evidences": ["Imported from database"], "value": "rs17649553", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS17649553"} ]} , { "annotation": "", "conames": [{ "name": "rs199498", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46788237"} , { "attrname": "BEGIN", "value": "46788237"} ], "id": "200", "contexts": { } , "evidences": ["Imported from database"], "value": "rs199498", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS199498"} ]} , { "annotation": "", "conames": [{ "name": "infant head circumference", "isPreferred": "true"} , { "name": "Head circumference (infant)", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Common variants at 12q15 and 12q24 are associated with infant head circumference."} , { "attrname": "CitNum", "value": "1"} , { "attrname": "URL", "value": "http: \/\/www.ebi.ac.uk\/efo\/EFO_0004577"} ], "id": "201", "contexts": { } , "evidences": ["Imported from database"], "value": "infant head circumference", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "INFANT HEAD CIRCUMFERENCE"} ]} , { "annotation": "", "conames": [{ "name": "rs11655470", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45718067"} , { "attrname": "BEGIN", "value": "45718067"} ], "id": "202", "contexts": { } , "evidences": ["Imported from database"], "value": "rs11655470", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS11655470"} ]} , { "annotation": "", "conames": [{ "name": "rs199533", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46751565"} , { "attrname": "BEGIN", "value": "46751565"} ], "id": "203", "contexts": { } , "evidences": ["Imported from database"], "value": "rs199533", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS199533"} ]} , { "annotation": "", "conames": [{ "name": "rs12185268", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45846317"} , { "attrname": "BEGIN", "value": "45846317"} ], "id": "204", "contexts": { } , "evidences": ["Imported from database"], "value": "rs12185268", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS12185268"} ]} , { "annotation": "", "conames": [{ "name": "Corticobasal degeneration", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy."} , { "attrname": "CitNum", "value": "1"} , { "attrname": "URL", "value": "http: \/\/www.orpha.net\/ORDO\/Orphanet_278"} ], "id": "205", "contexts": { } , "evidences": ["Imported from database"], "value": "Corticobasal degeneration", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "CORTICOBASAL DEGENERATION"} ]} , { "annotation": "", "conames": [{ "name": "rs8072451", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45816350"} , { "attrname": "BEGIN", "value": "45816350"} ], "id": "206", "contexts": { } , "evidences": ["Imported from database"], "value": "rs8072451", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS8072451"} ]} , { "annotation": "", "conames": [{ "name": "rs8070723", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "46003698"} , { "attrname": "BEGIN", "value": "46003698"} ], "id": "207", "contexts": { } , "evidences": ["Imported from database"], "value": "rs8070723", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS8070723"} ]} , { "annotation": "", "conames": [{ "name": "Progressive supranuclear palsy", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Study", "value": "Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy."} , { "attrname": "CitNum", "value": "1"} , { "attrname": "URL", "value": "http: \/\/www.orpha.net\/ORDO\/Orphanet_683"} ], "id": "208", "contexts": { } , "evidences": ["Imported from database"], "value": "Progressive supranuclear palsy", "ofType": "Trait", "coaccessions": [{ "elementOf": "EFO", "accession": "PROGRESSIVE SUPRANUCLEAR PALSY"} ]} , { "annotation": "", "conames": [{ "name": "rs393152", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45641777"} , { "attrname": "BEGIN", "value": "45641777"} ], "id": "209", "contexts": { } , "evidences": ["Imported from database"], "value": "rs393152", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS393152"} ]} , { "annotation": "", "conames": [{ "name": "rs242557", "isPreferred": "true"} ], "elementOf": "NHGRI-EBI", "description": "", "pid": "", "attributes": [{ "attrname": "Chromosome", "value": "17"} , { "attrname": "END", "value": "45942346"} , { "attrname": "BEGIN", "value": "45942346"} ], "id": "210", "contexts": { } , "evidences": ["Imported from database"], "value": "rs242557", "ofType": "SNP", "coaccessions": [{ "elementOf": "ENSV", "accession": "RS242557"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "211", "contexts": { } , "evidences": ["Imported from database"], "value": "P49841", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P49841"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "212", "contexts": { } , "evidences": ["Imported from database"], "value": "Q12800", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q12800"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "213", "contexts": { } , "evidences": ["Imported from database"], "value": "P08107", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P08107"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "214", "contexts": { } , "evidences": ["Imported from database"], "value": "P07900", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P07900"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "215", "contexts": { } , "evidences": ["Imported from database"], "value": "Q86WG3", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q86WG3"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "216", "contexts": { } , "evidences": ["Imported from database"], "value": "P11142", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P11142"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "217", "contexts": { } , "evidences": ["Imported from database"], "value": "Q7Z7E8", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q7Z7E8"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "218", "contexts": { } , "evidences": ["Imported from database"], "value": "Q38SD2", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q38SD2"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "219", "contexts": { } , "evidences": ["Imported from database"], "value": "P10636-8", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P10636-8"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "220", "contexts": { } , "evidences": ["Imported from database"], "value": "P04179", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P04179"} ]} , { "annotation": "", "conames": [{ "name": "Ribostamycin", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "221", "contexts": { } , "evidences": ["Imported from database"], "value": "Ribostamycin", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB03615"} ]} , { "annotation": "", "conames": [{ "name": "Adenosine monophosphate", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "3"} ], "id": "222", "contexts": { "context": { "id": 43} } , "evidences": ["Imported from database"], "value": "Adenosine monophosphate", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00131"} ]} , { "annotation": "", "conames": [{ "name": "Levodopa", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "14"} ], "id": "223", "contexts": { "context": { "id": 44} } , "evidences": ["Imported from database"], "value": "Levodopa", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01235"} ]} , { "annotation": "[VARIANTS PARK2 ASN-161; ASN-211; CYS-256; TRP-275; ASN-280; GLY-289; GLU-328; CYS-334; ASN-415 AND ASP-430]", "conames": [{ "name": "PMID: 10824074", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10824074", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The New England journal of medicine"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Association between early-onset Parkinson's disease and mutations in the parkin gene."} , { "attrname": "Abstract", "value": "Mutations in the parkin gene have recently been identified in patients with early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  but the frequency of the mutations and the associated phenotype have not been assessed in a large series of patients. We studied 73 families in which at least one of the affected family members was affected at or before the age of 45 years and had parents who were not affected,  as well as 100 patients with isolated <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> that began at or before the age of 45 years. All subjects were screened for mutations in the parkin gene with use of a semiquantitative polymerase-chain-reaction assay that simultaneously amplified several exons. We sequenced the coding exons in a subgroup of patients. We also compared the clinical features of patients with parkin mutations and those without mutations. Among the families with early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  36 (49 percent) had parkin mutations. The age at onset ranged from 7 to 58 years. Among the patients with isolated <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  mutations were detected in 10 of 13 patients (77 percent) with an age at onset of 20 years or younger,  but in only 2 of 64 patients (3 percent) with an age at onset of more than 30 years. The mean (+\/-SD) age at onset in the patients with parkin mutations was younger than that in those without mutations (32+\/-11 vs. 42+\/-11 years,  P<0.001),  and they were more likely to have symmetric involvement and dystonia at onset,  to have hyperreflexia at onset or later,  to have a good response to levodopa therapy,  and to have levodopa-induced dyskinesias during treatment. Nineteen different rearrangements of exons (deletions and multiplications) and 16 different point mutations were detected. Mutations in the parkin gene are a major cause of early-onset autosomal recessive familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and isolated juvenile-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (at or before the age of 20 years). Accurate diagnosis of these cases cannot be based only on the clinical manifestations of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Sequence Deletion,  Exons,  Humans,  Middle Aged,  Genotype,  Male,  Proteins,  Ubiquitin-Protein Ligases,  Point Mutation,  Phenotype,  Ligases,  Base Sequence,  Adolescent,  Age of Onset,  Polymerase Chain Reaction,  Adult,  Female,  Mutation,  Child]"} , { "attrname": "AUTHORS", "value": "[C B Lcking,  A Drr,  V Bonifati,  J Vaughan,  G De Michele,  T Gasser,  B S Harhangi,  G Meco,  P Denfle,  N W Wood,  Y Agid,  A Brice,   French <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Genetics Study Group,   European Consortium on Genetic Susceptibility in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 ASN-161; ASN-211; CYS-256; TRP-275; ASN-280; GLY-289; GLU-328; CYS-334; ASN-415 AND ASP-430]"} ], "id": "224", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10824074", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1056\/NEJM200005253422103"} , { "elementOf": "NLM", "accession": "10824074"} ]} , { "annotation": "[VARIANTS PARK2 ASN-161; CYS-256; TRP-275 AND ASN-415,  VARIANTS ASN-167; LEU-380 AND ASN-394]", "conames": [{ "name": "PMID: 10072423", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10072423", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A wide variety of mutations in the parkin gene are responsible for autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism in Europe. French <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Genetics Study Group and the European Consortium on Genetic Susceptibility in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP,  PARK2; OMIM 602544),  one of the monogenic forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  was initially described in Japan. It is characterized by early onset (before age 40),  marked response to levodopa treatment and levodopa-induced dyskinesias. The gene responsible for AR-JP was recently identified and designated parkin. We have analysed the 12 coding exons of the parkin gene in 35 mostly European families with early onset autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. In one family,  a homozygous deletion of exon 4 could be demonstrated. By direct sequencing of the exons in the index patients of the remaining 34 families,  eight previously undescribed point mutations (homozygous or heterozygous) were detected in eight families that included 20 patients. The mutations segregated with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in the families and were not detected on 110-166 control chromosomes. Four mutations caused truncation of the parkin protein. Three were frameshifts (202-203delAG,  255delA and 321-322insGT) and one a nonsense mutation (Trp453Stop). The other four were missense mutations (Lys161Asn,  Arg256Cys,  Arg275Trp and Thr415Asn) that probably affect amino acids that are important for the function of the parkin protein,  since they result in the same phenotype as truncating mutations or homozygous exon deletions. Mean age at onset was 38 +\/- 12 years,  but onset up to age 58 was observed. Mutations in the parkin gene are therefore not invariably associated with early onset <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. In many patients,  the phenotype is indistinguishable from that of idiopathic PD. This study has shown that a wide variety of different mutations in the parkin gene are a common cause of autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism in Europe and that different types of point mutations seem to be more frequently responsible for the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> phenotype than are deletions. "} , { "attrname": "MeSH", "value": "[Exons,  Europe,  Humans,  Family Health,  Genotype,  Male,  Genes,  Recessive,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Ubiquitin-Protein Ligases,  Point Mutation,  Phenotype,  Ligases,  Pedigree,  Gene Deletion,  Female,  Mutation,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[N Abbas,  C B Lcking,  S Ricard,  A Drr,  V Bonifati,  G De Michele,  S Bouley,  J R Vaughan,  T Gasser,  R Marconi,  E Broussolle,  C Brefel-Courbon,  B S Harhangi,  B A Oostra,  E Fabrizio,  G A Bhme,  L Pradier,  N W Wood,  A Filla,  G Meco,  P Denefle,  Y Agid,  A Brice]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 ASN-161; CYS-256; TRP-275 AND ASN-415,  VARIANTS ASN-167; LEU-380 AND ASN-394]"} ], "id": "225", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10072423", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/HMG\/8.4.567"} , { "elementOf": "NLM", "accession": "10072423"} ]} , { "annotation": "", "conames": [{ "name": "Glycine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "24"} ], "id": "226", "contexts": { "context": { "id": 47} } , "evidences": ["Imported from database"], "value": "Glycine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00145"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.75 ANGSTROMS) OF 61-65 IN COMPLEX WITH COPPER ION,  DOMAIN,  SUBUNIT];", "conames": [{ "name": "PMID: 11900542", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11900542", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Prions,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Molecular features of the copper binding sites in the octarepeat domain of the prion protein."} , { "attrname": "Abstract", "value": "Recent evidence suggests that the prion protein (PrP) is a copper binding protein. The N-terminal region of human PrP contains four sequential copies of the highly conserved octarepeat sequence PHGGGWGQ spanning residues 60-91. This region selectively binds Cu2+ in vivo. In a previous study using peptide design,  EPR,  and CD spectroscopy,  we showed that the HGGGW segment within each octarepeat comprises the fundamental Cu2+ binding unit [Aronoff-Spencer et al. (2000) Biochemistry 40,  13760-13771]. Here we present the first atomic resolution view of the copper binding site within an octarepeat. The crystal structure of HGGGW in a complex with Cu2+ reveals equatorial coordination by the histidine imidazole,  two deprotonated glycine amides,  and a glycine carbonyl,  along with an axial water bridging to the Trp indole. Companion S-band EPR,  X-band ESEEM,  and HYSCORE experiments performed on a library of 15N-labeled peptides indicate that the structure of the copper binding site in HGGGW and PHGGGWGQ in solution is consistent with that of the crystal structure. Moreover,  EPR performed on PrP(23-28,  57-91) and an 15N-labeled analogue demonstrates that the identified structure is maintained in the full PrP octarepeat domain. It has been shown that copper stimulates PrP endocytosis. The identified Gly-Cu linkage is unstable below pH approximately 6.5 and thus suggests a pH-dependent molecular mechanism by which PrP detects Cu2+ in the extracellular matrix or releases PrP-bound Cu2+ within the endosome. The structure also reveals an unusual complementary interaction between copper-structured HGGGW units that may facilitate molecular recognition between prion proteins,  thereby suggesting a mechanism for transmembrane signaling and perhaps conversion to the pathogenic form. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Repetitive Sequences,  Amino Acid,  Electron Spin Resonance Spectroscopy,  Humans,  Prions,  Models,  Molecular,  Molecular Sequence Data,  Protein Conformation,  Copper,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[Colin S Burns,  Eliah Aronoff-Spencer,  Christine M Dunham,  Paula Lario,  Nikolai I Avdievich,  William E Antholine,  Marilyn M Olmstead,  Alice Vrielink,  Gary J Gerfen,  Jack Peisach,  William G Scott,  Glenn L Millhauser]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (0.75 ANGSTROMS) OF 61-65 IN COMPLEX WITH COPPER ION,  DOMAIN,  SUBUNIT]"} ], "id": "227", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11900542", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI011922X"} , { "elementOf": "NLM", "accession": "11900542"} ]} , { "annotation": "[VARIANT AD3 SER-266]", "conames": [{ "name": "PMID: 11920851", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11920851", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of medical genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  9007-49-2 DNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Molecular evidence of presenilin 1 mutation in familial early onset dementia."} , { "attrname": "Abstract", "value": "Early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) has been associated with mutations in three genes,  of which presenilin 1 (PSEN1) mutations are the most frequent. We reported previously a variant form of FAD,  due to deletion of exon 9 of PSEN1,  with spastic paralysis and rigidity. We describe a novel PSEN1 mutation in a family of Japanese origin with six affected individuals of both genders in two generations. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is characterized by presenile dementia,  which is preceded by spastic paraparesis and apraxia. This mutation,  which is predicted to cause a missense substitution of serine for glycine,  occurred at codon 266 in exon 8 of PSEN1. The mutation was not found in 200 controls and 200 sporadic AD patients. On this basis alone,  it seems this mutation is pathogenic. Our findings provide a new clue to the etiology of the familial early onset dementia. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Sequence Homology,  Amino Acid,  DNA Mutational Analysis,  Pedigree,  Base Sequence,  DNA,  Age of Onset,  Fatal Outcome,  Adult,  Female,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Miho Matsubara-Tsutsui,  Minoru Yasuda,  Hidehisa Yamagata,  Takuo Nomura,  Keiko Taguchi,  Katsuhiko Kohara,  Koho Miyoshi,  Tetsuro Miki]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 SER-266]"} ], "id": "228", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11920851", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11920851"} , { "elementOf": "DOI", "accession": "10.1002\/AJMG.10250"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 58-85 AND 111-150]", "conames": [{ "name": "PMID: 1672107", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1672107", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[Codon,  PrPSc Proteins,  Prions,  Amyloid,  Viral Proteins,  TE7660XO1C Glycine]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Amyloid protein of Gerstmann-Strussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58."} , { "attrname": "Abstract", "value": "Gerstmann-Strussler-Scheinker (GSS) disease is a familial neurological disorder pathologically characterized by amyloid deposition in the cerebrum and cerebellum. The GSS amyloid is immunoreactive to antisera raised against the hamster prion protein (PrP) 27-30. This is a proteinase K-resistant glycoprotein of 27-30 kd that is derived from an abnormal isoform of a neuronal glycoprotein of 33-35 kd designated PrPSc and is a molecular marker of amyloid fibrils isolated from animals with scrapie and humans with related disorders. We have purified and characterized proteins extracted from amyloid plaque cores isolated from two patients of the Indiana kindred of GSS disease. We found that the major component of GSS amyloid is an 11 kd degradation product of PrP,  whose N-terminus corresponds to the glycine residue at position 58 of the amino acid sequence deduced from the human PrP cDNA. In addition,  amyloid fractions contained larger PrP fragments with apparently intact N-termini and amyloid P component. These findings suggest that the disease process leads to proteolytic cleavage of PrP,  generating an amyloidogenic peptide that polymerizes into insoluble fibrils. The N-terminal cleavage of PrP in GSS disease occurs at a tryptophan-glycine peptide bond identical to that cleaved by proteinase K in vitro to generate PrP 27-30 from hamster PrPSc at codon 90. Since no mutations of the structural PrP gene have been found in the Indiana family of GSS disease,  it is conceivable that factors other than the primary structure of PrP play a crucial role in the process of amyloid formation and the development of clinical neurologic dysfunction. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Scrapie,  Humans,  Molecular Sequence Data,  Cerebral Cortex,  Immunoblotting,  Viral Proteins,  Glycine,  Sequence Homology,  Nucleic Acid,  Animals,  Codon,  PrPSc Proteins,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Amyloid,  Basal Ganglia,  Chromatography,  Gel]"} , { "attrname": "AUTHORS", "value": "[F Tagliavini,  F Prelli,  J Ghiso,  O Bugiani,  D Serban,  S B Prusiner,  M R Farlow,  B Ghetti,  B Frangione]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 58-85 AND 111-150]"} ], "id": "229", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1672107", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1672107"} ]} , { "annotation": "[VARIANT GSD VAL-131]", "conames": [{ "name": "PMID: 11709001", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11709001", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[Prions]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "A new PRNP mutation (G131V) associated with Gerstmann-Strussler-Scheinker disease."} , { "attrname": "Abstract", "value": "Gerstmann-Strussler-Scheinker disease is a rare form of prion disease. To determine the prion mutation in a 51-year-old man without a family history of neurologic disease who died from Gerstmann-Strussler-Scheinker disease. The patient was a 51-year-old man who died after a 9-year illness characterized by dementia and eventually ataxia. Neuropathologic studies were performed,  the results of which revealed abundant prion protein-immunopositive amyloid plaques in the cerebellum without spongiform degeneration. Genetic analysis of the prion protein gene showed a novel mutation at codon 131 that caused a valine-for-glycine substitution (G131V) and homozygosity at codon 129 (129M). Proteinase K-resistant prion protein was detected by Western blot analysis. This is the first mutation described in the short,  antiparallel beta-sheet domain of the prion protein. This report highlights the importance of genetic analysis of patients with atypical dementia even in the absence of a family history. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Base Sequence,  Humans,  Middle Aged,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Molecular Sequence Data,  Male,  Mutation]"} , { "attrname": "AUTHORS", "value": "[P K Panegyres,  K Toufexis,  B A Kakulas,  L Cernevakova,  P Brown,  B Ghetti,  P Piccardo,  S R Dlouhy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD VAL-131]"} ], "id": "230", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11709001", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11709001"} , { "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.58.11.1899"} ]} , { "annotation": "[VARIANT AD3 ALA-206]", "conames": [{ "name": "PMID: 11710891", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11710891", "attributes": [{ "attrname": "JOURNAL_REF", "value": "JAMA"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Apolipoproteins E,  TE7660XO1C Glycine,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human,  OF5P57N2ZX Alanine]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "A founder mutation in presenilin 1 causing early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in unrelated Caribbean Hispanic families."} , { "attrname": "Abstract", "value": "Genetic determinants of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) have not been comprehensively examined in Caribbean Hispanics,  a population in the United States in whom the frequency of AD is higher compared with non-Hispanic whites. To identify variant alleles in genes related to familial early-onset AD among Caribbean Hispanics. Family-based case series conducted in 1998-2001 at an AD research center in New York,  NY,  and clinics in the Dominican Republic. Among 206 Caribbean Hispanic families with 2 or more living members with AD who were identified,  19 (9.2%) had at least 1 individual with onset of AD before the age of 55 years. The entire coding region of the presenilin 1 gene and exons 16 and 17 of the amyloid precursor protein gene were sequenced in probands from the 19 families and their living relatives. A G-to-C nucleotide change resulting in a glycine-alanine amino acid substitution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%) of the 19 families. A Caribbean Hispanic individual with the Gly206Ala mutation and early-onset familial <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was also found by sequencing the corresponding genes of 319 unrelated individuals in New York City. The Gly206Ala mutation was not found in public genetic databases but was reported in 5 individuals from 4 Hispanic families with AD referred for genetic testing. None of the members of these families were related to one another,  yet all carriers of the Gly206Ala mutation tested shared a variant allele at 2 nearby microsatellite polymorphisms,  indicating a common ancestor. No mutations were found in the amyloid precursor protein gene. The Gly206Ala mutation was found in 8 of 19 unrelated Caribbean Hispanic families with early-onset familial AD. This genetic change may be a prevalent cause of early-onset familial AD in the Caribbean Hispanic population. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Alanine,  Presenilin-1,  Puerto Rico,  Exons,  United States,  Humans,  Middle Aged,  Hispanic Americans,  Genotype,  Caribbean Region,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Glycine,  Polymorphism,  Genetic,  Membrane Proteins,  Phenotype,  DNA Mutational Analysis,  Age of Onset,  Dominican Republic,  Aged,  Apolipoproteins E,  Mutation,  Amyloid beta-Protein Precursor,  Microsatellite Repeats]"} , { "attrname": "AUTHORS", "value": "[E S Athan,  J Williamson,  A Ciappa,  V Santana,  S N Romas,  J H Lee,  H Rondon,  R A Lantigua,  M Medrano,  M Torres,  S Arawaka,  E Rogaeva,  Y Q Song,  C Sato,  T Kawarai,  K C Fafel,  M A Boss,  W K Seltzer,  Y Stern,  P St George-Hyslop,  B Tycko,  R Mayeux]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 ALA-206]"} ], "id": "231", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11710891", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1001\/JAMA.286.18.2257"} , { "elementOf": "NLM", "accession": "11710891"} ]} , { "annotation": "[STRUCTURE BY NMR IN COMPLEX WITH DETERGENT MICELLES]", "conames": [{ "name": "PMID: 15615727", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15615727", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[368GB5141J Sodium Dodecyl Sulfate,  SNCA protein,  human,  Phosphoproteins,  Micelles,  Nerve Tissue Proteins,  Detergents,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Structure and dynamics of micelle-bound human alpha-synuclein."} , { "attrname": "Abstract", "value": "Misfolding of the protein alpha-synuclein (aS),  which associates with presynaptic vesicles,  has been implicated in the molecular chain of events leading to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here,  the structure and dynamics of micelle-bound aS are reported. Val3-Val37 and Lys45-Thr92 form curved alpha-helices,  connected by a well ordered,  extended linker in an unexpected anti-parallel arrangement,  followed by another short extended region (Gly93-Lys97),  overlapping the recently identified chaperone-mediated autophagy recognition motif and a highly mobile tail (Asp98-Ala140). Helix curvature is significantly less than predicted based on the native micelle shape,  indicating a deformation of the micelle by aS. Structural and dynamic parameters show a reduced helical content for Ala30-Val37. A dynamic variation in interhelical distance on the microsecond timescale is complemented by enhanced sub-nanosecond timescale dynamics,  particularly in the remarkably glycine-rich segments of the helices. These unusually rich dynamics may serve to mitigate the effect of aS binding on membrane fluidity. The well ordered conformation of the helix-helix connector indicates a defined interaction with lipidic surfaces,  suggesting that,  when bound to larger diameter synaptic vesicles,  it can act as a switch between this structure and a previously proposed uninterrupted helix. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Magnetic Resonance Spectroscopy,  Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Nerve Tissue Proteins,  Detergents,  Synucleins,  Sodium Dodecyl Sulfate,  Phosphoproteins,  Micelles,  Binding Sites,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Tobias S Ulmer,  Ad Bax,  Nelson B Cole,  Robert L Nussbaum]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR IN COMPLEX WITH DETERGENT MICELLES]"} ], "id": "232", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15615727", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15615727"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M411805200"} ]} , { "annotation": "[VARIANT AD3 GLU-378]", "conames": [{ "name": "PMID: 10200054", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10200054", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Missense mutation in exon 11 (Codon 378) of the presenilin-1 gene in a French family with early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and transmission study by mismatch enhanced allele specific amplification. Mutations in brief no. 141. Online. besancon@rockefeller1.univ.lyon1.fr."} , { "attrname": "Abstract", "value": "Mutations in the presenilin-1 (PS1) gene account for the majority of familial early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOAD) cases. We screened the coding part of the PS1 gene for the present of mutations in a French family with EOAD,  using single strand conformation polymorphism (SSCP) analysis. Patients in the pedigree showed a missense mutation in exon 11 of the PS1 gene involving a transition of G to A,  altering glycine to glutamate at codon 378. The cosegregation of the mutation with EOAD in the family was studied by allele specific amplification,  enhanced by the introduction of a mismatch at the penultimate position near the 3' primer end. The mutation has not been described before and is located within the third large cytoplasmic loop and may lead to the appearance of a short additional a-helix. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Genetic Testing,  Exons,  Pedigree,  Humans,  Age of Onset,  Alleles,  Base Pair Mismatch,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[R Besanon,  A Lorenzi,  M Cruts,  S Radawiec,  F Sturtz,  E Broussolle,  G Chazot,  C van Broeckhoven,  G Chamba,  A Vandenberghe]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 GLU-378]"} ], "id": "233", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10200054", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10200054"} , { "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1998)11: 6<481: : AID-HUMU13>3.0.CO;2-N"} ]} , { "annotation": "", "conames": [{ "name": "Dopamine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "22"} ], "id": "234", "contexts": { "context": { "id": 239} } , "evidences": ["Imported from database"], "value": "Dopamine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00988"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH FBXW7 AND CUL1,  UBIQUITINATION OF CYCLIN E]", "conames": [{ "name": "PMID: 12628165", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12628165", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 SKP Cullin F-Box Protein Ligases,  EC 6.3.2.- Peptide Synthases,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  SIV03811UC Kainic Acid,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity."} , { "attrname": "Abstract", "value": "Mutations in parkin,  which encodes a RING domain protein associated with ubiquitin ligase activity,  lead to autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> characterized by midbrain dopamine neuron loss. Here we show that parkin functions in a multiprotein ubiquitin ligase complex that includes the F-box\/WD repeat protein hSel-10 and Cullin-1. HSel-10 serves to target the parkin ubiquitin ligase activity to cyclin E,  an hSel-10-interacting protein previously implicated in the regulation of neuronal apoptosis. Consistent with the notion that cyclin E is a substrate of the parkin ubiquitin ligase complex,  parkin deficiency potentiates the accumulation of cyclin E in cultured postmitotic neurons exposed to the glutamatergic excitotoxin kainate and promotes their apoptosis. Furthermore,  parkin overexpression attenuates the accumulation of cyclin E in toxin-treated primary neurons,  including midbrain dopamine neurons,  and protects them from apoptosis. "} , { "attrname": "MeSH", "value": "[Peptide Synthases,  Cell Survival,  Mitosis,  Neurons,  Humans,  Cells,  Cultured,  Kainic Acid,  SKP Cullin F-Box Protein Ligases,  Ubiquitin-Protein Ligases,  Animals,  Ligases,  Mice,  HeLa Cells,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[John F Staropoli,  Caroline McDermott,  Ccile Martinat,  Brenda Schulman,  Elena Demireva,  Asa Abeliovich]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH FBXW7 AND CUL1,  UBIQUITINATION OF CYCLIN E]"} ], "id": "235", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12628165", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12628165"} , { "elementOf": "DOI", "accession": "10.1016\/S0896-6273(03)00084-9"} ]} , { "annotation": "[FUNCTION]", "conames": [{ "name": "PMID: 24896179", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24896179", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[EC 3.1.2.- Thiolester Hydrolases,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 3.1.2.15 Usp30 protein,  human,  EC 2.7.- Protein Kinases,  Mitochondrial Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.4.19.12 Ubiquitin-Specific Proteases]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy."} , { "attrname": "Abstract", "value": "Cells maintain healthy mitochondria by degrading damaged mitochondria through mitophagy; defective mitophagy is linked to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here we report that USP30,  a deubiquitinase localized to mitochondria,  antagonizes mitophagy driven by the ubiquitin ligase parkin (also known as PARK2) and protein kinase PINK1,  which are encoded by two genes associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Parkin ubiquitinates and tags damaged mitochondria for clearance. Overexpression of USP30 removes ubiquitin attached by parkin onto damaged mitochondria and blocks parkin's ability to drive mitophagy,  whereas reducing USP30 activity enhances mitochondrial degradation in neurons. Global ubiquitination site profiling identified multiple mitochondrial substrates oppositely regulated by parkin and USP30. Knockdown of USP30 rescues the defective mitophagy caused by pathogenic mutations in parkin and improves mitochondrial integrity in parkin- or PINK1-deficient flies. Knockdown of USP30 in dopaminergic neurons protects flies against paraquat toxicity in vivo,  ameliorating defects in dopamine levels,  motor function and organismal survival. Thus USP30 inhibition is potentially beneficial for <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> by promoting mitochondrial clearance and quality control. "} , { "attrname": "MeSH", "value": "[Cell Line,  Neurons,  Humans,  Cells,  Cultured,  Rats,  Male,  Mitochondrial Proteins,  Gene Knockdown Techniques,  Mitochondrial Degradation,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Ubiquitin-Specific Proteases,  Ubiquitination,  Animals,  Protein Kinases,  HEK293 Cells,  Thiolester Hydrolases,  HeLa Cells,  Drosophila melanogaster]"} , { "attrname": "AUTHORS", "value": "[Baris Bingol,  Joy S Tea,  Lilian Phu,  Mike Reichelt,  Corey E Bakalarski,  Qinghua Song,  Oded Foreman,  Donald S Kirkpatrick,  Morgan Sheng]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION]"} ], "id": "236", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24896179", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE13418"} , { "elementOf": "NLM", "accession": "24896179"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH AIMP2]", "conames": [{ "name": "PMID: 16135753", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16135753", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[EC 2.7.11.24 p38 Mitogen-Activated Protein Kinases,  Coenzymes,  EC 2.3.2.27 parkin protein,  Catecholamines,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.1.1.- Amino Acyl-tRNA Synthetases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor,  p38\/JTV-1,  leads to catecholaminergic cell death."} , { "attrname": "Abstract", "value": "Autosomal-recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP) is caused by loss-of-function mutations of the parkin gene. Parkin,  a RING-type E3 ubiquitin ligase,  is responsible for the ubiquitination and degradation of substrate proteins that are important in the survival of dopamine neurons in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). Accordingly,  the abnormal accumulation of neurotoxic parkin substrates attributable to loss of parkin function may be the cause of neurodegeneration in parkin-related <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. We evaluated the known parkin substrates identified to date in parkin null mice to determine whether the absence of parkin results in accumulation of these substrates. Here we show that only the aminoacyl-tRNA synthetase cofactor p38 is upregulated in the ventral midbrain\/hindbrain of both young and old parkin null mice. Consistent with upregulation in parkin knock-out mice,  brains of AR-JP and idiopathic PD and diffuse Lewy body <span style=\"background-color: yellow\"><b>disease<\/b><\/span> also exhibit increased level of p38. In addition,  p38 interacts with parkin and parkin ubiquitinates and targets p38 for degradation. Furthermore,  overexpression of p38 induces cell death that increases with tumor necrosis factor-alpha treatment and parkin blocks the pro-cell death effect of p38,  whereas the R42P,  familial-linked mutant of parkin,  fails to rescue cell death. We further show that adenovirus-mediated overexpression of p38 in the substantia nigra in mice leads to loss of dopaminergic neurons. Together,  our study represents a major advance in our understanding of parkin function,  because it clearly identifies p38 as an important authentic pathophysiologic substrate of parkin. Moreover,  these results have important implications for understanding the molecular mechanisms of neurodegeneration in PD. "} , { "attrname": "MeSH", "value": "[Brain,  Coenzymes,  Humans,  Substrate Specificity,  Catecholamines,  Amino Acyl-tRNA Synthetases,  Mice,  Knockout,  Ubiquitin-Protein Ligases,  Animals,  Cell Death,  Cell Line,  Tumor,  Female,  Mice,  p38 Mitogen-Activated Protein Kinases]"} , { "attrname": "AUTHORS", "value": "[Han Seok Ko,  Rainer von Coelln,  Sathya R Sriram,  Seong Who Kim,  Kenny K K Chung,  Olga Pletnikova,  Juan Troncoso,  Brett Johnson,  Roya Saffary,  Eyleen L Goh,  Hongjun Song,  Bum-Joon Park,  Min Jung Kim,  Sunghoon Kim,  Valina L Dawson,  Ted M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH AIMP2]"} ], "id": "237", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16135753", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1523\/JNEUROSCI.2172-05.2005"} , { "elementOf": "NLM", "accession": "16135753"} ]} , { "annotation": "[FUNCTION,  UBIQUITINATION,  S-NITROSYLATION]", "conames": [{ "name": "PMID: 15105460", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15105460", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Ubiquitin,  Sncaip protein,  mouse,  EC 2.3.2.27 parkin protein,  Nerve Tissue Proteins,  Recombinant Proteins,  Synucleins,  EC 1.14.13.39 Nitric Oxide Synthase,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Nitric Oxide Donors,  Cysteine Proteinase Inhibitors,  SNCAIP protein,  human,  31C4KY9ESH Nitric Oxide,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function."} , { "attrname": "Abstract", "value": "Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). We show that parkin is S-nitrosylated in vitro,  as well as in vivo in a mouse model of PD and in brains of patients with PD and diffuse Lewy body <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Moreover,  S-nitrosylation inhibits parkin's ubiquitin E3 ligase activity and its protective function. The inhibition of parkin's ubiquitin E3 ligase activity by S-nitrosylation could contribute to the degenerative process in these disorders by impairing the ubiquitination of parkin substrates. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Brain,  Cell Line,  MPTP Poisoning,  Catalytic Domain,  Humans,  Lewy Body <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Nerve Tissue Proteins,  Nitric Oxide,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synucleins,  Mice,  Knockout,  Nitric Oxide Donors,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Animals,  Transfection,  Cysteine Proteinase Inhibitors,  Cell Death,  Nitric Oxide Synthase,  Mice,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Kenny K K Chung,  Bobby Thomas,  Xiaojie Li,  Olga Pletnikova,  Juan C Troncoso,  Laura Marsh,  Valina L Dawson,  Ted M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  UBIQUITINATION,  S-NITROSYLATION]"} ], "id": "238", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15105460", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15105460"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1093891"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH ZNF746,  CHARACTERIZATION OF VARIANTS PARK2 TRP-275; ASP-430 AND PHE-431]", "conames": [{ "name": "PMID: 21376232", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21376232", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cell"} , { "attrname": "Chemical", "value": "[Nrf1 protein,  mouse,  Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha,  Repressor Proteins,  Trans-Activators,  EC 2.3.2.27 parkin protein,  NF-E2-Related Factor 1,  VTD58H1Z2X Dopamine,  Transcription Factors,  ZNF746 protein,  mouse,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Ppargc1a protein,  mouse,  Nuclear Respiratory Factor 1]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "PARIS (ZNF746) repression of PGC-1 contributes to neurodegeneration in Parkinson's disease."} , { "attrname": "Abstract", "value": "A hallmark of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is the preferential loss of substantia nigra dopamine neurons. Here,  we identify a new parkin interacting substrate,  PARIS (ZNF746),  whose levels are regulated by the ubiquitin proteasome system via binding to and ubiquitination by the E3 ubiquitin ligase,  parkin. PARIS is a KRAB and zinc finger protein that accumulates in models of parkin inactivation and in human PD brain. PARIS represses the expression of the transcriptional coactivator,  PGC-1? and the PGC-1? target gene,  NRF-1 by binding to insulin response sequences in the PGC-1? promoter. Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons in a PARIS-dependent manner. Moreover,  overexpression of PARIS leads to the selective loss of DA neurons in the substantia nigra,  and this is reversed by either parkin or PGC-1? coexpression. The identification of PARIS provides a molecular mechanism for neurodegeneration due to parkin inactivation. "} , { "attrname": "MeSH", "value": "[Brain,  Neurodegenerative <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Dopamine,  Neurons,  Humans,  Mice,  Inbred C57BL,  Repressor Proteins,  Trans-Activators,  Rats,  Mice,  Knockout,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Animals,  Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha,  NF-E2-Related Factor 1,  Mice,  Transcription Factors,  Nuclear Respiratory Factor 1]"} , { "attrname": "AUTHORS", "value": "[Joo-Ho Shin,  Han Seok Ko,  Hochul Kang,  Yunjong Lee,  Yun-Il Lee,  Olga Pletinkova,  Juan C Troconso,  Valina L Dawson,  Ted M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH ZNF746,  CHARACTERIZATION OF VARIANTS PARK2 TRP-275; ASP-430 AND PHE-431]"} ], "id": "239", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21376232", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21376232"} , { "elementOf": "DOI", "accession": "10.1016\/J.CELL.2011.02.010"} ]} , { "annotation": "[VARIANT PARK2 MET-15,  VARIANTS LEU-380 AND ASN-394]", "conames": [{ "name": "PMID: 12397156", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12397156", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurology,  neurosurgery,  and psychiatry"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Relative high frequency of the c.255delA parkin gene mutation in Spanish patients with autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism is a neurodegenerative disorder associated with mutations in the parkin gene. To search for the presence of parkin gene mutations in Spanish patients with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) and characterise the phenotype associated with these mutations. Thirty seven PD patients with either early onset or autosomal recessive pattern of inheritance were selected for genetic study. Mutations were identified in seven index patients (19%). Homozygous mutations were detected in six patients and a heterozygous mutation in one. The age at onset was lower in patients with mutations than in patients without mutations. Dystonia at onset was present in two patients with parkin gene mutations. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> began in two patients with postural tremor in the upper limbs mimicking essential tremor. Four patients exhibited a long term response to dopamine agonists. The c.255delA mutation was identified in four unrelated families. This is a frameshift mutation leading to protein truncation. Parkin gene mutations are present in Spanish patients with early onset and\/or an autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. The c.255delA is the most frequent mutation found,  suggesting a relative high prevalence in the Spanish population. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Humans,  Middle Aged,  Male,  Incidence,  Spain,  Polymorphism,  Single-Stranded Conformational,  Ubiquitin-Protein Ligases,  Homozygote,  Point Mutation,  Phenotype,  DNA Mutational Analysis,  Ligases,  Age of Onset,  Polymerase Chain Reaction,  Adult,  Female]"} , { "attrname": "AUTHORS", "value": "[E Muoz,  E Tolosa,  P Pastor,  M J Mart,  F Valldeoriola,  J Campdelacreu,  R Oliva]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 MET-15,  VARIANTS LEU-380 AND ASN-394]"} ], "id": "240", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12397156", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1136\/JNNP.73.5.582"} , { "elementOf": "NLM", "accession": "12397156"} ]} , { "annotation": "", "conames": [{ "name": "Adenosine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "9"} ], "id": "241", "contexts": { "context": { "id": 43} } , "evidences": ["Imported from database"], "value": "Adenosine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00640"} ]} , { "annotation": "", "conames": [], "elementOf": "UNIPROTKB", "description": "", "pid": "2.7.11.1", "attributes": [], "id": "242", "contexts": { } , "evidences": ["Imported from database"], "value": "2.7.11.1", "ofType": "Enzyme Classification", "coaccessions": [{ "elementOf": "EC", "accession": "2.7.11.1"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 8,  AUTOSOMAL DOMINANT; PARK8", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "607060", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "243", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 8,  AUTOSOMAL DOMINANT; PARK8", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "607060"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>,  LATE-ONSET; PD", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "168600", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "244", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>,  LATE-ONSET; PD", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "168600"} ]} , { "annotation": "Interacting selectively and non-covalently with ATP,  adenosine 5'-triphosphate,  a universally important coenzyme and enzyme regulator. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "ATP binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005524", "attributes": [], "id": "245", "contexts": { } , "evidences": ["Imported from database"], "value": "ATP binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005524"} ]} , { "annotation": "Interacting selectively and non-covalently with a beta-catenin destruction complex. ( Reference:  GO_REF: 000102 GOC: bf GOC: PARL GOC: TermGenie PMID: 22899650 )", "conames": [{ "name": "beta-catenin destruction complex binding", "isPreferred": "true"} , { "name": "BDC binding", "isPreferred": "true"} , { "name": "beta-catenin degradation complex binding", "isPreferred": "true"} , { "name": "APC-Axin-1-beta-catenin complex binding", "isPreferred": "true"} , { "name": "23S APC complex binding", "isPreferred": "false"} , { "name": "Axin-APC-beta-catenin-GSK3B complex binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1904713", "attributes": [], "id": "246", "contexts": { } , "evidences": ["Imported from database"], "value": "BDC binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1904713"} ]} , { "annotation": "Interacting selectively and non-covalently with any subunit of protein kinase A. ( Reference:  GOC: ai )", "conames": [{ "name": "protein kinase A binding", "isPreferred": "true"} , { "name": "PKA binding", "isPreferred": "true"} , { "name": "protein kinase A anchoring", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051018", "attributes": [], "id": "247", "contexts": { } , "evidences": ["Imported from database"], "value": "PKA binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051018"} ]} , { "annotation": "Interacting selectively and non-covalently with monomeric or multimeric forms of tubulin,  including microtubules. ( Reference:  GOC: clt )", "conames": [{ "name": "tubulin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0015631", "attributes": [], "id": "248", "contexts": { } , "evidences": ["Imported from database"], "value": "tubulin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0015631"} ]} , { "annotation": "Interacting selectively and non-covalently with the SNAP receptor syntaxin-1. ( Reference:  GOC: ai )", "conames": [{ "name": "syntaxin-1 binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0017075", "attributes": [], "id": "249", "contexts": { } , "evidences": ["Imported from database"], "value": "syntaxin-1 binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0017075"} ]} , { "annotation": "Catalysis of the reaction:  GTP + H2O = GDP + phosphate. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "protein-synthesizing GTPase", "isPreferred": "false"} , { "name": "protein-synthesizing GTPase activity,  termination", "isPreferred": "false"} , { "name": "Ran small monomeric GTPase", "isPreferred": "false"} , { "name": "protein-synthesizing GTPase activity,  initiation", "isPreferred": "false"} , { "name": "protein-synthesizing GTPase activity,  elongation", "isPreferred": "false"} , { "name": "Sar small monomeric GTPase", "isPreferred": "false"} , { "name": "GTPase activity", "isPreferred": "true"} , { "name": "Rho small monomeric GTPase", "isPreferred": "false"} , { "name": "signal-recognition-particle GTPase", "isPreferred": "false"} , { "name": "RHEB small monomeric GTPase", "isPreferred": "false"} , { "name": "small monomeric GTPase", "isPreferred": "false"} , { "name": "Rab small monomeric GTPase", "isPreferred": "false"} , { "name": "heterotrimeric G-protein GTPase", "isPreferred": "false"} , { "name": "heterotrimeric G-protein GTPase,  alpha-subunit", "isPreferred": "false"} , { "name": "Ras small monomeric GTPase", "isPreferred": "false"} , { "name": "heterotrimeric G-protein GTPase,  gamma-subunit", "isPreferred": "false"} , { "name": "tubulin GTPase", "isPreferred": "false"} , { "name": "dynamin GTPase", "isPreferred": "false"} , { "name": "heterotrimeric G-protein GTPase,  beta-subunit", "isPreferred": "false"} , { "name": "ARF small monomeric GTPase", "isPreferred": "false"} , { "name": "hydrolase activity,  acting on acid anhydrides,  acting on GTP,  involved in cellular and subcellular movement", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0003924", "attributes": [], "id": "250", "contexts": { } , "evidences": ["Imported from database"], "value": "GTPase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0003924"} ]} , { "annotation": "Interacting selectively and non-covalently with a clathrin heavy or light chain,  the main components of the coat of coated vesicles and coated pits,  and which also occurs in synaptic vesicles. ( Reference:  GOC: jl GOC: mah ISBN: 0198506732 )", "conames": [{ "name": "clathrin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030276", "attributes": [], "id": "251", "contexts": { } , "evidences": ["Imported from database"], "value": "clathrin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030276"} ]} , { "annotation": "Interacting selectively and non-covalently with monomeric or multimeric forms of actin,  including actin filaments. ( Reference:  GOC: clt )", "conames": [{ "name": "membrane associated actin binding", "isPreferred": "false"} , { "name": "actin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0003779", "attributes": [], "id": "252", "contexts": { } , "evidences": ["Imported from database"], "value": "actin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0003779"} ]} , { "annotation": "Interacting selectively and non-covalently with an identical protein to form a homodimer. ( Reference:  GOC: jl )", "conames": [{ "name": "protein homodimerization activity", "isPreferred": "true"} , { "name": "dimerization", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042803", "attributes": [], "id": "253", "contexts": { } , "evidences": ["Imported from database"], "value": "protein homodimerization activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042803"} ]} , { "annotation": "Functions to provide a physical support for the assembly of a multiprotein receptor signaling complex. ( Reference:  GOC: mah )", "conames": [{ "name": "receptor signaling complex scaffold protein", "isPreferred": "true"} , { "name": "receptor signalling complex scaffold", "isPreferred": "true"} , { "name": "receptor signaling complex scaffold activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030159", "attributes": [], "id": "254", "contexts": { } , "evidences": ["Imported from database"], "value": "receptor signalling complex scaffold", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030159"} ]} , { "annotation": "Catalysis of the reactions:  ATP + protein serine = ADP + protein serine phosphate,  and ATP + protein threonine = ADP + protein threonine phosphate. ( Reference:  GOC: bf )", "conames": [{ "name": "threonine-specific protein kinase", "isPreferred": "false"} , { "name": "protein kinase (phosphorylating)", "isPreferred": "false"} , { "name": "serine kinase", "isPreferred": "false"} , { "name": "protein serine\/threonine kinase activity", "isPreferred": "true"} , { "name": "serine\/threonine protein kinase", "isPreferred": "true"} , { "name": "protein serine kinase", "isPreferred": "false"} , { "name": "protein phosphokinase", "isPreferred": "false"} , { "name": "serine protein kinase", "isPreferred": "false"} , { "name": "protein-serine kinase", "isPreferred": "false"} , { "name": "protein serine-threonine kinase", "isPreferred": "true"} , { "name": "serine-specific protein kinase", "isPreferred": "false"} , { "name": "serine(threonine) protein kinase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004674", "attributes": [], "id": "255", "contexts": { } , "evidences": ["Imported from database"], "value": "protein serine-threonine kinase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004674"} , { "elementOf": "GO", "accession": "GO: 0004696"} , { "elementOf": "GO", "accession": "GO: 0004695"} , { "elementOf": "GO", "accession": "GO: 0004700"} ]} , { "annotation": "Catalysis of the concomitant phosphorylation of threonine (T) and tyrosine (Y) residues in a Thr-Glu-Tyr (TEY) thiolester sequence in a MAP kinase (MAPK) substrate. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "MKK2", "isPreferred": "false"} , { "name": "MKK4", "isPreferred": "false"} , { "name": "MAP kinase kinase 7", "isPreferred": "false"} , { "name": "MAP kinase kinase 4", "isPreferred": "false"} , { "name": "MAPKK", "isPreferred": "false"} , { "name": "MAPKK1", "isPreferred": "false"} , { "name": "MKK", "isPreferred": "false"} , { "name": "MKK6", "isPreferred": "false"} , { "name": "MAP2K", "isPreferred": "false"} , { "name": "MKK7", "isPreferred": "false"} , { "name": "MAP kinase or ERK kinase", "isPreferred": "false"} , { "name": "MEK", "isPreferred": "false"} , { "name": "ERK activator kinase", "isPreferred": "true"} , { "name": "STK27", "isPreferred": "false"} , { "name": "MEK1", "isPreferred": "false"} , { "name": "MEK2", "isPreferred": "false"} , { "name": "ATP: protein phosphotransferase (MAPKKK-activated)", "isPreferred": "true"} , { "name": "mitogen-activated protein kinase kinase", "isPreferred": "true"} , { "name": "MAP kinase kinase activity", "isPreferred": "true"} , { "name": "MAPK activator", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004708", "attributes": [], "id": "256", "contexts": { } , "evidences": ["Imported from database"], "value": "MAPK activator", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004708"} ]} , { "annotation": "Interacting selectively and non-covalently with one or more specific sites on an ion channel,  a protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient. ( Reference:  GOC: BHF GOC: jl )", "conames": [{ "name": "ion channel binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044325", "attributes": [], "id": "257", "contexts": { } , "evidences": ["Imported from database"], "value": "ion channel binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044325"} ]} , { "annotation": "Interacting selectively and non-covalently with a glycoprotein,  a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans. ( Reference:  GOC: hjd ISBN: 0198506732 )", "conames": [{ "name": "glycoprotein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001948", "attributes": [], "id": "258", "contexts": { } , "evidences": ["Imported from database"], "value": "glycoprotein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001948"} ]} , { "annotation": "Interacting selectively and non-covalently with an identical protein or proteins. ( Reference:  GOC: jl )", "conames": [{ "name": "isoform-specific homophilic binding", "isPreferred": "true"} , { "name": "identical protein binding", "isPreferred": "true"} , { "name": "protein homopolymerization", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042802", "attributes": [], "id": "259", "contexts": { } , "evidences": ["Imported from database"], "value": "identical protein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042802"} ]} , { "annotation": "Catalysis of the phosphorylation of an amino acid residue in a protein,  usually according to the reaction:  a protein + ATP = a phosphoprotein + ADP. ( Reference:  MetaCyc: PROTEIN-KINASE-RXN )", "conames": [{ "name": "protamine kinase", "isPreferred": "false"} , { "name": "protein kinase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004672", "attributes": [], "id": "260", "contexts": { } , "evidences": ["Imported from database"], "value": "protein kinase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004672"} , { "elementOf": "GO", "accession": "GO: 0050222"} ]} , { "annotation": "Interacting selectively and non-covalently with Rho protein,  any member of the Rho subfamily of the Ras superfamily of monomeric GTPases. Proteins in the Rho subfamily are involved in relaying signals from cell-surface receptors to the actin cytoskeleton. ( Reference:  ISBN: 0198547684 PMID: 12581856 )", "conames": [{ "name": "Rho interactor", "isPreferred": "false"} , { "name": "Rho GTPase binding", "isPreferred": "true"} , { "name": "Rhophilin", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0017048", "attributes": [], "id": "261", "contexts": { } , "evidences": ["Imported from database"], "value": "Rho GTPase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0017048"} , { "elementOf": "GO", "accession": "GO: 0017031"} ]} , { "annotation": "Binds to and increases the activity of a GTPase,  an enzyme that catalyzes the hydrolysis of GTP. ( Reference:  GOC: mah )", "conames": [{ "name": "RanGAP", "isPreferred": "false"} , { "name": "Rap GTPase activator", "isPreferred": "false"} , { "name": "ARF GTPase activator", "isPreferred": "false"} , { "name": "Sar GTPase activator", "isPreferred": "false"} , { "name": "ARF GAP", "isPreferred": "false"} , { "name": "Rap GAP", "isPreferred": "false"} , { "name": "Rac GTPase activator", "isPreferred": "false"} , { "name": "Rac GAP", "isPreferred": "false"} , { "name": "Rho GAP", "isPreferred": "false"} , { "name": "Rab GAP", "isPreferred": "false"} , { "name": "Ral GTPase activator", "isPreferred": "false"} , { "name": "Ras GAP", "isPreferred": "false"} , { "name": "Rab GTPase activator", "isPreferred": "false"} , { "name": "Ral GAP", "isPreferred": "false"} , { "name": "Ran GAP", "isPreferred": "false"} , { "name": "Ras GTPase activator", "isPreferred": "false"} , { "name": "GAP", "isPreferred": "true"} , { "name": "Sar GAP", "isPreferred": "false"} , { "name": "Ran GTPase activator", "isPreferred": "false"} , { "name": "Rho GTPase activator", "isPreferred": "false"} , { "name": "GTPase activator activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005096", "attributes": [], "id": "262", "contexts": { } , "evidences": ["Imported from database"], "value": "GAP", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005099"} , { "elementOf": "GO", "accession": "GO: 0005098"} , { "elementOf": "GO", "accession": "GO: 0005101"} , { "elementOf": "GO", "accession": "GO: 0017123"} , { "elementOf": "GO", "accession": "GO: 0005100"} , { "elementOf": "GO", "accession": "GO: 0030675"} , { "elementOf": "GO", "accession": "GO: 0046582"} , { "elementOf": "GO", "accession": "GO: 0008060"} , { "elementOf": "GO", "accession": "GO: 0005097"} , { "elementOf": "GO", "accession": "GO: 0005096"} ]} , { "annotation": "Interacting selectively and non-covalently with a SNARE (soluble N-ethylmaleimide-sensitive factor attached protein receptor) protein. ( Reference:  PMID: 12642621 )", "conames": [{ "name": "SNAP receptor binding", "isPreferred": "true"} , { "name": "SNARE binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000149", "attributes": [], "id": "263", "contexts": { } , "evidences": ["Imported from database"], "value": "SNARE binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000149"} ]} , { "annotation": "Catalysis of the transfer of a phosphate group,  usually from ATP,  to a substrate molecule. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "kinase activity", "isPreferred": "true"} , { "name": "phosphokinase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016301", "attributes": [], "id": "264", "contexts": { } , "evidences": ["Imported from database"], "value": "phosphokinase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016301"} ]} , { "annotation": "Catalysis of the reaction:  ATP + a protein serine threonine = ADP + protein serine threonine phosphate,  dependent on the presence of GTP. ( Reference:  GOC: ecd PMID: 17200152 )", "conames": [{ "name": "GTP-dependent protein kinase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034211", "attributes": [], "id": "265", "contexts": { } , "evidences": ["Imported from database"], "value": "GTP-dependent protein kinase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034211"} ]} , { "annotation": "Interacting selectively and non-covalently with GTP,  guanosine triphosphate. ( Reference:  GOC: ai )", "conames": [{ "name": "GTP binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005525", "attributes": [], "id": "266", "contexts": { } , "evidences": ["Imported from database"], "value": "GTP binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005525"} ]} , { "annotation": "Interacts with,  and stops,  prevents or reduces the activity of a peroxidase. ( Reference:  GOC: bf GOC: PARL );", "conames": [{ "name": "peroxidase inhibitor activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0036479", "attributes": [], "id": "267", "contexts": { } , "evidences": ["Imported from database"], "value": "peroxidase inhibitor activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0036479"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "268", "contexts": { } , "evidences": ["Imported from database"], "value": "P62258", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62258"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "269", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13467", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13467"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "270", "contexts": { } , "evidences": ["Imported from database"], "value": "P46778", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P46778"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "271", "contexts": { } , "evidences": ["Imported from database"], "value": "O00429", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O00429"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "272", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9Y3D6", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9Y3D6"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "273", "contexts": { } , "evidences": ["Imported from database"], "value": "O95456", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95456"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "274", "contexts": { } , "evidences": ["Imported from database"], "value": "P07437", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P07437"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "275", "contexts": { } , "evidences": ["Imported from database"], "value": "Q6NTE8", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q6NTE8"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "276", "contexts": { } , "evidences": ["Imported from database"], "value": "Q5TA50", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q5TA50"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "277", "contexts": { } , "evidences": ["Imported from database"], "value": "Q5VVH5", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q5VVH5"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "278", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8ND71", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8ND71"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "279", "contexts": { } , "evidences": ["Imported from database"], "value": "Q86W54", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q86W54"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "280", "contexts": { } , "evidences": ["Imported from database"], "value": "Q99708", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q99708"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "281", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8NFW8", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8NFW8"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "282", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9H496", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9H496"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "283", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9BTP7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9BTP7"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "284", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9BSD3", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9BSD3"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "285", "contexts": { } , "evidences": ["Imported from database"], "value": "P23497", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P23497"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "286", "contexts": { } , "evidences": ["Imported from database"], "value": "P30084", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P30084"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "287", "contexts": { } , "evidences": ["Imported from database"], "value": "O95990", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95990"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "288", "contexts": { } , "evidences": ["Imported from database"], "value": "P33981", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P33981"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "289", "contexts": { } , "evidences": ["Imported from database"], "value": "P31751", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P31751"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "290", "contexts": { } , "evidences": ["Imported from database"], "value": "P11308", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P11308"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "291", "contexts": { } , "evidences": ["Imported from database"], "value": "P42679", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P42679"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "292", "contexts": { } , "evidences": ["Imported from database"], "value": "Q16670", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q16670"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "293", "contexts": { } , "evidences": ["Imported from database"], "value": "Q08E93", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q08E93"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "294", "contexts": { } , "evidences": ["Imported from database"], "value": "Q14195", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q14195"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "295", "contexts": { } , "evidences": ["Imported from database"], "value": "P62888", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62888"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "296", "contexts": { } , "evidences": ["Imported from database"], "value": "P62891", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62891"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "297", "contexts": { } , "evidences": ["Imported from database"], "value": "P62269", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62269"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "298", "contexts": { } , "evidences": ["Imported from database"], "value": "P62841", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62841"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "299", "contexts": { } , "evidences": ["Imported from database"], "value": "P15880", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P15880"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "300", "contexts": { } , "evidences": ["Imported from database"], "value": "P62249", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62249"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "301", "contexts": { } , "evidences": ["Imported from database"], "value": "P46821-PRO_0000018605", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P46821-PRO_0000018605"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "302", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9NWZ8", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9NWZ8"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "303", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9H7L9", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9H7L9"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "304", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9P209", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9P209"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "305", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9ULZ0", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9ULZ0"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "306", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9NQU5", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9NQU5"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "307", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9Y6A4", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9Y6A4"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "308", "contexts": { } , "evidences": ["Imported from database"], "value": "P62280", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62280"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "309", "contexts": { } , "evidences": ["Imported from database"], "value": "P23396", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P23396"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "310", "contexts": { } , "evidences": ["Imported from database"], "value": "P05141", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P05141"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "311", "contexts": { } , "evidences": ["Imported from database"], "value": "Q96PY6", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q96PY6"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "312", "contexts": { } , "evidences": ["Imported from database"], "value": "P10636-7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P10636-7"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "313", "contexts": { } , "evidences": ["Imported from database"], "value": "O76075", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O76075"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "314", "contexts": { } , "evidences": ["Imported from database"], "value": "P12235", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P12235"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "315", "contexts": { } , "evidences": ["Imported from database"], "value": "O43247", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O43247"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "316", "contexts": { } , "evidences": ["Imported from database"], "value": "Q16543", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q16543"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "317", "contexts": { } , "evidences": ["Imported from database"], "value": "P41220", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P41220"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "318", "contexts": { } , "evidences": ["Imported from database"], "value": "O95817", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95817"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "319", "contexts": { } , "evidences": ["Imported from database"], "value": "O95400", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95400"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "320", "contexts": { } , "evidences": ["Imported from database"], "value": "P61020", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61020"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "321", "contexts": { } , "evidences": ["Imported from database"], "value": "O75581", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O75581"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "322", "contexts": { } , "evidences": ["Imported from database"], "value": "P60953", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P60953"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "323", "contexts": { } , "evidences": ["Imported from database"], "value": "P10415-1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P10415-1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "324", "contexts": { } , "evidences": ["Imported from database"], "value": "Q14155-3", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q14155-3"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "325", "contexts": { } , "evidences": ["Imported from database"], "value": "P39054", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P39054"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "326", "contexts": { } , "evidences": ["Imported from database"], "value": "P49674", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P49674"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "327", "contexts": { } , "evidences": ["Imported from database"], "value": "P48730-1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P48730-1"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "328", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9H4B7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9H4B7"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "329", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9Y6M4", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9Y6M4"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "330", "contexts": { } , "evidences": ["Imported from database"], "value": "P10636-4", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P10636-4"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "331", "contexts": { } , "evidences": ["Imported from database"], "value": "Q99962", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q99962"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "332", "contexts": { } , "evidences": ["Imported from database"], "value": "P49207", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P49207"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "333", "contexts": { } , "evidences": ["Imported from database"], "value": "Q99469", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q99469"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "334", "contexts": { } , "evidences": ["Imported from database"], "value": "P31948", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P31948"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "335", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8IU85", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8IU85"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "336", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9UL15", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9UL15"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "337", "contexts": { } , "evidences": ["Imported from database"], "value": "Q96MW1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q96MW1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "338", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8NA70", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8NA70"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "339", "contexts": { } , "evidences": ["Imported from database"], "value": "A4UGR9", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "A4UGR9"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "340", "contexts": { } , "evidences": ["Imported from database"], "value": "P24844", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P24844"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "341", "contexts": { } , "evidences": ["Imported from database"], "value": "Q7L804", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q7L804"} ]} , { "annotation": "Created:  1994-10-01; Modified:  2016-01-20; Version:  188", "conames": [{ "name": "PARK1", "isPreferred": "false"} , { "name": "Non-A4 component of amyloid precursor", "isPreferred": "false"} , { "name": "NACP", "isPreferred": "false"} , { "name": "Non-A beta component of AD amyloid", "isPreferred": "false"} , { "name": "Alpha-synuclein", "isPreferred": "true"} , { "name": "SNCA", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "P37840", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "62"} ], "id": "342", "contexts": { "context": { "id": 15} } , "evidences": ["Imported from database"], "value": "Alpha-synuclein", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENST00000420646"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000426955"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000421485"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000422238"} , { "elementOf": "ENSEMBL", "accession": "ENST00000336904"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000343683"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000145335"} , { "elementOf": "ENSEMBL", "accession": "ENST00000618500"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000378442"} , { "elementOf": "ENSEMBL", "accession": "ENST00000394986"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000378440"} , { "elementOf": "ENSEMBL", "accession": "ENST00000345009"} , { "elementOf": "ENSEMBL", "accession": "ENST00000394989"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000396241"} , { "elementOf": "UNIPROTKB", "accession": "P37840"} , { "elementOf": "ENSEMBL", "accession": "ENST00000505199"} , { "elementOf": "ENSEMBL", "accession": "ENST00000508895"} , { "elementOf": "ENSEMBL", "accession": "ENST00000506244"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000378437"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000338345"} , { "elementOf": "ENSEMBL", "accession": "ENST00000394991"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000484044"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH SNCAIP]", "conames": [{ "name": "PMID: 15728840", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15728840", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[Ubiquitin,  SNCA protein,  human,  EC 2.3.2.27 parkin protein,  SNCAIP protein,  human,  Nerve Tissue Proteins,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  Synucleins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Recombinant Fusion Proteins,  alpha-Synuclein,  Carrier Proteins,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Parkin mediates nonclassical,  proteasomal-independent ubiquitination of synphilin-1:  implications for Lewy body formation."} , { "attrname": "Abstract", "value": "It is widely accepted that the familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD)-linked gene product,  parkin,  functions as a ubiquitin ligase involved in protein turnover via the ubiquitin-proteasome system. Substrates ubiquitinated by parkin are hence thought to be destined for proteasomal degradation. Because we demonstrated previously that parkin interacts with and ubiquitinates synphilin-1,  we initially expected synphilin-1 degradation to be enhanced in the presence of parkin. Contrary to our expectation,  we found that synphilin-1 is normally ubiquitinated by parkin in a nonclassical,  proteasomal-independent manner that involves lysine 63 (K63)-linked polyubiquitin chain formation. Parkin-mediated degradation of synphilin-1 occurs appreciably only at an unusually high parkin to synphilin-1 expression ratio or when primed for lysine 48 (K48)-linked ubiquitination. In addition we found that parkin-mediated ubiquitination of proteins within Lewy-body-like inclusions formed by the coexpression of synphilin-1,  alpha-synuclein,  and parkin occurs predominantly via K63 linkages and that the formation of these inclusions is enhanced by K63-linked ubiquitination. Our results suggest that parkin is a dual-function ubiquitin ligase and that K63-linked ubiquitination of synphilin-1 by parkin may be involved in the formation of Lewy body inclusions associated with PD. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Cell Line,  Gene Expression,  Humans,  Nerve Tissue Proteins,  Lewy Bodies,  Proteasome Endopeptidase Complex,  Synucleins,  Kidney,  Recombinant Fusion Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Transfection,  Lysine,  Protein Processing,  Post-Translational,  Catalysis,  alpha-Synuclein,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Kah Leong Lim,  Katherine C M Chew,  Jeanne M M Tan,  Cheng Wang,  Kenny K K Chung,  Yi Zhang,  Yuji Tanaka,  Wanli Smith,  Simone Engelender,  Christopher A Ross,  Valina L Dawson,  Ted M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH SNCAIP]"} ], "id": "343", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15728840", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15728840"} , { "elementOf": "DOI", "accession": "10.1523\/JNEUROSCI.4474-04.2005"} ]} , { "annotation": "[VARIANTS PARK2 GLU-56 AND TYR-212]", "conames": [{ "name": "PMID: 12056932", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12056932", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Nerve Tissue Proteins,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Molecular findings in familial Parkinson disease in Spain."} , { "attrname": "Abstract", "value": "Several genetic errors in alpha-synuclein (Park1) and ubiquitin carboxyl-terminal-hydrolase L1(Park5) genes cause autosomal dominant familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Mutations in the parkin gene (Park2) are the major cause of autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. To analyze the clinical and molecular data of 19 Spanish kindreds (13 with recessive,  4 with dominant,  and 2 with uncertain inheritance) who have familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We searched for the previously described mutations in Park1 and Park5 genes and for new or described mutations in Park2. We used single-strand conformation polymorphism,  direct sequencing,  and restriction digestion of polymerase chain reaction (PCR)-amplified genomic DNA for this study. None of these families have either Park1 or Park5 mutations. We found 5 different mutations in Park2 gene in 5 of the families with recessive inheritance. To our knowledge,  2 of these mutations,  V56E and C212Y,  have not been previously reported. The other mutations found (deletion of exons 3 and 5 and 225delA) have been described in other ethnic groups. Heterozygous carriers of a single Park2 mutation either were asymptomatic or developed clinical symptoms in late adulthood or after brief exposure to haloperidol therapy. Mutations in Park2 gene account for 38% of the families with recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism in Spain. We found 2 cases of simple heterozygous Park2 mutation carriers that developed clinical symptoms,  either in late adulthood or after brief exposure to <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>izing agents. Thus,  hereditary <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> has more variable clinical phenotype and molecular defects than previously thought since heterozygous mutations could be a risk factor for <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Blotting,  Southern,  Humans,  Male,  Nerve Tissue Proteins,  Synucleins,  Heterozygote Detection,  Spain,  Polymorphism,  Single-Stranded Conformational,  Phenotype,  DNA Mutational Analysis,  Pedigree,  Adult,  Female,  Thiolester Hydrolases,  Aged,  Polymorphism,  Single Nucleotide,  Mutation,  Ubiquitin Thiolesterase,  alpha-Synuclein,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Janet Hoenicka,  Ldice Vidal,  Blas Morales,  Israel Ampuero,  F Javier Jimnez-Jimnez,  Jose Berciano,  Teodoro del Ser,  Adriano Jimnez,  Pedro G Ruz,  Justo G de Ybenes]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 GLU-56 AND TYR-212]"} ], "id": "344", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12056932", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.59.6.966"} , { "elementOf": "NLM", "accession": "12056932"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  ISOPRENYLATION AT CYS-220]", "conames": [{ "name": "PMID: 19261853", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19261853", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[K848JZ4886 Cysteine,  FTI 277,  AE28F7PNPL Methionine,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Ubiquitin C-terminal hydrolase-L1 (UCH-L1) is linked to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) and memory and is selectively expressed in neurons at high levels. Its expression pattern suggests a function distinct from that of its widely expressed homolog UCH-L3. We report here that,  in contrast to UCH-L3,  UCH-L1 exists in a membrane-associated form (UCH-L1(M)) in addition to the commonly studied soluble form. C-terminal farnesylation promotes the association of UCH-L1 with cellular membranes,  including the endoplasmic reticulum. The amount of UCH-L1(M) in transfected cells is shown to correlate with the intracellular level of alpha-synuclein,  a protein whose accumulation is associated with neurotoxicity and the development of PD. Reduction of UCH-L1(M) in cell culture models of alpha-synuclein toxicity by treatment with a farnesyltransferase inhibitor (FTI-277) reduces alpha-synuclein levels and increases cell viability. Proteasome function is not affected by UCH-L1(M),  suggesting that it may negatively regulate the lysosomal degradation of alpha-synuclein. Therefore,  inhibition of UCH-L1 farnesylation may be a therapeutic strategy for slowing the progression of PD and related synucleinopathies. "} , { "attrname": "MeSH", "value": "[Prenylation,  Brain,  Cell Membrane,  Cysteine,  Neurons,  Humans,  Intracellular Membranes,  Methionine,  Cercopithecus aethiops,  Endoplasmic Reticulum,  Proteasome Endopeptidase Complex,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Cell Line,  Tumor,  Protein Binding,  Mice,  COS Cells,  Ubiquitin Thiolesterase,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Zhihua Liu,  Robin K Meray,  Tom N Grammatopoulos,  Ross A Fredenburg,  Mark R Cookson,  Yichin Liu,  Todd Logan,  Peter T Lansbury]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  ISOPRENYLATION AT CYS-220]"} ], "id": "345", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19261853", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19261853"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0806474106"} ]} , { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18]", "conames": [{ "name": "PMID: 12408865", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12408865", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cell"} , { "attrname": "Chemical", "value": "[Snca protein,  rat,  SNCA protein,  human,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Nerve Tissue Proteins,  Synucleins,  alpha-Synuclein,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> susceptibility."} , { "attrname": "Abstract", "value": "The assumption that each enzyme expresses a single enzymatic activity in vivo is challenged by the linkage of the neuronal enzyme ubiquitin C-terminal hydrolase-L1 (UCH-L1) to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). UCH-L1,  especially those variants linked to higher susceptibility to PD,  causes the accumulation of alpha-synuclein in cultured cells,  an effect that cannot be explained by its recognized hydrolase activity. UCH-L1 is shown here to exhibit a second,  dimerization-dependent,  ubiquityl ligase activity. A polymorphic variant of UCH-L1 that is associated with decreased PD risk (S18Y) has reduced ligase activity but comparable hydrolase activity as the wild-type enzyme. Thus,  the ligase activity as well as the hydrolase activity of UCH-L1 may play a role in proteasomal protein degradation,  a critical process for neuronal health. "} , { "attrname": "MeSH", "value": "[Rabbits,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Models,  Molecular,  Rats,  Gene Dosage,  Nerve Tissue Proteins,  Synucleins,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synaptic Vesicles,  Animals,  Transfection,  Ligases,  Thiolester Hydrolases,  Brain Chemistry,  Mutation,  COS Cells,  Dimerization,  Ubiquitin Thiolesterase,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Yichin Liu,  Lara Fallon,  Hilal A Lashuel,  Zhihua Liu,  Peter T Lansbury]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18]"} ], "id": "346", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12408865", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12408865"} , { "elementOf": "DOI", "accession": "10.1016\/S0092-8674(02)01012-7"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]", "conames": [{ "name": "PMID: 11431533", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11431533", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[EC 2.3.2.23 UBE2L3 protein,  human,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  SNCA protein,  human,  Ubiquitins,  EC 2.3.2.27 parkin protein,  Nerve Tissue Proteins,  Detergents,  Synucleins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  alpha-Synuclein,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Ubiquitination of a new form of alpha-synuclein by parkin from human brain:  implications for <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin. Rare inherited forms of PD are caused by autosomal dominant mutations in alpha-synuclein or by autosomal recessive mutations in parkin,  an E3 ubiquitin ligase. We hypothesized that these two gene products interact functionally,  namely,  that parkin ubiquitinates alpha-synuclein normally and that this process is altered in autosomal recessive PD. We have now identified a protein complex in normal human brain that includes parkin as the E3 ubiquitin ligase,  UbcH7 as its associated E2 ubiquitin conjugating enzyme,  and a new 22-kilodalton glycosylated form of alpha-synuclein (alphaSp22) as its substrate. In contrast to normal parkin,  mutant parkin associated with autosomal recessive PD failed to bind alphaSp22. In an in vitro ubiquitination assay,  alphaSp22 was modified by normal but not mutant parkin into polyubiquitinated,  high molecular weight species. Accordingly,  alphaSp22 accumulated in a non-ubiquitinated form in parkin-deficient PD brains. We conclude that alphaSp22 is a substrate for parkin's ubiquitin ligase activity in normal human brain and that loss of parkin function causes pathological alphaSp22 accumulation. These findings demonstrate a critical biochemical reaction between the two PD-linked gene products and suggest that this reaction underlies the accumulation of ubiquitinated alpha-synuclein in conventional PD. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Brain,  Cell Line,  Humans,  Substrate Specificity,  Glycosylation,  Nerve Tissue Proteins,  Lewy Bodies,  Mutation,  Missense,  Detergents,  Synucleins,  Freezing,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Ligases,  Ubiquitins,  Brain Stem,  Ubiquitin-Conjugating Enzymes,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[H Shimura,  M G Schlossmacher,  N Hattori,  M P Frosch,  A Trockenbacher,  R Schneider,  Y Mizuno,  K S Kosik,  D J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]"} ], "id": "347", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11431533", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1060627"} , { "elementOf": "NLM", "accession": "11431533"} ]} , { "annotation": "[VARIANTS ASN-167; TRP-366 AND LEU-380]", "conames": [{ "name": "PMID: 10965160", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10965160", "attributes": [{ "attrname": "JOURNAL_REF", "value": "European neurology"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Polymorphisms of the parkin gene in sporadic Parkinson's disease among Chinese in Taiwan."} , { "attrname": "Abstract", "value": "The role of genetics in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  previously controversial,  is now documented by several studies. A major breakthrough has been the discovery of two single-gene defects in familial PD. A single base pair change at position 209 from G to A (G209A) in the fourth exon of the alpha-synuclein gene has been identified in cases of autosomal dominant familial PD. Mutations in the Parkin gene can induce autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. A polymorphism of R\/W366 in the Parkin gene was found to be associated with a protective factor for sporadic PD. We surveyed the polymorphisms of the Parkin gene,  including S\/N167,  R\/W366 and V\/L380,  in 92 cases of sporadic PD and 98 nonaffected individuals in Taiwanese Chinese. The allele frequencies of these polymorphisms are not significantly different between PD and nonaffected controls. We conclude that polymorphisms of the Parkin gene,  S\/N167,  R\/W366,  V\/L380,  are not genetic factors for sporadic PD among Chinese in Taiwan. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Risk Factors,  Male,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Ubiquitin-Protein Ligases,  Ligases,  Alleles,  Taiwan,  Aged,  80 and over,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[C J Hu,  S M Sung,  H C Liu,  C C Lee,  C H Tsai,  J G Chang]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS ASN-167; TRP-366 AND LEU-380]"} ], "id": "348", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10965160", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10965160"} , { "elementOf": "DOI", "accession": "10.1159\/000008203"} ]} , { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 ARG-240; CYS-256; TRP-275 AND ASN-415,  MUTAGENESIS OF CYS-337; CYS-421 AND CYS-431]", "conames": [{ "name": "PMID: 11590439", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11590439", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature medicine"} , { "attrname": "Chemical", "value": "[Snca protein,  rat,  SNCA protein,  human,  Sncaip protein,  rat,  Ubiquitins,  EC 2.3.2.27 parkin protein,  SNCAIP protein,  human,  Nerve Tissue Proteins,  Synucleins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  alpha-Synuclein,  EC 6.- Ligases,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Parkin ubiquitinates the alpha-synuclein-interacting protein,  synphilin-1:  implications for Lewy-body formation in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons and the presence of intracytoplasmic-ubiquitinated inclusions (Lewy bodies). Mutations in alpha-synuclein (A53T,  A30P) and parkin cause familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Both these proteins are found in Lewy bodies. The absence of Lewy bodies in patients with parkin mutations suggests that parkin might be required for the formation of Lewy bodies. Here we show that parkin interacts with and ubiquitinates the alpha-synuclein-interacting protein,  synphilin-1. Co-expression of alpha-synuclein,  synphilin-1 and parkin result in the formation of Lewy-body-like ubiquitin-positive cytosolic inclusions. We further show that familial-linked mutations in parkin disrupt the ubiquitination of synphilin-1 and the formation of the ubiquitin-positive inclusions. These results provide a molecular basis for the ubiquitination of Lewy-body-associated proteins and link parkin and alpha-synuclein in a common pathogenic mechanism through their interaction with synphilin-1. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Rats,  Glycosylation,  Nerve Tissue Proteins,  Lewy Bodies,  Synucleins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Animals,  Mutagenesis,  Ligases,  Ubiquitins,  alpha-Synuclein,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[K K Chung,  Y Zhang,  K L Lim,  Y Tanaka,  H Huang,  J Gao,  C A Ross,  V L Dawson,  T M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 ARG-240; CYS-256; TRP-275 AND ASN-415,  MUTAGENESIS OF CYS-337; CYS-421 AND CYS-431]"} ], "id": "349", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11590439", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NM1001-1144"} , { "elementOf": "NLM", "accession": "11590439"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "350", "contexts": { } , "evidences": ["Imported from database"], "value": "P53350", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P53350"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "351", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8N2I9", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8N2I9"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "352", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8TC29", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8TC29"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "353", "contexts": { } , "evidences": ["Imported from database"], "value": "Q7L592", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q7L592"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "354", "contexts": { } , "evidences": ["Imported from database"], "value": "Q86V25", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q86V25"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "355", "contexts": { } , "evidences": ["Imported from database"], "value": "Q12972", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q12972"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "356", "contexts": { } , "evidences": ["Imported from database"], "value": "O00214", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O00214"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "357", "contexts": { } , "evidences": ["Imported from database"], "value": "O14625", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14625"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "358", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9H6T3", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9H6T3"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "359", "contexts": { } , "evidences": ["Imported from database"], "value": "P31946", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P31946"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "360", "contexts": { } , "evidences": ["Imported from database"], "value": "P61983", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61983"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "361", "contexts": { } , "evidences": ["Imported from database"], "value": "P27348", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P27348"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "362", "contexts": { } , "evidences": ["Imported from database"], "value": "-", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "-"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "363", "contexts": { } , "evidences": ["Imported from database"], "value": "P12369", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P12369"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "364", "contexts": { } , "evidences": ["Imported from database"], "value": "P31324", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P31324"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "365", "contexts": { } , "evidences": ["Imported from database"], "value": "O14966", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14966"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "366", "contexts": { } , "evidences": ["Imported from database"], "value": "O95140", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95140"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "367", "contexts": { } , "evidences": ["Imported from database"], "value": "P39053", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P39053"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "368", "contexts": { } , "evidences": ["Imported from database"], "value": "Q811U4", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q811U4"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "369", "contexts": { } , "evidences": ["Imported from database"], "value": "P04350", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P04350"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "370", "contexts": { } , "evidences": ["Imported from database"], "value": "O60313", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O60313"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "371", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9BUF5", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9BUF5"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "372", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9BVA1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9BVA1"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "373", "contexts": { } , "evidences": ["Imported from database"], "value": "P63000", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P63000"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "374", "contexts": { } , "evidences": ["Imported from database"], "value": "P02687", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P02687"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "375", "contexts": { } , "evidences": ["Imported from database"], "value": "O95295", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95295"} ]} , { "annotation": "Created:  2004-10-11; Modified:  2016-01-20; Version:  163", "conames": [{ "name": "PRKN", "isPreferred": "false"} , { "name": "Parkinson <span style=\"background-color: yellow\"><b>disease<\/b><\/span> protein 2", "isPreferred": "false"} , { "name": "Parkinson juvenile <span style=\"background-color: yellow\"><b>disease<\/b><\/span> protein 2", "isPreferred": "false"} , { "name": "E3 ubiquitin-protein ligase parkin", "isPreferred": "true"} , { "name": "PARK2", "isPreferred": "false"} , { "name": "Parkin", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "O60260", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "96"} ], "id": "376", "contexts": { "context": { "id": 383} } , "evidences": ["Imported from database"], "value": "E3 ubiquitin-protein ligase parkin", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENSP00000343589"} , { "elementOf": "ENSEMBL", "accession": "ENST00000338468"} , { "elementOf": "ENSEMBL", "accession": "ENST00000366898"} , { "elementOf": "ENSEMBL", "accession": "ENST00000366897"} , { "elementOf": "ENSEMBL", "accession": "ENST00000366896"} , { "elementOf": "ENSEMBL", "accession": "ENST00000366894"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000185345"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000355865"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000355863"} , { "elementOf": "ENSEMBL", "accession": "ENST00000479615"} , { "elementOf": "UNIPROTKB", "accession": "O60260"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000434414"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000355862"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000355860"} ]} , { "annotation": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION,  INTERACTION WITH PINK1,  CHARACTERIZATION OF VARIANTS PARK ASN-415 AND ASP-430]", "conames": [{ "name": "PMID: 19966284", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19966284", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Ionophores]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "PINK1-dependent recruitment of Parkin to mitochondria in mitophagy."} , { "attrname": "Abstract", "value": "Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1) and PARK2\/Parkin mutations cause autosomal recessive forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Upon a loss of mitochondrial membrane potential (DeltaPsi(m)) in human cells,  cytosolic Parkin has been reported to be recruited to mitochondria,  which is followed by a stimulation of mitochondrial autophagy. Here,  we show that the relocation of Parkin to mitochondria induced by a collapse of DeltaPsi(m) relies on PINK1 expression and that overexpression of WT but not of mutated PINK1 causes Parkin translocation to mitochondria,  even in cells with normal DeltaPsi(m). We also show that once at the mitochondria,  Parkin is in close proximity to PINK1,  but we find no evidence that Parkin catalyzes PINK1 ubiquitination or that PINK1 phosphorylates Parkin. However,  co-overexpression of Parkin and PINK1 collapses the normal tubular mitochondrial network into mitochondrial aggregates and\/or large perinuclear clusters,  many of which are surrounded by autophagic vacuoles. Our results suggest that Parkin,  together with PINK1,  modulates mitochondrial trafficking,  especially to the perinuclear region,  a subcellular area associated with autophagy. Thus by impairing this process,  mutations in either Parkin or PINK1 may alter mitochondrial turnover which,  in turn,  may cause the accumulation of defective mitochondria and,  ultimately,  neurodegeneration in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Autophagy,  Ionophores,  Protein Transport,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Mitochondria,  Protein Kinases,  Microtubules,  Membrane Potential,  Mitochondrial,  Protein Binding]"} , { "attrname": "AUTHORS", "value": "[Cristofol Vives-Bauza,  Chun Zhou,  Yong Huang,  Mei Cui,  Rosa L A de Vries,  Jiho Kim,  Jessica May,  Maja Aleksandra Tocilescu,  Wencheng Liu,  Han Seok Ko,  Jordi Magran,  Darren J Moore,  Valina L Dawson,  Regis Grailhe,  Ted M Dawson,  Chenjian Li,  Kim Tieu,  Serge Przedborski]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION,  INTERACTION WITH PINK1,  CHARACTERIZATION OF VARIANTS PARK ASN-415 AND ASP-430]"} ], "id": "377", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19966284", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19966284"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0911187107"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 17846173", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17846173", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of cell biology"} , { "attrname": "Chemical", "value": "[120904-94-1 Polyubiquitin,  EC 3.5.1.98 HDAC6 protein,  human,  EC 3.5.1.98 Histone Deacetylases,  EC 3.1.2.- PARK7 protein,  mouse,  EC 2.3.2.27 parkin protein,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.6.4.2 Dyneins,  EC 3.1.2.- Protein Deglycase DJ-1,  EC 3.5.1.98 Hdac6 protein,  mouse,  EC 3.1.2.- PARK7 protein,  human,  EC 1.11.1.15 Peroxiredoxins]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6."} , { "attrname": "Abstract", "value": "Sequestration of misfolded proteins into pericentriolar inclusions called aggresomes is a means that cells use to minimize misfolded protein-induced cytotoxicity. However,  the molecular mechanism by which misfolded proteins are recruited to aggresomes remains unclear. Mutations in the E3 ligase parkin cause autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> that is devoid of Lewy bodies,  which are similar to aggresomes. Here,  we report that parkin cooperates with heterodimeric E2 enzyme UbcH13\/Uev1a to mediate K63-linked polyubiquitination of misfolded DJ-1. K63-linked polyubiquitination of misfolded DJ-1 serves as a signal for interaction with histone deacetylase 6,  an adaptor protein that binds the dynein-dynactin complex. Through this interaction,  misfolded DJ-1 is linked to the dynein motor and transported to aggresomes. Furthermore,  fibroblasts lacking parkin display deficits in targeting misfolded DJ-1 to aggresomes. Our findings reveal a signaling role for K63-linked polyubiquitination in dynein-mediated transport,  identify parkin as a key regulator in the recruitment of misfolded DJ-1 to aggresomes,  and have important implications regarding the biogenesis of Lewy bodies. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  Histone Deacetylases,  Lewy Bodies,  Polyubiquitin,  Organelles,  Protein Folding,  Peroxiredoxins,  Ubiquitin-Protein Ligases,  Protein Deglycase DJ-1,  Animals,  Protein Binding,  Mice,  Protein Processing,  Post-Translational,  Mutation,  Dyneins]"} , { "attrname": "AUTHORS", "value": "[James A Olzmann,  Lian Li,  Maksim V Chudaev,  Jue Chen,  Francisco A Perez,  Richard D Palmiter,  Lih-Shen Chin]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION]"} ], "id": "378", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17846173", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1083\/JCB.200611128"} , { "elementOf": "NLM", "accession": "17846173"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ASN-211; ARG-240; ASN-280 AND GLU-328]", "conames": [{ "name": "PMID: 20404107", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20404107", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of cell biology"} , { "attrname": "Chemical", "value": "[Solvents,  Uncoupling Agents,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  Mitochondrial Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Receptors,  Cytoplasmic and Nuclear,  Recombinant Fusion Proteins,  Biomarkers,  YOW8V9698H Dimethyl Sulfoxide,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Fluorescent Dyes]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a prevalent neurodegenerative disorder. Recent identification of genes linked to familial forms of PD such as Parkin and PINK1 (PTEN-induced putative kinase 1) has revealed that ubiquitylation and mitochondrial integrity are key factors in <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis. However,  the exact mechanism underlying the functional interplay between Parkin-catalyzed ubiquitylation and PINK1-regulated mitochondrial quality control remains an enigma. In this study,  we show that PINK1 is rapidly and constitutively degraded under steady-state conditions in a mitochondrial membrane potential-dependent manner and that a loss in mitochondrial membrane potential stabilizes PINK1 mitochondrial accumulation. Furthermore,  PINK1 recruits Parkin from the cytoplasm to mitochondria with low membrane potential to initiate the autophagic degradation of damaged mitochondria. Interestingly,  the ubiquitin ligase activity of Parkin is repressed in the cytoplasm under steady-state conditions; however,  PINK1-dependent mitochondrial localization liberates the latent enzymatic activity of Parkin. Some pathogenic mutations of PINK1 and Parkin interfere with the aforementioned events,  suggesting an etiological importance. These results provide crucial insight into the pathogenic mechanisms of PD. "} , { "attrname": "MeSH", "value": "[Solvents,  Uncoupling Agents,  Humans,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Mitochondrial Proteins,  Receptors,  Cytoplasmic and Nuclear,  Recombinant Fusion Proteins,  Mice,  Knockout,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Mitochondria,  Animals,  Protein Kinases,  Membrane Potential,  Mitochondrial,  Biomarkers,  Fibroblasts,  Dimethyl Sulfoxide,  Mice,  HeLa Cells,  Fluorescent Dyes]"} , { "attrname": "AUTHORS", "value": "[Noriyuki Matsuda,  Shigeto Sato,  Kahori Shiba,  Kei Okatsu,  Keiko Saisho,  Clement A Gautier,  Yu-Shin Sou,  Shinji Saiki,  Sumihiro Kawajiri,  Fumiaki Sato,  Mayumi Kimura,  Masaaki Komatsu,  Nobutaka Hattori,  Keiji Tanaka]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ASN-211; ARG-240; ASN-280 AND GLU-328]"} ], "id": "379", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20404107", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20404107"} , { "elementOf": "DOI", "accession": "10.1083\/JCB.200910140"} ]} , { "annotation": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65]", "conames": [{ "name": "PMID: 24660806", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24660806", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Biochemical journal"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  452VLY9402 Serine,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65."} , { "attrname": "Abstract", "value": "We have previously reported that the <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated kinase PINK1 (PTEN-induced putative kinase 1) is activated by mitochondrial depolarization and stimulates the Parkin E3 ligase by phosphorylating Ser65 within its Ubl (ubiquitin-like) domain. Using phosphoproteomic analysis,  we identified a novel ubiquitin phosphopeptide phosphorylated at Ser65 that was enriched 14-fold in HEK (human embryonic kidney)-293 cells overexpressing wild-type PINK1 stimulated with the mitochondrial uncoupling agent CCCP (carbonyl cyanide m-chlorophenylhydrazone),  to activate PINK1,  compared with cells expressing kinase-inactive PINK1. Ser65 in ubiquitin lies in a similar motif to Ser65 in the Ubl domain of Parkin. Remarkably,  PINK1 directly phosphorylates Ser65 of ubiquitin invitro. We undertook a series of experiments that provide striking evidence that Ser65-phosphorylated ubiquitin (ubiquitinPhospho-Ser65) functions as a critical activator of Parkin. First,  we demonstrate that a fragment of Parkin lacking the Ubl domain encompassing Ser65 (?Ubl-Parkin) is robustly activated by ubiquitinPhospho-Ser65,  but not by non-phosphorylated ubiquitin. Secondly,  we find that the isolated Parkin Ubl domain phosphorylated at Ser65 (UblPhospho-Ser65) can also activate ?Ubl-Parkin similarly to ubiquitinPhospho-Ser65. Thirdly,  we establish that ubiquitinPhospho-Ser65,  but not non-phosphorylated ubiquitin or UblPhospho-Ser65,  activates full-length wild-type Parkin as well as the non-phosphorylatable S65A Parkin mutant. Fourthly,  we provide evidence that optimal activation of full-length Parkin E3 ligase is dependent on PINK1-mediated phosphorylation of both Parkin at Ser65 and ubiquitin at Ser65,  since only mutation of both proteins at Ser65 completely abolishes Parkin activation. In conclusion,  the findings of the present study reveal that PINK1 controls Parkin E3 ligase activity not only by phosphorylating Parkin at Ser65,  but also by phosphorylating ubiquitin at Ser65. We propose that phosphorylation of Parkin at Ser65 serves to prime the E3 ligase enzyme for activation by ubiquitinPhospho-Ser65,  suggesting that small molecules that mimic ubiquitinPhospho-Ser65 could hold promise as novel therapies for <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Ubiquitin-Protein Ligases,  Amino Acid Sequence,  Phosphorylation,  Protein Kinases,  Humans,  Serine,  HEK293 Cells,  Molecular Sequence Data]"} , { "attrname": "AUTHORS", "value": "[Agne Kazlauskaite,  Chandana Kondapalli,  Robert Gourlay,  David G Campbell,  Maria Stella Ritorto,  Kay Hofmann,  Dario R Alessi,  Axel Knebel,  Matthias Trost,  Miratul M K Muqit]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65]"} ], "id": "380", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24660806", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1042\/BJ20140334"} , { "elementOf": "NLM", "accession": "24660806"} ]} , { "annotation": "[STRUCTURE BY NMR OF 307-384 IN COMPLEX WITH ZINC IONS,  CHARACTERIZATION OF VARIANT PARK2 PRO-351,  MUTAGENESIS OF CYS-332 AND CYS-365,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 17360614", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17360614", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  J41CSQ7QDS Zinc,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Mutations in Parkin are one of the predominant hereditary factors found in patients suffering from autosomal recessive juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism. Parkin is a member of the E3 ubiquitin ligase family that is defined by a tripartite RING1-in-between-ring (IBR)-RING2 motif. In Parkin,  the IBR domain has been shown to augment binding of the E2 proteins UbcH7 and UbcH8,  and the subsequent ubiquitination of the proteins synphilin-1,  Sept5,  and SIM2. To facilitate our understanding of Parkin function,  the solution structure of the Parkin IBR domain was solved by using NMR spectroscopy. Folding of the IBR domain (residues M327-S378) was found to be zinc dependent,  and the structure reveals the domain forms a unique pair scissor-like and GAG knuckle-like zinc-binding sites,  different from other zinc-binding motifs such as the RING,  LIM,  PHD,  or B-box motifs. The N terminus of the IBR domain,  residues E307-E322,  is unstructured. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> causing mutation T351P causes global unfolding,  whereas the mutation R334C causes some structural rearrangement of the domain. In contrast,  the protein containing the mutation G328E appears to be properly folded. The structure of the Parkin IBR domain,  in combination with mutational data,  allows a model to be proposed where the IBR domain facilitates a close arrangement of the adjacent RING1 and RING2 domains to facilitate protein interactions and subsequent ubiquitination. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Protein Structure,  Tertiary,  Amino Acid Sequence,  Magnetic Resonance Spectroscopy,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Zinc,  Amino Acid Motifs,  Ubiquitin-Protein Ligases,  Sequence Alignment,  Protein Conformation,  Mutation,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[Steven A Beasley,  Ventzislava A Hristova,  Gary S Shaw]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 307-384 IN COMPLEX WITH ZINC IONS,  CHARACTERIZATION OF VARIANT PARK2 PRO-351,  MUTAGENESIS OF CYS-332 AND CYS-365,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "381", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17360614", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0610548104"} , { "elementOf": "NLM", "accession": "17360614"} ]} , { "annotation": "[FUNCTION,  ENZYME REGULATION]", "conames": [{ "name": "PMID: 24751536", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24751536", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of cell biology"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity."} , { "attrname": "Abstract", "value": "PINK1 kinase activates the E3 ubiquitin ligase Parkin to induce selective autophagy of damaged mitochondria. However,  it has been unclear how PINK1 activates and recruits Parkin to mitochondria. Although PINK1 phosphorylates Parkin,  other PINK1 substrates appear to activate Parkin,  as the mutation of all serine and threonine residues conserved between Drosophila and human,  including Parkin S65,  did not wholly impair Parkin translocation to mitochondria. Using mass spectrometry,  we discovered that endogenous PINK1 phosphorylated ubiquitin at serine 65,  homologous to the site phosphorylated by PINK1 in Parkin's ubiquitin-like domain. Recombinant TcPINK1 directly phosphorylated ubiquitin and phospho-ubiquitin activated Parkin E3 ubiquitin ligase activity in cell-free assays. In cells,  the phosphomimetic ubiquitin mutant S65D bound and activated Parkin. Furthermore,  expression of ubiquitin S65A,  a mutant that cannot be phosphorylated by PINK1,  inhibited Parkin translocation to damaged mitochondria. These results explain a feed-forward mechanism of PINK1-mediated initiation of Parkin E3 ligase activity. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Ubiquitin-Protein Ligases,  Cell Line,  Phosphorylation,  Animals,  Protein Kinases,  Humans,  Enzyme Activation,  Mutation,  Missense,  Drosophila melanogaster,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Lesley A Kane,  Michael Lazarou,  Adam I Fogel,  Yan Li,  Koji Yamano,  Shireen A Sarraf,  Soojay Banerjee,  Richard J Youle]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  ENZYME REGULATION]"} ], "id": "382", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24751536", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1083\/JCB.201402104"} , { "elementOf": "NLM", "accession": "24751536"} ]} , { "annotation": "[FUNCTION,  ENZYME REGULATION]", "conames": [{ "name": "PMID: 25527291", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "25527291", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[120904-94-1 Polyubiquitin,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  TAB2 protein,  human,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Endosomal Sorting Complexes Required for Transport,  EC 2.3.2.27 parkin protein,  EC 2.3.2.23 UBE2N protein,  human,  Mitochondrial Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 2.3.2.23 UBE2V1 protein,  human,  EC 3.4.19.12 Ubiquitin-Specific Proteases,  EC 2.3.2.23 CDC34 protein,  human,  Adaptor Proteins,  Signal Transducing,  TNF Receptor-Associated Factor 6,  EC 3.4.19.12 USP8 protein,  human,  EC 2.3.2.27 RNF31 protein,  human,  Phosphoproteins,  EC 3.4.- Endopeptidases,  EC 3.1.2.15 Usp30 protein,  human,  Transcription Factors,  EC 3.4.19.12 USP15 protein,  human,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2015"} , { "attrname": "AbstractHeader", "value": "Ubiquitin Ser65 phosphorylation affects ubiquitin structure,  chain assembly and hydrolysis."} , { "attrname": "Abstract", "value": "The protein kinase PINK1 was recently shown to phosphorylate ubiquitin (Ub) on Ser65,  and phosphoUb activates the E3 ligase Parkin allosterically. Here,  we show that PINK1 can phosphorylate every Ub in Ub chains. Moreover,  Ser65 phosphorylation alters Ub structure,  generating two conformations in solution. A crystal structure of the major conformation resembles Ub but has altered surface properties. NMR reveals a second phosphoUb conformation in which ?5-strand slippage retracts the C-terminal tail by two residues into the Ub core. We further show that phosphoUb has no effect on E1-mediated E2 charging but can affect discharging of E2 enzymes to form polyUb chains. Notably,  UBE2R1- (CDC34),  UBE2N\/UBE2V1- (UBC13\/UEV1A),  TRAF6- and HOIP-mediated chain assembly is inhibited by phosphoUb. While Lys63-linked poly-phosphoUb is recognized by the TAB2 NZF Ub binding domain (UBD),  10 out of 12 deubiquitinases (DUBs),  including USP8,  USP15 and USP30,  are impaired in hydrolyzing phosphoUb chains. Hence,  Ub phosphorylation has repercussions for ubiquitination and deubiquitination cascades beyond Parkin activation and may provide an independent layer of regulation in the Ub system. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Phosphorylation,  Endosomal Sorting Complexes Required for Transport,  Allosteric Regulation,  Humans,  Protein Multimerization,  Serine,  Mitochondrial Proteins,  Polyubiquitin,  Hydrolysis,  Ubiquitin-Protein Ligases,  Ubiquitin-Specific Proteases,  Adaptor Proteins,  Signal Transducing,  TNF Receptor-Associated Factor 6,  Ubiquitination,  Phosphoproteins,  Thiolester Hydrolases,  Transcription Factors,  Ubiquitin-Conjugating Enzymes,  Endopeptidases,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Tobias Wauer,  Kirby N Swatek,  Jane L Wagstaff,  Christina Gladkova,  Jonathan N Pruneda,  Martin A Michel,  Malte Gersch,  Christopher M Johnson,  Stefan M V Freund,  David Komander]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  ENZYME REGULATION]"} ], "id": "383", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 25527291", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "25527291"} , { "elementOf": "DOI", "accession": "10.15252\/EMBJ.201489847"} ]} , { "annotation": "[INTERACTION WITH PINK1]", "conames": [{ "name": "PMID: 20798600", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20798600", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Autophagy"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  RNA,  Small Interfering,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "The PINK1\/Parkin-mediated mitophagy is compromised by PD-associated mutations."} , { "attrname": "Abstract", "value": "Mitochondrial dysfunction is an early sign of many neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s. Very recently,  two <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) associated genes,  PINK1 and Parkin,  were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy). PINK1 kinase activity is needed for prompt and efficient Parkin recruitment to impaired mitochondria. PD-associated Parkin mutations interfere with the process of mitophagy at distinct steps. Here we show that whole mitochondria are turned over via macroautophagy. Moreover,  <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated PINK1 mutations also compromise the selective degradation of depolarized mitochondria. This may be due to the decreased physical binding activity of PD-linked PINK1 mutations to Parkin. Thus,  PINK1 mutations abrogate autophagy of impaired mitochondria upstream of Parkin. In addition to compromised PINK1 kinase activity,  reduced binding of PINK1 to Parkin leads to failure in Parkin mitochondrial translocation,  resulting in the accumulation of damaged mitochondria,  which may contribute to <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Mitochondria,  Animals,  Protein Kinases,  Humans,  HEK293 Cells,  RNA,  Small Interfering,  HeLa Cells,  Mutation,  Autophagy]"} , { "attrname": "AUTHORS", "value": "[Sven Geisler,  Kira M Holmstrm,  Angela Treis,  Diana Skujat,  Stephanie S Weber,  Fabienne C Fiesel,  Philipp J Kahle,  Wolfdieter Springer]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH PINK1]"} ], "id": "384", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20798600", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20798600"} , { "elementOf": "DOI", "accession": "10.4161\/AUTO.6.7.13286"} ]} , { "annotation": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65 AND TRP-403]", "conames": [{ "name": "PMID: 24784582", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24784582", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 2.7.- Protein Kinases,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  17885-08-4 Phosphoserine]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "Ubiquitin is phosphorylated by PINK1 to activate parkin."} , { "attrname": "Abstract", "value": "PINK1 (PTEN induced putative kinase 1) and PARKIN (also known as PARK2) have been identified as the causal genes responsible for hereditary recessive early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism. PINK1 is a Ser\/Thr kinase that specifically accumulates on depolarized mitochondria,  whereas parkin is an E3 ubiquitin ligase that catalyses ubiquitin transfer to mitochondrial substrates. PINK1 acts as an upstream factor for parkin and is essential both for the activation of latent E3 parkin activity and for recruiting parkin onto depolarized mitochondria. Recently,  mechanistic insights into mitochondrial quality control mediated by PINK1 and parkin have been revealed,  and PINK1-dependent phosphorylation of parkin has been reported. However,  the requirement of PINK1 for parkin activation was not bypassed by phosphomimetic parkin mutation,  and how PINK1 accelerates the E3 activity of parkin on damaged mitochondria is still obscure. Here we report that ubiquitin is the genuine substrate of PINK1. PINK1 phosphorylated ubiquitin at Ser?65 both in vitro and in cells,  and a Ser?65 phosphopeptide derived from endogenous ubiquitin was only detected in cells in the presence of PINK1 and following a decrease in mitochondrial membrane potential. Unexpectedly,  phosphomimetic ubiquitin bypassed PINK1-dependent activation of a phosphomimetic parkin mutant in cells. Furthermore,  phosphomimetic ubiquitin accelerates discharge of the thioester conjugate formed by UBCH7 (also known as UBE2L3) and ubiquitin (UBCH7?ubiquitin) in the presence of parkin in vitro,  indicating that it acts allosterically. The phosphorylation-dependent interaction between ubiquitin and parkin suggests that phosphorylated ubiquitin unlocks autoinhibition of the catalytic cysteine. Our results show that PINK1-dependent phosphorylation of both parkin and ubiquitin is sufficient for full activation of parkin E3 activity. These findings demonstrate that phosphorylated ubiquitin is a parkin activator. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Phosphorylation,  Humans,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Mitochondria,  Ubiquitination,  Animals,  Protein Kinases,  Membrane Potential,  Mitochondrial,  Fibroblasts,  Mice,  Enzyme Activation,  HeLa Cells,  Mutation,  Phosphoserine]"} , { "attrname": "AUTHORS", "value": "[Fumika Koyano,  Kei Okatsu,  Hidetaka Kosako,  Yasushi Tamura,  Etsu Go,  Mayumi Kimura,  Yoko Kimura,  Hikaru Tsuchiya,  Hidehito Yoshihara,  Takatsugu Hirokawa,  Toshiya Endo,  Edward A Fon,  Jean-Franois Trempe,  Yasushi Saeki,  Keiji Tanaka,  Noriyuki Matsuda]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  PHOSPHORYLATION AT SER-65,  UBIQUITIN-BINDING,  ENZYME REGULATION,  MUTAGENESIS OF SER-65 AND TRP-403]"} ], "id": "385", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24784582", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE13392"} , { "elementOf": "NLM", "accession": "24784582"} ]} , { "annotation": "[INTERACTION WITH BAG4; BAG5; HSPA1L; HSPA1A AND HSPA8]", "conames": [{ "name": "PMID: 24270810", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24270810", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Adaptor Proteins,  Signal Transducing,  TOMM7 protein,  human,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  HSPA1L protein,  human,  EC 2.7.- Protein Kinases,  RNA,  Small Interfering,  Mitochondrial Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  HSP70 Heat-Shock Proteins,  BAG4 protein,  human]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy."} , { "attrname": "Abstract", "value": "An increasing body of evidence points to mitochondrial dysfunction as a contributor to the molecular pathogenesis of neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s such as <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Recent studies of the <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> associated genes PINK1 (ref. 2) and parkin (PARK2,  ref. 3) indicate that they may act in a quality control pathway preventing the accumulation of dysfunctional mitochondria. Here we elucidate regulators that have an impact on parkin translocation to damaged mitochondria with genome-wide small interfering RNA (siRNA) screens coupled to high-content microscopy. Screening yielded gene candidates involved in diverse cellular processes that were subsequently validated in low-throughput assays. This led to characterization of TOMM7 as essential for stabilizing PINK1 on the outer mitochondrial membrane following mitochondrial damage. We also discovered that HSPA1L (HSP70 family member) and BAG4 have mutually opposing roles in the regulation of parkin translocation. The screens revealed that SIAH3,  found to localize to mitochondria,  inhibits PINK1 accumulation after mitochondrial insult,  reducing parkin translocation. Overall,  our screens provide a rich resource to understand mitochondrial quality control. "} , { "attrname": "MeSH", "value": "[Multigene Family,  Reproducibility of Results,  Mitochondrial Membranes,  HCT116 Cells,  Humans,  Mitochondrial Proteins,  Mitochondrial Degradation,  Protein Transport,  Membrane Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Adaptor Proteins,  Signal Transducing,  Mitochondria,  Protein Kinases,  RNA Interference,  HEK293 Cells,  RNA,  Small Interfering,  HeLa Cells,  Genome,  Human,  HSP70 Heat-Shock Proteins]"} , { "attrname": "AUTHORS", "value": "[Samuel A Hasson,  Lesley A Kane,  Koji Yamano,  Chiu-Hui Huang,  Danielle A Sliter,  Eugen Buehler,  Chunxin Wang,  Sabrina M Heman-Ackah,  Tara Hessa,  Rajarshi Guha,  Scott E Martin,  Richard J Youle]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH BAG4; BAG5; HSPA1L; HSPA1A AND HSPA8]"} ], "id": "386", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24270810", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE12748"} , { "elementOf": "NLM", "accession": "24270810"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-65,  FUNCTION,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 23754282", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23754282", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Ubiquitin,  K848JZ4886 Cysteine,  EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  Esters,  EC 2.7.- Protein Kinases,  Proton Ionophores,  452VLY9402 Serine,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "Parkin-catalyzed ubiquitin-ester transfer is triggered by PINK1-dependent phosphorylation."} , { "attrname": "Abstract", "value": "PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism. PINK1 is a mitochondrial Ser\/Thr kinase,  whereas Parkin functions as an E3 ubiquitin ligase. Under steady-state conditions,  Parkin localizes to the cytoplasm where its E3 activity is repressed. A decrease in mitochondrial membrane potential triggers Parkin E3 activity and recruits it to depolarized mitochondria for ubiquitylation of mitochondrial substrates. The molecular basis for how the E3 activity of Parkin is re-established by mitochondrial damage has yet to be determined. Here we provide in vitro biochemical evidence for ubiquitin-thioester formation on Cys-431 of recombinant Parkin. We also report that Parkin forms a ubiquitin-ester following a decrease in mitochondrial membrane potential in cells,  and that this event is essential for substrate ubiquitylation. Importantly,  the Parkin RING2 domain acts as a transthiolation or acyl-transferring domain rather than an E2-recruiting domain. Furthermore,  formation of the ubiquitin-ester depends on PINK1 phosphorylation of Parkin Ser-65. A phosphorylation-deficient mutation completely inhibited formation of the Parkin ubiquitin-ester intermediate,  whereas phosphorylation mimics,  such as Ser to Glu substitution,  enabled partial formation of the intermediate irrespective of Ser-65 phosphorylation. We propose that PINK1-dependent phosphorylation of Parkin leads to the ubiquitin-ester transfer reaction of the RING2 domain,  and that this is an essential step in Parkin activation. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Cysteine,  Phosphorylation,  Embryo,  Mammalian,  Humans,  Serine,  Substrate Specificity,  Esters,  Immunoblotting,  Ubiquitination,  HEK293 Cells,  Membrane Potential,  Mitochondrial,  Fibroblasts,  Binding Sites,  Biocatalysis,  Cells,  Cultured,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Proton Ionophores,  Mice,  Knockout,  Ubiquitin-Protein Ligases,  Animals,  Protein Kinases,  Models,  Biological,  Mice,  HeLa Cells]"} , { "attrname": "AUTHORS", "value": "[Masahiro Iguchi,  Yuki Kujuro,  Kei Okatsu,  Fumika Koyano,  Hidetaka Kosako,  Mayumi Kimura,  Norihiro Suzuki,  Shinichiro Uchiyama,  Keiji Tanaka,  Noriyuki Matsuda]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-65,  FUNCTION,  SUBCELLULAR LOCATION]"} ], "id": "387", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23754282", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "23754282"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M113.467530"} ]} , { "annotation": "[FUNCTION,  COMPONENT OF A COMPLEX COMPOSED OF PARK2; PARK7 AND PINK1,  SUBCELLULAR LOCATION,  UBIQUITINATION,  CHARACTERIZATION OF VARIANT PARK2 PRO-42]", "conames": [{ "name": "PMID: 19229105", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19229105", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of clinical investigation"} , { "attrname": "Chemical", "value": "[Ubiquitin,  SNCA protein,  human,  EC 2.3.2.27 parkin protein,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  EC 3.1.2.- PARK7 protein,  human,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  RNA,  Messenger,  alpha-Synuclein,  EC 3.1.2.- Protein Deglycase DJ-1]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Parkin,  PINK1,  and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation."} , { "attrname": "Abstract", "value": "Mutations in PARKIN,  pten-induced putative kinase 1 (PINK1),  and DJ-1 are individually linked to autosomal recessive early-onset familial forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). Although mutations in these genes lead to the same <span style=\"background-color: yellow\"><b>disease<\/b><\/span> state,  the functional relationships between them and how their respective <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated mutations cause PD are largely unknown. Here,  we show that Parkin,  PINK1,  and DJ-1 formed a complex (termed PPD complex) to promote ubiquitination and degradation of Parkin substrates,  including Parkin itself and Synphilin-1 in neuroblastoma cells and human brain lysates. Genetic ablation of either Pink1 or Dj-1 resulted in reduced ubiquitination of endogenous Parkin as well as decreased degradation and increased accumulation of aberrantly expressed Parkin substrates. Expression of PINK1 enhanced Parkin-mediated degradation of heat shock-induced misfolded protein. In contrast,  PD-pathogenic Parkin and PINK1 mutations showed reduced ability to promote degradation of Parkin substrates. This study identified a functional ubiquitin E3 ligase complex consisting of PD-associated Parkin,  PINK1,  and DJ-1 to promote degradation of un-\/misfolded proteins and suggests that their PD-pathogenic mutations impair E3 ligase activity of the complex,  which may constitute a mechanism underlying PD pathogenesis. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Humans,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  Neuroblastoma,  Cytosol,  Genes,  Recessive,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Protein Deglycase DJ-1,  Mitochondria,  Ubiquitination,  Gene Deletion,  Protein Denaturation,  Cell Line,  Tumor,  RNA,  Messenger,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Hui Xiong,  Danling Wang,  Linan Chen,  Yeun Su Choo,  Hong Ma,  Chengyuan Tang,  Kun Xia,  Wei Jiang,  Ze'ev Ronai,  Xiaoxi Zhuang,  Zhuohua Zhang]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  COMPONENT OF A COMPLEX COMPOSED OF PARK2; PARK7 AND PINK1,  SUBCELLULAR LOCATION,  UBIQUITINATION,  CHARACTERIZATION OF VARIANT PARK2 PRO-42]"} ], "id": "388", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19229105", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1172\/JCI37617"} , { "elementOf": "NLM", "accession": "19229105"} ]} , { "annotation": "[FUNCTION IN MITOPHAGY,  INTERACTION WITH MFN2,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 23620051", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23620051", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  EC 3.6.1.- GTP Phosphohydrolases,  EC 2.7.- Protein Kinases,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.6.1.- Mfn2 protein,  mouse]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria."} , { "attrname": "Abstract", "value": "Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> factors,  the mitochondrial kinase PINK1 (PTEN-induced putative kinase protein 1; PTEN is phosphatase and tensin homolog) and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and the identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes and in Parkin-deficient Drosophila heart tubes,  causing dilated cardiomyopathy. Thus,  Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  GTP Phosphohydrolases,  Myocytes,  Cardiac,  Phosphorylation,  Humans,  Molecular Sequence Data,  Autophagy,  Ubiquitin-Protein Ligases,  Mitochondria,  Ubiquitination,  Animals,  Protein Kinases,  Mice,  Mutant Strains,  HEK293 Cells,  Mitochondria,  Heart,  Fibroblasts,  Cardiomyopathies,  Mice,  Drosophila melanogaster]"} , { "attrname": "AUTHORS", "value": "[Yun Chen,  Gerald W Dorn]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN MITOPHAGY,  INTERACTION WITH MFN2,  SUBCELLULAR LOCATION]"} ], "id": "389", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23620051", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1231031"} , { "elementOf": "NLM", "accession": "23620051"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH FBXO7]", "conames": [{ "name": "PMID: 23933751", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23933751", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature neuroscience"} , { "attrname": "Chemical", "value": "[F-Box Proteins,  MAP1LC3A protein,  human,  EC 2.3.2.27 parkin protein,  FBXO7 protein,  human,  Microtubule-Associated Proteins,  RNA,  Small Interfering,  Proton Ionophores,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy."} , { "attrname": "Abstract", "value": "Compelling evidence indicates that two autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> genes,  PINK1 (PARK6) and Parkin (PARK2),  cooperate to mediate the autophagic clearance of damaged mitochondria (mitophagy). Mutations in the F-box domain-containing protein Fbxo7 (encoded by PARK15) also cause early-onset autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  by an unknown mechanism. Here we show that Fbxo7 participates in mitochondrial maintenance through direct interaction with PINK1 and Parkin and acts in Parkin-mediated mitophagy. Cells with reduced Fbxo7 expression showed deficiencies in translocation of Parkin to mitochondria,  ubiquitination of mitofusin 1 and mitophagy. In Drosophila,  ectopic overexpression of Fbxo7 rescued loss of Parkin,  supporting a functional relationship between the two proteins. <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-causing mutations in Fbxo7 interfered with this process,  emphasizing the importance of mitochondrial dysfunction in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis. "} , { "attrname": "MeSH", "value": "[Animals,  Genetically Modified,  Drosophila,  Humans,  Cells,  Cultured,  Microtubule-Associated Proteins,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Male,  Proton Ionophores,  Mitochondrial Degradation,  Protein Transport,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  F-Box Proteins,  Mitochondria,  Ubiquitination,  Animals,  Time Factors,  Fertility,  Cell Line,  Tumor,  Fibroblasts,  Female,  RNA,  Small Interfering,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Victoria S Burchell,  David E Nelson,  Alvaro Sanchez-Martinez,  Marta Delgado-Camprubi,  Rachael M Ivatt,  Joe H Pogson,  Suzanne J Randle,  Selina Wray,  Patrick A Lewis,  Henry Houlden,  Andrey Y Abramov,  John Hardy,  Nicholas W Wood,  Alexander J Whitworth,  Heike Laman,  Helene Plun-Favreau]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH FBXO7]"} ], "id": "390", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23933751", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NN.3489"} , { "elementOf": "NLM", "accession": "23933751"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "391", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13509", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13509"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "392", "contexts": { } , "evidences": ["Imported from database"], "value": "P62136", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62136"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "393", "contexts": { } , "evidences": ["Imported from database"], "value": "P62140", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62140"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "394", "contexts": { } , "evidences": ["Imported from database"], "value": "Q53EL6", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q53EL6"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "395", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13637", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13637"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "396", "contexts": { } , "evidences": ["Imported from database"], "value": "O15027", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O15027"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "397", "contexts": { } , "evidences": ["Imported from database"], "value": "A2AIX1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "A2AIX1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "398", "contexts": { } , "evidences": ["Imported from database"], "value": "O00429-3", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O00429-3"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "399", "contexts": { } , "evidences": ["Imported from database"], "value": "P20108", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P20108"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "400", "contexts": { } , "evidences": ["Imported from database"], "value": "P30048", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P30048"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "401", "contexts": { } , "evidences": ["Imported from database"], "value": "P26038", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P26038"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "402", "contexts": { } , "evidences": ["Imported from database"], "value": "P00634", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P00634"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "403", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13158", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13158"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "404", "contexts": { } , "evidences": ["Imported from database"], "value": "O14640-2", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14640-2"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "405", "contexts": { } , "evidences": ["Imported from database"], "value": "P21796", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P21796"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "406", "contexts": { } , "evidences": ["Imported from database"], "value": "P52564", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P52564"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "407", "contexts": { } , "evidences": ["Imported from database"], "value": "O14976", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14976"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "408", "contexts": { } , "evidences": ["Imported from database"], "value": "O14733", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14733"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "409", "contexts": { } , "evidences": ["Imported from database"], "value": "P46734", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P46734"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "410", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9WVI9", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9WVI9"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "411", "contexts": { } , "evidences": ["Imported from database"], "value": "O14641", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O14641"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "412", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8IVP1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8IVP1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "413", "contexts": { } , "evidences": ["Imported from database"], "value": "Q92997", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q92997"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "414", "contexts": { } , "evidences": ["Imported from database"], "value": "Q63481", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q63481"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "415", "contexts": { } , "evidences": ["Imported from database"], "value": "Q58A65", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q58A65"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "416", "contexts": { } , "evidences": ["Imported from database"], "value": "Q91YQ1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q91YQ1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "417", "contexts": { } , "evidences": ["Imported from database"], "value": "Q14155", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q14155"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "418", "contexts": { } , "evidences": ["Imported from database"], "value": "Q61081", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q61081"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "419", "contexts": { } , "evidences": ["Imported from database"], "value": "P17046", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P17046"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "420", "contexts": { } , "evidences": ["Imported from database"], "value": "P13473", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P13473"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "421", "contexts": { } , "evidences": ["Imported from database"], "value": "Q32KD4", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q32KD4"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "422", "contexts": { } , "evidences": ["Imported from database"], "value": "INTACT: EBI-6312987", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "INTACT: EBI-6312987"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "423", "contexts": { } , "evidences": ["Imported from database"], "value": "P61586", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61586"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "424", "contexts": { } , "evidences": ["Imported from database"], "value": "P53355", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P53355"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "425", "contexts": { } , "evidences": ["Imported from database"], "value": "P42684", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P42684"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "426", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13469", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13469"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "427", "contexts": { } , "evidences": ["Imported from database"], "value": "Q8N6T3-2", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q8N6T3-2"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "428", "contexts": { } , "evidences": ["Imported from database"], "value": "Q62848", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q62848"} ]} , { "annotation": "Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. ( Reference:  GOC: mah NIF_Subcellular: sao1045389829 )", "conames": [{ "name": "mitochondrial membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031966", "attributes": [], "id": "429", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031966"} ]} , { "annotation": "A compound membranous cytoplasmic organelle of eukaryotic cells,  consisting of flattened,  ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes,  appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum,  secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle,  while in invertebrates and plants,  where they are known usually as dictyosomes,  there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins,  and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function:  cis,  in the vicinity of the cis face,  trans,  in the vicinity of the trans face,  and medial,  lying between the cis and trans regions. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "Golgi ribbon", "isPreferred": "false"} , { "name": "Golgi complex", "isPreferred": "true"} , { "name": "Golgi", "isPreferred": "false"} , { "name": "Golgi apparatus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005794", "attributes": [], "id": "430", "contexts": { } , "evidences": ["Imported from database"], "value": "Golgi complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005794"} ]} , { "annotation": "That part of a multicellular organism outside the cells proper,  usually taken to be outside the plasma membranes,  and occupied by fluid. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "intercellular space", "isPreferred": "false"} , { "name": "extracellular space", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005615", "attributes": [], "id": "431", "contexts": { } , "evidences": ["Imported from database"], "value": "extracellular space", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005615"} ]} , { "annotation": "All of the contents of a dendrite,  excluding the surrounding plasma membrane. ( Reference:  GOC: mah )", "conames": [{ "name": "dendritic cytoplasm", "isPreferred": "true"} , { "name": "dendrite cytoplasm", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032839", "attributes": [], "id": "432", "contexts": { } , "evidences": ["Imported from database"], "value": "dendrite cytoplasm", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032839"} ]} , { "annotation": "The gel-like material,  with considerable fine structure,  that lies in the matrix space,  or lumen,  of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and,  in some organisms,  the enzymes concerned with fatty acid oxidation. ( Reference:  GOC: as ISBN: 0198506732 )", "conames": [{ "name": "mitochondrial stroma", "isPreferred": "false"} , { "name": "mitochondrial matrix", "isPreferred": "true"} , { "name": "mitochondrial lumen", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005759", "attributes": [], "id": "433", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial lumen", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031980"} , { "elementOf": "GO", "accession": "GO: 0005759"} ]} , { "annotation": "The portion of the cell soma (cell body) that excludes the nucleus. ( Reference:  GOC: jl )", "conames": [{ "name": "perikaryon", "isPreferred": "true"} , { "name": "cell soma cytoplasm", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043204", "attributes": [], "id": "434", "contexts": { } , "evidences": ["Imported from database"], "value": "perikaryon", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043204"} ]} , { "annotation": "The outer,  i.e. cytoplasm-facing,  lipid bilayer of the mitochondrial envelope. ( Reference:  GOC: ai )", "conames": [{ "name": "outer mitochondrial membrane", "isPreferred": "true"} , { "name": "mitochondrial outer membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005741", "attributes": [], "id": "435", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial outer membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005741"} ]} , { "annotation": "A cellular component that forms a specialized region of connection between two or more cells or between a cell and the extracellular matrix. At a cell junction,  anchoring proteins extend through the plasma membrane to link cytoskeletal proteins in one cell to cytoskeletal proteins in neighboring cells or to proteins in the extracellular matrix. ( Reference:  GOC: mah http: \/\/www.vivo.colostate.edu\/hbooks\/cmb\/cells\/pmemb\/junctions_a.html ISBN: 0198506732 )", "conames": [{ "name": "cell junction", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030054", "attributes": [], "id": "436", "contexts": { } , "evidences": ["Imported from database"], "value": "cell junction", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030054"} ]} , { "annotation": "The external (cytoplasmic) face of the mitochondrial outer membrane. ( Reference:  GOC: mah )", "conames": [{ "name": "external side of mitochondrial outer membrane", "isPreferred": "true"} , { "name": "external side of mitochondrial envelope", "isPreferred": "false"} , { "name": "cytosolic side of mitochondrial outer membrane", "isPreferred": "true"} , { "name": "cytoplasmic side of mitochondrial outer membrane", "isPreferred": "true"} , { "name": "external leaflet of mitochondrial outer membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032473", "attributes": [], "id": "437", "contexts": { } , "evidences": ["Imported from database"], "value": "external side of mitochondrial outer membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032473"} ]} , { "annotation": "A semiautonomous,  self replicating organelle that occurs in varying numbers,  shapes,  and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. ( Reference:  GOC: giardia ISBN: 0198506732 )", "conames": [{ "name": "mitochondria", "isPreferred": "true"} , { "name": "mitochondrion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005739", "attributes": [], "id": "438", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondria", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005739"} ]} , { "annotation": "A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases,  most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. ( Reference:  GOC: mah ISBN: 0198506732 )", "conames": [{ "name": "lysosome", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005764", "attributes": [], "id": "439", "contexts": { } , "evidences": ["Imported from database"], "value": "lysosome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005764"} ]} , { "annotation": "A discrete intracellular part formed of aggregated molecules such as proteins or other biopolymers. ( Reference:  GOC: mah PMID: 11121744 )", "conames": [{ "name": "inclusion body", "isPreferred": "true"} , { "name": "cellular inclusion", "isPreferred": "false"} , { "name": "neuronal cytoplasmic inclusion", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016234", "attributes": [], "id": "440", "contexts": { } , "evidences": ["Imported from database"], "value": "inclusion body", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016234"} ]} , { "annotation": "The lipid bilayer surrounding a synaptic vesicle. ( Reference:  GOC: mah )", "conames": [{ "name": "synaptic vesicle membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030672", "attributes": [], "id": "441", "contexts": { } , "evidences": ["Imported from database"], "value": "synaptic vesicle membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030672"} ]} , { "annotation": "A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes,  also simply called exosomes,  have a diameter of about 40-100 nm. ( Reference:  GOC: BHF GOC: mah PMID: 15908444 PMID: 17641064 PMID: 19442504 PMID: 19498381 PMID: 22418571 PMID: 24009894 )", "conames": [{ "name": "extracellular exosome", "isPreferred": "true"} , { "name": "extracellular vesicular exosome", "isPreferred": "true"} , { "name": "exosome", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070062", "attributes": [], "id": "442", "contexts": { } , "evidences": ["Imported from database"], "value": "exosome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070062"} ]} , { "annotation": "Any of the small (10-200 nm),  heterogeneous,  highly dynamic,  sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. ( Reference:  PMID: 16645198 PMID: 20044567 )", "conames": [{ "name": "membrane raft", "isPreferred": "true"} , { "name": "GEM domain", "isPreferred": "false"} , { "name": "lipid raft", "isPreferred": "true"} , { "name": "glycolipid-enriched membrane domain", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045121", "attributes": [], "id": "443", "contexts": { } , "evidences": ["Imported from database"], "value": "lipid raft", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045121"} ]} , { "annotation": "Terminal inflated portion of the axon,  containing the specialized apparatus necessary to release neurotransmitters. The axon terminus is considered to be the whole region of thickening and the terminal bouton is a specialized region of it. ( Reference:  GOC: dph GOC: mc GOC: nln PMID: 10218156 PMID: 8409967 )", "conames": [{ "name": "bouton", "isPreferred": "true"} , { "name": "synaptic bouton", "isPreferred": "true"} , { "name": "presynaptic bouton", "isPreferred": "true"} , { "name": "terminal bouton", "isPreferred": "true"} , { "name": "terminal button", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043195", "attributes": [], "id": "444", "contexts": { } , "evidences": ["Imported from database"], "value": "bouton", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043195"} ]} , { "annotation": "Any vesicle associated with the Golgi complex and involved in mediating transport within the Golgi or between the Golgi and other parts of the cell. ( Reference:  GOC: mah )", "conames": [{ "name": "Golgi-associated vesicle", "isPreferred": "true"} , { "name": "Golgi vesicle", "isPreferred": "false"} , { "name": "vesicular component", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005798", "attributes": [], "id": "445", "contexts": { } , "evidences": ["Imported from database"], "value": "Golgi-associated vesicle", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005798"} ]} , { "annotation": "A prolongation or process extending from a nerve cell,  e.g. an axon or dendrite. ( Reference:  GOC: jl http: \/\/www.cogsci.princeton.edu\/~wn\/ )", "conames": [{ "name": "neuron protrusion", "isPreferred": "true"} , { "name": "nerve fiber", "isPreferred": "false"} , { "name": "neuron projection", "isPreferred": "true"} , { "name": "neuron process", "isPreferred": "true"} , { "name": "neurite", "isPreferred": "false"} , { "name": "neuronal cell projection", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043005", "attributes": [], "id": "446", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron process", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043005"} ]} , { "annotation": "The portion of a neuron that includes the nucleus,  but excludes cell projections such as axons and dendrites. ( Reference:  GOC: go_curators )", "conames": [{ "name": "neuronal cell body", "isPreferred": "true"} , { "name": "neuron cell body", "isPreferred": "true"} , { "name": "neuronal cell soma", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043025", "attributes": [], "id": "447", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron cell body", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043025"} ]} , { "annotation": "All of the contents of a cell excluding the plasma membrane and nucleus,  but including other subcellular structures. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "cytoplasm", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005737", "attributes": [], "id": "448", "contexts": { } , "evidences": ["Imported from database"], "value": "cytoplasm", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005737"} ]} , { "annotation": "A membrane-bounded organelle to which materials ingested by endocytosis are delivered. ( Reference:  ISBN: 0198506732 PMID: 19696797 )", "conames": [{ "name": "endosome", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005768", "attributes": [], "id": "449", "contexts": { } , "evidences": ["Imported from database"], "value": "endosome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005768"} ]} , { "annotation": "The inner,  i.e. lumen-facing,  lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. ( Reference:  GOC: ai )", "conames": [{ "name": "inner mitochondrial membrane", "isPreferred": "true"} , { "name": "mitochondrial inner membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005743", "attributes": [], "id": "450", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial inner membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005743"} ]} , { "annotation": "An intracellular macromolecular complex containing both protein and RNA molecules. ( Reference:  GOC: krc GOC: vesicles )", "conames": [{ "name": "RNA-protein complex", "isPreferred": "false"} , { "name": "protein-RNA complex", "isPreferred": "false"} , { "name": "ribonucleoprotein complex", "isPreferred": "false"} , { "name": "RNP", "isPreferred": "false"} , { "name": "ribonucleoprotein", "isPreferred": "false"} , { "name": "intracellular ribonucleoprotein complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030529", "attributes": [], "id": "451", "contexts": { } , "evidences": ["Imported from database"], "value": "intracellular ribonucleoprotein complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030529"} ]} , { "annotation": "The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum,  from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination. ( Reference:  GOC: vw ISBN: 0815316194 )", "conames": [{ "name": "trans Golgi network", "isPreferred": "true"} , { "name": "late Golgi", "isPreferred": "false"} , { "name": "trans face", "isPreferred": "false"} , { "name": "Golgi trans-face", "isPreferred": "false"} , { "name": "TGN", "isPreferred": "true"} , { "name": "maturing face", "isPreferred": "false"} , { "name": "Golgi trans face", "isPreferred": "false"} , { "name": "trans-Golgi network", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005802", "attributes": [], "id": "452", "contexts": { } , "evidences": ["Imported from database"], "value": "TGN", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005802"} ]} , { "annotation": "The irregular network of unit membranes,  visible only by electron microscopy,  that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels,  which are often expanded into slitlike cavities called cisternae. The ER takes two forms,  rough (or granular),  with ribosomes adhering to the outer surface,  and smooth (with no ribosomes attached). ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "ER", "isPreferred": "true"} , { "name": "endoplasmic reticulum", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005783", "attributes": [], "id": "453", "contexts": { } , "evidences": ["Imported from database"], "value": "ER", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005783"} ]} , { "annotation": "A vesicle formed of membrane or protein,  found in the cytoplasm of a cell. ( Reference:  GOC: mah )", "conames": [{ "name": "cytoplasmic vesicle", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031410", "attributes": [], "id": "454", "contexts": { } , "evidences": ["Imported from database"], "value": "cytoplasmic vesicle", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031410"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein autoubiquitination. ( Reference:  GOC: rb GOC: TermGenie PMID: 24069405 )", "conames": [{ "name": "up regulation of protein self-ubiquitination", "isPreferred": "true"} , { "name": "activation of protein autoubiquitinylation", "isPreferred": "false"} , { "name": "up regulation of protein autoubiquitination", "isPreferred": "true"} , { "name": "upregulation of protein autoubiquitinylation", "isPreferred": "true"} , { "name": "positive regulation of protein auto-ubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein auto-ubiquitinylation", "isPreferred": "true"} , { "name": "activation of protein auto-ubiquitination", "isPreferred": "false"} , { "name": "positive regulation of protein auto-ubiquitinylation", "isPreferred": "true"} , { "name": "upregulation of protein autoubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein self-ubiquitinylation", "isPreferred": "true"} , { "name": "upregulation of protein auto-ubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein self-ubiquitination", "isPreferred": "true"} , { "name": "positive regulation of protein autoubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein autoubiquitinylation", "isPreferred": "true"} , { "name": "activation of protein auto-ubiquitinylation", "isPreferred": "false"} , { "name": "up regulation of protein auto-ubiquitinylation", "isPreferred": "true"} , { "name": "upregulation of protein self-ubiquitinylation", "isPreferred": "true"} , { "name": "positive regulation of protein self-ubiquitinylation", "isPreferred": "true"} , { "name": "positive regulation of protein autoubiquitinylation", "isPreferred": "true"} , { "name": "up regulation of protein auto-ubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein auto-ubiquitination", "isPreferred": "true"} , { "name": "upregulation of protein self-ubiquitination", "isPreferred": "true"} , { "name": "activation of protein autoubiquitination", "isPreferred": "false"} , { "name": "activation of protein self-ubiquitinylation", "isPreferred": "false"} , { "name": "activation of protein self-ubiquitination", "isPreferred": "false"} , { "name": "up regulation of protein self-ubiquitinylation", "isPreferred": "true"} , { "name": "up regulation of protein autoubiquitinylation", "isPreferred": "true"} , { "name": "upregulation of protein auto-ubiquitinylation", "isPreferred": "true"} , { "name": "positive regulation of protein self-ubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein autoubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902499", "attributes": [], "id": "455", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of protein autoubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902499"} ]} , { "annotation": "A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. ( Reference:  GOC: dph GOC: ef )", "conames": [{ "name": "regulation of excitatory post-synaptic membrane potential", "isPreferred": "true"} , { "name": "excitatory postsynaptic potential", "isPreferred": "true"} , { "name": "regulation of EPSP", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060079", "attributes": [], "id": "456", "contexts": { } , "evidences": ["Imported from database"], "value": "excitatory postsynaptic potential", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060079"} ]} , { "annotation": "The chemical reactions and pathways involving GTP,  guanosine triphosphate. ( Reference:  GOC: go_curators )", "conames": [{ "name": "GTP metabolism", "isPreferred": "true"} , { "name": "GTP metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046039", "attributes": [], "id": "457", "contexts": { } , "evidences": ["Imported from database"], "value": "GTP metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046039"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of glutamatergic synaptic transmission,  the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. ( Reference:  GOC: ai )", "conames": [{ "name": "regulation of synaptic transmission,  glutamatergic", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051966", "attributes": [], "id": "458", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synaptic transmission,  glutamatergic", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051966"} ]} , { "annotation": "The control of viability and duration in the adult phase of the life-cycle. ( Reference:  GOC: ems )", "conames": [{ "name": "determination of adult lifespan", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008340", "attributes": [], "id": "459", "contexts": { } , "evidences": ["Imported from database"], "value": "determination of adult lifespan", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008340"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution,  and replication of the mitochondrial genome as well as synthesis of new mitochondrial components. ( Reference:  GOC: dph GOC: jl GOC: mah GOC: sgd_curators PMID: 9786946 )", "conames": [{ "name": "mitochondrion organization", "isPreferred": "true"} , { "name": "mitochondrion organisation", "isPreferred": "true"} , { "name": "mitochondrion organization and biogenesis", "isPreferred": "false"} , { "name": "mitochondria organization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007005", "attributes": [], "id": "460", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondria organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007005"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of neuroblast proliferation. ( Reference:  GO_REF: 0000058 GOC: PARL GOC: rl GOC: TermGenie PMID: 21168496 )", "conames": [{ "name": "regulation of neuroblast proliferation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902692", "attributes": [], "id": "461", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of neuroblast proliferation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902692"} ]} , { "annotation": "Any intracellular signal transduction in which the signal is passed on within the cell via calcium ions. ( Reference:  GOC: signaling )", "conames": [{ "name": "calcium-mediated signalling", "isPreferred": "true"} , { "name": "calcium signaling", "isPreferred": "true"} , { "name": "calcium-mediated signaling", "isPreferred": "true"} , { "name": "calcium signalling", "isPreferred": "true"} , { "name": "calcium ion signaling", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019722", "attributes": [], "id": "462", "contexts": { } , "evidences": ["Imported from database"], "value": "calcium signaling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019722"} ]} , { "annotation": "Any series of molecular signals in which a small monomeric GTPase relays one or more of the signals. ( Reference:  GOC: mah )", "conames": [{ "name": "small GTPase-mediated signal transduction", "isPreferred": "true"} , { "name": "small GTPase mediated signal transduction", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007264", "attributes": [], "id": "463", "contexts": { } , "evidences": ["Imported from database"], "value": "small GTPase mediated signal transduction", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007264"} ]} , { "annotation": "The specific behavior of an organism in response to a novel environment or stimulus. ( Reference:  GOC: BHF GOC: pr PMID: 11682103 PMID: 9767169 )", "conames": [{ "name": "exploratory behavior", "isPreferred": "true"} , { "name": "exploration behaviour", "isPreferred": "true"} , { "name": "open-field behavior", "isPreferred": "false"} , { "name": "exploration behavior", "isPreferred": "true"} , { "name": "exploratory behaviour", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035640", "attributes": [], "id": "464", "contexts": { } , "evidences": ["Imported from database"], "value": "exploration behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035640"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of MAP kinase activity. ( Reference:  GOC: dph GOC: go_curators )", "conames": [{ "name": "up regulation of MAPK", "isPreferred": "true"} , { "name": "positive regulation of mitogen activated protein kinase", "isPreferred": "true"} , { "name": "stimulation of MAPK", "isPreferred": "false"} , { "name": "positive regulation of MAP kinase activity", "isPreferred": "true"} , { "name": "upregulation of MAPK", "isPreferred": "true"} , { "name": "up-regulation of MAPK", "isPreferred": "true"} , { "name": "positive regulation of mitogen-activated protein kinase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043406", "attributes": [], "id": "465", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of MAPK", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043406"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle exocytosis. ( Reference:  GOC: obol )", "conames": [{ "name": "regulation of synaptic vesicle exocytosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000300", "attributes": [], "id": "466", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synaptic vesicle exocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000300"} ]} , { "annotation": "The process in which a signal is passed on to downstream components within the cell,  which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. ( Reference:  GOC: bf GOC: jl GOC: signaling ISBN: 3527303782 )", "conames": [{ "name": "intracellular protein kinase cascade", "isPreferred": "false"} , { "name": "signal transduction via intracellular signaling cascade", "isPreferred": "false"} , { "name": "protein kinase cascade", "isPreferred": "false"} , { "name": "intracellular signaling pathway", "isPreferred": "false"} , { "name": "signal transmission via intracellular cascade", "isPreferred": "false"} , { "name": "intracellular signal transduction", "isPreferred": "true"} , { "name": "intracellular signal transduction pathway", "isPreferred": "false"} , { "name": "intracellular signaling chain", "isPreferred": "true"} , { "name": "intracellular signaling cascade", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035556", "attributes": [], "id": "467", "contexts": { } , "evidences": ["Imported from database"], "value": "intracellular signaling chain", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007243"} , { "elementOf": "GO", "accession": "GO: 0035556"} , { "elementOf": "GO", "accession": "GO: 0023013"} , { "elementOf": "GO", "accession": "GO: 0023034"} , { "elementOf": "GO", "accession": "GO: 0007242"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of deprivation of nourishment. ( Reference:  GOC: jl )", "conames": [{ "name": "cellular response to starvation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0009267", "attributes": [], "id": "468", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to starvation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0009267"} ]} , { "annotation": "Any process that prevents the establishment or decreases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. ( Reference:  GOC: BHF )", "conames": [{ "name": "negative regulation of EPSP", "isPreferred": "false"} , { "name": "negative regulation of excitatory postsynaptic potential", "isPreferred": "true"} , { "name": "negative regulation of excitatory post-synaptic membrane potential", "isPreferred": "true"} , { "name": "reduction of excitatory postsynaptic membrane potential", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090394", "attributes": [], "id": "469", "contexts": { } , "evidences": ["Imported from database"], "value": "reduction of excitatory postsynaptic membrane potential", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090394"} ]} , { "annotation": "The chemical reactions and pathways involving a reactive oxygen species,  any molecules or ions formed by the incomplete one-electron reduction of oxygen. They contribute to the microbicidal activity of phagocytes,  regulation of signal transduction and gene expression,  and the oxidative damage to biopolymers. ( Reference:  CHEBI: 26523 GOC: mah )", "conames": [{ "name": "ROS metabolic process", "isPreferred": "true"} , { "name": "reactive oxygen species metabolism", "isPreferred": "true"} , { "name": "reactive oxygen species metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0072593", "attributes": [], "id": "470", "contexts": { } , "evidences": ["Imported from database"], "value": "ROS metabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0072593"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of the Golgi apparatus. ( Reference:  GOC: dph GOC: jl GOC: mah )", "conames": [{ "name": "Golgi organization and biogenesis", "isPreferred": "false"} , { "name": "Golgi organization", "isPreferred": "true"} , { "name": "Golgi organisation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007030", "attributes": [], "id": "471", "contexts": { } , "evidences": ["Imported from database"], "value": "Golgi organisation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007030"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of hydrogen peroxide-induced cell death. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 14749723 PMID: 24252804 )", "conames": [{ "name": "downregulation of cell death in response to hydrogen peroxide", "isPreferred": "true"} , { "name": "downregulation of cell death in response to H2O2", "isPreferred": "true"} , { "name": "down regulation of cell death in response to H2O2", "isPreferred": "true"} , { "name": "downregulation of hydrogen peroxide-mediated cell death", "isPreferred": "false"} , { "name": "negative regulation of cell death in response to H2O2", "isPreferred": "true"} , { "name": "negative regulation of hydrogen peroxide-mediated cell death", "isPreferred": "false"} , { "name": "negative regulation of cell death in response to hydrogen peroxide", "isPreferred": "true"} , { "name": "negative regulation of hydrogen peroxide-induced cell death", "isPreferred": "true"} , { "name": "down-regulation of hydrogen peroxide-mediated cell death", "isPreferred": "false"} , { "name": "protection against H2O2-induced cell death", "isPreferred": "false"} , { "name": "inhibition of cell death in response to hydrogen peroxide", "isPreferred": "false"} , { "name": "protection against hydrogen peroxide-induced cell death", "isPreferred": "false"} , { "name": "down-regulation of cell death in response to H2O2", "isPreferred": "true"} , { "name": "down regulation of hydrogen peroxide-mediated cell death", "isPreferred": "false"} , { "name": "down regulation of cell death in response to hydrogen peroxide", "isPreferred": "true"} , { "name": "inhibition of cell death in response to H2O2", "isPreferred": "false"} , { "name": "down-regulation of cell death in response to hydrogen peroxide", "isPreferred": "true"} , { "name": "inhibition of hydrogen peroxide-mediated cell death", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903206", "attributes": [], "id": "472", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of cell death in response to H2O2", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903206"} ]} , { "annotation": "The migration of cells in the telencephalon from the subventricular zone to the olfactory bulb in which cells move orthogonally to the direction of radial migration and do not use radial glial cell processes as substrates for migration. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conames": [{ "name": "rostral migratory stream migration", "isPreferred": "true"} , { "name": "tangential migration from the subventricular zone to the olfactory bulb", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0022028", "attributes": [], "id": "473", "contexts": { } , "evidences": ["Imported from database"], "value": "rostral migratory stream migration", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0022028"} ]} , { "annotation": "The initiation of the activity of the inactive enzyme MAP kinase (MAPK). ( Reference:  PMID: 9561267 )", "conames": [{ "name": "activation of MAPK activity during sporulation", "isPreferred": "false"} , { "name": "activation of MAP kinase", "isPreferred": "true"} , { "name": "activation of MAPK activity", "isPreferred": "true"} , { "name": "MAPK activation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000187", "attributes": [], "id": "474", "contexts": { } , "evidences": ["Imported from database"], "value": "MAPK activation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000187"} ]} , { "annotation": "The progression of the olfactory bulb over time from its initial formation until its mature state. The olfactory bulb coordinates neuronal signaling involved in the perception of smell. It receives input from the sensory neurons and outputs to the olfactory cortex. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 ISBN: 0878937420 )", "conames": [{ "name": "olfactory bulb development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0021772", "attributes": [], "id": "475", "contexts": { } , "evidences": ["Imported from database"], "value": "olfactory bulb development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0021772"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle transport. ( Reference:  GO_REF: 0000058 GOC: kmv GOC: TermGenie PMID: 23527112 )", "conames": [{ "name": "regulation of synaptic vesicle fusion", "isPreferred": "false"} , { "name": "regulation of synaptic vesicle transport", "isPreferred": "true"} , { "name": "regulation of synaptic vesicle fission", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902803", "attributes": [], "id": "476", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synaptic vesicle transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902803"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a manganese ion stimulus. ( Reference:  GOC: mah )", "conames": [{ "name": "cellular response to manganese", "isPreferred": "true"} , { "name": "cellular response to manganese ion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0071287", "attributes": [], "id": "477", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to manganese", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0071287"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 21370995 )", "conames": [{ "name": "down-regulation of protein-mitochondrial targeting", "isPreferred": "true"} , { "name": "down regulation of protein-mitochondrial targeting", "isPreferred": "true"} , { "name": "negative regulation of protein import into mitochondrion", "isPreferred": "true"} , { "name": "negative regulation of protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "negative regulation of mitochondrial protein import", "isPreferred": "false"} , { "name": "downregulation of protein targeting to mitochondria", "isPreferred": "true"} , { "name": "down-regulation of mitochondrial translocation", "isPreferred": "false"} , { "name": "negative regulation of mitochondrial translocation", "isPreferred": "false"} , { "name": "downregulation of mitochondrial protein import", "isPreferred": "false"} , { "name": "down-regulation of protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "down regulation of mitochondrial translocation", "isPreferred": "false"} , { "name": "downregulation of mitochondrial translocation", "isPreferred": "false"} , { "name": "inhibition of protein targeting to mitochondria", "isPreferred": "false"} , { "name": "inhibition of protein-mitochondrial targeting", "isPreferred": "false"} , { "name": "inhibition of mitochondrial protein import", "isPreferred": "false"} , { "name": "down-regulation of protein targeting to mitochondria", "isPreferred": "true"} , { "name": "down regulation of protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "inhibition of protein import into mitochondrion", "isPreferred": "false"} , { "name": "down-regulation of mitochondrial protein import", "isPreferred": "false"} , { "name": "downregulation of protein-mitochondrial targeting", "isPreferred": "true"} , { "name": "down regulation of mitochondrial protein import", "isPreferred": "false"} , { "name": "down regulation of protein import into mitochondrion", "isPreferred": "true"} , { "name": "down-regulation of protein import into mitochondrion", "isPreferred": "true"} , { "name": "down regulation of protein targeting to mitochondria", "isPreferred": "true"} , { "name": "negative regulation of protein-mitochondrial targeting", "isPreferred": "true"} , { "name": "inhibition of protein targeting to mitochondrion", "isPreferred": "false"} , { "name": "negative regulation of protein targeting to mitochondria", "isPreferred": "true"} , { "name": "inhibition of mitochondrial translocation", "isPreferred": "false"} , { "name": "downregulation of protein import into mitochondrion", "isPreferred": "true"} , { "name": "downregulation of protein targeting to mitochondrion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903215", "attributes": [], "id": "478", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of protein-mitochondrial targeting", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903215"} ]} , { "annotation": "Any process that activates or increases the activity of a GTPase. ( Reference:  GOC: jl GOC: mah )", "conames": [{ "name": "upregulation of Ral GTPase", "isPreferred": "false"} , { "name": "positive regulation of Rho GTPase", "isPreferred": "false"} , { "name": "positive regulation of Cdc42 GTPase", "isPreferred": "false"} , { "name": "up regulation of GTPase", "isPreferred": "true"} , { "name": "up regulation of Ran GTPase", "isPreferred": "false"} , { "name": "positive regulation of Rab GTPase", "isPreferred": "false"} , { "name": "up-regulation of Ral GTPase", "isPreferred": "false"} , { "name": "up regulation of ARF GTPase", "isPreferred": "false"} , { "name": "positive regulation of ARF GTPase", "isPreferred": "false"} , { "name": "upregulation of Rap GTPase", "isPreferred": "false"} , { "name": "upregulation of ARF GTPase", "isPreferred": "false"} , { "name": "up-regulation of ARF GTPase", "isPreferred": "false"} , { "name": "up-regulation of Ran GTPase", "isPreferred": "false"} , { "name": "upregulation of GTPase", "isPreferred": "true"} , { "name": "up-regulation of Rap GTPase", "isPreferred": "false"} , { "name": "up regulation of Rap GTPase", "isPreferred": "false"} , { "name": "up-regulation of Rab GTPase", "isPreferred": "false"} , { "name": "upregulation of Ran GTPase", "isPreferred": "false"} , { "name": "up regulation of Ral GTPase", "isPreferred": "false"} , { "name": "positive regulation of Ran GTPase", "isPreferred": "false"} , { "name": "positive regulation of Rap GTPase", "isPreferred": "false"} , { "name": "stimulation of Ran GTPase", "isPreferred": "false"} , { "name": "stimulation of Ral GTPase", "isPreferred": "false"} , { "name": "positive regulation of Ral GTPase", "isPreferred": "false"} , { "name": "upregulation of Rab GTPase", "isPreferred": "false"} , { "name": "stimulation of Rap GTPase", "isPreferred": "false"} , { "name": "up regulation of Rab GTPase", "isPreferred": "false"} , { "name": "stimulation of Rac GTPase", "isPreferred": "false"} , { "name": "stimulation of Rab GTPase", "isPreferred": "false"} , { "name": "activation of GTPase", "isPreferred": "false"} , { "name": "stimulation of ARF GTPase", "isPreferred": "false"} , { "name": "up-regulation of Cdc42 GTPase", "isPreferred": "false"} , { "name": "up-regulation of Rho GTPase", "isPreferred": "false"} , { "name": "stimulation of Rho GTPase", "isPreferred": "false"} , { "name": "up regulation of Rho GTPase", "isPreferred": "false"} , { "name": "stimulation of GTPase", "isPreferred": "false"} , { "name": "upregulation of Cdc42 GTPase", "isPreferred": "false"} , { "name": "stimulation of Cdc42 GTPase", "isPreferred": "false"} , { "name": "up-regulation of GTPase", "isPreferred": "true"} , { "name": "up-regulation of Ras GTPase", "isPreferred": "false"} , { "name": "upregulation of Rho GTPase", "isPreferred": "false"} , { "name": "positive regulation of GTPase activity", "isPreferred": "true"} , { "name": "upregulation of Ras GTPase", "isPreferred": "false"} , { "name": "up regulation of Cdc42 GTPase", "isPreferred": "false"} , { "name": "up regulation of Ras GTPase", "isPreferred": "false"} , { "name": "stimulation of Ras GTPase", "isPreferred": "false"} , { "name": "positive regulation of Ras GTPase", "isPreferred": "false"} , { "name": "up-regulation of Rac GTPase", "isPreferred": "false"} , { "name": "positive regulation of Rac GTPase", "isPreferred": "false"} , { "name": "up regulation of Rac GTPase", "isPreferred": "false"} , { "name": "upregulation of Rac GTPase", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043547", "attributes": [], "id": "479", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of GTPase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032850"} , { "elementOf": "GO", "accession": "GO: 0032851"} , { "elementOf": "GO", "accession": "GO: 0043089"} , { "elementOf": "GO", "accession": "GO: 0032320"} , { "elementOf": "GO", "accession": "GO: 0032321"} , { "elementOf": "GO", "accession": "GO: 0032854"} , { "elementOf": "GO", "accession": "GO: 0032855"} , { "elementOf": "GO", "accession": "GO: 0043547"} , { "elementOf": "GO", "accession": "GO: 0032852"} , { "elementOf": "GO", "accession": "GO: 0032853"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the dopamine receptor protein signaling pathway. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. ( Reference:  GOC: dph );", "conames": [{ "name": "positive regulation of dopamine receptor signaling pathway", "isPreferred": "true"} , { "name": "positive regulation of dopamine receptor signalling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060161", "attributes": [], "id": "480", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of dopamine receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060161"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the addition of ubiquitin groups to a protein. ( Reference:  GOC: mah )", "conames": [{ "name": "activation of protein ubiquitination", "isPreferred": "false"} , { "name": "upregulation of protein ubiquitination", "isPreferred": "true"} , { "name": "positive regulation of protein ubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein ubiquitination", "isPreferred": "true"} , { "name": "up regulation of protein ubiquitination", "isPreferred": "true"} , { "name": "stimulation of protein ubiquitination", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031398", "attributes": [], "id": "481", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of protein ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031398"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of protein processing involved in protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 21370995 )", "conames": [{ "name": "downregulation of protein processing involved in protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "negative regulation of protein processing involved in protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "down regulation of protein processing involved in protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "down-regulation of protein processing involved in protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "downregulation of mitochondrial protein processing during import", "isPreferred": "false"} , { "name": "down regulation of mitochondrial protein processing during import", "isPreferred": "false"} , { "name": "inhibition of mitochondrial protein processing during import", "isPreferred": "false"} , { "name": "negative regulation of mitochondrial protein processing during import", "isPreferred": "false"} , { "name": "inhibition of protein processing involved in protein targeting to mitochondrion", "isPreferred": "false"} , { "name": "down-regulation of mitochondrial protein processing during import", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903217", "attributes": [], "id": "482", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of protein processing involved in protein targeting to mitochondrion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903217"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of late endosome to lysosome transport. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 23949442 )", "conames": [{ "name": "down regulation of late endosome to lysosome transport", "isPreferred": "true"} , { "name": "negative regulation of late endosome to lysosome transport", "isPreferred": "true"} , { "name": "downregulation of late endosome to lysosome transport", "isPreferred": "true"} , { "name": "inhibition of late endosome to lysosome transport", "isPreferred": "false"} , { "name": "down-regulation of late endosome to lysosome transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902823", "attributes": [], "id": "483", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of late endosome to lysosome transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902823"} ]} , { "annotation": "Any process that modulates the rate,  frequency,  or extent of protein kinase A signaling. PKA signaling is the series of reactions,  mediated by the intracellular serine threonine kinase protein kinase A,  which occurs as a result of a single trigger reaction or compound. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conames": [{ "name": "regulation of PKA signaling cascade", "isPreferred": "false"} , { "name": "regulation of protein kinase A signalling cascade", "isPreferred": "false"} , { "name": "regulation of protein kinase A signaling", "isPreferred": "true"} , { "name": "regulation of protein kinase A signaling cascade", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010738", "attributes": [], "id": "484", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of protein kinase A signaling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010738"} ]} , { "annotation": "Any process that stops or reduces the rate of GTP hydrolysis by a GTPase. ( Reference:  GO_REF: 0000058 GOC: mah GOC: rb GOC: TermGenie PMID: 16143306 PMID: 24335649 )", "conames": [{ "name": "downregulation of Rab GTPase", "isPreferred": "false"} , { "name": "down-regulation of GTPase", "isPreferred": "true"} , { "name": "down regulation of GTPase", "isPreferred": "true"} , { "name": "inhibition of Rab GTPase", "isPreferred": "false"} , { "name": "downregulation of regulation of Ran GTPase", "isPreferred": "false"} , { "name": "downregulation of Rho GTPase", "isPreferred": "false"} , { "name": "negative regulation of Ras GTPase", "isPreferred": "false"} , { "name": "down regulation of regulation of Ran GTPase", "isPreferred": "false"} , { "name": "down-regulation of Ras GTPase", "isPreferred": "false"} , { "name": "inhibition of regulation of Ran GTPase", "isPreferred": "false"} , { "name": "down regulation of Ras GTPase", "isPreferred": "false"} , { "name": "negative regulation of Ran GTPase", "isPreferred": "false"} , { "name": "negative regulation of guanosinetriphosphatase", "isPreferred": "true"} , { "name": "negative regulation of Rab GTPase", "isPreferred": "false"} , { "name": "down-regulation of Rab GTPase", "isPreferred": "false"} , { "name": "down regulation of Rab GTPase", "isPreferred": "false"} , { "name": "negative regulation of Rho GTPase", "isPreferred": "false"} , { "name": "down-regulation of Rho GTPase", "isPreferred": "false"} , { "name": "downregulation of Ras GTPase", "isPreferred": "false"} , { "name": "inhibition of Ras GTPase", "isPreferred": "false"} , { "name": "down-regulation of regulation of Ran GTPase", "isPreferred": "false"} , { "name": "inhibition of GTPase", "isPreferred": "false"} , { "name": "down regulation of Rho GTPase", "isPreferred": "false"} , { "name": "inhibition of Rho GTPase", "isPreferred": "false"} , { "name": "downregulation of GTPase", "isPreferred": "true"} , { "name": "negative regulation of GTPase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034260", "attributes": [], "id": "485", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of GTPase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034259"} , { "elementOf": "GO", "accession": "GO: 0034261"} , { "elementOf": "GO", "accession": "GO: 0034260"} , { "elementOf": "GO", "accession": "GO: 1902264"} , { "elementOf": "GO", "accession": "GO: 1902881"} ]} , { "annotation": "The specific movement from place to place of an organism in response to a novel environment. ( Reference:  GOC: sart PMID: 17151232 )", "conames": [{ "name": "locomotory exploration behavior", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035641", "attributes": [], "id": "486", "contexts": { } , "evidences": ["Imported from database"], "value": "locomotory exploration behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035641"} ]} , { "annotation": "Any process that activates,  maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "positive regulation of autophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010508", "attributes": [], "id": "487", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of autophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010508"} ]} , { "annotation": "Any process in which a protein is transported to,  and or maintained in,  a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell,  from within the cell to the cell surface,  or from one location to another at the surface of a cell. ( Reference:  GOC: mah )", "conames": [{ "name": "cellular protein localization", "isPreferred": "true"} , { "name": "cellular protein localisation", "isPreferred": "true"} , { "name": "channel localizer", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034613", "attributes": [], "id": "488", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular protein localisation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034613"} , { "elementOf": "GO", "accession": "GO: 0016249"} ]} , { "annotation": "Any process in which a mitochondrion or mitochondria are transported to,  and or maintained in,  a specific location within the cell. ( Reference:  GOC: ai )", "conames": [{ "name": "mitochondrion localization", "isPreferred": "true"} , { "name": "mitochondrial localization", "isPreferred": "true"} , { "name": "localization of mitochondrion", "isPreferred": "true"} , { "name": "mitochondria localization", "isPreferred": "true"} , { "name": "mitochondrion localisation", "isPreferred": "true"} , { "name": "localization of mitochondria", "isPreferred": "true"} , { "name": "establishment and maintenance of mitochondria localization", "isPreferred": "true"} , { "name": "establishment and maintenance of mitochondrion localization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051646", "attributes": [], "id": "489", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondria localization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051646"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of branching morphogenesis of a nerve. ( Reference:  GOC: BHF )", "conames": [{ "name": "regulation of branching morphogenesis of a nerve", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000172", "attributes": [], "id": "490", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of branching morphogenesis of a nerve", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000172"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the change in the membrane potential of the mitochondria from negative to positive. ( Reference:  GOC: ai )", "conames": [{ "name": "regulation of mitochondrial depolarization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051900", "attributes": [], "id": "491", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of mitochondrial depolarization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051900"} ]} , { "annotation": "An intracellular protein kinase cascade containing at least a MAPK,  a MAPKK and a MAP3K. The cascade can also contain two additional tiers:  the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. ( Reference:  GOC: bf GOC: mtg_signaling_feb11 PMID: 20811974 PMID: 9561267 )", "conames": [{ "name": "MAPK cascade", "isPreferred": "true"} , { "name": "MAPKKK cascade", "isPreferred": "true"} , { "name": "mitogen-activated protein kinase cascade", "isPreferred": "true"} , { "name": "MAPKKK cascade during sporulation", "isPreferred": "false"} , { "name": "MAP kinase kinase kinase cascade", "isPreferred": "true"} , { "name": "ERK\/MAPK cascade", "isPreferred": "false"} , { "name": "MAPK signalling", "isPreferred": "false"} , { "name": "MAP kinase cascade", "isPreferred": "true"} , { "name": "MAPK signal transduction", "isPreferred": "true"} , { "name": "MAPK signaling", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000165", "attributes": [], "id": "492", "contexts": { } , "evidences": ["Imported from database"], "value": "MAPK cascade", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000165"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of neuron death. ( Reference:  GOC: rph GOC: TermGenie )", "conames": [{ "name": "inhibition of neuronal cell death", "isPreferred": "false"} , { "name": "inhibition of neuron death", "isPreferred": "false"} , { "name": "negative regulation of neuron death", "isPreferred": "true"} , { "name": "down regulation of neuronal cell death", "isPreferred": "true"} , { "name": "down-regulation of neuronal cell death", "isPreferred": "true"} , { "name": "down regulation of neuron cell death", "isPreferred": "true"} , { "name": "inhibition of neuron cell death", "isPreferred": "false"} , { "name": "down-regulation of neuron cell death", "isPreferred": "true"} , { "name": "negative regulation of neuronal cell death", "isPreferred": "true"} , { "name": "down-regulation of neuron death", "isPreferred": "true"} , { "name": "downregulation of neuron cell death", "isPreferred": "true"} , { "name": "negative regulation of neuron cell death", "isPreferred": "true"} , { "name": "down regulation of neuron death", "isPreferred": "true"} , { "name": "downregulation of neuronal cell death", "isPreferred": "true"} , { "name": "downregulation of neuron death", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1901215", "attributes": [], "id": "493", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of neuron death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1901215"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of programmed cell death,  cell death resulting from activation of endogenous cellular processes. ( Reference:  GOC: jl )", "conames": [{ "name": "upregulation of programmed cell death", "isPreferred": "true"} , { "name": "stimulation of programmed cell death", "isPreferred": "false"} , { "name": "positive regulation of programmed cell death", "isPreferred": "true"} , { "name": "activation of programmed cell death", "isPreferred": "false"} , { "name": "up-regulation of programmed cell death", "isPreferred": "true"} , { "name": "positive regulation of non-apoptotic programmed cell death", "isPreferred": "false"} , { "name": "up regulation of programmed cell death", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043068", "attributes": [], "id": "494", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of programmed cell death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043068"} , { "elementOf": "GO", "accession": "GO: 0043071"} ]} , { "annotation": "The process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation. ( Reference:  GOC: autophagy ISBN: 0198547684 PMID: 11099404 PMID: 9412464 )", "conames": [{ "name": "autophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006914", "attributes": [], "id": "495", "contexts": { } , "evidences": ["Imported from database"], "value": "autophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016238"} , { "elementOf": "GO", "accession": "GO: 0006914"} ]} , { "annotation": "Any process that modulates the size of a kidney. ( Reference:  GOC: bf )", "conames": [{ "name": "regulation of kidney size", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035564", "attributes": [], "id": "496", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of kidney size", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035564"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a neuromuscular junction. ( Reference:  GOC: mtg_OBO2OWL_2013 )", "conames": [{ "name": "neuromuscular junction organization", "isPreferred": "true"} , { "name": "NMJ stability", "isPreferred": "false"} , { "name": "neuromuscular junction stability", "isPreferred": "false"} , { "name": "neuromuscular junction development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007528", "attributes": [], "id": "497", "contexts": { } , "evidences": ["Imported from database"], "value": "neuromuscular junction development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007528"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  e.g. superoxide anions,  hydrogen peroxide (H2O2),  and hydroxyl radicals. ( Reference:  GOC: mah )", "conames": [{ "name": "cellular response to oxidative stress", "isPreferred": "true"} , { "name": "adaptive response to oxidative stress", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034599", "attributes": [], "id": "498", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to oxidative stress", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034599"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a lysosome. A lysosome is a cytoplasmic,  membrane-bounded organelle that is found in most animal cells and that contains a variety of hydrolases. ( Reference:  GOC: mah )", "conames": [{ "name": "lysosome organisation", "isPreferred": "true"} , { "name": "lysosome organization and biogenesis", "isPreferred": "false"} , { "name": "lysosome organization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007040", "attributes": [], "id": "499", "contexts": { } , "evidences": ["Imported from database"], "value": "lysosome organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007040"} ]} , { "annotation": "The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell,  such as axons or dendrites. ( Reference:  GOC: mah )", "conames": [{ "name": "neuron projection morphogenesis", "isPreferred": "true"} , { "name": "neurite formation", "isPreferred": "false"} , { "name": "neurite growth", "isPreferred": "false"} , { "name": "neurite biosynthesis", "isPreferred": "false"} , { "name": "neurite morphogenesis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048812", "attributes": [], "id": "500", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron projection morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048812"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein binding. ( Reference:  GOC: mah )", "conames": [{ "name": "upregulation of protein binding", "isPreferred": "true"} , { "name": "activation of protein binding", "isPreferred": "false"} , { "name": "up regulation of protein binding", "isPreferred": "true"} , { "name": "stimulation of protein binding", "isPreferred": "false"} , { "name": "up-regulation of protein binding", "isPreferred": "true"} , { "name": "positive regulation of protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032092", "attributes": [], "id": "501", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of protein binding", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032092"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein binding. ( Reference:  GOC: mah )", "conames": [{ "name": "downregulation of protein binding", "isPreferred": "true"} , { "name": "negative regulation of protein binding", "isPreferred": "true"} , { "name": "inhibition of protein binding", "isPreferred": "false"} , { "name": "down-regulation of protein binding", "isPreferred": "true"} , { "name": "down regulation of protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032091", "attributes": [], "id": "502", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of protein binding", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032091"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds,  initiated by the covalent attachment of ubiquitin,  and mediated by the proteasome. ( Reference:  GOC: mah )", "conames": [{ "name": "positive regulation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "up regulation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "activation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "false"} , { "name": "up-regulation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "upregulation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "stimulation of proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032436", "attributes": [], "id": "503", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of proteasomal ubiquitin-dependent protein catabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032436"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of locomotion of a cell or organism. ( Reference:  GOC: ems )", "conames": [{ "name": "regulation of locomotion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0040012", "attributes": [], "id": "504", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of locomotion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0040012"} ]} , { "annotation": "A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. ( Reference:  GOC: mah ISBN: 0198506732 ISBN: 0716731363 )", "conames": [{ "name": "vesicle endocytosis", "isPreferred": "true"} , { "name": "nonselective vesicle endocytosis", "isPreferred": "false"} , { "name": "endocytosis", "isPreferred": "true"} , { "name": "plasma membrane invagination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006897", "attributes": [], "id": "505", "contexts": { } , "evidences": ["Imported from database"], "value": "endocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006897"} , { "elementOf": "GO", "accession": "GO: 0016193"} , { "elementOf": "GO", "accession": "GO: 0016196"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a dopamine stimulus. ( Reference:  GO_REF: 0000071 GOC: mr GOC: TermGenie PMID: 11118945 )", "conames": [{ "name": "cellular response to dopamine", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903351", "attributes": [], "id": "506", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to dopamine", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903351"} ]} , { "annotation": "The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. ( Reference:  RESID: AA0037 )", "conames": [{ "name": "peptidyl-serine phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0018105", "attributes": [], "id": "507", "contexts": { } , "evidences": ["Imported from database"], "value": "peptidyl-serine phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0018105"} ]} , { "annotation": "A process in which a protein is transported to,  or maintained in,  a location within the mitochondrion. ( Reference:  GOC: ecd )", "conames": [{ "name": "protein localisation in mitochondrion", "isPreferred": "true"} , { "name": "protein localization to mitochondrion", "isPreferred": "true"} , { "name": "protein localization in mitochondrion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070585", "attributes": [], "id": "508", "contexts": { } , "evidences": ["Imported from database"], "value": "protein localization in mitochondrion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070585"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of a dopamine receptor signaling pathway activity. A dopamine receptor signaling pathway is the series of molecular signals generated as a consequence of a dopamine receptor binding to one of its physiological ligands. ( Reference:  GOC: dph )", "conames": [{ "name": "regulation of dopamine receptor signalling pathway", "isPreferred": "true"} , { "name": "regulation of dopamine receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060159", "attributes": [], "id": "509", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of dopamine receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060159"} ]} , { "annotation": "Any process that decreases the rate,  frequency or extent of protein maturation by peptide bond cleavage. ( Reference:  GOC: dph GOC: mah GOC: tb )", "conames": [{ "name": "negative regulation of protein processing", "isPreferred": "true"} , { "name": "negative regulation of protein maturation by peptide bond cleavage", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010955", "attributes": [], "id": "510", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of protein processing", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010955"} ]} , { "annotation": "Any process that increases the rate,  frequency,  or extent of the Wnt signaling pathway through beta-catenin,  the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. ( Reference:  GOC: tb )", "conames": [{ "name": "positive regulation of canonical Wnt receptor signaling pathway", "isPreferred": "true"} , { "name": "positive regulation of canonical Wnt-activated signaling pathway", "isPreferred": "true"} , { "name": "positive regulation of canonical Wnt signaling pathway", "isPreferred": "true"} , { "name": "positive regulation of Wnt receptor signaling pathway through beta-catenin", "isPreferred": "true"} , { "name": "positive regulation of canonical Wnt receptor signalling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090263", "attributes": [], "id": "511", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of canonical Wnt signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090263"} ]} , { "annotation": "Any process that stops,  prevents or reduces the rate of addition of phosphate groups to amino acids within a protein. ( Reference:  GOC: hjd )", "conames": [{ "name": "negative regulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "down regulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "downregulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "inhibition of protein amino acid phosphorylation", "isPreferred": "false"} , { "name": "down-regulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "negative regulation of protein phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001933", "attributes": [], "id": "512", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of protein phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001933"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of oxidative stress,  a state often resulting from exposure to high levels of reactive oxygen species,  e.g. superoxide anions,  hydrogen peroxide (H2O2),  and hydroxyl radicals. ( Reference:  GOC: jl PMID: 12115731 )", "conames": [{ "name": "response to oxidative stress", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006979", "attributes": [], "id": "513", "contexts": { } , "evidences": ["Imported from database"], "value": "response to oxidative stress", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006979"} ]} , { "annotation": "The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. ( Reference:  RESID: AA0038 )", "conames": [{ "name": "peptidyl-threonine phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0018107", "attributes": [], "id": "514", "contexts": { } , "evidences": ["Imported from database"], "value": "peptidyl-threonine phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0018107"} ]} , { "annotation": "Any process that establishes the spatial arrangement of mitochondria within the cell. ( Reference:  GOC: jid )", "conames": [{ "name": "mitochondrion positioning within cell", "isPreferred": "true"} , { "name": "intracellular distribution of mitochondria", "isPreferred": "true"} , { "name": "mitochondria positioning within cell", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048312", "attributes": [], "id": "515", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondria positioning within cell", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048312"} ]} , { "annotation": "A peptidyl-threonine phosphorylation that results in negative regulation of thioredoxin peroxidase activity. ( Reference:  GO_REF: 0000063 GOC: bf GOC: PARL GOC: TermGenie PMID: 21850687 )", "conames": [{ "name": "negative regulation of TrxPx activity by peptidyl-threonine phosphorylation", "isPreferred": "true"} , { "name": "negative regulation of thiol peroxidase activity by peptidyl-threonine phosphorylation", "isPreferred": "true"} , { "name": "negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation", "isPreferred": "true"} , { "name": "negative regulation of TPx activity by peptidyl-threonine phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903125", "attributes": [], "id": "516", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of TPx activity by peptidyl-threonine phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903125"} ]} , { "annotation": "The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation),  or residues on an identical protein (trans-autophosphorylation). ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "protein autophosphorylation", "isPreferred": "true"} , { "name": "protein amino acid autophosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046777", "attributes": [], "id": "517", "contexts": { } , "evidences": ["Imported from database"], "value": "protein autophosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046777"} ]} , { "annotation": "Any process that modulates the rate,  frequency,  or extent of dendritic spine morphogenesis,  the process in which the anatomical structures of a dendritic spine are generated and organized. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission. ( Reference:  GOC: dph );", "conames": [{ "name": "regulation of dendritic spine morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0061001", "attributes": [], "id": "518", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of dendritic spine morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0061001"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of addition of phosphate groups to amino acids within a protein. ( Reference:  GOC: hjd )", "conames": [{ "name": "positive regulation of protein phosphorylation", "isPreferred": "true"} , { "name": "up-regulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "stimulation of protein amino acid phosphorylation", "isPreferred": "false"} , { "name": "upregulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "activation of protein amino acid phosphorylation", "isPreferred": "false"} , { "name": "positive regulation of protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "up regulation of protein amino acid phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001934", "attributes": [], "id": "519", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of protein phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001934"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. ( Reference:  GOC: BHF GOC: mtg_apoptosis GOC: rl GOC: TermGenie PMID: 20160352 )", "conames": [{ "name": "downregulation of intrinsic apoptotic signaling pathway induced by endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "inhibition of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "false"} , { "name": "down regulation of endoplasmic reticulum stress-induced apoptosis", "isPreferred": "true"} , { "name": "inhibition of endoplasmic reticulum stress-induced apoptosis", "isPreferred": "false"} , { "name": "inhibition of apoptosis triggered by ER stress", "isPreferred": "false"} , { "name": "down-regulation of ER stress-induced apoptosis", "isPreferred": "true"} , { "name": "down-regulation of apoptosis in response to ER stress", "isPreferred": "true"} , { "name": "negative regulation of apoptosis in response to ER stress", "isPreferred": "true"} , { "name": "negative regulation of apoptosis triggered by ER stress", "isPreferred": "true"} , { "name": "negative regulation of intrinsic apoptotic signaling pathway induced by endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "downregulation of apoptosis in response to ER stress", "isPreferred": "true"} , { "name": "inhibition of ER stress-induced apoptosis", "isPreferred": "false"} , { "name": "down-regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "negative regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "downregulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "down regulation of apoptosis in response to ER stress", "isPreferred": "true"} , { "name": "down regulation of apoptosis triggered by ER stress", "isPreferred": "true"} , { "name": "negative regulation of endoplasmic reticulum stress-induced apoptosis", "isPreferred": "true"} , { "name": "down regulation of ER stress-induced apoptosis", "isPreferred": "true"} , { "name": "inhibition of intrinsic apoptotic signaling pathway induced by endoplasmic reticulum stress", "isPreferred": "false"} , { "name": "inhibition of apoptosis in response to ER stress", "isPreferred": "false"} , { "name": "down-regulation of endoplasmic reticulum stress-induced apoptosis", "isPreferred": "true"} , { "name": "down regulation of intrinsic apoptotic signaling pathway induced by endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "down-regulation of apoptosis triggered by ER stress", "isPreferred": "true"} , { "name": "down-regulation of intrinsic apoptotic signaling pathway induced by endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "downregulation of ER stress-induced apoptosis", "isPreferred": "true"} , { "name": "down regulation of intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "downregulation of endoplasmic reticulum stress-induced apoptosis", "isPreferred": "true"} , { "name": "downregulation of apoptosis triggered by ER stress", "isPreferred": "true"} , { "name": "negative regulation of ER stress-induced apoptosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902236", "attributes": [], "id": "520", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of ER stress-induced apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902236"} ]} , { "annotation": "The process of introducing a phosphate group on to a protein. ( Reference:  GOC: hb )", "conames": [{ "name": "protein amino acid phosphorylation", "isPreferred": "true"} , { "name": "protein phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006468", "attributes": [], "id": "521", "contexts": { } , "evidences": ["Imported from database"], "value": "protein phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006468"} ]} , { "annotation": "The process of cell death in a neuron. ( Reference:  GOC: BHF GOC: mah )", "conames": [{ "name": "neuron cell death", "isPreferred": "true"} , { "name": "neuron death", "isPreferred": "true"} , { "name": "neuronal cell death", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070997", "attributes": [], "id": "522", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070997"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of neuron maturation,  the process leading to the attainment of the full functional capacity of a neuron. This process is independent of morphogenetic change. ( Reference:  GOC: ef )", "conames": [{ "name": "regulation of neuron maturation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0014041", "attributes": [], "id": "523", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of neuron maturation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0014041"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of peroxidase activity. ( Reference:  GOC: obol )", "conames": [{ "name": "negative regulation of oxyperoxidase", "isPreferred": "true"} , { "name": "negative regulation of peroxidase activity", "isPreferred": "true"} , { "name": "negative regulation of peroxidase reaction", "isPreferred": "true"} , { "name": "negative regulation of donor: hydrogen-peroxide oxidoreductase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000469", "attributes": [], "id": "524", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of oxyperoxidase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000469"} ]} , { "annotation": "Any process that modulates the establishment or extent of a membrane potential,  the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. ( Reference:  GOC: jl GOC: mtg_cardio GOC: tb ISBN: 0198506732 )", "conames": [{ "name": "regulation of membrane potential", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042391", "attributes": [], "id": "525", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of membrane potential", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042391"} ]} , { "annotation": "Any process that modulates the rate,  frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conames": [{ "name": "regulation of mitochondrial fission", "isPreferred": "true"} , { "name": "regulation of mitochondrial division", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090140", "attributes": [], "id": "526", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of mitochondrial fission", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090140"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of neuron death. ( Reference:  GOC: rph GOC: TermGenie )", "conames": [{ "name": "regulation of neuron death", "isPreferred": "true"} , { "name": "regulation of neuron cell death", "isPreferred": "true"} , { "name": "regulation of neuronal cell death", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1901214", "attributes": [], "id": "527", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of neuron death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1901214"} ]} , { "annotation": "The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK). ( Reference:  PMID: 9561267 )", "conames": [{ "name": "activation of MAPKK activity during sporulation", "isPreferred": "false"} , { "name": "activation of MAP kinase kinase", "isPreferred": "true"} , { "name": "positive regulation of MAPKK", "isPreferred": "false"} , { "name": "activation of MAP\/ERK kinase kinase", "isPreferred": "true"} , { "name": "activation of MAPKK activity", "isPreferred": "true"} , { "name": "activation of MAP2K", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000186", "attributes": [], "id": "528", "contexts": { } , "evidences": ["Imported from database"], "value": "activation of MAP2K", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007255"} , { "elementOf": "GO", "accession": "GO: 0000186"} ]} , { "annotation": "[VARIANTS PARK8 CYS-1441; HIS-1441 AND SER-2019]", "conames": [{ "name": "PMID: 16157909", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16157909", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations."} , { "attrname": "Abstract", "value": "Referral-based studies indicate that a mutation (G2019S) in exon 41 of the LRRK2 gene might be a common cause of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The authors sequenced leucine-rich repeat kinase 2 (LRRK2) exons 31,  35,  and 41 in 371 consecutively recruited patients with PD and found mutations in six (1.6%) subjects,  including two heterozygous for new putative pathogenic variants (R1441H,  IVS31 + 3A-->G). These data confirm the important contribution of LRRK2 to PD susceptibility in a clinic-based population. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Testing,  Exons,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Family Health,  Genotype,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Homozygote,  DNA Mutational Analysis,  Pedigree,  Female,  Heterozygote,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[C P Zabetian,  A Samii,  A D Mosley,  J W Roberts,  B C Leis,  D Yearout,  W H Raskind,  A Griffith]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 CYS-1441; HIS-1441 AND SER-2019]"} ], "id": "529", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16157909", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000172630.22804.73"} , { "elementOf": "NLM", "accession": "16157909"} ]} , { "annotation": "[VARIANTS PARK8 MET-793; THR-1869 AND SER-2019]", "conames": [{ "name": "PMID: 16157908", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16157908", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "LRRK2 mutations in Parkinson <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "To determine the frequency of LRRK2 mutations in idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  the authors studied 786 PD probands,  32 affected siblings,  1, 044 unaffected siblings,  and 278 unrelated controls. The authors designed allelic discrimination assays for nine LRRK2 mutations and identified these in six probands with PD,  one affected sibling,  one unaffected sibling,  and one unrelated control. Thus LRRK2 mutations only rarely cause idiopathic PD. "} , { "attrname": "MeSH", "value": "[Genetic Testing,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Family Health,  Genotype,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Founder Effect,  DNA Mutational Analysis,  Adult,  Female,  Heterozygote,  Aged,  Mutation,  Siblings]"} , { "attrname": "AUTHORS", "value": "[M Farrer,  J Stone,  I F Mata,  S Lincoln,  J Kachergus,  M Hulihan,  K J Strain,  D M Maraganore]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 MET-793; THR-1869 AND SER-2019]"} ], "id": "530", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16157908", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000169023.51764.B0"} , { "elementOf": "NLM", "accession": "16157908"} ]} , { "annotation": "[VARIANTS LYS-551; VAL-723; HIS-1398; GLN-1514; SER-1542; PRO-1628; THR-1646; THR-1647; ASP-2081 AND THR-2397]", "conames": [{ "name": "PMID: 22415848", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22415848", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Deep sequencing of the LRRK2 gene in 14, 002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe."} , { "attrname": "Abstract", "value": "Genetic variation in LRRK2 predisposes to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  which underpins its development as a therapeutic target. Here,  we aimed to identify novel genotype-phenotype associations that might support developing LRRK2 therapies for other conditions. We sequenced the 51 exons of LRRK2 in cases comprising 12 common <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s (n = 9, 582),  and in 4, 420 population controls. We identified 739 single-nucleotide variants,  62% of which were observed in only one person,  including 316 novel exonic variants. We found evidence of purifying selection for the LRRK2 gene and a trend suggesting that this is more pronounced in the central (ROC-COR-kinase) core protein domains of LRRK2 than the flanking domains. Population genetic analyses revealed that LRRK2 is not especially polymorphic or differentiated in comparison to 201 other drug target genes. Among Europeans,  we identified 17 carriers (0.13%) of pathogenic LRRK2 mutations that were not significantly enriched within any <span style=\"background-color: yellow\"><b>disease<\/b><\/span> or in those reporting a family history of PD. Analysis of pathogenic mutations within Europe reveals that the p.Arg1628Pro (c4883G>C) mutation arose independently in Europe and Asia. Taken together,  these findings demonstrate how targeted deep sequencing can help to reveal fundamental characteristics of clinically important loci. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetics,  Population,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Europe,  Humans,  Protein-Serine-Threonine Kinases,  European Continental Ancestry Group,  High-Throughput Nucleotide Sequencing,  Mutation,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Justin P Rubio,  Simon Topp,  Liling Warren,  Pamela L St Jean,  Daniel Wegmann,  Darren Kessner,  John Novembre,  Judong Shen,  Dana Fraser,  Jennifer Aponte,  Keith Nangle,  Lon R Cardon,  Margaret G Ehm,  Stephanie L Chissoe,  John C Whittaker,  Matthew R Nelson,  Vincent E Mooser]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS LYS-551; VAL-723; HIS-1398; GLN-1514; SER-1542; PRO-1628; THR-1646; THR-1647; ASP-2081 AND THR-2397]"} ], "id": "531", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22415848", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/HUMU.22075"} , { "elementOf": "NLM", "accession": "22415848"} ]} , { "annotation": "[VARIANTS PARK8 CYS-1441; GLY-1441 AND SER-2019]", "conames": [{ "name": "PMID: 16533964", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16533964", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  TE7660XO1C Glycine,  452VLY9402 Serine,  94ZLA3W45F Arginine]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "LRRK2 mutations in Spanish patients with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>:  frequency,  clinical features,  and incomplete penetrance."} , { "attrname": "Abstract", "value": "Several pathogenic mutations in the LRRK2 gene have been implicated in familial and sporadic cases of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The R1441G mutation is frequent in Spanish patients of Basque ethnicity with PD,  and the G2019S mutation is a common mutation found in several populations worldwide. To determine the frequency of the LRRK2 G2019S and R1441G mutations in PD patients from the non-Basque northeast region of Spain (Catalonia),  and to characterize their family history and clinical features. We screened patients for the presence of the LRRK2 R1441G and G2019S mutations. These LRRK2 mutations were detected by restriction endonuclease digestion,  and samples with an abnormal electrophoresis pattern were sequenced to identify the exact nucleotide change. The clinical features and family history of patients with LRRK2 mutations were studied in detail. The northeast region of Spain. Patients Three hundred two patients with PD. Onset age,  clinical features,  and family history of PD and LRRK2 mutations. The R1441G mutation was present in 0.7% of total PD cases. The G2019S mutation was found in 6.4% of familial and 3.4% of sporadic cases. Additionally,  we found 1 patient with the R1441C mutation. Age at onset ranged from 33 to 78 years. Clinical features were not different from classic PD,  except for 1 patient who presented with monosymptomatic leg rest tremor of 8 years' duration. In addition,  a 91-year-old unaffected relative of a patient with the G2019S mutation was found to be a mutation carrier. The G2019S mutation frequency in PD patients from northeast Spain is similar to that reported in other European regions. The R1441G mutation is very uncommon in Catalonia. The presence of an aged unaffected G2019S mutation carrier supports the previously described occurrence of incomplete penetrance in PD patients with LRRK2 mutations. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Serine,  Child,  Preschool,  Family Health,  Male,  Glycine,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Spain,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Arginine,  DNA Mutational Analysis,  Pedigree,  Adolescent,  Age of Onset,  Aged,  80 and over,  Adult,  Female,  Aged,  Mutation,  Child]"} , { "attrname": "AUTHORS", "value": "[Carles Gaig,  Mario Ezquerra,  Maria Jose Marti,  Esteban Muoz,  Francesc Valldeoriola,  Eduardo Tolosa]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 CYS-1441; GLY-1441 AND SER-2019]"} ], "id": "532", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16533964", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16533964"} , { "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.63.3.377"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15929036", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15929036", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation."} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Female,  Male,  Aged,  North America,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Hao Deng,  Weidong Le,  Yi Guo,  Christine B Hunter,  Wenjie Xie,  Joseph Jankovic]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "533", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15929036", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15929036"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20510"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  TISSUE SPECIFICITY,  VARIANTS PARK8 VAL-1122; CYS-1441; CYS-1699 AND THR-2020]", "conames": [{ "name": "PMID: 15541309", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15541309", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Lrrk2 protein,  mouse,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  leucine-rich repeat proteins,  EC 2.7.- Protein Kinases]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology."} , { "attrname": "Abstract", "value": "We have previously linked families with autosomal-dominant,  late-onset <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism to chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and candidate gene sequencing in 46 families,  we have found six <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-segregating mutations (five missense and one putative splice site mutation) in a gene encoding a large,  multifunctional protein,  LRRK2 (leucine-rich repeat kinase 2). It belongs to the ROCO protein family and includes a protein kinase domain of the MAPKKK class and several other major functional domains. Within affected carriers of families A and D,  six post mortem diagnoses reveal brainstem dopaminergic degeneration accompanied by strikingly diverse pathologies. These include abnormalities consistent with Lewy body <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  diffuse Lewy body <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  nigral degeneration without distinctive histopathology,  and progressive supranuclear palsy-like pathology. Clinical diagnoses of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism with dementia or amyotrophy or both,  with their associated pathologies,  are also noted. Hence,  LRRK2 may be central to the pathogenesis of several major neurodegenerative disorders associated with <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Amino Acid Sequence,  Brain,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Male,  Chromosome Mapping,  Lewy Bodies,  Reverse Transcriptase Polymerase Chain Reaction,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Proteins,  Blotting,  Northern,  Protein Kinases,  Pedigree,  Adult,  Female,  Mutation,  Nerve Degeneration,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[Alexander Zimprich,  Saskia Biskup,  Petra Leitner,  Peter Lichtner,  Matthew Farrer,  Sarah Lincoln,  Jennifer Kachergus,  Mary Hulihan,  Ryan J Uitti,  Donald B Calne,  A Jon Stoessl,  Ronald F Pfeiffer,  Nadja Patenge,  Iria Carballo Carbajal,  Peter Vieregge,  Friedrich Asmus,  Bertram Mller-Myhsok,  Dennis W Dickson,  Thomas Meitinger,  Tim M Strom,  Zbigniew K Wszolek,  Thomas Gasser]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA],  TISSUE SPECIFICITY,  VARIANTS PARK8 VAL-1122; CYS-1441; CYS-1699 AND THR-2020]"} ], "id": "534", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15541309", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15541309"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEURON.2004.11.005"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 16102999", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16102999", "attributes": [{ "attrname": "JOURNAL_REF", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism & related disorders"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  46627O600J Levodopa]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Clinical traits of LRRK2-associated <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in Ireland:  a link between familial and idiopathic PD."} , { "attrname": "Abstract", "value": "The role of genetics in <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism has been confirmed over the last decade with the identification of genetic variation in seven genes,  which are causative in familial forms of the disorder. A number of pathogenic mutations have been identified in the latest gene LRRK2,  with a Gly2019Ser amino acid substitution identified in two siblings and one patient with idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> from Ireland. The clinical features resemble the idiopathic variant with a tremor predominant clinical picture shared by the siblings,  slow progression of symptoms,  and no observation of cognitive disturbance in all. The family and the sporadic individual were apparently not related and originated from different regions of Ireland,  although haplotype analysis does suggest they share a common founder. The influence of the G2019S substitution on protein function and <span style=\"background-color: yellow\"><b>disease<\/b><\/span> phenotype has yet to be fully resolved,  but its elucidation will undoubtedly further our understanding of the mechanisms underlying <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  Male,  Cognition,  Functional Laterality,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Progression,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Neuropsychological Tests,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ireland,  Adult,  Levodopa,  Mutation,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[David Gosal,  Owen A Ross,  Joe Wiley,  G Brent Irvine,  Janet A Johnston,  Mathias Toft,  Ignacio F Mata,  Jennifer Kachergus,  Mary Hulihan,  Julie P Taylor,  Sarah J Lincoln,  Matthew J Farrer,  Timothy Lynch,  J Mark Gibson]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "535", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16102999", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.PARKRELDIS.2005.05.004"} , { "elementOf": "NLM", "accession": "16102999"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 16240353", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16240353", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  TE7660XO1C Glycine,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "G2019S LRRK2 mutation in French and North African families with Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in LRRK2 were recently identified in autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  including the G2019S mutation. To evaluate its frequency,  we analyzed 198 probands with autosomal dominant PD,  mostly from France and North Africa. Surprisingly,  the frequency in North African families (7\/17,  41%) was greater than those from Europe (5\/174,  2.9%). The clinical features in 21 patients,  including 1 with a homozygous mutation,  were those of typical PD,  with lower Mini-Mental State Examination scores. There were also 15 unaffected mutation carriers,  aged 32 to 74 years. LRRK2 mutations appear to be a common cause of autosomal dominant PD,  particularly in North Africa. "} , { "attrname": "MeSH", "value": "[Africa,  Northern,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Serine,  Family Health,  Genotype,  Male,  Glycine,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Aged,  80 and over,  Mental Status Schedule,  Adult,  Female,  Aged,  Mutation,  France]"} , { "attrname": "AUTHORS", "value": "[Suzanne Lesage,  Pablo Ibanez,  Ebba Lohmann,  Pierre Pollak,  Franois Tison,  Myriem Tazir,  Anne-Louise Leutenegger,  Joao Guimaraes,  Anne-Marie Bonnet,  Yves Agid,  Alexandra Drr,  Alexis Brice,   French <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Genetics Study Group]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "536", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16240353", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16240353"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20636"} ]} , { "annotation": "[VARIANT PARK8 GLN-1067]", "conames": [{ "name": "PMID: 16247070", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16247070", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Analysis of LRRK2 functional domains in nondominant Parkinson disease."} , { "attrname": "Abstract", "value": "A comprehensive sequence analysis of 29 exons that code for the functional domains of LRRK2 in 160 nondominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) patients was performed. Novel variant screening in a further 470 sporadic PD patients and 630 controls revealed two novel variants (R1067Q and IVS33 + 6 T>A),  which are likely to be pathogenic in five patients. One patient presented initially with a typical essential tremor phenotype,  expanding the phenotypic spectrum of LRRK2 mutations. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Amino Acid Sequence,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Testing,  Exons,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Genotype,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Phenotype,  DNA Mutational Analysis,  Age of Onset,  Aged,  80 and over,  Sex Distribution,  Adult,  Female,  Aged,  Mutation,  Continental Population Groups,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[L Skipper,  H Shen,  E Chua,  C Bonnard,  P Kolatkar,  L C S Tan,  R D Jamora,  K Puvan,  K Y Puong,  Y Zhao,  R Pavanni,  M C Wong,  Y Yuen,  M Farrer,  J J Liu,  E K Tan]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 GLN-1067]"} ], "id": "537", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16247070", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000180517.70572.37"} , { "elementOf": "NLM", "accession": "16247070"} ]} , { "annotation": "[VARIANTS PARK8 VAL-1371; CYS-1441 AND SER-2019]", "conames": [{ "name": "PMID: 16333314", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16333314", "attributes": [{ "attrname": "JOURNAL_REF", "value": "European journal of human genetics :  EJHG"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in the gene leucine-rich repeat kinase 2 (LRRK2) have been recently identified in families with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). However,  the prevalence and nature of LRRK2 mutations,  the polymorphism content of the gene,  and the associated phenotypes remain poorly understood. We performed a comprehensive study of this gene in a large sample of families with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> compatible with autosomal dominant inheritance (ADPD). The full-length open reading frame and splice sites of the LRRK2 gene (51 exons) were studied by genomic sequencing in 60 probands with ADPD (83% Italian). Pathogenic mutations were identified in six probands (10%):  the heterozygous p.G2019S mutation in four (6.6%),  and the heterozygous p.R1441C mutation in two (3.4%) probands. A further proband carried the heterozygous p.I1371 V mutation,  for which a pathogenic role could not be established with certainty. In total,  13 novel <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-unrelated variants and three intronic changes of uncertain significance were also characterized. The phenotype associated with LRRK2 pathogenic mutations is the one of typical PD,  but with a broad range of onset ages (mean 55.2,  range 38-68 years) and,  in some cases,  slow <span style=\"background-color: yellow\"><b>disease<\/b><\/span> progression. On the basis of the comprehensive study in a large sample,  we conclude that pathogenic LRRK2 mutations are frequent in ADPD,  and they cluster in the C-terminal half of the encoded protein. These data have implications both for understanding the molecular mechanisms of PD,  and for directing the genetic screening in clinical practice. "} , { "attrname": "MeSH", "value": "[Genetic Testing,  Alternative Splicing,  Exons,  Humans,  Middle Aged,  Open Reading Frames,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Family Health,  Male,  Genes,  Dominant,  Adult,  Female,  Protein Structure,  Tertiary,  Amino Acid Sequence,  Genotype,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Progression,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Phenotype,  Animals,  Pedigree,  Heterozygote,  Aged,  Models,  Genetic,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Alessio Di Fonzo,  Cristina Tassorelli,  Michele De Mari,  Hsin F Chien,  Joaquim Ferreira,  Christan F Roh,  Giulio Riboldazzi,  Angelo Antonini,  Gianni Albani,  Alessandro Mauro,  Roberto Marconi,  Giovanni Abbruzzese,  Leonardo Lopiano,  Emiliana Fincati,  Marco Guidi,  Paolo Marini,  Fabrizio Stocchi,  Marco Onofrj,  Vincenzo Toni,  Michele Tinazzi,  Giovanni Fabbrini,  Paolo Lamberti,  Nicola Vanacore,  Giuseppe Meco,  Petra Leitner,  Ryan J Uitti,  Zbigniew K Wszolek,  Thomas Gasser,  Erik J Simons,  Guido J Breedveld,  Stefano Goldwurm,  Gianni Pezzoli,  Cristina Sampaio,  Egberto Barbosa,  Emilia Martignoni,  Ben A Oostra,  Vincenzo Bonifati,   Italian <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s Genetics Network]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 VAL-1371; CYS-1441 AND SER-2019]"} ], "id": "538", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16333314", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/SJ.EJHG.5201539"} , { "elementOf": "NLM", "accession": "16333314"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15732108", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15732108", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  2C598205QX fluorodopa F 18,  63-84-3 Dihydroxyphenylalanine,  TE7660XO1C Glycine,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Clinical and positron emission tomography of Parkinson's disease caused by LRRK2."} , { "attrname": "Abstract", "value": "We have recently identified mutations in a gene leucine-rich repeat kinase-2 (LRRK2),  which cause autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here,  we describe two families with autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> caused by a LRRK2 G2019S mutation. We present here a clinical description of patients,  including 6-(18)F-fluoro-L-dopa positron emission tomography and discuss the potential implications of this mutation,  which alters a conserved residue in a domain required for kinase activation. "} , { "attrname": "MeSH", "value": "[Dihydroxyphenylalanine,  Amino Acid Sequence,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Family Health,  Genotype,  Male,  Positron-Emission Tomography,  Glycine,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  DNA Mutational Analysis,  Pedigree,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Dena G Hernandez,  Coro Paisn-Ruz,  Aideen McInerney-Leo,  Shushant Jain,  Andreas Meyer-Lindenberg,  E Whitney Evans,  Karen F Berman,  Janel Johnson,  Georg Auburger,  Alejandro A Schffer,  Grisel J Lopez,  Robert L Nussbaum,  Andrew B Singleton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "539", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15732108", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20401"} , { "elementOf": "NLM", "accession": "15732108"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 16272257", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16272257", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of medical genetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and originates from a common ancestor."} , { "attrname": "Abstract", "value": "Mutations in the gene Leucine-Rich Repeat Kinase 2 (LRRK2) were recently identified as the cause of PARK8 linked autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. To study recurrent LRRK2 mutations in a large sample of patients from Italy,  including early (<50 years) and late onset familial and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Among 629 probands,  13 (2.1%) were heterozygous carriers of the G2019S mutation. The mutation frequency was higher among familial (5.1%,  9\/177) than among sporadic probands (0.9%,  4\/452) (p<0.002),  and highest among probands with one affected parent (8.7%,  6\/69) (p<0.001). There was no difference in the frequency of the G2019S mutation in probands with early v late onset <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Among 600 probands,  one heterozygous R1441C but no R1441G or Y1699C mutations were detected. None of the four mutations was found in Italian controls. Haplotype analysis in families from five countries suggested that the G2019S mutation originated from a single ancient founder. The G2019S mutation was associated with the classical <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> phenotype and a broad range of onset age (34 to 73 years). G2019S is the most common genetic determinant of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> identified so far. It is especially frequent among cases with familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> of both early and late onset,  but less common among sporadic cases. These findings have important implications for diagnosis and genetic counselling in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Founder Effect,  Base Sequence,  Alleles,  Adult,  Female,  Heterozygote,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[S Goldwurm,  A Di Fonzo,  E J Simons,  C F Roh,  M Zini,  M Canesi,  S Tesei,  A Zecchinelli,  A Antonini,  C Mariani,  N Meucci,  G Sacilotto,  F Sironi,  G Salani,  J Ferreira,  H F Chien,  E Fabrizio,  N Vanacore,  A Dalla Libera,  F Stocchi,  C Diroma,  P Lamberti,  C Sampaio,  G Meco,  E Barbosa,  A M Bertoli-Avella,  G J Breedveld,  B A Oostra,  G Pezzoli,  V Bonifati]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "540", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16272257", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16272257"} , { "elementOf": "DOI", "accession": "10.1136\/JMG.2005.035568"} ]} , { "annotation": "[VARIANT PARK8 GLY-1441];", "conames": [{ "name": "PMID: 15925109", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15925109", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "LRRK2 R1441G in Spanish patients with Parkinson's disease."} , { "attrname": "Abstract", "value": "Pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2; PARK8) have been implicated in autosomal dominant,  late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The LRRK2 4321C>G (R1441G) mutation was originally identified in Spanish families originating from the Basque region. Within this ethnicity,  Lrrk2 R1441G substitutions have been suggested as a frequent cause of <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Herein we have assessed another referral-based series of 225 patients with PD from the neighboring region of Asturias,  Northern Spain. The LRRK2 4321C>G mutation was found in 5 (2.7%) of sporadic,  late-onset patients and was not present in control subjects. Although patients with a Lrrk2 R1441G substitution are apparently unrelated,  they share a chromosome 12q12 haplotype not found in controls and indicative of a common founder. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Genotype,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Spain,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Polymerase Chain Reaction,  Adult,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Ignacio F Mata,  Julie P Taylor,  Jennifer Kachergus,  Mary Hulihan,  Cecilia Huerta,  Carlos Lahoz,  Marta Blazquez,  Luis M Guisasola,  Carlos Salvador,  Renee Ribacoba,  Carmen Martinez,  Matthew Farrer,  Victoria Alvarez]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 GLY-1441]"} ], "id": "541", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15925109", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15925109"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEULET.2005.03.033"} ]} , { "annotation": "[VARIANT SER-2019]", "conames": [{ "name": "PMID: 16001413", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16001413", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Movement disorders :  official journal of the Movement Disorder Society"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  TE7660XO1C Glycine,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Escaping Parkinson's disease:  a neurologically healthy octogenarian with the LRRK2 G2019S mutation."} , { "attrname": "MeSH", "value": "[Follow-Up Studies,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Family Health,  Male,  Glycine,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Aged,  80 and over,  Adult,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Denise M Kay,  Patricia Kramer,  Don Higgins,  Cyrus P Zabetian,  Haydeh Payami]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT SER-2019]"} ], "id": "542", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16001413", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16001413"} , { "elementOf": "DOI", "accession": "10.1002\/MDS.20618"} ]} , { "annotation": "[VARIANTS PARK8 MET-793; ARG-930; CYS-1096 THR-1228; SER-2019 AND THR-2020,  VARIANT LYS-551]", "conames": [{ "name": "PMID: 16251215", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16251215", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Brain :  a journal of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  DNA Primers]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*."} , { "attrname": "MeSH", "value": "[Haplotypes,  Brain,  Exons,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Male,  Penetrance,  Mutation,  Missense,  DNA Primers,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Neuropsychological Tests,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Magnetic Resonance Imaging,  Echoencephalography,  Genes,  Dominant,  DNA Mutational Analysis,  Pedigree,  Adult,  Female,  Spectrometry,  Mass,  Matrix-Assisted Laser Desorption-Ionization]"} , { "attrname": "AUTHORS", "value": "[Daniela Berg,  Katherine J Schweitzer,  Petra Leitner,  Alexander Zimprich,  Peter Lichtner,  Petra Belcredi,  Theresa Brssel,  Claudia Schulte,  Sylvia Maass,  Thomas Ngele,  Zbigniew K Wszolek,  Thomas Gasser]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 MET-793; ARG-930; CYS-1096 THR-1228; SER-2019 AND THR-2020,  VARIANT LYS-551]"} ], "id": "543", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16251215", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16251215"} , { "elementOf": "DOI", "accession": "10.1093\/BRAIN\/AWH666"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1333-1516 IN COMPLEX WITH GDP,  FUNCTION,  GTPASE ACTIVITY,  SUBUNIT,  DOMAIN ROC,  MUTAGENESIS OF THR-1343 AND ARG-1398];", "conames": [{ "name": "PMID: 18230735", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18230735", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 3.6.1.- GTP Phosphohydrolases,  EC 3.6.5.2 ras Proteins]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Structure of the ROC domain from the <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase."} , { "attrname": "Abstract", "value": "Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). LRRK2 contains a Ras of complex proteins (ROC) domain that may act as a GTPase to regulate its protein kinase activity. The structure of ROC and the mechanism(s) by which it regulates kinase activity are not known. Here,  we report the crystal structure of the LRRK2 ROC domain in complex with GDP-Mg(2+) at 2.0-A resolution. The structure displays a dimeric fold generated by extensive domain-swapping,  resulting in a pair of active sites constructed with essential functional groups contributed from both monomers. Two PD-associated pathogenic residues,  R1441 and I1371,  are located at the interface of two monomers and provide exquisite interactions to stabilize the ROC dimer. The structure demonstrates that loss of stabilizing forces in the ROC dimer is likely related to decreased GTPase activity resulting from mutations at these sites. Our data suggest that the ROC domain may regulate LRRK2 kinase activity as a dimer,  possibly via the C-terminal of ROC (COR) domain as a molecular hinge. The structure of the LRRK2 ROC domain also represents a signature from a previously undescribed class of GTPases from complex proteins and results may provide a unique molecular target for therapeutics in PD. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Protein Structure,  Tertiary,  GTP Phosphohydrolases,  ras Proteins,  Humans,  Protein-Serine-Threonine Kinases,  Protein Conformation,  Dimerization,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Junpeng Deng,  Patrick A Lewis,  Elisa Greggio,  Eli Sluch,  Alexandra Beilina,  Mark R Cookson]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1333-1516 IN COMPLEX WITH GDP,  FUNCTION,  GTPASE ACTIVITY,  SUBUNIT,  DOMAIN ROC,  MUTAGENESIS OF THR-1343 AND ARG-1398]"} ], "id": "544", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18230735", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0709098105"} , { "elementOf": "NLM", "accession": "18230735"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK8 CYS-1441 AND SER-2019]", "conames": [{ "name": "PMID: 16269541", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16269541", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  DNA Primers,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) with a clinical appearance indistinguishable from idiopathic PD. Initial studies suggest that LRRK2 mutations are the most common yet identified determinant of PD susceptibility,  transmitted in an autosomal-dominant mode of inheritance. Herein,  we characterize the LRRK2 gene and transcript in human brain and subclone the predominant ORF. Exogenously expressed LRRK2 protein migrates at approximately 280 kDa and is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Familial-linked mutations G2019S or R1441C do not have an obvious effect on protein steady-state levels,  turnover,  or localization. However,  in vitro kinase assays using full-length recombinant LRRK2 reveal an increase in activity caused by familial-linked mutations in both autophosphorylation and the phosphorylation of a generic substrate. These results suggest a gain-of-function mechanism for LRRK2-linked <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a central role for kinase activity in the development of PD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Phosphorylation,  Humans,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  DNA Primers,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Base Sequence,  Fluorescent Antibody Technique,  Mutation,  Subcellular Fractions,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[Andrew B West,  Darren J Moore,  Saskia Biskup,  Artem Bugayenko,  Wanli W Smith,  Christopher A Ross,  Valina L Dawson,  Ted M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK8 CYS-1441 AND SER-2019]"} ], "id": "545", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16269541", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16269541"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0507360102"} ]} , { "annotation": "[WD REPEATS]", "conames": [{ "name": "PMID: 23776530", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23776530", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PloS one"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Proteins,  LRRN1 protein,  human,  Neoplasm Proteins]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "A method for WD40 repeat detection and secondary structure prediction."} , { "attrname": "Abstract", "value": "WD40-repeat proteins (WD40s),  as one of the largest protein families in eukaryotes,  play vital roles in assembling protein-protein\/DNA\/RNA complexes. WD40s fold into similar ?-propeller structures despite diversified sequences. A program WDSP (WD40 repeat protein Structure Predictor) has been developed to accurately identify WD40 repeats and predict their secondary structures. The method is designed specifically for WD40 proteins by incorporating both local residue information and non-local family-specific structural features. It overcomes the problem of highly diversified protein sequences and variable loops. In addition,  WDSP achieves a better prediction in identifying multiple WD40-domain proteins by taking the global combination of repeats into consideration. In secondary structure prediction,  the average Q3 accuracy of WDSP in jack-knife test reaches 93.7%. A disease related protein LRRK2 was used as a representive example to demonstrate the structure prediction. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Proteins,  Animals,  Protein Structure,  Secondary,  Databases,  Protein,  Humans,  Neoplasm Proteins]"} , { "attrname": "AUTHORS", "value": "[Yang Wang,  Fan Jiang,  Zhu Zhuo,  Xian-Hui Wu,  Yun-Dong Wu]"} , { "attrname": "PUB_TYPE", "value": "[WD REPEATS]"} ], "id": "546", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23776530", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PONE.0065705"} , { "elementOf": "NLM", "accession": "23776530"} ]} , { "annotation": "[SUBUNIT,  AUTOPHOSPHORYLATION];", "conames": [{ "name": "PMID: 22952686", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22952686", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PloS one"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.11.1 LRRK1 protein,  human,  leucine-rich repeat proteins,  8L70Q75FXE Adenosine Triphosphate]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers."} , { "attrname": "Abstract", "value": "Leucine-rich repeat kinase 1 and 2 (LRRK1 and LRRK2) are large multidomain proteins containing kinase,  GTPase and multiple protein-protein interaction domains,  but only mutations in LRRK2 are linked to familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). Independent studies suggest that LRRK2 exists in the cell as a complex compatible with the size of a dimer. However,  whether this complex is truly a homodimer or a heterologous complex formed by monomeric LRRK2 with other proteins has not been definitively proven due to the limitations in obtaining highly pure proteins suitable for structural characterization. Here,  we used stable expression of LRRK1 and LRRK2 in HEK293T cell lines to produce recombinant LRRK1 and LRRK2 proteins of greater than 90% purity. Both purified LRRKs are folded,  with a predominantly alpha-helical secondary structure and are capable of binding GTP with similar affinity. Furthermore,  recombinant LRRK2 exhibits robust autophosphorylation activity,  phosphorylation of model peptides in vitro and ATP binding. In contrast,  LRRK1 does not display significant autophosphorylation activity and fails to phosphorylate LRRK2 model substrates,  although it does bind ATP. Using these biochemically validated proteins,  we show that LRRK1 and LRRK2 are capable of forming homodimers as shown by single-particle transmission electron microscopy and immunogold labeling. These LRRK dimers display an elongated conformation with a mean particle size of 145  and 175  respectively,  which is disrupted by addition of 6M guanidinium chloride. Immunogold staining revealed double-labeled particles also in the pathological LRRK2 mutant G2019S and artificial mutants disrupting GTPase and kinase activities,  suggesting that point mutations do not hinder the dimeric conformation. Overall,  our findings indicate for the first time that purified and active LRRK1 and LRRK2 can form dimers in their full-length conformation. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Microscopy,  Electron,  Transmission,  Phosphorylation,  Humans,  Protein-Serine-Threonine Kinases,  Adenosine Triphosphate,  Lentivirus,  Chromatography,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Proteins,  Point Mutation,  HEK293 Cells,  Protein Binding,  Mutation,  Circular Dichroism,  Dimerization,  Microscopy,  Fluorescence]"} , { "attrname": "AUTHORS", "value": "[Laura Civiero,  Rene Vancraenenbroeck,  Elisa Belluzzi,  Alexandra Beilina,  Evy Lobbestael,  Lauran Reyniers,  Fangye Gao,  Ivan Micetic,  Marc De Maeyer,  Luigi Bubacco,  Veerle Baekelandt,  Mark R Cookson,  Elisa Greggio,  Jean-Marc Taymans]"} , { "attrname": "PUB_TYPE", "value": "[SUBUNIT,  AUTOPHOSPHORYLATION]"} ], "id": "547", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22952686", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22952686"} , { "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PONE.0043472"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 16250030", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16250030", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Movement disorders :  official journal of the Movement Disorder Society"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  TE7660XO1C Glycine,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Parkinson's disease and LRRK2:  frequency of a common mutation in U.S. movement disorder clinics."} , { "attrname": "Abstract", "value": "The G2019S mutation in the LRRK2 gene is reportedly a common cause of familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) and may also have a significant role in nonfamilial PD. The objective of this study was to assess mutation carrier frequency in PD patients from movement disorder clinics in the United States,  stratified by family history,  age at onset,  and geography; to determine carrier frequency in a large and well-characterized control population; to examine segregation of mutation in families of patients; and to correlate genotype with clinical phenotype. One thousand four hundred twenty-five unrelated PD patients from movement disorder clinics in Oregon,  Washington,  and New York and 1, 647 unrelated controls were studied. The G2019S mutation was detected using a TaqMan assay and verified by sequencing. Eighteen of 1, 425 patients and one of 1, 647 controls had the mutation. Carrier frequency (+\/- 2SE) in patients was 0.013 +\/- 0.006 overall,  0.030 +\/- 0.019 in familial PD,  0.007 +\/- 0.005 in nonfamilial PD,  0.016 +\/- 0.013 in early-onset PD,  and 0.012 +\/- 0.007 in late-onset PD. Geographic differences were insignificant. Age at onset of mutation carriers ranged from 28 to 71 years. Mutation carriers were clinically indistinguishable from idiopathic PD. LRRK2 G2019S is the single most common pathogenic mutation linked to neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span> to date. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  United States,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Serine,  Family Health,  Genotype,  Male,  Glycine,  Movement Disorders,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Mutational Analysis,  Adolescent,  Age of Onset,  Aged,  80 and over,  Adult,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Denise M Kay,  Cyrus P Zabetian,  Stewart A Factor,  John G Nutt,  Ali Samii,  Alida Griffith,  Tom D Bird,  Patricia Kramer,  Donald S Higgins,  Haydeh Payami]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "548", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16250030", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/MDS.20751"} , { "elementOf": "NLM", "accession": "16250030"} ]} , { "annotation": "[ASSOCIATION OF VARIANTS PRO-1628 AND ARG-2385 WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conames": [{ "name": "PMID: 21641266", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21641266", "attributes": [{ "attrname": "JOURNAL_REF", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism & related disorders"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a common neurodegenerative disorder characterized by the progressive and selective degeneration of nigrostriatal dopaminergic neurons. The discovery of at least six PD-causing genes in predominantly early-onset forms of the disorder has cemented a genetic component to the etiology. Notably,  the discovery of mutations in the LRRK2 gene in patients presenting with typical 'sporadic' PD with ages at onset in their sixties and seventies has shifted paradigms in the field of PD research. The G2019S mutation in LRRK2 has been found in diverse populations worldwide and usually resides on a common haplotype revealing that many of these individuals share a common ancestor,  probably of Middle Eastern origin. The only validated coding susceptibility alleles for PD,  G2385R and R1628P,  are both in this gene but to date have been found exclusively in Asian populations. Concomitant with genetic testing for PD is the need for appropriate and informed genetic counseling. Families of patients with LRRK2 mutations and susceptibility alleles need to be informed about the current lack of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> preventative strategies and the implications surrounding incomplete penetrance. In summary,  single-handedly LRRK2 has had a major impact on the field of PD research and the findings have been of interest to both clinicians and scientists. We anticipate that other genes of such major impact exist for PD and look forward to their discovery. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Protein-Serine-Threonine Kinases,  Mutation,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Soraya Bardien,  Suzanne Lesage,  Alexis Brice,  Jonathan Carr]"} , { "attrname": "PUB_TYPE", "value": "[ASSOCIATION OF VARIANTS PRO-1628 AND ARG-2385 WITH PARKINSON DISEASE]"} ], "id": "549", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21641266", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.PARKRELDIS.2010.11.008"} , { "elementOf": "NLM", "accession": "21641266"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 16298482", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16298482", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  46627O600J Levodopa]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repat kinase 2 (LRRK2) gene have been shown to cause both autosomal dominant and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The common G2019S mutation shows wide geographical distribution while R1441G has been only reported in Northern Spain. The overall frequency of these mutations remains to be established. To determine the prevalence of G2019S and R1441G mutations in our population of Cantabria (Northern Spain),  we recruited 105 consecutive PD patients and 310 controls and conducted genetic analysis of these mutations. G2019S was detected in eight late-onset patients (7.6%). Five of them had no relevant family history. R1441G was not detected in any of our study subjects. The prevalence of G2019S mutation in unselected late-onset PD patients might be higher than previously reported:  3\/16 (18.7%) of familial PD and 5\/82 (6.1%) of sporadic PD. "} , { "attrname": "MeSH", "value": "[Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Anti<span style=\"background-color: yellow\"><b>parkinson<\/b><\/span> Agents,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Spain,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Age of Onset,  Female,  Aged,  Levodopa,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Jon Infante,  Eloy Rodrguez,  Onofre Combarros,  Ignacio Mateo,  Ana Fontalba,  Julio Pascual,  Agustn Oterino,  Jos Miguel Polo,  Carlos Leno,  Jos Berciano]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "550", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16298482", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.NEULET.2005.10.083"} , { "elementOf": "NLM", "accession": "16298482"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANT PARK8 THR-2020]", "conames": [{ "name": "PMID: 16321986", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16321986", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The LRRK2 protein consists of multiple domains and belongs to the Roco family,  a novel group of the Ras\/GTPase superfamily. Besides the GTPase (Roc) domain,  it contains a predicted kinase domain,  with homology to MAP kinase kinase kinases. Using cell fractionation and immunofluorescence microscopy,  we show that LRRK2 is localized in the cytoplasm and is associated with cellular membrane structures. The purified LRRK2 protein demonstrates autokinase activity. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated I2020T mutant shows a significant increase in autophosphorylation of approximately 40% in comparison to wild-type protein in vitro. This suggests that the pathology of PD caused by the I2020T mutation is associated with an increase rather than a loss in LRRK2 kinase activity. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cell Line,  Cell Fractionation,  Phosphorylation,  Humans,  Mass Spectrometry,  Protein-Serine-Threonine Kinases,  Mutation,  Missense,  Blotting,  Western,  Cytoplasm,  Microscopy,  Fluorescence,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Christian Johannes Gloeckner,  Norbert Kinkl,  Annette Schumacher,  Ralf J Braun,  Eric O'Neill,  Thomas Meitinger,  Walter Kolch,  Holger Prokisch,  Marius Ueffing]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANT PARK8 THR-2020]"} ], "id": "551", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16321986", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16321986"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/DDI439"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH PRDX3,  CHARACTERIZATION OF VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 21850687", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21850687", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Reactive Oxygen Species,  EC 1.11.1.15 Peroxiredoxin III]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death."} , { "attrname": "Abstract", "value": "Mutations in the leucine rich repeat kinase 2 (LRRK2) gene are responsible for autosomal dominant and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  possibly exerting their effects via a toxic gain of function. A common p.G2019S mutation (rs34637584: A>G) is responsible for up to 30-40% of PD cases in some ethnic populations. Here,  we show that LRRK2 interacts with human peroxiredoxin 3 (PRDX3),  a mitochondrial member of the antioxidant family of thioredoxin (Trx) peroxidases. Importantly,  mutations in the LRRK2 kinase domain significantly increased phosphorylation of PRDX3 compared to wild-type. The increase in PRDX3 phosphorylation was associated with decreased peroxidase activity and increased death in LRRK2-expressing but not in LRRK2-depleted or vector-transfected neuronal cells. LRRK2 mutants stimulated mitochondrial factors involved in apoptosis and induced production of reactive oxygen species (ROS) and oxidative modification of macromolecules. Furthermore,  immunoblot and immunohistochemical analysis of postmortem human PD patients carrying the p.G2019S mutation showed a marked increase in phosphorylated PRDX3 (p-PRDX3) relative to normal brain. We showed that LRRK2 mutations increase the inhibition of an endogenous peroxidase by phosphorylation promoting dysregulation of mitochondrial function and oxidative damage. Our findings provide a mechanistic link between the enhanced kinase activity of PD-linked LRRK2 and neuronal cell death. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Mitochondria,  Phosphorylation,  Reactive Oxygen Species,  Oxidative Stress,  Neurons,  Humans,  Protein-Serine-Threonine Kinases,  Cell Death,  Mutation,  Peroxiredoxin III,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Dario C Angeles,  Bong-Hwa Gan,  Luisa Onstead,  Yi Zhao,  Kah-Leong Lim,  Justus Dachsel,  Heather Melrose,  Matt Farrer,  Zbigniew K Wszolek,  Dennis W Dickson,  Eng-King Tan]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION,  INTERACTION WITH PRDX3,  CHARACTERIZATION OF VARIANT PARK8 SER-2019]"} ], "id": "552", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21850687", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/HUMU.21582"} , { "elementOf": "NLM", "accession": "21850687"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 17120249", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17120249", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Lrrk2 protein,  mouse,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  R-SNARE Proteins]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Localization of LRRK2 to membranous and vesicular structures in mammalian brain."} , { "attrname": "Abstract", "value": "The PARK8 gene responsible for late-onset autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> encodes a large novel protein of unknown biological function termed leucine-rich repeat kinase 2 (LRRK2). The studies herein explore the localization of LRRK2 in the mammalian brain. Polyclonal antibodies generated against the amino or carboxy termini of LRRK2 were used to examine the biochemical,  subcellular,  and immunohistochemical distribution of LRRK2. LRRK2 is detected in rat brain as an approximate 280kDa protein by Western blot analysis. Subcellular fractionation demonstrates the presence of LRRK2 in microsomal,  synaptic vesicle-enriched and synaptosomal cytosolic fractions from rat brain,  as well as the mitochondrial outer membrane. Immunohistochemical analysis of rat and human brain tissue and primary rat cortical neurons,  with LRRK2-specific antibodies,  shows widespread neuronal-specific labeling localized exclusively to punctate structures within perikarya,  dendrites,  and axons. Confocal colocalization analysis of primary cortical neurons shows partial yet significant overlap of LRRK2 immunoreactivity with markers specific for mitochondria and lysosomes. Furthermore,  ultrastructural analysis in rodent basal ganglia detects LRRK2 immunoreactivity associated with membranous and vesicular intracellular structures,  including lysosomes,  endosomes,  transport vesicles,  and mitochondria. The association of LRRK2 with a variety of membrane and vesicular structures,  membrane-bound organelles,  and microtubules suggests an affinity of LRRK2 for lipids or lipid-associated proteins and may suggest a potential role in the biogenesis and\/or regulation of vesicular and membranous intracellular structures within the mammalian brain. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Neurons,  Humans,  Protein-Serine-Threonine Kinases,  R-SNARE Proteins,  Rats,  Antibody Affinity,  Blotting,  Western,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Animals,  Biological Transport,  Mice,  Subcellular Fractions]"} , { "attrname": "AUTHORS", "value": "[Saskia Biskup,  Darren J Moore,  Fulvio Celsi,  Shinji Higashi,  Andrew B West,  Shaida A Andrabi,  Kaisa Kurkinen,  Seong-Woon Yu,  Joseph M Savitt,  Henry J Waldvogel,  Richard L M Faull,  Piers C Emson,  Reidun Torp,  Ole P Ottersen,  Ted M Dawson,  Valina L Dawson]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]"} ], "id": "553", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17120249", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.21019"} , { "elementOf": "NLM", "accession": "17120249"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15811454", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15811454", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "LRRK2 mutations and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism."} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Age of Onset,  Amino Acid Substitution,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Mathias Toft,  Ignacio F Mata,  Jennifer M Kachergus,  Owen A Ross,  Matthew J Farrer]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "554", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15811454", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15811454"} , { "elementOf": "DOI", "accession": "10.1016\/S0140-6736(05)74809-1"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15726496", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15726496", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Identification of a novel LRRK2 mutation linked to autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism:  evidence of a common founder across European populations."} , { "attrname": "Abstract", "value": "Autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism has been attributed to pathogenic amino acid substitutions in leucine-rich repeat kinase 2 (LRRK2). By sequencing multiplex families consistent with a PARK8 assignment,  we identified a novel heterozygous LRRK2 mutation. A referral sample of 248 affected probands from families with autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism was subsequently assessed; 7 (2.8%) were found to carry a heterozygous LRRK2 6055G-->A transition (G2019S). These seven patients originate from the United States,  Norway,  Ireland,  and Poland. In samples of patients with idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) from the same populations,  further screening identified six more patients with LRRK2 G2019S; no mutations were found in matched control individuals. Subsequently,  42 family members of the 13 probands were examined; 22 have an LRRK2 G2019S substitution,  7 with a diagnosis of PD. Of note,  all patients share an ancestral haplotype indicative of a common founder,  and,  within families,  LRRK2 G2019S segregates with <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (multipoint LOD score 2.41). Penetrance is age dependent,  increasing from 17% at age 50 years to 85% at age 70 years. In summary,  our study demonstrates that LRRK2 G2019S accounts for <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism in several families within Europe and North America. Our work highlights the fact that a proportion of clinically typical,  late-onset PD cases have a genetic basis. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Age Factors,  United States,  Gene Frequency,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  European Continental Ancestry Group,  Male,  Penetrance,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genes,  Dominant,  Norway,  Pedigree,  Ireland,  Poland,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Jennifer Kachergus,  Ignacio F Mata,  Mary Hulihan,  Julie P Taylor,  Sarah Lincoln,  Jan Aasly,  J Mark Gibson,  Owen A Ross,  Timothy Lynch,  Joseph Wiley,  Haydeh Payami,  John Nutt,  Demetrius M Maraganore,  Krzysztof Czyzewski,  Maria Styczynska,  Zbigniew K Wszolek,  Matthew J Farrer,  Mathias Toft]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "555", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15726496", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15726496"} , { "elementOf": "DOI", "accession": "10.1086\/429256"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15680456", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15680456", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in the LRRK2 gene have been identified in families with autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. We amplified and sequenced the coding region of LRRK2 from genomic DNA by PCR,  and identified a heterozygous mutation (Gly2019 ser) present in four of 61 (6.6%) unrelated families with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and autosomal dominant inheritance. The families originated from Italy,  Portugal,  and Brazil,  indicating the presence of the mutation in different populations. The associated phenotype was broad,  including early and late <span style=\"background-color: yellow\"><b>disease<\/b><\/span> onset. These findings confirm the association of LRRK2 with neurodegeneration,  and identify a common mutation associated with dominantly inherited <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Genotype,  Sequence Analysis,  DNA,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Phenotype,  Genes,  Dominant,  Age of Onset,  Polymerase Chain Reaction,  Adult,  Aged]"} , { "attrname": "AUTHORS", "value": "[Alessio Di Fonzo,  Christan F Roh,  Joaquim Ferreira,  Hsin F Chien,  Laura Vacca,  Fabrizio Stocchi,  Leonor Guedes,  Edito Fabrizio,  Mario Manfredi,  Nicola Vanacore,  Stefano Goldwurm,  Guido Breedveld,  Cristina Sampaio,  Giuseppe Meco,  Egberto Barbosa,  Ben A Oostra,  Vincenzo Bonifati,   Italian <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> Genetics Network]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "556", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15680456", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0140-6736(05)70236-1"} , { "elementOf": "NLM", "accession": "15680456"} ]} , { "annotation": "[VARIANT PARK8 SER-2019]", "conames": [{ "name": "PMID: 15680455", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15680455", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene cause some forms of autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We measured the frequency of a novel mutation (Gly2019 ser) in familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> by screening genomic DNA of patients and controls. Of 767 affected individuals from 358 multiplex families,  35 (5%) individuals were either heterozygous (34) or homozygous (one) for the mutation,  and had typical clinical findings of idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Thus,  our results suggest that a single LRRK2 mutation causes <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in 5% of individuals with familial <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Screening for this mutation should be a component of genetic testing for <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Testing,  Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Genotype,  Male,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Homozygote,  Point Mutation,  Adolescent,  Aged,  80 and over,  Adult,  Heterozygote,  Aged]"} , { "attrname": "AUTHORS", "value": "[William C Nichols,  Nathan Pankratz,  Dena Hernandez,  Coro Paisn-Ruz,  Shushant Jain,  Cheryl A Halter,  Veronika E Michaels,  Terry Reed,  Alice Rudolph,  Clifford W Shults,  Andrew Singleton,  Tatiana Foroud,   <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> Study Group-PROGENI investigators]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 SER-2019]"} ], "id": "557", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15680455", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0140-6736(05)70235-X"} , { "elementOf": "NLM", "accession": "15680455"} ]} , { "annotation": "[FUNCTION,  SUBCELLULAR LOCATION,  ELECTRON MICROSCOPY,  WD REPEATS,  CHARACTERIZATION OF VARIANT ARG-2385]", "conames": [{ "name": "PMID: 24687852", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24687852", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular and cellular biology"} , { "attrname": "Chemical", "value": "[Mutant Proteins,  EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Neurotoxins,  Neuropeptides,  Gnb2-rs1 protein,  mouse]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "Leucine-rich repeat kinase 2 binds to neuronal vesicles through protein interactions mediated by its C-terminal WD40 domain."} , { "attrname": "Abstract", "value": "Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). LRRK2 is a complex protein that consists of multiple domains,  including predicted C-terminal WD40 repeats. In this study,  we analyzed functional and molecular features conferred by the WD40 domain. Electron microscopic analysis of the purified LRRK2 C-terminal domain revealed doughnut-shaped particles,  providing experimental evidence for its WD40 fold. We demonstrate that LRRK2 WD40 binds and sequesters synaptic vesicles via interaction with vesicle-associated proteins. In fact,  a domain-based pulldown approach combined with mass spectrometric analysis identified LRRK2 as being part of a highly specific protein network involved in synaptic vesicle trafficking. In addition,  we found that a C-terminal sequence variant associated with an increased risk of developing PD,  G2385R,  correlates with a reduced binding affinity of LRRK2 WD40 to synaptic vesicles. Our data demonstrate a critical role of the WD40 domain within LRRK2 function. "} , { "attrname": "MeSH", "value": "[Neurotoxins,  Neurons,  Humans,  Mice,  Inbred C57BL,  Protein-Serine-Threonine Kinases,  Cells,  Cultured,  Neuropeptides,  Structure-Activity Relationship,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Protein Interaction Mapping,  Mutant Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synaptic Vesicles,  Animals,  Protein Binding,  Mice,  Protein Interaction Domains and Motifs,  Mutation,  Synapses]"} , { "attrname": "AUTHORS", "value": "[Giovanni Piccoli,  Franco Onofri,  Maria Daniela Cirnaru,  Christoph J O Kaiser,  Pravinkumar Jagtap,  Andreas Kastenmller,  Francesca Pischedda,  Antonella Marte,  Felix von Zweydorf,  Andreas Vogt,  Florian Giesert,  Lifeng Pan,  Flavia Antonucci,  Christina Kiel,  Mingjie Zhang,  Sevil Weinkauf,  Michael Sattler,  Carlo Sala,  Michela Matteoli,  Marius Ueffing,  Christian Johannes Gloeckner]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  SUBCELLULAR LOCATION,  ELECTRON MICROSCOPY,  WD REPEATS,  CHARACTERIZATION OF VARIANT ARG-2385]"} ], "id": "558", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24687852", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "24687852"} , { "elementOf": "DOI", "accession": "10.1128\/MCB.00914-13"} ]} , { "annotation": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]", "conames": [{ "name": "PMID: 16087219", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16087219", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Mechanisms of ageing and development"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "LRRK2 mutations are not common in Alzheimer's disease."} , { "attrname": "Abstract", "value": "The development of common age-related neurodegenerative disorders as <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) are influenced by genetic factors. Recently,  pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been identified in familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism. Individuals in some of these families developed symptoms of dementia with Lewy-bodies and AD. The LRRK2 gene is also located within a locus on chromosome 12 reported in late-onset AD,  and is therefore a good candidate gene for dementia. A series of 242 patients from Norway diagnosed clinically with dementia were included in the study,  the majority were diagnosed with AD. Individuals were screened for the presence of seven known pathogenic mutations previously reported in the LRRK2 gene. We did not identify LRRK2 mutations in our series of dementia patients,  indicating that known pathogenic mutations are not common in patients clinically diagnosed with AD. However,  these results do not exclude a possible role of other genetic variants within the LRRK2 gene in AD or other forms of dementia. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Protein-Serine-Threonine Kinases,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  Polymorphism,  Genetic,  Neuropsychological Tests,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Aged,  80 and over,  Female,  Aged,  Chromosomes,  Human,  Pair 12,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Mathias Toft,  Sigrid Botne Sando,  Stacey Melquist,  Owen A Ross,  Linda R White,  Jan O Aasly,  Matthew J Farrer]"} , { "attrname": "PUB_TYPE", "value": "[<span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>]"} ], "id": "559", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16087219", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16087219"} , { "elementOf": "DOI", "accession": "10.1016\/J.MAD.2005.06.010"} ]} , { "annotation": "[VARIANTS PARK8 GLY-1441 AND CYS-1699,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 15541308", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15541308", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuron"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 2.7.- Protein Kinases,  Nerve Tissue Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD; OMIM #168600) is the second most common neurodegenerative disorder in the Western world and presents as a progressive movement disorder. The hallmark pathological features of PD are loss of dopaminergic neurons from the substantia nigra and neuronal intracellular Lewy body inclusions. <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism is typically sporadic in nature; however,  several rare familial forms are linked to genetic loci,  and the identification of causal mutations has provided insight into the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> process. PARK8,  identified in 2002 by Funayama and colleagues,  appears to be a common cause of familial PD. We describe here the cloning of a novel gene that contains missense mutations segregating with PARK8-linked PD in five families from England and Spain. Because of the tremor observed in PD and because a number of the families are of Basque descent,  we have named this protein dardarin,  derived from the Basque word dardara,  meaning tremor. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Amino Acid Sequence,  Humans,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Male,  Chromosome Mapping,  Nerve Tissue Proteins,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Northern,  Animals,  Protein Kinases,  Pedigree,  Cloning,  Molecular,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Coro Paisn-Ruz,  Shushant Jain,  E Whitney Evans,  William P Gilks,  Javier Simn,  Marcel van der Brug,  Adolfo Lpez de Munain,  Silvia Aparicio,  Angel Martnez Gil,  Naheed Khan,  Janel Johnson,  Javier Ruiz Martinez,  David Nicholl,  Itxaso Marti Carrera,  Amets Sanz Pena,  Rohan de Silva,  Andrew Lees,  Jos Flix Mart-Mass,  Jordi Prez-Tur,  Nick W Wood,  Andrew B Singleton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 GLY-1441 AND CYS-1699,  TISSUE SPECIFICITY]"} ], "id": "560", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15541308", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15541308"} , { "elementOf": "DOI", "accession": "10.1016\/J.NEURON.2004.10.023"} ]} , { "annotation": "[VARIANTS PARK8 VAL-712; LEU-1728; HIS-1728; SER-2019; MET-2141; HIS-2143 AND HIS-2466,  VARIANTS SER-228; VAL-716; GLU-871; PHE-1870 AND LYS-2395]", "conames": [{ "name": "PMID: 18213618", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18213618", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  9007-49-2 DNA]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Comprehensive analysis of LRRK2 in publicly available <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cases and neurologically normal controls."} , { "attrname": "Abstract", "value": "Mutation of LRRK2,  encoding dardarin,  is the most common known genetic cause of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The large size of this gene and the relative ease with which the most common mutations can be screened means that although more than 50 LRRK2 screening papers have been published,  few have analyzed the entire coding sequence. Furthermore,  no comprehensive sequence-based analysis has been performed on control samples. Here,  we present sequencing of all coding exons in a series of 275 PD cases and 275 neurologically normal controls and analysis of the LRRK2 locus for whole gene multiplications or deletions. We also present case-control SNP association results using 74 SNPs genotyped across LRRK2. We identified six novel <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated missense mutations,  including two that altered the same residue of the protein. These data and analysis of previously reported <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-segregating mutations shows that the majority of <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-causing mutations lie in the C-terminal half of the protein. "} , { "attrname": "MeSH", "value": "[Gene Duplication,  Exons,  Humans,  Protein-Serine-Threonine Kinases,  Gene Dosage,  Mutation,  Missense,  Case-Control Studies,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Base Sequence,  DNA,  Gene Deletion,  Polymorphism,  Single Nucleotide,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Coro Paisn-Ruz,  Priti Nath,  Nicole Washecka,  J Raphael Gibbs,  Andrew B Singleton]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK8 VAL-712; LEU-1728; HIS-1728; SER-2019; MET-2141; HIS-2143 AND HIS-2466,  VARIANTS SER-228; VAL-716; GLU-871; PHE-1870 AND LYS-2395]"} ], "id": "561", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18213618", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "18213618"} , { "elementOf": "DOI", "accession": "10.1002\/HUMU.20668"} ]} , { "annotation": "[VARIANT PARK8 THR-2020]", "conames": [{ "name": "PMID: 15880653", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15880653", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 LRRK2 protein,  human,  EC 2.7.11.1 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2,  EC 2.7.11.1 Protein-Serine-Threonine Kinases]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family."} , { "attrname": "Abstract", "value": "We detected a missense mutation in the kinase domain of the LRRK2 gene in members with autosomal dominant <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> of the Japanese family (the Sagamihara family) who served as the basis for the original defining of the PARK8 <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> locus. The results of the Sagamihara family,  in combination with the unique pathological features characterized by pure nigral degeneration without Lewy bodies,  provided us with valuable information for elucidating the protein structure-pathogenesis relationship for the gene product of LRRK2. We did not detect this mutation or other known mutations of the LRRK2 gene in Japanese patients with sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acid Sequence,  Pedigree,  Humans,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Family Health,  Mutation,  Missense,  Leucine-Rich Repeat Serine-Threonine Protein Kinase-2]"} , { "attrname": "AUTHORS", "value": "[Manabu Funayama,  Kazuko Hasegawa,  Etsuro Ohta,  Noriko Kawashima,  Masaru Komiyama,  Hisayuki Kowa,  Shoji Tsuji,  Fumiya Obata]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK8 THR-2020]"} ], "id": "562", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15880653", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15880653"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20484"} ]} , { "annotation": "", "conames": [{ "name": "Glutathione", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "11"} ], "id": "563", "contexts": { "context": { "id": 77} } , "evidences": ["Imported from database"], "value": "Glutathione", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00143"} ]} , { "annotation": "", "conames": [{ "name": "Imatinib", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "1"} ], "id": "564", "contexts": { "context": { "id": 71} } , "evidences": ["Imported from database"], "value": "Imatinib", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00619"} ]} , { "annotation": "", "conames": [{ "name": "Sulindac", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "1"} ], "id": "565", "contexts": { "context": { "id": 82} } , "evidences": ["Imported from database"], "value": "Sulindac", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00605"} ]} , { "annotation": "", "conames": [{ "name": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>; AD", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "104300", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "566", "contexts": { } , "evidences": ["Imported from database"], "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>; AD", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "104300"} ]} , { "annotation": "Interacting selectively and non-covalently with an acetylcholine receptor. ( Reference:  GOC: mah )", "conames": [{ "name": "acetylcholine receptor binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0033130", "attributes": [], "id": "567", "contexts": { } , "evidences": ["Imported from database"], "value": "acetylcholine receptor binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0033130"} ]} , { "annotation": "Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). ( Reference:  GOC: dph GOC: jl GOC: tb GOC: vw )", "conames": [{ "name": "plasmid binding", "isPreferred": "false"} , { "name": "microtubule\/chromatin interaction", "isPreferred": "false"} , { "name": "DNA binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0003677", "attributes": [], "id": "568", "contexts": { } , "evidences": ["Imported from database"], "value": "DNA binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0003677"} ]} , { "annotation": "Interacting selectively and non-covalently with a transition metal ions; a transition metal is an element whose atom has an incomplete d-subshell of extranuclear electrons,  or which gives rise to a cation or cations with an incomplete d-subshell. Transition metals often have more than one valency state. Biologically relevant transition metals include vanadium,  manganese,  iron,  copper,  cobalt,  nickel,  molybdenum and silver. ( Reference:  ISBN: 0198506732 );", "conames": [{ "name": "transition metal ion binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046914", "attributes": [], "id": "569", "contexts": { } , "evidences": ["Imported from database"], "value": "transition metal ion binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046914"} ]} , { "annotation": "Interacting selectively and non-covalently with one or more specific sites on a receptor molecule,  a macromolecule that undergoes combination with a hormone,  neurotransmitter,  drug or intracellular messenger to initiate a change in cell function. ( Reference:  GOC: bf GOC: ceb ISBN: 0198506732 )", "conames": [{ "name": "receptor binding", "isPreferred": "true"} , { "name": "receptor ligand", "isPreferred": "false"} , { "name": "receptor-associated protein", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005102", "attributes": [], "id": "570", "contexts": { } , "evidences": ["Imported from database"], "value": "receptor binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005102"} ]} , { "annotation": "Interacting selectively and non-covalently with a phosphotyrosine-binding (PTB) domain of a protein. ( Reference:  Pfam: PF02174.5 PMID: 15924411 )", "conames": [{ "name": "phosphotyrosine-interacting domain binding", "isPreferred": "true"} , { "name": "PTB domain binding", "isPreferred": "true"} , { "name": "PID binding", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051425", "attributes": [], "id": "571", "contexts": { } , "evidences": ["Imported from database"], "value": "PTB domain binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051425"} ]} , { "annotation": "Binds to and increases the activity of a peptidase,  any enzyme that catalyzes the hydrolysis peptide bonds. ( Reference:  GOC: ai )", "conames": [{ "name": "protease activator", "isPreferred": "false"} , { "name": "peptidase activator activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016504", "attributes": [], "id": "572", "contexts": { } , "evidences": ["Imported from database"], "value": "peptidase activator activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016504"} ]} , { "annotation": "Stops,  prevents or reduces the activity of serine-type endopeptidases,  enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. ( Reference:  GOC: ai )", "conames": [{ "name": "serine protease inhibitor", "isPreferred": "false"} , { "name": "serine-type endopeptidase inhibitor activity", "isPreferred": "true"} , { "name": "serpin", "isPreferred": "false"} , { "name": "serine proteinase inhibitor", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004867", "attributes": [], "id": "573", "contexts": { } , "evidences": ["Imported from database"], "value": "serine-type endopeptidase inhibitor activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004867"} ]} , { "annotation": "Interacting selectively and non-covalently with <span style=\"background-color: yellow\"><b>heparin<\/b><\/span>,  any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. ( Reference:  GOC: jl ISBN: 0198506732 )", "conames": [{ "name": "<span style=\"background-color: yellow\"><b>heparin<\/b><\/span> binding", "isPreferred": "true"} , { "name": "heparan sulfate binding", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008201", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "574", "contexts": { } , "evidences": ["Imported from database"], "value": "<span style=\"background-color: yellow\"><b>heparin<\/b><\/span> binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008201"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "575", "contexts": { } , "evidences": ["Imported from database"], "value": "P05412", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P05412"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "576", "contexts": { } , "evidences": ["Imported from database"], "value": "Q13813", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q13813"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "577", "contexts": { } , "evidences": ["Imported from database"], "value": "P01137", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P01137"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "578", "contexts": { } , "evidences": ["Imported from database"], "value": "P49840", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P49840"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "579", "contexts": { } , "evidences": ["Imported from database"], "value": "P01100", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P01100"} ]} , { "annotation": "Created:  1996-10-01; Modified:  2016-01-20; Version:  190", "conames": [{ "name": "PS1-CTF12", "isPreferred": "false"} , { "name": "AD3", "isPreferred": "false"} , { "name": "Presenilin-1", "isPreferred": "true"} , { "name": "PS-1", "isPreferred": "false"} , { "name": "Presenilin-1 CTF subunit", "isPreferred": "true"} , { "name": "Presenilin-1 CTF12", "isPreferred": "true"} , { "name": "Presenilin-1 NTF subunit", "isPreferred": "true"} , { "name": "PSEN1", "isPreferred": "false"} , { "name": "Protein S182", "isPreferred": "false"} , { "name": "PSNL1", "isPreferred": "false"} , { "name": "PS1", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: UNIPROTKB-SwissProt", "description": "", "pid": "P49768", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "96"} ], "id": "580", "contexts": { "context": { "id": 61} } , "evidences": ["Imported from database"], "value": "Presenilin-1", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENST00000357710"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000377719"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000080815"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000452242"} , { "elementOf": "ENSEMBL", "accession": "ENST00000557511"} , { "elementOf": "ENSEMBL", "accession": "ENST00000553855"} , { "elementOf": "UNIPROTKB", "accession": "P49768"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000326366"} , { "elementOf": "ENSEMBL", "accession": "ENST00000555386"} , { "elementOf": "ENSEMBL", "accession": "ENST00000324501"} , { "elementOf": "ENSEMBL", "accession": "ENST00000394164"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000450845"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000377712"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000451429"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000350342"} , { "elementOf": "ENSEMBL", "accession": "ENST00000394157"} ]} , { "annotation": "[VARIANT AD3 ASN-116]", "conames": [{ "name": "PMID: 10439444", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10439444", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Peptide Fragments,  Presenilin-1,  Amyloid beta-Peptides,  Apolipoproteins E,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease."} , { "attrname": "Abstract", "value": "Mutation in the presenilin-1 (PS-1) gene at chromosome 14q24.3 is the most common cause of autosomal dominant early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here,  we report a novel missense mutation in the presenilin-1 gene found in a three-generation Danish family with autopsy-verified early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Two affected first-degree relatives in two generations were found to be heterozygous for a cytosine to adenine transversion at the second position of codon 116,  which changes the amino acid at that position from threonine to asparagine. This conservative amino acid substitution occurs in an evolutionary highly conserved region of the PS-1 protein and is associated with onset of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> between age 35 and 41 years and 4-8 years' duration of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Analysis of amyloid beta-protein (A beta) deposition in brain specimens from one affected family member showed predominance of A beta 42(43). Onset and progression of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> were very similar in two sibs homozygous for the epsilon 3 allele and the epsilon 4 allele,  respectively,  of the polymorphic apolipoprotein E locus. The lack of effect of the high risk epsilon 4\/epsilon 4 genotype on the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in this family corroborates and extends previous observations that the presence of one copy of the epsilon 4 allele does not modulate PS-1 associated <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Brain,  Peptide Fragments,  Presenilin-1,  Humans,  Genotype,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Pedigree,  Age of Onset,  Amyloid beta-Peptides,  Adult,  Female,  Apolipoproteins E,  Mutation,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[I Romero,  P Jrgensen,  G Bolwig,  P E Fraser,  E Rogaeva,  D Mann,  A M Havsager,  A L Jrgensen]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 ASN-116]"} ], "id": "581", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10439444", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10439444"} , { "elementOf": "DOI", "accession": "10.1097\/00001756-199908020-00006"} ]} , { "annotation": "[FUNCTION,  MUTAGENESIS OF LEU-286]", "conames": [{ "name": "PMID: 10811883", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10811883", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Receptors,  Notch,  Codon,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch."} , { "attrname": "Abstract", "value": "Most of the genetically inherited <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cases are caused by mutations in the presenilin genes,  PS1 and PS2. PS mutations result in the enhanced production of the highly amyloidogenic 42\/43 amino acid variant of amyloid beta-peptide (Abeta). We have introduced arbitrary mutations at position 286 of PS1,  where a naturally occurring PS1 mutation has been described (L286V). Introduction of charged amino acids (L286E or L286R) resulted in an increase of Abeta42\/43 production,  which reached almost twice the level of the naturally occurring PS1 mutation. Although pathological Abeta production was increased,  endoproteolysis of Notch and nuclear transport of its cytoplasmic domain was significantly inhibited. These results demonstrate that the biological function of PS proteins in the endoproteolysis of beta-amyloid precursor protein and Notch can be separated. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Mutagenesis,  Site-Directed,  Animals,  Genetically Modified,  Humans,  Cells,  Cultured,  Models,  Molecular,  Substrate Specificity,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Caenorhabditis elegans,  Point Mutation,  Receptors,  Notch,  Animals,  Codon,  Amyloid beta-Peptides,  Protein Processing,  Post-Translational,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[L Kulic,  J Walter,  G Multhaup,  D B Teplow,  R Baumeister,  H Romig,  A Capell,  H Steiner,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  MUTAGENESIS OF LEU-286]"} ], "id": "582", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10811883", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.100049897"} , { "elementOf": "NLM", "accession": "10811883"} ]} , { "annotation": "[VARIANTS AD3 ASP-120; ARG-163; VAL-209; VAL-260; LEU-264; TYR-410 AND PRO-426]", "conames": [{ "name": "PMID: 9521423", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9521423", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene."} , { "attrname": "Abstract", "value": "Mutations in the presenilin genes (PS-1 and PS-2) cause early onset autosomal dominant <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). Eight early-onset,  autopsy-documented familial AD kindreds were screened for mutations in PS-1,  and seven different mutations were identified. Three of these were new mutations (G209V,  A426P,  and E120D),  two were previously reported mutations in new families,  and three mutations were confirmed in previously published families. Two of these new mutations are found within predicted transmembrane domains (TMDs 4,  7,  and 8). The A426P mutation is the most C-terminal PS-1 mutation identified to date. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Genetic Testing,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Point Mutation,  Genes,  Dominant,  DNA Mutational Analysis,  Age of Onset,  Aged,  80 and over,  Adult,  Chromosomes,  Human,  Pair 14,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[P Poorkaj,  V Sharma,  L Anderson,  E Nemens,  M E Alonso,  H Orr,  J White,  L Heston,  T D Bird,  G D Schellenberg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 ASP-120; ARG-163; VAL-209; VAL-260; LEU-264; TYR-410 AND PRO-426]"} ], "id": "583", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9521423", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1998)11: 3<216: : AID-HUMU6>3.3.CO;2-O"} , { "elementOf": "NLM", "accession": "9521423"} ]} , { "annotation": "[INTERACTION WITH HERPUD1]", "conames": [{ "name": "PMID: 11799129", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11799129", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Amyloid beta-Peptides,  HERPUD1 protein,  human,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Endoplasmic reticulum stress-inducible protein,  Herp,  enhances presenilin-mediated generation of amyloid beta-protein."} , { "attrname": "Abstract", "value": "Presenilin (PS) is essential for the gamma-cleavage required for the generation of the C terminus of amyloid beta-protein (Abeta). However,  the mechanism underlying PS-mediated gamma-cleavage remains unclear. We have identified Herp cDNA by our newly developed screening method for the isolation of cDNAs that increase the degree of gamma-cleavage. Herp was originally identified as a homocysteine-responsive protein,  and its expression is up-regulated by endoplasmic reticulum stress. Herp is an endoplasmic reticulum-localized membrane protein that has a ubiquitin-like domain. Here,  we report that a high expression of Herp in cells increases the level of Abeta generation,  although not in PS-deficient cells. We found that Herp interacts with both PS1 and PS2. Thus,  Herp regulates PS-mediated Abeta generation,  possibly through its binding to PS. Immunohistochemical analysis of a normal human brain section with an anti-Herp antibody revealed the exclusive staining of neurons and vascular smooth muscle cells. Moreover,  the antibody strongly stained activated microglia in senile plaques in the brain of patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Taken together,  Herp could be involved in Abeta accumulation,  including the formation of senile plaques and vascular Abeta deposits. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Membrane Proteins,  Cell Line,  Presenilin-2,  Presenilin-1,  Humans,  Amyloid beta-Peptides,  Endoplasmic Reticulum]"} , { "attrname": "AUTHORS", "value": "[Xiaorei Sai,  Yuuki Kawamura,  Koichi Kokame,  Haruyasu Yamaguchi,  Hirohisa Shiraishi,  Ryo Suzuki,  Toshiharu Suzuki,  Masashi Kawaichi,  Toshiyuki Miyata,  Toshio Kitamura,  Bart De Strooper,  Katsuhiko Yanagisawa,  Hiroto Komano]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH HERPUD1]"} ], "id": "584", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11799129", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M112372200"} , { "elementOf": "NLM", "accession": "11799129"} ]} , { "annotation": "[REVIEW ON VARIANTS];", "conames": [{ "name": "PMID: 8875251", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8875251", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "The presenilin genes:  a new gene family involved in Alzheimer disease pathology."} , { "attrname": "Abstract", "value": "A positional cloning approach has led to the identification of two closely related genes,  the presenilins (PS),  for autosomal dominant presenile <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD):  PS-1 at 14q24.3 and PS-2 at 1q31-q42. The PS-1 gene was identified by direct cDNA selection of yeast artificial chromosomes containing the candidate chromosomal region. Subsequently,  the PS-2 gene was identified due to its high sequence homology with PS-1 and its location within the candidate region defined by linkage studies. To date,  30 different missense mutations and one in-frame splice site mutation were described in PS-1,  while only two missense mutations were detected in PS-2,  suggesting that PS-1 mutations are more frequently involved in familial presenile AD. The PS transcripts encode novel proteins that resemble integral transmembrane proteins of roughly 450 amino acids and at least seven transmembrane domains. The genomic organization of the PS genes is very similar showing that full length PS-1 and PS-2 are encoded by 10 exons. However,  different alternative splicing patterns have been observed for PS-1 and PS-2 indicating that the corresponding proteins (ps-1 and ps-2) may have similar but not identical biological functions. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Sequence Homology,  Amino Acid,  Amino Acid Sequence,  Presenilin-2,  Gene Expression,  Presenilin-1,  Animals,  Humans,  Cloning,  Molecular,  Molecular Sequence Data,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[M Cruts,  L Hendriks,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "585", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8875251", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8875251"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 8574969", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8574969", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature medicine"} , { "attrname": "Chemical", "value": "[PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Psen2 protein,  rat,  Psen1 protein,  rat,  Biomarkers,  PSEN1 protein,  human,  RNA Probes]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>-associated presenilins 1 and 2:  neuronal expression in brain and localization to intracellular membranes in mammalian cells."} , { "attrname": "Abstract", "value": "Mutations in two recently identified genes appear to cause the majority of early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). These two novel genes,  presenilin 1 (PS1) and presenilin 2 (PS2) are members of an evolutionarily conserved gene family. The normal biological role(s) of the presenilins and the mechanism(s) by which the FAD-associated mutations exert their effect remain unknown. Employing in situ hybridization,  we demonstrate that the expression patterns of PS1 and PS2 in the brain are extremely similar to each other and that messages for both are primarily detectable in neuronal populations. Immunochemical analyses indicate that PS1 and PS2 are similar in size and localized to similar intracellular compartments (endoplasmic reticulum and Golgi complex). FAD-associated mutations in PS1 and PS2 do not significantly modify either their migration patterns on SDS-polyacrylamide gel electrophoresis or their overall subcellular localization,  although subtle differences in perinuclear staining were noted for mutant PS1. "} , { "attrname": "MeSH", "value": "[Brain,  Cell Membrane,  Presenilin-2,  Presenilin-1,  Neurons,  Humans,  Middle Aged,  Molecular Sequence Data,  Rats,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  RNA Probes,  Cell Compartmentation,  Animals,  In Situ Hybridization,  Base Sequence,  Biomarkers,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[D M Kovacs,  H J Fausett,  K J Page,  T W Kim,  R D Moir,  D E Merriam,  R D Hollister,  O G Hallmark,  R Mancini,  K M Felsenstein,  B T Hyman,  R E Tanzi,  W Wasco]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  TISSUE SPECIFICITY]"} ], "id": "586", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8574969", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NM0296-224"} , { "elementOf": "NLM", "accession": "8574969"} ]} , { "annotation": "[VARIANT CMD1U GLY-333]", "conames": [{ "name": "PMID: 17186461", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17186461", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[SY7Q814VUP Calcium,  Presenilin-2,  Presenilin-1]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Mutations of presenilin genes in dilated cardiomyopathy and heart failure."} , { "attrname": "Abstract", "value": "Two common disorders of the elderly are heart failure and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). Heart failure usually results from dilated cardiomyopathy (DCM). DCM of unknown cause in families has recently been shown to result from genetic <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  highlighting newly discovered <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mechanisms. AD is the most frequent neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span> of older Americans. Familial AD is caused most commonly by presenilin 1 (PSEN1) or presenilin 2 (PSEN2) mutations,  a discovery that has greatly advanced the field. The presenilins are also expressed in the heart and are critical to cardiac development. We hypothesized that mutations in presenilins may also be associated with DCM and that their discovery could provide new insight into the pathogenesis of DCM and heart failure. A total of 315 index patients with DCM were evaluated for sequence variation in PSEN1 and PSEN2. Families positive for mutations underwent additional clinical,  genetic,  and functional studies. A novel PSEN1 missense mutation (Asp333Gly) was identified in one family,  and a single PSEN2 missense mutation (Ser130Leu) was found in two other families. Both mutations segregated with DCM and heart failure. The PSEN1 mutation was associated with complete penetrance and progressive <span style=\"background-color: yellow\"><b>disease<\/b><\/span> that resulted in the necessity of cardiac transplantation or in death. The PSEN2 mutation showed partial penetrance,  milder <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and a more favorable prognosis. Calcium signaling was altered in cultured skin fibroblasts from PSEN1 and PSEN2 mutation carriers. These data indicate that PSEN1 and PSEN2 mutations are associated with DCM and heart failure and implicate novel mechanisms of myocardial <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-2,  Presenilin-1,  Calcium,  Humans,  Middle Aged,  Cells,  Cultured,  Molecular Sequence Data,  Male,  Penetrance,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cardiomyopathy,  Dilated,  Pedigree,  Fibroblasts,  Heart Failure,  Adult,  Female,  Aged,  Mutation,  Calcium Signaling]"} , { "attrname": "AUTHORS", "value": "[Duanxiang Li,  Sharie B Parks,  Jessica D Kushner,  Deirdre Nauman,  Donna Burgess,  Susan Ludwigsen,  Julie Partain,  Randal R Nixon,  Charles N Allen,  Robert P Irwin,  Petra M Jakobs,  Michael Litt,  Ray E Hershberger]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CMD1U GLY-333]"} ], "id": "587", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17186461", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1086\/509900"} , { "elementOf": "NLM", "accession": "17186461"} ]} , { "annotation": "[VARIANT AD4 ILE-148]", "conames": [{ "name": "PMID: 10732806", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10732806", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurogenetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Apolipoproteins E,  Amyloid beta-Protein Precursor,  Apolipoprotein E3,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Mutations in the presenilin-2 (PS-2) gene are less frequent than mutations in the PS-1 gene. All mutations described in the PS-1 gene were found in early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) patients. At present,  there are two missense mutations described for the PS-2 gene in some AD pedigrees. We have therefore analyzed transmembrane 2 (TM2) and TM5 domains of the PS-2 gene in AD patients and in a group of age-matched healthy controls. In a patient who was clinically diagnosed as having late-onset AD,  we found a novel missense mutation consisting of a G->A substitution on exon 5 of the PS-2 gene,  which results in a Val to Ile substitution at codon 148 within the predicted TM2 domain of the PS-2 protein. This is the third mutation described in the PS-2 gene and the first presenilin mutation detected in a Spanish AD patient. Both,  the N141I mutation and the V148I mutation described here are located within the predicted TM2 domain and both were found in late-onset AD kindreds,  whereas the mutation within the predicted TM5 domain was found in an early-onset AD pedigree. Carriers of mutations within TM2 of PS-1 have a mean age at onset of 40 years,  while the other mutations in PS-1 occur in families with a mean age at onset of 47 years. In summary,  we report here the first mutation in a presenilin gene in a Spanish AD case,  which is the third mutation detected for the PS-2 gene. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Presenilin-2,  Presenilin-1,  Genetic Testing,  Gene Frequency,  Humans,  Middle Aged,  European Continental Ancestry Group,  Male,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Apolipoprotein E3,  Spain,  Membrane Proteins,  Aged,  80 and over,  Adult,  Aged,  Apolipoproteins E,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[J I Lao,  K Beyer,  L Fernndez-Novoa,  R Cacabelos]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD4 ILE-148]"} ], "id": "588", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10732806", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10732806"} , { "elementOf": "DOI", "accession": "10.1007\/S100480050044"} ]} , { "annotation": "[FUNCTION,  MUTAGENESIS OF MET-292]", "conames": [{ "name": "PMID: 10545183", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10545183", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Amyloidogenic function of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated presenilin 1 in the absence of endoproteolysis."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is characterized by the invariant accumulation of senile plaques predominantly composed of the pathologically relevant 42-amino acid amyloid beta-peptide (Abeta42). The presenilin (PS) proteins play a key role in Abeta generation. FAD-associated mutations in PS1 and PS2 enhance the production of Abeta42,  and PS1 is required for physiological Abeta production,  since a gene knockout of PS1 and dominant negative mutations of PS1 abolish Abeta generation. PS proteins undergo endoproteolytic processing,  and current evidence indicates that fragment formation may be required for the amyloidogenic function of PS. We have now determined the sequence requirements for endoproteolysis of PS1. Mutagenizing amino acids at the previously determined major cleavage site (amino acid 298) had no effect on PS1 endoproteolysis. In contrast,  mutations or deletions at the additional cleavage site around amino acid 292 blocked endoproteolysis. The uncleavable PS1 derivatives accumulated as full-length proteins and replaced the endogenous PS1 proteins. In contrast to the previously described aspartate mutations within transmembrane domains 6 and 7,  the uncleaved PS1 variants do not act as dominant negative inhibitors of Abeta production. Moreover,  when a FAD-associated mutation (M146L) was combined with a mutation blocking endoproteolysis,  Abeta42 production still reached pathological levels. These data therefore demonstrate that endoproteolysis of presenilins is not an absolute prerequisite for the amyloidogenic function of PS1. These data also show that accumulation of the PS1 holoprotein is not associated with the pathological activity of PS1 mutations as suggested previously. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Presenilin-1,  Humans,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Point Mutation,  Transfection,  Amyloid beta-Peptides,  Mutation,  Binding Sites,  Endopeptidases,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[H Steiner,  H Romig,  B Pesold,  U Philipp,  M Baader,  M Citron,  H Loetscher,  H Jacobsen,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  MUTAGENESIS OF MET-292]"} ], "id": "589", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10545183", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI9914210"} , { "elementOf": "NLM", "accession": "10545183"} ]} , { "annotation": "[PHOSPHORYLATION]", "conames": [{ "name": "PMID: 9144240", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9144240", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  EC 3.1.3.1 Alkaline Phosphatase,  Recombinant Proteins,  DNA Primers,  PSEN1 protein,  human,  EC 2.7.11.13 Protein Kinase C]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Proteolytic processing of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated presenilin-1 generates an in vivo substrate for protein kinase C."} , { "attrname": "Abstract", "value": "The majority of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mutations are linked to the recently cloned presenilin (PS) genes,  which encode two highly homologous proteins (PS-1 and PS-2). It was shown that the full-length PS-2 protein is phosphorylated constitutively within its N-terminal domain by casein kinases,  whereas the PS-1 protein is not. Full-length PS proteins undergo endoproteolytic cleavage within their hydrophilic loop domain resulting in the formation of approximately 20-kDa C-terminal fragments (CTF) and approximately 30-kDa N-terminal fragments [Thinakaran,  G.,  et al. (1996) Neuron 17,  181-190]. Here we describe the surprising finding that the CTF of PS-1 is phosphorylated by protein kinase C (PKC). Stimulation of PKC causes a 4- to 5-fold increase of the phosphorylation of the approximately 20-kDa CTF of PS-1 resulting in reduced mobility in SDS gels. PKC-stimulated phosphorylation occurs predominantly on serine residues and can be induced either by direct stimulation of PKC with phorbol-12, 13-dibutyrate or by activation of the m1 acetylcholine receptor-signaling pathway with the muscarinic agonist carbachol. However,  phosphorylation of full-length PS-1 and PS-2 is not altered upon PKC stimulation. In addition,  a mutant form of PS-1 lacking exon 10,  which does not undergo endoproteolytic cleavage [Thinakaran,  G.,  et al. (1996) Neuron 17,  181-190] is not phosphorylated by PKC,  although it still contains all PKC phosphorylation sites conserved between different species. These results show that PKC phosphorylates the PS-1 CTF. Therefore,  endoproteolytic cleavage of full-length PS-1 results in the generation of an in vivo substrate for PKC. The selective phosphorylation of the PS-1 CTF indicates that the physiological and\/or pathological properties of the CTF are regulated by PKC activity. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Presenilin-1,  Protein Structure,  Secondary,  Humans,  Molecular Sequence Data,  Substrate Specificity,  Alkaline Phosphatase,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Kidney,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Transfection,  Base Sequence,  Polymerase Chain Reaction,  Conserved Sequence,  Protein Processing,  Post-Translational,  Protein Kinase C]"} , { "attrname": "AUTHORS", "value": "[J Walter,  J Grnberg,  A Capell,  B Pesold,  A Schindzielorz,  M Citron,  K Mendla,  P S George-Hyslop,  G Multhaup,  D J Selkoe,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION]"} ], "id": "590", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9144240", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9144240"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.94.10.5349"} ]} , { "annotation": "[REVIEW ON VARIANTS]", "conames": [{ "name": "PMID: 9521418", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9521418", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Presenilin mutations in Alzheimer's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "The presenilins (PS-1 and PS-2) are 2 members of a novel family of genes encoding integral membrane proteins recently implicated in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) pathology. To date,  43 mutations have been identified in PS-1 and 2 in PS-2 that lead to familial presenile AD (onset before age 65 years). The normal and pathological functions of the PS proteins (ps-1 and ps-2) are unknown,  but their high degree of homology predicts similar biological activities. Homologies with ps from other species suggest that they may play a role in intracellular protein sorting and trafficking,  in intercellular cell signaling,  or in cell death. Since to date only missense mutations and in-frame deletions were identified,  it is believed that mutated ps act through either a gain of (dys-)function or a dominant negative effect. In vivo and in vitro studies have linked PS mutations to amyloid deposition,  an early pathological event in AD brains. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-2,  Presenilin-1,  Humans,  Age of Onset,  Mutation,  Alzheimer Disease]"} , { "attrname": "AUTHORS", "value": "[M Cruts,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "591", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9521418", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1998)11: 3<183: : AID-HUMU1>3.0.CO;2-J"} , { "elementOf": "NLM", "accession": "9521418"} ]} , { "annotation": "[VARIANT AD3 MET-174]", "conames": [{ "name": "PMID: 12484344", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12484344", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurogenetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Apolipoproteins E,  Genetic Markers,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease."} , { "attrname": "Abstract", "value": "We studied a Cuban family with presenile dementia (autosomal dominant) consisting of 281 members within six generations,  the proband descended from a Spanish founder. Mean age at onset was 59 years of age. Memory impairment was the main symptom in all patients,  additionally,  ischemic episodes were described in 4 (n = 18) patients. Neuropathological examination of brain material (1 patient) revealed neuronal loss,  amyloid plaques,  and neurofibrillary tangles. Thirty DNA samples were genotyped (regions on chromosome 1,  3,  10,  12,  14,  17,  19,  20,  and 21). A maximum Lod score of 3.79 at theta = 0 was obtained for marker D14S43,  located in a 9-cM interval in which all patients shared the same haplotype. Sequencing of the PSEN1 gene revealed a heterozygous base substitution,  C520A (exon 6),  which is predicted to cause an amino acid change from leucine to methionine in the TMIII of the presenilin 1 protein. The mutation was found to co-segregate with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> phenotype and the associated <span style=\"background-color: yellow\"><b>disease<\/b><\/span> haplotype. The C --> A change was not observed in 80 control chromosomes from the Cuban population. Leucine at position 174 is highly conserved among species and is identical in presenilin 1 and presenilin 2 proteins. We propose the L174 M mutation might lead to an abnormal N-terminal and probably C-terminal fragments and malfunction of the protein complex. In conclusion,  we found a novel PSEN1 mutation in a large family with clinical and pathological diagnosis of early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  which may be relevant for other Hispanic populations. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Humans,  Hispanic Americans,  Molecular Sequence Data,  Family Health,  Genotype,  Male,  Genetic Markers,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Cuba,  Point Mutation,  Pedigree,  Age of Onset,  Conserved Sequence,  Female,  Apolipoproteins E]"} , { "attrname": "AUTHORS", "value": "[A M Bertoli Avella,  B Marcheco Teruel,  J J Llibre Rodriguez,  N Gomez Viera,  I Borrajero Martinez,  E A Severijnen,  M Joosse,  C M van Duijn,  L Heredero Baute,  P Heutink]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 MET-174]"} ], "id": "592", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12484344", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12484344"} , { "elementOf": "DOI", "accession": "10.1007\/S10048-002-0136-6"} ]} , { "annotation": "[INTERACTION WITH FLNA AND FLNB]", "conames": [{ "name": "PMID: 9437013", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9437013", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Microfilament Proteins,  Antibodies,  Monoclonal,  PSEN1 protein,  human,  Carrier Proteins,  Contractile Proteins,  FLNC protein,  human,  Filamins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Interaction of presenilins with the filamin family of actin-binding proteins."} , { "attrname": "Abstract", "value": "Mutations in presenilin genes PS1 and PS2 account for approximately 50% of early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). The PS1 and PS2 genes encode highly homologous transmembrane proteins related to the Caenorhabditis elegans sel-12 and spe-4 gene products. A hydrophilic loop region facing the cytoplasmic compartment is likely to be functionally important because at least 14 mutations in FAD patients have been identified in this region. We report here that the loop regions of PS1 and PS2 interact with nonmuscle filamin (actin-binding protein 280,  ABP280) and a structurally related protein (filamin homolog 1,  Fh1). Overexpression of PS1 appears to modify the distribution of ABP280 and Fh1 proteins in cultured cells. A monoclonal antibody recognizing ABP280 and Fh1 binds to blood vessels,  astrocytes,  neurofibrillary tangles,  neuropil threads,  and dystrophic neurites in the AD brain. Detection of ABP280\/Fh1 proteins in these structures suggests that these presenilin-interacting proteins may be involved in the development of AD and that interactions between presenilins and ABP280\/Fh1 may be functionally significant. The ABP280 gene is located on the human X chromosome,  whereas the newly identified Fh1 gene maps to human chromosome 3. These results provide a new basis for understanding the function of presenilin proteins and further implicate cytoskeletal elements in AD pathogenesis. "} , { "attrname": "MeSH", "value": "[Presenilin-2,  Yeasts,  Presenilin-1,  Humans,  Molecular Sequence Data,  Male,  Chromosomes,  Human,  Pair 3,  Transfection,  Aged,  80 and over,  Female,  Carrier Proteins,  Protein Structure,  Tertiary,  Chromosome Mapping,  Neuropil,  Antibodies,  Monoclonal,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Filamins,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Animals,  Microfilament Proteins,  Protein Binding,  Cytoskeleton,  Aged,  Brain Chemistry,  Mutation,  COS Cells,  Contractile Proteins]"} , { "attrname": "AUTHORS", "value": "[W Zhang,  S W Han,  D W McKeel,  A Goate,  J Y Wu]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH FLNA AND FLNB]"} ], "id": "593", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9437013", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9437013"} ]} , { "annotation": "[VARIANT AD3 ALA-280]", "conames": [{ "name": "PMID: 9298817", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9298817", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  9007-49-2 DNA,  Apolipoproteins E,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles."} , { "attrname": "Abstract", "value": "A single base substitution of a glutamic acid to an alanine codon 280 was found in the presenilin-1 (PS-1) gene on chromosome 14 in affected individuals in each of seven Colombian early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) kindreds. The mutation segregated with <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in kindreds tested. In the largest kindred (C2),  the maximum two-point lod score between the mutation and AD was Z = 8.14 at theta = 0. The presence of a single mutation and the common geographic origin,  with all families from the state of Antioquia,  suggest a founder effect in this population. This finding is supported by the observation of a rare haplotype inherited with AD in all kindreds. These kindreds form the largest collection of AD cases with the same PS-1 mutation and the same educational,  environmental,  and ethnic background in which to study the phenotypic effect of putative risk factors,  such as the epsilon4 allele of apolipoprotein E (ApoE) or head trauma. Of the few AD cases having a history of head trauma,  the age of onset was not lowered. No effect of ApoE genotype on the age of onset was detected. Previous investigations of the effect of ApoE genotype on the age of onset were confounded by small patient numbers,  familial clustering of ApoE genotypes,  and combining data from unrelated families with different mutations. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Presenilin-1,  Humans,  Middle Aged,  Genotype,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Analysis,  DNA,  Membrane Proteins,  Founder Effect,  Point Mutation,  Phenotype,  DNA Mutational Analysis,  Pedigree,  DNA,  Age of Onset,  Alleles,  Adult,  Apolipoproteins E,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[C L Lendon,  A Martinez,  I M Behrens,  K S Kosik,  L Madrigal,  J Norton,  R Neuman,  A Myers,  F Busfield,  M Wragg,  M Arcos,  J C Arango Viana,  J Ossa,  A Ruiz,  A M Goate,  F Lopera]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 ALA-280]"} ], "id": "594", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9298817", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9298817"} , { "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1997)10: 3<186: : AID-HUMU2>3.3.CO;2-K"} ]} , { "annotation": "[VARIANTS AD3 VAL-139; VAL-146; TYR-163; THR-267; ALA-280 AND GLY-280]", "conames": [{ "name": "PMID: 7550356", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7550356", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  DNA Primers,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families."} , { "attrname": "Abstract", "value": "Genetic linkage studies place a gene causing early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) on chromosome 14q24.3 (refs 1-4). Five mutations within the S182 (Presenilin 1:  PS-1) gene,  which maps to this region,  have recently been reported in several early onset FAD kindreds. We have localized the PS-1 gene to a 75 kb region and present the structure of this gene,  evidence for alternative splicing and describe six novel mutations in early onset FAD pedigrees all of which alter residues conserved in the STM2 (Presenilin 2:  PS-2) gene. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Age Factors,  Alternative Splicing,  Exons,  Introns,  Humans,  Genomic Library,  Molecular Sequence Data,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Membrane Proteins,  Point Mutation,  Pedigree,  Base Sequence,  Age of Onset,  Polymerase Chain Reaction,  Chromosomes,  Human,  Pair 14,  Family,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[ Alzheimer's <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Collaborative Group]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 VAL-139; VAL-146; TYR-163; THR-267; ALA-280 AND GLY-280]"} ], "id": "595", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7550356", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7550356"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA]]", "conames": [{ "name": "PMID: 8618867", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8618867", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  Genetic Markers,  RNA,  Messenger,  PSEN1 protein,  human,  DNA,  Complementary,  DNA-Binding Proteins]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Identification and expression analysis of a potential familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> gene on chromosome 1 related to AD3."} , { "attrname": "Abstract", "value": "The inheritance of much early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) has been linked to a dominant-acting locus on chromosome 14. Recently,  the gene likely responsible for this genetic linkage has been identified and termed AD3. Five mutations have been found in AD3 that segregate with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> phenotype in seven AD families and are not present in unaffected individuals. Here we report the existence of a gene encoding a seven transmembrane domain protein very similar to that encoded by AD3 in structure and sequence. This gene is located on chromosome 1,  is expressed in a variety of tissues,  including brain,  and is predicted to harbor mutations causing nonchromosome 14 familial AD. The presence of several S\/TPXX DNA binding motifs in both the AD3 protein and the AD3-like protein \/AD4 protein suggests a possible role in intracellular signaling and gene expression or in linking chromatin to the nuclear membrane. Ways in which mutations in either gene could lead to AD are discussed. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Presenilin-2,  Presenilin-1,  Chromosomes,  Artificial,  Yeast,  Humans,  Molecular Sequence Data,  Chromosome Mapping,  Genetic Markers,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Organ Specificity,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Blotting,  Northern,  Chromosomes,  Human,  Pair 1,  Cloning,  Molecular,  Models,  Genetic,  Mutation,  Binding Sites,  RNA,  Messenger,  DNA,  Complementary,  DNA-Binding Proteins,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[J Li,  J Ma,  H Potter]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA]]"} ], "id": "596", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8618867", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8618867"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.92.26.12180"} ]} , { "annotation": "[INTERACTION WITH CTNND2]", "conames": [{ "name": "PMID: 10037471", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10037471", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[CTNNB1 protein,  human,  Cytoskeletal Proteins,  delta catenin,  Presenilin-2,  Presenilin-1,  beta Catenin,  Cell Adhesion Molecules,  PKP4 protein,  human,  Trans-Activators,  Nerve Tissue Proteins,  Catenins,  Membrane Proteins,  PSEN2 protein,  human,  Armadillo Domain Proteins,  CTNNB1 protein,  mouse,  Phosphoproteins,  Plakophilins,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin."} , { "attrname": "Abstract", "value": "Missense substitutions in the presenilin 1 (PS1) and presenilin 2 (PS2) proteins are associated with early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We have used yeast-two-hybrid and coimmunoprecipitation methods to show that the large cytoplasmic loop domains of PS1 and PS2 interact specifically with three members of the armadillo protein family,  including beta-catenin,  p0071,  and a novel neuronal-specific armadillo protein--neural plakophilin-related armadillo protein (NPRAP). The PS1: NPRAP interaction occurs between the arm repeats of NPRAP and residues 372-399 at the C-terminal end of the large cytoplasmic loop of PS1. The latter residues contain a single arm-like domain and are highly conserved in the presenilins,  suggesting that they form a functional armadillo protein binding site for the presenilins. "} , { "attrname": "MeSH", "value": "[Cytoskeletal Proteins,  Immunohistochemistry,  Presenilin-2,  Presenilin-1,  Cell Adhesion Molecules,  Humans,  Molecular Sequence Data,  Catenins,  Transfection,  Armadillo Domain Proteins,  Phosphoproteins,  Plakophilins,  Amino Acid Sequence,  beta Catenin,  Trans-Activators,  Cells,  Cultured,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Precipitin Tests,  Membrane Proteins,  Microscopy,  Confocal,  Animals,  Chromatography,  Affinity,  Protein Binding,  Mice]"} , { "attrname": "AUTHORS", "value": "[G Levesque,  G Yu,  M Nishimura,  D M Zhang,  L Levesque,  H Yu,  D Xu,  Y Liang,  E Rogaeva,  M Ikeda,  M Duthie,  N Murgolo,  L Wang,  P VanderVere,  M L Bayne,  C D Strader,  J M Rommens,  P E Fraser,  P St George-Hyslop]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH CTNND2]"} ], "id": "597", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10037471", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1046\/J.1471-4159.1999.0720999.X"} , { "elementOf": "NLM", "accession": "10037471"} ]} , { "annotation": "[VARIANT AD3 ASP-135]", "conames": [{ "name": "PMID: 9225696", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9225696", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation."} , { "attrname": "Abstract", "value": "We describe a new mutation causing <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) in presenilin-1 (N135D) that is at the homologous site to the presenilin 2 mutation (N141I) in Volga German kindreds. The phenotype of PS1 N135D is an early-onset (34-38 years) <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The mutation forms part of,  and extends,  the alpha-helical array of mutations in transmembrane 2 of the presenilins and leads to the suggestion that disruption of this helical face is the molecular insult that leads to <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Sequence Homology,  Phenotype,  Presenilin-1,  Pedigree,  Humans,  Adult,  Female,  Male,  Models,  Genetic,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[R Crook,  R Ellis,  M Shanks,  L J Thal,  J Perez-Tur,  M Baker,  M Hutton,  T Haltia,  J Hardy,  D Galasko]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 ASP-135]"} ], "id": "598", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9225696", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.410420121"} , { "elementOf": "NLM", "accession": "9225696"} ]} , { "annotation": "[TOPOLOGY]", "conames": [{ "name": "PMID: 15385547", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15385547", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Polysaccharides,  Presenilin-1,  EC 3.4.23.- signal peptide peptidase,  EC 3.4.23.- Aspartic Acid Endopeptidases,  RNA,  Messenger,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins."} , { "attrname": "Abstract", "value": "The human genome encodes seven intramembrane-cleaving GXGD aspartic proteases. These are the two presenilins that activate signaling molecules and are implicated in Alzheimer's disease,  signal peptide peptidase (SPP),  required for immune surveillance,  and four SPP-like candidate proteases (SPPLs),  of unknown function. Here we describe a comparative analysis of the topologies of SPP and its human homologues,  SPPL2a,  -2b,  -2c,  and -3. We demonstrate that their N-terminal extensions are located in the extracellular space and,  except for SPPL3,  are modified with N-glycans. Whereas SPPL2a,  -2b,  and -2c contain a signal sequence,  SPP and SPPL3 contain a type I signal anchor sequence for initiation of protein translocation and membrane insertion. The hydrophilic loops joining the transmembrane regions,  which contain the catalytic residues,  are facing the exoplasm. The C termini of all these proteins are exposed toward the cytosol. Taken together,  our study demonstrates that SPP and its homologues are all of the same principal structure with a catalytic domain embedded in the membrane in opposite orientation to that of presenilins. Other than presenilins,  SPPL2a,  -2b,  -2c,  and -3 are therefore predicted to cleave type II-oriented substrate peptides like the prototypic protease SPP. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Protein Biosynthesis,  Oligonucleotide Array Sequence Analysis,  Humans,  Phylogeny,  Cytosol,  Tissue Distribution,  Polysaccharides,  Aspartic Acid Endopeptidases,  Cloning,  Molecular,  Transcription,  Genetic,  Catalysis,  Binding Sites,  Fluorescent Antibody Technique,  Indirect,  Protein Structure,  Tertiary,  Cell Line,  Catalytic Domain,  Gene Library,  Electrophoresis,  Polyacrylamide Gel,  Glycosylation,  Blotting,  Western,  Protein Transport,  Membrane Proteins,  Cell-Free System,  Plasmids,  HeLa Cells,  RNA,  Messenger,  Microscopy,  Fluorescence,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Elena Friedmann,  Marius K Lemberg,  Andreas Weihofen,  Kumlesh K Dev,  Uwe Dengler,  Giorgio Rovelli,  Bruno Martoglio]"} , { "attrname": "PUB_TYPE", "value": "[TOPOLOGY]"} ], "id": "599", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15385547", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15385547"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M407898200"} ]} , { "annotation": "[FUNCTION,  ACTIVE SITE ASP-366,  MUTAGENESIS OF ASP-366]", "conames": [{ "name": "PMID: 10497236", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10497236", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Peptide Fragments,  Receptors,  Notch,  amyloid beta-protein (1-42),  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling."} , { "attrname": "Abstract", "value": "Presenilin-1 (PS1) facilitates gamma-secretase cleavage of the beta-amyloid precursor protein and the intramembraneous cleavage of Notch1. Although Alzheimer's disease-associated mutations in the homologous presenilin (PS2) gene elevate amyloid beta-peptide (Abeta42) production like PS1 mutations,  here we demonstrate that a gene ablation of PS2 (unlike that of PS1) in mice does not result in a severe phenotype resembling that of Notch-ablated animals. To investigate the amyloidogenic function of PS2 more directly,  we mutagenized a conserved aspartate at position 366 to alanine,  because the corresponding residue of PS1 is known to be required for its amyloidogenic function. Cells expressing the PS2 D366A mutation exhibit significant deficits in proteolytic processing of beta-amyloid precursor protein indicating a defect in gamma-secretase activity. The reduced gamma-secretase activity results in the almost complete inhibition of Abeta and p3 production in cells stably expressing PS2 D366A,  whereas cells overexpressing the wild-type PS2 cDNA produce robust levels of Abeta and p3. Using highly sensitive in vivo assays,  we demonstrate that the PS2 D366A mutation not only blocks gamma-secretase activity but also inactivates PS2 activity in Notch signaling by inhibiting the proteolytic release of the cytoplasmic Notch1 domain. These data suggest that PS2 is functionally involved in Abeta production and Notch signaling by facilitating similar proteolytic cleavages. "} , { "attrname": "MeSH", "value": "[Cell Line,  Presenilin-2,  Peptide Fragments,  Signal Transduction,  Animals,  Genetically Modified,  Humans,  Mice,  Knockout,  Hydrolysis,  Membrane Proteins,  Receptors,  Notch,  Animals,  Amyloid beta-Peptides,  Mice,  Mutation]"} , { "attrname": "AUTHORS", "value": "[H Steiner,  K Duff,  A Capell,  H Romig,  M G Grim,  S Lincoln,  J Hardy,  X Yu,  M Picciano,  K Fechteler,  M Citron,  R Kopan,  B Pesold,  S Keck,  M Baader,  T Tomita,  T Iwatsubo,  R Baumeister,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  ACTIVE SITE ASP-366,  MUTAGENESIS OF ASP-366]"} ], "id": "600", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10497236", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.274.40.28669"} , { "elementOf": "NLM", "accession": "10497236"} ]} , { "annotation": "[TISSUE SPECIFICITY,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 11987239", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11987239", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Blood cells,  molecules & <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  RNA,  Messenger,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Identification of the presenilins in hematopoietic cells with localization of presenilin 1 to neutrophil and platelet granules."} , { "attrname": "Abstract", "value": "Most cases of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) are caused by mutations in presenilin 1 (PS1) and presenilin 2 (PS2). Presenilins are required for the proteolytic processing of the beta amyloid precursor protein,  which yields beta amyloid peptide,  the major component of extracellular amyloid plaques. In addition,  presenilins are essential for proteolytic processing of other membrane proteins,  including Notch,  TrkB,  and APLP2. Notch directs neural and hematopoietic development. Here we show mRNA and protein expression of PS1 in both lymphoid and myeloid cells,  while PS2 mRNA is present only in lymphocytes. Expression of PS1 was found throughout myeloid development from CD34+ stem cells to platelets and neutrophils. PS1 expression was found in avian as well as mammalian blood cells. In neutrophils,  PS1 colocalized with myeloperoxidase and CD63 within the azurophil granules as demonstrated by subcellular fractionation and double labeling immunogold electron microscopy. In platelets,  PS1 colocalized with glucose transporter (GLUT-3) in the membrane of alpha granules,  as evidenced by immunogold electron microscopy. The colocalization of PS1 and amyloid precursor protein in cell-specific granules suggests a conserved function across different tissues. These studies indicate that PS1 may play multiple roles in blood cell physiology and that blood tissue may provide a model to study PS1 interactions with other proteins. "} , { "attrname": "MeSH", "value": "[Presenilin-2,  Cell Fractionation,  Presenilin-1,  Cytoplasmic Granules,  Humans,  Blood Platelets,  Neutrophils,  Microscopy,  Electron,  Myeloid Cells,  Membrane Proteins,  Animals,  Lymphocytes,  Chickens,  Adult,  Tumor Cells,  Cultured,  RNA,  Messenger,  Hematopoietic Stem Cells]"} , { "attrname": "AUTHORS", "value": "[Zeljka Korade Mirinics,  Jero Calafat,  Lene Udby,  Josh Lovelock,  Lars Kjeldsen,  Kristi Rothermund,  Sangram S Sisodia,  Niels Borregaard,  Seth J Corey]"} , { "attrname": "PUB_TYPE", "value": "[TISSUE SPECIFICITY,  SUBCELLULAR LOCATION]"} ], "id": "601", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11987239", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11987239"} , { "elementOf": "DOI", "accession": "10.1006\/BCMD.2002.0486"} ]} , { "annotation": "[VARIANTS AD3 VAL-260; VAL-285 AND VAL-392]", "conames": [{ "name": "PMID: 7651536", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7651536", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  9007-49-2 DNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in kindreds with missense mutations in a gene on chromosome 1 related to the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> type 3 gene."} , { "attrname": "Abstract", "value": "We report the cloning of a novel gene (E5-1) encoded on chromosome 1 which has substantial nucleotide and amino-acid sequence similarity to the S182 gene on chromosome 14q24.3. Mutations,  including three new missense mutations in the S182 gene,  are associated with the AD3 subtype of early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). Both the E5-1 and the S182 proteins are predicted to be integral membrane proteins with seven membrane-spanning domains,  and a large exposed loop between the sixth and seventh transmembrane domains. Analysis of the nucleotide sequence of the open reading frame (ORF) of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50-70 years versus 30-60 years for AD3). These observations imply that the E5-1 gene on chromosome 1 and the S182 gene on chromosome 14q24.3 are members of a family of genes (presenilins) with related functions,  and indicates that mutations in conserved residues of E5-1 could also play a role in the genesis of AD. Our results also indicate that still other AD susceptibility genes exist. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Sequence Homology,  Amino Acid,  Amino Acid Sequence,  Presenilin-2,  Presenilin-1,  Chromosomes,  Human,  Pair 1,  Base Sequence,  DNA,  Humans,  Molecular Sequence Data,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[E I Rogaev,  R Sherrington,  E A Rogaeva,  G Levesque,  M Ikeda,  Y Liang,  H Chi,  C Lin,  K Holman,  T Tsuda]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 VAL-260; VAL-285 AND VAL-392]"} ], "id": "602", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7651536", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7651536"} , { "elementOf": "DOI", "accession": "10.1038\/376775A0"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "603", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9Y2H9", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9Y2H9"} ]} , { "annotation": "Created:  1986-11-01; Modified:  2016-01-20; Version:  208", "conames": [{ "name": "PRNP", "isPreferred": "false"} , { "name": "PrP33-35C", "isPreferred": "false"} , { "name": "ALTPRP", "isPreferred": "false"} , { "name": "PrP27-30", "isPreferred": "false"} , { "name": "PRIP", "isPreferred": "false"} , { "name": "Major prion protein", "isPreferred": "true"} , { "name": "PrP", "isPreferred": "false"} , { "name": "ASCR", "isPreferred": "false"} , { "name": "PRP", "isPreferred": "false"} ], "elementOf": "DrugBank: ENSEMBL: IntAct_AD: IntAct_PD: UNIPROTKB-SwissProt", "description": "", "pid": "P04156", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "67"} ], "id": "604", "contexts": { "context": { "id": 607} } , "evidences": ["Imported from database"], "value": "Major prion protein", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENSP00000399376"} , { "elementOf": "ENSEMBL", "accession": "ENST00000379440"} , { "elementOf": "UNIPROTKB", "accession": "P04156"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000171867"} , { "elementOf": "ENSEMBL", "accession": "ENST00000430350"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000368752"} ]} , { "annotation": "[VARIANT CJD HIS-208]", "conames": [{ "name": "PMID: 8909447", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8909447", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Prions]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease."} , { "attrname": "Abstract", "value": "Four point mutations and one insertion within the prion protein (PrP) gene have been tightly linked to the development of inherited prion disease. We developed a denaturing gradient gel electrophoresis system that allowed us to screen the entire open reading frame of the PrP gene. Using this system,  we found a new mutation of the PrP gene in a patient with pathologically confirmed Creutzfeldt-Jakob disease and a negative family history for dementia. DNA sequencing revealed an adenine substitution for guanine at the second position of codon 208,  which results in the nonconservative substitution of histidine for arginine. The same PrP mutation was identified in another younger member of the pedigree but was not present in more than 200 alleles tested. Such findings suggest that the frequency of inherited prion disease might be higher than ascertained by clinical history alone. "} , { "attrname": "MeSH", "value": "[Pedigree,  Base Sequence,  Humans,  Middle Aged,  Prions,  Molecular Sequence Data,  Male,  Mutation,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[J A Mastrianni,  C Iannicola,  R M Myers,  S DeArmond,  S B Prusiner]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD HIS-208]"} ], "id": "605", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8909447", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.47.5.1305"} , { "elementOf": "NLM", "accession": "8909447"} ]} , { "annotation": "[INVOLVEMENT IN HDL1]", "conames": [{ "name": "PMID: 9792871", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9792871", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Genetic Markers]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "A Huntington disease-like neurodegenerative disorder maps to chromosome 20p."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Huntington<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (HD) is an autosomal dominant neurodegenerative disorder characterized by motor disturbance,  cognitive loss,  and psychiatric manifestations. The <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is associated with a CAG trinucleotide-repeat expansion in the <span style=\"background-color: yellow\"><b>Huntington<\/b><\/span> gene (IT15) on chromosome 4p16.3. One family with a history of HD was referred to us initially for predictive testing using linkage analysis. However,  the chromosome 4p region was completely excluded by polymorphic markers,  and later no CAG-repeat expansion in the HD gene was detected. To map the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> trait segregating in this family,  whole-genome screening with highly polymorphic dinucleotide-,  trinucleotide-,  and tetranucleotide-repeat DNA markers was performed. A positive LOD score of 3.01 was obtained for the marker D20S482 on chromosome 20p,  by two-point LOD-score analysis with the MLINK program. Haplotype analysis indicated that the gene responsible for the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is likely located in a 2.7-cM region between the markers D20S193 and D20S895. Candidate genes from the mapping region were screened for mutations. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Huntington<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Trinucleotide Repeats,  Brain,  Neurodegenerative <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Humans,  Middle Aged,  Genotype,  Male,  Chromosome Mapping,  Genetic Markers,  Chromosomes,  Human,  Pair 4,  Atrophy,  Magnetic Resonance Imaging,  Sweden,  Pedigree,  Age of Onset,  Adult,  Female,  Chromosomes,  Human,  Pair 20]"} , { "attrname": "AUTHORS", "value": "[F Xiang,  E W Almqvist,  M Huq,  A Lundin,  M R Hayden,  L Edstrm,  M Anvret,  Z Zhang]"} , { "attrname": "PUB_TYPE", "value": "[INVOLVEMENT IN HDL1]"} ], "id": "606", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9792871", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9792871"} , { "elementOf": "DOI", "accession": "10.1086\/302093"} ]} , { "annotation": "[COPPER-BINDING,  FUNCTION]", "conames": [{ "name": "PMID: 12732622", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12732622", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[CAV1 protein,  human,  Caveolins,  Ions,  9050-30-0 Heparitin Sulfate,  789U1901C5 Copper,  Cav1 protein,  mouse,  Caveolin 1,  PQ6CK8PD0R Ascorbic Acid,  Prions,  Amyloid beta-Peptides,  PrPC Proteins,  Heparan Sulfate Proteoglycans,  J41CSQ7QDS Zinc,  N08U5BOQ1K Glucosamine,  31C4KY9ESH Nitric Oxide,  N762921K75 Nitrogen]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Prion,  amyloid beta-derived Cu(II) ions,  or free Zn(II) ions support S-nitroso-dependent autocleavage of glypican-1 heparan sulfate."} , { "attrname": "Abstract", "value": "Copper are generally bound to proteins,  e.g. the prion and the amyloid beta proteins. We have previously shown that copper ions are required to nitrosylate thiol groups in the core protein of glypican-1,  a heparan sulfate-substituted proteoglycan. When S-nitrosylated glypican-1 is then exposed to an appropriate reducing agent,  such as ascorbate,  nitric oxide is released and autocatalyzes deaminative cleavage of the glypican-1 heparan sulfate side chains at sites where the glucosamines are N-unsubstituted. These processes take place in a stepwise manner,  whereas glypican-1 recycles via a caveolin-1-associated pathway where copper ions could be provided by the prion protein. Here we show,  by using both biochemical and microscopic techniques,  that (a) the glypican-1 core protein binds copper(II) ions,  reduces them to copper(I) when the thiols are nitrosylated and reoxidizes copper(I) to copper(II) when ascorbate releases nitric oxide; (b) maximally S-nitrosylated glypican-1 can cleave its own heparan sulfate chains at all available sites in a nitroxyl ion-dependent reaction; (c) free zinc(II) ions,  which are redox inert,  also support autocleavage of glypican-1 heparan sulfate,  probably via transnitrosation,  whereas they inhibit copper(II)-supported degradation; and (d) copper(II)-loaded but not zinc(II)-loaded prion protein or amyloid beta peptide support heparan sulfate degradation. As glypican-1 in prion null cells is poorly S-nitrosylated and as ectopic expression of cellular prion protein restores S-nitrosylation of glypican-1 in these cells,  we propose that one function of the cellular prion protein is to deliver copper(II) for the S-nitrosylation of recycling glypican-1. "} , { "attrname": "MeSH", "value": "[Glucosamine,  Oxidation-Reduction,  Caveolins,  Heparitin Sulfate,  Humans,  Ions,  Nitric Oxide,  Nitrogen,  Chromatography,  Zinc,  Microscopy,  Confocal,  Ascorbic Acid,  Animals,  Caveolin 1,  Models,  Biological,  Prions,  Amyloid beta-Peptides,  PrPC Proteins,  Heparan Sulfate Proteoglycans,  Mice,  Tumor Cells,  Cultured,  Copper,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[Katrin Mani,  Fang Cheng,  Birgitta Havsmark,  Mats Jnsson,  Mattias Belting,  Lars-Ake Fransson]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING,  FUNCTION]"} ], "id": "607", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12732622", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12732622"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M300394200"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "608", "contexts": { } , "evidences": ["Imported from database"], "value": "P60709", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P60709"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "609", "contexts": { } , "evidences": ["Imported from database"], "value": "P04040", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P04040"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "610", "contexts": { } , "evidences": ["Imported from database"], "value": "P27797", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P27797"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "611", "contexts": { } , "evidences": ["Imported from database"], "value": "P13984", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P13984"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "612", "contexts": { } , "evidences": ["Imported from database"], "value": "P14136", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P14136"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "613", "contexts": { } , "evidences": ["Imported from database"], "value": "P62937", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P62937"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "614", "contexts": { } , "evidences": ["Imported from database"], "value": "O75955", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O75955"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "615", "contexts": { } , "evidences": ["Imported from database"], "value": "P35579", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P35579"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "616", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9P2D7", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9P2D7"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "617", "contexts": { } , "evidences": ["Imported from database"], "value": "P18669", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P18669"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "618", "contexts": { } , "evidences": ["Imported from database"], "value": "P02647", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P02647"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "619", "contexts": { } , "evidences": ["Imported from database"], "value": "P46459", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P46459"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "620", "contexts": { } , "evidences": ["Imported from database"], "value": "Q99683", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q99683"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "621", "contexts": { } , "evidences": ["Imported from database"], "value": "P61812", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61812"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "622", "contexts": { } , "evidences": ["Imported from database"], "value": "P02511", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P02511"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "623", "contexts": { } , "evidences": ["Imported from database"], "value": "P56817", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P56817"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "624", "contexts": { } , "evidences": ["Imported from database"], "value": "P02686", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P02686"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "625", "contexts": { } , "evidences": ["Imported from database"], "value": "Q16594", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q16594"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "626", "contexts": { } , "evidences": ["Imported from database"], "value": "P61764", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61764"} ]} , { "annotation": "", "conames": [], "elementOf": "DrugBank: IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "627", "contexts": { } , "evidences": ["Imported from database"], "value": "P36544", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P36544"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "628", "contexts": { } , "evidences": ["Imported from database"], "value": "P61457", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P61457"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "629", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9UQF2", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9UQF2"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "630", "contexts": { } , "evidences": ["Imported from database"], "value": "O35827", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O35827"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "631", "contexts": { } , "evidences": ["Imported from database"], "value": "Q99714", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q99714"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "632", "contexts": { } , "evidences": ["Imported from database"], "value": "O00213", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O00213"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "633", "contexts": { } , "evidences": ["Imported from database"], "value": "O95704", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O95704"} ]} , { "annotation": "Created:  1989-07-01; Modified:  2016-01-20; Version:  182", "conames": [{ "name": "UCHL1", "isPreferred": "false"} , { "name": "Ubiquitin thioesterase L1", "isPreferred": "false"} , { "name": "UCH-L1", "isPreferred": "false"} , { "name": "PGP9.5", "isPreferred": "false"} , { "name": "Ubiquitin carboxyl-terminal hydrolase isozyme L1", "isPreferred": "true"} , { "name": "PGP 9.5", "isPreferred": "false"} , { "name": "Neuron cytoplasmic protein 9.5", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: UNIPROTKB-SwissProt", "description": "", "pid": "P09936", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "24"} ], "id": "634", "contexts": { "context": { "id": 346} } , "evidences": ["Imported from database"], "value": "Ubiquitin carboxyl-terminal hydrolase isozyme L1", "ofType": "Protein", "coaccessions": [{ "elementOf": "ENSEMBL", "accession": "ENST00000284440"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000154277"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000422542"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000284440"} , { "elementOf": "UNIPROTKB", "accession": "P09936"} , { "elementOf": "ENSEMBL", "accession": "ENST00000503431"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "635", "contexts": { } , "evidences": ["Imported from database"], "value": "P15253", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P15253"} ]} , { "annotation": "Created:  1996-10-01; Modified:  2016-01-20; Version:  174", "conames": [{ "name": "STM2", "isPreferred": "false"} , { "name": "Presenilin-2", "isPreferred": "true"} , { "name": "Presenilin-2 CTF subunit", "isPreferred": "true"} , { "name": "AD3LP", "isPreferred": "false"} , { "name": "PSEN2", "isPreferred": "false"} , { "name": "STM-2", "isPreferred": "false"} , { "name": "PS-2", "isPreferred": "false"} , { "name": "PS2", "isPreferred": "false"} , { "name": "AD4", "isPreferred": "false"} , { "name": "AD5", "isPreferred": "false"} , { "name": "E5-1", "isPreferred": "false"} , { "name": "Presenilin-2 NTF subunit", "isPreferred": "true"} , { "name": "PSNL2", "isPreferred": "false"} ], "elementOf": "ENSEMBL: IntAct_AD: UNIPROTKB-SwissProt", "description": "", "pid": "P49810", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "30"} , { "attrname": "TAXID", "value": "9606"} , { "attrname": "CitNum", "value": "38"} ], "id": "636", "contexts": { "context": { "id": 61} } , "evidences": ["Imported from database"], "value": "Presenilin-2", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P49810"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000355747"} , { "elementOf": "ENSEMBL", "accession": "ENST00000422240"} , { "elementOf": "ENSEMBL", "accession": "ENSG00000143801"} , { "elementOf": "ENSEMBL", "accession": "ENSP00000403737"} , { "elementOf": "ENSEMBL", "accession": "ENST00000366783"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "637", "contexts": { } , "evidences": ["Imported from database"], "value": "Q9NP59", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q9NP59"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "638", "contexts": { } , "evidences": ["Imported from database"], "value": "Q05193", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q05193"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "639", "contexts": { } , "evidences": ["Imported from database"], "value": "P07196", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P07196"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "640", "contexts": { } , "evidences": ["Imported from database"], "value": "O75509", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "O75509"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "641", "contexts": { } , "evidences": ["Imported from database"], "value": "P21359", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P21359"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "642", "contexts": { } , "evidences": ["Imported from database"], "value": "P56817-1", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P56817-1"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD: IntAct_PD", "description": "", "pid": "", "attributes": [], "id": "643", "contexts": { } , "evidences": ["Imported from database"], "value": "P30101", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P30101"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "644", "contexts": { } , "evidences": ["Imported from database"], "value": "Q92876", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "Q92876"} ]} , { "annotation": "", "conames": [], "elementOf": "IntAct_AD", "description": "", "pid": "", "attributes": [], "id": "645", "contexts": { } , "evidences": ["Imported from database"], "value": "P78536", "ofType": "Protein", "coaccessions": [{ "elementOf": "UNIPROTKB", "accession": "P78536"} ]} , { "annotation": "A part of the endomembrane system in the form of an invagination of a membrane upon which a clathrin coat forms,  and that can be converted by vesicle budding into a clathrin-coated vesicle. Coated pits form on the plasma membrane,  where they are involved in receptor-mediated selective transport of many proteins and other macromolecules across the cell membrane,  in the trans-Golgi network,  and on some endosomes. ( Reference:  GOC: mah ISBN: 0198506732 NIF_Subcellular: sao1969557946 PMID: 10559856 PMID: 17284835 )", "conames": [{ "name": "coated pit", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005905", "attributes": [], "id": "646", "contexts": { } , "evidences": ["Imported from database"], "value": "coated pit", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005905"} ]} , { "annotation": "A small,  membranous protrusion from a dendrite that forms a postsynaptic compartment - typically receiving input from a single presynapse.  They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable including   ( Reference:  GOC: nln )", "conames": [{ "name": "stubby dendritic spine", "isPreferred": "false"} , { "name": "dendrite spine", "isPreferred": "true"} , { "name": "sessile dendritic spine", "isPreferred": "false"} , { "name": "thin dendritic spine", "isPreferred": "false"} , { "name": "dendritic spine", "isPreferred": "true"} , { "name": "branched dendritic spine", "isPreferred": "false"} , { "name": "mushroom dendritic spine", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043197", "attributes": [], "id": "647", "contexts": { } , "evidences": ["Imported from database"], "value": "dendrite spine", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043197"} ]} , { "annotation": "Cylindric portion of the dendrite,  directly stemming from the perikaryon,  and carrying the dendritic spines. ( Reference:  GOC: nln )", "conames": [{ "name": "trunk", "isPreferred": "false"} , { "name": "dendritic shaft", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043198", "attributes": [], "id": "648", "contexts": { } , "evidences": ["Imported from database"], "value": "dendritic shaft", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043198"} ]} , { "annotation": "The volume enclosed by the membrane of an endosome. ( Reference:  GOC: mah )", "conames": [{ "name": "endosome lumen", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031904", "attributes": [], "id": "649", "contexts": { } , "evidences": ["Imported from database"], "value": "endosome lumen", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031904"} ]} , { "annotation": "The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. ( Reference:  GOC: dos GOC: go_curators )", "conames": [{ "name": "integral to membrane", "isPreferred": "false"} , { "name": "transmembrane", "isPreferred": "false"} , { "name": "integral component of membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016021", "attributes": [], "id": "650", "contexts": { } , "evidences": ["Imported from database"], "value": "integral component of membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016021"} ]} , { "annotation": "Any protein complex that undergoes combination with a hormone,  neurotransmitter,  drug or intracellular messenger to initiate a change in cell function. ( Reference:  GOC: go_curators )", "conames": [{ "name": "receptor complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043235", "attributes": [], "id": "651", "contexts": { } , "evidences": ["Imported from database"], "value": "receptor complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043235"} ]} , { "annotation": "The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. ( Reference:  GOC: dos GOC: go_curators )", "conames": [{ "name": "integral to plasma membrane", "isPreferred": "false"} , { "name": "integral component of plasma membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005887", "attributes": [], "id": "652", "contexts": { } , "evidences": ["Imported from database"], "value": "integral component of plasma membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005887"} ]} , { "annotation": "Cytoplasm situated near,  or occurring around,  the nucleus. ( Reference:  GOC: jid )", "conames": [{ "name": "perinuclear region of cytoplasm", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048471", "attributes": [], "id": "653", "contexts": { } , "evidences": ["Imported from database"], "value": "perinuclear region of cytoplasm", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048471"} ]} , { "annotation": "The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network. ( Reference:  GOC: mah )", "conames": [{ "name": "Golgi trans face membrane", "isPreferred": "false"} , { "name": "trans Golgi network membrane", "isPreferred": "true"} , { "name": "trans-Golgi network membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032588", "attributes": [], "id": "654", "contexts": { } , "evidences": ["Imported from database"], "value": "trans-Golgi network membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032588"} ]} , { "annotation": "The external part of the cell wall and or plasma membrane. ( Reference:  GOC: jl GOC: mtg_sensu GOC: sm )", "conames": [{ "name": "cell surface", "isPreferred": "true"} , { "name": "cell bound", "isPreferred": "true"} , { "name": "cell associated", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0009986", "attributes": [], "id": "655", "contexts": { } , "evidences": ["Imported from database"], "value": "cell bound", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0009986"} , { "elementOf": "GO", "accession": "GO: 0009929"} , { "elementOf": "GO", "accession": "GO: 0009928"} ]} , { "annotation": "Organized structure of distinctive morphology and function,  bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus,  mitochondria,  plastids,  vacuoles,  and vesicles. Excludes the plasma membrane. ( Reference:  GOC: go_curators )", "conames": [{ "name": "intracellular membrane-bounded organelle", "isPreferred": "true"} , { "name": "intracellular membrane-enclosed organelle", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043231", "attributes": [], "id": "656", "contexts": { } , "evidences": ["Imported from database"], "value": "intracellular membrane-bounded organelle", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043231"} ]} , { "annotation": "The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. ( Reference:  GOC: go_curators )", "conames": [{ "name": "extracellular", "isPreferred": "true"} , { "name": "extracellular region", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005576", "attributes": [], "id": "657", "contexts": { } , "evidences": ["Imported from database"], "value": "extracellular", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005576"} ]} , { "annotation": "The region between the two lipid bilayers of the nuclear envelope; 20-40 nm wide. ( Reference:  GOC: ai )", "conames": [{ "name": "perinuclear space", "isPreferred": "true"} , { "name": "nuclear envelope lumen", "isPreferred": "true"} , { "name": "nuclear intermembrane space", "isPreferred": "true"} , { "name": "nuclear membrane lumen", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005641", "attributes": [], "id": "658", "contexts": { } , "evidences": ["Imported from database"], "value": "perinuclear space", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005653"} , { "elementOf": "GO", "accession": "GO: 0005641"} ]} , { "annotation": "The volume enclosed by the membrane of the platelet alpha granule. ( Reference:  GOC: mah PMID: 8467233 )", "conames": [{ "name": "platelet alpha-granule lumen", "isPreferred": "true"} , { "name": "platelet alpha granule lumen", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031093", "attributes": [], "id": "659", "contexts": { } , "evidences": ["Imported from database"], "value": "platelet alpha granule lumen", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031093"} ]} , { "annotation": "The junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell; the site of interneuronal communication. As the nerve fiber approaches the synapse it enlarges into a specialized structure,  the presynaptic nerve ending,  which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it,  and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell,  known as the postsynaptic membrane. In response to the arrival of nerve impulses,  the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "electrotonic synapse", "isPreferred": "false"} , { "name": "mixed synapse", "isPreferred": "false"} , { "name": "synaptic junction", "isPreferred": "true"} , { "name": "synapse", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045202", "attributes": [], "id": "660", "contexts": { } , "evidences": ["Imported from database"], "value": "synapse", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045202"} ]} , { "annotation": "An immune response against a fungus mediated through a body fluid. An example of this process is the antifungal humoral response in Drosophila melanogaster. ( Reference:  GOC: go_curators GOC: mtg_sensu )", "conames": [{ "name": "antifungal humoral response", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019732", "attributes": [], "id": "661", "contexts": { } , "evidences": ["Imported from database"], "value": "antifungal humoral response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019732"} , { "elementOf": "GO", "accession": "GO: 0019734"} , { "elementOf": "GO", "accession": "GO: 0006966"} ]} , { "annotation": "The directed movement of substances from the Golgi to other parts of the cell,  including organelles and the plasma membrane,  mediated by small transport vesicles. ( Reference:  GOC: ai GOC: mah )", "conames": [{ "name": "post-Golgi transport", "isPreferred": "true"} , { "name": "post-Golgi vesicle-mediated transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006892", "attributes": [], "id": "662", "contexts": { } , "evidences": ["Imported from database"], "value": "post-Golgi transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006892"} ]} , { "annotation": "The process whose specific outcome is the progression of the dendrite over time,  from its formation to the mature structure. A dendrite is a freely branching protoplasmic process of a nerve cell. ( Reference:  GOC: jl ISBN: 0198506732 )", "conames": [{ "name": "dendrite development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016358", "attributes": [], "id": "663", "contexts": { } , "evidences": ["Imported from database"], "value": "dendrite development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016358"} ]} , { "annotation": "Any process involved in the maintenance of an internal steady state of copper ions at the level of a cell. ( Reference:  GOC: ai GOC: mah )", "conames": [{ "name": "cellular copper ion homeostasis", "isPreferred": "true"} , { "name": "copper homeostasis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006878", "attributes": [], "id": "664", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular copper ion homeostasis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006878"} ]} , { "annotation": "The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "cleavage and polyadenylylation specificity factor", "isPreferred": "false"} , { "name": "mRNA polyadenylation", "isPreferred": "true"} , { "name": "mRNA polyadenylylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006378", "attributes": [], "id": "665", "contexts": { } , "evidences": ["Imported from database"], "value": "mRNA polyadenylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006378"} ]} , { "annotation": "An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. ( Reference:  GOC: go_curators GOC: mtg_sensu )", "conames": [{ "name": "antibacterial humoral response", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019731", "attributes": [], "id": "666", "contexts": { } , "evidences": ["Imported from database"], "value": "antibacterial humoral response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019731"} , { "elementOf": "GO", "accession": "GO: 0019733"} , { "elementOf": "GO", "accession": "GO: 0006961"} ]} , { "annotation": "The process in which outgrowths develop from the axons of intact undamaged neurons. ( Reference:  GOC: dgh GOC: dph GOC: jid GOC: lm )", "conames": [{ "name": "collateral sprouting in absence of injury", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048669", "attributes": [], "id": "667", "contexts": { } , "evidences": ["Imported from database"], "value": "collateral sprouting in absence of injury", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048669"} ]} , { "annotation": "The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. ( Reference:  GOC: add )", "conames": [{ "name": "platelet exocytosis", "isPreferred": "true"} , { "name": "platelet degranulation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0002576", "attributes": [], "id": "668", "contexts": { } , "evidences": ["Imported from database"], "value": "platelet exocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002576"} ]} , { "annotation": "Locomotory behavior in a fully developed and mature organism. ( Reference:  GOC: ai )", "conames": [{ "name": "adult locomotory behaviour", "isPreferred": "true"} , { "name": "adult locomotory behavior", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008344", "attributes": [], "id": "669", "contexts": { } , "evidences": ["Imported from database"], "value": "adult locomotory behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008344"} ]} , { "annotation": "The developmentally regulated remodeling of neuronal projections such as pruning to eliminate the extra dendrites and axons projections set up in early stages of nervous system development. ( Reference:  GOC: hb )", "conames": [{ "name": "axon pruning", "isPreferred": "false"} , { "name": "neuron remodeling", "isPreferred": "true"} , { "name": "neuronal remodeling", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016322", "attributes": [], "id": "670", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron remodeling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016322"} ]} , { "annotation": "The attachment of a cell,  either to another cell or to an underlying substrate such as the extracellular matrix,  via cell adhesion molecules. ( Reference:  GOC: hb GOC: pf )", "conames": [{ "name": "cell adhesion", "isPreferred": "true"} , { "name": "cell adhesion molecule", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007155", "attributes": [], "id": "671", "contexts": { } , "evidences": ["Imported from database"], "value": "cell adhesion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007155"} ]} , { "annotation": "A series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell,  followed by the movement of ions through a channel in the receptor complex. Ends with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: signaling ISBN: 0198506732 )", "conames": [{ "name": "ionotropic glutamate receptor signalling pathway", "isPreferred": "true"} , { "name": "ionotropic glutamate receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035235", "attributes": [], "id": "672", "contexts": { } , "evidences": ["Imported from database"], "value": "ionotropic glutamate receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035235"} ]} , { "annotation": "The behavioral interactions between organisms for the purpose of mating,  or sexual reproduction resulting in the formation of zygotes. ( Reference:  GOC: ai GOC: dph )", "conames": [{ "name": "mating behaviour", "isPreferred": "true"} , { "name": "mating behavior", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007617", "attributes": [], "id": "673", "contexts": { } , "evidences": ["Imported from database"], "value": "mating behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007617"} ]} , { "annotation": "A series of progressive,  overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change,  adhesiveness,  aggregation,  and release reactions. When carried through to completion,  these events lead to the formation of a stable hemostatic plug. ( Reference:  http: \/\/www.graylab.ac.uk\/omd\/ )", "conames": [{ "name": "blood coagulation,  platelet activation", "isPreferred": "true"} , { "name": "platelet activation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030168", "attributes": [], "id": "674", "contexts": { } , "evidences": ["Imported from database"], "value": "platelet activation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030168"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA. ( Reference:  GOC: isa_complete )", "conames": [{ "name": "regulation of protein anabolism", "isPreferred": "true"} , { "name": "regulation of protein biosynthesis", "isPreferred": "true"} , { "name": "regulation of translation", "isPreferred": "true"} , { "name": "regulation of protein formation", "isPreferred": "true"} , { "name": "regulation of protein synthesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006417", "attributes": [], "id": "675", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of translation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006445"} , { "elementOf": "GO", "accession": "GO: 0006417"} ]} , { "annotation": "Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. ( Reference:  GOC: ai )", "conames": [{ "name": "defence response to Gram-negative bacterium", "isPreferred": "true"} , { "name": "defence response to Gram-negative bacteria", "isPreferred": "true"} , { "name": "defense response to Gram-negative bacterium", "isPreferred": "true"} , { "name": "Gram-negative antibacterial peptide", "isPreferred": "false"} , { "name": "defense response to Gram-negative bacteria", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050829", "attributes": [], "id": "676", "contexts": { } , "evidences": ["Imported from database"], "value": "defense response to Gram-negative bacteria", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050829"} ]} , { "annotation": "The sequential process in which the multiple coagulation factors of the blood interact,  ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages:  stage 1,  the formation of intrinsic and extrinsic prothrombin converting principle; stage 2,  the formation of thrombin; stage 3,  the formation of stable fibrin polymers. ( Reference:  http: \/\/www.graylab.ac.uk\/omd\/ ISBN: 0198506732 )", "conames": [{ "name": "blood coagulation", "isPreferred": "true"} , { "name": "blood clotting", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007596", "attributes": [], "id": "677", "contexts": { } , "evidences": ["Imported from database"], "value": "blood clotting", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007596"} ]} , { "annotation": "Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. ( Reference:  GO_REF: 0000022 GOC: add GOC: ebc GOC: mtg_15nov05 GOC: mtg_sensu )", "conames": [{ "name": "innate immunity", "isPreferred": "true"} , { "name": "innate immune response", "isPreferred": "true"} , { "name": "nonspecific immune response", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045087", "attributes": [], "id": "678", "contexts": { } , "evidences": ["Imported from database"], "value": "innate immunity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002226"} , { "elementOf": "GO", "accession": "GO: 0045087"} ]} , { "annotation": "Any apoptotic process in a neuron,  the basic cellular unit of nervous tissue. Each neuron consists of a body,  an axon,  and dendrites. Their purpose is to receive,  conduct,  and transmit impulses in the nervous system. ( Reference:  CL: 0000540 GOC: mtg_apoptosis MeSH: A.08.663 )", "conames": [{ "name": "apoptosis of neuronal cells", "isPreferred": "true"} , { "name": "programmed cell death,  neuronal cells", "isPreferred": "true"} , { "name": "programmed cell death of neuronal cells by apoptosis", "isPreferred": "true"} , { "name": "programmed cell death,  neurons", "isPreferred": "true"} , { "name": "neuronal cell programmed cell death by apoptosis", "isPreferred": "true"} , { "name": "programmed cell death of neurons by apoptosis", "isPreferred": "true"} , { "name": "apoptosis of neurons", "isPreferred": "true"} , { "name": "neuron apoptotic process", "isPreferred": "true"} , { "name": "neuronal cell apoptosis", "isPreferred": "true"} , { "name": "neuron apoptosis", "isPreferred": "false"} , { "name": "neuron programmed cell death by apoptosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051402", "attributes": [], "id": "679", "contexts": { } , "evidences": ["Imported from database"], "value": "apoptosis of neurons", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051402"} ]} , { "annotation": "A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell,  and ending with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: go_curators GOC: signaling )", "conames": [{ "name": "N signaling pathway", "isPreferred": "true"} , { "name": "Notch receptor signaling pathway", "isPreferred": "true"} , { "name": "Notch signaling pathway", "isPreferred": "true"} , { "name": "Notch signalling pathway", "isPreferred": "true"} , { "name": "Notch-receptor signalling pathway", "isPreferred": "true"} , { "name": "Notch-receptor signaling pathway", "isPreferred": "true"} , { "name": "Notch receptor signalling pathway", "isPreferred": "true"} , { "name": "N signalling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007219", "attributes": [], "id": "680", "contexts": { } , "evidences": ["Imported from database"], "value": "N signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030179"} , { "elementOf": "GO", "accession": "GO: 0007219"} ]} , { "annotation": "The recognition of molecules at the central nervous system midline choice point by an axon growth cone; this choice point determines whether the growth cone will cross the midline. ( Reference:  PMID: 11376484 )", "conames": [{ "name": "axon midline choice point recognition", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016199", "attributes": [], "id": "681", "contexts": { } , "evidences": ["Imported from database"], "value": "axon midline choice point recognition", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016199"} ]} , { "annotation": "De novo generation of a long process of a neuron,  that carries efferent (outgoing) action potentials from the cell body towards target cells. Refers to the morphogenesis or creation of shape or form of the developing axon. ( Reference:  GOC: dph GOC: jid GOC: pg GOC: pr ISBN: 0198506732 )", "conames": [{ "name": "axonogenesis", "isPreferred": "true"} , { "name": "axon growth", "isPreferred": "false"} , { "name": "neuron long process generation", "isPreferred": "true"} , { "name": "axon morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007409", "attributes": [], "id": "682", "contexts": { } , "evidences": ["Imported from database"], "value": "axonogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007410"} , { "elementOf": "GO", "accession": "GO: 0007409"} ]} , { "annotation": "Any process that activates or increases the rate or extent of progression through the mitotic cell cycle. ( Reference:  GOC: dph GOC: go_curators GOC: tb )", "conames": [{ "name": "activation of progression through mitotic cell cycle", "isPreferred": "false"} , { "name": "positive regulation of mitotic cell cycle progression", "isPreferred": "true"} , { "name": "positive regulation of mitotic cell cycle", "isPreferred": "true"} , { "name": "up regulation of progression through mitotic cell cycle", "isPreferred": "true"} , { "name": "stimulation of progression through mitotic cell cycle", "isPreferred": "false"} , { "name": "upregulation of progression through mitotic cell cycle", "isPreferred": "true"} , { "name": "positive regulation of progression through mitotic cell cycle", "isPreferred": "true"} , { "name": "up-regulation of progression through mitotic cell cycle", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045931", "attributes": [], "id": "683", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of mitotic cell cycle", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045931"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of EGF-activated receptor activity. ( Reference:  GOC: dph GOC: go_curators )", "conames": [{ "name": "regulation of epidermal growth factor receptor", "isPreferred": "true"} , { "name": "regulation of EGFR", "isPreferred": "true"} , { "name": "regulation of epidermal growth factor-activated receptor activity", "isPreferred": "true"} , { "name": "regulation of EGF receptor", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007176", "attributes": [], "id": "684", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of EGFR", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007176"} ]} , { "annotation": "Any process that modulates the physical form or the activity of a synapse,  the junction between a neuron and a target (neuron,  muscle,  or secretory cell). ( Reference:  GOC: ai );", "conames": [{ "name": "regulation of synapse structure or activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050803", "attributes": [], "id": "685", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synapse structure or activity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050803"} ]} , { "annotation": "The process whose specific outcome is the progression of a neuron projection over time,  from its formation to the mature structure. A neuron projection is any process extending from a neural cell,  such as axons or dendrites (collectively called neurites). ( Reference:  GOC: mah )", "conames": [{ "name": "neurite formation", "isPreferred": "false"} , { "name": "neuron projection development", "isPreferred": "true"} , { "name": "neurite growth", "isPreferred": "false"} , { "name": "neurite biosynthesis", "isPreferred": "false"} , { "name": "neurite development", "isPreferred": "false"} , { "name": "neurite outgrowth", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031175", "attributes": [], "id": "686", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron projection development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031175"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of an extracellular matrix. ( Reference:  GOC: mah )", "conames": [{ "name": "extracellular matrix organisation", "isPreferred": "true"} , { "name": "extracellular matrix organization and biogenesis", "isPreferred": "false"} , { "name": "extracellular matrix organization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030198", "attributes": [], "id": "687", "contexts": { } , "evidences": ["Imported from database"], "value": "extracellular matrix organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030198"} ]} , { "annotation": "A series of molecular signals generated as a consequence of a nucleotide-binding domain,  leucine rich repeat containing receptor (NLR) binding to one of its physiological ligands. NLRs are cytoplasmic receptors defined by their tripartite domain architecture that contains:  a variable C-terminus,  a middle nucleotide-binding domain,  and a LRR domain that is variable in the repeats composition and number. The NLR signaling pathway begins with binding of a ligand to a NLR receptor and ends with regulation of a downstream cellular process. ( Reference:  GOC: sj PMID: 18280719 Reactome: 168643 )", "conames": [{ "name": "nucleotide-binding domain,  leucine rich repeat containing receptor signal transduction pathway", "isPreferred": "true"} , { "name": "NOD-like receptor signaling pathway", "isPreferred": "false"} , { "name": "nucleotide-binding domain,  leucine rich repeat containing receptor signaling pathway", "isPreferred": "true"} , { "name": "nucleotide-binding domain leucine-rich repeat containing receptor signaling pathway", "isPreferred": "true"} , { "name": "NLR signaling pathway", "isPreferred": "true"} , { "name": "nucleotide-binding domain,  leucine rich repeat containing receptor signal transduction", "isPreferred": "true"} , { "name": "nucleotide-binding domain,  leucine rich repeat containing receptor signalling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035872", "attributes": [], "id": "688", "contexts": { } , "evidences": ["Imported from database"], "value": "NLR signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035872"} ]} , { "annotation": "A process which results in the assembly,  arrangement of constituent parts,  or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells,  and,  in eukaryotes,  many organelles; may be a single or double lipid bilayer; also includes associated proteins. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "membrane organisation", "isPreferred": "true"} , { "name": "membrane organization", "isPreferred": "true"} , { "name": "cellular membrane organization", "isPreferred": "true"} , { "name": "membrane organization and biogenesis", "isPreferred": "false"} , { "name": "cellular membrane organisation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0061024", "attributes": [], "id": "689", "contexts": { } , "evidences": ["Imported from database"], "value": "membrane organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016044"} , { "elementOf": "GO", "accession": "GO: 0061024"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of growth of the body of an organism so that it reaches its usual body size. ( Reference:  GOC: dph GOC: ems GOC: tb )", "conames": [{ "name": "regulation of multicellular organism growth", "isPreferred": "true"} , { "name": "regulation of body size", "isPreferred": "true"} , { "name": "regulation of body growth", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0040014", "attributes": [], "id": "690", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of body size", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0040014"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stimulus from a yeast species. ( Reference:  PMID: 14707091 )", "conames": [{ "name": "response to yeast", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001878", "attributes": [], "id": "691", "contexts": { } , "evidences": ["Imported from database"], "value": "response to yeast", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001878"} ]} , { "annotation": "Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. ( Reference:  GOC: ai )", "conames": [{ "name": "defense response to Gram-positive bacteria", "isPreferred": "true"} , { "name": "defense response to Gram-positive bacterium", "isPreferred": "true"} , { "name": "defence response to Gram-positive bacteria", "isPreferred": "true"} , { "name": "defence response to Gram-positive bacterium", "isPreferred": "true"} , { "name": "Gram-positive antibacterial peptide", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050830", "attributes": [], "id": "692", "contexts": { } , "evidences": ["Imported from database"], "value": "defence response to Gram-positive bacteria", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050830"} ]} , { "annotation": "Any process that decreases the frequency,  rate or extent of endopeptidase activity,  the endohydrolysis of peptide bonds within proteins. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "negative regulation of endopeptidase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010951", "attributes": [], "id": "693", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of endopeptidase activity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010951"} ]} , { "annotation": "The chemical reactions and pathways involving a specific protein,  rather than of proteins in general,  occurring at the level of an individual cell. Includes cellular protein modification. ( Reference:  GOC: jl )", "conames": [{ "name": "cellular protein metabolism", "isPreferred": "true"} , { "name": "cellular protein metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044267", "attributes": [], "id": "694", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular protein metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044267"} ]} , { "annotation": "The specific movement from place to place of an organism in response to external or internal stimuli. Locomotion of a whole organism in a manner dependent upon some combination of that organism's internal state and external conditions. ( Reference:  GOC: dph )", "conames": [{ "name": "locomotory behaviour", "isPreferred": "true"} , { "name": "locomotory behavior", "isPreferred": "true"} , { "name": "locomotory behavioral response to stimulus", "isPreferred": "true"} , { "name": "locomotion in response to stimulus", "isPreferred": "true"} , { "name": "behavior via locomotion", "isPreferred": "true"} , { "name": "locomotory behavioural response to stimulus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007626", "attributes": [], "id": "695", "contexts": { } , "evidences": ["Imported from database"], "value": "locomotory behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007626"} ]} , { "annotation": "Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue. ( Reference:  GOC: jid ISBN: 0582227089 )", "conames": [{ "name": "visual learning", "isPreferred": "true"} , { "name": "spatial learning", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008542", "attributes": [], "id": "696", "contexts": { } , "evidences": ["Imported from database"], "value": "visual learning", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008542"} ]} , { "annotation": "[INTERACTION WITH APPBP2,  MUTAGENESIS OF TYR-728]", "conames": [{ "name": "PMID: 9843960", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9843960", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Proteins,  PAT1 protein,  S cerevisiae,  Saccharomyces cerevisiae Proteins,  RNA-Binding Proteins,  Amyloid beta-Protein Precursor,  DNA-Binding Proteins]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "PAT1,  a microtubule-interacting protein,  recognizes the basolateral sorting signal of amyloid precursor protein."} , { "attrname": "Abstract", "value": "In epithelial cells,  sorting of membrane proteins to the basolateral surface depends on the presence of a basolateral sorting signal (BaSS) in their cytoplasmic domain. Amyloid precursor protein (APP),  a basolateral protein implicated in the pathogenesis of Alzheimer's disease,  contains a tyrosine-based BaSS,  and mutation of the tyrosine residue results in nonpolarized transport of APP. Here we report identification of a protein,  termed PAT1 (protein interacting with APP tail 1),  that interacts with the APP-BaSS but binds poorly when the critical tyrosine is mutated and does not bind the tyrosine-based endocytic signal of APP. PAT1 shows homology to kinesin light chain,  which is a component of the plus-end directed microtubule-based motor involved in transporting membrane proteins to the basolateral surface. PAT1,  a cytoplasmic protein,  associates with membranes,  cofractionates with APP-containing vesicles,  and binds microtubules in a nucleotide-sensitive manner. Cotransfection of PAT1 with a reporter protein shows that PAT1 is functionally linked with intracellular transport of APP. We propose that PAT1 is involved in the translocation of APP along microtubules toward the cell surface. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Signal Transduction,  Molecular Sequence Data,  RNA-Binding Proteins,  Proteins,  Sequence Alignment,  Animals,  Microtubules,  Saccharomyces cerevisiae Proteins,  Protein Binding,  Sequence Analysis,  COS Cells,  Amyloid beta-Protein Precursor,  DNA-Binding Proteins]"} , { "attrname": "AUTHORS", "value": "[P Zheng,  J Eastman,  S Vande Pol,  S W Pimplikar]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APPBP2,  MUTAGENESIS OF TYR-728]"} ], "id": "697", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9843960", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9843960"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.95.25.14745"} ]} , { "annotation": "[MUTAGENESIS OF VAL-717]", "conames": [{ "name": "PMID: 8886002", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8886002", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[HG18B9YRS7 Valine,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43)."} , { "attrname": "Abstract", "value": "In some pedigrees of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD),  three mutations of beta amyloid precursor protein (APP) have been found at the Val717 residue (to Ile,  Phe,  or Cly) and these mutations increase the secretion of A beta 42(43). To study the specificity of the effects of these mutations on APP processing,  we transiently expressed APP genes with mutations of Val717 to Lys,  Ser,  Glu,  or Cys in COS cells. The three familial AD-linked mutations increased the levels or ratios of A beta 42(43),  whereas the secretion of A beta 40 was decreased. Other mutations irrelevant to FAD except Val717 to Lys had little effect on the ratio of A beta 42(43). Substitution to Lys decreased the secretion of A beta 42(43); substitution to Glu or Gly decreased the amount of intracellular C-terminal fragment produced by alpha-secretase,  whereas it was increased by mutations to Phe,  Cys,  or Lys. However,  the levels of secretion of soluble APP were constant,  but a substitution to Glu reduced it. These results suggest a specific role of the Val717 residue in APP processing and,  especially,  in gamma-cleavage. "} , { "attrname": "MeSH", "value": "[Point Mutation,  Animals,  Valine,  Protein Processing,  Post-Translational,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  COS Cells,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[K Maruyama,  T Tomita,  K Shinozaki,  H Kume,  H Asada,  T C Saido,  S Ishiura,  T Iwatsubo,  K Obata]"} , { "attrname": "PUB_TYPE", "value": "[MUTAGENESIS OF VAL-717]"} ], "id": "698", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8886002", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.1996.1577"} , { "elementOf": "NLM", "accession": "8886002"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 656-737]", "conames": [{ "name": "PMID: 2675837", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2675837", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[9088-41-9 Trypsin Inhibitor,  Kunitz Soybean,  9007-49-2 DNA,  Amyloid beta-Peptides,  Amyloid,  Nerve Tissue Proteins]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid peptide is encoded by two exons and shows similarity to soybean trypsin inhibitor."} , { "attrname": "Abstract", "value": "To better understand the processing of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid precursor protein,  we have cloned and sequenced that region of the human genome coding for the amyloid peptide. Two exons separated by a 6.2kb intron define this region. Characterization of the A4 peptide amino acid sequence shows similarity to the structure of soybean trypsin inhibitor (Kunitz). Our observation describes a different region of PreA4 than the previously characterized domain of larger amyloid precursor molecules PreA4 751 and 770(2). Moreover,  the exon organization,  Kunitz domain duplication and transmembrane location of A4 suggest that PreA4 is similar to growth factor precursors and thus may be processed similarly. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Exons,  Genes,  Humans,  Trypsin Inhibitor,  Kunitz Soybean,  Information Systems,  Molecular Sequence Data,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Restriction Mapping,  Sequence Homology,  Nucleic Acid,  Base Sequence,  DNA,  Amyloid beta-Peptides,  Cloning,  Molecular,  Amyloid]"} , { "attrname": "AUTHORS", "value": "[E M Johnstone,  M O Chaney,  R E Moore,  K E Ward,  F H Norris,  S P Little]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 656-737]"} ], "id": "699", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2675837", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2675837"} , { "elementOf": "DOI", "accession": "10.1016\/0006-291X(89)91112-1"} ]} , { "annotation": "[FUNCTION OF BETA-AMYLOID PEPTIDE AS LIPID PEROXIDATION INHIBITOR,  MUTAGENESIS OF MET-706]", "conames": [{ "name": "PMID: 9168929", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9168929", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Antioxidants,  TE895536Y5 1-palmitoyl-2-oleoylphosphatidylcholine,  Peptide Fragments,  Phosphatidylcholines,  Lipid Bilayers,  Amyloid beta-Peptides,  18285-71-7 1, 2-dilauroylphosphatidylcholine,  Membrane Lipids,  amyloid beta-protein (25-35)]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions."} , { "attrname": "Abstract", "value": "The biological activity of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid beta protein may be related to modulation of membrane lipid peroxidation. The effect of amyloid beta protein fragment 25-35 [A beta(25-35)] on lipid peroxidation was examined in liposomes enriched with polyunsaturated fatty acids. The activity of A beta(25-35) was compared to that of A beta(25-35) with either a scrambled sequence [A beta(25-35)scram] or a peptide sequence in which methionine was replaced with leucine [A beta(25-35) met]. A beta(25-35) inhibited lipid peroxidation in a dose- and time-dependent manner. The antioxidant activity of A beta(25-35) was observed at concentrations as low as 10 nM. The relative antioxidant activities of the amyloid beta protein fragments were as follows:  A beta(25-35) > A beta(25-35) met > A beta(25-35)scram. The two more potent peptides intercalated into the membrane hydrocarbon core,  as determined by small-angle x-ray diffraction approaches. These findings indicate that the amphiphilic A beta(25-35) peptide inhibits lipid peroxidation at low concentrations as a result of physicochemical interactions with the membrane lipid bilayer. "} , { "attrname": "MeSH", "value": "[Antioxidants,  Amino Acid Sequence,  Peptide Fragments,  Phosphatidylcholines,  Lipid Bilayers,  Humans,  Amyloid beta-Peptides,  Membrane Lipids,  Molecular Structure,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  In Vitro Techniques,  Lipid Peroxidation]"} , { "attrname": "AUTHORS", "value": "[M F Walter,  P E Mason,  R P Mason]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION OF BETA-AMYLOID PEPTIDE AS LIPID PEROXIDATION INHIBITOR,  MUTAGENESIS OF MET-706]"} ], "id": "700", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9168929", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9168929"} , { "elementOf": "DOI", "accession": "10.1006\/BBRC.1997.6547"} ]} , { "annotation": "[PHOSPHORYLATION AT THR-743]", "conames": [{ "name": "PMID: 8131745", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8131745", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[Phosphates,  AE28F7PNPL Methionine,  Peptides,  2ZD004190S Threonine,  Phosphopeptides,  EC 2.7.11.22 CDC2 Protein Kinase,  Amyloid beta-Protein Precursor,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinases]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Cell cycle-dependent regulation of the phosphorylation and metabolism of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> amyloid precursor protein."} , { "attrname": "Abstract", "value": "Accumulation of the amyloid A beta peptide,  which is derived from a larger precursor protein (APP),  and the formation of plaques,  are major events believed to be involved in the etiology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Abnormal regulation of the metabolism of APP may contribute to the deposition of plaques. APP is an integral membrane protein containing several putative phosphorylation sites within its cytoplasmic domain. We report here that APP is phosphorylated at Thr668 by p34cdc2 protein kinase (cdc2 kinase) in vitro,  and in a cell cycle-dependent manner in vivo. At the G2\/M phase of the cell cycle,  when APP phosphorylation is maximal,  the levels of mature APP (mAPP) and immature APP (imAPP) do not change significantly. However,  imAPP is altered qualitatively. Furthermore,  the level of the secreted extracellular N-terminal domain (APPS) is decreased and that of the truncated intracellular C-terminal fragment (APPCOOH) is increased. These findings suggest the possibility that phosphorylation-dependent events occurring during the cell cycle affect the metabolism of APP. Alterations in these events might play a role in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Phosphates,  Amino Acid Sequence,  CDC2 Protein Kinase,  Phosphorylation,  Peptides,  Threonine,  Mitosis,  Humans,  Methionine,  Molecular Sequence Data,  Electrophoresis,  Gel,  Two-Dimensional,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Calcium-Calmodulin-Dependent Protein Kinases,  PC12 Cells,  Animals,  Cell Cycle,  Peptide Mapping,  G2 Phase,  Phosphopeptides,  HeLa Cells,  Kinetics,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[T Suzuki,  M Oishi,  D R Marshak,  A J Czernik,  A C Nairn,  P Greengard]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT THR-743]"} ], "id": "701", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8131745", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8131745"} ]} , { "annotation": "[IDENTIFICATION OF GAMMA-CTFS BY MASS SPECTROMETRY,  MUTAGENESIS OF ASP-739]", "conames": [{ "name": "PMID: 12214090", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12214090", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of Alzheimer's disease :  JAD"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor."} , { "attrname": "Abstract", "value": "The amyloid beta protein precursor (AbetaPP) is sequentially processed by beta- and gamma-secretases to generate the Abeta peptide. The biochemical path leading to Abeta formation has been extensively studied since extracellular aggregates of amyloidogenic forms of Abeta peptide (Abeta42) are considered the culprit of Alzheimer's disease. Aside from its pathological relevance,  the biological role of AbetaPP proteolysis is unknown. Although never previously described,  cleavage of AbetaPP by gamma-secretase should release,  together with Abeta,  a COOH-terminal AbetaPP Intracellular Domain,  herein termed AID. We have now identified AID-like peptides in brain tissue of normal control and patients with sporadic Alzheimer's disease and demonstrate that AID acts as a positive regulator of apoptosis. Thus,  overproduction of AID may add to the toxic effect of Abeta42 aggregates and further accelerate neurodegeneration. "} , { "attrname": "AUTHORS", "value": "[B Passer,  L Pellegrini,  C Russo,  R M Siegel,  M J Lenardo,  G Schettini,  M Bachmann,  M Tabaton,  L D'Adamio]"} , { "attrname": "PUB_TYPE", "value": "[IDENTIFICATION OF GAMMA-CTFS BY MASS SPECTROMETRY,  MUTAGENESIS OF ASP-739]"} ], "id": "702", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12214090", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12214090"} ]} , { "annotation": "[IDENTITY OF APP WITH NEXIN-II]", "conames": [{ "name": "PMID: 2506449", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2506449", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Protease Inhibitors,  9007-49-2 DNA,  Protein Precursors,  Amyloid,  Nerve Tissue Proteins,  EC 3.4.21.4 Trypsin,  Amyloid beta-Protein Precursor,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "The secreted form of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein with the Kunitz domain is protease nexin-II."} , { "attrname": "Abstract", "value": "The A4 protein (or beta-protein) is a 42- or 43-amino-acid peptide present in the extracellular neuritic plaques in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and is derived from a membrane-bound amyloid protein precursor (APP). Three forms of APP have been described and are referred to as APP695,  APP751 and APP770,  reflecting the number of amino acids encoded for by their respective complementary DNAs. The two larger APPs contain a 57-amino-acid insert with striking homology to the Kunitz family of protease inhibitors. Here we report that the deduced amino-terminal sequence of APP is identical to the sequence of a cell-secreted protease inhibitor,  protease nexin-II (PN-II). To confirm this finding,  APP751 and APP695 cDNAs were over-expressed in the human 293 cell line,  and the secreted N-terminal extracellular domains of these APPs were purified to near homogeneity from the tissue-culture medium. The relative molecular mass and high-affinity binding to dextran sulphate of secreted APP751 were consistent with that of PN-II. Functionally,  secreted APP751 formed stable,  non-covalent,  inhibitory complexes with trypsin. Secreted APP695 did not form complexes with trypsin. We conclude that the secreted form of APP with the Kunitz protease inhibitor domain is PN-II. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Molecular Weight,  Humans,  Protease Inhibitors,  Molecular Sequence Data,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  Trypsin,  Transfection,  DNA,  Protein Precursors,  Amyloid,  Amyloid beta-Protein Precursor,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[T Oltersdorf,  L C Fritz,  D B Schenk,  I Lieberburg,  K L Johnson-Wood,  E C Beattie,  P J Ward,  R W Blacher,  H F Dovey,  S Sinha]"} , { "attrname": "PUB_TYPE", "value": "[IDENTITY OF APP WITH NEXIN-II]"} ], "id": "703", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2506449", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2506449"} , { "elementOf": "DOI", "accession": "10.1038\/341144A0"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP639),  TISSUE SPECIFICITY];", "conames": [{ "name": "PMID: 12859342", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12859342", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The European journal of neuroscience"} , { "attrname": "Chemical", "value": "[DNA Probes,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Identification of a novel alternative splicing isoform of human amyloid precursor protein gene,  APP639."} , { "attrname": "Abstract", "value": "Senile plaques,  neurofibrillary tangles and amyloid-laden cerebral vessels are characteristic features in the brains of individuals with Alzheimer's disease (AD). The principal component of amyloid in senile plaque and amyloid-laden cerebral vessels is beta-amyloid (Abeta),  a peptide proteolytically derived from a large amyloid precursor protein (APP). To date,  several alternatively spliced human APP transcripts have been described. Here,  we report the identification of a novel alternative splicing isoform of the human APP gene,  APP639,  which excludes exon 2 as well as exons 7 and 8. RT-PCR and Southern blot analysis show that APP639 mRNA is expressed in many human fetal tissues. In contrast,  the APP639 transcript is hardly detected in the aged human cerebral cortex from both pathologically confirmed sporadic AD cases and nondemented controls. However,  APP639 mRNA exists in the adult human liver. Western blot analysis shows that the protein product produced from the APP639 cDNA could be recognized by the APP antibody,  and it does lack the exon 2 coding region. These results suggest that APP639,  a novel alternative splicing isoform of human APP gene,  does exist in human tissues in vivo. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Blotting,  Southern,  Cell Line,  DNA Probes,  Alternative Splicing,  Exons,  Humans,  Molecular Sequence Data,  Reverse Transcriptase Polymerase Chain Reaction,  Isomerism,  Blotting,  Western,  Recombinant Fusion Proteins,  Pregnancy,  Tissue Distribution,  Transfection,  Plasmids,  Adult,  Female,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Ke Tang,  Chen Wang,  Chengyong Shen,  Shuli Sheng,  Rivka Ravid,  Naihe Jing]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP639),  TISSUE SPECIFICITY]"} ], "id": "704", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12859342", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12859342"} , { "elementOf": "DOI", "accession": "10.1046\/J.1460-9568.2003.02731.X"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 287-367]", "conames": [{ "name": "PMID: 2893291", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2893291", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Protease Inhibitors,  9007-49-2 DNA,  DNA,  Recombinant,  Protein Precursors,  Amyloid,  Amyloid beta-Protein Precursor,  Trypsin Inhibitors]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is characterized by cerebral deposits of amyloid beta-protein (AP) as senile plaque core and vascular amyloid,  and a complementary DNA encoding a precursor of this protein (APP) has been cloned from human brain. From a cDNA library of a human glioblastoma cell line,  we have isolated a cDNA identical to that previously reported,  together with a new cDNA which contains a 225-nucleotide insert. The sequence of the 56 amino acids at the N-terminal of the protein deduced from this insert is highly homologous to the basic trypsin inhibitor family,  and the lysate from COS-1 cells transfected with the longer APP cDNA showed an increased inhibition of trypsin activity. Partial sequencing of the genomic DNA encoding APP showed that the 225 nucleotides are located in two exons. At least three messenger RNA species,  apparently transcribed from a single APP gene by alternative splicing,  were found in human brain. We suggest that protease inhibition by the longer APP(s) could be related to aberrant APP catabolism. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Nucleic Acid Hybridization,  Humans,  Protease Inhibitors,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  Down Syndrome,  RNA Splicing,  Base Sequence,  DNA,  DNA,  Recombinant,  Protein Precursors,  Amyloid,  Brain Chemistry,  Tumor Cells,  Cultured,  Amyloid beta-Protein Precursor,  Trypsin Inhibitors]"} , { "attrname": "AUTHORS", "value": "[N Kitaguchi,  Y Takahashi,  Y Tokushima,  S Shiojiri,  H Ito]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 287-367]"} ], "id": "705", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2893291", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/331530A0"} , { "elementOf": "NLM", "accession": "2893291"} ]} , { "annotation": "[VARIANT VAL-713]", "conames": [{ "name": "PMID: 1307241", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1307241", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  Codon,  9007-49-2 DNA,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia."} , { "attrname": "Abstract", "value": "Following reports of mutations of codon 717 in exon 17 of the amyloid precursor protein (APP) gene in early-onset familial Alzheimer's disease,  we screened exon 17 for new mutations in presenile dementia. The majority of the 105 patients screened had definite or probable Alzheimer's disease,  but we also included atypical cases and some chronic schizophrenics. We identified a single abnormal case--a chronic schizophrenic with cognitive defects. Sequencing revealed a C to T nucleotide substitution which produces an alanine to valine change at codon 713. We were unable to detect the mutation in the remaining members of the original cohort nor in a further 100 chronic schizophrenics and 100 non-demented controls. Nonetheless,  the position of the mutation in a critical portion of the APP gene suggests that it may well prove to be pathogenic. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Oligodeoxyribonucleotides,  Exons,  Humans,  Middle Aged,  Molecular Sequence Data,  Schizophrenia,  Male,  Point Mutation,  Codon,  Pedigree,  Base Sequence,  DNA,  Polymerase Chain Reaction,  Female,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[C T Jones,  S Morris,  C M Yates,  A Moffoot,  C Sharpe,  D J Brock,  D St Clair]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT VAL-713]"} ], "id": "706", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1307241", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1307241"} , { "elementOf": "DOI", "accession": "10.1038\/NG0792-306"} ]} , { "annotation": "[VARIANT AD1 ILE-717]", "conames": [{ "name": "PMID: 1678058", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1678058", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  Protein Precursors,  RNA,  Transfer,  Val,  Amyloid beta-Protein Precursor,  RNA,  Transfer,  Ile]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Exons,  Humans,  Japan,  Amyloid beta-Peptides,  Protein Precursors,  Molecular Sequence Data,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  RNA,  Transfer,  Val,  Amyloid beta-Protein Precursor,  RNA,  Transfer,  Ile]"} , { "attrname": "AUTHORS", "value": "[S Naruse,  S Igarashi,  H Kobayashi,  K Aoki,  T Inuzuka,  K Kaneko,  T Shimizu,  K Iihara,  T Kojima,  T Miyatake]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-717]"} ], "id": "707", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1678058", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1678058"} , { "elementOf": "DOI", "accession": "10.1016\/0140-6736(91)91612-X"} ]} , { "annotation": "[IMPORTANCE OF CYS-144 IN COPPER REDUCTION,  MUTAGENESIS OF CYS-144 AND 147-HIS--HIS-149]", "conames": [{ "name": "PMID: 10461923", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10461923", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[K848JZ4886 Cysteine,  Peptide Fragments,  789U1901C5 Copper,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein."} , { "attrname": "Abstract", "value": "The beta-amyloid precursor protein (beta-APP) contains a copper-binding site localized between amino acids 135 and 156 (beta-APP(135-156)). We have employed synthetic beta-APP peptides to characterize their capacities to reduce Cu(II) to Cu(I). Analogues of the wild-type beta-APP(135-156) peptide,  containing specific amino acid substitutions,  were used to establish which residues are specifically involved in the reduction of copper by beta-APP(135-156). We report here that beta-APP's copper-binding domain reduced Cu(II) to Cu(I). The single-mutant beta-APP(His147-->Ala) and the double-mutant beta-APP(His147-->Ala\/His149-->Ala) showed a small decrease in copper reduction in relation to the wild-type peptide and the beta-APP(Cys144-->Ser) mutation abolished it,  suggesting that Cys144 is the key amino acid in the oxidoreduction reaction. Our results confirm that soluble beta-APP is involved in the reduction of Cu(II) to Cu(I). "} , { "attrname": "MeSH", "value": "[Cysteine,  Peptide Fragments,  Oxidation-Reduction,  Humans,  Mutation,  Copper,  Potentiometry,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[F H Ruiz,  M Gonzlez,  M Bodini,  C Opazo,  N C Inestrosa]"} , { "attrname": "PUB_TYPE", "value": "[IMPORTANCE OF CYS-144 IN COPPER REDUCTION,  MUTAGENESIS OF CYS-144 AND 147-HIS--HIS-149]"} ], "id": "708", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10461923", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1046\/J.1471-4159.1999.0731288.X"} , { "elementOf": "NLM", "accession": "10461923"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-198 AND SER-206 BY CASEIN KINASES,  MUTAGENESIS OF SER-198 AND SER-206]", "conames": [{ "name": "PMID: 8999878", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8999878", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.- Protein Kinases,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Ectodomain phosphorylation of beta-amyloid precursor protein at two distinct cellular locations."} , { "attrname": "Abstract", "value": "The beta-amyloid precursor protein (betaAPP) is a transmembrane protein that is exclusively phosphorylated on serine residues within its ectodomain. To identify the cellular site of betaAPP phosphorylation,  we took advantage of an antibody that specifically detects the free C terminus of beta-secretase-cleaved betaAPP containing the Swedish missense mutation (APPssw-beta). This antibody previously established the cellular location of the beta-secretase cleavage of Swedish betaAPP as a post-Golgi secretory compartment (Haass,  C.,  Lemere,  C.,  Capell,  A.,  Citron,  M.,  Seubert,  P.,  Schenk,  D.,  Lannfelt,  L.,  and Selkoe,  D. J. (1995) Nature Med. 1,  1291-1296). We have now localized the selective ectodomain phosphorylation of betaAPP to the same compartment. Moreover,  the phosphorylation sites of betaAPP were identified at Ser198 and Ser206 of betaAPP695 by tryptic peptide mapping,  mass spectrometry,  and site-directed mutagenesis. Intracellular phosphorylation of betaAPP was inhibited by Brefeldin A and by incubating cells at 20 degrees C,  thus excluding phosphorylation in the endoplasmic reticulum or trans-Golgi network. Ectodomain phosphorylation within a post-Golgi compartment occurred not only with mutant Swedish betaAPP,  but also with wild type betaAPP. In addition to phosphorylation within a post-Golgi compartment,  betaAPP was also found to undergo phosphorylation at the cell surface by an ectoprotein kinase. Therefore,  this study revealed two distinct cellular locations for betaAPP phosphorylation. "} , { "attrname": "MeSH", "value": "[Cell Line,  Cell Membrane,  Golgi Apparatus,  Phosphorylation,  Protein Kinases,  Humans,  Mutation,  Subcellular Fractions,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J Walter,  A Capell,  A Y Hung,  H Langen,  M Schnlzer,  G Thinakaran,  S S Sisodia,  D J Selkoe,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-198 AND SER-206 BY CASEIN KINASES,  MUTAGENESIS OF SER-198 AND SER-206]"} ], "id": "709", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8999878", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.272.3.1896"} , { "elementOf": "NLM", "accession": "8999878"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 672-679 IN COMPLEX WITH IGG]", "conames": [{ "name": "PMID: 17895381", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17895381", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Oligopeptides,  Amyloid beta-Peptides,  Antibodies,  Monoclonal,  Epitopes]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Molecular basis for passive immunotherapy of Alzheimer's disease."} , { "attrname": "Abstract", "value": "Amyloid aggregates of the amyloid-beta (Abeta) peptide are implicated in the pathology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Anti-Abeta monoclonal antibodies (mAbs) have been shown to reduce amyloid plaques in vitro and in animal studies. Consequently,  passive immunization is being considered for treating <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s,  and anti-Abeta mAbs are now in phase II trials. We report the isolation of two mAbs (PFA1 and PFA2) that recognize Abeta monomers,  protofibrils,  and fibrils and the structures of their antigen binding fragments (Fabs) in complex with the Abeta(1-8) peptide DAEFRHDS. The immunodominant EFRHD sequence forms salt bridges,  hydrogen bonds,  and hydrophobic contacts,  including interactions with a striking WWDDD motif of the antigen binding fragments. We also show that a similar sequence (AKFRHD) derived from the human protein GRIP1 is able to cross-react with both PFA1 and PFA2 and,  when cocrystallized with PFA1,  binds in an identical conformation to Abeta(1-8). Because such cross-reactivity has implications for potential side effects of immunotherapy,  our structures provide a template for designing derivative mAbs that target Abeta with improved specificity and higher affinity. "} , { "attrname": "MeSH", "value": "[Cross Reactions,  Surface Plasmon Resonance,  Enzyme-Linked Immunosorbent Assay,  Oligopeptides,  Humans,  Immunotherapy,  Amyloid beta-Peptides,  Antibodies,  Monoclonal,  Epitopes,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Binding Sites,  Antibody]"} , { "attrname": "AUTHORS", "value": "[Anna S Gardberg,  Lezlee T Dice,  Susan Ou,  Rebecca L Rich,  Elizabeth Helmbrecht,  Jan Ko,  Ronald Wetzel,  David G Myszka,  Paul H Patterson,  Chris Dealwis]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 672-679 IN COMPLEX WITH IGG]"} ], "id": "710", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17895381", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "17895381"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0705888104"} ]} , { "annotation": "[STRUCTURE BY NMR OF 672-711]", "conames": [{ "name": "PMID: 7588758", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7588758", "attributes": [{ "attrname": "JOURNAL_REF", "value": "European journal of biochemistry"} , { "attrname": "Chemical", "value": "[amyloid beta-protein (1-40),  Peptide Fragments,  Prions,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease."} , { "attrname": "Abstract", "value": "One of the principle peptide components of the amyloid plaque deposits of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in humans is the 40-amino-acid peptide beta-amyloid A4-(1-40)-peptide. The full-length A4-(1-40)-peptide was chemically synthesized and the solution structure determined by two-dimensional nuclear magnetic resonance spectroscopy and restrained molecular-dynamics calculations. Synthetic human A4-(1-40)-peptide was soluble and non-aggregating for several days in 40% (by vol.) trifluoroethanol\/water. All spin systems could be unambiguously assigned,  and a total of 203 sequential and medium-range cross-peaks were found in the NOESY (nuclear Overhauser enhancement spectroscopy) spectrum. Long-range NOE cross-peaks that would indicate tertiary structure of the peptide were absent. The main secondary-structure elements found by chemical-shift analysis,  sequential and medium-range NOESY data,  and NOE-based restrained molecular-dynamics calculations were two helices,  Gln15-Asp23 and Ile31-Met35,  whereas the rest of the peptide was in random-coil conformation. A similar secondary structure is suggested for the aggregation part of prions,  the postulated causative agents of the transmissible spongiform encephalopathy. The sequence of the helical part of prion proteins was observed to be remarkably similar to the sequence of the helical part of human A4-(1-40)-peptide. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Magnetic Resonance Spectroscopy,  Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Thermodynamics,  Prions,  Amyloid beta-Peptides,  Molecular Structure]"} , { "attrname": "AUTHORS", "value": "[H Sticht,  P Bayer,  D Willbold,  S Dames,  C Hilbich,  K Beyreuther,  R W Frank,  P Rsch]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 672-711]"} ], "id": "711", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7588758", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7588758"} , { "elementOf": "DOI", "accession": "10.1111\/J.1432-1033.1995.293_1.X"} ]} , { "annotation": "[COPPER-BINDING,  DISULFIDE BOND FORMATION]", "conames": [{ "name": "PMID: 9585534", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9585534", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[48TCX9A1VT Cystine,  BBX060AN9V Hydrogen Peroxide,  Peptide Fragments,  17493-86-6 cuprous ion,  73348-75-1 bathocuproine sulfonate,  Free Radical Scavengers,  789U1901C5 Copper,  7A314HQM0I Pentetic Acid,  EC 3.4.- Endopeptidases,  Phenanthrolines,  YOW8V9698H Dimethyl Sulfoxide,  Amyloid beta-Protein Precursor,  Chelating Agents]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Copper-binding amyloid precursor protein undergoes a site-specific fragmentation in the reduction of hydrogen peroxide."} , { "attrname": "Abstract", "value": "The extracellular domain of transmembrane Abeta amyloid precursor protein (APP) has a Cu(II) reducing activity upon Cu(II) binding associated with the formation of a new disulfide bridge. The complete assignment of the disulfide bond revealed the involvement of cysteines 144 and 158 around copper-binding histidine residues. The vulnerability of APP-Cu(I) complexes to reactive oxygen species was elaborated as a site-specific and random fragmentation of APP in a time-dependent manner and at low concentrations of H2O2. Analysis of the specific reaction revealed the generation of C-terminal polypeptides,  containing the Abeta domain. APP catalyzed the reduction of H2O2 and oxidation of Cu(I) to Cu(II) in a \"peroxidative\" reaction in vitro. The resulting bound copper-hydroxyl radical intermediate [APP-Cu(II)(.OH)] then likely participated in a Fenton type of reaction with radical formation as a prerequisite for protein degradation. Evidence from two observations suggests that the reaction takes place in two phases. Bathocuproine,  a trapping agent for Cu(I),  abolished the initial fragmentation,  and chelation of Cu(II) by DTPA (diethylenetriaminepentaacetic acid) interrupted the reaction cascade induced by H2O2 at later stages. Consequently,  the results suggest that a cytotoxic gain-of-function of APP-Cu(I) complexes might result in a perturbation of free radical homeostasis. What significance such a perturbation may have for the pathogenesis of Alzheimer's disease remains to be determined. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Oxidation-Reduction,  Pentetic Acid,  Electrophoresis,  Polyacrylamide Gel,  Humans,  Hydrogen Peroxide,  Molecular Sequence Data,  Free Radical Scavengers,  Cystine,  Hydrolysis,  Mass Spectrometry,  Phenanthrolines,  Protein Binding,  Dimethyl Sulfoxide,  Copper,  Endopeptidases,  Amyloid beta-Protein Precursor,  Chelating Agents]"} , { "attrname": "AUTHORS", "value": "[G Multhaup,  T Ruppert,  A Schlicksupp,  L Hesse,  E Bill,  R Pipkorn,  C L Masters,  K Beyreuther]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING,  DISULFIDE BOND FORMATION]"} ], "id": "712", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9585534", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9585534"} , { "elementOf": "DOI", "accession": "10.1021\/BI980022M"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 286-366];", "conames": [{ "name": "PMID: 2893290", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2893290", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Protease Inhibitors,  9007-49-2 DNA,  Protein Precursors,  Serine Proteinase Inhibitors,  Amyloid,  Nerve Tissue Proteins,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Amyloid B-protein\/amyloid A4 is a peptide present in the neuritic plaques,  neurofibrillary tangles and cerebrovascular deposits in patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and Down's syndrome (trisomy 21) and may be involved in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Recent molecular genetic studies have indicated that amyloid protein is encoded as part of a larger protein by a gene on human chromosome 21 (refs 6-9). The amyloid protein precursor (APP) gene is expressed in brain and in several peripheral tissues,  but the specific biochemical events leading to deposition of amyloid are not known. We have now screened complementary DNA libraries constructed from peripheral tissues to determine whether the messenger RNA encoding APP in these tissues is identical to that expressed in brain,  and we identify a second APP mRNA that encodes an additional internal domain with a sequence characteristic of a Kunitz-type serine protease inhibitor. The alternative APP mRNA is present in both brain and peripheral tissues of normal individuals and those with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  but its pattern of expression differs from that of the previously reported APP mRNA. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Nucleic Acid Hybridization,  Humans,  Protease Inhibitors,  Molecular Sequence Data,  Serine Proteinase Inhibitors,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  Down Syndrome,  Base Sequence,  DNA,  Protein Precursors,  Amyloid,  Brain Chemistry,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[R E Tanzi,  A I McClatchey,  E D Lamperti,  L Villa-Komaroff,  J F Gusella,  R L Neve]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 286-366]"} ], "id": "713", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2893290", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2893290"} , { "elementOf": "DOI", "accession": "10.1038\/331528A0"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 609-713,  GLYCOSYLATION AT SER-614; SER-623; SER-628; SER-679 AND SER-697]", "conames": [{ "name": "PMID: 22576872", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22576872", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of mass spectrometry :  JMS"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid ? and amyloid precursor protein in human and cat cerebrospinal fluid."} , { "attrname": "Abstract", "value": "Amyloid precursor protein (APP) is the precursor protein to amyloid ? (A?),  the main constituent of senile plaques in Alzheimer's disease (AD). Endogenous A? peptides reflect the APP processing,  and greater knowledge of different APP degradation pathways is important to understand the mechanism underlying AD pathology. When one analyzes longer A? peptides by low-energy collision-induced dissociation tandem mass spectrometry (MS\/MS),  mainly long b-fragments are observed,  limiting the possibility to determine variations such as amino acid variants or post-translational modifications (PTMs) within the N-terminal half of the peptide. However,  by using electron capture dissociation (ECD),  we obtained a more comprehensive sequence coverage for several APP\/A? peptide species,  thus enabling a deeper characterization of possible variants and PTMs. Abnormal APP\/A? processing has also been described in the lysosomal storage disease Niemann-Pick type C and the major large animal used for studying this disease is cat. By ECD MS\/MS,  a substitution of Asp7 ? Glu in cat A? was identified. Further,  sialylated core 1 like O-glycans at Tyr10,  recently discovered in human A? (a previously unknown glycosylation type),  were identified also in cat cerebrospinal fluid (CSF). It is therefore likely that this unusual type of glycosylation is common for (at least) species belonging to the magnorder Boreoeutheria. We here describe a detailed characterization of endogenous APP\/A? peptide species in CSF by using an online top-down MS-based method. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cats,  Immunoprecipitation,  Humans,  Molecular Sequence Data,  Glycosylation,  Sequence Analysis,  Protein,  Sequence Alignment,  Animals,  Spectrometry,  Mass,  Electrospray Ionization,  Amyloid beta-Peptides,  Chromatography,  Liquid,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Gunnar Brinkmalm,  Erik Portelius,  Annika hrfelt,  Niklas Mattsson,  Rita Persson,  Mikael K Gustavsson,  Charles H Vite,  Johan Gobom,  Jan-Eric Mnsson,  Jonas Nilsson,  Adnan Halim,  Gran Larson,  Ulla Retschi,  Henrik Zetterberg,  Kaj Blennow,  Ann Brinkmalm]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 609-713,  GLYCOSYLATION AT SER-614; SER-623; SER-628; SER-679 AND SER-697]"} ], "id": "714", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22576872", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/JMS.2987"} , { "elementOf": "NLM", "accession": "22576872"} ]} , { "annotation": "[BETA-AMYLOID COPPER AND ZINC-BINDING]", "conames": [{ "name": "PMID: 11274207", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11274207", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  J41CSQ7QDS Zinc,  Spin Labels,  789U1901C5 Copper,  EC 1.15.1.1 Superoxide Dismutase]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits."} , { "attrname": "Abstract", "value": "Amyloid beta peptide (Abeta) is the major constituent of extracellular plaques and perivascular amyloid deposits,  the pathognomonic neuropathological lesions of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Cu(2+) and Zn(2+) bind Abeta,  inducing aggregation and giving rise to reactive oxygen species. These reactions may play a deleterious role in the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> state,  because high concentrations of iron,  copper,  and zinc have been located in amyloid in <span style=\"background-color: yellow\"><b>disease<\/b><\/span>d brains. Here we show that coordination of metal ions to Abeta is the same in both aqueous solution and lipid environments,  with His(6),  His(13),  and His(14) all involved. At Cu(2+)\/peptide molar ratios >0.3,  Abeta coordinated a second Cu(2+) atom in a highly cooperative manner. This effect was abolished if the histidine residues were methylated at N(epsilon)2,  indicating the presence of bridging histidine residues,  as found in the active site of superoxide dismutase. Addition of Cu(2+) or Zn(2+) to Abeta in a negatively charged lipid environment caused a conformational change from beta-sheet to alpha-helix,  accompanied by peptide oligomerization and membrane penetration. These results suggest that metal binding to Abeta generated an allosterically ordered membrane-penetrating oligomer linked by superoxide dismutase-like bridging histidine residues. "} , { "attrname": "MeSH", "value": "[Cell Membrane,  Electron Spin Resonance Spectroscopy,  Oxidation-Reduction,  Allosteric Regulation,  Humans,  Spin Labels,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Zinc,  Amyloid beta-Peptides,  Nuclear Magnetic Resonance,  Biomolecular,  Protein Binding,  Copper,  Circular Dichroism,  Superoxide Dismutase]"} , { "attrname": "AUTHORS", "value": "[C C Curtain,  F Ali,  I Volitakis,  R A Cherny,  R S Norton,  K Beyreuther,  C J Barrow,  C L Masters,  A I Bush,  K J Barnham]"} , { "attrname": "PUB_TYPE", "value": "[BETA-AMYLOID COPPER AND ZINC-BINDING]"} ], "id": "715", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11274207", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11274207"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M100175200"} ]} , { "annotation": "[PHOSPHORYLATION,  MUTAGENESIS OF THR-743]", "conames": [{ "name": "PMID: 10341243", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10341243", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[2ZD004190S Threonine,  Nerve Tissue Proteins,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein (APP),  the precursor of beta-amyloid (Abeta),  is an integral membrane protein with a receptor-like structure. We recently demonstrated that the mature APP (mAPP; N- and O-glycosylated form) is phosphorylated at Thr668 (numbering for APP695 isoform),  specifically in neurons. Phosphorylation of mAPP appears to occur during,  and after,  neuronal differentiation. Here we report that the phosphorylation of mAPP begins 48-72 hr after treatment of PC12 cells with NGF and that this correlates with the timing of neurite outgrowth. The phosphorylated form of APP is distributed in neurites and mostly in the growth cones of differentiating PC12 cells. PC12 cells stably expressing APP with Thr668Glu substitution showed remarkably reduced neurite extension after treatment with NGF. These observations suggest that the phosphorylated form of APP may play an important role in neurite outgrowth of differentiating neurons. "} , { "attrname": "MeSH", "value": "[Phosphorylation,  Animals,  Threonine,  Neurons,  Rats,  Cell Differentiation,  Nerve Tissue Proteins,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  PC12 Cells,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[K Ando,  M Oishi,  S Takeda,  K Iijima,  T Isohara,  A C Nairn,  Y Kirino,  P Greengard,  T Suzuki]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION,  MUTAGENESIS OF THR-743]"} ], "id": "716", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10341243", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10341243"} ]} , { "annotation": "[STRUCTURE BY NMR OF 672-699]", "conames": [{ "name": "PMID: 7516706", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7516706", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Ion Channels,  Solutions,  Amyloid beta-Peptides,  amyloid beta-protein (1-28)]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Solution structure of residues 1-28 of the amyloid beta-peptide."} , { "attrname": "Abstract", "value": "The three-dimensional solution structure of residues 1-28 of the amyloid beta-peptide was determined using nuclear magnetic resonance spectroscopy,  distance geometry,  and molecular dynamic techniques. The nuclear magnetic resonance data used to derive the structure consisted of nuclear Overhauser enhancements,  vicinal coupling constants,  and temperature coefficients of the amide-NH chemical shifts. The beta-peptide is the major proteinaceous component of amyloid deposits in Alzheimer's disease. In membrane-like media,  the peptide folds to form a predominately alpha-helical structure with a bend centered at residue 12. The side chains of histidine-13 and lysine-16 are close,  residing on the same face of the helix. Their proximity may constitute a binding motif with the heparan sulfate proteoglycans. The molecular details of the structure shown here could facilitate the design of rational treatments to curtail the binding of heparan sulfate proteoglycans or to prevent an alpha-helix-->beta-sheet conversion that may occur during the early stages of amyloid formation in Alzheimer's disease. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Hydrogen Bonding,  Ion Channels,  Magnetic Resonance Spectroscopy,  Protein Structure,  Secondary,  Solutions,  Humans,  Amyloid beta-Peptides,  Molecular Sequence Data]"} , { "attrname": "AUTHORS", "value": "[J Talafous,  K J Marcinowski,  G Klopman,  M G Zagorski]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 672-699]"} ], "id": "717", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7516706", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI00191A006"} , { "elementOf": "NLM", "accession": "7516706"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 672-711 IN COMPLEX WITH IDE]", "conames": [{ "name": "PMID: 17051221", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17051221", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Islet Amyloid Polypeptide,  Amyloid beta-Peptides,  9007-92-5 Glucagon,  Amyloid,  EC 3.4.24.56 Insulysin,  Insulin]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism."} , { "attrname": "Abstract", "value": "Insulin-degrading enzyme (IDE),  a Zn2+-metalloprotease,  is involved in the clearance of insulin and amyloid-beta (refs 1-3). Loss-of-function mutations of IDE in rodents cause glucose intolerance and cerebral accumulation of amyloid-beta,  whereas enhanced IDE activity effectively reduces brain amyloid-beta (refs 4-7). Here we report structures of human IDE in complex with four substrates (insulin B chain,  amyloid-beta peptide (1-40),  amylin and glucagon). The amino- and carboxy-terminal domains of IDE (IDE-N and IDE-C,  respectively) form an enclosed cage just large enough to encapsulate insulin. Extensive contacts between IDE-N and IDE-C keep the degradation chamber of IDE inaccessible to substrates. Repositioning of the IDE domains enables substrate access to the catalytic cavity. IDE uses size and charge distribution of the substrate-binding cavity selectively to entrap structurally diverse polypeptides. The enclosed substrate undergoes conformational changes to form beta-sheets with two discrete regions of IDE for its degradation. Consistent with this model,  mutations disrupting the contacts between IDE-N and IDE-C increase IDE catalytic activity 40-fold. The molecular basis for substrate recognition and allosteric regulation of IDE could aid in designing IDE-based therapies to control cerebral amyloid-beta and blood sugar concentrations. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Amino Acid Sequence,  Glucagon,  Humans,  Insulysin,  Models,  Molecular,  Molecular Sequence Data,  Substrate Specificity,  Crystallography,  X-Ray,  Insulin,  Islet Amyloid Polypeptide,  Amyloid beta-Peptides,  Amyloid]"} , { "attrname": "AUTHORS", "value": "[Yuequan Shen,  Andrzej Joachimiak,  Marsha Rich Rosner,  Wei-Jen Tang]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 672-711 IN COMPLEX WITH IDE]"} ], "id": "718", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17051221", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "17051221"} , { "elementOf": "DOI", "accession": "10.1038\/NATURE05143"} ]} , { "annotation": "[VARIANT CAA-APP ASN-694]", "conames": [{ "name": "PMID: 12654973", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12654973", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Codon,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation."} , { "attrname": "Abstract", "value": "The authors searched for mutations in the beta-amyloid precursor protein in a Spanish family with a hereditary syndrome of hemorrhagic stroke,  dementia,  leukoencephalopathy,  and occipital calcifications. DNA from two affected members demonstrated the Iowa amyloid precursor protein mutation previously identified as a cause of severe amyloid angiopathy without hemorrhagic stroke. These data point to other genetic or environmental factors that may determine the occurrence of symptomatic hemorrhage in amyloid angiopathy. "} , { "attrname": "MeSH", "value": "[Cerebral Hemorrhage,  Humans,  Middle Aged,  Male,  Cerebral Amyloid Angiopathy,  Familial,  Disease Progression,  Spain,  Iowa,  Carotid Artery,  External,  Codon,  Calcinosis,  Age of Onset,  Aged,  Occipital Lobe,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[S M Greenberg,  Y Shin,  T J Grabowski,  G E Cooper,  G W Rebeck,  S Iglesias,  F Chapon,  E Tournier-Lasserve,  J-C Baron]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CAA-APP ASN-694]"} ], "id": "719", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12654973", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000050140.10044.A8"} , { "elementOf": "NLM", "accession": "12654973"} ]} , { "annotation": "[REVIEW]", "conames": [{ "name": "PMID: 12142279", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12142279", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annual review of cell and developmental biology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-1,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  EC 3.4.- Peptide Hydrolases,  EC 3.4.23.- Aspartic Acid Endopeptidases,  nicastrin protein,  EC 3.4.23.46 BACE1 protein,  human,  Membrane Glycoproteins,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "A cell biological perspective on Alzheimer's disease."} , { "attrname": "Abstract", "value": "The amyloid precursor protein and the proteases cleaving this protein are important players in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> via the generation of the amyloid peptide. Physiologically,  the amyloid precursor protein is implied in axonal vesicular trafficking and the proteases are implicated in developmentally important signaling pathways,  most significantly those involving regulated intramembrane proteolysis or RIP. We discuss the cell biology behind the amyloid and tangle hypothesis for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  drawing on the many links to the fields of cell biology and developmental biology that have been established in the recent years. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Neurons,  Humans,  Intracellular Membranes,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Animals,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Peptide Hydrolases,  Membrane Glycoproteins,  Endopeptidases,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Wim Annaert,  Bart De Strooper]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW]"} ], "id": "720", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12142279", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12142279"} , { "elementOf": "DOI", "accession": "10.1146\/ANNUREV.CELLBIO.18.020402.142302"} ]} , { "annotation": "[INTERACTION WITH APBB1,  FUNCTION,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 11544248", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11544248", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Drosophila Proteins,  EC 3.4.24.86 ADAM17 Protein,  Peptide Fragments,  Repressor Proteins,  Trans-Activators,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  EC 3.4.24.86 ADAM17 protein,  human,  suppressor of Hairless protein,  Drosophila,  Nerve Tissue Proteins,  Nuclear Proteins,  Membrane Proteins,  EC 3.4.24.- ADAM Proteins,  EC 3.4.24.- Metalloendopeptidases,  Receptors,  Notch,  EC 3.4.- Endopeptidases,  EC 2.3.1.48 CREB-Binding Protein,  APBB1 protein,  human,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner."} , { "attrname": "Abstract", "value": "The beta-amyloid precursor protein (APP) is a ubiquitous receptor-like molecule without a known function. However,  the recent recognition that APP and Notch undergo highly similar proteolytic processing has suggested a potential signaling function for APP. After ligand binding,  Notch is cleaved by the ADAM-17 metalloprotease followed by an intramembrane cleavage mediated by gamma-secretase. The gamma-secretase cut releases the Notch intracellular domain (NICD),  which enters the nucleus and modulates transcription. Because APP is processed similarly by ADAM-17 and gamma-secretase,  we reasoned that the APP intracellular domain (AICD) has a role analogous to the NICD. We therefore generated a plasmid encoding the AICD sequence and studied the subcellular localization of the expressed protein (C60). Our results demonstrate that the cytoplasmic domain of APP is a highly labile fragment that is stabilized by forming complexes with Fe65 and can then enter the nucleus in neurons and non-neural cells. These findings strongly support the hypothesis that APP signals in the nucleus in a manner analogous to the function of Notch. "} , { "attrname": "MeSH", "value": "[ADAM17 Protein,  Drosophila Proteins,  Peptide Fragments,  Signal Transduction,  CREB-Binding Protein,  Repressor Proteins,  Trans-Activators,  Half-Life,  Metalloendopeptidases,  ADAM Proteins,  Nerve Tissue Proteins,  Nuclear Proteins,  Membrane Proteins,  Receptors,  Notch,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Protein Binding,  Protein Processing,  Post-Translational,  Active Transport,  Cell Nucleus,  Endopeptidases,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[W T Kimberly,  J B Zheng,  S Y Gunette,  D J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APBB1,  FUNCTION,  SUBCELLULAR LOCATION]"} ], "id": "721", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11544248", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11544248"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.C100447200"} ]} , { "annotation": "[STRUCTURE BY NMR OF 681-706]", "conames": [{ "name": "PMID: 10940221", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10940221", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of structural biology"} , { "attrname": "Chemical", "value": "[Solvents,  Peptides,  Amyloid beta-Peptides,  059QF0KO0R Water]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "The Alzheimer's peptide a beta adopts a collapsed coil structure in water."} , { "attrname": "Abstract", "value": "The self-assembly of the soluble peptide Abeta into Alzheimer's disease amyloid is believed to involve a conformational change. Hence the solution conformation of Abeta is of significant interest. In contrast to studies in other solvents,  in water Abeta is collapsed into a compact series of loops,  strands,  and turns and has no alpha-helical or beta-sheet structure. Conformational stabilization is primarily attributed to van der Waals and electrostatic forces. A large conspicuous uninterrupted hydrophobic patch covers approximately 25% of the surface. The compact coil structure appears meta-stable,  and because fibrillization leads to formation of intermolecular beta-sheet secondary structure,  a global conformational rearrangement is highly likely. A molecular hypothesis for amyloidosis includes at least two primary driving forces,  changes in solvation thermodynamics during formation of amyloid deposits and relief of internal conformational stress within the soluble precursor during formation of lower-energy amyloid fibrils. "} , { "attrname": "MeSH", "value": "[Water,  Solvents,  Peptides,  Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Static Electricity,  Protein Folding,  Thermodynamics,  Hydrogen Bonding,  Amyloid beta-Peptides,  Nuclear Magnetic Resonance,  Biomolecular,  Protein Conformation]"} , { "attrname": "AUTHORS", "value": "[S Zhang,  K Iwata,  M J Lachenmann,  J W Peng,  S Li,  E R Stimson,  Y Lu,  A M Felix,  J E Maggio,  J P Lee]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 681-706]"} ], "id": "722", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10940221", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10940221"} , { "elementOf": "DOI", "accession": "10.1006\/JSBI.2000.4288"} ]} , { "annotation": "[STRUCTURE BY NMR OF 672-699]", "conames": [{ "name": "PMID: 10940222", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10940222", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of structural biology"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  368GB5141J Sodium Dodecyl Sulfate,  Peptides,  Solutions,  EC 3.4.- Endopeptidases,  Micelles,  Amyloid beta-Peptides,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E,  K16F)."} , { "attrname": "Abstract", "value": "NMRsolution structures are reported for two mutants (K16E,  K16F) of the soluble amyloid beta peptide Abeta(1-28). The structural effects of these mutations of a positively charged residue to anionic and hydrophobic residues at the alpha-secretase cleavage site (Lys16-Leu17) were examined in the membrane-simulating solvent aqueous SDS micelles. Overall the three-dimensional structures were similar to that for the native Abeta(1-28) sequence in that they contained an unstructured N-terminus and a helical C-terminus. These structural elements are similar to those seen in the corresponding regions of full-length Abeta peptides Abeta(1-40) and Abeta(1-42),  showing that the shorter peptides are valid model systems. The K16E mutation,  which might be expected to stabilize the macrodipole of the helix,  slightly increased the helix length (residues 13-24) relative to the K16F mutation,  which shortened the helix to between residues 16 and 24. The observed sequence-dependent control over conformation in this region provides an insight into possible conformational switching roles of mutations in the amyloid precursor protein from which Abeta peptides are derived. In addition,  if conformational transitions from helix to random coil to sheet precede aggregation of Abeta peptides in vivo,  as they do in vitro,  the conformation-inducing effects of mutations at Lys16 may also influence aggregation and fibril formation. "} , { "attrname": "MeSH", "value": "[Peptides,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Sodium Dodecyl Sulfate,  Thermodynamics,  Solutions,  Aspartic Acid Endopeptidases,  Base Sequence,  Computer Simulation,  Micelles,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Nuclear Magnetic Resonance,  Biomolecular,  Protein Conformation,  Mutation,  Binding Sites,  Endopeptidases,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[S A Poulsen,  A A Watson,  D P Fairlie,  D J Craik]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 672-699]"} ], "id": "723", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10940222", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10940222"} , { "elementOf": "DOI", "accession": "10.1006\/JSBI.2000.4267"} ]} , { "annotation": "[VARIANT AD1 THR-713]", "conames": [{ "name": "PMID: 1303275", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1303275", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "More missense in amyloid gene."} , { "attrname": "MeSH", "value": "[DNA Mutational Analysis,  Pedigree,  Base Sequence,  DNA,  Humans,  Middle Aged,  Molecular Sequence Data,  Female,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[D A Carter,  E Desmarais,  M Bellis,  D Campion,  F Clerget-Darpoux,  A Brice,  Y Agid,  A Jaillard-Serradt,  J Mallet]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 THR-713]"} ], "id": "724", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1303275", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NG1292-255"} , { "elementOf": "NLM", "accession": "1303275"} ]} , { "annotation": "[VARIANT AD1 GLY-717]", "conames": [{ "name": "PMID: 1944558", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1944558", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  Codon,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> caused by mutations at codon 717 of the beta-amyloid precursor protein gene."} , { "attrname": "Abstract", "value": "A mutation at codon 717 of the beta-amyloid precursor protein gene has been found to cosegregate with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in a single family. This mutation has been reported in a further five out of approximately 100 families multiply affected by <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We have identified another family,  F19,  in which we have detected linkage between the beta-amyloid precursor protein gene and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Direct sequencing of exon 17 in affected individuals from this family has revealed a base change producing a Val----Gly substitution,  also at codon 717. The occurrence of a second allelic variant at codon 717 linked to the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s phenotype supports the hypothesis that they are pathogenic mutations. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Oligodeoxyribonucleotides,  Exons,  Genes,  Humans,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Codon,  Base Composition,  Pedigree,  Base Sequence,  Polymerase Chain Reaction,  Female,  Mutation,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[M C Chartier-Harlin,  F Crawford,  H Houlden,  A Warren,  D Hughes,  L Fidani,  A Goate,  M Rossor,  P Roques,  J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 GLY-717]"} ], "id": "725", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1944558", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1944558"} , { "elementOf": "DOI", "accession": "10.1038\/353844A0"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 672-713]", "conames": [{ "name": "PMID: 8248178", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8248178", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Oligopeptides,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits:  implications for the pathology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Reinvestigation of the chemical structure of beta-amyloid peptide (A beta) deposits in the vascular tissue of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains revealed that the 42-residue form A beta-(1-42),  rather than the more soluble A beta-(1-40) form,  is the predominant peptide. Following removal of the surrounding tissue with SDS and collagenase,  A beta was solubilized in formic acid and purified by Superose 12 chromatography. Peptides generated by enzymatic and chemical digestion of the A beta were purified by HPLC and characterized by amino acid analysis,  sequence analysis,  and mass spectrometry. In the leptomeningeal vessels,  the average ratio of A beta-(1-42)\/A beta-(1-40) was 58: 42,  whereas in the parenchymal vessels this ratio was 75: 25. Interestingly,  vascular A beta contains considerably less isomerized and racemized aspartyl residues than does neuritic plaque A beta,  suggesting that the vascular amyloid is \"younger.\" The discrete nature of the bands and spherical deposits of A beta associated with arterioles and capillaries,  respectively,  suggests that this amyloid arises from the vascular tissue itself. Increasing A beta deposition appears to lead to the distortion and occlusion of capillaries,  which may contribute significantly to the pathology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Oligopeptides,  Humans,  Mass Spectrometry,  Amyloid beta-Peptides,  Molecular Sequence Data,  Brain Chemistry,  Cerebrovascular Circulation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microscopy,  Fluorescence,  Blood-Brain Barrier]"} , { "attrname": "AUTHORS", "value": "[A E Roher,  J D Lowenson,  S Clarke,  A S Woods,  R J Cotter,  E Gowing,  M J Ball]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 672-713]"} ], "id": "726", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8248178", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.90.22.10836"} , { "elementOf": "NLM", "accession": "8248178"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-703]", "conames": [{ "name": "PMID: 2949367", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2949367", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Amyloid beta protein gene:  cDNA,  mRNA distribution,  and genetic linkage near the Alzheimer locus."} , { "attrname": "Abstract", "value": "The amyloid beta protein has been identified as an important component of both cerebrovascular amyloid and amyloid plaques of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and Down syndrome. A complementary DNA for the beta protein suggests that it derives from a larger protein expressed in a variety of tissues. Overexpression of the gene in brain tissue from fetuses with Down syndrome (trisomy 21) can be explained by dosage since the locus encoding the beta protein maps to chromosome 21. Regional localization of this gene by both physical and genetic mapping places it in the vicinity of the genetic defect causing the inherited form of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Humans,  Gene Expression Regulation,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Down Syndrome,  Tissue Distribution,  DNA,  Transcription,  Genetic,  Amyloid,  Amyloidosis,  Chromosomes,  Human,  Pair 21,  RNA,  Messenger,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[R E Tanzi,  J F Gusella,  P C Watkins,  G A Bruns,  P St George-Hyslop,  M L Van Keuren,  D Patterson,  S Pagan,  D M Kurnit,  R L Neve]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-703]"} ], "id": "727", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2949367", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2949367"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.2949367"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 672-701]", "conames": [{ "name": "PMID: 8229004", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8229004", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Peptides,  Amyloid beta-Peptides,  Antibodies,  Monoclonal]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Characterization of beta-amyloid peptide from human cerebrospinal fluid."} , { "attrname": "Abstract", "value": "beta-Amyloid peptide (A beta) is one of the main components of senile plaques in the brain tissue of Alzheimer's disease (AD) patients. A beta is proteolytically cleaved from the amyloid precursor protein (APP),  an integral membrane protein possessing a large extracellular N-terminal domain followed by a single membrane-spanning region and a short cytoplasmic C-terminal tail. A beta has been isolated from senile plaques and cerebral vascular tissue of AD brain and characterized as a heterogeneous peptide containing 28-43 amino acids whose sequence begins in the extracellular domain of APP and extends into the putative transmembrane sequence. It has long been speculated that A beta may also be present in body fluids,  such as CSF,  that contact neuritic plaques. Recently using a specific enzyme-linked immunosorbent assay we were able to quantify one form of A beta in CSF. In this report,  using one of these antibodies covalently bound as an affinity matrix,  multiple complex forms of A beta have been isolated and characterized from CSF derived from patients with either meningitis or other neurological disorders. Amino acid sequencing reveals A beta species with N-termini of Asp1,  Glu3,  His6,  Glu11,  and Val12,  although on a molar basis,  Asp1 represents the predominant aminoterminus. Laser desorption mass spectrometry confirmed the presence in CSF of A beta species containing 27,  28,  30,  34,  35,  40,  42,  and 43 amino acids,  all beginning at Asp1; two stable trimers,  (Asp1-Met35)3 and (His6-Ala42)3; and one stable dimer containing (Asp1-Val40)2.(ABSTRACT TRUNCATED AT 250 WORDS) "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Molecular Weight,  Peptides,  Humans,  Molecular Sequence Data,  Antibodies,  Monoclonal,  Chromatography,  Affinity,  Amyloid beta-Peptides,  Adult,  Meningitis,  Child,  Nervous System Diseases]"} , { "attrname": "AUTHORS", "value": "[C Vigo-Pelfrey,  D Lee,  P Keim,  I Lieberburg,  D B Schenk]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 672-701]"} ], "id": "728", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8229004", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.1993.TB09841.X"} , { "elementOf": "NLM", "accession": "8229004"} ]} , { "annotation": "[SIGNAL SEQUENCE CLEAVAGE SITE,  TOPOLOGY]", "conames": [{ "name": "PMID: 2900137", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2900137", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[Protein Precursors,  Receptors,  Cell Surface,  Amyloid,  Membrane Glycoproteins,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "Identification,  transmembrane orientation and biogenesis of the amyloid A4 precursor of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "The precursor of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-specific amyloid A4 protein is an integral,  glycosylated membrane protein which spans the bilayer once. The carboxy-terminal domain of 47 residues was located at the cytoplasmic site of the membrane. The three domains following the transient signal sequence of 17 residues face the opposite side of the membrane. The C-terminal 100 residues of the precursor comprising the amyloid A4 part and the cytoplasmic domain have a high tendency to aggregate,  and proteinase K treatment results in peptides of the size of amyloid A4. This finding suggests that there is a precursor-product relationship between precursor and amyloid A4 and we conclude that besides proteolytic cleavage other events such as post-translational modification and membrane injury are primary events that precede the release of the small aggregating amyloid A4 subunit. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Membrane,  Protein Biosynthesis,  Humans,  Molecular Sequence Data,  Receptors,  Cell Surface,  Glycosylation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Base Sequence,  Protein Precursors,  Transcription,  Genetic,  Amyloid,  Membrane Glycoproteins,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[T Dyrks,  A Weidemann,  G Multhaup,  J M Salbaum,  H G Lemaire,  J Kang,  B Mller-Hill,  C L Masters,  K Beyreuther]"} , { "attrname": "PUB_TYPE", "value": "[SIGNAL SEQUENCE CLEAVAGE SITE,  TOPOLOGY]"} ], "id": "729", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2900137", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2900137"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF KUNITZ DOMAIN IN COMPLEX WITH CHYMOTRYPSIN; TRYPSIN AND BASIC PANCREATIC TRYPSIN INHIBITOR]", "conames": [{ "name": "PMID: 9300481", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9300481", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Protein science :  a publication of the Protein Society"} , { "attrname": "Chemical", "value": "[EC 3.4.21.1 Chymotrypsin,  EC 3.4.21.4 Trypsin,  Amyloid beta-Protein Precursor,  9087-70-1 Aprotinin]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI):  engineering of inhibitors with altered specificities."} , { "attrname": "Abstract", "value": "The crystal structures of the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) complexed to bovine chymotrypsin (C-APPI) and trypsin (T-APPI) and basic pancreatic trypsin inhibitor (BPTI) bound to chymotrypsin (C-BPTI) have been solved and analyzed at 2.1 A,  1.8 A,  and 2.6 A resolution,  respectively. APPI and BPTI belong to the Kunitz family of inhibitors,  which is characterized by a distinctive tertiary fold with three conserved disulfide bonds. At the specificity-determining site of these inhibitors (P1),  residue 15(I)4 is an arginine in APPI and a lysine in BPTI,  residue types that are counter to the chymotryptic hydrophobic specificity. In the chymotrypsin complexes,  the Arg and Lys P1 side chains of the inhibitors adopt conformations that bend away from the bottom of the binding pocket to interact productively with elements of the binding pocket other than those observed for specificity-matched P1 side chains. The stereochemistry of the nucleophilic hydroxyl of Ser 195 in chymotrypsin relative to the scissile P1 bond of the inhibitors is identical to that observed for these groups in the trypsin-APPI complex,  where Arg 15(I) is an optimal side chain for tryptic specificity. To further evaluate the diversity of sequences that can be accommodated by one of these inhibitors,  APPI,  we used phage display to randomly mutate residues 11,  13,  15,  17,  and 19,  which are major binding determinants. Inhibitors variants were selected that bound to either trypsin or chymotrypsin. As expected,  trypsin specificity was principally directed by having a basic side chain at P1 (position 15); however,  the P1 residues that were selected for chymotrypsin binding were His and Asn,  rather than the expected large hydrophobic types. This can be rationalized by modeling these hydrophilic side chains to have similar H-bonding interactions to those observed in the structures of the described complexes. The specificity,  or lack thereof,  for the other individual subsites is discussed in the context of the \"allowed\" residues determined from a phage display mutagenesis selection experiment. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Crystallization,  Models,  Molecular,  Crystallography,  X-Ray,  Structure-Activity Relationship,  Chymotrypsin,  Trypsin,  Animals,  Mutagenesis,  Cattle,  Base Sequence,  Protein Engineering,  Protein Conformation,  Aprotinin,  Binding Sites,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[A J Scheidig,  T R Hynes,  L A Pelletier,  J A Wells,  A A Kossiakoff]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF KUNITZ DOMAIN IN COMPLEX WITH CHYMOTRYPSIN; TRYPSIN AND BASIC PANCREATIC TRYPSIN INHIBITOR]"} ], "id": "730", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9300481", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9300481"} , { "elementOf": "DOI", "accession": "10.1002\/PRO.5560060902"} ]} , { "annotation": "[INTERACTION WITH FPRL1]", "conames": [{ "name": "PMID: 11689470", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11689470", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FASEB journal :  official publication of the Federation of American Societies for Experimental Biology"} , { "attrname": "Chemical", "value": "[EC 3.6.1.- GTP-Binding Proteins,  Peptide Fragments,  SML2Y3J35T Colchicine,  amyloid beta-protein (1-42),  Oligopeptides,  Amyloid beta-Peptides,  Receptors,  Formyl Peptide,  Receptors,  Peptide,  FPR2 protein,  human,  Receptors,  Immunologic,  Trp-Lys-Tyr-Met-Val-Met,  Receptors,  Lipoxin]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages."} , { "attrname": "Abstract", "value": "The 42 amino acid form of beta amyloid (Abeta42) plays a pivotal role in neurotoxicity and the activation of mononuclear phagocytes in Alzheimer's disease (AD). Our recent study revealed that FPRL1,  a G-protein-coupled receptor,  mediates the chemotactic and activating effect of Abeta42 on mononuclear phagocytes (monocytes and microglia),  suggesting that FPRL1 may be involved in the proinflammatory responses in AD. We investigated the role of FPRL1 in cellular uptake and the subsequent fibrillar formation of Abeta42 by using fluorescence confocal microscopy. We found that upon incubation with macrophages or HEK293 cells genetically engineered to express FPRL1,  Abeta42 associated with FPRL1 and the Abeta42\/FPRL1 complexes were rapidly internalized into the cytoplasmic compartment. The maximal internalization of Abeta42\/FPRL1 complexes occurred by 30 min after incubation. Removal of free Abeta42 from culture supernatants at 30 min resulted in a progressive recycling of FPRL1 to the cell surface and degradation of the internalized Abeta42. However,  persistent exposure of the cells to Abeta42 over 24 h resulted in retention of Abeta42\/FPRL1 complexes in the cytoplasmic compartment and the formation of Congo red positive fibrils in macrophages but not in HEK 293 cell transfected with FPRL1. These results suggest that besides mediating the proinflammatory activity of Abeta42,  FPRL1 is also involved in the internalization of Abeta42,  which culminates in the formation of fibrils only in macrophages. "} , { "attrname": "MeSH", "value": "[Cell Line,  Peptide Fragments,  Oligopeptides,  Humans,  Cells,  Cultured,  Macrophages,  Dose-Response Relationship,  Drug,  Microscopy,  Confocal,  Endocytosis,  Time Factors,  Amyloid beta-Peptides,  Receptors,  Formyl Peptide,  Receptors,  Peptide,  Receptors,  Immunologic,  Protein Conformation,  Colchicine,  GTP-Binding Proteins,  Apoptosis,  Receptors,  Lipoxin]"} , { "attrname": "AUTHORS", "value": "[H Yazawa,  Z X Yu,   Takeda,  Y Le,  W Gong,  V J Ferrans,  J J Oppenheim,  C C Li,  J M Wang]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH FPRL1]"} ], "id": "731", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11689470", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11689470"} , { "elementOf": "DOI", "accession": "10.1096\/FJ.01-0251COM"} ]} , { "annotation": "[STRUCTURE OF CAA-APP VARIANTS]", "conames": [{ "name": "PMID: 10821838", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10821838", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Codon,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Substitutions at codon 22 of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells."} , { "attrname": "Abstract", "value": "Cerebral amyloid angiopathy is commonly associated with normal aging and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and it is also the principal feature of hereditary cerebral hemorrhage with amyloidosis Dutch type,  a familial condition associated to a point mutation G to C at codon 693 of the amyloid beta (Abeta) precursor protein gene resulting in a Glu to Gln substitution at position 22 of the Abeta (E22Q). The patients carrying the AbetaE22Q variant usually present with lobar cerebral hemorrhages before 50 years of age. A different mutation described in several members of three Italian kindred who presented with recurrent hemorrhagic strokes late in life,  between 60 and 70 years of age,  also associated with extensive cerebrovascular amyloid deposition has been found at the same position 22,  this time resulting in a Glu to Lys substitution (E22K). We have compared the secondary structure,  aggregation,  and fibrillization properties of the two Abeta40 variants and the wild type peptide. Using flow cytometry analysis after staining with propidium iodide and annexin V,  we also evaluated the cytotoxic effects of the peptides on human cerebral endothelial cells in culture. Under the conditions tested,  the E22Q peptide exhibited the highest content of beta-sheet conformation and the fastest aggregation\/fibrillization properties. The Dutch variant also induced apoptosis of cerebral endothelial cells at a concentration of 25 micrometer,  whereas the wild type Abeta and the E22K mutant had no effect. The data suggest that different amino acids at position 22 confer distinct structural properties to the peptides that appear to influence the onset and aggressiveness of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> rather than the phenotype. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Brain,  Humans,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Codon,  Amyloid beta-Peptides,  Aged,  80 and over,  Female,  Protein Conformation,  Aged,  Mutation,  Circular Dichroism,  Endothelium,  Vascular,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[L Miravalle,  T Tokuda,  R Chiarle,  G Giaccone,  O Bugiani,  F Tagliavini,  B Frangione,  J Ghiso]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE OF CAA-APP VARIANTS]"} ], "id": "732", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10821838", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M003154200"} , { "elementOf": "NLM", "accession": "10821838"} ]} , { "annotation": "[REVIEW ON FUNCTION OF BETA-AMYLOID AS ANTIOXIDANT]", "conames": [{ "name": "PMID: 11775062", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11775062", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cellular and molecular neurobiology"} , { "attrname": "Chemical", "value": "[Antioxidants,  Lipoproteins,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins."} , { "attrname": "Abstract", "value": "1. Increased production of A beta in a form of lipoprotein antioxidant under the action of increased oxidative stress in aging with subsequent chelation of transition metal ions by A beta,  accumulation of toxic A beta-metal lipoprotein complexes,  production of reactive oxygen species,  and neurotoxicity are reviewed and postulated to form the temporal sequence of events in the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). 2. Since (i) A beta binds copper stronger than iron and other transition metals,  and (ii) copper is a more efficient catalyst of oxidation than other transition metals,  chelation of copper by A beta is proposed to be a most important part of this pathway. 3. Whereas this amyloid-binds-copper (ABC) model does not remove A beta peptide from its central place in our current thinking of AD,  it places additional factors in the center of discussion. 4. Most importantly,  they embrace pathological mechanisms known to develop in aging (which is the most important risk factor for AD),  such as increased production of reactive oxygen species by mitochondria,  that can be positioned upstream relative to the generation of A beta. "} , { "attrname": "MeSH", "value": "[Antioxidants,  Brain,  Lipoproteins,  Animals,  Humans,  Amyloid beta-Peptides,  Alzheimer Disease]"} , { "attrname": "AUTHORS", "value": "[A Kontush]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON FUNCTION OF BETA-AMYLOID AS ANTIOXIDANT]"} ], "id": "733", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11775062", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11775062"} , { "elementOf": "DOI", "accession": "10.1023\/A: 1012629603390"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 672-678 IN COMPLEXES WITH ANTIBODY FAB FRAGMENTS]", "conames": [{ "name": "PMID: 19923222", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19923222", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Cross-Linking Reagents,  Amyloid beta-Peptides,  Epitopes,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Immunotherapy targeting of amyloid beta (Abeta) peptide in transgenic mouse models of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) has been widely demonstrated to resolve amyloid deposition as well as associated neuronal,  glial,  and inflammatory pathologies. These successes have provided the basis for ongoing clinical trials of immunotherapy for treatment of AD in humans. Acute as well as chronic Abeta-targeted immunotherapy has also been demonstrated to reverse Abeta-related behavioral deficits assessing memory in AD transgenic mouse models. We observe that three antibodies targeting the same linear epitope of Abeta,  Abeta(3-7),  differ in their ability to reverse contextual fear deficits in Tg2576 mice in an acute testing paradigm. Reversal of contextual fear deficit by the antibodies does not correlate with in vitro recognition of Abeta in a consistent or correlative manner. To better define differences in antigen recognition at the atomic level,  we determined crystal structures of Fab fragments in complex with Abeta. The conformation of the Abeta peptide recognized by all three antibodies was highly related and is also remarkably similar to that observed in independently reported Abeta: antibody crystal structures. Sequence and structural differences between the antibodies,  particularly in CDR3 of the heavy chain variable region,  are proposed to account for differing in vivo properties of the antibodies under study. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to underlie cognitive deficits in AD. "} , { "attrname": "MeSH", "value": "[Cross-Linking Reagents,  Humans,  Molecular Conformation,  Crystallography,  X-Ray,  Male,  Epitopes,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Behavior,  Animal,  Animals,  Amyloid beta-Peptides,  Heterozygote,  Mice,  Kinetics,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Models,  Animal]"} , { "attrname": "AUTHORS", "value": "[Guriqbal S Basi,  Hadar Feinberg,  Farshid Oshidari,  John Anderson,  Robin Barbour,  Jeanne Baker,  Thomas A Comery,  Linnea Diep,  Davinder Gill,  Kelly Johnson-Wood,  Amita Goel,  Katerina Grantcharova,  Mike Lee,  Jingzhi Li,  Anthony Partridge,  Irene Griswold-Prenner,  Nicolas Piot,  Don Walker,  Angela Widom,  Menelas N Pangalos,  Peter Seubert,  J Steven Jacobsen,  Dale Schenk,  William I Weis]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 672-678 IN COMPLEXES WITH ANTIBODY FAB FRAGMENTS]"} ], "id": "734", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19923222", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19923222"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M109.045187"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 18-50]", "conames": [{ "name": "PMID: 3597385", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3597385", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Protease Nexins,  Receptors,  Cell Surface,  Amyloid beta-Protein Precursor,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Purification of protease nexin II from human fibroblasts."} , { "attrname": "Abstract", "value": "Normal human fibroblasts secrete a protein named protease nexin II (PN II) which previously was shown to form sodium dodecyl sulfate (SDS)-stable complexes with epidermal growth factor-binding protein (EGF-BP). These complexes then bind to the same cells and are rapidly internalized and degraded (Knauer,  D.J.,  and Cunningham,  D.D. (1982) Proc. Natl. Acad. Sci. U.S.A. 79,  2310-2314). Here we describe a procedure for purifying PN II to apparent homogeneity from serum-free culture medium conditioned by human fibroblasts. The first step employed dextran sulfate-Sepharose affinity chromatography. Further purification was achieved by ion-exchange chromatography on DEAE-Sepharose followed by gel filtration on Sephacryl S-400. Sequence analysis of purified PN II identified 33 amino-terminal amino acids; a computer search of several protein sequence data banks failed to reveal homologies with other reported amino acid sequences. Purified PN II had an apparent Mr of 106, 000 and an isoelectric point of approximately 7.2. It retained full activity after incubation in the presence of 0.05% SDS or at a pH of 1.5. PN II formed SDS-stable complexes with EGF-BP,  the gamma subunit of 7 S nerve growth factor,  and trypsin with estimated Mr of 120, 000,  120, 000,  and 110, 000,  respectively. PN II was metabolically labeled with [35S]methionine and purified; the metabolically labeled protein formed complexes with EGF-BP. Complexes between purified PN II and EGF-BP bound to human fibroblasts. These results show that the purified protein possesses the properties previously attributed to PN II in cell culture medium. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Chromatography,  Ion Exchange,  Molecular Weight,  Humans,  Male,  Receptors,  Cell Surface,  Chromatography,  Affinity,  Protease Nexins,  Fibroblasts,  Skin,  Chromatography,  Gel,  Amyloid beta-Protein Precursor,  Infant,  Newborn,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[W E Van Nostrand,  D D Cunningham]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 18-50]"} ], "id": "735", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3597385", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "3597385"} ]} , { "annotation": "[IMPORTANCE OF MET-706 IN FREE RADICAL OXIDATIVE STRESS,  MUTAGENESIS OF MET-706]", "conames": [{ "name": "PMID: 10535332", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10535332", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Brain research bulletin"} , { "attrname": "Chemical", "value": "[Tetrazolium Salts,  Neurotoxins,  AE28F7PNPL Methionine,  Free Radicals,  Amyloid beta-Peptides,  I2ZWO3LS3M Trypan Blue]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress."} , { "attrname": "Abstract", "value": "Amyloid beta-peptide (Abeta),  the central constituent of senile plaques in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) brain,  has been shown to be a source of free radical oxidative stress that may lead to neurodegeneration. In the current study Abeta(1-40),  found in AD brain,  and the amyloid fragment Abeta(25-35) were used in conjunction with electron paramagnetic resonance spin trapping techniques to demonstrate that these peptides mediate free radical production. The methionine residue in these peptides is believed to play an important role in their neurotoxicity. Substitution of methionine by structurally similar norleucine in both Abeta(1-40) and Abeta(25-35),  and the substitution of methionine by valine,  or the removal of the methionine in Abeta(25-35),  abrogates free radical production and protein oxidation of and toxicity to hippocampal neurons. These results are discussed with relevance to the hypothesis that neurodegeneration in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> may be due in part to Abeta-associated free radical oxidative stress that involves methionine,  and to the use of spin trapping methods to infer mechanistic information about Abeta. "} , { "attrname": "MeSH", "value": "[Neurotoxins,  Free Radicals,  Oxidative Stress,  Neurons,  Cells,  Cultured,  Methionine,  Rats,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Rats,  Sprague-Dawley,  Tetrazolium Salts,  Animals,  Spin Trapping,  Amyloid beta-Peptides,  Trypan Blue,  Fetus]"} , { "attrname": "AUTHORS", "value": "[S Varadarajan,  S Yatin,  J Kanski,  F Jahanshahi,  D A Butterfield]"} , { "attrname": "PUB_TYPE", "value": "[IMPORTANCE OF MET-706 IN FREE RADICAL OXIDATIVE STRESS,  MUTAGENESIS OF MET-706]"} ], "id": "736", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10535332", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0361-9230(99)00093-3"} , { "elementOf": "NLM", "accession": "10535332"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  ASSOCIATION OF AMYLOID FIBRILS WITH GCP1]", "conames": [{ "name": "PMID: 15084524", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15084524", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FASEB journal :  official publication of the Federation of American Societies for Experimental Biology"} , { "attrname": "Chemical", "value": "[Glycosphingolipids,  67526-95-8 Thapsigargin,  Amyloid beta-Peptides,  Heparan Sulfate Proteoglycans,  9050-30-0 Heparitin Sulfate,  Detergents,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Glypican-1 as an Abeta binding HSPG in the human brain:  its localization in DIG domains and possible roles in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Previous studies have suggested that heparan sulfate proteoglycans (HSPGs) play a role in deposition of beta-amyloid protein (Abeta) in the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) brain. In the present study,  we demonstrated that glypican-1 can bind fibrillar Abeta,  and the binding is mainly mediated by heparan sulfate (HS) chains. Further analysis revealed that glypican-1 is the major HSPG localized in detergent-insoluble glycosphingolipid-enriched (DIG) domains where all machineries for Abeta production exist and Abeta is accumulated as monomeric and oligomeric forms. Immunohistochemical studies demonstrated that glypican-1 is localized in primitive plaques as well as classic plaques. Moreover,  overexpression of glypican-1 and amyloid precursor protein in SH-SY5Y cells resulted in reduced cell viability and made cells more susceptible to thapsigargin-induced stress and Abeta toxicity. The results raise the possibility that glypican-1 interacts with oligomerized or polymerized Abeta in such a specific compartment as DIG,  resulting not only in amyloid deposition in senile plaques of AD brain,  but also in accelerating neuronal cell death in response to stress and Abeta. "} , { "attrname": "MeSH", "value": "[Brain,  Cell Line,  Cell Survival,  Heparitin Sulfate,  Humans,  Solubility,  Male,  Endoplasmic Reticulum,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Detergents,  Plaque,  Amyloid,  Thapsigargin,  Glycosphingolipids,  Time Factors,  Amyloid beta-Peptides,  Protein Structure,  Quaternary,  Heparan Sulfate Proteoglycans,  Protein Binding,  Female,  Aged,  Brain Chemistry,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Norifumi Watanabe,  Wataru Araki,  De-Hua Chui,  Takao Makifuchi,  Yasuo Ihara,  Takeshi Tabira]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  ASSOCIATION OF AMYLOID FIBRILS WITH GCP1]"} ], "id": "737", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15084524", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15084524"} , { "elementOf": "DOI", "accession": "10.1096\/FJ.03-1040FJE"} ]} , { "annotation": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]", "conames": [{ "name": "PMID: 2569763", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2569763", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[DNA Probes,  Protein Precursors,  Receptors,  Cell Surface,  Amyloid,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein."} , { "attrname": "Abstract", "value": "The gene,  encoding the A4 peptide found in the amyloid core of senile plaques isolated from the cerebral cortex of patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  produces at least three precursors that resemble cell surface receptors. A clone isolated from a human brain complementary DNA library contained the structural sequence for an A4 amyloid peptide precursor with a serine protease inhibitor domain in which 208 amino acids at the carboxyl terminal are replaced by 20 amino acids derived from nucleotide sequences with homology to the Alu repeat family. This protein devoid of the transmembrane domain most likely represents a secreted form of the A4 amyloid peptide precursor. "} , { "attrname": "MeSH", "value": "[Cerebellum,  Amino Acid Sequence,  DNA Probes,  Nucleic Acid Hybridization,  Humans,  Middle Aged,  Molecular Sequence Data,  Cerebral Cortex,  Receptors,  Cell Surface,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  Gene Amplification,  Base Sequence,  Protein Precursors,  Amyloid,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[F de Sauvage,  J N Octave]"} , { "attrname": "PUB_TYPE", "value": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]"} ], "id": "738", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2569763", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2569763"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.2569763"} ]} , { "annotation": "[VARIANT AD1 670-ASN-LEU-671]", "conames": [{ "name": "PMID: 1302033", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1302033", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  Codon,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "A pathogenic mutation for probable <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in the APP gene at the N-terminus of beta-amyloid."} , { "attrname": "Abstract", "value": "Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in two large (probably related) early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> families from Sweden. Two base pair transversions (G to T,  A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal\/lysosomal cleavage site of the molecule. Thus,  pathogenic mutations in APP frame the beta-amyloid sequence. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Oligodeoxyribonucleotides,  Exons,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Genetic Variation,  Point Mutation,  Codon,  Pedigree,  Base Sequence,  Female,  Transcription,  Genetic,  Amyloid beta-Protein Precursor,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[M Mullan,  F Crawford,  K Axelman,  H Houlden,  L Lilius,  B Winblad,  L Lannfelt]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 670-ASN-LEU-671]"} ], "id": "739", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1302033", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NG0892-345"} , { "elementOf": "NLM", "accession": "1302033"} ]} , { "annotation": "[VARIANT AD1 GLY-693]", "conames": [{ "name": "PMID: 1415269", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1415269", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region."} , { "attrname": "Abstract", "value": "A large number of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) kindreds were examined to determine whether mutations in the amyloid precursor protein (APP) gene could be responsible for the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Previous studies have identified three mutations at APP codon 717 which are pathogenic for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). Samples from affected subjects were examined for mutations in exons 16 and 17 of the APP gene. A combination of direct sequencing and single-strand conformational polymorphism analysis was used. Sporadic AD and normal controls were also examined by the same methods. Five sequence variants were identified. One variant at APP codon 693 resulted in a Glu-->Gly change. This is the same codon as the hereditary cerebral hemorrhage with amyloidosis-Dutch type Glu-->Gln mutation. Another single-base change at APP codon 708 did not alter the amino acid encoded at this site. Two point mutations and a 6-bp deletion were identified in the intronic sequences surrounding exon 17. None of the variants could be unambiguously determined to be responsible for FAD. The larger families were also analyzed by testing for linkage of FAD to a highly polymorphic short tandem repeat marker (D21S210) that is tightly linked to APP. Highly negative LOD scores were obtained for the family groups tested,  and linkage was formally excluded beyond theta = .10 for the Volga German kindreds,  theta = .20 for early-onset non-Volga Germans,  and theta = .10 for late-onset families. LOD scores for linkage of FAD to markers centromeric to APP (D21S1\/S11,  D21S13,  and D21S215) were also negative in the three family groups. These studies show that APP mutations account for AD in only a small fraction of FAD kindreds. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Blotting,  Southern,  Oligodeoxyribonucleotides,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Lod Score,  Pedigree,  Base Sequence,  Polymerase Chain Reaction,  Aged,  80 and over,  Adult,  Female,  Aged,  Chromosomes,  Human,  Pair 21,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[K Kamino,  H T Orr,  H Payami,  E M Wijsman,  M E Alonso,  S M Pulst,  L Anderson,  S O'dahl,  E Nemens,  J A White]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 GLY-693]"} ], "id": "740", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1415269", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1415269"} ]} , { "annotation": "[ENDOCYTOSIS SIGNAL,  MUTAGENESIS OF TYR-728; GLY-756; TYR-757; ASN-759; PRO-760 AND TYR-762]", "conames": [{ "name": "PMID: 10383380", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10383380", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  amyloid beta-protein (1-42),  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis,  turnover,  and the generation of secreted fragments,  including Abeta42."} , { "attrname": "Abstract", "value": "It has long been assumed that the C-terminal motif,  NPXY,  is the internalization signal for beta-amyloid precursor protein (APP) and that the NPXY tyrosine (Tyr743 by APP751 numbering,  Tyr682 in APP695) is required for APP endocytosis. To evaluate this tenet and to identify the specific amino acids subserving APP endocytosis,  we mutated all tyrosines in the APP cytoplasmic domain and amino acids within the sequence GYENPTY (amino acids 737-743). Stable cell lines expressing these mutations were assessed for APP endocytosis,  secretion,  and turnover. Normal APP endocytosis was observed for cells expressing Y709A,  G737A,  and Y743A mutations. However,  Y738A,  N740A,  and P741A or the double mutation of Y738A\/P741A significantly impaired APP internalization to a level similar to that observed for cells lacking nearly the entire APP cytoplasmic domain (DeltaC),  arguing that the dominant signal for APP endocytosis is the tetrapeptide YENP. Although not an APP internalization signal,  Tyr743 regulates rapid APP turnover because half-life increased by 50% with the Y743A mutation alone. Secretion of the APP-derived proteolytic fragment,  Abeta,  was tightly correlated with APP internalization,  such that Abeta secretion was unchanged for cells having normal APP endocytosis but significantly decreased for endocytosis-deficient cell lines. Remarkably,  secretion of the Abeta42 isoform was also reduced in parallel with endocytosis from internalization-deficient cell lines,  suggesting an important role for APP endocytosis in the secretion of this highly pathogenic Abeta species. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cricetinae,  Endocytosis,  Peptide Fragments,  Animals,  Mutagenesis,  Site-Directed,  Enzyme-Linked Immunosorbent Assay,  Amyloid beta-Peptides,  Molecular Sequence Data,  Structure-Activity Relationship,  Amyloid beta-Protein Precursor,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[R G Perez,  S Soriano,  J D Hayes,  B Ostaszewski,  W Xia,  D J Selkoe,  X Chen,  G B Stokin,  E H Koo]"} , { "attrname": "PUB_TYPE", "value": "[ENDOCYTOSIS SIGNAL,  MUTAGENESIS OF TYR-728; GLY-756; TYR-757; ASN-759; PRO-760 AND TYR-762]"} ], "id": "741", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10383380", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.274.27.18851"} , { "elementOf": "NLM", "accession": "10383380"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]", "conames": [{ "name": "PMID: 2881207", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2881207", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid beta-Peptides,  Protein Precursors,  Amyloid,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles,  plaques and blood vessel deposits is an insoluble,  highly aggregating small polypeptide of relative molecular mass 4, 500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor,  we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence,  together with the localization of its gene on chromosome 21,  suggests that the cerebral amyloid deposited in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor. "} , { "attrname": "MeSH", "value": "[Brain,  Nucleic Acid Hybridization,  Humans,  Neurofibrils,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Down Syndrome,  Base Sequence,  DNA,  Amyloid beta-Peptides,  Protein Precursors,  Fetus,  Amyloid,  Brain Chemistry,  Protein Processing,  Post-Translational,  Chromosomes,  Human,  Pair 21,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J Kang,  H G Lemaire,  A Unterbeck,  J M Salbaum,  C L Masters,  K H Grzeschik,  G Multhaup,  K Beyreuther,  B Mller-Hill]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]"} ], "id": "742", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2881207", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/325733A0"} , { "elementOf": "NLM", "accession": "2881207"} ]} , { "annotation": "[STRUCTURE BY NMR OF 289-344]", "conames": [{ "name": "PMID: 1718421", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1718421", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Serine Proteinase Inhibitors,  Amyloid beta-Protein Precursor,  9087-70-1 Aprotinin]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Sequential NMR resonance assignment and structure determination of the Kunitz-type inhibitor domain of the Alzheimer's beta-amyloid precursor protein."} , { "attrname": "Abstract", "value": "Certain precursor proteins (APP751 and APP770) of the amyloid beta-protein (AP) present in Alzheimer's disease contain a Kunitz-type serine protease inhibitor domain (APPI). In this study,  the domain is obtained as a functional inhibitor through both recombinant (APPIr) and synthetic (APPIs) methodologies,  and the solution structure of APPI is determined by 1H 2D NMR techniques. Complete sequence-specific resonance assignments (except for P13 and G37 NH) for both APPIr and APPIs are achieved using standard procedures. Ambiguities arising from degeneracies in the NMR resonances are resolved by varying sample conditions. Qualitative interpretation of short- and long-range NOEs reveals secondary structural features similar to those extensively documented by NMR for bovine pancreatic trypsin inhibitor (BPTI). A more rigorous interpretation of the NOESY spectra yields NOE-derived interresidue distance restraints which are used in conjunction with dynamic simulated annealing to generate a family of APPI structures. Within this family,  the beta-sheet and helical regions are in good agreement with the crystal structure of BPTI,  whereas portions of the protease-binding loops deviate from those in BPTI. These deviations are consistent with those recently described in the crystal structure of APPI (Hynes et al.,  1990). Also supported in the NMR study is the hydrophobic patch in the protease-binding domain created by side chain-side chain NOE contacts between M17 and F34. In addition,  the NMR spectra indicate that the rotation of the W21 ring in APPI is hindered,  unlike Y21 in BPTI,  showing a greater than 90% preference for one orientation in the hydrophobic groove. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Magnetic Resonance Spectroscopy,  Humans,  Molecular Sequence Data,  Serine Proteinase Inhibitors,  Protein Conformation,  Aprotinin,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S L Heald,  R F Tilton,  L J Hammond,  A Lee,  R M Bayney,  M E Kamarck,  T V Ramabhadran,  R N Dreyer,  G Davis,  A Unterbeck]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 289-344]"} ], "id": "743", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1718421", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI00107A015"} , { "elementOf": "NLM", "accession": "1718421"} ]} , { "annotation": "[ERRATUM]", "conames": [{ "name": "PMID: 1908403", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1908403", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Gene"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid beta-Peptides,  Protein Precursors,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Genomic organization of the human-amyloid beta-protein precursor gene."} , { "attrname": "MeSH", "value": "[Exons,  Base Sequence,  DNA,  Humans,  Amyloid beta-Peptides,  Protein Precursors,  Molecular Sequence Data,  Restriction Mapping,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S Yoshikai,  H Sasaki,  K Doh-ura,  H Furuya,  Y Sakaki]"} , { "attrname": "PUB_TYPE", "value": "[ERRATUM]"} ], "id": "744", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1908403", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1908403"} , { "elementOf": "DOI", "accession": "10.1016\/0378-1119(91)90093-Q"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 133-189,  DISULFIDE BONDS]", "conames": [{ "name": "PMID: 17909280", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17909280", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Acta crystallographica. Section F,  Structural biology and crystallization communications"} , { "attrname": "Chemical", "value": "[Cations,  Divalent,  789U1901C5 Copper,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Structure of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid precursor protein copper-binding domain at atomic resolution."} , { "attrname": "Abstract", "value": "Amyloid precursor protein (APP) plays a central role in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  as its cleavage generates the Abeta peptide that is toxic to cells. APP is able to bind Cu2+ and reduce it to Cu+ through its copper-binding domain (CuBD). The interaction between Cu2+ and APP leads to a decrease in Abeta production and to alleviation of the symptoms of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in mouse models. Structural studies of CuBD have been undertaken in order to better understand the mechanism behind the process. Here,  the crystal structure of CuBD in the metal-free form determined to ultrahigh resolution (0.85 A) is reported. The structure shows that the copper-binding residues of CuBD are rather rigid but that Met170,  which is thought to be the electron source for Cu2+ reduction,  adopts two different side-chain conformations. These observations shed light on the copper-binding and redox mechanisms of CuBD. The structure of CuBD at atomic resolution provides an accurate framework for structure-based design of molecules that will deplete Abeta production. "} , { "attrname": "MeSH", "value": "[Cations,  Divalent,  Crystallography,  X-Ray,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Copper,  Binding Sites,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Geoffrey Kwai-Wai Kong,  Julian J Adams,  Roberto Cappai,  Michael W Parker]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (0.85 ANGSTROMS) OF 133-189,  DISULFIDE BONDS]"} ], "id": "745", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17909280", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1107\/S1744309107041139"} , { "elementOf": "NLM", "accession": "17909280"} ]} , { "annotation": "[COPPER-MEDIATED LIPID PEROXIDATION,  MUTAGENESIS OF HIS-147 AND HIS-151]", "conames": [{ "name": "PMID: 11784781", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11784781", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[Organometallic Compounds,  Peptide Fragments,  68VAV8QID7 cupric glycinate,  TE7660XO1C Glycine,  Recombinant Proteins,  789U1901C5 Copper,  Amyloid beta-Protein Precursor,  Lipoproteins,  LDL]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Contrasting,  species-dependent modulation of copper-mediated neurotoxicity by the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid precursor protein."} , { "attrname": "Abstract", "value": "The amyloid precursor protein (APP) of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) has a copper binding domain (CuBD) located in the N-terminal cysteine-rich region that can strongly bind copper(II) and reduce it to Cu(I) in vitro. The CuBD sequence is similar among the APP family paralogs [amyloid precursor-like proteins (APLP1 and APLP2)] and its orthologs (including Drosophila melanogaster,  Xenopus laevis,  and Caenorhabditis elegans),  suggesting an overall conservation in its function or activity. The APP CuBD is involved in modulating Cu homeostasis and amyloid beta peptide production. In this paper,  we demonstrate for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro. APP Cu neurotoxicity can be induced directly or potentiated through Cu(I)-mediated oxidation of low-density lipoprotein,  a finding that may have important implications for the role of lipoproteins and membrane cholesterol composition in AD. Cu toxicity induced by human APP,  Xenopus APP,  and APLP2 CuBDs is dependent on conservation of histidine residues at positions corresponding to 147 and 151 of human APP. Intriguingly,  APP orthologs with different amino acid residues at these positions had dramatically altered Cu phenotypes. The corresponding C. elegans APL-1 CuBD,  which has tyrosine and lysine residues at positions 147 and 151,  respectively,  strongly protected against Cu-mediated lipid peroxidation and neurotoxicity in vitro. Replacement of histidines 147 and 151 with tyrosine and lysine residues conferred this neuroprotective Cu phenotype to human APP,  APLP2,  and Xenopus APP CuBD peptides. Moreover,  we show that the toxic and protective CuBD phenotypes are associated with differences in Cu binding and reduction. These studies identify a significant evolutionary change in the function of the CuBD in modulating Cu metabolism. Our findings also suggest that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP. "} , { "attrname": "MeSH", "value": "[Xenopus,  Peptide Fragments,  Species Specificity,  Takifugu,  Humans,  Structure-Activity Relationship,  Recombinant Proteins,  Glycine,  Organometallic Compounds,  Conserved Sequence,  Copper,  Binding Sites,  Protein Structure,  Tertiary,  Mutagenesis,  Site-Directed,  Oxidation-Reduction,  Neurons,  Drosophila,  Cells,  Cultured,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Caenorhabditis elegans,  Animals,  Mice,  Lipid Peroxidation,  Amyloid beta-Protein Precursor,  Lipoproteins,  LDL]"} , { "attrname": "AUTHORS", "value": "[Anthony R White,  Gerd Multhaup,  Denise Galatis,  William J McKinstry,  Michael W Parker,  Rdiger Pipkorn,  Konrad Beyreuther,  Colin L Masters,  Roberto Cappai]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-MEDIATED LIPID PEROXIDATION,  MUTAGENESIS OF HIS-147 AND HIS-151]"} ], "id": "746", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11784781", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11784781"} ]} , { "annotation": "[REVIEW ON ZINC-BINDING]", "conames": [{ "name": "PMID: 12032279", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12032279", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[E1UOL152H7 Iron,  Amyloid beta-Peptides,  J41CSQ7QDS Zinc,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "The galvanization of beta-amyloid in Alzheimer's disease."} , { "attrname": "MeSH", "value": "[Humans,  Amyloid beta-Peptides,  Aging,  Iron,  Models,  Neurological,  Alzheimer Disease,  Copper,  Zinc]"} , { "attrname": "AUTHORS", "value": "[Ashley I Bush,  Rudolph E Tanzi]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON ZINC-BINDING]"} ], "id": "747", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12032279", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12032279"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.122249699"} ]} , { "annotation": "[INTERACTION WITH S100A9]", "conames": [{ "name": "PMID: 22457725", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22457725", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PloS one"} , { "attrname": "Chemical", "value": "[Calgranulin B,  amyloid beta-protein (1-40),  Peptide Fragments,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "MRP14 (S100A9) protein interacts with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> beta-amyloid peptide and induces its fibrillization."} , { "attrname": "Abstract", "value": "Increasing evidence supports the contribution of local inflammation to the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) pathology,  although the precise mechanisms are not clear. In this study,  we demonstrate that the pro-inflammatory protein S100A9 interacts with the A?1-40 peptide and promotes the formation of fibrillar ?-amyloid structures. This interaction also results in reduced S100A9 cytotoxicity by the binding of S100A9 toxic species to A?1-40 amyloid structures. These results suggest that secretion of S100A9 during inflammation promotes the formation of amyloid plaques. By acting as a sink for toxic species,  plaque formation may be the result of a protective response within the brain of AD patients,  in part mediated by S100A9. "} , { "attrname": "MeSH", "value": "[Calgranulin B,  Cell Line,  Peptide Fragments,  Protein Structure,  Secondary,  Electrophoresis,  Polyacrylamide Gel,  Humans,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Peptides,  Microscopy,  Atomic Force,  Protein Binding,  Electrophoretic Mobility Shift Assay,  Kinetics,  Circular Dichroism]"} , { "attrname": "AUTHORS", "value": "[Ce Zhang,  Yonggang Liu,  Jonathan Gilthorpe,  Johan R C van der Maarel]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH S100A9]"} ], "id": "748", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22457725", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22457725"} , { "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PONE.0032953"} ]} , { "annotation": "[PHOSPHORYLATION,  INTERACTION WITH APBB1,  MUTAGENESIS OF THR-743]", "conames": [{ "name": "PMID: 11517218", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11517218", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[APLP2 protein,  human,  Adaptor Proteins,  Signal Transducing,  2ZD004190S Threonine,  Amyloid beta-Peptides,  DAB1 protein,  human,  Nerve Tissue Proteins,  APBB1 protein,  human,  Apbb1 protein,  mouse,  APLP1 protein,  human,  Amyloid beta-Protein Precursor,  Aplp2 protein,  mouse,  Nuclear Proteins]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid."} , { "attrname": "Abstract", "value": "Neuronal Fe65 is an adapter protein that interacts with the cytoplasmic domain of the beta-amyloid precursor protein (APP). Although the interaction has been reported to occur between the second phosphotyrosine interaction domain of Fe65 and the YENPTY motif in the cytoplasmic domain of APP,  the regulatory mechanism and biological function of this interaction remain unknown. We report here that (i) a single amino acid mutation at the Thr-668 residue of APP695,  located 14 amino acids toward the amino-terminal end from the (682)YENPTY(687) motif,  reduced the interaction between members of the Fe65 family of proteins and APP,  whereas interaction of APP with the phosphotyrosine interaction domain of other APP binders such as X11-like and mammalian disabled-1 was not influenced by this mutation; (ii) the phosphorylation of APP at Thr-668 diminished the interaction of APP with Fe65 by causing a conformational change in the cytoplasmic domain that contains the Fe65-binding motif,  YENPTY; and (iii) the expression of Fe65 slightly suppressed maturation of APP and decreased production of beta-amyloid (Abeta). Mutation at Thr-668 of APP abolished the effect of Fe65 on APP maturation. This mutation blocked the Fe65-dependent suppression of Abeta production and resulted in the release of increased levels of Abeta in the presence of Fe65. We previously reported that during maturation of APP in neurons,  the protein is specifically phosphorylated at Thr-668 and undergoes O-glycosylation. The present results suggest that the phosphorylation of O-glycosylated mature APP at Thr-668 causes a conformational change in its cytoplasmic domain that prevents binding of Fe65 in neurons and may lead to an alteration in the production of Abeta. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Phosphorylation,  Threonine,  Humans,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acid Motifs,  Nuclear Proteins,  Two-Hybrid System Techniques,  Adaptor Proteins,  Signal Transducing,  Amyloid beta-Peptides,  Protein Binding,  Protein Conformation,  Binding Sites,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[K Ando,  K I Iijima,  J I Elliott,  Y Kirino,  T Suzuki]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION,  INTERACTION WITH APBB1,  MUTAGENESIS OF THR-743]"} ], "id": "749", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11517218", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11517218"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M104059200"} ]} , { "annotation": "[PHOSPHORYLATION AT TYR-757,  INTERACTION WITH SHC1,  MUTAGENESIS OF THR-743 AND TYR-757]", "conames": [{ "name": "PMID: 11877420", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11877420", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.10.1 Receptor,  trkA,  Enzyme Inhibitors,  Neuropeptides,  Nerve Tissue Proteins,  Shc1 protein,  mouse,  pervanadate,  Shc3 protein,  mouse,  Adaptor Proteins,  Vesicular Transport,  Recombinant Fusion Proteins,  Proteins,  Src Homology 2 Domain-Containing,  Transforming Protein 3,  Adaptor Proteins,  Signal Transducing,  Src Homology 2 Domain-Containing,  Transforming Protein 1,  42HK56048U Tyrosine,  SHC1 protein,  human,  SHC3 protein,  human,  EC 2.5.1.18 Glutathione Transferase,  3WHH0066W5 Vanadates,  Amyloid beta-Protein Precursor,  Shc Signaling Adaptor Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc."} , { "attrname": "Abstract", "value": "beta-Amyloid precursor protein (APP) is a widely expressed transmembrane protein of unknown function that is involved in the pathogenesis of Alzheimer's disease. The cytoplasmic tail of APP interacts with phosphotyrosine binding (PTB) domain containing proteins (Fe65,  X11,  mDab-1,  and JIP-1) and may modulate gene expression and apoptosis. We now identify Shc A and Shc C,  PTB-containing adapter proteins that signal to cellular differentiation and survival pathways,  as novel APP-interacting proteins. The APP cytoplasmic tail contains a PTB-binding motif (Y(682)ENPTY(687)) that,  when phosphorylated on Tyr(682),  precipitated the PTB domain of Shc A and Shc C,  as well as endogenous full-length Shc A. APP and Shc C were physically associated in adult mouse brain homogenates. Increase in phosphorylation of APP by overexpression of the nerve growth factor receptor Trk A in 293T cells promoted the interaction of transfected APP and endogenous Shc A. Pervanadate treatment of N2a neuroblastoma cells resulted in tyrosine phosphorylation and association of endogenous APP and Shc A. Thus,  APP and Shc proteins interact in vitro,  in cells,  and in the mouse brain. Tyrosine phosphorylation of APP may promote the interaction with Shc proteins. "} , { "attrname": "MeSH", "value": "[Receptor,  trkA,  Brain,  Cell Membrane,  Enzyme Inhibitors,  Phosphorylation,  Protein Biosynthesis,  Humans,  Immunoblotting,  Neuropeptides,  Neuroblastoma,  Adaptor Proteins,  Vesicular Transport,  Recombinant Fusion Proteins,  Proteins,  Transcription,  Genetic,  Cell Differentiation,  Glutathione Transferase,  Binding Sites,  Shc Signaling Adaptor Proteins,  Protein Structure,  Tertiary,  Tyrosine,  Cell Line,  Nerve Tissue Proteins,  Precipitin Tests,  Amino Acid Motifs,  Src Homology 2 Domain-Containing,  Transforming Protein 3,  Adaptor Proteins,  Signal Transducing,  Animals,  Src Homology 2 Domain-Containing,  Transforming Protein 1,  Models,  Biological,  Vanadates,  Protein Binding,  Mice,  Mice,  Inbred BALB C,  COS Cells,  Amyloid beta-Protein Precursor,  Cytoplasm,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[Philip E Tarr,  Roberta Roncarati,  Giuliana Pelicci,  Pier Giuseppe Pelicci,  Luciano D'Adamio]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT TYR-757,  INTERACTION WITH SHC1,  MUTAGENESIS OF THR-743 AND TYR-757]"} ], "id": "750", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11877420", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M110286200"} , { "elementOf": "NLM", "accession": "11877420"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 672-704,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 1406936", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1406936", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Amyloid beta-Peptides,  Antibodies,  Monoclonal,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids."} , { "attrname": "Abstract", "value": "Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein,  no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid,  plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography,  we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and therapeutic strategies aimed at reducing the cerebral deposition of A beta. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Peptide Fragments,  Enzyme-Linked Immunosorbent Assay,  Humans,  Cells,  Cultured,  Solubility,  Molecular Sequence Data,  Antibodies,  Monoclonal,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cross Reactions,  Radioimmunoassay,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[P Seubert,  C Vigo-Pelfrey,  F Esch,  M Lee,  H Dovey,  D Davis,  S Sinha,  M Schlossmacher,  J Whaley,  C Swindlehurst]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 672-704,  TISSUE SPECIFICITY]"} ], "id": "751", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1406936", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/359325A0"} , { "elementOf": "NLM", "accession": "1406936"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 18-40]", "conames": [{ "name": "PMID: 12665801", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12665801", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature biotechnology"} , { "attrname": "Chemical", "value": "[Peptides,  Proteome]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides."} , { "attrname": "Abstract", "value": "Current non-gel techniques for analyzing proteomes rely heavily on mass spectrometric analysis of enzymatically digested protein mixtures. Prior to analysis,  a highly complex peptide mixture is either separated on a multidimensional chromatographic system or it is first reduced in complexity by isolating sets of representative peptides. Recently,  we developed a peptide isolation procedure based on diagonal electrophoresis and diagonal chromatography. We call it combined fractional diagonal chromatography (COFRADIC). In previous experiments,  we used COFRADIC to identify more than 800 Escherichia coli proteins by tandem mass spectrometric (MS\/MS) analysis of isolated methionine-containing peptides. Here,  we describe a diagonal method to isolate N-terminal peptides. This reduces the complexity of the peptide sample,  because each protein has one N terminus and is thus represented by only one peptide. In this new procedure,  free amino groups in proteins are first blocked by acetylation and then digested with trypsin. After reverse-phase (RP) chromatographic fractionation of the generated peptide mixture,  internal peptides are blocked using 2, 4, 6-trinitrobenzenesulfonic acid (TNBS); they display a strong hydrophobic shift and therefore segregate from the unaltered N-terminal peptides during a second identical separation step. N-terminal peptides can thereby be specifically collected for further liquid chromatography (LC)-MS\/MS analysis. Omitting the acetylation step results in the isolation of non-lysine-containing N-terminal peptides from in vivo blocked proteins. "} , { "attrname": "MeSH", "value": "[Cell Membrane,  Peptides,  Humans,  Mass Spectrometry,  Blood Platelets,  Proteome,  Cytosol]"} , { "attrname": "AUTHORS", "value": "[Kris Gevaert,  Marc Goethals,  Lennart Martens,  Jozef Van Damme,  An Staes,  Grgoire R Thomas,  Jol Vandekerckhove]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 18-40]"} ], "id": "752", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12665801", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NBT810"} , { "elementOf": "NLM", "accession": "12665801"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 691-698,  CLEAVAGE BY THETA-SECRETASE]", "conames": [{ "name": "PMID: 16816112", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16816112", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FASEB journal :  official publication of the Federation of American Societies for Experimental Biology"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Enzyme Inhibitors,  Amyloid beta-Peptides,  EC 3.4.23.- Aspartic Acid Endopeptidases,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "BACE2,  as a novel APP theta-secretase,  is not responsible for the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in Down syndrome."} , { "attrname": "Abstract", "value": "Amyloid beta protein (Abeta),  the major component of neuritic plaques in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD),  is derived from APP by sequential cleavages of beta- and gamma-secretases. Beta-site APP cleaving enzyme 1 (BACE1) is the major beta-secretase in vivo. Beta-site APP cleaving enzyme 2 (BACE2) is the homologue of BACE1. The majority of people with Down syndrome (DS),  also called Trisomy 21 syndrome,  will develop AD neuropathology after middle age. We and others have shown that APP C99,  the major beta-secretase product,  and Abeta are markedly increased in DS. Since BACE2 is located on chromosome 21,  it is speculated that BACE2 may play a role in AD pathogenesis in DS. In this report we found that BACE2 cleaves APP at a novel theta site downstream of the alpha site,  abolishing Abeta production. Overexpression of BACE2 by lentivirus markedly reduced Abeta production in primary neurons derived from Swedish mutant APP transgenic mice. Despite an extra copy of the BACE2 gene in DS and the increase of its transcription,  BACE2 protein levels are unchanged. Our data clearly demonstrate that BACE2,  as a novel theta-secretase to cleave APP within the Abeta domain,  is not involved in the AD pathogenesis of DS patients; instead,  therapeutic interventions that potentiate BACE2 may prevent AD pathogenesis. "} , { "attrname": "MeSH", "value": "[Cell Line,  Enzyme Inhibitors,  Neurons,  Humans,  Cells,  Cultured,  Mice,  Transgenic,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Reverse Transcriptase Polymerase Chain Reaction,  Kidney,  Down Syndrome,  Animals,  Transfection,  Plasmids,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Cloning,  Molecular,  Polymerase Chain Reaction,  Transcription,  Genetic,  Mice,  Genetic Vectors]"} , { "attrname": "AUTHORS", "value": "[Xiulian Sun,  Guiqiong He,  Weihong Song]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 691-698,  CLEAVAGE BY THETA-SECRETASE]"} ], "id": "753", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16816112", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1096\/FJ.05-5632COM"} , { "elementOf": "NLM", "accession": "16816112"} ]} , { "annotation": "[INTERACTION WITH APP-BP1]", "conames": [{ "name": "PMID: 8626687", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8626687", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[amyloid protein precursor-binding protein 1,  human,  DNA Primers,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  DNA,  Complementary,  DNA-Binding Proteins]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "APP-BP1,  a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein."} , { "attrname": "Abstract", "value": "beta-Amyloid protein precursors (APPs,  695-770 amino acids) are the source of the 39-43 amino acid beta-amyloid (A beta) peptides that comprise diffuse and fibrillar deposits in the cerebral cortex and vasculature of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains. A beta is thought to play a role in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and,  hence,  considerable effort has been invested in defining the means by which A beta is generated from the APPs. Knowledge of the normal function of the APPs is sure to provide insights into the genesis and pathological persistence of A beta in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. APP is a cell surface protein with a large extracellular amino-terminal domain,  a single transmembrane segment,  and a short cytoplasmic tail. Its location and structural features characteristic of a receptor for signal transduction led us to search for potential effector proteins capable of binding and interacting with its cytoplasmic domain. Here,  we report the cloning of a cDNA encoding one such protein. This ubiquitously expressed 59-kDa APP-binding protein,  called APP-BP1,  is 61% similar to a protein encoded by the Arabidopsis AXR1 gene,  required for normal response to the hormone auxin,  and is a relative of the ubiquitin activating enzyme E1. "} , { "attrname": "MeSH", "value": "[Brain,  Humans,  Molecular Sequence Data,  Cerebral Cortex,  Recombinant Fusion Proteins,  Triticum,  Base Sequence,  Cloning,  Molecular,  Polymerase Chain Reaction,  Adult,  Fetus,  Binding Sites,  DNA-Binding Proteins,  Amino Acid Sequence,  Gene Library,  In Situ Hybridization,  Fluorescence,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Organ Specificity,  Sequence Homology,  Amino Acid,  Blotting,  Northern,  Animals,  Chromosomes,  Human,  Pair 16,  Protein Binding,  Mice,  Muscle,  Skeletal,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[N Chow,  J R Korenberg,  X N Chen,  R L Neve]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APP-BP1]"} ], "id": "754", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8626687", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.271.19.11339"} , { "elementOf": "NLM", "accession": "8626687"} ]} , { "annotation": "[VARIANT ASP-665]", "conames": [{ "name": "PMID: 8154870", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8154870", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Codon,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Amyloid plaques in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> contain beta-amyloid,  encoded by portions of exons 16 and 17 of the amyloid precursor protein. The specific association of rare amyloid precursor protein mutations with some kindreds with early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> suggests that specific abnormalities in amyloid precursor protein may contribute to the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Until now,  there has been no evidence suggesting that amyloid precursor protein mutations could be involved in late-onset or sporadic <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We used reverse transcription-polymerase chain reaction,  denaturing gradient gel electrophoresis,  and direct DNA sequencing to analyze amyloid precursor protein exons 16 and 17 from postmortem cerebellar samples from patients with histologically confirmed <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and control subjects. We found a novel point mutation,  substitution of cytosine for guanine,  at nucleotide 2119 (amyloid precursor protein 770 messenger RNA transcript) in a patient with late-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. This substitution deletes a BglII site and substitutes aspartate for glutamine at codon 665. Denaturing gradient gel electrophoresis analysis showed that this mutation was absent in 40 control subjects and 127 dementia patients. Whether this mutation is a rare but normal variant or contributes to the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is not known. The BglII restriction fragment length polymorphism enables investigators to determine the frequency of this polymorphism in normal subjects and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patients. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Humans,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Genetic,  Point Mutation,  Codon,  Time Factors,  Pedigree,  Aged,  80 and over,  Female,  Aged,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[M L Peacock,  D L Murman,  A A Sima,  J T Warren,  A D Roses,  J K Fink]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT ASP-665]"} ], "id": "755", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8154870", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.410350410"} , { "elementOf": "NLM", "accession": "8154870"} ]} , { "annotation": "[FUNCTION,  CLEAVAGE,  INTERACTION WITH TNFRSF21]", "conames": [{ "name": "PMID: 19225519", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19225519", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Tnfrsf21 protein,  mouse,  EC 3.4.22.- Caspases,  Peptide Fragments,  Receptors,  Tumor Necrosis Factor,  Bax protein,  mouse,  Ligands,  EC 3.4.22.- Caspase 6,  bcl-2-Associated X Protein,  Amyloid beta-Protein Precursor,  EC 3.4.22.- Caspase 3]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "APP binds DR6 to trigger axon pruning and neuron death via distinct caspases."} , { "attrname": "Abstract", "value": "Naturally occurring axonal pruning and neuronal cell death help to sculpt neuronal connections during development,  but their mechanistic basis remains poorly understood. Here we report that beta-amyloid precursor protein (APP) and death receptor 6 (DR6,  also known as TNFRSF21) activate a widespread caspase-dependent self-destruction program. DR6 is broadly expressed by developing neurons,  and is required for normal cell body death and axonal pruning both in vivo and after trophic-factor deprivation in vitro. Unlike neuronal cell body apoptosis,  which requires caspase 3,  we show that axonal degeneration requires caspase 6,  which is activated in a punctate pattern that parallels the pattern of axonal fragmentation. DR6 is activated locally by an inactive surface ligand(s) that is released in an active form after trophic-factor deprivation,  and we identify APP as a DR6 ligand. Trophic-factor deprivation triggers the shedding of surface APP in a beta-secretase (BACE)-dependent manner. Loss- and gain-of-function studies support a model in which a cleaved amino-terminal fragment of APP (N-APP) binds DR6 and triggers degeneration. Genetic support is provided by a common neuromuscular junction phenotype in mutant mice. Our results indicate that APP and DR6 are components of a neuronal self-destruction pathway,  and suggest that an extracellular fragment of APP,  acting via DR6 and caspase 6,  contributes to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Peptide Fragments,  Signal Transduction,  Neurons,  bcl-2-Associated X Protein,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Axons,  Animals,  Receptors,  Tumor Necrosis Factor,  Cell Death,  Caspase 3,  Protein Binding,  Ligands,  Mice,  Caspases,  Caspase 6,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Anatoly Nikolaev,  Todd McLaughlin,  Dennis D M O'Leary,  Marc Tessier-Lavigne]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  CLEAVAGE,  INTERACTION WITH TNFRSF21]"} ], "id": "756", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19225519", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19225519"} , { "elementOf": "DOI", "accession": "10.1038\/NATURE07767"} ]} , { "annotation": "[INTERACTION OF BETA-AMYLOID PEPTIDE WITH HADH2]", "conames": [{ "name": "PMID: 9338779", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9338779", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[EC 1.1.- Hydroxysteroid Dehydrogenases,  EC 1.1.1.35 HSD17B10 protein,  human,  Amyloid beta-Peptides,  EC 1.1.1.- 3-Hydroxyacyl CoA Dehydrogenases,  EC 1.1.1.35 Hadh2 protein,  mouse,  Recombinant Fusion Proteins,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Amyloid-beta is a neurotoxic peptide which is implicated in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. It binds an intracellular polypeptide known as ERAB,  thought to be a hydroxysteroid dehydrogenase enzyme,  which is expressed in normal tissues,  but is overexpressed in neurons affected in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. ERAB immunoprecipitates with amyloid-beta,  and when cell cultures are exposed to amyloid-beta,  ERAB inside the cell is rapidly redistributed to the plasma membrane. The toxic effect of amyloid-beta on these cells is prevented by blocking ERAB and is enhanced by overexpression of ERAB. By interacting with intracellular amyloid-beta,  ERAB may therefore contribute to the neuronal dysfunction associated with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  3-Hydroxyacyl CoA Dehydrogenases,  Humans,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Recombinant Fusion Proteins,  Hydroxysteroid Dehydrogenases,  Animals,  Transfection,  Amyloid beta-Peptides,  Cloning,  Molecular,  Protein Binding,  HeLa Cells,  COS Cells,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[S D Yan,  J Fu,  C Soto,  X Chen,  H Zhu,  F Al-Mohanna,  K Collison,  A Zhu,  E Stern,  T Saido,  M Tohyama,  S Ogawa,  A Roher,  D Stern]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION OF BETA-AMYLOID PEPTIDE WITH HADH2]"} ], "id": "757", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9338779", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/39522"} , { "elementOf": "NLM", "accession": "9338779"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 346-551,  PARTIAL PROTEIN SEQUENCE,  MUTAGENESIS OF ARG-499 AND LYS-503,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 15304215", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15304215", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular cell"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain."} , { "attrname": "Abstract", "value": "Amyloid beta-peptide,  which forms neuronal and vascular amyloid deposits in Alzheimer's disease,  is derived from an integral membrane protein precursor. The biological function of the precursor is currently unclear. Here we describe the X-ray structure of E2,  the largest of the three conserved domains of the precursor. The structure of E2 consists of two coiled-coil substructures connected through a continuous helix and bears an unexpected resemblance to the spectrin family of protein structures. E2 can reversibly dimerize in the solution,  and the dimerization occurs along the longest dimension of the molecule in an antiparallel orientation,  which enables the N-terminal substructure of one monomer to pack against the C-terminal substructure of a second monomer. Heparan sulfate proteoglycans,  the putative ligand for the precursor present in extracellular matrix,  bind to E2 at a conserved and positively charged site near the dimer interface. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Amino Acid Sequence,  Signal Transduction,  X-Ray Diffraction,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Cell Adhesion,  Dimerization,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Yongcheng Wang,  Ya Ha]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 346-551,  PARTIAL PROTEIN SEQUENCE,  MUTAGENESIS OF ARG-499 AND LYS-503,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "758", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15304215", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15304215"} , { "elementOf": "DOI", "accession": "10.1016\/J.MOLCEL.2004.06.037"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT AD1 GLY-692]", "conames": [{ "name": "PMID: 11311152", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11311152", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Biochemical journal"} , { "attrname": "Chemical", "value": "[368GB5141J Sodium Dodecyl Sulfate,  Peptide Fragments,  Amyloid beta-Peptides,  TE7660XO1C Glycine,  OF5P57N2ZX Alanine]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "In a Flemish kindred,  an Ala(692)-->Gly amino acid substitution in the amyloid beta-protein precursor (AbetaPP) causes a form of early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) which displays prominent amyloid angiopathy and unusually large senile plaque cores. The mechanistic basis of this Flemish form of AD is unknown. Previous in vitro studies of amyloid beta-protein (Abeta) production in HEK-293 cells transfected with cDNA encoding Flemish AbetaPP have shown that full-length [Abeta(1-40)] and truncated [Abeta(5-40) and Abeta(11-40)] forms of Abeta are produced. In an effort to determine how these peptides might contribute to the pathogenesis of the Flemish <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  comparative biophysical and neurotoxicity studies were performed on wild-type and Flemish Abeta(1-40),  Abeta(5-40) and Abeta(11-40). The results revealed that the Flemish amino acid substitution increased the solubility of each form of peptide,  decreased the rate of formation of thioflavin-T-positive assemblies,  and increased the SDS-stability of peptide oligomers. Although the kinetics of peptide assembly were altered by the Ala(21)-->Gly substitution,  all three Flemish variants formed fibrils,  as did the wild-type peptides. Importantly,  toxicity studies using cultured primary rat cortical cells showed that the Flemish assemblies were as potent a neurotoxin as were the wild-type assemblies. Our results are consistent with a pathogenetic process in which conformational changes in Abeta induced by the Ala(21)-->Gly substitution would facilitate peptide adherence to the vascular endothelium,  creating nidi for amyloid growth. Increased peptide solubility and assembly stability would favour formation of larger deposits and inhibit their elimination. In addition,  increased concentrations of neurotoxic assemblies would accelerate neuronal injury and death. "} , { "attrname": "MeSH", "value": "[Alanine,  Peptide Fragments,  Animals,  Humans,  Amyloid beta-Peptides,  Cells,  Cultured,  Solubility,  Rats,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Glycine,  Sodium Dodecyl Sulfate,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[D M Walsh,  D M Hartley,  M M Condron,  D J Selkoe,  D B Teplow]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT AD1 GLY-692]"} ], "id": "759", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11311152", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11311152"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75]", "conames": [{ "name": "PMID: 2538123", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2538123", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Oligonucleotide Probes,  EC 3.1.- Endonucleases,  9007-49-2 DNA,  Protein Precursors,  Amyloid,  Transcription Factors,  EC 3.1.30.1 Single-Strand Specific DNA and RNA Endonucleases,  EC 3.1.21.- DNA Restriction Enzymes,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene."} , { "attrname": "Abstract", "value": "Human genomic clones encoding the promoter region and the first two exons of the beta-amyloid protein precursor (beta-APP) gene were isolated. The first exon is 205 base pairs (bp) long and encodes 19 amino acids. The second exon is 168 bp long and encodes 56 amino acids. The 5'-flanking sequence of the beta-APP gene was found to display promoter activity in several cell lines including PC12 cells where the highest activity was detected. The promoter region of this gene lacks the typical \"TATAA\" and \"CAAT\" boxes usually associated with eukaryotic promoters. Five copies of the GGGCGC sequence are located between positions -107 and -188 and one copy is located within the first exon of the beta-APP gene. Consensus sequences recognized by the transcription factors Sp1 and AP-1 are located upstream from the RNA start site. Palindromic sequences capable of forming stable hairpin-like structures are found around the main transcription initiation site. The structural characteristics of the beta-APP promoter indicate that multiple elements participate in the regulation of the expression of this gene. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Oligonucleotide Probes,  Promoter Regions,  Genetic,  Nucleic Acid Hybridization,  Exons,  Introns,  Humans,  Single-Strand Specific DNA and RNA Endonucleases,  Gene Expression Regulation,  Molecular Sequence Data,  Rats,  Animals,  DNA Restriction Enzymes,  Base Sequence,  DNA,  Endonucleases,  Protein Precursors,  Transcription,  Genetic,  Amyloid,  Transcription Factors,  Tumor Cells,  Cultured,  Nucleic Acid Conformation,  Chromosomes,  Human,  Pair 21,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[G La Fauci,  D K Lahiri,  S R Salton,  N K Robakis]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-75]"} ], "id": "760", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2538123", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0006-291X(89)92437-6"} , { "elementOf": "NLM", "accession": "2538123"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]", "conames": [{ "name": "PMID: 2893289", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2893289", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Protease Inhibitors,  9007-49-2 DNA,  DNA,  Recombinant,  Protein Precursors,  Serine Proteinase Inhibitors,  Receptors,  Cell Surface,  Amyloid,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors."} , { "attrname": "Abstract", "value": "The amyloid proteins isolated from neuritic plaques and the cerebrovasculature of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> are self-aggregating moieties termed A4 protein and beta-protein,  respectively. A putative A4 amyloid precursor (herein termed A4(695] has been characterized by analysis of a human brain complementary DNA. We report here the sequence of a closely related amyloid cDNA,  A4(751),  distinguished from A4(695) by the presence of a 168 base-pair (bp) sequence which adds 57 amino acids to,  and removes one residue from,  the predicted A4(695) protein. The peptide predicted from this insert is very similar to the Kunitz family of serine proteinase inhibitors. The two A4-specific messenger RNAs are differentially expressed:  in a limited survey,  A4(751) mRNA appears to be ubiquitous,  whereas A4(695) mRNA has a restricted pattern of expression which includes cells from neuronal tissue. These data may have significant implications for understanding amyloid deposition in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Nucleic Acid Hybridization,  Humans,  Protease Inhibitors,  Molecular Sequence Data,  Serine Proteinase Inhibitors,  Receptors,  Cell Surface,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  Base Sequence,  DNA,  DNA,  Recombinant,  Protein Precursors,  Amyloid,  Brain Chemistry,  Tumor Cells,  Cultured,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[P Ponte,  P Gonzalez-DeWhitt,  J Schilling,  J Miller,  D Hsu,  B Greenberg,  K Davis,  W Wallace,  I Lieberburg,  F Fuller]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP751)]"} ], "id": "761", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2893289", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2893289"} , { "elementOf": "DOI", "accession": "10.1038\/331525A0"} ]} , { "annotation": "[STRUCTURE BY NMR OF 672-711]", "conames": [{ "name": "PMID: 9693002", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9693002", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  amyloid beta-protein (1-40),  368GB5141J Sodium Dodecyl Sulfate,  Peptide Fragments,  Solutions,  Micelles,  Amyloid beta-Peptides,  059QF0KO0R Water]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?"} , { "attrname": "Abstract", "value": "The three-dimensional solution structure of the 40 residue amyloid beta-peptide,  Abeta(1-40),  has been determined using NMR spectroscopy at pH 5.1,  in aqueous sodium dodecyl sulfate (SDS) micelles. In this environment,  which simulates to some extent a water-membrane medium,  the peptide is unstructured between residues 1 and 14 which are mainly polar and likely solvated by water. However,  the rest of the protein adopts an alpha-helical conformation between residues 15 and 36 with a kink or hinge at 25-27. This largely hydrophobic region is likely solvated by SDS. Based on the derived structures,  evidence is provided in support of a possible new location for the transmembrane domain of Abeta within the amyloid precursor protein (APP). Studies between pH 4.2 and 7.9 reveal a pH-dependent helix-coil conformational switch. At the lower pH values,  where the carboxylate residues are protonated,  the helix is uncharged,  intact,  and lipid-soluble. As the pH increases above 6. 0,  part of the helical region (15-24) becomes less structured,  particularly near residues E22 and D23 where deprotonation appears to facilitate unwinding of the helix. This pH-dependent unfolding to a random coil conformation precedes any tendency of this peptide to aggregate to a beta-sheet as the pH increases. The structural biology described herein for Abeta(1-40) suggests that (i) the C-terminal two-thirds of the peptide is an alpha-helix in membrane-like environments,  (ii) deprotonation of two acidic amino acids in the helix promotes a helix-coil conformational transition that precedes aggregation,  (iii) a mobile hinge exists in the helical region of Abeta(1-40) and this may be relevant to its membrane-inserting properties and conformational rearrangements,  and (iv) the location of the transmembrane domain of amyloid precursor proteins may be different from that accepted in the literature. These results may provide new insight to the structural properties of amyloid beta-peptides of relevance to Alzheimer's disease. "} , { "attrname": "MeSH", "value": "[Water,  Amino Acid Sequence,  Peptide Fragments,  Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Crystallography,  X-Ray,  Sodium Dodecyl Sulfate,  Membrane Proteins,  Solutions,  Micelles,  Amyloid beta-Peptides,  Nuclear Magnetic Resonance,  Biomolecular,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[M Coles,  W Bicknell,  A A Watson,  D P Fairlie,  D J Craik]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 672-711]"} ], "id": "762", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9693002", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI972979F"} , { "elementOf": "NLM", "accession": "9693002"} ]} , { "annotation": "[VARIANT CAA-APP ASN-694]", "conames": [{ "name": "PMID: 11409420", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11409420", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy."} , { "attrname": "Abstract", "value": "Several mutations in the amyloid precursor protein (APP) gene have been found to associate with pathologic deposition of the beta-amyloid peptide (Abeta) in neuritic plaques or in the walls of cerebral vessels. We report a mutation at a novel site in APP in a three-generation Iowa family with autosomal dominant dementia beginning in the sixth or seventh decade of life. The proband and an affected brother had progressive aphasic dementia,  leukoencephalopathy,  and occipital calcifications. Neuropathological examination of the proband revealed severe cerebral amyloid angiopathy,  widespread neurofibrillary tangles,  and unusually extensive distribution of Abeta40 in plaques. The affected brothers shared a missense mutation in APP,  resulting in substitution of asparagine for aspartic acid at position 694. This site corresponds to residue 23 of Abeta,  thus differing from familial Alzheimer's disease mutations,  which occur outside the Abeta sequence. Restriction enzyme analysis of DNA from 94 unrelated patients with sporadic cerebral amyloid angiopathy-related hemorrhage found no other instances of this mutation. These results suggest a novel site within Abeta that may promote its deposition and toxicity. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Middle Aged,  Male,  Tomography,  X-Ray Computed,  Mutation,  Missense,  Magnetic Resonance Imaging,  Iowa,  Genes,  Dominant,  Autopsy,  DNA Mutational Analysis,  Pedigree,  Base Sequence,  Age of Onset,  Cerebral Amyloid Angiopathy,  Female,  Aged,  Occipital Lobe,  Amyloid beta-Protein Precursor,  Germany,  Dementia]"} , { "attrname": "AUTHORS", "value": "[T J Grabowski,  H S Cho,  J P Vonsattel,  G W Rebeck,  S M Greenberg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CAA-APP ASN-694]"} ], "id": "763", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11409420", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11409420"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.1009"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 655-737,  VARIANTS AD1 GLY-717; ILE-717 AND PHE-717]", "conames": [{ "name": "PMID: 8476439", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8476439", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[RNA,  Catalytic,  9007-49-2 DNA,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "A system for studying the effect(s) of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mutations on the processing of the beta-amyloid peptide precursor."} , { "attrname": "Abstract", "value": "Three different point mutations have been observed in some familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pedigrees at a unique valine,  Val717,  near the carboxyl end of the beta Amyloid Peptide Precursor (beta APP). The effects of these mutations on the processing and cellular functions of beta APP can best be determined in the absence of the normal form(s) of the protein. We have used targeted mRNA degradation by a trans-acting hammerhead ribozyme to cleave and inactivate beta APP expression in vitro. The consensus ribozyme cleavage site,  5'GUC decreases X3,  matches the Val717 nucleotide sequence in beta APP mRNA. Introduction of FAD point mutations which change Val717 decrease the rate of ribozyme cleavage by more than three orders of magnitude. Thus,  ribozyme targeting of this site should allow the study of protein processing in vivo. Furthermore,  a ribozyme targeted to mutant beta APP mRNA (Val717-->Ile) cleaved the mutant sequence 300-fold faster than the normal sequence. This suggests that ribozymes might lower mutant beta APP mRNA levels in FAD cells. "} , { "attrname": "MeSH", "value": "[RNA,  Catalytic,  Amino Acid Sequence,  Point Mutation,  Base Sequence,  DNA,  Humans,  Molecular Sequence Data,  Protein Processing,  Post-Translational,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[R B Denman,  R Rosenzcwaig,  D L Miller]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 655-737,  VARIANTS AD1 GLY-717; ILE-717 AND PHE-717]"} ], "id": "764", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8476439", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.1993.1386"} , { "elementOf": "NLM", "accession": "8476439"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 133-189 IN COMPLEXES WITH COPPER IONS,  DISULFIDE BONDS]", "conames": [{ "name": "PMID: 17239395", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "17239395", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of molecular biology"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "Structural studies of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein copper-binding domain reveal how it binds copper ions."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is the major cause of dementia. Amyloid beta peptide (Abeta),  generated by proteolytic cleavage of the amyloid precursor protein (APP),  is central to AD pathogenesis. APP can function as a metalloprotein and modulate copper (Cu) transport,  presumably via its extracellular Cu-binding domain (CuBD). Cu binding to the CuBD reduces Abeta levels,  suggesting that a Cu mimetic may have therapeutic potential. We describe here the atomic structures of apo CuBD from three crystal forms and found they have identical Cu-binding sites despite the different crystal lattices. The structure of Cu(2+)-bound CuBD reveals that the metal ligands are His147,  His151,  Tyr168 and two water molecules,  which are arranged in a square pyramidal geometry. The site resembles a Type 2 non-blue Cu center and is supported by electron paramagnetic resonance and extended X-ray absorption fine structure studies. A previous study suggested that Met170 might be a ligand but we suggest that this residue plays a critical role as an electron donor in CuBDs ability to reduce Cu ions. The structure of Cu(+)-bound CuBD is almost identical to the Cu(2+)-bound structure except for the loss of one of the water ligands. The geometry of the site is unfavorable for Cu(+),  thus providing a mechanism by which CuBD could readily transfer Cu ions to other proteins. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Amyloid beta-Peptides,  Protein Conformation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Copper,  Crystallography]"} , { "attrname": "AUTHORS", "value": "[Geoffrey K-W Kong,  Julian J Adams,  Hugh H Harris,  John F Boas,  Cyril C Curtain,  Denise Galatis,  Colin L Masters,  Kevin J Barnham,  William J McKinstry,  Roberto Cappai,  Michael W Parker]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 133-189 IN COMPLEXES WITH COPPER IONS,  DISULFIDE BONDS]"} ], "id": "765", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 17239395", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "17239395"} , { "elementOf": "DOI", "accession": "10.1016\/J.JMB.2006.12.041"} ]} , { "annotation": "[VARIANT AD1 ILE-717]", "conames": [{ "name": "PMID: 1908231", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1908231", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Oligonucleotide Probes,  Amyloid beta-Peptides,  Protein Precursors,  HG18B9YRS7 Valine,  04Y7590D77 Isoleucine,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "The 717Val----Ile substitution in amyloid precursor protein is associated with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> regardless of ethnic groups."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is a devastating neurological disorder and the leading cause of dementia among aged individuals. The human amyloid beta protein,  which is a cleavage product of amyloid precursor protein (APP),  is a major component of the amyloid deposited in the brain of patients with AD. By using PCR direct sequencing of exon 17 (encoding part of the beta protein) of the APP gene,  we have found that a Japanese AD patient harbours a C to T substitution,  responsible for a valine to isoleucine change at position 717,  heterogeneously. The mutation is exactly the same as that found in a Caucasian AD family by Goate et al. (1). Furthermore,  the mutation was shown to co-segregate with AD in his family. These results suggest that the Val----Ile change in the APP causes AD,  regardless of ethnic background. "} , { "attrname": "MeSH", "value": "[Oligonucleotide Probes,  Exons,  Humans,  Japan,  Molecular Sequence Data,  European Continental Ancestry Group,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ethnic Groups,  Pedigree,  Valine,  Base Sequence,  Amyloid beta-Peptides,  Polymerase Chain Reaction,  Protein Precursors,  Female,  Mutation,  Amyloid beta-Protein Precursor,  Isoleucine]"} , { "attrname": "AUTHORS", "value": "[K Yoshioka,  T Miki,  T Katsuya,  T Ogihara,  Y Sakaki]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-717]"} ], "id": "766", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1908231", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0006-291X(91)91011-Z"} , { "elementOf": "NLM", "accession": "1908231"} ]} , { "annotation": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]", "conames": [{ "name": "PMID: 10742146", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10742146", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature medicine"} , { "attrname": "Chemical", "value": "[EC 3.4.22.- CASP9 protein,  human,  EC 3.4.22.- Casp9 protein,  mouse,  EC 3.4.22.- Caspases,  Peptide Fragments,  amyloid precursor protein,  carboxy-terminal 100 residues,  Peptides,  EC 3.4.22.- Caspase 9,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor."} , { "attrname": "Abstract", "value": "The amyloid beta-protein precursor gives rise to the amyloid beta-protein,  the principal constituent of senile plaques and a cytotoxic fragment involved in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here we show that amyloid beta-protein precursor was proteolytically cleaved by caspases in the C terminus to generate a second unrelated peptide,  called C31. The resultant C31 peptide was a potent inducer of apoptosis. Both caspase-cleaved amyloid beta-protein precursor and activated caspase-9 were present in brains of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patients but not in control brains. These findings indicate the possibility that caspase cleavage of amyloid beta-protein precursor with the generation of C31 may be involved in the neuronal death associated with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Brain,  Caspase 9,  Peptide Fragments,  Peptides,  Humans,  Substrate Specificity,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Mice,  Caspases,  Enzyme Activation,  Amyloid beta-Protein Precursor,  Cell Line,  Transformed,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[D C Lu,  S Rabizadeh,  S Chandra,  R F Shayya,  L M Ellerby,  X Ye,  G S Salvesen,  E H Koo,  D E Bredesen]"} , { "attrname": "PUB_TYPE", "value": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]"} ], "id": "767", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10742146", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/74656"} , { "elementOf": "NLM", "accession": "10742146"} ]} , { "annotation": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]", "conames": [{ "name": "PMID: 10319819", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10319819", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cell"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  EC 3.4.22.- Caspases,  Enzyme Inhibitors,  Excitatory Amino Acid Agonists,  Oligopeptides,  143313-51-3 L 709049,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  EC 3.4.23.46 Bace1 protein,  mouse,  30KYC7MIAI Aspartic Acid,  EC 3.4.22.- Casp3 protein,  rat,  EC 3.4.22.- Caspase 3,  acetyl-aspartyl-glutamyl-valyl-aspartal,  EC 3.4.- Endopeptidases,  Cysteine Proteinase Inhibitors,  Amyloid beta-Peptides,  Enzyme Precursors,  SIV03811UC Kainic Acid,  XT3Z54Z28A Camptothecin,  Amyloid beta-Protein Precursor,  EC 3.4.22.- CASP3 protein,  human,  EC 3.4.22.- Casp3 protein,  mouse]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Involvement of caspases in proteolytic cleavage of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid-beta precursor protein and amyloidogenic A beta peptide formation."} , { "attrname": "Abstract", "value": "The amyloid-beta precursor protein (APP) is directly and efficiently cleaved by caspases during apoptosis,  resulting in elevated amyloid-beta (A beta) peptide formation. The predominant site of caspase-mediated proteolysis is within the cytoplasmic tail of APP,  and cleavage at this site occurs in hippocampal neurons in vivo following acute excitotoxic or ischemic brain injury. Caspase-3 is the predominant caspase involved in APP cleavage,  consistent with its marked elevation in dying neurons of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brains and colocalization of its APP cleavage product with A beta in senile plaques. Caspases thus appear to play a dual role in proteolytic processing of APP and the resulting propensity for A beta peptide formation,  as well as in the ultimate apoptotic death of neurons in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Camptothecin,  Enzyme Inhibitors,  Excitatory Amino Acid Agonists,  Oligopeptides,  Rats,  Wistar,  Humans,  Male,  Aspartic Acid,  Kainic Acid,  Sweden,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Caspase 3,  Brain <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Tumor Cells,  Cultured,  In Situ Nick-End Labeling,  Rabbits,  Acute <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Neurons,  Mice,  Inbred C57BL,  Rats,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Cysteine Proteinase Inhibitors,  Amyloidosis,  Mice,  Caspases,  Enzyme Precursors,  Mutation,  Leukemia,  Erythroblastic,  Acute,  Endopeptidases,  Amyloid beta-Protein Precursor,  Hippocampus,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[F G Gervais,  D Xu,  G S Robertson,  J P Vaillancourt,  Y Zhu,  J Huang,  A LeBlanc,  D Smith,  M Rigby,  M S Shearman,  E E Clarke,  H Zheng,  L H Van Der Ploeg,  S C Ruffolo,  N A Thornberry,  S Xanthoudakis,  R J Zamboni,  S Roy,  D W Nicholson]"} , { "attrname": "PUB_TYPE", "value": "[CLEAVAGE BY CASPASES,  MUTAGENESIS OF ASP-739]"} ], "id": "768", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10319819", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0092-8674(00)80748-5"} , { "elementOf": "NLM", "accession": "10319819"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 672-701 AND 707-713]", "conames": [{ "name": "PMID: 8109908", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8109908", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "The amino acid sequence of neuritic plaque amyloid from a familial Alzheimer's disease patient."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Neurites,  Humans,  Middle Aged,  Amyloid beta-Peptides,  Molecular Sequence Data,  Female,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[T Wisniewski,  M Lalowski,  E Levy,  M R Marques,  B Frangione]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 672-701 AND 707-713]"} ], "id": "769", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8109908", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.410350223"} , { "elementOf": "NLM", "accession": "8109908"} ]} , { "annotation": "[VARIANT AD1 GLY-692,  CHARACTERIZATION OF PHENOTYPE]", "conames": [{ "name": "PMID: 9754958", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9754958", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Acta neuropathologica"} , { "attrname": "Chemical", "value": "[Amyloid,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Presenile <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala-->Gly mutation."} , { "attrname": "Abstract", "value": "Mutations at codons 717 and 670\/671 in the amyloid precursor protein (APP) are rare genetic causes of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). A mutation at codon 693 of APP has also been described as the genetic defect in hereditary cerebral hemorrhage with amyloidosis of the Dutch type (HCHWA-D). We have reported a APP692Ala-->Gly (Flemish) mutation as a cause of intracerebral hemorrhage and presenile dementia diagnosed as probable AD in a Dutch family. We now describe the post-mortem examination of two demented patients with the APP692 mutation. The neuropathological findings support the diagnosis of AD. Leptomeningial and parenchymal vessels showed extensive deposition of Abeta amyloid protein. Numerous senile plaques consisted of large Abeta amyloid cores,  often measuring more than 30 microm in diameter and were surrounded by a fine meshwork of dystrophic neurites. In addition,  there were a large number of paired helical filaments in pyramidal neurons and dystrophic neurites. Our findings show that the APP692 mutation leads to morphological abnormalities that are similar to AD,  but the morphology of senile plaques is clearly distinct from that described in sporadic and chromosome 14-linked AD patients,  in patients with APP717 mutations causing familial,  presenile AD and in patients with the APP693 mutation causing HCHWA-D. "} , { "attrname": "MeSH", "value": "[Brain,  Humans,  Middle Aged,  Cell Size,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microscopy,  Electron,  Plaque,  Amyloid,  Cerebral Amyloid Angiopathy,  Female,  Amyloid,  Mutation,  Amyloid beta-Protein Precursor,  Amino Acid Substitution,  Dementia]"} , { "attrname": "AUTHORS", "value": "[P Cras,  F van Harskamp,  L Hendriks,  C Ceuterick,  C M van Duijn,  S Z Stefanko,  A Hofman,  J M Kros,  C Van Broeckhoven,  J J Martin]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 GLY-692,  CHARACTERIZATION OF PHENOTYPE]"} ], "id": "770", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9754958", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1007\/S004010050892"} , { "elementOf": "NLM", "accession": "9754958"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]", "conames": [{ "name": "PMID: 9108164", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9108164", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nucleic acids research"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "A novel method for making nested deletions and its application for sequencing of a 300 kb region of human APP locus."} , { "attrname": "Abstract", "value": "We developed a novel in vitro method for making nested deletions and applied it to a large-scale DNA sequencing. A DNA fragment to be sequenced (up to 15 kb long) was cloned with a new vector possessing two unique Sfi I sites,  digested by Sfi I and ligated to generate a large head-to-tail concatemer. The large concatemer was randomly fragmented by sonication and then redigested by Sfi I to separate insert and vector DNAs. The fragments of various length were then cloned into the other vector(s) specifically designed for selective cloning of insert-derived DNA fragments to generate a library of nested deletions. This method allowed a single person to generate >20 nested deletion libraries sufficient to cover 100 kb in a few days. We applied the method for sequencing of P1 clones and successfully determined the complete sequence of approximately 300 kb of the human amyloid precursor protein (APP) locus on chromosome 21 with a redundancy of 3.8,  reasonably low cost and very few gaps remaining to be closed. Development of some new instruments and software is also described which makes this method more applicable for large-scale sequencing. "} , { "attrname": "MeSH", "value": "[Sequence Deletion,  Base Sequence,  Humans,  Molecular Sequence Data,  Chromosome Mapping,  Chromosomes,  Human,  Pair 21,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[M Hattori,  F Tsukahara,  Y Furuhata,  H Tanahashi,  M Hirose,  M Saito,  S Tsukuni,  Y Sakaki]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]"} ], "id": "771", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9108164", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9108164"} , { "elementOf": "DOI", "accession": "10.1093\/NAR\/25.9.1802"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L-APP733)]", "conames": [{ "name": "PMID: 1587857", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1587857", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells."} , { "attrname": "Abstract", "value": "The gene for the beta A4-amyloid precursor protein (APP) consists of 19 exons which code for a typical N- and O-glycosylated transmembrane protein with four extracellular domains followed by the transmembrane domain and a short cytoplasmic domain. The beta A4-amyloid sequence is part of exons 16 and 17. Several APP isoforms can be generated by alternative splicing of exons 7 and 8,  encoding domains with homologies to Kunitz-type protease inhibitors and the MRC OX-2 antigen,  respectively. The mechanism by which the pathological beta A4 is generated is unknown,  it is however a critical event in Alzheimer's disease and is distinct from the normally occurring cleavage and secretion of APPs within the beta A4 sequence. We report here for the first time considerable APP mRNA expression by rat brain microglial cells. In addition we showed by S1 nuclease protection and polymerase chain reaction analysis of reverse transcribed RNA (RT-PCR) that T-lymphocytes,  macrophages,  and microglial cells expressed a new APP isoform by selection of a novel alternative splice site and exclusion of exon 15 of the APP gene. This leads to a transmembrane,  beta A4 sequence containing APP variant,  lacking 18 amino acid residues close to the amyloidogenic region. The use of this novel alternative splice site alters the structure of APP in close proximity to the beta A4 region and thus may determine a variant,  potentially pathogenic processing of leukocyte-derived APP in brain. "} , { "attrname": "MeSH", "value": "[Brain,  Gene Expression,  Exons,  Humans,  Neuroglia,  Molecular Sequence Data,  Leukocytes,  Autoradiography,  Blotting,  Northern,  RNA Splicing,  Base Sequence,  Polymerase Chain Reaction,  RNA,  Messenger,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[G Knig,  U Mnning,  C Czech,  R Prior,  R Banati,  U Schreiter-Gasser,  J Bauer,  C L Masters,  K Beyreuther]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM L-APP733)]"} ], "id": "772", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1587857", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1587857"} ]} , { "annotation": "[VARIANT CAA-APP GLN-693]", "conames": [{ "name": "PMID: 2111584", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2111584", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Protein Precursors,  Amyloid,  EC 3.1.21.- endodeoxyribonuclease MboII,  Amyloid beta-Protein Precursor,  EC 3.1.21.4 Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage,  Dutch type."} , { "attrname": "Abstract", "value": "An amyloid protein that precipitates in the cerebral vessel walls of Dutch patients with hereditary cerebral hemorrhage with amyloidosis is similar to the amyloid protein in vessel walls and senile plaques in brains of patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  Down syndrome,  and sporadic cerebral amyloid angiopathy. Cloning and sequencing of the two exons that encode the amyloid protein from two patients with this amyloidosis revealed a cytosine-to-guanine transversion,  a mutation that caused a single amino acid substitution (glutamine instead of glutamic acid) at position 22 of the amyloid protein. The mutation may account for the deposition of this amyloid protein in the cerebral vessel walls of these patients,  leading to cerebral hemorrhages and premature death. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cerebral Hemorrhage,  Cerebrovascular Disorders,  Exons,  Humans,  Middle Aged,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Netherlands,  Genes,  Dominant,  Base Sequence,  DNA,  Alleles,  Polymerase Chain Reaction,  Protein Precursors,  Aged,  80 and over,  Female,  Aged,  Amyloid,  Amyloidosis,  Brain Chemistry,  Mutation,  Amyloid beta-Protein Precursor,  Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "AUTHORS", "value": "[E Levy,  M D Carman,  I J Fernandez-Madrid,  M D Power,  I Lieberburg,  S G van Duinen,  G T Bots,  W Luyendijk,  B Frangione]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CAA-APP GLN-693]"} ], "id": "773", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2111584", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.2111584"} , { "elementOf": "NLM", "accession": "2111584"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]", "conames": [{ "name": "PMID: 2110105", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2110105", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Gene"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Protein Precursors,  Amyloid,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "Genomic organization of the human amyloid beta-protein precursor gene."} , { "attrname": "Abstract", "value": "Amyloid beta-protein (BP) deposited in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brains is a cleavage product of a larger precursor (BPP). The BPP gene encodes three types of mRNA generated by alternative splicing,  two of which contain the sequence encoding Kunitz-type serine-protease inhibitor (serpin). To investigate the regulatory mechanisms of BPP synthesis at the gene level,  we isolated 36 genomic DNA clones covering all the exons of the human BPP gene. This gene consists of 18 exons and spans more than 170 kb. BP is encoded by the 16th and the 17th exons and the serpin domain by the 7th exon. Sequence analysis showed that the 7th and 8th introns lack a typical branchpoint for splicing. This might relate to the alternative splicing. The promoter of the BPP gene has some characteristics of those of housekeeping genes and contains a number of possible methylation sites. The methylation status of the promoter was analyzed by Southern blotting but no alteration was observed among tissues and between control and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brains. We also tested the roles of two possible activator protein-1-binding sites and a possible heat-shock element found within the promoter. Northern blotting showed that the transcription of the BPP gene was apparently induced by 12-O-tetradecanoylphorbol-13-acetate (phorbol derivative) in HeLa cells. "} , { "attrname": "MeSH", "value": "[Blotting,  Southern,  Promoter Regions,  Genetic,  Exons,  Introns,  Genes,  Humans,  Gene Expression Regulation,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Restriction Mapping,  Blotting,  Northern,  RNA Splicing,  Base Sequence,  DNA,  Protein Precursors,  Transcription,  Genetic,  Amyloid,  Methylation,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S Yoshikai,  H Sasaki,  K Doh-ura,  H Furuya,  Y Sakaki]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP770)]"} ], "id": "774", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2110105", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2110105"} , { "elementOf": "DOI", "accession": "10.1016\/0378-1119(90)90310-N"} ]} , { "annotation": "[INTERACTION WITH BBP]", "conames": [{ "name": "PMID: 11278849", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11278849", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.22.- Caspases,  EC 3.6.1.- GTP-Binding Proteins,  TM2D1 protein,  human,  Peptides,  Tm2d1 protein,  mouse,  Amyloid beta-Peptides,  Recombinant Proteins,  Carrier Proteins,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "beta -Amyloid peptide-induced apoptosis regulated by a novel protein containing a g protein activation module."} , { "attrname": "Abstract", "value": "Degeneration of neurons in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is mediated by beta-amyloid peptide by diverse mechanisms,  which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta-amyloid peptide-binding protein (denoted BBP) containing a G protein-coupling module. BBP is one member of a family of three proteins containing this conserved structure. The BBP subtype bound human beta-amyloid peptide in vitro with high affinity and specificity. Expression of BBP in cell culture induced caspase-dependent vulnerability to beta-amyloid peptide toxicity. Expression of a signaling-deficient dominant negative BBP mutant suppressed sensitivity of human Ntera-2 neurons to beta-amyloid peptide mediated toxicity. These findings suggest that BBP is a target of neurotoxic beta-amyloid peptide and provide new insight into the molecular pathophysiology of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Brain,  Cell Membrane,  Protein Biosynthesis,  Peptides,  Humans,  Molecular Sequence Data,  Immunoblotting,  Recombinant Proteins,  Dose-Response Relationship,  Drug,  Tissue Distribution,  In Situ Hybridization,  Amyloid beta-Peptides,  Conserved Sequence,  Binding Sites,  Carrier Proteins,  Binding,  Competitive,  Protein Structure,  Tertiary,  Amino Acid Sequence,  Cell Line,  Gene Library,  Signal Transduction,  Neurons,  Cells,  Cultured,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Reverse Transcriptase Polymerase Chain Reaction,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Two-Hybrid System Techniques,  Blotting,  Northern,  Models,  Biological,  Protein Binding,  Caspases,  GTP-Binding Proteins,  Kinetics,  Mutation,  Apoptosis,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[E M Kajkowski,  C F Lo,  X Ning,  S Walker,  H J Sofia,  W Wang,  W Edris,  P Chanda,  E Wagner,  S Vile,  K Ryan,  B McHendry-Rinde,  S C Smith,  A Wood,  K J Rhodes,  J D Kennedy,  J Bard,  J S Jacobsen,  B A Ozenberger]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH BBP]"} ], "id": "775", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11278849", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M011161200"} , { "elementOf": "NLM", "accession": "11278849"} ]} , { "annotation": "[CHARACTERIZATION OF L-APP733,  MUTAGENESIS OF SER-656]", "conames": [{ "name": "PMID: 7737970", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7737970", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Prion Proteins,  PRNP protein,  human,  Prions,  9007-28-7 Chondroitin Sulfates,  Protein Precursors,  Amyloid,  DNA Primers,  Prnp protein,  mouse,  RNA,  Messenger,  Chondroitin Sulfate Proteoglycans]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor gene."} , { "attrname": "Abstract", "value": "Appicans are secreted and cell-associated chondroitin sulfate proteoglycans containing Alzheimer amyloid precursor (APP) as their core protein. Appicans are found in brain tissue,  and in cell cultures their expression depends on both cell type and growth conditions. Here we report that the core protein of appicans derives from an APP mRNA lacking exon 15. Splicing out of this exon creates a new consensus sequence for the attachment of a chondroitin sulfate chain in the resulting APP product. Transfection of C6 glioma or 293 kidney fibroblast cells with APP cDNAs containing exon 15 produced no appican,  while transfection with an APP cDNA lacking this exon induced high levels of appican production. Polymerase chain reactions indicated that appican-producing cells contained an APP mRNA species without exon 15,  whereas cells without this mRNA produced no appican. Site-directed mutagenesis combined with immunoreactivity experiments showed that the chondroitin sulfate chain is attached to a serine residue 16 amino acids upstream of the amino terminus of the A beta sequence of APP. The attachment of a glycosaminoglycan chain close to the A beta sequence of APP may affect the proteolytic processing of APP and production of A beta. The proteoglycan nature of APP suggests that addition of the chondroitin sulfate glycosaminoglycan is important for the implementation of the biological function of these proteins. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Prion Proteins,  Gene Expression,  Mutagenesis,  Site-Directed,  Alternative Splicing,  Exons,  Humans,  Molecular Sequence Data,  Rats,  Structure-Activity Relationship,  DNA Primers,  Chondroitin Sulfate Proteoglycans,  Animals,  Chondroitin Sulfates,  Base Sequence,  Prions,  Protein Precursors,  Protein Binding,  Amyloid,  Mice,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[M N Pangalos,  S Efthimiopoulos,  J Shioi,  N K Robakis]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF L-APP733,  MUTAGENESIS OF SER-656]"} ], "id": "776", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7737970", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.270.18.10388"} , { "elementOf": "NLM", "accession": "7737970"} ]} , { "annotation": "[VARIANT AD1 PHE-717]", "conames": [{ "name": "PMID: 1925564", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1925564", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is a form of localized amyloidosis characterized by cerebral cortical amyloid plaques,  neurofibrillary tangles,  and amyloid deposits within the walls of leptomeningeal vessels. Although most cases of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> are sporadic,  kindreds with autosomal-dominant inheritance of the syndrome suggest that a single mutation may be important in pathogenesis. Direct sequencing of DNA from a family with autopsy-proven <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> revealed a single amino acid substitution (Phe for Val) in the transmembrane domain of the amyloid precursor protein. This mutation correlates with the presence of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in all patients in this study,  and may be the inherited factor causing both amyloid fibril formation and dementia. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  DNA Mutational Analysis,  Exons,  Pedigree,  Base Sequence,  Humans,  Polymerase Chain Reaction,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Neurofibrillary Tangles,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J Murrell,  M Farlow,  B Ghetti,  M D Benson]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 PHE-717]"} ], "id": "777", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1925564", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1925564"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1925564"} ]} , { "annotation": "[VARIANT AD1 MET-715,  CHARACTERIZATION OF VARIANT AD1 MET-715]", "conames": [{ "name": "PMID: 10097173", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10097173", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[AE28F7PNPL Methionine,  Amyloid beta-Peptides,  Recombinant Proteins,  HG18B9YRS7 Valine,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "We have identified a novel beta amyloid precursor protein (betaAPP) mutation (V715M-betaAPP770) that cosegregates with early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) in a pedigree. Unlike other familial AD-linked betaAPP mutations reported to date,  overexpression of V715M-betaAPP in human HEK293 cells and murine neurons reduces total Abeta production and increases the recovery of the physiologically secreted product,  APPalpha. V715M-betaAPP significantly reduces Abeta40 secretion without affecting Abeta42 production in HEK293 cells. However,  a marked increase in N-terminally truncated Abeta ending at position 42 (x-42Abeta) is observed,  whereas its counterpart x-40Abeta is not affected. These results suggest that,  in some cases,  familial AD may be associated with a reduction in the overall production of Abeta but may be caused by increased production of truncated forms of Abeta ending at the 42 position. "} , { "attrname": "MeSH", "value": "[Cell Line,  Mutagenesis,  Site-Directed,  Humans,  Methionine,  Male,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Phenotype,  Transfection,  Pedigree,  Valine,  Age of Onset,  Amyloid beta-Peptides,  Female,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[K Ancolio,  C Dumanchin,  H Barelli,  J M Warter,  A Brice,  D Campion,  T Frbourg,  F Checler]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 MET-715,  CHARACTERIZATION OF VARIANT AD1 MET-715]"} ], "id": "778", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10097173", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10097173"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.96.7.4119"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-10]", "conames": [{ "name": "PMID: 3140222", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3140222", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nucleic acids research"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Protein Precursors,  Amyloid,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "A cDNA specifying the human amyloid beta precursor protein (ABPP) encodes a 95-kDa polypeptide."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Base Sequence,  DNA,  Humans,  Cloning,  Molecular,  Protein Precursors,  Molecular Sequence Data,  Amyloid,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S Mita,  J Sadlock,  J Herbert,  E A Schon]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-10]"} ], "id": "779", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3140222", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "3140222"} , { "elementOf": "DOI", "accession": "10.1093\/NAR\/16.19.9351"} ]} , { "annotation": "[INTERACTION WITH APBB2]", "conames": [{ "name": "PMID: 8855266", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8855266", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Apbb1 protein,  rat,  Nerve Tissue Proteins,  Recombinant Proteins,  APBB1 protein,  human,  Amyloid beta-Protein Precursor,  Nuclear Proteins]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein."} , { "attrname": "Abstract", "value": "We identified a novel human homologue of the rat FE65 gene,  hFE65L,  by screening the cytoplasmic domain of beta-amyloid precursor protein (beta PP) with the \"interaction trap.\" The cytoplasmic domains of the beta PP homologues,  APLP1 and APLP2 (amyloid precursor-like proteins),  were also tested for interaction with hFE65L. APLP2,  but not APLP1,  was found to interact with hFE65L. We confirmed these interactions in vivo by successfully coimmunoprecipatating endogenous beta PP and APLP2 from mammalian cells overexpressing a hemagglutinin-tagged fusion of the C-terminal region of hFE65L. We report the existence of a human FE65 gene family and evidence supporting specific interactions between members of the beta PP and FE65 protein families. Sequence analysis of the FE65 human gene family reveals the presence of two phosphotyrosine interaction (PI) domains. Our data show that a single PI domain is sufficient for binding of hFE65L to the cytoplasmic domain of beta PP and APLP2. The PI domain of the protein,  Shc,  is known to interact with the NPXYp motif found in the cytoplasmic domain of a number of different growth factor receptors. Thus,  it is likely that the PI domains present in the C-terminal moiety of the hFE65L protein bind the NPXY motif located in the cytoplasmic domain of beta PP and APLP2. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Gene Expression,  Multigene Family,  Humans,  Molecular Sequence Data,  Rats,  Nerve Tissue Proteins,  Recombinant Proteins,  Precipitin Tests,  Nuclear Proteins,  Sequence Homology,  Amino Acid,  Sequence Alignment,  Animals,  Cloning,  Molecular,  Protein Binding,  Amyloid beta-Protein Precursor,  Cytoplasm]"} , { "attrname": "AUTHORS", "value": "[S Y Gunette,  J Chen,  P D Jondro,  R E Tanzi]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APBB2]"} ], "id": "780", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8855266", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8855266"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.93.20.10832"} ]} , { "annotation": "[INTERACTION WITH APBA2]", "conames": [{ "name": "PMID: 9890987", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9890987", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Adaptor Proteins,  Signal Transducing,  Nerve Tissue Proteins,  APBA1 protein,  human,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Interaction of a neuron-specific protein containing PDZ domains with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein."} , { "attrname": "Abstract", "value": "A novel protein,  human X11-like (human X11L),  contains a phosphotyrosine interaction (PI) domain and two PDZ domains and displays 55.2% amino acid homology with the human X11 (human X11). The PI domain of human X11L interacts with a sequence containing the NPXY motif found in the cytoplasmic domain of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein. A construct lacking the carboxyl-terminal domain,  which comprises two PDZ domains (N + PI),  enhances PI binding to APP,  whereas another construct lacking an amino-terminal domain relative to PI domain (PI + C) suppresses PI binding to APP. Overexpression of full-length human X11L (N + PI + C) in cells that express APP695 stably decreased the secretion of Abeta40 but not that of Abeta42. However,  overexpression of the PI domain alone and the N + PI construct in cells did not affect the secretion of Abeta despite their ability to bind to the cytoplasmic domain of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid precursor protein. These observations suggest that the amino-terminal domain regulates PI binding to APP and that the carboxyl-terminal domain containing PDZ motifs is essential to modulate APP processing. Because expression of the human X11L gene is specific to brain,  the present observations should contribute to shedding light on the molecular mechanism of APP processing in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Neurons,  Humans,  Molecular Sequence Data,  Chromosome Mapping,  Nerve Tissue Proteins,  Chromosomes,  Human,  Pair 9,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Adaptor Proteins,  Signal Transducing,  Animals,  Cloning,  Molecular,  Protein Binding,  Protein Processing,  Post-Translational,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[S Tomita,  T Ozaki,  H Taru,  S Oguchi,  S Takeda,  Y Yagi,  S Sakiyama,  Y Kirino,  T Suzuki]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APBA2]"} ], "id": "781", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9890987", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.274.4.2243"} , { "elementOf": "NLM", "accession": "9890987"} ]} , { "annotation": "[VARIANT AD1 ILE-714,  CHARACTERIZATION OF VARIANT AD1 ILE-714,  MUTAGENESIS OF VAL-717]", "conames": [{ "name": "PMID: 11063718", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11063718", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Peptide Fragments,  amyloid beta-protein (1-42),  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Amyloidogenic processing of the amyloid precursor protein (APP) with deposition in brain of the 42 amino acid long amyloid beta-peptide (A beta(42)) is considered central to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) pathology. However,  it is generally believed that nonfibrillar pre-amyloid A beta(42) deposits have to mature in the presence of A beta(40) into fibrillar amyloid plaques to cause neurodegeneration. Here,  we describe an aggressive form of AD caused by a novel missense mutation in APP (T714I) directly involving gamma-secretase cleavages of APP. The mutation had the most drastic effect on A beta(42)\/A beta(40) ratio in vitro of approximately 11-fold,  simultaneously increasing A beta(42) and decreasing A beta(40) secretion,  as measured by matrix-assisted laser disorption ionization time-of-flight mass spectrometry. This coincided in brain with deposition of abundant and predominant nonfibrillar pre-amyloid plaques composed primarily of N-truncated A beta(42) in complete absence of A beta(40). These data indicate that N-truncated A beta(42) as diffuse nonfibrillar plaques has an essential but undermined role in AD pathology. Importantly,  inhibiting secretion of full-length A beta(42 )by therapeutic targeting of APP processing should not result in secretion of an equally toxic N-truncated A beta(42). "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Cell Line,  Peptide Fragments,  Enzyme-Linked Immunosorbent Assay,  Humans,  Solubility,  Male,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Plaque,  Amyloid,  Transfection,  Pedigree,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Female,  Protein Processing,  Post-Translational,  Spectrometry,  Mass,  Matrix-Assisted Laser Desorption-Ionization,  Endopeptidases,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[S Kumar-Singh,  C De Jonghe,  M Cruts,  R Kleinert,  R Wang,  M Mercken,  B De Strooper,  H Vanderstichele,  A Lfgren,  I Vanderhoeven,  H Backhovens,  E Vanmechelen,  P M Kroisel,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-714,  CHARACTERIZATION OF VARIANT AD1 ILE-714,  MUTAGENESIS OF VAL-717]"} ], "id": "782", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11063718", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/HMG\/9.18.2589"} , { "elementOf": "NLM", "accession": "11063718"} ]} , { "annotation": "[VARIANT AD1 ALA-714]", "conames": [{ "name": "PMID: 12034808", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12034808", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "An Iranian family with Alzheimer's disease caused by a novel APP mutation (Thr714Ala)."} , { "attrname": "MeSH", "value": "[Iran,  Pedigree,  Humans,  Middle Aged,  Female,  Male,  Aged,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Analysis,  DNA,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[P Pasalar,  H Najmabadi,  A R Noorian,  B Moghimi,  A Jannati,  A Soltanzadeh,  T Krefft,  R Crook,  J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ALA-714]"} ], "id": "783", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12034808", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.58.10.1574"} , { "elementOf": "NLM", "accession": "12034808"} ]} , { "annotation": "[VARIANT AD1 PRO-723]", "conames": [{ "name": "PMID: 10665499", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10665499", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  amyloid beta-protein (1-42),  amyloid beta-protein (1-43),  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Novel Leu723Pro amyloid precursor protein mutation increases amyloid beta42(43) peptide levels and induces apoptosis."} , { "attrname": "Abstract", "value": "A novel missense mutation,  Leu723Pro,  in the amyloid precursor protein (APP) gene was discovered in an early-onset Alzheimer's disease family. Expression of L723P mutant APP complementary DNA in CHO cells resulted in a 1.4- to 1.9-fold increased production of the 42(43)-amino acid length amyloid beta peptide compared with the wild-type sequence and was capable of causing apoptosis. The mutation is predicted to alter the luminal transmembrane length and helical arrangement of the APP molecule and thus affect the gamma-secretase cleavage site. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cricetinae,  Peptide Fragments,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  Mutation,  Missense,  Animals,  Pedigree,  Base Sequence,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  Apoptosis,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[J B Kwok,  Q X Li,  M Hallupp,  S Whyte,  D Ames,  K Beyreuther,  C L Masters,  P R Schofield]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 PRO-723]"} ], "id": "784", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10665499", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10665499"} , { "elementOf": "DOI", "accession": "10.1002\/1531-8249(200002)47: 2<249: : AID-ANA18>3.0.CO;2-8"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH AGER]", "conames": [{ "name": "PMID: 19901339", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19901339", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.7.11.22 Mok protein,  mouse,  EC 2.7.11.24 Mitogen-Activated Protein Kinases,  EC 2.7.11.24 p38 Mitogen-Activated Protein Kinases,  Amyloid beta-Peptides]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction."} , { "attrname": "Abstract", "value": "Intracellular amyloid-beta peptide (Abeta) has been implicated in neuronal death associated with Alzheimer's disease. Although Abeta is predominantly secreted into the extracellular space,  mechanisms of Abeta transport at the level of the neuronal cell membrane remain to be fully elucidated. We demonstrate that receptor for advanced glycation end products (RAGE) contributes to transport of Abeta from the cell surface to the intracellular space. Mouse cortical neurons exposed to extracellular human Abeta subsequently showed detectable peptide intracellularly in the cytosol and mitochondria by confocal microscope and immunogold electron microscopy. Pretreatment of cultured neurons from wild-type mice with neutralizing antibody to RAGE,  and neurons from RAGE knockout mice displayed decreased uptake of Abeta and protection from Abeta-mediated mitochondrial dysfunction. Abeta activated p38 MAPK,  but not SAPK\/JNK,  and then stimulated intracellular uptake of Abeta-RAGE complex. Similar intraneuronal co-localization of Abeta and RAGE was observed in the hippocampus of transgenic mice overexpressing mutant amyloid precursor protein. These findings indicate that RAGE contributes to mechanisms involved in the translocation of Abeta from the extracellular to the intracellular space,  thereby enhancing Abeta cytotoxicity. "} , { "attrname": "MeSH", "value": "[Mitogen-Activated Protein Kinases,  Brain,  Signal Transduction,  Neurons,  Humans,  Mice,  Inbred C57BL,  Cells,  Cultured,  Mice,  Transgenic,  Mice,  Knockout,  Mitochondria,  Animals,  Biological Transport,  Amyloid beta-Peptides,  Mice,  Enzyme Activation,  p38 Mitogen-Activated Protein Kinases]"} , { "attrname": "AUTHORS", "value": "[Kazuhiro Takuma,  Fang Fang,  Wensheng Zhang,  Shiqiang Yan,  Emiko Fukuzaki,  Heng Du,  Alexander Sosunov,  Guy McKhann,  Yoko Funatsu,  Noritaka Nakamichi,  Taku Nagai,  Hiroyuki Mizoguchi,  Daisuke Ibi,  Osamu Hori,  Satoshi Ogawa,  David M Stern,  Kiyofumi Yamada,  Shirley Shidu Yan]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH AGER]"} ], "id": "785", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19901339", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19901339"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0905686106"} ]} , { "annotation": "[VARIANT CAA-APP VAL-705]", "conames": [{ "name": "PMID: 16178030", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16178030", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[GMW67QNF9C Leucine,  Amyloid beta-Peptides,  HG18B9YRS7 Valine,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy."} , { "attrname": "Abstract", "value": "Mutations in AbetaPP cause deposition of Abeta amyloid fibrils in brain parenchyma and cerebral vessels,  resulting in Alzheimer's disease (AD) and\/or cerebral amyloid angiopathy (CAA). We report a novel mutation (L705V) within the Abeta sequence of AbetaPP in a family with autosomal dominant,  recurrent intracerebral hemorrhages. Pathological examination disclosed severe CAA,  without parenchymal amyloid plaques or neurofibrillary tangles. This variant highlights the vascular tropism of mutated Abeta,  resulting in CAA instead of the pathological hallmarks of AD. "} , { "attrname": "MeSH", "value": "[Brain,  Humans,  Family Health,  Tomography,  X-Ray Computed,  Leucine,  Neurofibrillary Tangles,  Cerebral Amyloid Angiopathy,  Familial,  Blotting,  Northern,  DNA Mutational Analysis,  Pedigree,  Valine,  Amyloid beta-Peptides,  Mutation,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Laura Obici,  Andrea Demarchi,  Giulia de Rosa,  Vittorio Bellotti,  Sabrina Marciano,  Simona Donadei,  Eloisa Arbustini,  Giovanni Palladini,  Marta Diegoli,  Egidio Genovese,  Giancarlo Ferrari,  Sergio Coverlizza,  Giampaolo Merlini]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CAA-APP VAL-705]"} ], "id": "786", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16178030", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16178030"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20571"} ]} , { "annotation": "[INTERACTION WITH APBB1]", "conames": [{ "name": "PMID: 18468999", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18468999", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[H2AFX protein,  human,  Histones,  gamma-H2AX protein,  mouse,  Nerve Tissue Proteins,  506T60A25R Sorbitol,  8L70Q75FXE Adenosine Triphosphate,  APBB1 protein,  human,  Apbb1 protein,  mouse,  Amyloid beta-Protein Precursor,  Nuclear Proteins,  Sweetening Agents]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Regulation of FE65 nuclear translocation and function by amyloid beta-protein precursor in osmotically stressed cells."} , { "attrname": "Abstract", "value": "FE65,  a neural adaptor protein,  interacts with amyloid beta-protein precursor (APP) and is known to regulate amyloid beta generation from APP. FE65 also associates with nuclear proteins; however,  its physiological function in the nucleus remains unclear. A fixed population of cytoplasmic FE65 is tethered to membranes by binding APP. This membrane-tethered FE65 is liberated from membranes by APP phosphorylation,  which is facilitated by a stress-activated protein kinase in sorbitol-treated cells. Here we show that liberated FE65,  which is distinct from \"virgin\" FE65 in the cytoplasm,  translocates into the nucleus and accumulates in the nuclear matrix forming a patched structure. Targeting of FE65 into the nuclear matrix was suppressed by the APP intracellular domain fragment,  which is generated by consecutive cleavages of APP. Thus,  nuclear translocation of FE65 is under the regulation of APP. In the nucleus,  FE65 induced gammaH2AX,  which plays an important role in DNA repair as a cellular response by stress-damaged cells. These observations suggest that APP-regulated FE65 plays an important role in the early stress response of cells and that FE65 deregulated from APP induces apoptosis. "} , { "attrname": "MeSH", "value": "[Sorbitol,  Osmotic Pressure,  Humans,  Nerve Tissue Proteins,  Adenosine Triphosphate,  Nuclear Proteins,  Nuclear Matrix,  Animals,  DNA Repair,  Cell Line,  Tumor,  Histones,  Mice,  Active Transport,  Cell Nucleus,  Amyloid beta-Protein Precursor,  Cytoplasm,  Apoptosis,  Sweetening Agents]"} , { "attrname": "AUTHORS", "value": "[Tadashi Nakaya,  Tomoko Kawai,  Toshiharu Suzuki]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APBB1]"} ], "id": "787", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18468999", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "18468999"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M801827200"} ]} , { "annotation": "[VARIANT AD1 THR-713]", "conames": [{ "name": "PMID: 15365148", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15365148", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Codon,  EC 3.4.- Endopeptidases,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene."} , { "attrname": "Abstract", "value": "Three members of an Italian family with autosomal dominant dementia and multiple strokes had the A713T mutation of the APP gene. The neuropathologic examination of the proband disclosed <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) with severe cerebral amyloid angiopathy and multiple infarcts. This indicates that the A713T mutation of the APP gene,  lying at the gamma-secretase cleavage site,  can be responsible for AD with symptomatic cerebral amyloid angiopathy. "} , { "attrname": "MeSH", "value": "[Brain,  Humans,  Middle Aged,  Male,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Progression,  Magnetic Resonance Imaging,  Point Mutation,  Cerebral Infarction,  Codon,  Genes,  Dominant,  DNA Mutational Analysis,  Pedigree,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Cerebral Amyloid Angiopathy,  Female,  Italy,  Endopeptidases,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[G Rossi,  G Giaccone,  R Maletta,  M Morbin,  R Capobianco,  M Mangieri,  A R Giovagnoli,  A Bizzi,  C Tomaino,  M Perri,  M Di Natale,  F Tagliavini,  O Bugiani,  A C Bruni]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 THR-713]"} ], "id": "788", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15365148", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000137048.80666.86"} , { "elementOf": "NLM", "accession": "15365148"} ]} , { "annotation": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]", "conames": [{ "name": "PMID: 3035574", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3035574", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  9007-49-2 DNA,  Amyloid,  EC 3.1.21.- DNA Restriction Enzymes]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides."} , { "attrname": "Abstract", "value": "Deposits of amyloid fibers are found in large numbers in the walls of blood vessels and in neuritic plaques in the brains of patients with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and adults with Down syndrome. We used the amino acid sequence of the amyloid peptide to synthesize oligonucleotide probes specific for the gene encoding this peptide. When a human brain cDNA library was screened with this probe,  a clone was found with a 1.7-kilobase insert that contains a long open reading frame coding for 412 amino acid residues including the 28 amino acids of the amyloid peptide. RNA gel blots revealed that a 3.3-kilobase mRNA species was present in the brains of individuals with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  with Down syndrome,  or with no apparent neurological disorders. Southern blots showed that homologous genes are present in the genomic DNA of humans,  rabbits,  sheep,  hamsters,  and mice,  suggesting that this gene has been conserved through mammalian evolution. Localization of the corresponding genomic sequences on human chromosome 21 suggests a genetic relationship between <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and Down syndrome,  and it may explain the early appearance of large numbers of neuritic plaques in adult Down syndrome patients. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Axons,  Brain,  Oligodeoxyribonucleotides,  DNA Restriction Enzymes,  Base Sequence,  DNA,  Genes,  Humans,  Cloning,  Molecular,  Amyloid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[N K Robakis,  N Ramakrishna,  G Wolfe,  H M Wisniewski]"} , { "attrname": "PUB_TYPE", "value": "[PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM APP695)]"} ], "id": "789", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3035574", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.84.12.4190"} , { "elementOf": "NLM", "accession": "3035574"} ]} , { "annotation": "[PHOSPHORYLATION BY MAPK10,  MUTAGENESIS OF THR-743]", "conames": [{ "name": "PMID: 11146006", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11146006", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.24 Mitogen-Activated Protein Kinases,  Isoenzymes,  EC 2.7.11.- Glycogen Synthase Kinases,  EC 2.7.10.1 Protein-Tyrosine Kinases,  Recombinant Fusion Proteins,  EC 2.7.1.- Mitogen-Activated Protein Kinase 10,  EC 2.7.11.17 Calcium-Calmodulin-Dependent Protein Kinases,  EC 2.7.11.22 Cyclin-Dependent Kinases,  2ZD004190S Threonine,  108688-71-7 neurofilament protein H,  EC 2.7.11.1 Cyclin-Dependent Kinase 5,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  Neurofilament Proteins,  EC 2.7.11.24 Mitogen-Activated Protein Kinase 1,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of thr(668) in the cytoplasmic domain of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3)."} , { "attrname": "Abstract", "value": "Threonine(668) (thr(668)) within the carboxy-terminus of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid precursor protein (APP) is a known in vivo phosphorylation site. Phosphorylation of APPthr(668) is believed to regulate APP function and metabolism. Thr(668) precedes a proline,  which suggests that it is targeted for phosphorylation by proline-directed kinase(s). We have investigated the ability of four major neuronally active proline-directed kinases,  cyclin dependent protein kinase-5,  glycogen synthase kinase-3 beta,  p42 mitogen-activated protein kinase and stress-activated protein kinase-1b,  to phosphorylate APPthr(668) and report here that SAPK1b induces robust phosphorylation of this site both in vitro and in vivo. This finding provides a molecular framework to link cellular stresses with APP metabolism in both normal and <span style=\"background-color: yellow\"><b>disease<\/b><\/span> states. "} , { "attrname": "MeSH", "value": "[Mitogen-Activated Protein Kinases,  Protein Structure,  Tertiary,  Cricetinae,  Phosphorylation,  Threonine,  Isoenzymes,  Glycogen Synthase Kinase 3,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Calcium-Calmodulin-Dependent Protein Kinases,  Recombinant Fusion Proteins,  Cyclin-Dependent Kinase 5,  Glycogen Synthase Kinases,  Animals,  Mitogen-Activated Protein Kinase 10,  Transfection,  Neurofilament Proteins,  Cyclin-Dependent Kinases,  Mitogen-Activated Protein Kinase 1,  Protein-Tyrosine Kinases,  Binding Sites,  COS Cells,  Amyloid beta-Protein Precursor,  CHO Cells]"} , { "attrname": "AUTHORS", "value": "[C L Standen,  J Brownlees,  A J Grierson,  S Kesavapany,  K F Lau,  D M McLoughlin,  C C Miller]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION BY MAPK10,  MUTAGENESIS OF THR-743]"} ], "id": "790", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11146006", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1046\/J.1471-4159.2001.00102.X"} , { "elementOf": "NLM", "accession": "11146006"} ]} , { "annotation": "[SUBUNIT]", "conames": [{ "name": "PMID: 11438549", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11438549", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[K848JZ4886 Cysteine,  Cross-Linking Reagents,  9007-34-5 Collagen,  Disulfides,  Recombinant Proteins,  Amyloid beta-Protein Precursor,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "We reported previously that the carbohydrate domain of the amyloid precursor protein is involved in amyloid precursor protein (APP)-APP interactions. Functional in vitro studies suggested that this interaction occurs through the collagen binding site of APP. The physiological significance remained unknown,  because it is not understood whether and how APP dimerization occurs in vivo. Here we report that cellular APP exists as homodimers matching best with a two-site model. Consistent with our published crystallographic data,  we show that a deletion of the entire sequence after the kunitz protease inhibitor domain did not abolish APP homodimerization,  suggesting that two domains are critically involved but that neither is essential for homodimerization. Finally,  we generated stabilized dimers by expressing mutant APP with a single cysteine in the ectodomain juxtamembrane region. Mutation of Lys(624) to cysteine produced approximately 6-8-fold more A beta than cells expressing normal APP. Our results suggest that amyloid A beta production can in principle be positively regulated by dimerization in vivo. We suggest that dimerization could be a physiologically important mechanism for regulating the proposed signal activity of APP. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Cell Membrane,  Cross-Linking Reagents,  Cysteine,  Mutagenesis,  Site-Directed,  Signal Transduction,  Humans,  Disulfides,  Immunoblotting,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Animals,  Transfection,  Lysine,  Collagen,  Protein Binding,  Mutation,  Tumor Cells,  Cultured,  Chromatography,  Gel,  Binding Sites,  COS Cells,  Dimerization,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[S Scheuermann,  B Hambsch,  L Hesse,  J Stumm,  C Schmidt,  D Beher,  T A Bayer,  K Beyreuther,  G Multhaup]"} , { "attrname": "PUB_TYPE", "value": "[SUBUNIT]"} ], "id": "791", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11438549", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11438549"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M105410200"} ]} , { "annotation": "[INTERACTION WITH APBA1 AND APBB1,  MUTAGENESIS OF TYR-728; TYR-757; ASN-759 AND TYR-762]", "conames": [{ "name": "PMID: 8887653", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8887653", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular and cellular biology"} , { "attrname": "Chemical", "value": "[Adaptor Proteins,  Signal Transducing,  Proto-Oncogene Proteins c-myc,  21820-51-9 Phosphotyrosine,  Nerve Tissue Proteins,  Recombinant Proteins,  APBA1 protein,  human,  APBB1 protein,  human,  Amyloid beta-Protein Precursor,  Nuclear Proteins]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein."} , { "attrname": "Abstract", "value": "The phosphotyrosine interaction (PI) domains (also known as the PTB,  or phosphotyrosine binding,  domains) of Shc and IRS-1 are recently described domains that bind peptides phosphorylated on tyrosine residues. The PI\/PTB domains differ from Src homology 2 (SH2) domains in that their binding specificity is determined by residues that lie amino terminal and not carboxy terminal to the phosphotyrosine. Recently,  it has been appreciated that other cytoplasmic proteins also contain PI domains. We now show that the PI domain of X11 and one of the PI domains of FE65,  two neuronal proteins,  bind to the cytoplasmic domain of the amyloid precursor protein ((beta)APP). (beta)APP is an integral transmembrane glycoprotein whose cellular function is unknown. One of the processing pathways of (beta)APP leads to the secretion of A(beta),  the major constituent of the amyloid deposited in the brain parenchyma and vessel walls of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patients. We have found that the X11 PI domain binds a YENPTY motif in the intracellular domain of (beta)APP that is strikingly similar to the NPXY motifs that bind the Shc and IRS-1 PI\/PTB domains. However,  unlike the case for binding of the Shc PI\/PTB domain,  tyrosine phosphorylation of the YENPTY motif is not required for the binding of (beta)APP to X11 or FE65. The binding site of the FE65 PI domain appears to be different from that of X11,  as mutations within the YENPTY motif differentially affect the binding of X11 and FE65. Using site-directed mutagenesis,  we have identified a crucial residue within the PI domain involved in X11 and FE65 binding to (beta)APP. The binding of X11 or FE65 PI domains to residues of the YENPTY motif of (beta)APP identifies PI domains as general protein interaction domains and may have important implications for the processing of (beta)APP. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Cell Line,  Proto-Oncogene Proteins c-myc,  Neurons,  Humans,  Phosphotyrosine,  Molecular Sequence Data,  Nerve Tissue Proteins,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Kidney,  Nuclear Proteins,  src Homology Domains,  Adaptor Proteins,  Signal Transducing,  Transfection,  Genetic Vectors,  Binding Sites,  Friedreich Ataxia,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[J P Borg,  J Ooi,  E Levy,  B Margolis]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH APBA1 AND APBB1,  MUTAGENESIS OF TYR-728; TYR-757; ASN-759 AND TYR-762]"} ], "id": "792", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8887653", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8887653"} ]} , { "annotation": "[INTERACTION WITH ITM2C]", "conames": [{ "name": "PMID: 19366692", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19366692", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[APLP2 protein,  human,  Membrane Proteins,  ITM2B protein,  human,  Amyloid,  Nerve Tissue Proteins,  BRI3 protein,  human,  Membrane Glycoproteins,  Codon,  Terminator,  DNA Primers,  Itm2b protein,  mouse,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is characterized by senile plaques,  which are mainly composed of beta amyloid (Abeta) peptides. Abeta is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing:  beta-secretase,  followed by gamma-secretase. Here,  we show that BRI3,  a member of the BRI gene family that includes the familial British and Danish dementia gene BRI2,  interacts with APP and serves as an endogenous negative regulator of Abeta production. BRI3 colocalizes with APP along neuritis in differentiated N2a cells; endogenous BRI3-APP complexes are readily detectable in mouse brain extract; reducing endogenous BRI3 levels by RNA interference results in increased Abeta secretion. BRI3 resembles BRI2,  because BRI3 overexpression reduces both alpha- and beta-APP cleavage. We propose that BRI3 inhibits the various processing of APP by blocking the access of alpha- and beta-secretases to APP. However,  unlike BRI2,  the binding of BRI3 to the beta-secretase cleaved APP C-terminal fragment is negligible and BRI3 does not cause the massive accumulation of this APP fragment,  suggesting that,  unlike BRI2,  BRI3 is a poor gamma-cleavage inhibitor. Competitive inhibition of APP processing by BRI3 may provide a new approach to AD therapy and prevention. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Middle Aged,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Kidney,  Membrane Proteins,  Animals,  Transfection,  Cloning,  Molecular,  Protein Binding,  Amyloid,  Mice,  HeLa Cells,  Membrane Glycoproteins,  Mutation,  Codon,  Terminator,  Amyloid beta-Protein Precursor,  Dementia]"} , { "attrname": "AUTHORS", "value": "[Shuji Matsuda,  Yukiko Matsuda,  Luciano D'Adamio]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH ITM2C]"} ], "id": "793", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19366692", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19366692"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M109.006403"} ]} , { "annotation": "[VARIANT AD1 ILE-717]", "conames": [{ "name": "PMID: 1671712", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1671712", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Amyloid beta-Peptides,  Protein Precursors,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Segregation of a missense mutation in the amyloid precursor protein gene with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "A locus segregating with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) has been mapped to chromosome 21,  close to the amyloid precursor protein (APP) gene. Recombinants between the APP gene and the AD locus have been reported which seemed to exclude it as the site of the mutation causing familial AD. But recent genetic analysis of a large number of AD families has demonstrated that the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is heterogeneous. Families with late-onset AD do not show linkage to chromosome 21 markers. Some families with early-onset AD show linkage to chromosome 21 markers,  but some do not. This has led to the suggestion that there is non-allelic genetic heterogeneity even within early onset familial AD. To avoid the problems that heterogeneity poses for genetic analysis,  we have examined the cosegregation of AD and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy. Here we demonstrate that in this kindred,  which shows linkage to chromosome 21 markers,  there is a point mutation in the APP gene. This mutation causes an amino-acid substitution (Val----Ile) close to the carboxy terminus of the beta-amyloid peptide. Screening other cases of familial AD revealed a second unrelated family in which this variant occurs. This suggests that some cases of AD could be caused by mutations in the APP gene. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Genetic Testing,  Exons,  Humans,  Molecular Sequence Data,  Genotype,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Restriction Fragment Length,  Pedigree,  Base Sequence,  Amyloid beta-Peptides,  Polymerase Chain Reaction,  Protein Precursors,  Mutation,  Chromosomes,  Human,  Pair 21,  Amyloid beta-Protein Precursor,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[A Goate,  M C Chartier-Harlin,  M Mullan,  J Brown,  F Crawford,  L Fidani,  L Giuffra,  A Haynes,  N Irving,  L James]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-717]"} ], "id": "794", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1671712", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/349704A0"} , { "elementOf": "NLM", "accession": "1671712"} ]} , { "annotation": "[BETA-AMYLOID ZINC-BINDING,  MUTAGENESIS OF ARG-676; TYR-681 AND HIS-684]", "conames": [{ "name": "PMID: 10413512", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10413512", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Cations,  Divalent,  Solutions,  Amyloid beta-Peptides,  J41CSQ7QDS Zinc,  amyloid beta-protein (1-28),  4QD397987E Histidine,  Chelating Agents]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Metal ions such as Zn(2+) and Cu(2+) have been implicated in both the aggregation and neurotoxicity of the beta-amyloid (Abeta) peptide that is present in the brains of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s sufferers. Zinc ions in particular have been shown to induce rapid aggregation of Abeta. Rat Abeta binds zinc ions much less avidly than human Abeta,  and rats do not form cerebral Abeta amyloid. Rat Abeta differs from human Abeta by the substitution of Gly for Arg,  Phe for Tyr,  and Arg for His at positions 5,  10,  and 13,  respectively. Through the use of synthetic peptides corresponding to the first 28 residues of human Abeta,  rat Abeta,  and single-residue variations,  we use circular dichroism spectroscopy,  sedimentation assays,  and immobilized metal ion affinity chromatography to show that the substitution of Arg for His-13 is responsible for the different Zn(2+)-induced aggregation behavior of rat and human Abeta. The coordination of Zn(2+) to histidine-13 is critical to the zinc ion induced aggregation of Abeta. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Peptide Fragments,  Protein Structure,  Secondary,  Humans,  Molecular Sequence Data,  Rats,  Chromatography,  High Pressure Liquid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Zinc,  Dose-Response Relationship,  Drug,  Animals,  Histidine,  Cations,  Divalent,  Solutions,  Amyloid beta-Peptides,  Circular Dichroism,  Chelating Agents,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[S T Liu,  G Howlett,  C J Barrow]"} , { "attrname": "PUB_TYPE", "value": "[BETA-AMYLOID ZINC-BINDING,  MUTAGENESIS OF ARG-676; TYR-681 AND HIS-684]"} ], "id": "795", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10413512", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10413512"} , { "elementOf": "DOI", "accession": "10.1021\/BI990205O"} ]} , { "annotation": "[INTERACTION WITH ANKS1B]", "conames": [{ "name": "PMID: 15347684", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15347684", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Peptides,  Protein Isoforms,  ANKS1B protein,  human,  EC 1.13.12.- Luciferases,  EC 2.5.1.18 Glutathione Transferase,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  Carrier Proteins,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Amyloid-beta protein precursor (AbetaPP) intracellular domain-associated protein-1 proteins bind to AbetaPP and modulate its processing in an isoform-specific manner."} , { "attrname": "Abstract", "value": "The amyloid-beta protein precursor (AbetaPP) is a type I transmembrane molecule that undergoes several finely regulated cleavage events. The physiopathological relevance of AbetaPP derives from the fact that its aberrant processing strongly correlates with the onset of Alzheimer's disease (AD). AD is a neurodegenerative disorder characterized by neuronal cell death,  loss of synapses,  and deposition of misfolded protein plaques in the brain; the main constituent of these plaques is the amyloid-beta peptide,  a 40-42 amino-acid-long protein fragment derived by AbetaPP upon two sequential processing events. Mutations in the genes encoding for AbetaPP and some of the enzymes responsible for its processing are strongly associated with familial forms of early onset AD. Therefore,  the elucidation of the mechanisms underlying AbetaPP metabolism appears crucial to understanding the basis for the onset of AD. Apart from Abeta,  upon processing of AbetaPP other fragments are generated. The long extracellular domain is released in the extracellular space,  whereas the short cytoplasmic tail,  named AbetaPP intracellular domain (AID) is released intracellularly. AID appears be involved in several cellular processes,  apoptosis,  calcium homeostasis,  and transcriptional regulation. We have recently reported the cloning and characterization of different isoforms of AID associated protein-1 (AIDA-1),  a novel AID-binding protein. Here we further analyzed the interaction between several AIDA-1 isoforms and the cytoplasmic tail of AbetaPP. Our data demonstrated that the interaction between the two molecules is regulated by alternative splicing of the AIDA-1 proteins. Furthermore,  we provide data supporting a possible function for AIDA-1a as a modulator of AbetaPP processing. "} , { "attrname": "MeSH", "value": "[Brain,  Peptides,  Exons,  Humans,  Molecular Sequence Data,  Recombinant Fusion Proteins,  Tissue Distribution,  Transfection,  Time Factors,  Luciferases,  Gene Deletion,  Cloning,  Molecular,  Fluorescence Resonance Energy Transfer,  Transcription,  Genetic,  Glutathione Transferase,  Carrier Proteins,  Protein Structure,  Tertiary,  Cell Line,  Enzyme-Linked Immunosorbent Assay,  Neurons,  Blotting,  Western,  Amino Acid Motifs,  Animals,  Protein Isoforms,  Protein Binding,  Mice,  HeLa Cells,  Mutation,  Amyloid beta-Protein Precursor,  Cytoplasm,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Enrico Ghersi,  Cristiana Noviello,  Luciano D'Adamio]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH ANKS1B]"} ], "id": "796", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15347684", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M405329200"} , { "elementOf": "NLM", "accession": "15347684"} ]} , { "annotation": "[VARIANT AD1 GLY-693]", "conames": [{ "name": "PMID: 11528419", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11528419", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature neuroscience"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Culture Media,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "The 'Arctic' APP mutation (E693G) causes <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> by enhanced Abeta protofibril formation."} , { "attrname": "Abstract", "value": "Several pathogenic <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) mutations have been described,  all of which cause increased amyloid beta-protein (Abeta) levels. Here we present studies of a pathogenic amyloid precursor protein (APP) mutation,  located within the Abeta sequence at codon 693 (E693G),  that causes AD in a Swedish family. Carriers of this 'Arctic' mutation showed decreased Abeta42 and Abeta40 levels in plasma. Additionally,  low levels of Abeta42 were detected in conditioned media from cells transfected with APPE693G. Fibrillization studies demonstrated no difference in fibrillization rate,  but Abeta with the Arctic mutation formed protofibrils at a much higher rate and in larger quantities than wild-type (wt) Abeta. The finding of increased protofibril formation and decreased Abeta plasma levels in the Arctic AD may reflect an alternative pathogenic mechanism for AD involving rapid Abeta protofibril formation leading to accelerated buildup of insoluble Abeta intra- and\/or extracellularly. "} , { "attrname": "MeSH", "value": "[Cell Line,  Peptide Fragments,  Sweden,  Culture Media,  Pedigree,  Humans,  Middle Aged,  Amyloid beta-Peptides,  Heterozygote,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[C Nilsberth,  A Westlind-Danielsson,  C B Eckman,  M M Condron,  K Axelman,  C Forsell,  C Stenh,  J Luthman,  D B Teplow,  S G Younkin,  J Nslund,  L Lannfelt]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 GLY-693]"} ], "id": "797", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11528419", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NN0901-887"} , { "elementOf": "NLM", "accession": "11528419"} ]} , { "annotation": "[VARIANT AD1 ILE-714]", "conames": [{ "name": "PMID: 15668448", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15668448", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "An African American family with early-onset Alzheimer disease and an APP (T714I) mutation."} , { "attrname": "Abstract", "value": "The occurrence of an APP T174I mutation is described in a large American family of African descent with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The clinical characteristics were an unusually early onset of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (early 30s),  similar to a previously reported age at onset of this mutation in an Austrian family. Distinct from that family,  seizures and myoclonus were prominent features of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in this kindred. "} , { "attrname": "MeSH", "value": "[Point Mutation,  Genes,  Dominant,  Pedigree,  Humans,  Age of Onset,  African Americans,  Adult,  Female,  Male,  Mutation,  Missense,  Amyloid beta-Protein Precursor,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[T Edwards-Lee,  J M Ringman,  J Chung,  J Werner,  A Morgan,  P St George Hyslop,  P Thompson,  R Dutton,  A Mlikotic,  E Rogaeva,  J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 ILE-714]"} ], "id": "798", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15668448", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000149761.70566.3E"} , { "elementOf": "NLM", "accession": "15668448"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 672-723,  VARIANT AD1 ASN-678]", "conames": [{ "name": "PMID: 15201367", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15201367", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurology,  neurosurgery,  and psychiatry"} , { "attrname": "Chemical", "value": "[Carrier Proteins]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Novel amyloid precursor protein gene missense mutation (D678N) in probable familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "To describe a novel missense mutation,  Asp678Asn (D678N),  in the amyloid precursor protein (APP) gene in a Japanese pedigree of probable familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). The proband was a women of 72. Symptoms of dementia that fulfilled the criteria for probable <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> appeared at about 60 years of age,  and slowly worsened over more than 10 years without evident cerebrovascular complications,  either clinically or neuroradiologically. Polymerase chain reaction single strand conformational polymorphism (PCR-SSCP) analysis followed by sequence analysis was used to examine genomic DNA of the proband for mutations in the APP gene exons 16 and 17. Analysis of the APP exon 16 in the proband showed a GAC to AAC nucleotide substitution in codon 678 of the APP gene,  causing an amino acid substitution of Asp to Asn (D678N). Heterozygosity of the APP D678N mutation was found in the proband and in the demented elder sister. The production and accumulation of mutated Abeta (Asn7-Abeta) or the misfunction of D678N mutant APP may have pathogenic properties for the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in this pedigree. "} , { "attrname": "MeSH", "value": "[Brain,  Gene Expression,  Exons,  Humans,  Middle Aged,  Tomography,  Emission-Computed,  Single-Photon,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Reverse Transcriptase Polymerase Chain Reaction,  Atrophy,  Neuropsychological Tests,  Polymorphism,  Single-Stranded Conformational,  Magnetic Resonance Imaging,  Cognition Disorders,  Pedigree,  Polymerase Chain Reaction,  Aged,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Y Wakutani,  K Watanabe,  Y Adachi,  K Wada-Isoe,  K Urakami,  H Ninomiya,  T C Saido,  T Hashimoto,  T Iwatsubo,  K Nakashima]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 672-723,  VARIANT AD1 ASN-678]"} ], "id": "799", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15201367", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15201367"} , { "elementOf": "DOI", "accession": "10.1136\/JNNP.2003.010611"} ]} , { "annotation": "[REVIEW ON VARIANTS];", "conames": [{ "name": "PMID: 1363811", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1363811", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[Codon,  3KX376GY7L Glutamic Acid,  Amyloid beta-Peptides,  Glutamates,  0RH81L854J Glutamine]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Framing beta-amyloid."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Cerebrovascular Disorders,  Protein Structure,  Secondary,  Humans,  Molecular Sequence Data,  Genotype,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Glutamic Acid,  Phenotype,  Codon,  Amyloid beta-Peptides,  Mutation,  Glutamates,  Glutamine]"} , { "attrname": "AUTHORS", "value": "[J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "800", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1363811", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NG0792-233"} , { "elementOf": "NLM", "accession": "1363811"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP695)]", "conames": [{ "name": "PMID: 2783775", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2783775", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nucleic acids research"} , { "attrname": "Chemical", "value": "[Protein Precursors,  EC 3.1.21.4 TCGA-specific type II deoxyribonucleases,  Serum Amyloid A Protein,  EC 3.1.21.4 Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is characterized by the cerebral deposition of fibrillar aggregates of the amyloid A4 protein. Complementary DNA's coding for the precursor of the amyloid A4 protein have been described. In order to identify the structure of the precursor gene relevant clones from several human genomic libraries were isolated. Sequence analysis of the various clones revealed 16 exons to encode the 695 residue precursor protein (PreA4(695] of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid A4 protein. The DNA sequence coding for the amyloid A4 protein is interrupted by an intron. This finding supports the idea that amyloid A4 protein arises by incomplete proteolysis of a larger precursor,  and not by aberrant splicing. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Gene Amplification,  Exons,  Introns,  Base Sequence,  Humans,  Cloning,  Molecular,  Protein Precursors,  Molecular Sequence Data,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Serum Amyloid A Protein,  Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "AUTHORS", "value": "[H G Lemaire,  J M Salbaum,  G Multhaup,  J Kang,  R M Bayney,  A Unterbeck,  K Beyreuther,  B Mller-Hill]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM APP695)]"} ], "id": "801", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2783775", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2783775"} , { "elementOf": "DOI", "accession": "10.1093\/NAR\/17.2.517"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 287-344]", "conames": [{ "name": "PMID: 2125487", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2125487", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Protease Inhibitors,  Amyloid beta-Peptides,  Protein Precursors,  Serine Proteinase Inhibitors,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "X-ray crystal structure of the protease inhibitor domain of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid beta-protein precursor."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s amyloid beta-protein precursor contains a Kunitz protease inhibitor domain (APPI) potentially involved in proteolytic events leading to cerebral amyloid deposition. To facilitate the identification of the physiological target of the inhibitor,  the crystal structure of APPI has been determined and refined to 1.5-A resolution. Sequences in the inhibitor-protease interface of the correct protease target will reflect the molecular details of the APPI structure. While the overall tertiary fold of APPI is very similar to that of the Kunitz inhibitor BPTI,  a significant rearrangement occurs in the backbone conformation of one of the two protease binding loops. A number of Kunitz inhibitors have similar loop sequences,  indicating the structural alteration is conserved and potentially an important determinant of inhibitor specificity. In a separate region of the protease binding loops,  APPI side chains Met-17 and Phe-34 create an exposed hydrophobic surface in place of Arg-17 and Val-34 in BPTI. The restriction this change places on protease target sequences is seen when the structure of APPI is superimposed on BPTI complexed to serine proteases,  where the hydrophobic surface of APPI faces a complementary group of nonpolar side chains on kallikrein A versus polar side chains on trypsin. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Protease Inhibitors,  Models,  Molecular,  Molecular Sequence Data,  Serine Proteinase Inhibitors,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Nucleic Acid,  X-Ray Diffraction,  Amyloid beta-Peptides,  Protein Precursors,  Protein Conformation,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[T R Hynes,  M Randal,  L A Kennedy,  C Eigenbrot,  A A Kossiakoff]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 287-344]"} ], "id": "802", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2125487", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI00495A002"} , { "elementOf": "NLM", "accession": "2125487"} ]} , { "annotation": "[INTERACTION WITH G(O)]", "conames": [{ "name": "PMID: 8446172", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8446172", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[EC 3.6.1.- GTP-Binding Proteins,  Oligodeoxyribonucleotides,  Receptor,  IGF Type 2,  Peptides,  37589-80-3 Guanosine 5'-O-(3-Thiotriphosphate),  Recombinant Proteins,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)"} , { "attrname": "Abstract", "value": "The most characteristic change in progressive dementia of Alzheimer's type is a tissue deposit of amyloid beta\/A4 protein,  which is derived from its precursor protein APP (ref.2). Structural alterations of APP are implicated in the pathogenesis of Alzheimer's disease,  but it is not known how they cause the disease. Although APP has a receptor-like architecture,  is located on the neuronal surface,  and has a conserved cytoplasmic domain,  no receptor function has been demonstrated for APP. Here we report that APP forms a complex with G(o),  a major GTP-binding protein in brain. The cytoplasmic APP sequence His 657-Lys 676 shows a specific G(o)-activating function and is necessary for complex formation. G(o) protein treated with GTP-gamma S lost the ability to associate with APP. This suggests that APP is a receptor coupled to G(o) and that abnormal APP-G(o) signalling is involved in the Alzheimer's disease process. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Oligodeoxyribonucleotides,  Molecular Weight,  Mutagenesis,  Site-Directed,  Receptor,  IGF Type 2,  Peptides,  Protein Structure,  Secondary,  Humans,  Molecular Sequence Data,  Recombinant Proteins,  Restriction Mapping,  Animals,  Guanosine 5'-O-(3-Thiotriphosphate),  Transfection,  Baculoviridae,  Insects,  Base Sequence,  Cloning,  Molecular,  GTP-Binding Proteins,  Kinetics,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[I Nishimoto,  T Okamoto,  Y Matsuura,  S Takahashi,  T Okamoto,  Y Murayama,  E Ogata]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH G(O)]"} ], "id": "803", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8446172", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/362075A0"} , { "elementOf": "NLM", "accession": "8446172"} ]} , { "annotation": "[VARIANT AD1 VAL-716]", "conames": [{ "name": "PMID: 9328472", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9328472", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  amyloid beta-protein (1-42),  amyloid beta-protein (1-43),  Amyloid beta-Peptides,  APP717,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43)."} , { "attrname": "Abstract", "value": "We report a novel mutation in the amyloid precursor protein gene (APP I716V) which probably leads to familial early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with an onset age in the mid 50s. Cells transfected with cDNAs bearing this mutation produce more A beta 1-42(43) than those transfected with wild-type APP and this effect is additive with that of the previously reported APP V717I mutation thus providing a novel approach for further increasing A beta 1-42(43) in model systems. "} , { "attrname": "MeSH", "value": "[Point Mutation,  Peptide Fragments,  Humans,  Middle Aged,  Age of Onset,  Amyloid beta-Peptides,  Female,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[C B Eckman,  N D Mehta,  R Crook,  J Perez-tur,  G Prihar,  E Pfeiffer,  N Graff-Radford,  P Hinder,  D Yager,  B Zenk,  L M Refolo,  C M Prada,  S G Younkin,  M Hutton,  J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 VAL-716]"} ], "id": "804", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9328472", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9328472"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/6.12.2087"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-770]", "conames": [{ "name": "PMID: 3810169", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3810169", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Characterization and chromosomal localization of a cDNA encoding brain amyloid of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Four clones were isolated from an adult human brain complementary DNA library with an oligonucleotide probe corresponding to the first 20 amino acids of the beta peptide of brain amyloid from <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The open reading frame of the sequenced clone coded for 97 amino acids,  including the known amino acid sequence of this polypeptide. The 3.5-kilobase messenger RNA was detected in mammalian brains and human thymus. The gene is highly conserved in evolution and has been mapped to human chromosome 21. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  DNA,  Humans,  Cloning,  Molecular,  Solubility,  Protein Conformation,  Transcription,  Genetic,  Amyloid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Chromosomes,  Human,  Pair 21,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[D Goldgaber,  M I Lerman,  O W McBride,  U Saffiotti,  D C Gajdusek]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 674-770]"} ], "id": "805", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3810169", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "3810169"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.3810169"} ]} , { "annotation": "[GLYCOSYLATION AT THR-633; THR-651; THR-652; SER-656; THR-663 AND SER-667 PROTEOLYTIC PROCESSING,  STRUCTURE OF CARBOHYDRATES,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 21712440", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21712440", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[42HK56048U Tyrosine,  2ZD004190S Threonine,  Amyloid beta-Peptides,  452VLY9402 Serine,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Site-specific characterization of threonine,  serine,  and tyrosine glycosylations of amyloid precursor protein\/amyloid beta-peptides in human cerebrospinal fluid."} , { "attrname": "Abstract", "value": "The proteolytic processing of human amyloid precursor protein (APP) into shorter aggregating amyloid ? (A?)-peptides,  e.g.,  A?1-42,  is considered a critical step in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). Although APP is a well-known membrane glycoprotein carrying both N- and O-glycans,  nothing is known about the occurrence of released APP\/A? glycopeptides in cerebrospinal fluid (CSF). We used the 6E10 antibody and immunopurified A? peptides and glycopeptides from CSF samples and then liquid chromatography-tandem mass spectrometry for structural analysis using collision-induced dissociation and electron capture dissociation. In addition to 33 unglycosylated APP\/A? peptides,  we identified 37 APP\/A? glycopeptides with sialylated core 1 like O-glycans attached to Thr(-39,  -21,  -20,  and -13),  in a series of APP\/A?X-15 glycopeptides,  where X was -63,  -57,  -52,  and -45,  in relation to Asp1 of the A? sequence. Unexpectedly,  we also identified a series of 27 glycopeptides,  the A?1-X series,  where X was 20 (DAEFRHDSGYEVHHQKLVFF),  19,  18,  17,  16,  and 15,  which were all uniquely glycosylated on Tyr10. The Tyr10 linked O-glycans were (Neu5Ac)(1-2)Hex(Neu5Ac)HexNAc-O- structures with the disialylated terminals occasionally O-acetylated or lactonized,  indicating a terminal Neu5Ac?2, 8Neu5Ac linkage. We could not detect any glycosylation of the A?1-38\/40\/42 isoforms. We observed an increase of up to 2.5 times of Tyr10 glycosylated A? peptides in CSF in six AD patients compared to seven non-AD patients. APP\/A? sialylated O-glycans,  including that of a Tyr residue,  the first in a mammalian protein,  may modulate APP processing,  inhibiting the amyloidogenic pathway associated with AD. "} , { "attrname": "MeSH", "value": "[Tyrosine,  Amino Acid Sequence,  Threonine,  Humans,  Serine,  Molecular Sequence Data,  Glycosylation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Tandem Mass Spectrometry,  Amyloid beta-Peptides,  Proteomics,  Chromatography,  Liquid,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Adnan Halim,  Gunnar Brinkmalm,  Ulla Retschi,  Ann Westman-Brinkmalm,  Erik Portelius,  Henrik Zetterberg,  Kaj Blennow,  Gran Larson,  Jonas Nilsson]"} , { "attrname": "PUB_TYPE", "value": "[GLYCOSYLATION AT THR-633; THR-651; THR-652; SER-656; THR-663 AND SER-667 PROTEOLYTIC PROCESSING,  STRUCTURE OF CARBOHYDRATES,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "806", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21712440", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.1102664108"} , { "elementOf": "NLM", "accession": "21712440"} ]} , { "annotation": "[VARIANT AD1 PHE-717]", "conames": [{ "name": "PMID: 8290042", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8290042", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Clinical characteristics in a kindred with early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene."} , { "attrname": "Abstract", "value": "Patients from five generations of a family developed presenile <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) early in the fifth decade. Recent memory,  information-processing speed,  sequential tracking,  and conceptual reasoning were the earliest cognitive functions affected. Language and visuoperceptual skills were largely spared early in the course of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Later,  there were progressive cognitive deficits and inability to perform the activities of daily living. Death occurred,  on average,  6 years after onset. Three autopsies in affected members revealed cerebral amyloid deposits and neurofibrillary tangles. Clinical and pathologic features were typical for familial AD. Direct DNA sequencing revealed a G-->T change at position 2149 of the amyloid precursor protein (APP) gene that resulted in the substitution of phenylalanine for valine in the transmembrane domain of the mature protein. This mutation was present in DNA from all four examined affected individuals and linked to the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a lod score of 3.25,  and was the most probable cause of AD in this family. "} , { "attrname": "MeSH", "value": "[Brain,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Neuropsychological Tests,  Pedigree,  Base Sequence,  DNA,  Age of Onset,  Adult,  Female,  Mutation,  Amyloid beta-Protein Precursor,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[M Farlow,  J Murrell,  B Ghetti,  F Unverzagt,  S Zeldenrust,  M Benson]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD1 PHE-717]"} ], "id": "807", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8290042", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.44.1.105"} , { "elementOf": "NLM", "accession": "8290042"} ]} , { "annotation": "[INTERACTION WITH MAPK8IP1,  MUTAGENESIS OF TYR-757]", "conames": [{ "name": "PMID: 11724784", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11724784", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[MAPK8IP1 protein,  human,  Adaptor Proteins,  Signal Transducing,  Mapk8ip protein,  mouse,  Recombinant Proteins,  EC 1.13.12.- Luciferases,  Amyloid beta-Protein Precursor,  Recombinant Fusion Proteins,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s beta-amyloid precursor protein (APP)."} , { "attrname": "Abstract", "value": "The familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> gene product amyloid beta precursor protein (APP) is sequentially processed by beta- and gamma-secretases to generate the Abeta peptide. The biochemical pathway leading to Abeta formation has been extensively studied since extracellular aggregates of Abeta peptides are considered the culprit of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Aside from its pathological relevance,  the biological role of APP processing is unknown. Cleavage of APP by gamma-secretase releases,  together with Abeta,  a COOH-terminal APP intracellular domain,  termed AID. This peptide has recently been identified in brain tissue of normal control and patients with sporadic <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We have previously shown that AID acts as a positive regulator of apoptosis. Nevertheless,  the molecular mechanism by which AID regulates this process remains unknown. Hoping to gain clues about the function of APP,  we used the yeast two-hybrid system to identify interaction between the AID region of APP and JNK-interacting protein-1 (JIP1). This molecular interaction is confirmed in vitro,  in vivo by fluorescence resonance energy transfer (FRET),  and in mouse brain lysates. These data provide a link between APP and its processing by gamma-secretase,  and stress kinase signaling pathways. These pathways are known regulators of apoptosis and may be involved in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Humans,  Molecular Sequence Data,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Recombinant Fusion Proteins,  Adaptor Proteins,  Signal Transducing,  Transfection,  Luciferases,  Cloning,  Molecular,  Binding Sites,  Saccharomyces cerevisiae,  Amyloid beta-Protein Precursor,  Cytoplasm,  Genes,  Reporter,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Meir H Scheinfeld,  Roberta Roncarati,  Pasquale Vito,  Peter A Lopez,  Mona Abdallah,  Luciano D'Adamio]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH MAPK8IP1,  MUTAGENESIS OF TYR-757]"} ], "id": "808", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11724784", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11724784"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M108357200"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 507-770]", "conames": [{ "name": "PMID: 2893379", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2893379", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[RNA Precursors,  9007-49-2 DNA,  Amyloid beta-Peptides,  DNA,  Recombinant,  24937-83-5 Poly A,  Amyloid,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1988"} , { "attrname": "AbstractHeader", "value": "Molecular cloning of amyloid cDNA derived from mRNA of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> brain:  coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex."} , { "attrname": "Abstract", "value": "To gain insight into factors associated with the excessive accumulation of beta-amyloid in the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) brain,  the present studies were initiated to distinguish between a unique primary structure of the AD-specific amyloid precursor mRNA vis a vis other determinants that may affect amyloid levels. Previous molecular cloning experiments focused on amyloid derived from sources other than AD cases. In the present work,  we cloned and characterized amyloid cDNA derived directly from AD brain mRNA. Poly(A)+ RNA from AD cortices was used for the preparation of lambda gt11 recombinant cDNA libraries. An insert of 1564 nucleotides was isolated that included the beta-amyloid domain and corresponded to 75% of the coding region and approximately equal to 70% of the 3'-noncoding region of the fetal precursor amyloid cDNA reported by others. On RNA blots,  the AD amyloid mRNA consisted of a doublet of 3.2 and 3.4 kilobases. In control and AD cases,  the amyloid mRNA levels were nonuniform and were independent of glial-specific mRNA levels. Based on the sequence analysis data,  we conclude that a segment of the amyloid gene is expressed in the AD cortex as a high molecular weight precursor mRNA with major coding and 3'-noncoding regions that are identical to the fetal brain gene product. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  RNA Precursors,  Humans,  Molecular Sequence Data,  Cerebral Cortex,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Base Sequence,  DNA,  Amyloid beta-Peptides,  DNA,  Recombinant,  Aged,  Amyloid,  RNA,  Messenger,  Poly A]"} , { "attrname": "AUTHORS", "value": "[S B Zain,  M Salim,  W G Chou,  E M Sajdel-Sulkowska,  R E Majocha,  C A Marotta]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 507-770]"} ], "id": "809", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2893379", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2893379"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.85.3.929"} ]} , { "annotation": "", "conames": [{ "name": "Lithium", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "5"} ], "id": "810", "contexts": { "context": { "id": 81} } , "evidences": ["Imported from database"], "value": "Lithium", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01356"} ]} , { "annotation": "", "conames": [{ "name": "Rifabutin", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "811", "contexts": { } , "evidences": ["Imported from database"], "value": "Rifabutin", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00615"} ]} , { "annotation": "", "conames": [{ "name": "Nedocromil", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "1"} ], "id": "812", "contexts": { } , "evidences": ["Imported from database"], "value": "Nedocromil", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00716"} ]} , { "annotation": "", "conames": [{ "name": "Vincristine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "1"} ], "id": "813", "contexts": { } , "evidences": ["Imported from database"], "value": "Vincristine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00541"} ]} , { "annotation": "", "conames": [{ "name": "Colchicine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "814", "contexts": { } , "evidences": ["Imported from database"], "value": "Colchicine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01394"} ]} , { "annotation": "", "conames": [{ "name": "Podofilox", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "815", "contexts": { } , "evidences": ["Imported from database"], "value": "Podofilox", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01179"} ]} , { "annotation": "", "conames": [{ "name": "Vinblastine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "816", "contexts": { } , "evidences": ["Imported from database"], "value": "Vinblastine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00570"} ]} , { "annotation": "", "conames": [{ "name": "Vinorelbine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "817", "contexts": { } , "evidences": ["Imported from database"], "value": "Vinorelbine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00361"} ]} , { "annotation": "", "conames": [{ "name": "Clodronate", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "818", "contexts": { } , "evidences": ["Imported from database"], "value": "Clodronate", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00720"} ]} , { "annotation": "", "conames": [{ "name": "Adenosine triphosphate", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "3"} ], "id": "819", "contexts": { } , "evidences": ["Imported from database"], "value": "Adenosine triphosphate", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00171"} ]} , { "annotation": "", "conames": [{ "name": "Vindesine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "820", "contexts": { } , "evidences": ["Imported from database"], "value": "Vindesine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00309"} ]} , { "annotation": "", "conames": [{ "name": "Cabazitaxel", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "821", "contexts": { } , "evidences": ["Imported from database"], "value": "Cabazitaxel", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB06772"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4,  AUTOSOMAL DOMINANT; PARK4", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "605543", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "822", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4,  AUTOSOMAL DOMINANT; PARK4", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "605543"} ]} , { "annotation": "", "conames": [{ "name": "DEMENTIA,  LEWY BODY; DLB", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "127750", "attributes": [], "id": "823", "contexts": { } , "evidences": ["Imported from database"], "value": "DEMENTIA,  LEWY BODY; DLB", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "127750"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 1,  AUTOSOMAL DOMINANT; PARK1", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "168601", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "824", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 1,  AUTOSOMAL DOMINANT; PARK1", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "168601"} ]} , { "annotation": "Interacting selectively and non-covalently with magnesium (Mg) ions. ( Reference:  GOC: ai )", "conames": [{ "name": "magnesium ion binding", "isPreferred": "true"} , { "name": "magnesium binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000287", "attributes": [], "id": "825", "contexts": { } , "evidences": ["Imported from database"], "value": "magnesium binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000287"} ]} , { "annotation": "Interacting selectively and non-covalently with ferrous iron,  Fe(II). ( Reference:  GOC: ai )", "conames": [{ "name": "ferrous iron binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008198", "attributes": [], "id": "826", "contexts": { } , "evidences": ["Imported from database"], "value": "ferrous iron binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008198"} ]} , { "annotation": "Interacting selectively and non-covalently with Hsp70 proteins,  any of a group of heat shock proteins around 70kDa in size. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "Hsp70 protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030544", "attributes": [], "id": "827", "contexts": { } , "evidences": ["Imported from database"], "value": "Hsp70 protein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030544"} ]} , { "annotation": "Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA,  which may be a gene,  cistron,  or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. ( Reference:  GOC: jl GOC: txnOH SO: 0005836 )", "conames": [{ "name": "transcription regulatory region DNA binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044212", "attributes": [], "id": "828", "contexts": { } , "evidences": ["Imported from database"], "value": "transcription regulatory region DNA binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044212"} ]} , { "annotation": "Interacting selectively and non-covalently and stoichiometrically with kinesin,  a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation. ( Reference:  GOC: curators PMID: 8606779 )", "conames": [{ "name": "kinesin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019894", "attributes": [], "id": "829", "contexts": { } , "evidences": ["Imported from database"], "value": "kinesin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019894"} ]} , { "annotation": "Interacting selectively and non-covalently with phospholipids,  a class of lipids containing phosphoric acid as a mono- or diester. ( Reference:  ISBN: 0198506732 );", "conames": [{ "name": "phospholipid binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005543", "attributes": [], "id": "830", "contexts": { } , "evidences": ["Imported from database"], "value": "phospholipid binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005543"} ]} , { "annotation": "Interacting selectively and non-covalently with the microtubule constituent protein alpha-tubulin. ( Reference:  GOC: jl )", "conames": [{ "name": "alpha-tubulin binding", "isPreferred": "true"} , { "name": "alpha tubulin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043014", "attributes": [], "id": "831", "contexts": { } , "evidences": ["Imported from database"], "value": "alpha tubulin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043014"} ]} , { "annotation": "Interacting selectively and non-covalently with calcium ions (Ca2+). ( Reference:  GOC: ai )", "conames": [{ "name": "calcium ion storage", "isPreferred": "false"} , { "name": "calcium ion binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005509", "attributes": [], "id": "832", "contexts": { } , "evidences": ["Imported from database"], "value": "calcium ion binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005509"} ]} , { "annotation": "Catalysis of an oxidation-reduction (redox) reaction,  a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized,  while the other acts as hydrogen or electron acceptor and becomes reduced. ( Reference:  GOC: go_curators )", "conames": [{ "name": "oxidoreductase activity", "isPreferred": "true"} , { "name": "oxidoreductase activity,  acting on other substrates", "isPreferred": "false"} , { "name": "redox", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016491", "attributes": [], "id": "833", "contexts": { } , "evidences": ["Imported from database"], "value": "redox", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016491"} ]} , { "annotation": "Interacting selectively and non-covalently with tau protein. tau is a microtubule-associated protein,  implicated in Alzheimer's disease,  Down Syndrome and ALS. ( Reference:  GOC: jid )", "conames": [{ "name": "tau protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048156", "attributes": [], "id": "834", "contexts": { } , "evidences": ["Imported from database"], "value": "tau protein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048156"} ]} , { "annotation": "Interacting selectively and non-covalently with dynein,  the multisubunit protein complex that is associated with microtubules. ( Reference:  GOC: bf )", "conames": [{ "name": "dynein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045502", "attributes": [], "id": "835", "contexts": { } , "evidences": ["Imported from database"], "value": "dynein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045502"} ]} , { "annotation": "Interacting selectively and non-covalently with copper (Cu) ions. ( Reference:  GOC: ai )", "conames": [{ "name": "copper ion binding", "isPreferred": "true"} , { "name": "copper\/cadmium binding", "isPreferred": "false"} , { "name": "copper binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005507", "attributes": [], "id": "836", "contexts": { } , "evidences": ["Imported from database"], "value": "copper binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005507"} ]} , { "annotation": "Stops,  prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis PMID: 14744432 Wikipedia: Caspase )", "conames": [{ "name": "cysteine-type endopeptidase inhibitor activity involved in apoptotic process", "isPreferred": "true"} , { "name": "caspase inhibitor", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043027", "attributes": [], "id": "837", "contexts": { } , "evidences": ["Imported from database"], "value": "cysteine-type endopeptidase inhibitor activity involved in apoptotic process", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043027"} ]} , { "annotation": "Interacting selectively and non-covalently with a phosphorylated protein. ( Reference:  GOC: ai )", "conames": [{ "name": "phosphorylated protein binding", "isPreferred": "true"} , { "name": "phosphoprotein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051219", "attributes": [], "id": "838", "contexts": { } , "evidences": ["Imported from database"], "value": "phosphoprotein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051219"} ]} , { "annotation": "Interacting selectively and non-covalently with a histone,  any of a group of water-soluble proteins found in association with the DNA of plant and animal chromosomes. They are involved in the condensation and coiling of chromosomes during cell division and have also been implicated in nonspecific suppression of gene activity. ( Reference:  GOC: jl )", "conames": [{ "name": "histone-specific chaperone", "isPreferred": "false"} , { "name": "histone binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042393", "attributes": [], "id": "839", "contexts": { } , "evidences": ["Imported from database"], "value": "histone binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042393"} ]} , { "annotation": "Interacting selectively and non-covalently with zinc (Zn) ions. ( Reference:  GOC: ai )", "conames": [{ "name": "zinc binding", "isPreferred": "true"} , { "name": "zinc ion binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008270", "attributes": [], "id": "840", "contexts": { } , "evidences": ["Imported from database"], "value": "zinc binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008270"} ]} , { "annotation": "An intracellular organelle,  about 200 A in diameter,  consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits,  one large and one small,  each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients,  expressed in Svedberg units (symbol:  S). Hence,  the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit,  while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation,  namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes,  eukaryotes,  mitochondria,  and chloroplasts have characteristically distinct ribosomal proteins. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "ribosomal RNA", "isPreferred": "false"} , { "name": "ribosome", "isPreferred": "true"} , { "name": "membrane bound ribosome", "isPreferred": "false"} , { "name": "free ribosome", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005840", "attributes": [], "id": "841", "contexts": { } , "evidences": ["Imported from database"], "value": "ribosome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0033279"} , { "elementOf": "GO", "accession": "GO: 0005840"} ]} , { "annotation": "The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. ( Reference:  GOC: jl ISBN: 0395825172 ISBN: 0815316194 )", "conames": [{ "name": "actin cytoskeleton", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0015629", "attributes": [], "id": "842", "contexts": { } , "evidences": ["Imported from database"], "value": "actin cytoskeleton", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0015629"} ]} , { "annotation": "Extracellular matrix material consisting of polysaccharides and protein. ( Reference:  PMID: 12704238 )", "conames": [{ "name": "fibril", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043205", "attributes": [], "id": "843", "contexts": { } , "evidences": ["Imported from database"], "value": "fibril", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043205"} ]} , { "annotation": "A secretory organelle,  typically 50 nm in diameter,  of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. ( Reference:  PMID: 10099709 PMID: 12563290 )", "conames": [{ "name": "docked vesicle", "isPreferred": "false"} , { "name": "synaptic vesicle", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008021", "attributes": [], "id": "844", "contexts": { } , "evidences": ["Imported from database"], "value": "synaptic vesicle", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008021"} ]} , { "annotation": "The lipid bilayer surrounding a cytoplasmic vesicle. ( Reference:  GOC: mah )", "conames": [{ "name": "cytoplasmic vesicle membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030659", "attributes": [], "id": "845", "contexts": { } , "evidences": ["Imported from database"], "value": "cytoplasmic vesicle membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030659"} ]} , { "annotation": "A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. ( Reference:  GOC: dos GOC: mah ISBN: 0815316194 )", "conames": [{ "name": "membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016020", "attributes": [], "id": "846", "contexts": { } , "evidences": ["Imported from database"], "value": "membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016020"} ]} , { "annotation": "The region of a cell that lies just beneath the plasma membrane and often,  but not always,  contains a network of actin filaments and associated proteins. ( Reference:  GOC: mah ISBN: 0815316194 )", "conames": [{ "name": "peripheral cytoplasm", "isPreferred": "false"} , { "name": "cell periphery", "isPreferred": "false"} , { "name": "cell cortex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005938", "attributes": [], "id": "847", "contexts": { } , "evidences": ["Imported from database"], "value": "cell cortex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005938"} ]} , { "annotation": "The outer,  i.e. cytoplasm-facing,  lipid bilayer of the nuclear envelope; continuous with the endoplasmic reticulum of the cell and sometimes studded with ribosomes. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "perinuclear membrane", "isPreferred": "true"} , { "name": "nuclear outer membrane", "isPreferred": "true"} , { "name": "outer envelope", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005640", "attributes": [], "id": "848", "contexts": { } , "evidences": ["Imported from database"], "value": "perinuclear membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005640"} ]} , { "annotation": "The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins),  the proteins of the lysosomes,  or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "RER", "isPreferred": "true"} , { "name": "rough endoplasmic reticulum", "isPreferred": "true"} , { "name": "rough ER", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005791", "attributes": [], "id": "849", "contexts": { } , "evidences": ["Imported from database"], "value": "RER", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005791"} ]} , { "annotation": "A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells,  the nucleus contains all of the cell's chromosomes except the organellar chromosomes,  and is the site of RNA synthesis and processing. In some species,  or in specialized cell types,  RNA metabolism or DNA replication may be absent. ( Reference:  GOC: go_curators )", "conames": [{ "name": "cell nucleus", "isPreferred": "true"} , { "name": "nucleus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005634", "attributes": [], "id": "850", "contexts": { } , "evidences": ["Imported from database"], "value": "nucleus", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005634"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an iron(II) ion stimulus. ( Reference:  GOC: sm )", "conames": [{ "name": "response to iron(II) ion", "isPreferred": "true"} , { "name": "response to iron(II)", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010040", "attributes": [], "id": "851", "contexts": { } , "evidences": ["Imported from database"], "value": "response to iron(II)", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010040"} ]} , { "annotation": "A metabolic process that results in the removal or addition of one or more electrons to or from a substance,  with or without the concomitant removal or addition of a proton or protons. ( Reference:  GOC: dhl GOC: ecd GOC: jh2 GOC: jid GOC: mlg GOC: rph )", "conames": [{ "name": "oxidation-reduction process", "isPreferred": "true"} , { "name": "oxidation reduction", "isPreferred": "true"} , { "name": "oxidoreductase process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0055114", "attributes": [], "id": "852", "contexts": { } , "evidences": ["Imported from database"], "value": "oxidation reduction", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0055114"} ]} , { "annotation": "Any process that stops or reduces the activity of a monooxygenase. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of monooxygenase activity", "isPreferred": "true"} , { "name": "down-regulation of monooxygenase", "isPreferred": "true"} , { "name": "down regulation of monooxygenase", "isPreferred": "true"} , { "name": "inhibition of monooxygenase", "isPreferred": "false"} , { "name": "downregulation of monooxygenase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032769", "attributes": [], "id": "853", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of monooxygenase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032769"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of extracellular fibrils,  extracellular matrix material consisting of polysaccharides and or proteins. ( Reference:  GOC: mlg GOC: pr )", "conames": [{ "name": "extracellular fibril organisation", "isPreferred": "true"} , { "name": "fibril organization", "isPreferred": "false"} , { "name": "extracellular fibril organization", "isPreferred": "true"} , { "name": "extracellular fibril organization and biogenesis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043206", "attributes": [], "id": "854", "contexts": { } , "evidences": ["Imported from database"], "value": "extracellular fibril organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043206"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of norepinephrine into a cell. ( Reference:  GOC: ai )", "conames": [{ "name": "negative regulation of norepinephrine uptake", "isPreferred": "true"} , { "name": "negative regulation of levarterenol uptake", "isPreferred": "true"} , { "name": "downregulation of norepinephrine uptake", "isPreferred": "true"} , { "name": "down-regulation of norepinephrine uptake", "isPreferred": "true"} , { "name": "negative regulation of noradrenaline uptake", "isPreferred": "true"} , { "name": "negative regulation of norepinephrine import", "isPreferred": "true"} , { "name": "down regulation of norepinephrine uptake", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051622", "attributes": [], "id": "855", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of norepinephrine uptake", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051622"} ]} , { "annotation": "The chemical reactions and pathways involving fatty acids,  aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "fatty acid metabolic process", "isPreferred": "true"} , { "name": "fatty acid metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006631", "attributes": [], "id": "856", "contexts": { } , "evidences": ["Imported from database"], "value": "fatty acid metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006631"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of microtubule polymerization. ( Reference:  GOC: mah )", "conames": [{ "name": "down-regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "negative regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "down regulation of microtubule polymerization", "isPreferred": "true"} , { "name": "downregulation of microtubule polymerization", "isPreferred": "true"} , { "name": "inhibition of microtubule polymerization", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031115", "attributes": [], "id": "857", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of microtubule polymerization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031115"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of synaptic vesicle recycling. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 22745285 )", "conames": [{ "name": "regulation of synaptic vesicle recycling", "isPreferred": "true"} , { "name": "regulation of kiss-and-run synaptic vesicle recycling", "isPreferred": "false"} , { "name": "regulation of kiss-and-stay synaptic vesicle recycling", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903421", "attributes": [], "id": "858", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synaptic vesicle recycling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903421"} ]} , { "annotation": "The directed movement of dopamine into a presynaptic neuron or glial cell. In this context,  dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: ai )", "conames": [{ "name": "dopamine import involved in synaptic transmission", "isPreferred": "true"} , { "name": "dopamine uptake involved in synaptic transmission", "isPreferred": "true"} , { "name": "dopamine reuptake involved in synaptic transmission", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051583", "attributes": [], "id": "859", "contexts": { } , "evidences": ["Imported from database"], "value": "dopamine uptake involved in synaptic transmission", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051583"} ]} , { "annotation": "The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine,  chemokine,  cellular ligand,  or soluble factor. ( Reference:  GOC: mgi_curators PMID: 10626665 PMID: 10695728 PMID: 12580336 PMID: 9893949 )", "conames": [{ "name": "microglial cell activation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001774", "attributes": [], "id": "860", "contexts": { } , "evidences": ["Imported from database"], "value": "microglial cell activation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001774"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone,  and released by certain neurons to act as a neurotransmitter active in the central nervous system. ( Reference:  CHEBI: 33568 GOC: BHF GOC: mah )", "conames": [{ "name": "cellular response to adrenaline stimulus", "isPreferred": "true"} , { "name": "cellular response to epinephrine stimulus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0071872", "attributes": [], "id": "861", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to adrenaline stimulus", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0071872"} ]} , { "annotation": "A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. ( Reference:  GOC: bf GOC: mah GOC: signaling PMID: 15006537 PMID: 19643732 )", "conames": [{ "name": "receptor internalization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031623", "attributes": [], "id": "862", "contexts": { } , "evidences": ["Imported from database"], "value": "receptor internalization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031623"} ]} , { "annotation": "Any process that results in a change in state or activity of an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. ( Reference:  GOC: add ISBN: 0721601464 )", "conames": [{ "name": "response to LPS", "isPreferred": "true"} , { "name": "response to endotoxin", "isPreferred": "false"} , { "name": "response to lipopolysaccharide", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032496", "attributes": [], "id": "863", "contexts": { } , "evidences": ["Imported from database"], "value": "response to LPS", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032496"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a magnesium ion stimulus. ( Reference:  GOC: mah );", "conames": [{ "name": "response to magnesium ion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032026", "attributes": [], "id": "864", "contexts": { } , "evidences": ["Imported from database"], "value": "response to magnesium ion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032026"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of cell death by apoptotic process in neurons. ( Reference:  GOC: go_curators GOC: mtg_apoptosis )", "conames": [{ "name": "negative regulation of programmed cell death,  neurons", "isPreferred": "true"} , { "name": "negative regulation of neuron apoptotic process", "isPreferred": "true"} , { "name": "down regulation of neuron apoptosis", "isPreferred": "true"} , { "name": "inhibition of neuron apoptosis", "isPreferred": "false"} , { "name": "down-regulation of neuron apoptosis", "isPreferred": "true"} , { "name": "negative regulation of neuron apoptosis", "isPreferred": "false"} , { "name": "neuron survival", "isPreferred": "false"} , { "name": "downregulation of neuron apoptosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043524", "attributes": [], "id": "865", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of neuron apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043524"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of phospholipase activity,  the hydrolysis of a phospholipid. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conames": [{ "name": "regulation of phospholipase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010517", "attributes": [], "id": "866", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of phospholipase activity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010517"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of cell death by apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conames": [{ "name": "anti-apoptosis", "isPreferred": "true"} , { "name": "down regulation of apoptosis", "isPreferred": "true"} , { "name": "inhibition of apoptosis", "isPreferred": "false"} , { "name": "pro-survival", "isPreferred": "false"} , { "name": "negative regulation of apoptosis", "isPreferred": "false"} , { "name": "down-regulation of apoptosis", "isPreferred": "true"} , { "name": "apoptosis inhibitor", "isPreferred": "false"} , { "name": "downregulation of apoptosis", "isPreferred": "true"} , { "name": "negative regulation of apoptotic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043066", "attributes": [], "id": "867", "contexts": { } , "evidences": ["Imported from database"], "value": "anti-apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006916"} , { "elementOf": "GO", "accession": "GO: 0043066"} ]} , { "annotation": "The chemical reactions and pathways resulting in the formation of dopamine,  a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: jl ISBN: 0198506732 )", "conames": [{ "name": "dopamine anabolism", "isPreferred": "true"} , { "name": "dopamine biosynthesis", "isPreferred": "true"} , { "name": "dopamine synthesis", "isPreferred": "true"} , { "name": "dopamine biosynthetic process", "isPreferred": "true"} , { "name": "dopamine formation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042416", "attributes": [], "id": "868", "contexts": { } , "evidences": ["Imported from database"], "value": "dopamine formation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042416"} ]} , { "annotation": "The transfer of electrons through a series of electron donors and acceptors,  generating energy that is ultimately used for synthesis of ATP,  as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane. ( Reference:  GOC: mtg_sensu ISBN: 0716731363 )", "conames": [{ "name": "organelle ATP synthesis coupled electron transport", "isPreferred": "false"} , { "name": "mitochondrial electron transport", "isPreferred": "false"} , { "name": "mitochondrial ATP synthesis coupled electron transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042775", "attributes": [], "id": "869", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial ATP synthesis coupled electron transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042775"} ]} , { "annotation": "Any process that increases the rate,  frequency,  or extent of protein serine threonine kinase activity. ( Reference:  GOC: mah )", "conames": [{ "name": "positive regulation of protein serine\/threonine kinase activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0071902", "attributes": [], "id": "870", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of protein serine\/threonine kinase activity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0071902"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. ( Reference:  GOC: ai )", "conames": [{ "name": "positive regulation of cytoplasmic release of sequestered calcium ion (Ca2+)", "isPreferred": "false"} , { "name": "up-regulation of release of sequestered calcium ion into cytosol", "isPreferred": "true"} , { "name": "positive regulation of release of sequestered calcium ion into cytosol", "isPreferred": "true"} , { "name": "up regulation of release of sequestered calcium ion into cytosol", "isPreferred": "true"} , { "name": "positive regulation of release of stored calcium ion (Ca2+) into cytosol", "isPreferred": "true"} , { "name": "activation of release of sequestered calcium ion into cytosol", "isPreferred": "false"} , { "name": "positive regulation of calcium mobilization", "isPreferred": "false"} , { "name": "positive regulation of release of stored calcium ion (Ca2+) into cytoplasm", "isPreferred": "false"} , { "name": "positive regulation of release of stored calcium ion (Ca2+)", "isPreferred": "false"} , { "name": "stimulation of release of sequestered calcium ion into cytosol", "isPreferred": "false"} , { "name": "upregulation of release of sequestered calcium ion into cytosol", "isPreferred": "true"} , { "name": "positive regulation of release of sequestered calcium ion (Ca2+)", "isPreferred": "false"} , { "name": "positive regulation of release of sequestered calcium ion into cytoplasm", "isPreferred": "false"} , { "name": "positive regulation of cytoplasmic release of stored calcium ion (Ca2+)", "isPreferred": "false"} , { "name": "positive regulation of cytosolic release of stored calcium ion (Ca2+)", "isPreferred": "true"} , { "name": "positive regulation of calcium ion (Ca2+) mobilization", "isPreferred": "false"} , { "name": "positive regulation of cytosolic release of sequestered calcium ion (Ca2+)", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051281", "attributes": [], "id": "871", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of release of sequestered calcium ion into cytosol", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051281"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an interleukin-1 stimulus. ( Reference:  GOC: BHF GOC: mah )", "conames": [{ "name": "response to IL-1", "isPreferred": "true"} , { "name": "response to interleukin-1", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070555", "attributes": [], "id": "872", "contexts": { } , "evidences": ["Imported from database"], "value": "response to IL-1", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070555"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the platelet-derived growth factor receptor signaling pathway. ( Reference:  GOC: dph GOC: hjd GOC: tb )", "conames": [{ "name": "negative regulation of platelet-derived growth factor receptor signalling pathway", "isPreferred": "true"} , { "name": "negative regulation of platelet-derived growth factor receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010642", "attributes": [], "id": "873", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of platelet-derived growth factor receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010642"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of glutathione peroxidase activity. ( Reference:  GO_REF: 0000059 GOC: bf GOC: PARL GOC: TermGenie PMID: 23507046 )", "conames": [{ "name": "up-regulation of selenium-glutathione peroxidase", "isPreferred": "true"} , { "name": "positive regulation of non-selenium glutathione peroxidase", "isPreferred": "false"} , { "name": "upregulation of non-selenium glutathione peroxidase", "isPreferred": "false"} , { "name": "activation of reduced glutathione peroxidase", "isPreferred": "false"} , { "name": "up-regulation of glutathione: hydrogen-peroxide oxidoreductase", "isPreferred": "true"} , { "name": "up-regulation of reduced glutathione peroxidase", "isPreferred": "true"} , { "name": "upregulation of glutathione: hydrogen-peroxide oxidoreductase", "isPreferred": "true"} , { "name": "up regulation of selenium-glutathione peroxidase", "isPreferred": "true"} , { "name": "upregulation of GSH peroxidase", "isPreferred": "true"} , { "name": "activation of non-selenium glutathione peroxidase", "isPreferred": "false"} , { "name": "up regulation of non-selenium glutathione peroxidase", "isPreferred": "false"} , { "name": "up regulation of glutathione peroxidase", "isPreferred": "true"} , { "name": "activation of GSH peroxidase", "isPreferred": "false"} , { "name": "up regulation of GSH peroxidase", "isPreferred": "true"} , { "name": "upregulation of reduced glutathione peroxidase", "isPreferred": "true"} , { "name": "activation of selenium-glutathione peroxidase", "isPreferred": "false"} , { "name": "up regulation of reduced glutathione peroxidase", "isPreferred": "true"} , { "name": "up-regulation of non-selenium glutathione peroxidase", "isPreferred": "false"} , { "name": "up regulation of glutathione: hydrogen-peroxide oxidoreductase", "isPreferred": "true"} , { "name": "activation of glutathione peroxidase", "isPreferred": "false"} , { "name": "upregulation of selenium-glutathione peroxidase", "isPreferred": "true"} , { "name": "positive regulation of glutathione peroxidase activity", "isPreferred": "true"} , { "name": "positive regulation of GSH peroxidase", "isPreferred": "true"} , { "name": "up-regulation of GSH peroxidase", "isPreferred": "true"} , { "name": "positive regulation of glutathione: hydrogen-peroxide oxidoreductase", "isPreferred": "true"} , { "name": "positive regulation of selenium-glutathione peroxidase", "isPreferred": "true"} , { "name": "up-regulation of glutathione peroxidase", "isPreferred": "true"} , { "name": "activation of glutathione: hydrogen-peroxide oxidoreductase", "isPreferred": "false"} , { "name": "positive regulation of reduced glutathione peroxidase", "isPreferred": "true"} , { "name": "enhancement of GPX", "isPreferred": "true"} , { "name": "upregulation of glutathione peroxidase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903284", "attributes": [], "id": "874", "contexts": { } , "evidences": ["Imported from database"], "value": "enhancement of GPX", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903284"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of thrombin receptor protein signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin receptor binding to one of its physiological ligands. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of thrombin receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of thrombin receptor signalling pathway", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070495", "attributes": [], "id": "875", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of thrombin receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070495"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of reactive oxygen species biosynthetic process. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 24252804 )", "conames": [{ "name": "regulation of reactive oxygen species anabolism", "isPreferred": "true"} , { "name": "regulation of reactive oxygen species biosynthesis", "isPreferred": "true"} , { "name": "regulation of reactive oxygen species generation", "isPreferred": "false"} , { "name": "regulation of reactive oxygen species biosynthetic process", "isPreferred": "true"} , { "name": "regulation of ROS formation", "isPreferred": "false"} , { "name": "regulation of ROS generation", "isPreferred": "false"} , { "name": "regulation of reactive oxygen species formation", "isPreferred": "true"} , { "name": "regulation of reactive oxygen species synthesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903426", "attributes": [], "id": "876", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of reactive oxygen species synthesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903426"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of endocytosis. ( Reference:  GOC: go_curators )", "conames": [{ "name": "up-regulation of endocytosis", "isPreferred": "true"} , { "name": "upregulation of endocytosis", "isPreferred": "true"} , { "name": "activation of endocytosis", "isPreferred": "false"} , { "name": "up regulation of endocytosis", "isPreferred": "true"} , { "name": "positive regulation of endocytosis", "isPreferred": "true"} , { "name": "stimulation of endocytosis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045807", "attributes": [], "id": "877", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of endocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045807"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon. ( Reference:  GOC: add ISBN: 0126896631 PMID: 15546383 )", "conames": [{ "name": "response to gamma-interferon", "isPreferred": "false"} , { "name": "response to interferon-gamma", "isPreferred": "true"} , { "name": "response to type II IFN", "isPreferred": "false"} , { "name": "response to immune interferon", "isPreferred": "true"} , { "name": "response to type II interferon", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034341", "attributes": [], "id": "878", "contexts": { } , "evidences": ["Imported from database"], "value": "response to interferon-gamma", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034341"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of cell death by apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conames": [{ "name": "stimulation of apoptosis", "isPreferred": "false"} , { "name": "up-regulation of apoptosis", "isPreferred": "true"} , { "name": "upregulation of apoptosis", "isPreferred": "true"} , { "name": "positive regulation of apoptotic process", "isPreferred": "true"} , { "name": "pro-apoptosis", "isPreferred": "false"} , { "name": "positive regulation of apoptosis", "isPreferred": "false"} , { "name": "activation of apoptosis", "isPreferred": "false"} , { "name": "up regulation of apoptosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043065", "attributes": [], "id": "879", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043065"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a synapse,  the junction between a neuron and a target (neuron,  muscle,  or secretory cell). ( Reference:  GOC: ai GOC: pr )", "conames": [{ "name": "synapse development", "isPreferred": "true"} , { "name": "synapse organization", "isPreferred": "true"} , { "name": "synapse organization and biogenesis", "isPreferred": "false"} , { "name": "synapse organisation", "isPreferred": "true"} , { "name": "synapse morphogenesis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050808", "attributes": [], "id": "880", "contexts": { } , "evidences": ["Imported from database"], "value": "synapse development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050808"} ]} , { "annotation": "Clathrin-mediated endocytosis of presynaptic membrane that recycles synaptic vesicle membrane and its components following synaptic vesicle exocytosis. This process starts with coating of the membrane with adaptor proteins and clathrin prior to invagination and ends when uncoating has finished. ( Reference:  GOC: jid GOC: lmg GOC: mah PMID: 20448150 )", "conames": [{ "name": "synaptic vesicle endocytosis", "isPreferred": "true"} , { "name": "synaptic vesicle retrieval", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048488", "attributes": [], "id": "881", "contexts": { } , "evidences": ["Imported from database"], "value": "synaptic vesicle endocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048488"} , { "elementOf": "GO", "accession": "GO: 0008099"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the regulated release of a neurotransmitter. ( Reference:  GOC: hjd )", "conames": [{ "name": "activation of neurotransmitter secretion", "isPreferred": "false"} , { "name": "up regulation of neurotransmitter secretion", "isPreferred": "true"} , { "name": "stimulation of neurotransmitter secretion", "isPreferred": "false"} , { "name": "up-regulation of neurotransmitter secretion", "isPreferred": "true"} , { "name": "upregulation of neurotransmitter secretion", "isPreferred": "true"} , { "name": "positive regulation of neurotransmitter secretion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001956", "attributes": [], "id": "882", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of neurotransmitter secretion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001956"} ]} , { "annotation": "The chemical reactions and pathways involving phospholipids,  any lipid containing phosphoric acid as a mono- or diester. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "phospholipid metabolic process", "isPreferred": "true"} , { "name": "phospholipid metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006644", "attributes": [], "id": "883", "contexts": { } , "evidences": ["Imported from database"], "value": "phospholipid metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006644"} ]} , { "annotation": "Any process that decreases the stability of a protein,  making it more vulnerable to degradative processes or aggregation. ( Reference:  GOC: mah )", "conames": [{ "name": "protein destabilization", "isPreferred": "true"} , { "name": "negative regulation of protein stability", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031648", "attributes": [], "id": "884", "contexts": { } , "evidences": ["Imported from database"], "value": "protein destabilization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031648"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the addition of an acetyl group to a histone protein. ( Reference:  GOC: bf )", "conames": [{ "name": "negative regulation of histone acetylation", "isPreferred": "true"} , { "name": "inhibition of histone acetylation", "isPreferred": "false"} , { "name": "down regulation of histone acetylation", "isPreferred": "true"} , { "name": "downregulation of histone acetylation", "isPreferred": "true"} , { "name": "down-regulation of histone acetylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035067", "attributes": [], "id": "885", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of histone acetylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035067"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the phosphorylation of peptidyl-serine. ( Reference:  GOC: mah )", "conames": [{ "name": "positive regulation of peptidyl-serine phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0033138", "attributes": [], "id": "886", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of peptidyl-serine phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0033138"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of mitochondrial electron transport,  NADH to ubiquinone. ( Reference:  GO_REF: 0000058 GOC: dph GOC: TermGenie PMID: 23530063 )", "conames": [{ "name": "inhibition of oxidative phosphorylation,  NADH to ubiquinone", "isPreferred": "false"} , { "name": "downregulation of mitochondrial electron transport,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "down-regulation of mitochondrial electron transport,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "negative regulation of complex I (NADH to ubiquinone)", "isPreferred": "false"} , { "name": "negative regulation of mitochondrial electron transport,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "inhibition of mitochondrial electron transport,  NADH to ubiquinone", "isPreferred": "false"} , { "name": "downregulation of oxidative phosphorylation,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "downregulation of complex I (NADH to ubiquinone)", "isPreferred": "false"} , { "name": "down regulation of complex I (NADH to ubiquinone)", "isPreferred": "false"} , { "name": "negative regulation of oxidative phosphorylation,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "down regulation of mitochondrial electron transport,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "down-regulation of complex I (NADH to ubiquinone)", "isPreferred": "false"} , { "name": "inhibition of complex I (NADH to ubiquinone)", "isPreferred": "false"} , { "name": "down-regulation of oxidative phosphorylation,  NADH to ubiquinone", "isPreferred": "true"} , { "name": "down regulation of oxidative phosphorylation,  NADH to ubiquinone", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902957", "attributes": [], "id": "887", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of oxidative phosphorylation,  NADH to ubiquinone", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902957"} ]} , { "annotation": "A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate,  or frequency of synaptic transmission at the synapse. ( Reference:  GOC: dgh GOC: dph )", "conames": [{ "name": "LTP", "isPreferred": "false"} , { "name": "long-term synaptic potentiation", "isPreferred": "true"} , { "name": "long-term potentiation", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060291", "attributes": [], "id": "888", "contexts": { } , "evidences": ["Imported from database"], "value": "long-term synaptic potentiation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060291"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. ( Reference:  GOC: jl GOC: mtg_apoptosis )", "conames": [{ "name": "negative regulation of caspase", "isPreferred": "false"} , { "name": "negative regulation of caspase activation", "isPreferred": "true"} , { "name": "down-regulation of caspase", "isPreferred": "true"} , { "name": "downregulation of caspase", "isPreferred": "true"} , { "name": "inhibition of caspase", "isPreferred": "false"} , { "name": "inhibition of caspase activation", "isPreferred": "false"} , { "name": "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process", "isPreferred": "true"} , { "name": "down regulation of caspase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043154", "attributes": [], "id": "889", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of caspase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001719"} , { "elementOf": "GO", "accession": "GO: 0043154"} ]} , { "annotation": "A process that modulates long-term neuronal synaptic plasticity,  the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers. ( Reference:  GOC: jid http: \/\/www.mercksource.com PMID: 11891290 )", "conames": [{ "name": "regulation of long-term neuronal synaptic plasticity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048169", "attributes": [], "id": "890", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of long-term neuronal synaptic plasticity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048169"} ]} , { "annotation": "A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease,  homeostasis,  and fertility,  as well as wear and tear. Aging includes cellular senescence,  but is more inclusive. May precede death (GO: 0016265) and may succeed developmental maturation (GO: 0021700). ( Reference:  GOC: PO_curators )", "conames": [{ "name": "ageing", "isPreferred": "true"} , { "name": "aging", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007568", "attributes": [], "id": "891", "contexts": { } , "evidences": ["Imported from database"], "value": "aging", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007568"} , { "elementOf": "GO", "accession": "GO: 0016280"} ]} , { "annotation": "Any process that stops or reduces the activity of a transporter. ( Reference:  GOC: mah )", "conames": [{ "name": "down-regulation of transporter", "isPreferred": "true"} , { "name": "downregulation of transporter", "isPreferred": "true"} , { "name": "negative regulation of transporter activity", "isPreferred": "true"} , { "name": "inhibition of transporter", "isPreferred": "false"} , { "name": "down regulation of transporter", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032410", "attributes": [], "id": "892", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of transporter", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032410"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of dopamine into a presynaptic neuron or glial cell. ( Reference:  GOC: ai )", "conames": [{ "name": "negative regulation of dopamine import involved in synaptic transmission", "isPreferred": "true"} , { "name": "down-regulation of dopamine uptake involved in synaptic transmission", "isPreferred": "true"} , { "name": "downregulation of dopamine uptake involved in synaptic transmission", "isPreferred": "true"} , { "name": "negative regulation of dopamine uptake involved in synaptic transmission", "isPreferred": "true"} , { "name": "down regulation of dopamine uptake involved in synaptic transmission", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051585", "attributes": [], "id": "893", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of dopamine uptake involved in synaptic transmission", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051585"} ]} , { "annotation": "Any process that modulates the frequency or rate of macrophage activation. ( Reference:  GOC: jl )", "conames": [{ "name": "regulation of macrophage activation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043030", "attributes": [], "id": "894", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of macrophage activation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043030"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of exocytosis. ( Reference:  GOC: go_curators )", "conames": [{ "name": "inhibition of exocytosis", "isPreferred": "false"} , { "name": "downregulation of exocytosis", "isPreferred": "true"} , { "name": "negative regulation of exocytosis", "isPreferred": "true"} , { "name": "down-regulation of exocytosis", "isPreferred": "true"} , { "name": "down regulation of exocytosis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045920", "attributes": [], "id": "895", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of exocytosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045920"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the chemical reactions and pathways involving dopamine. ( Reference:  GOC: go_curators )", "conames": [{ "name": "inhibition of dopamine metabolic process", "isPreferred": "false"} , { "name": "downregulation of dopamine metabolic process", "isPreferred": "true"} , { "name": "negative regulation of dopamine metabolism", "isPreferred": "true"} , { "name": "down regulation of dopamine metabolic process", "isPreferred": "true"} , { "name": "down-regulation of dopamine metabolic process", "isPreferred": "true"} , { "name": "negative regulation of dopamine metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045963", "attributes": [], "id": "896", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of dopamine metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045963"} ]} , { "annotation": "Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. ( Reference:  GOC: al GOC: dph GOC: jl GOC: mtg_apoptosis GOC: tb PMID: 14744432 PMID: 18328827 Wikipedia: Caspase )", "conames": [{ "name": "activation of cysteine-type endopeptidase activity involved in apoptotic process", "isPreferred": "true"} , { "name": "activation of caspase", "isPreferred": "false"} , { "name": "activation of metacaspase", "isPreferred": "false"} , { "name": "caspase activation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006919", "attributes": [], "id": "897", "contexts": { } , "evidences": ["Imported from database"], "value": "caspase activation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006919"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis,  treatment or prevention of a disease. ( Reference:  GOC: jl )", "conames": [{ "name": "drug susceptibility\/resistance", "isPreferred": "false"} , { "name": "response to drug", "isPreferred": "true"} , { "name": "drug resistance", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042493", "attributes": [], "id": "898", "contexts": { } , "evidences": ["Imported from database"], "value": "response to drug", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0017035"} , { "elementOf": "GO", "accession": "GO: 0042493"} ]} , { "annotation": "Any process that results in a change in the behavior of an organism as a result of a cocaine stimulus. ( Reference:  GOC: jid )", "conames": [{ "name": "behavioural response to cocaine", "isPreferred": "true"} , { "name": "behavioral response to cocaine", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048148", "attributes": [], "id": "899", "contexts": { } , "evidences": ["Imported from database"], "value": "behavioral response to cocaine", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048148"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a copper ion stimulus. ( Reference:  GOC: mah )", "conames": [{ "name": "cellular response to copper", "isPreferred": "true"} , { "name": "cellular response to copper ion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0071280", "attributes": [], "id": "900", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to copper", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0071280"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the directed movement of serotonin into a cell. ( Reference:  GOC: ai )", "conames": [{ "name": "negative regulation of serotonin uptake", "isPreferred": "true"} , { "name": "negative regulation of 5HT uptake", "isPreferred": "true"} , { "name": "negative regulation of 5-HT uptake", "isPreferred": "true"} , { "name": "negative regulation of 5-hydroxytryptamine uptake", "isPreferred": "true"} , { "name": "negative regulation of serotonin import", "isPreferred": "true"} , { "name": "down regulation of serotonin uptake", "isPreferred": "true"} , { "name": "down-regulation of serotonin uptake", "isPreferred": "true"} , { "name": "downregulation of serotonin uptake", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051612", "attributes": [], "id": "901", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of 5HT uptake", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051612"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of transcription from an RNA polymerase II promoter. ( Reference:  GOC: go_curators GOC: txnOH )", "conames": [{ "name": "negative regulation of gene-specific transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "inhibition of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "negative regulation of transcription from Pol II promoter", "isPreferred": "true"} , { "name": "inhibition of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "negative regulation of global transcription from Pol II promoter", "isPreferred": "false"} , { "name": "downregulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "down regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "negative regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "down regulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "down-regulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "downregulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "negative regulation of transcription from RNA polymerase II promoter,  global", "isPreferred": "false"} , { "name": "down-regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000122", "attributes": [], "id": "902", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of transcription from Pol II promoter", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010553"} , { "elementOf": "GO", "accession": "GO: 0000122"} , { "elementOf": "GO", "accession": "GO: 0045816"} ]} , { "annotation": "Any process that increases the rate,  frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate,  1, 2, 3, 4, 5, 6-cyclohexanehexol,  with one or more phosphate groups attached. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "positive regulation of inositol phosphate biosynthetic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060732", "attributes": [], "id": "903", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of inositol phosphate biosynthetic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060732"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an fibroblast growth factor stimulus. ( Reference:  GOC: jl GOC: yaf )", "conames": [{ "name": "cellular response to FGF stimulus", "isPreferred": "true"} , { "name": "cellular response to fibroblast growth factor stimulus", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044344", "attributes": [], "id": "904", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to FGF stimulus", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044344"} ]} , { "annotation": "The chemical reactions and pathways involving neutral lipids,  lipids only soluble in solvents of very low polarity. ( Reference:  ISBN: 0198547684 )", "conames": [{ "name": "neutral lipid metabolic process", "isPreferred": "true"} , { "name": "neutral lipid metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006638", "attributes": [], "id": "905", "contexts": { } , "evidences": ["Imported from database"], "value": "neutral lipid metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006638"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the regulated release of dopamine. ( Reference:  GOC: ef )", "conames": [{ "name": "regulation of dopamine secretion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0014059", "attributes": [], "id": "906", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of dopamine secretion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0014059"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of hydrogen peroxide catabolic process. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23507046 )", "conames": [{ "name": "up-regulation of hydrogen peroxide degradation", "isPreferred": "true"} , { "name": "up-regulation of H2O2 scavenging", "isPreferred": "false"} , { "name": "activation of hydrogen peroxide catabolic process", "isPreferred": "false"} , { "name": "activation of hydrogen peroxide breakdown", "isPreferred": "false"} , { "name": "up-regulation of hydrogen peroxide scavenging", "isPreferred": "false"} , { "name": "upregulation of hydrogen peroxide scavenging", "isPreferred": "false"} , { "name": "upregulation of hydrogen peroxide catabolic process", "isPreferred": "true"} , { "name": "positive regulation of hydrogen peroxide scavenging", "isPreferred": "false"} , { "name": "upregulation of hydrogen peroxide breakdown", "isPreferred": "true"} , { "name": "upregulation of hydrogen peroxide removal", "isPreferred": "false"} , { "name": "up regulation of detoxification of hydrogen peroxide", "isPreferred": "false"} , { "name": "positive regulation of hydrogen peroxide degradation", "isPreferred": "true"} , { "name": "positive regulation of detoxification of hydrogen peroxide", "isPreferred": "false"} , { "name": "positive regulation of hydrogen peroxide catabolic process", "isPreferred": "true"} , { "name": "up regulation of hydrogen peroxide scavenging", "isPreferred": "false"} , { "name": "activation of hydrogen peroxide catabolism", "isPreferred": "false"} , { "name": "up regulation of hydrogen peroxide degradation", "isPreferred": "true"} , { "name": "activation of hydrogen peroxide scavenging", "isPreferred": "false"} , { "name": "up-regulation of hydrogen peroxide removal", "isPreferred": "false"} , { "name": "activation of hydrogen peroxide removal", "isPreferred": "false"} , { "name": "up-regulation of hydrogen peroxide catabolic process", "isPreferred": "true"} , { "name": "up regulation of H2O2 catabolic process", "isPreferred": "true"} , { "name": "up regulation of hydrogen peroxide catabolic process", "isPreferred": "true"} , { "name": "upregulation of H2O2 scavenging", "isPreferred": "false"} , { "name": "up-regulation of H2O2 catabolic process", "isPreferred": "true"} , { "name": "up-regulation of detoxification of H2O2", "isPreferred": "false"} , { "name": "up regulation of hydrogen peroxide breakdown", "isPreferred": "true"} , { "name": "up regulation of hydrogen peroxide catabolism", "isPreferred": "true"} , { "name": "upregulation of hydrogen peroxide catabolism", "isPreferred": "true"} , { "name": "up regulation of hydrogen peroxide removal", "isPreferred": "false"} , { "name": "up regulation of H2O2 scavenging", "isPreferred": "false"} , { "name": "up-regulation of detoxification of hydrogen peroxide", "isPreferred": "false"} , { "name": "upregulation of H2O2 catabolic process", "isPreferred": "true"} , { "name": "upregulation of hydrogen peroxide degradation", "isPreferred": "true"} , { "name": "up regulation of detoxification of H2O2", "isPreferred": "false"} , { "name": "up-regulation of hydrogen peroxide breakdown", "isPreferred": "true"} , { "name": "positive regulation of hydrogen peroxide catabolism", "isPreferred": "true"} , { "name": "activation of detoxification of hydrogen peroxide", "isPreferred": "false"} , { "name": "activation of H2O2 scavenging", "isPreferred": "false"} , { "name": "upregulation of detoxification of hydrogen peroxide", "isPreferred": "false"} , { "name": "positive regulation of detoxification of H2O2", "isPreferred": "false"} , { "name": "activation of hydrogen peroxide degradation", "isPreferred": "false"} , { "name": "activation of detoxification of H2O2", "isPreferred": "false"} , { "name": "upregulation of detoxification of H2O2", "isPreferred": "false"} , { "name": "positive regulation of H2O2 catabolic process", "isPreferred": "true"} , { "name": "up-regulation of hydrogen peroxide catabolism", "isPreferred": "true"} , { "name": "activation of H2O2 catabolic process", "isPreferred": "false"} , { "name": "positive regulation of H2O2 scavenging", "isPreferred": "false"} , { "name": "positive regulation of hydrogen peroxide breakdown", "isPreferred": "true"} , { "name": "positive regulation of hydrogen peroxide removal", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903285", "attributes": [], "id": "907", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of H2O2 catabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903285"} ]} , { "annotation": "A process that is carried out at the cellular level which results in the assembly,  arrangement of constituent parts,  or disassembly of a mitochondrial membrane,  either of the lipid bilayer surrounding a mitochondrion. ( Reference:  GOC: ai GOC: dph GOC: jl GOC: mah )", "conames": [{ "name": "mitochondrial membrane organization", "isPreferred": "true"} , { "name": "mitochondrial membrane organization and biogenesis", "isPreferred": "false"} , { "name": "mitochondrial membrane organisation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007006", "attributes": [], "id": "908", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial membrane organisation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007006"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways resulting in the formation of acyl-CoA. ( Reference:  GOC: ai )", "conames": [{ "name": "regulation of acyl-CoA anabolism", "isPreferred": "true"} , { "name": "regulation of acyl-CoA biosynthesis", "isPreferred": "true"} , { "name": "regulation of acyl-CoA biosynthetic process", "isPreferred": "true"} , { "name": "regulation of acyl-CoA formation", "isPreferred": "true"} , { "name": "regulation of acyl-CoA synthesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050812", "attributes": [], "id": "909", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of acyl-CoA synthesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050812"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of receptor recycling. ( Reference:  GOC: add )", "conames": [{ "name": "up-regulation of receptor recycling", "isPreferred": "true"} , { "name": "activation of receptor recycling", "isPreferred": "false"} , { "name": "stimulation of receptor recycling", "isPreferred": "false"} , { "name": "positive regulation of receptor recycling", "isPreferred": "true"} , { "name": "up regulation of receptor recycling", "isPreferred": "true"} , { "name": "upregulation of receptor recycling", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001921", "attributes": [], "id": "910", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of receptor recycling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001921"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the controlled release of glutamate. ( Reference:  GOC: ef )", "conames": [{ "name": "regulation of glutamate secretion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0014048", "attributes": [], "id": "911", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of glutamate secretion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0014048"} ]} , { "annotation": "[VARIANT PARK1 GLN-50]", "conames": [{ "name": "PMID: 23457019", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23457019", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Movement disorders :  official journal of the Movement Disorder Society"} , { "attrname": "Chemical", "value": "[4QD397987E Histidine,  0RH81L854J Glutamine,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "Alpha-synuclein p.H50Q,  a novel pathogenic mutation for Parkinson's disease."} , { "attrname": "Abstract", "value": "Alpha-synuclein plays a central role in the pathophysiology of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Three missense mutations in SNCA,  the gene encoding alpha-synuclein,  as well as genomic multiplications have been identified as causes for autosomal-dominantly inherited <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism. Here,  we describe a novel missense mutation in exon 4 of SNCA encoding a H50Q substitution in a patient with dopa-responsive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with a family history of <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism and dementia. The variant was not observed in public databases or identified in unrelated subjects. The substitution's evolutionary conservation and protein modeling provide additional support for pathogenicity as the amino acid perturbs the same amphipathic alpha helical structure as the previously described pathogenic mutations. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Histidine,  Pedigree,  Humans,  Middle Aged,  Male,  Mutation,  alpha-Synuclein,  Glutamine]"} , { "attrname": "AUTHORS", "value": "[Silke Appel-Cresswell,  Carles Vilarino-Guell,  Mary Encarnacion,  Holly Sherman,  Irene Yu,  Brinda Shah,  David Weir,  Christina Thompson,  Chelsea Szu-Tu,  Joanne Trinh,  Jan O Aasly,  Alex Rajput,  Ali H Rajput,  A Jon Stoessl,  Matthew J Farrer]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK1 GLN-50]"} ], "id": "912", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23457019", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/MDS.25421"} , { "elementOf": "NLM", "accession": "23457019"} ]} , { "annotation": "[INTERACTION WITH PHOSPHOLIPASE D]", "conames": [{ "name": "PMID: 11821392", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11821392", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Enzyme Inhibitors,  NI40JAQ945 Tetradecanoylphorbol Acetate,  Nerve Tissue Proteins,  pervanadate,  Synucleins,  platelet protein P47,  Recombinant Fusion Proteins,  Snca protein,  rat,  EC 3.1.4.4 Phospholipase D,  SNCA protein,  human,  42HK56048U Tyrosine,  Blood Proteins,  Phosphoproteins,  Protein Isoforms,  EC 2.5.1.18 Glutathione Transferase,  3WHH0066W5 Vanadates,  alpha-Synuclein,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells."} , { "attrname": "Abstract", "value": "alpha-Synuclein has been implicated in the pathogenesis of many neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  including <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Although the function of alpha-synuclein remains largely unknown,  recent studies have demonstrated that this protein can interact with phospholipids. To address the role of alpha-synuclein in neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  we have investigated whether it binds phospholipase D (PLD) and affects PLD activity in human embryonic kidney (HEK)-293 cells overexpressing wild type alpha-synuclein or the mutant forms of alpha-synuclein (A53T,  A30P) associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Tyrosine phosphorylation of alpha-synuclein appears to play a modulatory role in the inhibition of PLD,  because mutation of Tyr(125) to Phe slightly increases inhibitory effect of alpha-synuclein on PLD activity. Treatment with pervanadate or phorbol myristate acetate inhibits PLD more in HEK 293 cells overexpressing alpha-synuclein than in control cells. Binding of alpha-synuclein to PLD requires phox and pleckstrin homology domain of PLD and the amphipathic repeat region and non-Abeta component of alpha-synuclein. Although biologically important,  co-transfection studies indicate that the interaction of alpha-synuclein with PLD does not influence the tendency of alpha-synuclein to form pathological inclusions. These results suggest that the association of alpha-synuclein with PLD,  and modulation of PLD activity,  is biologically important,  but PLD does not appear to play an essential role in the pathophysiology of alpha-synuclein. "} , { "attrname": "MeSH", "value": "[Brain,  Enzyme Inhibitors,  Phosphorylation,  Tetradecanoylphorbol Acetate,  Humans,  Recombinant Fusion Proteins,  Transfection,  Time Factors,  Phosphoproteins,  Glutathione Transferase,  Protein Structure,  Tertiary,  Tyrosine,  Cell Line,  Rats,  Nerve Tissue Proteins,  Synucleins,  Blotting,  Western,  Phospholipase D,  Precipitin Tests,  Animals,  Blood Proteins,  Protein Isoforms,  Vanadates,  Protein Binding,  Enzyme Activation,  Mutation,  Cytoplasm,  Microscopy,  Fluorescence,  alpha-Synuclein,  DNA,  Complementary,  Eosinophils]"} , { "attrname": "AUTHORS", "value": "[Bong-Hyun Ahn,  Hyangshuk Rhim,  Shi Yeon Kim,  Young-Mo Sung,  Mun-Yong Lee,  Ju-Youn Choi,  Benjamin Wolozin,  Jong-Soo Chang,  Young Han Lee,  Taeg Kyu Kwon,  Kwang Chul Chung,  Shin-Hee Yoon,  Sang June Hahn,  Myung-Suk Kim,  Yang-Hyeok Jo,  Do Sik Min]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH PHOSPHOLIPASE D]"} ], "id": "913", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11821392", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M110414200"} , { "elementOf": "NLM", "accession": "11821392"} ]} , { "annotation": "[SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 15282274", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15282274", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of neuroscience :  the official journal of the Society for Neuroscience"} , { "attrname": "Chemical", "value": "[1UQM1K0W9X mevastatin,  S5UOB36OCZ Mevalonic Acid,  methyl-beta-cyclodextrin,  Fumonisins,  Nerve Tissue Proteins,  Sphingolipids,  KOO5CM684H Digitonin,  Detergents,  Synucleins,  97C5T2UQ7J Cholesterol,  Recombinant Fusion Proteins,  9LHU78OQFD Lovastatin,  Snca protein,  rat,  3ZZM97XZ32 fumonisin B1,  1400-61-9 Nystatin,  SNCA protein,  human,  Snca protein,  mouse,  beta-Cyclodextrins,  Membrane Lipids,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Lipid rafts mediate the synaptic localization of alpha-synuclein."} , { "attrname": "Abstract", "value": "Alpha-synuclein contributes to the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  but its precise role in the disorder and its normal function remain poorly understood. Consistent with a presumed role in neurotransmitter release and its prominent deposition in the dystrophic neurites of PD,  alpha-synuclein localizes almost exclusively to the nerve terminal. In brain extracts,  however,  alpha-synuclein behaves as a soluble,  monomeric protein. Using a binding assay to characterize the association of alpha-synuclein with cell membranes,  we find that alpha-synuclein binds saturably and with high affinity to characteristic intracellular structures that double label for components of lipid rafts. Biochemical analysis demonstrates the interaction of alpha-synuclein with detergent-resistant membranes and reveals a shift in electrophoretic mobility of the raft-associated protein. In addition,  the A30P mutation associated with PD disrupts the interaction of alpha-synuclein with lipid rafts. Furthermore,  we find that both the A30P mutation and raft disruption redistribute alpha-synuclein away from synapses,  indicating an important role for raft association in the normal function of alpha-synuclein and its role in the pathogenesis of PD. "} , { "attrname": "MeSH", "value": "[Membrane Microdomains,  Mevalonic Acid,  Humans,  Cell Membrane Permeability,  Lovastatin,  Sphingolipids,  Mutation,  Missense,  Kidney,  Recombinant Fusion Proteins,  Cell Compartmentation,  Transfection,  Membrane Lipids,  Nystatin,  Fumonisins,  Mice,  Inbred C57BL,  Cells,  Cultured,  Rats,  Mice,  Transgenic,  Nerve Tissue Proteins,  Detergents,  Synucleins,  Cholesterol,  Mice,  Inbred C3H,  Animals,  beta-Cyclodextrins,  Protein Binding,  Brain Chemistry,  Mice,  HeLa Cells,  Hippocampus,  alpha-Synuclein,  Amino Acid Substitution,  Digitonin]"} , { "attrname": "AUTHORS", "value": "[Doris L Fortin,  Matthew D Troyer,  Ken Nakamura,  Shin-ichiro Kubo,  Malcolm D Anthony,  Robert H Edwards]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION]"} ], "id": "914", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15282274", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15282274"} , { "elementOf": "DOI", "accession": "10.1523\/JNEUROSCI.1594-04.2004"} ]} , { "annotation": "[INTERACTION WITH HISTONES,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 12859192", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12859192", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  PLG39H7695 Paraquat,  Histones,  Nerve Tissue Proteins,  Recombinant Proteins,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Nuclear localization of alpha-synuclein and its interaction with histones."} , { "attrname": "Abstract", "value": "The aggregation of alpha-synuclein is believed to play an important role in the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> as well as other neurodegenerative disorders (\"synucleinopathies\"). However,  the function of alpha-synuclein under physiologic and pathological conditions is unknown,  and the mechanism of alpha-synuclein aggregation is not well understood. Here we show that alpha-synuclein forms a tight 2: 1 complex with histones and that the fibrillation rate of alpha-synuclein is dramatically accelerated in the presence of histones in vitro. We also describe the presence of alpha-synuclein and its co-localization with histones in the nuclei of nigral neurons from mice exposed to a toxic insult (i.e.,  injections of the herbicide paraquat). These observations indicate that translocation into the nucleus and binding with histones represent potential mechanisms underlying alpha-synuclein pathophysiology. "} , { "attrname": "MeSH", "value": "[Escherichia coli,  Humans,  Gene Expression Regulation,  Nerve Tissue Proteins,  Recombinant Proteins,  Microscopy,  Electron,  Synucleins,  Cloning,  Molecular,  Histones,  Protein Binding,  Paraquat,  Kinetics,  Cell Nucleus,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[John Goers,  Amy B Manning-Bog,  Alison L McCormack,  Ian S Millett,  Sebastian Doniach,  Donato A Di Monte,  Vladimir N Uversky,  Anthony L Fink]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH HISTONES,  SUBCELLULAR LOCATION]"} ], "id": "915", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12859192", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI0341152"} , { "elementOf": "NLM", "accession": "12859192"} ]} , { "annotation": "[REVIEW]", "conames": [{ "name": "PMID: 12558071", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12558071", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Current molecular medicine"} , { "attrname": "Chemical", "value": "[Snca protein,  mouse,  Nerve Tissue Proteins,  Recombinant Proteins,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Recent advances on alpha-synuclein cell biology:  functions and dysfunctions."} , { "attrname": "Abstract", "value": "Alpha-synuclein is a recently discovered protein that was first identified as the major non amyloid component of senile plaques,  the cerebral lesion likely responsible for <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The role of alpha-synuclein in another brain <span style=\"background-color: yellow\"><b>disease<\/b><\/span> namely <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  has been more deeply documented. It appears that alpha-synuclein fills up the intracytoplasmic inclusions called Lewy bodies that likely contribute to the etiology of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Furthermore,  rare familial forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> have been shown to be linked to autosomal dominant mutations of alpha-synucleins. Is alpha-synuclein a bridge between <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s? Could it be seen as a common denominator for these two neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s? These issues could be better addressed by further delineating the physiological function of alpha-synuclein and,  as a corollary,  the dysfunction taking place along with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s. Here,  I will review the recent advances concerning the physiology of alpha-synuclein and will particularly focus on the post-traductional events leading to drastic biophysical transformations. I will describe recent works suggesting that these modifications directly modulate the normal function of alpha-synuclein,  likely accounting for the dysfunction associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and perhaps contributing to <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s pathology. "} , { "attrname": "MeSH", "value": "[Brain,  Nerve Tissue Proteins,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synucleins,  Mice,  Knockout,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Neuronal Plasticity,  Transport Vesicles,  Cell Death,  Mice,  Synapses,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[C Alves da Costa]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW]"} ], "id": "916", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12558071", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.2174\/1566524033361690"} , { "elementOf": "NLM", "accession": "12558071"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2-4 AND 2-5)]", "conames": [{ "name": "PMID: 7601450", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7601450", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Genomics"} , { "attrname": "Chemical", "value": "[Protein Precursors,  Amyloid,  Nerve Tissue Proteins,  Synucleins]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "The NACP\/synuclein gene:  chromosomal assignment and screening for alterations in Alzheimer disease."} , { "attrname": "Abstract", "value": "The major component of the vascular and plaque amyloid deposits in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is the amyloid beta peptide (A beta). A second intrinsic component of amyloid,  the NAC (non-A beta component of amyloid) peptide,  has recently been identified,  and its precursor protein was named NACP. A computer homology search allowed us to establish that the human NACP gene was homologous to the rat synuclein gene. We mapped the NACP\/synuclein gene to chromosome 4 and cloned three alternatively spliced transcripts in lymphocytes derived from a normal subject. We analyzed by RT-PCR and direct sequencing the entire coding region of the NACP\/synuclein gene in a group of patients with familial early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. No mutation was found in 26 unrelated patients. Further studies are required to investigate the implication of the NACP\/synuclein gene in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Susceptibility,  Genes,  Humans,  Hybrid Cells,  Molecular Sequence Data,  Rats,  Chromosome Mapping,  Nerve Tissue Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synucleins,  Chromosomes,  Human,  Pair 4,  Animals,  DNA Mutational Analysis,  Lymphocytes,  Base Sequence,  Age of Onset,  Protein Precursors,  Amyloid,  Cell Line,  Transformed]"} , { "attrname": "AUTHORS", "value": "[D Campion,  C Martin,  R Heilig,  F Charbonnier,  V Moreau,  J M Flaman,  J L Petit,  D Hannequin,  A Brice,  T Frebourg]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2-4 AND 2-5)]"} ], "id": "917", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7601450", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7601450"} , { "elementOf": "DOI", "accession": "10.1016\/0888-7543(95)80208-4"} ]} , { "annotation": "[ROLE OF THE C-TERMINUS IN FIBRILLOGENESIS]", "conames": [{ "name": "PMID: 12859200", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12859200", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  SNCA protein,  human,  Nerve Tissue Proteins,  Recombinant Proteins,  DNA Primers,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Role of alpha-synuclein carboxy-terminus on fibril formation in vitro."} , { "attrname": "Abstract", "value": "Alpha-synuclein (alpha-syn) is the major component of intracellular inclusions in several neurodegenerative diseases,  and the conversion of soluble alpha-syn into filamentous aggregates may contribute to disease pathogenesis. Since mechanisms leading to the formation of alpha-syn inclusions are unclear,  in vitro models of alpha-syn aggregation may yield insights into this process. To that end,  we examined the consequences on the progressive deletion of the carboxy-terminus of alpha-syn in regulating fibril formation,  and we show here that carboxy-terminal truncated alpha-syn proteins aggregate faster than the full-length molecule. Protease digestion and immunoelectron microscopy indicate that the alpha-syn amino- and carboxy-termini are more solvent exposed than the central core and that filaments formed from carboxy-terminal truncated alpha-syn are narrower in diameter than the full-length molecule. Moreover,  seeding experiments under conditions where full-length alpha-syn did not readily aggregate revealed that carboxy-truncated alpha-syn extending from amino acids 1-102 and 1-110 but not 1-120 were efficient in seeding full-length alpha-syn aggregation over a range of concentrations. Using site-directed mutagenesis,  the negatively charged residues 104,  105 and 114,  115 in the carboxy-terminus were implicated in this reduced aggregation and the lack of seeding of full-length alpha-syn fibrillogenesis by 1-120. Our data support the view that the middle region of alpha-syn forms the core of alpha-syn filaments and that negative charges in the carboxy-terminus counteract alpha-syn aggregation. Thus,  the carboxy-terminus of alpha-syn may regulate aggregation of full-length alpha-syn and determine the diameter of alpha-syn filaments. "} , { "attrname": "MeSH", "value": "[Actin Cytoskeleton,  Peptide Fragments,  Protein Structure,  Secondary,  Escherichia coli,  Humans,  Spectrometry,  Fluorescence,  Nerve Tissue Proteins,  Recombinant Proteins,  DNA Primers,  Synucleins,  Microscopy,  Immunoelectron,  Base Sequence,  Cloning,  Molecular,  Microfibrils,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Ian V J Murray,  Benoit I Giasson,  Shawn M Quinn,  Vishwanath Koppaka,  Paul H Axelsen,  Harry Ischiropoulos,  John Q Trojanowski,  Virginia M-Y Lee]"} , { "attrname": "PUB_TYPE", "value": "[ROLE OF THE C-TERMINUS IN FIBRILLOGENESIS]"} ], "id": "918", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12859200", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12859200"} , { "elementOf": "DOI", "accession": "10.1021\/BI027363R"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT LYS-46]", "conames": [{ "name": "PMID: 15498564", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15498564", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Snca protein,  mouse,  Nerve Tissue Proteins,  Phospholipids,  Liposomes,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein."} , { "attrname": "Abstract", "value": "Missense mutations (A30P and A53T) in alpha-synuclein and the overproduction of the wild-type protein cause familial forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and dementia with Lewy bodies. Alpha-synuclein is the major component of the filamentous Lewy bodies and Lewy neurites that define these <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s at a neuropathological level. Recently,  a third missense mutation (E46K) in alpha-synuclein was described in an inherited form of dementia with Lewy bodies. Here,  we have investigated the functional effects of this novel mutation on phospholipid binding and filament assembly of alpha-synuclein. When compared to the wild-type protein,  the E46K mutation caused a significantly increased ability of alpha-synuclein to bind to negatively charged liposomes,  unlike the previously described mutations. The E46K mutation increased the rate of filament assembly to the same extent as the A53T mutation. Filaments formed from E46K alpha-synuclein often had a twisted morphology with a cross-over spacing of 43 nm. The observed effects on lipid binding and filament assembly may explain the pathogenic nature of the E46K mutation in alpha-synuclein. "} , { "attrname": "MeSH", "value": "[Mutagenesis,  Site-Directed,  Humans,  L Cells (Cell Line),  Lewy Body <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Nerve Tissue Proteins,  Phospholipids,  Mutation,  Missense,  Synucleins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Mice,  Kinetics,  Liposomes,  Binding Sites,  alpha-Synuclein,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Woong Choi,  Shahin Zibaee,  Ross Jakes,  Louise C Serpell,  Bazbek Davletov,  R Anthony Crowther,  Michel Goedert]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT LYS-46]"} ], "id": "919", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15498564", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.FEBSLET.2004.09.038"} , { "elementOf": "NLM", "accession": "15498564"} ]} , { "annotation": "[VARIANT PARK1\/DLB LYS-46]", "conames": [{ "name": "PMID: 14755719", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14755719", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Nerve Tissue Proteins,  DNA Primers,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "The new mutation,  E46K,  of alpha-synuclein causes Parkinson and Lewy body dementia."} , { "attrname": "Abstract", "value": "Familial <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism and dementia with cortical and subcortical Lewy bodies is uncommon,  and no genetic defect has been reported in the previously described sibships. We present a Spanish family with autosomal dominant <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  dementia,  and visual hallucinations of variable severity. The postmortem examination showed atrophy of the substantia nigra,  lack of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> pathology,  and numerous Lewy bodies which were immunoreactive to alpha-synuclein and ubiquitin in cortical and subcortical areas. Sequencing of the alpha-synuclein gene showed a novel,  nonconservative E46K mutation in heterozygosis. The E46K mutation was present in all affected family members and in three young asymptomatic subjects,  but it was absent in healthy and pathological controls. The novel mutation,  that substitutes a dicarboxylic amino acid,  glutamic acid,  with a basic amino acid such as lysine in a much conserved area of the protein,  is likely to produce severe disturbance of protein function. Our data show that,  in addition to the previously described hereditary alpha-synucleinopathies,  dementia with Lewy bodies is related to mutation of alpha-synuclein. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Amino Acid Sequence,  Brain,  Humans,  Middle Aged,  Tomography,  Emission-Computed,  Single-Photon,  Molecular Sequence Data,  Lewy Body <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Male,  Nerve Tissue Proteins,  Lewy Bodies,  DNA Primers,  Synucleins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  DNA Mutational Analysis,  Pedigree,  Base Sequence,  Polymerase Chain Reaction,  Female,  Aged,  Mutation,  Nerve Degeneration,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Juan J Zarranz,  Javier Alegre,  Juan C Gmez-Esteban,  Elena Lezcano,  Raquel Ros,  Israel Ampuero,  Ldice Vidal,  Janet Hoenicka,  Olga Rodriguez,  Begoa Atars,  Vernica Llorens,  Estrella Gomez Tortosa,  Teodoro del Ser,  David G Muoz,  Justo G de Yebenes]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK1\/DLB LYS-46]"} ], "id": "920", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14755719", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14755719"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10795"} ]} , { "annotation": "[COPPER-BINDING,  MUTAGENESIS OF ASP-2 AND HIS-50];", "conames": [{ "name": "PMID: 21319811", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21319811", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[789U1901C5 Copper,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Coordination features and affinity of the Cu+ site in the ?-synuclein protein of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is the second most prevalent age-related,  neurodegenerative disorder,  affecting >1% of the population over the age of 60. PD pathology is marked by intracellular inclusions composed primarily of the protein ?-synuclein (?-syn). These inclusions also contain copper,  and the interaction of Cu(2+) with ?-syn may play an important role in PD fibrillogenesis. Here we report the stoichiometry,  affinity,  and coordination structure of the Cu(2+)-?-syn complex. Electron paramagnetic resonance (EPR) titrations show that monomeric ?-syn binds 1.0 equiv of Cu(2+) at the protein N-terminus. Next,  an EPR competition technique demonstrates that ?-syn binds Cu(2+) with a K(d) of ?0.10 nM. Finally,  EPR and electron spin echo modulation (ESEEM) applied to a suite of mutant and truncated ?-syn constructs reveal a coordination sphere arising from the N-terminal amine,  the Asp2 amide backbone and side chain carboxyl group,  and the His50 imidazole. The high binding affinity identified here,  in accord with previous measurements,  suggests that copper uptake and sequestration may be a part of ?-syn's natural function,  perhaps modulating copper's redox properties. The findings further suggest that the long-range interaction between the N-terminus and His50 may have a weakening effect on the interaction of ?-syn with lipid membranes,  thereby mobilizing monomeric ?-syn and hastening fibrillogenesis. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Electron Spin Resonance Spectroscopy,  Humans,  Models,  Molecular,  Kinetics,  Copper,  Binding Sites,  Circular Dichroism,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Christopher G Dudzik,  Eric D Walter,  Glenn L Millhauser]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING,  MUTAGENESIS OF ASP-2 AND HIS-50]"} ], "id": "921", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21319811", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21319811"} , { "elementOf": "DOI", "accession": "10.1021\/BI101912Q"} ]} , { "annotation": "[PHOSPHORYLATION AT TYR-125 BY FYN]", "conames": [{ "name": "PMID: 11162638", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11162638", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[EC 2.7.11.24 Mitogen-Activated Protein Kinases,  EC 2.7.10.2 Focal Adhesion Kinase 1,  EC 2.7.1.24 Mitogen-Activated Protein Kinase 9,  EC 2.7.10.2 Focal Adhesion Kinase 2,  EC 2.7.10.2 PTK2 protein,  human,  Recombinant Fusion Proteins,  SNCA protein,  human,  42HK56048U Tyrosine,  EC 2.7.11.1 Cyclin-Dependent Kinase 5,  Proto-Oncogene Proteins,  EC 2.5.1.18 Glutathione Transferase,  EC 2.7.11.24 Mitogen-Activated Protein Kinase 3,  EC 2.7.11.13 Protein Kinase C,  EC 2.7.11.22 CDK5 protein,  human,  EC 2.7.10.2 lyn protein-tyrosine kinase,  EC 2.7.10.2 src-Family Kinases,  Nerve Tissue Proteins,  EC 2.7.10.1 Protein-Tyrosine Kinases,  Synucleins,  EC 2.7.10.2 Focal Adhesion Protein-Tyrosine Kinases,  EC 2.7.11.22 Cyclin-Dependent Kinases,  EC 2.7.10.2 FYN protein,  human,  EC 2.7.10.2 Proto-Oncogene Proteins c-fyn,  alpha-Synuclein,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125."} , { "attrname": "Abstract", "value": "alpha-Synuclein is a presynaptic protein of unknown function that has been implicated in the pathogenesis of several neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  including <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s. To gain insight into the functions of alpha-synuclein,  we sought protein kinases that phosphorylate alpha-synuclein in the central nervous system. In contrast to Lyn,  PYK2,  FAK,  MAPK\/ERK1,  SAPK\/JNK,  and Cdk5,  only Fyn could phosphorylate alpha-synuclein. In addition,  A30P and A53T mutations did not affect the phosphorylation of alpha-synuclein by Fyn. Mutation analysis revealed that activated Fyn phosphorylates specifically tyrosine residue 125 of alpha-synuclein. The distribution of alpha-synuclein and Fyn expression was similar in various parts of the brain and was colocalized in subcellular structures. Since Fyn regulates various signal transduction pathways in the central nervous system and plays an essential role in the neuronal cell differentiation,  survival,  and plasticity,  results of this paper indicate that phosphorylation of alpha-synuclein might be involved in one of the Fyn-mediated signaling pathways in neuronal cells. "} , { "attrname": "MeSH", "value": "[Brain,  Phosphorylation,  src-Family Kinases,  Humans,  Proto-Oncogene Proteins c-fyn,  Focal Adhesion Kinase 2,  Focal Adhesion Kinase 1,  Recombinant Fusion Proteins,  Tissue Distribution,  Time Factors,  DNA Mutational Analysis,  Proto-Oncogene Proteins,  Cyclin-Dependent Kinases,  Glutathione Transferase,  Mitogen-Activated Protein Kinases,  Tyrosine,  Mutagenesis,  Site-Directed,  Signal Transduction,  Neurons,  Focal Adhesion Protein-Tyrosine Kinases,  Nerve Tissue Proteins,  Synucleins,  Precipitin Tests,  Cyclin-Dependent Kinase 5,  Microscopy,  Confocal,  Blotting,  Northern,  Animals,  Central Nervous System,  Mitogen-Activated Protein Kinase 9,  Enzyme Activation,  Mutation,  Protein-Tyrosine Kinases,  COS Cells,  Microscopy,  Fluorescence,  Mitogen-Activated Protein Kinase 3,  alpha-Synuclein,  DNA,  Complementary,  Protein Kinase C]"} , { "attrname": "AUTHORS", "value": "[T Nakamura,  H Yamashita,  T Takahashi,  S Nakamura]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT TYR-125 BY FYN]"} ], "id": "922", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11162638", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.2000.4253"} , { "elementOf": "NLM", "accession": "11162638"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANTS PARK1 PRO-30; LYS-46; GLN-50 AND THR-53,  MUTAGENESIS OF GLU-35 AND GLU-57,  SUBCELLULAR LOCATION,  SUBUNIT]", "conames": [{ "name": "PMID: 25561023", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "25561023", "attributes": [{ "attrname": "JOURNAL_REF", "value": "ACS chemical neuroscience"} , { "attrname": "Chemical", "value": "[alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2015"} , { "attrname": "AbstractHeader", "value": "Molecular determinants of -synuclein mutants' oligomerization and membrane interactions."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is associated with the formation of toxic ?-synuclein oligomers that can penetrate the cell membrane. Familial forms of PD are caused by the point mutations A53T,  A30P,  E46K,  and H50Q. Artificial point mutations E35K and E57K also increase oligomerization and pore formation. We generated structural conformations of ?-synuclein and the above-mentioned mutants using molecular dynamics. We elucidated four main regions in these conformers contacting the membrane and found that the region including residues 39-45 (Zone2) may have maximum membrane penetration. E57K mutant had the highest rate of interaction with the membrane,  followed by A53T,  E46K,  and E35K mutants and wild type (wt) ?-synuclein. The mutant A30P had the smallest percentage of conformers that contact the membrane by Zone 2 than all other mutants and wt ?-synuclein. These results were confirmed experimentally in vitro. We identified the key amino acids that can interact with the membrane (Y38,  E62,  and N65 (first hydrophilic layer); E104,  E105,  and D115 (second hydrophilic layer),  and V15 and V26 (central hydrophobic layer)) and the residues that are involved in the interprotein contacts (L38,  V48,  V49,  Q62,  and T64). Understanding the molecular interactions of ?-synuclein mutants is important for the design of compounds blocking the formation of toxic oligomers. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Cell Membrane,  Humans,  Models,  Molecular,  Rats,  Neuroblastoma,  Magnetic Resonance Imaging,  Point Mutation,  Animals,  Transfection,  Computer Simulation,  Cell Line,  Tumor,  Protein Conformation,  Nonlinear Dynamics,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Igor F Tsigelny,  Yuriy Sharikov,  Valentina L Kouznetsova,  Jerry P Greenberg,  Wolf Wrasidlo,  Cassia Overk,  Tania Gonzalez,  Margarita Trejo,  Brian Spencer,  Kori Kosberg,  Eliezer Masliah]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANTS PARK1 PRO-30; LYS-46; GLN-50 AND THR-53,  MUTAGENESIS OF GLU-35 AND GLU-57,  SUBCELLULAR LOCATION,  SUBUNIT]"} ], "id": "923", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 25561023", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/CN500332W"} , { "elementOf": "NLM", "accession": "25561023"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-129]", "conames": [{ "name": "PMID: 11813001", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11813001", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature cell biology"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Phosphoproteins,  Nerve Tissue Proteins,  Recombinant Proteins,  Synucleins,  452VLY9402 Serine,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "alpha-Synuclein is phosphorylated in synucleinopathy lesions."} , { "attrname": "Abstract", "value": "The deposition of the abundant presynaptic brain protein alpha-synuclein as fibrillary aggregates in neurons or glial cells is a hallmark lesion in a subset of neurodegenerative disorders. These disorders include <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  dementia with Lewy bodies (DLB) and multiple system atrophy,  collectively referred to as synucleinopathies. Importantly,  the identification of missense mutations in the alpha-synuclein gene in some pedigrees of familial PD has strongly implicated alpha-synuclein in the pathogenesis of PD and other synucleinopathies. However,  specific post-translational modifications that underlie the aggregation of alpha-synuclein in affected brains have not,  as yet,  been identified. Here,  we show by mass spectrometry analysis and studies with an antibody that specifically recognizes phospho-Ser 129 of alpha-synuclein,  that this residue is selectively and extensively phosphorylated in synucleinopathy lesions. Furthermore,  phosphorylation of alpha-synuclein at Ser 129 promoted fibril formation in vitro. These results highlight the importance of phosphorylation of filamentous proteins in the pathogenesis of neurodegenerative disorders. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Neurodegenerative <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>s,  Humans,  Serine,  Molecular Sequence Data,  Cerebral Cortex,  Nerve Tissue Proteins,  Lewy Bodies,  Recombinant Proteins,  Synucleins,  Phosphoproteins,  Mass Spectrometry,  Aged,  Brain Chemistry,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Hideo Fujiwara,  Masato Hasegawa,  Naoshi Dohmae,  Akiko Kawashima,  Eliezer Masliah,  Matthew S Goldberg,  Jie Shen,  Koji Takio,  Takeshi Iwatsubo]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-129]"} ], "id": "924", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11813001", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11813001"} , { "elementOf": "DOI", "accession": "10.1038\/NCB748"} ]} , { "annotation": "[VARIANT PARK1 PRO-30]", "conames": [{ "name": "PMID: 9462735", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9462735", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  9DLQ4CIU6V Proline,  Nerve Tissue Proteins,  Synucleins,  alpha-Synuclein,  OF5P57N2ZX Alanine]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Alanine,  Humans,  Proline,  Male,  Nerve Tissue Proteins,  Synucleins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Single-Stranded Conformational,  Point Mutation,  Pedigree,  Base Sequence,  Female,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[R Krger,  W Kuhn,  T Mller,  D Woitalla,  M Graeber,  S Ksel,  H Przuntek,  J T Epplen,  L Schls,  O Riess]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK1 PRO-30]"} ], "id": "925", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9462735", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9462735"} , { "elementOf": "DOI", "accession": "10.1038\/NG0298-106"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT PARK1 GLN-50,  SUBCELLULAR LOCATION,  SUBUNIT,  PHOSPHORYLATION AT SER-129]", "conames": [{ "name": "PMID: 24936070", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "24936070", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Mutant Proteins,  Protein Aggregates,  SNCA protein,  human,  Metals,  Recombinant Proteins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2014"} , { "attrname": "AbstractHeader", "value": "The H50Q mutation enhances -synuclein aggregation,  secretion,  and toxicity."} , { "attrname": "Abstract", "value": "Over the last two decades,  the identification of missense mutations in the ?-synuclein (?-Syn) gene SNCA in families with inherited <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) has reinforced the central role of ?-Syn in PD pathogenesis. Recently,  a new missense mutation (H50Q) in ?-Syn was described in patients with a familial form of PD and dementia. Here we investigated the effects of this novel mutation on the biophysical properties of ?-Syn and the consequences for its cellular function. We found that the H50Q mutation affected neither the structure of free or membrane-bound ?-Syn monomer,  its interaction with metals,  nor its capacity to be phosphorylated in vitro. However,  compared with the wild-type (WT) protein,  the H50Q mutation accelerated ?-Syn fibrillization in vitro. In cell-based models,  H50Q mutation did not affect ?-Syn subcellular localization or its ability to be phosphorylated by PLK2 and GRK6. Interestingly,  H50Q increased ?-Syn secretion from SHSY5Y cells into culture medium and induced more mitochondrial fragmentation in hippocampal neurons. Although the transient overexpression of WT or H50Q did not induce toxicity,  both species induced significant cell death when added to the culture medium of hippocampal neurons. Strikingly,  H50Q exhibited more toxicity,  suggesting that the H50Q-related enhancement of ?-Syn aggregation and secretion may play a role in the extracellular toxicity of this mutant. Together,  our results provide novel insight into the mechanism by which this newly described PD-associated mutation may contribute to the pathogenesis of PD and related disorders. "} , { "attrname": "MeSH", "value": "[Protein Aggregates,  Cell Line,  Phosphorylation,  Neurons,  Humans,  Metals,  Cells,  Cultured,  Lipid Metabolism,  Mutation,  Missense,  Recombinant Proteins,  Protein Aggregation,  Pathological,  Mutant Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Cell Death,  Protein Structure,  Quaternary,  Mice,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Ossama Khalaf,  Bruno Fauvet,  Abid Oueslati,  Igor Dikiy,  Anne-Laure Mahul-Mellier,  Francesco Simone Ruggeri,  Martial K Mbefo,  Filip Vercruysse,  Giovanni Dietler,  Seung-Jae Lee,  David Eliezer,  Hilal A Lashuel]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT PARK1 GLN-50,  SUBCELLULAR LOCATION,  SUBUNIT,  PHOSPHORYLATION AT SER-129]"} ], "id": "926", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 24936070", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "24936070"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M114.553297"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2-4)]", "conames": [{ "name": "PMID: 11156617", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11156617", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Genome research"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Snca protein,  mouse,  Nerve Tissue Proteins,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Human and mouse alpha-synuclein genes:  comparative genomic sequence analysis and identification of a novel gene regulatory element."} , { "attrname": "Abstract", "value": "The human alpha-synuclein gene (SNCA) encodes a presynaptic nerve terminal protein that was originally identified as a precursor of the non-beta-amyloid component of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> plaques. More recently,  mutations in SNCA have been identified in some cases of familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  presenting numerous new areas of investigation for this important <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Molecular studies would benefit from detailed information about the long-range sequence context of SNCA. To that end,  we have established the complete genomic sequence of the chromosomal regions containing the human and mouse alpha-synuclein genes,  with the objective of using the resulting sequence information to identify conserved regions of biological importance through comparative sequence analysis. These efforts have yielded approximately 146 and approximately 119 kb of high-accuracy human and mouse genomic sequence,  respectively,  revealing the precise genetic architecture of the alpha-synuclein gene in both species. A simple repeat element upstream of SNCA\/Snca has been identified and shown to be necessary for normal expression in transient transfection assays using a luciferase reporter construct. Together,  these studies provide valuable data that should facilitate more detailed analysis of this medically important gene. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Mice,  Inbred C57BL,  Regulatory Sequences,  Nucleic Acid,  Molecular Sequence Data,  Chromosome Mapping,  Nerve Tissue Proteins,  Synucleins,  Sequence Analysis,  DNA,  Animals,  Base Sequence,  Repetitive Sequences,  Nucleic Acid,  Mice,  alpha-Synuclein,  Databases,  Factual]"} , { "attrname": "AUTHORS", "value": "[J W Touchman,  A Dehejia,  O Chiba-Falek,  D E Cabin,  J R Schwartz,  B M Orrison,  M H Polymeropoulos,  R L Nussbaum]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2-4)]"} ], "id": "927", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11156617", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11156617"} , { "elementOf": "DOI", "accession": "10.1101\/GR.165801"} ]} , { "annotation": "[VARIANT PARK1 GLN-50,  CHARACTERIZATION OF VARIANT PARK1 GLN-50]", "conames": [{ "name": "PMID: 23427326", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23427326", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "A novel -synuclein missense mutation in Parkinson disease."} , { "attrname": "Abstract", "value": "Alpha-synuclein (SNCA) is central to the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  with 3 missense mutations reported to date. We report a novel mutation (p.H50Q) in a pathologically proven case. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acid Sequence,  Humans,  Fatal Outcome,  Aged,  80 and over,  Molecular Sequence Data,  Female,  Mutation,  Missense,  alpha-Synuclein,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Christos Proukakis,  Christopher G Dudzik,  Timothy Brier,  Donna S MacKay,  J Mark Cooper,  Glenn L Millhauser,  Henry Houlden,  Anthony H Schapira]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK1 GLN-50,  CHARACTERIZATION OF VARIANT PARK1 GLN-50]"} ], "id": "928", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23427326", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.0B013E31828727BA"} , { "elementOf": "NLM", "accession": "23427326"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1),  PROTEIN SEQUENCE OF 61-95]", "conames": [{ "name": "PMID: 8248242", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8248242", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Protein Precursors,  Amyloid,  Nerve Tissue Proteins,  Recombinant Proteins,  Synucleins,  RNA,  Messenger,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease."} , { "attrname": "Abstract", "value": "A neuropathological hallmark of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is a widespread amyloid deposition. We analyzed the entire amino acid sequences in an amyloid preparation and found,  in addition to the major beta\/A4-protein (A beta) fragment,  two unknown peptides. We raised antibodies against synthetic peptides using subsequences of these peptides. These antibodies immunostained amyloid in neuritic and diffuse plaques as well as vascular amyloid. Electron microscopic analysis demonstrated that the immunostaining was localized on amyloid fibrils. We have isolated an apparently full-length cDNA encoding a 140-amino-acid protein within which two previously unreported amyloid sequences are encoded in tandem in the most hydrophobic domain. We tentatively named this 35-amino acid peptide NAC (non-A beta component of AD amyloid) and its precursor NACP. NAC is the second component,  after A beta,  identified chemically in the purified AD amyloid preparation. Secondary structure predictions indicate that the NAC peptide sequence has a strong tendency to form beta-structures consistent with its association with amyloid. NACP is detected as a M(r) 19, 000 protein in the cytosolic fraction of brain homogenates and comigrates on immunoblots with NACP synthesized in Escherichia coli from NACP cDNA. NACP mRNA is expressed principally in brain but is also expressed in low concentrations in all tissues examined except in liver,  suggesting its ubiquitous and brain-specific functions. The availability of the cDNA encoding full-length NACP should help to elucidate the mechanisms of amyloidosis in AD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Gene Expression,  Humans,  Molecular Sequence Data,  Nerve Tissue Proteins,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Synucleins,  Immunoenzyme Techniques,  Sequence Homology,  Amino Acid,  Sequence Alignment,  Base Sequence,  Cloning,  Molecular,  Protein Precursors,  Repetitive Sequences,  Nucleic Acid,  Amyloid,  RNA,  Messenger,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[K Uda,  H Fukushima,  E Masliah,  Y Xia,  A Iwai,  M Yoshimoto,  D A Otero,  J Kondo,  Y Ihara,  T Saitoh]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1),  PROTEIN SEQUENCE OF 61-95]"} ], "id": "929", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8248242", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8248242"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.90.23.11282"} ]} , { "annotation": "[ACETYLATION AT MET-1]", "conames": [{ "name": "PMID: 22407793", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22407793", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Protein science :  a publication of the Protein Society"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Amyloid,  Recombinant Proteins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "N-Terminal acetylation is critical for forming -helical oligomer of -synuclein."} , { "attrname": "Abstract", "value": "The aggregation of the protein ?-synuclein (AS) is critical to the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Although generally described as an unstructured monomer,  recent evidence suggests that the native form of AS may be an ?-helical tetramer which resists aggregation. Here,  we show that N-terminal acetylation in combination with a mild purification protocol results in an oligomeric form of AS with partial ?-helical structure. N-terminal acetylation of AS could have important implications for both the native and pathological structures and functions of AS. Through our demonstration of a recombinant expression system,  our results represent an important step toward biochemical and biophysical characterization of this potentially important form of AS. "} , { "attrname": "MeSH", "value": "[Spectrometry,  Mass,  Electrospray Ionization,  Humans,  Amyloid,  Acetylation,  Recombinant Proteins,  Chromatography,  Gel,  Circular Dichroism,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[Adam J Trexler,  Elizabeth Rhoades]"} , { "attrname": "PUB_TYPE", "value": "[ACETYLATION AT MET-1]"} ], "id": "930", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22407793", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "22407793"} , { "elementOf": "DOI", "accession": "10.1002\/PRO.2056"} ]} , { "annotation": "[PHOSPHORYLATION BY G-PROTEIN COUPLED RECEPTOR KINASE]", "conames": [{ "name": "PMID: 10852916", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10852916", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 Protein-Serine-Threonine Kinases,  EC 3.1.4.4 Phospholipase D,  EC 3.6.1.- GTP-Binding Proteins,  EC 2.7.11.11 Cyclic AMP-Dependent Protein Kinases,  Nerve Tissue Proteins,  Phospholipids,  EC 3.1.4.- phospholipase D2,  Synucleins,  EC 2.7.11.16 G-Protein-Coupled Receptor Kinase 5,  alpha-Synuclein,  EC 2.7.11.15 beta-Adrenergic Receptor Kinases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Synucleins are a novel class of substrates for G protein-coupled receptor kinases."} , { "attrname": "Abstract", "value": "G protein-coupled receptor kinases (GRKs) specifically recognize and phosphorylate the agonist-occupied form of numerous G protein-coupled receptors (GPCRs),  ultimately resulting in desensitization of receptor signaling. Until recently,  GPCRs were considered to be the only natural substrates for GRKs. However,  the recent discovery that GRKs also phosphorylate tubulin raised the possibility that additional GRK substrates exist and that the cellular role of GRKs may be much broader than just GPCR regulation. Here we report that synucleins are a novel class of GRK substrates. Synucleins (alpha,  beta,  gamma,  and synoretin) are 14-kDa proteins that are highly expressed in brain but also found in numerous other tissues. alpha-Synuclein has been linked to the development of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s. We found that all synucleins are GRK substrates,  with GRK2 preferentially phosphorylating the alpha and beta isoforms,  whereas GRK5 prefers alpha-synuclein as a substrate. GRK-mediated phosphorylation of synuclein is activated by factors that stimulate receptor phosphorylation,  such as lipids (all GRKs) and Gbetagamma subunits (GRK2\/3),  suggesting that GPCR activation may regulate synuclein phosphorylation. GRKs phosphorylate synucleins at a single serine residue within the C-terminal domain. Although the function of synucleins remains largely unknown,  recent studies have demonstrated that these proteins can interact with phospholipids and are potent inhibitors of phospholipase D2 (PLD2) in vitro. PLD2 regulates the breakdown of phosphatidylcholine and has been implicated in vesicular trafficking. We found that GRK-mediated phosphorylation inhibits synuclein's interaction with both phospholipids and PLD2. These findings suggest that GPCRs may be able to indirectly stimulate PLD2 activity via their ability to regulate GRK-promoted phosphorylation of synuclein. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Phosphorylation,  Protein-Serine-Threonine Kinases,  Molecular Sequence Data,  Nerve Tissue Proteins,  Phospholipids,  Structure-Activity Relationship,  Synucleins,  Phospholipase D,  Animals,  Cattle,  GTP-Binding Proteins,  Binding Sites,  Cyclic AMP-Dependent Protein Kinases,  alpha-Synuclein,  G-Protein-Coupled Receptor Kinase 5,  beta-Adrenergic Receptor Kinases]"} , { "attrname": "AUTHORS", "value": "[A N Pronin,  A J Morris,  A Surguchov,  J L Benovic]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION BY G-PROTEIN COUPLED RECEPTOR KINASE]"} ], "id": "931", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10852916", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10852916"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M003542200"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-87 AND SER-129 BY CK1 AND CK2]", "conames": [{ "name": "PMID: 10617630", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10617630", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Snca protein,  rat,  EC 2.7.11.1 Protein-Serine-Threonine Kinases,  Protein Kinase Inhibitors,  SNCA protein,  human,  Phosphoproteins,  EC 2.7.11.1 Casein Kinases,  EC 2.7.- Protein Kinases,  Nerve Tissue Proteins,  Synucleins,  452VLY9402 Serine,  EC 2.7.11.1 Casein Kinase II,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein."} , { "attrname": "Abstract", "value": "alpha-Synuclein has been implicated in the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  since rare autosomal dominant mutations are associated with early onset of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and alpha-synuclein was found to be a major constituent of Lewy bodies. We have analyzed alpha-synuclein expression in transfected cell lines. In pulse-chase experiments alpha-synuclein appeared to be stable over long periods (t((1)\/(2)) 54 h) and no endoproteolytic processing was observed. alpha-Synuclein was constitutively phosphorylated in human kidney 293 cells as well as in rat pheochromocytoma PC12 cells. In both cell lines phosphorylation was highly sensitive to phosphatases,  since okadaic acid markedly stabilized phosphate incorporation. Phosphoamino acid analysis revealed that phosphorylation occurred predominantly on serine. Using site-directed mutagenesis we have identified a major phosphorylation site at serine 129 within the C-terminal domain of alpha-synuclein. An additional site,  which was phosphorylated less efficiently,  was mapped to serine 87. The major phosphorylation site was located within a consensus recognition sequence of casein kinase 1 (CK-1). In vitro experiments and two-dimensional phosphopeptide mapping provided further evidence that serine 129 was phosphorylated by CK-1 and CK-2. Moreover,  phosphorylation of serine 129 was reduced in vivo upon inhibition of CK-1 or CK-2. These data demonstrate that alpha-synuclein is constitutively phosphorylated within its C terminus and may indicate that the function of alpha-synuclein is regulated by phosphorylation\/dephosphorylation. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Antibody Specificity,  Phosphorylation,  Casein Kinase II,  Mutagenesis,  Site-Directed,  Casein Kinases,  Humans,  Protein-Serine-Threonine Kinases,  Serine,  Molecular Sequence Data,  Rats,  Nerve Tissue Proteins,  Synucleins,  PC12 Cells,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Protein Kinase Inhibitors,  Animals,  Protein Kinases,  Phosphoproteins,  Brain Chemistry,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[M Okochi,  J Walter,  A Koyama,  S Nakajo,  M Baba,  T Iwatsubo,  L Meijer,  P J Kahle,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-87 AND SER-129 BY CK1 AND CK2]"} ], "id": "932", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10617630", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10617630"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.275.1.390"} ]} , { "annotation": "[FIBRILS FORMATION,  DOMAIN NAC,  MUTAGENESIS OF 67-GLY--VAL-71; 71-VAL--VAL-82; 76-ALA-VAL-77; VAL-77; ALA-78 AND 85-ALA--PHE-94]", "conames": [{ "name": "PMID: 19722699", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19722699", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Amyloid,  HG18B9YRS7 Valine,  Polymers,  alpha-Synuclein,  OF5P57N2ZX Alanine]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Characterization of hydrophobic residue requirements for alpha-synuclein fibrillization."} , { "attrname": "Abstract", "value": "alpha-Synuclein is the major component of pathological inclusions characteristic of <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s like <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  dementia with Lewy bodies,  and multiple-system atrophy. A role for alpha-synuclein in neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s is further supported by point mutations and duplication and triplication of the alpha-synuclein gene (SNCA) that are causative of these disorders. The middle hydrophobic region of the alpha-synuclein protein,  also termed the \"non-Abeta component of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> amyloid plaque (NAC)\" domain,  is required for alpha-synuclein to polymerize into amyloid filaments,  which are the major components of alpha-synuclein pathological inclusions. In this study,  we assessed the importance of specific stretches of hydrophobic residues in driving the intrinsic ability of alpha-synuclein to polymerize. Several small deletions,  even one with as few as two amino acid residues (A76 and V77),  dramatically impaired the ability of alpha-synuclein to polymerize into mature amyloidogenic fibrils,  and instead,  it preferentially formed oligomers. However,  this inhibition of filament assembly was clearly dependent on the spatial context,  since similar and larger hydrophobic deletions in other parts of the NAC domain reduced only the rate of fibril formation,  without abrogating filament assembly. Further,  mutation of residue E83 to an A rescued the ability of mutant Delta76-77 alpha-synuclein to polymerize. These findings support the notion that while both the location and hydrophobicity of protein segments are important elements that affect the propensity to form amyloid fibrils,  the intrinsic ability of a polypeptide to fold structurally into amyloid is also critical. "} , { "attrname": "MeSH", "value": "[Microscopy,  Electron,  Transmission,  Alanine,  Peptide Fragments,  Mutagenesis,  Site-Directed,  Humans,  Microscopy,  Immunoelectron,  Protein Folding,  Valine,  Hydrophobic and Hydrophilic Interactions,  Amyloid,  Polymers,  alpha-Synuclein,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Elisa A Waxman,  Joseph R Mazzulli,  Benoit I Giasson]"} , { "attrname": "PUB_TYPE", "value": "[FIBRILS FORMATION,  DOMAIN NAC,  MUTAGENESIS OF 67-GLY--VAL-71; 71-VAL--VAL-82; 76-ALA-VAL-77; VAL-77; ALA-78 AND 85-ALA--PHE-94]"} ], "id": "933", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19722699", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI900539P"} , { "elementOf": "NLM", "accession": "19722699"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2-4)]", "conames": [{ "name": "PMID: 7802671", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7802671", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Protein Precursors,  Amyloid,  Nerve Tissue Proteins,  DNA Primers,  Synucleins,  RNA,  Messenger,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Tissue-dependent alternative splicing of mRNA for NACP,  the precursor of non-A beta component of Alzheimer's disease amyloid."} , { "attrname": "Abstract", "value": "A cDNA clone encoding an alternatively spliced form of the precursor of the non-A beta component of Alzheimer's disease amyloid (NACP) was isolated from a human fetal brain cDNA library. This cDNA contains the entire NAC coding sequence but lacks an 84-base-pair nucleotide stretch 3' to the NAC sequence,  resulting in a 112-amino-acid protein,  NACP112,  in contrast with the originally cloned molecule,  NACP140. RT-PCR analysis demonstrated that the mRNA for two types of NACP mRNA are expressed in both fetal and adult brain. Northern blot analysis revealed that NACP140 mRNA was expressed mostly in brain and in minor amount in all the tissues examined. However,  the expression levels of NACP140 mRNA apart from brain were higher in heart,  skeletal muscle,  and pancreas,  contrasting with the predominant expression of total NACP mRNA in brain with a slight expression in placenta. These results suggest differential regulation of NACP RNA splicing among tissues. "} , { "attrname": "MeSH", "value": "[Brain,  Alternative Splicing,  Humans,  Molecular Sequence Data,  Restriction Mapping,  Electrophoresis,  Agar Gel,  Base Sequence,  Polymerase Chain Reaction,  Protein Precursors,  Female,  Fetus,  Amyloid,  Pancreas,  Amino Acid Sequence,  Gene Expression,  Gene Library,  Rats,  Nerve Tissue Proteins,  DNA Primers,  Organ Specificity,  Synucleins,  Pregnancy,  Sequence Homology,  Amino Acid,  Blotting,  Northern,  Animals,  Placenta,  Myocardium,  Muscle,  Skeletal,  RNA,  Messenger,  Amyloid beta-Protein Precursor,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[K Uda,  T Saitoh,  H Mori]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2-4)]"} ], "id": "934", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7802671", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.1994.2816"} , { "elementOf": "NLM", "accession": "7802671"} ]} , { "annotation": "[MUTAGENESIS OF TYR-39; TYR-125; TYR-133 AND TYR-136,  CHARACTERIZATION OF VARIANT THR-53,  PHOSPHORYLATION AT TYR-125]", "conames": [{ "name": "PMID: 12893833", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12893833", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  src kinase associated phosphoprotein 2,  Intracellular Signaling Peptides and Proteins,  EC 2.7.10.2 src-Family Kinases,  EC 2.7.10.2 Focal Adhesion Kinase 2,  Nerve Tissue Proteins,  EC 2.7.10.1 Protein-Tyrosine Kinases,  Synucleins,  Adaptor Proteins,  Vesicular Transport,  alpha-Synuclein,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Identification and characterization of a novel Pyk2\/related adhesion focal tyrosine kinase-associated protein that inhibits alpha-synuclein phosphorylation."} , { "attrname": "Abstract", "value": "alpha-Synuclein is a presynaptic protein involved in the pathogenesis of several neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  such as <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Pyk2\/related adhesion focal tyrosine kinase (RAFTK) tyrosine kinase is an upstream regulator of Src family kinases in the central nervous system that is involved in alpha-synuclein phosphorylation. The present study reports the cloning and characterization of a novel adaptor protein,  Pyk2\/RAFTK-associated protein (PRAP),  that specifically binds to Pyk2\/RAFTK and inhibits alpha-synuclein tyrosine phosphorylation. PRAP contains a coiled-coil domain,  a pleckstrin homology domain,  and a SH3 domain; the SH3 domain binds to the proline-rich domain of Pyk2\/RAFTK. PRAP was observed to be present throughout the brain,  including substantia nigra dopaminergic neurons,  in which it localized to the cytoplasm. PRAP was found to function as a substrate for Src family kinases,  such as c-Src or Fyn,  but not for Pyk2\/RAFTK. Hyperosmotic stress induced phosphorylation of tyrosine 125 of alpha-synuclein via Pyk2\/RAFTK,  which acted through Src family kinases. Such phosphorylation was inhibited by PRAP expression,  suggesting that PRAP negatively regulates alpha-synuclein phosphorylation following cell stress. In conclusion,  PRAP functions as a downstream target for Pyk2\/RAFTK and plays a role in alpha-synuclein phosphorylation. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Osmotic Pressure,  Phosphorylation,  src-Family Kinases,  Humans,  Intracellular Signaling Peptides and Proteins,  Molecular Sequence Data,  Nerve Tissue Proteins,  Focal Adhesion Kinase 2,  Synucleins,  Adaptor Proteins,  Vesicular Transport,  Tissue Distribution,  Two-Hybrid System Techniques,  Cloning,  Molecular,  Protein Binding,  Brain Chemistry,  Protein-Tyrosine Kinases,  alpha-Synuclein,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Tetsuya Takahashi,  Hiroshi Yamashita,  Yoshito Nagano,  Takeshi Nakamura,  Hiromitsu Ohmori,  Hava Avraham,  Shalom Avraham,  Mineo Yasuda,  Masayasu Matsumoto]"} , { "attrname": "PUB_TYPE", "value": "[MUTAGENESIS OF TYR-39; TYR-125; TYR-133 AND TYR-136,  CHARACTERIZATION OF VARIANT THR-53,  PHOSPHORYLATION AT TYR-125]"} ], "id": "935", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12893833", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M213217200"} , { "elementOf": "NLM", "accession": "12893833"} ]} , { "annotation": "[VARIANT PARK1 THR-53]", "conames": [{ "name": "PMID: 9197268", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9197268", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[SNCA protein,  human,  Nerve Tissue Proteins,  Genetic Markers,  Synucleins,  alpha-Synuclein]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Mutation in the alpha-synuclein gene identified in families with Parkinson's disease."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a common neurodegenerative disorder with a lifetime incidence of approximately 2 percent. A pattern of familial aggregation has been documented for the disorder,  and it was recently reported that a PD susceptibility gene in a large Italian kindred is located on the long arm of human chromosome 4. A mutation was identified in the alpha-synuclein gene,  which codes for a presynaptic protein thought to be involved in neuronal plasticity,  in the Italian kindred and in three unrelated families of Greek origin with autosomal dominant inheritance for the PD phenotype. This finding of a specific molecular alteration associated with PD will facilitate the detailed understanding of the pathophysiology of the disorder. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Protein Structure,  Secondary,  Humans,  Molecular Sequence Data,  Male,  Chromosome Mapping,  Nerve Tissue Proteins,  Genetic Markers,  Synucleins,  Chromosomes,  Human,  Pair 4,  Greece,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Phenotype,  Animals,  Genes,  Dominant,  Pedigree,  Base Sequence,  Age of Onset,  Polymerase Chain Reaction,  Female,  Italy,  alpha-Synuclein]"} , { "attrname": "AUTHORS", "value": "[M H Polymeropoulos,  C Lavedan,  E Leroy,  S E Ide,  A Dehejia,  A Dutra,  B Pike,  H Root,  J Rubenstein,  R Boyer,  E S Stenroos,  S Chandrasekharappa,  A Athanassiadou,  T Papapetropoulos,  W G Johnson,  A M Lazzarini,  R C Duvoisin,  G Di Iorio,  L I Golbe,  R L Nussbaum]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK1 THR-53]"} ], "id": "936", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9197268", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.276.5321.2045"} , { "elementOf": "NLM", "accession": "9197268"} ]} , { "annotation": "", "conames": [{ "name": "Dextromethorphan", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "937", "contexts": { } , "evidences": ["Imported from database"], "value": "Dextromethorphan", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00514"} ]} , { "annotation": "", "conames": [{ "name": "Haloperidol", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "3"} ], "id": "938", "contexts": { "context": { "id": 344} } , "evidences": ["Imported from database"], "value": "Haloperidol", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00502"} ]} , { "annotation": "", "conames": [], "elementOf": "UNIPROTKB", "description": "", "pid": "6.3.2.-", "attributes": [], "id": "939", "contexts": { } , "evidences": ["Imported from database"], "value": "6.3.2.-", "ofType": "Enzyme Classification", "coaccessions": [{ "elementOf": "EC", "accession": "6.3.2.-"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 2,  AUTOSOMAL RECESSIVE JUVENILE; PARK2", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "600116", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "940", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 2,  AUTOSOMAL RECESSIVE JUVENILE; PARK2", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "600116"} ]} , { "annotation": "Interacting selectively and non-covalently with the beta subunit of the catenin complex. ( Reference:  GOC: bf )", "conames": [{ "name": "beta-catenin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008013", "attributes": [], "id": "941", "contexts": { } , "evidences": ["Imported from database"], "value": "beta-catenin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008013"} ]} , { "annotation": "Interacting selectively and non-covalently with a PDZ domain of a protein,  a domain found in diverse signaling proteins. ( Reference:  GOC: go_curators Pfam: PF00595 )", "conames": [{ "name": "DHR-domain binding", "isPreferred": "true"} , { "name": "PDZ domain binding", "isPreferred": "true"} , { "name": "GLGF-domain binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030165", "attributes": [], "id": "942", "contexts": { } , "evidences": ["Imported from database"], "value": "PDZ domain binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030165"} ]} , { "annotation": "Interacting selectively and non-covalently with a heat shock protein,  any protein synthesized or activated in response to heat shock. ( Reference:  GOC: mah GOC: vw )", "conames": [{ "name": "heat shock protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031072", "attributes": [], "id": "943", "contexts": { } , "evidences": ["Imported from database"], "value": "heat shock protein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031072"} ]} , { "annotation": "Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X,  where both X-Ub and Y-Ub are covalent linkages. ( Reference:  GOC: BioGRID GOC: jh2 PMID: 9635407 )", "conames": [{ "name": "ubiquitin ligase", "isPreferred": "false"} , { "name": "anaphase-promoting complex", "isPreferred": "false"} , { "name": "ubiquitin-conjugating enzyme", "isPreferred": "false"} , { "name": "ubiquitin-protein transferase activity", "isPreferred": "true"} , { "name": "ubiquitin conjugating enzyme", "isPreferred": "false"} , { "name": "ubiquitin protein ligase", "isPreferred": "false"} , { "name": "E2", "isPreferred": "false"} , { "name": "E3", "isPreferred": "false"} , { "name": "ubiquitin protein-ligase", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004842", "attributes": [], "id": "944", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin-protein transferase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004841"} , { "elementOf": "GO", "accession": "GO: 0004840"} , { "elementOf": "GO", "accession": "GO: 0004842"} ]} , { "annotation": "Catalysis of the joining of two substances,  or two groups within a single molecule,  with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate. ( Reference:  EC: 6 GOC: mah )", "conames": [{ "name": "ligase activity", "isPreferred": "true"} , { "name": "synthetase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016874", "attributes": [], "id": "945", "contexts": { } , "evidences": ["Imported from database"], "value": "synthetase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016874"} ]} , { "annotation": "Interacting selectively and non-covalently with a chaperone protein,  a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport. ( Reference:  http: \/\/www.onelook.com )", "conames": [{ "name": "co-chaperone", "isPreferred": "false"} , { "name": "chaperone protein binding", "isPreferred": "true"} , { "name": "chaperone binding", "isPreferred": "true"} , { "name": "co-chaperonin", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051087", "attributes": [], "id": "946", "contexts": { } , "evidences": ["Imported from database"], "value": "chaperone binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051087"} ]} , { "annotation": "Interacting selectively and non-covalently with an F-box domain of a protein. ( Reference:  GOC: bf GOC: PARL InterPro: IPR001810 PMID: 12628165 )", "conames": [{ "name": "F-box domain binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1990444", "attributes": [], "id": "947", "contexts": { } , "evidences": ["Imported from database"], "value": "F-box domain binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1990444"} ]} , { "annotation": "Interacting selectively and non-covalently with any member of the cullin family,  hydrophobic proteins that act as scaffolds for ubiquitin ligases (E3). ( Reference:  GOC: ha InterPro: IPR016158 PMID: 18698375 )", "conames": [{ "name": "cullin binding", "isPreferred": "false"} , { "name": "cullin family protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0097602", "attributes": [], "id": "948", "contexts": { } , "evidences": ["Imported from database"], "value": "cullin family protein binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0097602"} ]} , { "annotation": "Interacting selectively and non-covalently with ubiquitin,  a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation. ( Reference:  GOC: ecd )", "conames": [{ "name": "ubiquitin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043130", "attributes": [], "id": "949", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043130"} ]} , { "annotation": "Interacting selectively and non-covalently with a ubiquitin conjugating enzyme,  any of the E2 proteins. ( Reference:  GOC: vp )", "conames": [{ "name": "ubiquitin conjugating enzyme binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031624", "attributes": [], "id": "950", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin conjugating enzyme binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031624"} ]} , { "annotation": "Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme,  any of the E3 proteins. ( Reference:  GOC: vp )", "conames": [{ "name": "ubiquitin ligase binding", "isPreferred": "true"} , { "name": "ubiquitin protein ligase binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031625", "attributes": [], "id": "951", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin ligase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031625"} ]} , { "annotation": "Any ubiquitin protein ligase activity that is involved in the ERAD pathway (the targeting of endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome). ( Reference:  GO_REF: 0000061 GOC: bf GOC: PARL GOC: TermGenie PMID: 23990462 )", "conames": [{ "name": "E3 involved in endoplasmic reticulum-associated protein degradation pathway", "isPreferred": "false"} , { "name": "ubiquitin protein ligase activity involved in endoplasmic reticulum-associated degradation", "isPreferred": "true"} , { "name": "ER-associated E3 ligase", "isPreferred": "false"} , { "name": "E3 involved in ER-associated degradation pathway", "isPreferred": "false"} , { "name": "E3 involved in ERAD pathway", "isPreferred": "false"} , { "name": "ubiquitin ligase activity involved in ERAD pathway", "isPreferred": "true"} , { "name": "ubiquitin protein ligase activity involved in ERAD pathway", "isPreferred": "true"} , { "name": "ubiquitin protein ligase activity involved in ER-associated degradation pathway", "isPreferred": "false"} , { "name": "protein ubiquitination activity involved in endoplasmic reticulum-associated protein degradation pathway", "isPreferred": "false"} , { "name": "ubiquitin ligase activity involved in ER-associated degradation pathway", "isPreferred": "false"} , { "name": "ubiquitin protein ligase activity involved in endoplasmic reticulum-associated protein degradation pathway", "isPreferred": "false"} , { "name": "protein ubiquitination activity involved in ERAD pathway", "isPreferred": "true"} , { "name": "protein ubiquitination activity involved in ER-associated degradation pathway", "isPreferred": "false"} , { "name": "protein ubiquitination activity involved in endoplasmic reticulum-associated degradation", "isPreferred": "true"} , { "name": "ubiquitin ligase activity involved in endoplasmic reticulum-associated protein degradation pathway", "isPreferred": "false"} , { "name": "ubiquitin ligase activity involved in endoplasmic reticulum-associated degradation", "isPreferred": "true"} , { "name": "E3 involved in endoplasmic reticulum-associated degradation", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1904264", "attributes": [], "id": "952", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin ligase activity involved in ERAD pathway", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1904264"} ]} , { "annotation": "Interacting selectively and non-covalently with a protein kinase,  any enzyme that catalyzes the transfer of a phosphate group,  usually from ATP,  to a protein substrate. ( Reference:  GOC: jl )", "conames": [{ "name": "protein kinase binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019901", "attributes": [], "id": "953", "contexts": { } , "evidences": ["Imported from database"], "value": "protein kinase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019901"} ]} , { "annotation": "Interacting selectively and non-covalently with any phospholipase,  enzymes that catalyze of the hydrolysis of a glycerophospholipid. ( Reference:  GOC: jl )", "conames": [{ "name": "phospholipase binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043274", "attributes": [], "id": "954", "contexts": { } , "evidences": ["Imported from database"], "value": "phospholipase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043274"} ]} , { "annotation": "Interacting selectively and non-covalently with the enzyme histone deacetylase. ( Reference:  GOC: jl )", "conames": [{ "name": "histone deacetylase binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042826", "attributes": [], "id": "955", "contexts": { } , "evidences": ["Imported from database"], "value": "histone deacetylase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042826"} ]} , { "annotation": "Interacting selectively and non-covalently with a ubiquitin-specific protease. ( Reference:  GOC: bf GOC: PARL PMID: 24063750 )", "conames": [{ "name": "deubiquitinase binding", "isPreferred": "true"} , { "name": "deubiquitinating enzyme binding", "isPreferred": "true"} , { "name": "ubiquitin-specific protease binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1990381", "attributes": [], "id": "956", "contexts": { } , "evidences": ["Imported from database"], "value": "deubiquitinase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1990381"} ]} , { "annotation": "Interacting selectively and non-covalently with a kinase,  any enzyme that catalyzes the transfer of a phosphate group. ( Reference:  GOC: jl )", "conames": [{ "name": "kinase binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019900", "attributes": [], "id": "957", "contexts": { } , "evidences": ["Imported from database"], "value": "kinase binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019900"} ]} , { "annotation": "Interacting selectively and non-covalently with a G-protein coupled receptor. ( Reference:  GOC: ceb GOC: dph )", "conames": [{ "name": "G-protein-coupled receptor binding", "isPreferred": "true"} , { "name": "G protein coupled receptor binding", "isPreferred": "true"} , { "name": "G-protein-coupled receptor ligand", "isPreferred": "false"} , { "name": "G protein coupled receptor ligand", "isPreferred": "false"} , { "name": "G-protein coupled receptor binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001664", "attributes": [], "id": "958", "contexts": { } , "evidences": ["Imported from database"], "value": "G-protein coupled receptor binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001664"} ]} , { "annotation": "Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S --> X + S-ubiquitin,  where X is either an E2 or E3 enzyme,  the X-ubiquitin linkage is a thioester bond,  and the S-ubiquitin linkage is an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate. Note that this may include the extension of ubiquitin chains. ( Reference:  GOC: BioGRID GOC: dph );", "conames": [{ "name": "ubiquitin ligase", "isPreferred": "true"} , { "name": "protein ubiquitination", "isPreferred": "true"} , { "name": "ubiquitin protein ligase activity", "isPreferred": "true"} , { "name": "E3", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0061630", "attributes": [], "id": "959", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin ligase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0061630"} ]} , { "annotation": "Cytoplasmic,  spherical inclusion commonly found in damaged neurons,  and composed of abnormally phosphorylated,  neurofilament proteins aggregated with ubiquitin and alpha-synuclein. ( Reference:  NIF_Subcellular: sao4933778419 )", "conames": [{ "name": "cytoplasmic inclusion", "isPreferred": "false"} , { "name": "Lewy body", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0097413", "attributes": [], "id": "960", "contexts": { } , "evidences": ["Imported from database"], "value": "Lewy body", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0097413"} ]} , { "annotation": "An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules. ( Reference:  PMID: 11121744 )", "conames": [{ "name": "aggresome", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016235", "attributes": [], "id": "961", "contexts": { } , "evidences": ["Imported from database"], "value": "aggresome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016235"} ]} , { "annotation": "A ubiquitin ligase complex containing Parkin (PARK2),  the F-box protein FBXW7 (also called SEL-10) and a cullin from the Cul1 subfamily; substrate specificity is conferred by the F-box protein. ( Reference:  GOC: bf GOC: PARL PMID: 12628165 )", "conames": [{ "name": "Parkin-HSel-10-Cullin-1 complex", "isPreferred": "false"} , { "name": "Parkin-FBXW7-Cul1 ubiquitin ligase complex", "isPreferred": "true"} , { "name": "Parkin\/Cul1\/F-box protein complex", "isPreferred": "true"} , { "name": "Parkin-FBXW7-Cul1 protein complex", "isPreferred": "true"} , { "name": "PARK2-FBXW7-Cul1 complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1990452", "attributes": [], "id": "962", "contexts": { } , "evidences": ["Imported from database"], "value": "PARK2-FBXW7-Cul1 complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1990452"} ]} , { "annotation": "A protein complex that includes a ubiquitin-protein ligase and enables ubiquitin protein ligase activity. The complex also contains other proteins that may confer substrate specificity on the complex. ( Reference:  GOC: jh2 PMID: 9529603 )", "conames": [{ "name": "ubiquitin ligase complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000151", "attributes": [], "id": "963", "contexts": { } , "evidences": ["Imported from database"], "value": "ubiquitin ligase complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000151"} ]} , { "annotation": "Any process that decreases the frequency,  rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "negative regulation of gene expression", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010629", "attributes": [], "id": "964", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of gene expression", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010629"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of a process involved in the formation,  arrangement of constituent parts,  or disassembly of a mitochondrion. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "regulation of mitochondrion organisation", "isPreferred": "true"} , { "name": "regulation of mitochondrion organization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010821", "attributes": [], "id": "965", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of mitochondrion organization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010821"} ]} , { "annotation": "Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation. ( Reference:  GOC: ai )", "conames": [{ "name": "lysosomal protein stabilization", "isPreferred": "false"} , { "name": "protein sequestering", "isPreferred": "false"} , { "name": "positive regulation of protein stability", "isPreferred": "true"} , { "name": "protein stabilization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050821", "attributes": [], "id": "966", "contexts": { } , "evidences": ["Imported from database"], "value": "protein stabilization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050821"} ]} , { "annotation": "Addition of a single ubiquitin group to a protein. ( Reference:  GOC: ai )", "conames": [{ "name": "protein monoubiquitylation", "isPreferred": "true"} , { "name": "protein monoubiquitination", "isPreferred": "true"} , { "name": "protein monoubiquitinylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006513", "attributes": [], "id": "967", "contexts": { } , "evidences": ["Imported from database"], "value": "protein monoubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006513"} ]} , { "annotation": "Any process that decreases the rate,  frequency,  or extent of the Wnt signaling pathway through beta-catenin,  the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "negative regulation of canonical Wnt receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of canonical Wnt signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of Wnt receptor signaling pathway through beta-catenin", "isPreferred": "true"} , { "name": "negative regulation of canonical Wnt receptor signalling pathway", "isPreferred": "true"} , { "name": "negative regulation of canonical Wnt-activated signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090090", "attributes": [], "id": "968", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of canonical Wnt signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090090"} ]} , { "annotation": "Any process that modulates the establishment or extent of the mitochondrial membrane potential,  the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. ( Reference:  GOC: ai )", "conames": [{ "name": "regulation of mitochondrial membrane potential", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051881", "attributes": [], "id": "969", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of mitochondrial membrane potential", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051881"} ]} , { "annotation": "A protein ubiquitination process in which ubiquitin monomers are attached to a protein,  and then ubiquitin polymers are formed by linkages between lysine residues at position 11 of the ubiquitin monomers. K11-linked polyubiquitination targets the substrate protein for degradation. The anaphase-promoting complex promotes the degradation of mitotic regulators by assembling K11-linked polyubiquitin chains. ( Reference:  GOC: jsg GOC: pr GOC: sp PMID: 18485873 PMID: 20655260 PMID: 21113135 )", "conames": [{ "name": "protein K11-linked ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070979", "attributes": [], "id": "970", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K11-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070979"} ]} , { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 6 of the ubiquitin monomers,  is added to a protein. K6-linked ubiquitination is involved in DNA repair. ( Reference:  GOC: sp )", "conames": [{ "name": "protein K6-linked polyubiquitination", "isPreferred": "true"} , { "name": "protein K6-linked ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0085020", "attributes": [], "id": "971", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K6-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0085020"} ]} , { "annotation": "Any process that increases the frequency,  rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). ( Reference:  GOC: dph GOC: jl GOC: tb )", "conames": [{ "name": "upregulation of DNA binding", "isPreferred": "true"} , { "name": "activation of DNA binding", "isPreferred": "false"} , { "name": "positive regulation of DNA binding", "isPreferred": "true"} , { "name": "stimulation of DNA binding", "isPreferred": "false"} , { "name": "up-regulation of DNA binding", "isPreferred": "true"} , { "name": "up regulation of DNA binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043388", "attributes": [], "id": "972", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of DNA binding", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043388"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of primary amine oxidase activity. ( Reference:  GOC: TermGenie PMID: 23349812 )", "conames": [{ "name": "down-regulation of primary amine oxidase", "isPreferred": "true"} , { "name": "downregulation of amine oxidase (copper-containing)", "isPreferred": "false"} , { "name": "down regulation of primary amine oxidase", "isPreferred": "true"} , { "name": "inhibition of amine oxidase (copper-containing)", "isPreferred": "false"} , { "name": "down-regulation of amine oxidase (copper-containing)", "isPreferred": "false"} , { "name": "down regulation of amine oxidase (copper-containing)", "isPreferred": "false"} , { "name": "negative regulation of primary-amine: oxygen oxidoreductase (deaminating)", "isPreferred": "true"} , { "name": "inhibition of primary amine oxidase", "isPreferred": "false"} , { "name": "negative regulation of amine oxidase (copper-containing)", "isPreferred": "false"} , { "name": "inhibition of primary-amine: oxygen oxidoreductase (deaminating)", "isPreferred": "false"} , { "name": "downregulation of primary amine oxidase", "isPreferred": "true"} , { "name": "negative regulation of primary amine oxidase activity", "isPreferred": "true"} , { "name": "down regulation of primary-amine: oxygen oxidoreductase (deaminating)", "isPreferred": "true"} , { "name": "down-regulation of primary-amine: oxygen oxidoreductase (deaminating)", "isPreferred": "true"} , { "name": "downregulation of primary-amine: oxygen oxidoreductase (deaminating)", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902283", "attributes": [], "id": "973", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of primary amine oxidase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902283"} ]} , { "annotation": "A process in which a host organism stops,  prevents or reduces the frequency,  rate or extent of viral genome replication. ( Reference:  GOC: jl )", "conames": [{ "name": "negative regulation by host of viral genome replication", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044828", "attributes": [], "id": "974", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation by host of viral genome replication", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044828"} ]} , { "annotation": "The aggregation,  arrangement and bonding together of a set of components to form an aggresome; requires the microtubule cytoskeleton and dynein. ( Reference:  GOC: BHF GOC: rl PMID: 14675537 )", "conames": [{ "name": "aggresome assembly", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070842", "attributes": [], "id": "975", "contexts": { } , "evidences": ["Imported from database"], "value": "aggresome assembly", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070842"} ]} , { "annotation": "Any process that increases the frequency,  rate or extent of merging of two or more mitochondria within a cell to form a single compartment. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "positive regulation of mitochondrial fusion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010636", "attributes": [], "id": "976", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of mitochondrial fusion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010636"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the assembly of actin filament bundles. ( Reference:  GOC: mah )", "conames": [{ "name": "inhibition of actin filament bundle formation", "isPreferred": "false"} , { "name": "down-regulation of actin filament bundle formation", "isPreferred": "true"} , { "name": "downregulation of actin filament bundle formation", "isPreferred": "true"} , { "name": "negative regulation of actin filament bundle assembly", "isPreferred": "true"} , { "name": "down regulation of actin filament bundle formation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032232", "attributes": [], "id": "977", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of actin filament bundle formation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032232"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 15790595 )", "conames": [{ "name": "protection against oxidative stress-induced neuron apoptosis", "isPreferred": "false"} , { "name": "negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "down-regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "negative regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "down regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "down-regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "negative regulation of oxidative stress-induced neuron apoptosis", "isPreferred": "true"} , { "name": "inhibition of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "protection against oxidative stress-induced neuronal apoptosis", "isPreferred": "false"} , { "name": "downregulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "inhibition of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "false"} , { "name": "negative regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "downregulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "down regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "neuroprotection against oxidative stress-induced apoptosis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903377", "attributes": [], "id": "978", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of oxidative stress-induced neuron apoptosis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903377"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of proteasomal protein catabolic process. ( Reference:  GOC: BHF GOC: rl GOC: TermGenie PMID: 21669198 )", "conames": [{ "name": "activation of proteasomal protein catabolic process", "isPreferred": "false"} , { "name": "positive regulation of proteasomal protein catabolic process", "isPreferred": "true"} , { "name": "up regulation of proteasome-mediated protein catabolic process", "isPreferred": "true"} , { "name": "upregulation of proteasome-mediated protein catabolic process", "isPreferred": "true"} , { "name": "up-regulation of proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "activation of proteasome-mediated protein catabolic process", "isPreferred": "true"} , { "name": "up-regulation of proteasomal protein catabolic process", "isPreferred": "true"} , { "name": "positive regulation of proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "up regulation of proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "upregulation of proteasomal protein catabolic process", "isPreferred": "true"} , { "name": "upregulation of proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "activation of proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "up regulation of proteasomal protein catabolic process", "isPreferred": "true"} , { "name": "up-regulation of proteasome-mediated protein catabolic process", "isPreferred": "true"} , { "name": "positive regulation of proteasome-mediated protein catabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1901800", "attributes": [], "id": "979", "contexts": { } , "evidences": ["Imported from database"], "value": "activation of proteasome-mediated protein catabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1901800"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of spontaneous neurotransmitter secretion. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 22314364 )", "conames": [{ "name": "downregulation of spontaneous neurotransmitter secretion", "isPreferred": "true"} , { "name": "downregulation of stimulus-independent neurotransmitter secretion", "isPreferred": "true"} , { "name": "negative regulation of spontaneous neurotransmitter secretion", "isPreferred": "true"} , { "name": "inhibition of stimulus-independent neurotransmitter secretion", "isPreferred": "false"} , { "name": "negative regulation of stimulus-independent neurotransmitter secretion", "isPreferred": "true"} , { "name": "down regulation of stimulus-independent neurotransmitter secretion", "isPreferred": "true"} , { "name": "down-regulation of stimulus-independent neurotransmitter secretion", "isPreferred": "true"} , { "name": "inhibition of spontaneous neurotransmitter secretion", "isPreferred": "false"} , { "name": "down regulation of spontaneous neurotransmitter secretion", "isPreferred": "true"} , { "name": "down-regulation of spontaneous neurotransmitter secretion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1904049", "attributes": [], "id": "980", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of spontaneous neurotransmitter secretion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1904049"} ]} , { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 29 of the ubiquitin monomers,  is added to a protein. K29-linked ubiquitination targets the substrate protein for degradation. ( Reference:  PMID: 17028573 )", "conames": [{ "name": "protein K29-linked polyubiquitination", "isPreferred": "true"} , { "name": "protein K29-linked ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035519", "attributes": [], "id": "981", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K29-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035519"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of oxidative stress-induced cell death. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 24252804 )", "conames": [{ "name": "down regulation of cell death in response to oxidative stress", "isPreferred": "true"} , { "name": "negative regulation of oxidative stress-induced cell death", "isPreferred": "true"} , { "name": "protection against oxidative stress-induced cell death", "isPreferred": "false"} , { "name": "down-regulation of cell death in response to oxidative stress", "isPreferred": "true"} , { "name": "inhibition of cell death in response to oxidative stress", "isPreferred": "false"} , { "name": "negative regulation of cell death in response to oxidative stress", "isPreferred": "true"} , { "name": "downregulation of cell death in response to oxidative stress", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903202", "attributes": [], "id": "982", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of oxidative stress-induced cell death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903202"} ]} , { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 63 of the ubiquitin monomers,  is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation,  but is involved in several pathways,  notably as a signal to promote error-free DNA postreplication repair. ( Reference:  GOC: mah PMID: 15556404 )", "conames": [{ "name": "protein K63-linked ubiquitination", "isPreferred": "true"} , { "name": "protein K63-linked polyubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070534", "attributes": [], "id": "983", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K63-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070534"} ]} , { "annotation": "Addition of multiple ubiquitin groups to a protein,  forming a ubiquitin chain. ( Reference:  ISBN: 0815316194 )", "conames": [{ "name": "protein polyubiquitination", "isPreferred": "true"} , { "name": "protein polyubiquitylation", "isPreferred": "true"} , { "name": "protein polyubiquitinylation", "isPreferred": "true"} , { "name": "polyubiquitin", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000209", "attributes": [], "id": "984", "contexts": { } , "evidences": ["Imported from database"], "value": "protein polyubiquitylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000209"} ]} , { "annotation": "Any process that decreases the rate,  frequency or extent of release of cytochrome c from mitochondria,  the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol,  which is an early step in apoptosis and leads to caspase activation. ( Reference:  GOC: BHF GOC: dph GOC: mtg_apoptosis GOC: tb )", "conames": [{ "name": "negative regulation of release of cytochrome c from mitochondria", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090201", "attributes": [], "id": "985", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of release of cytochrome c from mitochondria", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090201"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the addition of ubiquitin groups to a protein. ( Reference:  GOC: mah )", "conames": [{ "name": "regulation of protein ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031396", "attributes": [], "id": "986", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of protein ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031396"} ]} , { "annotation": "The process in which one or more ubiquitin groups are added to a protein. ( Reference:  GOC: ai )", "conames": [{ "name": "protein ubiquitinylation", "isPreferred": "true"} , { "name": "protein ubiquitination", "isPreferred": "true"} , { "name": "protein ubiquitylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016567", "attributes": [], "id": "987", "contexts": { } , "evidences": ["Imported from database"], "value": "protein ubiquitylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016567"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie )", "conames": [{ "name": "positive regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "up-regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "activation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "false"} , { "name": "up regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "up regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "activation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "upregulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "positive regulation of neuron apoptosis in response to oxidative stress", "isPreferred": "false"} , { "name": "upregulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} , { "name": "up-regulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903378", "attributes": [], "id": "988", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of neuron intrinsic apoptotic signaling pathway in response to oxidative stress", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903378"} ]} , { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 27 of the ubiquitin monomers,  is added to a protein. ( Reference:  PMID: 19345326 )", "conames": [{ "name": "protein K27-linked polyubiquitination", "isPreferred": "true"} , { "name": "protein K27-linked ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044314", "attributes": [], "id": "989", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K27-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044314"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the chemical reactions and pathways involving dopamine. ( Reference:  GOC: go_curators )", "conames": [{ "name": "regulation of dopamine metabolism", "isPreferred": "true"} , { "name": "regulation of dopamine metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042053", "attributes": [], "id": "990", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of dopamine metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042053"} ]} , { "annotation": "Any process that increases the frequency,  rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "positive regulation of gene expression", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010628", "attributes": [], "id": "991", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of gene expression", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010628"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of tumor necrosis factor-mediated signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23453807 )", "conames": [{ "name": "activation of tumor necrosis factor alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "upregulation of adipocytokine signaling pathway", "isPreferred": "false"} , { "name": "up regulation of tumor necrosis factor-mediated signaling pathway", "isPreferred": "true"} , { "name": "positive regulation of tumor necrosis factor-mediated signaling pathway", "isPreferred": "true"} , { "name": "up-regulation of tumor necrosis factor-mediated signalling pathway", "isPreferred": "true"} , { "name": "upregulation of tumor necrosis factor-mediated signalling pathway", "isPreferred": "true"} , { "name": "up-regulation of tumor necrosis factor-mediated signaling pathway", "isPreferred": "true"} , { "name": "upregulation of tumor necrosis factor-mediated signaling pathway", "isPreferred": "true"} , { "name": "up-regulation of TNF-alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "up regulation of tumor necrosis factor alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "activation of tumor necrosis factor-mediated signaling pathway", "isPreferred": "false"} , { "name": "positive regulation of TNF-alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "up regulation of tumor necrosis factor-mediated signalling pathway", "isPreferred": "true"} , { "name": "upregulation of TNF-alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "positive regulation of adipocytokine signaling pathway", "isPreferred": "false"} , { "name": "upregulation of tumor necrosis factor alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "up-regulation of adipocytokine signaling pathway", "isPreferred": "false"} , { "name": "positive regulation of tumor necrosis factor-mediated signalling pathway", "isPreferred": "true"} , { "name": "up regulation of adipocytokine signaling pathway", "isPreferred": "false"} , { "name": "activation of TNF-alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "activation of tumor necrosis factor-mediated signalling pathway", "isPreferred": "false"} , { "name": "positive regulation of tumor necrosis factor alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "up-regulation of tumor necrosis factor alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "up regulation of TNF-alpha-mediated signaling pathway", "isPreferred": "false"} , { "name": "activation of adipocytokine signaling pathway", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903265", "attributes": [], "id": "992", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of tumor necrosis factor-mediated signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903265"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of the directed movement of lipids into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: mah )", "conames": [{ "name": "regulation of lipid transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032368", "attributes": [], "id": "993", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of lipid transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032368"} ]} , { "annotation": "The chemical reactions and pathways involving norepinephrine,  a hormone secreted by the adrenal medulla,  and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts in the central nervous system. It is also the demethylated biosynthetic precursor of epinephrine. ( Reference:  GOC: jl ISBN: 0198506732 )", "conames": [{ "name": "norepinephrine metabolic process", "isPreferred": "true"} , { "name": "noradrenaline metabolic process", "isPreferred": "true"} , { "name": "levarterenol metabolic process", "isPreferred": "true"} , { "name": "noradrenaline metabolism", "isPreferred": "true"} , { "name": "norepinephrine metabolism", "isPreferred": "true"} , { "name": "levarterenol metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042415", "attributes": [], "id": "994", "contexts": { } , "evidences": ["Imported from database"], "value": "levarterenol metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042415"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of cellular response to oxidative stress. ( Reference:  GOC: mah GOC: TermGenie )", "conames": [{ "name": "regulation of cellular response to oxidative stress", "isPreferred": "true"} , { "name": "regulation of adaptive response to oxidative stress", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1900407", "attributes": [], "id": "995", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of cellular response to oxidative stress", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1900407"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of transcription from an RNA polymerase II promoter. ( Reference:  GOC: go_curators GOC: txnOH )", "conames": [{ "name": "up-regulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "positive regulation of transcription from RNA polymerase II promoter,  global", "isPreferred": "false"} , { "name": "activation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "up-regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "up regulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "activation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "positive regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "stimulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "upregulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "positive regulation of gene-specific transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "positive regulation of global transcription from Pol II promoter", "isPreferred": "false"} , { "name": "stimulation of global transcription from RNA polymerase II promoter", "isPreferred": "false"} , { "name": "positive regulation of transcription from Pol II promoter", "isPreferred": "true"} , { "name": "up regulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} , { "name": "upregulation of transcription from RNA polymerase II promoter", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045944", "attributes": [], "id": "996", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of transcription from Pol II promoter", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045944"} , { "elementOf": "GO", "accession": "GO: 0010552"} , { "elementOf": "GO", "accession": "GO: 0045817"} ]} , { "annotation": "The cellular synthesis of RNA on a template of DNA. ( Reference:  GOC: jl GOC: txnOH )", "conames": [{ "name": "transcription regulator", "isPreferred": "false"} , { "name": "cellular transcription", "isPreferred": "false"} , { "name": "transcription", "isPreferred": "false"} , { "name": "transcription,  DNA-templated", "isPreferred": "true"} , { "name": "DNA-dependent transcription", "isPreferred": "true"} , { "name": "cellular transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "transcription,  DNA-dependent", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006351", "attributes": [], "id": "997", "contexts": { } , "evidences": ["Imported from database"], "value": "DNA-dependent transcription", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0061018"} , { "elementOf": "GO", "accession": "GO: 0006350"} , { "elementOf": "GO", "accession": "GO: 0006351"} , { "elementOf": "GO", "accession": "GO: 0061022"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell. ( Reference:  GOC: ai )", "conames": [{ "name": "activation of neurotransmitter uptake", "isPreferred": "false"} , { "name": "positive regulation of neurotransmitter import", "isPreferred": "true"} , { "name": "up-regulation of neurotransmitter uptake", "isPreferred": "true"} , { "name": "stimulation of neurotransmitter uptake", "isPreferred": "false"} , { "name": "up regulation of neurotransmitter uptake", "isPreferred": "true"} , { "name": "upregulation of neurotransmitter uptake", "isPreferred": "true"} , { "name": "positive regulation of neurotransmitter uptake", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051582", "attributes": [], "id": "998", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of neurotransmitter uptake", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051582"} ]} , { "annotation": "A protein ubiquitination process in which a polymer of ubiquitin,  formed by linkages between lysine residues at position 48 of the ubiquitin monomers,  is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation. ( Reference:  GOC: cvs PMID: 15556404 )", "conames": [{ "name": "protein K48-linked ubiquitination", "isPreferred": "true"} , { "name": "protein K48-linked polyubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070936", "attributes": [], "id": "999", "contexts": { } , "evidences": ["Imported from database"], "value": "protein K48-linked ubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070936"} ]} , { "annotation": "The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein,  includes retrotranslocation (dislocation) of the protein from the ER to the cytosol,  protein modifications necessary for correct substrate transfer (e.g. ubiquitination),  transport of the protein to the proteasome,  and ends with degradation of the protein by the cytoplasmic proteasome. ( Reference:  GOC: bf GOC: PARL )", "conames": [{ "name": "ER-associated degradation pathway", "isPreferred": "false"} , { "name": "ERAD pathway", "isPreferred": "true"} , { "name": "endoplasmic reticulum-associated degradation", "isPreferred": "true"} , { "name": "endoplasmic reticulum-associated protein degradation pathway", "isPreferred": "false"} , { "name": "protein degradation by ERAD", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0036503", "attributes": [], "id": "1000", "contexts": { } , "evidences": ["Imported from database"], "value": "ERAD pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0036503"} ]} , { "annotation": "The process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. ( Reference:  GOC: kmv )", "conames": [{ "name": "synaptic transmission,  glutamatergic", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035249", "attributes": [], "id": "1001", "contexts": { } , "evidences": ["Imported from database"], "value": "synaptic transmission,  glutamatergic", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035249"} ]} , { "annotation": "Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease,  rather than simply deteriorating gradually over time,  which culminates in cell death. ( Reference:  GOC: BHF GOC: dph GOC: tb );", "conames": [{ "name": "negative regulation of cell death", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060548", "attributes": [], "id": "1002", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of cell death", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060548"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a toxic stimulus. ( Reference:  GOC: pr )", "conames": [{ "name": "cellular response to toxic substance", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0097237", "attributes": [], "id": "1003", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to toxic substance", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0097237"} ]} , { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein by individual cells. ( Reference:  GOC: jl )", "conames": [{ "name": "cellular protein catabolism", "isPreferred": "true"} , { "name": "cellular protein breakdown", "isPreferred": "true"} , { "name": "cellular protein degradation", "isPreferred": "true"} , { "name": "cellular protein catabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044257", "attributes": [], "id": "1004", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular protein breakdown", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044257"} ]} , { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds,  initiated by the covalent attachment of ubiquitin,  and mediated by the proteasome. ( Reference:  GOC: go_curators )", "conames": [{ "name": "proteasomal processing", "isPreferred": "false"} , { "name": "proteasomal ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "proteasomal ubiquitin-dependent protein breakdown", "isPreferred": "true"} , { "name": "proteasomal ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "proteasomal pathway", "isPreferred": "true"} , { "name": "proteasome-mediated ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "proteasomal ubiquitin-dependent protein degradation", "isPreferred": "true"} , { "name": "proteasome pathway", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043161", "attributes": [], "id": "1005", "contexts": { } , "evidences": ["Imported from database"], "value": "proteasomal pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043161"} ]} , { "annotation": "The chemical reactions and pathways involving dopamine,  a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. ( Reference:  GOC: jl ISBN: 0198506732 )", "conames": [{ "name": "dopamine metabolic process", "isPreferred": "true"} , { "name": "dopamine metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042417", "attributes": [], "id": "1006", "contexts": { } , "evidences": ["Imported from database"], "value": "dopamine metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042417"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of glucokinase activity,  the catalysis of the transfer of a phosphate group,  usually from ATP,  to a glucose molecule. ( Reference:  GOC: mah )", "conames": [{ "name": "down regulation of glucokinase", "isPreferred": "true"} , { "name": "negative regulation of glucokinase activity", "isPreferred": "true"} , { "name": "glucokinase inhibitor", "isPreferred": "false"} , { "name": "down-regulation of glucokinase", "isPreferred": "true"} , { "name": "inhibition of glucokinase", "isPreferred": "false"} , { "name": "downregulation of glucokinase", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0033132", "attributes": [], "id": "1007", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of glucokinase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0033132"} ]} , { "annotation": "The ubiquitination by a protein of one or more of its own amino acid residues,  or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. ( Reference:  GOC: ai )", "conames": [{ "name": "protein autoubiquitination", "isPreferred": "true"} , { "name": "protein auto-ubiquitinylation", "isPreferred": "true"} , { "name": "protein autoubiquitinylation", "isPreferred": "true"} , { "name": "protein self-ubiquitinylation", "isPreferred": "true"} , { "name": "protein auto-ubiquitination", "isPreferred": "true"} , { "name": "protein self-ubiquitination", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051865", "attributes": [], "id": "1008", "contexts": { } , "evidences": ["Imported from database"], "value": "protein autoubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051865"} ]} , { "annotation": "The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome. ( Reference:  GOC: tb )", "conames": [{ "name": "proteasome-mediated protein catabolism", "isPreferred": "true"} , { "name": "proteasome-mediated protein catabolic process", "isPreferred": "true"} , { "name": "proteasomal protein catabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010498", "attributes": [], "id": "1009", "contexts": { } , "evidences": ["Imported from database"], "value": "proteasomal protein catabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010498"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of protein linear polyubiquitination. ( Reference:  GOC: TermGenie PMID: 21931591 )", "conames": [{ "name": "activation of M1 linkage", "isPreferred": "false"} , { "name": "activation of protein linear polyubiquitination", "isPreferred": "false"} , { "name": "up regulation of M1 linkage", "isPreferred": "false"} , { "name": "upregulation of protein linear polyubiquitination", "isPreferred": "true"} , { "name": "positive regulation of protein linear polyubiquitination", "isPreferred": "true"} , { "name": "up-regulation of M1 linkage", "isPreferred": "false"} , { "name": "upregulation of M1 linkage", "isPreferred": "false"} , { "name": "up regulation of protein linear polyubiquitination", "isPreferred": "true"} , { "name": "up-regulation of protein linear polyubiquitination", "isPreferred": "true"} , { "name": "positive regulation of M1 linkage", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902530", "attributes": [], "id": "1010", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of protein linear polyubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902530"} ]} , { "annotation": "An action or movement due to the application of a sudden unexpected stimulus. ( Reference:  GOC: dph )", "conames": [{ "name": "startle response", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001964", "attributes": [], "id": "1011", "contexts": { } , "evidences": ["Imported from database"], "value": "startle response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001964"} ]} , { "annotation": "The autophagic process in which mitochondria are delivered to the vacuole and degraded in response to changing cellular conditions. ( Reference:  GOC: autophagy PMID: 15798367 PMID: 19289147 PMID: 23065344 )", "conames": [{ "name": "mitophagy", "isPreferred": "true"} , { "name": "mitochondrion autophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000422", "attributes": [], "id": "1012", "contexts": { } , "evidences": ["Imported from database"], "value": "mitophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000422"} ]} , { "annotation": "Any process that increases the rate,  frequency or extent of mitochondrial fission. Mitochondrial fission is the division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conames": [{ "name": "positive regulation of mitochondrial division", "isPreferred": "true"} , { "name": "positive regulation of mitochondrial fission", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0090141", "attributes": [], "id": "1013", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of mitochondrial fission", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0090141"} ]} , { "annotation": "Any process in an organism in which a relatively long-lasting adaptive behavioral change occurs as the result of experience. ( Reference:  ISBN: 0582227089 ISBN: 0721662544 )", "conames": [{ "name": "learning", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007612", "attributes": [], "id": "1014", "contexts": { } , "evidences": ["Imported from database"], "value": "learning", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007612"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of reactive oxygen species metabolic process. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of ROS metabolic process", "isPreferred": "true"} , { "name": "negative regulation of reactive oxygen species metabolism", "isPreferred": "true"} , { "name": "negative regulation of reactive oxygen species metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000378", "attributes": [], "id": "1015", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of ROS metabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000378"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of signal transduction mediated by the JNK cascade. ( Reference:  GOC: bf )", "conames": [{ "name": "negative regulation of JNK cascade", "isPreferred": "true"} , { "name": "downregulation of JNK cascade", "isPreferred": "true"} , { "name": "down regulation of JNK cascade", "isPreferred": "true"} , { "name": "inhibition of JNK cascade", "isPreferred": "false"} , { "name": "down-regulation of JNK cascade", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046329", "attributes": [], "id": "1016", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of JNK cascade", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046329"} ]} , { "annotation": "The process whose specific outcome is the progression of the central nervous system over time,  from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain,  cerebral ganglia and a nerve cord. ( Reference:  GOC: bf GOC: jid ISBN: 0582227089 )", "conames": [{ "name": "central nervous system development", "isPreferred": "true"} , { "name": "CNS development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007417", "attributes": [], "id": "1017", "contexts": { } , "evidences": ["Imported from database"], "value": "CNS development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007417"} ]} , { "annotation": "Any process involved in the maintenance of an internal steady state of zinc ions within an organism or cell. ( Reference:  GOC: ai GOC: jid GOC: mah )", "conames": [{ "name": "zinc homeostasis", "isPreferred": "false"} , { "name": "zinc ion homeostasis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0055069", "attributes": [], "id": "1018", "contexts": { } , "evidences": ["Imported from database"], "value": "zinc ion homeostasis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0055069"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of mitochondrion degradation (mitophagy). ( Reference:  GO_REF: 0000058 GOC: autophagy GOC: bf GOC: PARL GOC: TermGenie PMID: 24600391 )", "conames": [{ "name": "regulation of mitochondrion degradation", "isPreferred": "false"} , { "name": "regulation of mitophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903146", "attributes": [], "id": "1019", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of mitophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903146"} ]} , { "annotation": "Any process that modulates the rate,  frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose,  the aldohexose gluco-hexose. ( Reference:  GOC: BHF GOC: tb )", "conames": [{ "name": "regulation of glucose metabolic process", "isPreferred": "true"} , { "name": "regulation of glucose metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010906", "attributes": [], "id": "1020", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of glucose metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010906"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of protein targeting to mitochondrion. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie )", "conames": [{ "name": "regulation of protein targeting to mitochondrion", "isPreferred": "true"} , { "name": "regulation of protein-mitochondrial targeting", "isPreferred": "true"} , { "name": "regulation of mitochondrial translocation", "isPreferred": "false"} , { "name": "regulation of protein import into mitochondrion", "isPreferred": "true"} , { "name": "regulation of protein targeting to mitochondria", "isPreferred": "true"} , { "name": "regulation of mitochondrial protein import", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903214", "attributes": [], "id": "1021", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of protein-mitochondrial targeting", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903214"} ]} , { "annotation": "Degradation of a mitochondrion by macroautophagy. ( Reference:  PMID: 15798367 )", "conames": [{ "name": "macromitophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000423", "attributes": [], "id": "1022", "contexts": { } , "evidences": ["Imported from database"], "value": "macromitophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000423"} ]} , { "annotation": "The process in which a ubiquitin group,  or multiple groups,  are covalently attached to the target protein,  thereby initiating the degradation of that protein. ( Reference:  GOC: go_curators )", "conames": [{ "name": "protein degradation tagging", "isPreferred": "false"} , { "name": "myofibrillar protein ubiquitination during ubiquitin-dependent protein breakdown", "isPreferred": "false"} , { "name": "myofibrillar protein ubiquitination during ubiquitin-dependent protein degradation", "isPreferred": "false"} , { "name": "protein ubiquitinylation during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "protein ubiquitylation during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "protein ubiquitination during ubiquitin-dependent protein catabolic process", "isPreferred": "false"} , { "name": "protein ubiquitination during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "protein ubiquitination during ubiquitin-dependent protein degradation", "isPreferred": "true"} , { "name": "protein ubiquitylation during ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "protein ubiquitination involved in ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "protein ubiquitination during ubiquitin-dependent protein breakdown", "isPreferred": "true"} , { "name": "myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolic process", "isPreferred": "false"} , { "name": "myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolism", "isPreferred": "false"} , { "name": "protein ubiquitinylation during ubiquitin-dependent protein catabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042787", "attributes": [], "id": "1023", "contexts": { } , "evidences": ["Imported from database"], "value": "protein ubiquitination during ubiquitin-dependent protein breakdown", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043432"} , { "elementOf": "GO", "accession": "GO: 0042787"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of reactive oxygen species metabolic process. ( Reference:  GOC: mah )", "conames": [{ "name": "regulation of reactive oxygen species metabolism", "isPreferred": "true"} , { "name": "regulation of reactive oxygen species metabolic process", "isPreferred": "true"} , { "name": "regulation of ROS metabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000377", "attributes": [], "id": "1024", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of ROS metabolic process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000377"} ]} , { "annotation": "The cellular homeostatic process that preserves a neuron in a stable,  differentiated functional and structural state. ( Reference:  GOC: BHF GOC: mah )", "conames": [{ "name": "neuron maintenance", "isPreferred": "true"} , { "name": "neuron cellular homeostasis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070050", "attributes": [], "id": "1025", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron maintenance", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070050"} ]} , { "annotation": "The division of a mitochondrion within a cell to form two or more separate mitochondrial compartments. ( Reference:  PMID: 11038192 )", "conames": [{ "name": "mitochondrial proliferation", "isPreferred": "false"} , { "name": "mitochondrial fission", "isPreferred": "true"} , { "name": "mitochondrial division", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000266", "attributes": [], "id": "1026", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial fission", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000266"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of dendrite extension. ( Reference:  GO_REF: 0000058 GOC: pad GOC: PARL GOC: TermGenie PMID: 24898855 )", "conames": [{ "name": "positive regulation of dendrite extension", "isPreferred": "true"} , { "name": "up regulation of dendrite extension", "isPreferred": "true"} , { "name": "upregulation of dendrite extension", "isPreferred": "true"} , { "name": "up-regulation of dendrite extension", "isPreferred": "true"} , { "name": "activation of dendrite extension", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903861", "attributes": [], "id": "1027", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of dendrite extension", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903861"} ]} , { "annotation": "Any process that decreases the frequency,  rate or extent of merging of two or more mitochondria within a cell to form a single compartment. ( Reference:  GOC: dph GOC: tb )", "conames": [{ "name": "negative regulation of mitochondrial fusion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010637", "attributes": [], "id": "1028", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of mitochondrial fusion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010637"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the regulated release of insulin. ( Reference:  GOC: ai )", "conames": [{ "name": "inhibition of insulin secretion", "isPreferred": "false"} , { "name": "down-regulation of insulin secretion", "isPreferred": "true"} , { "name": "negative regulation of insulin secretion", "isPreferred": "true"} , { "name": "downregulation of insulin secretion", "isPreferred": "true"} , { "name": "down regulation of insulin secretion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046676", "attributes": [], "id": "1029", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of insulin secretion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046676"} ]} , { "annotation": "The macromitophagy process that is triggered by a detection of the loss of mitochondrial membrane potential. ( Reference:  GOC: PARL PMID: 18200046 PMID: 23985961 )", "conames": [{ "name": "mitophagy in response to mitochondrial depolarization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0098779", "attributes": [], "id": "1030", "contexts": { } , "evidences": ["Imported from database"], "value": "mitophagy in response to mitochondrial depolarization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0098779"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of I-kappaB kinase NF-kappaB signaling. ( Reference:  GOC: jl )", "conames": [{ "name": "stimulation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} , { "name": "positive regulation of I-kappaB kinase\/NF-kappaB signaling", "isPreferred": "true"} , { "name": "up-regulation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} , { "name": "up regulation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} , { "name": "upregulation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} , { "name": "activation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} , { "name": "positive regulation of I-kappaB kinase\/NF-kappaB cascade", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043123", "attributes": [], "id": "1031", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of I-kappaB kinase\/NF-kappaB signaling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043123"} ]} , { "annotation": "The major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells,  it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane-bounded autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane-bounded structure.  Autophagosomes then fuse with a lysosome (or vacuole) releasing single-membrane-bounded autophagic bodies that are then degraded within the lysosome (or vacuole). Though once thought to be a purely non-selective process,  it appears that some types of macroautophagy,  e.g. macropexophagy,  macromitophagy,  may involve selective targeting of the targets to be degraded. ( Reference:  PMID: 11099404 PMID: 12914914 PMID: 15798367 PMID: 16973210 PMID: 20159618 PMID: 9412464 );", "conames": [{ "name": "non-specific autophagy", "isPreferred": "true"} , { "name": "starvation-induced autophagy", "isPreferred": "true"} , { "name": "autophagy in response to cellular starvation", "isPreferred": "true"} , { "name": "macroautophagy", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016236", "attributes": [], "id": "1032", "contexts": { } , "evidences": ["Imported from database"], "value": "macroautophagy", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016236"} , { "elementOf": "GO", "accession": "GO: 0034262"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen. ( Reference:  GOC: cjm GOC: mah )", "conames": [{ "name": "response to ER stress", "isPreferred": "true"} , { "name": "response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "cellular response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "ER stress response", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034976", "attributes": [], "id": "1033", "contexts": { } , "evidences": ["Imported from database"], "value": "ER stress response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034976"} ]} , { "annotation": "The process of creating free ubiquitin chains,  compounds composed of a large number of ubiquitin monomers. These chains are not conjugated to a protein. ( Reference:  GOC: BHF GOC: dph GOC: tb )", "conames": [{ "name": "free ubiquitin chain polymerization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0010994", "attributes": [], "id": "1034", "contexts": { } , "evidences": ["Imported from database"], "value": "free ubiquitin chain polymerization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0010994"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of an endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway. ( Reference:  GO_REF: 0000058 GOC: bf GOC: PARL GOC: TermGenie PMID: 23453807 )", "conames": [{ "name": "negative regulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "downregulation of neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "negative regulation of neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "down-regulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "downregulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "inhibition of ER stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "false"} , { "name": "down regulation of neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "down regulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "inhibition of neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "false"} , { "name": "negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "down regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "down-regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} , { "name": "down-regulation of neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress", "isPreferred": "true"} , { "name": "inhibition of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "false"} , { "name": "downregulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1903382", "attributes": [], "id": "1035", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of ER stress-induced neuron intrinsic apoptotic signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1903382"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of an unfolded protein stimulus. ( Reference:  GOC: mah )", "conames": [{ "name": "heat shock protein", "isPreferred": "false"} , { "name": "cellular response to unfolded protein", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034620", "attributes": [], "id": "1036", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to unfolded protein", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034620"} ]} , { "annotation": "[INTERACTION WITH RNF41,  UBIQUITINATION,  MUTAGENESIS OF CYS-421,  FUNCTION]", "conames": [{ "name": "PMID: 18541373", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18541373", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[Reactive Oxygen Species,  EC 2.3.2.27 RNF41 protein,  human,  EC 2.3.2.27 parkin protein,  RNA,  Small Interfering,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Parkin is ubiquitinated by Nrdp1 and abrogates Nrdp1-induced oxidative stress."} , { "attrname": "Abstract", "value": "Parkin plays an important role in the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We previously described that Nrdp1,  a RING-finger ubiquitin E3 ligase,  interacted with Parkin by the yeast two-hybrid assay and by co-immunoprecipitation. Here we further demonstrated that overexpression of Nrdp1 significantly reduced the endogenous Parkin level in an Nrdp1 dosage-dependent and proteasome-dependent manner. More importantly,  Nrdp1 ubiquitinated Parkin and catalyzed the poly-ubiquitin chains on Parkin in vitro as well as in cells,  indicating Parkin is an Nrdp1 substrate. In addition,  we demonstrated that overexpression of Nrdp1 increased the production of reactive oxygen species (ROS),  which was abrogated by co-expression of Parkin. Conversely,  suppression of Nrdp1 by shRNA conferred SH-SY5Y cells a lower ROS level. Together,  we provided evidence that interactions between Nrdp1 and Parkin negatively regulated Parkin level and affected ROS production,  suggesting that Nrdp1 may play a role in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Dose-Response Relationship,  Drug,  Ubiquitin-Protein Ligases,  Cell Line,  Ubiquitination,  Immunoprecipitation,  Reactive Oxygen Species,  Transfection,  Oxidative Stress,  Humans,  Gene Expression Regulation,  RNA,  Small Interfering,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Furong Yu,  Jianhua Zhou]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH RNF41,  UBIQUITINATION,  MUTAGENESIS OF CYS-421,  FUNCTION]"} ], "id": "1037", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18541373", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.NEULET.2008.05.052"} , { "elementOf": "NLM", "accession": "18541373"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  SUBCELLULAR LOCATION,  TISSUE SPECIFICITY,  VARIANTS ARG-311 AND THR-371,  IDENTIFICATION BY MASS SPECTROMETRY]", "conames": [{ "name": "PMID: 19501131", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19501131", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[Molecular Chaperones,  EC 2.3.2.27 parkin protein,  Recombinant Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  RNA,  Messenger,  PACRG protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Evidence for the presence of full-length PARK2 mRNA and Parkin protein in human blood."} , { "attrname": "Abstract", "value": "Research on <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> fails to pinpoint a single gene or a gene product as the causative factor. However,  the early onset form of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> may be caused by mutations in PARK2 gene. Some studies related to the biochemistry or other aspects of the PARK2 gene or its product mostly used cDNA generated from substantia nigra of the mid-brain. This is essentially because the presence of the 1.4kb full-length PARK2 cDNA in human leukocytes is,  so far,  not demonstrated although some splice variants and short RT-PCR products were reported. In this study,  we synthesized a 1.4kb full-length PARK2 cDNA from human leukocytes,  cloned and expressed it both in Escherichia coli and in HeLa cells. The presence of Parkin protein was also demonstrated in human serum using Western blotting and MALDI-TOF analysis. The results of this study showed a simple way for routine amplification of PARK2 cDNA from human blood and may become a useful diagnostic tool in the future. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Molecular Chaperones,  Escherichia coli,  Humans,  HeLa Cells,  Leukocytes,  Mutation,  Recombinant Proteins,  RNA,  Messenger,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Murat Kasap,  Gurler Akpinar,  Ali Sazci,  Halil A Idrisoglu,  Haluk Vahabolu]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA],  SUBCELLULAR LOCATION,  TISSUE SPECIFICITY,  VARIANTS ARG-311 AND THR-371,  IDENTIFICATION BY MASS SPECTROMETRY]"} ], "id": "1038", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19501131", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.NEULET.2009.05.079"} , { "elementOf": "NLM", "accession": "19501131"} ]} , { "annotation": "[SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 10319893", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10319893", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Immunohistochemical and subcellular localization of Parkin protein:  absence of protein in autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism patients."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP) is a distinct clinical entity characterized by a selective degeneration of nigral neurons. Recently,  the parkin gene responsible for AR-JP has been identified. Now,  we report the subcellular localization of Parkin protein in patients with AR-JP or <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) and in controls by immunoblotting and immunohistochemistry using antibodies raised against the Parkin molecule. Parkin protein was absent in all regions of the brains of patients with AR-JP. Parkin protein was not decreased in the brains of sporadic PD patients. Immunoreactivity was detected in a few Lewy bodies. Parkin protein was located in both the Golgi complex and cytosol. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Ubiquitin-Protein Ligases,  Brain,  Ligases,  Humans,  Middle Aged,  Female,  Genes,  Recessive]"} , { "attrname": "AUTHORS", "value": "[H Shimura,  N Hattori,  S Kubo,  M Yoshikawa,  T Kitada,  H Matsumine,  S Asakawa,  S Minoshima,  Y Yamamura,  N Shimizu,  Y Mizuno]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION]"} ], "id": "1039", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10319893", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/1531-8249(199905)45: 5<668: : AID-ANA19>3.0.CO;2-Z"} , { "elementOf": "NLM", "accession": "10319893"} ]} , { "annotation": "[VARIANTS PARK2 GLU-82; CYS-256; TRP-275; GLU-328 AND ARG-441]", "conames": [{ "name": "PMID: 12116199", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12116199", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of medical genetics"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Complex relationship between Parkin mutations and Parkinson disease."} , { "attrname": "Abstract", "value": "Mutations in the Parkin gene cause juvenile and early onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism. While Parkin-related <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is presumed to be an autosomal-recessive disorder,  cases have been reported where only a single Parkin allele is mutated and raise the possibility of a dominant effect. In this report,  we re-evaluate twenty heterozygous cases and extend the mutation screening to include the promoter and intron\/exon boundaries. Novel deletion,  point and intronic splice site mutations are described,  along with promoter variation. These data,  coupled with a complete review of published Parkin mutations,  confirms that not only is recessive loss of Parkin a risk factor for juvenile and early onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism but that Parkin haplo-insufficiency may be sufficient for <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in some cases. "} , { "attrname": "MeSH", "value": "[Promoter Regions,  Genetic,  Sequence Deletion,  Alternative Splicing,  Exons,  Introns,  Gene Frequency,  Humans,  Middle Aged,  Genotype,  Male,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  DNA Mutational Analysis,  Ligases,  Review Literature as Topic,  DNA,  Adolescent,  Alleles,  Adult,  Female,  Heterozygote,  Polymorphism,  Single Nucleotide,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Andrew West,  Magali Periquet,  Sarah Lincoln,  Christoph B Lcking,  David Nicholl,  Vincenzo Bonifati,  Nina Rawal,  Thomas Gasser,  Ebba Lohmann,  Jean-Franois Deleuze,  Demetrius Maraganore,  Allan Levey,  Nick Wood,  Alexandra Drr,  John Hardy,  Alexis Brice,  Matt Farrer,   French <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Genetics Study Group and the European Consortium on Genetic Susceptibility on <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 GLU-82; CYS-256; TRP-275; GLU-328 AND ARG-441]"} ], "id": "1040", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12116199", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12116199"} , { "elementOf": "DOI", "accession": "10.1002\/AJMG.10525"} ]} , { "annotation": "[INTERACTION WITH PSMA7]", "conames": [{ "name": "PMID: 15987638", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15987638", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 3.4.25.1 alpha4 subunit,  proteasome 20S,  human,  EC 3.4.22.- Cysteine Endopeptidases,  Multienzyme Complexes,  EC 2.3.2.27 parkin protein,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Parkin interacts with the proteasome subunit alpha4."} , { "attrname": "Abstract", "value": "Mutations in the parkin gene encoding an E3 ligase are responsible for autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Putative parkin substrates and interacting partners have been identified,  but the molecular mechanism underlying parkin-related neurodegeneration is still unclear. We have identified the 20S proteasomal subunit alpha4 (synonyms:  PSMA7,  XAPC7,  subunit alpha type 7) as a new interacting partner of parkin. The C-terminal IBR-RING domain of parkin and the C-terminal part of alpha4 were essential for the interaction. Biochemical studies revealed that alpha4 was not a substrate for parkin-dependent ubiquitylation. Putative functions of the interaction might therefore be substrate presentation to the proteasome or regulation of proteasomal activity. Full-length parkin and parkin lacking the N-terminal ubiquitin-like domain slightly increased the proteasomal activity in HEK 293T cells,  in line with the latter hypothesis. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Cell Line,  Cysteine Endopeptidases,  Immunoprecipitation,  Multienzyme Complexes,  Signal Transduction,  Humans,  Rats,  Proteasome Endopeptidase Complex,  PC12 Cells,  Ubiquitin-Protein Ligases,  Two-Hybrid System Techniques,  Animals,  Plasmids,  Protein Binding,  Models,  Genetic,  Mutation,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[J C Dchsel,  C B Lcking,  S Deeg,  E Schultz,  M Lalowski,  E Casademunt,  O Corti,  C Hampe,  N Patenge,  K Vaupel,  A Yamamoto,  M Dichgans,  A Brice,  E E Wanker,  P J Kahle,  T Gasser]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH PSMA7]"} ], "id": "1041", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15987638", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.FEBSLET.2005.06.003"} , { "elementOf": "NLM", "accession": "15987638"} ]} , { "annotation": "[VARIANTS PARK2 ASN-211; TRP-275; ASP-430 AND LEU-437]", "conames": [{ "name": "PMID: 12114481", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12114481", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of medical genetics"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  Genetic Markers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> families."} , { "attrname": "MeSH", "value": "[Genetic Testing,  Humans,  Middle Aged,  Genetic Markers,  Heterozygote Detection,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  DNA Mutational Analysis,  Ligases,  Adult,  Aged,  Mutation,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[W C Nichols,  N Pankratz,  S K Uniacke,  M W Pauciulo,  C Halter,  A Rudolph,  P M Conneally,  T Foroud]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 ASN-211; TRP-275; ASP-430 AND LEU-437]"} ], "id": "1042", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12114481", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12114481"} , { "elementOf": "DOI", "accession": "10.1136\/JMG.39.7.489"} ]} , { "annotation": "[FUNCTION,  REACTION MECHANISM,  INTERACTION WITH UBE2L3]", "conames": [{ "name": "PMID: 21532592", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21532592", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Ubiquitin,  K848JZ4886 Cysteine,  EC 2.3.2.23 UBE2L3 protein,  human,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  ARIH1 protein,  human,  Mutant Chimeric Proteins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Carrier Proteins,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "UBCH7 reactivity profile reveals parkin and HHARI to be RING\/HECT hybrids."} , { "attrname": "Abstract", "value": "Although the functional interaction between ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) is essential in ubiquitin (Ub) signalling,  the criteria that define an active E2-E3 pair are not well established. The human E2 UBCH7 (also known as UBE2L3) shows broad specificity for HECT-type E3s,  but often fails to function with RING E3s in vitro despite forming specific complexes. Structural comparisons of inactive UBCH7-RING complexes with active UBCH5-RING complexes reveal no defining differences,  highlighting a gap in our understanding of Ub transfer. Here we show that,  unlike many E2s that transfer Ub with RINGs,  UBCH7 lacks intrinsic,  E3-independent reactivity with lysine,  explaining its preference for HECTs. Despite lacking lysine reactivity,  UBCH7 exhibits activity with the RING-in-between-RING (RBR) family of E3s that includes parkin (also known as PARK2) and human homologue of ariadne (HHARI; also known as ARIH1). Found in all eukaryotes,  RBRs regulate processes such as translation and immune signalling. RBRs contain a canonical C3HC4-type RING,  followed by two conserved Cys\/His-rich Zn(2+)-binding domains,  in-between-RING (IBR) and RING2 domains,  which together define this E3 family. We show that RBRs function like RING\/HECT hybrids:  they bind E2s via a RING domain,  but transfer Ub through an obligate thioester-linked Ub (denoted ?Ub),  requiring a conserved cysteine residue in RING2. Our results define the functional cadre of E3s for UBCH7,  an E2 involved in cell proliferation and immune function,  and indicate a novel mechanism for an entire class of E3s. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Amino Acid Sequence,  Catalytic Domain,  Cysteine,  Mutant Chimeric Proteins,  Humans,  Molecular Sequence Data,  Ubiquitin-Protein Ligases,  Sequence Alignment,  Lysine,  Protein Binding,  Ubiquitin-Conjugating Enzymes,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Dawn M Wenzel,  Alexei Lissounov,  Peter S Brzovic,  Rachel E Klevit]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  REACTION MECHANISM,  INTERACTION WITH UBE2L3]"} ], "id": "1043", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21532592", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE09966"} , { "elementOf": "NLM", "accession": "21532592"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH BCL2,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ARG-240; PHE-431 AND LEU-437];", "conames": [{ "name": "PMID: 20889974", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20889974", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Beclin-1,  Membrane Proteins,  BECN1 protein,  human,  Apoptosis Regulatory Proteins,  EC 2.3.2.27 parkin protein,  Microtubule-Associated Proteins,  light chain 3,  human,  Proto-Oncogene Proteins c-bcl-2,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Parkin mono-ubiquitinates Bcl-2 and regulates autophagy."} , { "attrname": "Abstract", "value": "Parkin is an E3 ubiquitin ligase that mediates the ubiquitination of protein substrates. The mutations in the parkin gene can lead to a loss of function of parkin and cause autosomal recessive juvenile onset parkinsonism. Recently,  parkin was reported to be involved in the regulation of mitophagy. Here,  we identify the Bcl-2,  an anti-apoptotic and autophagy inhibitory protein,  as a substrate for parkin. Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2,  which increases the steady-state levels of Bcl-2. Overexpression of parkin,  but not its ligase-deficient forms,  decreases autophagy marker LC3 conversion,  whereas knockdown of parkin increases LC3 II levels. In HeLa cells,  a parkin-deficient cell line,  knockdown of parkin does not change LC3 conversion. Moreover,  overexpression of parkin enhances the interactions between Bcl-2 and Beclin 1. Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2. "} , { "attrname": "MeSH", "value": "[Beclin-1,  Membrane Proteins,  Ubiquitin-Protein Ligases,  Ubiquitination,  Apoptosis Regulatory Proteins,  Humans,  Dystonic Disorders,  Microtubule-Associated Proteins,  Protein Binding,  HeLa Cells,  Proto-Oncogene Proteins c-bcl-2,  Autophagy]"} , { "attrname": "AUTHORS", "value": "[Dong Chen,  Feng Gao,  Bin Li,  Hongfeng Wang,  Yuxia Xu,  Cuiqing Zhu,  Guanghui Wang]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH BCL2,  SUBCELLULAR LOCATION,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; ARG-240; PHE-431 AND LEU-437]"} ], "id": "1044", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20889974", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M110.101469"} , { "elementOf": "NLM", "accession": "20889974"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2),  INVOLVEMENT IN PARK2]", "conames": [{ "name": "PMID: 9560156", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9560156", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Proteins,  Ubiquitins,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is a common neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with complex clinical features. Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP) maps to the long arm of chromosome 6 (6q25.2-q27) and is linked strongly to the markers D6S305 and D6S253; the former is deleted in one Japanese AR-JP patient. By positional cloning within this microdeletion,  we have now isolated a complementary DNA done of 2, 960 base pairs with a 1, 395-base-pair open reading frame,  encoding a protein of 465 amino acids with moderate similarity to ubiquitin at the amino terminus and a RING-finger motif at the carboxy terminus. The gene spans more than 500 kilobases and has 12 exons,  five of which (exons 3-7) are deleted in the patient. Four other AR-JP patients from three unrelated families have a deletion affecting exon 4 alone. A 4.5-kilobase transcript that is expressed in many human tissues but is abundant in the brain,  including the substantia nigra,  is shorter in brain tissue from one of the groups of exon-4-deleted patients. Mutations in the newly identified gene appear to be responsible for the pathogenesis of AR-JP,  and we have therefore named the protein product 'Parkin'. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Blotting,  Southern,  Exons,  Introns,  Humans,  Molecular Sequence Data,  Male,  Chromosomes,  Human,  Pair 6,  Genes,  Recessive,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Sequence Homology,  Amino Acid,  Ubiquitin-Protein Ligases,  Blotting,  Northern,  Ligases,  Pedigree,  Gene Deletion,  Ubiquitins,  Polymerase Chain Reaction,  Adult,  Female]"} , { "attrname": "AUTHORS", "value": "[T Kitada,  S Asakawa,  N Hattori,  H Matsumine,  Y Yamamura,  S Minoshima,  M Yokochi,  Y Mizuno,  N Shimizu]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2),  INVOLVEMENT IN PARK2]"} ], "id": "1045", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9560156", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/33416"} , { "elementOf": "NLM", "accession": "9560156"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH CHPF,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 22082830", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "22082830", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 2.4.1.- N-Acetylgalactosaminyltransferases,  EC 2.4.1.175 chondroitin synthase,  Protein Isoforms,  EC 2.3.2.27 parkin protein,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2012"} , { "attrname": "AbstractHeader", "value": "Parkin interacts with Klokin1 for mitochondrial import and maintenance of membrane potential."} , { "attrname": "Abstract", "value": "Parkin is a multifunctional protein,  including maintaining mitochondrial homeostasis. Recent evidence suggests that Parkin is recruited from the cytoplasm to damaged mitochondria with low membrane potential. We found that intracellular localization of Parkin changed with cellular growth phase. Parkin was preferentially localized in the mitochondria of cultured cells. The mitochondria with large amounts of Parkin showed preserved membrane potentials even during treatment with carbonyl cyanide m-chlorophenylhydrazone. Here we report a novel protein named Klokin 1 that transports Parkin to the mitochondria. Klokin 1 was localized to the mitochondria and enhanced mitochondrial expression of Parkin. Klokin 1 enhanced cell viability in Parkin-silenced cells. Klokin 1 expression was enhanced in the brains of Parkin-deficient mice but not in an autopsied PARK2 brain. Our findings indicate that mitochondrial Parkin prevents mitochondrial depolarization and that Klokin 1 may compensate for Parkin deficiency. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Cell Proliferation,  Cell Survival,  N-Acetylgalactosaminyltransferases,  Humans,  Cercopithecus aethiops,  Molecular Sequence Data,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Ubiquitin-Protein Ligases,  Mitochondria,  Animals,  Base Sequence,  Protein Isoforms,  Membrane Potential,  Mitochondrial,  Mice,  HeLa Cells,  COS Cells]"} , { "attrname": "AUTHORS", "value": "[Yukiko Kuroda,  Wataru Sako,  Satoshi Goto,  Tomoyo Sawada,  Daisuke Uchida,  Yuishin Izumi,  Tetsuya Takahashi,  Noriko Kagawa,  Masayasu Matsumoto,  Mitsuru Matsumoto,  Ryosuke Takahashi,  Ryuji Kaji,  Takao Mitsui]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH CHPF,  SUBCELLULAR LOCATION]"} ], "id": "1046", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 22082830", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/HMG\/DDR530"} , { "elementOf": "NLM", "accession": "22082830"} ]} , { "annotation": "[STRUCTURE BY NMR OF 1-76,  INTERACTION WITH PSMD4]", "conames": [{ "name": "PMID: 12634850", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12634850", "attributes": [{ "attrname": "JOURNAL_REF", "value": "EMBO reports"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 3.4.99.- ATP dependent 26S protease,  EC 2.3.2.27 parkin protein,  EC 3.4.- Peptide Hydrolases,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  PSMD4 protein,  human,  EC 6.- Ligases,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain."} , { "attrname": "Abstract", "value": "Parkin,  a product of the causative gene of autosomal-recessive juvenile parkinsonism (AR-JP),  is a RING-type E3 ubiquitin ligase and has an amino-terminal ubiquitin-like (Ubl) domain. Although a single mutation that causes an Arg to Pro substitution at position 42 of the Ubl domain (the Arg 42 mutation) has been identified in AR-JP patients,  the function of this domain is not clear. In this study,  we determined the three-dimensional structure of the Ubl domain of parkin by NMR,  in particular by extensive use of backbone (15)N-(1)H residual dipolar-coupling data. Inspection of chemical-shift-perturbation data showed that the parkin Ubl domain binds the Rpn10 subunit of 26S proteasomes via the region of parkin that includes position 42. Our findings suggest that the Arg 42 mutation induces a conformational change in the Rpn10-binding site of Ubl,  resulting in impaired proteasomal binding of parkin,  which could be the cause of AR-JP. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Ubiquitin,  Amino Acid Sequence,  Mutagenesis,  Site-Directed,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Proteasome Endopeptidase Complex,  Genes,  Recessive,  Sequence Homology,  Amino Acid,  Ubiquitin-Protein Ligases,  Sequence Alignment,  Ligases,  Protein Conformation,  Peptide Hydrolases,  Binding Sites,  Amino Acid Substitution,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Eri Sakata,  Yoshiki Yamaguchi,  Eiji Kurimoto,  Jun Kikuchi,  Shigeyuki Yokoyama,  Shingo Yamada,  Hiroyuki Kawahara,  Hideyoshi Yokosawa,  Nobutaka Hattori,  Yoshikuni Mizuno,  Keiji Tanaka,  Koichi Kato]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 1-76,  INTERACTION WITH PSMD4]"} ], "id": "1047", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12634850", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/SJ.EMBOR.EMBOR764"} , { "elementOf": "NLM", "accession": "12634850"} ]} , { "annotation": "[VARIANTS PARK2 ARG-211; TRP-275 AND ASP-430]", "conames": [{ "name": "PMID: 11179010", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11179010", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Genetic Markers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Origin of the mutations in the parkin gene in Europe:  exon rearrangements are independent recurrent events,  whereas point mutations may result from Founder effects."} , { "attrname": "Abstract", "value": "A wide variety of mutations in the parkin gene,  including exon deletions and duplications,  as well as point mutations,  result in autosomal recessive early-onset <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. Interestingly,  several of these anomalies were found repeatedly in unrelated patients and may therefore result from recurrent,  de novo mutational events or from founder effects. In the present study,  haplotype analysis,  using 10 microsatellite markers covering a 4.7-cM region known to contain the parkin gene,  was performed in 48 families,  mostly from European countries,  with early-onset autosomal recessive <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. The patients carried 14 distinct mutations in the parkin gene,  and each mutation was detected in more than one family. Our results support the hypothesis that exon rearrangements occurred independently,  whereas some point mutations,  found in families from different geographic origins,  may have been transmitted by a common founder. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Sequence Deletion,  Exons,  Europe,  Humans,  Nuclear Family,  European Continental Ancestry Group,  Chromosome Mapping,  Genetic Markers,  Chromosomes,  Human,  Pair 6,  Genes,  Recessive,  Linkage Disequilibrium,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Founder Effect,  Point Mutation,  Ligases,  Gene Rearrangement,  Age of Onset,  Family,  Mutation,  Microsatellite Repeats]"} , { "attrname": "AUTHORS", "value": "[M Periquet,  C Lcking,  J Vaughan,  V Bonifati,  A Drr,  G De Michele,  M Horstink,  M Farrer,  S N Illarioshkin,  P Pollak,  M Borg,  C Brefel-Courbon,  P Denefle,  G Meco,  T Gasser,  M M Breteler,  N Wood,  Y Agid,  A Brice,   French <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Genetics Study Group. The European Consortium on Genetic Susceptibility in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 ARG-211; TRP-275 AND ASP-430]"} ], "id": "1048", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11179010", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11179010"} , { "elementOf": "DOI", "accession": "10.1086\/318791"} ]} , { "annotation": "[VARIANT PARK2 ARG-240]", "conames": [{ "name": "PMID: 9731209", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9731209", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  Codon,  Terminator,  DNA Primers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP) is a distinct clinical and genetic entity characterized by selective degeneration of nigral neurons. Recently,  the parkin gene responsible for AR-JP has been identified. To date,  we found two different deletional mutations including single and multiple exonic deletions. In the present study,  we identified two types of point mutations (Thr240Arg and Gln311Stop) involving exons 6 and 8 in the parkin gene of the AR-JP patients from two Turkish families. This is the first report on point mutations for the parkin gene. Furthermore,  the Thr240Arg mutation was located on a consensus sequence for the site of phosphorylation by casein kinase II. Identification of its mutation provides an important clue as to the role of the Parkin protein in degeneration of the substantia nigra in the brain of AR-JP patients. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Exons,  Humans,  Male,  DNA Primers,  Genes,  Recessive,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Ubiquitin-Protein Ligases,  Point Mutation,  Turkey,  Polymorphism,  Restriction Fragment Length,  Ligases,  Pedigree,  Base Sequence,  Adolescent,  Polymerase Chain Reaction,  Adult,  Female,  Consanguinity,  Codon,  Terminator]"} , { "attrname": "AUTHORS", "value": "[N Hattori,  H Matsumine,  S Asakawa,  T Kitada,  H Yoshino,  B Elibol,  A J Brookes,  Y Yamamura,  T Kobayashi,  M Wang,  A Yoritaka,  S Minoshima,  N Shimizu,  Y Mizuno]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 ARG-240]"} ], "id": "1049", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9731209", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.1998.9134"} , { "elementOf": "NLM", "accession": "9731209"} ]} , { "annotation": "[VARIANTS PARK2 PRO-42; LEU-192; CYS-256; TRP-275; ASP-430 AND LEU-437]", "conames": [{ "name": "PMID: 11971093", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11971093", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations."} , { "attrname": "Abstract", "value": "Early onset PD has been associated with different mutations in the Parkin gene,  including exon deletions and duplications. The authors performed an extensive mutational analysis on 50 probands with onset of PD at younger than 50 years of age. Thirteen probands were ascertained from a registry of familial PD and 37 probands by age at onset at younger than 50 years,  blind to family history. Mutational analysis was undertaken on the probands and available family members and included conventional techniques (single strand conformation polymorphism analysis and sequencing) and a newly developed method of quantitative duplex PCR to detect alterations of gene dosage (exon deletions and duplications) in PARKIN:  Using this new technique,  the authors detected eight alterations of gene dosage in the probands,  whereas 12 mutations were found by conventional methods among the probands and another different mutation in an affected family member. In total,  the authors identified compound heterozygous mutations in 14%,  heterozygous mutations in 12%,  and no Parkin mutation in 74% of the 50 probands. We expanded the occurrence of Parkin mutations to another ethnic group (African-American). The authors systematically screened all 12 Parkin exons by quantitative PCR and conventional methods in 50 probands. Eight mutations were newly reported,  2 of which are localized in exon 1,  and 38% of the mutations were gene dosage alterations. These results underline the need to screen all exons and to undertake gene dosage studies. Furthermore,  this study reveals a frequency of heterozygous mutation carriers that may signify a unique mode of inheritance and expression of the Parkin gene. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Exons,  Humans,  Male,  Gene Dosage,  Reverse Transcriptase Polymerase Chain Reaction,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  DNA Mutational Analysis,  Ligases,  Pedigree,  Age of Onset,  Adult,  Female,  Heterozygote,  Mutation]"} , { "attrname": "AUTHORS", "value": "[K Hedrich,  K Marder,  J Harris,  M Kann,  T Lynch,  H Meija-Santana,  P P Pramstaller,  E Schwinger,  S B Bressman,  S Fahn,  C Klein]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 PRO-42; LEU-192; CYS-256; TRP-275; ASP-430 AND LEU-437]"} ], "id": "1050", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11971093", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.58.8.1239"} , { "elementOf": "NLM", "accession": "11971093"} ]} , { "annotation": "[INTERACTION WITH RANBP2]", "conames": [{ "name": "PMID: 16332688", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16332688", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Ubiquitin,  Molecular Chaperones,  Nuclear Pore Complex Proteins,  EC 2.3.2.27 parkin protein,  134193-27-4 Synaptotagmins,  EC 2.5.1.18 Glutathione Transferase,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  ran-binding protein 2,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Parkin ubiquitinates and promotes the degradation of RanBP2."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is a common neurodegenerative disorder,  which involves the deterioration of dopaminergic neurons in the pars compacta of the substantia nigra. The etiology of PD is still unknown,  but recent identification of mutations in familial cases of PD has advanced the understanding of the molecular mechanisms of this neurological <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Mutations in the parkin gene,  which encodes for ubiquitin-protein ligase (E3),  have been implicated in autosomal recessive juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism,  an early onset and common familial form of PD. Here we reported that Parkin selectively binds to RanBP2,  which is localized in the cytoplasmic filament of the nuclear pore complex and belongs to the small ubiquitin-related modifier E3 ligase family. We also demonstrated that RanBP2 becomes a target for Parkin E3 ubiquitin-ligase and is processed via Parkin-mediated ubiquitination and subsequent proteasomal degradation. Furthermore,  Parkin controls the intracellular levels of sumoylated HDAC4,  as a result of the ubiquitination and degradation of RanBP2. Our findings suggested that the intracellular levels of RanBP2 and its functional activity may be modulated by Parkin-mediated ubiquitination and proteasomal pathways. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Immunoprecipitation,  Humans,  Immunoblotting,  Proteasome Endopeptidase Complex,  Transfection,  RNA Interference,  Glutathione Transferase,  Protein Structure,  Tertiary,  Cell Line,  Molecular Chaperones,  Nuclear Pore Complex Proteins,  Gene Library,  Neurons,  Rats,  Blotting,  Western,  Amino Acid Motifs,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Two-Hybrid System Techniques,  Animals,  Cell Line,  Tumor,  Protein Binding,  Synaptotagmins,  Mice,  Mutation,  Cytoplasm,  Hippocampus,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Ji Won Um,  Do Sik Min,  Hyewhon Rhim,  Jongsun Kim,  Seung R Paik,  Kwang Chul Chung]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH RANBP2]"} ], "id": "1051", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16332688", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16332688"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M504994200"} ]} , { "annotation": "[VARIANTS HIS-100; SER-271 AND SER-339]", "conames": [{ "name": "PMID: 12781599", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12781599", "attributes": [{ "attrname": "JOURNAL_REF", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ism & related disorders"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Parkin mutations are rare in patients with young-onset parkinsonism in a US population."} , { "attrname": "Abstract", "value": "Parkin mutations have been associated with an autosomal recessive-juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  but it is unclear how common such patients are in a US based clinic population. In this study,  we screened for parkin gene mutations in a clinic-based series of 27 consecutive patients in the US with typical <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism beginning before the age of 50 years. Two patients began the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> before the age of 30 years. Among the 27 patients screened,  only one patient,  whose <span style=\"background-color: yellow\"><b>disease<\/b><\/span> began at the age of 24 years,  was found to harbor a parkin mutation (a 40 bp deletion in exon 3). In addition,  we also identified four new polymorphisms in the open reading frames of the parkin gene in this population. Our results suggest <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism due to mutations in the parkin gene is extremely rare in the US population when the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> begins over the age of 30. "} , { "attrname": "MeSH", "value": "[Exons,  United States,  Humans,  Middle Aged,  Male,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Ligases,  Age of Onset,  Adult,  Female,  Mutation]"} , { "attrname": "AUTHORS", "value": "[R Chen,  N S Gosavi,  J W Langston,  P Chan]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS HIS-100; SER-271 AND SER-339]"} ], "id": "1052", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12781599", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12781599"} ]} , { "annotation": "[INTERACTION WITH SYT11,  CHARACTERIZATION OF VARIANTS PARK2 GLY-289 AND ARG-418]", "conames": [{ "name": "PMID: 12925569", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12925569", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Ubiquitin,  Calcium-Binding Proteins,  147336-22-9 Green Fluorescent Proteins,  EC 2.3.2.27 parkin protein,  SYT11 protein,  human,  Nerve Tissue Proteins,  134193-27-4 Synaptotagmins,  Membrane Glycoproteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Luminescent Proteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "The autosomal recessive juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> gene product,  parkin,  interacts with and ubiquitinates synaptotagmin XI."} , { "attrname": "Abstract", "value": "Inactivating mutations of the gene encoding parkin are responsible for some forms of autosomal recessive juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Parkin is a ubiquitin ligase that ubiquitinates misfolded proteins targeted for the proteasome-dependent protein degradation pathway. Using the yeast two-hybrid system and co-immunoprecipitation methods,  we identified synaptotagmin XI as a protein that interacts with parkin. Parkin binds to the C2A and C2B domains of synaptotagmin XI resulting in the polyubiquitination of synaptotagmin XI. Truncated and missense mutated parkins reduce parkin-sytXI binding affinity and ubiquitination. Parkin-mediated ubiquitination also enhances the turnover of sytXI. In sporadic PD brain sections,  sytXI was found in the core of the Lewy bodies. Since synaptotagmin XI is a member of the synaptotagmin family that is well characterized in their importance for vesicle formation and docking,  the interaction with this protein suggests a role for parkin in the regulation of the synaptic vesicle pool and in vesicle release. Loss of parkin could thus affect multiple proteins controlling vesicle pools,  docking and release and explain the deficits in dopaminergic function seen in patients with parkin mutations. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Ubiquitin,  Brain,  Green Fluorescent Proteins,  Humans,  Mutation,  Missense,  Transfection,  Time Factors,  Membrane Glycoproteins,  Luminescent Proteins,  Protein Structure,  Tertiary,  Cell Line,  Calcium-Binding Proteins,  Neurons,  Substantia Nigra,  Nerve Tissue Proteins,  Genes,  Recessive,  Blotting,  Western,  Precipitin Tests,  Ubiquitin-Protein Ligases,  Two-Hybrid System Techniques,  Animals,  Plasmids,  Protein Binding,  Synaptotagmins,  Models,  Genetic,  Mutation,  COS Cells,  Microscopy,  Fluorescence]"} , { "attrname": "AUTHORS", "value": "[Duong P Huynh,  Daniel R Scoles,  Dung Nguyen,  Stefan M Pulst]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH SYT11,  CHARACTERIZATION OF VARIANTS PARK2 GLY-289 AND ARG-418]"} ], "id": "1053", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12925569", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12925569"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/DDG269"} ]} , { "annotation": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]", "conames": [{ "name": "PMID: 10888878", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10888878", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[EC 2.3.2.23 UBE2L3 protein,  human,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  Ubiquitins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Recombinant Fusion Proteins,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Familial Parkinson disease gene product,  parkin,  is a ubiquitin-protein ligase."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP),  one of the most common familial forms of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  is characterized by selective dopaminergic neural cell death and the absence of the Lewy body,  a cytoplasmic inclusion body consisting of aggregates of abnormally accumulated proteins. We previously cloned PARK2,  mutations of which cause AR-JP (ref. 2),  but the function of the gene product,  parkin,  remains unknown. We report here that parkin is involved in protein degradation as a ubiquitin-protein ligase collaborating with the ubiquitin-conjugating enzyme UbcH7,  and that mutant parkins from AR-JP patients show loss of the ubiquitin-protein ligase activity. Our findings indicate that accumulation of proteins that have yet to be identified causes a selective neural cell death without formation of Lewy bodies. Our findings should enhance the exploration of the molecular mechanisms of neurodegeneration in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> as well as in other neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s that are characterized by involvement of abnormal protein ubiquitination,  including <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  other tauopathies,  CAG triplet repeat disorders and amyotrophic lateral sclerosis. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Ligases,  Humans,  Ubiquitins,  Tumor Cells,  Cultured,  Ubiquitin-Conjugating Enzymes,  Recombinant Fusion Proteins]"} , { "attrname": "AUTHORS", "value": "[H Shimura,  N Hattori,  S i Kubo,  Y Mizuno,  S Asakawa,  S Minoshima,  N Shimizu,  K Iwai,  T Chiba,  K Tanaka,  T Suzuki]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  CHARACTERIZATION OF VARIANTS PARK2 PRO-42 AND ARG-240]"} ], "id": "1054", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10888878", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/77060"} , { "elementOf": "NLM", "accession": "10888878"} ]} , { "annotation": "[VARIANT PARK2 PRO-46]", "conames": [{ "name": "PMID: 12362318", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12362318", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "[A new point mutation on exon 2 of parkin gene in Parkinson's disease]."} , { "attrname": "Abstract", "value": "To detect the relationship between point mutations on exon 2 of parkin gene and sporadic early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The point mutations on exon 2 of parkin gene were detected using polymerase chain reaction(PCR),  agarose electrophoresis,  single strand conformation polymorphism(SSCP),  DNA sequencing and analysis of restrict enzyme in DNA of 60 <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> patients with an onset age under 50 and 120 normal controls. One homozygous mutation (G(237)-->C) on exon 2 was found by sequencing and verified by analysis of restrict enzyme,  whereas no mutation was found in normal controls. Point mutations on exon 2 of parkin gene are likely to be related to sporadic early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Middle Aged,  Male,  Sequence Analysis,  DNA,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Single-Stranded Conformational,  Ubiquitin-Protein Ligases,  Point Mutation,  Ligases,  Aged,  80 and over,  Adult,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[Yanming Xu,  Zhuolin Liu,  Yukai Wang,  Enxiang Tao,  Guojun Chen,  Biao Chen]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 PRO-46]"} ], "id": "1055", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12362318", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12362318"} ]} , { "annotation": "[VARIANTS PARK2 GLN-33; GLU-82; ASP-430 AND LEU-437,  VARIANTS PARK TYR-253; CYS-256; TRP-275 AND ASN-280,  VARIANTS LEU-380 AND ASN-394]", "conames": [{ "name": "PMID: 12730996", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12730996", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  DNA Primers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  RNA,  Messenger,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Parkin mutations and susceptibility alleles in late-onset Parkinson's disease."} , { "attrname": "Abstract", "value": "Parkin,  an E2-dependent ubiquitin protein ligase,  carries pathogenic mutations in patients with autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  but its role in the late-onset form of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is not firmly established. Previously,  we detected linkage of idiopathic PD to the region on chromosome 6 containing the Parkin gene (D6S305,  logarithm of odds score,  5.47) in families with at least one subject with age at onset (AAO) younger than 40 years. Mutation analysis of the Parkin gene in the 174 multiplex families from the genomic screen and 133 additional PD families identified mutations in 18% of early-onset and 2% of late-onset families (5% of total families screened). The AAO of patients with Parkin mutations ranged from 12 to 71 years. Excluding exon 7 mutations,  the mean AAO of patients with Parkin mutations was 31.5 years. However,  mutations in exon 7,  the first RING finger (Cys253Trp,  Arg256Cys,  Arg275Trp,  and Asp280Asn) were observed primarily in heterozygous PD patients with a much later AAO (mean AAO,  49.2 years) but were not found in controls in this study or several previous reports (920 chromosomes). These findings suggest that mutations in Parkin contribute to the common form of PD and that heterozygous mutations,  especially those lying in exon 7,  act as susceptibility alleles for late-onset form of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Middle Aged,  Genotype,  Male,  Chromatography,  High Pressure Liquid,  DNA Primers,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Point Mutation,  DNA Mutational Analysis,  Ligases,  Adolescent,  Alleles,  Polymerase Chain Reaction,  Aged,  80 and over,  Adult,  Female,  Aged,  Child,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[Sofia A Oliveira,  William K Scott,  Eden R Martin,  Martha A Nance,  Ray L Watts,  Jean P Hubble,  William C Koller,  Rajesh Pahwa,  Matthew B Stern,  Bradley C Hiner,  William G Ondo,  Fred H Allen,  Burton L Scott,  Christopher G Goetz,  Gary W Small,  Frank Mastaglia,  Jeffrey M Stajich,  Fengyu Zhang,  Michael W Booze,  Michelle P Winn,  Lefkos T Middleton,  Jonathan L Haines,  Margaret A Pericak-Vance,  Jeffery M Vance]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 GLN-33; GLU-82; ASP-430 AND LEU-437,  VARIANTS PARK TYR-253; CYS-256; TRP-275 AND ASN-280,  VARIANTS LEU-380 AND ASN-394]"} ], "id": "1056", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12730996", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12730996"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10524"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 137-465,  ACTIVE SITE,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]", "conames": [{ "name": "PMID: 23770887", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23770887", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature communications"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  47E5O17Y3R Phenylalanine,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases."} , { "attrname": "Abstract", "value": "Parkin is a RING-between-RING E3 ligase that functions in the covalent attachment of ubiquitin to specific substrates,  and mutations in Parkin are linked to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  cancer and mycobacterial infection. The RING-between-RING family of E3 ligases are suggested to function with a canonical RING domain and a catalytic cysteine residue usually restricted to HECT E3 ligases,  thus termed 'RING\/HECT hybrid' enzymes. Here we present the 1.58  structure of Parkin-R0RBR,  revealing the fold architecture for the four RING domains,  and several unpredicted interfaces. Examination of the Parkin active site suggests a catalytic network consisting of C431 and H433. In cells,  mutation of C431 eliminates Parkin-catalysed degradation of mitochondria,  and capture of an ubiquitin oxyester confirms C431 as Parkin's cellular active site. Our data confirm that Parkin is a RING\/HECT hybrid,  and provide the first crystal structure of an RING-between-RING E3 ligase at atomic resolution,  providing insight into this <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-related protein. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Protein Structure,  Tertiary,  Ubiquitin-Protein Ligases,  Catalytic Domain,  Mitochondria,  Biocatalysis,  Phenylalanine,  Humans,  Models,  Molecular,  Mutation]"} , { "attrname": "AUTHORS", "value": "[B E Riley,  J C Lougheed,  K Callaway,  M Velasquez,  E Brecht,  L Nguyen,  T Shaler,  D Walker,  Y Yang,  K Regnstrom,  L Diep,  Z Zhang,  S Chiou,  M Bova,  D R Artis,  N Yao,  J Baker,  T Yednock,  J A Johnston]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 137-465,  ACTIVE SITE,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]"} ], "id": "1057", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23770887", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "23770887"} , { "elementOf": "DOI", "accession": "10.1038\/NCOMMS2982"} ]} , { "annotation": "[REVIEW]", "conames": [{ "name": "PMID: 15229644", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15229644", "attributes": [{ "attrname": "JOURNAL_REF", "value": "EMBO reports"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "How does parkin ligate ubiquitin to Parkinson's disease?"} , { "attrname": "Abstract", "value": "Recessive mutations in the human PARKIN gene are the most common cause of hereditary <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  which arises from the degeneration of dopaminergic neurons in the substantia nigra. However,  the molecular mechanisms by which the loss of parkin causes dopaminergic neurodegeneration are not well understood. Parkin is an enzyme that ubiquitinates several candidate substrate proteins and thereby targets them for proteasomal degradation. Hypothesis-driven searches have led to the discovery of aggregation-prone protein substrates of parkin. Moreover,  the enzyme is upregulated when under unfolded protein stress. Thus,  loss-of-function mutations of parkin might impair the removal of potentially toxic protein aggregates. However,  the limited neuropathological information that is available from parkin-proven patients,  as well as the recent knockout of the parkin gene in fruit flies and mice,  may indicate a more complex <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mechanism,  possibly involving the misfolding of parkin itself or of additional substrates. The risk factors that predispose dopaminergic neurons to degenerate on parkin failure are yet to be identified. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Cell Line,  Animals,  Genetically Modified,  Neurons,  Drosophila,  Humans,  Risk Factors,  Chromosome Mapping,  Genes,  Recessive,  Protein Folding,  Mice,  Knockout,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Animals,  Protein Binding,  Mice,  Mutation,  Chromosomes]"} , { "attrname": "AUTHORS", "value": "[Philipp J Kahle,  Christian Haass]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW]"} ], "id": "1058", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15229644", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "15229644"} , { "elementOf": "DOI", "accession": "10.1038\/SJ.EMBOR.7400188"} ]} , { "annotation": "[PRESENCE OF ATYPICAL RING FINGER DOMAINS]", "conames": [{ "name": "PMID: 12446796", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12446796", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular biology and evolution"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Comparative genomics of the RBR family,  including the <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-related gene parkin and the genes of the ariadne subfamily."} , { "attrname": "Abstract", "value": "Genes of the RBR family are characterized by the RBR signature (two RING finger domains separated by an IBR\/DRIL domain). The RBR family is widespread in eukaryotes,  with numerous members in animals (mammals,  Drosophila,  Caenorhabditis) and plants (Arabidopsis). But yeasts,  such as Saccharomyces cerevisiae or Schizosaccharomyces pombe,  contain only two RBR genes. We determined the phylogenetic relationships and the most likely orthologs in different species of several family members for which functional data are available. These include:  (1) parkin,  whose mutations are involved in forms of familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>; (2) the ariadne genes,  recently characterized in Drosophila and mammals; (3) XYbp and Dorfin,  two mammalian genes whose products interact with the centrosome; (4) XAP3,  RBCK1,  and UIP28,  mammalian genes encoding Protein Kinase-C-binding proteins; and (5) ARA54,  an androgen receptor coactivator. Because several of these genes are involved in ubiquitination,  we used phylogenetic and structural analyses to explore the hypothesis that all RBR proteins might play a role in ubiquitination. We show that the involvement of RBR proteins in ubiquitination predates the animals-plants-fungi divergence. On the basis of the evidence provided by cases of gene fusion,  we suggest that Ariadne proteins interact with cullin domain-containing proteins to form complexes with ubiquitin-ligase activity. "} , { "attrname": "MeSH", "value": "[Ubiquitin-Protein Ligases,  Animals,  Ligases,  Genomics,  Humans,  Phylogeny,  Butterflies]"} , { "attrname": "AUTHORS", "value": "[Ignacio Marn,  Alberto Ferrs]"} , { "attrname": "PUB_TYPE", "value": "[PRESENCE OF ATYPICAL RING FINGER DOMAINS]"} ], "id": "1059", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12446796", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/OXFORDJOURNALS.MOLBEV.A004029"} , { "elementOf": "NLM", "accession": "12446796"} ]} , { "annotation": "[FUNCTION IN PROTECTION OF APOPTOSIS,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; CYS-256; TRP-275; ARG-418 AND ARG-441,  DOMAIN];", "conames": [{ "name": "PMID: 19801972", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19801972", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature cell biology"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Mutations of the ubiquitin ligase parkin account for most autosomal recessive forms of juvenile <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AR-JP). Several studies have suggested that parkin possesses DNA-binding and transcriptional activity. We report here that parkin is a p53 transcriptional repressor. First,  parkin prevented 6-hydroxydopamine-induced caspase-3 activation in a p53-dependent manner. Concomitantly,  parkin reduced p53 expression and activity,  an effect abrogated by familial parkin mutations known to either abolish or preserve its ligase activity. ChIP experiments indicate that overexpressed and endogenous parkin interact physically with the p53 promoter and that pathogenic mutations abolish DNA binding to and promoter transactivation of p53. Parkin lowered p53 mRNA levels and repressed p53 promoter transactivation through its Ring1 domain. Conversely,  parkin depletion enhanced p53 expression and mRNA levels in fibroblasts and mouse brains,  and increased cellular p53 activity and promoter transactivation in cells. Finally,  familial parkin missense and deletion mutations enhanced p53 expression in human brains affected by AR-JP. This study reveals a ubiquitin ligase-independent function of parkin in the control of transcription and a functional link between parkin and p53 that is altered by AR-JP mutations. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Promoter Regions,  Genetic,  Genes,  p53,  Humans,  Adolescent,  Transcription,  Genetic,  Mutation,  Genes,  Recessive]"} , { "attrname": "AUTHORS", "value": "[Cristine Alves da Costa,  Claire Sunyach,  Emilie Giaime,  Andrew West,  Olga Corti,  Alexis Brice,  Stephen Safe,  Patrick M Abou-Sleiman,  Nicholas W Wood,  Hitoshi Takahashi,  Mathew S Goldberg,  Jie Shen,  Frdric Checler]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN PROTECTION OF APOPTOSIS,  CHARACTERIZATION OF VARIANTS PARK2 ASN-161; CYS-256; TRP-275; ARG-418 AND ARG-441,  DOMAIN]"} ], "id": "1060", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19801972", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NCB1981"} , { "elementOf": "NLM", "accession": "19801972"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 137-465,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]", "conames": [{ "name": "PMID: 23727886", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23727886", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  J41CSQ7QDS Zinc,  58-98-0 Uridine Diphosphate,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "Structure of the human Parkin ligase domain in an autoinhibited state."} , { "attrname": "Abstract", "value": "Mutations in the protein Parkin are associated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD),  the second most common neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in men. Parkin is an E3 ubiquitin (Ub) ligase of the structurally uncharacterized RING-in-between-RING(IBR)-RING (RBR) family,  which,  in an HECT-like fashion,  forms a catalytic thioester intermediate with Ub. We here report the crystal structure of human Parkin spanning the Unique Parkin domain (UPD,  also annotated as RING0) and RBR domains,  revealing a tightly packed structure with unanticipated domain interfaces. The UPD adopts a novel elongated Zn-binding fold,  while RING2 resembles an IBR domain. Two key interactions keep Parkin in an autoinhibited conformation. A linker that connects the IBR with the RING2 over a 50- distance blocks the conserved E2?Ub binding site of RING1. RING2 forms a hydrophobic interface with the UPD,  burying the catalytic Cys431,  which is part of a conserved catalytic triad. Opening of intra-domain interfaces activates Parkin,  and enables Ub-based suicide probes to modify Cys431. The structure further reveals a putative phospho-peptide docking site in the UPD,  and explains many PD-causing mutations. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Protein Structure,  Tertiary,  Ubiquitin-Protein Ligases,  Protein Structure,  Secondary,  Humans,  Uridine Diphosphate,  Crystallography,  X-Ray,  Mutation,  Protein Folding,  Zinc]"} , { "attrname": "AUTHORS", "value": "[Tobias Wauer,  David Komander]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 137-465,  ENZYME REGULATION,  MUTAGENESIS OF CYS-431; HIS-433 AND GLU-444]"} ], "id": "1061", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23727886", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/EMBOJ.2013.125"} , { "elementOf": "NLM", "accession": "23727886"} ]} , { "annotation": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 19029340", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19029340", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of cell biology"} , { "attrname": "Chemical", "value": "[EC 3.6.1.- Mfn1 protein,  mouse,  Uncoupling Agents,  EC 2.3.2.27 parkin protein,  EC 3.6.1.- GTP Phosphohydrolases,  Microtubule-Associated Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.6.1.- Mfn2 protein,  mouse,  Recombinant Fusion Proteins]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Parkin is recruited selectively to impaired mitochondria and promotes their autophagy."} , { "attrname": "Abstract", "value": "Loss-of-function mutations in Park2,  the gene coding for the ubiquitin ligase Parkin,  are a significant cause of early onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Although the role of Parkin in neuron maintenance is unknown,  recent work has linked Parkin to the regulation of mitochondria. Its loss is associated with swollen mitochondria and muscle degeneration in Drosophila melanogaster,  as well as mitochondrial dysfunction and increased susceptibility to mitochondrial toxins in other species. Here,  we show that Parkin is selectively recruited to dysfunctional mitochondria with low membrane potential in mammalian cells. After recruitment,  Parkin mediates the engulfment of mitochondria by autophagosomes and the selective elimination of impaired mitochondria. These results show that Parkin promotes autophagy of damaged mitochondria and implicate a failure to eliminate dysfunctional mitochondria in the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[GTP Phosphohydrolases,  Uncoupling Agents,  Neurons,  Humans,  Microtubule-Associated Proteins,  Rats,  Autophagy,  Recombinant Fusion Proteins,  Mice,  Knockout,  Protein Transport,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Mitochondria,  Animals,  Transfection,  Time Factors,  Membrane Potential,  Mitochondrial,  Fibroblasts,  Mice,  HeLa Cells]"} , { "attrname": "AUTHORS", "value": "[Derek Narendra,  Atsushi Tanaka,  Der-Fen Suen,  Richard J Youle]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN MITOCHONDRIAL AUTOPHAGY,  SUBCELLULAR LOCATION]"} ], "id": "1062", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19029340", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1083\/JCB.200809125"} , { "elementOf": "NLM", "accession": "19029340"} ]} , { "annotation": "[UBIQUITINATION OF GPR37]", "conames": [{ "name": "PMID: 11439185", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11439185", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Cell"} , { "attrname": "Chemical", "value": "[EC 2.3.2.23 UBE2L3 protein,  human,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  Cysteine Proteinase Inhibitors,  Ubiquitins,  EC 2.3.2.27 parkin protein,  Receptors,  Cell Surface,  WYQ7N0BPYC Acetylcysteine,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  133343-34-7 lactacystin,  Recombinant Fusion Proteins,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "An unfolded putative transmembrane polypeptide,  which can lead to endoplasmic reticulum stress,  is a substrate of Parkin."} , { "attrname": "Abstract", "value": "A putative G protein-coupled transmembrane polypeptide,  named Pael receptor,  was identified as an interacting protein with Parkin,  a gene product responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When overexpressed in cells,  this receptor tends to become unfolded,  insoluble,  and ubiquitinated in vivo. The insoluble Pael receptor leads to unfolded protein-induced cell death. Parkin specifically ubiquitinates this receptor in the presence of ubiquitin-conjugating enzymes resident in the endoplasmic reticulum and promotes the degradation of insoluble Pael receptor,  resulting in suppression of the cell death induced by Pael receptor overexpression. Moreover,  the insoluble form of Pael receptor accumulates in the brains of AR-JP patients. Here,  we show that the unfolded Pael receptor is a substrate of Parkin,  the accumulation of which may cause selective neuronal death in AR-JP. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Brain,  Humans,  Cells,  Cultured,  Acetylcysteine,  Receptors,  Cell Surface,  Endoplasmic Reticulum,  Precipitin Tests,  Protein Folding,  Recombinant Fusion Proteins,  Ubiquitin-Protein Ligases,  Two-Hybrid System Techniques,  Ligases,  Cysteine Proteinase Inhibitors,  Ubiquitins,  Cell Death,  Protein Binding,  Ubiquitin-Conjugating Enzymes,  Microscopy,  Fluorescence]"} , { "attrname": "AUTHORS", "value": "[Y Imai,  M Soda,  H Inoue,  N Hattori,  Y Mizuno,  R Takahashi]"} , { "attrname": "PUB_TYPE", "value": "[UBIQUITINATION OF GPR37]"} ], "id": "1063", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11439185", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11439185"} , { "elementOf": "DOI", "accession": "10.1016\/S0092-8674(01)00407-X"} ]} , { "annotation": "[VARIANT PARK2 PHE-431]", "conames": [{ "name": "PMID: 10939576", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10939576", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Proteins,  EC 2.3.2.27 parkin protein,  Codon,  Nonsense,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Novel mutations,  pseudo-dominant inheritance,  and possible familial affects in patients with autosomal recessive juvenile parkinsonism."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile parkinsonism is a hereditary neurodegenerative disorder,  usually beginning before the age of 40. We found three exonic deletions and two novel point mutations (Arg33Stop and Cys431Phe) in six families with autosomal recessive juvenile parkinsonism. In 1 family,  in which an autosomal dominant mode of inheritance was suspected,  multiple mutant alleles were identified. Although a wide range of ages at onset was observed,  there was no correlation between age at onset and genotype. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Exons,  Humans,  Genotype,  Male,  Gene Dosage,  Codon,  Nonsense,  Mutation,  Missense,  Proteins,  Ubiquitin-Protein Ligases,  Phenotype,  Genes,  Dominant,  DNA Mutational Analysis,  Ligases,  Pedigree,  Gene Deletion,  Adolescent,  Adult,  Female,  Mutation,  Child]"} , { "attrname": "AUTHORS", "value": "[M Maruyama,  T Ikeuchi,  M Saito,  A Ishikawa,  T Yuasa,  H Tanaka,  S Hayashi,  K Wakabayashi,  H Takahashi,  S Tsuji]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 PHE-431]"} ], "id": "1064", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10939576", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10939576"} , { "elementOf": "DOI", "accession": "10.1002\/1531-8249(200008)48: 2<245: : AID-ANA15>3.0.CO;2-2"} ]} , { "annotation": "[INVOLVEMENT IN CANCER]", "conames": [{ "name": "PMID: 14614460", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14614460", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Oncogene"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  DNA Primers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Alterations in the common fragile site gene Parkin in ovarian and other cancers."} , { "attrname": "Abstract", "value": "The cloning and characterization of the common fragile site (CFS) FRA6E (6q26) identified Parkin,  the gene involved in the pathogenesis of many cases of juvenile,  early-onset and,  rarely,  late-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  as the third large gene to be localized within a large CFS. Initial analyses of Parkin indicated that in addition to playing a role in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  it might also be involved in the development and\/or progression of ovarian cancer. These analyses also indicated striking similarities among the large CFS-locus genes:  fragile histidine triad gene (FHIT; 3p14.2),  WW domain-containing oxidoreductase gene (WWOX; 16q23),  and Parkin (6q26). Analyses of FHIT and WWOX in a variety of different cancer types have identified the presence of alternative transcripts with whole exon deletions. Interestingly,  various whole exon duplications and deletions have been identified for Parkin in juvenile and early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s patients. Therefore,  we performed mutational\/exon rearrangement analysis of Parkin in ovarian cancer cell lines and primary tumors. Four (66.7%) cell lines and four (18.2%) primary tumors were identified as being heterozygous for the duplication or deletion of a Parkin exon. Additionally,  three of 23 (13.0%) nonovarian tumor-derived cell lines were also identified as having a duplication or deletion of one or more Parkin exons. Analysis of Parkin protein expression with antibodies revealed that most of the ovarian cancer cell lines and primary tumors had diminished or absent Parkin expression. While functional analyses have not yet been performed for Parkin,  these data suggest that like FHIT and WWOX,  Parkin may represent a tumor suppressor gene. "} , { "attrname": "MeSH", "value": "[Gene Duplication,  Alternative Splicing,  Humans,  In Situ Hybridization,  Fluorescence,  DNA Primers,  Blotting,  Western,  Ubiquitin-Protein Ligases,  Homozygote,  Base Sequence,  Gene Deletion,  Female,  Ovarian Neoplasms,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[Stacy R Denison,  Fang Wang,  Nicole A Becker,  Birgitt Schle,  Norman Kock,  Leslie A Phillips,  Christine Klein,  David I Smith]"} , { "attrname": "PUB_TYPE", "value": "[INVOLVEMENT IN CANCER]"} ], "id": "1065", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14614460", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14614460"} , { "elementOf": "DOI", "accession": "10.1038\/SJ.ONC.1207072"} ]} , { "annotation": "[VARIANTS PARK2 LEU-37 AND PRO-351]", "conames": [{ "name": "PMID: 12112109", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12112109", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Role of parkin mutations in 111 community-based patients with early-onset parkinsonism."} , { "attrname": "Abstract", "value": "Early-onset parkinsonism is frequently reported in connection with mutations in the parkin gene. In this study,  we present the results of extensive genetic screening for parkin mutations in 111 community-derived early-onset parkinsonism patients (age of onset <50 years) from Germany with an overall mutation rate of 9.0%. Gene dosage alterations represented 67% of the mutations found,  underlining the importance of quantitative analyses of parkin. In summary,  parkin mutations accounted for a low but significant percentage of early-onset parkinsonism patients in a community-derived sample. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Ubiquitin-Protein Ligases,  Residence Characteristics,  Exons,  Ligases,  Humans,  Middle Aged,  Age of Onset,  Adult,  Female,  Male,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Martin Kann,  Helfried Jacobs,  Kathrin Mohrmann,  Kirsten Schumacher,  Katja Hedrich,  Jennifer Garrels,  Karin Wiegers,  Eberhard Schwinger,  Peter P Pramstaller,  Xandra O Breakefield,  Laurie J Ozelius,  Peter Vieregge,  Christine Klein]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 LEU-37 AND PRO-351]"} ], "id": "1066", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12112109", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12112109"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.10179"} ]} , { "annotation": "[VARIANTS PARK2 VAL-192; ASN-211; MET-240 AND LEU-437,  VARIANT ASN-167,  INVOLVEMENT IN LATE-ONSET PARK]", "conames": [{ "name": "PMID: 12629236", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12629236", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease."} , { "attrname": "Abstract", "value": "The vast majority of the parkin mutations previously identified have been found in individuals with juvenile or early onset PD. Previous screening of later onset PD cohorts has not identified substantial numbers of parkin mutations. Families with at least two siblings with PD were ascertained to identify genes contributing to PD susceptibility. Screening of the parkin gene,  by both quantitative PCR and exon sequencing,  was performed in those families with either early onset PD (age onset < or =50 years) or positive lod score with a marker in intron 7 of the parkin gene. A total of 25 different mutations in the parkin gene were identified in 103 individuals from 47 families. Mutations were found in both parkin alleles in 41 of the individuals,  whereas a single mutation in only one of the two parkin alleles was observed in 62 individuals. Thirty-five of the subjects (34%) with a parkin mutation had an age at onset of 60 years or above with 30 of these 35 (86%) having a detectable mutation on only one parkin allele. Few significant clinical differences were observed among the individuals with two,  one,  or no mutated copies of the parkin gene. Mutations in the parkin gene occur among individuals with PD with an older age at onset (> or =60 years) who have a positive family history of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. In addition,  the clinical findings of parkin-positive individuals are remarkably similar to those without mutations. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Genetic Testing,  Humans,  Middle Aged,  Age of Onset,  Heterozygote,  Aged,  Mutation,  North America]"} , { "attrname": "AUTHORS", "value": "[T Foroud,  S K Uniacke,  L Liu,  N Pankratz,  A Rudolph,  C Halter,  C Shults,  K Marder,  P M Conneally,  W C Nichols,   <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> Study Group]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 VAL-192; ASN-211; MET-240 AND LEU-437,  VARIANT ASN-167,  INVOLVEMENT IN LATE-ONSET PARK]"} ], "id": "1067", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12629236", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/01.WNL.0000049470.00180.07"} , { "elementOf": "NLM", "accession": "12629236"} ]} , { "annotation": "[INTERACTION WITH STUB1 AND HSP70,  UBIQUITINATION OF STUB1]", "conames": [{ "name": "PMID: 12150907", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12150907", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Molecular cell"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 STUB1 protein,  human,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  HSP70 Heat-Shock Proteins,  EC 6.- Ligases,  Macromolecular Substances]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "CHIP is associated with Parkin,  a gene responsible for familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and enhances its ubiquitin ligase activity."} , { "attrname": "Abstract", "value": "Unfolded Pael receptor (Pael-R) is a substrate of the E3 ubiquitin ligase Parkin. Accumulation of Pael-R in the endoplasmic reticulum (ER) of dopaminergic neurons induces ER stress leading to neurodegeneration. Here,  we show that CHIP,  Hsp70,  Parkin,  and Pael-R formed a complex in vitro and in vivo. The amount of CHIP in the complex was increased during ER stress. CHIP promoted the dissociation of Hsp70 from Parkin and Pael-R,  thus facilitating Parkin-mediated Pael-R ubiquitination. Moreover,  CHIP enhanced Parkin-mediated in vitro ubiquitination of Pael-R in the absence of Hsp70. Furthermore,  CHIP enhanced the ability of Parkin to inhibit cell death induced by Pael-R. Taken together,  these results indicate that CHIP is a mammalian E4-like molecule that positively regulates Parkin E3 activity. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>ian Disorders,  Rats,  Wistar,  Substantia Nigra,  Humans,  Gene Expression Regulation,  Rats,  Male,  Endoplasmic Reticulum,  Blotting,  Western,  Protein Folding,  Macromolecular Substances,  Protein Transport,  Ubiquitin-Protein Ligases,  Animals,  Transfection,  Ligases,  Models,  Biological,  Cell Death,  Protein Binding,  Mice,  Tumor Cells,  Cultured,  HSP70 Heat-Shock Proteins]"} , { "attrname": "AUTHORS", "value": "[Yuzuru Imai,  Mariko Soda,  Shigetsugu Hatakeyama,  Takumi Akagi,  Tsutomu Hashikawa,  Kei Ichi Nakayama,  Ryosuke Takahashi]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH STUB1 AND HSP70,  UBIQUITINATION OF STUB1]"} ], "id": "1068", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12150907", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12150907"} , { "elementOf": "DOI", "accession": "10.1016\/S1097-2765(02)00583-X"} ]} , { "annotation": "[VARIANT PARK2 GLU-82]", "conames": [{ "name": "PMID: 11487568", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11487568", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "The importance of gene dosage studies:  mutational analysis of the parkin gene in early-onset parkinsonism."} , { "attrname": "Abstract", "value": "Early-onset parkinsonism (EOP) may be associated with different mutations in the parkin gene,  including exon deletions and duplications. To test for gene dosage alterations,  we developed a new method of quantitative duplex PCR using the fluorescence resonance energy transfer technique on the LightCycler (Roche Diagnostics). In 21 patients with EOP,  three mutations (a single base pair substitution in exon 3 and small deletions in exon 9) were detected by conventional mutational screening (single-strand conformation polymorphism and sequence analysis),  while alterations of gene dosage were found in seven patients. We identified heterozygous and compound heterozygous deletions of exons 2,  3,  5 and 7. The latter was also found in the homozygous state. In addition,  two heterozygous duplications of exon 4 were observed. Remarkably,  two patients carried more than two parkin mutations. This is the first study systematically screening all 12 exons of parkin by real-time,  kinetic quantification and clearly shows that mutational analysis of the parkin gene should include gene dosage studies. Furthermore,  our method of quantitative PCR is easily applicable to any other gene to be screened for deletions or duplications of whole exons. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Blotting,  Southern,  Humans,  Middle Aged,  Male,  Gene Dosage,  Ubiquitin-Protein Ligases,  Homozygote,  DNA Mutational Analysis,  Ligases,  Pedigree,  Age of Onset,  Polymerase Chain Reaction,  Female,  Heterozygote,  Mutation]"} , { "attrname": "AUTHORS", "value": "[K Hedrich,  M Kann,  A J Lanthaler,  A Dalski,  C Eskelson,  O Landt,  E Schwinger,  P Vieregge,  A E Lang,  X O Breakefield,  L J Ozelius,  P P Pramstaller,  C Klein]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 GLU-82]"} ], "id": "1069", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11487568", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11487568"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/10.16.1649"} ]} , { "annotation": "[INTERACTION WITH PACRG]", "conames": [{ "name": "PMID: 14532270", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14532270", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Proteins,  Molecular Chaperones,  EC 3.4.22.- Cysteine Endopeptidases,  GPR37 receptor,  human,  Multienzyme Complexes,  EC 2.3.2.27 parkin protein,  Receptors,  G-Protein-Coupled,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  HSP70 Heat-Shock Proteins,  PACRG protein,  human]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death."} , { "attrname": "Abstract", "value": "Parkin,  a RING-type ubiquitin ligase,  is the product of the gene responsible for autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism. A reverse strand gene located upstream of the parkin gene in the human genome has been identified. The gene product,  termed Glup\/PACRG,  forms a large molecular chaperone complex containing heat shock proteins 70 and 90 and chaperonin components. Glup suppressed cell death induced by accumulation of unfolded Pael receptor (Pael-R),  a substrate of Parkin. On the other hand,  Glup facilitated the formation of inclusions consisting of Pael-R,  molecular chaperones,  protein degradation molecules,  and Glup itself,  when proteasome is inhibited. Glup knockdown attenuated the formation of Pael-R inclusions,  which resulted in the promotion of cell death with extensive vacuolization. Moreover,  Glup turned out to be a component of Lewy bodies in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cases. These data suggest that Glup may play an important role in the formation of Lewy bodies and protection of dopaminergic neurons against <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Cell Line,  Cysteine Endopeptidases,  Molecular Chaperones,  Multienzyme Complexes,  Neurons,  Humans,  Receptors,  G-Protein-Coupled,  Molecular Sequence Data,  Lewy Bodies,  Proteasome Endopeptidase Complex,  Proteins,  Ubiquitin-Protein Ligases,  Inclusion Bodies,  Transfection,  Base Sequence,  Cell Death,  HSP70 Heat-Shock Proteins]"} , { "attrname": "AUTHORS", "value": "[Yuzuru Imai,  Mariko Soda,  Tetsuro Murakami,  Mikio Shoji,  Koji Abe,  Ryosuke Takahashi]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH PACRG]"} ], "id": "1070", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14532270", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M309655200"} , { "elementOf": "NLM", "accession": "14532270"} ]} , { "annotation": "[VARIANT ASN-167]", "conames": [{ "name": "PMID: 10511432", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10511432", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Proteins,  Codon,  EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Association of codon 167 Ser\/Asn heterozygosity in the parkin gene with sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "A variety of deletional and point mutations has been identified in the parkin gene on chromosome 6q25.2-27 in patients with autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  a distinct form of familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). To study the potential involvement of the parkin gene in development of non-hereditary idiopathic PD,  a codon 167 serine\/asparagine (167S\/N) polymorphism located in its exon 4 was analyzed by direct sequencing in 71 patients with sporadic PD and 109 age-matched non-PD controls. The frequency of either 167S or 167N allele was not statistically different between PD patients and controls,  while the frequency of 167S\/N heterozygotes was significantly higher in PD patients (62.0% vs 45.9%),  compared with that of both 167S\/S and 167N\/N homozygotes combined (chi2 4.467,  p = 0.0346; odds ratio = 1.92,  95% confidence interval = 1.05-3.54). These observations suggest that the heterozygosity at codon 167 in the parkin gene might represent a genetic risk factor for development of sporadic PD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Gene Frequency,  Humans,  Middle Aged,  Genotype,  Male,  Reference Values,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteins,  Ubiquitin-Protein Ligases,  Codon,  Ligases,  Alleles,  Aged,  80 and over,  Adult,  Female,  Heterozygote,  Aged]"} , { "attrname": "AUTHORS", "value": "[J Satoh,  Y Kuroda]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT ASN-167]"} ], "id": "1071", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10511432", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1097\/00001756-199909090-00008"} , { "elementOf": "NLM", "accession": "10511432"} ]} , { "annotation": "[INTERACTION WITH UBE2L6 AND SEPT5,  UBIQUITINATION OF SEPT5]", "conames": [{ "name": "PMID: 11078524", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11078524", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  AE28F7PNPL Methionine,  EC 3.6.1.- SEPT5 protein,  human,  EC 3.6.1.- Septins,  Ubiquitins,  EC 2.3.2.23 UBE2E2 protein,  human,  Nerve Tissue Proteins,  Recombinant Proteins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Cell Cycle Proteins,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein,  CDCrel-1."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is a common neurodegenerative disorder in which familial-linked genes have provided novel insights into the pathogenesis of this disorder. Mutations in Parkin,  a ring-finger-containing protein of unknown function,  are implicated in the pathogenesis of autosomal recessive familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here,  we show that Parkin binds to the E2 ubiquitin-conjugating human enzyme 8 (UbcH8) through its C-terminal ring-finger. Parkin has ubiquitin-protein ligase activity in the presence of UbcH8. Parkin also ubiquitinates itself and promotes its own degradation. We also identify and show that the synaptic vesicle-associated protein,  CDCrel-1,  interacts with Parkin through its ring-finger domains. Furthermore,  Parkin ubiquitinates and promotes the degradation of CDCrel-1. Familial-linked mutations disrupt the ubiquitin-protein ligase function of Parkin and impair Parkin and CDCrel-1 degradation. These results suggest that Parkin functions as an E3 ubiquitin-protein ligase through its ring domains and that it may control protein levels via ubiquitination. The loss of Parkin's ubiquitin-protein ligase function in familial-linked mutations suggests that this may be the cause of familial autosomal recessive <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Humans,  Methionine,  Septins,  Molecular Sequence Data,  Nerve Tissue Proteins,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Ubiquitin-Protein Ligases,  Sequence Alignment,  Synaptic Vesicles,  Transfection,  Ligases,  Ubiquitins,  Cloning,  Molecular,  Ubiquitin-Conjugating Enzymes,  Binding Sites,  Cell Cycle Proteins]"} , { "attrname": "AUTHORS", "value": "[Y Zhang,  J Gao,  K K Chung,  H Huang,  V L Dawson,  T M Dawson]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH UBE2L6 AND SEPT5,  UBIQUITINATION OF SEPT5]"} ], "id": "1072", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11078524", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11078524"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.240347797"} ]} , { "annotation": "[FUNCTION]", "conames": [{ "name": "PMID: 25621951", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "25621951", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature cell biology"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 3.1.2.- Thiolester Hydrolases,  147336-22-9 Green Fluorescent Proteins,  EC 2.3.2.27 parkin protein,  EC 3.1.2.15 Usp30 protein,  human,  Cell Extracts,  Mitochondrial Proteins,  555-60-2 Carbonyl Cyanide m-Chlorophenyl Hydrazone,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.4.19.12 Ubiquitin-Specific Proteases,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2015"} , { "attrname": "AbstractHeader", "value": "USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria."} , { "attrname": "Abstract", "value": "Multiple lines of evidence indicate that mitochondrial dysfunction is central to <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Here we investigate the mechanism by which parkin,  an E3 ubiquitin ligase,  and USP30,  a mitochondrion-localized deubiquitylase,  regulate mitophagy. We find that mitochondrial damage stimulates parkin to assemble Lys 6,  Lys 11 and Lys 63 chains on mitochondria,  and that USP30 is a ubiquitin-specific deubiquitylase with a strong preference for cleaving Lys 6- and Lys 11-linked multimers. Using mass spectrometry,  we show that recombinant USP30 preferentially removes these linkage types from intact ubiquitylated mitochondria and counteracts parkin-mediated ubiquitin chain formation in cells. These results,  combined with a series of chimaera and localization studies,  afford insights into the mechanism by which a balance of ubiquitylation and deubiquitylation regulates mitochondrial homeostasis,  and suggest a general mechanism for organelle autophagy. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Green Fluorescent Proteins,  Catalytic Domain,  Humans,  Homeostasis,  Substrate Specificity,  Carbonyl Cyanide m-Chlorophenyl Hydrazone,  Mitochondrial Proteins,  Gene Knockdown Techniques,  Mitochondrial Degradation,  Ubiquitin-Protein Ligases,  Ubiquitin-Specific Proteases,  Mitochondria,  Peroxisomes,  Ubiquitination,  Lysine,  Models,  Biological,  Mass Spectrometry,  HEK293 Cells,  Membrane Potential,  Mitochondrial,  Cell Extracts,  Thiolester Hydrolases,  HeLa Cells,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[Christian N Cunningham,  Joshua M Baughman,  Lilian Phu,  Joy S Tea,  Christine Yu,  Mary Coons,  Donald S Kirkpatrick,  Baris Bingol,  Jacob E Corn]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION]"} ], "id": "1073", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 25621951", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "25621951"} , { "elementOf": "DOI", "accession": "10.1038\/NCB3097"} ]} , { "annotation": "[REVIEW ON VARIANTS];", "conames": [{ "name": "PMID: 14976155", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14976155", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Parkin genetics:  one model for Parkinson's disease."} , { "attrname": "Abstract", "value": "The genetic epidemiology of late-onset idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) and 'parkin-proven' <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism (AR-JP) are limited. The clinical phenotype,  prognosis and treatments are similar although PD is prevalent while AR-JP is rare. Molecular genetic and functional analysis suggests the E3 ubiquitin protein ligase activity of parkin,  and the ubiquitin-proteosomal pathway,  is central to <span style=\"background-color: yellow\"><b>disease<\/b><\/span> pathogenesis. Herein,  we compare and contrast PD and AR-JP and discuss the implications of recent data about parkin's genomic organization,  regulation and function. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Animals,  Humans,  Substrate Specificity,  Mutation,  Chromosomes,  Human,  Pair 6,  <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Models,  Animal,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[Ignacio F Mata,  Paul J Lockhart,  Matthew J Farrer]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "1074", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14976155", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/HMG\/DDH089"} , { "elementOf": "NLM", "accession": "14976155"} ]} , { "annotation": "[VARIANT PARK2 TYR-212]", "conames": [{ "name": "PMID: 11163284", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11163284", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[K848JZ4886 Cysteine,  42HK56048U Tyrosine,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile Parkinsonism in a population from North West Colombia."} , { "attrname": "Abstract", "value": "We report the molecular characterization of three multiplex families and a sporadic case of juvenile Parkinsonism identified in the province of Antioquia (Colombia). Linkage and haplotype analysis using markers in 6q25.2-27 indicated that Parkinsonism in the pedigrees is linked to the parkin gene (maximum LOD-score of 3.85) but that they carry two different mutant haplotypes. Sequence analysis revealed a novel G to A transition in exon 6 at position 736 (G736A) of parkin. This change results in a non-conservative cysteine for tyrosine substitution. All affected individuals from two families were homozygous for this mutation,  which was not detected in 100 normal controls. Patients from the family carrying the second haplotype and the sporadic case were homozygous for a GT insertion in exon 3. This mutation has been previously identified in French families with juvenile Parkinsonism. The concomitant presence of founder effects and allelic heterogeneity in Antioquia might relate to the founding admixture at the origin of this population. "} , { "attrname": "MeSH", "value": "[Parkinsonian Disorders,  Tyrosine,  Colombia,  Cysteine,  Humans,  Family Health,  Male,  Genetic Heterogeneity,  Ubiquitin-Protein Ligases,  Founder Effect,  Point Mutation,  Ligases,  Pedigree,  Adolescent,  Age of Onset,  Alleles,  Adult,  Female]"} , { "attrname": "AUTHORS", "value": "[N Pineda-Trujillo,  L G Carvajal-Carmona,  O Buritic,  S Moreno,  C Uribe,  D Pineda,  M Toro,  F Garca,  W Arias,  G Bedoya,  F Lopera,  A Ruiz-Linares]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT PARK2 TYR-212]"} ], "id": "1075", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11163284", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11163284"} , { "elementOf": "DOI", "accession": "10.1016\/S0304-3940(00)01733-X"} ]} , { "annotation": "[FUNCTION IN UBIQUITINATION]", "conames": [{ "name": "PMID: 10973942", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10973942", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Neuroprotective Agents,  Ubiquitins,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  RNA,  Messenger,  Recombinant Fusion Proteins,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity."} , { "attrname": "Abstract", "value": "Autosomal recessive juvenile parkinsonism (AR-JP) is caused by mutations in the parkin gene. Parkin protein is characterized by a ubiquitin-like domain at its NH(2)-terminus and two RING finger motifs and an IBR (in between RING fingers) at its COOH terminus (RING-IBR-RING). Here,  we show that Parkin is a RING-type E3 ubiquitin-protein ligase which binds to E2 ubiquitin-conjugating enzymes,  including UbcH7 and UbcH8,  through its RING-IBR-RING motif. Moreover,  we found that unfolded protein stress induces up-regulation of both the mRNA and protein level of Parkin. Furthermore,  overexpression of Parkin,  but not a set of mutants without the E3 activity,  specifically suppressed unfolded protein stress-induced cell death. These findings demonstrate that Parkin is an E3 enzyme and suggest that it is involved in the ubiquitination pathway for misfolded proteins derived from endoplasmic reticulum and contributes to protection from neurotoxicity induced by unfolded protein stresses. "} , { "attrname": "MeSH", "value": "[Cell Line,  Neuroprotective Agents,  Up-Regulation,  Humans,  Protein Folding,  Recombinant Fusion Proteins,  Amino Acid Motifs,  Ubiquitin-Protein Ligases,  Animals,  Transfection,  Ligases,  Ubiquitins,  Cell Death,  Protein Denaturation,  Protein Binding,  Mutation,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[Y Imai,  M Soda,  R Takahashi]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION IN UBIQUITINATION]"} ], "id": "1076", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10973942", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.C000447200"} , { "elementOf": "NLM", "accession": "10973942"} ]} , { "annotation": "[FUNCTION,  INVOLVEMENT IN CANCER]", "conames": [{ "name": "PMID: 12719539", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12719539", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 2.3.2.27 parkin protein,  Genetic Markers,  DNA Primers,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  Tumor Suppressor Proteins,  EC 6.- Ligases]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Parkin,  a gene implicated in autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  is a candidate tumor suppressor gene on chromosome 6q25-q27."} , { "attrname": "Abstract", "value": "In an effort to identify tumor suppressor gene(s) associated with the frequent loss of heterozygosity observed on chromosome 6q25-q27,  we constructed a contig derived from the sequences of bacterial artificial chromosomeP1 bacteriophage artificial chromosome clones defined by the genetic interval D6S1581-D6S1579-D6S305-D6S1599-D6S1008. Sequence analysis of this contig found it to contain eight known genes,  including the complete genomic structure of the Parkin gene. Loss of heterozygosity (LOH) analysis of 40 malignant breast and ovarian tumors identified a common minimal region of loss,  including the markers D6S305 (50%) and D6S1599 (32%). Both loci exhibited the highest frequencies of LOH in this study and are each located within the Parkin genomic structure. Whereas mutation analysis revealed no missense substitutions,  expression of the Parkin gene appeared to be down-regulated or absent in the tumor biopsies and tumor cell lines examined. In addition,  the identification of two truncating deletions in 3 of 20 ovarian tumor samples,  as well as homozygous deletion of exon 2 in the lung adenocarcinoma cell lines Calu-3 and H-1573,  supports the hypothesis that hemizygous or homozygous deletions are responsible for the abnormal expression of Parkin in these samples. These data suggest that the LOH observed at chromosome 6q25-q26 may contribute to the initiation andor progression of cancer by inactivating or reducing the expression of the Parkin gene. Because Parkin maps to FRA6E,  one of the most active common fragile sites in the human genome,  it represents another example of a large tumor suppressor gene,  like FHIT and WWOX,  located at a common fragile site. "} , { "attrname": "MeSH", "value": "[Cell Line,  Humans,  Chromosome Mapping,  Genetic Markers,  Breast Neoplasms,  Chromosomes,  Human,  Pair 6,  DNA Primers,  Reverse Transcriptase Polymerase Chain Reaction,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Ligases,  Base Sequence,  Female,  Ovarian Neoplasms,  Genes,  Tumor Suppressor,  Tumor Suppressor Proteins]"} , { "attrname": "AUTHORS", "value": "[Rossano Cesari,  Eric S Martin,  George A Calin,  Francesca Pentimalli,  Roberta Bichi,  Holly McAdams,  Francesco Trapasso,  Alessandra Drusco,  Masayoshi Shimizu,  Valeria Masciullo,  Giuseppina D'Andrilli,  Giovanni Scambia,  Maria Cristina Picchio,  Hansjuerg Alder,  Andrew K Godwin,  Carlo M Croce]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INVOLVEMENT IN CANCER]"} ], "id": "1077", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12719539", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12719539"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0931262100"} ]} , { "annotation": "[VARIANTS PARK2 PRO-42; CYS-402; ASN-415 AND ARG-418]", "conames": [{ "name": "PMID: 15584030", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15584030", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Movement disorders :  official journal of the Movement Disorder Society"} , { "attrname": "Chemical", "value": "[EC 2.7.11.1 PTEN-induced putative kinase,  EC 2.3.2.27 parkin protein,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  EC 3.1.2.- PARK7 protein,  human,  EC 2.7.- Protein Kinases,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  EC 3.1.2.- Protein Deglycase DJ-1]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Novel parkin mutations detected in patients with early-onset Parkinson's disease."} , { "attrname": "Abstract", "value": "A multiethnic series of patients with early-onset <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOP) was studied to assess the frequency and nature of parkin\/PARK2 gene mutations and to investigate phenotype-genotype relationships. Forty-six EOP probands with an onset age of < 45 years,  and 14 affected relatives were ascertained from Italy,  Brazil,  Cuba,  and Turkey. The genetic screening included direct sequencing and exon dosage using a new,  cost-effective,  real-time polymerase chain reaction method. Mutations were found in 33% of the indexes overall,  and in 53% of those with family history compatible with autosomal recessive inheritance. Fifteen parkin alterations (10 exon deletions and five point mutations) were identified,  including four novel mutations:  Arg402Cys,  Cys418Arg,  IVS11-3C > G,  and exon 8-9-10 deletion. Homozygous mutations,  two heterozygous mutations,  and a single heterozygous mutation were found in 8,  6,  and 1 patient,  respectively. Heterozygous exon deletions represented 28% of the mutant alleles. The patients with parkin mutations showed significantly earlier onset,  longer <span style=\"background-color: yellow\"><b>disease<\/b><\/span> duration,  more frequently symmetric onset,  and slower <span style=\"background-color: yellow\"><b>disease<\/b><\/span> progression than the patients without mutations,  in agreement with previous studies. This study confirms the frequent involvement of parkin and the importance of genetic testing in the diagnostic work-up of EOP. "} , { "attrname": "MeSH", "value": "[Gene Library,  Exons,  Humans,  Middle Aged,  Intracellular Signaling Peptides and Proteins,  Oncogene Proteins,  Genotype,  Male,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Ubiquitin-Protein Ligases,  Point Mutation,  Protein Deglycase DJ-1,  Phenotype,  Mass Screening,  Protein Kinases,  Cost-Benefit Analysis,  Adolescent,  Age of Onset,  Polymerase Chain Reaction,  Adult,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[Aida M Bertoli-Avella,  Jos L Giroud-Benitez,  Ali Akyol,  Egberto Barbosa,  Onno Schaap,  Herma C van der Linde,  Emilia Martignoni,  Leonardo Lopiano,  Paolo Lamberti,  Emiliana Fincati,  Angelo Antonini,  Fabrizio Stocchi,  Pasquale Montagna,  Ferdinando Squitieri,  Paolo Marini,  Giovanni Abbruzzese,  Giovanni Fabbrini,  Roberto Marconi,  Alessio Dalla Libera,  Giorgio Trianni,  Marco Guidi,  Antonio De Gaetano,  Gustavo Boff Maegawa,  Antonino De Leo,  Virgilio Gallai,  Giulia de Rosa,  Nicola Vanacore,  Giuseppe Meco,  Cornelia M van Duijn,  Ben A Oostra,  Peter Heutink,  Vincenzo Bonifati,   Italian <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> Genetics Network]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS PARK2 PRO-42; CYS-402; ASN-415 AND ARG-418]"} ], "id": "1078", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15584030", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/MDS.20343"} , { "elementOf": "NLM", "accession": "15584030"} ]} , { "annotation": "[INTERACTION WITH SUMO1,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 16955485", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16955485", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuroscience research"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 2.3.2.23 Ubiquitin-Conjugating Enzymes,  Molecular Chaperones,  Nuclear Pore Complex Proteins,  EC 2.3.2.27 parkin protein,  SUMO-1 Protein,  EC 2.3.2.27 Ubiquitin-Protein Ligases,  ran-binding protein 2]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Functional modulation of parkin through physical interaction with SUMO-1."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) is the second most common neurodegenerative disorder and is characterized by the extensive and progressive loss of dopaminergic neurons in the CNS substantia nigra pars compacta region. Mutations in the parkin gene,  which encodes for E3 ubiquitin ligase,  have been implicated in autosomal recessive juvenile <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism,  an early-onset and common familial form of PD. Although several parkin substrates have already been identified,  the molecular mechanism underlying the regulation of enzymatic activity of parkin has yet to be clarified. In a previous study,  we demonstrated that RanBP2 becomes a new target for parkin E3 ubiquitin ligase and is processed via parkin-mediated ubiquitination and subsequent proteasomal degradation. RanBP2,  which is localized in the cytoplasmic filament of the nuclear pore complex,  belongs to the small ubiquitin-related modifier (SUMO) E3 ligase family. Here we show that parkin appears to bind selectively to the SUMO-1 in vivo and in vitro. Moreover,  the physical association of SUMO-1 with parkin results in an increase in the nuclear transport of parkin as well as its self-ubiquitination. Our findings suggest that the E3 ubiquitin ligase activity of parkin and its intracellular localization may be modulated through the SUMO-1 association. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Ubiquitin,  Cell Line,  Molecular Chaperones,  Immunoprecipitation,  Nuclear Pore Complex Proteins,  Neurons,  Humans,  Rats,  Neuroblastoma,  SUMO-1 Protein,  Blotting,  Western,  Ubiquitin-Protein Ligases,  Animals,  Transfection,  RNA Interference,  Protein Binding,  Ubiquitin-Conjugating Enzymes,  Subcellular Fractions,  Hippocampus]"} , { "attrname": "AUTHORS", "value": "[Ji Won Um,  Kwang Chul Chung]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH SUMO1,  SUBCELLULAR LOCATION]"} ], "id": "1079", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16955485", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/JNR.21041"} , { "elementOf": "NLM", "accession": "16955485"} ]} , { "annotation": "", "conames": [{ "name": "Ixabepilone", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1080", "contexts": { } , "evidences": ["Imported from database"], "value": "Ixabepilone", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB04845"} ]} , { "annotation": "", "conames": [{ "name": "Dihydroxyaluminium", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1081", "contexts": { } , "evidences": ["Imported from database"], "value": "Dihydroxyaluminium", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01375"} ]} , { "annotation": "", "conames": [{ "name": "Dasatinib", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1082", "contexts": { } , "evidences": ["Imported from database"], "value": "Dasatinib", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01254"} ]} , { "annotation": "", "conames": [{ "name": "Pseudoephedrine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1083", "contexts": { } , "evidences": ["Imported from database"], "value": "Pseudoephedrine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00852"} ]} , { "annotation": "", "conames": [{ "name": "Arsenic trioxide", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1084", "contexts": { } , "evidences": ["Imported from database"], "value": "Arsenic trioxide", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01169"} ]} , { "annotation": "", "conames": [{ "name": "Irbesartan", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1085", "contexts": { } , "evidences": ["Imported from database"], "value": "Irbesartan", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01029"} ]} , { "annotation": "", "conames": [{ "name": "Hyaluronidase (Human Recombinant)", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "BiotechDrug"} ], "id": "1086", "contexts": { } , "evidences": ["Imported from database"], "value": "Hyaluronidase (Human Recombinant)", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB06205"} ]} , { "annotation": "", "conames": [{ "name": "Hyaluronidase", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "BiotechDrug"} ], "id": "1087", "contexts": { } , "evidences": ["Imported from database"], "value": "Hyaluronidase", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00070"} ]} , { "annotation": "", "conames": [{ "name": "Nadroparin", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1088", "contexts": { } , "evidences": ["Imported from database"], "value": "Nadroparin", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB08813"} ]} , { "annotation": "", "conames": [], "elementOf": "UNIPROTKB", "description": "", "pid": "3.4.23.-", "attributes": [], "id": "1089", "contexts": { } , "evidences": ["Imported from database"], "value": "3.4.23.-", "ofType": "Enzyme Classification", "coaccessions": [{ "elementOf": "EC", "accession": "3.4.23.-"} ]} , { "annotation": "", "conames": [{ "name": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 3", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "607822", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "1090", "contexts": { } , "evidences": ["Imported from database"], "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 3", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "607822"} ]} , { "annotation": "Interacting selectively and non-covalently with cadherin,  a type I membrane protein involved in cell adhesion. ( Reference:  GOC: bf )", "conames": [{ "name": "cadherin binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045296", "attributes": [], "id": "1091", "contexts": { } , "evidences": ["Imported from database"], "value": "cadherin binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045296"} ]} , { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "aspartate protease", "isPreferred": "false"} , { "name": "aspartic-type endopeptidase activity", "isPreferred": "true"} , { "name": "carboxyl protease", "isPreferred": "false"} , { "name": "aspartyl protease", "isPreferred": "false"} , { "name": "aspartic endopeptidase", "isPreferred": "true"} , { "name": "aspartic protease", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004190", "attributes": [], "id": "1092", "contexts": { } , "evidences": ["Imported from database"], "value": "aspartic endopeptidase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004190"} ]} , { "annotation": "Enables the facilitated diffusion of a calcium ion (by an energy-independent process) involving passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism. ( Reference:  GOC: mtg_transport GOC: pr ISBN: 0815340729 )", "conames": [{ "name": "calcium channel activity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005262", "attributes": [], "id": "1093", "contexts": { } , "evidences": ["Imported from database"], "value": "calcium channel activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005262"} ]} , { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain. ( Reference:  http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#ENDOPEPTIDASE )", "conames": [{ "name": "elastase", "isPreferred": "false"} , { "name": "proteinase", "isPreferred": "false"} , { "name": "endoprotease", "isPreferred": "false"} , { "name": "endopeptidase activity", "isPreferred": "true"} , { "name": "proteasome endopeptidase", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004175", "attributes": [], "id": "1094", "contexts": { } , "evidences": ["Imported from database"], "value": "endopeptidase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004175"} , { "elementOf": "GO", "accession": "GO: 0016809"} ]} , { "annotation": "The lipid bilayer surrounding the endoplasmic reticulum. ( Reference:  GOC: mah )", "conames": [{ "name": "endoplasmic reticulum membrane", "isPreferred": "true"} , { "name": "ER membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005789", "attributes": [], "id": "1095", "contexts": { } , "evidences": ["Imported from database"], "value": "ER membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005789"} ]} , { "annotation": "A protein complex that has aspartic-type endopeptidase activity,  and contains a catalytic subunit,  presenilin (PS),  that is a prototypical member of the GxGD-type aspartyl peptidases. The complex also contains additional subunits,  including nicastrin,  APH-1,  PEN-2,  and a regulatory subunit,  CD147. Gamma-secretase cleaves several transmembrane proteins including the cell surface receptor Notch and the beta-amyloid precursor protein. ( Reference:  GOC: mah PMID: 15286082 PMID: 15890777 PMID: 17047368 )", "conames": [{ "name": "gamma-secretase complex (APH1A,  PSEN2,  PSENEN,  NCSTN)", "isPreferred": "false"} , { "name": "gamma-secretase complex", "isPreferred": "true"} , { "name": "gamma-secretase complex (APH1B,  PSEN2,  PSENEN,  NCSTN)", "isPreferred": "false"} , { "name": "gamma-secretase complex (APH1B,  PSEN1,  PSENEN,  NCSTN)", "isPreferred": "false"} , { "name": "CD147-gamma-secretase complex (APH-1a,  PS-1,  PEN-2,  NCT variant)", "isPreferred": "false"} , { "name": "gamma-secretase complex (APH1A,  PSEN1,  PSENEN,  NCSTN variant)", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070765", "attributes": [], "id": "1096", "contexts": { } , "evidences": ["Imported from database"], "value": "gamma-secretase complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070765"} ]} , { "annotation": "A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules. ( Reference:  GOC: elh )", "conames": [{ "name": "kinetochore", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000776", "attributes": [], "id": "1097", "contexts": { } , "evidences": ["Imported from database"], "value": "kinetochore", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000776"} , { "elementOf": "GO", "accession": "GO: 0005699"} ]} , { "annotation": "A structure comprised of a core structure (in most organisms,  a pair of centrioles) and peripheral material from which a microtubule-based structure,  such as a spindle apparatus,  is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells,  though in animal cells it changes continually during the cell-division cycle. ( Reference:  GOC: mah ISBN: 0198547684 )", "conames": [{ "name": "centrosome", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005813", "attributes": [], "id": "1098", "contexts": { } , "evidences": ["Imported from database"], "value": "centrosome", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005813"} ]} , { "annotation": "The region of the plasma membrane located at the apical end of the cell. ( Reference:  GOC: curators )", "conames": [{ "name": "apical plasma membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016324", "attributes": [], "id": "1099", "contexts": { } , "evidences": ["Imported from database"], "value": "apical plasma membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016324"} ]} , { "annotation": "The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm. ( Reference:  GOC: ai )", "conames": [{ "name": "lysosomal membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005765", "attributes": [], "id": "1100", "contexts": { } , "evidences": ["Imported from database"], "value": "lysosomal membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005765"} ]} , { "annotation": "The smooth endoplasmic reticulum (smooth ER or SER) has no ribosomes attached to it. The smooth ER is the recipient of the proteins synthesized in the rough ER. Those proteins to be exported are passed to the Golgi complex,  the resident proteins are returned to the rough ER and the lysosomal proteins after phosphorylation of their mannose residues are passed to the lysosomes. Glycosylation of the glycoproteins also continues. The smooth ER is the site of synthesis of lipids,  including the phospholipids. The membranes of the smooth ER also contain enzymes that catalyze a series of reactions to detoxify both lipid-soluble drugs and harmful products of metabolism. Large quantities of certain compounds such as phenobarbital cause an increase in the amount of the smooth ER. ( Reference:  ISBN: 0198506732 )", "conames": [{ "name": "SER", "isPreferred": "true"} , { "name": "smooth ER", "isPreferred": "true"} , { "name": "smooth endoplasmic reticulum", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005790", "attributes": [], "id": "1101", "contexts": { } , "evidences": ["Imported from database"], "value": "SER", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005790"} ]} , { "annotation": "Platelike region of a muscle sarcomere to which the plus ends of actin filaments are attached. ( Reference:  GOC: mtg_muscle ISBN: 0815316194 )", "conames": [{ "name": "Z line", "isPreferred": "true"} , { "name": "Z disk", "isPreferred": "true"} , { "name": "Z disc", "isPreferred": "true"} , { "name": "Z band", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030018", "attributes": [], "id": "1102", "contexts": { } , "evidences": ["Imported from database"], "value": "Z band", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030018"} ]} , { "annotation": "The lipid bilayer surrounding any of the compartments of the Golgi apparatus. ( Reference:  GOC: mah );", "conames": [{ "name": "Golgi membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000139", "attributes": [], "id": "1103", "contexts": { } , "evidences": ["Imported from database"], "value": "Golgi membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000139"} ]} , { "annotation": "The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials,  the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber,  leading to a change in post-synaptic potential. ( Reference:  GOC: nln )", "conames": [{ "name": "neuromuscular junction", "isPreferred": "true"} , { "name": "motor endplate", "isPreferred": "false"} , { "name": "NMJ", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031594", "attributes": [], "id": "1104", "contexts": { } , "evidences": ["Imported from database"], "value": "neuromuscular junction", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031594"} ]} , { "annotation": "A cytoskeleton-like structure,  originating from the basal body at the proximal end of a cilium,  and extending proximally toward the cell nucleus. Rootlets are typically 80-100 nm in diameter and contain cross striae distributed at regular intervals of approximately 55-70 nm. ( Reference:  GOC: cilia PMID: 12427867 );", "conames": [{ "name": "cilium rootlet", "isPreferred": "true"} , { "name": "cilial rootlet", "isPreferred": "true"} , { "name": "ciliary rootlet", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035253", "attributes": [], "id": "1105", "contexts": { } , "evidences": ["Imported from database"], "value": "cilial rootlet", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035253"} ]} , { "annotation": "Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. ( Reference:  GOC: mah GOC: pz )", "conames": [{ "name": "nuclear membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031965", "attributes": [], "id": "1106", "contexts": { } , "evidences": ["Imported from database"], "value": "nuclear membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031965"} ]} , { "annotation": "A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. ( Reference:  GOC: add )", "conames": [{ "name": "T cell receptor signaling pathway", "isPreferred": "true"} , { "name": "T-cell receptor signaling pathway", "isPreferred": "true"} , { "name": "TCR signaling pathway", "isPreferred": "true"} , { "name": "T-lymphocyte receptor signaling pathway", "isPreferred": "true"} , { "name": "T-cell receptor signalling pathway", "isPreferred": "true"} , { "name": "T-lymphocyte receptor signalling pathway", "isPreferred": "true"} , { "name": "T lymphocyte receptor signalling pathway", "isPreferred": "true"} , { "name": "T lymphocyte receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050852", "attributes": [], "id": "1107", "contexts": { } , "evidences": ["Imported from database"], "value": "TCR signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050852"} ]} , { "annotation": "The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell,  a class of cell types including myeloid progenitor cells and lymphoid progenitor cells. ( Reference:  GOC: add GOC: rl ISBN: 0781735149 PMID: 16551251 )", "conames": [{ "name": "haematopoietic progenitor cell differentiation", "isPreferred": "true"} , { "name": "haemopoietic progenitor cell differentiation", "isPreferred": "true"} , { "name": "hemopoietic progenitor cell differentiation", "isPreferred": "true"} , { "name": "hematopoietic progenitor cell differentiation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0002244", "attributes": [], "id": "1108", "contexts": { } , "evidences": ["Imported from database"], "value": "hemopoietic progenitor cell differentiation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002244"} ]} , { "annotation": "A process that results in the breakdown of the extracellular matrix. ( Reference:  GOC: jid )", "conames": [{ "name": "extracellular matrix disassembly", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0022617", "attributes": [], "id": "1109", "contexts": { } , "evidences": ["Imported from database"], "value": "extracellular matrix disassembly", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0022617"} ]} , { "annotation": "Any process involved in the maintenance of an internal steady state of calcium ions within the smooth endoplasmic reticulum of a cell or between the smooth endoplasmic reticulum and its surroundings. ( Reference:  GOC: ai GOC: mah )", "conames": [{ "name": "smooth endoplasmic reticulum calcium ion homeostasis", "isPreferred": "true"} , { "name": "regulation of smooth ER calcium ion concentration", "isPreferred": "true"} , { "name": "calcium ion homeostasis in smooth endoplasmic reticulum", "isPreferred": "true"} , { "name": "regulation of smooth endoplasmic reticulum calcium ion concentration", "isPreferred": "true"} , { "name": "calcium ion homeostasis in smooth ER", "isPreferred": "true"} , { "name": "regulation of calcium ion concentration in smooth ER", "isPreferred": "true"} , { "name": "regulation of calcium ion concentration in smooth endoplasmic reticulum", "isPreferred": "true"} , { "name": "smooth endoplasmic reticulum calcium ion concentration regulation", "isPreferred": "true"} , { "name": "smooth ER calcium ion concentration regulation", "isPreferred": "true"} , { "name": "smooth ER calcium ion homeostasis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051563", "attributes": [], "id": "1110", "contexts": { } , "evidences": ["Imported from database"], "value": "smooth ER calcium ion homeostasis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051563"} ]} , { "annotation": "Any process that increases the rate,  frequency,  or extent of dendritic spine development,  the process whose specific outcome is the progression of the dendritic spine over time,  from its formation to the mature structure. ( Reference:  GOC: dph )", "conames": [{ "name": "positive regulation of dendritic spine development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060999", "attributes": [], "id": "1111", "contexts": { } , "evidences": ["Imported from database"], "value": "positive regulation of dendritic spine development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060999"} ]} , { "annotation": "The process in which a monocyte acquires the specialized features of a dendritic cell,  an immunocompetent cell of the lymphoid and hemopoietic systems and skin. ( Reference:  CL: 0000782 GOC: jl )", "conames": [{ "name": "myeloid dendritic cell differentiation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043011", "attributes": [], "id": "1112", "contexts": { } , "evidences": ["Imported from database"], "value": "myeloid dendritic cell differentiation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043011"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of cellular DNA-templated transcription. ( Reference:  GOC: go_curators GOC: txnOH )", "conames": [{ "name": "positive regulation of cellular transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "positive regulation of transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "activation of transcription,  DNA-dependent", "isPreferred": "false"} , { "name": "upregulation of transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "stimulation of transcription,  DNA-dependent", "isPreferred": "false"} , { "name": "transcription activator", "isPreferred": "false"} , { "name": "up-regulation of transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "upregulation of gene-specific transcription", "isPreferred": "false"} , { "name": "activation of gene-specific transcription", "isPreferred": "false"} , { "name": "up-regulation of gene-specific transcription", "isPreferred": "false"} , { "name": "positive regulation of gene-specific transcription", "isPreferred": "false"} , { "name": "stimulation of gene-specific transcription", "isPreferred": "false"} , { "name": "up regulation of gene-specific transcription", "isPreferred": "false"} , { "name": "up regulation of transcription,  DNA-dependent", "isPreferred": "true"} , { "name": "positive regulation of transcription,  DNA-templated", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0045893", "attributes": [], "id": "1113", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of transcription,  DNA-dependent", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0045941"} , { "elementOf": "GO", "accession": "GO: 0043193"} , { "elementOf": "GO", "accession": "GO: 0045893"} , { "elementOf": "GO", "accession": "GO: 0061020"} ]} , { "annotation": "The series of successive proteolytic cleavages of the Notch protein,  which result in an active form of the receptor. ( Reference:  PMID: 12651094 PMID: 14986688 )", "conames": [{ "name": "Notch receptor processing", "isPreferred": "true"} , { "name": "N receptor processing", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007220", "attributes": [], "id": "1114", "contexts": { } , "evidences": ["Imported from database"], "value": "N receptor processing", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007220"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein ubiquitination involved in ubiquitin-dependent protein catabolic process. ( Reference:  GOC: BHF )", "conames": [{ "name": "negative regulation of protein ubiquitinylation during ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "negative regulation of myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolism", "isPreferred": "false"} , { "name": "negative regulation of myofibrillar protein ubiquitination during ubiquitin-dependent protein breakdown", "isPreferred": "false"} , { "name": "negative regulation of protein ubiquitination during ubiquitin-dependent protein breakdown", "isPreferred": "true"} , { "name": "negative regulation of protein ubiquitination during ubiquitin-dependent protein degradation", "isPreferred": "true"} , { "name": "negative regulation of protein ubiquitination during ubiquitin-dependent protein catabolic process", "isPreferred": "false"} , { "name": "negative regulation of protein degradation tagging", "isPreferred": "false"} , { "name": "negative regulation of protein ubiquitination during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "negative regulation of myofibrillar protein ubiquitination during ubiquitin-dependent protein catabolic process", "isPreferred": "false"} , { "name": "negative regulation of protein ubiquitylation during ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process", "isPreferred": "true"} , { "name": "negative regulation of protein ubiquitylation during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "negative regulation of protein ubiquitinylation during ubiquitin-dependent protein catabolism", "isPreferred": "true"} , { "name": "negative regulation of myofibrillar protein ubiquitination during ubiquitin-dependent protein degradation", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2000059", "attributes": [], "id": "1115", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of protein ubiquitination during ubiquitin-dependent protein breakdown", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2000059"} ]} , { "annotation": "The process whose specific outcome is the progression of a neuron over time,  from initial commitment of the cell to a specific fate,  to the fully functional differentiated cell. ( Reference:  GOC: dph )", "conames": [{ "name": "neuron development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048666", "attributes": [], "id": "1116", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048666"} ]} , { "annotation": "Transport of substances into,  out of or within a mitochondrion. ( Reference:  GOC: ai )", "conames": [{ "name": "mitochondrial aspartate\/glutamate transport", "isPreferred": "false"} , { "name": "mitochondrial sodium\/calcium ion exchange", "isPreferred": "false"} , { "name": "mitochondrial transport", "isPreferred": "true"} , { "name": "mitochondrial alpha-ketoglutarate\/malate transport", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006839", "attributes": [], "id": "1117", "contexts": { } , "evidences": ["Imported from database"], "value": "mitochondrial transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006839"} ]} , { "annotation": "The process whose specific outcome is the progression of the thymus over time,  from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells,  with unique vascular,  nervous,  epithelial,  and lymphoid cell components. ( Reference:  GOC: add ISBN: 0781735149 )", "conames": [{ "name": "thymus development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048538", "attributes": [], "id": "1118", "contexts": { } , "evidences": ["Imported from database"], "value": "thymus development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048538"} ]} , { "annotation": "A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. ( Reference:  GOC: mah )", "conames": [{ "name": "calcium ion membrane transport", "isPreferred": "true"} , { "name": "transmembrane calcium transport", "isPreferred": "true"} , { "name": "calcium ion transmembrane transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070588", "attributes": [], "id": "1119", "contexts": { } , "evidences": ["Imported from database"], "value": "calcium ion membrane transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070588"} ]} , { "annotation": "The process whose specific outcome is the progression of a blood vessel over time,  from its formation to the mature structure. The blood vessel is the vasculature carrying blood. ( Reference:  GOC: hjd UBERON: 0001981 )", "conames": [{ "name": "blood vessel development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001568", "attributes": [], "id": "1120", "contexts": { } , "evidences": ["Imported from database"], "value": "blood vessel development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001568"} ]} , { "annotation": "The chemical reactions and pathways involving beta-amyloid,  a glycoprotein associated with Alzheimer's disease,  and its precursor,  amyloid precursor protein (APP). ( Reference:  GOC: ai )", "conames": [{ "name": "beta-amyloid metabolic process", "isPreferred": "true"} , { "name": "beta-amyloid metabolism", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050435", "attributes": [], "id": "1121", "contexts": { } , "evidences": ["Imported from database"], "value": "beta-amyloid metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050435"} ]} , { "annotation": "The activities involved in the mental information processing system that receives (registers),  modifies,  stores,  and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition),  storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). ( Reference:  GOC: curators http: \/\/www.onelook.com\/ ISBN: 0582227089 )", "conames": [{ "name": "memory", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007613", "attributes": [], "id": "1122", "contexts": { } , "evidences": ["Imported from database"], "value": "memory", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007613"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of protein binding. ( Reference:  GOC: go_curators )", "conames": [{ "name": "regulation of protein binding", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043393", "attributes": [], "id": "1123", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of protein binding", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043393"} ]} , { "annotation": "The process in which the anatomical structures of the brain are generated and organized. The brain is one of the two components of the central nervous system and is the center of thought and emotion. It is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight,  hearing,  smell,  etc.). ( Reference:  GOC: dgh GOC: jid )", "conames": [{ "name": "brain morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048854", "attributes": [], "id": "1124", "contexts": { } , "evidences": ["Imported from database"], "value": "brain morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048854"} ]} , { "annotation": "The orderly movement of cells from one site to another in the cerebral cortex. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conames": [{ "name": "cerebral cortex cell migration", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0021795", "attributes": [], "id": "1125", "contexts": { } , "evidences": ["Imported from database"], "value": "cerebral cortex cell migration", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0021795"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of ubiquitin transferase activity. ( Reference:  GOC: ai GOC: tb )", "conames": [{ "name": "negative regulation of ubiquitin-protein transferase activity", "isPreferred": "true"} , { "name": "anaphase-promoting complex inhibition", "isPreferred": "false"} , { "name": "down-regulation of ubiquitin transferase", "isPreferred": "true"} , { "name": "APC inhibitor", "isPreferred": "false"} , { "name": "negative regulation of ubiquitin transferase", "isPreferred": "true"} , { "name": "anaphase promoting complex inhibitor", "isPreferred": "false"} , { "name": "APC inhibition", "isPreferred": "false"} , { "name": "SCF complex inhibitor", "isPreferred": "false"} , { "name": "downregulation of ubiquitin transferase", "isPreferred": "true"} , { "name": "inhibition of ubiquitin transferase", "isPreferred": "false"} , { "name": "anaphase-promoting complex inhibitor", "isPreferred": "false"} , { "name": "down regulation of ubiquitin transferase", "isPreferred": "true"} , { "name": "anaphase promoting complex inhibition", "isPreferred": "false"} , { "name": "ubiquitin transferase inhibitor", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051444", "attributes": [], "id": "1126", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of ubiquitin transferase", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051444"} ]} , { "annotation": "The process involved in the specification of cell identity. Once specification has taken place,  a cell will be committed to differentiate down a specific pathway if left in its normal environment. ( Reference:  GOC: go_curators )", "conames": [{ "name": "cell fate specification", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001708", "attributes": [], "id": "1127", "contexts": { } , "evidences": ["Imported from database"], "value": "cell fate specification", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001708"} ]} , { "annotation": "The progression of the neural retina over time from its initial formation to the mature structure. The neural retina is the part of the retina that contains neurons and photoreceptor cells. ( Reference:  GOC: ascb_2009 GOC: dph GOC: tb )", "conames": [{ "name": "neural retina development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0003407", "attributes": [], "id": "1128", "contexts": { } , "evidences": ["Imported from database"], "value": "neural retina development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0003407"} ]} , { "annotation": "The generation of beta-amyloid by cleavage of the amyloid precursor protein (APP). ( Reference:  GOC: mah )", "conames": [{ "name": "beta-amyloid formation", "isPreferred": "true"} , { "name": "beta-amyloid polypeptide formation from amyloid precursor protein", "isPreferred": "true"} , { "name": "beta-amyloid polypeptide formation from APP", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0034205", "attributes": [], "id": "1129", "contexts": { } , "evidences": ["Imported from database"], "value": "beta-amyloid formation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034205"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. ( Reference:  GOC: go_curators )", "conames": [{ "name": "DNA damage response", "isPreferred": "true"} , { "name": "cellular DNA damage response", "isPreferred": "true"} , { "name": "response to DNA damage stimulus", "isPreferred": "false"} , { "name": "cellular response to DNA damage stimulus", "isPreferred": "true"} , { "name": "response to genotoxic stress", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006974", "attributes": [], "id": "1130", "contexts": { } , "evidences": ["Imported from database"], "value": "DNA damage response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0034984"} , { "elementOf": "GO", "accession": "GO: 0006974"} ]} , { "annotation": "The process in which synaptic vesicles are directed to specific destination membranes,  mediated by molecules at the vesicle membrane and target membrane surfaces. ( Reference:  GOC: mah )", "conames": [{ "name": "synaptic vesicle targeting", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016080", "attributes": [], "id": "1131", "contexts": { } , "evidences": ["Imported from database"], "value": "synaptic vesicle targeting", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016080"} ]} , { "annotation": "Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. ( Reference:  GOC: curators GOC: jl GOC: jsg )", "conames": [{ "name": "protein maturation by proteolysis", "isPreferred": "false"} , { "name": "protein processing", "isPreferred": "true"} , { "name": "protein maturation by peptide bond hydrolysis", "isPreferred": "true"} , { "name": "peptidolysis during protein maturation", "isPreferred": "false"} , { "name": "protein maturation by peptide bond cleavage", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016485", "attributes": [], "id": "1132", "contexts": { } , "evidences": ["Imported from database"], "value": "protein processing", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016485"} , { "elementOf": "GO", "accession": "GO: 0051605"} ]} , { "annotation": "The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen,  cytokine,  chemokine,  cellular ligand,  or an antigen for which it is specific,  leading to the initiation or perpetuation of an immune response. ( Reference:  GOC: add ISBN: 0781735149 )", "conames": [{ "name": "T cell activation involved in immune response", "isPreferred": "true"} , { "name": "T cell activation during immune response", "isPreferred": "false"} , { "name": "T lymphocyte activation during immune response", "isPreferred": "false"} , { "name": "T-cell activation during immune response", "isPreferred": "false"} , { "name": "T-lymphocyte activation during immune response", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0002286", "attributes": [], "id": "1133", "contexts": { } , "evidences": ["Imported from database"], "value": "T cell activation involved in immune response", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002286"} ]} , { "annotation": "The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell,  followed by propagation of the signal via beta-catenin,  and ending with a change in transcription of target genes. In this pathway,  the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation,  thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes. ( Reference:  GOC: bf GOC: dph PMID: 11532397 PMID: 19619488 )", "conames": [{ "name": "frizzled-1 receptor signaling pathway", "isPreferred": "false"} , { "name": "Wnt receptor signaling pathway via beta-catenin", "isPreferred": "true"} , { "name": "canonical Wnt signaling pathway", "isPreferred": "true"} , { "name": "Wnt receptor signalling pathway through beta-catenin", "isPreferred": "true"} , { "name": "canonical Wnt receptor signaling pathway", "isPreferred": "true"} , { "name": "canonical Wnt-activated signaling pathway", "isPreferred": "true"} , { "name": "Wnt receptor signaling pathway through beta-catenin", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060070", "attributes": [], "id": "1134", "contexts": { } , "evidences": ["Imported from database"], "value": "canonical Wnt signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060070"} ]} , { "annotation": "The attachment of one cell to another cell via adhesion molecules,  where both cells are part of the same organism. ( Reference:  GOC: hb )", "conames": [{ "name": "single organismal cell-cell adhesion", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016337", "attributes": [], "id": "1135", "contexts": { } , "evidences": ["Imported from database"], "value": "single organismal cell-cell adhesion", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016337"} ]} , { "annotation": "The process in which the anatomical structures of the skeleton are generated and organized. ( Reference:  GOC: dph GOC: dsf GOC: jid GOC: tb )", "conames": [{ "name": "skeletal system morphogenesis", "isPreferred": "true"} , { "name": "skeletal morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048705", "attributes": [], "id": "1136", "contexts": { } , "evidences": ["Imported from database"], "value": "skeletal morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048705"} ]} , { "annotation": "The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain). ( Reference:  GOC: jl http: \/\/www.copewithcytokines.de\/ )", "conames": [{ "name": "ectoderm shedding", "isPreferred": "false"} , { "name": "membrane protein solubilization", "isPreferred": "false"} , { "name": "receptor shedding", "isPreferred": "false"} , { "name": "membrane protein ectodomain proteolysis", "isPreferred": "true"} , { "name": "ectodomain cleavage", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006509", "attributes": [], "id": "1137", "contexts": { } , "evidences": ["Imported from database"], "value": "ectodomain cleavage", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006509"} ]} , { "annotation": "The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP),  the precursor of beta-amyloid,  a glycoprotein associated with Alzheimer's disease. ( Reference:  GOC: go_curators )", "conames": [{ "name": "amyloid precursor protein catabolic process", "isPreferred": "true"} , { "name": "amyloid precursor protein degradation", "isPreferred": "true"} , { "name": "APP catabolism", "isPreferred": "true"} , { "name": "amyloid precursor protein breakdown", "isPreferred": "true"} , { "name": "amyloid precursor protein catabolism", "isPreferred": "true"} , { "name": "APP catabolic process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042987", "attributes": [], "id": "1138", "contexts": { } , "evidences": ["Imported from database"], "value": "APP catabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042987"} ]} , { "annotation": "The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation. ( Reference:  GOC: dph PMID: 12094232 )", "conames": [{ "name": "cardiac looping", "isPreferred": "true"} , { "name": "heart looping", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001947", "attributes": [], "id": "1139", "contexts": { } , "evidences": ["Imported from database"], "value": "heart looping", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001947"} ]} , { "annotation": "The process in which the neural tube is regionalized in the dorsoventral axis. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 PMID: 11262869 )", "conames": [{ "name": "dorsal\/ventral neural tube patterning", "isPreferred": "true"} , { "name": "dorsal-ventral neural tube patterning", "isPreferred": "true"} , { "name": "dorsoventral neural tube patterning", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0021904", "attributes": [], "id": "1140", "contexts": { } , "evidences": ["Imported from database"], "value": "dorsoventral neural tube patterning", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0021904"} ]} , { "annotation": "The process,  occurring in the embryo,  by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. ( Reference:  GOC: bf GOC: jl ISBN: 0395825172 )", "conames": [{ "name": "embryonic limb morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030326", "attributes": [], "id": "1141", "contexts": { } , "evidences": ["Imported from database"], "value": "embryonic limb morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030326"} ]} , { "annotation": "The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers,  an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper,  and being thrown off in the superficial layers,  as well as an inner,  sensitive and vascular dermis (cutis,  corium or true skin) composed mostly of connective tissue. ( Reference:  GOC: jl UBERON: 0002097 )", "conames": [{ "name": "skin morphogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043589", "attributes": [], "id": "1142", "contexts": { } , "evidences": ["Imported from database"], "value": "skin morphogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043589"} ]} , { "annotation": "The directed movement of proteins into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai )", "conames": [{ "name": "protein transport", "isPreferred": "true"} , { "name": "enzyme transport", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0015031", "attributes": [], "id": "1143", "contexts": { } , "evidences": ["Imported from database"], "value": "protein transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0015831"} , { "elementOf": "GO", "accession": "GO: 0015031"} ]} , { "annotation": "The directed movement of L-glutamate,  the L enantiomer anion of 2-aminopentanedioic acid,  into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai GOC: dph GOC: tb )", "conames": [{ "name": "mitochondrial aspartate\/glutamate transport", "isPreferred": "false"} , { "name": "L-glutamate transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0015813", "attributes": [], "id": "1144", "contexts": { } , "evidences": ["Imported from database"], "value": "L-glutamate transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0015813"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of apoptotic signaling pathway. ( Reference:  GOC: mtg_apoptosis )", "conames": [{ "name": "negative regulation of apoptotic signalling pathway", "isPreferred": "true"} , { "name": "negative regulation of apoptotic signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 2001234", "attributes": [], "id": "1145", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of apoptotic signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 2001234"} ]} , { "annotation": "The formation of a double membrane-bounded structure,  the autophagosome,  that occurs when a specialized membrane sac,  called the isolation membrane,  starts to enclose a portion of the cytoplasm. ( Reference:  GOC: autophagy PMID: 9412464 )", "conames": [{ "name": "autophagic vacuole formation", "isPreferred": "false"} , { "name": "PAS formation", "isPreferred": "false"} , { "name": "autophagosome biosynthesis", "isPreferred": "true"} , { "name": "autophagosome formation", "isPreferred": "true"} , { "name": "autophagic vacuole assembly", "isPreferred": "true"} , { "name": "autophagosome assembly", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0000045", "attributes": [], "id": "1146", "contexts": { } , "evidences": ["Imported from database"], "value": "autophagosome assembly", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0000045"} ]} , { "annotation": "A protein modification process that results in the addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid,  e.g. the addition of glycan chains to proteins. ( Reference:  GOC: curators GOC: pr )", "conames": [{ "name": "protein amino acid glycosylation", "isPreferred": "true"} , { "name": "protein glycosylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006486", "attributes": [], "id": "1147", "contexts": { } , "evidences": ["Imported from database"], "value": "protein glycosylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006486"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of EGF-activated receptor activity. ( Reference:  GOC: go_curators )", "conames": [{ "name": "negative regulation of epidermal growth factor-activated receptor activity", "isPreferred": "true"} , { "name": "down regulation of epidermal growth factor receptor", "isPreferred": "true"} , { "name": "inhibition of epidermal growth factor receptor", "isPreferred": "false"} , { "name": "down-regulation of epidermal growth factor receptor", "isPreferred": "true"} , { "name": "negative regulation of epidermal growth factor receptor", "isPreferred": "true"} , { "name": "negative regulation of EGF receptor", "isPreferred": "true"} , { "name": "downregulation of epidermal growth factor receptor", "isPreferred": "true"} , { "name": "EGF receptor downregulation", "isPreferred": "true"} , { "name": "negative regulation of EGFR", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007175", "attributes": [], "id": "1148", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of EGFR", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007177"} , { "elementOf": "GO", "accession": "GO: 0007175"} ]} , { "annotation": "Any process that modulates the establishment or extent of a resting potential,  the electrical charge across the plasma membrane,  with the interior of the cell negative with respect to the exterior. The resting potential is the membrane potential of a cell that is not stimulated to be depolarized or hyperpolarized. ( Reference:  GOC: dph GOC: ef ISBN: 0195088433 )", "conames": [{ "name": "regulation of resting membrane potential", "isPreferred": "true"} , { "name": "regulation of resting potential", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060075", "attributes": [], "id": "1149", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of resting potential", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060075"} ]} , { "annotation": "The process in which a neuroblast acquires specialized structural and or functional features of a Cajal-Retzius cell,  one of a transient population of pioneering neurons in the cerebral cortex. These cells are slender bipolar cells of the developing marginal zone. One feature of these cells in mammals is that they express the Reelin gene. ( Reference:  GO_REF: 0000021 GOC: cls GOC: dgh GOC: dph GOC: jid GOC: mtg_15jun06 )", "conames": [{ "name": "Cajal-Retzius cell differentiation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0021870", "attributes": [], "id": "1150", "contexts": { } , "evidences": ["Imported from database"], "value": "Cajal-Retzius cell differentiation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0021870"} ]} , { "annotation": "The directed movement of choline into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. Choline (2-hydroxyethyltrimethylammonium) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids and in the neurotransmitter acetylcholine. ( Reference:  GOC: ai )", "conames": [{ "name": "choline transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0015871", "attributes": [], "id": "1151", "contexts": { } , "evidences": ["Imported from database"], "value": "choline transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0015871"} ]} , { "annotation": "Any process that activates or increases the activity of an enzyme. ( Reference:  GOC: jl GOC: tb )", "conames": [{ "name": "activation of enzyme", "isPreferred": "false"} , { "name": "up regulation of enzyme", "isPreferred": "true"} , { "name": "upregulation of enzyme", "isPreferred": "true"} , { "name": "up-regulation of enzyme", "isPreferred": "true"} , { "name": "positive regulation of enzyme", "isPreferred": "true"} , { "name": "positive regulation of catalytic activity", "isPreferred": "true"} , { "name": "stimulation of enzyme", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043085", "attributes": [], "id": "1152", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of enzyme", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043085"} ]} , { "annotation": "A process that modulates synaptic plasticity,  the ability of synapses to change as circumstances require. They may alter function,  such as increasing or decreasing their sensitivity,  or they may increase or decrease in actual numbers. ( Reference:  GOC: dph GOC: jid GOC: tb http: \/\/www.mercksource.com PMID: 11891290 )", "conames": [{ "name": "regulation of synaptic plasticity", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048167", "attributes": [], "id": "1153", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of synaptic plasticity", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048167"} ]} , { "annotation": "The process whose specific outcome is the progression of the organism over time,  from the completion of embryonic development to the mature structure. See embryonic development. ( Reference:  GOC: go_curators )", "conames": [{ "name": "post-embryonic development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0009791", "attributes": [], "id": "1154", "contexts": { } , "evidences": ["Imported from database"], "value": "post-embryonic development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0009791"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of axonogenesis. ( Reference:  GOC: ai )", "conames": [{ "name": "negative regulation of axonogenesis", "isPreferred": "true"} , { "name": "down regulation of axonogenesis", "isPreferred": "true"} , { "name": "inhibition of axonogenesis", "isPreferred": "false"} , { "name": "downregulation of axonogenesis", "isPreferred": "true"} , { "name": "down-regulation of axonogenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050771", "attributes": [], "id": "1155", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of axonogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050771"} ]} , { "annotation": "Any process that activates or increases the frequency,  rate or extent of coagulation. ( Reference:  GOC: ai )", "conames": [{ "name": "upregulation of coagulation", "isPreferred": "true"} , { "name": "activation of coagulation", "isPreferred": "false"} , { "name": "stimulation of coagulation", "isPreferred": "false"} , { "name": "positive regulation of coagulation", "isPreferred": "true"} , { "name": "up-regulation of coagulation", "isPreferred": "true"} , { "name": "up regulation of coagulation", "isPreferred": "true"} , { "name": "positive regulation of clotting", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050820", "attributes": [], "id": "1156", "contexts": { } , "evidences": ["Imported from database"], "value": "upregulation of coagulation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050820"} ]} , { "annotation": "Any process involved in the maintenance of an internal steady state of calcium ions within the endoplasmic reticulum of a cell or between the endoplasmic reticulum and its surroundings. ( Reference:  GOC: mah )", "conames": [{ "name": "calcium ion homeostasis in endoplasmic reticulum", "isPreferred": "true"} , { "name": "calcium ion homeostasis in ER", "isPreferred": "true"} , { "name": "regulation of calcium ion concentration in endoplasmic reticulum", "isPreferred": "true"} , { "name": "endoplasmic reticulum calcium ion concentration regulation", "isPreferred": "true"} , { "name": "ER calcium ion homeostasis", "isPreferred": "true"} , { "name": "regulation of ER calcium ion concentration", "isPreferred": "true"} , { "name": "endoplasmic reticulum calcium ion homeostasis", "isPreferred": "true"} , { "name": "regulation of calcium ion concentration in ER", "isPreferred": "true"} , { "name": "regulation of endoplasmic reticulum calcium ion concentration", "isPreferred": "true"} , { "name": "ER calcium ion concentration regulation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032469", "attributes": [], "id": "1157", "contexts": { } , "evidences": ["Imported from database"], "value": "ER calcium ion homeostasis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032469"} ]} , { "annotation": "The multiplication or reproduction of epithelial cells,  resulting in the expansion of a cell population. Epithelial cells make up the epithelium,  the covering of internal and external surfaces of the body,  including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. ( Reference:  ISBN: 0721662544 )", "conames": [{ "name": "epithelial cell proliferation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050673", "attributes": [], "id": "1158", "contexts": { } , "evidences": ["Imported from database"], "value": "epithelial cell proliferation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050673"} ]} , { "annotation": "The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo. ( Reference:  ISBN: 0721662544 )", "conames": [{ "name": "somitogenesis", "isPreferred": "true"} , { "name": "formation of mesodermal clusters", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001756", "attributes": [], "id": "1159", "contexts": { } , "evidences": ["Imported from database"], "value": "somitogenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001756"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of addition of phosphate groups into a molecule. ( Reference:  GOC: jl )", "conames": [{ "name": "regulation of phosphorylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042325", "attributes": [], "id": "1160", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of phosphorylation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042325"} ]} , { "annotation": "[VARIANT AD3 SER-92]", "conames": [{ "name": "PMID: 11027672", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11027672", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Caenorhabditis elegans Proteins,  Peptide Fragments,  Presenilin-1,  Helminth Proteins,  amyloid beta-protein (1-42),  SEL-12 protein,  C elegans,  Amyloid beta-Peptides,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "The presenilin 1 C92S mutation increases abeta 42 production."} , { "attrname": "Abstract", "value": "Although wild-type human presenilin 1 (PS1) rescues the C. elegans egg-laying (egl) phenotype that is caused by a loss of function mutation in the C. elegans presenilin homologue sel12,  most familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD)-linked PS1 mutants only partially rescue this phenotype. To investigate the effects of the loss of function sel12 mutation on Abeta production in mammalian cells,  we analyzed Abeta production in transfected H4 neuroglioma cells expressing the PS1 homologue of the sel12 C60S mutant,  PS1 C92S. This analysis revealed that PS1 C92S increased Abeta42 levels in a similar fashion to other pathogenic <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) PS1 mutations. Significantly,  the PS1 C92S mutation has recently been identified as the pathogenic mutation in an Italian family with FAD. Thus,  placing a mutation that results in loss of function in C. elegans into a context whereby its effect on mammalian cells can be evaluated suggests that all FAD-linked PS1 mutants result in increased Abeta42 production through a partial loss of function mechanism. "} , { "attrname": "MeSH", "value": "[Up-Regulation,  Caenorhabditis elegans Proteins,  Peptide Fragments,  Presenilin-1,  Humans,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Membrane Proteins,  Caenorhabditis elegans,  Animals,  Helminth Proteins,  Transfection,  Glioma,  Amyloid beta-Peptides,  Mutation,  Tumor Cells,  Cultured,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[P A Lewis,  J Perez-Tur,  T E Golde,  J Hardy]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 SER-92]"} ], "id": "1161", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11027672", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11027672"} , { "elementOf": "DOI", "accession": "10.1006\/BBRC.2000.3646"} ]} , { "annotation": "[SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)]", "conames": [{ "name": "PMID: 14759258", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14759258", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Genome biology"} , { "attrname": "Chemical", "value": "[EC 2.7.11.22 Cyclin-Dependent Kinases,  Protein Isoforms,  EC 3.4.22.- calpain 10,  Codon,  Nonsense,  RNA,  Messenger,  EC 3.4.22.- Calpain]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "An unappreciated role for RNA surveillance."} , { "attrname": "Abstract", "value": "Nonsense-mediated mRNA decay (NMD) is a eukaryotic mRNA surveillance mechanism that detects and degrades mRNAs with premature termination codons (PTC+ mRNAs). In mammals,  a termination codon is recognized as premature if it lies more than about 50 nucleotides upstream of the final intron position. More than a third of reliably inferred alternative splicing events in humans have been shown to result in PTC+ mRNA isoforms. As the mechanistic details of NMD have only recently been elucidated,  we hypothesized that many PTC+ isoforms may have been cloned,  characterized and deposited in the public databases,  even though they would be targeted for degradation in vivo. We analyzed the human alternative protein isoforms described in the SWISS-PROT database and found that 144 (5.8% of 2, 483) isoform sequences amenable to analysis,  from 107 (7.9% of 1, 363) SWISS-PROT entries,  derive from PTC+ mRNA. For several of the PTC+ isoforms we identified,  existing experimental evidence can be reinterpreted and is consistent with the action of NMD to degrade the transcripts. Several genes with mRNA isoforms that we identified as PTC+--calpain-10,  the CDC-like kinases (CLKs) and LARD--show how previous experimental results may be understood in light of NMD. "} , { "attrname": "MeSH", "value": "[Alternative Splicing,  Databases,  Protein,  Humans,  Protein Isoforms,  Calpain,  Codon,  Nonsense,  Cyclin-Dependent Kinases,  RNA Stability,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[R Tyler Hillman,  Richard E Green,  Steven E Brenner]"} , { "attrname": "PUB_TYPE", "value": "[SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S)]"} ], "id": "1162", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14759258", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14759258"} , { "elementOf": "DOI", "accession": "10.1186\/GB-2004-5-2-R8"} ]} , { "annotation": "[VARIANT AD3 LYS-139]", "conames": [{ "name": "PMID: 9719376", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9719376", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of medical genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "De novo presenilin 1 mutations are rare in clinically sporadic,  early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cases. French <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> Study Group."} , { "attrname": "Abstract", "value": "The presenilin 1 (PS1) gene,  located on chromosome 14,  is the major gene involved in the autosomal dominant forms of early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). In order to estimate the frequency of de novo PS1 mutations,  we have sequenced the PS1 open reading frame in 13 clinically diagnosed patients with no affected relatives,  who had developed AD before the age of 50. In one case with onset at 37 years,  we identified a missense mutation resulting in a methionine to lysine substitution at codon 139 of the PS1 gene. This substitution is the fourth identified at the same codon. This study,  in agreement with previous reports,  suggests that de novo PS1 mutations can occur but at a low frequency. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Pedigree,  Age of Onset,  Aged,  80 and over,  Adult,  Female,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[C Dumanchin,  A Brice,  D Campion,  D Hannequin,  C Martin,  V Moreau,  Y Agid,  M Martinez,  F Clerget-Darpoux,  T Frebourg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 LYS-139]"} ], "id": "1163", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9719376", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9719376"} , { "elementOf": "DOI", "accession": "10.1136\/JMG.35.8.672"} ]} , { "annotation": "[INTERACTION WITH CTNNB1,  SUBCELLULAR LOCATION]", "conames": [{ "name": "PMID: 9738936", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9738936", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[CTNNB1 protein,  human,  Cytoskeletal Proteins,  Membrane Proteins,  Peptide Fragments,  Presenilin-1,  beta Catenin,  Trans-Activators,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Direct association of presenilin-1 with beta-catenin."} , { "attrname": "Abstract", "value": "Families bearing mutations in the presenilin-1 (PSI) gene develop <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD). However,  the mechanism through which PS1 causes AD is unclear. The co-immunoprecipitation with PS1 in transfected COS-7 cells indicates that PSI directly interacts with endogenous beta-catenin,  and the interaction requires residues 322450 of PSI and 445-676 of beta-catenin. Both proteins are co-localized in the endoplasmic reticulum. Over-expression of PS1 reduces the level of cytoplasmic beta-catenin,  and inhibits beta-catenin-T cell factor-regulated transcription. These results indicate that PSI plays a role as inhibitor of the beta-catenin signal,  which may be connected with the AD dysfunction. "} , { "attrname": "MeSH", "value": "[Cytoskeletal Proteins,  Gene Expression,  Peptide Fragments,  Presenilin-1,  Mutagenesis,  Site-Directed,  Signal Transduction,  beta Catenin,  Humans,  Trans-Activators,  Structure-Activity Relationship,  Endoplasmic Reticulum,  Neuroblastoma,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Immunosorbent Techniques,  Animals,  Transfection,  Tumor Cells,  Cultured,  Binding Sites,  COS Cells,  Cytoplasm]"} , { "attrname": "AUTHORS", "value": "[M Murayama,  S Tanaka,  J Palacino,  O Murayama,  T Honda,  X Sun,  K Yasutake,  N Nihonmatsu,  B Wolozin,  A Takashima]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH CTNNB1,  SUBCELLULAR LOCATION]"} ], "id": "1164", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9738936", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0014-5793(98)00886-2"} , { "elementOf": "NLM", "accession": "9738936"} ]} , { "annotation": "[PROTEOLYTIC PROCESSING]", "conames": [{ "name": "PMID: 9173929", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9173929", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurobiology of <span style=\"background-color: yellow\"><b>disease<\/b><\/span>"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Peptide Fragments,  Presenilin-1,  EC 3.4.- Peptide Hydrolases,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> brain tissue."} , { "attrname": "Abstract", "value": "Humans inheriting missense mutations in the presenilin (PS)1 and -2 genes undergo progressive cerebral deposition of the amyloid beta-protein at an early age and develop a clinically and pathologically severe form of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). Because PS1 mutations cause the most aggressive known form of AD,  it is important to elucidate the structure and function of this multitransmembrane protein in the brain. Using a panel of region-specific PS antibodies,  we characterized the presenilin polypeptides in mammalian tissues,  including brains of normal,  AD,  and PS1-linked FAD subjects,  and in transfected and nontransfected cell lines. Very little full-length PS1 or -2 was detected in brain and untransfected cells; instead the protein occurred as a heterogeneous array of stable N- and C-terminal proteolytic fragments that differed subtly among cell types and mammalian tissues. Sequencing of the major C-terminal fragment from PS1-transfected human 293 cells showed that the principal endoproteolytic cleavage occurs at and near Met298 in the proximal portion of the large hydrophilic loop. Full-length PS1 in these cells is quickly turned over (T1\/2 approximately 60 min),  in part to the two major fragments. The sizes and amounts of the PS fragments were not significantly altered in four FAD brains with the Cys410Tyr PS1 missense mutation. Our results indicate that presenilins are rapidly processed to N- and C-terminal fragments in both neural and nonneural cells and that interference with this processing is not an obligatory feature of FAD-causing mutations. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Presenilin-2,  Peptide Fragments,  Presenilin-1,  Neurons,  Humans,  Neuroglia,  Cells,  Cultured,  Reference Values,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Precipitin Tests,  Haplorhini,  Membrane Proteins,  Animals,  Mice,  Peptide Hydrolases]"} , { "attrname": "AUTHORS", "value": "[M B Podlisny,  M Citron,  P Amarante,  R Sherrington,  W Xia,  J Zhang,  T Diehl,  G Levesque,  P Fraser,  C Haass,  E H Koo,  P Seubert,  P St George-Hyslop,  D B Teplow,  D J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[PROTEOLYTIC PROCESSING]"} ], "id": "1165", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9173929", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/NBDI.1997.0129"} , { "elementOf": "NLM", "accession": "9173929"} ]} , { "annotation": "[VARIANT AD3 LEU-117]", "conames": [{ "name": "PMID: 9507958", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9507958", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  9007-49-2 DNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "A novel Polish presenilin-1 mutation (P117L) is associated with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and leads to death as early as the age of 28 years."} , { "attrname": "Abstract", "value": "The majority of early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) is associated with mutations in the presenilin-1 (PS1) gene. We describe a novel Polish PS1 mutation of Pro117Leu,  associated with the earliest average age of onset and death so far reported in a PS-linked,  FAD kindred. Human kidney 293 and mouse neuroblastoma N2a cells were stably transfected with wild-type and PS1 P117L. There was a significant increase in the amyloid beta42\/40 ratio in the N2a P117L PS1 transfected cells compared with N2a transfected with wild-type PS1. What role PS has in the pathogenesis of AD remains to be determined,  however,  the severity of the clinical picture associated with this PS1 mutation stresses the importance of presenilin. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Humans,  Cells,  Cultured,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Membrane Proteins,  Transfection,  Life Expectancy,  Pedigree,  DNA,  Polymerase Chain Reaction,  Adult,  Female,  Mutation]"} , { "attrname": "AUTHORS", "value": "[T Wisniewski,  W K Dowjat,  J D Buxbaum,  O Khorkova,  S Efthimiopoulos,  J Kulczycki,  W Lojkowska,  J Wegiel,  H M Wisniewski,  B Frangione]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 LEU-117]"} ], "id": "1166", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9507958", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1097\/00001756-199801260-00008"} , { "elementOf": "NLM", "accession": "9507958"} ]} , { "annotation": "[FUNCTION OF PAL MOTIF,  MUTAGENESIS OF PRO-433; ALA-434 AND LEU-435]", "conames": [{ "name": "PMID: 16305624", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16305624", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  Enzyme Inhibitors,  Presenilin-1,  EC 3.4.23.- signal peptide peptidase,  EC 3.4.- Endopeptidases,  EC 3.4.- Peptide Hydrolases,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation."} , { "attrname": "Abstract", "value": "The Alzheimer's disease-associated beta-amyloid peptide is produced through cleavage of amyloid precursor protein by beta-secretase and gamma-secretase. gamma-Secretase is a complex containing presenilin (PS) as the catalytic component and three essential cofactors:  Nicastrin,  anterior pharynx defective (APH-1) and presenilin enhancer-2 (PEN-2). PS and signal peptide peptidase (SPP) define a novel family of aspartyl proteases that cleave substrates within the transmembrane domain presumptively using two membrane-embedded aspartic acid residues for catalysis. Apart from the two aspartate-containing active site motifs,  the only other region that is conserved between PS and SPP is a PAL sequence at the C-terminus. Although it has been well documented that this motif is essential for gamma-secretase activity,  the mechanism underlying such a critical role is not understood. Here we show that mutations in this motif affect the conformation of the active site of gamma-secretase resulting in a complete loss of PS binding to a gamma-secretase transition state analog inhibitor,  Merck C. Analogous mutations in SPP significantly inhibit its enzymatic activity. Furthermore,  these mutations also abolish SPP binding to Merck C,  indicating that SPP and gamma-secretase share a similar active site conformation,  which is dependent on the PAL motif. Exploring the amino acid requirements within this motif reveals a very small side chain requirement,  which is conserved during evolution. Together,  these observations strongly support the hypothesis that the PAL motif contributes to the active site conformation of gamma-secretase and of SPP. "} , { "attrname": "MeSH", "value": "[Cell Line,  Enzyme Inhibitors,  Presenilin-1,  Enzyme-Linked Immunosorbent Assay,  Humans,  Structure-Activity Relationship,  Amino Acid Motifs,  Hydrolysis,  Membrane Proteins,  Transfection,  Plasmids,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Protein Binding,  Protein Conformation,  Peptide Hydrolases,  Mutation,  Binding Sites,  Endopeptidases]"} , { "attrname": "AUTHORS", "value": "[Jun Wang,  Dirk Beher,  Andrew C Nyborg,  Mark S Shearman,  Todd E Golde,  Alison Goate]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION OF PAL MOTIF,  MUTAGENESIS OF PRO-433; ALA-434 AND LEU-435]"} ], "id": "1167", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16305624", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.2005.03548.X"} , { "elementOf": "NLM", "accession": "16305624"} ]} , { "annotation": "[INTERACTION WITH CDH1 AND CTNNB1]", "conames": [{ "name": "PMID: 16126725", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16126725", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Ubiquitin,  Presenilin-1,  beta Catenin,  Cadherins,  Detergents,  PSEN1 protein,  human,  Macromolecular Substances]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stability."} , { "attrname": "Abstract", "value": "Presenilin1 (PS1),  a protein involved in cellular development,  forms functional complexes with beta-catenin,  a regulator of Wnt signaling and cell-cell adhesion. In addition,  both proteins have been shown to play important roles in <span style=\"background-color: yellow\"><b>disease<\/b><\/span> including cancer and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Although PS1 and beta-catenin are found in the same complexes,  it is not clear whether they bind directly to each other or a third complex component,  like cadherin,  may mediate their interactions. Here we show that PS1 and beta-catenin form no detectable complexes in cells that express no cadherin. In contrast,  these complexes are readily found in E-cadherin containing cells. Furthermore,  binding of both PS1 and beta-catenin to E-cadherin is necessary for the formation of PS1\/beta-catenin complexes. Importantly,  our data show that binding of PS1 to cadherin mediates the effects of PS1 on the phosphorylation,  ubiquitination,  and destabilization of beta-catenin. Thus,  cadherins mediate both the association of PS1 and beta-catenin and the effects of PS1 on the cellular levels of beta-catenin. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Ubiquitin,  Phosphorylation,  Presenilin-1,  Immunoprecipitation,  Signal Transduction,  beta Catenin,  Humans,  Detergents,  Cell Adhesion,  Blotting,  Western,  Macromolecular Substances,  Membrane Proteins,  Transfection,  Plasmids,  Cell Line,  Tumor,  Protein Binding,  Cadherins]"} , { "attrname": "AUTHORS", "value": "[Geo Serban,  Zen Kouchi,  Lia Baki,  Anastasios Georgakopoulos,  Claudia M Litterst,  Junichi Shioi,  Nikolaos K Robakis]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH CDH1 AND CTNNB1]"} ], "id": "1168", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16126725", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M507503200"} , { "elementOf": "NLM", "accession": "16126725"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA \/ MRNA] (ISOFORMS 1 AND 2),  VARIANTS AD3 LEU-146; ARG-163; GLU-246 AND VAL-286]", "conames": [{ "name": "PMID: 7596406", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7596406", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease."} , { "attrname": "Abstract", "value": "Some cases of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> are inherited as an autosomal dominant trait. Genetic linkage studies have mapped a locus (AD3) associated with susceptibility to a very aggressive form of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> to chromosome 14q24.3. We have defined a minimal cosegregating region containing the AD3 gene,  and isolated at least 19 different transcripts encoded within this region. One of these transcripts (S182) corresponds to a novel gene whose product is predicted to contain multiple transmembrane domains and resembles an integral membrane protein. Five different missense mutations have been found that cosegregate with early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Because these changes occurred in conserved domains of this gene,  and are not present in normal controls,  they are likely to be causative of AD3. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Protein Structure,  Secondary,  Humans,  Open Reading Frames,  Molecular Sequence Data,  Male,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Animals,  Pedigree,  Base Sequence,  Cloning,  Molecular,  Chromosomes,  Human,  Pair 14,  Female,  Transcription,  Genetic,  Mice,  Mutation]"} , { "attrname": "AUTHORS", "value": "[R Sherrington,  E I Rogaev,  Y Liang,  E A Rogaeva,  G Levesque,  M Ikeda,  H Chi,  C Lin,  G Li,  K Holman,  T Tsuda,  L Mar,  J F Foncin,  A C Bruni,  M P Montesi,  S Sorbi,  I Rainero,  L Pinessi,  L Nee,  I Chumakov,  D Pollen,  A Brookes,  P Sanseau,  R J Polinsky,  W Wasco,  H A Da Silva,  J L Haines,  M A Perkicak-Vance,  R E Tanzi,  A D Roses,  P E Fraser,  J M Rommens,  P H St George-Hyslop]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA \/ MRNA] (ISOFORMS 1 AND 2),  VARIANTS AD3 LEU-146; ARG-163; GLU-246 AND VAL-286]"} ], "id": "1169", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7596406", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7596406"} , { "elementOf": "DOI", "accession": "10.1038\/375754A0"} ]} , { "annotation": "[INTERACTION WITH GFAP,  MUTAGENESIS OF 66-ASP--ASP-72; 76-LYS-TYR-77; 82-VAL-ILE-83; VAL-82 AND 84-MET-LEU-85,  CHARACTERIZATION OF VARIANTS AD3 VAL-79 AND LEU-82]", "conames": [{ "name": "PMID: 12058025", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12058025", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Glial Fibrillary Acidic Protein,  Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Presenilin-1,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "A new splice variant of glial fibrillary acidic protein,  GFAP epsilon,  interacts with the presenilin proteins."} , { "attrname": "Abstract", "value": "We describe a new human isoform,  GFAP epsilon,  of the intermediary filament protein GFAP (glial fibrillary acidic protein). GFAP epsilon mRNA is the result of alternative splicing and a new polyadenylation signal,  and thus GFAP epsilon has a new C-terminal protein sequence. This provides GFAP epsilon with the capacity for specific binding of presenilin proteins in yeast and in vitro. Our observations suggest a direct link between the presenilins and the cytoskeleton where GFAP epsilon is incorporated. Mutations in GFAP and presenilins are associated with Alexander disease and Alzheimer's disease,  respectively. Accordingly,  GFAP epsilon should be taken into consideration when studying neurodegenerative diseases. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-2,  Presenilin-1,  Alternative Splicing,  Exons,  Humans,  Molecular Sequence Data,  Sequence Homology,  Nucleic Acid,  Glial Fibrillary Acidic Protein,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Animals,  Base Sequence,  Protein Binding,  Saccharomyces cerevisiae,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Anders Lade Nielsen,  Ida E Holm,  Marianne Johansen,  Bjarne Bonven,  Poul Jrgensen,  Arne Lund Jrgensen]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH GFAP,  MUTAGENESIS OF 66-ASP--ASP-72; 76-LYS-TYR-77; 82-VAL-ILE-83; VAL-82 AND 84-MET-LEU-85,  CHARACTERIZATION OF VARIANTS AD3 VAL-79 AND LEU-82]"} ], "id": "1170", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12058025", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12058025"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M112121200"} ]} , { "annotation": "[VARIANT FRONTOTEMPORAL DEMENTIA PRO-113]", "conames": [{ "name": "PMID: 11094121", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11094121", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation."} , { "attrname": "Abstract", "value": "The authors report a presenilin 1 (PSEN1) mutation (L113P) in a family with six cases of dementia. The patients had personality changes and behavioral disorders,  whereas spatial orientation and praxis were preserved late in the course of the illness. Neuroimaging features were consistent with the diagnosis of frontotemporal dementia. The authors conclude that PSEN1 mutations can be associated with clinical features of frontotemporal dementia. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Frontal Lobe,  Temporal Lobe,  Pedigree,  Humans,  Middle Aged,  Adult,  Female,  Male,  Mutation,  Dementia]"} , { "attrname": "AUTHORS", "value": "[G Raux,  R Gantier,  C Thomas-Anterion,  J Boulliat,  P Verpillat,  D Hannequin,  A Brice,  T Frebourg,  D Campion]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FRONTOTEMPORAL DEMENTIA PRO-113]"} ], "id": "1171", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11094121", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11094121"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.55.10.1577"} ]} , { "annotation": "[COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1\/PSEN2 AND NCSTN]", "conames": [{ "name": "PMID: 12740439", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12740439", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  APH-1 protein,  C elegans,  Caenorhabditis elegans Proteins,  Homeodomain Proteins,  EC 3.4.- Endopeptidases,  nicastrin protein,  Membrane Glycoproteins]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Gamma-secretase is a membrane protein complex comprised of presenilin,  nicastrin,  Aph-1,  and Pen-2."} , { "attrname": "Abstract", "value": "gamma-Secretase catalyzes the intramembrane proteolysis of Notch,  beta-amyloid precursor protein,  and other substrates as part of a new signaling paradigm and as a key step in the pathogenesis of Alzheimer's disease. This unusual protease has eluded identification,  though evidence suggests that the presenilin heterodimer comprises the catalytic site and that a highly glycosylated form of nicastrin associates with it. The formation of presenilin heterodimers from the holoprotein is tightly gated by unknown limiting cellular factors. Here we show that Aph-1 and Pen-2,  two recently identified membrane proteins genetically linked to gamma-secretase,  associate directly with presenilin and nicastrin in the active protease complex. Coexpression of all four proteins leads to marked increases in presenilin heterodimers,  full glycosylation of nicastrin,  and enhanced gamma-secretase activity. These findings suggest that the four membrane proteins comprise the limiting components of gamma-secretase and coassemble to form the active enzyme in mammalian cells. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Caenorhabditis elegans Proteins,  Cricetinae,  Animals,  Cricetulus,  Homeodomain Proteins,  Amyloid Precursor Protein Secretases,  Membrane Glycoproteins,  Endopeptidases]"} , { "attrname": "AUTHORS", "value": "[W Taylor Kimberly,  Matthew J LaVoie,  Beth L Ostaszewski,  Wenjuan Ye,  Michael S Wolfe,  Dennis J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[COMPONENT OF A GAMMA-SECRETASE COMPLEX WITH PEN2; PSEN1\/PSEN2 AND NCSTN]"} ], "id": "1172", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12740439", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12740439"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.1037392100"} ]} , { "annotation": "[INTERACTION WITH CDH2,  SUBCELLULAR LOCATION,  MUTAGENESIS OF ASP-385]", "conames": [{ "name": "PMID: 14515347", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14515347", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuroscience research"} , { "attrname": "Chemical", "value": "[CTNNB1 protein,  human,  Cytoskeletal Proteins,  Membrane Proteins,  Presenilin-1,  beta Catenin,  Trans-Activators,  Cadherins,  PSEN1 protein,  human,  Macromolecular Substances]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Presenilin 1 is involved in maturation and trafficking of N-cadherin to the plasma membrane."} , { "attrname": "Abstract", "value": "One pathological characteristic of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is extensive synapse loss. Presenilin 1 (PS1) is linked to the pathogenesis of early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) and is localized at the synapse,  where it binds N-cadherin and modulates its adhesive activity. To elucidate the role of the PS1\/N-cadherin interaction in synaptic contact,  we established SH-SY5Y cells stably expressing wild-type (wt) PS1 and dominant-negative (D385A) PS1. We show that the formation of cadherin-based cell-cell contact among SH-SY5Y cells stably expressing D385A PS1 was suppressed. Conversely,  wt PS1 cells exhibited enhanced cell-cell contact and colony formation. Suppression of cell-cell contact in D385A cells was accompanied by an alteration in N-cadherin subcellular localization; N-cadherin was retained mainly in the endoplasmic reticulum (ER) and cell surface expression was reduced. We conclude that PS1 is essential for efficient trafficking of N-cadherin from the ER to the plasma membrane. PS1-mediated delivery of N-cadherin to the plasma membrane is important for N-cadherin to exert its physiological function,  and it may control the state of cell-cell contact. "} , { "attrname": "MeSH", "value": "[Cytoskeletal Proteins,  Brain,  Cell Line,  Cell Membrane,  Presenilin-1,  Molecular Weight,  beta Catenin,  Humans,  Trans-Activators,  Cell Communication,  Endoplasmic Reticulum,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Cell Adhesion,  Macromolecular Substances,  Protein Transport,  Membrane Proteins,  Cell Aggregation,  Presynaptic Terminals,  Protein Binding,  Cadherins,  Mutation,  Synaptic Membranes]"} , { "attrname": "AUTHORS", "value": "[Kengo Uemura,  Naoyuki Kitagawa,  Ryuichi Kohno,  Akira Kuzuya,  Takashi Kageyama,  Kazuhisa Chonabayashi,  Hiroshi Shibasaki,  Shun Shimohama]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH CDH2,  SUBCELLULAR LOCATION,  MUTAGENESIS OF ASP-385]"} ], "id": "1173", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14515347", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14515347"} , { "elementOf": "DOI", "accession": "10.1002\/JNR.10753"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)]", "conames": [{ "name": "PMID: 8641442", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8641442", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Peptide Fragments,  Presenilin-1,  Antibodies,  Recombinant Proteins,  DNA Primers,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Identification and characterization of presenilin I-467,  I-463 and I-374."} , { "attrname": "Abstract", "value": "We cloned a novel isoform of presenilin I (presenilin I-374) besides previously published presenilin I-467 and I-463 in human lymphocytes. Presenilin I-463 was identical to presenilin I-467 except a 12 bp nucleotides deletion in its amino terminal region. Another isoform,  presenilin I-374 was produced by an alternative splicing with an additional exon consisting of 92 bp nucleotides (exon 11),  which resulted in the frame shift with a stop codon to generate a truncated presenilin consisting of 374 amino acids. The transcripts for presenilin I-467\/463 was ubiquitously detected while that for presenilin I-374 was selectively detected in liver,  spleen,  kidney. Abnormal behavior of presenilin I on gel electrophoresis was found with affinity-purified antibodies against presenilin I. "} , { "attrname": "MeSH", "value": "[Brain,  Sequence Deletion,  Peptide Fragments,  Presenilin-1,  Protein Biosynthesis,  Exons,  Humans,  Liver,  Antibodies,  Molecular Sequence Data,  Leukocytes,  Recombinant Proteins,  Kidney,  Base Sequence,  Cloning,  Molecular,  Polymerase Chain Reaction,  Transcription,  Genetic,  Spleen,  Amino Acid Sequence,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Organ Specificity,  Membrane Proteins,  Sequence Homology,  Amino Acid,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[N Sahara,  Y Yahagi,  H Takagi,  T Kondo,  M Okochi,  M Usami,  T Shirasawa,  H Mori]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)]"} ], "id": "1174", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8641442", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8641442"} , { "elementOf": "DOI", "accession": "10.1016\/0014-5793(96)00054-3"} ]} , { "annotation": "[VARIANTS AD3 PHE-96; ARG-163 AND THR-213]", "conames": [{ "name": "PMID: 8733303", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8733303", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families."} , { "attrname": "Abstract", "value": "Presenilin-1 (PS-1) gene of three Japanese pedigrees with early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) disclosed two novel missense mutations resulting in Val96Phe and Ile213Thr,  and one mutation resulting in His163Arg. The mean age at onset in a family with His163Arg mutation was similar to those reported in other families with His163Arg. Our results suggested the existence of a variety of PS-1 mutations,  and that early-onset FAD with PS-1 mutations is highly penetrant and is only rarely subject to modulation by genetic or environmental modifying factors. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Humans,  Age of Onset,  Mutation,  Alzheimer Disease]"} , { "attrname": "AUTHORS", "value": "[K Kamino,  S Sato,  Y Sakaki,  A Yoshiiwa,  Y Nishiwaki,  M Takeda,  H Tanabe,  T Nishimura,  K Ii,  P H St George-Hyslop,  T Miki,  T Ogihara]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 PHE-96; ARG-163 AND THR-213]"} ], "id": "1175", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8733303", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8733303"} , { "elementOf": "DOI", "accession": "10.1016\/0304-3940(96)12587-8"} ]} , { "annotation": "[VARIANTS AD3 LEU-169 AND GLN-436]", "conames": [{ "name": "PMID: 9831473", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9831473", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Mutations in the presenilin-1 (PS-1) gene account for the majority of early onset autosomal-dominant familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD) cases. We identified three missense mutations in the coding sequence of the PS-1 gene in three early onset (EO),  FAD pedigrees. <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> was confirmed in one pedigree by autopsy. Mutation analysis of PCR products amplified from genomic DNA templates of affected individuals showed two novel mutations resulting in Ser169Leu and Pro436Gln and one known mutation resulting in Glu318Gly. The two new mutations are located within predicted transmembrane domains three (TM-3) and seven (TM-7),  and are associated with a very early age of onset which is consistent with a marked loss of function of the protein. The age of onset in the pedigree with Glu318Gly mutation was similar to that reported previously in a separate pedigree with this mutation. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Humans,  Middle Aged,  Family Health,  Genotype,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Point Mutation,  DNA Mutational Analysis,  Pedigree,  Age of Onset,  Alleles,  Fatal Outcome,  Adult,  Female]"} , { "attrname": "AUTHORS", "value": "[K Taddei,  J B Kwok,  J J Kril,  G M Halliday,  H Creasey,  M Hallupp,  C Fisher,  W S Brooks,  C Chung,  C Andrews,  C L Masters,  P R Schofield,  R N Martins]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 LEU-169 AND GLN-436]"} ], "id": "1176", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9831473", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1097\/00001756-199810050-00034"} , { "elementOf": "NLM", "accession": "9831473"} ]} , { "annotation": "[VARIANTS AD3 LEU-233; ARG-282 AND THR-409,  VARIANT GLY-318]", "conames": [{ "name": "PMID: 10533070", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10533070", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  DNA Primers,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "DGGE method for the mutational analysis of the coding and proximal promoter regions of the <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> presenilin-1 gene:  two novel mutations."} , { "attrname": "Abstract", "value": "Many different mutations that cause <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) have been found in the presenilin-1 gene (PSEN1) and are associated with the most aggressive forms of the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. With the aim of screening for PSEN1 genetic variations,  we developed a method based on denaturing gradient gel electrophoresis (DGGE) that allows the mutational analysis of all the coding exons and the proximal promoter of PSEN1 using only four DGGE gels. The analysis by this methodology of a sample of 58 early-onset AD (EOAD) patients nonselected for family history resulted in finding four genetic variants within the PSEN1 coding region,  two of which are novel mutations (M233L and A409T),  whereas the other two have been reported previously (L282R and E318G). We also found a novel mutation within the PSEN1 proximal promoter (-280 C-->G) that,  interestingly,  provokes significant changes in the transcriptional activity of the gene in cell lines of neuronal and astrocytic,  but not hepatic origin. These data strongly suggest that the region around -280 of PSEN1 promoter contains a regulatory element that controls its transcription specifically in neural cells. "} , { "attrname": "MeSH", "value": "[Promoter Regions,  Genetic,  Presenilin-1,  Electrophoresis,  Polyacrylamide Gel,  Humans,  Middle Aged,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Case-Control Studies,  Membrane Proteins,  Point Mutation,  DNA Mutational Analysis,  Base Sequence,  Age of Onset,  Aged,  80 and over,  Adult,  Transcription,  Genetic,  Aged,  Mutation]"} , { "attrname": "AUTHORS", "value": "[J Aldudo,  M J Bullido,  F Valdivieso]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 LEU-233; ARG-282 AND THR-409,  VARIANT GLY-318]"} ], "id": "1177", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10533070", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(199911)14: 5<433: : AID-HUMU10>3.0.CO;2-K"} , { "elementOf": "NLM", "accession": "10533070"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-113]", "conames": [{ "name": "PMID: 9070286", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9070286", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  presenilin-alpha protein,  Xenopus,  Presenilins,  Xenopus Proteins,  DNA,  Complementary,  presenilin-beta,  protein,  Xenopus]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Cloning of Xenopus presenilin-alpha and -beta cDNAs and their differential expression in oogenesis and embryogenesis."} , { "attrname": "Abstract", "value": "Human presenilin (ps)-1 and -2 genes have recently been shown to be involved in genesis of early-onset familial Alzheimer's disease. By probing with human (H-) ps-1 cDNA,  we isolated two types of cDNA clones,  named X-ps-alpha and -beta,  from a Xenopus brain cDNA library. The encoded proteins,  X-PS-alpha and -beta,  may correspond to H-PS-1 and -2 with 89.4 and 85.9% similarity,  respectively. The strongest expression of these genes was observed in ovaries and in the early stages of oogenesis,  although weak or moderate expression was detected ubiquitously for both X-ps-alpha and -beta genes in multiple tissues. Upon oocyte maturation,  the X-ps-beta mRNA level was constant even after fertilization until the midblastula transition. Zygotic expression of these genes became evident only at the tailbud stage. We propose that presenilins may function in preventing cells from undergoing apoptotic degeneration particularly prior to embryonic development and in developmentally matured tissues. "} , { "attrname": "MeSH", "value": "[Xenopus,  Amino Acid Sequence,  Brain,  Presenilins,  Humans,  Molecular Sequence Data,  Xenopus Proteins,  Oocytes,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Animals,  Gene Expression Regulation,  Developmental,  Apoptosis,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[A Tsujimura,  K Yasojima,  T Hashimoto-Gotoh]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-113]"} ], "id": "1178", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9070286", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/BBRC.1996.6043"} , { "elementOf": "NLM", "accession": "9070286"} ]} , { "annotation": "[VARIANT AD3 ARG-209]", "conames": [{ "name": "PMID: 10447269", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10447269", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A novel missense mutation (G209R) in exon 8 of the presenilin 1 gene in a Japanese family with presenile familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Mutation in brief no. 254. Online."} , { "attrname": "Abstract", "value": "Over fifty missense mutations in the presenilin-1 (PSEN1) gene have been reported in families with presenile familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). We describe a novel missense mutation (G209R) within the predicted fourth transmembrane domain of the PSEN1 in a Japanese family with presenile FAD. The affected cases showed similar <span style=\"background-color: yellow\"><b>disease<\/b><\/span> histories with the mean age at onset of 49.6 +\/- 3.1 years and rapid progressive dementia characterized by memory impairment,  amnestic aphasia,  disorientation and personality change,  but lacking parietal focal symptoms such as apraxia or agnosia. Compared with the previously reported cases of same Gly209 mutation (G209V),  the clinical features of the G209R-FAD cases appear to be less critical than those of G209V-FAD cases,  although the Gly to Arg mutation is considered to be less conservative than the Gly to Val mutation. These findings may suggest the possible existence of other genetic and\/or environmental factors or the possibility that these two different Gly209 mutations may underlie different pathomechanisms in the development of presenile FAD. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Exons,  Humans,  Japan,  Middle Aged,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>]"} , { "attrname": "AUTHORS", "value": "[N Sugiyama,  K Suzuki,  T Matsumura,  C Kawanishi,  H Onishi,  Y Yamada,  E Iseki,  K Kosaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 ARG-209]"} ], "id": "1179", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10447269", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1999)14: 1<90: : AID-HUMU19>3.0.CO;2-S"} , { "elementOf": "NLM", "accession": "10447269"} ]} , { "annotation": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]", "conames": [{ "name": "PMID: 10206644", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10206644", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Coenzymes,  Peptide Fragments,  Presenilin-1,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  30KYC7MIAI Aspartic Acid,  Recombinant Proteins,  Membrane Proteins,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  Amyloid beta-Protein Precursor,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity."} , { "attrname": "Abstract", "value": "Accumulation of the amyloid-beta protein (Abeta) in the cerebral cortex is an early and invariant event in the pathogenesis of <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The final step in the generation of Abeta from the beta-amyloid precursor protein is an apparently intramembranous proteolysis by the elusive gamma-secretase(s). The most common cause of familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> is mutation of the genes encoding presenilins 1 and 2,  which alters gamma-secretase activity to increase the production of the highly amyloidogenic Abeta42 isoform. Moreover,  deletion of presenilin-1 in mice greatly reduces gamma-secretase activity,  indicating that presenilin-1 mediates most of this proteolytic event. Here we report that mutation of either of two conserved transmembrane (TM) aspartate residues in presenilin-1,  Asp 257 (in TM6) and Asp 385 (in TM7),  substantially reduces Abeta production and increases the amounts of the carboxy-terminal fragments of beta-amyloid precursor protein that are the substrates of gamma-secretase. We observed these effects in three different cell lines as well as in cell-free microsomes. Either of the Asp --> Ala mutations also prevented the normal endoproteolysis of presenilin-1 in the TM6 --> TM7 cytoplasmic loop. In a functional presenilin-1 variant (carrying a deletion in exon 9) that is associated with familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and which does not require this cleavage,  the Asp 385 --> Ala mutation still inhibited gamma-secretase activity. Our results indicate that the two transmembrane aspartate residues are critical for both presenilin-1 endoproteolysis and gamma-secretase activity,  and suggest that presenilin 1 is either a unique diaspartyl cofactor for gamma-secretase or is itself gamma-secretase,  an autoactivated intramembranous aspartyl protease. "} , { "attrname": "MeSH", "value": "[Cell Membrane,  Peptide Fragments,  Presenilin-1,  Exons,  Humans,  Aspartic Acid,  Recombinant Proteins,  Transfection,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  CHO Cells,  Cell Line,  Coenzymes,  Cricetinae,  Mutagenesis,  Site-Directed,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Microsomes,  Protein Folding,  Membrane Proteins,  Animals,  Cell-Free System,  Electrochemistry,  COS Cells,  Endopeptidases,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[M S Wolfe,  W Xia,  B L Ostaszewski,  T S Diehl,  W T Kimberly,  D J Selkoe]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  MUTAGENESIS OF ASP-257 AND ASP-385]"} ], "id": "1180", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10206644", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/19077"} , { "elementOf": "NLM", "accession": "10206644"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 24-32,  ALTERNATIVE SPLICING (ISOFORMS 6 AND 7)];", "conames": [{ "name": "PMID: 8804415", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8804415", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  HLA-DR Antigens,  63231-63-0 RNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s presenilin 1 gene expression in platelets and megakaryocytes. Identification of a novel splice variant."} , { "attrname": "Abstract", "value": "The presenilin 1 (PS1) gene located on chromosome 14 has been linked with the majority of early-onset FAD. The normal biological role of PS1 as well as the mechanism by which mutations in PS1 cause FAD remains unknown. PS1 expression in platelets and the Dami megakaryocytic cell line was examined by Western blot analysis and RT-PCR. Using an anti-N-terminus PS1 antibody we detected PS1 immunoreactive bands of 44,  32 and 27 kDa in both cell types. After RT-PCR we observed that platelets and megakaryocytes carry at least four different PS1 transcripts. One of them is a novel PS1 splice variant that lacks the coding sequence for exon 10 resulting in a shorter 409 amino acid protein. "} , { "attrname": "MeSH", "value": "[Cell Line,  Gene Expression,  Presenilin-1,  HLA-DR Antigens,  Alternative Splicing,  RNA,  Exons,  Humans,  Blood Platelets,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Blotting,  Western,  Membrane Proteins,  Polymerase Chain Reaction,  Megakaryocytes]"} , { "attrname": "AUTHORS", "value": "[R Vidal,  J Ghiso,  T Wisniewski,  B Frangione]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 24-32,  ALTERNATIVE SPLICING (ISOFORMS 6 AND 7)]"} ], "id": "1181", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8804415", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8804415"} , { "elementOf": "DOI", "accession": "10.1016\/0014-5793(96)00845-9"} ]} , { "annotation": "[VARIANTS AD3 LEU-82; HIS-115; THR-139; ARG-163; THR-231; LEU-264; VAL-392 AND TYR-410]", "conames": [{ "name": "PMID: 8634712", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8634712", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  9007-49-2 DNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Mutations of the presenilin I gene in families with early-onset Alzheimer's disease."} , { "attrname": "Abstract", "value": "We analyzed 12 families with autosomal dominant early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>' s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (EOAD)for mutations in the coding region of the presenilin I (PSNLI) gene corresponding to the AD3 locus on chromosome 14q24.3. A total of eight missense mutations at codons 82,  115,  139,  163,  231,  264,  392,  and 410 including six novel mutations,  were identified in eight families. Cosegregation of the mutations with EOAD was confirmed in three families,  one including 36 affected individuals. This study underlines the great allelic heterogeneity and the large distribution of the mutations within the PSNLI coding region. Our results support the notion that PSNLI is the major gene involved in autosomal dominant EOAD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-1,  Humans,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  DNA Mutational Analysis,  Pedigree,  Base Sequence,  DNA,  Age of Onset,  Female,  Mutation,  Cell Line,  Transformed]"} , { "attrname": "AUTHORS", "value": "[D Campion,  J M Flaman,  A Brice,  D Hannequin,  B Dubois,  C Martin,  V Moreau,  F Charbonnier,  O Didierjean,  S Tardieu]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 LEU-82; HIS-115; THR-139; ARG-163; THR-231; LEU-264; VAL-392 AND TYR-410]"} ], "id": "1182", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8634712", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8634712"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/4.12.2373"} ]} , { "annotation": "[PHOSPHORYLATION AT SER-310 AND SER-346,  MUTAGENESIS OF SER-310 AND SER-346]", "conames": [{ "name": "PMID: 14576165", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14576165", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 2.7.11.1 Glycogen Synthase Kinase 3 beta,  EC 3.4.22.- Caspases,  Presenilin-1,  EC 2.7.11.11 Cyclic AMP-Dependent Protein Kinases,  EC 2.7.11.26 Glycogen Synthase Kinase 3,  452VLY9402 Serine,  PSEN1 protein,  human,  EC 2.7.11.13 Protein Kinase C]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Phosphorylation of presenilin 1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis."} , { "attrname": "Abstract", "value": "The Alzheimer's disease-associated presenilin (PS) 1 is intimately involved in gamma-secretase cleavage of beta-amyloid precursor protein and other proteins. In addition,  PS1 plays a role in beta-catenin signaling and in the regulation of apoptosis. Here we demonstrate that phosphorylation of PS1 is regulated by two independent signaling pathways involving protein kinase (PK) A and PKC and that both kinases can directly phosphorylate the large hydrophilic domain of PS1 in vitro and in cultured cells. A phosphorylation site at serine residue 346 was identified that is selectively phosphorylated by PKC but not by PKA. This site is localized within a recognition motif for caspases,  and phosphorylation strongly inhibits proteolytic processing of PS1 by caspase activity during apoptosis. Moreover,  PS1 phosphorylation reduces the progression of apoptosis. Our data indicate that phosphorylation\/dephosphorylation at the caspase recognition site provides a mechanism to reversibly regulate properties of PS1 in apoptosis. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Phosphorylation,  Presenilin-1,  Humans,  Serine,  Molecular Sequence Data,  Glycogen Synthase Kinase 3,  Glycogen Synthase Kinase 3 beta,  Membrane Proteins,  Animals,  Caspases,  COS Cells,  Cyclic AMP-Dependent Protein Kinases,  Apoptosis,  Protein Kinase C]"} , { "attrname": "AUTHORS", "value": "[Regina Fluhrer,  Arno Friedlein,  Christian Haass,  Jochen Walter]"} , { "attrname": "PUB_TYPE", "value": "[PHOSPHORYLATION AT SER-310 AND SER-346,  MUTAGENESIS OF SER-310 AND SER-346]"} ], "id": "1183", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14576165", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14576165"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M306653200"} ]} , { "annotation": "[VARIANTS AD3 THR-143 AND ALA-384]", "conames": [{ "name": "PMID: 8634711", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8634711", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Molecular genetic analysis of familial early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> linked to chromosome 14q24.3."} , { "attrname": "Abstract", "value": "Genetic linkage studies have indicated that chromosome 14q24.3 harbours a major locus for early-onset (onset age <65 years) <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD3). Positional cloning efforts have identified a novel gene S182 or presenilin 1 as the AD3 gene. We have mapped S182 in the AD3 candidate region between D14S277 and D14S284 defined by genetic linkage studies in the two chromosome 14 linked,  early-onset AD families AD\/A and AD\/B. We have shown that S182 is expressed in lymphoblasts and have determined the complete cDNA in both brain and lymphoblasts by RT-PCR sequencing. S182 is alternatively spliced in both brain and lymphoblasts within a putative phosphorylation site located 5' in the coding region. We identified two novel mutations,  Ile143Thr and Gly384la located in,  respectively,  the second transmembrane domain and in the sixth hydrophilic loop of the putative transmembrane structure of S182. As families AD\/A and AD\/B have very similar AD phenotype our observation of two mutations in functionally different domains suggest that onset age and severity of AD may not be very helpful predictors of the location of putative S182 mutations. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Chromosomes,  Artificial,  Yeast,  Humans,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Linkage Disequilibrium,  Membrane Proteins,  Pedigree,  Base Sequence,  Age of Onset,  Chromosomes,  Human,  Pair 14,  Female,  Mutation,  DNA,  Complementary,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[M Cruts,  H Backhovens,  S Y Wang,  G Van Gassen,  J Theuns,  C D De Jonghe,  A Wehnert,  J De Voecht,  G De Winter,  P Cras]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 THR-143 AND ALA-384]"} ], "id": "1184", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8634711", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1093\/HMG\/4.12.2363"} , { "elementOf": "NLM", "accession": "8634711"} ]} , { "annotation": "[SUBCELLULAR LOCATION,  INTERACTION WITH UBQLN1]", "conames": [{ "name": "PMID: 21143716", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21143716", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Traffic (Copenhagen,  Denmark)"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-1,  UBQLN1 protein,  human,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  Cell Cycle Proteins,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated ubiquilin-1 regulates presenilin-1 accumulation and aggresome formation."} , { "attrname": "Abstract", "value": "The <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD)-associated ubiquilin-1 regulates proteasomal degradation of proteins,  including presenilin (PS). PS-dependent ?-secretase generates ?-amyloid (A?) peptides,  which excessively accumulate in AD brain. Here,  we have characterized the effects of naturally occurring ubiquilin-1 transcript variants (TVs) on the levels and subcellular localization of PS1 and other ?-secretase complex components and subsequent ?-secretase function in human embryonic kidney 293,  human neuroblastoma SH-SY5Y and mouse primary cortical cells. Full-length ubiquilin-1 TV1 and TV3 that lacks the proteasome-interaction domain increased full-length PS1 levels as well as induced accumulation of high-molecular-weight PS1 and aggresome formation. Accumulated PS1 colocalized with TV1 or TV3 in the aggresomes. Electron microscopy indicated that aggresomes containing TV1 or TV3 were targeted to autophagosomes. TV1- and TV3-expressing cells did not accumulate other unrelated proteasome substrates,  suggesting that the increase in PS1 levels was not because of a general impairment of the ubiquitin-proteasome system. Furthermore,  PS1 accumulation and aggresome formation coincided with alterations in A? levels,  particularly in cells overexpressing TV3. These effects were not related to altered ?-secretase activity or PS1 binding to TV3. Collectively,  our results indicate that specific ubiquilin-1 TVs can cause PS1 accumulation and aggresome formation,  which may impact AD pathogenesis or susceptibility. "} , { "attrname": "MeSH", "value": "[Gene Expression,  Presenilin-1,  Humans,  Cells,  Cultured,  Phagosomes,  Mice,  Transgenic,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Proteasome Endopeptidase Complex,  Animals,  Models,  Biological,  Amyloid Precursor Protein Secretases,  HEK293 Cells,  Mice,  Protein Stability,  Cell Cycle Proteins,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Jayashree Viswanathan,  Annakaisa Haapasalo,  Claudia Bttcher,  Riitta Miettinen,  Kaisa M A Kurkinen,  Alice Lu,  Anne Thomas,  Christa J Maynard,  Donna Romano,  Bradley T Hyman,  Oksana Berezovska,  Lars Bertram,  Hilkka Soininen,  Nico P Dantuma,  Rudolph E Tanzi,  Mikko Hiltunen]"} , { "attrname": "PUB_TYPE", "value": "[SUBCELLULAR LOCATION,  INTERACTION WITH UBQLN1]"} ], "id": "1185", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21143716", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21143716"} , { "elementOf": "DOI", "accession": "10.1111\/J.1600-0854.2010.01149.X"} ]} , { "annotation": "[VARIANT GLY-318]", "conames": [{ "name": "PMID: 9851450", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9851450", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Missense mutation E318G of the presenilin-1 gene appears to be a nonpathogenic polymorphism."} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Humans,  Middle Aged,  Aged,  80 and over,  Adult,  Aged,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[J Aldudo,  M J Bullido,  A Frank,  F Valdivieso]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GLY-318]"} ], "id": "1186", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9851450", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.410440624"} , { "elementOf": "NLM", "accession": "9851450"} ]} , { "annotation": "[INTERACTION WITH MTCH1]", "conames": [{ "name": "PMID: 10551805", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10551805", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Drosophila Proteins,  Peptide Fragments,  Presenilin-1,  MTCH1 protein,  human,  143513-41-1 discs large 1 protein,  Drosophila,  Nerve Tissue Proteins,  TJP1 protein,  human,  Mitochondrial Proteins,  Membrane Proteins,  Zonula Occludens-1 Protein,  Phosphoproteins,  postsynaptic density proteins,  RNA,  Messenger,  Insect Proteins,  PSEN1 protein,  human,  Tumor Suppressor Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Identification of a novel PSD-95\/Dlg\/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1."} , { "attrname": "Abstract", "value": "Presenilin-1 (PS-1) is the most causative Alzheimer gene product,  and its function is not well understood. In an attempt to elucidate the function of PS-1,  we screened a human brain cDNA library for PS-1-interacting proteins using the yeast two-hybrid system and isolated a novel protein containing a PSD-95\/Dlg\/ZO-1 (PDZ)-like domain. This novel PS-1-associated protein (PSAP) shares a significant similarity with a Caenorhabditis elegans protein of unknown function. Northern blot analysis revealed that PSAP is predominantly expressed in the brain. Deletion of the first four C-terminal amino acid residues of PS-1,  which contain the PDZ domain-binding motif (Gln-Phe-Tyr-Ile),  reduced the binding activity of PS-1 toward PSAP 4-fold. These data suggest that PS-1 may associate with a PDZ-like domain-containing protein in vivo and thus may participate in receptor or channel clustering and intracellular signaling events in the brain. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Cell Line,  Drosophila Proteins,  Gene Expression,  Peptide Fragments,  Phosphorylation,  Presenilin-1,  Humans,  Molecular Sequence Data,  Nerve Tissue Proteins,  Mitochondrial Proteins,  Membrane Proteins,  Sequence Alignment,  Transfection,  Zonula Occludens-1 Protein,  Phosphoproteins,  Cloning,  Molecular,  Protein Binding,  Binding Sites,  RNA,  Messenger,  Insect Proteins,  Tumor Suppressor Proteins]"} , { "attrname": "AUTHORS", "value": "[X Xu,  Y c Shi,  X Wu,  P Gambetti,  D Sui,  M Z Cui]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH MTCH1]"} ], "id": "1187", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10551805", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10551805"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.274.46.32543"} ]} , { "annotation": "[INVOLVEMENT IN ACNINV3]", "conames": [{ "name": "PMID: 20929727", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20929727", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  EC 3.4.- Amyloid Precursor Protein Secretases,  Presenilin-1,  nicastrin protein,  Membrane Glycoproteins,  PSEN1 protein,  human,  PSENEN protein,  human]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Gamma-secretase gene mutations in familial acne inversa."} , { "attrname": "Abstract", "value": "Acne inversa (AI),  also known as hidradenitis suppurativa,  is a chronic,  recurrent,  inflammatory <span style=\"background-color: yellow\"><b>disease<\/b><\/span> of hair follicles that often runs in families. We studied six Chinese families with features of AI as well as additional skin lesions on back,  face,  nape,  and waist and found independent loss-of-function mutations in PSENEN,  PSEN1,  or NCSTN,  the genes encoding essential components of the ?-secretase multiprotein complex. Our results identify the ?-secretase component genes as the culprits for a subset of familial AI,  implicate the ?-secretase-Notch pathway in the molecular pathogenesis of AI,  and demonstrate that familial AI can be an allelic disorder of early-onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Hidradenitis Suppurativa,  Presenilin-1,  Humans,  Middle Aged,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Reverse Transcriptase Polymerase Chain Reaction,  Membrane Proteins,  Young Adult,  Asian Continental Ancestry Group,  Chromosomes,  Human,  Pair 19,  DNA Mutational Analysis,  Adolescent,  Alleles,  Amyloid Precursor Protein Secretases,  Aged,  80 and over,  Adult,  Female,  Aged,  Membrane Glycoproteins,  Mutation]"} , { "attrname": "AUTHORS", "value": "[Baoxi Wang,  Wei Yang,  Wen Wen,  Jing Sun,  Bin Su,  Bo Liu,  Donglai Ma,  Dan Lv,  Yaran Wen,  Tao Qu,  Min Chen,  Miao Sun,  Yan Shen,  Xue Zhang]"} , { "attrname": "PUB_TYPE", "value": "[INVOLVEMENT IN ACNINV3]"} ], "id": "1188", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20929727", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1196284"} , { "elementOf": "NLM", "accession": "20929727"} ]} , { "annotation": "[VARIANT AD3 SER-405]", "conames": [{ "name": "PMID: 10644793", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10644793", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurology,  neurosurgery,  and psychiatry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Amyloid beta-Peptides,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy."} , { "attrname": "Abstract", "value": "To clarify the phenotypic heterogeneity in deposition of amyloid beta (Abeta) in the parenchyma and in cerebral vessels of the brains of the patients having presenilin-1 (PS1) mutations. Mutations in PS1 induce increased production of Abeta42(43),  resulting in an enhanced overall deposition of Abeta protein within the cerebral cortex. Sequence analysis of the PS1 gene of DNA from patients with early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and immunostaining of brain tissues by end specific monoclonal antibodies against Abeta. Sequence analysis disclosed a novel mutation (N405S) in the PS1 gene in a Japanese patient with early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Postmortem examination of one patient with N405S showed limited cerebral amyloid angiopathy,  whereas postmortem examination of another Japanese patient with <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> with the E184D mutation disclosed severe cerebral amyloid angiopathy. The brains of both patients showed widespread neuritic plaques,  neurofibrillary tangles,  and neuronal loss. Immunostaining showed that Abeta42 was predominant over Abeta40 in neuritic plaques in both patients,  whereas Abeta40 was found to be predominant over Abeta42 in cerebral amyloid angiopathy in the patient with E184D. However,  most cortical vessels of the patient with N405S were not reactive with either of the antibodies. The N405S mutation of PS1 is a major determinant of cortical Abeta deposition but not cerebral amyloid angiopathy in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[Severity of Illness Index,  Brain,  Gene Expression,  Presenilin-1,  Humans,  Middle Aged,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Neurofibrillary Tangles,  Membrane Proteins,  Plaque,  Amyloid,  Point Mutation,  DNA Mutational Analysis,  Amyloid beta-Peptides,  Fatal Outcome,  Cerebral Amyloid Angiopathy,  Female]"} , { "attrname": "AUTHORS", "value": "[M Yasuda,  S Maeda,  T Kawamata,  A Tamaoka,  Y Yamamoto,  S Kuroda,  K Maeda,  C Tanaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 SER-405]"} ], "id": "1189", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10644793", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10644793"} , { "elementOf": "DOI", "accession": "10.1136\/JNNP.68.2.220"} ]} , { "annotation": "[VARIANTS AD3 PHE-143 AND SER-436]", "conames": [{ "name": "PMID: 10090481", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10090481", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in the UK. Mutations in brief no. 223. Online."} , { "attrname": "Abstract", "value": "Familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is an autosomal dominant disorder characterized by memory impairment and multiple cognitive deficits which occurs in mid to late life. Early onset AD has been associated with mutations in three genes,  of which presenilin 1 (PS1) mutations are the most frequent. We sequenced the open reading frame from genomic DNA of a series of 21 early onset AD (AD3) UK families in which there were at least two affected individuals in two or more generations with a diagnosis of probable or definite AD. We found PS1 mutations in six of these families with no sequence variation in the remaining 15. The six families contained between them five different mutations of which two,  I143F and P436S,  have not been found elsewhere. I143F shows incomplete penetration within the affected family. P436S is the most carboxy-terminal presenilin 1 mutation reported to date. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Humans,  United Kingdom,  Mutation,  Alzheimer Disease]"} , { "attrname": "AUTHORS", "value": "[M S Palmer,  J A Beck,  T A Campbell,  C B Humphries,  P K Roques,  N C Fox,  R Harvey,  M N Rossor,  J Collinge]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS AD3 PHE-143 AND SER-436]"} ], "id": "1190", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10090481", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10090481"} , { "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(1999)13: 3<256: : AID-HUMU11>3.0.CO;2-P"} ]} , { "annotation": "[FUNCTION,  ACTIVE SITES ASP-257 AND ASP-385,  MUTAGENESIS OF TYR-256; ASP-257; ASP-385 AND TYR-389]", "conames": [{ "name": "PMID: 15341515", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15341515", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neurochemistry"} , { "attrname": "Chemical", "value": "[EC 3.4.- Amyloid Precursor Protein Secretases,  amyloid beta-protein (1-40),  Enzyme Inhibitors,  Peptide Fragments,  amyloid beta-protein (1-42),  Chromosomal Proteins,  Non-Histone,  EC 3.4.23.- Aspartic Acid Endopeptidases,  EC 3.4.23.46 BACE1 protein,  human,  30KYC7MIAI Aspartic Acid,  Detergents,  Cholic Acids,  Culture Media,  Conditioned,  42HK56048U Tyrosine,  EC 3.4.- Endopeptidases,  Amyloid beta-Peptides,  82473-24-3 chapso,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Conserved residues within the putative active site of gamma-secretase differentially influence enzyme activity and inhibitor binding."} , { "attrname": "Abstract", "value": "Gamma-secretase performs the final processing step in the generation of amyloid-beta (Abeta) peptides,  which are believed to be causative for Alzheimer's disease. Presenilins (PS) are required for gamma-secretase activity and the presence of two essential intramembranous aspartates (D257 and D385) has implicated this region as the putative catalytic centre of an aspartyl protease. The presence of several key hydrogen-bonding residues around the active site of classical aspartyl proteases led us to investigate the role of both the critical aspartates and two nearby conserved hydrogen bond donors in PS1. Generation of cell lines stably overexpressing the D257E,  D385E,  Y256F and Y389F engineered mutations has enabled us to determine their role in enzyme catalysis and binding of a transition state analogue gamma-secretase inhibitor. Here we report that replacement of either tyrosine residue alters gamma-secretase cleavage specificity,  resulting in an increase in the production of the more pathogenic Abeta42 peptide in both cells and membranous enzyme preparations,  without affecting inhibitor binding. In contrast,  replacement of either of the aspartate residues precludes inhibitor binding in addition to inactivation of the enzyme. Together,  these data further incriminate the region around the intramembranous aspartates as the active site of the enzyme,  targeted by transition state analogue inhibitors,  and highlight the roles of individual residues. "} , { "attrname": "MeSH", "value": "[Cell Membrane,  Enzyme Inhibitors,  Peptide Fragments,  Embryo,  Mammalian,  Humans,  Substrate Specificity,  Aspartic Acid,  Cholic Acids,  Kidney,  Transfection,  Aspartic Acid Endopeptidases,  Amyloid Precursor Protein Secretases,  Amyloid beta-Peptides,  Conserved Sequence,  Binding Sites,  Protein Structure,  Tertiary,  Tyrosine,  Cell Line,  Mutagenesis,  Site-Directed,  Chromosomal Proteins,  Non-Histone,  Detergents,  Blotting,  Western,  Protein Folding,  Culture Media,  Conditioned,  Cell-Free System,  Protein Binding,  Enzyme Activation,  Endopeptidases,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[Jonathan D J Wrigley,  Emma J Nunn,  Omar Nyabi,  Earl E Clarke,  Peter Hunt,  Alan Nadin,  Bart De Strooper,  Mark S Shearman,  Dirk Beher]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  ACTIVE SITES ASP-257 AND ASP-385,  MUTAGENESIS OF TYR-256; ASP-257; ASP-385 AND TYR-389]"} ], "id": "1191", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15341515", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1111\/J.1471-4159.2004.02596.X"} , { "elementOf": "NLM", "accession": "15341515"} ]} , { "annotation": "[VARIANT GLY-318]", "conames": [{ "name": "PMID: 18485326", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18485326", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[9007-49-2 DNA,  Codon,  Nonsense,  DNA Primers,  Basic Helix-Loop-Helix Transcription Factors]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "Mutations in the MESP2 gene cause spondylothoracic dysostosis\/Jarcho-Levin syndrome."} , { "attrname": "Abstract", "value": "Spondylothoracic dysostosis (STD),  also known as Jarcho-Levin syndrome (JLS),  is an autosomal-recessive disorder characterized by abnormal vertebral segmentation and defects affecting spine formation,  with complete bilateral fusion of the ribs at the costovertebral junction producing a \"crab-like\" configuration of the thorax. The shortened spine and trunk can severely affect respiratory function during early childhood. The condition is prevalent in the Puerto Rican population,  although it is a panethnic disorder. By sequencing a set of candidate genes involved in mouse segmentation,  we identified a recessive E103X nonsense mutation in the mesoderm posterior 2 homolog (MESP2) gene in a patient,  of Puerto Rican origin and from the Boston area,  who had been diagnosed with STD\/JLS. We then analyzed 12 Puerto Rican families with STD probands for the MESP2 E103X mutation. Ten patients were homozygous for the E103X mutation,  three patients were compound heterozygous for a second nonsense mutation,  E230X,  or a missense mutation,  L125V,  which affects a conserved leucine residue within the bHLH region. Thus,  all affected probands harbored the E103X mutation. Our findings suggest a founder-effect mutation in the MESP2 gene as a major cause of the classical Puerto Rican form of STD\/JLS. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Puerto Rico,  Humans,  Hispanic Americans,  Abnormalities,  Multiple,  Molecular Sequence Data,  Male,  Codon,  Nonsense,  Mutation,  Missense,  DNA Primers,  Dysostoses,  Genes,  Recessive,  Ribs,  Syndrome,  Sequence Homology,  Amino Acid,  Founder Effect,  Thoracic Vertebrae,  Base Sequence,  DNA,  Female,  Polymorphism,  Single Nucleotide,  Mutation,  Basic Helix-Loop-Helix Transcription Factors]"} , { "attrname": "AUTHORS", "value": "[Alberto S Cornier,  Karen Staehling-Hampton,  Kym M Delventhal,  Yumiko Saga,  Jean-Francois Caubet,  Nobuo Sasaki,  Sian Ellard,  Elizabeth Young,  Norman Ramirez,  Simon E Carlo,  Jose Torres,  John B Emans,  Peter D Turnpenny,  Olivier Pourqui]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GLY-318]"} ], "id": "1192", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18485326", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/J.AJHG.2008.04.014"} , { "elementOf": "NLM", "accession": "18485326"} ]} , { "annotation": "[CASPASE CLEAVAGE SITE,  MUTAGENESIS OF ASP-345; ASP-373 AND ASP-385]", "conames": [{ "name": "PMID: 9485372", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9485372", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Peptide Fragments,  Presenilin-1,  EC 3.4.22.- Cysteine Endopeptidases,  DNA Primers,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> associated presenilin-1 holoprotein and its 18-20 kDa C-terminal fragment are death substrates for proteases of the caspase family."} , { "attrname": "Abstract", "value": "Mutations in the presenilin (PS) genes are linked to early onset familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (FAD). PS-1 proteins are proteolytically processed by an unknown protease leading to the formation of two stable fragments of approximately 30 and approximately 20 kDa [Thinakaran,  G.,  et al. (1996) Neuron 17,  181-190]. In addition to the conventional fragments,  alternative cleavage products were observed as well. Here we characterize an alternative proteolytic pathway of PS-1 which involves proteases of the caspase superfamily. Caspase mediated cleavage occurs between aspartate 345 and serine 346 C-terminal to the conventional cleavage determined previously [Podlisny,  M.,  et al.,  (1997) Neurobiol. Dis. 3,  325-337]. Full-length PS-1 can serve as a substrate for caspase-like proteases,  as demonstrated by the generation of the alternative C-terminal fragment in cells expressing PS-1 containing the Deltaexon 10 deletion which is known to accumulate as a full-length molecule [Thinakaran,  G.,  et al. (1996)]. By inhibition of de novo protein synthesis in untransfected cells we demonstrate that the conventional C-terminal fragment of PS-1 is a substrate for caspase-like proteases as well. Therefore full-length and the conventional C-terminal fragment of PS-1 can serve as potential death substrates. Due to the fact that very little full-length PS-1 is expressed in vivo,  the much more abundant C-terminal fragment and not the full-length precursor is the major in vivo substrate for the alternative cleavage of PS-1 by proteases of the caspase superfamily. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cell Line,  Cysteine Endopeptidases,  Peptide Fragments,  Presenilin-1,  Molecular Weight,  Mutagenesis,  Site-Directed,  Humans,  Substrate Specificity,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Membrane Proteins,  Animals,  Base Sequence,  Cell Death,  Polymerase Chain Reaction,  Protein Processing,  Post-Translational,  Mutation,  In Vitro Techniques,  Binding Sites]"} , { "attrname": "AUTHORS", "value": "[J Grunberg,  J Walter,  H Loetscher,  U Deuschle,  H Jacobsen,  C Haass]"} , { "attrname": "PUB_TYPE", "value": "[CASPASE CLEAVAGE SITE,  MUTAGENESIS OF ASP-345; ASP-373 AND ASP-385]"} ], "id": "1193", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9485372", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI972106L"} , { "elementOf": "NLM", "accession": "9485372"} ]} , { "annotation": "[VARIANT AD3 PRO-171]", "conames": [{ "name": "PMID: 9833068", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9833068", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annales de genetique"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  9DLQ4CIU6V Proline,  GMW67QNF9C Leucine,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "A search for mutations in exons 6,  7,  9 and 12 of the PS1 gene in four Mexican families with Early-Onset (36-40 years) <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> yielded the discovery in one family of a T-->C mismatch in exon 7 which correspond to nucleotide 760 of cDNA,  leading to a Leu171Pro mutation. The pedigree analysis and the literature data strongly suggest an etiopathogenic relationship of the mutation with the disorder. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Humans,  Proline,  Leucine,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Pedigree,  Age of Onset,  Polymerase Chain Reaction,  Adult,  Mexico,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[M G Ramirez-Dueas,  E A Rogaeva,  C A Leal,  C Lin,  G A Ramirez-Casillas,  J A Hernandez-Romo,  P H St George-Hyslop,  J M Cantu]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 PRO-171]"} ], "id": "1194", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9833068", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9833068"} ]} , { "annotation": "[FUNCTION,  INTERACTION WITH CDH1]", "conames": [{ "name": "PMID: 11226248", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11226248", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Cytoskeletal Proteins,  Membrane Proteins,  Presenilin-1,  CTNNB1 protein,  mouse,  beta Catenin,  Trans-Activators,  Cadherins]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Presenilin-1 binds cytoplasmic epithelial cadherin,  inhibits cadherin\/p120 association,  and regulates stability and function of the cadherin\/catenin adhesion complex."} , { "attrname": "Abstract", "value": "Here we show that presenilin-1 (PS1),  a protein involved in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  binds directly to epithelial cadherin (E-cadherin). This binding is mediated by the large cytoplasmic loop of PS1 and requires the membrane-proximal cytoplasmic sequence 604-615 of mature E-cadherin. This sequence is also required for E-cadherin binding of protein p120,  a known regulator of cadherin-mediated cell adhesion. Using wild-type and PS1 knockout cells,  we found that increasing PS1 levels suppresses p120\/E-cadherin binding,  and increasing p120 levels suppresses PS1\/E-cadherin binding. Thus PS1 and p120 bind to and mutually compete for cellular E-cadherin. Furthermore,  PS1 stimulates E-cadherin binding to beta- and gamma-catenin,  promotes cytoskeletal association of the cadherin\/catenin complexes,  and increases Ca(2+)-dependent cell-cell aggregation. Remarkably,  PS1 familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mutant DeltaE9 increased neither the levels of cadherin\/catenin complexes nor cell aggregation,  suggesting that this familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span> mutation interferes with cadherin-based cell-cell adhesion. These data identify PS1 as an E-cadherin-binding protein and a regulator of E-cadherin function in vivo. "} , { "attrname": "MeSH", "value": "[Binding,  Competitive,  Cytoskeletal Proteins,  Cell Line,  Presenilin-1,  beta Catenin,  Trans-Activators,  Epithelial Cells,  Cell Adhesion,  Membrane Proteins,  Animals,  Protein Binding,  Cadherins,  Cytoskeleton,  Mice,  Cytoplasm]"} , { "attrname": "AUTHORS", "value": "[L Baki,  P Marambaud,  S Efthimiopoulos,  A Georgakopoulos,  P Wen,  W Cui,  J Shioi,  E Koo,  M Ozawa,  V L Friedrich,  N K Robakis]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  INTERACTION WITH CDH1]"} ], "id": "1195", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11226248", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.041603398"} , { "elementOf": "NLM", "accession": "11226248"} ]} , { "annotation": "[VARIANT GLY-318]", "conames": [{ "name": "PMID: 9915968", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9915968", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Codon,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "The Glu318Gly substitution in presenilin 1 is not causally related to Alzheimer disease."} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Presenilin-1,  Codon,  Exons,  Gene Frequency,  Humans,  Aged,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[B Dermaut,  M Cruts,  A J Slooter,  S Van Gestel,  C De Jonghe,  H Vanderstichele,  E Vanmechelen,  M M Breteler,  A Hofman,  C M van Duijn,  C Van Broeckhoven]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GLY-318]"} ], "id": "1196", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9915968", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9915968"} , { "elementOf": "DOI", "accession": "10.1086\/302200"} ]} , { "annotation": "[VARIANT AD3 PRO-169]", "conames": [{ "name": "PMID: 10025789", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10025789", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures."} , { "attrname": "Abstract", "value": "To characterize the mutation responsible for early-onset AD in a large Spanish kindred. Mutations in the presenilin 1 (PS1) gene have been identified and are known to be responsible for 18 to 50% of familial early-onset AD cases. Patients were characterized clinically. The proband was further studied with EEG,  CSF analysis,  CT,  brain biopsy,  and histology. Other members were studied using EEG,  CT,  MRI,  and SPECT. Genetic analysis of PS1 was performed using PCR amplification of PS1 exons and direct sequencing followed by PS1 modeling of the normal and mutant PS1 proteins. A novel mutation (Ser169Pro) in exon 6 of the PS1 gene was identified in different affected members. The Ser169Pro mutation is located at a site of the PS1 protein that is not a cluster of mutations. The mutation was not present in 100 general population controls and in 50 unrelated sporadic AD cases. The Ser169Pro mutation is associated with generalized myoclonic seizures several years after the initial symptoms of AD,  a very early AD onset (< or =35 years),  and a rapidly progressive cognitive decline. The absence of the PS1 Ser169Pro mutation in the general population and in sporadic AD cases together with its detection in the affected members of this kindred suggests that it is a pathogenic mutation. The serine to proline change predicts a kink in the alpha-helix of the transmembrane domain of the PS1 protein that could radically disrupt its normal structure. Further characterization of the effect of this mutation could help identify the function of the PS1 protein and the pathogenic mechanisms of AD. "} , { "attrname": "MeSH", "value": "[Membrane Proteins,  Amino Acid Sequence,  Phenotype,  Presenilin-1,  Time Factors,  Exons,  Pedigree,  Epilepsies,  Myoclonic,  Molecular Sequence Data,  Mutation,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Spain]"} , { "attrname": "AUTHORS", "value": "[M Ezquerra,  C Carnero,  R Blesa,  J L Gelp,  F Ballesta,  R Oliva]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 PRO-169]"} ], "id": "1197", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10025789", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.52.3.566"} , { "elementOf": "NLM", "accession": "10025789"} ]} , { "annotation": "[VARIANT AD3 PRO-219]", "conames": [{ "name": "PMID: 10208579", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10208579", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  Presenilin-1,  Codon,  9007-49-2 DNA,  PSEN1 protein,  human]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Early-onset Alzheimer's disease caused by a novel mutation at codon 219 of the presenilin-1 gene."} , { "attrname": "Abstract", "value": "Mutations in the presenilin 1 (PS1) gene are responsible for approximately 50% of early onset autosomal-dominant <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> cases. A PCR based mutation detection method,  chemical cleavage of mismatch,  was used to detect a novel PS1 mutation in the coding sequence of the PS1 gene. Sequencing confirmed a T to C transition altering a leucine to proline at codon 219 of the PS1 gene. This is a novel mutation in exon 7 of the PS1 gene occurring outside the transmembrane regions of IV and V. "} , { "attrname": "MeSH", "value": "[Presenilin-1,  Exons,  Humans,  Middle Aged,  Male,  Mutation,  Missense,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Membrane Proteins,  Codon,  DNA Mutational Analysis,  DNA,  Age of Onset,  Polymerase Chain Reaction,  Female,  Aged,  Genome,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[M J Smith,  R J Gardner,  M A Knight,  S M Forrest,  K Beyreuther,  E Storey,  C A McLean,  R G Cotton,  R Cappal,  C L Masters]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT AD3 PRO-219]"} ], "id": "1198", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10208579", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10208579"} , { "elementOf": "DOI", "accession": "10.1097\/00001756-199902250-00011"} ]} , { "annotation": "", "conames": [{ "name": "HUNTINGTON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>-LIKE 1; HDL1", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "603218", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "1199", "contexts": { } , "evidences": ["Imported from database"], "value": "HUNTINGTON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span>-LIKE 1; HDL1", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "603218"} ]} , { "annotation": "The component of a membrane consisting of gene products and protein complexes that are loosely bound to one of its surfaces,  but not integrated into the hydrophobic region. ( Reference:  GOC: dos GOC: jl GOC: mah )", "conames": [{ "name": "extrinsic to membrane", "isPreferred": "true"} , { "name": "peripheral membrane protein", "isPreferred": "true"} , { "name": "extrinsic component of membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019898", "attributes": [], "id": "1200", "contexts": { } , "evidences": ["Imported from database"], "value": "extrinsic to membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030396"} , { "elementOf": "GO", "accession": "GO: 0019898"} ]} , { "annotation": "The component of a membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor,  such as a lipid group that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping. ( Reference:  GOC: dos GOC: mah )", "conames": [{ "name": "anchored component of membrane", "isPreferred": "true"} , { "name": "anchored to membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031225", "attributes": [], "id": "1201", "contexts": { } , "evidences": ["Imported from database"], "value": "anchored to membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031225"} ]} , { "annotation": "", "conames": [{ "name": "Tetracycline", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1202", "contexts": { } , "evidences": ["Imported from database"], "value": "Tetracycline", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00759"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the calcineurin-NFAT signaling cascade. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of calcineurin-NFAT signaling cascade", "isPreferred": "true"} , { "name": "downregulation of calcineurin-NFAT signaling cascade", "isPreferred": "true"} , { "name": "termination of calcineurin-NFAT signaling cascade", "isPreferred": "false"} , { "name": "down regulation of calcineurin-NFAT signaling cascade", "isPreferred": "true"} , { "name": "negative regulation of calcineurin-NFAT signalling cascade", "isPreferred": "true"} , { "name": "inhibition of calcineurin-NFAT signaling cascade", "isPreferred": "false"} , { "name": "negative regulation of calcineurin-NFAT signaling pathway", "isPreferred": "false"} , { "name": "down-regulation of calcineurin-NFAT signaling cascade", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0070885", "attributes": [], "id": "1203", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of calcineurin-NFAT signaling cascade", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0070885"} ]} , { "annotation": "The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. ( Reference:  ISBN: 0878932437 )", "conames": [{ "name": "axon pathfinding", "isPreferred": "true"} , { "name": "axon growth cone guidance", "isPreferred": "false"} , { "name": "axon guidance", "isPreferred": "true"} , { "name": "axon chemotaxis", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007411", "attributes": [], "id": "1204", "contexts": { } , "evidences": ["Imported from database"], "value": "axon guidance", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007411"} , { "elementOf": "GO", "accession": "GO: 0008040"} ]} , { "annotation": "The chemical reactions and pathways,  including anabolism and catabolism,  by which living organisms transform chemical substances. Metabolic processes typically transform small molecules,  but also include macromolecular processes such as DNA repair and replication,  and protein synthesis and degradation. ( Reference:  GOC: go_curators ISBN: 0198547684 )", "conames": [{ "name": "metabolic process resulting in cell growth", "isPreferred": "false"} , { "name": "metabolic process", "isPreferred": "true"} , { "name": "metabolism", "isPreferred": "true"} , { "name": "metabolism resulting in cell growth", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008152", "attributes": [], "id": "1205", "contexts": { } , "evidences": ["Imported from database"], "value": "metabolism", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008152"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of interleukin-2 production. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of IL-2 production", "isPreferred": "true"} , { "name": "down regulation of interleukin-2 production", "isPreferred": "true"} , { "name": "negative regulation of interleukin-2 production", "isPreferred": "true"} , { "name": "downregulation of interleukin-2 production", "isPreferred": "true"} , { "name": "inhibition of interleukin-2 production", "isPreferred": "false"} , { "name": "down-regulation of interleukin-2 production", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032703", "attributes": [], "id": "1206", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of IL-2 production", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032703"} ]} , { "annotation": "Any process that stops,  prevents or reduces the rate or extent of activated T cell proliferation. ( Reference:  GOC: go_curators )", "conames": [{ "name": "down regulation of activated T cell proliferation", "isPreferred": "true"} , { "name": "negative regulation of activated T cell proliferation", "isPreferred": "true"} , { "name": "down-regulation of activated T cell proliferation", "isPreferred": "true"} , { "name": "negative regulation of activated T lymphocyte proliferation", "isPreferred": "true"} , { "name": "negative regulation of activated T-lymphocyte proliferation", "isPreferred": "true"} , { "name": "downregulation of activated T cell proliferation", "isPreferred": "true"} , { "name": "inhibition of activated T cell proliferation", "isPreferred": "false"} , { "name": "negative regulation of activated T-cell proliferation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046007", "attributes": [], "id": "1207", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of activated T cell proliferation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046007"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis,  treatment or prevention of a disease. ( Reference:  GOC: sl )", "conames": [{ "name": "cellular response to drug", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0035690", "attributes": [], "id": "1208", "contexts": { } , "evidences": ["Imported from database"], "value": "cellular response to drug", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0035690"} ]} , { "annotation": "The process of creating protein oligomers,  compounds composed of a small number,  usually between three and ten,  of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer. ( Reference:  GOC: ai )", "conames": [{ "name": "protein homooligomerization", "isPreferred": "true"} , { "name": "protein homooligomer assembly", "isPreferred": "true"} , { "name": "protein homooligomer biosynthesis", "isPreferred": "true"} , { "name": "protein homooligomer biosynthetic process", "isPreferred": "true"} , { "name": "protein homooligomer formation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0051260", "attributes": [], "id": "1209", "contexts": { } , "evidences": ["Imported from database"], "value": "protein homooligomerization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0051260"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of potassium ion transmembrane transport. ( Reference:  GOC: BHF GOC: TermGenie )", "conames": [{ "name": "regulation of potassium ion transmembrane transport", "isPreferred": "true"} , { "name": "regulation of potassium ion membrane transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1901379", "attributes": [], "id": "1210", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of potassium ion membrane transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1901379"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of the activity of a transcription factor,  any factor involved in the initiation or regulation of transcription. ( Reference:  GOC: jl )", "conames": [{ "name": "inhibition of transcription factor", "isPreferred": "false"} , { "name": "down regulation of transcription factor", "isPreferred": "true"} , { "name": "downregulation of transcription factor", "isPreferred": "true"} , { "name": "negative regulation of transcription factor", "isPreferred": "false"} , { "name": "negative regulation of sequence-specific DNA binding transcription factor activity", "isPreferred": "true"} , { "name": "down-regulation of transcription factor", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043433", "attributes": [], "id": "1211", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of transcription factor", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043433"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell. ( Reference:  GOC: ai )", "conames": [{ "name": "downregulation of T cell receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of T cell receptor signalling pathway", "isPreferred": "true"} , { "name": "negative regulation of T-lymphocyte receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of T-cell receptor signaling pathway", "isPreferred": "true"} , { "name": "inhibition of T cell receptor signaling pathway", "isPreferred": "false"} , { "name": "negative regulation of T lymphocyte receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of TCR signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of T lymphocyte receptor signalling pathway", "isPreferred": "true"} , { "name": "negative regulation of T cell receptor signaling pathway", "isPreferred": "true"} , { "name": "down-regulation of T cell receptor signaling pathway", "isPreferred": "true"} , { "name": "negative regulation of T-lymphocyte receptor signalling pathway", "isPreferred": "true"} , { "name": "down regulation of T cell receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050860", "attributes": [], "id": "1212", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of TCR signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050860"} ]} , { "annotation": "Any process that results in a change in state or activity of a cell or an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a cadmium (Cd) ion stimulus. ( Reference:  GOC: ai )", "conames": [{ "name": "response to cadmium ion", "isPreferred": "true"} , { "name": "response to cadmium", "isPreferred": "true"} , { "name": "cadmium sensitivity\/resistance", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0046686", "attributes": [], "id": "1213", "contexts": { } , "evidences": ["Imported from database"], "value": "response to cadmium", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0046686"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. ( Reference:  GOC: add GOC: mah )", "conames": [{ "name": "negative regulation of interferon-gamma production", "isPreferred": "true"} , { "name": "negative regulation of type II interferon production", "isPreferred": "false"} , { "name": "downregulation of interferon-gamma production", "isPreferred": "true"} , { "name": "inhibition of interferon-gamma production", "isPreferred": "false"} , { "name": "down regulation of interferon-gamma production", "isPreferred": "true"} , { "name": "down-regulation of interferon-gamma production", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032689", "attributes": [], "id": "1214", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of interferon-gamma production", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032689"} ]} , { "annotation": "Any process that modulates the frequency,  rate or extent of any process in which a protein is transported to,  or maintained in,  a specific location. ( Reference:  GOC: dph GOC: mah GOC: tb )", "conames": [{ "name": "regulation of protein localisation", "isPreferred": "true"} , { "name": "regulation of protein localization", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032880", "attributes": [], "id": "1215", "contexts": { } , "evidences": ["Imported from database"], "value": "regulation of protein localization", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032880"} ]} , { "annotation": "A regulatory process that halts progression through the cell cycle during one of the normal phases (G1,  S,  G2,  M). ( Reference:  GOC: dph GOC: mah GOC: tb )", "conames": [{ "name": "arrest of cell cycle progression", "isPreferred": "true"} , { "name": "termination of cell cycle", "isPreferred": "true"} , { "name": "cell cycle arrest", "isPreferred": "true"} , { "name": "cessation of cell cycle", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007050", "attributes": [], "id": "1216", "contexts": { } , "evidences": ["Imported from database"], "value": "cell cycle arrest", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007050"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate,  or extent of production of any member of the interleukin-17 family of cytokines. ( Reference:  GOC: add GOC: mah )", "conames": [{ "name": "negative regulation of interleukin-17 production", "isPreferred": "true"} , { "name": "inhibition of interleukin-17 production", "isPreferred": "false"} , { "name": "down-regulation of interleukin-17 production", "isPreferred": "true"} , { "name": "downregulation of interleukin-17 production", "isPreferred": "true"} , { "name": "negative regulation of IL-17 production", "isPreferred": "true"} , { "name": "down regulation of interleukin-17 production", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0032700", "attributes": [], "id": "1217", "contexts": { } , "evidences": ["Imported from database"], "value": "negative regulation of IL-17 production", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0032700"} ]} , { "annotation": "The acquisition and processing of information and or the storage and retrieval of this information over time. ( Reference:  GOC: jid PMID: 8938125 )", "conames": [{ "name": "learning or memory", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007611", "attributes": [], "id": "1218", "contexts": { } , "evidences": ["Imported from database"], "value": "learning or memory", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007611"} ]} , { "annotation": "[REVIEW ON VARIANTS];", "conames": [{ "name": "PMID: 8364585", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8364585", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Prions]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Mutations and polymorphisms in the prion protein gene."} , { "attrname": "Abstract", "value": "Inherited forms of prion diseases are associated with mutations in the prion protein gene. A common polymorphism at codon 129 is also implicated in the predisposition of individuals to sporadic or iatrogenic forms of the disease. This update lists all the currently published mutations and polymorphisms together with their clinical phenotypes,  and discusses the significance of the codon 129 genotype in inherited,  sporadic,  and iatrogenic cases. There are two categories of mutation. Insertions of additional numbers of an octapeptide lying within an octapeptide repeat region now account for six variations and there are also six point mutations. The identification of mutations in this gene has lead to a broadening of the spectrum of clinical phenotypes that can be classified as prion diseases and have provided an important tool in the diagnosis of familial dementias. "} , { "attrname": "MeSH", "value": "[Point Mutation,  Phenotype,  Prion Diseases,  Humans,  Prions,  Repetitive Sequences,  Nucleic Acid,  Genotype,  Chromosome Mapping,  Mutation,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[M S Palmer,  J Collinge]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS]"} ], "id": "1219", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8364585", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/HUMU.1380020303"} , { "elementOf": "NLM", "accession": "8364585"} ]} , { "annotation": "[VARIANT CJD LYS-200]", "conames": [{ "name": "PMID: 7913755", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7913755", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Philosophical transactions of the Royal Society of London. Series B,  Biological sciences"} , { "attrname": "Chemical", "value": "[Codon,  PrPSc Proteins,  Prions,  DNA Primers]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease."} , { "attrname": "Abstract", "value": "Various mutations in the prion protein (PrP) gene are associated with Creutzfeldt-Jakob disease (CJD),  a transmissible fatal neurodegenerative disorder. Among Libyan Jews,  CJD is a familial disease with an incidence about 100 times higher than the worldwide population. CJD in this community segregates with a point mutation at codon 200 of the PrP gene which causes the substitution of lysine for glutamate. This mutation was found in all definitely affected individuals and yields a maximum lod score of 4.85. Some healthy elderly mutation carries above 65 years of age were identified,  suggesting partial penetrance. Homozygous patients have the same disease pattern and age of onset as heterozygous patients,  which argues that CJD associated with the codon 200 lysine mutation is a true dominant disorder. In the caucasian population,  Palmer et al. (1991) reported an association between homozygosity in a polymorphic site at codon 129 of the PrP gene,  coding for either valine or methionine,  with a tendency to acquire the sporadic or iatrogenic forms of CJD,  as well as with disease age of appearance in the genetic type. The incidence of the polymorphism at codon 129 in the control Libyan population is similar to the one found in the caucasian population. In the Libyan CJD patients,  the codon 200 mutation is within a Met129-encoding allele. The incidence of the Met allele is significantly higher in the affected pedigrees than in the control Libyan population; however,  no difference was detected between CJD patients,  codon 200 healthy carriers,  and their normal family members.(ABSTRACT TRUNCATED AT 250 WORDS) "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Molecular Sequence Data,  Genotype,  Male,  DNA Primers,  Libya,  Polymorphism,  Genetic,  Homozygote,  Point Mutation,  Phenotype,  Codon,  Jews,  PrPSc Proteins,  Base Sequence,  Prions,  Alleles,  Adult,  Female,  Heterozygote,  Aged,  Creutzfeldt-Jakob Syndrome,  Genetic Linkage]"} , { "attrname": "AUTHORS", "value": "[R Gabizon,  H Rosenman,  Z Meiner,  I Kahana,  E Kahana,  Y Shugart,  J Ott,  S B Prusiner]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD LYS-200]"} ], "id": "1220", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7913755", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7913755"} , { "elementOf": "DOI", "accession": "10.1098\/RSTB.1994.0033"} ]} , { "annotation": "[COPPER-BINDING]", "conames": [{ "name": "PMID: 19381258", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19381258", "attributes": [{ "attrname": "JOURNAL_REF", "value": "PLoS pathogens"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions,  4QD397987E Histidine,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Early onset prion disease from octarepeat expansion correlates with copper binding properties."} , { "attrname": "Abstract", "value": "Insertional mutations leading to expansion of the octarepeat domain of the prion protein (PrP) are directly linked to prion disease. While normal PrP has four PHGGGWGQ octapeptide segments in its flexible N-terminal domain,  expanded forms may have up to nine additional octapeptide inserts. The type of prion disease segregates with the degree of expansion. With up to four extra octarepeats,  the average onset age is above 60 years,  whereas five to nine extra octarepeats results in an average onset age between 30 and 40 years,  a difference of almost three decades. In wild-type PrP,  the octarepeat domain takes up copper (Cu(2+)) and is considered essential for in vivo function. Work from our lab demonstrates that the copper coordination mode depends on the precise ratio of Cu(2+) to protein. At low Cu(2+) levels,  coordination involves histidine side chains from adjacent octarepeats,  whereas at high levels each repeat takes up a single copper ion through interactions with the histidine side chain and neighboring backbone amides. Here we use both octarepeat constructs and recombinant PrP to examine how copper coordination modes are influenced by octarepeat expansion. We find that there is little change in affinity or coordination mode populations for octarepeat domains with up to seven segments (three inserts). However,  domains with eight or nine total repeats (four or five inserts) become energetically arrested in the multi-histidine coordination mode,  as dictated by higher copper uptake capacity and also by increased binding affinity. We next pooled all published cases of human prion disease resulting from octarepeat expansion and find remarkable agreement between the sudden length-dependent change in copper coordination and onset age. Together,  these findings suggest that either loss of PrP copper-dependent function or loss of copper-mediated protection against PrP polymerization makes a significant contribution to early onset prion disease. "} , { "attrname": "MeSH", "value": "[Cricetinae,  Humans,  Middle Aged,  Models,  Molecular,  Prion Diseases,  Repetitive Sequences,  Amino Acid,  Animals,  Histidine,  PrPSc Proteins,  Prions,  Age of Onset,  Mesocricetus,  Adult,  Mice,  Copper]"} , { "attrname": "AUTHORS", "value": "[Daniel J Stevens,  Eric D Walter,  Abel Rodrguez,  David Draper,  Paul Davies,  David R Brown,  Glenn L Millhauser]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING]"} ], "id": "1221", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19381258", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19381258"} , { "elementOf": "DOI", "accession": "10.1371\/JOURNAL.PPAT.1000390"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 119-226,  DOMAIN,  SUBUNIT]", "conames": [{ "name": "PMID: 11524679", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11524679", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature structural biology"} , { "attrname": "Chemical", "value": "[Prions,  Disulfides]"} , { "attrname": "YEAR", "value": "2001"} , { "attrname": "AbstractHeader", "value": "Crystal structure of the human prion protein reveals a mechanism for oligomerization."} , { "attrname": "Abstract", "value": "The pathogenesis of transmissible encephalopathies is associated with the conversion of the cellular prion protein,  PrP(C),  into a conformationally altered oligomeric form,  PrP(Sc). Here we report the crystal structure of the human prion protein in dimer form at 2 A resolution. The dimer results from the three-dimensional swapping of the C-terminal helix 3 and rearrangement of the disulfide bond. An interchain two-stranded antiparallel beta-sheet is formed at the dimer interface by residues that are located in helix 2 in the monomeric NMR structures. Familial prion disease mutations map to the regions directly involved in helix swapping. This crystal structure suggests that oligomerization through 3D domain-swapping may constitute an important step on the pathway of the PrP(C) --> PrP(Sc) conversion. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Humans,  Prions,  Disulfides,  Models,  Molecular,  Protein Binding,  Crystallography,  X-Ray,  Dimerization]"} , { "attrname": "AUTHORS", "value": "[K J Knaus,  M Morillas,  W Swietnicki,  M Malone,  W K Surewicz,  V C Yee]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 119-226,  DOMAIN,  SUBUNIT]"} ], "id": "1222", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11524679", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "11524679"} , { "elementOf": "DOI", "accession": "10.1038\/NSB0901-770"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 119-231 IN COMPLEX WITH FAB FRAGMENT OF MONOCLONAL ANTIBODY ICSM 18,  SUBUNIT]", "conames": [{ "name": "PMID: 19204296", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19204296", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Prions,  Antibodies,  Monoclonal,  Immunoglobulin Fab Fragments]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Crystal structure of human prion protein bound to a therapeutic antibody."} , { "attrname": "Abstract", "value": "Prion infection is characterized by the conversion of host cellular prion protein (PrP(C)) into disease-related conformers (PrP(Sc)) and can be arrested in vivo by passive immunization with anti-PrP monoclonal antibodies. Here,  we show that the ability of an antibody to cure prion-infected cells correlates with its binding affinity for PrP(C) rather than PrP(Sc). We have visualized this interaction at the molecular level by determining the crystal structure of human PrP bound to the Fab fragment of monoclonal antibody ICSM 18,  which has the highest affinity for PrP(C) and the highest therapeutic potency in vitro and in vivo. In this crystal structure,  human PrP is observed in its native PrP(C) conformation. Interactions between neighboring PrP molecules in the crystal structure are mediated by close homotypic contacts between residues at position 129 that lead to the formation of a 4-strand intermolecular beta-sheet. The importance of this residue in mediating protein-protein contact could explain the genetic susceptibility and prion strain selection determined by polymorphic residue 129 in human prion disease,  one of the strongest common susceptibility polymorphisms known in any human disease. "} , { "attrname": "MeSH", "value": "[Flow Cytometry,  Prions,  Models,  Molecular,  Crystallography,  X-Ray,  Protein Conformation,  Antibodies,  Monoclonal,  Immunoglobulin Fab Fragments]"} , { "attrname": "AUTHORS", "value": "[S V Antonyuk,  C R Trevitt,  R W Strange,  G S Jackson,  D Sangar,  M Batchelor,  S Cooper,  C Fraser,  S Jones,  T Georgiou,  A Khalili-Shirazi,  A R Clarke,  S S Hasnain,  J Collinge]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 119-231 IN COMPLEX WITH FAB FRAGMENT OF MONOCLONAL ANTIBODY ICSM 18,  SUBUNIT]"} ], "id": "1223", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19204296", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0809170106"} , { "elementOf": "NLM", "accession": "19204296"} ]} , { "annotation": "[COPPER-BINDING,  CIRCULAR DICHROISM,  DOMAIN,  FUNCTION,  SUBUNIT]", "conames": [{ "name": "PMID: 20564047", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20564047", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of cellular biochemistry"} , { "attrname": "Chemical", "value": "[Acids,  Prions,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Copper (II) promotes the formation of soluble neurotoxic PrP oligomers in acidic environment."} , { "attrname": "Abstract", "value": "Prion diseases are classically considered to be \"amyloid diseases\" caused by the deposition of amyloid fibrils in the brain. Recent studies identified soluble oligomers of PrP (prion protein) in damaged neuronal tissue. However,  the details of PrP oligomerization are still unclear. In this study,  we demonstrate that Cu(2+) plays a vital role in the formation of soluble PrP oligomers. A Cu(2+)-triggered structural conversion of PrP (90-231) to a ?-sheet isoform in pH 5.0 buffer was revealed by circular dichroism spectra and fluorescence measurement. Soluble oligomers were isolated by size exclusion chromatography from experimental solutions,  allowing atomic force microscopy to reveal their morphology. 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and flow cytometry assays demonstrated that oligomeric PrP induced significant damage in and apoptosis of neuroblastoma SK-N-SH cells. These results indicate that in an acidic environment,  Cu(2+) promotes the formation of neurotoxic soluble PrP oligomers. "} , { "attrname": "MeSH", "value": "[Acids,  Humans,  Prions,  Protein Multimerization,  Solubility,  Cell Line,  Tumor,  Protein Conformation,  Neuroblastoma,  Copper,  Apoptosis,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[Di Wu,  Wentao Zhang,  Qingying Luo,  Kan Luo,  Liqin Huang,  Wenxi Wang,  Tao Huang,  Rui Chen,  Yi Lin,  Daiwen Pang,  Gengfu Xiao]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING,  CIRCULAR DICHROISM,  DOMAIN,  FUNCTION,  SUBUNIT]"} ], "id": "1224", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20564047", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20564047"} , { "elementOf": "DOI", "accession": "10.1002\/JCB.22743"} ]} , { "annotation": "[ALTERNATIVE INITIATION (ISOFORM 2),  SUBCELLULAR LOCATION,  MUTAGENESIS OF MET-1 AND MET-8];", "conames": [{ "name": "PMID: 19059915", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19059915", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[AE28F7PNPL Methionine,  Prions,  Protein Isoforms,  DNA Primers]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation."} , { "attrname": "Abstract", "value": "The cellular prion protein PrP(C) is synthesized as a family of four distinct forms. Of these,  (Cyt)PrP is a minor member that segregates outside of the secretory route and can generate cytotoxic forms. Using signal sequence mutants,  we found that (Cyt)PrP is translated from a downstream AUG (coding for Met-8 in human PrP or Met-15 in Syrian hamster PrP). Shortening of the signal sequence dictated the spillage of this isoform into the cytosol,  from where it accessed the nucleus or formed insoluble cytosolic aggregates if the proteasome is inhibited. The PrP isoform isolated from the nuclear fractions of cell and brain homogenates was partially SUMO-1-conjugated. Expression of HaPrP(M15) in cells caused an antiproliferative phenotype due to a cell cycle arrest at the G(0)\/G(1) phase. The identification of this PrP isoform and its properties provides novel insight into PrP(C) physiological and pathological functions. "} , { "attrname": "MeSH", "value": "[Cricetinae,  Immunoprecipitation,  Humans,  Methionine,  DNA Primers,  Blotting,  Western,  Animals,  Base Sequence,  Prions,  Protein Isoforms,  Mesocricetus,  Cell Nucleus,  Cytoplasm]"} , { "attrname": "AUTHORS", "value": "[Mara E Juanes,  Gema Elvira,  Aranzazu Garca-Grande,  Miguel Calero,  Mara Gasset]"} , { "attrname": "PUB_TYPE", "value": "[ALTERNATIVE INITIATION (ISOFORM 2),  SUBCELLULAR LOCATION,  MUTAGENESIS OF MET-1 AND MET-8]"} ], "id": "1225", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19059915", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1074\/JBC.M804051200"} , { "elementOf": "NLM", "accession": "19059915"} ]} , { "annotation": "[VARIANT CJD ILE-210]", "conames": [{ "name": "PMID: 7902693", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7902693", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions,  Nerve Tissue Proteins]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease."} , { "attrname": "Abstract", "value": "Complete sequencing of the prion protein open reading frame of a 68-year-old woman affected by a familial form of Creutzfeldt-Jakob disease (CJD) revealed a new mutation at codon 210 resulting in the substitution of isoleucine for valine. Moreover,  a new 24-bp deletion encompassing codons 54 to 61 or 62 to 69 was found in the other allele. Four of the 17 asymptomatic relatives tested carry the 210 mutation. Two of them were 81 and 82 years old. Four of 22 patients with CJD whose recorded familial history was negative for demented illnesses,  but none of 103 healthy control subjects,  tested positive for the 210 mutation. These data suggest that the 210 mutation is associated with CJD,  but that environmental factors or incomplete penetrance may contribute to the development of the disease. This finding also suggests that in Italy,  familial CJD is more common than previously reported. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Open Reading Frames,  Molecular Sequence Data,  Male,  Nerve Tissue Proteins,  Point Mutation,  PrPSc Proteins,  Pedigree,  Base Sequence,  Prions,  Aged,  80 and over,  Female,  Aged,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[M Pocchiari,  M Salvatore,  F Cutruzzol,  M Genuardi,  C T Allocatelli,  C Masullo,  G Macchi,  G Alem,  S Galgani,  Y G Xi]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD ILE-210]"} ], "id": "1226", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7902693", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7902693"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.410340608"} ]} , { "annotation": "[VARIANTS CJD LYS-196; ILE-203 AND GLN-211]", "conames": [{ "name": "PMID: 10790216", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10790216", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human mutation"} , { "attrname": "Chemical", "value": "[Prion Proteins,  PRNP protein,  human,  3KX376GY7L Glutamic Acid,  Prions,  Protein Precursors,  Amyloid,  HG18B9YRS7 Valine,  04Y7590D77 Isoleucine,  0RH81L854J Glutamine,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Identification of three novel mutations (E196K,  V203I,  E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype."} , { "attrname": "Abstract", "value": "Inherited prion diseases are characterized by mutations in the PRNP gene encoding the prion protein (PrP). As the other sporadic or infectious prion disease forms,  they are almost all characterized by the accumulation in the brain of an abnormal misfolded form of the patient's PrP. Brain extracts can often transmit the disease once inoculated in a recipient animal. Inherited prion diseases with Creutzfeldt-Jakob disease (CJD) phenotype are autosomal forms,  although sporadic cases have been reported. We report three novel mutations of the PRNP gene in unrelated patients with clinical and histopathologic features of CJD. The three mutations were missense:  c635G>A (E196K),  c656G>A (V203I) and c680G>C (E211Q). Familial history of neurologic disorders was evidenced for patients carrying the E196K and E211Q mutations. E196K would be predicted to have more severe effects on protein stability than V203I and E211Q. These mutations expand the spectrum of mutations in PRNP and reduce the proportion of CJD patients in whom genetic alterations have not been found. "} , { "attrname": "MeSH", "value": "[Prion Proteins,  Humans,  Middle Aged,  Male,  Mutation,  Missense,  Glutamic Acid,  Phenotype,  Lysine,  Valine,  Prions,  Protein Precursors,  Female,  Aged,  Amyloid,  Creutzfeldt-Jakob Syndrome,  Amino Acid Substitution,  Glutamine,  Isoleucine]"} , { "attrname": "AUTHORS", "value": "[K Peoc'h,  P Manivet,  P Beaudry,  F Attane,  G Besson,  D Hannequin,  N Delasnerie-Lauprtre,  J L Laplanche]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS CJD LYS-196; ILE-203 AND GLN-211]"} ], "id": "1227", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10790216", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/(SICI)1098-1004(200005)15: 5<482: : AID-HUMU16>3.0.CO;2-1"} , { "elementOf": "NLM", "accession": "10790216"} ]} , { "annotation": "[VARIANT GSD LEU-102]", "conames": [{ "name": "PMID: 2564168", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2564168", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Prions,  Viral Proteins,  105268-27-7 PrP 27-30 Protein]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "Linkage of a prion protein missense variant to Gerstmann-Strussler syndrome."} , { "attrname": "Abstract", "value": "Gerstmann-Strussler syndrome is a rare familial neurodegenerative condition that is vertically transmitted,  in an apparently autosomal dominant way. It can also be horizontally transmitted to non-human primates and rodents through intracerebral inoculation of brain homogenates from patients with the disease. The exact incidence of the syndrome is unknown but is estimated to be between one and ten per hundred million. Patients initially suffer from ataxia or dementia and deteriorate until they die,  in one to ten years. Protease-resistant prion protein (PrP) and PrP-immunoreactive amyloid plaques with characteristic morphology accumulate in the brains of these patients. Current diagnostic criteria for Gerstmann-Strussler syndrome incorporate clinical and neuropathological features,  as animal transmission studies can be unreliable. PrP is implicated in the pathogenesis and transmission of the condition and in scrapie,  an equivalent animal disease. It was discovered by enriching scrapie-infected hamster brain fractions for infectivity. Because there is compelling evidence that the scrapie isoform of PrP is a necessary component of the infectious particle,  it seemed possible that the PrP gene on the short arm of human chromosome 20 in Gerstmann-Strussler syndrome might be abnormal. We show here that PrP codon 102 is linked to the putative gene for the syndrome in two pedigrees,  providing the best evidence to date that this familial condition is inherited despite also being infectious,  and that substitution of leucine for proline at PrP codon 102 may lead to the development of Gerstmann-Strussler syndrome. "} , { "attrname": "MeSH", "value": "[Pedigree,  PrP 27-30 Protein,  Humans,  Prions,  Female,  Male,  Slow Virus Diseases,  Chromosome Mapping,  Viral Proteins,  Mutation,  Chromosomes,  Human,  Pair 20,  Restriction Mapping]"} , { "attrname": "AUTHORS", "value": "[K Hsiao,  H F Baker,  T J Crow,  M Poulter,  F Owen,  J D Terwilliger,  D Westaway,  J Ott,  S B Prusiner]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD LEU-102]"} ], "id": "1228", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2564168", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2564168"} , { "elementOf": "DOI", "accession": "10.1038\/338342A0"} ]} , { "annotation": "[VARIANTS LEU-102; VAL-117 AND VAL-129]", "conames": [{ "name": "PMID: 2783132", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2783132", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[9DLQ4CIU6V Proline,  GMW67QNF9C Leucine,  Prions,  9007-49-2 DNA,  Viral Proteins]"} , { "attrname": "YEAR", "value": "1989"} , { "attrname": "AbstractHeader", "value": "Pro----leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Strussler syndrome."} , { "attrname": "Abstract", "value": "The host-encoded prion protein (PrP) is a component of transmissible amyloid deposited in the brains affected by Gerstmann-Strussler syndrome (GSS). Recently GSS in two unrelated Caucasian families has been reported to be linked to an amino acid change in PrP codon 102,  proline to leucine (Leu102). However,  it has not been clear whether the change is commonly found to GSS regardless of ethnic origin. We report here that Leu102 is also found in all the Japanese GSS patients tested. Interestingly,  one French GSS patient was found to have another change,  alanine to valine in codon 117 (Val117),  instead of Leu102. Our results indicate that Leu102 is closely related to GSS irrespective of ethnic origin,  but not the sole mutation related to GSS. Val117 may also be related to GSS. "} , { "attrname": "MeSH", "value": "[Nucleic Acid Hybridization,  Humans,  Proline,  Slow Virus Diseases,  Viral Proteins,  Leucine,  Polymorphism,  Genetic,  Ethnic Groups,  DNA,  Prions,  Alleles,  Genes,  Viral,  Mutation]"} , { "attrname": "AUTHORS", "value": "[K Doh-ura,  J Tateishi,  H Sasaki,  T Kitamoto,  Y Sakaki]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS LEU-102; VAL-117 AND VAL-129]"} ], "id": "1229", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2783132", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0006-291X(89)92317-6"} , { "elementOf": "NLM", "accession": "2783132"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA]]", "conames": [{ "name": "PMID: 3755672", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3755672", "attributes": [{ "attrname": "JOURNAL_REF", "value": "DNA (Mary Ann Liebert,  Inc.)"} , { "attrname": "Chemical", "value": "[Prions,  9007-49-2 DNA,  Nerve Tissue Proteins,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1986"} , { "attrname": "AbstractHeader", "value": "Molecular cloning of a human prion protein cDNA."} , { "attrname": "Abstract", "value": "Creutzfeldt-Jakob disease (CJD) of humans and scrapie of animals are degenerative,  transmissible neurologic diseases caused by prions. The only known macromolecules within prions are prion proteins (PrP). The cDNA encoding the hamster prion protein (PrP 27-30) has been cloned and sequenced (Oesch et al.,  1985). Using that hamster PrP cDNA,  we screened a human retina cDNA library and sequenced the cDNA clone with the longest hybridizing insert. This insert was found to contain a long open reading frame (ORF) encoding the human prion protein. Northern transfer analysis showed that a related poly(A)+RNA measuring approximately 2.5 kb is expressed in a variety of human neuroectodermal cell lines. Human PrP differed from hamster PrP at 27 of 253 amino acids and at 98 of 759 ORF nucleotides. Conservation of PrP amino acid sequence between hamster and human is nearly 90%,  reflecting similar structural features and shared antigenicity of the two proteins (Bockman et al.,  1985). The human PrP sequence contained a presumptive amino-terminal signal peptide of 22 amino acids,  two hydrophobic segments of sufficient length to span membranes,  and two possible sites for N-glycosylation. The conservation between the hamster and human prion proteins suggests that they may have an important role in cellular metabolism and may explain the similarities between scrapie and CJD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cricetinae,  Animals,  DNA,  Humans,  Prions,  Cloning,  Molecular,  Melanoma,  Nerve Tissue Proteins,  Retinoblastoma,  RNA,  Messenger,  Sequence Homology,  Nucleic Acid]"} , { "attrname": "AUTHORS", "value": "[H A Kretzschmar,  L E Stowring,  D Westaway,  W H Stubblebine,  S B Prusiner,  S J Dearmond]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA]]"} ], "id": "1230", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3755672", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "3755672"} , { "elementOf": "DOI", "accession": "10.1089\/DNA.1986.5.315"} ]} , { "annotation": "[STRUCTURE BY NMR OF 23-230]", "conames": [{ "name": "PMID: 10618385", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10618385", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Prions,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "NMR solution structure of the human prion protein."} , { "attrname": "Abstract", "value": "The NMR structures of the recombinant human prion protein,  hPrP(23-230),  and two C-terminal fragments,  hPrP(90-230) and hPrP(121-230),  include a globular domain extending from residues 125-228,  for which a detailed structure was obtained,  and an N-terminal flexibly disordered \"tail.\" The globular domain contains three alpha-helices comprising the residues 144-154,  173-194,  and 200-228 and a short anti-parallel beta-sheet comprising the residues 128-131 and 161-164. Within the globular domain,  three polypeptide segments show increased structural disorder:  i.e.,  a loop of residues 167-171,  the residues 187-194 at the end of helix 2,  and the residues 219-228 in the C-terminal part of helix 3. The local conformational state of the polypeptide segments 187-193 in helix 2 and 219-226 in helix 3 is measurably influenced by the length of the N-terminal tail,  with the helical states being most highly populated in hPrP(23-230). When compared with the previously reported structures of the murine and Syrian hamster prion proteins,  the length of helix 3 coincides more closely with that in the Syrian hamster protein whereas the disordered loop 167-171 is shared with murine PrP. These species variations of local structure are in a surface area of the cellular form of PrP that has previously been implicated in intermolecular interactions related both to the species barrier for infectious transmission of prion disease and to immune reactions. "} , { "attrname": "MeSH", "value": "[Cricetinae,  Peptide Fragments,  Animals,  Magnetic Resonance Spectroscopy,  Protein Structure,  Secondary,  Humans,  Prions,  Cloning,  Molecular,  Models,  Molecular,  Molecular Sequence Data,  Mice,  Recombinant Proteins]"} , { "attrname": "AUTHORS", "value": "[R Zahn,  A Liu,  T Lhrs,  R Riek,  C von Schroetter,  F Lpez Garca,  M Billeter,  L Calzolai,  G Wider,  K Wthrich]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 23-230]"} ], "id": "1231", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10618385", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.97.1.145"} , { "elementOf": "NLM", "accession": "10618385"} ]} , { "annotation": "[VARIANT SENF ALA-183]", "conames": [{ "name": "PMID: 9266722", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9266722", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[Prions,  DNA Primers]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Familial spongiform encephalopathy associated with a novel prion protein gene mutation."} , { "attrname": "Abstract", "value": "Human prion diseases include Creutzfeldt-Jakob disease,  Gerstmann-Strussler-Scheinker disease,  fatal familial insomnia,  and kuru. Each of these diseases has a specific clinical presentation while spongiform encephalopathy,  neuronal loss,  and gliosis are their neuropathological hallmarks. We studied a Brazilian family with an autosomal dominant form of dementia. Nine members of the family were affected by a dementia with frontotemporal clinical features,  with a mean age at onset of 44.8 +\/- 3.8 years and a mean duration of symptoms of 4.2 +\/- 2.4 years. Neuropathological examination of 3 patients showed severe spongiform change and neuronal loss in the deep cortical layers and in the putamen,  but minimal gliosis in the most severely affected areas. The putamen and cerebellum,  but not other areas of the affected brain,  displayed prion protein immunoreactivity. A novel prion protein gene mutation causing a nonconservative substitution at codon 183 was identified in 2 neuropathologically confirmed affected individuals (mother and son). The mutation was transmitted in a mendelian fashion to 12 members of the family. Therefore,  we identified a novel prion disease variant characterized by an early onset and long duration of the symptoms,  severe spongiform change with minimal gliosis,  associated with a prion protein gene mutation at codon 183. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Exons,  Humans,  Middle Aged,  Male,  DNA Primers,  Prion Diseases,  Genes,  Dominant,  Pedigree,  Base Sequence,  Prions,  Age of Onset,  Polymerase Chain Reaction,  Brazil,  Gerstmann-Straussler-Scheinker Disease,  Adult,  Female,  Mutation]"} , { "attrname": "AUTHORS", "value": "[R Nitrini,  S Rosemberg,  M R Passos-Bueno,  L S da Silva,  P Iughetti,  M Papadopoulos,  P M Carrilho,  P Caramelli,  S Albrecht,  M Zatz,  A LeBlanc]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT SENF ALA-183]"} ], "id": "1232", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9266722", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9266722"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.410420203"} ]} , { "annotation": "[COPPER-BINDING,  ZINC-BINDING]", "conames": [{ "name": "PMID: 18034490", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18034490", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of the American Chemical Society"} , { "attrname": "Chemical", "value": "[copper-binding protein,  Prions,  J41CSQ7QDS Zinc,  789U1901C5 Copper,  Carrier Proteins]"} , { "attrname": "YEAR", "value": "2007"} , { "attrname": "AbstractHeader", "value": "The prion protein is a combined zinc and copper binding protein:  Zn2+ alters the distribution of Cu2+ coordination modes."} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Electron Spin Resonance Spectroscopy,  Prions,  Models,  Molecular,  Protein Binding,  Copper,  Zinc,  Carrier Proteins]"} , { "attrname": "AUTHORS", "value": "[Eric D Walter,  Daniel J Stevens,  Micah P Visconte,  Glenn L Millhauser]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING,  ZINC-BINDING]"} ], "id": "1233", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18034490", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/JA077146J"} , { "elementOf": "NLM", "accession": "18034490"} ]} , { "annotation": "[STRUCTURE BY NMR OF 118-221]", "conames": [{ "name": "PMID: 10900000", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10900000", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Prions,  Protein Isoforms]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "NMR structures of three single-residue variants of the human prion protein."} , { "attrname": "Abstract", "value": "The NMR structures of three single-amino acid variants of the C-terminal domain of the human prion protein,  hPrP(121-230),  are presented. In hPrP(M166V) and hPrP(R220K) the substitution is with the corresponding residue in murine PrP,  and in hPrP(S170N) it is with the corresponding Syrian hamster residue. All three substitutions are in the surface region of the structure of the cellular form of PrP (PrP(C)) that is formed by the C-terminal part of helix 3,  with residues 218-230,  and a loop of residues 166-172. This molecular region shows high species variability and has been implicated in specific interactions with a so far not further characterized \"protein X, \" and it is related to the species barrier for transmission of prion diseases. As expected,  the three variant hPrP(121-230) structures have the same global architecture as the previously determined wild-type bovine,  human,  murine,  and Syrian hamster prion proteins,  but with the present study two localized \"conformational markers\" could be related with single amino acid exchanges. These are the length and quality of definition of helix 3,  and the NMR-observability of the residues in the loop 166-172. Poor definition of the C-terminal part of helix 3 is characteristic for murine PrP and has now been observed also for hPrP(R220K),  and NMR observation of the complete loop 166-172 has so far been unique for Syrian hamster PrP and is now also documented for hPrP(S170N). "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cricetinae,  Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Molecular Sequence Data,  Genetic Variation,  Animals,  Cattle,  Prions,  Protein Isoforms,  Nuclear Magnetic Resonance,  Biomolecular,  Sheep,  Mice]"} , { "attrname": "AUTHORS", "value": "[L Calzolai,  D A Lysek,  P Guntert,  C von Schroetter,  R Riek,  R Zahn,  K Wthrich]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 118-221]"} ], "id": "1234", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10900000", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10900000"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.97.15.8340"} ]} , { "annotation": "[VARIANT CJD LYS-200]", "conames": [{ "name": "PMID: 1975028", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1975028", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[Codon,  Nerve Tissue Proteins,  105268-27-7 PrP 27-30 Protein,  DNA,  Viral,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia."} , { "attrname": "MeSH", "value": "[Codon,  PrP 27-30 Protein,  Humans,  Female,  Aged,  Czechoslovakia,  Nerve Tissue Proteins,  Mutation,  Creutzfeldt-Jakob Syndrome,  Space-Time Clustering,  DNA,  Viral,  RNA,  Messenger]"} , { "attrname": "AUTHORS", "value": "[L G Goldfarb,  E Mitrov,  P Brown,  B K Toh,  D C Gajdusek]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD LYS-200]"} ], "id": "1235", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1975028", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1975028"} , { "elementOf": "DOI", "accession": "10.1016\/0140-6736(90)92073-Q"} ]} , { "annotation": "[STRUCTURE BY NMR OF 90-231 OF MUTANT LYS-200]", "conames": [{ "name": "PMID: 10954699", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10954699", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Solutions,  Prions]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Solution structure of the E200K variant of human prion protein. Implications for the mechanism of pathogenesis in familial prion diseases."} , { "attrname": "Abstract", "value": "Prion propagation in transmissible spongiform encephalopathies involves the conversion of cellular prion protein,  PrP(C),  into a pathogenic conformer,  PrP(Sc). Hereditary forms of the disease are linked to specific mutations in the gene coding for the prion protein. To gain insight into the molecular basis of these disorders,  the solution structure of the familial Creutzfeldt-Jakob disease-related E200K variant of human prion protein was determined by multi-dimensional nuclear magnetic resonance spectroscopy. Remarkably,  apart from minor differences in flexible regions,  the backbone tertiary structure of the E200K variant is nearly identical to that reported for the wild-type human prion protein. The only major consequence of the mutation is the perturbation of surface electrostatic potential. The present structural data strongly suggest that protein surface defects leading to abnormalities in the interaction of prion protein with auxiliary proteins\/chaperones or cellular membranes should be considered key determinants of a spontaneous PrP(C) --> PrP(Sc) conversion in the E200K form of hereditary prion disease. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Secondary,  Solutions,  Base Sequence,  Humans,  Prions,  Molecular Sequence Data,  Mutation,  Creutzfeldt-Jakob Syndrome,  Protein Folding]"} , { "attrname": "AUTHORS", "value": "[Y Zhang,  W Swietnicki,  M G Zagorski,  W K Surewicz,  F D Snnichsen]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 90-231 OF MUTANT LYS-200]"} ], "id": "1236", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10954699", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10954699"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.C000483200"} ]} , { "annotation": "[SUBUNIT,  DOMAIN]", "conames": [{ "name": "PMID: 20375014", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20375014", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[Prions,  Amyloid]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3."} , { "attrname": "Abstract", "value": "Aggregation and misfolding of the prion protein (PrP) are thought to be the cause of a family of lethal neurodegenerative diseases affecting humans and other animals. Although the structures of PrP from several species have been solved,  still little is known about the mechanisms that lead to the misfolded species. Here,  we show that the region of PrP comprising the hairpin formed by the helices H2 and H3 is a stable independently folded unit able to retain its secondary and tertiary structure also in the absence of the rest of the sequence. We also prove that the isolated H2H3 is highly fibrillogenic and forms amyloid fibers morphologically similar to those obtained for the full-length protein. Fibrillization of H2H3 but not of full-length PrP is concomitant with formation of aggregates. These observations suggest a \"banana-peeling\" mechanism for misfolding of PrP in which H2H3 is the aggregation seed that needs to be first exposed to promote conversion from a helical to a beta-rich structure. "} , { "attrname": "MeSH", "value": "[Neurodegenerative Diseases,  Magnetic Resonance Spectroscopy,  Escherichia coli,  Humans,  Microscopy,  Electron,  Protein Folding,  Genetic Variation,  Thermodynamics,  Animals,  Prions,  Protein Denaturation,  Protein Conformation,  Sheep,  Amyloid,  Kinetics,  Chromatography,  Gel,  Circular Dichroism]"} , { "attrname": "AUTHORS", "value": "[Miquel Adrover,  Kris Pauwels,  Stephanie Prigent,  Cesira de Chiara,  Zhou Xu,  Cline Chapuis,  Annalisa Pastore,  Human Rezaei]"} , { "attrname": "PUB_TYPE", "value": "[SUBUNIT,  DOMAIN]"} ], "id": "1237", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20375014", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20375014"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M110.111815"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT GSD ARG-187]", "conames": [{ "name": "PMID: 10581485", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10581485", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of medical genetics"} , { "attrname": "Chemical", "value": "[Prion Proteins,  PRNP protein,  human,  Prions,  Protein Precursors,  Amyloid,  EC 3.1.21.4 Deoxyribonucleases,  Type II Site-Specific,  EC 3.1.21.4 GCGC-specific type II deoxyribonucleases]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Novel PRNP sequence variant associated with familial encephalopathy."} , { "attrname": "Abstract", "value": "Human transmissible spongiform encephalopathies (TSEs) are a group of chronic progressive neurodegenerative disorders that may be hereditary,  infectious,  or sporadic. Hereditary TSEs are associated with mutations in the PRNP gene on chromosome 20p12-pter. We report on a family in which seven patients developed limb and truncal ataxia,  dysarthria,  myoclonic jerks,  and cognitive decline. The age of onset in the 30s,  40s,  or 50s,  prolonged disease duration,  cerebellar atrophy on imaging,  and the presence of synchronic periodic discharges on electroencephalogram suggested a familial encephalopathy resembling Gerstmann-Strussler-Scheinker disease. A novel H187R mutation has been identified in affected,  but not in unaffected,  family members or unrelated controls suggesting a pathogenic role for this mutation. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88: 653-656,  1999. Published 1999 Wiley-Liss,  Inc. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Prion Proteins,  United States,  Humans,  Middle Aged,  England,  Molecular Sequence Data,  Male,  Genetic Variation,  Genes,  Dominant,  DNA Mutational Analysis,  Pedigree,  Base Sequence,  Prions,  Age of Onset,  Protein Precursors,  Gerstmann-Straussler-Scheinker Disease,  Adult,  Female,  Amyloid,  Mutation,  Deoxyribonucleases,  Type II Site-Specific,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[L Cervenkov,  C Buetefisch,  H S Lee,  I Taller,  G Stone,  C J Gibbs,  P Brown,  M Hallett,  L G Goldfarb]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT GSD ARG-187]"} ], "id": "1238", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10581485", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10581485"} , { "elementOf": "DOI", "accession": "10.1002\/(SICI)1096-8628(19991215)88: 6<653: : AID-AJMG14>3.0.CO;2-E"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 8-253]", "conames": [{ "name": "PMID: 3014653", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "3014653", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Prions,  9007-49-2 DNA,  Viral Proteins,  EC 3.1.21.- DNA Restriction Enzymes]"} , { "attrname": "YEAR", "value": "1986"} , { "attrname": "AbstractHeader", "value": "Human prion protein cDNA:  molecular cloning,  chromosomal mapping,  and biological implications."} , { "attrname": "Abstract", "value": "A human complementary DNA whose protein product is considered to be the major component of scrapie-associated fibrils in Creutzfeldt-Jakob disease,  kuru,  and Gerstmann-Straussler syndrome has been identified and characterized. The extensive homology of this gene sequence to the hamster PrP 27- to 30-kilodalton prion protein complementary DNA clone,  and its existence as a single copy in the human genome,  leads to the conclusion that this is the human prion gene. This human prion gene has been mapped to human chromosome 20,  negating a direct link between the prion protein and Down's syndrome or the amyloid of Alzheimer's disease. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cricetinae,  Humans,  Chromosome Mapping,  Viral Proteins,  Chromosomes,  Human,  21-22 and Y,  Animals,  DNA Restriction Enzymes,  Base Sequence,  DNA,  Prions,  Cloning,  Molecular,  Chromosomes,  Human,  19-20,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[Y C Liao,  R V Lebo,  G A Clawson,  E A Smuckler]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 8-253]"} ], "id": "1239", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 3014653", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "3014653"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.3014653"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]", "conames": [{ "name": "PMID: 9799790", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9799790", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Genome research"} , { "attrname": "Chemical", "value": "[Prions,  Viral Structural Proteins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Complete genomic sequence and analysis of the prion protein gene region from three mammalian species."} , { "attrname": "Abstract", "value": "The prion protein (PrP),  first identified in scrapie-infected rodents,  is encoded by a single exon of a single-copy chromosomal gene. In addition to the protein-coding exon,  PrP genes in mammals contain one or two 5'-noncoding exons. To learn more about the genomic organization of regions surrounding the PrP exons,  we sequenced 10(5) bp of DNA from clones containing human,  sheep,  and mouse PrP genes isolated in cosmids or lambda phage. Our findings are as follows:  (1) Although the human PrP transcript does not include the untranslated exon 2 found in its mouse and sheep counterparts,  the large intron of the human PrP gene contains an exon 2-like sequence flanked by consensus splice acceptor and donor sites. (2) The mouse Prnpa but not the Prnpb allele found in 44 inbred lines contains a 6593 nucleotide retroviral genome inserted into the anticoding strand of intron 2. This intracisternal A-particle element is flanked by duplications of an AAGGCT nucleotide motif. (3) We found that the PrP gene regions contain from 40% to 57% genome-wide repetitive elements that independently increased the size of the locus in all three species by numerous mutations. The unusually long sheep PrP 3'-untranslated region contains a \"fossil\" 1.2-kb mariner transposable element. (4) We identified sequences in noncoding DNA that are conserved between the three species and may represent biologically functional sites. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Molecular Sequence Data,  Retroviridae,  Mice,  Inbred Strains,  Sequence Analysis,  DNA,  Viral Structural Proteins,  Short Interspersed Nucleotide Elements,  Sequence Alignment,  Animals,  Base Composition,  Long Interspersed Nucleotide Elements,  Base Sequence,  Prions,  Genes,  Viral,  CpG Islands,  Sheep,  Mice]"} , { "attrname": "AUTHORS", "value": "[I Y Lee,  D Westaway,  A F Smit,  K Wang,  J Seto,  L Chen,  C Acharya,  M Ankener,  D Baskin,  C Cooper,  H Yao,  S B Prusiner,  L E Hood]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]"} ], "id": "1240", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9799790", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9799790"} ]} , { "annotation": "[VARIANT FFI ASN-178]", "conames": [{ "name": "PMID: 1347910", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1347910", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Codon,  PrPSc Proteins,  Prions]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Fatal familial insomnia:  a second kindred with mutation of prion protein gene at codon 178."} , { "attrname": "Abstract", "value": "Fatal familial insomnia (FFI),  a condition characterized by inability to sleep,  dysautonomia,  motor disturbances,  and selective thalamic atrophy is a prion disease linked to a GAC----AAC mutation at codon 178 of the prion gene. These data were obtained from one kindred. We now report a second kindred affected by FFI and carrying the same mutation. The finding of the same disease phenotype and genotype in a second family further validates FFI as a distinct disease entity and a phenotype of the GAC----AAC mutation at codon 178 of the prion gene. "} , { "attrname": "MeSH", "value": "[Codon,  PrPSc Proteins,  Pedigree,  Base Sequence,  Humans,  Middle Aged,  Prions,  Molecular Sequence Data,  Male,  Mutation,  Sleep Initiation and Maintenance Disorders]"} , { "attrname": "AUTHORS", "value": "[R Medori,  P Montagna,  H J Tritschler,  A LeBlanc,  P Cortelli,  P Tinuper,  E Lugaresi,  P Gambetti]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT FFI ASN-178]"} ], "id": "1241", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1347910", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.42.3.669"} , { "elementOf": "NLM", "accession": "1347910"} ]} , { "annotation": "[VARIANT LYS-219,  CHARACTERIZATION OF VARIANT LYS-219,  POLYMORPHISM]", "conames": [{ "name": "PMID: 9482303", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9482303", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[Codon,  Prions]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease."} , { "attrname": "MeSH", "value": "[Codon,  Humans,  Prions,  Creutzfeldt-Jakob Syndrome,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[S Shibuya,  J Higuchi,  R W Shin,  J Tateishi,  T Kitamoto]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT LYS-219,  CHARACTERIZATION OF VARIANT LYS-219,  POLYMORPHISM]"} ], "id": "1242", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9482303", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9482303"} , { "elementOf": "DOI", "accession": "10.1016\/S0140-6736(05)78358-6"} ]} , { "annotation": "[STRUCTURE BY NMR OF 61-68,  DISULFIDE BOND,  SUBUNIT]", "conames": [{ "name": "PMID: 14623188", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14623188", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of molecular biology"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  Prions,  789U1901C5 Copper,  prion protein (23-231)]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site."} , { "attrname": "Abstract", "value": "Structural studies of mammalian prion protein at pH values between 4.5 and 5.5 established that the N-terminal 100 residue domain is flexibly disordered. Here,  we show that at pH values between 6.5 and 7.8,  i.e. the pH at the cell membrane,  the octapeptide repeats in recombinant human prion protein hPrP(23-230) encompassing the highly conserved amino acid sequence PHGGGWGQ are structured. The nuclear magnetic resonance solution structure of the octapeptide repeats at pH 6.2 reveals a new structural motif that causes a reversible pH-dependent PrP oligomerization. Within the aggregation motif the segments HGGGW and GWGQ adopt a loop conformation and a beta-turn-like structure,  respectively. Comparison with the crystal structure of HGGGW-Cu(2+) indicates that the binding of copper ions induces a conformational transition that presumably modulates PrP aggregation. The knowledge that the cellular prion protein is immobilized on the cell surface along with our results suggests a functional role of aggregation in endocytosis or homophilic cell adhesion. "} , { "attrname": "MeSH", "value": "[Peptide Fragments,  Repetitive Sequences,  Amino Acid,  Humans,  Prions,  Models,  Molecular,  Nuclear Magnetic Resonance,  Biomolecular,  Protein Conformation,  Copper,  Binding Sites,  Protein Folding,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[Ralph Zahn]"} , { "attrname": "PUB_TYPE", "value": "[STRUCTURE BY NMR OF 61-68,  DISULFIDE BOND,  SUBUNIT]"} ], "id": "1243", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14623188", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14623188"} , { "elementOf": "DOI", "accession": "10.1016\/J.JMB.2003.09.048"} ]} , { "annotation": "[VARIANT VAL-129,  CHARACTERIZATION OF VARIANT VAL-129]", "conames": [{ "name": "PMID: 12690204", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12690204", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[AE28F7PNPL Methionine,  Codon,  PrPC Proteins,  HG18B9YRS7 Valine]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics."} , { "attrname": "Abstract", "value": "Kuru is an acquired prion disease largely restricted to the Fore linguistic group of the Papua New Guinea Highlands,  which was transmitted during endocannibalistic feasts. Heterozygosity for a common polymorphism in the human prion protein gene (PRNP) confers relative resistance to prion diseases. Elderly survivors of the kuru epidemic,  who had multiple exposures at mortuary feasts,  are,  in marked contrast to younger unexposed Fore,  predominantly PRNP 129 heterozygotes. Kuru imposed strong balancing selection on the Fore,  essentially eliminating PRNP 129 homozygotes. Worldwide PRNP haplotype diversity and coding allele frequencies suggest that strong balancing selection at this locus occurred during the evolution of modern humans. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Papua New Guinea,  Humans,  Middle Aged,  Male,  Cannibalism,  Codon,  Ethnic Groups,  Disease Outbreaks,  Adult,  Female,  Child,  History,  Ancient,  Gene Frequency,  History,  20th Century,  Methionine,  Selection,  Genetic,  Immunity,  Innate,  Kuru,  Linkage Disequilibrium,  Polymorphism,  Genetic,  Homozygote,  Animals,  Valine,  PrPC Proteins,  Heterozygote,  History,  19th Century,  Mutation,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[Simon Mead,  Michael P H Stumpf,  Jerome Whitfield,  Jonathan A Beck,  Mark Poulter,  Tracy Campbell,  James B Uphill,  David Goldstein,  Michael Alpers,  Elizabeth M C Fisher,  John Collinge]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT VAL-129,  CHARACTERIZATION OF VARIANT VAL-129]"} ], "id": "1244", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12690204", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12690204"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1083320"} ]} , { "annotation": "[VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  CHARACTERIZATION OF VARIANT VAL-129,  CHARACTERIZATION OF VARIANT CJD ASN-178,  CHARACTERIZATION OF VARIANT FFI ASN-178,  POLYMORPHISM]", "conames": [{ "name": "PMID: 1439789", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1439789", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Codon,  Prions,  9007-49-2 DNA,  7006-34-0 Asparagine,  HG18B9YRS7 Valine]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Fatal familial insomnia and familial Creutzfeldt-Jakob disease:  disease phenotype determined by a DNA polymorphism."} , { "attrname": "Abstract", "value": "Fatal familial insomnia (FFI) and a subtype of familial Creutzfeldt-Jakob disease (CJD),  two clinically and pathologically distinct diseases,  are linked to the same mutation at codon 178 (Asn178) of the prion protein gene. The possibility that a second genetic component modified the phenotypic expression of the Asn178 mutation was investigated. FFI and the familial CJD subtype segregated with different genotypes determined by the Asn178 mutation and the methionine-valine polymorphism at codon 129. The Met129,  Asn178 allele segregated with FFI in all 15 affected members of five kindreds whereas the Val129,  Asn178 allele segregated with the familial CJD subtype in all 15 affected members of six kindreds. Thus,  two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism. "} , { "attrname": "MeSH", "value": "[Humans,  Middle Aged,  Genotype,  Polymorphism,  Genetic,  Phenotype,  Prion Diseases,  Codon,  Valine,  DNA,  Prions,  Asparagine,  Adult,  Mutation,  Chromosomes,  Human,  Pair 20,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[L G Goldfarb,  R B Petersen,  M Tabaton,  P Brown,  A C LeBlanc,  P Montagna,  P Cortelli,  J Julien,  C Vital,  W W Pendelbury]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  CHARACTERIZATION OF VARIANT VAL-129,  CHARACTERIZATION OF VARIANT CJD ASN-178,  CHARACTERIZATION OF VARIANT FFI ASN-178,  POLYMORPHISM]"} ], "id": "1245", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1439789", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1126\/SCIENCE.1439789"} , { "elementOf": "NLM", "accession": "1439789"} ]} , { "annotation": "[COPPER-BINDING]", "conames": [{ "name": "PMID: 16144413", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16144413", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of the American Chemical Society"} , { "attrname": "Chemical", "value": "[Organometallic Compounds,  Peptide Fragments,  Prions,  789U1901C5 Copper]"} , { "attrname": "YEAR", "value": "2005"} , { "attrname": "AbstractHeader", "value": "The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4."} , { "attrname": "Abstract", "value": "The prion protein (PrP) binds Cu2+ in its N-terminal octarepeat domain. This unusual domain is comprised of four or more tandem repeats of the fundamental sequence PHGGGWGQ. Previous work from our laboratories demonstrates that at full copper occupancy,  each HGGGW segment binds a single Cu2+. However,  several recent studies suggest that low copper occupancy favors different coordination modes,  possibly involving imidazoles from histidines in adjacent octapeptide segments. This is investigated here using a combination of X-band EPR,  S-band EPR,  and ESEEM,  along with a library of modified peptides designed to favor different coordination interactions. At pH 7.4,  three distinct coordination modes are identified. Each mode is fully characterized to reveal a series of copper-dependent octarepeat domain structures. Multiple His coordination is clearly identified at low copper stoichiometry. In addition,  EPR detected copper-copper interactions at full occupancy suggest that the octarepeat domain partially collapses,  perhaps stabilizing this specific binding mode and facilitating cooperative copper uptake. This work provides the first complete characterization of all dominant copper coordination modes at pH 7.4. "} , { "attrname": "MeSH", "value": "[Organometallic Compounds,  Protein Structure,  Tertiary,  Peptide Fragments,  Repetitive Sequences,  Amino Acid,  Prions,  Protein Conformation,  Copper,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[Madhuri Chattopadhyay,  Eric D Walter,  Dustin J Newell,  Pilgrim J Jackson,  Eliah Aronoff-Spencer,  Jack Peisach,  Gary J Gerfen,  Brian Bennett,  William E Antholine,  Glenn L Millhauser]"} , { "attrname": "PUB_TYPE", "value": "[COPPER-BINDING]"} ], "id": "1246", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16144413", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16144413"} , { "elementOf": "DOI", "accession": "10.1021\/JA053254Z"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-85,  VARIANT 56-GLY--GLY-63 DEL]", "conames": [{ "name": "PMID: 7485229", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7485229", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of medical genetics"} , { "attrname": "Chemical", "value": "[Prions,  9007-49-2 DNA,  DNA Primers]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> family."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) is a progressive,  degenerative neurological disorder of the central nervous system. AD is the fourth leading cause of death in elderly persons 65 years or older in Western industrialized societies. The etiology of AD is unknown,  but clinical,  pathological,  epidemiological,  and molecular investigations suggest it is etiologically heterogeneous. Mutations in the amyloid protein are rare and segregate with the <span style=\"background-color: yellow\"><b>disease<\/b><\/span> in a few early-onset familial AD (FAD) families. Similarities between AD and the unconventional viral (UCV) <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s,  and between the amyloid and prion proteins,  implicate the human prion protein gene (PRNP) as another candidate gene. Single strand conformation polymorphism (SSCP) analysis was used to screen for mutations at this locus in 82 AD patients from 54 families (30 FAD),  vs. 39 age-matched controls. A 24-bp deletion around codon 68 that codes for one of five Gly-Pro rich octarepeats was identified in two affected sibs and one offspring of one late-onset FAD family. Two other affected sibs,  three unaffected sibs,  and three offspring from this family,  in addition to one sporadic AD patient and three age-matched controls,  were heterozygous for another octarepeat deletion located around codon 82. Two of the four affected sibs had features of PD,  including one who was autopsy-verified AD and PD. Although these deletions were found infrequently in other AD patients and controls,  they appear to be a rare polymorphism that is segregating in this FAD family. It does not appear that mutations at the PRNP locus are frequently associated with AD in this population. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Sequence Deletion,  Humans,  Molecular Sequence Data,  Male,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Case-Control Studies,  Polymorphism,  Single-Stranded Conformational,  Pedigree,  Base Sequence,  DNA,  Prions,  Female,  Microsatellite Repeats]"} , { "attrname": "AUTHORS", "value": "[R T Perry,  R C Go,  L E Harrell,  R T Acton]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-85,  VARIANT 56-GLY--GLY-63 DEL]"} ], "id": "1247", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7485229", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/AJMG.1320600104"} , { "elementOf": "NLM", "accession": "7485229"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT 56-GLY--GLY-63 DEL]", "conames": [{ "name": "PMID: 1678248", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1678248", "attributes": [{ "attrname": "JOURNAL_REF", "value": "American journal of human genetics"} , { "attrname": "Chemical", "value": "[Oligonucleotide Probes,  PrPSc Proteins,  Prions,  9007-49-2 DNA,  Viral Proteins,  EC 3.1.21.4 CAGCTG-specific type II deoxyribonucleases,  EC 3.1.21.4 Deoxyribonucleases,  Type II Site-Specific,  Viral Structural Proteins]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Genomic structure of the human prion protein gene."} , { "attrname": "Abstract", "value": "Creutzfeld-Jacob disease and Gerstmann-Strussler syndrome are rare degenerative disorders of the nervous system which have been genetically linked to the prion protein (PrP) gene. The PrP gene encodes a host glycoprotein of unknown function and is located on the short arm of chromosome 20,  a region with few known genes or anonymous markers. The complete structure of the PrP gene in man has not been determined despite considerable interest in its relationship to these unusual disorders. We have determined that the human PrP gene has the same simple genomic structure seen in the hamster gene and consists of two exons and a single intron. In contrast to the hamster PrP gene the human gene appears to have a single major transcriptional start site. The region immediately 5' of the transcriptional start site of the human PrP gene demonstrates the GC-rich features commonly seen in housekeeping genes. Curiously,  the genomic clone we have isolated contains a 24-bp deletion that removes one of five octameric peptide repeats predicted to form a B-pleated sheet in this region of the PrP. We have also identified 5' of the PrP gene an RFLP which has a high degree of heterozygosity and which should serve as a useful marker for the pter-12 region of human chromosome 20. "} , { "attrname": "MeSH", "value": "[Chromosome Deletion,  Amino Acid Sequence,  Brain,  Oligonucleotide Probes,  Gene Library,  Humans,  Molecular Sequence Data,  Viral Proteins,  Restriction Mapping,  Viral Structural Proteins,  Polymorphism,  Restriction Fragment Length,  PrPSc Proteins,  Base Sequence,  DNA,  Prions,  Genes,  Viral,  Polymerase Chain Reaction,  Transcription,  Genetic,  Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "AUTHORS", "value": "[C Puckett,  P Concannon,  C Casey,  L Hood]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA],  VARIANT 56-GLY--GLY-63 DEL]"} ], "id": "1248", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1678248", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1678248"} ]} , { "annotation": "[REVIEW ON VARIANTS,  INVOLVEMENT IN DISEASE]", "conames": [{ "name": "PMID: 8105771", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8105771", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Archives of neurology"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Genetic and infectious prion diseases."} , { "attrname": "Abstract", "value": "Enriching fractions from Syrian hamster (SHa) brain for scrapie prion infectivity led to the discovery of the prion protein (PrP). Prion diseases include scrapie of sheep and bovine spongiform encephalopathy of cattle as well as Creutzfeldt-Jakob disease (CJD) and Gerstmann-Strussler-Scheinker syndrome (GSS) of humans. Transgenic (Tg) mice expressing both SHa and mouse (Mo) PrP genes were used to probe the molecular basis of the species barrier and the mechanism of scrapie prion replication. Bioassays of brain extracts from two scrapie-infected Tg lines showed that the prion inoculum determines that prions are synthesized de novo,  even though the cells express both PrP genes. Studies with artificial prions produced from chimeric Mo\/SHaPrP transgenes underscore the concept that inoculated prion dictates which prion will be replicated. Discovery of mutations in the PrP genes of humans with GSS and familial CJD established that prion diseases are both genetic and infectious. Transgenic mice expressing high levels of MoPrP-P101L,  corresponding to the GSS point mutation (P102L) in human PrP,  spontaneously develop neurologic dysfunction,  spongiform degeneration,  and astrocytic gliosis. Inoculation of brain extracts prepared from these Tg (MoPrP-P101L) mice produced neurodegeneration in recipient animals after prolonged incubation times. These results are in accord with those of other studies and argue that prions are devoid of foreign nucleic acid. Structural investigations of cellular prion protein (PrPC) and prion protein scrapie (PrPSc) suggest that the difference may be conformational. Conditions that diminished the beta-sheet content of PrPSc were the same as those identified previously that inactivate prion infectivity. Whether prion diversity as reflected by distinct \"strains\" producing different patterns of PrPSc accumulation is due to different conformers of PrPSc remains to be established. Advances in the purification and characterization of both PrPC and PrPSc seem to have identified the central event in PrPSc synthesis and prion propagation,  ie,  the unfolding of PrPC followed by its refolding into PrPSc. These findings underscore the fundamental features of prion structure and propagation that differentiate prions from other transmissible pathogens. "} , { "attrname": "MeSH", "value": "[Goats,  Scrapie,  Humans,  Rats,  Terminology as Topic,  Kuru,  Goat Diseases,  Prion Diseases,  Animals,  PrPSc Proteins,  Cattle,  Animal Diseases,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Sheep,  Mice,  Rodent Diseases,  Encephalopathy,  Bovine Spongiform,  Iatrogenic Disease,  Mutation,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[S B Prusiner]"} , { "attrname": "PUB_TYPE", "value": "[REVIEW ON VARIANTS,  INVOLVEMENT IN DISEASE]"} ], "id": "1249", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8105771", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8105771"} , { "elementOf": "DOI", "accession": "10.1001\/ARCHNEUR.1993.00540110011002"} ]} , { "annotation": "[VARIANT VAL-127,  CHARACTERIZATION OF VARIANT VAL-127,  INVOLVEMENT IN KURU,  POLYMORPHISM]", "conames": [{ "name": "PMID: 26061765", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "26061765", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions]"} , { "attrname": "YEAR", "value": "2015"} , { "attrname": "AbstractHeader", "value": "A naturally occurring variant of the human prion protein completely prevents prion disease."} , { "attrname": "Abstract", "value": "Mammalian prions,  transmissible agents causing lethal neurodegenerative diseases,  are composed of assemblies of misfolded cellular prion protein (PrP). A novel PrP variant,  G127V,  was under positive evolutionary selection during the epidemic of kuru--an acquired prion disease epidemic of the Fore population in Papua New Guinea--and appeared to provide strong protection against disease in the heterozygous state. Here we have investigated the protective role of this variant and its interaction with the common,  worldwide M129V PrP polymorphism. V127 was seen exclusively on a M129 PRNP allele. We demonstrate that transgenic mice expressing both variant and wild-type human PrP are completely resistant to both kuru and classical Creutzfeldt-Jakob disease (CJD) prions (which are closely similar) but can be infected with variant CJD prions,  a human prion strain resulting from exposure to bovine spongiform encephalopathy prions to which the Fore were not exposed. Notably,  mice expressing only PrP V127 were completely resistant to all prion strains,  demonstrating a different molecular mechanism to M129V,  which provides its relative protection against classical CJD and kuru in the heterozygous state. Indeed,  this single amino acid substitution (G?V) at a residue invariant in vertebrate evolution is as protective as deletion of the protein. Further study in transgenic mice expressing different ratios of variant and wild-type PrP indicates that not only is PrP V127 completely refractory to prion conversion but acts as a potent dose-dependent inhibitor of wild-type prion propagation. "} , { "attrname": "MeSH", "value": "[Papua New Guinea,  Humans,  Mice,  Transgenic,  Kuru,  Polymorphism,  Genetic,  Homozygote,  Prion Diseases,  Animals,  PrPSc Proteins,  Cattle,  Prions,  Alleles,  Female,  Heterozygote,  Mice,  Encephalopathy,  Bovine Spongiform,  Creutzfeldt-Jakob Syndrome,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Emmanuel A Asante,  Michelle Smidak,  Andrew Grimshaw,  Richard Houghton,  Andrew Tomlinson,  Asif Jeelani,  Tatiana Jakubcova,  Shyma Hamdan,  Angela Richard-Londt,  Jacqueline M Linehan,  Sebastian Brandner,  Michael Alpers,  Jerome Whitfield,  Simon Mead,  Jonathan D F Wadsworth,  John Collinge]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT VAL-127,  CHARACTERIZATION OF VARIANT VAL-127,  INVOLVEMENT IN KURU,  POLYMORPHISM]"} ], "id": "1250", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 26061765", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/NATURE14510"} , { "elementOf": "NLM", "accession": "26061765"} ]} , { "annotation": "[BICISTRONIC GENE]", "conames": [{ "name": "PMID: 21478263", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21478263", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FASEB journal :  official publication of the Federation of American Societies for Experimental Biology"} , { "attrname": "Chemical", "value": "[Prion Proteins,  PRNP protein,  human,  Leupeptins,  Peptides,  Prions,  EC 3.4.25.1 Proteasome Endopeptidase Complex,  Mitochondrial Proteins,  Proteasome Inhibitors,  RF1P63GW3K benzyloxycarbonylleucyl-leucyl-leucine aldehyde,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "An overlapping reading frame in the PRNP gene encodes a novel polypeptide distinct from the prion protein."} , { "attrname": "Abstract", "value": "The prion protein gene PRNP directs the synthesis of one of the most intensively studied mammalian proteins,  the prion protein (PrP). Yet the physiological function of PrP has remained elusive and has created controversies in the literature. We found a downstream alternative translation initiation AUG codon surrounded by an optimal Kozak sequence in the +3 reading frame of PRNP. The corresponding alternative open reading frame encodes a polypeptide termed alternative prion protein (AltPrP) with a completely different amino acid sequence from PrP. We introduced a hemagglutinin (HA) tag in frame with AltPrP in PrP cDNAs from different species to test the expression of this novel polypeptide using anti-HA antibodies. AltPrP is constitutively coexpressed with human,  bovine,  sheep,  and deer PrP. AltPrP is localized at the mitochondria and is up-regulated by endoplasmic reticulum stress and proteasomal inhibition. Generation of anti-AltPrP antibodies allowed us to test for endogenous expression of AltPrP in wild-type human cells expressing PrP. By transfecting cells with siRNA against PrP mRNA,  we repressed expression of both PrP and AltPrP,  confirming endogenous expression of AltPrP from PRNP. AltPrP was also detected in human brain homogenate,  primary neurons,  and peripheral blood mononuclear cells. These results demonstrate an unexpected function for PRNP,  which,  in addition to plasma membrane-anchored PrP,  also encodes a second polypeptide termed AltPrP. "} , { "attrname": "MeSH", "value": "[Prion Proteins,  Peptides,  Humans,  Open Reading Frames,  Molecular Sequence Data,  Immunoblotting,  Endoplasmic Reticulum,  Genes,  Overlapping,  Leukocytes,  Mononuclear,  Mitochondrial Proteins,  Proteasome Endopeptidase Complex,  RNA Interference,  Base Sequence,  HEK293 Cells,  Gene Expression,  Neurons,  Cells,  Cultured,  Sequence Homology,  Nucleic Acid,  Microscopy,  Confocal,  Animals,  Leupeptins,  Prions,  Cell Line,  Tumor,  Proteasome Inhibitors,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[Benot Vanderperre,  Antanas B Staskevicius,  Guillaume Tremblay,  Marie McCoy,  Megan A O'Neill,  Neil R Cashman,  Xavier Roucou]"} , { "attrname": "PUB_TYPE", "value": "[BICISTRONIC GENE]"} ], "id": "1251", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21478263", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21478263"} , { "elementOf": "DOI", "accession": "10.1096\/FJ.10-173815"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-232,  VARIANT 56-GLY--GLY-63 DEL]", "conames": [{ "name": "PMID: 1363802", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1363802", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  PrPSc Proteins,  Prions,  Nerve Tissue Proteins]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Deletion in the prion protein gene in a demented patient."} , { "attrname": "MeSH", "value": "[Brain,  Sequence Deletion,  Oligodeoxyribonucleotides,  Humans,  Molecular Sequence Data,  Male,  Nerve Tissue Proteins,  PrPSc Proteins,  Base Sequence,  Prions,  Polymerase Chain Reaction,  Female,  Aged,  Dementia]"} , { "attrname": "AUTHORS", "value": "[J F Diedrich,  D S Knopman,  J F List,  K Olson,  W H Frey,  C R Emory,  J H Sung,  A T Haase]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 9-232,  VARIANT 56-GLY--GLY-63 DEL]"} ], "id": "1252", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1363802", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1363802"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/1.6.443"} ]} , { "annotation": "[GLYCOSYLATION AT ASN-181,  VARIANT SENF ALA-183,  CHARACTERIZATION OF VARIANT SENF ALA-183]", "conames": [{ "name": "PMID: 12214108", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12214108", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of Alzheimer's disease :  JAD"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "The Thr183Ala Mutation,  Not the Loss of the First Glycosylation Site,  Alters the Physical Properties of the Prion Protein."} , { "attrname": "Abstract", "value": "The abnormal form of the prion protein has increased resistance to protease digestion and is insoluble in non-ionic detergents. The normal prion protein is modified by the non-obligatory addition of two N-linked glycans. One pathogenic mutation,  Thr to Ala at residue 183 of the human prion protein,  blocks addition of the first glycan to the Asp residue 181. This mutation has been reported to result in intracellular retention of the mutant protein and its acquisition of pathogenic properties,  presumably due to the lack of the glycan. We report that the lack of the N-linked glycan at residue 181 is not responsible for the block in transport or the acquisition of pathogen-like properties,  rather,  the Thr to Ala mutation is itself the probable cause of the pathogenic phenotype. "} , { "attrname": "AUTHORS", "value": "[Sabina Capellari,  Syed I.A. Zaidi,  Amy C. Long,  Eunice E. Kwon,  Robert B. Petersen]"} , { "attrname": "PUB_TYPE", "value": "[GLYCOSYLATION AT ASN-181,  VARIANT SENF ALA-183,  CHARACTERIZATION OF VARIANT SENF ALA-183]"} ], "id": "1253", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12214108", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12214108"} ]} , { "annotation": "[VARIANT VAL-127,  INVOLVEMENT IN KURU]", "conames": [{ "name": "PMID: 19923577", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19923577", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The New England journal of medicine"} , { "attrname": "Chemical", "value": "[Prion Proteins,  PRNP protein,  human,  Prions]"} , { "attrname": "YEAR", "value": "2009"} , { "attrname": "AbstractHeader", "value": "A novel protective prion protein variant that colocalizes with kuru exposure."} , { "attrname": "Abstract", "value": "Kuru is a devastating epidemic prion disease that affected a highly restricted geographic area of the Papua New Guinea highlands; at its peak,  it predominantly affected adult women and children of both sexes. Its incidence has steadily declined since the cessation of its route of transmission,  endocannibalism. We performed genetic and selected clinical and genealogic assessments of more than 3000 persons from Eastern Highland populations,  including 709 who participated in cannibalistic mortuary feasts,  152 of whom subsequently died of kuru. Persons who were exposed to kuru and survived the epidemic in Papua New Guinea are predominantly heterozygotes at the known resistance factor at codon 129 of the prion protein gene (PRNP). We now report a novel PRNP variant--G127V--that was found exclusively in people who lived in the region in which kuru was prevalent and that was present in half of the otherwise susceptible women from the region of highest exposure who were homozygous for methionine at PRNP codon 129. Although this allele is common in the area with the highest incidence of kuru,  it is not found in patients with kuru and in unexposed population groups worldwide. Genealogic analysis reveals a significantly lower incidence of kuru in pedigrees that harbor the protective allele than in geographically matched control families. The 127V polymorphism is an acquired prion disease resistance factor selected during the kuru epidemic,  rather than a pathogenic mutation that could have triggered the kuru epidemic. Variants at codons 127 and 129 of PRNP demonstrate the population genetic response to an epidemic of prion disease and represent a powerful episode of recent selection in humans. "} , { "attrname": "MeSH", "value": "[Haplotypes,  Prion Proteins,  Genetic Predisposition to Disease,  Papua New Guinea,  Gene Frequency,  Humans,  Middle Aged,  Genotype,  Male,  Cannibalism,  Kuru,  Polymorphism,  Genetic,  Young Adult,  Genetic Fitness,  Disease Outbreaks,  Prions,  Adolescent,  Adult,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[Simon Mead,  Jerome Whitfield,  Mark Poulter,  Paresh Shah,  James Uphill,  Tracy Campbell,  Huda Al-Dujaily,  Holger Hummerich,  Jon Beck,  Charles A Mein,  Claudio Verzilli,  John Whittaker,  Michael P Alpers,  John Collinge]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT VAL-127,  INVOLVEMENT IN KURU]"} ], "id": "1254", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19923577", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1056\/NEJMOA0809716"} , { "elementOf": "NLM", "accession": "19923577"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 125-227 OF VARIANT VAL-129,  VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  VARIANT GSD SER-198,  SUBUNIT,  DOMAIN]", "conames": [{ "name": "PMID: 19927125", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "19927125", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The EMBO journal"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Conformational diversity in prion protein variants influences intermolecular beta-sheet formation."} , { "attrname": "Abstract", "value": "A conformational transition of normal cellular prion protein (PrP(C)) to its pathogenic form (PrP(Sc)) is believed to be a central event in the transmission of the devastating neurological diseases known as spongiform encephalopathies. The common methionine\/valine polymorphism at residue 129 in the PrP influences disease susceptibility and phenotype. We report here seven crystal structures of human PrP variants:  three of wild-type (WT) PrP containing V129,  and four of the familial variants D178N and F198S,  containing either M129 or V129. Comparison of these structures with each other and with previously published WT PrP structures containing M129 revealed that only WT PrPs were found to crystallize as domain-swapped dimers or closed monomers; the four mutant PrPs crystallized as non-swapped dimers. Three of the four mutant PrPs aligned to form intermolecular beta-sheets. Several regions of structural variability were identified,  and analysis of their conformations provides an explanation for the structural features,  which can influence the formation and conformation of intermolecular beta-sheets involving the M\/V129 polymorphic residue. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Secondary,  Humans,  Models,  Molecular,  Crystallography,  X-Ray,  Recombinant Proteins,  Genetic Variation,  Point Mutation,  Prion Diseases,  PrPSc Proteins,  Prions,  Protein Structure,  Quaternary,  Nuclear Magnetic Resonance,  Biomolecular,  Protein Conformation,  In Vitro Techniques,  Dimerization,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Seungjoo Lee,  Lizamma Antony,  Rune Hartmann,  Karen J Knaus,  Krystyna Surewicz,  Witold K Surewicz,  Vivien C Yee]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 125-227 OF VARIANT VAL-129,  VARIANT VAL-129,  VARIANT CJD ASN-178,  VARIANT FFI ASN-178,  VARIANT GSD SER-198,  SUBUNIT,  DOMAIN]"} ], "id": "1255", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 19927125", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "19927125"} , { "elementOf": "DOI", "accession": "10.1038\/EMBOJ.2009.333"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 84-91]", "conames": [{ "name": "PMID: 1683708", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1683708", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Oligodeoxyribonucleotides,  PrPSc Proteins,  Prions,  Amyloid beta-Protein Precursor]"} , { "attrname": "YEAR", "value": "1992"} , { "attrname": "AbstractHeader", "value": "Transmissible familial Creutzfeldt-Jakob disease associated with five,  seven,  and eight extra octapeptide coding repeats in the PRNP gene."} , { "attrname": "Abstract", "value": "The PRNP gene,  encoding the amyloid precursor protein that is centrally involved in Creutzfeldt-Jakob disease (CJD),  has an unstable region of five variant tandem octapeptide coding repeats between codons 51 and 91. We screened a total of 535 individuals for the presence of extra repeats in this region,  including patients with sporadic and familial forms of spongiform encephalopathy,  members of their families,  other neurological and non-neurological patients,  and normal controls. We identified three CJD families (in each of which the proband's disease was neuropathologically confirmed and experimentally transmitted to primates) that were heterozygous for alleles with 10,  12,  or 13 repeats,  some of which had \"wobble\" nucleotide substitutions. We also found one individual with 9 repeats and no nucleotide substitutions who had no evidence of neurological disease. These observations,  together with data on published British patients with 11 and 14 repeats,  strongly suggest that the occurrence of 10 or more octapeptide repeats in the encoded amyloid precursor protein predisposes to CJD. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Oligodeoxyribonucleotides,  Crossing Over,  Genetic,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  Phenotype,  Animals,  PrPSc Proteins,  Base Sequence,  Prions,  Alleles,  Cloning,  Molecular,  Polymerase Chain Reaction,  Primates,  Repetitive Sequences,  Nucleic Acid,  Adult,  Female,  Mutation,  Creutzfeldt-Jakob Syndrome,  Amyloid beta-Protein Precursor]"} , { "attrname": "AUTHORS", "value": "[L G Goldfarb,  P Brown,  W R McCombie,  D Goldgaber,  G D Swergold,  P R Wills,  L Cervenakova,  H Baron,  C J Gibbs,  D C Gajdusek]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 84-91]"} ], "id": "1256", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1683708", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.88.23.10926"} , { "elementOf": "NLM", "accession": "1683708"} ]} , { "annotation": "[VARIANT CJD LYS-200]", "conames": [{ "name": "PMID: 7906019", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7906019", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Codon,  PrPSc Proteins,  Prions,  9007-49-2 DNA,  EC 3.1.21.- endodeoxyribonuclease BsmAI,  EC 3.1.21.4 Deoxyribonucleases,  Type II Site-Specific,  K3Z4F929H6 Lysine]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "Japanese family with Creutzfeldt-Jakob disease with codon 200 point mutation of the prion protein gene."} , { "attrname": "Abstract", "value": "We report the first Japanese case of familial Creutzfeldt-Jakob disease (CJD) with the heterozygous point mutation at codon 200 of the prion protein gene. This suggests that the mutation is not race-specific. The clinical and pathologic features of this case are not different from those of sporadic CJD without point mutations. Some healthy members of the family also carry the same mutation in the autosomal dominant inheritance expression. "} , { "attrname": "MeSH", "value": "[Cerebellum,  Immunohistochemistry,  Humans,  Japan,  Middle Aged,  Male,  Genetic Variation,  Point Mutation,  Codon,  PrPSc Proteins,  Lymphocytes,  Lysine,  Pedigree,  DNA,  Prions,  Adolescent,  Polymerase Chain Reaction,  Adult,  Female,  Creutzfeldt-Jakob Syndrome,  Deoxyribonucleases,  Type II Site-Specific]"} , { "attrname": "AUTHORS", "value": "[I Inoue,  T Kitamoto,  K Doh-ura,  H Shii,  I Goto,  J Tateishi]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD LYS-200]"} ], "id": "1257", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7906019", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7906019"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.44.2.299"} ]} , { "annotation": "[VARIANT GSD LEU-105]", "conames": [{ "name": "PMID: 7699395", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7699395", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of the neurological sciences"} , { "attrname": "Chemical", "value": "[Codon,  PrPC Proteins]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "A variant of Gerstmann-Strussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene:  a clinicopathological study."} , { "attrname": "Abstract", "value": "A case was reported of variant Gerstmann-Strussler-Scheinker disease (GSS) carrying codon 105 mutation (Pro to Leu) with codon 129 polymorphism (Met\/Val) of the prion protein (PrP) gene. The male patient had developed clumsiness of the right hand at age 42,  and subsequently exhibited slowly progressive spastic paraparesis,  ataxia,  dysarthria,  memory disturbance and apraxia. Myoclonus or periodic synchronous discharge was not observed. He died at age 53. The cerebral cortex and white matter showed atrophy,  which was prominent in the frontal regions. There were numerous amyloid plaques throughout the cerebral cortex,  which were reactive with the antibody to PrP,  but not to beta\/A 4 peptide. PrP immunostaining also revealed many amorphous deposits in the deep cortical layers,  where neuronal loss and glial proliferation was evident. The cerebellum was almost intact,  except a few amyloid plaques in the white matter. This variant GSS with codon 105 mutation has been found in four pedigrees,  only in Japan up to the present,  and the clinicopathological phenotype is summarized as follows:  (1) onset at age 38-48,  with a duration of 7-11 years,  (2) prominent spastic paraparesis,  associated with dementia and ataxia,  (3) numerous amyloid plaques in the cerebral cortex,  (4) amorphous PrP deposits with neuronal loss in the deep cortical layers,  and (5) minor change of cerebellum. "} , { "attrname": "MeSH", "value": "[Brain,  Codon,  DNA Mutational Analysis,  Humans,  Age of Onset,  Fatal Outcome,  PrPC Proteins,  Gerstmann-Straussler-Scheinker Disease,  Adult,  Male,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[Y Itoh,  M Yamada,  M Hayakawa,  T Shozawa,  J Tanaka,  M Matsushita,  T Kitamoto,  J Tateishi,  E Otomo]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD LEU-105]"} ], "id": "1258", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7699395", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7699395"} , { "elementOf": "DOI", "accession": "10.1016\/0022-510X(94)90138-4"} ]} , { "annotation": "[VARIANT GSD LEU-102,  VARIANT LYS-219]", "conames": [{ "name": "PMID: 8797472", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8797472", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Prions]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Strussler-Scheinker disease (PrP-P102L mutation)."} , { "attrname": "Abstract", "value": "We present a new,  large,  Italian family affected by Gerstmann-Strussler-Scheinker syndrome (GSS) associated with the Pro to Leu point mutation at codon 102 of the prion protein gene (PRNP). The affected members of this family show a remarkable phenotypic variability of the disease:  three of them had a clinical picture characterized by dementia and a brief illness duration (less than 1 year),  while the other five members presented an ataxic,  slowly evolving syndrome (a clinical duration of 3 to 4 years) with no evidence of cognitive impairment. Despite these remarkable clinical differences among affected members,  we found no correlation between the clinical presentation and the codon 129 or codon 219 genotypes. These data suggest that factors as yet unidentified may influence the clinical expression of the disease. "} , { "attrname": "MeSH", "value": "[Phenotype,  Pedigree,  Humans,  Middle Aged,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Female,  Male,  Aged,  Mutation,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[P Barbanti,  G Fabbrini,  M Salvatore,  R Petraroli,  F Cardone,  B Maras,  M Equestre,  G Macchi,  G L Lenzi,  M Pocchiari]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD LEU-102,  VARIANT LYS-219]"} ], "id": "1259", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8797472", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8797472"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.47.3.734"} ]} , { "annotation": "[VARIANTS ARG-188 AND SER-238]", "conames": [{ "name": "PMID: 10987652", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10987652", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human genetics"} , { "attrname": "Chemical", "value": "[Prions,  9007-49-2 DNA]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "Molecular genetics of human prion diseases in Germany."} , { "attrname": "Abstract", "value": "Human prion diseases may be acquired as infectious diseases,  they may be inherited in an autosomal dominant fashion or occur sporadically. Mutations and polymorphisms in the sequence of the coding region of the prion protein gene (PRNP) have been established as an important factor in all of these three types of prion diseases. Therefore,  a total of 578 patients with suspect prion diseases referred to the German Creutzfeldt-Jakob disease (CJD) surveillance unit over a period of 4.5 years have been examined for mutations and polymorphisms in the coding region of PRNP. We found 40 cases with a missense mutation previously reported as pathogenic. Amongst these,  the aspartate to asparagine change at codon 178 (D178N) was the most common mutation. All of these cases carried the D178N mutation in coupling with methionine at codon 129,  resulting in the typical fatal familial insomnia (FFI) genotype. Most cases with pathogenic mutations were not found in the group of clinically \"probable\" cases according to established clinical criteria,  supporting the notion that inherited prion diseases often exhibit atypical features. Two novel missense mutations (T188R and P238S) and several silent polymorphisms were found,  demonstrating the quality of our screening procedure based on a modified version of the single-stranded conformational polymorphism technique. In \"definite\" CJD cases with no pathogenic mutation,  the patients clinically classified as \"probable\" were mostly homozygous for methionine at the common polymorphism at codon 129,  whereas there was a marked over-representation of patients homozygous for valine amongst those clinically classified as \"possible\". This large study on suspect cases of human prion diseases in Germany clearly shows that PRNP genetics is essential for a comprehensive analysis of prion diseases. "} , { "attrname": "MeSH", "value": "[Prion Diseases,  DNA Mutational Analysis,  DNA,  Humans,  Prions,  Genotype,  Mutagenesis,  Insertional,  Mutation,  Mutation,  Missense,  Germany,  Incidence,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[O Windl,  A Giese,  W Schulz-Schaeffer,  I Zerr,  K Skworc,  S Arendt,  C Oberdieck,  M Bodemer,  S Poser,  H A Kretzschmar]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS ARG-188 AND SER-238]"} ], "id": "1260", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10987652", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10987652"} , { "elementOf": "DOI", "accession": "10.1007\/S004390051096"} ]} , { "annotation": "[VARIANT GSD LEU-105]", "conames": [{ "name": "PMID: 7902972", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7902972", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[Codon,  PrPSc Proteins,  Prions]"} , { "attrname": "YEAR", "value": "1994"} , { "attrname": "AbstractHeader", "value": "A missense mutation at codon 105 with codon 129 polymorphism of the prion protein gene in a new variant of Gerstmann-Strussler-Scheinker disease."} , { "attrname": "MeSH", "value": "[Codon,  PrPSc Proteins,  Base Sequence,  Genes,  Humans,  Middle Aged,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Molecular Sequence Data,  Male,  Mutation,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[M Yamada,  Y Itoh,  H Fujigasaki,  S Naruse,  K Kaneko,  T Kitamoto,  J Tateishi,  E Otomo,  M Hayakawa,  J Tanaka]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD LEU-105]"} ], "id": "1261", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7902972", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1212\/WNL.43.12.2723-A"} , { "elementOf": "NLM", "accession": "7902972"} ]} , { "annotation": "[VARIANT CJD ASN-178]", "conames": [{ "name": "PMID: 1671440", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1671440", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Lancet (London,  England)"} , { "attrname": "Chemical", "value": "[Codon,  PrPC Proteins,  Protein Precursors,  Viral Proteins]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred."} , { "attrname": "MeSH", "value": "[Codon,  Disease Susceptibility,  Humans,  Middle Aged,  Finland,  PrPC Proteins,  Protein Precursors,  Viral Proteins,  Mutation,  Creutzfeldt-Jakob Syndrome]"} , { "attrname": "AUTHORS", "value": "[L G Goldfarb,  M Haltia,  P Brown,  A Nieto,  J Kovanen,  W R McCombie,  S Trapp,  D C Gajdusek]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT CJD ASN-178]"} ], "id": "1262", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1671440", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0140-6736(91)91198-4"} , { "elementOf": "NLM", "accession": "1671440"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-253,  VARIANT SCHIZOAFFECTIVE DISORDER SER-171]", "conames": [{ "name": "PMID: 9384372", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9384372", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[Prions]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "A prion-linked psychiatric disorder."} , { "attrname": "MeSH", "value": "[Prion Diseases,  Pedigree,  Humans,  Prions,  Schizophrenia,  Female,  Male,  Psychotic Disorders,  Mutation]"} , { "attrname": "AUTHORS", "value": "[H B Samaia,  J J Mari,  H P Vallada,  R P Moura,  A J Simpson,  R R Brentani]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-253,  VARIANT SCHIZOAFFECTIVE DISORDER SER-171]"} ], "id": "1263", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9384372", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/36757"} , { "elementOf": "NLM", "accession": "9384372"} ]} , { "annotation": "[VARIANT GSD LEU-102]", "conames": [{ "name": "PMID: 7783876", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7783876", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neurology"} , { "attrname": "Chemical", "value": "[AE28F7PNPL Methionine,  Codon,  Prions]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Gerstmann-Strussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients."} , { "attrname": "Abstract", "value": "We present two patients with Gerstmann-Strussler-Scheinker disease (GSS),  one from a previously undescribed kindred and one from the Canadian branch of a previously reported British kindred. In both patients,  GSS is caused by a substitution of thymine for cytosine at codon 102 of the prion protein gene (PRNP). In each patient,  we confirmed the clinical diagnosis by neuropathologic examination. The mutation,  causing a substitution of leucine for proline at residue 102 (P102L) of the prion protein,  has been previously reported in at least 30 other families. In the patients described here,  the mutation was in coupling with methionine at PRNP codon 129. "} , { "attrname": "MeSH", "value": "[Codon,  Base Sequence,  Humans,  Middle Aged,  Prions,  Methionine,  Gerstmann-Straussler-Scheinker Disease,  Molecular Sequence Data,  Adult,  Female,  Male,  Mutation]"} , { "attrname": "AUTHORS", "value": "[K Young,  C K Jones,  P Piccardo,  A Lazzarini,  L I Golbe,  T R Zimmerman,  D W Dickson,  D C McLachlan,  P St George-Hyslop,  A Lennox]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD LEU-102]"} ], "id": "1264", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7783876", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7783876"} , { "elementOf": "DOI", "accession": "10.1212\/WNL.45.6.1127"} ]} , { "annotation": "[VARIANTS GSD ASN-202 AND PRO-212]", "conames": [{ "name": "PMID: 9786248", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9786248", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Journal of neuropathology and experimental neurology"} , { "attrname": "Chemical", "value": "[Prions,  9007-49-2 DNA]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Phenotypic variability of Gerstmann-Strussler-Scheinker disease is associated with prion protein heterogeneity."} , { "attrname": "Abstract", "value": "Gerstmann-Strussler-Scheinker disease (GSS),  a cerebello-pyramidal syndrome associated with dementia and caused by mutations in the prion protein gene (PRNP),  is phenotypically heterogeneous. The molecular mechanisms responsible for such heterogeneity are unknown. Since we hypothesize that prion protein (PrP) heterogeneity may be associated with clinico-pathologic heterogeneity,  the aim of this study was to analyze PrP in several GSS variants. Among the pathologic phenotypes of GSS,  we recognize those without and with marked spongiform degeneration. In the latter (i.e. a subset of GSS P102L patients) we observed 3 major proteinase-K resistant PrP (PrPres) isoforms of ca. 21-30 kDa,  similar to those seen in Creutzfeldt-Jakob disease. In contrast,  the 21-30 kDa isoforms were not prominent in GSS variants without spongiform changes,  including GSS A117V,  GSS D202N,  GSS Q212P,  GSS Q217R,  and 2 cases of GSS P102L. This suggests that spongiform changes in GSS are related to the presence of high levels of these distinct 21-30 kDa isoforms. Variable amounts of smaller,  distinct PrPres isoforms of ca. 7-15 kDa were seen in all GSS variants. This suggests that GSS is characterized by the presence PrP isoforms that can be partially cleaved to low molecular weight PrPres peptides. "} , { "attrname": "MeSH", "value": "[Brain,  Molecular Weight,  Humans,  Middle Aged,  Male,  Blotting,  Western,  Phenotype,  DNA,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Adult,  Female,  Aged,  Brain Chemistry]"} , { "attrname": "AUTHORS", "value": "[P Piccardo,  S R Dlouhy,  P M Lievens,  K Young,  T D Bird,  D Nochlin,  D W Dickson,  H V Vinters,  T R Zimmerman,  I R Mackenzie,  S J Kish,  L C Ang,  C De Carli,  M Pocchiari,  P Brown,  C J Gibbs,  D C Gajdusek,  O Bugiani,  J Ironside,  F Tagliavini,  B Ghetti]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS GSD ASN-202 AND PRO-212]"} ], "id": "1265", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9786248", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9786248"} , { "elementOf": "DOI", "accession": "10.1097\/00005072-199810000-00010"} ]} , { "annotation": "[VARIANTS CJD ILE-180 AND ARG-232]", "conames": [{ "name": "PMID: 8461023", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8461023", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Codon,  Prions,  DNA,  Single-Stranded]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Strussler syndrome."} , { "attrname": "Abstract", "value": "We found 3 novel missense variants in the open reading frame of the prion protein (PrP) gene. The codon 105 point mutation (proline to leucine) was found on a codon 129 (Valine) PrP allele in 4 patients from 3 different Japanese families with Gerstmann-Strussler syndrome. The codon 180 variant PrP (valine to isoleucine) was found in Creutzfeldt-Jakob disease (CJD) patients with a similar clinical course to that of codon 178 mutation. The codon 232 variant PrP (methionine to arginine) was documented in the CJD patients with typical clinical and pathological findings. These variant PrP molecules were not detected in 200 normal Japanese PrP alleles. PrP has a large repertoire of variant forms,  and each primary structure of PrP corresponds to the distinct phenotype of prion diseases. "} , { "attrname": "MeSH", "value": "[Codon,  DNA Mutational Analysis,  Base Sequence,  Humans,  Open Reading Frames,  Prions,  Polymerase Chain Reaction,  Gerstmann-Straussler-Scheinker Disease,  Molecular Sequence Data,  DNA,  Single-Stranded,  Creutzfeldt-Jakob Syndrome,  Polymorphism,  Genetic]"} , { "attrname": "AUTHORS", "value": "[T Kitamoto,  M Ohta,  K Doh-ura,  S Hitoshi,  Y Terao,  J Tateishi]"} , { "attrname": "PUB_TYPE", "value": "[VARIANTS CJD ILE-180 AND ARG-232]"} ], "id": "1266", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8461023", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "8461023"} , { "elementOf": "DOI", "accession": "10.1006\/BBRC.1993.1275"} ]} , { "annotation": "[VARIANT GSD ARG-217]", "conames": [{ "name": "PMID: 1363810", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1363810", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature genetics"} , { "attrname": "Chemical", "value": "[PrPSc Proteins,  Prions,  9007-49-2 DNA]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Mutant prion proteins in Gerstmann-Strussler-Scheinker disease with neurofibrillary tangles."} , { "attrname": "Abstract", "value": "Two families with Gerstmann-Strussler-Scheinker disease (GSS) are atypical in possessing neocortical neurofibrillary tangles (NFTs),  which are few or absent in other kindreds with GSS,  in addition to amyloid plaques that react with prion protein (PrP) antibodies and protease-resistant PrP accumulation in the brain. A leucine substitution at PrP codon 102 has been genetically linked to GSS in some families. We examined the PrP gene in these families. A serine for phenylalanine substitution was found at codon 198 in the Indiana patients; arginine for glutamine substitution at codon 217 in the Swedish patients. These mutations in PrP are the first to be associated with the appearance of both PrP amyloid plaques and neocortical NFTs in GSS patients. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  Neurofibrillary Tangles,  Point Mutation,  PrPSc Proteins,  Base Sequence,  DNA,  Prions,  Gerstmann-Straussler-Scheinker Disease,  Adult,  Female,  Aged]"} , { "attrname": "AUTHORS", "value": "[K Hsiao,  S R Dlouhy,  M R Farlow,  C Cass,  M Da Costa,  P M Conneally,  M E Hodes,  B Ghetti,  S B Prusiner]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT GSD ARG-217]"} ], "id": "1267", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1363810", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1363810"} , { "elementOf": "DOI", "accession": "10.1038\/NG0492-68"} ]} , { "annotation": "", "conames": [{ "name": "Fomepizole", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1268", "contexts": { } , "evidences": ["Imported from database"], "value": "Fomepizole", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01213"} ]} , { "annotation": "", "conames": [{ "name": "Antihemophilic Factor (Recombinant)", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "BiotechDrug"} ], "id": "1269", "contexts": { } , "evidences": ["Imported from database"], "value": "Antihemophilic Factor (Recombinant)", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00025"} ]} , { "annotation": "", "conames": [{ "name": "Melatonin", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "3"} ], "id": "1270", "contexts": { } , "evidences": ["Imported from database"], "value": "Melatonin", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01065"} ]} , { "annotation": "", "conames": [{ "name": "Tenecteplase", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "BiotechDrug"} ], "id": "1271", "contexts": { } , "evidences": ["Imported from database"], "value": "Tenecteplase", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00031"} ]} , { "annotation": "", "conames": [{ "name": "L-Proline", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1272", "contexts": { } , "evidences": ["Imported from database"], "value": "L-Proline", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00172"} ]} , { "annotation": "", "conames": [{ "name": "Cyclosporine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1273", "contexts": { } , "evidences": ["Imported from database"], "value": "Cyclosporine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00091"} ]} , { "annotation": "", "conames": [{ "name": "Thiopental", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1274", "contexts": { } , "evidences": ["Imported from database"], "value": "Thiopental", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00599"} ]} , { "annotation": "", "conames": [{ "name": "Methylphenobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1275", "contexts": { } , "evidences": ["Imported from database"], "value": "Methylphenobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00849"} ]} , { "annotation": "", "conames": [{ "name": "Amobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1276", "contexts": { } , "evidences": ["Imported from database"], "value": "Amobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01351"} ]} , { "annotation": "", "conames": [{ "name": "Secobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1277", "contexts": { } , "evidences": ["Imported from database"], "value": "Secobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00418"} ]} , { "annotation": "", "conames": [{ "name": "Varenicline", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1278", "contexts": { } , "evidences": ["Imported from database"], "value": "Varenicline", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01273"} ]} , { "annotation": "", "conames": [{ "name": "Talbutal", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1279", "contexts": { } , "evidences": ["Imported from database"], "value": "Talbutal", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00306"} ]} , { "annotation": "", "conames": [{ "name": "Cytisine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1280", "contexts": { } , "evidences": ["Imported from database"], "value": "Cytisine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB09028"} ]} , { "annotation": "", "conames": [{ "name": "Aprobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1281", "contexts": { } , "evidences": ["Imported from database"], "value": "Aprobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01352"} ]} , { "annotation": "", "conames": [{ "name": "Butalbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1282", "contexts": { } , "evidences": ["Imported from database"], "value": "Butalbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00241"} ]} , { "annotation": "", "conames": [{ "name": "Ethanol", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "2"} ], "id": "1283", "contexts": { } , "evidences": ["Imported from database"], "value": "Ethanol", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00898"} ]} , { "annotation": "", "conames": [{ "name": "Phenobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "1"} ], "id": "1284", "contexts": { } , "evidences": ["Imported from database"], "value": "Phenobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01174"} ]} , { "annotation": "", "conames": [{ "name": "Nicotine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} , { "attrname": "CitNum", "value": "19"} ], "id": "1285", "contexts": { "context": { "id": 63} } , "evidences": ["Imported from database"], "value": "Nicotine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00184"} ]} , { "annotation": "", "conames": [{ "name": "Primidone", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1286", "contexts": { } , "evidences": ["Imported from database"], "value": "Primidone", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00794"} ]} , { "annotation": "", "conames": [{ "name": "Pentobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1287", "contexts": { } , "evidences": ["Imported from database"], "value": "Pentobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00312"} ]} , { "annotation": "", "conames": [{ "name": "Butabarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1288", "contexts": { } , "evidences": ["Imported from database"], "value": "Butabarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00237"} ]} , { "annotation": "", "conames": [{ "name": "Hexobarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1289", "contexts": { } , "evidences": ["Imported from database"], "value": "Hexobarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01355"} ]} , { "annotation": "", "conames": [{ "name": "Butethal", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1290", "contexts": { } , "evidences": ["Imported from database"], "value": "Butethal", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01353"} ]} , { "annotation": "", "conames": [{ "name": "Galantamine", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1291", "contexts": { } , "evidences": ["Imported from database"], "value": "Galantamine", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB00674"} ]} , { "annotation": "", "conames": [{ "name": "Heptabarbital", "isPreferred": "true"} ], "elementOf": "DrugBank", "description": "", "pid": "", "attributes": [{ "attrname": "DRUG_TYPE", "value": "SmallMoleculeDrug"} ], "id": "1292", "contexts": { } , "evidences": ["Imported from database"], "value": "Heptabarbital", "ofType": "Drug", "coaccessions": [{ "elementOf": "DrugBank", "accession": "DB01354"} ]} , { "annotation": "", "conames": [], "elementOf": "UNIPROTKB", "description": "", "pid": "6.-.-.-", "attributes": [], "id": "1293", "contexts": { } , "evidences": ["Imported from database"], "value": "6.-.-.-", "ofType": "Enzyme Classification", "coaccessions": [{ "elementOf": "EC", "accession": "6.-.-.-"} ]} , { "annotation": "", "conames": [], "elementOf": "UNIPROTKB", "description": "", "pid": "3.4.19.12", "attributes": [], "id": "1294", "contexts": { } , "evidences": ["Imported from database"], "value": "3.4.19.12", "ofType": "Enzyme Classification", "coaccessions": [{ "elementOf": "EC", "accession": "3.4.19.12"} ]} , { "annotation": "", "conames": [{ "name": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 5,  AUTOSOMAL DOMINANT,  SUSCEPTIBILITY TO; PARK5", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "613643", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "1295", "contexts": { } , "evidences": ["Imported from database"], "value": "PARKINSON <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 5,  AUTOSOMAL DOMINANT,  SUSCEPTIBILITY TO; PARK5", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "613643"} ]} , { "annotation": "Interacting selectively and non-covalently with an alpha-2A adrenergic receptor. ( Reference:  GOC: mah GOC: nln )", "conames": [{ "name": "alpha-2A adrenergic receptor binding", "isPreferred": "true"} , { "name": "alpha-2A adrenergic receptor ligand", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031694", "attributes": [], "id": "1296", "contexts": { } , "evidences": ["Imported from database"], "value": "alpha-2A adrenergic receptor binding", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031694"} ]} , { "annotation": "Catalysis of the removal of terminal peptide residues that are substituted,  cyclized or linked by isopeptide bonds (peptide linkages other than those of alpha-carboxyl to alpha-amino groups). ( Reference:  EC: 3.4.19.- )", "conames": [{ "name": "omega peptidase activity", "isPreferred": "true"} , { "name": "peptidase activity,  acting on peptides containing modified amino acids", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008242", "attributes": [], "id": "1297", "contexts": { } , "evidences": ["Imported from database"], "value": "omega peptidase activity", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008242"} ]} , { "annotation": "Catalysis of the hydrolysis of internal,  alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile. ( Reference:  GOC: mah http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#CATTYPE http: \/\/merops.sanger.ac.uk\/about\/glossary.htm#ENDOPEPTIDASE )", "conames": [{ "name": "lysosomal cysteine-type endopeptidase", "isPreferred": "false"} , { "name": "metacaspase", "isPreferred": "false"} , { "name": "thiol endopeptidase", "isPreferred": "true"} , { "name": "cysteine-type endopeptidase activity", "isPreferred": "true"} , { "name": "caspase", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004197", "attributes": [], "id": "1298", "contexts": { } , "evidences": ["Imported from database"], "value": "thiol endopeptidase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004197"} ]} , { "annotation": "Catalysis of the thiol-dependent hydrolysis of a peptide bond formed by the C-terminal glycine of ubiquitin and another protein. ( Reference:  GOC: jh2 ISBN: 0120793709 )", "conames": [{ "name": "UBP", "isPreferred": "false"} , { "name": "ubiquitin hydrolase", "isPreferred": "false"} , { "name": "deubiquitinating enzyme", "isPreferred": "false"} , { "name": "ubiquitin-specific protease", "isPreferred": "false"} , { "name": "ubiquitin C-terminal hydrolase", "isPreferred": "true"} , { "name": "deubiquitylase", "isPreferred": "true"} , { "name": "thiol-dependent ubiquitin-specific protease activity", "isPreferred": "true"} , { "name": "deubiquitinase", "isPreferred": "false"} , { "name": "UCH2", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0004843", "attributes": [], "id": "1299", "contexts": { } , "evidences": ["Imported from database"], "value": "deubiquitylase", "ofType": "Molecular_Function", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0004843"} ]} , { "annotation": "An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells:  Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. ( Reference:  GOC: cjm GOC: jl NIF_Subcellular: sao-593830697 Wikipedia: Myelin )", "conames": [{ "name": "oligodendrocyte myelin sheath", "isPreferred": "false"} , { "name": "Schwann cell myelin sheath", "isPreferred": "false"} , { "name": "myelin sheath", "isPreferred": "true"} , { "name": "astrocyte sheath", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043209", "attributes": [], "id": "1300", "contexts": { } , "evidences": ["Imported from database"], "value": "myelin sheath", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043209"} ]} , { "annotation": "That part of the nuclear content other than the chromosomes or the nucleolus. ( Reference:  GOC: ma ISBN: 0124325653 )", "conames": [{ "name": "nucleoplasm", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005654", "attributes": [], "id": "1301", "contexts": { } , "evidences": ["Imported from database"], "value": "nucleoplasm", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005654"} ]} , { "annotation": "The specialized,  terminal region of a neuron projection such as an axon or a dendrite. ( Reference:  GOC: jl )", "conames": [{ "name": "nerve terminal", "isPreferred": "false"} , { "name": "neuron terminal specialization", "isPreferred": "true"} , { "name": "neuron projection terminus", "isPreferred": "true"} , { "name": "neuron projection terminal", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0044306", "attributes": [], "id": "1302", "contexts": { } , "evidences": ["Imported from database"], "value": "neuron projection terminal", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0044306"} ]} , { "annotation": "Any process pertaining to the functions of the nervous and muscular systems of an organism. ( Reference:  GOC: ai );", "conames": [{ "name": "neuromuscular process", "isPreferred": "true"} , { "name": "neuromuscular physiological process", "isPreferred": "true"} , { "name": "neuromotor process", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0050905", "attributes": [], "id": "1303", "contexts": { } , "evidences": ["Imported from database"], "value": "neuromotor process", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0050905"} ]} , { "annotation": "The process whose specific outcome is the progression of the muscle fiber over time,  from its formation to the mature structure. In skeletal muscle,  fibers are formed by the maturation of myotubes. They can be classed as slow,  intermediate fast or fast. ( Reference:  GOC: dph GOC: jid GOC: lm GOC: mtg_muscle )", "conames": [{ "name": "muscle fibre development", "isPreferred": "true"} , { "name": "muscle fiber development", "isPreferred": "true"} , { "name": "myofibre development", "isPreferred": "true"} , { "name": "myofiber development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048747", "attributes": [], "id": "1304", "contexts": { } , "evidences": ["Imported from database"], "value": "myofiber development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048747"} ]} , { "annotation": "The specific behavior of an organism relating to the intake of food,  any substance (usually solid) that can be metabolized by an organism to give energy and build tissue. ( Reference:  GOC: jl GOC: pr ISBN: 01928006X )", "conames": [{ "name": "eating behavior", "isPreferred": "true"} , { "name": "eating behaviour", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0042755", "attributes": [], "id": "1305", "contexts": { } , "evidences": ["Imported from database"], "value": "eating behavior", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0042755"} ]} , { "annotation": "The directed movement of mitochondria along microtubules in nerve cell axons. ( Reference:  GOC: ai )", "conames": [{ "name": "axon transport of mitochondrion", "isPreferred": "true"} , { "name": "axon transport of mitochondria", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019896", "attributes": [], "id": "1306", "contexts": { } , "evidences": ["Imported from database"], "value": "axon transport of mitochondria", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019896"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of MAP kinase activity. ( Reference:  GOC: dph GOC: go_curators )", "conames": [{ "name": "down regulation of MAPK", "isPreferred": "true"} , { "name": "downregulation of MAPK", "isPreferred": "true"} , { "name": "negative regulation of mitogen-activated protein kinase", "isPreferred": "true"} , { "name": "negative regulation of mitogen activated protein kinase", "isPreferred": "true"} , { "name": "negative regulation of MAP kinase activity", "isPreferred": "true"} , { "name": "inhibition of MAPK", "isPreferred": "false"} , { "name": "down-regulation of MAPK", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043407", "attributes": [], "id": "1307", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of MAPK", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043407"} ]} , { "annotation": "The removal of one or more ubiquitin groups from a protein. ( Reference:  GOC: ai )", "conames": [{ "name": "protein deubiquitination", "isPreferred": "true"} , { "name": "protein deubiquitylation", "isPreferred": "true"} , { "name": "deubiquitination", "isPreferred": "true"} , { "name": "protein deubiquitinylation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0016579", "attributes": [], "id": "1308", "contexts": { } , "evidences": ["Imported from database"], "value": "deubiquitination", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0016579"} , { "elementOf": "GO", "accession": "GO: 0006514"} ]} , { "annotation": "Any process that results in a change in state or activity of an organism (in terms of movement,  secretion,  enzyme production,  gene expression,  etc.) as a result of a inadequate blood supply. ( Reference:  GOC: hjd )", "conames": [{ "name": "response to ischemia", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0002931", "attributes": [], "id": "1309", "contexts": { } , "evidences": ["Imported from database"], "value": "response to ischemia", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002931"} ]} , { "annotation": "The process in which an axon recognizes and binds to a set of cells with which it may form stable connections. ( Reference:  ISBN: 0878932437 )", "conames": [{ "name": "axon target recognition", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0007412", "attributes": [], "id": "1310", "contexts": { } , "evidences": ["Imported from database"], "value": "axon target recognition", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0007412"} ]} , { "annotation": "The series of events required for an organism to receive a painful stimulus,  convert it to a molecular signal,  and recognize and characterize the signal. Pain is medically defined as the physical sensation of discomfort or distress caused by injury or illness,  so can hence be described as a harmful stimulus which signals current (or impending) tissue damage. Pain may come from extremes of temperature,  mechanical damage,  electricity or from noxious chemical substances. This is a neurological process. ( Reference:  http: \/\/www.onelook.com\/ )", "conames": [{ "name": "nociception", "isPreferred": "true"} , { "name": "perception of physiological pain", "isPreferred": "false"} , { "name": "sensory perception of pain", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0019233", "attributes": [], "id": "1311", "contexts": { } , "evidences": ["Imported from database"], "value": "nociception", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0019233"} ]} , { "annotation": "The multiplication or reproduction of cells,  resulting in the expansion of a cell population. ( Reference:  GOC: mah GOC: mb )", "conames": [{ "name": "cell proliferation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0008283", "attributes": [], "id": "1312", "contexts": { } , "evidences": ["Imported from database"], "value": "cell proliferation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0008283"} ]} , { "annotation": "[ACTIVE SITE,  MUTAGENESIS OF GLN-73; CYS-90; HIS-97; HIS-161 AND ASP-176,  BIOPHYSICOCHEMICAL PROPERTIES]", "conames": [{ "name": "PMID: 8639624", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8639624", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[K848JZ4886 Cysteine,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Isoenzymes,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "1996"} , { "attrname": "AbstractHeader", "value": "Substrate binding and catalysis by ubiquitin C-terminal hydrolases:  identification of two active site residues."} , { "attrname": "Abstract", "value": "Ubiquitin C-terminal hydrolases (UCH's) are a newly-defined class of thiol proteases implicated in the proteolytic processing of polymeric ubiquitin. They are important for the generation of monomeric ubiquitin,  the active component of the eukaryotic ubiquitin-dependent proteolytic system. There are at least three mammalian isozymes which are tissue specific and developmentally regulated. To study the structure and functional roles of these highly homologous enzymes,  we have subcloned and overexpressed two of these isozymes,  UCH-L1 and UCH-L3. Here,  we report their purification,  physical characteristics,  and the mutagenesis of UCH-L1. Site-directed mutagenesis of UCH-L1 reveals that C90 and H161 are involved in catalytic rate enhancement. Data from circular dichroic and Raman spectroscopy,  as well as secondary structure prediction algorithms,  indicate that both isozymes have a significant amount of alpha-helix (> 35%),  and contain no disulfide bonds. Both enzymes are reasonably stable,  undergoing a reversible thermal denaturation at 52 degrees C. These transitions are characterized by thermodynamic parameters typical of single domain globular proteins. Substrate binding affinity to UCH-L3 was directly measured by equilibrium gel filtration (Kd = 0.5 microM),  and the results are similar to the kinetically determined Km for ubiquitin ethyl ester (o.6 microM). The binding is primarily electrostatic in nature and indicates the existence of a specific and extensive binding site for ubiquitin on the surface of the enzyme. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Cysteine,  Protein Structure,  Secondary,  Isoenzymes,  Drosophila,  Escherichia coli,  Humans,  Molecular Sequence Data,  Recombinant Proteins,  Sequence Homology,  Amino Acid,  Thermodynamics,  Animals,  Cloning,  Molecular,  Thiolester Hydrolases,  Catalysis,  Kinetics,  Binding Sites,  Saccharomyces cerevisiae,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[C N Larsen,  J S Price,  K D Wilkinson]"} , { "attrname": "PUB_TYPE", "value": "[ACTIVE SITE,  MUTAGENESIS OF GLN-73; CYS-90; HIS-97; HIS-161 AND ASP-176,  BIOPHYSICOCHEMICAL PROPERTIES]"} ], "id": "1313", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8639624", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI960099F"} , { "elementOf": "NLM", "accession": "8639624"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS),  SUBUNIT]", "conames": [{ "name": "PMID: 16537382", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16537382", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Structural basis for conformational plasticity of the <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated ubiquitin hydrolase UCH-L1."} , { "attrname": "Abstract", "value": "The ubiquitin C-terminal hydrolase UCH-L1 (PGP9.5) comprises >1% of total brain protein but is almost absent from other tissues [Wilkinson,  K. D.,  et al. (1989) Science 246,  670-673]. Mutations in the UCH-L1 gene have been reported to be linked to susceptibility to and protection from <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> [Leroy,  E.,  et al. (1998) Nature 395,  451-452; Maraganore,  D. M.,  et al. (1999) Neurology 53,  1858-1860]. Abnormal overexpression of UCH-L1 has been shown to correlate with several forms of cancer [Hibi,  K.,  et al. (1998) Cancer Res. 58,  5690-5694]. Because the amino acid sequence of UCH-L1 is similar to that of other ubiquitin C-terminal hydrolases,  including the ubiquitously expressed UCH-L3,  which appear to be unconnected to neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  the structure of UCH-L1 and the effects of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> associated mutations on the structure and function are of considerable importance. We have determined the three-dimensional structure of human UCH-L1 at 2.4-A resolution by x-ray crystallography. The overall fold resembles that of other ubiquitin hydrolases,  including UCH-L3,  but there are a number of significant differences. In particular,  the geometry of the catalytic residues in the active site of UCH-L1 is distorted in such a way that the hydrolytic activity would appear to be impossible without substrate induced conformational rearrangements. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Amino Acid Sequence,  Models,  Biological,  Humans,  Molecular Sequence Data,  Crystallography,  X-Ray,  Protein Conformation,  Binding Sites,  Dimerization,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Chittaranjan Das,  Quyen Q Hoang,  Cheryl A Kreinbring,  Sarah J Luchansky,  Robin K Meray,  Soumya S Ray,  Peter T Lansbury,  Dagmar Ringe,  Gregory A Petsko]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS),  SUBUNIT]"} ], "id": "1314", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16537382", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1073\/PNAS.0510403103"} , { "elementOf": "NLM", "accession": "16537382"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT TYR-18,  ANTIOXIDANT FUNCTION IN NEURONAL CELLS]", "conames": [{ "name": "PMID: 18411255", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "18411255", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Human molecular genetics"} , { "attrname": "Chemical", "value": "[Antioxidants,  Ubiquitin,  Reactive Oxygen Species,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human,  EC 3.4.25.1 Proteasome Endopeptidase Complex]"} , { "attrname": "YEAR", "value": "2008"} , { "attrname": "AbstractHeader", "value": "The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells."} , { "attrname": "Abstract", "value": "A number of studies have associated the S18Y polymorphic variant of UCH-L1 with protection from sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>Disease<\/b><\/span> (PD). The mechanism involved in this protective function is unknown,  but has generally been assumed to be linked to the ubiquitin-proteasome system (UPS). In the current study,  we have investigated the effects of overexpression of UCH-L1 and its variants,  including S18Y,  in neuronal cells. We find that S18Y,  but not WT,  UCH-L1 confers a specific antioxidant protective function when expressed at physiological levels in human neuroblastoma cells and primary cortical neurons. In contrast,  neither WT nor S18Y UCH-L1 appear to directly impact the proteasome,  although they both lead to stabilization of free ubiquitin. Lack of WT mouse UCH-L1 in neurons derived from gad mice led to a decrease of free ubiquitin,  but no overall decrease in UPS function or enhanced sensitivity to oxidative stress. We conclude that the S18Y variant of UCH-L1 confers a novel antioxidant function that is not present in the WT form and that this function may underlie the protective effects of this variant in certain PD populations. Our results furthermore provide indirect evidence for the importance of oxidative stress as a pathogenetic factor in certain forms of sporadic PD. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Reactive Oxygen Species,  Oxidative Stress,  Neurons,  Humans,  Cells,  Cultured,  Rats,  Male,  Proteasome Endopeptidase Complex,  Mice,  Knockout,  Polymorphism,  Genetic,  Antioxidants,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Animals,  Cell Line,  Tumor,  Female,  Mice,  Ubiquitin Thiolesterase,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[Elli Kyratzi,  Maria Pavlaki,  Leonidas Stefanis]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT TYR-18,  ANTIOXIDANT FUNCTION IN NEURONAL CELLS]"} ], "id": "1315", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 18411255", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "18411255"} , { "elementOf": "DOI", "accession": "10.1093\/HMG\/DDN115"} ]} , { "annotation": "[VARIANT TYR-18]", "conames": [{ "name": "PMID: 15048890", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "15048890", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.3.48 Antigens,  CD45]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "UCHL1 is a Parkinson's disease susceptibility gene."} , { "attrname": "Abstract", "value": "The reported inverse association between the S18Y variant of the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) gene and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) has strong biological plausibility. If confirmed,  genetic association of this variant with PD may support molecular targeting of the UCHL1 gene and its product as a therapeutic strategy for PD. In this light,  we performed a collaborative pooled analysis of individual-level data from all 11 published studies of the UCHL1 S18Y gene variant and PD. There were 1, 970 cases and 2, 224 unrelated controls. We found a statistically significant inverse association of S18Y with PD. Carriers of the variant allele (Y\/Y plus Y\/S vs S\/S) had an odds ratio (OR) of 0.84 (95% confidence interval [CI],  0.73-0.95) and homozygotes for the variant allele (Y\/Y vs S\/S plus Y\/S) had an OR of 0.71 (95% CI,  0.57-0.88). There was a linear trend in the log OR consistent with a gene dose effect (p = 0.01). The inverse association was most apparent for young cases compared with young controls. There was no evidence for publication bias and the associations remained significant after excluding the first published,  hypothesis-generating study. These findings confirm that UCHL1 is a susceptibility gene for PD and a potential target for <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-modifying therapies. "} , { "attrname": "MeSH", "value": "[Antigens,  CD45,  Confidence Intervals,  Genetic Predisposition to <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Humans,  Middle Aged,  Genotype,  Logistic Models,  Male,  Genetic Variation,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Aged,  80 and over,  Adult,  Female,  Aged,  Odds Ratio,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Demetrius M Maraganore,  Timothy G Lesnick,  Alexis Elbaz,  Marie-Christine Chartier-Harlin,  Thomas Gasser,  Rejko Krger,  Nobutaka Hattori,  George D Mellick,  Aldo Quattrone,  Jun-Ichi Satoh,  Tatsushi Toda,  Jian Wang,  John P A Ioannidis,  Mariza de Andrade,  Walter A Rocca,  Taksushi Toda,   UCHL1 Global Genetics Consortium]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT TYR-18]"} ], "id": "1316", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 15048890", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1002\/ANA.20017"} , { "elementOf": "NLM", "accession": "15048890"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 20-25; 79-81; 106-121 AND 134-151]", "conames": [{ "name": "PMID: 1849484", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1849484", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Isoenzymes,  Neuropeptides]"} , { "attrname": "YEAR", "value": "1991"} , { "attrname": "AbstractHeader", "value": "Neuronal protein gene product 9.5 (IEF SSP 6104) is expressed in cultured human MRC-5 fibroblasts of normal origin and is strongly down-regulated in their SV40 transformed counterparts."} , { "attrname": "Abstract", "value": "Neuronal protein gene product 9.5 (PGP 9.5) most likely identical to ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) has been reported to be expressed almost exclusively in neuronal and neuroendocrine tissues. By two-dimensional (2D) immunoblotting,  comigration and microsequencing of proteins recovered from 2D gels we have identified PGP 9.5 UCH-L1 as polypeptide IEF SSP 6104 (Mr = 27, 000,  pI = 5.49) in the comprehensive 2D gel cellular protein database of human embryonal lung MRC-5 fibroblasts [(1989) Electrophoresis 10,  76 115; (1990) Electrophoresis 11,  1072 1113]. This protein is expressed at high levels in quiescent and proliferating cultured normal fibroblasts and is strongly down-regulated (about 10 times) in their transformed counterparts. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Isoenzymes,  Down-Regulation,  Humans,  Cells,  Cultured,  Molecular Sequence Data,  Electrophoresis,  Gel,  Two-Dimensional,  Neuropeptides,  Simian virus 40,  Fluorescent Antibody Technique,  Fibroblasts,  Thiolester Hydrolases,  Ubiquitin Thiolesterase,  Cell Transformation,  Viral]"} , { "attrname": "AUTHORS", "value": "[B Honor,  H H Rasmussen,  J Vandekerckhove,  J E Celis]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 20-25; 79-81; 106-121 AND 134-151]"} ], "id": "1317", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1849484", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0014-5793(91)80300-R"} , { "elementOf": "NLM", "accession": "1849484"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 20-25; 79-91; 106-123 AND 136-151]", "conames": [{ "name": "PMID: 1286667", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "1286667", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Electrophoresis"} , { "attrname": "Chemical", "value": "[Proteins]"} , { "attrname": "YEAR", "value": "1993"} , { "attrname": "AbstractHeader", "value": "Microsequences of 145 proteins recorded in the two-dimensional gel protein database of normal human epidermal keratinocytes."} , { "attrname": "Abstract", "value": "Microsequencing of proteins recovered from two-dimensional (2-D) gels is being used systematically to identify proteins in the master human keratinocyte 2-D gel database. To date,  about 250 protein spots recorded in human 2-D gel databases have been microsequenced and,  of these,  145 are recorded in the keratinocyte database under the entry partial amino acid sequence. Coomassie Brilliant Blue-stained protein spots cut from several (up to 40) dry gels were concentrated by elution-concentration gel electrophoresis,  electroblotted onto PVDF membranes and digested in situ with trypsin. Eluting peptides were separated by reversed-phase HPLC,  collected individually and sequenced. Computer search using the FASTA and TFASTA programs from Genetics Computer Group indicated that 110 of the microsequenced polypeptides shared significant similarity with proteins contained in the PIR,  Mipsx or GenEMBL databases. Only 35 polypeptides corresponded to hitherto unknown proteins. Peptide sequences of all 145 proteins are listed together with their coordinates (apparent molecular weight and pI) in the keratinocyte database. "} , { "attrname": "MeSH", "value": "[Proteins,  Sequence Homology,  Amino Acid,  Amino Acid Sequence,  Humans,  Keratinocytes,  Molecular Sequence Data,  Electrophoresis,  Gel,  Two-Dimensional,  Reference Values,  Software,  Databases,  Factual]"} , { "attrname": "AUTHORS", "value": "[H H Rasmussen,  J van Damme,  M Puype,  B Gesser,  J E Celis,  J Vandekerckhove]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 20-25; 79-91; 106-123 AND 136-151]"} ], "id": "1318", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 1286667", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "1286667"} , { "elementOf": "DOI", "accession": "10.1002\/ELPS.11501301199"} ]} , { "annotation": "[VARIANT TYR-18]", "conames": [{ "name": "PMID: 21268678", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "21268678", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Ophthalmic genetics"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human]"} , { "attrname": "YEAR", "value": "2011"} , { "attrname": "AbstractHeader", "value": "Ubiquitin carboxyl-terminal esterase L1 (UCHL1) S18Y polymorphism in patients with cataracts."} , { "attrname": "Abstract", "value": "?Cataract is characterized by light-scattering protein aggregates. The ubiquitin-proteasome system has been proposed a role in proteolytic removal of these protein aggregates. Ubiquitin carboxyl-terminal esterase L1 (UCHL1) is a de-ubiquitinating enzyme with important functions in recycling of ubiquitin. A protective role of the p.S18Y polymorphism of the UCHL1 gene has been shown in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>`s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. The current study aimed to examine possible effects on cataract formation. ?Patients with cataract (n?=?493) and controls (n?=?142) were analyzed for the UCHL1 p.S18Y polymorphism using dynamic allele-specific hybridization. ?Significant differences were observed in allele and genotype frequencies of the p.S18Y polymorphism between controls and cataract patients,  where a positive UCHL1 allele A carrier status was associated with the cataract diagnosis (adjusted OR 1.7 [95% CI?=?1.1-2.6] p?=?0.02). No significant differences were seen in genotype distribution when stratifying for type of cataract. Nor did the mean age at cataract surgery differ between genotypes. ?The current study does not support a protective role for the UCHL1 S18Y polymorphism in cataract development,  but may instead suggest a <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-promoting effect. "} , { "attrname": "MeSH", "value": "[Cataract,  Nucleic Acid Hybridization,  Humans,  Middle Aged,  Polymerase Chain Reaction,  Aged,  80 and over,  Female,  Genotype,  Male,  Aged,  Polymorphism,  Single Nucleotide,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Thiemo Rudolph,  Annica Sjlander,  Mona Seibt Palmr,  Lennart Minthon,  Anders Wallin,  Niels Andreasen,  Gunnar Tasa,  Erkki Juronen,  Kaj Blennow,  Henrik Zetterberg,  Madeleine Zetterberg]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT TYR-18]"} ], "id": "1319", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 21268678", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "21268678"} , { "elementOf": "DOI", "accession": "10.3109\/13816810.2010.544360"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-15]", "conames": [{ "name": "PMID: 2163617", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2163617", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Biochemical journal"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  Ubiquitins,  Neuropeptides,  RNA,  Messenger]"} , { "attrname": "YEAR", "value": "1990"} , { "attrname": "AbstractHeader", "value": "The structure of the human gene encoding protein gene product 9.5 (PGP9.5),  a neuron-specific ubiquitin C-terminal hydrolase."} , { "attrname": "Abstract", "value": "Database search using a bovine thymus ubiquitin C-terminal hydrolase sequence indicated 54% sequence identity with the abundant human neuron-specific protein gene product 9.5 (PGP9.5),  which was then shown to possess the same activity [Wilkinson,  Lee,  Deshpande,  Duerksen-Hughes,  Boss & Pohl (1989) Science 246,  670-673]. A yeast counterpart of the enzyme is also known. The human PGP9.5 gene,  described here,  spans 10 kb,  contains nine exons and displays 5' features some common to many genes and some common with neurofilament neuron-specific enolase and Thy-1-antigen gene 5' regions. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Exons,  Base Sequence,  Humans,  Ubiquitins,  Molecular Sequence Data,  Neuropeptides,  Chromosome Mapping,  RNA,  Messenger,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[I N Day,  L J Hinks,  R J Thompson]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 1-15]"} ], "id": "1320", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2163617", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "2163617"} ]} , { "annotation": "[VARIANT TYR-18]", "conames": [{ "name": "PMID: 11027850", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "11027850", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[42HK56048U Tyrosine,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Nerve Tissue Proteins,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2000"} , { "attrname": "AbstractHeader", "value": "The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "The ubiquitin carboxy-terminal hydrolase L1gene (UCH-L1) has been implicated in the aetiology of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). A rare Ile93Met mutation in UCH-L1 in a German PD sib-pair has been reported. Recently,  a S18Y (C54A) polymorphism in exon 3 of UCH-L1 was found to be under-represented in PD patients compared to controls. To test the reproducibility of this negative association,  we conducted an allele-association study of the S18Y polymorphism in an Australian case-control sample consisting of 142 PD cases and 142 closely matched control subjects. Genotypes were determined using polymerase chain reaction and RsaI restriction enzyme assay. Analysis revealed no significant difference between PD patients and controls for genotype or allele frequencies of the S18Y polymorphism. The frequency of the S18Y allele in Australian subjects is similar to that reported elsewhere. This study suggests that the S18Y polymorphism in UCH-L1 does not influence the risk for developing PD. "} , { "attrname": "MeSH", "value": "[Tyrosine,  Humans,  Middle Aged,  Serine,  Genotype,  Male,  Nerve Tissue Proteins,  Case-Control Studies,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Electrophoresis,  Agar Gel,  Alleles,  Aged,  80 and over,  Adult,  Female,  Thiolester Hydrolases,  Aged,  Ubiquitin Thiolesterase,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[G D Mellick,  P A Silburn]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT TYR-18]"} ], "id": "1321", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 11027850", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/S0304-3940(00)01510-X"} , { "elementOf": "NLM", "accession": "11027850"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 16-223,  VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  BIOPHYSICOCHEMICAL PROPERTIES]", "conames": [{ "name": "PMID: 9774100", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9774100", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Nature"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Ubiquitins,  9007-49-2 DNA,  Recombinant Proteins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "The ubiquitin pathway in Parkinson's <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Brain,  Escherichia coli,  Humans,  Middle Aged,  Molecular Sequence Data,  Rats,  Male,  Recombinant Proteins,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Animals,  Base Sequence,  DNA,  Ubiquitins,  Female,  Thiolester Hydrolases,  Mice,  Catalysis,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[E Leroy,  R Boyer,  G Auburger,  B Leube,  G Ulm,  E Mezey,  G Harta,  M J Brownstein,  S Jonnalagada,  T Chernova,  A Dehejia,  C Lavedan,  T Gasser,  P J Steinbach,  K D Wilkinson,  M H Polymeropoulos]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 16-223,  VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT PARK5 MET-93,  BIOPHYSICOCHEMICAL PROPERTIES]"} ], "id": "1322", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9774100", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/26652"} , { "elementOf": "NLM", "accession": "9774100"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA] OF 7-223,  PARTIAL PROTEIN SEQUENCE]", "conames": [{ "name": "PMID: 2947814", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "2947814", "attributes": [{ "attrname": "JOURNAL_REF", "value": "FEBS letters"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  9007-49-2 DNA,  Neuropeptides]"} , { "attrname": "YEAR", "value": "1987"} , { "attrname": "AbstractHeader", "value": "Molecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells."} , { "attrname": "Abstract", "value": "The co-ordinate sequencing of the human neuronal and neuroendocrine marker protein PGP 9.5 and its cDNA is described. The cDNA encodes the complete protein (212 amino acids),  and the 340 nucleotide 3'-noncoding region including the polyadenylation signal,  indicating an mRNA slightly larger than 1 kb in size. Protein sequencing of 50% of PGP 9.5 confirms the deduced protein sequence. "} , { "attrname": "MeSH", "value": "[Neurosecretory Systems,  Amino Acid Sequence,  Neurons,  Base Sequence,  DNA,  Genes,  Humans,  Cloning,  Molecular,  Neuropeptides,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[I N Day,  R J Thompson]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA] OF 7-223,  PARTIAL PROTEIN SEQUENCE]"} ], "id": "1323", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 2947814", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1016\/0014-5793(87)81327-3"} , { "elementOf": "NLM", "accession": "2947814"} ]} , { "annotation": "[VARIANT NDGOA ALA-7,  CHARACTERIZATION OF VARIANT NDGOA ALA-7]", "conames": [{ "name": "PMID: 23359680", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "23359680", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human]"} , { "attrname": "YEAR", "value": "2013"} , { "attrname": "AbstractHeader", "value": "Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration."} , { "attrname": "Abstract", "value": "Ubiquitin C-terminal hydrolase-L1 (UCHL1),  a neuron-specific de-ubiquitinating enzyme,  is one of the most abundant proteins in the brain. We describe three siblings from a consanguineous union with a previously unreported early-onset progressive neurodegenerative syndrome featuring childhood onset blindness,  cerebellar ataxia,  nystagmus,  dorsal column dysfuction,  and spasticity with upper motor neuron dysfunction. Through homozygosity mapping of the affected individuals followed by whole-exome sequencing of the index case,  we identified a previously undescribed homozygous missense mutation within the ubiquitin binding domain of UCHL1 (UCHL1(GLU7ALA)),  shared by all affected subjects. As demonstrated by isothermal titration calorimetry,  purified UCHL1(GLU7ALA),  compared with WT,  exhibited at least sevenfold reduced affinity for ubiquitin. In vitro,  the mutation led to a near complete loss of UCHL1 hydrolase activity. The GLU7ALA variant is predicted to interfere with the substrate binding by restricting the proper positioning of the substrate for tunneling underneath the cross-over loop spanning the catalytic cleft of UCHL1. This interference with substrate binding,  combined with near complete loss of hydrolase activity,  resulted in a >100-fold reduction in the efficiency of UCHL1(GLU7ALA) relative to WT. These findings demonstrate a broad requirement of UCHL1 in the maintenance of the nervous system. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Humans,  Child,  Preschool,  Molecular Sequence Data,  Substrate Specificity,  Male,  Mutation,  Missense,  Exome,  Thermodynamics,  Base Sequence,  Adult,  Female,  Amino Acid Sequence,  Neurons,  Models,  Molecular,  Genes,  Recessive,  Sequence Analysis,  DNA,  Syndrome,  Hydrolysis,  Homozygote,  Pedigree,  Age of Onset,  Protein Binding,  Nerve Degeneration,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Kaya Bilguvar,  Navneet K Tyagi,  Cigdem Ozkara,  Beyhan Tuysuz,  Mehmet Bakircioglu,  Murim Choi,  Sakir Delil,  Ahmet O Caglayan,  Jacob F Baranoski,  Ozdem Erturk,  Cengiz Yalcinkaya,  Murat Karacorlu,  Alp Dincer,  Michele H Johnson,  Shrikant Mane,  Sreeganga S Chandra,  Angeliki Louvi,  Titus J Boggon,  Richard P Lifton,  Arthur L Horwich,  Murat Gunel]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT NDGOA ALA-7,  CHARACTERIZATION OF VARIANT NDGOA ALA-7]"} ], "id": "1324", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 23359680", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "23359680"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.1222732110"} ]} , { "annotation": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF VARIANTS TYR-18 AND MET-93 IN COMPLEX WITH UBIQUITIN,  CATALYTIC ACTIVITY,  ACTIVE SITE,  MUTAGENESIS OF CYS-90 AND PHE-204]", "conames": [{ "name": "PMID: 20439756", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "20439756", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Proceedings of the National Academy of Sciences of the United States of America"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  Ubiquitins,  ubiquitin vinylmethyl ester,  EC 3.1.2.15 UCHL1 protein,  human]"} , { "attrname": "YEAR", "value": "2010"} , { "attrname": "AbstractHeader", "value": "Ubiquitin vinyl methyl ester binding orients the misaligned active site of the ubiquitin hydrolase UCHL1 into productive conformation."} , { "attrname": "Abstract", "value": "Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) is a <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated,  putative cysteine protease found abundantly and selectively expressed in neurons. The crystal structure of apo UCHL1 showed that the active-site residues are not aligned in a canonical form,  with the nucleophilic cysteine being 7.7 A from the general base histidine,  an arrangement consistent with an inactive form of the enzyme. Here we report the crystal structures of the wild type and two <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>-associated variants of the enzyme,  S18Y and I93M,  bound to a ubiquitin-based suicide substrate,  ubiquitin vinyl methyl ester. These structures reveal that ubiquitin vinyl methyl ester binds primarily at two sites on the enzyme,  with its carboxy terminus at the active site and with its amino-terminal beta-hairpin at the distal site-a surface-exposed hydrophobic crevice 17 A away from the active site. Binding at the distal site initiates a cascade of side-chain movements in the enzyme that starts at a highly conserved,  surface-exposed phenylalanine and is relayed to the active site resulting in the reorientation and proximal placement of the general base within 4 A of the catalytic cysteine,  an arrangement found in productive cysteine proteases. Mutation of the distal-site,  surface-exposed phenylalanine to alanine reduces ubiquitin binding and severely impairs the catalytic activity of the enzyme. These results suggest that the activity of UCHL1 may be regulated by its own substrate. "} , { "attrname": "MeSH", "value": "[Catalytic Domain,  Escherichia coli,  Humans,  Ubiquitins,  Crystallization,  Models,  Molecular,  Protein Binding,  Calorimetry,  Protein Conformation,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[David A Boudreaux,  Tushar K Maiti,  Christopher W Davies,  Chittaranjan Das]"} , { "attrname": "PUB_TYPE", "value": "[X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF VARIANTS TYR-18 AND MET-93 IN COMPLEX WITH UBIQUITIN,  CATALYTIC ACTIVITY,  ACTIVE SITE,  MUTAGENESIS OF CYS-90 AND PHE-204]"} ], "id": "1325", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 20439756", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "20439756"} , { "elementOf": "DOI", "accession": "10.1073\/PNAS.0910870107"} ]} , { "annotation": "[VARIANT TYR-18,  LACK OF ASSOCIATION OF VARIANT TYR-18 WITH <span style=\"background-color: yellow\"><b>PARKINSON<\/b><\/span> DISEASE]", "conames": [{ "name": "PMID: 16450370", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16450370", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Annals of neurology"} , { "attrname": "Chemical", "value": "[42HK56048U Tyrosine,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.15 UCHL1 protein,  human,  452VLY9402 Serine]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "UCHL-1 is not a Parkinson's disease susceptibility gene."} , { "attrname": "Abstract", "value": "The UCHL-1 gene is widely cited as a susceptibility factor for sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The strongest evidence comes from a meta-analysis of small studies that reported the S18Y polymorphism as protective against PD,  after pooling studies of white and Asian subjects. Here,  we present data that challenge this association. In a new large case-control study in white individuals (3, 023 subjects),  the S18Y variant was not protective against PD under any genetic model of inheritance. Similarly,  a more powerful haplotype-tagging approach did not detect other associated variants. Finally,  in an updated S18Y-PD meta-analysis (6, 594 subjects),  no significant association was observed under additive,  recessive,  or dominant models (odds ratio = 1.00 [95% confidence interval:  0.74-1.33]; odds ratio = 1.01 [95% confidence interval:  0.76-1.35]; and odds ratio = 0.96 [95% confidence interval:  0.86-1.08],  respectively),  and a cumulative meta-analysis showed a trend toward a null effect. Based on the current evidence,  the UCHL-1 gene does not exhibit a protective effect in PD. "} , { "attrname": "MeSH", "value": "[Tyrosine,  Confidence Intervals,  Meta-Analysis as Topic,  Humans,  Middle Aged,  Serine,  Genotype,  Male,  Case-Control Studies,  Linkage Disequilibrium,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Female,  Odds Ratio,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Daniel G Healy,  Patrick M Abou-Sleiman,  Juan P Casas,  Kourosh R Ahmadi,  Timothy Lynch,  Sonia Gandhi,  Miratul M K Muqit,  Thomas Foltynie,  Roger Barker,  Kailash P Bhatia,  Niall P Quinn,  Andrew J Lees,  J Mark Gibson,  Janice L Holton,  Tamas Revesz,  David B Goldstein,  Nicholas W Wood]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT TYR-18,  LACK OF ASSOCIATION OF VARIANT TYR-18 WITH PARKINSON DISEASE]"} ], "id": "1326", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16450370", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "16450370"} , { "elementOf": "DOI", "accession": "10.1002\/ANA.20757"} ]} , { "annotation": "[PROTEIN SEQUENCE OF 1-15 AND 214-221,  SUSCEPTIBILITY TO OXIDATION,  IDENTIFICATION BY MASS SPECTROMETRY,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 14722078", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "14722078", "attributes": [{ "attrname": "JOURNAL_REF", "value": "The Journal of biological chemistry"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  Coloring Agents,  Protein Isoforms,  S88TT14065 Oxygen,  Proteome,  EC 3.4.21.4 Trypsin,  EC 3.1.2.15 Ubiquitin carboxyl-Terminal Hydrolase L-1,  mouse]"} , { "attrname": "YEAR", "value": "2004"} , { "attrname": "AbstractHeader", "value": "Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s and <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s."} , { "attrname": "Abstract", "value": "<span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) and <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD) are the two most common neurodegenerative <span style=\"background-color: yellow\"><b>disease<\/b><\/span>s that occur either in relatively rare,  familial forms or in common,  sporadic forms. The genetic defects underlying several monogenic familial forms of AD and PD have recently been identified,  however,  the causes of other AD and PD cases,  particularly sporadic cases,  remain unclear. To gain insights into the pathogenic mechanisms involved in AD and PD,  we used a proteomic approach to identify proteins with altered expression levels and\/or oxidative modifications in idiopathic AD and PD brains. Here,  we report that the protein level of ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1),  a neuronal de-ubiquitinating enzyme whose mutation has been linked to an early-onset familial PD,  is down-regulated in idiopathic PD as well as AD brains. By using a combination of two-dimensional gel electrophoresis and mass spectrometry,  we have identified three human brain UCH-L1 isoforms,  a full-length form and two amino-terminally truncated forms. Our proteomic analyses reveal that the full-length UCH-L1 is a major target of oxidative damage in AD and PD brains,  which is extensively modified by carbonyl formation,  methionine oxidation,  and cysteine oxidation. Furthermore,  immunohistochemical studies show that prominent UCH-L1 immunostaining is associated with neurofibrillary tangles and that the level of soluble UCH-L1 protein is inversely proportional to the number of tangles in AD brains. Together,  these results provide evidence supporting a direct link between oxidative damage to the neuronal ubiquitination\/de-ubiquitination machinery and the pathogenesis of sporadic AD and PD. "} , { "attrname": "MeSH", "value": "[Immunohistochemistry,  Protein Structure,  Tertiary,  Amino Acid Sequence,  Brain,  Oxygen,  Oxidative Stress,  Coloring Agents,  Down-Regulation,  Humans,  Molecular Sequence Data,  Electrophoresis,  Gel,  Two-Dimensional,  Immunoblotting,  Proteome,  Chromatography,  High Pressure Liquid,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Sequence Homology,  Amino Acid,  Trypsin,  Image Processing,  Computer-Assisted,  Mass Spectrometry,  Protein Isoforms,  Mutation,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Joungil Choi,  Allan I Levey,  Susan T Weintraub,  Howard D Rees,  Marla Gearing,  Lih-Shen Chin,  Lian Li]"} , { "attrname": "PUB_TYPE", "value": "[PROTEIN SEQUENCE OF 1-15 AND 214-221,  SUSCEPTIBILITY TO OXIDATION,  IDENTIFICATION BY MASS SPECTROMETRY,  TISSUE SPECIFICITY]"} ], "id": "1327", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 14722078", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "14722078"} , { "elementOf": "DOI", "accession": "10.1074\/JBC.M314124200"} ]} , { "annotation": "[VARIANT TYR-18]", "conames": [{ "name": "PMID: 10203348", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10203348", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroreport"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "A coding substitution (I93M) in the ubiquitin carboxy-terminal L1 (UCH-L1) gene has recently been identified in a German family with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. We have sequenced the entire coding region of the gene in 11 families who have a pattern of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> consistent with autosomal dominant inheritance. We found a polymorphism (S18Y) in exon 3,  two polymorphisms in the 5' non-coding region,  upstream of the transcription start,  and an insertion\/deletion polymorphism in intron 4. The S18Y allele is present on approximately 20% of chromosomes in a Caucasian population. These changes are,  therefore,  unlikely to be pathogenic. We conclude that the I93M variant must either be a rare cause of <span style=\"background-color: yellow\"><b>disease<\/b><\/span> or a harmless substitution whose occurrence in the family reflects a chance co-occurrence. "} , { "attrname": "MeSH", "value": "[Gene Frequency,  Humans,  Middle Aged,  Male,  Reference Values,  Polymorphism,  Genetic,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Alleles,  Adult,  Female,  Thiolester Hydrolases,  Aged,  Mutation,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[S Lincoln,  J Vaughan,  N Wood,  M Baker,  J Adamson,  K Gwinn-Hardy,  T Lynch,  J Hardy,  M Farrer]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT TYR-18]"} ], "id": "1328", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10203348", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10203348"} , { "elementOf": "DOI", "accession": "10.1097\/00001756-199902050-00040"} ]} , { "annotation": "[FUNCTION,  TISSUE SPECIFICITY]", "conames": [{ "name": "PMID: 9790970", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "9790970", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[Peptide Fragments,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  NEDD8 protein,  human,  Ubiquitins]"} , { "attrname": "YEAR", "value": "1998"} , { "attrname": "AbstractHeader", "value": "Cleavage of the C-terminus of NEDD8 by UCH-L3."} , { "attrname": "Abstract", "value": "NEDD8 is a novel ubiquitin-like protein that has been shown to conjugate to nuclear proteins in a manner analogous to ubiquitination and sentrinization. To identify proteins that are involved in the NEDD8-conjugation and de-conjugation pathway,  the yeast two-hybrid system was used to screen a human heart cDNA library using NEDD8 as a bait. Seven strongly positive clones were found to contain a cDNA insert encoding the ubiquitin C-terminal hydrolase,  UCH-L3. In vitro GST pull-down assay demonstrated that UCH-L3 bound to both NEDD8 and ubiquitin. In contrast,  UCH-L3 did not bind to sentrin-1,  sentrin-2,  or sentrin-3. Recombinant UCH-L3,  but not UCH-L1,  was able to cleave the C-terminus of NEDD8. Thus,  UCH-L3 can function as a C-terminal hydrolase for both NEDD8 and ubiquitin. UCH-L3 may play a physiologically significant role in the cleavage of the C-terminus of NEDD8,  which is required for NEDD8 to conjugate to target proteins. "} , { "attrname": "MeSH", "value": "[Peptide Fragments,  Gene Library,  Down-Regulation,  Humans,  Selection,  Genetic,  Hydrolysis,  Tissue Distribution,  Ubiquitins,  Protein Binding,  Thiolester Hydrolases,  Protein Processing,  Post-Translational,  Saccharomyces cerevisiae,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[H Wada,  K Kito,  L S Caskey,  E T Yeh,  T Kamitani]"} , { "attrname": "PUB_TYPE", "value": "[FUNCTION,  TISSUE SPECIFICITY]"} ], "id": "1329", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 9790970", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "9790970"} , { "elementOf": "DOI", "accession": "10.1006\/BBRC.1998.9532"} ]} , { "annotation": "[INTERACTION WITH COPS5]", "conames": [{ "name": "PMID: 12082530", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12082530", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Oncogene"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  EC 3.4.- Peptide Hydrolases,  Intracellular Signaling Peptides and Proteins,  Macromolecular Substances,  147604-94-2 Cyclin-Dependent Kinase Inhibitor p27,  EC 3.4.-.- COPS5 protein,  human,  Culture Media,  Neoplasm Proteins,  Transcription Factors,  Cell Cycle Proteins,  Tumor Suppressor Proteins,  DNA-Binding Proteins,  Proto-Oncogene Proteins c-jun]"} , { "attrname": "YEAR", "value": "2002"} , { "attrname": "AbstractHeader", "value": "Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1)."} , { "attrname": "Abstract", "value": "PGP9.5 (UCH-L1) is a member of the ubiquitin C-terminal hydrolase (UCH) family of proteins that is expressed in neuronal tissues. Our previous studies have shown that PGP9.5 was highly expressed in primary lung cancers and lung cancer cell lines. Additionally,  the frequency of PGP9.5 over expression increases with tumor stage,  indicating that PGP9.5 may play a role in lung cancer tumorigenesis. We used the yeast two-hybrid system to identify proteins that interact with PGP9.5. We show that PGP9.5 interacts with at least three proteins,  one of which is JAB1,  a Jun activation domain binding protein that can bind to p27(Kip1) and is involved in the cytoplasmic transportation of p27(Kip1) for its degradation. We also show that PGP9.5 is associated with JAB1 in vitro and in vivo; and that both proteins can be a part of a heteromeric complex containing p27(Kip1) in the nucleus in lung cancer cells. Furthermore,  under serum-restimulation,  nuclear translocation of both PGP9.5 and JAB1 coincides with a reduced level of p27(Kip1) in the nucleus. In contrast,  when cells are contact inhibited,  both PGP9.5 and JAB1 became more perinuclear and cytoplasmic in localization while p27(Kip1) was present only in the nucleus. Therefore,  PGP9.5 may contribute to p27(Kip1) degradation via its interaction and nuclear translocation with JAB1. "} , { "attrname": "MeSH", "value": "[Protein Structure,  Tertiary,  Humans,  Transcriptional Activation,  Intracellular Signaling Peptides and Proteins,  Lung Neoplasms,  Cyclin-Dependent Kinase Inhibitor p27,  Macromolecular Substances,  Protein Interaction Mapping,  Two-Hybrid System Techniques,  Culture Media,  Neoplasm Proteins,  Blood Physiological Phenomena,  Protein Binding,  Thiolester Hydrolases,  Peptide Hydrolases,  Transcription Factors,  Active Transport,  Cell Nucleus,  Tumor Cells,  Cultured,  Ubiquitin Thiolesterase,  Cell Cycle Proteins,  Tumor Suppressor Proteins,  DNA-Binding Proteins,  Proto-Oncogene Proteins c-jun]"} , { "attrname": "AUTHORS", "value": "[Otvia L Caballero,  Vicente Resto,  Meera Patturajan,  Daoud Meerzaman,  Ming Zhou Guo,  James Engles,  Robert Yochem,  Edward Ratovitski,  David Sidransky,  Jin Jen]"} , { "attrname": "PUB_TYPE", "value": "[INTERACTION WITH COPS5]"} ], "id": "1330", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12082530", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1038\/SJ.ONC.1205390"} , { "elementOf": "NLM", "accession": "12082530"} ]} , { "annotation": "[VARIANT MET-93]", "conames": [{ "name": "PMID: 10454131", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "10454131", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Neuroscience letters"} , { "attrname": "Chemical", "value": "[EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Nerve Tissue Proteins,  DNA Primers]"} , { "attrname": "YEAR", "value": "1999"} , { "attrname": "AbstractHeader", "value": "The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>."} , { "attrname": "Abstract", "value": "Recently an Ile93Met mutation in the ubiquitin-carboxy-terminal-hydrolase-L1 gene (UCH-L1) has been described in a German family with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (PD). The authors showed that this mutation is responsible for an impaired proteolytic activity of the UCH-L1 protein and may lead to an abnormal aggregation of proteins in the brain. In order to determine the importance of this or any other mutation in the coding region of the UCH-L1 gene in PD,  we performed mutation analysis on Caucasian families with at least two affected sibs. We did not detect any mutations in the UCH-L1 gene,  however,  we cannot exclude mutations in the regulatory or intronic regions of the UCH-L1 gene since these regions were not sequenced. We conclude that the UCH-L1 gene is not a major gene responsible for familial PD. "} , { "attrname": "MeSH", "value": "[Exons,  Humans,  Middle Aged,  Nuclear Family,  European Continental Ancestry Group,  Male,  Nerve Tissue Proteins,  DNA Primers,  <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Point Mutation,  Netherlands,  Polymerase Chain Reaction,  Female,  Italy,  Thiolester Hydrolases,  Aged,  France,  Ubiquitin Thiolesterase,  Germany,  Amino Acid Substitution]"} , { "attrname": "AUTHORS", "value": "[B S Harhangi,  M J Farrer,  S Lincoln,  V Bonifati,  G Meco,  G De Michele,  A Brice,  A Drr,  M Martinez,  T Gasser,  B Bereznai,  J R Vaughan,  N W Wood,  J Hardy,  B A Oostra,  M M Breteler]"} , { "attrname": "PUB_TYPE", "value": "[VARIANT MET-93]"} ], "id": "1331", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 10454131", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "10454131"} , { "elementOf": "DOI", "accession": "10.1016\/S0304-3940(99)00465-6"} ]} , { "annotation": "[CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18,  MUTAGENESIS OF CYS-90,  BIOPHYSICOCHEMICAL PROPERTIES]", "conames": [{ "name": "PMID: 12705903", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "12705903", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemical and biophysical research communications"} , { "attrname": "Chemical", "value": "[K1CVM13F96 4-hydroxy-2-nonenal,  EC 3.4.19.12 Ubiquitin Thiolesterase,  EC 3.1.2.- Thiolester Hydrolases,  Ubiquitins,  Coumarins,  ubiquitin C-terminal 7-amido-4-methylcoumarin,  Recombinant Proteins,  Aldehydes]"} , { "attrname": "YEAR", "value": "2003"} , { "attrname": "AbstractHeader", "value": "Alterations of structure and hydrolase activity of <span style=\"background-color: yellow\"><b>parkinson<\/b><\/span>ism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants."} , { "attrname": "Abstract", "value": "Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) is a neuron-specific ubiquitin recycling enzyme. A mutation at residue 93 and polymorphism at residue 18 within human UCH-L1 are linked to familial <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> and a decreased <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> risk,  respectively. Thus,  we constructed recombinant human UCH-L1 variants and examined their structure (using circular dichroism) and hydrolase activities. We confirmed that an I93M substitution results in a decrease in kcat (45.6%) coincident with an alteration in alpha-helical content. These changes may contribute to the pathogenesis of <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. In contrast,  an S18Y substitution results in an increase in kcat (112.6%) without altering the circular dichroistic spectrum. These data suggest that UCH-L1 hydrolase activity may be inversely correlated with <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> risk and that the hydrolase activity is protective against the <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. Furthermore,  we found that oxidation of UCH-L1 by 4-hydroxynonenal,  a candidate for endogenous mediator of oxidative stress-induced neuronal cell death,  results in a loss of hydrolase activity. Taken together,  these results suggest that further studies of altered UCH-L1 hydrolase function may provide new insights into a possible common pathogenic mechanism between familial and sporadic <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. "} , { "attrname": "MeSH", "value": "[<span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Protein Structure,  Secondary,  Humans,  Ubiquitins,  Coumarins,  Thiolester Hydrolases,  Kinetics,  Mutation,  Recombinant Proteins,  Aldehydes,  Circular Dichroism,  Ubiquitin Thiolesterase]"} , { "attrname": "AUTHORS", "value": "[Kaori Nishikawa,  Hang Li,  Ryoichi Kawamura,  Hitoshi Osaka,  Yu-Lai Wang,  Yoko Hara,  Takatsugu Hirokawa,  Yoshimasa Manago,  Taiju Amano,  Mami Noda,  Shunsuke Aoki,  Keiji Wada]"} , { "attrname": "PUB_TYPE", "value": "[CHARACTERIZATION OF VARIANT PARK5 MET-93,  CHARACTERIZATION OF VARIANT TYR-18,  MUTAGENESIS OF CYS-90,  BIOPHYSICOCHEMICAL PROPERTIES]"} ], "id": "1332", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 12705903", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "12705903"} , { "elementOf": "DOI", "accession": "10.1016\/S0006-291X(03)00555-2"} ]} , { "annotation": "[ACTIVE SITE]", "conames": [{ "name": "PMID: 16475834", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "16475834", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Biochemistry"} , { "attrname": "Chemical", "value": "[Ubiquitin,  EC 3.4.19.12 Ubiquitin Thiolesterase,  Ubiquitins,  Coumarins,  451W47IQ8X Sodium Chloride,  ubiquitin C-terminal 7-amido-4-methylcoumarin,  EC 3.- Hydrolases]"} , { "attrname": "YEAR", "value": "2006"} , { "attrname": "AbstractHeader", "value": "Mechanistic studies of ubiquitin C-terminal hydrolase L1."} , { "attrname": "Abstract", "value": "Ubiquitin C-terminal hydrolases (UCHs) cleave Ub-X bonds (Ub is ubiquitin and X an alcohol,  an amine,  or a protein) through a thioester intermediate that is produced by nucleophilic attack of the Cys residue of a Cys-SH\/His-Im catalytic diad. We are studying the mechanism of UCH-L1,  a UCH that is implicated in <span style=\"background-color: yellow\"><b>Parkinson<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  and now wish to report our initial findings. (i) Pre-steady-state kinetic studies for UCH-L1-catalyzed hydrolysis of Ub-AMC (AMC,  7-amido-4-methylcoumarin) indicate that k(cat) is rate-limited by acyl-enzyme formation. Thus,  K(m) = K(s),  the dissociation constant for the Michaelis complex,  and k(cat) = k(2),  the rate constant for acyl-enzyme formation. (ii) For K(assoc) (=K(s)(-)(1)),  DeltaC(p) = -0.8 kcal mol(-)(1) deg(-)(1) and is consistent with coupling between substrate association and a conformational change of the enzyme. For k(2),  DeltaS(++) = 0 and suggests that in the E-S,  substrate and active site residues are precisely aligned for reaction. (iii) Solvent isotope effects are (D)K(assoc) = 0.5 and (D)k(2) = 0.9,  suggesting that the substrate binds to a form of free enzyme in which the active site Cys exists as the thiol. In the resultant Michaelis complex,  the diad has tautomerized to ion pair Cys-S(-)\/His-ImH(+). Subsequent attack of thiolate produces the acyl-enzyme species. In contrast,  isotope effects for association of UCH-L1 with transition-state analogue ubiquitin aldehyde suggest that an alternative mechanistic pathway can sometimes be available to UCH-L1 involving general base-catalyzed attack of Cys-SH by His-Im. "} , { "attrname": "MeSH", "value": "[Ubiquitin,  Thermodynamics,  Sodium Chloride,  Temperature,  Models,  Chemical,  Ubiquitins,  Coumarins,  Hydrolases,  Kinetics,  Ubiquitin Thiolesterase,  Acylation,  Hydrogen-Ion Concentration]"} , { "attrname": "AUTHORS", "value": "[April Case,  Ross L Stein]"} , { "attrname": "PUB_TYPE", "value": "[ACTIVE SITE]"} ], "id": "1333", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 16475834", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1021\/BI052135T"} , { "elementOf": "NLM", "accession": "16475834"} ]} , { "annotation": "", "conames": [{ "name": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4", "isPreferred": "true"} ], "elementOf": "OMIM: UNIPROTKB", "description": "", "pid": "606889", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "70"} ], "id": "1334", "contexts": { } , "evidences": ["Imported from database"], "value": "ALZHEIMER <span style=\"background-color: yellow\"><b>DISEASE<\/b><\/span> 4", "ofType": "Disease", "coaccessions": [{ "elementOf": "OMIM", "accession": "606889"} ]} , { "annotation": "A membrane-tethered,  short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum) that is similar in structure to a centriole and derives from it. The cilium basal body is the site of assembly and remodelling of the cilium and serves as a nucleation site for axoneme growth. As well as anchoring the cilium,  it is thought to provide a selective gateway regulating the entry of ciliary proteins and vesicles by intraflagellar transport. ( Reference:  GOC: cilia GOC: clt PMID: 21750193 )", "conames": [{ "name": "cilial basal body", "isPreferred": "true"} , { "name": "microtubule basal body", "isPreferred": "true"} , { "name": "ciliary basal body", "isPreferred": "true"} , { "name": "basal body", "isPreferred": "false"} , { "name": "cilium basal body", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0036064", "attributes": [], "id": "1335", "contexts": { } , "evidences": ["Imported from database"], "value": "cilium basal body", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005932"} , { "elementOf": "GO", "accession": "GO: 0036064"} ]} , { "annotation": "The inner,  i.e. lumen-facing,  lipid bilayer of the nuclear envelope. ( Reference:  GOC: ma )", "conames": [{ "name": "inner envelope", "isPreferred": "false"} , { "name": "nuclear inner membrane", "isPreferred": "true"} , { "name": "inner nuclear membrane", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0005637", "attributes": [], "id": "1336", "contexts": { } , "evidences": ["Imported from database"], "value": "inner nuclear membrane", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0005637"} ]} , { "annotation": "A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. ( Reference:  GOC: go_curators http: \/\/www.ebi.ac.uk\/intact\/complex\/documentation\/ )", "conames": [{ "name": "protein complex", "isPreferred": "true"} , { "name": "protein-protein complex", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0043234", "attributes": [], "id": "1337", "contexts": { } , "evidences": ["Imported from database"], "value": "protein complex", "ofType": "Cellular_Component", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0043234"} ]} , { "annotation": "The process whose specific outcome is the progression of the hair follicle over time,  from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open. ( Reference:  GOC: dph UBERON: 0002073 )", "conames": [{ "name": "hair follicle development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0001942", "attributes": [], "id": "1338", "contexts": { } , "evidences": ["Imported from database"], "value": "hair follicle development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0001942"} , { "elementOf": "GO", "accession": "GO: 0001943"} ]} , { "annotation": "Muscle contraction of cardiac muscle tissue. ( Reference:  GOC: dph )", "conames": [{ "name": "heart muscle contraction", "isPreferred": "true"} , { "name": "cardiac muscle contraction", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0060048", "attributes": [], "id": "1339", "contexts": { } , "evidences": ["Imported from database"], "value": "heart muscle contraction", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0060048"} ]} , { "annotation": "A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal,  and ends when the execution phase of apoptosis is triggered. ( Reference:  GOC: mtg_apoptosis )", "conames": [{ "name": "apoptotic signalling pathway", "isPreferred": "true"} , { "name": "apoptotic signaling pathway", "isPreferred": "true"} , { "name": "induction of apoptosis by extracellular signals", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0097190", "attributes": [], "id": "1340", "contexts": { } , "evidences": ["Imported from database"], "value": "apoptotic signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0097190"} , { "elementOf": "GO", "accession": "GO: 0008624"} ]} , { "annotation": "The process whose specific outcome is the progression of the alveolus over time,  from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways. ( Reference:  GOC: mtg_lung PMID: 9751757 )", "conames": [{ "name": "lung alveolus development", "isPreferred": "true"} , { "name": "alveolarization", "isPreferred": "true"} , { "name": "alveologenesis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048286", "attributes": [], "id": "1341", "contexts": { } , "evidences": ["Imported from database"], "value": "alveologenesis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048286"} ]} , { "annotation": "The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage. ( Reference:  GOC: add PMID: 16551251 )", "conames": [{ "name": "myeloid leucocyte differentiation", "isPreferred": "true"} , { "name": "myeloid leukocyte differentiation", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0002573", "attributes": [], "id": "1342", "contexts": { } , "evidences": ["Imported from database"], "value": "myeloid leukocyte differentiation", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0002573"} ]} , { "annotation": "Any process that stops,  prevents or reduces the frequency,  rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. ( Reference:  GOC: TermGenie PMID: 17245429 );", "conames": [{ "name": "down-regulation of death receptor-mediated apoptosis", "isPreferred": "false"} , { "name": "down regulation of extrinsic apoptotic signaling pathway via death domain receptors", "isPreferred": "true"} , { "name": "inhibition of extrinsic apoptotic signaling pathway via death domain receptors", "isPreferred": "false"} , { "name": "downregulation of extrinsic apoptotic signaling pathway via death domain receptors", "isPreferred": "true"} , { "name": "negative regulation of death receptor-mediated apoptosis", "isPreferred": "false"} , { "name": "down-regulation of extrinsic apoptotic signaling pathway via death domain receptors", "isPreferred": "true"} , { "name": "down regulation of death receptor-mediated apoptosis", "isPreferred": "false"} , { "name": "inhibition of death receptor-mediated apoptosis", "isPreferred": "false"} , { "name": "downregulation of death receptor-mediated apoptosis", "isPreferred": "false"} , { "name": "negative regulation of extrinsic apoptotic signaling pathway via death domain receptors", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 1902042", "attributes": [], "id": "1343", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of extrinsic apoptotic signaling pathway via death domain receptors", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 1902042"} ]} , { "annotation": "Any process that stops,  prevents,  or reduces the frequency,  rate or extent of protein complex assembly. ( Reference:  GOC: mah )", "conames": [{ "name": "negative regulation of protein complex assembly", "isPreferred": "true"} , { "name": "down regulation of protein complex assembly", "isPreferred": "true"} , { "name": "downregulation of protein complex assembly", "isPreferred": "true"} , { "name": "inhibition of protein complex assembly", "isPreferred": "false"} , { "name": "down-regulation of protein complex assembly", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031333", "attributes": [], "id": "1344", "contexts": { } , "evidences": ["Imported from database"], "value": "downregulation of protein complex assembly", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031333"} ]} , { "annotation": "The directed movement of calcium (Ca) ions into,  out of or within a cell,  or between cells,  by means of some agent such as a transporter or pore. ( Reference:  GOC: ai )", "conames": [{ "name": "mitochondrial sodium\/calcium ion exchange", "isPreferred": "false"} , { "name": "calcium ion transport", "isPreferred": "true"} , { "name": "sodium: calcium exchange", "isPreferred": "false"} , { "name": "calcium transport", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0006816", "attributes": [], "id": "1345", "contexts": { } , "evidences": ["Imported from database"], "value": "calcium transport", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0006816"} ]} , { "annotation": "The process whose specific outcome is the progression of the forebrain over time,  from its formation to the mature structure. The forebrain is the anterior of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates,  includes especially the cerebral hemispheres,  the thalamus,  and the hypothalamus and especially in higher vertebrates is the main control center for sensory and associative information processing,  visceral functions,  and voluntary motor functions). ( Reference:  http: \/\/www2.merriam-webster.com\/cgi-bin\/mwmednlm?book=Medical&va=forebrain )", "conames": [{ "name": "forebrain development", "isPreferred": "true"} , { "name": "prosencephalon development", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0030900", "attributes": [], "id": "1346", "contexts": { } , "evidences": ["Imported from database"], "value": "forebrain development", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0030900"} ]} , { "annotation": "The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin. ( Reference:  GOC: ceb )", "conames": [{ "name": "Eph receptor signalling pathway", "isPreferred": "true"} , { "name": "Eph receptor signaling pathway", "isPreferred": "true"} , { "name": "ephrin receptor signaling pathway", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048013", "attributes": [], "id": "1347", "contexts": { } , "evidences": ["Imported from database"], "value": "Eph receptor signaling pathway", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048013"} ]} , { "annotation": "The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain. ( Reference:  PMID: 12808018 )", "conames": [{ "name": "membrane protein solubilization", "isPreferred": "false"} , { "name": "membrane protein intracellular domain proteolysis", "isPreferred": "true"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0031293", "attributes": [], "id": "1348", "contexts": { } , "evidences": ["Imported from database"], "value": "membrane protein intracellular domain proteolysis", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0031293"} ]} , { "annotation": "A series of molecular signals initiated by the binding of a neurotrophin to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity,  and ending with regulation of a downstream cellular process,  e.g. transcription. ( Reference:  GOC: bf GOC: ceb GOC: jc GOC: signaling PMID: 12065629 Wikipedia: Trk_receptor )", "conames": [{ "name": "TrkB signaling pathway", "isPreferred": "false"} , { "name": "neurotrophin TRK receptor signaling pathway", "isPreferred": "true"} , { "name": "tropomyosin-receptor-kinase signaling", "isPreferred": "true"} , { "name": "TrkA signaling pathway", "isPreferred": "false"} , { "name": "TrkC signaling pathway", "isPreferred": "false"} ], "elementOf": "GO: UNIPROTKB", "description": "", "pid": "GO: 0048011", "attributes": [], "id": "1349", "contexts": { } , "evidences": ["Imported from database"], "value": "tropomyosin-receptor-kinase signaling", "ofType": "Biological_Process", "coaccessions": [{ "elementOf": "GO", "accession": "GO: 0048011"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [MRNA],  VARIANT AD4 ILE-141]", "conames": [{ "name": "PMID: 7638622", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "7638622", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Science (New York,  N.Y.)"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Psen2 protein,  mouse,  DNA,  Complementary]"} , { "attrname": "YEAR", "value": "1995"} , { "attrname": "AbstractHeader", "value": "Candidate gene for the chromosome 1 familial Alzheimer's disease locus."} , { "attrname": "Abstract", "value": "A candidate gene for the chromosome 1 <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span>'s <span style=\"background-color: yellow\"><b>disease<\/b><\/span> (AD) locus was identified (STM2). The predicted amino acid sequence for STM2 is homologous to that of the recently cloned chromosome 14 AD gene (S182). A point mutation in STM2,  resulting in the substitution of an isoleucine for an asparagine (N141l),  was identified in affected people from Volga German AD kindreds. This N141l mutation occurs at an amino acid residue that is conserved in human S182 and in the mouse S182 homolog. The presence of missense mutations in AD subjects in two highly similar genes strongly supports the hypothesis that mutations in both are pathogenic. "} , { "attrname": "MeSH", "value": "[Amino Acid Sequence,  Presenilin-2,  Gene Expression,  Humans,  Middle Aged,  Molecular Sequence Data,  Male,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  Lod Score,  Membrane Proteins,  Point Mutation,  Chromosomes,  Human,  Pair 1,  Pedigree,  Base Sequence,  Cloning,  Molecular,  Adult,  Female,  Aged,  Mutation,  Germany,  DNA,  Complementary]"} , { "attrname": "AUTHORS", "value": "[E Levy-Lahad,  W Wasco,  P Poorkaj,  D M Romano,  J Oshima,  W H Pettingell,  C E Yu,  P D Jondro,  S D Schmidt,  K Wang]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [MRNA],  VARIANT AD4 ILE-141]"} ], "id": "1350", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 7638622", "ofType": "Publication", "coaccessions": [{ "elementOf": "NLM", "accession": "7638622"} , { "elementOf": "DOI", "accession": "10.1126\/SCIENCE.7638622"} ]} , { "annotation": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]", "conames": [{ "name": "PMID: 8661049", "isPreferred": "true"} ], "elementOf": "NLM: UNIPROTKB", "description": "", "pid": "8661049", "attributes": [{ "attrname": "JOURNAL_REF", "value": "Genomics"} , { "attrname": "Chemical", "value": "[Membrane Proteins,  PSEN2 protein,  human,  Presenilin-2,  Psen2 protein,  mouse,  Recombinant Proteins,  DNA Primers]"} , { "attrname": "YEAR", "value": "1997"} , { "attrname": "AbstractHeader", "value": "Genomic structure and expression of STM2,  the chromosome 1 familial Alzheimer disease gene."} , { "attrname": "Abstract", "value": "Mutations in the gene STM2 result in autosomal dominant familial <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>. To screen for mutations and to identify regulatory elements for this gene,  the genomic DNA sequence and intron-exon structure were determined. Twelve exons including 10 coding exons were identified in a genomic region spanning 23, 737 bp. The first 2 exons encode the 5'-untranslated region. Expression analysis of STM2 indicates that two transcripts of 2.4 and 2.8 kb are found in skeletal muscle,  pancreas,  and heart. In addition,  a splice variant of the 2.4-kb transcript was identified that is the result of the use of an alternative splice acceptor site located in exon 10. The use of this site results in a transcript lacking a single glutamate. The promotor for this gene and the alternatively spliced exons leading to the 2.8-kb form of the gene remain to be identified. Expression of STM2 was high in skeletal muscle and pancreas,  with comparatively low levels observed in brain. This expression pattern is intriguing since in <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>disease<\/b><\/span>,  pathology and degeneration are observed only in the central nervous system. "} , { "attrname": "MeSH", "value": "[Brain,  Presenilin-2,  Alternative Splicing,  Humans,  Regulatory Sequences,  Nucleic Acid,  Molecular Sequence Data,  Recombinant Proteins,  Chromosomes,  Human,  Pair 1,  Base Sequence,  Cloning,  Molecular,  Polymerase Chain Reaction,  Transcription,  Genetic,  Pancreas,  Amino Acid Sequence,  Promoter Regions,  Genetic,  Introns,  Chromosome Mapping,  <span style=\"background-color: yellow\"><b>Alzheimer<\/b><\/span> <span style=\"background-color: yellow\"><b>Disease<\/b><\/span>,  DNA Primers,  Organ Specificity,  Membrane Proteins,  Sequence Homology,  Amino Acid,  Myocardium,  Muscle,  Skeletal,  Apoptosis]"} , { "attrname": "AUTHORS", "value": "[E Levy-Lahad,  P Poorkaj,  K Wang,  Y H Fu,  J Oshima,  J Mulligan,  G D Schellenberg]"} , { "attrname": "PUB_TYPE", "value": "[NUCLEOTIDE SEQUENCE [GENOMIC DNA]]"} ], "id": "1351", "contexts": { } , "evidences": ["Imported from database"], "value": "PMID: 8661049", "ofType": "Publication", "coaccessions": [{ "elementOf": "DOI", "accession": "10.1006\/GENO.1996.0266"} , { "elementOf": "NLM", "accession": "8661049"} ]} ], "numberOfConcepts": 1351, "numberOfRelations": 1601, "relations": [{ "toConcept": "1", "fromConcept": "18", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e1", "contexts": { } , "evidences": ["Imported from database"], "ofType": "encodes"} , { "toConcept": "19", "fromConcept": "1", "attributes": [{ "attrname": "CoCitNum", "value": "1"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "0.28831276753551904"} , { "attrname": "PMID", "value": "27067015"} , { "attrname": "MAX_TFIDF", "value": "0.28831276753551904"} , { "attrname": "EVIDENCE", "value": "[Other associated loci included interesting candidate genes on chromosome 1 (GRIK3 (glutamate receptor ionotropic kainate 3)),  chromosome 4 (KLHL2 (Kelch-like protein 2)),  chromosome 17 (CRHR1 (corticotropin-releasing hormone receptor 1) and MAPT (microtubule-associated protein Tau)) and on chromosome 18 (CELF4 (CUGBP elav-like family member 4)).]"} ], "id": "e2", "contexts": { } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "20", "fromConcept": "1", "attributes": [{ "attrname": "CoCitNum", "value": "6"} , { "attrname": "CoSenNum", "value": "3"} , { "attrname": "visible", "value": "true"} , { "attrname": "IP_TFIDF", "value": "4.238652283947431"} , { "attrname": "size", "value": "5"} , { "attrname": "PMID", "value": "11601501,  11601501,  10899436,  10899436,  11089577,  11089577"} , { "attrname": "MAX_TFIDF", "value": "1.3782680691240188"} , { "attrname": "EVIDENCE", "value": "[In the presence of heparin,  tau proteins with the K369I mutation formed short,  slender filaments.,  In addition,  the K257T mutation was found to stimulate heparin-induced assembly of 3-repeat tau into filaments.,  Several missense mutations also have a stimulatory effect on heparin-induced tau filament formation.]"} ], "id": "e3", "contexts": { "context": { "id": 14} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "30", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e4", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "31", "fromConcept": "1", "attributes": [], "id": "e5", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "32", "fromConcept": "1", "attributes": [], "id": "e6", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "has_function"} , { "toConcept": "33", "fromConcept": "1", "attributes": [], "id": "e7", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "34", "fromConcept": "1", "attributes": [], "id": "e8", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "35", "fromConcept": "1", "attributes": [], "id": "e9", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "36", "fromConcept": "1", "attributes": [], "id": "e10", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "37", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0813\"(proximity ligation assay)"} ], "id": "e11", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "38", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e12", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "39", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0049\"(filter binding)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e13", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "40", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e14", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "41", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e15", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "54", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e16", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "55", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0813\"(proximity ligation assay)"} ], "id": "e17", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "56", "fromConcept": "1", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0081\"(peptide array)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0081\"(peptide array)"} ], "id": "e18", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "85", "fromConcept": "1", "attributes": [], "id": "e19", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "located_in"} , { "toConcept": "86", "fromConcept": "1", "attributes": [], "id": "e20", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "87", "fromConcept": "1", "attributes": [], "id": "e21", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "88", "fromConcept": "1", "attributes": [], "id": "e22", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "89", "fromConcept": "1", "attributes": [], "id": "e23", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "90", "fromConcept": "1", "attributes": [], "id": "e24", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "1", "attributes": [], "id": "e25", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "92", "fromConcept": "1", "attributes": [], "id": "e26", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "93", "fromConcept": "1", "attributes": [], "id": "e27", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "94", "fromConcept": "1", "attributes": [], "id": "e28", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "95", "fromConcept": "1", "attributes": [], "id": "e29", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "96", "fromConcept": "1", "attributes": [], "id": "e30", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "1", "attributes": [], "id": "e31", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "98", "fromConcept": "1", "attributes": [], "id": "e32", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1", "fromConcept": "99", "attributes": [], "id": "e33", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "1", "fromConcept": "100", "attributes": [], "id": "e34", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "101", "fromConcept": "1", "attributes": [], "id": "e35", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "102", "fromConcept": "1", "attributes": [], "id": "e36", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "103", "fromConcept": "1", "attributes": [], "id": "e37", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "104", "fromConcept": "1", "attributes": [], "id": "e38", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "105", "fromConcept": "1", "attributes": [], "id": "e39", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "106", "fromConcept": "1", "attributes": [], "id": "e40", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "107", "fromConcept": "1", "attributes": [], "id": "e41", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "108", "fromConcept": "1", "attributes": [], "id": "e42", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "109", "fromConcept": "1", "attributes": [], "id": "e43", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "110", "fromConcept": "1", "attributes": [], "id": "e44", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "111", "fromConcept": "1", "attributes": [], "id": "e45", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "112", "fromConcept": "1", "attributes": [], "id": "e46", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "113", "fromConcept": "1", "attributes": [], "id": "e47", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "114", "fromConcept": "1", "attributes": [], "id": "e48", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "115", "fromConcept": "1", "attributes": [], "id": "e49", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "116", "fromConcept": "1", "attributes": [], "id": "e50", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "117", "fromConcept": "1", "attributes": [], "id": "e51", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "118", "fromConcept": "1", "attributes": [], "id": "e52", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "119", "fromConcept": "1", "attributes": [], "id": "e53", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "120", "fromConcept": "1", "attributes": [], "id": "e54", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "121", "fromConcept": "1", "attributes": [], "id": "e55", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "122", "fromConcept": "1", "attributes": [], "id": "e56", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "123", "fromConcept": "1", "attributes": [], "id": "e57", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "124", "fromConcept": "1", "attributes": [], "id": "e58", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "125", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e59", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "7", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e60", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "126", "fromConcept": "1", "attributes": [], "id": "e61", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "127", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e62", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "128", "fromConcept": "1", "attributes": [], "id": "e63", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "129", "fromConcept": "1", "attributes": [], "id": "e64", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "130", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e65", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "131", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e66", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "132", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e67", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "133", "fromConcept": "1", "attributes": [], "id": "e68", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "134", "fromConcept": "1", "attributes": [], "id": "e69", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "135", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e70", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "17", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e71", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "14", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e72", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "136", "fromConcept": "1", "attributes": [], "id": "e73", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "137", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e74", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "138", "fromConcept": "1", "attributes": [], "id": "e75", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "139", "fromConcept": "1", "attributes": [], "id": "e76", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "140", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e77", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "141", "fromConcept": "1", "attributes": [], "id": "e78", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "142", "fromConcept": "1", "attributes": [], "id": "e79", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "143", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e80", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "9", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e81", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "144", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e82", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "145", "fromConcept": "1", "attributes": [], "id": "e83", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "146", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e84", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "147", "fromConcept": "1", "attributes": [], "id": "e85", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "148", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e86", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "149", "fromConcept": "1", "attributes": [], "id": "e87", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "3", "fromConcept": "1", "attributes": [], "id": "e88", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "150", "fromConcept": "1", "attributes": [], "id": "e89", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "151", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e90", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "152", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e91", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "153", "fromConcept": "1", "attributes": [], "id": "e92", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "6", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e93", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "154", "fromConcept": "1", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e94", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "155", "fromConcept": "1", "attributes": [], "id": "e95", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "156", "fromConcept": "1", "attributes": [], "id": "e96", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "157", "fromConcept": "1", "attributes": [], "id": "e97", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "158", "fromConcept": "1", "attributes": [], "id": "e98", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "159", "fromConcept": "1", "attributes": [], "id": "e99", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "10", "fromConcept": "1", "attributes": [], "id": "e100", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "160", "fromConcept": "1", "attributes": [], "id": "e101", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "161", "fromConcept": "1", "attributes": [], "id": "e102", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "162", "fromConcept": "1", "attributes": [], "id": "e103", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "163", "fromConcept": "1", "attributes": [], "id": "e104", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "164", "fromConcept": "1", "attributes": [], "id": "e105", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "11", "fromConcept": "1", "attributes": [], "id": "e106", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "165", "fromConcept": "1", "attributes": [], "id": "e107", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "166", "fromConcept": "1", "attributes": [], "id": "e108", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "167", "fromConcept": "1", "attributes": [], "id": "e109", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "168", "fromConcept": "1", "attributes": [], "id": "e110", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "169", "fromConcept": "1", "attributes": [], "id": "e111", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "170", "fromConcept": "1", "attributes": [], "id": "e112", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "171", "fromConcept": "1", "attributes": [], "id": "e113", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "172", "fromConcept": "1", "attributes": [], "id": "e114", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "173", "fromConcept": "1", "attributes": [], "id": "e115", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "174", "fromConcept": "1", "attributes": [], "id": "e116", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "175", "fromConcept": "1", "attributes": [], "id": "e117", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "176", "fromConcept": "1", "attributes": [], "id": "e118", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "177", "fromConcept": "1", "attributes": [], "id": "e119", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "178", "fromConcept": "1", "attributes": [], "id": "e120", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "179", "fromConcept": "1", "attributes": [], "id": "e121", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "180", "fromConcept": "1", "attributes": [], "id": "e122", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "181", "fromConcept": "1", "attributes": [], "id": "e123", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "182", "fromConcept": "1", "attributes": [], "id": "e124", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "183", "fromConcept": "1", "attributes": [], "id": "e125", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "184", "fromConcept": "185", "attributes": [{ "attrname": "SNP_risk_allele", "value": "H1H2-?"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "0.0"} ], "id": "e126", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "185", "fromConcept": "18", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e127", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "186", "fromConcept": "187", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs17690703-C"} , { "attrname": "PVALUE", "value": "6.0E-9"} ], "id": "e128", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "187", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e129", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "189", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e130", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "188", "fromConcept": "189", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs1864325-T"} , { "attrname": "PVALUE", "value": "5.0E-11"} ], "id": "e131", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "184", "fromConcept": "190", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs11012-T"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "6.0E-8"} ], "id": "e132", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "190", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "3_prime_UTR_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e133", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "191", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs2942168-G"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "1.0E-28"} ], "id": "e134", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "191", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "non_coding_transcript_exon_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e135", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "192", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e136", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "192", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs17577094-?"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "8.0E-9"} ], "id": "e137", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "193", "fromConcept": "194", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs1981997-G"} , { "attrname": "PVALUE", "value": "9.0E-14"} ], "id": "e138", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "194", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "non_coding_transcript_exon_variant"} ], "id": "e139", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "196", "fromConcept": "195", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs9303525-G"} , { "attrname": "PVALUE", "value": "8.0E-15"} ], "id": "e140", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "195", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e141", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "198", "fromConcept": "197", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs2732703-T"} , { "attrname": "PVALUE", "value": "6.0E-9"} ], "id": "e142", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "197", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e143", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "199", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs17649553-C"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "0.0"} ], "id": "e144", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "199", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e145", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "200", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs199498-T"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "2.0E-6"} ], "id": "e146", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "200", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e147", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "202", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e148", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "201", "fromConcept": "202", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs11655470-T"} , { "attrname": "PVALUE", "value": "4.0E-6"} ], "id": "e149", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "184", "fromConcept": "203", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs199533-C"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "1.0E-14"} ], "id": "e150", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "203", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "synonymous_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e151", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "204", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs12185268-A"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "3.0E-14"} ], "id": "e152", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "204", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "missense_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e153", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "205", "fromConcept": "204", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs12185268-?"} , { "attrname": "PVALUE", "value": "1.0E-9"} ], "id": "e154", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "196", "fromConcept": "206", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs8072451-?"} , { "attrname": "PVALUE", "value": "1.0E-8"} ], "id": "e155", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "206", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e156", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "208", "fromConcept": "207", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs8070723-?"} , { "attrname": "PVALUE", "value": "0.0"} ], "id": "e157", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "207", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e158", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "207", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs8070723-?"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "7.0E-12"} ], "id": "e159", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "205", "fromConcept": "209", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs393152-?"} , { "attrname": "PVALUE", "value": "1.0E-12"} ], "id": "e160", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "209", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "non_coding_transcript_exon_variant"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e161", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "184", "fromConcept": "209", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs393152-A"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "PVALUE", "value": "2.0E-16"} ], "id": "e162", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "208", "fromConcept": "210", "attributes": [{ "attrname": "SNP_risk_allele", "value": "rs242557-?"} , { "attrname": "PVALUE", "value": "9.0E-18"} ], "id": "e163", "contexts": { } , "evidences": ["GWAS", "Imported from database"], "ofType": "associated_with"} , { "toConcept": "210", "fromConcept": "18", "attributes": [{ "attrname": "Context", "value": "intron_variant"} ], "id": "e164", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_variation"} , { "toConcept": "41", "fromConcept": "38", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e165", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "211", "fromConcept": "38", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e166", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "212", "fromConcept": "38", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e167", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "213", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e168", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "214", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e169", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "215", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0049\"(filter binding)"} ], "id": "e170", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "216", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0049\"(filter binding)"} ], "id": "e171", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "217", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e172", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "218", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e173", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "41", "fromConcept": "39", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e174", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "219", "fromConcept": "40", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0065\"(isothermal titration calorimetry)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0065\"(isothermal titration calorimetry)"} ], "id": "e175", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "220", "fromConcept": "40", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e176", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "40", "fromConcept": "221", "attributes": [], "id": "e177", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "222", "fromConcept": "41", "attributes": [{ "attrname": "CoCitNum", "value": "2"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "1.476866105680756"} , { "attrname": "PMID", "value": "22012985,  22012985"} , { "attrname": "MAX_TFIDF", "value": "0.8529489040374756"} , { "attrname": "EVIDENCE", "value": "[Here we report that LRRK2 activates a calcium-dependent protein kinase kinase-? (CaMKK-?)\/adenosine monophosphate (AMP)-activated protein kinase (AMPK) pathway which is followed by a persistent increase in autophagosome formation.]"} ], "id": "e178", "contexts": { "context": { "id": 43} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "41", "fromConcept": "223", "attributes": [{ "attrname": "CoCitNum", "value": "7"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "9.091679122418274"} , { "attrname": "PMID", "value": "15852371,  15852371,  15852371,  16172858,  16172858,  16272164,  16272164"} , { "attrname": "MAX_TFIDF", "value": "3.8248040080070496"} , { "attrname": "EVIDENCE", "value": "[Leucine-rich repeat kinase 2 (LRRK2) mutations have been implicated in autosomal dominant parkinsonism,  consistent with typical levodopa-responsive Parkinson's disease.]"} ], "id": "e179", "contexts": { "context": { "id": 44} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "226", "fromConcept": "41", "attributes": [{ "attrname": "CoCitNum", "value": "4"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "2.9673378257774132"} , { "attrname": "PMID", "value": "15680457,  15680457,  17019612,  17019612"} , { "attrname": "MAX_TFIDF", "value": "1.262767518313268"} , { "attrname": "EVIDENCE", "value": "[The glycine at position 2385 is a candidate site for N-myristoylation,  and the Gly2385Arg variant replaces the hydrophobic glycine with the hydrophilic arginine,  and increases the net positive charge of the LRRK2 WD40 domain.]"} ], "id": "e180", "contexts": { "context": { "id": 47} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "234", "fromConcept": "41", "attributes": [{ "attrname": "CoCitNum", "value": "7"} , { "attrname": "CoSenNum", "value": "4"} , { "attrname": "IP_TFIDF", "value": "26.35539762602566"} , { "attrname": "PMID", "value": "21812969,  16081470,  16081470,  16532471,  16532471,  23395371,  23395371"} , { "attrname": "MAX_TFIDF", "value": "18.844530521328807"} , { "attrname": "EVIDENCE", "value": "[We found a high and strikingly specific expression of LRRK2 mRNA in rodent striatum and parts of cortex and no signals in dopamine neurons.,  Deficiency of the PARK16 locus gene RAB7L1 in primary rodent neurons,  or of a RAB7L1 ortholog in Drosophila dopamine neurons,  recapitulated degeneration observed with expression of a familial PD mutant form of LRRK2,  whereas RAB7L1 overexpression rescued the LRRK2 mutant phenotypes.,  In human tissue,  LRRK2 mRNA was found in the corresponding brain areas caudatus and putamen at lower levels and dopamine neurons were also devoid of LRRK2 mRNA.,  LRRK2 expression linked to dopamine-innervated areas.]"} ], "id": "e181", "contexts": { "context": { "id": 46} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "241", "fromConcept": "41", "attributes": [{ "attrname": "CoCitNum", "value": "4"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "1.2777003010597303"} , { "attrname": "PMID", "value": "22012985,  22012985,  22012985,  22012985"} , { "attrname": "MAX_TFIDF", "value": "0.4259971082210541"} , { "attrname": "EVIDENCE", "value": "[Here we report that LRRK2 activates a calcium-dependent protein kinase kinase-? (CaMKK-?)\/adenosine monophosphate (AMP)-activated protein kinase (AMPK) pathway which is followed by a persistent increase in autophagosome formation.]"} ], "id": "e182", "contexts": { "context": { "id": 43} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "242", "fromConcept": "41", "attributes": [], "id": "e183", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "243", "fromConcept": "41", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e184", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "244", "fromConcept": "41", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e185", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "245", "fromConcept": "41", "attributes": [], "id": "e186", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "246", "fromConcept": "41", "attributes": [], "id": "e187", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "has_function"} , { "toConcept": "247", "fromConcept": "41", "attributes": [], "id": "e188", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "248", "fromConcept": "41", "attributes": [], "id": "e189", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "249", "fromConcept": "41", "attributes": [], "id": "e190", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "250", "fromConcept": "41", "attributes": [], "id": "e191", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "251", "fromConcept": "41", "attributes": [], "id": "e192", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "252", "fromConcept": "41", "attributes": [], "id": "e193", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "253", "fromConcept": "41", "attributes": [], "id": "e194", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "254", "fromConcept": "41", "attributes": [], "id": "e195", "contexts": { } , "evidences": ["ECO: 0000305"], "ofType": "has_function"} , { "toConcept": "255", "fromConcept": "41", "attributes": [], "id": "e196", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "256", "fromConcept": "41", "attributes": [], "id": "e197", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "257", "fromConcept": "41", "attributes": [], "id": "e198", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "258", "fromConcept": "41", "attributes": [], "id": "e199", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "259", "fromConcept": "41", "attributes": [], "id": "e200", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "260", "fromConcept": "41", "attributes": [], "id": "e201", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "261", "fromConcept": "41", "attributes": [], "id": "e202", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "262", "fromConcept": "41", "attributes": [], "id": "e203", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "263", "fromConcept": "41", "attributes": [], "id": "e204", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "264", "fromConcept": "41", "attributes": [], "id": "e205", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "265", "fromConcept": "41", "attributes": [], "id": "e206", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "has_function"} , { "toConcept": "266", "fromConcept": "41", "attributes": [], "id": "e207", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "267", "fromConcept": "41", "attributes": [], "id": "e208", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "219", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e209", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "268", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e210", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "269", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e211", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "270", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e212", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "271", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e213", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "272", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e214", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "273", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e215", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "274", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e216", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "275", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e217", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "276", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e218", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "277", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e219", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "278", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e220", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "279", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e221", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "280", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e222", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "281", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e223", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "282", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e224", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "283", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e225", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "284", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e226", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "285", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e227", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "286", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e228", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "287", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e229", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "288", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e230", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "289", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e231", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "290", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e232", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "291", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e233", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "292", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e234", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "293", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e235", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "294", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e236", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "295", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e237", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "296", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e238", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "297", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e239", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "298", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e240", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "299", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e241", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "300", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e242", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "301", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e243", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "302", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e244", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "303", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e245", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "304", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e246", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "305", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e247", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "306", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e248", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "307", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e249", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "308", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e250", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "309", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e251", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "310", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e252", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "311", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e253", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "312", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e254", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "313", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e255", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "314", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e256", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "315", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e257", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "316", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e258", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "317", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e259", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "318", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e260", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "319", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e261", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "218", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e262", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "320", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e263", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "321", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e264", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "322", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e265", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "323", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e266", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "324", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e267", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "325", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e268", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "326", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e269", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "327", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e270", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "328", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e271", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "329", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e272", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "330", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e273", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "331", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e274", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "211", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e275", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "332", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e276", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "333", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e277", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "334", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e278", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "335", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e279", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "336", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e280", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "337", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e281", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "338", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e282", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "339", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e283", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "340", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e284", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "341", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e285", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "342", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e286", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "350", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e287", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "351", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e288", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "352", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e289", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "353", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e290", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "354", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e291", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "355", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e292", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "356", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e293", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "357", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e294", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "358", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e295", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "359", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e296", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "360", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0047\"(far western blotting)"} ], "id": "e297", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "361", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0053\"(fluorescence polarization spectroscopy)"} ], "id": "e298", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "362", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e299", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "363", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e300", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "364", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e301", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "365", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e302", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "366", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e303", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "367", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e304", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "368", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e305", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "369", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e306", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "370", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e307", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "371", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e308", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "372", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e309", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "373", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e310", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "374", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e311", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "375", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e312", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "376", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e313", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "391", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e314", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "392", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e315", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "393", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e316", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "394", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e317", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "395", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e318", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "396", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e319", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "397", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e320", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "398", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e321", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "399", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e322", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "400", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e323", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "401", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e324", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "402", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 1019\"(protein phosphatase assay)"} ], "id": "e325", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "403", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e326", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "404", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e327", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "405", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e328", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "406", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e329", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "407", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e330", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "408", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e331", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "409", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e332", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "410", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0019\"(coimmunoprecipitation)"} ], "id": "e333", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "411", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e334", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "412", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e335", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "413", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e336", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "216", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e337", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "38", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0053\"(fluorescence polarization spectroscopy)"} ], "id": "e338", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "414", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e339", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "415", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0019\"(coimmunoprecipitation)"} ], "id": "e340", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "416", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e341", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "417", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e342", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "418", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e343", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "419", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e344", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "420", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e345", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "421", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0663\"(confocal microscopy)"} ], "id": "e346", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "422", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e347", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "423", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e348", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "424", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e349", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "425", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0089\"(protein array)"} ], "id": "e350", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "426", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e351", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "427", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e352", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "428", "fromConcept": "41", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0808\"(comigration in sds page)"} ], "id": "e353", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "88", "fromConcept": "41", "attributes": [], "id": "e354", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "429", "fromConcept": "41", "attributes": [], "id": "e355", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "41", "attributes": [], "id": "e356", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "431", "fromConcept": "41", "attributes": [], "id": "e357", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "98", "fromConcept": "41", "attributes": [], "id": "e358", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "432", "fromConcept": "41", "attributes": [], "id": "e359", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "433", "fromConcept": "41", "attributes": [], "id": "e360", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "434", "fromConcept": "41", "attributes": [], "id": "e361", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "435", "fromConcept": "41", "attributes": [], "id": "e362", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "41", "attributes": [], "id": "e363", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "436", "fromConcept": "41", "attributes": [], "id": "e364", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "437", "fromConcept": "41", "attributes": [], "id": "e365", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "438", "fromConcept": "41", "attributes": [], "id": "e366", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "439", "fromConcept": "41", "attributes": [], "id": "e367", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "440", "fromConcept": "41", "attributes": [], "id": "e368", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "located_in"} , { "toConcept": "441", "fromConcept": "41", "attributes": [], "id": "e369", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "442", "fromConcept": "41", "attributes": [], "id": "e370", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "443", "fromConcept": "41", "attributes": [], "id": "e371", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "444", "fromConcept": "41", "attributes": [], "id": "e372", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "445", "fromConcept": "41", "attributes": [], "id": "e373", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "446", "fromConcept": "41", "attributes": [], "id": "e374", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "447", "fromConcept": "41", "attributes": [], "id": "e375", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "41", "attributes": [], "id": "e376", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "449", "fromConcept": "41", "attributes": [], "id": "e377", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "450", "fromConcept": "41", "attributes": [], "id": "e378", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "451", "fromConcept": "41", "attributes": [], "id": "e379", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "452", "fromConcept": "41", "attributes": [], "id": "e380", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "94", "fromConcept": "41", "attributes": [], "id": "e381", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "453", "fromConcept": "41", "attributes": [], "id": "e382", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "454", "fromConcept": "41", "attributes": [], "id": "e383", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "41", "attributes": [], "id": "e384", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "455", "fromConcept": "41", "attributes": [], "id": "e385", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "456", "fromConcept": "41", "attributes": [], "id": "e386", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "457", "fromConcept": "41", "attributes": [], "id": "e387", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "458", "fromConcept": "41", "attributes": [], "id": "e388", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "459", "fromConcept": "41", "attributes": [], "id": "e389", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "460", "fromConcept": "41", "attributes": [], "id": "e390", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "461", "fromConcept": "41", "attributes": [], "id": "e391", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "462", "fromConcept": "41", "attributes": [], "id": "e392", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "463", "fromConcept": "41", "attributes": [], "id": "e393", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "464", "fromConcept": "41", "attributes": [], "id": "e394", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "465", "fromConcept": "41", "attributes": [], "id": "e395", "contexts": { } , "evidences": ["ECO: 0000305"], "ofType": "participates_in"} , { "toConcept": "466", "fromConcept": "41", "attributes": [], "id": "e396", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "467", "fromConcept": "41", "attributes": [], "id": "e397", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "468", "fromConcept": "41", "attributes": [], "id": "e398", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "469", "fromConcept": "41", "attributes": [], "id": "e399", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "470", "fromConcept": "41", "attributes": [], "id": "e400", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "471", "fromConcept": "41", "attributes": [], "id": "e401", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "472", "fromConcept": "41", "attributes": [], "id": "e402", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "473", "fromConcept": "41", "attributes": [], "id": "e403", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "474", "fromConcept": "41", "attributes": [], "id": "e404", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "475", "fromConcept": "41", "attributes": [], "id": "e405", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "476", "fromConcept": "41", "attributes": [], "id": "e406", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "477", "fromConcept": "41", "attributes": [], "id": "e407", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "478", "fromConcept": "41", "attributes": [], "id": "e408", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "479", "fromConcept": "41", "attributes": [], "id": "e409", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "480", "fromConcept": "41", "attributes": [], "id": "e410", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "481", "fromConcept": "41", "attributes": [], "id": "e411", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "482", "fromConcept": "41", "attributes": [], "id": "e412", "contexts": { } , "evidences": ["ECO: 0000305"], "ofType": "participates_in"} , { "toConcept": "483", "fromConcept": "41", "attributes": [], "id": "e413", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "484", "fromConcept": "41", "attributes": [], "id": "e414", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "485", "fromConcept": "41", "attributes": [], "id": "e415", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "486", "fromConcept": "41", "attributes": [], "id": "e416", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "487", "fromConcept": "41", "attributes": [], "id": "e417", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "488", "fromConcept": "41", "attributes": [], "id": "e418", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "489", "fromConcept": "41", "attributes": [], "id": "e419", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "490", "fromConcept": "41", "attributes": [], "id": "e420", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "491", "fromConcept": "41", "attributes": [], "id": "e421", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "492", "fromConcept": "41", "attributes": [], "id": "e422", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "493", "fromConcept": "41", "attributes": [], "id": "e423", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "494", "fromConcept": "41", "attributes": [], "id": "e424", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "495", "fromConcept": "41", "attributes": [], "id": "e425", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "496", "fromConcept": "41", "attributes": [], "id": "e426", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "497", "fromConcept": "41", "attributes": [], "id": "e427", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "498", "fromConcept": "41", "attributes": [], "id": "e428", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "499", "fromConcept": "41", "attributes": [], "id": "e429", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "500", "fromConcept": "41", "attributes": [], "id": "e430", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "501", "fromConcept": "41", "attributes": [], "id": "e431", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "502", "fromConcept": "41", "attributes": [], "id": "e432", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "503", "fromConcept": "41", "attributes": [], "id": "e433", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "504", "fromConcept": "41", "attributes": [], "id": "e434", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "505", "fromConcept": "41", "attributes": [], "id": "e435", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "116", "fromConcept": "41", "attributes": [], "id": "e436", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "506", "fromConcept": "41", "attributes": [], "id": "e437", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "507", "fromConcept": "41", "attributes": [], "id": "e438", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "508", "fromConcept": "41", "attributes": [], "id": "e439", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "509", "fromConcept": "41", "attributes": [], "id": "e440", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "510", "fromConcept": "41", "attributes": [], "id": "e441", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "511", "fromConcept": "41", "attributes": [], "id": "e442", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "512", "fromConcept": "41", "attributes": [], "id": "e443", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "513", "fromConcept": "41", "attributes": [], "id": "e444", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "514", "fromConcept": "41", "attributes": [], "id": "e445", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "515", "fromConcept": "41", "attributes": [], "id": "e446", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "516", "fromConcept": "41", "attributes": [], "id": "e447", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "517", "fromConcept": "41", "attributes": [], "id": "e448", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "518", "fromConcept": "41", "attributes": [], "id": "e449", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "519", "fromConcept": "41", "attributes": [], "id": "e450", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "520", "fromConcept": "41", "attributes": [], "id": "e451", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "521", "fromConcept": "41", "attributes": [], "id": "e452", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "522", "fromConcept": "41", "attributes": [], "id": "e453", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "523", "fromConcept": "41", "attributes": [], "id": "e454", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "524", "fromConcept": "41", "attributes": [], "id": "e455", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "525", "fromConcept": "41", "attributes": [], "id": "e456", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "526", "fromConcept": "41", "attributes": [], "id": "e457", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "527", "fromConcept": "41", "attributes": [], "id": "e458", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "528", "fromConcept": "41", "attributes": [], "id": "e459", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "529", "fromConcept": "41", "attributes": [], "id": "e460", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "530", "fromConcept": "41", "attributes": [], "id": "e461", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "45", "fromConcept": "41", "attributes": [], "id": "e462", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "531", "fromConcept": "41", "attributes": [], "id": "e463", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "532", "fromConcept": "41", "attributes": [], "id": "e464", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "533", "fromConcept": "41", "attributes": [], "id": "e465", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "534", "fromConcept": "41", "attributes": [], "id": "e466", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "5", "fromConcept": "41", "attributes": [], "id": "e467", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "535", "fromConcept": "41", "attributes": [], "id": "e468", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "536", "fromConcept": "41", "attributes": [], "id": "e469", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "537", "fromConcept": "41", "attributes": [], "id": "e470", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "53", "fromConcept": "41", "attributes": [], "id": "e471", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "538", "fromConcept": "41", "attributes": [], "id": "e472", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "42", "fromConcept": "41", "attributes": [], "id": "e473", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "539", "fromConcept": "41", "attributes": [], "id": "e474", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "52", "fromConcept": "41", "attributes": [], "id": "e475", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "540", "fromConcept": "41", "attributes": [], "id": "e476", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "541", "fromConcept": "41", "attributes": [], "id": "e477", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "13", "fromConcept": "41", "attributes": [], "id": "e478", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "46", "fromConcept": "41", "attributes": [], "id": "e479", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "542", "fromConcept": "41", "attributes": [], "id": "e480", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "51", "fromConcept": "41", "attributes": [], "id": "e481", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "47", "fromConcept": "41", "attributes": [], "id": "e482", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "543", "fromConcept": "41", "attributes": [], "id": "e483", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "544", "fromConcept": "41", "attributes": [], "id": "e484", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "545", "fromConcept": "41", "attributes": [], "id": "e485", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "546", "fromConcept": "41", "attributes": [], "id": "e486", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "547", "fromConcept": "41", "attributes": [], "id": "e487", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "548", "fromConcept": "41", "attributes": [], "id": "e488", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "48", "fromConcept": "41", "attributes": [], "id": "e489", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "549", "fromConcept": "41", "attributes": [], "id": "e490", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "550", "fromConcept": "41", "attributes": [], "id": "e491", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "551", "fromConcept": "41", "attributes": [], "id": "e492", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "552", "fromConcept": "41", "attributes": [], "id": "e493", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "553", "fromConcept": "41", "attributes": [], "id": "e494", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "554", "fromConcept": "41", "attributes": [], "id": "e495", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "49", "fromConcept": "41", "attributes": [], "id": "e496", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "555", "fromConcept": "41", "attributes": [], "id": "e497", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "2", "fromConcept": "41", "attributes": [], "id": "e498", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "556", "fromConcept": "41", "attributes": [], "id": "e499", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "50", "fromConcept": "41", "attributes": [], "id": "e500", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "557", "fromConcept": "41", "attributes": [], "id": "e501", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "558", "fromConcept": "41", "attributes": [], "id": "e502", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "44", "fromConcept": "41", "attributes": [], "id": "e503", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "559", "fromConcept": "41", "attributes": [], "id": "e504", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "560", "fromConcept": "41", "attributes": [], "id": "e505", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "561", "fromConcept": "41", "attributes": [], "id": "e506", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "43", "fromConcept": "41", "attributes": [], "id": "e507", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "562", "fromConcept": "41", "attributes": [], "id": "e508", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "312", "fromConcept": "54", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e509", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "563", "fromConcept": "56", "attributes": [{ "attrname": "CoCitNum", "value": "2"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "0.5059400449904672"} , { "attrname": "PMID", "value": "11238726,  11238726"} , { "attrname": "MAX_TFIDF", "value": "0.32182765007019043"} , { "attrname": "EVIDENCE", "value": "[Direct binding of fibulin-1 to the secreted form of APP (sAPP) was demonstrated with a pull-down assay using fragments of both fibulin-1 fused with glutathione-S transferase and sAPP,  produced in bacteria and yeast,  respectively.]"} ], "id": "e510", "contexts": { "context": { "id": 77} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "564", "fromConcept": "56", "attributes": [{ "attrname": "CoCitNum", "value": "2"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "0.42339209098988206"} , { "attrname": "PMID", "value": "20811458,  20811458"} , { "attrname": "MAX_TFIDF", "value": "0.32834988832473755"} , { "attrname": "EVIDENCE", "value": "[We demonstrate that imatinib,  an anticancer drug previously found to inhibit amyloid-beta formation without affecting Notch cleavage,  achieves its amyloid-beta-lowering effect by preventing GSAP interaction with the gamma-secretase substrate,  APP-CTF.]"} ], "id": "e511", "contexts": { "context": { "id": 71} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "565", "fromConcept": "56", "attributes": [{ "attrname": "CoCitNum", "value": "1"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "0.11640245104253388"} , { "attrname": "PMID", "value": "15274632"} , { "attrname": "MAX_TFIDF", "value": "0.11640245104253388"} , { "attrname": "EVIDENCE", "value": "[Using the purified gamma-secretase,  we describe factors that modulate the production of specific Abeta species:  (1) phosphatidylcholine and sphingomyelin dramatically improve activity without changing cleavage specificity within an APP substrate; (2) increasing CHAPSO concentrations from 0.1 to 0.25% yields a approximately 100% increase in Abeta42 production; (3) exposure of an APP-based recombinant substrate to 0.5% SDS modulates cleavage specificity from a disease-mimicking pattern (high Abeta42\/43) to a physiological pattern (high Abeta40); and (4) sulindac sulfide directly and preferentially decreases Abeta42 cleavage within the purified complex.]"} ], "id": "e512", "contexts": { "context": { "id": 82} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "56", "fromConcept": "20", "attributes": [{ "attrname": "CoCitNum", "value": "17"} , { "attrname": "CoSenNum", "value": "15"} , { "attrname": "visible", "value": "true"} , { "attrname": "IP_TFIDF", "value": "24.58079246354872"} , { "attrname": "size", "value": "5"} , { "attrname": "PMID", "value": "8158260,  8158260,  8158260,  20212142,  20212142,  7913895,  7913895,  9357988,  9357988,  10806211"} , { "attrname": "MAX_TFIDF", "value": "3.9096083641052246"} , { "attrname": "EVIDENCE", "value": "[Limited proteolysis confirms that the heparin-bridged E1 dimers obtained in solution correspond to a dimer contact in our crystal,  enabling us to model this heparin-[APP-E1](2) complex.,  Moreover,  our data also indicate that the collagen binding site is involved in APP-APP interaction that can be modulated by Zn(II) and heparin.,  Correspondingly,  the APP-based signal transduction,  cell-cell- and\/or cell-ECM interaction should depend on dimerization induced by heparin,  as well as on pH,  arguing that APP could fulfill different functions depending on its (sub)cellular localization.  ,  Taken together,  the data suggest that the regulation of APP binding to collagen type I by heparin occurs through the competitive binding of heparin and APP to collagen.  ,  A 14 K N-terminal fragment of APP was found to bind heparin and a region close to the N-terminus of APP (residues 96-110) identified as a potential heparin-binding domain based on secondary structure predictions and molecular modeling.,  Two E1 entities dimerize upon their interaction with heparin,  requiring 8-12 sugar rings to form the heparin-bridged APP-E1 dimer in an endothermic and pH-dependent process that is characterized by a low micromolar dissociation constant.,  Mutagenesis of three basic residues (lysine-99,  arginine-100,  and arginine-102) resulted in a recombinant protein (APPhep) with decreased heparin-binding capacity.,  Peptides homologous to APP316-346 and APP416-447 were found to bind heparin.,  We localized the site of APP that mediates collagen binding within residues 448-465 of APP695,  which are encoded by the ubiquitously expressed APP exon 12,  whereas the high affinity heparin binding site of APP is located in exon 9.,  Zinc increased binding of APP to heparin and has been shown to potentiate the inhibition of coagulation factor XIa by an APP isoform containing a Kunitz-type inhibitory domain (Komiyama,  Y.,  Murakami,  T.,  Egawa,  H.,  Okubo,  S.,  Yasunaga,  K.,  and Murata,  K. (1992) Thromb.,  Circular dichroism studies show that APP416-447 shifted towards an alpha-helical conformation in the presence of heparin.,  Previously it has been shown that the extracellular domain of transmembrane beta A4 amyloid precursor protein (APP) includes binding sites for zinc(II) and for molecules of the extracellular matrix such as collagen,  laminin and the heparin sulfate chains of proteoglycans (HSPGs).,  APP did not bind to collagen type I-heparin complexes,  which suggests that there are overlapping binding sites for heparin and APP on collagen.,  Here we describe the 1.8 A resolution crystal structure of the N-terminal,  heparin-binding domain of APP (residues 28-123),  which is responsible,  among other things,  for stimulation of neurite outgrowth.,  A peptide homologous to the heparin-binding domain was synthesized and found to bind strongly to heparin and to inhibit binding of 125I-labeled APP to heparin (IC50 approximately 10(-7) M).]"} ], "id": "e513", "contexts": { "context": { "id": 28} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "566", "fromConcept": "56", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e514", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "34", "fromConcept": "56", "attributes": [], "id": "e515", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "567", "fromConcept": "56", "attributes": [], "id": "e516", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "568", "fromConcept": "56", "attributes": [], "id": "e517", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "has_function"} , { "toConcept": "569", "fromConcept": "56", "attributes": [], "id": "e518", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "570", "fromConcept": "56", "attributes": [], "id": "e519", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "571", "fromConcept": "56", "attributes": [], "id": "e520", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "572", "fromConcept": "56", "attributes": [], "id": "e521", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "259", "fromConcept": "56", "attributes": [], "id": "e522", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "573", "fromConcept": "56", "attributes": [], "id": "e523", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "574", "fromConcept": "56", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e524", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "575", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e525", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "38", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e526", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "576", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e527", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "577", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0031\"(protein cross-linking with a bifunctional reagent)"} ], "id": "e528", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "578", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0424\"(protein kinase assay)"} ], "id": "e529", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "579", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e530", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "580", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e531", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "603", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0397\"(two hybrid array)"} ], "id": "e532", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "604", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} , { "attrname": "Interaction_detection_1", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e533", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "608", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e534", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "609", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0411\"(enzyme linked immunosorbent assay)"} ], "id": "e535", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "610", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0404\"(comigration in non denaturing gel electrophoresis)"} ], "id": "e536", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "611", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e537", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "612", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e538", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "613", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e539", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "614", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e540", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "274", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e541", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "615", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e542", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "616", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e543", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "617", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e544", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "618", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0007\"(anti tag coimmunoprecipitation)"} ], "id": "e545", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "619", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e546", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "620", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e547", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "621", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0031\"(protein cross-linking with a bifunctional reagent)"} ], "id": "e548", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "622", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e549", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "623", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0990\"(cleavage assay)"} ], "id": "e550", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "624", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e551", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "625", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e552", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "626", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e553", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "627", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0428\"(imaging technique)"} ], "id": "e554", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "628", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0034\"(display technology)"} ], "id": "e555", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "629", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0055\"(fluorescent resonance energy transfer)"} ], "id": "e556", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "630", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e557", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "631", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0030\"(cross-linking study)"} ], "id": "e558", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "632", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e559", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "633", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0018\"(two hybrid)"} ], "id": "e560", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "634", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e561", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "635", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0411\"(enzyme linked immunosorbent assay)"} ], "id": "e562", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "636", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} , { "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e563", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "316", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0397\"(two hybrid array)"} ], "id": "e564", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "637", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e565", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "638", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e566", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "214", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e567", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "639", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e568", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "640", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0440\"(saturation binding)"} ], "id": "e569", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "641", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e570", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "642", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0416\"(fluorescence microscopy)"} ], "id": "e571", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "216", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0006\"(anti bait coimmunoprecipitation)"} ], "id": "e572", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "643", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0096\"(pull down)"} ], "id": "e573", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "644", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0435\"(protease assay)"} ], "id": "e574", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "645", "fromConcept": "56", "attributes": [{ "attrname": "Interaction_detection_method", "value": "psi-mi: \"MI: 0435\"(protease assay)"} ], "id": "e575", "contexts": { } , "evidences": ["Imported from database"], "ofType": "interacts_with"} , { "toConcept": "646", "fromConcept": "56", "attributes": [], "id": "e576", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "431", "fromConcept": "56", "attributes": [], "id": "e577", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "647", "fromConcept": "56", "attributes": [], "id": "e578", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "648", "fromConcept": "56", "attributes": [], "id": "e579", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "56", "attributes": [], "id": "e580", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "449", "fromConcept": "56", "attributes": [], "id": "e581", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "649", "fromConcept": "56", "attributes": [], "id": "e582", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "650", "fromConcept": "56", "attributes": [], "id": "e583", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "651", "fromConcept": "56", "attributes": [], "id": "e584", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "56", "attributes": [], "id": "e585", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "652", "fromConcept": "56", "attributes": [], "id": "e586", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "56", "attributes": [], "id": "e587", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "653", "fromConcept": "56", "attributes": [], "id": "e588", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "654", "fromConcept": "56", "attributes": [], "id": "e589", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "655", "fromConcept": "56", "attributes": [], "id": "e590", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "656", "fromConcept": "56", "attributes": [], "id": "e591", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "88", "fromConcept": "56", "attributes": [], "id": "e592", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "443", "fromConcept": "56", "attributes": [], "id": "e593", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "657", "fromConcept": "56", "attributes": [], "id": "e594", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "658", "fromConcept": "56", "attributes": [], "id": "e595", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "442", "fromConcept": "56", "attributes": [], "id": "e596", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "56", "attributes": [], "id": "e597", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "444", "fromConcept": "56", "attributes": [], "id": "e598", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "659", "fromConcept": "56", "attributes": [], "id": "e599", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "660", "fromConcept": "56", "attributes": [], "id": "e600", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "661", "fromConcept": "56", "attributes": [], "id": "e601", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "662", "fromConcept": "56", "attributes": [], "id": "e602", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "663", "fromConcept": "56", "attributes": [], "id": "e603", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "664", "fromConcept": "56", "attributes": [], "id": "e604", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "665", "fromConcept": "56", "attributes": [], "id": "e605", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "666", "fromConcept": "56", "attributes": [], "id": "e606", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "667", "fromConcept": "56", "attributes": [], "id": "e607", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "668", "fromConcept": "56", "attributes": [], "id": "e608", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "669", "fromConcept": "56", "attributes": [], "id": "e609", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "670", "fromConcept": "56", "attributes": [], "id": "e610", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "671", "fromConcept": "56", "attributes": [], "id": "e611", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "672", "fromConcept": "56", "attributes": [], "id": "e612", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "673", "fromConcept": "56", "attributes": [], "id": "e613", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "674", "fromConcept": "56", "attributes": [], "id": "e614", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "675", "fromConcept": "56", "attributes": [], "id": "e615", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "676", "fromConcept": "56", "attributes": [], "id": "e616", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "677", "fromConcept": "56", "attributes": [], "id": "e617", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "678", "fromConcept": "56", "attributes": [], "id": "e618", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "679", "fromConcept": "56", "attributes": [], "id": "e619", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "680", "fromConcept": "56", "attributes": [], "id": "e620", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "521", "fromConcept": "56", "attributes": [], "id": "e621", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "681", "fromConcept": "56", "attributes": [], "id": "e622", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "682", "fromConcept": "56", "attributes": [], "id": "e623", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "683", "fromConcept": "56", "attributes": [], "id": "e624", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "684", "fromConcept": "56", "attributes": [], "id": "e625", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "685", "fromConcept": "56", "attributes": [], "id": "e626", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "686", "fromConcept": "56", "attributes": [], "id": "e627", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "687", "fromConcept": "56", "attributes": [], "id": "e628", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "688", "fromConcept": "56", "attributes": [], "id": "e629", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "689", "fromConcept": "56", "attributes": [], "id": "e630", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "690", "fromConcept": "56", "attributes": [], "id": "e631", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "691", "fromConcept": "56", "attributes": [], "id": "e632", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "692", "fromConcept": "56", "attributes": [], "id": "e633", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "693", "fromConcept": "56", "attributes": [], "id": "e634", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "112", "fromConcept": "56", "attributes": [], "id": "e635", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "694", "fromConcept": "56", "attributes": [], "id": "e636", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "695", "fromConcept": "56", "attributes": [], "id": "e637", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "505", "fromConcept": "56", "attributes": [], "id": "e638", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "696", "fromConcept": "56", "attributes": [], "id": "e639", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "697", "fromConcept": "56", "attributes": [], "id": "e640", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "698", "fromConcept": "56", "attributes": [], "id": "e641", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "699", "fromConcept": "56", "attributes": [], "id": "e642", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "700", "fromConcept": "56", "attributes": [], "id": "e643", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "701", "fromConcept": "56", "attributes": [], "id": "e644", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "702", "fromConcept": "56", "attributes": [], "id": "e645", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "77", "fromConcept": "56", "attributes": [], "id": "e646", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "703", "fromConcept": "56", "attributes": [], "id": "e647", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "76", "fromConcept": "56", "attributes": [], "id": "e648", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "24", "fromConcept": "56", "attributes": [], "id": "e649", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "704", "fromConcept": "56", "attributes": [], "id": "e650", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "705", "fromConcept": "56", "attributes": [], "id": "e651", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "706", "fromConcept": "56", "attributes": [], "id": "e652", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "81", "fromConcept": "56", "attributes": [], "id": "e653", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "707", "fromConcept": "56", "attributes": [], "id": "e654", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "26", "fromConcept": "56", "attributes": [], "id": "e655", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "708", "fromConcept": "56", "attributes": [], "id": "e656", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "709", "fromConcept": "56", "attributes": [], "id": "e657", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "710", "fromConcept": "56", "attributes": [], "id": "e658", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "711", "fromConcept": "56", "attributes": [], "id": "e659", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "712", "fromConcept": "56", "attributes": [], "id": "e660", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "69", "fromConcept": "56", "attributes": [], "id": "e661", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "713", "fromConcept": "56", "attributes": [], "id": "e662", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "84", "fromConcept": "56", "attributes": [], "id": "e663", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "714", "fromConcept": "56", "attributes": [], "id": "e664", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "715", "fromConcept": "56", "attributes": [], "id": "e665", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "716", "fromConcept": "56", "attributes": [], "id": "e666", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "22", "fromConcept": "56", "attributes": [], "id": "e667", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "717", "fromConcept": "56", "attributes": [], "id": "e668", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "16", "fromConcept": "56", "attributes": [], "id": "e669", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "718", "fromConcept": "56", "attributes": [], "id": "e670", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "719", "fromConcept": "56", "attributes": [], "id": "e671", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "720", "fromConcept": "56", "attributes": [], "id": "e672", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "721", "fromConcept": "56", "attributes": [], "id": "e673", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "27", "fromConcept": "56", "attributes": [], "id": "e674", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "722", "fromConcept": "56", "attributes": [], "id": "e675", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "723", "fromConcept": "56", "attributes": [], "id": "e676", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "724", "fromConcept": "56", "attributes": [], "id": "e677", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "725", "fromConcept": "56", "attributes": [], "id": "e678", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "70", "fromConcept": "56", "attributes": [], "id": "e679", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "726", "fromConcept": "56", "attributes": [], "id": "e680", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "727", "fromConcept": "56", "attributes": [], "id": "e681", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "728", "fromConcept": "56", "attributes": [], "id": "e682", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "729", "fromConcept": "56", "attributes": [], "id": "e683", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "730", "fromConcept": "56", "attributes": [], "id": "e684", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "731", "fromConcept": "56", "attributes": [], "id": "e685", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "732", "fromConcept": "56", "attributes": [], "id": "e686", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "733", "fromConcept": "56", "attributes": [], "id": "e687", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "734", "fromConcept": "56", "attributes": [], "id": "e688", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "735", "fromConcept": "56", "attributes": [], "id": "e689", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "736", "fromConcept": "56", "attributes": [], "id": "e690", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "21", "fromConcept": "56", "attributes": [], "id": "e691", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "737", "fromConcept": "56", "attributes": [], "id": "e692", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "738", "fromConcept": "56", "attributes": [], "id": "e693", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "25", "fromConcept": "56", "attributes": [], "id": "e694", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "739", "fromConcept": "56", "attributes": [], "id": "e695", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "740", "fromConcept": "56", "attributes": [], "id": "e696", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "28", "fromConcept": "56", "attributes": [], "id": "e697", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "65", "fromConcept": "56", "attributes": [], "id": "e698", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "741", "fromConcept": "56", "attributes": [], "id": "e699", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "742", "fromConcept": "56", "attributes": [], "id": "e700", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "743", "fromConcept": "56", "attributes": [], "id": "e701", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "744", "fromConcept": "56", "attributes": [], "id": "e702", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "745", "fromConcept": "56", "attributes": [], "id": "e703", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "746", "fromConcept": "56", "attributes": [], "id": "e704", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "80", "fromConcept": "56", "attributes": [], "id": "e705", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "747", "fromConcept": "56", "attributes": [], "id": "e706", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "748", "fromConcept": "56", "attributes": [], "id": "e707", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "749", "fromConcept": "56", "attributes": [], "id": "e708", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "57", "fromConcept": "56", "attributes": [], "id": "e709", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "750", "fromConcept": "56", "attributes": [], "id": "e710", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "62", "fromConcept": "56", "attributes": [], "id": "e711", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "751", "fromConcept": "56", "attributes": [], "id": "e712", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "752", "fromConcept": "56", "attributes": [], "id": "e713", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "753", "fromConcept": "56", "attributes": [], "id": "e714", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "754", "fromConcept": "56", "attributes": [], "id": "e715", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "755", "fromConcept": "56", "attributes": [], "id": "e716", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "756", "fromConcept": "56", "attributes": [], "id": "e717", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "757", "fromConcept": "56", "attributes": [], "id": "e718", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "73", "fromConcept": "56", "attributes": [], "id": "e719", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "758", "fromConcept": "56", "attributes": [], "id": "e720", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "759", "fromConcept": "56", "attributes": [], "id": "e721", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "760", "fromConcept": "56", "attributes": [], "id": "e722", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "761", "fromConcept": "56", "attributes": [], "id": "e723", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "762", "fromConcept": "56", "attributes": [], "id": "e724", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "763", "fromConcept": "56", "attributes": [], "id": "e725", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "764", "fromConcept": "56", "attributes": [], "id": "e726", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "765", "fromConcept": "56", "attributes": [], "id": "e727", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "766", "fromConcept": "56", "attributes": [], "id": "e728", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "63", "fromConcept": "56", "attributes": [], "id": "e729", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "767", "fromConcept": "56", "attributes": [], "id": "e730", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "768", "fromConcept": "56", "attributes": [], "id": "e731", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "769", "fromConcept": "56", "attributes": [], "id": "e732", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "4", "fromConcept": "56", "attributes": [], "id": "e733", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "770", "fromConcept": "56", "attributes": [], "id": "e734", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "771", "fromConcept": "56", "attributes": [], "id": "e735", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "772", "fromConcept": "56", "attributes": [], "id": "e736", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "74", "fromConcept": "56", "attributes": [], "id": "e737", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "773", "fromConcept": "56", "attributes": [], "id": "e738", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "23", "fromConcept": "56", "attributes": [], "id": "e739", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "774", "fromConcept": "56", "attributes": [], "id": "e740", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "12", "fromConcept": "56", "attributes": [], "id": "e741", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "775", "fromConcept": "56", "attributes": [], "id": "e742", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "776", "fromConcept": "56", "attributes": [], "id": "e743", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "777", "fromConcept": "56", "attributes": [], "id": "e744", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "778", "fromConcept": "56", "attributes": [], "id": "e745", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "779", "fromConcept": "56", "attributes": [], "id": "e746", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "780", "fromConcept": "56", "attributes": [], "id": "e747", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "781", "fromConcept": "56", "attributes": [], "id": "e748", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "782", "fromConcept": "56", "attributes": [], "id": "e749", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "783", "fromConcept": "56", "attributes": [], "id": "e750", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "784", "fromConcept": "56", "attributes": [], "id": "e751", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "785", "fromConcept": "56", "attributes": [], "id": "e752", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "786", "fromConcept": "56", "attributes": [], "id": "e753", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "787", "fromConcept": "56", "attributes": [], "id": "e754", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "788", "fromConcept": "56", "attributes": [], "id": "e755", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "789", "fromConcept": "56", "attributes": [], "id": "e756", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "790", "fromConcept": "56", "attributes": [], "id": "e757", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "791", "fromConcept": "56", "attributes": [], "id": "e758", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "792", "fromConcept": "56", "attributes": [], "id": "e759", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "793", "fromConcept": "56", "attributes": [], "id": "e760", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "794", "fromConcept": "56", "attributes": [], "id": "e761", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "795", "fromConcept": "56", "attributes": [], "id": "e762", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "796", "fromConcept": "56", "attributes": [], "id": "e763", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "797", "fromConcept": "56", "attributes": [], "id": "e764", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "798", "fromConcept": "56", "attributes": [], "id": "e765", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "799", "fromConcept": "56", "attributes": [], "id": "e766", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "800", "fromConcept": "56", "attributes": [], "id": "e767", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "75", "fromConcept": "56", "attributes": [], "id": "e768", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "71", "fromConcept": "56", "attributes": [], "id": "e769", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "801", "fromConcept": "56", "attributes": [], "id": "e770", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "802", "fromConcept": "56", "attributes": [], "id": "e771", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "803", "fromConcept": "56", "attributes": [], "id": "e772", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "804", "fromConcept": "56", "attributes": [], "id": "e773", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "805", "fromConcept": "56", "attributes": [], "id": "e774", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "806", "fromConcept": "56", "attributes": [], "id": "e775", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "807", "fromConcept": "56", "attributes": [], "id": "e776", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "808", "fromConcept": "56", "attributes": [], "id": "e777", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "809", "fromConcept": "56", "attributes": [], "id": "e778", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "59", "fromConcept": "56", "attributes": [], "id": "e779", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "211", "fromConcept": "810", "attributes": [], "id": "e780", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "214", "fromConcept": "811", "attributes": [], "id": "e781", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "214", "fromConcept": "812", "attributes": [], "id": "e782", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "274", "fromConcept": "813", "attributes": [], "id": "e783", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "274", "fromConcept": "814", "attributes": [], "id": "e784", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "274", "fromConcept": "815", "attributes": [], "id": "e785", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "274", "fromConcept": "816", "attributes": [], "id": "e786", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "274", "fromConcept": "817", "attributes": [], "id": "e787", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "310", "fromConcept": "818", "attributes": [], "id": "e788", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "314", "fromConcept": "818", "attributes": [], "id": "e789", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "314", "fromConcept": "819", "attributes": [], "id": "e790", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "328", "fromConcept": "820", "attributes": [], "id": "e791", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "328", "fromConcept": "821", "attributes": [], "id": "e792", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "328", "fromConcept": "99", "attributes": [], "id": "e793", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "328", "fromConcept": "814", "attributes": [], "id": "e794", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "328", "fromConcept": "100", "attributes": [], "id": "e795", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "822", "fromConcept": "342", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e796", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "823", "fromConcept": "342", "attributes": [], "id": "e797", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "244", "fromConcept": "342", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e798", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "824", "fromConcept": "342", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e799", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "825", "fromConcept": "342", "attributes": [], "id": "e800", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "826", "fromConcept": "342", "attributes": [], "id": "e801", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "827", "fromConcept": "342", "attributes": [], "id": "e802", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "828", "fromConcept": "342", "attributes": [], "id": "e803", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "has_function"} , { "toConcept": "829", "fromConcept": "342", "attributes": [], "id": "e804", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "830", "fromConcept": "342", "attributes": [], "id": "e805", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "259", "fromConcept": "342", "attributes": [], "id": "e806", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "831", "fromConcept": "342", "attributes": [], "id": "e807", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "832", "fromConcept": "342", "attributes": [], "id": "e808", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "833", "fromConcept": "342", "attributes": [], "id": "e809", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "834", "fromConcept": "342", "attributes": [], "id": "e810", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "835", "fromConcept": "342", "attributes": [], "id": "e811", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "836", "fromConcept": "342", "attributes": [], "id": "e812", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "837", "fromConcept": "342", "attributes": [], "id": "e813", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "838", "fromConcept": "342", "attributes": [], "id": "e814", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "839", "fromConcept": "342", "attributes": [], "id": "e815", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "840", "fromConcept": "342", "attributes": [], "id": "e816", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "657", "fromConcept": "342", "attributes": [], "id": "e817", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "841", "fromConcept": "342", "attributes": [], "id": "e818", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "842", "fromConcept": "342", "attributes": [], "id": "e819", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "843", "fromConcept": "342", "attributes": [], "id": "e820", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "439", "fromConcept": "342", "attributes": [], "id": "e821", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "440", "fromConcept": "342", "attributes": [], "id": "e822", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "844", "fromConcept": "342", "attributes": [], "id": "e823", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "845", "fromConcept": "342", "attributes": [], "id": "e824", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "88", "fromConcept": "342", "attributes": [], "id": "e825", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "846", "fromConcept": "342", "attributes": [], "id": "e826", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "342", "attributes": [], "id": "e827", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "653", "fromConcept": "342", "attributes": [], "id": "e828", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "431", "fromConcept": "342", "attributes": [], "id": "e829", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "436", "fromConcept": "342", "attributes": [], "id": "e830", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "438", "fromConcept": "342", "attributes": [], "id": "e831", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "342", "attributes": [], "id": "e832", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "847", "fromConcept": "342", "attributes": [], "id": "e833", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "444", "fromConcept": "342", "attributes": [], "id": "e834", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "848", "fromConcept": "342", "attributes": [], "id": "e835", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "849", "fromConcept": "342", "attributes": [], "id": "e836", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "850", "fromConcept": "342", "attributes": [], "id": "e837", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "342", "attributes": [], "id": "e838", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "342", "attributes": [], "id": "e839", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "98", "fromConcept": "342", "attributes": [], "id": "e840", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "851", "fromConcept": "342", "attributes": [], "id": "e841", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "852", "fromConcept": "342", "attributes": [], "id": "e842", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "853", "fromConcept": "342", "attributes": [], "id": "e843", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "854", "fromConcept": "342", "attributes": [], "id": "e844", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "855", "fromConcept": "342", "attributes": [], "id": "e845", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "856", "fromConcept": "342", "attributes": [], "id": "e846", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "857", "fromConcept": "342", "attributes": [], "id": "e847", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "858", "fromConcept": "342", "attributes": [], "id": "e848", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "859", "fromConcept": "342", "attributes": [], "id": "e849", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "860", "fromConcept": "342", "attributes": [], "id": "e850", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "861", "fromConcept": "342", "attributes": [], "id": "e851", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "862", "fromConcept": "342", "attributes": [], "id": "e852", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "863", "fromConcept": "342", "attributes": [], "id": "e853", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "864", "fromConcept": "342", "attributes": [], "id": "e854", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "865", "fromConcept": "342", "attributes": [], "id": "e855", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "866", "fromConcept": "342", "attributes": [], "id": "e856", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "512", "fromConcept": "342", "attributes": [], "id": "e857", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "867", "fromConcept": "342", "attributes": [], "id": "e858", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "868", "fromConcept": "342", "attributes": [], "id": "e859", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "498", "fromConcept": "342", "attributes": [], "id": "e860", "contexts": { } , "evidences": ["ECO: 0000305"], "ofType": "participates_in"} , { "toConcept": "869", "fromConcept": "342", "attributes": [], "id": "e861", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "504", "fromConcept": "342", "attributes": [], "id": "e862", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "870", "fromConcept": "342", "attributes": [], "id": "e863", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "871", "fromConcept": "342", "attributes": [], "id": "e864", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "872", "fromConcept": "342", "attributes": [], "id": "e865", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "873", "fromConcept": "342", "attributes": [], "id": "e866", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "874", "fromConcept": "342", "attributes": [], "id": "e867", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "875", "fromConcept": "342", "attributes": [], "id": "e868", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "876", "fromConcept": "342", "attributes": [], "id": "e869", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "877", "fromConcept": "342", "attributes": [], "id": "e870", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "456", "fromConcept": "342", "attributes": [], "id": "e871", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "878", "fromConcept": "342", "attributes": [], "id": "e872", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "879", "fromConcept": "342", "attributes": [], "id": "e873", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "880", "fromConcept": "342", "attributes": [], "id": "e874", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "881", "fromConcept": "342", "attributes": [], "id": "e875", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "882", "fromConcept": "342", "attributes": [], "id": "e876", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "883", "fromConcept": "342", "attributes": [], "id": "e877", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "884", "fromConcept": "342", "attributes": [], "id": "e878", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "885", "fromConcept": "342", "attributes": [], "id": "e879", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "886", "fromConcept": "342", "attributes": [], "id": "e880", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "887", "fromConcept": "342", "attributes": [], "id": "e881", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "888", "fromConcept": "342", "attributes": [], "id": "e882", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "889", "fromConcept": "342", "attributes": [], "id": "e883", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "890", "fromConcept": "342", "attributes": [], "id": "e884", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "891", "fromConcept": "342", "attributes": [], "id": "e885", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "892", "fromConcept": "342", "attributes": [], "id": "e886", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "893", "fromConcept": "342", "attributes": [], "id": "e887", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "694", "fromConcept": "342", "attributes": [], "id": "e888", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "894", "fromConcept": "342", "attributes": [], "id": "e889", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "895", "fromConcept": "342", "attributes": [], "id": "e890", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "896", "fromConcept": "342", "attributes": [], "id": "e891", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "897", "fromConcept": "342", "attributes": [], "id": "e892", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "669", "fromConcept": "342", "attributes": [], "id": "e893", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "898", "fromConcept": "342", "attributes": [], "id": "e894", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "899", "fromConcept": "342", "attributes": [], "id": "e895", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "900", "fromConcept": "342", "attributes": [], "id": "e896", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "901", "fromConcept": "342", "attributes": [], "id": "e897", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "902", "fromConcept": "342", "attributes": [], "id": "e898", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "903", "fromConcept": "342", "attributes": [], "id": "e899", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "904", "fromConcept": "342", "attributes": [], "id": "e900", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "905", "fromConcept": "342", "attributes": [], "id": "e901", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "906", "fromConcept": "342", "attributes": [], "id": "e902", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "907", "fromConcept": "342", "attributes": [], "id": "e903", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "908", "fromConcept": "342", "attributes": [], "id": "e904", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "909", "fromConcept": "342", "attributes": [], "id": "e905", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "910", "fromConcept": "342", "attributes": [], "id": "e906", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "911", "fromConcept": "342", "attributes": [], "id": "e907", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "912", "fromConcept": "342", "attributes": [], "id": "e908", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "913", "fromConcept": "342", "attributes": [], "id": "e909", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "914", "fromConcept": "342", "attributes": [], "id": "e910", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "915", "fromConcept": "342", "attributes": [], "id": "e911", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "232", "fromConcept": "342", "attributes": [], "id": "e912", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "916", "fromConcept": "342", "attributes": [], "id": "e913", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "917", "fromConcept": "342", "attributes": [], "id": "e914", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "918", "fromConcept": "342", "attributes": [], "id": "e915", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "919", "fromConcept": "342", "attributes": [], "id": "e916", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "920", "fromConcept": "342", "attributes": [], "id": "e917", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "921", "fromConcept": "342", "attributes": [], "id": "e918", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "922", "fromConcept": "342", "attributes": [], "id": "e919", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "923", "fromConcept": "342", "attributes": [], "id": "e920", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "924", "fromConcept": "342", "attributes": [], "id": "e921", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "925", "fromConcept": "342", "attributes": [], "id": "e922", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "926", "fromConcept": "342", "attributes": [], "id": "e923", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "927", "fromConcept": "342", "attributes": [], "id": "e924", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "928", "fromConcept": "342", "attributes": [], "id": "e925", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "929", "fromConcept": "342", "attributes": [], "id": "e926", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "930", "fromConcept": "342", "attributes": [], "id": "e927", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "931", "fromConcept": "342", "attributes": [], "id": "e928", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "932", "fromConcept": "342", "attributes": [], "id": "e929", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "933", "fromConcept": "342", "attributes": [], "id": "e930", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "934", "fromConcept": "342", "attributes": [], "id": "e931", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "935", "fromConcept": "342", "attributes": [], "id": "e932", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "936", "fromConcept": "342", "attributes": [], "id": "e933", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "373", "fromConcept": "937", "attributes": [], "id": "e934", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "376", "fromConcept": "938", "attributes": [{ "attrname": "CoCitNum", "value": "2"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "0.5678769185924142"} , { "attrname": "PMID", "value": "12056932,  12056932"} , { "attrname": "MAX_TFIDF", "value": "0.3090100586414337"} , { "attrname": "EVIDENCE", "value": "[Heterozygous carriers of a single Park2 mutation either were asymptomatic or developed clinical symptoms in late adulthood or after brief exposure to haloperidol therapy.]"} ], "id": "e935", "contexts": { "context": { "id": 344} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "234", "fromConcept": "376", "attributes": [{ "attrname": "CoCitNum", "value": "12"} , { "attrname": "CoSenNum", "value": "6"} , { "attrname": "IP_TFIDF", "value": "8.847191050021475"} , { "attrname": "PMID", "value": "12628165,  12628165,  21376232,  21376232,  16135753,  16135753,  12397156,  12397156,  15105460,  15105460"} , { "attrname": "MAX_TFIDF", "value": "2.11678549488164"} , { "attrname": "EVIDENCE", "value": "[Mutations in parkin,  which encodes a RING domain protein associated with ubiquitin ligase activity,  lead to autosomal recessive Parkinson's disease characterized by midbrain dopamine neuron loss.,  Furthermore,  parkin overexpression attenuates the accumulation of cyclin E in toxin-treated primary neurons,  including midbrain dopamine neurons,  and protects them from apoptosis.  ,  Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons in a PARIS-dependent manner.,  Parkin is an E3 ubiquitin ligase involved in the ubiquitination of proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD).,  A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine neurons.,  Parkin,  a RING-type E3 ubiquitin ligase,  is responsible for the ubiquitination and degradation of substrate proteins that are important in the survival of dopamine neurons in Parkinson's disease (PD).]"} ], "id": "e936", "contexts": { "context": { "id": 239} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "223", "fromConcept": "376", "attributes": [{ "attrname": "CoCitNum", "value": "4"} , { "attrname": "CoSenNum", "value": "1"} , { "attrname": "IP_TFIDF", "value": "2.436023257640285"} , { "attrname": "PMID", "value": "10824074,  10824074,  10072423,  10072423"} , { "attrname": "MAX_TFIDF", "value": "1.0060346752030824"} , { "attrname": "EVIDENCE", "value": "[The mean (+\/-SD) age at onset in the patients with parkin mutations was younger than that in those without mutations (32+\/-11 vs. 42+\/-11 years,  P<0.001),  and they were more likely to have symmetric involvement and dystonia at onset,  to have hyperreflexia at onset or later,  to have a good response to levodopa therapy,  and to have levodopa-induced dyskinesias during treatment.]"} ], "id": "e937", "contexts": { "context": { "id": 225} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "939", "fromConcept": "376", "attributes": [], "id": "e938", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "940", "fromConcept": "376", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e939", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "244", "fromConcept": "376", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e940", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "941", "fromConcept": "376", "attributes": [], "id": "e941", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "942", "fromConcept": "376", "attributes": [], "id": "e942", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "248", "fromConcept": "376", "attributes": [], "id": "e943", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "943", "fromConcept": "376", "attributes": [], "id": "e944", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "34", "fromConcept": "376", "attributes": [], "id": "e945", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "840", "fromConcept": "376", "attributes": [], "id": "e946", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "has_function"} , { "toConcept": "944", "fromConcept": "376", "attributes": [], "id": "e947", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "945", "fromConcept": "376", "attributes": [], "id": "e948", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "946", "fromConcept": "376", "attributes": [], "id": "e949", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "947", "fromConcept": "376", "attributes": [], "id": "e950", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "948", "fromConcept": "376", "attributes": [], "id": "e951", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "949", "fromConcept": "376", "attributes": [], "id": "e952", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "31", "fromConcept": "376", "attributes": [], "id": "e953", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "has_function"} , { "toConcept": "950", "fromConcept": "376", "attributes": [], "id": "e954", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "951", "fromConcept": "376", "attributes": [], "id": "e955", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "827", "fromConcept": "376", "attributes": [], "id": "e956", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "952", "fromConcept": "376", "attributes": [], "id": "e957", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "has_function"} , { "toConcept": "953", "fromConcept": "376", "attributes": [], "id": "e958", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "252", "fromConcept": "376", "attributes": [], "id": "e959", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "954", "fromConcept": "376", "attributes": [], "id": "e960", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "955", "fromConcept": "376", "attributes": [], "id": "e961", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "259", "fromConcept": "376", "attributes": [], "id": "e962", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "956", "fromConcept": "376", "attributes": [], "id": "e963", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "957", "fromConcept": "376", "attributes": [], "id": "e964", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "958", "fromConcept": "376", "attributes": [], "id": "e965", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "959", "fromConcept": "376", "attributes": [], "id": "e966", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "453", "fromConcept": "376", "attributes": [], "id": "e967", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "88", "fromConcept": "376", "attributes": [], "id": "e968", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "960", "fromConcept": "376", "attributes": [], "id": "e969", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "376", "attributes": [], "id": "e970", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "961", "fromConcept": "376", "attributes": [], "id": "e971", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "446", "fromConcept": "376", "attributes": [], "id": "e972", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "962", "fromConcept": "376", "attributes": [], "id": "e973", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "located_in"} , { "toConcept": "850", "fromConcept": "376", "attributes": [], "id": "e974", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "376", "attributes": [], "id": "e975", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "963", "fromConcept": "376", "attributes": [], "id": "e976", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "653", "fromConcept": "376", "attributes": [], "id": "e977", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "438", "fromConcept": "376", "attributes": [], "id": "e978", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "964", "fromConcept": "376", "attributes": [], "id": "e979", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "965", "fromConcept": "376", "attributes": [], "id": "e980", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "966", "fromConcept": "376", "attributes": [], "id": "e981", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "967", "fromConcept": "376", "attributes": [], "id": "e982", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "968", "fromConcept": "376", "attributes": [], "id": "e983", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "969", "fromConcept": "376", "attributes": [], "id": "e984", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "970", "fromConcept": "376", "attributes": [], "id": "e985", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "971", "fromConcept": "376", "attributes": [], "id": "e986", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "972", "fromConcept": "376", "attributes": [], "id": "e987", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "973", "fromConcept": "376", "attributes": [], "id": "e988", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "460", "fromConcept": "376", "attributes": [], "id": "e989", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "974", "fromConcept": "376", "attributes": [], "id": "e990", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "975", "fromConcept": "376", "attributes": [], "id": "e991", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "976", "fromConcept": "376", "attributes": [], "id": "e992", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "977", "fromConcept": "376", "attributes": [], "id": "e993", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "978", "fromConcept": "376", "attributes": [], "id": "e994", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "979", "fromConcept": "376", "attributes": [], "id": "e995", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "980", "fromConcept": "376", "attributes": [], "id": "e996", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "981", "fromConcept": "376", "attributes": [], "id": "e997", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "982", "fromConcept": "376", "attributes": [], "id": "e998", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "983", "fromConcept": "376", "attributes": [], "id": "e999", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "984", "fromConcept": "376", "attributes": [], "id": "e1000", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "985", "fromConcept": "376", "attributes": [], "id": "e1001", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "986", "fromConcept": "376", "attributes": [], "id": "e1002", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "503", "fromConcept": "376", "attributes": [], "id": "e1003", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "987", "fromConcept": "376", "attributes": [], "id": "e1004", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "988", "fromConcept": "376", "attributes": [], "id": "e1005", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "989", "fromConcept": "376", "attributes": [], "id": "e1006", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "990", "fromConcept": "376", "attributes": [], "id": "e1007", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "991", "fromConcept": "376", "attributes": [], "id": "e1008", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "992", "fromConcept": "376", "attributes": [], "id": "e1009", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "506", "fromConcept": "376", "attributes": [], "id": "e1010", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "993", "fromConcept": "376", "attributes": [], "id": "e1011", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "994", "fromConcept": "376", "attributes": [], "id": "e1012", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "508", "fromConcept": "376", "attributes": [], "id": "e1013", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "995", "fromConcept": "376", "attributes": [], "id": "e1014", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "884", "fromConcept": "376", "attributes": [], "id": "e1015", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "996", "fromConcept": "376", "attributes": [], "id": "e1016", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "997", "fromConcept": "376", "attributes": [], "id": "e1017", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "998", "fromConcept": "376", "attributes": [], "id": "e1018", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "999", "fromConcept": "376", "attributes": [], "id": "e1019", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1000", "fromConcept": "376", "attributes": [], "id": "e1020", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "1001", "fromConcept": "376", "attributes": [], "id": "e1021", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1002", "fromConcept": "376", "attributes": [], "id": "e1022", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1003", "fromConcept": "376", "attributes": [], "id": "e1023", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "865", "fromConcept": "376", "attributes": [], "id": "e1024", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "477", "fromConcept": "376", "attributes": [], "id": "e1025", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1004", "fromConcept": "376", "attributes": [], "id": "e1026", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "512", "fromConcept": "376", "attributes": [], "id": "e1027", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1005", "fromConcept": "376", "attributes": [], "id": "e1028", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1006", "fromConcept": "376", "attributes": [], "id": "e1029", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1007", "fromConcept": "376", "attributes": [], "id": "e1030", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1008", "fromConcept": "376", "attributes": [], "id": "e1031", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "669", "fromConcept": "376", "attributes": [], "id": "e1032", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "513", "fromConcept": "376", "attributes": [], "id": "e1033", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1009", "fromConcept": "376", "attributes": [], "id": "e1034", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "116", "fromConcept": "376", "attributes": [], "id": "e1035", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1010", "fromConcept": "376", "attributes": [], "id": "e1036", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "1011", "fromConcept": "376", "attributes": [], "id": "e1037", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1012", "fromConcept": "376", "attributes": [], "id": "e1038", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "520", "fromConcept": "376", "attributes": [], "id": "e1039", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "476", "fromConcept": "376", "attributes": [], "id": "e1040", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "859", "fromConcept": "376", "attributes": [], "id": "e1041", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1013", "fromConcept": "376", "attributes": [], "id": "e1042", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1014", "fromConcept": "376", "attributes": [], "id": "e1043", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1015", "fromConcept": "376", "attributes": [], "id": "e1044", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "1016", "fromConcept": "376", "attributes": [], "id": "e1045", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1017", "fromConcept": "376", "attributes": [], "id": "e1046", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1018", "fromConcept": "376", "attributes": [], "id": "e1047", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1019", "fromConcept": "376", "attributes": [], "id": "e1048", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1020", "fromConcept": "376", "attributes": [], "id": "e1049", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1021", "fromConcept": "376", "attributes": [], "id": "e1050", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "1022", "fromConcept": "376", "attributes": [], "id": "e1051", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1023", "fromConcept": "376", "attributes": [], "id": "e1052", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1024", "fromConcept": "376", "attributes": [], "id": "e1053", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1025", "fromConcept": "376", "attributes": [], "id": "e1054", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1026", "fromConcept": "376", "attributes": [], "id": "e1055", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1027", "fromConcept": "376", "attributes": [], "id": "e1056", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1028", "fromConcept": "376", "attributes": [], "id": "e1057", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "493", "fromConcept": "376", "attributes": [], "id": "e1058", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "1029", "fromConcept": "376", "attributes": [], "id": "e1059", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "906", "fromConcept": "376", "attributes": [], "id": "e1060", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1030", "fromConcept": "376", "attributes": [], "id": "e1061", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1031", "fromConcept": "376", "attributes": [], "id": "e1062", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1032", "fromConcept": "376", "attributes": [], "id": "e1063", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1033", "fromConcept": "376", "attributes": [], "id": "e1064", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1034", "fromConcept": "376", "attributes": [], "id": "e1065", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1035", "fromConcept": "376", "attributes": [], "id": "e1066", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1036", "fromConcept": "376", "attributes": [], "id": "e1067", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1037", "fromConcept": "376", "attributes": [], "id": "e1068", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1038", "fromConcept": "376", "attributes": [], "id": "e1069", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "384", "fromConcept": "376", "attributes": [], "id": "e1070", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1039", "fromConcept": "376", "attributes": [], "id": "e1071", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "382", "fromConcept": "376", "attributes": [], "id": "e1072", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1040", "fromConcept": "376", "attributes": [], "id": "e1073", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1041", "fromConcept": "376", "attributes": [], "id": "e1074", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1042", "fromConcept": "376", "attributes": [], "id": "e1075", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1043", "fromConcept": "376", "attributes": [], "id": "e1076", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1044", "fromConcept": "376", "attributes": [], "id": "e1077", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "377", "fromConcept": "376", "attributes": [], "id": "e1078", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "344", "fromConcept": "376", "attributes": [], "id": "e1079", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1045", "fromConcept": "376", "attributes": [], "id": "e1080", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "347", "fromConcept": "376", "attributes": [], "id": "e1081", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1046", "fromConcept": "376", "attributes": [], "id": "e1082", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "239", "fromConcept": "376", "attributes": [], "id": "e1083", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "388", "fromConcept": "376", "attributes": [], "id": "e1084", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "236", "fromConcept": "376", "attributes": [], "id": "e1085", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1047", "fromConcept": "376", "attributes": [], "id": "e1086", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "379", "fromConcept": "376", "attributes": [], "id": "e1087", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1048", "fromConcept": "376", "attributes": [], "id": "e1088", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "240", "fromConcept": "376", "attributes": [], "id": "e1089", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "48", "fromConcept": "376", "attributes": [], "id": "e1090", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1049", "fromConcept": "376", "attributes": [], "id": "e1091", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1050", "fromConcept": "376", "attributes": [], "id": "e1092", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1051", "fromConcept": "376", "attributes": [], "id": "e1093", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1052", "fromConcept": "376", "attributes": [], "id": "e1094", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1053", "fromConcept": "376", "attributes": [], "id": "e1095", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1054", "fromConcept": "376", "attributes": [], "id": "e1096", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "349", "fromConcept": "376", "attributes": [], "id": "e1097", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "390", "fromConcept": "376", "attributes": [], "id": "e1098", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1055", "fromConcept": "376", "attributes": [], "id": "e1099", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1056", "fromConcept": "376", "attributes": [], "id": "e1100", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1057", "fromConcept": "376", "attributes": [], "id": "e1101", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "381", "fromConcept": "376", "attributes": [], "id": "e1102", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "380", "fromConcept": "376", "attributes": [], "id": "e1103", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "383", "fromConcept": "376", "attributes": [], "id": "e1104", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1058", "fromConcept": "376", "attributes": [], "id": "e1105", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1059", "fromConcept": "376", "attributes": [], "id": "e1106", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1060", "fromConcept": "376", "attributes": [], "id": "e1107", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1061", "fromConcept": "376", "attributes": [], "id": "e1108", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "237", "fromConcept": "376", "attributes": [], "id": "e1109", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1062", "fromConcept": "376", "attributes": [], "id": "e1110", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "378", "fromConcept": "376", "attributes": [], "id": "e1111", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1063", "fromConcept": "376", "attributes": [], "id": "e1112", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1064", "fromConcept": "376", "attributes": [], "id": "e1113", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "385", "fromConcept": "376", "attributes": [], "id": "e1114", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1065", "fromConcept": "376", "attributes": [], "id": "e1115", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "343", "fromConcept": "376", "attributes": [], "id": "e1116", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1066", "fromConcept": "376", "attributes": [], "id": "e1117", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1067", "fromConcept": "376", "attributes": [], "id": "e1118", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1068", "fromConcept": "376", "attributes": [], "id": "e1119", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1069", "fromConcept": "376", "attributes": [], "id": "e1120", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "238", "fromConcept": "376", "attributes": [], "id": "e1121", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1070", "fromConcept": "376", "attributes": [], "id": "e1122", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1071", "fromConcept": "376", "attributes": [], "id": "e1123", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "386", "fromConcept": "376", "attributes": [], "id": "e1124", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "13", "fromConcept": "376", "attributes": [], "id": "e1125", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "389", "fromConcept": "376", "attributes": [], "id": "e1126", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "225", "fromConcept": "376", "attributes": [], "id": "e1127", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "387", "fromConcept": "376", "attributes": [], "id": "e1128", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "235", "fromConcept": "376", "attributes": [], "id": "e1129", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1072", "fromConcept": "376", "attributes": [], "id": "e1130", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1073", "fromConcept": "376", "attributes": [], "id": "e1131", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1074", "fromConcept": "376", "attributes": [], "id": "e1132", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1075", "fromConcept": "376", "attributes": [], "id": "e1133", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1076", "fromConcept": "376", "attributes": [], "id": "e1134", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "348", "fromConcept": "376", "attributes": [], "id": "e1135", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1077", "fromConcept": "376", "attributes": [], "id": "e1136", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1078", "fromConcept": "376", "attributes": [], "id": "e1137", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "224", "fromConcept": "376", "attributes": [], "id": "e1138", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1079", "fromConcept": "376", "attributes": [], "id": "e1139", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "391", "fromConcept": "1080", "attributes": [], "id": "e1140", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "405", "fromConcept": "1081", "attributes": [], "id": "e1141", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "425", "fromConcept": "1082", "attributes": [], "id": "e1142", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "425", "fromConcept": "819", "attributes": [], "id": "e1143", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "575", "fromConcept": "1083", "attributes": [], "id": "e1144", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "575", "fromConcept": "1084", "attributes": [], "id": "e1145", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "575", "fromConcept": "1085", "attributes": [], "id": "e1146", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "575", "fromConcept": "816", "attributes": [], "id": "e1147", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "577", "fromConcept": "1086", "attributes": [], "id": "e1148", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "577", "fromConcept": "1087", "attributes": [], "id": "e1149", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "579", "fromConcept": "1088", "attributes": [], "id": "e1150", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "579", "fromConcept": "1083", "attributes": [], "id": "e1151", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "580", "fromConcept": "226", "attributes": [{ "attrname": "CoCitNum", "value": "9"} , { "attrname": "CoSenNum", "value": "4"} , { "attrname": "IP_TFIDF", "value": "13.032011623122713"} , { "attrname": "PMID", "value": "10200054,  10200054,  11920851,  11920851,  11920851,  9851443,  9851443,  11710891,  11710891"} , { "attrname": "MAX_TFIDF", "value": "5.966891944408417"} , { "attrname": "EVIDENCE", "value": "[A G-to-C nucleotide change resulting in a glycine-alanine amino acid substitution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%) of the 19 families.,  Patients in the pedigree showed a missense mutation in exon 11 of the PS1 gene involving a transition of G to A,  altering glycine to glutamate at codon 378.,  We detected an A-to-G transition in the PS-1 gene,  resulting in a glutamic acid (Glu)-to-glycine (Gly) substitution at codon 318 in 2 familial and 2 sporadic AD patients.,  This mutation,  which is predicted to cause a missense substitution of serine for glycine,  occurred at codon 266 in exon 8 of PSEN1.]"} ], "id": "e1152", "contexts": { "context": { "id": 233} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "1089", "fromConcept": "580", "attributes": [], "id": "e1153", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "1090", "fromConcept": "580", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e1154", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "941", "fromConcept": "580", "attributes": [], "id": "e1155", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "942", "fromConcept": "580", "attributes": [], "id": "e1156", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "1091", "fromConcept": "580", "attributes": [], "id": "e1157", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "has_function"} , { "toConcept": "1092", "fromConcept": "580", "attributes": [], "id": "e1158", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "1093", "fromConcept": "580", "attributes": [], "id": "e1159", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "has_function"} , { "toConcept": "1094", "fromConcept": "580", "attributes": [], "id": "e1160", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "454", "fromConcept": "580", "attributes": [], "id": "e1161", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1095", "fromConcept": "580", "attributes": [], "id": "e1162", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "453", "fromConcept": "580", "attributes": [], "id": "e1163", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "846", "fromConcept": "580", "attributes": [], "id": "e1164", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1096", "fromConcept": "580", "attributes": [], "id": "e1165", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "655", "fromConcept": "580", "attributes": [], "id": "e1166", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1097", "fromConcept": "580", "attributes": [], "id": "e1167", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "443", "fromConcept": "580", "attributes": [], "id": "e1168", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1098", "fromConcept": "580", "attributes": [], "id": "e1169", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "961", "fromConcept": "580", "attributes": [], "id": "e1170", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1099", "fromConcept": "580", "attributes": [], "id": "e1171", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "848", "fromConcept": "580", "attributes": [], "id": "e1172", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "580", "attributes": [], "id": "e1173", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "98", "fromConcept": "580", "attributes": [], "id": "e1174", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "648", "fromConcept": "580", "attributes": [], "id": "e1175", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1100", "fromConcept": "580", "attributes": [], "id": "e1176", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1101", "fromConcept": "580", "attributes": [], "id": "e1177", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1102", "fromConcept": "580", "attributes": [], "id": "e1178", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "847", "fromConcept": "580", "attributes": [], "id": "e1179", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "850", "fromConcept": "580", "attributes": [], "id": "e1180", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "447", "fromConcept": "580", "attributes": [], "id": "e1181", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "650", "fromConcept": "580", "attributes": [], "id": "e1182", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "849", "fromConcept": "580", "attributes": [], "id": "e1183", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "450", "fromConcept": "580", "attributes": [], "id": "e1184", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1103", "fromConcept": "580", "attributes": [], "id": "e1185", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "438", "fromConcept": "580", "attributes": [], "id": "e1186", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "580", "attributes": [], "id": "e1187", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "652", "fromConcept": "580", "attributes": [], "id": "e1188", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1104", "fromConcept": "580", "attributes": [], "id": "e1189", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1105", "fromConcept": "580", "attributes": [], "id": "e1190", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "436", "fromConcept": "580", "attributes": [], "id": "e1191", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1106", "fromConcept": "580", "attributes": [], "id": "e1192", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "653", "fromConcept": "580", "attributes": [], "id": "e1193", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "580", "attributes": [], "id": "e1194", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1107", "fromConcept": "580", "attributes": [], "id": "e1195", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1108", "fromConcept": "580", "attributes": [], "id": "e1196", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "867", "fromConcept": "580", "attributes": [], "id": "e1197", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "528", "fromConcept": "580", "attributes": [], "id": "e1198", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1109", "fromConcept": "580", "attributes": [], "id": "e1199", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1110", "fromConcept": "580", "attributes": [], "id": "e1200", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "1111", "fromConcept": "580", "attributes": [], "id": "e1201", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1112", "fromConcept": "580", "attributes": [], "id": "e1202", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1113", "fromConcept": "580", "attributes": [], "id": "e1203", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1114", "fromConcept": "580", "attributes": [], "id": "e1204", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1115", "fromConcept": "580", "attributes": [], "id": "e1205", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "679", "fromConcept": "580", "attributes": [], "id": "e1206", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "458", "fromConcept": "580", "attributes": [], "id": "e1207", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "879", "fromConcept": "580", "attributes": [], "id": "e1208", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1116", "fromConcept": "580", "attributes": [], "id": "e1209", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1117", "fromConcept": "580", "attributes": [], "id": "e1210", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1118", "fromConcept": "580", "attributes": [], "id": "e1211", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1119", "fromConcept": "580", "attributes": [], "id": "e1212", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "1120", "fromConcept": "580", "attributes": [], "id": "e1213", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "687", "fromConcept": "580", "attributes": [], "id": "e1214", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1121", "fromConcept": "580", "attributes": [], "id": "e1215", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "1122", "fromConcept": "580", "attributes": [], "id": "e1216", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1123", "fromConcept": "580", "attributes": [], "id": "e1217", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1124", "fromConcept": "580", "attributes": [], "id": "e1218", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1125", "fromConcept": "580", "attributes": [], "id": "e1219", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1126", "fromConcept": "580", "attributes": [], "id": "e1220", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "465", "fromConcept": "580", "attributes": [], "id": "e1221", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1127", "fromConcept": "580", "attributes": [], "id": "e1222", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "467", "fromConcept": "580", "attributes": [], "id": "e1223", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "503", "fromConcept": "580", "attributes": [], "id": "e1224", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1128", "fromConcept": "580", "attributes": [], "id": "e1225", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1129", "fromConcept": "580", "attributes": [], "id": "e1226", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "910", "fromConcept": "580", "attributes": [], "id": "e1227", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1130", "fromConcept": "580", "attributes": [], "id": "e1228", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1131", "fromConcept": "580", "attributes": [], "id": "e1229", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1132", "fromConcept": "580", "attributes": [], "id": "e1230", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1133", "fromConcept": "580", "attributes": [], "id": "e1231", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1134", "fromConcept": "580", "attributes": [], "id": "e1232", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "1135", "fromConcept": "580", "attributes": [], "id": "e1233", "contexts": { } , "evidences": ["ECO: 0000315"], "ofType": "participates_in"} , { "toConcept": "865", "fromConcept": "580", "attributes": [], "id": "e1234", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1136", "fromConcept": "580", "attributes": [], "id": "e1235", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1137", "fromConcept": "580", "attributes": [], "id": "e1236", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "513", "fromConcept": "580", "attributes": [], "id": "e1237", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "902", "fromConcept": "580", "attributes": [], "id": "e1238", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1138", "fromConcept": "580", "attributes": [], "id": "e1239", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1139", "fromConcept": "580", "attributes": [], "id": "e1240", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1140", "fromConcept": "580", "attributes": [], "id": "e1241", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1141", "fromConcept": "580", "attributes": [], "id": "e1242", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1142", "fromConcept": "580", "attributes": [], "id": "e1243", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1143", "fromConcept": "580", "attributes": [], "id": "e1244", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1144", "fromConcept": "580", "attributes": [], "id": "e1245", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1145", "fromConcept": "580", "attributes": [], "id": "e1246", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1146", "fromConcept": "580", "attributes": [], "id": "e1247", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1147", "fromConcept": "580", "attributes": [], "id": "e1248", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1148", "fromConcept": "580", "attributes": [], "id": "e1249", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1149", "fromConcept": "580", "attributes": [], "id": "e1250", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1150", "fromConcept": "580", "attributes": [], "id": "e1251", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1151", "fromConcept": "580", "attributes": [], "id": "e1252", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1152", "fromConcept": "580", "attributes": [], "id": "e1253", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1153", "fromConcept": "580", "attributes": [], "id": "e1254", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "680", "fromConcept": "580", "attributes": [], "id": "e1255", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "120", "fromConcept": "580", "attributes": [], "id": "e1256", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1154", "fromConcept": "580", "attributes": [], "id": "e1257", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1155", "fromConcept": "580", "attributes": [], "id": "e1258", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1156", "fromConcept": "580", "attributes": [], "id": "e1259", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1157", "fromConcept": "580", "attributes": [], "id": "e1260", "contexts": { } , "evidences": ["ECO: 0000316"], "ofType": "participates_in"} , { "toConcept": "1158", "fromConcept": "580", "attributes": [], "id": "e1261", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1159", "fromConcept": "580", "attributes": [], "id": "e1262", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1160", "fromConcept": "580", "attributes": [], "id": "e1263", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1161", "fromConcept": "580", "attributes": [], "id": "e1264", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1162", "fromConcept": "580", "attributes": [], "id": "e1265", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "231", "fromConcept": "580", "attributes": [], "id": "e1266", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "60", "fromConcept": "580", "attributes": [], "id": "e1267", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "587", "fromConcept": "580", "attributes": [], "id": "e1268", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "581", "fromConcept": "580", "attributes": [], "id": "e1269", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "590", "fromConcept": "580", "attributes": [], "id": "e1270", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1163", "fromConcept": "580", "attributes": [], "id": "e1271", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1164", "fromConcept": "580", "attributes": [], "id": "e1272", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "594", "fromConcept": "580", "attributes": [], "id": "e1273", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1165", "fromConcept": "580", "attributes": [], "id": "e1274", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1166", "fromConcept": "580", "attributes": [], "id": "e1275", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "72", "fromConcept": "580", "attributes": [], "id": "e1276", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "79", "fromConcept": "580", "attributes": [], "id": "e1277", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1167", "fromConcept": "580", "attributes": [], "id": "e1278", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1168", "fromConcept": "580", "attributes": [], "id": "e1279", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1169", "fromConcept": "580", "attributes": [], "id": "e1280", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1170", "fromConcept": "580", "attributes": [], "id": "e1281", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "601", "fromConcept": "580", "attributes": [], "id": "e1282", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "585", "fromConcept": "580", "attributes": [], "id": "e1283", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "593", "fromConcept": "580", "attributes": [], "id": "e1284", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1171", "fromConcept": "580", "attributes": [], "id": "e1285", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1172", "fromConcept": "580", "attributes": [], "id": "e1286", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1173", "fromConcept": "580", "attributes": [], "id": "e1287", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1174", "fromConcept": "580", "attributes": [], "id": "e1288", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "592", "fromConcept": "580", "attributes": [], "id": "e1289", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1175", "fromConcept": "580", "attributes": [], "id": "e1290", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1176", "fromConcept": "580", "attributes": [], "id": "e1291", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1177", "fromConcept": "580", "attributes": [], "id": "e1292", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1178", "fromConcept": "580", "attributes": [], "id": "e1293", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "49", "fromConcept": "580", "attributes": [], "id": "e1294", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "595", "fromConcept": "580", "attributes": [], "id": "e1295", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1179", "fromConcept": "580", "attributes": [], "id": "e1296", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "78", "fromConcept": "580", "attributes": [], "id": "e1297", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "82", "fromConcept": "580", "attributes": [], "id": "e1298", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1180", "fromConcept": "580", "attributes": [], "id": "e1299", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1181", "fromConcept": "580", "attributes": [], "id": "e1300", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "61", "fromConcept": "580", "attributes": [], "id": "e1301", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1182", "fromConcept": "580", "attributes": [], "id": "e1302", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "591", "fromConcept": "580", "attributes": [], "id": "e1303", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1183", "fromConcept": "580", "attributes": [], "id": "e1304", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "597", "fromConcept": "580", "attributes": [], "id": "e1305", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1184", "fromConcept": "580", "attributes": [], "id": "e1306", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1185", "fromConcept": "580", "attributes": [], "id": "e1307", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "68", "fromConcept": "580", "attributes": [], "id": "e1308", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1186", "fromConcept": "580", "attributes": [], "id": "e1309", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1187", "fromConcept": "580", "attributes": [], "id": "e1310", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1188", "fromConcept": "580", "attributes": [], "id": "e1311", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "602", "fromConcept": "580", "attributes": [], "id": "e1312", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "233", "fromConcept": "580", "attributes": [], "id": "e1313", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1189", "fromConcept": "580", "attributes": [], "id": "e1314", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "586", "fromConcept": "580", "attributes": [], "id": "e1315", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "228", "fromConcept": "580", "attributes": [], "id": "e1316", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1190", "fromConcept": "580", "attributes": [], "id": "e1317", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "66", "fromConcept": "580", "attributes": [], "id": "e1318", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "589", "fromConcept": "580", "attributes": [], "id": "e1319", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1191", "fromConcept": "580", "attributes": [], "id": "e1320", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "599", "fromConcept": "580", "attributes": [], "id": "e1321", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1192", "fromConcept": "580", "attributes": [], "id": "e1322", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1193", "fromConcept": "580", "attributes": [], "id": "e1323", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "583", "fromConcept": "580", "attributes": [], "id": "e1324", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1194", "fromConcept": "580", "attributes": [], "id": "e1325", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "67", "fromConcept": "580", "attributes": [], "id": "e1326", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "8", "fromConcept": "580", "attributes": [], "id": "e1327", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1195", "fromConcept": "580", "attributes": [], "id": "e1328", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "598", "fromConcept": "580", "attributes": [], "id": "e1329", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1196", "fromConcept": "580", "attributes": [], "id": "e1330", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "80", "fromConcept": "580", "attributes": [], "id": "e1331", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1197", "fromConcept": "580", "attributes": [], "id": "e1332", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "584", "fromConcept": "580", "attributes": [], "id": "e1333", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "582", "fromConcept": "580", "attributes": [], "id": "e1334", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "64", "fromConcept": "580", "attributes": [], "id": "e1335", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1198", "fromConcept": "580", "attributes": [], "id": "e1336", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "604", "fromConcept": "226", "attributes": [{ "attrname": "CoCitNum", "value": "6"} , { "attrname": "CoSenNum", "value": "2"} , { "attrname": "IP_TFIDF", "value": "8.384427176094928"} , { "attrname": "PMID", "value": "1672107,  1672107,  11709001,  11709001,  11900542,  11900542"} , { "attrname": "MAX_TFIDF", "value": "3.5550869941698693"} , { "attrname": "EVIDENCE", "value": "[We found that the major component of GSS amyloid is an 11 kd degradation product of PrP,  whose N-terminus corresponds to the glycine residue at position 58 of the amino acid sequence deduced from the human PrP cDNA.,  The N-terminal cleavage of PrP in GSS disease occurs at a tryptophan-glycine peptide bond identical to that cleaved by proteinase K in vitro to generate PrP 27-30 from hamster PrPSc at codon 90.]"} ], "id": "e1337", "contexts": { "context": { "id": 230} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "604", "fromConcept": "20", "attributes": [{ "attrname": "CoCitNum", "value": "2"} , { "attrname": "CoSenNum", "value": "2"} , { "attrname": "visible", "value": "true"} , { "attrname": "IP_TFIDF", "value": "1.251515070280309"} , { "attrname": "size", "value": "5"} , { "attrname": "PMID", "value": "19936054,  19936054"} , { "attrname": "MAX_TFIDF", "value": "0.8028488255350545"} , { "attrname": "EVIDENCE", "value": "[We then utilised a transmembrane-anchored form of PrP (PrP-TM),  which is targeted to rafts solely by its N-terminal domain,  to show that both heparin and phosphatidylinositol-specific phospholipase C can inhibit its association with detergent-resistant rafts,  implying that a GPI-anchored HSPG targets PrP(C) to rafts.,  We show that heparin displaces PrP(C) from rafts and promotes its endocytosis,  suggesting that heparin competes with an endogenous raft-resident HSPG for binding to PrP(C).]"} ], "id": "e1338", "contexts": { "context": { "id": 29} } , "evidences": ["Transitive"], "ofType": "cooccurs_with"} , { "toConcept": "1199", "fromConcept": "604", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e1339", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "836", "fromConcept": "604", "attributes": [], "id": "e1340", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "33", "fromConcept": "604", "attributes": [], "id": "e1341", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "248", "fromConcept": "604", "attributes": [], "id": "e1342", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "259", "fromConcept": "604", "attributes": [], "id": "e1343", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "430", "fromConcept": "604", "attributes": [], "id": "e1344", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "604", "attributes": [], "id": "e1345", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1200", "fromConcept": "604", "attributes": [], "id": "e1346", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "604", "attributes": [], "id": "e1347", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "453", "fromConcept": "604", "attributes": [], "id": "e1348", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "850", "fromConcept": "604", "attributes": [], "id": "e1349", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "655", "fromConcept": "604", "attributes": [], "id": "e1350", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1201", "fromConcept": "604", "attributes": [], "id": "e1351", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "442", "fromConcept": "604", "attributes": [], "id": "e1352", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "443", "fromConcept": "604", "attributes": [], "id": "e1353", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "604", "fromConcept": "1202", "attributes": [], "id": "e1354", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "1203", "fromConcept": "604", "attributes": [], "id": "e1355", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1204", "fromConcept": "604", "attributes": [], "id": "e1356", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1205", "fromConcept": "604", "attributes": [], "id": "e1357", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1206", "fromConcept": "604", "attributes": [], "id": "e1358", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1207", "fromConcept": "604", "attributes": [], "id": "e1359", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "664", "fromConcept": "604", "attributes": [], "id": "e1360", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "1208", "fromConcept": "604", "attributes": [], "id": "e1361", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1209", "fromConcept": "604", "attributes": [], "id": "e1362", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1210", "fromConcept": "604", "attributes": [], "id": "e1363", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1211", "fromConcept": "604", "attributes": [], "id": "e1364", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "512", "fromConcept": "604", "attributes": [], "id": "e1365", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "867", "fromConcept": "604", "attributes": [], "id": "e1366", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1212", "fromConcept": "604", "attributes": [], "id": "e1367", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1213", "fromConcept": "604", "attributes": [], "id": "e1368", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "513", "fromConcept": "604", "attributes": [], "id": "e1369", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1214", "fromConcept": "604", "attributes": [], "id": "e1370", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1215", "fromConcept": "604", "attributes": [], "id": "e1371", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1216", "fromConcept": "604", "attributes": [], "id": "e1372", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "900", "fromConcept": "604", "attributes": [], "id": "e1373", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1217", "fromConcept": "604", "attributes": [], "id": "e1374", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "participates_in"} , { "toConcept": "1218", "fromConcept": "604", "attributes": [], "id": "e1375", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1219", "fromConcept": "604", "attributes": [], "id": "e1376", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1220", "fromConcept": "604", "attributes": [], "id": "e1377", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1221", "fromConcept": "604", "attributes": [], "id": "e1378", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1222", "fromConcept": "604", "attributes": [], "id": "e1379", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "227", "fromConcept": "604", "attributes": [], "id": "e1380", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1223", "fromConcept": "604", "attributes": [], "id": "e1381", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "29", "fromConcept": "604", "attributes": [], "id": "e1382", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1224", "fromConcept": "604", "attributes": [], "id": "e1383", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1225", "fromConcept": "604", "attributes": [], "id": "e1384", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1226", "fromConcept": "604", "attributes": [], "id": "e1385", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1227", "fromConcept": "604", "attributes": [], "id": "e1386", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1228", "fromConcept": "604", "attributes": [], "id": "e1387", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1229", "fromConcept": "604", "attributes": [], "id": "e1388", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1230", "fromConcept": "604", "attributes": [], "id": "e1389", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1231", "fromConcept": "604", "attributes": [], "id": "e1390", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1232", "fromConcept": "604", "attributes": [], "id": "e1391", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "80", "fromConcept": "604", "attributes": [], "id": "e1392", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1233", "fromConcept": "604", "attributes": [], "id": "e1393", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1234", "fromConcept": "604", "attributes": [], "id": "e1394", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1235", "fromConcept": "604", "attributes": [], "id": "e1395", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1236", "fromConcept": "604", "attributes": [], "id": "e1396", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1237", "fromConcept": "604", "attributes": [], "id": "e1397", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1238", "fromConcept": "604", "attributes": [], "id": "e1398", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "15", "fromConcept": "604", "attributes": [], "id": "e1399", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1239", "fromConcept": "604", "attributes": [], "id": "e1400", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1240", "fromConcept": "604", "attributes": [], "id": "e1401", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "58", "fromConcept": "604", "attributes": [], "id": "e1402", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "229", "fromConcept": "604", "attributes": [], "id": "e1403", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1241", "fromConcept": "604", "attributes": [], "id": "e1404", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1242", "fromConcept": "604", "attributes": [], "id": "e1405", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1243", "fromConcept": "604", "attributes": [], "id": "e1406", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1244", "fromConcept": "604", "attributes": [], "id": "e1407", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1245", "fromConcept": "604", "attributes": [], "id": "e1408", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1246", "fromConcept": "604", "attributes": [], "id": "e1409", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "605", "fromConcept": "604", "attributes": [], "id": "e1410", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1247", "fromConcept": "604", "attributes": [], "id": "e1411", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1248", "fromConcept": "604", "attributes": [], "id": "e1412", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1249", "fromConcept": "604", "attributes": [], "id": "e1413", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1250", "fromConcept": "604", "attributes": [], "id": "e1414", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1251", "fromConcept": "604", "attributes": [], "id": "e1415", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "606", "fromConcept": "604", "attributes": [], "id": "e1416", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1252", "fromConcept": "604", "attributes": [], "id": "e1417", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1253", "fromConcept": "604", "attributes": [], "id": "e1418", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1254", "fromConcept": "604", "attributes": [], "id": "e1419", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1255", "fromConcept": "604", "attributes": [], "id": "e1420", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1256", "fromConcept": "604", "attributes": [], "id": "e1421", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1257", "fromConcept": "604", "attributes": [], "id": "e1422", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1258", "fromConcept": "604", "attributes": [], "id": "e1423", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1259", "fromConcept": "604", "attributes": [], "id": "e1424", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1260", "fromConcept": "604", "attributes": [], "id": "e1425", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1261", "fromConcept": "604", "attributes": [], "id": "e1426", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "230", "fromConcept": "604", "attributes": [], "id": "e1427", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1262", "fromConcept": "604", "attributes": [], "id": "e1428", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1263", "fromConcept": "604", "attributes": [], "id": "e1429", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1264", "fromConcept": "604", "attributes": [], "id": "e1430", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1265", "fromConcept": "604", "attributes": [], "id": "e1431", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1266", "fromConcept": "604", "attributes": [], "id": "e1432", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1267", "fromConcept": "604", "attributes": [], "id": "e1433", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "607", "fromConcept": "604", "attributes": [], "id": "e1434", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "609", "fromConcept": "1268", "attributes": [], "id": "e1435", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "610", "fromConcept": "1269", "attributes": [], "id": "e1436", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "610", "fromConcept": "1270", "attributes": [], "id": "e1437", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "610", "fromConcept": "1271", "attributes": [], "id": "e1438", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "613", "fromConcept": "1272", "attributes": [], "id": "e1439", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "613", "fromConcept": "1273", "attributes": [], "id": "e1440", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1274", "attributes": [], "id": "e1441", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1275", "attributes": [], "id": "e1442", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1276", "attributes": [], "id": "e1443", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1277", "attributes": [], "id": "e1444", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1278", "attributes": [], "id": "e1445", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1279", "attributes": [], "id": "e1446", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1280", "attributes": [], "id": "e1447", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1281", "attributes": [], "id": "e1448", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1282", "attributes": [], "id": "e1449", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1283", "attributes": [], "id": "e1450", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1284", "attributes": [], "id": "e1451", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1285", "attributes": [], "id": "e1452", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1286", "attributes": [], "id": "e1453", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1287", "attributes": [], "id": "e1454", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "937", "attributes": [], "id": "e1455", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1288", "attributes": [], "id": "e1456", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1289", "attributes": [], "id": "e1457", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1290", "attributes": [], "id": "e1458", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1291", "attributes": [], "id": "e1459", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "627", "fromConcept": "1292", "attributes": [], "id": "e1460", "contexts": { } , "evidences": ["Imported from database"], "ofType": "has_target"} , { "toConcept": "1293", "fromConcept": "634", "attributes": [], "id": "e1461", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "1294", "fromConcept": "634", "attributes": [], "id": "e1462", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "1295", "fromConcept": "634", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e1463", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "1296", "fromConcept": "634", "attributes": [], "id": "e1464", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "1297", "fromConcept": "634", "attributes": [], "id": "e1465", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "1298", "fromConcept": "634", "attributes": [], "id": "e1466", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "1299", "fromConcept": "634", "attributes": [], "id": "e1467", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "has_function"} , { "toConcept": "945", "fromConcept": "634", "attributes": [], "id": "e1468", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "951", "fromConcept": "634", "attributes": [], "id": "e1469", "contexts": { } , "evidences": ["ECO: 0000353"], "ofType": "has_function"} , { "toConcept": "949", "fromConcept": "634", "attributes": [], "id": "e1470", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "has_function"} , { "toConcept": "88", "fromConcept": "634", "attributes": [], "id": "e1471", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "634", "attributes": [], "id": "e1472", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "447", "fromConcept": "634", "attributes": [], "id": "e1473", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1095", "fromConcept": "634", "attributes": [], "id": "e1474", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1300", "fromConcept": "634", "attributes": [], "id": "e1475", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1301", "fromConcept": "634", "attributes": [], "id": "e1476", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "442", "fromConcept": "634", "attributes": [], "id": "e1477", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "448", "fromConcept": "634", "attributes": [], "id": "e1478", "contexts": { } , "evidences": ["ECO: 0000250"], "ofType": "located_in"} , { "toConcept": "1302", "fromConcept": "634", "attributes": [], "id": "e1479", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1303", "fromConcept": "634", "attributes": [], "id": "e1480", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1304", "fromConcept": "634", "attributes": [], "id": "e1481", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1305", "fromConcept": "634", "attributes": [], "id": "e1482", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1306", "fromConcept": "634", "attributes": [], "id": "e1483", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1307", "fromConcept": "634", "attributes": [], "id": "e1484", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "111", "fromConcept": "634", "attributes": [], "id": "e1485", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1308", "fromConcept": "634", "attributes": [], "id": "e1486", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1005", "fromConcept": "634", "attributes": [], "id": "e1487", "contexts": { } , "evidences": ["ECO: 0000303"], "ofType": "participates_in"} , { "toConcept": "1309", "fromConcept": "634", "attributes": [], "id": "e1488", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1310", "fromConcept": "634", "attributes": [], "id": "e1489", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1311", "fromConcept": "634", "attributes": [], "id": "e1490", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1312", "fromConcept": "634", "attributes": [], "id": "e1491", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1313", "fromConcept": "634", "attributes": [], "id": "e1492", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1314", "fromConcept": "634", "attributes": [], "id": "e1493", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1315", "fromConcept": "634", "attributes": [], "id": "e1494", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1316", "fromConcept": "634", "attributes": [], "id": "e1495", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1317", "fromConcept": "634", "attributes": [], "id": "e1496", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1318", "fromConcept": "634", "attributes": [], "id": "e1497", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1319", "fromConcept": "634", "attributes": [], "id": "e1498", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1320", "fromConcept": "634", "attributes": [], "id": "e1499", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1321", "fromConcept": "634", "attributes": [], "id": "e1500", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1322", "fromConcept": "634", "attributes": [], "id": "e1501", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1323", "fromConcept": "634", "attributes": [], "id": "e1502", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1324", "fromConcept": "634", "attributes": [], "id": "e1503", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1325", "fromConcept": "634", "attributes": [], "id": "e1504", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1326", "fromConcept": "634", "attributes": [], "id": "e1505", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "345", "fromConcept": "634", "attributes": [], "id": "e1506", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "346", "fromConcept": "634", "attributes": [], "id": "e1507", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1327", "fromConcept": "634", "attributes": [], "id": "e1508", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1328", "fromConcept": "634", "attributes": [], "id": "e1509", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1329", "fromConcept": "634", "attributes": [], "id": "e1510", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1330", "fromConcept": "634", "attributes": [], "id": "e1511", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1331", "fromConcept": "634", "attributes": [], "id": "e1512", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1332", "fromConcept": "634", "attributes": [], "id": "e1513", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1333", "fromConcept": "634", "attributes": [], "id": "e1514", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1089", "fromConcept": "636", "attributes": [], "id": "e1515", "contexts": { } , "evidences": ["Imported from database"], "ofType": "part_of_catalyzing_class"} , { "toConcept": "1334", "fromConcept": "636", "attributes": [{ "attrname": "visible", "value": "true"} , { "attrname": "size", "value": "5"} ], "id": "e1516", "contexts": { } , "evidences": ["Imported from database"], "ofType": "is_involved_in"} , { "toConcept": "1092", "fromConcept": "636", "attributes": [], "id": "e1517", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "has_function"} , { "toConcept": "1094", "fromConcept": "636", "attributes": [], "id": "e1518", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "has_function"} , { "toConcept": "453", "fromConcept": "636", "attributes": [], "id": "e1519", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1335", "fromConcept": "636", "attributes": [], "id": "e1520", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "447", "fromConcept": "636", "attributes": [], "id": "e1521", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "97", "fromConcept": "636", "attributes": [], "id": "e1522", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "98", "fromConcept": "636", "attributes": [], "id": "e1523", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1095", "fromConcept": "636", "attributes": [], "id": "e1524", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1100", "fromConcept": "636", "attributes": [], "id": "e1525", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "652", "fromConcept": "636", "attributes": [], "id": "e1526", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1104", "fromConcept": "636", "attributes": [], "id": "e1527", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1336", "fromConcept": "636", "attributes": [], "id": "e1528", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "655", "fromConcept": "636", "attributes": [], "id": "e1529", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1098", "fromConcept": "636", "attributes": [], "id": "e1530", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "443", "fromConcept": "636", "attributes": [], "id": "e1531", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1097", "fromConcept": "636", "attributes": [], "id": "e1532", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1103", "fromConcept": "636", "attributes": [], "id": "e1533", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "1337", "fromConcept": "636", "attributes": [], "id": "e1534", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "846", "fromConcept": "636", "attributes": [], "id": "e1535", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "88", "fromConcept": "636", "attributes": [], "id": "e1536", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "located_in"} , { "toConcept": "653", "fromConcept": "636", "attributes": [], "id": "e1537", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1105", "fromConcept": "636", "attributes": [], "id": "e1538", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "1102", "fromConcept": "636", "attributes": [], "id": "e1539", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "847", "fromConcept": "636", "attributes": [], "id": "e1540", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "648", "fromConcept": "636", "attributes": [], "id": "e1541", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "91", "fromConcept": "636", "attributes": [], "id": "e1542", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "located_in"} , { "toConcept": "1099", "fromConcept": "636", "attributes": [], "id": "e1543", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "450", "fromConcept": "636", "attributes": [], "id": "e1544", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "located_in"} , { "toConcept": "430", "fromConcept": "636", "attributes": [], "id": "e1545", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "located_in"} , { "toConcept": "1114", "fromConcept": "636", "attributes": [], "id": "e1546", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1137", "fromConcept": "636", "attributes": [], "id": "e1547", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "684", "fromConcept": "636", "attributes": [], "id": "e1548", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1153", "fromConcept": "636", "attributes": [], "id": "e1549", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1338", "fromConcept": "636", "attributes": [], "id": "e1550", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1339", "fromConcept": "636", "attributes": [], "id": "e1551", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "680", "fromConcept": "636", "attributes": [], "id": "e1552", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1156", "fromConcept": "636", "attributes": [], "id": "e1553", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1340", "fromConcept": "636", "attributes": [], "id": "e1554", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1122", "fromConcept": "636", "attributes": [], "id": "e1555", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1121", "fromConcept": "636", "attributes": [], "id": "e1556", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "1341", "fromConcept": "636", "attributes": [], "id": "e1557", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1124", "fromConcept": "636", "attributes": [], "id": "e1558", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1342", "fromConcept": "636", "attributes": [], "id": "e1559", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1107", "fromConcept": "636", "attributes": [], "id": "e1560", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1108", "fromConcept": "636", "attributes": [], "id": "e1561", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "867", "fromConcept": "636", "attributes": [], "id": "e1562", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "512", "fromConcept": "636", "attributes": [], "id": "e1563", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1343", "fromConcept": "636", "attributes": [], "id": "e1564", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1152", "fromConcept": "636", "attributes": [], "id": "e1565", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1138", "fromConcept": "636", "attributes": [], "id": "e1566", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "879", "fromConcept": "636", "attributes": [], "id": "e1567", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1344", "fromConcept": "636", "attributes": [], "id": "e1568", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1141", "fromConcept": "636", "attributes": [], "id": "e1569", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1118", "fromConcept": "636", "attributes": [], "id": "e1570", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1143", "fromConcept": "636", "attributes": [], "id": "e1571", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1140", "fromConcept": "636", "attributes": [], "id": "e1572", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1345", "fromConcept": "636", "attributes": [], "id": "e1573", "contexts": { } , "evidences": ["ECO: 0000318"], "ofType": "participates_in"} , { "toConcept": "1157", "fromConcept": "636", "attributes": [], "id": "e1574", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1346", "fromConcept": "636", "attributes": [], "id": "e1575", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1347", "fromConcept": "636", "attributes": [], "id": "e1576", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1132", "fromConcept": "636", "attributes": [], "id": "e1577", "contexts": { } , "evidences": ["ECO: 0000314"], "ofType": "participates_in"} , { "toConcept": "1159", "fromConcept": "636", "attributes": [], "id": "e1578", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1133", "fromConcept": "636", "attributes": [], "id": "e1579", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1127", "fromConcept": "636", "attributes": [], "id": "e1580", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "502", "fromConcept": "636", "attributes": [], "id": "e1581", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "1348", "fromConcept": "636", "attributes": [], "id": "e1582", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1349", "fromConcept": "636", "attributes": [], "id": "e1583", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "1204", "fromConcept": "636", "attributes": [], "id": "e1584", "contexts": { } , "evidences": ["ECO: 0000304"], "ofType": "participates_in"} , { "toConcept": "467", "fromConcept": "636", "attributes": [], "id": "e1585", "contexts": { } , "evidences": ["ECO: 0000501"], "ofType": "participates_in"} , { "toConcept": "584", "fromConcept": "636", "attributes": [], "id": "e1586", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "64", "fromConcept": "636", "attributes": [], "id": "e1587", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "588", "fromConcept": "636", "attributes": [], "id": "e1588", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "591", "fromConcept": "636", "attributes": [], "id": "e1589", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1350", "fromConcept": "636", "attributes": [], "id": "e1590", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "600", "fromConcept": "636", "attributes": [], "id": "e1591", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "587", "fromConcept": "636", "attributes": [], "id": "e1592", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "68", "fromConcept": "636", "attributes": [], "id": "e1593", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "1351", "fromConcept": "636", "attributes": [], "id": "e1594", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "602", "fromConcept": "636", "attributes": [], "id": "e1595", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "586", "fromConcept": "636", "attributes": [], "id": "e1596", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "593", "fromConcept": "636", "attributes": [], "id": "e1597", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "596", "fromConcept": "636", "attributes": [], "id": "e1598", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "599", "fromConcept": "636", "attributes": [], "id": "e1599", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "83", "fromConcept": "636", "attributes": [], "id": "e1600", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} , { "toConcept": "80", "fromConcept": "636", "attributes": [], "id": "e1601", "contexts": { } , "evidences": ["Imported from database"], "ofType": "published_in"} ], "version": "1.0"} };